PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Spring, K; Fournier, P; Lapointe, L; Chabot, C; Roussy, J; Pommey, S; Stagg, J; Royal, I				Spring, K.; Fournier, P.; Lapointe, L.; Chabot, C.; Roussy, J.; Pommey, S.; Stagg, J.; Royal, I.			The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis	ONCOGENE			English	Article							C-SRC; KINASE INHIBITOR; BONE METASTASIS; IN-VITRO; CORTACTIN; GROWTH; ACTIVATION; MIGRATION; RECEPTOR; PHOSPHORYLATION	DEP-1/PTPRJ is a receptor-like protein tyrosine phosphatase mainly known for its antiproliferative and tumor-suppressive functions. Many identified substrates are growth factor receptors, and DEP-1 is deleted and/or mutated in human cancers including that of the breast. However, DEP-1 was also identified as a promoter of Src activation and proinvasive functions in the endothelium, suggesting it could perhaps mediate breast cancer invasiveness that is likewise driven by Src family kinases. We show here that DEP-1 expression was greater in highly invasive breast cancer cells (MDA-MB-231, Hs578T, BT-549) than in the less invasive or untransformed cell lines tested (MCF-7, T47D, SK-BR3 and MCF10A). DEP-1 silencing experiments in invasive cells demonstrated that moderately expressed and catalytically active DEP-1 was required, in collaboration with basal epidermal growth factor receptor activity, for Src activation and the phosphorylation of its substrate Cortactin, and for their colocalization at the cell's leading edge. This correlated with an increased number of cell protrusions, and an enhanced capacity of the cells to migrate and invade. Similarly, moderate overexpression of DEP-1 in the low-invasive cells resulted in the promotion of their invasiveness in an Src-dependent manner. Consistent with these data, the expression of endogenous DEP-1 was elevated in a bone metastatic cell line derived from MDA-MB-231 cells, and promoted increased Src Y418 and Cortactin Y421 phosphorylation, as well as pro-MMP9 secretion and Matrigel invasion. Importantly, the silencing of DEP-1 in MDA-MB-231 cells greatly decreased their ability to metastasize, despite having no effect on tumor growth or angiogenesis. Hence, we found that moderate expression of DEP-1 was associated with the increased relapse and decreased survival of breast cancer patients. These results therefore identify a new and unsuspected role for DEP-1 as a mediator of an invasive cell program implicating Src activation and the promotion of breast cancer progression.	[Spring, K.; Fournier, P.; Lapointe, L.; Chabot, C.; Roussy, J.; Pommey, S.; Stagg, J.; Royal, I.] CHUM, Ctr Rech, Inst Canc Montreal, Montreal, PQ H2X 0A9, Canada; [Stagg, J.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Royal, I.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Royal, I (corresponding author), CHUM, Ctr Rech, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.	isabelle.royal@umontreal.ca		Royal, Isabelle/0000-0002-7548-1182; Spring, Kathleen/0000-0001-6747-7725	Cancer Research Society/Quebec Breast Cancer Foundation; FRQS [25988]; CIHR [292353]	Cancer Research Society/Quebec Breast Cancer Foundation; FRQS; CIHR(Canadian Institutes of Health Research (CIHR))	We thank our colleagues for their generous gifts of plasmid DNAs and cell lines. This work was supported by a Cancer Research Society/Quebec Breast Cancer Foundation grant (to IR). KS and CC held partial studentships from Universite de Montreal. PF was supported by FRQS (25988) and CIHR (292353) studentships. KS, PF, CC and JR also held partial studentships from the Montreal Cancer Institute.	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Aya-Bonilla C, 2013, GENE CHROMOSOME CANC, V52, P467, DOI 10.1002/gcc.22044; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Bentires-Alj M, 2007, CANCER RES, V67, P2420, DOI 10.1158/0008-5472.CAN-06-4610; Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chiorean R, 2013, BREAST, V22, P1026, DOI 10.1016/j.breast.2013.08.007; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Elias D, 2014, ONCOGENE, P1; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Foley John, 2010, Semin Cell Dev Biol, V21, P951, DOI 10.1016/j.semcdb.2010.08.009; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hardy S, 2010, CANCER RES, V70, P8959, DOI 10.1158/0008-5472.CAN-10-2041; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Iuliano R, 2004, ONCOGENE, V23, P8432, DOI 10.1038/sj.onc.1207766; Iuliano R, 2010, ENDOCR-RELAT CANCER, V17, P1001, DOI 10.1677/ERC-10-0143; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Julien SG, 2007, NAT GENET, V39, P338, DOI 10.1038/ng1963; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Keane MM, 1996, CANCER RES, V56, P4236; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Li YS, 2001, CANCER RES, V61, P6906; Ma JG, 2011, BREAST CANCER RES TR, V130, P85, DOI 10.1007/s10549-010-1302-4; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Majumder S, 2014, ARTERIOSCL THROM VAS, V34, P419, DOI 10.1161/ATVBAHA.113.302689; Mezi S, 2012, INT J ONCOL, V41, P2128, DOI 10.3892/ijo.2012.1642; Mita Y, 2010, J CANCER RES CLIN, V136, P249, DOI 10.1007/s00432-009-0656-7; Myoui A, 2003, CANCER RES, V63, P5028; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Petermann A, 2011, BRAIN PATHOL, V21, P405, DOI 10.1111/j.1750-3639.2010.00464.x; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rucci N, 2006, J PHARMACOL EXP THER, V318, P161, DOI 10.1124/jpet.106.102004; Ruivenkamp C, 2003, ONCOGENE, V22, P3472, DOI 10.1038/sj.onc.1206246; Sabe H, 2008, CELL ADHES MIGR, V2, P71, DOI 10.4161/cam.2.2.6191; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Senis YA, 2009, BLOOD, V113, P4942, DOI 10.1182/blood-2008-08-174318; Shields BJ, 2013, MOL CELL BIOL, V33, P557, DOI 10.1128/MCB.01016-12; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Smart CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040742; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Spring K, 2014, CELL SIGNAL, V26, P1283, DOI 10.1016/j.cellsig.2014.02.008; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Sung BH, 2011, CURR BIOL, V21, P1460, DOI 10.1016/j.cub.2011.06.065; Takahashi K, 1996, EXP CELL RES, V226, P214, DOI 10.1006/excr.1996.0221; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Verbeek BS, 1996, J PATHOL, V180, P383, DOI 10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N; Yu M, 2012, MOL CELL BIOL, V32, P3913, DOI 10.1128/MCB.00068-12; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024	79	23	23	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2015	34	44					5536	5547		10.1038/onc.2015.9	http://dx.doi.org/10.1038/onc.2015.9			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9FX	25772245				2022-12-26	WOS:000364594000003
J	Canduela, MJ; Mendizabal-Zubiaga, J; Puente, N; Reguero, L; Elezgarai, I; Ramos-Uriarte, A; Gerrikagoitia, I; Grandes, P				Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro			Visualization by High Resolution Immunoelectron Microscopy of the Transient Receptor Potential Vanilloid-1 at Inhibitory Synapses of the Mouse Dentate Gyrus	PLOS ONE			English	Article							LONG-TERM DEPRESSION; TRPV1 CHANNELS; IMMUNOHISTOCHEMICAL LOCALIZATION; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR; SYNAPTIC PLASTICITY; BRAIN; MICE; HIPPOCAMPUS; ACTIVATION	We have recently shown that the transient receptor potential vanilloid type 1 (TRPV1), a non-selective cation channel in the peripheral and central nervous system, is localized at postsynaptic sites of the excitatory perforant path synapses in the hippocampal dentate molecular layer (ML). In the present work, we have studied the distribution of TRPV1 at inhibitory synapses in the ML. With this aim, a preembedding immunogold method for high resolution electron microscopy was applied to mouse hippocampus. About 30% of the inhibitory synapses in the ML are TRPV1 immunopositive, which is mostly localized perisynaptically (similar to 60% of total immunoparticles) at postsynaptic dendritic membranes receiving symmetric synapses in the inner 1/3 of the layer. This TRPV1 pattern distribution is not observed in the ML of TRPV1 knock-out mice. These findings extend the knowledge of the subcellular localization of TRPV1 to inhibitory synapses of the dentate molecular layer where the channel, in addition to excitatory synapses, is present.	[Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Neurosci, E-48940 Leioa, Spain; [Canduela, Miren-Josune; Mendizabal-Zubiaga, Juan; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Ramos-Uriarte, Almudena; Gerrikagoitia, Inmaculada; Grandes, Pedro] Achucarro Basque Ctr Neurosci, Zamudio, Spain	University of Basque Country	Grandes, P (corresponding author), Univ Basque Country UPV EHU, Fac Med & Dent, Dept Neurosci, E-48940 Leioa, Spain.	pedro.grandes@ehu.es	Mendizabal, Juan Luis/H-6874-2015; Elezgarai, Izaskun/H-7076-2015; Ramos-Uriarte, Almudena/H-3179-2015; Grandes, Pedro/AAA-1627-2019; Grandes, Pedro/H-7494-2015; Gerrikagoitia, Inmaculada/H-7042-2015; Ramos, Almudena/AAS-1563-2020; Puente, Nagore/H-7054-2015; Reguero, Leire/H-6865-2015	Mendizabal, Juan Luis/0000-0002-4750-4797; Elezgarai, Izaskun/0000-0003-0880-8058; Ramos-Uriarte, Almudena/0000-0002-2632-1625; Grandes, Pedro/0000-0003-3947-4230; Gerrikagoitia, Inmaculada/0000-0002-5651-9405; Ramos, Almudena/0000-0002-2632-1625; Puente, Nagore/0000-0003-0866-5747; Alonso-Alconada, Daniel/0000-0002-9874-2947; Reguero, Leire/0000-0002-0267-5568	Ministerio de Economia y Competitividad [BFU2012-33334]; Basque Government grant [IT764-13]; University of the Basque Country [UFI11/41]; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III [RD07/0001/2001, RD12/0028/0004]	Ministerio de Economia y Competitividad(Spanish Government); Basque Government grant(Basque Government); University of the Basque Country; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III(Instituto de Salud Carlos III)	P. Grandes' laboratory is provided by Ministerio de Economia y Competitividad (BFU2012-33334); Basque Government grant IT764-13; University of the Basque Country (UFI11/41) and by Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, grant number: RD07/0001/2001, RD12/0028/0004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Chavez AE, 2014, J NEUROSCI, V34, P16621, DOI 10.1523/JNEUROSCI.3635-14.2014; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Cristino L, 2008, NEUROSCIENCE, V151, P955, DOI 10.1016/j.neuroscience.2007.11.047; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Egertova M, 2008, J COMP NEUROL, V506, P604, DOI 10.1002/cne.21568; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Kauer JA, 2009, TRENDS NEUROSCI, V32, P215, DOI 10.1016/j.tins.2008.12.006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Li HB, 2008, BIOL PSYCHIAT, V64, P286, DOI 10.1016/j.biopsych.2008.02.020; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Maione S, 2009, J PHYSIOL-LONDON, V587, P2521, DOI 10.1113/jphysiol.2009.171900; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Micale V, 2009, NEUROPSYCHOPHARMACOL, V34, P593, DOI 10.1038/npp.2008.98; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Nyilas R, 2008, J NEUROSCI, V28, P1058, DOI 10.1523/JNEUROSCI.5102-07.2008; Puente N, 2015, BRAIN STRUCT FUNCT, V220, P1187, DOI 10.1007/s00429-014-0711-2; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sanchez JF, 2001, NEUROSCIENCE, V107, P373, DOI 10.1016/S0306-4522(01)00373-6; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	32	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119401	10.1371/journal.pone.0119401	http://dx.doi.org/10.1371/journal.pone.0119401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775089	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500089
J	Chaudhry, M; Rashid, HB; Thrusfield, M; Welburn, S; Bronsvoort, BM				Chaudhry, Mamoona; Rashid, Hamad B.; Thrusfield, Michael; Welburn, Sue; Bronsvoort, Barend MdeC.			A Case-Control Study to Identify Risk Factors Associated with Avian Influenza Subtype H9N2 on Commercial Poultry Farms in Pakistan	PLOS ONE			English	Article							A VIRUS H5N1; LOW-PATHOGENICITY; CHICKEN FARMS; WILD BIRDS; OUTBREAKS; INFECTION; EPIDEMIOLOGY; SURVEILLANCE; SPREAD; KOREA	A 1:1 matched case-control study was conducted to identify risk factors for avian influenza subtype H9N2 infection on commercial poultry farms in 16 districts of Punjab, and 1 administrative unit of Pakistan. One hundred and thirty-three laboratory confirmed positive case farms were matched on the date of sample submission with 133 negative control farms. The association between a series of farm-level characteristics and the presence or absence of H9N2 was assessed by univariable analysis. Characteristics associated with H9N2 risk that passed the initial screening were included in a multivariable conditional logistic regression model. Manual and automated approaches were used, which produced similar models. Key risk factors from all approaches included selling of eggs/birds directly to live bird retail stalls, being near case/infected farms, a previous history of infectious bursal disease (IBD) on the farm and having cover on the water storage tanks. The findings of current study are in line with results of many other studies conducted in various countries to identify similar risk factors for AI subtype H9N2 infection. Enhancing protective measures and controlling risks identified in this study could reduce spread of AI subtype H9N2 and other AI viruses between poultry farms in Pakistan.	[Chaudhry, Mamoona; Welburn, Sue] Univ Edinburgh, Sch Med, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland; [Rashid, Hamad B.] Univ Vet & Anim Sci, Dept Clin Med & Surg, Lahore, Pakistan; [Thrusfield, Michael] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Bronsvoort, Barend MdeC.] Univ Edinburgh, Roslin Inst RDSVS, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Veterinary & Animal Science - Pakistan; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Chaudhry, M (corresponding author), Univ Edinburgh, Sch Med, Div Infect & Pathway Med, Edinburgh, Midlothian, Scotland.	mamoona.chaudhry@gmail.com	Chaudhry, Mamoona/D-5026-2016; Chaudhry, M/AEV-6074-2022	Chaudhry, Mamoona/0000-0002-3151-3648; Thrusfield, Michael/0000-0003-1110-4094; Bronsvoort, Mark/0000-0002-3271-8485	Higher Education Commission; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133] Funding Source: UKRI	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by Higher Education Commission (10% Overseas Scholarship Batch-II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2009, VIROLOGY, V390, P212, DOI 10.1016/j.virol.2009.05.008; Abbas MA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-137; Abbas T, 2012, BERL MUNCH TIERARZTL, V125, P110, DOI 10.2376/0005-9366-125-110; Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; ALEXANDER DJ, 1995, J COMP PATHOL, V112, P105, DOI 10.1016/S0021-9975(05)80054-4; [Anonymous], 2004, ENV CODE PRACTICE PO; [Anonymous], 1998, GUIDELINES ESTABLISH; [Anonymous], 2001, MISSING DATA; Bano S, 2003, AVIAN DIS, V47, P817, DOI 10.1637/0005-2086-47.s3.817; Beeler E, 2009, VET CLIN N AM-SMALL, V39, P251, DOI 10.1016/j.cvsm.2008.10.011; Biswas PK, 2009, VET REC, V164, P743, DOI 10.1136/vr.164.24.743; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Brugh M, 1987, P 2 INT S AV INFL US, P177; Buscaglia C, 2007, AVIAN DIS, V51, P467, DOI 10.1637/7542.1; Capua I, 2003, AVIAN DIS, V47, P839, DOI 10.1637/0005-2086-47.s3.839; Cohen J., 1983, APPL MULTIPLE REGRES; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; FAO, 2004, HIGHL PATH AV INFL A; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iqbal Munir, 2009, J Mol Genet Med, V3, P119; Kung NY, 2007, EMERG INFECT DIS, V13, P412, DOI 10.3201/eid1303.060365; Lavoie ET, 2007, DEV COMP IMMUNOL, V31, P407, DOI 10.1016/j.dci.2006.07.009; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Mannelli A, 2006, PREV VET MED, V73, P273, DOI 10.1016/j.prevetmed.2005.09.005; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; Naeem K, 2007, AVIAN DIS, V51, P189, DOI 10.1637/7617-042506R.1; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Nishiguchi A, 2007, ZOONOSES PUBLIC HLTH, V54, P337, DOI 10.1111/j.1863-2378.2007.01074.x; Pantin-Jackwood MJ, 2012, VIRUS RES, V167, P196, DOI 10.1016/j.virusres.2012.04.015; PRI, 2011, PUNJ POULTR SECT STA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Nieto G, 2010, AVIAN DIS, V54, P513, DOI 10.1637/8902-042809-Reg.1; Si YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053362; Siddique N, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-300; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Susilowati S H, 2013, LIVESTOCK RES RURAL, V25; Terregino C, 2007, AVIAN PATHOL, V36, P337, DOI 10.1080/03079450701488345; Therneau T, 2011, SURVIVAL SURVIVAL AN; Tombari W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053524; Trevennec K, 2011, ACTA TROP, V120, P160, DOI 10.1016/j.actatropica.2011.07.010; Turner Elizabeth L, 2010, Epidemiol Perspect Innov, V7, P9, DOI 10.1186/1742-5573-7-9; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Wee SH, 2006, VET REC, V158, P341, DOI 10.1136/vr.158.10.341; Woo JT, 2008, J VET SCI, V9, P161, DOI 10.4142/jvs.2008.9.2.161	53	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119019	10.1371/journal.pone.0119019	http://dx.doi.org/10.1371/journal.pone.0119019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774768	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500059
J	Gaston, JR; Roberts, SA; Humphreys, TL				Gaston, Jordan R.; Roberts, Sally A.; Humphreys, Tricia L.			Molecular Phylogenetic Analysis of Non-Sexually Transmitted Strains of Haemophilus ducreyi	PLOS ONE			English	Article							FIBRINOGEN-BINDING; DEFICIENT MUTANT; DSRA; INFECTION; COMPETENCE; DIVERGENCE; EVOLUTION; VIRULENCE; BACTERIA; SEQUENCE	Haemophilus ducreyi, the etiologic agent of chancroid, has been previously reported to show genetic variance in several key virulence factors, placing strains of the bacterium into two genetically distinct classes. Recent studies done in yaws-endemic areas of the South Pacific have shown that H. ducreyi is also a major cause of cutaneous limb ulcers (CLU) that are not sexually transmitted. To genetically assess CLU strains relative to the previously described class I, class II phylogenetic hierarchy, we examined nucleotide sequence diversity at 11 H. ducreyi loci, including virulence and housekeeping genes, which encompass approximately 1% of the H. ducreyi genome. Sequences for all 11 loci indicated that strains collected from leg ulcers exhibit DNA sequences homologous to class I strains of H. ducreyi. However, sequences for 3 loci, including a hemoglobin receptor (hgbA), serum resistance protein (dsrA), and a collagen adhesin (ncaA) contained informative amounts of variation. Phylogenetic analyses suggest that these non-sexually transmitted strains of H. ducreyi comprise a sub-clonal population within class I strains of H. ducreyi. Molecular dating suggests that CLU strains are the most recently developed, having diverged approximately 0.355 million years ago, fourteen times more recently than the class I/class II divergence. The CLU strains' divergence falls after the divergence of humans from chimpanzees, making it the first known H. ducreyi divergence event directly influenced by the selective pressures accompanying human hosts.	[Gaston, Jordan R.; Humphreys, Tricia L.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Roberts, Sally A.] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand	Allegheny College; Auckland District Health Board	Humphreys, TL (corresponding author), Allegheny Coll, Dept Biol, Meadville, PA 16335 USA.	thumphre@allegheny.edu			Allegheny College	Allegheny College	This study was funded by Allegheny College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tawfiq JA, 2000, J INFECT DIS, V181, P1049, DOI 10.1086/315309; Al-Tawfiq JA, 1998, J INFECT DIS, V178, P1684, DOI 10.1086/314483; ALBRITTON WL, 1989, MICROBIOL REV, V53, P377, DOI 10.1128/MMBR.53.4.377-389.1989; Bauer ME, 2009, J INFECT DIS, V199, P684, DOI 10.1086/596656; Bong CTH, 2001, INFECT IMMUN, V69, P1488, DOI 10.1128/IAI.69.3.1488-1491.2001; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Fusco WG, 2013, INFECT IMMUN, V81, P4443, DOI 10.1128/IAI.00743-13; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; Haydock AK, 1999, J INFECT DIS, V179, P1423, DOI 10.1086/314771; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Humphrey S, 2007, J AM ACAD DERMATOL, V56, pAB121; Janowicz DM, 2009, J INFECT DIS, V199, P1671, DOI 10.1086/598966; Leduc I, 2004, INFECT IMMUN, V72, P3418, DOI 10.1128/IAI.72.6.3418-3428.2004; Leduc I, 2008, INFECT IMMUN, V76, P1608, DOI 10.1128/IAI.00994-07; MARCKMANN P, 1989, GENITOURIN MED, V65, P126; Marks M, 2014, EMERG INFECT DIS, V20, P1705, DOI 10.3201/eid2010.140573; McBride WJH, 2008, AUSTRALAS J DERMATOL, V49, P98, DOI 10.1111/j.1440-0960.2008.00439.x; Mitja O, 2014, LANCET GLOB HEALTH, V2, pE235, DOI 10.1016/S2214-109X(14)70019-1; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Peel TN, 2010, MED J AUSTRALIA, V192, P348, DOI 10.5694/j.1326-5377.2010.tb03537.x; Post DMB, 2007, PROTEOMICS, V7, P3131, DOI 10.1002/pmic.200600830; Redfield RJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-82; Ricotta EE, 2011, J BACTERIOL, V193, P2941, DOI 10.1128/JB.01400-10; SPINOLA SM, 1992, INFECT IMMUN, V60, P385, DOI 10.1128/IAI.60.2.385-391.1992; SPINOLA SM, 1994, J INFECT DIS, V169, P1146, DOI 10.1093/infdis/169.5.1146; Spinola SM, 2014, LANCET GLOB HEALTH, V2, pE387, DOI 10.1016/S2214-109X(14)70250-5; Spratt BG, 1999, CURR OPIN MICROBIOL, V2, P312, DOI 10.1016/S1369-5274(99)80054-X; Steen R, 2012, CURR OPIN INFECT DIS, V25, P100, DOI 10.1097/QCO.0b013e32834e9ad1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ussher JE, 2007, CLIN INFECT DIS, V44, pE85, DOI 10.1086/515404; Ward CK, 1998, J BACTERIOL, V180, P6013, DOI 10.1128/JB.180.22.6013-6022.1998; Wasserheit JN, SEXUALLY TRANSMITTED, V19, P61; White CD, 2005, INFECT IMMUN, V73, P2387, DOI 10.1128/IAI.73.4.2387-2399.2005	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118613	10.1371/journal.pone.0118613	http://dx.doi.org/10.1371/journal.pone.0118613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774793	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500032
J	Pilling, D; Cox, N; Vakil, V; Verbeek, JS; Gomer, RH				Pilling, Darrell; Cox, Nehemiah; Vakil, Varsha; Verbeek, J. Sjef; Gomer, Richard H.			The Long Pentraxin PTX3 Promotes Fibrocyte Differentiation	PLOS ONE			English	Article							SERUM AMYLOID-P; FC-GAMMA RECEPTORS; C-REACTIVE PROTEIN; PERIPHERAL-BLOOD FIBROCYTES; INDUCED PULMONARY-FIBROSIS; HUMORAL INNATE IMMUNITY; CIRCULATING FIBROCYTES; EPITHELIAL-CELLS; MOUSE MODEL; ALPHA-RI	Monocyte-derived, fibroblast-like cells called fibrocytes are associated with fibrotic lesions. The plasma protein serum amyloid P component (SAP; also known as pentraxin-2, PTX2) inhibits fibrocyte differentiation in vitro, and injections of SAP inhibit fibrosis in vivo. SAP is a member of the pentraxin family of proteins that includes C-reactive protein (CRP; PTX1) and pentraxin-3 (PTX3). All three pentraxins are associated with fibrosis, but only SAP and CRP have been studied for their effects on fibrocyte differentiation. We find that compared to SAP and CRP, PTX3 promotes human and murine fibrocyte differentiation. The effect of PTX3 is dependent on Fc gamma RI. In competition studies, the fibrocyte-inhibitory activity of SAP is dominant over PTX3. Binding competition studies indicate that SAP and PTX3 bind human Fc gamma RI at different sites. In murine models of lung fibrosis, PTX3 is present in fibrotic areas, and the PTX3 distribution is associated with collagen deposition. In lung tissue from pulmonary fibrosis patients, PTX3 has a widespread distribution, both in unaffected tissue and in fibrotic lesions, whereas SAP is restricted to areas adjacent to vessels, and absent from fibrotic areas. These data suggest that the relative levels of SAP and PTX3 present at sites of fibrosis may have a significant effect on the ability of monocytes to differentiate into fibrocytes.	[Pilling, Darrell; Cox, Nehemiah; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Vakil, Varsha; Gomer, Richard H.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Verbeek, J. Sjef] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Texas A&M University System; Texas A&M University College Station; Rice University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pilling, D (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	dpilling@bio.tamu.edu; rgomer@tamu.edu		Gomer, Richard/0000-0003-2361-4307; Cox, Nehemiah/0000-0002-2369-4741; Pilling, Darrell/0000-0002-7413-2773	National Institutes of Health (NIH) [R01 HL083029, R01 HL118507]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118507, R01HL083029] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants (www.nih.gov) R01 HL083029 and R01 HL118507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Aiba S, 1997, J CUTAN PATHOL, V24, P65; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balhara J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00127; Banerjee ER, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt112; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bianchetti L, 2012, J CELL MOL MED, V16, P483, DOI 10.1111/j.1582-4934.2011.01344.x; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Bottazzi B, 1997, J BIOL CHEM, V272, P32817, DOI 10.1074/jbc.272.52.32817; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Castano AP, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000111; Cowper SE, 2003, CURR OPIN RHEUMATOL, V15, P785, DOI 10.1097/00002281-200311000-00017; Cox N, 2014, J IMMUNOL, V193, P1701, DOI 10.4049/jimmunol.1400281; Cox N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045674; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Daigo K, 2014, PROTECTIVE EFFECT LO, pra88; Deban L, 2011, CELL TISSUE RES, V343, P237, DOI 10.1007/s00441-010-1018-0; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Dillingh MR, 2013, PULM PHARMACOL THER, V26, P672, DOI 10.1016/j.pupt.2013.01.008; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Doni A, 2006, J LEUKOCYTE BIOL, V79, P797, DOI 10.1189/jlb.0905493; Epperly MW, 2003, AM J RESP CELL MOL, V29, P213, DOI 10.1165/rcmb.2002-0069OC; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Han B, 2005, J IMMUNOL, V175, P8303, DOI 10.4049/jimmunol.175.12.8303; Hartlapp I, 2001, FASEB J, V15, P2215, DOI 10.1096/fj.01-0049com; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Herlihy SE, 2013, J IMMUNOL, V190, P6468, DOI 10.4049/jimmunol.1202583; Hughes AL, 1996, J MOL EVOL, V43, P4, DOI 10.1007/BF02352293; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; Introna M, 1996, BLOOD, V87, P1862; Ioan-Facsinay A, 2002, IMMUNITY, V16, P391, DOI 10.1016/S1074-7613(02)00294-7; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jaillon S, 2013, J IMMUNOL, V191, P1873, DOI 10.4049/jimmunol.1201642; Job ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059623; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kitaura J, 2004, J IMMUNOL, V173, P4317, DOI 10.4049/jimmunol.173.7.4317; Kleaveland KR, 2014, EXPERT REV RESP MED, V8, P163, DOI 10.1586/17476348.2014.862154; LEE GW, 1993, J IMMUNOL, V150, P1804; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Lu JH, 2012, IMMUNOL REV, V250, P230, DOI 10.1111/j.1600-065X.2012.01162.x; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Ma YJ, 2011, J BIOL CHEM, V286, P3405, DOI 10.1074/jbc.M110.190637; Maharjan AS, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-2; Maharjan AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026078; Maharjan AS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-23; Mantovani A, 2013, ANN NY ACAD SCI, V1285, P1, DOI 10.1111/nyas.12043; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Moalli F, 2010, BLOOD, V116, P5170, DOI 10.1182/blood-2009-12-258376; Monteiro RC, 2003, ANNU REV IMMUNOL, V21, P177, DOI 10.1146/annurev.immunol.21.120601.141011; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Nebuloni Manuela, 2011, Cardiovasc Pathol, V20, pe27, DOI 10.1016/j.carpath.2010.02.005; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Okutani D, 2007, AM J PHYSIOL-LUNG C, V292, pL144, DOI 10.1152/ajplung.00002.2006; Pauwels NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-134; Pegues MA, 2013, AM J PHYSIOL-RENAL, V304, pF1358, DOI 10.1152/ajprenal.00476.2012; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2014, J LEUKOCYTE BIOL, V96; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093730; Pilling D, 2009, J IMMUNOL METHODS, V351, P62, DOI 10.1016/j.jim.2009.09.011; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Quan TE, 2004, INT J BIOCHEM CELL B, V36, P598, DOI 10.1016/j.biocel.2003.10.005; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Singh V, 2011, EXP EYE RES, V93, P810, DOI 10.1016/j.exer.2011.09.012; Smadja DM, 2014, THROMB HAEMOSTASIS, V112, P1002, DOI 10.1160/TH13-08-0711; Sprong T, 2009, SHOCK, V31, P28, DOI 10.1097/SHK.0b013e31817fd543; Teoh H, 2008, ATHEROSCLEROSIS, V201, P318, DOI 10.1016/j.atherosclerosis.2008.02.034; van Egmond M, 1999, BLOOD, V93, P4387, DOI 10.1182/blood.V93.12.4387.412k08_4387_4394; van Rossum AP, 2004, ARTHRITIS RHEUM-US, V50, P2667, DOI 10.1002/art.20370; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Varcoe RL, 2006, J THROMB HAEMOST, V4, P1125, DOI 10.1111/j.1538-7836.2006.01924.x; Verzijl D, 2011, PURINERG SIGNAL, V7, P171, DOI 10.1007/s11302-011-9232-0; Wagenaar JFP, 2009, J INFECTION, V58, P425, DOI 10.1016/j.jinf.2009.04.004; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; White MJV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070795; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Zhang JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034965	112	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119709	10.1371/journal.pone.0119709	http://dx.doi.org/10.1371/journal.pone.0119709			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774777	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500112
J	Bian, XJ; Shen, YJ; Zhang, GM; Gu, CY; Cai, Y; Wang, CF; Zhu, YP; Zhu, Y; Zhang, HL; Dai, B; Ye, DW				Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Cai, Ying; Wang, Chaofu; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei			Expression of Dicer and Its Related MiRNAs in the Progression of Prostate Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; DOWN-REGULATION; MICRORNA; MIR-31; APOPTOSIS; INVASION	Dicer is aberrantly expressed in several types of malignancies. Cleaved by Dicer, the small noncoding microRNAs (miRNAs) are considered potential tools for the diagnosis and prognosis of cancer. This study investigated the expression of miRNAs thought to target Dicer. Expression of 1,205 human miRNAs and miRNA*s were examined in four patients with prostate cancer (PCa) by miRNA array in which the threshold was set as two-fold. Seventy-three miRNAs and miRNA*s were significantly down-regulated while 10 were up-regulated in PCa tissues compared with matched histologically normal glands. Of these, miR-29b-1, miR-200a, miR-370, and miR-31, which were the most down/up-regulated and closely potentially target to the Dicer 3' UTR, were investigated further. Tissues of primary tumors and matched normal prostate glands from 185 patients with PCa were collected for further investigation. Dicer mRNA levels were negatively correlated with miR-29b-1 (rho s = -0.177, p = 0.017), miR-200a (rho s = -0.489, p < 0.0001) and miR-31 (rho s = -0.314, p < 0.0001) expression. Compared with adjacent normal glands, PCa tissues showed significantly lower miR-200a and miR-31 expression levels. Furthermore, in metastatic PCa, the expression levels of miR-200a, miR-370, and miR-31 were dramatically higher than in localized PCa. Additionally, elevated expression levels of miR-200a and miR-31 appeared to be associated with castration-resistant PCa. These findings suggest possibilities that miR-200a and miR-31 target Dicer and are involved in the carcinogenesis, migration, and behavior of castration-resistant PCa, indicating that they could be potential biomarkers for monitoring PCa progression.	[Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China; [Bian, Xiaojie; Shen, Yijun; Zhang, Guiming; Gu, Chenyuan; Cai, Ying; Wang, Chaofu; Zhu, Yiping; Zhu, Yao; Zhang, Hailiang; Dai, Bo; Ye, Dingwei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Cai, Ying; Wang, Chaofu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Ye, DW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai 200433, Peoples R China.	dwyeli@163.com	Shen, Yi/GRS-3602-2022; Wang, Chao/GXF-8353-2022; Zhang, Hailiang/AAF-4937-2020	Shen, Yijun/0000-0002-7138-1221	National Natural Science Foundation of China [81272837]; Advanced Technology Foundation of Shanghai [SHDC12013122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advanced Technology Foundation of Shanghai	Funding: This study was supported in part by grants from National Natural Science Foundation of China (No. 81272837) and Advanced Technology Foundation of Shanghai (SHDC12013122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barron N, 2012, PROSTATE, V72, P1193, DOI 10.1002/pros.22469; Bhatnagar N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.85; Bian XJ, 2014, TUMOR BIOL, V35, P11571, DOI 10.1007/s13277-014-2462-3; Boyd LK, 2012, NAT REV UROL, V9, P652, DOI 10.1038/nrurol.2012.185; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chan YT, 2013, PLOS ONE, V8, pe58169, DOI [doi: 10.1371/ journal. pone. 0058169 PMID: 23472152, DOI 10.1371/J0URNAL.P0NE.0058169]; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Ferraz C, 2013, J CLIN ENDOCR METAB, V98, pE8, DOI 10.1210/jc.2012-2564; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Han YH, 2013, J SURG ONCOL, V107, P201, DOI 10.1002/jso.23214; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Kala Rishabh, 2013, J Clin Bioinforma, V3, P6, DOI 10.1186/2043-9113-3-6; Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lo SS, 2012, ONCOGENE, V31, P226, DOI 10.1038/onc.2011.226; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mateescu B, 2011, NAT MED, V17, P1627, DOI 10.1038/nm.2512; Namiki M, 2010, JPN J CLIN ONCOL, V40, pi70, DOI 10.1093/jjco/hyq130; Narayanan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013637; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Vaksman O, 2012, HUM PATHOL, V43, P2062, DOI 10.1016/j.humpath.2012.02.016; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Wu QH, 2011, GYNECOL ONCOL, V122, P149, DOI 10.1016/j.ygyno.2011.03.026; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yang JS, 2012, RNA, V18, P945, DOI 10.1261/rna.032938.112; Zhang B, 2014, ONCOGENE, V33, P3099, DOI 10.1038/onc.2013.281	34	16	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120159	10.1371/journal.pone.0120159	http://dx.doi.org/10.1371/journal.pone.0120159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768283	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500111
J	Fagerberg, B; Gullberg, UP; Alm, R; Nilsson, J; Fredrikson, GN				Fagerberg, Bjoern; Gullberg, Ulrica Prahl; Alm, Ragnar; Nilsson, Jan; Fredrikson, Gunilla Nordin			Circulating Autoantibodies against the Apolipoprotein B-100 Peptides p45 and p210 in Relation to the Occurrence of Carotid Plaques in 64-Year-Old Women	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; IMPAIRED GLUCOSE-TOLERANCE; CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; OXIDIZED LDL; CARDIOVASCULAR EVENTS; IMMUNE-RESPONSES; APO B-100; VASCULAR COMPLICATIONS; IGM AUTOANTIBODIES	Objectives Immune responses against oxidized low density lipoprotein (LDL) play a key role in atherosclerosis. Previous studies have indicated inverse associations between autoantibodies to epitopes in oxidized LDL and cardiovascular disease. In this study we investigated the associations between autoantibodies against the apolipoprotein B-100 (apoB-100) peptides p45 and p210 and occurrence of carotid plaques. Design The study cohort consisted of a population-based sample of 64-year-old women with varying degrees of glucose tolerance (n=594). To identify and record the occurrence of carotid atherosclerotic plaques ultrasonography was used. Measurements of plasma IgM and IgG autoantibodies against the native and malondialdehyde (MDA)-modified apoB-100 peptides p45 and p210 were performed by ELISA. Results Women with carotid plaques were found to have lower levels of IgM MDA-p210 autoantibodies compared to plaque-free women. The number of carotid plaques in each subject and the total carotid plaque area correlated inversely with IgM MDA-p210 levels (r=-0.11, P=0.009 and r=-0.11, P=0.013, respectively). Furthermore, levels of IgM MDA-p210 above the lowest tertile were associated with an odds ratio of 0.55 (95% CI 0.38-0.79, P=0.001) for occurrence of carotid plaques, independently of other risk markers and statin treatment. Associations between apo-B100 peptide autoantibodies and cardiovascular risk factors were generally weak but subjects with impaired glucose tolerance had higher levels of IgM against MDA-p210. Conclusion The present study demonstrates that high levels of IgM against MDA-p210 are associated with less severe carotid disease in women. These findings provide additional support for a role of immune responses against oxidized LDL in cardiovascular disease.	[Fagerberg, Bjoern; Gullberg, Ulrica Prahl] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Alm, Ragnar; Nilsson, Jan; Fredrikson, Gunilla Nordin] Lund Univ, Skane Univ, Hosp Malmo, Dept Clin Sci, Malmo, Sweden	University of Gothenburg; Lund University; Skane University Hospital	Fredrikson, GN (corresponding author), Lund Univ, Skane Univ, Hosp Malmo, Dept Clin Sci, Malmo, Sweden.	gunilla.nordin_fredrikson@med.lu.se			Swedish Research Council [K2011-65X-0125-01-6]; Swedish Heart-Lung Foundation [20120407]; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg foundation; VINNOVA; Albert Pahlsson foundation; AstraZeneca R&D Molndal, Sweden; Region Vastra Gotaland; Sahlgrenska University Hospital	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); VINNOVA(Vinnova); Albert Pahlsson foundation; AstraZeneca R&D Molndal, Sweden(AstraZeneca); Region Vastra Gotaland; Sahlgrenska University Hospital	Funding: This study was supported by the Swedish Research Council (GNF, K2011-65X-0125-01-6), the Swedish Heart-Lung Foundation (GNF, 20120407), the Swedish Foundation for Strategic Research (JN), the Knut and Alice Wallenberg foundation (JN), VINNOVA (JN), the Albert Pahlsson foundation (GNF), AstraZeneca R&D Molndal, Sweden (BF), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital (BF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Behre CJ, 2006, J INTERN MED, V260, P238, DOI 10.1111/j.1365-2796.2006.01683.x; BOULLIER A, 1995, CLIN CHIM ACTA, V238, P1, DOI 10.1016/0009-8981(95)06054-H; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Brohall G, 2006, DIABETES CARE, V29, P363, DOI 10.2337/diacare.29.02.06.dc05-1229; Brohall G, 2009, NUTR METAB CARDIOVAS, V19, P327, DOI 10.1016/j.numecd.2008.02.002; Buono C, 2005, P NATL ACAD SCI USA, V102, P1596, DOI 10.1073/pnas.0409015102; Choi SH, 2008, J AM COLL CARDIOL, V52, P24, DOI 10.1016/j.jacc.2008.02.066; Engelbertsen D, 2012, J INTERN MED, V271, P82, DOI 10.1111/j.1365-2796.2011.02411.x; Festa A, 1998, DIABETOLOGIA, V41, P350, DOI 10.1007/s001250050914; Fredrikson GN, 2008, J INTERN MED, V264, P563, DOI 10.1111/j.1365-2796.2008.01995.x; Fredrikson GN, 2009, DIABETOLOGIA, V52, P1426, DOI 10.1007/s00125-009-1377-9; Fredrikson GN, 2005, AUTOIMMUNITY, V38, P171, DOI 10.1080/08916930500050525; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P872, DOI 10.1161/01.ATV.0000067935.02679.B0; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; FROSTEGARD J, 1992, ARTERIOSCLER THROMB, V12, P461, DOI 10.1161/01.ATV.12.4.461; Garrido-Sanchez L, 2010, INT J CARDIOL, V145, P263, DOI 10.1016/j.ijcard.2009.09.472; Garrido-Sanchez L, 2009, EUR J CLIN INVEST, V39, P800, DOI 10.1111/j.1365-2362.2009.02156.x; Goncalves I, 2005, ARTERIOSCL THROM VAS, V25, P1250, DOI 10.1161/01.ATV.0000166518.96137.38; Gupta S, 1997, J CLIN INVEST, V99, P2752, DOI 10.1172/JCI119465; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hulthe J, 2001, ARTERIOSCL THROM VAS, V21, P101, DOI 10.1161/01.ATV.21.1.101; Karvonen J, 2003, CIRCULATION, V108, P2107, DOI 10.1161/01.CIR.0000092891.55157.A7; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; McLeod O, 2014, ATHEROSCLEROSIS, V232, P242, DOI 10.1016/j.atherosclerosis.2013.11.041; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P18, DOI 10.1161/01.ATV.0000149142.42590.a2; Nilsson J, 2008, CURR OPIN LIPIDOL, V19, P519, DOI 10.1097/MOL.0b013e32830f47cd; Niskanen L, 1998, DIABETES CARE, V21, P1861, DOI 10.2337/diacare.21.11.1861; Palinski W, 2000, J INTERN MED, V247, P371, DOI 10.1046/j.1365-2796.2000.00656.x; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Prahl U, 2010, ANGIOLOGY, V61, P793, DOI 10.1177/0003319710370959; Prahl U, 2010, ULTRASOUND MED BIOL, V36, P218, DOI 10.1016/j.ultrasmedbio.2009.10.002; Ravandi A, 2011, J LIPID RES, V52, P1829, DOI 10.1194/jlr.M015776; Sampi M, 2010, J CLIN ENDOCR METAB, V95, P2467, DOI 10.1210/jc.2009-1858; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Sjogren P, 2008, EUR HEART J, V29, P2218, DOI 10.1093/eurheartj/ehn336; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Su J, 2006, ATHEROSCLEROSIS, V188, P160, DOI 10.1016/j.atherosclerosis.2005.10.017; Tornvall P, 2003, ATHEROSCLEROSIS, V167, P347, DOI 10.1016/S0021-9150(03)00021-2; Tsimikas S, 2007, J LIPID RES, V48, P425, DOI 10.1194/jlr.M600361-JLR200; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32	44	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120744	10.1371/journal.pone.0120744	http://dx.doi.org/10.1371/journal.pone.0120744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768285	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500135
J	Gaudet, JM; Ribot, EJ; Chen, YH; Gilbert, KM; Foster, PJ				Gaudet, Jeffrey M.; Ribot, Emeline J.; Chen, Yuhua; Gilbert, Kyle M.; Foster, Paula J.			Tracking the Fate of Stem Cell Implants with Fluorine-19 MRI	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; IN-VIVO TRACKING; DENDRITIC CELLS; TRANSPLANTATION; SURVIVAL; PLATFORM; BIOLOGY; IMAGE	Background In this study we used cellular magnetic resonance imaging (MRI) to detect mesenchymal stem cells (MSC) labeled with a Fluorine-19 (F-19) agent. F-19-MRI offers unambiguous detection and in vivo quantification of labeled cells. Methods We investigated two common stem cell transplant mouse models: an immune competent, syngeneic transplant model and an immune compromised, xenograft transplant model. 19F labelled stem cells were implanted intramuscularly into the hindlimb of healthy mice. The transplant was then monitored for up to 17 days using F-19-MRI, after which the tissue was excised for fluorescence microscopy and immunohistochemisty. Results Immediately following transplantation, F-19-MRI quantification correlated very well with the expected cell number in both models. The 19F signal decreased over time in both models, with a more rapid decrease in the syngeneic model. By endpoint, only 2/7 syngeneic mice had any detectable 19F signal. In the xenograft model, all mice had detectable signal at endpoint. Fluorescence microscopy and immunohistochemistry were used to show that the 19F signal was related to the presence of bystander labeled macrophages, and not original MSC. Conclusions Our results show that F-19-MRI is an excellent tool for verifying the delivery of therapeutic cells early after transplantation. However, in certain circumstances the transfer of cellular label to other bystander cells may confuse interpretation of the long-term fate of the transplanted cells.	[Gaudet, Jeffrey M.; Ribot, Emeline J.; Chen, Yuhua; Gilbert, Kyle M.; Foster, Paula J.] Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada; [Gaudet, Jeffrey M.; Foster, Paula J.] Univ Western Ontario, Dept Med Biophys, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Gaudet, JM (corresponding author), Robarts Res Inst, Imaging Res Labs, London, ON N6A 5C1, Canada.	jgaudet@robarts.ca	Foster, Paula/M-2201-2013	Foster, Paula/0000-0002-4868-3395; Gaudet, Jeffrey/0000-0003-3519-5015; RIBOT, Emeline/0000-0002-3063-1263	Ontario Preclinical Imaging Consortium, Ontario Research Fund [R4174A17]	Ontario Preclinical Imaging Consortium, Ontario Research Fund	This study was supported by R4174A17 Ontario Preclinical Imaging Consortium, Ontario Research Fund, PF (URL:https://www.ontario.ca/business-and-economy/ontario-research-fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOTONICS INT; Addicott B, 2011, CONTRAST MEDIA MOL I, V6, P7, DOI 10.1002/cmmi.396; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Ahrens ET, 2014, MAGN RESON MED; Becker Daniel E, 2008, Anesth Prog, V55, P124, DOI 10.2344/0003-3006-55.4.124; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Bonetto F, 2011, INT J CANCER, V129, P365, DOI 10.1002/ijc.25672; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chagastelles Pedro Cesar, 2010, Science Progress, V93, P113, DOI 10.3184/003685010X12708175591515; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Frangioni JV, 2004, CIRCULATION, V110, P3378, DOI 10.1161/01.CIR.0000149840.46523.FC; Gonzalez-Lara LE, 2011, MOL IMAGING BIOL, V13, P702, DOI 10.1007/s11307-010-0393-y; Helfer BM, 2010, CYTOTHERAPY, V12, P238, DOI 10.3109/14653240903446902; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Janjic JM, 2008, J AM CHEM SOC, V130, P2832, DOI 10.1021/ja077388j; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Li XX, 2013, INT J NANOMED, V8, P1063, DOI 10.2147/IJN.S42578; Mathiasen AB, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/353105; Meirelles LD, 2009, FRONT BIOSCI-LANDMRK, V14, P4281, DOI 10.2741/3528; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Noad J, 2012, NMR BIOMED; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Ribot EJ, 2014, INT J NANOMED, V9, P1731, DOI 10.2147/IJN.S59127; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2009, MAGN RESON MED, V62, P747, DOI 10.1002/mrm.22063; Terrovitis J, 2008, CIRCULATION, V117, P1555, DOI 10.1161/CIRCULATIONAHA.107.732073; Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q	37	55	56	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118544	10.1371/journal.pone.0118544	http://dx.doi.org/10.1371/journal.pone.0118544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767871	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500028
J	Li, D; Lu, WJ; Liu, YJ; Guo, HW; Xu, S; Ming, ZY; Wang, HT				Li, Dong; Lu, Wenjing; Liu, Yanjun; Guo, Hanwen; Xu, Sai; Ming, Zhongyuan; Wang, Hongtao			Analysis of Relative Concentration of Ethanol and Other Odorous Compounds (OCs) Emitted from the Working Surface at a Landfill in China	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; MUNICIPAL SOLID-WASTE; CHROMATOGRAPHY-MASS SPECTROMETRY; EMISSIONS; SITE; GAS; DEGRADATION; METHANE; VOC	Estimating odor emissions from landfill sites is a complicated task because of the various chemical and biological species that exist in landfill gases. In this study, the relative concentration of ethanol and other odorous compounds emitted from the working surface at a landfill in China was analyzed. Gas sampling was conducted at the landfill on a number of selected days from March 2012 to March 2014, which represented different periods throughout the two years. A total of 41, 59, 66, 54, 63, 54, 41, and 42 species of odorous compounds were identified and quantified in eight sampling activities, respectively; a number of 86 species of odorous compounds were identified and quantified all together in the study. The measured odorous compounds were classified into six different categories (Oxygenated compounds, Halogenated compounds, Terpenes, Sulfur compounds, Aromatics, and Hydrocarbons). The total average concentrations of the oxygenated compounds, sulfur compounds, aromatics, halogenated compounds, hydrocarbons, and terpenes were 2.450 mg/m(3), 0.246 mg/m(3), 0.203 mg/m(3), 0.319 mg/m(3), 0.530 mg/m(3), and 0.217 mg/m(3), respectively. The relative concentrations of 59 odorous compounds with respect to the concentration of ethyl alcohol (1000 ppm) were determined. The dominant contaminants that cause odor pollution around the landfill are ethyl sulfide, methyl mercaptan, acetaldehyde, and hydrogen sulfide; dimethyl disulfide and dimethyl sulfide also contribute to the pollution to a certain degree.	[Li, Dong; Lu, Wenjing; Liu, Yanjun; Guo, Hanwen; Xu, Sai; Ming, Zhongyuan; Wang, Hongtao] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Wang, HT (corresponding author), Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China.	htwang@mail.tsinghua.edu.cn	刘, 严君/GZL-5764-2022; liu, yan/HCI-5542-2022; liu, yan/HGV-1365-2022; Xu, Sai/L-9259-2016	Xu, Sai/0000-0002-5395-4903	Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China [201209022]	Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China	This study was financially supported by Special Fund of Environmental Protection Research for Public Welfare, Ministry of Environmental Protection, People's Republic of China (http://www.zhb.gov.cn/; No. 201209022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 1997, ENVIRON SCI TECHNOL, V31, P1054, DOI 10.1021/es9605634; Bogner JE, 2010, ENVIRON SCI TECHNOL, V44, P1197, DOI 10.1021/es901796k; Chemel C, 2012, J ENVIRON MANAGE, V93, P85, DOI 10.1016/j.jenvman.2011.08.016; Chiriac R, 2011, WASTE MANAGE, V31, P2294, DOI 10.1016/j.wasman.2011.06.009; Chu BW, 2013, FRONT ENV SCI ENG, V7, P1, DOI 10.1007/s11783-012-0476-x; Davoli E, 2010, WASTE MANAGE, V30, P1608, DOI 10.1016/j.wasman.2009.10.013; Demeestere K, 2008, J CHROMATOGR A, V1186, P348, DOI 10.1016/j.chroma.2007.11.036; Dincer F, 2006, J CHROMATOGR A, V1122, P222, DOI 10.1016/j.chroma.2006.04.075; Ding Y, 2012, WASTE MANAGE, V32, P317, DOI 10.1016/j.wasman.2011.07.016; Duan ZH, 2014, ATMOS ENVIRON, V88, P230, DOI 10.1016/j.atmosenv.2014.01.051; Durmusoglu E, 2010, J HAZARD MATER, V176, P870, DOI 10.1016/j.jhazmat.2009.11.117; Fang JJ, 2012, WASTE MANAGE, V32, P1401, DOI 10.1016/j.wasman.2012.02.013; Gallego E, 2014, SCI TOTAL ENVIRON, V470, P587, DOI 10.1016/j.scitotenv.2013.09.105; Nagata Y., 2003, ODOR MEASUREMENT REV, P118; Sadowska-Rociek A, 2009, WASTE MANAGE RES, V27, P966, DOI 10.1177/0734242X09334616; Saral A, 2009, J HAZARD MATER, V168, P338, DOI 10.1016/j.jhazmat.2009.02.043; Schuetz C, 2003, ENVIRON SCI TECHNOL, V37, P5150, DOI 10.1021/es034016b; Suffet IH, 2009, WATER ENVIRON RES, V81, P670, DOI 10.2175/106143008X390762; Tagaris E, 2003, J AIR WASTE MANAGE, V53, P629, DOI 10.1080/10473289.2003.10466198; Tassi F, 2009, SCI TOTAL ENVIRON, V407, P4513, DOI 10.1016/j.scitotenv.2009.04.022; U. S. Environmental Protection Agency (US EPA), 1998, COMP AIR POLL EM SE; United States Environmental Protection Agency (U.S. EPA), 2005, LANDF GAS EM MOD LAN; Zhang YY, 2012, WASTE MANAGE, V32, P1116, DOI 10.1016/j.wasman.2012.01.005; Zhang YY, 2012, J ENVIRON MANAGE, V101, P54, DOI 10.1016/j.jenvman.2011.10.018; Zou SC, 2003, CHEMOSPHERE, V51, P1015, DOI 10.1016/S0045-6535(03)00004-3	25	8	9	6	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119305	10.1371/journal.pone.0119305	http://dx.doi.org/10.1371/journal.pone.0119305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769100	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500075
J	Li, WY; Zhang, B; Li, RZ; Chang, XP; Jing, RL				Li, Weiyu; Zhang, Bin; Li, Runzhi; Chang, Xiaoping; Jing, Ruilian			Favorable Alleles for Stem Water-Soluble Carbohydrates Identified by Association Analysis Contribute to Grain Weight under Drought Stress Conditions in Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORYZA-SATIVA L.; GENOTYPIC VARIATION; POSTANTHESIS CHANGES; WINTER-WHEAT; BREAD WHEAT; AESTIVUM L.; DRY-MATTER; ACCUMULATION; MOBILIZATION	Drought is a major environmental constraint to crop distribution and productivity. Stem water-soluble carbohydrates (WSC) buffer wheat grain yield against conditions unfavorable for photosynthesis during the grain filling stage. In this study, 262 winter wheat accessions and 209 genome-wide SSR markers were collected and used to undertake association analysis based on a mixed linear model (MLM). The WSC in different internodes at three growth stages and 1000-grain weight (TGW) were investigated under four environmental regimes (well-watered, drought stress during the whole growth period, and two levels of terminal drought stress imposed by chemical desiccation under the well-watered and drought stress during the whole growth period conditions). Under diverse drought stress conditions, WSC in lower internodes showed significant positive correlations with TGW, especially at the flowering stage under well-watered conditions and at grain filling under drought stress. Sixteen novel WSC-favorable alleles were identified, and five of them contributed to significantly higher TGW. In addition, pyramiding WSC favorable alleles was not only effective for obtaining accessions with higher WSC, but also for enhancing TGW under different water regimes. During the past fifty years of wheat breeding, WSC was selected incidentally. The average number of favorable WSC alleles increased from 1.13 in the pre-1960 period to 4.41 in the post-2000 period. The results indicate a high potential for using marker-assisted selection to pyramid WSC favorable alleles in improving WSC and TGW in wheat.	[Li, Weiyu; Zhang, Bin; Chang, Xiaoping; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Li, Weiyu; Li, Runzhi] Shanxi Agr Univ, Agron Coll, Taigu 030801, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanxi Agricultural University	Jing, RL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	jingrl@caas.net.cn		Zhang, Bin/0000-0002-7347-0367	National High-tech RD Program [2011AA100501]; National Natural Science Foundation of China [31271720]	National High-tech RD Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High-tech R&D Program (2011AA100501), and the National Natural Science Foundation of China (31271720). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero RA, 2011, FUNCT INTEGR GENOMIC, V11, P37, DOI 10.1007/s10142-010-0208-x; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BLUM A, 1994, AUST J PLANT PHYSIOL, V21, P771, DOI 10.1071/PP9940771; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; DEVRIES AP, 1971, EUPHYTICA, V20, P152, DOI 10.1007/BF00056076; Dreccer MF, 2009, FIELD CROP RES, V112, P43, DOI 10.1016/j.fcr.2009.02.006; Ehdaie B, 2006, CROP SCI, V46, P2093, DOI 10.2135/cropsci2006.01.0013; Ehdaie B, 2006, CROP SCI, V46, P735, DOI 10.2135/cropsci2005.04-0033; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; GALLAGHER JN, 1976, NATURE, V264, P541, DOI 10.1038/264541a0; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; Gupta A. K., 2011, American Journal of Plant Sciences, V2, P70, DOI 10.4236/ajps.2011.21010; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He Z, 2012, CROP SCI, V52, P44; Homayoun H., 2011, Advances in Environmental Biology, V5, P1721; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jing R., 1999, AGR RES ARID AREAS, V17, P79; LAWLOR DW, 1981, J AGR SCI-CAMBRIDGE, V96, P167, DOI 10.1017/S002185960003197X; Li WeiYu, 2012, Acta Agronomica Sinica, V38, P962; Nagata K, 2002, BREEDING SCI, V52, P275, DOI 10.1270/jsbbs.52.275; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NICOLAS ME, 1993, FIELD CROP RES, V31, P155, DOI 10.1016/0378-4290(93)90058-U; Rebetzke GJ, 2008, AUST J AGR RES, V59, P891, DOI 10.1071/AR08067; REGAN KL, 1993, AUST J AGR RES, V44, P1683, DOI 10.1071/AR9931683; Rohlf FJ, 1998, NTSYS PC NUMERICAL T; Rosenow, 1981, P 36 ANN CORN SORGH, P18; Ruuska SA, 2006, FUNCT PLANT BIOL, V33, P799, DOI 10.1071/FP06062; Shearman VJ, 2005, CROP SCI, V45, P175; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Teulat B, 2001, THEOR APPL GENET, V103, P161, DOI 10.1007/s001220000503; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Turner LB, 2006, NEW PHYTOL, V169, P45, DOI 10.1111/j.1469-8137.2005.01575.x; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wang J, 2005, CHINESE J SOIL SCI, V36, P908; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang ZH, 2011, ANAL LETT, V44, P2478, DOI 10.1080/00032719.2011.551859; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P255, DOI 10.1071/PP9940255; Yang DL, 2007, GENETICS, V176, P571, DOI 10.1534/genetics.106.068361; Yang JC, 2006, NEW PHYTOL, V169, P223, DOI 10.1111/j.1469-8137.2005.01597.x; Yang JC, 2003, PLANT CELL ENVIRON, V26, P1621, DOI 10.1046/j.1365-3040.2003.01081.x; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu LX, 2012, THEOR APPL GENET, V125, P749, DOI 10.1007/s00122-012-1867-x; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102917; Zhang DL, 2012, PLANTA, V236, P1507, DOI 10.1007/s00425-012-1708-9; Zhang JH, 1998, FIELD CROP RES, V59, P91, DOI 10.1016/S0378-4290(98)00104-X; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8	50	28	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119438	10.1371/journal.pone.0119438	http://dx.doi.org/10.1371/journal.pone.0119438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768726	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500081
J	Meyer, MA; Chand, T; Priess, JA				Meyer, Markus A.; Chand, Tanzila; Priess, Joerg A.			Comparing Bioenergy Production Sites in the Southeastern US Regarding Ecosystem Service Supply and Demand	PLOS ONE			English	Article							LAND-USE; LANDSCAPE STRUCTURE; BIODIVERSITY CONSERVATION; CORN STOVER; CARBON; TRADE; SOIL; CERTIFICATION; INDICATORS; BIOFUELS	Biomass for bioenergy is debated for its potential synergies or tradeoffs with other provisioning and regulating ecosystem services (ESS). This biomass may originate from different production systems and may be purposefully grown or obtained from residues. Increased concerns globally about the sustainable production of biomass for bioenergy has resulted in numerous certification schemes focusing on best management practices, mostly operating at the plot/field scale. In this study, we compare the ESS of two watersheds in the southeastern US. We show the ESS tradeoffs and synergies of plantation forestry, i.e., pine poles, and agricultural production, i.e., wheat straw and corn stover, with the counterfactual natural or semi-natural forest in both watersheds. The plantation forestry showed less distinct tradeoffs than did corn and wheat production, i.e., for carbon storage, P and sediment retention, groundwater recharge, and biodiversity. Using indicators of landscape composition and configuration, we showed that landscape planning can affect the overall ESS supply and can partly determine if locally set environmental thresholds are being met. Indicators on landscape composition, configuration and naturalness explained more than 30% of the variation in ESS supply. Landscape elements such as largely connected forest patches or more complex agricultural patches, e.g., mosaics with shrub and grassland patches, may enhance ESS supply in both of the bioenergy production systems. If tradeoffs between biomass production and other ESS are not addressed by landscape planning, it may be reasonable to include rules in certification schemes that require, e.g., the connectivity of natural or semi-natural forest patches in plantation forestry or semi-natural landscape elements in agricultural production systems. Integrating indicators on landscape configuration and composition into certification schemes is particularly relevant considering that certification schemes are governance tools used to ensure comparable sustainability standards for biomass produced in countries with variable or absent legal frameworks for landscape planning.	[Meyer, Markus A.; Chand, Tanzila; Priess, Joerg A.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Meyer, MA (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany.	markus.meyer@ufz.de	Meyer, Markus/HIK-1821-2022; Meyer, Markus/AAY-9170-2020; Meyer, Markus/AAV-5608-2020; Priess, Joerg A./G-1697-2012	Meyer, Markus/0000-0003-4872-7164; Meyer, Markus/0000-0002-9463-1975; Priess, Joerg A./0000-0002-0384-9240	European Union [282826]; Higher Education Commission Pakistan	European Union(European Commission); Higher Education Commission Pakistan(Higher Education Commission of Pakistan)	This work was partly funded by the European Union FP7 project SECTOR (Production of Solid Sustainable Energy Carriers by Means of Torrefaction), grant agreement number 282826, https://sector-project.eu/, and the Higher Education Commission Pakistan in cooperation with the German Academic Exchange Service (DAAD), http://www.hec.gov.pk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2008, ENVIRON SCI TECHNOL, V42, P822, DOI 10.1021/es0716103; Allen RG, 2001, CROP EVAPOTRANSPIRAT; [Anonymous], 2013, GROUNDWATER DEPLETIO; Arnold JG, 2005, HYDROL PROCESS, V19, P563, DOI 10.1002/hyp.5611; Baessler C, 2006, AGR ECOSYST ENVIRON, V115, P43, DOI 10.1016/j.agee.2005.12.007; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bennett EM, 2007, FRONT ECOL ENVIRON, V5, P191, DOI 10.1890/1540-9295(2007)5[191:TFOPSI]2.0.CO;2; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Birdsey R, 1992, CARBON STORAGE ACCUM, DOI DOI 10.2737/WO-GTR-59; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Board M, 2005, ECOSYSTEMS HUMAN WEL; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bourke D, 2014, GCB BIOENERGY, V6, P275, DOI 10.1111/gcbb.12089; Brandt P, 2014, BIOL CONSERV, V169, P362, DOI 10.1016/j.biocon.2013.12.003; Bridgeman TG, 2008, FUEL, V87, P844, DOI 10.1016/j.fuel.2007.05.041; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Bringezu S, 2012, LAND USE POLICY, V29, P224, DOI 10.1016/j.landusepol.2011.06.010; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Brockerhoff EG, 2013, FOREST ECOL MANAG, V301, P43, DOI 10.1016/j.foreco.2012.09.018; Burns LA, 1992, PESTICIDE IND CHEM R; Campbell Group, 2013, JUV PIN PLANT UNPUB; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chum H, 2011, IPCC SPECIAL REPORT; Clark B. R., 2011, 1785 US GEOL SOC; Convertino M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065056; Dale VH, 2007, ECOL ECON, V64, P286, DOI 10.1016/j.ecolecon.2007.05.009; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Desiree JI, 2014, GCB BIOENERGY, V6, P183, DOI 10.1111/gcbb.12067; Diaz-Chavez R, 2011, BIOFUEL BIOPROD BIOR, V5, P445, DOI 10.1002/bbb.319; DISSMEYER GE, 1984, GUIDE PREDICTING SHE; Dripps WR, 2007, HYDROGEOL J, V15, P433, DOI 10.1007/s10040-007-0160-6; Efroymson RA, 2013, ENVIRON MANAGE, V51, P291, DOI 10.1007/s00267-012-9907-5; EPD, 2001, SAT RIV BAS DISS OX; *FAO GEON, 2004, GLOB MAP MONTHL REF; Fernandez C, 2003, J SOIL WATER CONSERV, V58, P128; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fonseca M.B., 2010, IMPACTS EU BIOFUEL T; Frank S, 2014, LANDSCAPE ECOLOGY, P1; Frank S, 2012, ECOL INDIC, V21, P30, DOI 10.1016/j.ecolind.2011.04.027; Franzluebbers AJ, 2005, SOIL TILL RES, V83, P120, DOI 10.1016/j.still.2005.02.012; Gasparatos A, 2011, AGR ECOSYST ENVIRON, V142, P111, DOI 10.1016/j.agee.2011.04.020; Ghazoul J, 2009, FOREST ECOL MANAG, V258, P1889, DOI 10.1016/j.foreco.2009.01.038; Goh CS, 2013, BIOFUEL BIOPROD BIOR, V7, P24, DOI 10.1002/bbb.1366; Goldman RL, 2007, ECOL ECON, V64, P333, DOI 10.1016/j.ecolecon.2007.01.012; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Gos Pierre, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P93, DOI 10.1080/21513732.2011.646303; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Harmel D, 2006, J AM WATER RESOUR AS, V42, P1163, DOI 10.1111/j.1752-1688.2006.tb05604.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; IPCC, 2019, 2006 IPCC GUIDELINES, DOI DOI 10.35-10.49; Johnson JMF, 2014, BIOENERG RES, V7, P68, DOI 10.1007/s12155-013-9349-9; Jones KB, 2001, LANDSCAPE ECOL, V16, P301, DOI 10.1023/A:1011175013278; Junginger M, 2011, ENERG POLICY, V39, P2028, DOI 10.1016/j.enpol.2011.01.040; Kadam KL, 2003, BIORESOURCE TECHNOL, V88, P17, DOI 10.1016/S0960-8524(02)00269-9; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kim KH, 2007, LAND USE POLICY, V24, P264, DOI 10.1016/j.landusepol.2005.12.001; KRAMER E, 2003, GAP ANAL GEORGIA; Kremen C., 2012, ECOLOGY SOC, V17; Lamers P, 2013, BIOMASS BIOENERG, V55, P212, DOI 10.1016/j.biombioe.2013.02.002; Lamers P, 2012, RENEW SUST ENERG REV, V16, P3176, DOI 10.1016/j.rser.2012.02.027; Lautenbach S, 2013, ENVIRON MODELL SOFTW, V48, P98, DOI 10.1016/j.envsoft.2013.06.006; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Lewandowski I, 2006, BIOMASS BIOENERG, V30, P83, DOI 10.1016/j.biombioe.2005.11.003; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Manning P, 2014, GCB BIOENERGY; Martin A, 2003, ENVIRON SCI POLLUT R, V10, P245, DOI 10.1065/espr2003.05.153; Martin-Lopez B, 2007, BIOL CONSERV, V139, P67, DOI 10.1016/j.biocon.2007.06.005; McBride AC, 2011, ECOL INDIC, V11, P1277, DOI 10.1016/j.ecolind.2011.01.010; McCarty JL, 2007, REMOTE SENS ENVIRON, V108, P151, DOI 10.1016/j.rse.2006.03.020; McCarty JL, 2011, J AIR WASTE MANAGE, V61, P22, DOI 10.3155/1047-3289.61.1.22; McGarigal K., 2012, TECH REP; MDEQ, 2003, TMDL FOR ORGANIC ENR; MDEQ, 2008, TOT MAX DAIL LOAD TO; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Meyer MA, 2014, BIOMASS BIOENERG, V65, P151, DOI 10.1016/j.biombioe.2014.03.041; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Mishra HS, 1997, IRRIGATION SCI, V17, P69, DOI 10.1007/s002710050024; Mitchell MGE, 2013, ECOSYSTEMS, V16, P894, DOI 10.1007/s10021-013-9647-2; Morgan R.P.C, 2005, SOIL EROSION CONSERV, V3rd, DOI DOI 10.1111/J.1365-2389.2005.0756F.X; Mouchet MA, 2014, GLOBAL ENVIRON CHANG, V28, P298, DOI 10.1016/j.gloenvcha.2014.07.012; Mullen CA, 2010, BIOMASS BIOENERG, V34, P67, DOI 10.1016/j.biombioe.2009.09.012; Muth DJ, 2013, APPL ENERG, V102, P403, DOI 10.1016/j.apenergy.2012.07.028; Natural Resources Conservation Service (NRCS), 2012, NRCS ENG FIELD HDB; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Payne DF, 2005, SIMULATION GROUND WA; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perica S., 2013, PRECIPITATION FREQUE; Perlack RD, 2011, IEA BIOENERGY; Priest S, 2004, EVALUATION GROUND WA; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; R Core Team, 2020, R LANG ENV STAT COMP; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reckhow KH, 1980, MODELING PHOSPHOROUS; Roose E, 1996, LAND HUSBANDRY COMPO; Ruesch A., 2008, NEW IPCC TIER 1 GLOB; Sainju UM, 2005, PLANT SOIL, V273, P219, DOI 10.1007/s11104-004-7611-9; Scarlat N, 2011, ENERG POLICY, V39, P1630, DOI 10.1016/j.enpol.2010.12.039; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scurlock J.M.O., 2001, WORLDWIDE HIST ESTIM; Smith JE., 2006, METHODS CALCULATING; Snipes C., 2005, CURRENT AGR PRACTICE; Suarez LA., 2005, PRZM 3 MODEL PREDICT; Susaeta A, 2013, INT J SUSTAIN ENERGY, V32, P544, DOI 10.1080/14786451.2013.774003; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Tallis HT, 2013, VEST 2 5 7 USERS GUI; Terrado M, 2014, ECOL INDIC, V37, P199, DOI 10.1016/j.ecolind.2013.01.016; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2014, CONSERVATION LETT; USDA NASS, 2014, CORN WINT WHEAT PROD; USDA NASS, 2010, CROPL DAT LAYER CDL; USDA NRCS, 2014, WEB SOIL SURV SOIL S; USDA NRCS, 2002, C FACT US ER PRED MI; USDA NRCS and ARS, 2000, REV UN SOIL LOSS EQ; USGS and USDOI, 2010, LANDF 1 2 0 ENV SIT; USGS GAP, 2011, ASPECT; USGS GAP, 2011, SLOP; USGS GAP, 2011, HUM IMP AV; USGS GAP (US Geological Survey Gap Analysis Program), 2011, NAT LAND COV VERS 2; van Dam J, 2010, RENEW SUST ENERG REV, V14, P2445, DOI 10.1016/j.rser.2010.07.010; Vigerstol KL, 2011, J ENVIRON MANAGE, V92, P2403, DOI 10.1016/j.jenvman.2011.06.040; VILELLA FJ, 2003, GAP ANAL MISSISSIPPI; Villa F, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0220, DOI 10.1098/RSTB.2013.0220]; Welch HL, 2011, HYDROGEOL J, V19, P1239, DOI 10.1007/s10040-011-0748-8; Werling BP, 2014, P NATL ACAD SCI; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Westenbroek S., 2010, SWB A MODIFIED THORN; Wischmeier W.H., 1978, PREDICTING RAINFALL; Wolock D.M., 2003, ESTIMATED MEAN ANN N; Wrbka T, 2004, LAND USE POLICY, V21, P289, DOI 10.1016/j.landusepol.2003.10.012; Yeh S, 2011, BIOFUEL BIOPROD BIOR, V5, P361, DOI 10.1002/bbb.308; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024	135	18	18	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116336	10.1371/journal.pone.0116336	http://dx.doi.org/10.1371/journal.pone.0116336			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768660	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500008
J	Papler, TB; Bokal, EV; Lovrecic, L; Kopitar, AN; Maver, A				Papler, Tanja Burnik; Bokal, Eda Vrtacnik; Lovrecic, Luca; Kopitar, Andreja Natasa; Maver, Ales			No Specific Gene Expression Signature in Human Granulosa and Cumulus Cells for Prediction of Oocyte Fertilisation and Embryo Implantation	PLOS ONE			English	Article							IDENTIFICATION; BIOMARKERS; SELECTION; MARKERS; OVARY; IVF	In human IVF procedures objective and reliable biomarkers of oocyte and embryo quality are needed in order to increase the use of single embryo transfer (SET) and thus prevent multiple pregnancies. During folliculogenesis there is an intense bi-directional communication between oocyte and follicular cells. For this reason gene expression profile of follicular cells could be an important indicator and biomarker of oocyte and embryo quality. The objective of this study was to identify gene expression signature(s) in human granulosa (GC) and cumulus (CC) cells predictive of successful embryo implantation and oocyte fertilization. Forty-one patients were included in the study and individual GC and CC samples were collected; oocytes were cultivated separately, allowing a correlation with IVF outcome and elective SET was performed. Gene expression analysis was performed using microarrays, followed by a quantitative real-time PCR validation. After statistical analysis of microarray data, there were no significantly differentially expressed genes (FDR<0,05) between nonfertilized and fertilized oocytes and non-implanted and implanted embryos in either of the cell type. Furthermore, the results of quantitative real-time PCR were in consent with microarray data as there were no significant differences in gene expression of genes selected for validation. In conclusion, we did not find biomarkers for prediction of oocyte fertilization and embryo implantation in IVF procedures in the present study.	[Papler, Tanja Burnik; Bokal, Eda Vrtacnik] Univ Med Ctr Ljubljana, Div Gynaecol, Dept Human Reprod, SI-1000 Ljubljana, Slovenia; [Lovrecic, Luca; Maver, Ales] Univ Med Ctr, Div Obstet & Gynaecol, Clin Inst Med Genet, SI-1000 Ljubljana, Slovenia; [Kopitar, Andreja Natasa] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, SI-1000 Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Maver, A (corresponding author), Univ Med Ctr, Div Obstet & Gynaecol, Clin Inst Med Genet, Slajmerjeva 3, SI-1000 Ljubljana, Slovenia.	ales.maver@gmail.com	Lovrecic, Luca/S-8196-2018	Lovrecic, Luca/0000-0003-4119-9530	Slovenian Research Agency [P3-0326]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by the Slovenian Research Agency (https://www.arrs.gov.si/en/novo.asp), grant number P3-0326. Tanja Burnik Papler is funded as a young researcher by the Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens T, 2010, HUM REPROD, V25, P1259, DOI 10.1093/humrep/deq049; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; BUCCIONE R, 1990, BIOL REPROD, V43, P543, DOI 10.1095/biolreprod43.4.543; Devjak R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047106; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Eppig John J., 1997, Human Reproduction (Oxford), V12, P127; Fragouli E, 2014, MOL HUM REPROD, V20, P117, DOI 10.1093/molehr/gat073; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; Gardner DK, 2008, REPROD FERT DEVELOP, V20, P9, DOI 10.1071/RD07160; Gardner DK, 2011, HUM REPROD, V26, P1981, DOI 10.1093/humrep/der143; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gonzalez RR, 2000, HUM REPROD UPDATE, V6, P290, DOI 10.1093/humupd/6.3.290; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Grondahl ML, 2009, FERTIL STERIL, V91, P1820, DOI 10.1016/j.fertnstert.2008.02.137; Guerif F, 2007, HUM REPROD, V22, P1973, DOI 10.1093/humrep/dem100; Hamel M, 2008, HUM REPROD, V23, P1118, DOI 10.1093/humrep/den048; Hamel M, 2010, MOL HUM REPROD, V16, P87, DOI 10.1093/molehr/gap079; Haouzi D, 2012, HUM REPROD, V27, P3523, DOI 10.1093/humrep/des325; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Katz-Jaffe MG, 2006, FERTIL STERIL, V85, P101, DOI 10.1016/j.fertnstert.2005.09.011; Konishi T, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S6; Kovalevsky G, 2005, FERTIL STERIL, V84, P325, DOI 10.1016/j.fertnstert.2005.04.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matos L, 2009, MOL HUM REPROD, V15, P411, DOI 10.1093/molehr/gap034; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; Penzias AS, 2012, FERTIL STERIL, V97, P1033, DOI 10.1016/j.fertnstert.2012.03.017; Pinborg A, 2005, HUM REPROD UPDATE, V11, P575, DOI 10.1093/humupd/dmi027; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Schoolcraft WB, 2001, FERTIL STERIL, V76, P863, DOI 10.1016/S0015-0282(01)02731-5; Scott L, 2003, HUM REPROD UPDATE, V9, P237, DOI 10.1093/humupd/dmg023; Scott L, 2008, REPROD BIOMED ONLINE, V17, P461, DOI 10.1016/S1472-6483(10)60232-5; Sfontouris Ioannis A, 2013, J Hum Reprod Sci, V6, P133, DOI 10.4103/0974-1208.117174; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Wathlet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054226; Wathlet S, 2012, FERTIL STERIL, V98, P432, DOI 10.1016/j.fertnstert.2012.05.007; Yanaihara A, 2005, FERTIL STERIL, V84, P464, DOI 10.1016/j.fertnstert.2005.02.034; Zhang SD, 2004, BIOINFORMATICS, V20, P2821, DOI 10.1093/bioinformatics/bth336	46	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115865	10.1371/journal.pone.0115865	http://dx.doi.org/10.1371/journal.pone.0115865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769026	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500003
J	Valdes-Baizabal, C; Soto, E; Vega, R				Valdes-Baizabal, Catalina; Soto, Enrique; Vega, Rosario			Dopaminergic Modulation of the Voltage-Gated Sodium Current in the Cochlear Afferent Neurons of the Rat	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; GUINEA-PIG COCHLEA; D1 RECEPTOR; CONSTITUTIVE ACTIVITY; EFFERENT INNERVATION; SIGNAL-TRANSDUCTION; MOUSE COCHLEA; D-1 RECEPTORS; NA+ CHANNELS; IMMUNOREACTIVITY	The cochlear inner hair cells synapse onto type I afferent terminal dendrites, constituting the main afferent pathway for auditory information flow. This pathway receives central control input from the lateral olivocochlear efferent neurons that release various neurotransmitters, among which dopamine (DA) plays a salient role. DA receptors activation exert a protective role in the over activation of the afferent glutamatergic synapses, which occurs when an animal is exposed to intense sound stimuli or during hypoxic events. However, the mechanism of action of DA at the cellular level is still not completely understood. In this work, we studied the actions of DA and its receptor agonists and antagonists on the voltage-gated sodium current (I-Na) in isolated cochlear afferent neurons of the rat to define the mechanisms of dopaminergic control of the afferent input in the cochlear pathway. Experiments were performed using the voltage and current clamp techniques in the whole-cell configuration in primary cultures of cochlear spiral ganglion neurons (SGNs). Recordings of the INa showed that DA receptor activation induced a significant inhibition of the peak current amplitude, leading to a significant decrease in cell excitability. Inhibition of the INa was produced by a phosphorylation of the sodium channels as shown by the use of phosphatase inhibitor that produced an inhibition analogous to that caused by DA receptor activation. Use of specific agonists and antagonists showed that inhibitory action of DA was mediated both by activation of D1- and D2-like DA receptors. The action of the D1- and D2-like receptors was shown to be mediated by a G(as)/AC/cAMP/PKA and G(alpha q)/PLC/PKC pathways respectively. These results showed that DA receptor activation constitutes a significant modulatory input to SGNs, effectively modulating their excitability and information flow in the auditory pathway.	[Valdes-Baizabal, Catalina; Soto, Enrique; Vega, Rosario] Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico	Benemerita Universidad Autonoma de Puebla	Vega, R (corresponding author), Benemerita Univ Autonoma Puebla, Inst Fisiol, Puebla, Mexico.	axolotl_56@yahoo.com.mx	Baizabal, Catalina Valdés/V-8463-2018; soto, Enrique/C-4073-2013; Valdés-Baizabal, Catalina/ABB-8697-2020	Baizabal, Catalina Valdés/0000-0002-4063-7546; soto, Enrique/0000-0003-2428-7416; Vega, Rosario/0000-0001-7532-2483	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT) [167052]; VIEP-BUAP; PIFI; CONACyT [216652]	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); VIEP-BUAP; PIFI; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding: This work was supported by a grant from Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT) grant 167052 to ES, grants VIEP-BUAP to RV and ES, and PIFI 2012-2013 grant. CVB was supported by CONACyT fellowship 216652. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CL, 2002, J NEUROSCI, V22, P1385, DOI 10.1523/JNEUROSCI.22-04-01385.2002; ALTSCHULER RA, 1985, BRAIN RES, V338, P1, DOI 10.1016/0006-8993(85)90242-2; ALTSCHULER RA, 1986, AM J OTOLARYNG, V7, P100, DOI 10.1016/S0196-0709(86)80038-2; Arrang JM, 2007, TRENDS PHARMACOL SCI, V28, P350, DOI 10.1016/j.tips.2007.05.002; Bartolome M Visitacion, 2005, Int Tinnitus J, V11, P119; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Cabello N, 2009, J NEUROCHEM, V109, P1497, DOI 10.1111/j.1471-4159.2009.06078.x; Cantrell AR, 1999, J NEUROSCI, V19, P5301; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; DALDIN C, 1995, HEARING RES, V90, P202, DOI 10.1016/0378-5955(95)00167-5; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Drescher MJ, 2006, NEUROSCIENCE, V142, P139, DOI 10.1016/j.neuroscience.2006.05.065; EYBALIN M, 1984, HEARING RES, V13, P135, DOI 10.1016/0378-5955(84)90104-7; EYBALIN M, 1988, NEUROSCIENCE, V24, P29, DOI 10.1016/0306-4522(88)90308-9; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Franco R, 2007, J NEURAL TRANSM, V114, P93, DOI 10.1007/s00702-006-0566-7; Garrett AR, 2011, AUDIOL NEURO-OTOL, V16, P145, DOI 10.1159/000316674; GILLOYZAGA P, 1989, DEV BRAIN RES, V48, P157, DOI 10.1016/0165-3806(89)90100-4; GILLOYZAGA P, 1994, HEARING RES, V79, P178, DOI 10.1016/0378-5955(94)90138-4; Guinan JJ, 2010, CURR OPIN OTOLARYNGO, V18, P447, DOI 10.1097/MOO.0b013e32833e05d6; Hossain WA, 2005, J NEUROSCI, V25, P6857, DOI 10.1523/JNEUROSCI.0123-05.2005; Inoue T, 2006, NEUROSCI LETT, V399, P226, DOI 10.1016/j.neulet.2006.01.063; Karadaghy AA, 1997, MOL BRAIN RES, V44, P151, DOI 10.1016/S0169-328X(96)00261-6; Kozell LB, 1997, MOL PHARMACOL, V52, P1137, DOI 10.1124/mol.52.6.1137; Kuroiwa M, 2008, J NEUROCHEM, V107, P1014, DOI 10.1111/j.1471-4159.2008.05702.x; Lee FJS, 2004, BIOCHEM SOC T, V32, P1032, DOI 10.1042/BST0321032; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Limon A, 2005, J NEUROPHYSIOL, V94, P3751, DOI 10.1152/jn.00177.2005; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; LU SM, 1987, HEARING RES, V31, P137, DOI 10.1016/0378-5955(87)90119-5; Maison SF, 2012, J NEUROSCI, V32, P344, DOI 10.1523/JNEUROSCI.4720-11.2012; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mo ZL, 1997, J NEUROPHYSIOL, V78, P3019, DOI 10.1152/jn.1997.78.6.3019; Niu X, 2006, NEUROSCIENCE, V137, P981, DOI 10.1016/j.neuroscience.2005.10.044; Niu X, 2004, NEUROSCIENCE, V125, P725, DOI 10.1016/j.neuroscience.2004.02.023; Niu XZ, 2007, PHYSIOL BEHAV, V92, P34, DOI 10.1016/j.physbeh.2007.05.020; Oestreicher E, 1997, HEARING RES, V107, P46, DOI 10.1016/S0378-5955(97)00023-3; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Perreault ML, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00031; Polony G, 2014, NEUROSCIENCE, V265, P263, DOI 10.1016/j.neuroscience.2014.01.057; PUJOL R, 1994, BRIT J AUDIOL, V28, P185, DOI 10.3109/03005369409086567; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; Ruel J, 2006, J NEUROCHEM, V97, P190, DOI 10.1111/j.1471-4159.2006.03722.x; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; SLIWINSKAKOWALSKA M, 1989, HEARING RES, V42, P83, DOI 10.1016/0378-5955(89)90119-6; SPOENDLIN H, 1985, AM J OTOLARYNG, V6, P453, DOI 10.1016/S0196-0709(85)80026-0; Sun W, 2001, NEUROREPORT, V12, P803, DOI 10.1097/00001756-200103260-00037; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Szabo ZS, 2002, EUR J NEUROSCI, V16, P1887, DOI 10.1046/j.1460-9568.2002.02258.x; Sziklai I, 2011, LARYNGOSCOPE, V121, P888, DOI 10.1002/lary.21461; Verma V, 2010, J BIOL CHEM, V285, P35092, DOI 10.1074/jbc.M109.088625; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1	53	20	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120808	10.1371/journal.pone.0120808	http://dx.doi.org/10.1371/journal.pone.0120808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768433	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500136
J	Van Den Ham, KM; Shio, MT; Rainone, A; Fournier, S; Krawczyk, CM; Olivier, M				Van Den Ham, Kristin M.; Shio, Marina Tiemi; Rainone, Anthony; Fournier, Sylvie; Krawczyk, Connie M.; Olivier, Martin			Iron Prevents the Development of Experimental Cerebral Malaria by Attenuating CXCR3-Mediated T Cell Chemotaxis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; IFN-GAMMA; DENDRITIC CELLS; PARASITE SEQUESTRATION; CUTTING EDGE; BRAIN; RECEPTOR; SUSCEPTIBILITY; EXPRESSION; CD4(+)	Cerebral malaria is a severe neurological complication of Plasmodium falciparum infection. Previous studies have suggested that iron overload can suppress the generation of a cytotoxic immune response; however, the effect of iron on experimental cerebral malaria (ECM) is yet unknown. Here we determined that the incidence of ECM was markedly reduced in mice treated with iron dextran. Protection was concomitant with a significant decrease in the sequestration of CD4(+) and CD8(+) T cells within the brain. CD4(+) T cells demonstrated markedly decreased CXCR3 expression and had reduced IFN gamma-responsiveness, as indicated by mitigated expression of IFN gamma R2 and T-bet. Additional analysis of the splenic cell populations indicated that parenteral iron supplementation was also associated with a decrease in NK cells and increase in regulatory T cells. Altogether, these results suggest that iron is able to inhibit ECM pathology by attenuating the capacity of T cells to migrate to the brain.	[Van Den Ham, Kristin M.; Shio, Marina Tiemi; Rainone, Anthony; Fournier, Sylvie; Krawczyk, Connie M.; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Van Den Ham, Kristin M.; Shio, Marina Tiemi; Olivier, Martin] McGill Univ, Ctr Hlth, Res Inst, McGill Int TB Ctr, Montreal, PQ, Canada	McGill University; McGill University	Olivier, M (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816	Canadian Institutes of Health Research; Natural Sciences and Engineering Council	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and Natural Sciences and Engineering Council (http://www.nserc-crsng.gc.ca/index_eng.asp) to MO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; BURKITT MJ, 1991, P NATL ACAD SCI USA, V88, P8440, DOI 10.1073/pnas.88.19.8440; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; CHANLING T, 1992, AM J PATHOL, V140, P1121; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; GOOD MF, 1987, CLIN EXP IMMUNOL, V68, P375; GRAU GE, 1990, J EXP MED, V172, P1505, DOI 10.1084/jem.172.5.1505; GRAU GE, 1989, IMMUNOL REV, V112, P49, DOI 10.1111/j.1600-065X.1989.tb00552.x; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GRAU GE, 1990, IMMUNOL LETT, V25, P189, DOI 10.1016/0165-2478(90)90113-5; Gwamaka M, 2012, CLIN INFECT DIS, V54, P1137, DOI 10.1093/cid/cis010; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Hermsen CC, 1998, J INFECT DIS, V178, P1225, DOI 10.1086/515691; HERSHKO C, 1988, J EXP MED, V168, P375, DOI 10.1084/jem.168.1.375; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Kossodo S, 1997, IMMUNOLOGY, V91, P536, DOI 10.1046/j.1365-2567.1997.00290.x; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0; Manning L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001972; Matsuzaki-Moriya C, 2011, EUR J IMMUNOL, V41, P1365, DOI 10.1002/eji.201040942; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Piva L, 2012, J IMMUNOL, V189, P1128, DOI 10.4049/jimmunol.1201171; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Regis G, 2005, BLOOD, V105, P3214, DOI 10.1182/blood-2004-07-2686; Reimer T, 2010, EUR J IMMUNOL, V40, P764, DOI 10.1002/eji.200939996; Sarween N, 2004, J IMMUNOL, V173, P2942, DOI 10.4049/jimmunol.173.5.2942; SCOTT MD, 1990, BRIT J HAEMATOL, V75, P598, DOI 10.1111/j.1365-2141.1990.tb07805.x; Smith HJ, 2010, COCHRANE DB SYST REV; Spottiswoode N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00125; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yanez DM, 1996, J IMMUNOL, V157, P1620	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118451	10.1371/journal.pone.0118451	http://dx.doi.org/10.1371/journal.pone.0118451			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768944	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500026
J	Ellis, JM; Bowman, CE; Wolfgang, MJ				Ellis, Jessica M.; Bowman, Caitlyn E.; Wolfgang, Michael J.			Metabolic and Tissue-Specific Regulation of Acyl-CoA Metabolism	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; COENZYME-A-SYNTHETASE; STRUCTURAL BASIS; THIOESTERASE; MOUSE; PROTEIN; LOCALIZATION; PURIFICATION; EXPRESSION; OXIDATION	Acyl-CoA formation initiates cellular fatty acid metabolism. Acyl-CoAs are generated by the ligation of a fatty acid to Coenzyme A mediated by a large family of acyl-CoA synthetases (ACS). Conversely, acyl-CoAs can be hydrolyzed by a family of acyl-CoA thioesterases (ACOT). Here, we have determined the transcriptional regulation of all ACS and ACOT enzymes across tissues and in response to metabolic perturbations. We find patterns of coordinated regulation within and between these gene families as well as distinct regulation occurring in a tissue- and physiologically-dependent manner. Due to observed changes in long-chain ACOT mRNA and protein abundance in liver and adipose tissue, we determined the consequence of increasing cytosolic long-chain thioesterase activity on fatty acid metabolism in these tissues by generating transgenic mice overexpressing a hyperactive mutant of Acot7 in the liver or adipose tissue. Doubling cytosolic acyl-CoA thioesterase activity failed to protect mice from diet-induced obesity, fatty liver or insulin resistance, however, overexpression of Acot7 in adipocytes rendered mice cold intolerant. Together, these data suggest distinct modes of regulation of the ACS and ACOT enzymes and that these enzymes act in a coordinated fashion to control fatty acid metabolism in a tissue-dependent manner.	[Ellis, Jessica M.; Bowman, Caitlyn E.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Metab & Obes Res, Baltimore, MD 21205 USA	Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Ctr Metab & Obes Res, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu			National Institutes of Health grant [NS072241]; Baltimore Diabetes Research and Training Center (DRTC) [P60DK079637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072241] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Diabetes Research and Training Center (DRTC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.J.W. was supported by a National Institutes of Health grant (NS072241) and the Baltimore Diabetes Research and Training Center (DRTC) Grant P60DK079637.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brocker Chad, 2010, Hum Genomics, V4, P411; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Choi JY, 1996, J BIOL CHEM, V271, P3581; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Durgan DJ, 2006, AM J PHYSIOL-HEART C, V290, pH2480, DOI 10.1152/ajpheart.01344.2005; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Ellis JM, 2010, CURR OPIN LIPIDOL, V21, P212, DOI 10.1097/MOL.0b013e32833884bb; Smith ME, 2013, BIOCHEM BIOPH RES CO, V430, P272, DOI 10.1016/j.bbrc.2012.10.138; Faergeman NJ, 1997, BIOCHEM J, V323, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Fujita M, BIOL PHARM B, V34, P87; Gargiulo CE, 1999, J LIPID RES, V40, P881; Hertz R, 1998, NATURE, V392, P512, DOI 10.1038/33185; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hunt MC, 2007, CELL MOL LIFE SCI, V64, P1558, DOI 10.1007/s00018-007-7062-6; Hunt MC, 2006, FASEB J, V20, P1855, DOI 10.1096/fj.06-6042com; Hunt MC, 2002, J BIOL CHEM, V277, P1128, DOI 10.1074/jbc.M106458200; Hunt MC, 1999, J BIOL CHEM, V274, P34317, DOI 10.1074/jbc.274.48.34317; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Kuramochi Y, 2002, MOL BRAIN RES, V98, P81; Li LO, 2009, J BIOL CHEM, V284, P27816, DOI 10.1074/jbc.M109.022467; LI QL, 1993, J CELL BIOCHEM, V51, P458, DOI 10.1002/jcb.2400510411; LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lousa CD, 2013, P NATL ACAD SCI USA, V110, P1279, DOI 10.1073/pnas.1218034110; Mashek DG, 2006, J LIPID RES, V47, P2004, DOI 10.1194/jlr.M600150-JLR200; Melton EM, 2013, BIOCHEM BIOPH RES CO, V440, P743, DOI 10.1016/j.bbrc.2013.09.137; Mitchell GA, 2008, MOL GENET METAB, V94, P4, DOI 10.1016/j.ymgme.2007.12.005; Moffat C, 2014, J LIPID RES, V55, P2458, DOI 10.1194/jlr.M046961; NAGGERT J, 1987, BIOCHEM J, V243, P597, DOI 10.1042/bj2430597; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Reamy AA, 2011, J NEUROCHEM, V118, P388, DOI 10.1111/j.1471-4159.2011.07312.x; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Rodriguez-Guilbe M, 2013, J BIOL CHEM, V288, P10841, DOI 10.1074/jbc.M112.446765; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schuler AM, 2005, MOL GENET METAB, V85, P7, DOI 10.1016/j.ymgme.2004.09.006; Serek R, 2006, ACTA CRYSTALLOGR F, V62, P133, DOI 10.1107/S1744309106000030; Sone H, 2002, AM J PHYSIOL-ENDOC M, V282, pE222, DOI 10.1152/ajpendo.00189.2001; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; WAKU K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P101, DOI 10.1016/0005-2760(92)90085-A; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Yamada J, 2004, NEUROSCI LETT, V355, P89, DOI 10.1016/j.neulet.2003.10.049; Yang SG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029652, 10.1371/journal.pone.0035836]; Zhang YZ, 2012, P NATL ACAD SCI USA, V109, P5417, DOI 10.1073/pnas.1116011109; Zhuravleva E, 2012, MOL CELL BIOL, V32, P2685, DOI 10.1128/MCB.00312-12	60	61	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116587	10.1371/journal.pone.0116587	http://dx.doi.org/10.1371/journal.pone.0116587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760036	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000007
J	Forreryd, A; Albrekt, HJ; Borrebaeck, CAK; Lindstedt, M				Forreryd, Andy; Albrekt, Henrik Johansson; Borrebaeck, Carl A. K.; Lindstedt, Malin			Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker Signature	PLOS ONE			English	Article							DISCRIMINATING GENETIC-MARKERS; SERUM IGE CONCENTRATION; EPITHELIAL-CELL LINE; LYMPH-NODE ASSAY; TEST H-CLAT; OCCUPATIONAL ASTHMA; SKIN SENSITIZERS; TRIMELLITIC ANHYDRIDE; PATHWAY ANALYSIS; BROWN-NORWAY	Background Repeated exposure to certain low molecular weight (LMW) chemical compounds may result in development of allergic reactions in the skin or in the respiratory tract. In most cases, a certain LMW compound selectively sensitize the skin, giving rise to allergic contact dermatitis (ACD), or the respiratory tract, giving rise to occupational asthma (OA). To limit occurrence of allergic diseases, efforts are currently being made to develop predictive assays that accurately identify chemicals capable of inducing such reactions. However, while a few promising methods for prediction of skin sensitization have been described, to date no validated method, in vitro or in vivo, exists that is able to accurately classify chemicals as respiratory sensitizers. Results Recently, we presented the in vitro based Genomic Allergen Rapid Detection (GARD) assay as a novel testing strategy for classification of skin sensitizing chemicals based on measurement of a genomic biomarker signature. We have expanded the applicability domain of the GARD assay to classify also respiratory sensitizers by identifying a separate biomarker signature containing 389 differentially regulated genes for respiratory sensitizers in comparison to non-respiratory sensitizers. By using an independent data set in combination with supervised machine learning, we validated the assay, showing that the identified genomic biomarker is able to accurately classify respiratory sensitizers. Conclusions We have identified a genomic biomarker signature for classification of respiratory sensitizers. Combining this newly identified biomarker signature with our previously identified biomarker signature for classification of skin sensitizers, we have developed a novel in vitro testing strategy with a potent ability to predict both skin and respiratory sensitization in the same sample.	[Forreryd, Andy; Albrekt, Henrik Johansson; Borrebaeck, Carl A. K.; Lindstedt, Malin] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Albrekt, Henrik Johansson] SenzaGen AB, Lund, Sweden	Lund University	Lindstedt, M (corresponding author), Lund Univ, Dept Immunotechnol, Lund, Sweden.	Malin.Lindstedt@immun.lth.se	Lindstedt, Malin/A-3855-2009	Lindstedt, Malin/0000-0001-9136-1087	Swedish Fund for Research Without Animal Experiments; Swedish Research Council [K2010-79X-21371-01-3]; Swedish Research Council Formas [2011-1418]; Carl Trygger Foundation; Faculty of Engineering at Lund University; SenzaGen AB	Swedish Fund for Research Without Animal Experiments; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Carl Trygger Foundation; Faculty of Engineering at Lund University; SenzaGen AB	This work was supported by grants from the Swedish Fund for Research Without Animal Experiments (http://www.forskautandjurforsok.se), the Swedish Research Council (K2010-79X-21371-01-3) (http://www.vr.se), Swedish Research Council Formas (2011-1418) (http://www.formas.se), the Carl Trygger Foundation (http://www.carltryggersstiftelse.se/) and the Faculty of Engineering at Lund University (http://www.lth.se/). HJ is employed by SenzaGen AB. SenzaGen AB provided support in the form of salaries for HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Arts JHE, 1997, TOXICOLOGY, V117, P229, DOI 10.1016/S0300-483X(96)03576-7; Ashikaga T, 2006, TOXICOL IN VITRO, V20, P767, DOI 10.1016/j.tiv.2005.10.012; Banks D E, 2000, Curr Opin Pulm Med, V6, P37, DOI 10.1097/00063198-200001000-00008; Basketter DA, 2002, FOOD CHEM TOXICOL, V40, P593, DOI 10.1016/S0278-6915(01)00130-2; Bello D, 2007, ENVIRON HEALTH PERSP, V115, P328, DOI 10.1289/ehp.9557; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNSTEIN DI, 1982, J ALLERGY CLIN IMMUN, V69, P311, DOI 10.1016/S0091-6749(82)80009-2; Bharadwaj A, 2004, INT IMMUNOPHARMACOL, V4, P495, DOI 10.1016/j.intimp.2004.02.001; BOURNE MS, 1979, BRIT MED J, V2, P10, DOI 10.1136/bmj.2.6181.10; Boverhof DR, 2008, TOXICOL APPL PHARM, V226, P1, DOI 10.1016/j.taap.2007.10.008; Carlsson A, 2011, P NATL ACAD SCI USA, V108, P14252, DOI 10.1073/pnas.1103125108; CARTIER A, 1989, J ALLERGY CLIN IMMUN, V84, P507, DOI 10.1016/0091-6749(89)90364-3; Cary R, 1999, CONCISE INT CHEM ASS; COOPER JA, 1979, BRIT J CANCER, V39, P87, DOI 10.1038/bjc.1979.10; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cullinan P, 1998, CLIN EXP ALLERGY, V28, P668; Dearman RJ, 2001, J APPL TOXICOL, V21, P153, DOI 10.1002/jat.743; Dearman RJ, 1999, METHODS, V19, P56, DOI 10.1006/meth.1999.0827; DEARMAN RJ, 1992, J APPL TOXICOL, V12, P317, DOI 10.1002/jat.2550120505; DOCKER A, 1987, BRIT J IND MED, V44, P534; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; European Commission, 2008, OJ L, VL353, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerberick GF, 2004, TOXICOL SCI, V81, P332, DOI 10.1093/toxsci/kfh213; Haneke KE, 2001, REGUL TOXICOL PHARM, V34, P274, DOI 10.1006/rtph.2001.1498; Hilton J, 1996, J APPL TOXICOL, V16, P165, DOI 10.1002/(SICI)1099-1263(199603)16:2<165::AID-JAT325>3.0.CO;2-M; Holsapple MP, 2006, TOXICOL SCI, V91, P4, DOI 10.1093/toxsci/kfj074; Hu ZB, 1996, LEUKEMIA, V10, P1025; Huang S, 2013, TOXICOL IN VITRO, V27, P1151, DOI 10.1016/j.tiv.2012.10.010; Institute for Health and Consumer Protection European Chemicals Bureau, 2005, EUR UN RISK ASS REP, V56, P159; Isola D, 2008, J APPL TOXICOL, V28, P249, DOI 10.1002/jat.1336; Johansson H, 2014, TOXICOL SCI, V139, P362, DOI 10.1093/toxsci/kfu046; Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; KAROL MH, 1981, TOXICOL APPL PHARM, V58, P221, DOI 10.1016/0041-008X(81)90426-9; Kimber I, 2003, FOOD CHEM TOXICOL, V41, P1799, DOI 10.1016/S0278-6915(03)00223-0; Kimber I, 2002, TOXICOLOGY, V181, P311, DOI 10.1016/S0300-483X(02)00299-8; Kimber I, 2007, ATLA-ALTERN LAB ANIM, V35, P243, DOI 10.1177/026119290703500212; Kimber I, 2014, TOXICOLOGY, V318, P32, DOI 10.1016/j.tox.2014.02.001; Kopferschmitt-Kubler MC, 2002, EUR RESPIR J, V19, P84, DOI 10.1183/09031936.02.00102202; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lalko JF, 2011, TOXICOL IN VITRO, V25, P433, DOI 10.1016/j.tiv.2010.11.007; Larsson K, 2006, IMMUNOLOGY, V117, P156, DOI 10.1111/j.1365-2567.2005.02274.x; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Masterson AJ, 2002, BLOOD, V100, P701, DOI 10.1182/blood.V100.2.701; Mehling A, 2012, ARCH TOXICOL, V86, P1273, DOI 10.1007/s00204-012-0867-6; Meuleman L, 1999, ALLERGY, V54, P752, DOI 10.1111/j.1398-9995.1999.00103.x; Meyer D, 2014, E1071 MISC FUNCTIONS; Munoz X, 2003, CHEST, V123, P2124, DOI 10.1378/chest.123.6.2124; MURDOCH RD, 1986, BRIT J IND MED, V43, P37; Natsch A, 2011, TOXICOL IN VITRO, V25, P733, DOI 10.1016/j.tiv.2010.12.014; Natsch A, 2010, TOXICOL SCI, V113, P284, DOI 10.1093/toxsci/kfp228; Nukada Y, 2011, CONTACT DERMATITIS, V65, P343, DOI 10.1111/j.1600-0536.2011.01952.x; OECD, 2010, TEST 429 SKIN SENS L, DOI [10.1787/9789264071100-en, DOI 10.1787/9789264071100-EN]; OECD, 2012, OECD ENV HLTH SAF PU, V168, P1, DOI DOI 10.1787/9789264221444-EN; Orriols R, 2006, OCCUP ENVIRON MED, V63, P255, DOI 10.1136/oem.2005.022525; Pauluhn J, 2003, TOXICOLOGY, V194, P1, DOI 10.1016/S0300-483X(03)00285-3; Pauluhn J, 2002, TOXICOLOGY, V171, P147, DOI 10.1016/S0300-483X(01)00571-6; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Quentmeier H, 1996, IMMUNOLOGY, V89, P606, DOI 10.1046/j.1365-2567.1996.d01-780.x; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Sallstad DM, 2003, TOXICOLOGY, V194, P147, DOI 10.1016/S030-483X(03)00338-X; Santegoets SJAM, 2006, J LEUKOCYTE BIOL, V80, P1337, DOI 10.1189/jlb.0206111; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; Scheerens H, 1996, AM J RESP CRIT CARE, V154, P858, DOI 10.1164/ajrccm.154.4.8887575; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tarlo SM, 2014, NEW ENGL J MED, V370, P640, DOI 10.1056/NEJMra1301758; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2003, TOXICOL SCI, V76, P338, DOI 10.1093/toxsci/kfg235; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Verstraelen S, 2008, TOXICOL IN VITRO, V22, P1419, DOI 10.1016/j.tiv.2008.05.008; Verstraelen S, 2009, TOXICOL IN VITRO, V23, P1151, DOI 10.1016/j.tiv.2009.06.007; Verstraelen S, 2009, TOXICOL LETT, V185, P16, DOI 10.1016/j.toxlet.2008.11.017; Verstraelen S, 2009, TOXICOLOGY, V255, P151, DOI 10.1016/j.tox.2008.10.014; Warbrick EV, 2002, J APPL TOXICOL, V22, P1, DOI 10.1002/jat.830; ZAMMITTABONA M, 1983, AM REV RESPIR DIS, V128, P226	81	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118808	10.1371/journal.pone.0118808	http://dx.doi.org/10.1371/journal.pone.0118808			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760038	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000040
J	Nilsson, J; Ohlsson, M; Hoglund, P; Ekmehag, B; Koul, B; Andersson, B				Nilsson, Johan; Ohlsson, Mattias; Hoglund, Peter; Ekmehag, Bjorn; Koul, Bansi; Andersson, Bodil			The International Heart Transplant Survival Algorithm (IHTSA): A New Model to Improve Organ Sharing and Survival	PLOS ONE			English	Article							MORTALITY PREDICTION; UNITED NETWORK; RISK INDEX; DONOR; OUTCOMES; IMPACT; LIMITATIONS; ALLOCATION; REGISTRY; SOCIETY	Background Heart transplantation is life saving for patients with end-stage heart disease. However, a number of factors influence how well recipients and donor organs tolerate this procedure. The main objective of this study was to develop and validate a flexible risk model for prediction of survival after heart transplantation using the largest transplant registry in the world. Methods and Findings We developed a flexible, non-linear artificial neural networks model (IHTSA) and classification and regression tree to comprehensively evaluate the impact of recipient-donor variables on survival over time. We analyzed 56,625 heart-transplanted adult patients, corresponding to 294,719 patient-years. We compared the discrimination power with three existing scoring models, donor risk index (DRI), risk-stratification score (RSS) and index for mortality prediction after cardiac transplantation (IMPACT). The accuracy of the model was excellent (C-index 0.600 [95% CI: 0.595-0.604]) with predicted versus actual 1-year, 5-year and 10-year survival rates of 83.7% versus 82.6%, 71.4% - 70.8%, and 54.8% - 54.3% in the derivation cohort; 83.7% versus 82.8%, 71.5% - 71.1%, and 54.9% - 53.8% in the internal validation cohort; and 84.5% versus 84.4%, 72.9% - 75.6%, and 57.5% - 57.5% in the external validation cohort. The IHTSA model showed superior or similar discrimination in all of the cohorts. The receiver operating characteristic area under the curve to predict one-year mortality was for the IHTSA: 0.650 (95% CI: 0.640-0.655), DRI 0.56 (95% CI: 0.56-0.57), RSS 0.61 (95% CI: 0.60-0.61), and IMPACT 0.61 (0.61-0.62), respectively. The decision-tree showed that recipients matched to a donor younger than 38 years had additional expected median survival time of 2.8 years. Furthermore, the number of suitable donors could be increased by up to 22%. Conclusions We show that the IHTSA model can be used to predict both short-term and long-term mortality with high accuracy globally. The model also estimates the expected benefit to the individual patient.	[Nilsson, Johan; Koul, Bansi] Lund Univ, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden; [Nilsson, Johan; Koul, Bansi] Skane Univ Hosp, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden; [Ohlsson, Mattias] Lund Univ, Dept Astron & Theoret Phys Computat Biol & Biol P, Lund, Sweden; [Hoglund, Peter] Lund Univ, Competence Ctr Clin Res, Lund, Sweden; [Hoglund, Peter] Skane Univ Hosp, Competence Ctr Clin Res, Lund, Sweden; [Ekmehag, Bjorn] Lund Univ, Dept Clin Sci Lund Cardiol, Lund, Sweden; [Ekmehag, Bjorn] Skane Univ Hosp, Dept Clin Sci Lund Cardiol, Lund, Sweden; [Andersson, Bodil] Lund Univ, Dept Clin Sci Lund Surg, Lund, Sweden; [Andersson, Bodil] Skane Univ, Dept Clin Sci Lund Surg, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Lund University	Nilsson, J (corresponding author), Lund Univ, Dept Clin Sci Lund Cardiothorac Surg, Lund, Sweden.	johan.nilsson@med.lu.se	Höglund, Peter/H-4774-2014; Nilsson, Johan/A-4742-2011	Höglund, Peter/0000-0002-8395-922X; Nilsson, Johan/0000-0001-6860-6090; Ohlsson, Mattias/0000-0003-1145-4297	Swedish National Infrastructure for Computing; Swedish Heart-Lung Foundation; Swedish Society of Medicine; Government grant for clinical research; Region Skane Research Funds; Donation Funds of Lund University Hospital; Crafoord Foundation	Swedish National Infrastructure for Computing; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Society of Medicine; Government grant for clinical research; Region Skane Research Funds; Donation Funds of Lund University Hospital; Crafoord Foundation	Funding provided to JN: Swedish National Infrastructure for Computing (http://www.snic.vr.se); JN: Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se); JN: Swedish Society of Medicine (http://www.sls.se); JN: Government grant for clinical research (http://www.skane.se/fou/alf); JN: Region Skane Research Funds (http://www.skane.se/fou); JN: Donation Funds of Lund University Hospital (http://www.skane.se/fou); JN: Crafoord Foundation (http://www.crafoord.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GLOBAL OBSERVATORY D; Ansari D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01922; Anyanwu AC, 1999, EUR J CARDIO-THORAC, V16, P424, DOI 10.1016/S1010-7940(99)00238-9; Biganzoli E, 1998, STAT MED, V17, P1169, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1169::AID-SIM796>3.0.CO;2-D; Breiman L., 1984, CLASSIFICATION REGRE; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Dellgren G, 2013, EUR J HEART FAIL, V15, P308, DOI 10.1093/eurjhf/hfs160; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dickinson DM, 2004, AM J TRANSPLANT, V4, P13, DOI 10.1111/j.1600-6135.2004.00395.x; Dorent R, 2011, J HEART LUNG TRANSPL, V30, P1299, DOI 10.1016/j.healun.2011.06.008; Dronavalli VB, 2010, J AM COLL CARDIOL, V56, P352, DOI 10.1016/j.jacc.2010.02.055; Harrell FE, 2001, REGRESSION MODELING; Hong KN, 2011, ANN THORAC SURG, V92, P520, DOI 10.1016/j.athoracsur.2011.02.086; John R, 2005, SEMIN THORAC CARDIOV, V16, P364; Kattan MW, 1998, COMPUT BIOMED RES, V31, P363, DOI 10.1006/cbmr.1998.1488; Khush KK, 2013, CIRC-HEART FAIL, V6, P300, DOI 10.1161/CIRCHEARTFAILURE.112.000165; Kilic A, 2013, J HEART LUNG TRANSPL, V32, P492, DOI 10.1016/j.healun.2013.02.001; Kilic A, 2012, ANN THORAC SURG, V93, P699, DOI 10.1016/j.athoracsur.2011.09.037; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; Koch A, 2006, THORAC CARDIOV SURG, V54, P414, DOI 10.1055/s-2006-924245; Krakauer H, 2005, J HEART LUNG TRANSPL, V24, P680, DOI 10.1016/j.healun.2004.04.015; Lietz K, 2004, J AM COLL CARDIOL, V43, P1553, DOI 10.1016/j.jacc.2004.02.002; Lippmann RP, 1997, ANN THORAC SURG, V63, P1635, DOI 10.1016/S0003-4975(97)00225-7; Medved D, 2013, STREAMLINING TRANSPL; Nativi JN, 2010, J HEART LUNG TRANSPL, V29, P235, DOI 10.1016/j.healun.2009.05.036; Newson R, 2006, STATA J, V6, P309, DOI 10.1177/1536867X0600600302; OPELZ G, 1994, NEW ENGL J MED, V330, P816, DOI 10.1056/NEJM199403243301203; Patel ND, 2008, CIRCULATION, V118, pS83, DOI 10.1161/CIRCULATIONAHA.107.756866; Pedotti P, 2005, TRANSPLANTATION, V80, P1026, DOI 10.1097/01.tp.0000172215.14630.a1; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; REICHART B, 1992, J HEART LUNG TRANSPL, V11, pS199; Russo MJ, 2007, J THORAC CARDIOV SUR, V133, P554, DOI 10.1016/j.jtcvs.2006.09.019; Russo MJ, 2010, TRANSPLANTATION, V90, P444, DOI 10.1097/TP.0b013e3181e6f1eb; Smits JM, 2012, J HEART LUNG TRANSPL, V31, P387, DOI 10.1016/j.healun.2011.11.005; Stehlik J, 2012, J HEART LUNG TRANSPL, V31, P1052, DOI 10.1016/j.healun.2012.08.002; Thompson David, 2004, Health Care Manag Sci, V7, P331, DOI 10.1007/s10729-004-7541-3; Weiss ES, 2012, J HEART LUNG TRANSPL, V31, P266, DOI 10.1016/j.healun.2011.10.004; Weiss ES, 2011, ANN THORAC SURG, V92, P914, DOI 10.1016/j.athoracsur.2011.04.030; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	40	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118644	10.1371/journal.pone.0118644	http://dx.doi.org/10.1371/journal.pone.0118644			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760647	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000033
J	Young, M; Carr, M				Young, Mary; Carr, Mark			Assessment of Habitat Representation across a Network of Marine Protected Areas with Implications for the Spatial Design of Monitoring	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; REEF FISH ASSEMBLAGE; RIPPLED SCOUR DEPRESSIONS; BIOLOGICAL DIVERSITY; MULTIBEAM BATHYMETRY; CONTINENTAL-SHELF; RESERVE NETWORKS; CALIFORNIA; CONSERVATION; SEA	Networks of marine protected areas (MPAs) are being adopted globally to protect ecosystems and supplement fisheries management. The state of California recently implemented a coast-wide network of MPAs, a statewide seafloor mapping program, and ecological characterizations of species and ecosystems targeted for protection by the network. The main goals of this study were to use these data to evaluate how well seafloor features, as proxies for habitats, are represented and replicated across an MPA network and how well ecological surveys representatively sampled fish habitats inside MPAs and adjacent reference sites. Seafloor data were classified into broad substrate categories (rock and sediment) and finer scale geomorphic classifications standard to marine classification schemes using surface analyses (slope, ruggedness, etc.) done on the digital elevation model derived from multibeam bathymetry data. These classifications were then used to evaluate the representation and replication of seafloor structure within the MPAs and across the ecological surveys. Both the broad substrate categories and the finer scale geomorphic features were proportionately represented for many of the classes with deviations of 1-6% and 0-7%, respectively. Within MPAs, however, representation of seafloor features differed markedly from original estimates, with differences ranging up to 28%. Seafloor structure in the biological monitoring design had mismatches between sampling in the MPAs and their corresponding reference sites and some seafloor structure classes were missed entirely. The geomorphic variables derived from multibeam bathymetry data for these analyses are known determinants of the distribution and abundance of marine species and for coastal marine biodiversity. Thus, analyses like those performed in this study can be a valuable initial method of evaluating and predicting the conservation value of MPAs across a regional network.	[Young, Mary; Carr, Mark] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Young, Mary] Deakin Univ, Ctr Integrat Ecol, Warrnambool, Vic, Australia	University of California System; University of California Santa Cruz; Deakin University	Young, M (corresponding author), Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	mary.young@deakin.edu.au			California Ocean Protection Council; California State Coastal Conservancy; California Department of Fish and Wildlife; NOAA National Marine Sanctuaries; NOAA Office of Coast Survey; Seafloor Mapping Lab at CSUMB; Fugro Pelagos, Inc.; San Diego Office; U. S. Geological Survey; Western Coastal and Marine Geology; Moss Landing Marine Lab; Center for Habitat Studies; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO) [448]; David and Lucile Packard Foundation; Directorate For Geosciences [1232779] Funding Source: National Science Foundation; Division Of Ocean Sciences [1233839] Funding Source: National Science Foundation	California Ocean Protection Council; California State Coastal Conservancy; California Department of Fish and Wildlife; NOAA National Marine Sanctuaries; NOAA Office of Coast Survey; Seafloor Mapping Lab at CSUMB; Fugro Pelagos, Inc.; San Diego Office; U. S. Geological Survey(United States Geological Survey); Western Coastal and Marine Geology; Moss Landing Marine Lab; Center for Habitat Studies; Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors received no specific funding for this project, but the data used in the study were funded by the following: We thank all the partners in the California State Mapping Program for the funding and collection of the data used in this study (California Ocean Protection Council, California State Coastal Conservancy, California Department of Fish and Wildlife, NOAA National Marine Sanctuaries, NOAA Office of Coast Survey, Seafloor Mapping Lab at CSUMB, Fugro Pelagos, Inc., San Diego Office, U. S. Geological Survey, Western Coastal and Marine Geology, Moss Landing Marine Lab, Center for Habitat Studies). Support and data for this study were provided by the Partnership for Interdisciplinary Studies of Coastal Oceans (PISCO; contribution # 448), a Long-Term Ecological Consortium funded by the David and Lucile Packard Foundation.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allen LG, 2006, ECOLOGY OF MARINE FISHES: CALIFORNIA AND ADJACENT WATERS, P1; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Allison GW, 2003, ECOL APPL, V13, pS8; Bianchi Carlo Nike, 2012, Diversity-Basel, V4, P419, DOI 10.3390/d4040419; Botsford LW, 2014, ADV MARINE IN PRESS; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Brown JH, 2011, P NATL ACAD SCI USA, V108, P11735, DOI 10.1073/pnas.1109139108; California Marine Life Protection Act Initiative, 2008, METH US EV DRAFT MPA; Carr MH, 2011, FRONT ECOL ENVIRON, V9, P342, DOI 10.1890/090096; Carr MH, 2003, ECOL APPL, V13, pS90; Carr MH, ECOSYSTEMS IN PRESS; Cavanaugh KC, 2011, MAR ECOL PROG SER, V429, P1, DOI 10.3354/meps09141; Cavanaugh KC, 2010, MAR ECOL PROG SER, V403, P13, DOI 10.3354/meps08467; Clarke JEH, 1996, MAR GEOPHYS RES, V18, P607, DOI 10.1007/BF00313877; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J., 2011, MARINE PROTECTED ARE; Cogan CB, 2009, ICES J MAR SCI, V66, P2033, DOI 10.1093/icesjms/fsp214; Conroy MJ, 1996, ECOL APPL, V6, P763, DOI 10.2307/2269481; Copeland A, 2013, J COAST CONSERV, V17, P225, DOI 10.1007/s11852-011-0172-1; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Dalleau M, 2010, CONSERV BIOL, V24, P541, DOI 10.1111/j.1523-1739.2009.01394.x; Davis ACD, 2013, CONT SHELF RES, V69, P88, DOI 10.1016/j.csr.2013.09.010; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P39, DOI 10.3354/meps064039; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18286, DOI 10.1073/pnas.0906473107; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Gilliland PM, 2008, MAR POLICY, V32, P787, DOI 10.1016/j.marpol.2008.03.022; Gleason M, 2013, OCEAN COAST MANAGE, V74, P90, DOI 10.1016/j.ocecoaman.2012.08.013; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Gleason MG, 2006, FRONT ECOL ENVIRON, V4, P249, DOI 10.1890/1540-9295(2006)004[0249:AGIMCI]2.0.CO;2; GREENE HG, 2004, FISHERIES HABITAT CH; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Hallenbeck TR, 2012, MAR ECOL PROG SER, V468, P119, DOI 10.3354/meps09948; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2012, MAR POLICY, V36, P198, DOI 10.1016/j.marpol.2011.05.004; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hamilton SL, 2010, P NATL ACAD SCI USA, V107, P18272, DOI 10.1073/pnas.0908091107; Iampietro PJ, 2005, MAR TECHNOL SOC J, V39, P83, DOI 10.4031/002533205787442495; Jagielo T, 2003, FISH B-NOAA, V101, P545; Jordan A, 2005, AQUAT CONSERV, V15, P51, DOI 10.1002/aqc.657; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Kvitek R, 2010, OCEAN GLOBE, P75; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lubchenco J, 2003, ECOL APPL, V13, pS3; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; MAPSTONE BD, 1995, ECOL APPL, V5, P401, DOI 10.2307/1942031; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Nasby-Lucas NM, 2002, FISH B-NOAA, V100, P739; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Rees MJ, 2014, DIVERS DISTRIB, V20, P284, DOI 10.1111/ddi.12134; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts DM, 2000, FULLY PROTECTED MARI; Rovere A, 2013, J MAPS, V9, P279, DOI 10.1080/17445647.2013.778081; Rovere A, 2010, J MAPS, V6, P505, DOI 10.4113/jom.2010.1137; Saarman E, 2013, OCEAN COAST MANAGE, V74, P45, DOI 10.1016/j.ocecoaman.2012.08.021; Sobel JA, 2004, MARINE RESERVES GUID; Starr RM, 2010, MAR COAST FISH, V2, P159, DOI 10.1577/C08-056.1; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Ward TJ, 1999, ECOL APPL, V9, P691; Westera M, 2003, J EXP MAR BIOL ECOL, V294, P145, DOI 10.1016/S0022-0981(03)00268-5; Young MA, 2010, MAR ECOL PROG SER, V415, P247, DOI 10.3354/meps08760	66	18	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116200	10.1371/journal.pone.0116200	http://dx.doi.org/10.1371/journal.pone.0116200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760858	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000002
J	Xu, B; Liu, W; Deng, Y; Yang, TY; Feng, S; Xu, ZF				Xu, Bin; Liu, Wei; Deng, Yu; Yang, Tian-Yao; Feng, Shu; Xu, Zhao-Fa			Inhibition of Calpain Prevents Manganese-Induced Cell Injury and Alpha-Synuclein Oligomerization in Organotypic Brain Slice Cultures	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXPOSURE; AGGREGATION; EXPRESSION; CLEAVAGE; CALCIUM; NEURONS; STRESS; DEATH; RAT	Overexposure to manganese has been known to promote alpha-synuclein oligomerization and enhance cellular toxicity. However, the exact mechanism of Mn-induced alpha-synuclein oligomerization is unclear. To explore whether alpha-synuclein oligomerization was associated with the cleavage of alpha-synuclein by calpain, we made a rat brain slice model of manganism and pretreated slices with calpain inhibitor II, a cell-permeable peptide that restricts the activity of calpain. After slices were treated with 400 mu M Mn for 24 h, there were significant increases in the percentage of apoptotic cells, lactate dehydrogenase release, intracellular [Ca2+](i), calpain activity, and the mRNA and protein expression of calpain 1 and alpha-synuclein. Moreover, the number of C- and N-terminal fragments of alpha-synuclein and the amount of alpha-synuclein oligomerization also increased. These results also showed that calpain inhibitor II pretreatment could reduce Mn-induced nerve cell injury and alpha-synuclein oligomerization. Additionally, there was a significant decrease in the number of C- and N-terminal fragments of alpha-synuclein in calpain inhibitor II-pretreated slices. These findings revealed that Mn induced the cleavage of alpha-synuclein protein via overactivation of calpain and subsequent alpha-synuclein oligomerization in cultured slices. Moreover, the cleavage of alpha-synuclein by calpain 1 is an important signaling event in Mn-induced alpha-synuclein oligomerization.	[Xu, Bin; Liu, Wei; Deng, Yu; Yang, Tian-Yao; Feng, Shu; Xu, Zhao-Fa] China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Xu, B (corresponding author), China Med Univ, Sch Publ Hlth, Dept Environm Hlth, Shenyang 110001, Liaoning, Peoples R China.	xubin@mail.cmu.edu.cn			National Natural Science Foundation of China [81372942, 81102098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China, Grant no. 81372942 and 81102098, http://www.nsfc.gov.cn/; http://nsfc.biomart.cn/6a4cc8df8; http://nsfc. biomart.cn/73d4080855. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnandis T, 2014, BIOCHEM J, V459, P355, DOI 10.1042/BJ20130847; Boudia N, 2006, SCI TOTAL ENVIRON, V366, P143, DOI 10.1016/j.scitotenv.2005.09.094; BUROKERKILGORE M, 1993, ANAL BIOCHEM, V208, P387, DOI 10.1006/abio.1993.1066; Criswell SR, 2012, OCCUP ENVIRON MED, V69, P437, DOI 10.1136/oemed-2011-100119; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Fabiani G, 2007, ARQ NEURO-PSIQUIAT, V65, P685, DOI 10.1590/S0004-282X2007000400027; Fukushima T, 2010, NEUROEPIDEMIOLOGY, V34, P18, DOI 10.1159/000255462; Hardy IJ, 2008, CURR OPIN CLIN NUTR, V11, P289, DOI 10.1097/MCO.0b013e3282f9e889; He Y, 2011, ASN NEURO, V3, P13, DOI 10.1042/AN20100025; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Mortimer JA, 2012, NEUROLOGY, V79, P1174, DOI 10.1212/WNL.0b013e3182698ced; Ohnishi M, 2010, BRAIN RES, V1347, P170, DOI 10.1016/j.brainres.2010.05.077; Paillusson S, 2010, J NEUROCHEM, V115, P694, DOI 10.1111/j.1471-4159.2010.06962.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Prasad K, 2012, BRAIN PATHOL, V22, P811, DOI 10.1111/j.1750-3639.2012.00597.x; Ryan BJ, 2014, FREE RADICAL BIO MED, V67, P58, DOI 10.1016/j.freeradbiomed.2013.10.008; Sakaue M, 2005, TOXICOLOGY, V213, P97, DOI 10.1016/j.tox.2005.05.013; Sidoryk-Wegrzynowicz M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-23; Silverman-Gavrila LB, 2013, J NEUROSCI, V33, P1975, DOI 10.1523/JNEUROSCI.3092-12.2013; Singh PK, 2013, ACS CHEM NEUROSCI, V4, P393, DOI 10.1021/cn3001203; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tuschl K, 2013, INT REV NEUROBIOL, V110, P277, DOI 10.1016/B978-0-12-410502-7.00013-2; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Verina T, 2013, TOXICOL LETT, V217, P177, DOI 10.1016/j.toxlet.2012.12.006; VILLALBA M, 1995, NEUROBIOL AGING, V16, P809, DOI 10.1016/0197-4580(95)00087-U; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Xu B, 2014, MOL NEUROBIOL, V49, P399, DOI 10.1007/s12035-013-8527-2; Xu B, 2013, TOXICOLOGY, V305, P71, DOI 10.1016/j.tox.2013.01.006; Xu B, 2009, NEUROTOXICOLOGY, V30, P941, DOI 10.1016/j.neuro.2009.07.011; Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119205	10.1371/journal.pone.0119205	http://dx.doi.org/10.1371/journal.pone.0119205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756858	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700040
J	Ordonez, A; Perez, J; Tan, L; Dickens, JA; Motamedi-Shad, N; Irving, JA; Haq, I; Ekeowa, U; Marciniak, SJ; Miranda, E; Lomas, DA				Ordonez, Adriana; Perez, Juan; Tan, Lu; Dickens, Jennifer A.; Motamedi-Shad, Neda; Irving, James A.; Haq, Imran; Ekeowa, Ugo; Marciniak, Stefan J.; Miranda, Elena; Lomas, David A.			A single-chain variable fragment intrabody prevents intracellular polymerization of Z alpha(1)-antitrypsin while allowing its antiproteinase activity	FASEB JOURNAL			English	Article						monoclonal antibody; scFv intrabody; serpin polymer; liver disease	ENDOPLASMIC-RETICULUM; SERPIN POLYMERIZATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CAUSE DEMENTIA; PRION PROTEIN; DEFICIENCY; LIVER; DISEASE; ACCUMULATION	Mutant Z alpha(1)-antitrypsin (E342K) accumulates as polymers within the endoplasmic reticulum (ER) of hepatocytes predisposing to liver disease, whereas low levels of circulating Z alpha(1)-antitrypsin lead to emphysema by loss of inhibition of neutrophil elastase. The ideal therapy should prevent polymer formation while preserving inhibitory activity. Here we used mAb technology to identify interactors with Z alpha(1)-antitrypsin that comply with both requirements. We report the generation of an mAb (4B12) that blocked alpha(1)-antitrypsin polymerization in vitro at a 1:1 molar ratio, causing a small increase of the stoichiometry of inhibition for neutrophil elastase. Asingle-chain variable fragment (scFv) intrabody was generated based on the sequence of mAb4B12. The expression of scFv4B12 within the ER (scFv4B12(KDEL)) and along the secretory pathway (scFv4B12) reduced the intracellular polymerization of Z alpha(1)-antitrypsin by 60%. The scFv4B12 intrabody also increased the secretion of Z alpha(1)-antitrypsin that retained inhibitory activity against neutrophil elastase. MAb4B12 recognizeda discontinuous epitope probably located in the region of helices A/C/G/H/I and seems to act by altering protein dynamics rather than binding preferentially to the native state. This novel approach could reveal new target sites for small-molecule intervention that may block the transition to aberrant polymers without compromising the inhibitory activity of Z alpha(1)-antitrypsin.	[Ordonez, Adriana; Tan, Lu; Dickens, Jennifer A.; Ekeowa, Ugo; Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Perez, Juan] Univ Malaga, Dept Cell Biol Genet & Physiol, E-29071 Malaga, Spain; [Motamedi-Shad, Neda; Irving, James A.; Haq, Imran; Lomas, David A.] UCL, Wolfson Inst Biomed Res, London, England; [Miranda, Elena] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Dept Biol & Biotechnol, I-00185 Rome, Italy; [Miranda, Elena] Univ Roma La Sapienza, Cenci Bolognetti Fdn, Inst Pasteur, I-00185 Rome, Italy	University of Cambridge; Universidad de Malaga; University of London; University College London; Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Miranda, E (corresponding author), Univ Roma La Sapienza, Cenci Bolognetti Fdn, Dept Biol & Biotechnol, Ple Aldo Moro 5, I-00185 Rome, Italy.	mariaelena.mirandabanos@uniroma1.it; d.lomas@ucl.ac.uk	Irving, James A/I-8467-2015; Irving, James/P-3860-2019	Irving, James/0000-0003-3204-6356; Marciniak, Stefan/0000-0001-8472-7183	Medical Research Council (MRC; United Kingdom); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre; Sackler Studentship; Federation of European Biochemical Studies fellowship; Marie Curie fellowship; GlaxoSmithKline; Alpha1 Foundation; MRC [G1002610]; Pasteur Institute-Cenci Bolognetti Foundation; Telethon Foundation [GGP11057B]; NIHR University College London Hospitals Biomedical Research Centre; MRC [G0901786, G0601840, G1000277] Funding Source: UKRI; Medical Research Council [G0901786, G1000277, G0601840, G1002610] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10070] Funding Source: researchfish	Medical Research Council (MRC; United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Sackler Studentship; Federation of European Biochemical Studies fellowship; Marie Curie fellowship(European Commission); GlaxoSmithKline(GlaxoSmithKline); Alpha1 Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pasteur Institute-Cenci Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Telethon Foundation(Fondazione Telethon); NIHR University College London Hospitals Biomedical Research Centre(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	A.O. and J.A.I. are funded by the Medical Research Council (MRC; United Kingdom). L.T. is supported by the Cambridge National Institute for Health Research (NIHR) Biomedical Research Centre. J.A.D. is an MRC Clinical Training Fellow and the recipient of a Sackler Studentship. N.M.-S. is supported by Federation of European Biochemical Studies and Marie Curie fellowships. I.H. is funded by GlaxoSmithKline. S.J.M. is an MRC Senior Clinical Fellow. This work was supported by the Alpha1 Foundation (Pilot and Feasibility Grant 2010 to D.A.L., E.M., and J.P.), the MRC (to D.A.L. and G1002610 to S.J.M.), the Pasteur Institute-Cenci Bolognetti Foundation and the Telethon Foundation (Grant GGP11057B to E.M.), and the NIHR University College London Hospitals Biomedical Research Centre (to D.A.L.). E.M. and D.A.L. share senior authorship of this article. The authors declare no conflicts of interest.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; BIOCCA S, 1995, TRENDS CELL BIOL, V5, P248, DOI 10.1016/S0962-8924(00)89019-4; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Boldicke T, 2012, METHODS, V56, P338, DOI 10.1016/j.ymeth.2011.10.008; Brantl S, 2002, BBA-GENE STRUCT EXPR, V1575, P15, DOI 10.1016/S0167-4781(02)00280-4; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brocks B, 1997, IMMUNOTECHNOLOGY, V3, P173, DOI 10.1016/S1380-2933(97)00011-0; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cardinale A, 2005, J BIOL CHEM, V280, P685, DOI 10.1074/jbc.M407360200; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Cardinale A, 2008, CURR MOL MED, V8, P2; Cardinale Alessio, 2013, Int J Cell Biol, V2013, P710406, DOI 10.1155/2013/710406; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chang YP, 2006, AM J RESP CELL MOL, V35, P540, DOI 10.1165/rcmb.2005-0207OC; Devlin GL, 2002, J MOL BIOL, V324, P859, DOI 10.1016/S0022-2836(02)01088-4; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; Filesi I, 2007, J NEUROCHEM, V101, P1516, DOI 10.1111/j.1471-4159.2006.04439.x; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Fra AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038405; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; Miranda E, 2004, J BIOL CHEM, V279, P28283, DOI 10.1074/jbc.M313166200; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Sharp LK, 2006, FEBS J, V273, P2540, DOI 10.1111/j.1742-4658.2006.05262.x; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Ulrich Henning, 2005, Med Chem, V1, P199; Wang ZD, 2000, J IMMUNOL METHODS, V233, P167, DOI 10.1016/S0022-1759(99)00184-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	48	35	39	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2667	2678		10.1096/fj.14-267351	http://dx.doi.org/10.1096/fj.14-267351			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757566	Green Published, hybrid			2022-12-26	WOS:000355209500041
J	Russwurm, C; Koesling, D; Russwurm, M				Russwurm, Corina; Koesling, Doris; Russwurm, Michael			Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase Anchoring Protein (AKAP); Cell Signaling; Cyclic AMP (cAMP); Phosphodiesterases; Protein Complex; Protein Kinase A (PKA)	DEPENDENT PROTEIN-KINASE; CAMP-SPECIFIC PHOSPHODIESTERASE; NUCLEOTIDE PHOSPHODIESTERASE; ENRICHED PHOSPHODIESTERASE; SUBCELLULAR-LOCALIZATION; PDE10A; PHOSPHORYLATION; ACTIVATION; CGMP; CALCINEURIN	Background: In striatum, cortical glutamatergic and midbrain dopaminergic inputs are integrated via cAMP. Results: PDE10A, the major cAMP-hydrolyzing enzyme in striatum, is targeted into a signaling complex containing the scaffolding proteins AKAP150, PSD95, and the NMDA receptor and released upon phosphorylation. Conclusion: Targeting of PDE10 is under control of cAMP/PKA activity. Significance: Phosphorylation-dependent release of PDE10 gives rise to a feed forward mechanism. Phosphodiesterase 10A (PDE10A) is a dual substrate PDE that can hydrolyze both cGMP and cAMP. In brain, PDE10A is almost exclusively expressed in the striatum. In several studies, PDE10A has been implicated in regulation of striatal output using either specific inhibitors or PDE10A knock-out mice and has been suggested as a promising target for novel antipsychotic drugs. In striatal medium spiny neurons, PDE10A is localized at the plasma membrane and in dendritic spines close to postsynaptic densities. In the present study, we identify PDE10A as the major cAMP PDE in mouse striatum and monitor PKA-dependent PDE10A phosphorylation. With recombinantly expressed PDE10A we demonstrate that phosphorylation does not alter PDE10A activity. In striatum, PDE10A was found to be associated with the A kinase anchoring protein AKAP150 suggesting the existence of a multiprotein signaling complex localizing PDE10A to a specific functional context at synaptic membranes. Furthermore, the cAMP effector PKA, the NMDA receptor subunits NR2A and -B, as well as PSD95, were tethered to the complex. In agreement, PDE10A was almost exclusively found in multiprotein complexes as indicated by migration in high molecular weight fractions in size exclusion chromatography. Finally, affinity of PDE10A to the signaling complexes formed around AKAP150 was reduced by PDE10A phosphorylation. The data indicate that phosphorylation of PDE10 has an impact on the interaction with other signaling proteins and adds an additional line of complexity to the role of PDE10 in regulation of synaptic transmission.	[Russwurm, Corina; Koesling, Doris; Russwurm, Michael] Ruhr Univ Bochum, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany	Ruhr University Bochum	Russwurm, M (corresponding author), Ruhr Univ Bochum, Fak Med, Inst Pharmakol & Toxikol, D-44780 Bochum, Germany.	michael.russwurm@ruhr-uni-bochum.de			Deutsche Forschungsgemeinschaft [KO 1157/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KO 1157/4-1.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 2000, EUR J BIOCHEM, V267, P5943, DOI 10.1046/j.1432-1327.2000.01661.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; GRANT PG, 1988, P NATL ACAD SCI USA, V85, P9071, DOI 10.1073/pnas.85.23.9071; Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; Jager R, 2010, BRIT J PHARMACOL, V161, P1645, DOI 10.1111/j.1476-5381.2010.00977.x; Kapur S, 2004, TRENDS PHARMACOL SCI, V25, P402, DOI 10.1016/j.tips.2004.06.005; Kotera J, 2004, J BIOL CHEM, V279, P4366, DOI 10.1074/jbc.M308471200; Kotera J, 1999, BIOCHEM BIOPH RES CO, V261, P551, DOI 10.1006/bbrc.1999.1013; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; Nishi A, 1999, J NEUROCHEM, V72, P2015, DOI 10.1046/j.1471-4159.1999.0722015.x; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nishi A, 2010, J PHARMACOL SCI, V114, P6, DOI 10.1254/jphs.10R01FM; O'Connor V, 2004, J BIOL CHEM, V279, P15841, DOI 10.1074/jbc.M312500200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ostroveanu A, 2007, BRAIN RES, V1145, P97, DOI 10.1016/j.brainres.2007.01.117; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Russwurm M, 2001, J BIOL CHEM, V276, P44647, DOI 10.1074/jbc.M105587200; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SETTE C, 1994, J BIOL CHEM, V269, P9245; SHARMA RK, 1985, P NATL ACAD SCI USA, V82, P2603, DOI 10.1073/pnas.82.9.2603; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wyatt TA, 1998, AM J PHYSIOL-HEART C, V274, pH448, DOI 10.1152/ajpheart.1998.274.2.H448; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200	54	28	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					11936	11947		10.1074/jbc.M114.595769	http://dx.doi.org/10.1074/jbc.M114.595769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25762721	Green Published, hybrid			2022-12-26	WOS:000354388600012
J	Frey, DL; Gagnon, P				Frey, Desta L.; Gagnon, Patrick			Thermal and Hydrodynamic Environments Mediate Individual and Aggregative Feeding of a Functionally Important Omnivore in Reef Communities	PLOS ONE			English	Article							GREEN SEA-URCHIN; STRONGYLOCENTROTUS-DROEBACHIENSIS; INTERSPECIFIC INTERACTIONS; GONAD GROWTH; TEMPERATURE; MARINE; KELP; DYNAMICS; ADAPTATION; STABILITY	In eastern Canada, the destruction of kelp beds by dense aggregations (fronts) of the omnivorous green sea urchin, Strongylocentrotus droebachiensis, is a key determinant of the structure and dynamics of shallow reef communities. Recent studies suggest that hydrodynamic forces, but not sea temperature, determine the strength of urchin-kelp interactions, which deviates from the tenets of the metabolic theory of ecology (MTE). We tested the hypothesis that water temperature can predict short-term kelp bed destruction by S. droebachiensis in calm hydrodynamic environments. Specifically, we experimentally determined relationships among water temperature, body size, and individual feeding in the absence of waves, as well as among wave velocity, season, and aggregative feeding. We quantified variation in kelp-bed boundary dynamics, sea temperature, and wave height over three months at one subtidal site in Newfoundland to test the validity of thermal tipping ranges and regression equations derived from laboratory results. Consistent with the MTE, individual feeding during early summer (June-July) obeyed a non-linear, size-and temperature-dependent relationship: feeding in large urchins was consistently highest and positively correlated with temperature <12 degrees C and dropped within and above the 12-15 degrees C tipping range. This relationship was more apparent in large than small urchins. Observed and expected rates of kelp loss based on sea temperature and urchin density and size structure at the front were highly correlated and differed by one order of magnitude. The present study speaks to the importance of considering body size and natural variation in sea temperature in studies of urchin-kelp interactions. It provides the first compelling evidence that sea temperature, and not only hydrodynamic forces, can predict kelp bed destruction by urchin fronts in shallow reef communities. Studying urchin-seaweed-predator interactions within the conceptual foundations of the MTE holds high potential for improving capacity to predict and manage shifts in marine food web structure and productivity.	[Frey, Desta L.; Gagnon, Patrick] Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada	Memorial University Newfoundland	Gagnon, P (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, Ctr Ocean Sci, St John, NF A1C 5S7, Canada.	pgagnon@mun.ca		Gagnon, Patrick/0000-0001-5834-0217	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Research and Development Corporation of Newfoundland and Labrador	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Research and Development Corporation of Newfoundland and Labrador	Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), and Research and Development Corporation of Newfoundland and Labrador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blain C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098204; Blain C, 2013, J EXP MAR BIOL ECOL, V440, P176, DOI 10.1016/j.jembe.2012.12.013; BREEN PA, 1976, J FISH RES BOARD CAN, V33, P1278, DOI 10.1139/f76-164; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bruno JF, 2001, MARINE COMMUNITY ECOLOGY, P201; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Caines S, 2012, MAR BIOL, V159, P1817, DOI 10.1007/s00227-012-1972-z; Chen Q, 2005, J WATERW PORT COAST, V131, P137, DOI 10.1061/(ASCE)0733-950X(2005)131:4(137); CONOVER W. J, 1980, PRACTICAL NONPARAMET; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denny M. W., 1988, BIOL MECH WAVE SWEPT; Dong YW, 2009, J EXP BIOL, V212, P169, DOI 10.1242/jeb.024505; Eckman JE, 2003, MAR ECOL PROG SER, V265, P45, DOI 10.3354/meps265045; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; Feehan C, 2012, MAR ECOL PROG SER, V444, P69, DOI 10.3354/meps09441; Gagnon P, 2003, MAR ECOL PROG SER, V258, P125, DOI 10.3354/meps258125; Gagnon P, 2005, J PHYCOL, V41, P498, DOI 10.1111/j.1529-8817.2005.00078.x; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Gagnon P, 2006, J EXP MAR BIOL ECOL, V334, P10, DOI 10.1016/j.jembe.2006.01.012; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gracey AY, 2008, CURR BIOL, V18, P1501, DOI 10.1016/j.cub.2008.08.049; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2013, ANN NY ACAD SCI, V1297, P73, DOI 10.1111/nyas.12228; HIMMELMAN J H, 1984, Naturaliste Canadien (Quebec), V111, P337; HIMMELMAN JH, 1986, MAR ECOL PROG SER, V33, P295, DOI 10.3354/meps033295; HIMMELMAN JH, 1969, THESIS MEMORIAL U NE; Jenkins SR, 2001, J EXP MAR BIOL ECOL, V258, P123, DOI 10.1016/S0022-0981(01)00211-8; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Kawamata S, 1998, J EXP MAR BIOL ECOL, V224, P31, DOI 10.1016/S0022-0981(97)00165-2; Kleinbaum D.G., 2008, APPL REGRESSION ANAL; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; LARSON BR, 1980, MAR BIOL, V59, P49, DOI 10.1007/BF00396982; Lauzon-Guay JS, 2007, MAR BIOL, V151, P2109, DOI 10.1007/s00227-007-0668-2; Lauzon-Guay JS, 2007, MAR ECOL PROG SER, V329, P191, DOI 10.3354/meps329191; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; Lauzon-Guay JS, 2009, MAR ECOL PROG SER, V375, P25, DOI 10.3354/meps07758; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI [10.1029/2004JC002711, 10.1029/2004JC002788]; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Matheson K, 2012, J EXP MAR BIOL ECOL, V414, P6, DOI 10.1016/j.jembe.2012.01.006; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; MILLER RJ, 1973, MAR BIOL, V18, P99, DOI 10.1007/BF00348685; MUNDA IM, 1977, HELGOLAND WISS MEER, V29, P311, DOI 10.1007/BF01614267; NOAA, 2001, NOAA DIV MAN DIV SCI; O'Connor MI, 2011, AM NAT, V178, P626, DOI 10.1086/662171; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; PERCY JA, 1972, PHYSIOL ZOOL, V45, P277, DOI 10.1086/physzool.45.4.30155584; Poore AGB, 2013, OECOLOGIA, V173, P1113, DOI 10.1007/s00442-013-2683-y; Rilov G, 2005, MAR BIOL, V147, P421, DOI 10.1007/s00227-005-1568-y; Robles CD, 2001, OECOLOGIA, V128, P142, DOI 10.1007/s004420100638; ROCHETTE R, 1994, MAR ECOL PROG SER, V106, P93, DOI 10.3354/meps106093; Sanford E, 2002, INTEGR COMP BIOL, V42, P881, DOI 10.1093/icb/42.4.881; Scheibling RE, 2007, DEV AQUAC FISH SCI, V37, P353, DOI 10.1016/S0167-9309(07)80082-2; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; SCHEINER M, 2001, DESIGN ANAL ECOLOGIC; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Siikavuopio SI, 2006, AQUACULTURE, V255, P389, DOI 10.1016/j.aquaculture.2005.12.021; Siikavuopio SI, 2008, AQUACULTURE, V281, P77, DOI 10.1016/j.aquaculture.2008.05.033; Smee DL, 2010, ECOLOGY, V91, P1391, DOI 10.1890/09-0017.1; Snedecor G.W., 1989, AMES IOWA STATE U PR; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Taylor DL, 2003, MAR ECOL PROG SER, V263, P217, DOI 10.3354/meps263217; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; VADAS RL, 1977, ECOL MONOGR, V47, P337, DOI 10.2307/1942173; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1	69	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118583	10.1371/journal.pone.0118583	http://dx.doi.org/10.1371/journal.pone.0118583			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774674	Green Accepted, gold, Green Published			2022-12-26	WOS:000351183500031
J	Hoylaerts, MF; Van Kerckhoven, S; Kiffer-Moreira, T; Sheen, C; Narisawa, S; Millan, JL				Hoylaerts, Marc F.; Van Kerckhoven, Soetkin; Kiffer-Moreira, Tina; Sheen, Campbell; Narisawa, Sonoko; Millan, Jose Luis			Functional Significance of Calcium Binding to Tissue-Nonspecific Alkaline Phosphatase	PLOS ONE			English	Article							STRUCTURAL EVIDENCE; MATRIX VESICLES; SWISS-MODEL; BONE; MECHANISM; PLATE; ZINC	The conserved active site of alkaline phosphatases (AP) contains catalytically important Zn2+ (M1 and M2) and Mg2+-sites (M3) and a fourth peripheral Ca2+ site (M4) of unknown significance. We have studied Ca2+ binding to M1-4 of tissue-nonspecific AP (TNAP), an enzyme crucial for skeletal mineralization, using recombinant TNAP and a series of M4 mutants. Ca2+ could substitute for Mg2+ at M3, with maximal activity for Ca2+/Zn2+-TNAP around 40% that of Mg2+/Zn2+-TNAP at pH 9.8 and 7.4. At pH 7.4, allosteric TNAP-activation at M3 by Ca2+ occurred faster than by Mg2+. Several TNAP M4 mutations eradicated TNAP activity, while others mildly influenced the affinity of Ca2+ and Mg2+ for M3 similarly, excluding a catalytic role for Ca2+ in the TNAP M4 site. At pH 9.8, Ca2+ competed with soluble Zn2+ for binding to M1 and M2 up to 1 mM and at higher concentrations, it even displaced M1- and M2-bound Zn2+, forming Ca2+/Ca2+-TNAP with a catalytic activity only 4-6% that of Mg2+/Zn2+-TNAP. At pH 7.4, competition with Zn2+ and its displacement from M1 and M2 required >10-fold higher Ca2+ concentrations, to generate weakly active Ca2+/Ca2+-TNAP. Thus, in a Ca2+-rich environment, such as during skeletal mineralization at pH 7.4, Ca2+ adequately activates Zn2+-TNAP at M3, but very high Ca2+ concentrations compete with available Zn2+ for binding to M1 and M2 and ultimately displace Zn2+ from the active site, virtually inactivating TNAP. Those ALPL mutations that substitute critical TNAP amino acids involved in coordinating Ca2+ to M4 cause hypophosphatasia because of their 3D-structural impact, but M4-bound Ca2+ is catalytically inactive. In conclusion, during skeletal mineralization, the building Ca2+ gradient first activates TNAP, but gradually inactivates it at high Ca2+ concentrations, toward completion of mineralization.	[Hoylaerts, Marc F.; Van Kerckhoven, Soetkin] Univ Leuven, Ctr Mol & Vasc Biol, Dept Cardiovasc Sci, Leuven, Belgium; [Kiffer-Moreira, Tina; Sheen, Campbell; Narisawa, Sonoko; Millan, Jose Luis] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA	KU Leuven; Sanford Burnham Prebys Medical Discovery Institute	Millan, JL (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, La Jolla, CA 92037 USA.	millan@sanfordburnham.org		Hoylaerts, Marc/0000-0002-6474-3933	National Institute of Dental and Craniofacial Research [R01 DE 12889]; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA [R01 AR53102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053102] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	R01 DE 12889 from the National Institute of Dental and Craniofacial Research and R01 AR53102 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health USA.	Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; CATHALA G, 1975, J BIOL CHEM, V250, P6046; CATHALA G, 1975, J BIOL CHEM, V250, P6040; Ciancaglini P, 2010, J BONE MINER RES, V25, P716, DOI 10.1359/jbmr.091023; DEBERNARD B, 1986, J CELL BIOL, V103, P1615, DOI 10.1083/jcb.103.4.1615; Di Mauro S, 2002, J BONE MINER RES, V17, P1383, DOI 10.1359/jbmr.2002.17.8.1383; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Gomez S, 1999, BONE, V25, P33, DOI 10.1016/S8756-3282(99)00102-7; GREENWALD I, 1945, J BIOL CHEM, V161, P697; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hoylaerts MF, 2006, BIOCHEMISTRY-US, V45, P9756, DOI 10.1021/bi052471+; HOYLAERTS MF, 1992, BIOCHEM J, V286, P23, DOI 10.1042/bj2860023; Hoylaerts MF, 1997, J BIOL CHEM, V272, P22781, DOI 10.1074/jbc.272.36.22781; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiffer-Moreira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089374; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Le Du MH, 2002, J BIOL CHEM, V277, P49808, DOI 10.1074/jbc.M207394200; Leone FA, 1997, J INORG BIOCHEM, V68, P123, DOI 10.1016/S0162-0134(97)00047-0; Llinas P, 2005, J MOL BIOL, V350, P441, DOI 10.1016/j.jmb.2005.04.068; Lowe NM, 2004, J NUTR, V134, P2178, DOI 10.1093/jn/134.9.2178; Fernandez JM, 2014, BIOMETALS, V27, P601, DOI 10.1007/s10534-014-9733-8; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MCLEAN FM, 1987, J BIOL CHEM, V262, P10481; Millan J.L., 2006, MAMMALIAN ALKALINE P; Millan JL, 2008, J BONE MINER RES, V23, P777, DOI 10.1359/JBMR.071213; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Nakano Y, 2007, BONE, V41, P549, DOI 10.1016/j.bone.2007.06.011; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sekiya F, 1996, J BIOL CHEM, V271, P8541, DOI 10.1074/jbc.271.15.8541; Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH933, DOI 10.1152/ajpheart.00374.2014; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x	34	23	24	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119874	10.1371/journal.pone.0119874	http://dx.doi.org/10.1371/journal.pone.0119874			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775211	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500135
J	Kobus, K; Hartl, D; Ott, CE; Osswald, M; Huebner, A; von der Hagen, M; Emmerich, D; Kuhnisch, J; Morreau, H; Hes, FJ; Mautner, VF; Harder, A; Tinschert, S; Mundlos, S; Kolanczyk, M				Kobus, Karolina; Hartl, Daniela; Ott, Claus Eric; Osswald, Monika; Huebner, Angela; von der Hagen, Maja; Emmerich, Denise; Kuehnisch, Jirko; Morreau, Hans; Hes, Frederik J.; Mautner, Victor F.; Harder, Anja; Tinschert, Sigrid; Mundlos, Stefan; Kolanczyk, Mateusz			Double NF1 Inactivation Affects Adrenocortical Function in NF1Prx1 Mice and a Human Patient	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; MITOCHONDRIAL KINASE COMPLEX; NEUROFIBROMATOSIS TYPE-1; ADRENAL-GLAND; STEROIDOGENIC ACTIVITY; PRECOCIOUS PUBERTY; BLOOD-PRESSURE; MOUSE; GROWTH; GENE	Background Neurofibromatosis type I (NF1, MIM#162200) is a relatively frequent genetic condition, which predisposes to tumor formation. Apart from tumors, individuals with NF1 often exhibit endocrine abnormalities such as precocious puberty (2,5-5% of NF1 patients) and some cases of hypertension (16% of NF1 patients). Several cases of adrenal cortex adenomas have been described in NF1 individuals supporting the notion that neurofibromin might play a role in adrenal cortex homeostasis. However, no experimental data were available to prove this hypothesis. Materials and Methods We analysed Nf1Prx1 mice and one case of adrenal cortical hyperplasia in a NF1patient. Results In Nf1Prx1 mice Nf1 is inactivated in the developing limbs, head mesenchyme as well as in the adrenal gland cortex, but not the adrenal medulla or brain. We show that adrenal gland size is increased in NF1Prx1 mice. Nf1Prx1 female mice showed corticosterone and aldosterone overproduction. Molecular analysis of Nf1 deficient adrenals revealed deregulation of multiple proteins, including steroidogenic acute regulatory protein (StAR), a vital mitochondrial factor promoting transfer of cholesterol into steroid making mitochondria. This was associated with a marked upregulation of MAPK pathway and a female specific increase of cAMP concentration in murine adrenal lysates. Complementarily, we characterized a patient with neurofibromatosis type I with macronodular adrenal hyperplasia with ACTH-independent cortisol overproduction. Comparison of normal control tissue-and adrenal hyperplasia-derived genomic DNA revealed loss of heterozygosity (LOH) of the wild type NF1 allele, showing that biallelic NF1 gene inactivation occurred in the hyperplastic adrenal gland. Conclusions Our data suggest that biallelic loss of Nf1 induces autonomous adrenal hyper-activity. We conclude that Nf1 is involved in the regulation of adrenal cortex function in mice and humans.	[Kobus, Karolina; Hartl, Daniela; Kuehnisch, Jirko; Mundlos, Stefan; Kolanczyk, Mateusz] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Kobus, Karolina; Ott, Claus Eric; Osswald, Monika; Emmerich, Denise; Kuehnisch, Jirko; Mundlos, Stefan; Kolanczyk, Mateusz] Max Planck Inst Mol Genet, FG Dev & Dis, D-14195 Berlin, Germany; [Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Morreau, Hans] Leiden Univ Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands; [Hes, Frederik J.] Leiden Univ Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Mautner, Victor F.] Univ Hosp Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Harder, Anja] Univ Hosp Munster, Inst Neuropathol, Munster, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Huebner, Angela] Tech Univ Dresden, Klin Kinder & Jugendmed, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany; [von der Hagen, Maja] Tech Univ Dresden, Abt Neuropadiatrie, Med Fak Carl Gustav Carus, D-01062 Dresden, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Medical University of Innsbruck; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Kobus, K (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	kolanshy@molgen.mpg.de; kobus@molgen.mp.de	Kühnisch, Jirko/L-7761-2013; Ott, Claus/U-8226-2019; Kühnisch, Jirko/M-3744-2019; Mundlos, Stefan/ABH-9585-2020; Ott, Claus E/G-1936-2011	Ott, Claus/0000-0003-3627-3791; Kühnisch, Jirko/0000-0003-4744-5421; Ott, Claus E/0000-0003-3627-3791; Hes, Frederik/0000-0002-3025-0882; Jahn, Denise/0000-0001-8912-5851; Mundlos, Stefan/0000-0002-9788-3166; Harder, nee Klose, Anja/0000-0002-3045-2222	Bundesministerium fur Bildung und Forschung (BMBF) [NF1-01GM0844]; Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant [89735103]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant	MK was supported by the grant from Bundesministerium fur Bildung und Forschung (BMBF), Grant NF1-01GM0844. KK was supported by the grant from Bundesverband Neurofibromatose Von Recklinghausen Gesellschaft e.V. Grant #89735103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Baasanjav S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-110; Banerjee S, 2010, CANCER RES, V70, P1356, DOI 10.1158/0008-5472.CAN-09-2178; Biagi P, 1999, J INTERN MED, V246, P509, DOI 10.1046/j.1365-2796.1999.00577.x; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Burnichon N, 2012, HUM MOL GENET, V21, P5397, DOI 10.1093/hmg/dds374; Daginakatte GC, 2008, CANCER RES, V68, P10358, DOI 10.1158/0008-5472.CAN-08-2506; Dang I, 2011, NEUROCHEM RES, V36, P1697, DOI 10.1007/s11064-011-0433-2; DASTON MM, 1992, DEV DYNAM, V195, P216, DOI 10.1002/aja.1001950307; de Joussineau C, 2012, MOL CELL ENDOCRINOL, V351, P28, DOI 10.1016/j.mce.2011.10.006; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; DOMALIK LJ, 1991, MOL ENDOCRINOL, V5, P1853, DOI 10.1210/mend-5-12-1853; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Gottfried ON, NEUROSURG FOCUS, V28, pE8, DOI [10.3171/2010.3.FOCUS09324, DOI 10.3171/2010.3.FOCUS09324]; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; GUTMANN DH, 1994, GENE CHROMOSOME CANC, V10, P55, DOI 10.1002/gcc.2870100109; Habiby R, 1997, J PEDIATR-US, V131, P786, DOI 10.1016/S0022-3476(97)70117-3; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Hegedus B, 2008, HUM MOL GENET, V17, P2956, DOI 10.1093/hmg/ddn194; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102; Kim HA, 2001, J NEUROSCI, V21, P1110; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kolanczyk M, 2007, HUM MOL GENET, V16, P874, DOI 10.1093/hmg/ddm032; Korf BR, 2013, HAND CLINIC, V111, P333, DOI 10.1016/B978-0-444-52891-9.00039-7; Kossler N, 2011, HUM MOL GENET, V20, P2697, DOI 10.1093/hmg/ddr149; Lama G, 2004, PEDIATR NEPHROL, V19, P413, DOI 10.1007/s00467-003-1397-5; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Lumbroso S, 2002, J PEDIATR ENDOCR MET, V15, P875; Manna PR, 2006, MOL ENDOCRINOL, V20, P362, DOI 10.1210/me.2004-0526; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; Miller WL, 1999, J STEROID BIOCHEM, V69, P131, DOI 10.1016/S0960-0760(98)00153-8; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nebrich G, 2007, ELECTROPHORESIS, V28, P1607, DOI 10.1002/elps.200600656; NOWAK KW, 1995, LIFE SCI, V57, P833, DOI 10.1016/0024-3205(95)02015-B; Ott CE, 2010, HUM MUTAT, V31, pE1587, DOI 10.1002/humu.21298; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Paz C, 2009, METHOD ENZYMOL, V457, P169, DOI 10.1016/S0076-6879(09)05010-1; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Riccardi VM, 2010, BIRTH DEFECTS RES A, V88, P9, DOI 10.1002/bdra.20616; Roth TM, 2008, AM J MED GENET A, V146A, P1624, DOI 10.1002/ajmg.a.32301; SARTORI P, 1989, ACTA PAEDIATR SCAND, V78, P476, DOI 10.1111/j.1651-2227.1989.tb11116.x; Saruhan BG, 2005, SAUDI MED J, V26, P1705; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Tedesco MA, 2001, AM J HYPERTENS, V14, P559, DOI 10.1016/S0895-7061(00)01303-0; Tron'ko M D, 2008, Ukr Biokhim Zh (1999), V80, P65; Ueda K, 2013, AM J MED GENET A, V161A, P1154, DOI 10.1002/ajmg.a.35829; Virdis R, 2000, J PEDIATR ENDOCR MET, V13, P841; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101; ZOLLER M, 1995, ACTA DERM-VENEREOL, V75, P136	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119030	10.1371/journal.pone.0119030	http://dx.doi.org/10.1371/journal.pone.0119030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775093	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500062
J	Luo, ST; Chiang, PS; Chung, WY; Chia, MY; Tsao, KC; Wang, YH; Lin, TY; Lee, MS				Luo, Shu-Ting; Chiang, Pai-Shan; Chung, Wan-Yu; Chia, Min-Yuan; Tsao, Kuo-Chien; Wang, Ying-Hsiang; Lin, Tzou-Yien; Lee, Min-Shi			Reemergence of Enterovirus 71 Epidemic in Northern Taiwan, 2012	PLOS ONE			English	Article							YOUNG-CHILDREN; MOUTH-DISEASE; INFECTIONS; COXSACKIEVIRUS; CHINA; FOOT; HAND	Background Enterovirus 71 (EV71) belongs to picornavirus family and could be classified phylogenetically into three major genogroups (A, B and C) including 11 genotypes (A, B1-B5 and C1C5). Since 1997, EV71 has caused large-scale of epidemics with neurological complications in Asian children. In Taiwan, nationwide EV71 epidemics with different predominant genotypes have occurred cyclically since 1998. A nationwide EV71 epidemic occurred again in 2012. We conducted genetic and antigenic characterizations of the 2012 epidemic. Methods Chang Gung Memorial Hospital (CGMH) is a medical center in northern Taiwan. In CGMH, specimens were collected from pediatric inpatients with suspected enterovirus infections for virus isolation. Enterovirus isolates were serotyped and genotyped and sera from EV71 inpatients were collected for measuring neutralizing antibody titers. Results There were 10, 16 and 99 EV71 inpatients identified in 2010, 2011 and 2012, respectively. There were 82 EV71 isolates genotyped, which identified 17 genotype C4a viruses and 65 genotype B5 viruses. The genotype B5 viruses were not detected until November 2011 and caused epidemics in 2012. Interestingly, the B5-2011 viruses were genetically distinguishable from the B5 viruses causing the 2008 epidemic and are likely introduced from China or Southeastern Asia. Based on antigenic analysis, minor antigenic variations were detected among the B5-2008, B5-2011, C4a-2008 and C4a-2012 viruses but these viruses antigenically differed from genotype A. Conclusions Genotype B5 and C4a viruses antigenically differ from genotype A viruses which have disappeared globally for 30 years but have been detected in China since 2008. Enterovirus surveillance should monitor genetic and antigenic variations of EV71.	[Luo, Shu-Ting; Chiang, Pai-Shan; Chung, Wan-Yu; Chia, Min-Yuan; Lee, Min-Shi] NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan; [Tsao, Kuo-Chien] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Gueishan Town, Taoyuan County, Taiwan; [Tsao, Kuo-Chien] Linkou Chang Gung Mem Hosp, Dept Lab Med, Gueishan Town, Taoyuan County, Taiwan; [Wang, Ying-Hsiang] Chiayi Chang Gung Mem Hosp, Dept Pediat, Puzi City, Chiayi County, Taiwan; [Lin, Tzou-Yien] Linkou Chang Gung Mem Hosp, Dept Pediat, Gueishan Town, Taoyuan County, Taiwan; [Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Gueishan Town, Taoyuan County, Taiwan	National Health Research Institutes - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, MS (corresponding author), NHRI, Natl Inst Infect Dis & Vaccinol, Zhunan Town, Miaoli County, Taiwan.	minshi@nhri.org.tw	Lee, Min-Shi/E-3992-2010		National Science Council [NSC101-2811-B-400-026]; Taiwan and National Health Research Institutes	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan and National Health Research Institutes	This study was funded by the National Science Council (NSC101-2811-B-400-026), Taiwan and National Health Research Institutes. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chia MY, 2014, PEDIATR NEONATOL, V55, P243, DOI 10.1016/j.pedneo.2013.07.007; Chua K B, 2007, Malays J Pathol, V29, P69; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang MC, 2006, PEDIATRICS, V118, pE1785, DOI 10.1542/peds.2006-1547; Huang ML, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002067; Huang ML, 2010, J VIROL METHODS, V165, P42, DOI 10.1016/j.jviromet.2009.12.015; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080942; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Thoa LPK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069895; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001737; Lee MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001476; Lee MS, 2010, PEDIATR INFECT DIS J, V29, P1030, DOI 10.1097/INF.0b013e3181e52945; Lin TL, 2008, J CLIN MICROBIOL, V46, P785, DOI 10.1128/JCM.01114-07; Luo ST, 2009, EMERG INFECT DIS, V15, P581, DOI 10.3201/eid1504.081550; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Rao CD, 2012, EMERG INFECT DIS, V18, P1833, DOI 10.3201/eid1811.111457; Seiff A, 2012, LANCET, V380, P205, DOI 10.1016/S0140-6736(12)61200-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Wu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083711; Yang Z, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01112-13; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	28	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116322	10.1371/journal.pone.0116322	http://dx.doi.org/10.1371/journal.pone.0116322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774888	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500006
J	Tekari, A; Luginbuehl, R; Hofstetter, W; Egli, RJ				Tekari, Adel; Luginbuehl, Reto; Hofstetter, Willy; Egli, Rainer J.			Transforming Growth Factor Beta Signaling Is Essential for the Autonomous Formation of Cartilage-Like Tissue by Expanded Chondrocytes	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; MESENCHYMAL STEM-CELLS; TGF-BETA; GENE-EXPRESSION; OSTEOARTHRITIC CARTILAGE; EXPANSION; DIFFERENTIATION; IMPLANTATION; PHENOTYPE; KNEE	Cartilage is a tissue with limited self-healing potential. Hence, cartilage defects require surgical attention to prevent or postpone the development of osteoarthritis. For cell-based cartilage repair strategies, in particular autologous chondrocyte implantation, articular chondrocytes are isolated from cartilage and expanded in vitro to increase the number of cells required for therapy. During expansion, the cells lose the competence to autonomously form a cartilage-like tissue, that is in the absence of exogenously added chondrogenic growth factors, such as TGF-beta s. We hypothesized that signaling elicited by autocrine and/or paracrine TGF-beta is essential for the formation of cartilage-like tissue and that alterations within the TGF-beta signaling pathway during expansion interfere with this process. Primary bovine articular chondrocytes were harvested and expanded in monolayer culture up to passage six and the formation of cartilage tissue was investigated in high density pellet cultures grown for three weeks. Chondrocytes expanded for up to three passages maintained the potential for autonomous cartilage-like tissue formation. After three passages, however, exogenous TGF-beta 1 was required to induce the formation of cartilage-like tissue. When TGF-beta signaling was blocked by inhibiting the TGF-beta receptor 1 kinase, the autonomous formation of cartilage-like tissue was abrogated. At the initiation of pellet culture, chondrocytes from passage three and later showed levels of transcripts coding for TGF-beta receptors 1 and 2 and TGF-beta 2 to be three-, five- and five-fold decreased, respectively, as compared to primary chondrocytes. In conclusion, the autonomous formation of cartilage-like tissue by expanded chondrocytes is dependent on signaling induced by autocrine and/or paracrine TGF-beta. We propose that a decrease in the expression of the chondrogenic growth factor TGF-beta 2 and of the TGF-beta receptors in expanded chondrocytes accounts for a decrease in the activity of the TGF-beta signaling pathway and hence for the loss of the potential for autonomous cartilage-like tissue formation.	[Tekari, Adel; Hofstetter, Willy; Egli, Rainer J.] Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland; [Tekari, Adel] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Luginbuehl, Reto; Egli, Rainer J.] RMS Fdn, Bettlach, Switzerland	University of Bern; University of Bern	Egli, RJ (corresponding author), Univ Bern, Dept Clin Res, Grp Bone Biol & Orthopaed Res, Bern, Switzerland.	rainer.egli@rms-foundation.ch	Tekari, Adel/E-1134-2019; Tekari, Adel/A-5101-2016	Hofstetter, Wilhelm/0000-0003-0126-8423; Tekari, Adel/0000-0003-1676-0920	RMS Foundation [E10_0007]	RMS Foundation	This study was supported by a grant of the RMS Foundation to WH (E10_0007). No individual (other than the named authors) employed or contracted by the funder was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; Barbero A, 2006, J CELL BIOCHEM, V98, P1140, DOI 10.1002/jcb.20754; Bauge C, 2013, AGE, V35, P1105, DOI 10.1007/s11357-012-9433-7; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Biant LC, 2014, AM J SPORT MED, V42, P2178, DOI 10.1177/0363546514539345; BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P109, DOI 10.2106/00004623-200300003-00017; Brittberg M, 2008, INJURY, V39, pS40, DOI 10.1016/j.injury.2008.01.040; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399; Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008; Davidson ENB, 2005, ARTHRITIS RES THER, V7, pR1338, DOI 10.1186/ar1833; Dehne T, 2010, GENE, V462, P8, DOI 10.1016/j.gene.2010.04.006; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Ebert JR, 2011, AM J SPORT MED, V39, P753, DOI 10.1177/0363546510390476; Egli RJ, 2008, J ORTHOP RES, V26, P977, DOI 10.1002/jor.20603; Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658; Gan L, 2007, TISSUE ENG, V13, P831, DOI 10.1089/ten.2006.0231; Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007; Giovannini S, 2010, J CELL PHYSIOL, V222, P411, DOI 10.1002/jcp.21965; Goessler UR, 2005, CELL MOL BIOL LETT, V10, P345; Goessler UR, 2005, IN VIVO, V19, P501; Goldberg AJ, 2005, J BONE JOINT SURG BR, V87B, P128, DOI 10.1302/0301-620X.87B1.14154; Hdud IM, 2012, INT J MOL SCI, V13, P4433, DOI 10.3390/ijms13044433; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hunter WVI, 1743, PHILOS T R SOC LOND, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; KULYK WM, 1989, DEV BIOL, V135, P424, DOI 10.1016/0012-1606(89)90191-7; Lehmann M, 2013, EUR J HISTOCHEM, V57, P205, DOI 10.4081/ejh.2013.e31; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Lin Z, 2008, J ORTHOP RES, V26, P1230, DOI 10.1002/jor.20523; Marlovits S, 2004, J BONE JOINT SURG BR, V86B, P286, DOI 10.1302/0301-620X.86B2.14918; Minas T, 2012, OPER TECHN SPORT MED, V20, P72, DOI 10.1053/j.otsm.2012.03.009; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Narcisi R, 2012, J CELL PHYSIOL, V227, P3282, DOI 10.1002/jcp.24024; Ossendorf C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2180; Pei M, 2012, J CELL PHYSIOL, V227, P2163, DOI 10.1002/jcp.22950; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; Schulze-Tanzil G, 2004, OSTEOARTHR CARTILAGE, V12, P448, DOI 10.1016/j.joca.2004.02.007; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Tallheden T, 2004, OSTEOARTHR CARTILAGE, V12, P525, DOI 10.1016/j.joca.2004.03.004; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Tekari A, 2014, J ORTHOP RES, V32, P1503, DOI 10.1002/jor.22690; van Osch GJVM, 2001, PLAST RECONSTR SURG, V107, P433, DOI 10.1097/00006534-200102000-00020; Verdier MP, 2005, RHEUMATOL INT, V25, P118, DOI 10.1007/s00296-003-0409-x; VILLIGER PM, 1992, J CELL PHYSIOL, V151, P318, DOI 10.1002/jcp.1041510213; Yamaoka H, 2010, CELL PROLIFERAT, V43, P67, DOI 10.1111/j.1365-2184.2009.00655.x; Yang KGA, 2006, TISSUE ENG, V12, P2435, DOI 10.1089/ten.2006.12.2435; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zeifang F, 2010, AM J SPORT MED, V38, P924, DOI 10.1177/0363546509351499; Zhang Y, 2012, BIOMATERIALS, V33, P7394, DOI 10.1016/j.biomaterials.2012.06.070	61	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120857	10.1371/journal.pone.0120857	http://dx.doi.org/10.1371/journal.pone.0120857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775021	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500196
J	Huang, WJ; Arai, F; Kawahara, T				Huang, Wenjing; Arai, Fumihito; Kawahara, Tomohiro			Egg-in-Cube: Design and Fabrication of a Novel Artificial Eggshell with Functionalized Surface	PLOS ONE			English	Article							CHICK-EMBRYO; CHORIOALLANTOIC MEMBRANE; OXYGEN CONCENTRATION; ZEBRAFISH; PERMEABILITY; CULTURE; VITRO; EXPRESSION; SORPTION; GROWTH	An eggshell is a porous microstructure that regulates the passage of gases to allow respiration. The chick embryo and its circulatory system enclosed by the eggshell has become an important model for biomedical research such as the control of angiogenesis, cancer therapy, and drug delivery test, because the use of embryo is ethically acceptable and it is inexpensive and small. However, chick embryo and extra-embryonic blood vessels cannot be accessed freely and has poor observability because the eggshell is tough and cannot be seen through, which limits its application. In this study, a novel artificial eggshell with functionalized surface is proposed, which allows the total amount of oxygen to pass into the egg for the chick embryo culturing and has high observability and accessibility for embryo manipulation. First, a 40-mm enclosed cubic-shaped eggshell consisting of a membrane structure and a rigid frame structure is designed, and then the threshold of the membrane thickness suitable for the embryo survival is figured out according to the oxygen-permeability of the membrane structure. The designed artificial eggshell was actually fabricated by using polydimethylsiloxane (PDMS) and polycarbonate (PC) in the current study. Using the fabricated eggshell, chick embryo and extra-embryonic blood vessels can be observed from multiple directions. To test the effectiveness of the design, the cubic eggshells were used to culture chick embryos and survivability was confirmed when PDMS membranes with adequate oxygen permeability were used. Since the surface of the eggshell is transparent, chick embryo tissue development could be observed during the culture period. Additionally, the chick embryo tissues could be accessed and manipulated from outside the cubic eggshell, by using mechanical tools without breakage of the eggshell. The proposed "Egg-in-Cube" with functionalized surface has great potential to serve as a promising platform for biomedical research.	[Huang, Wenjing; Kawahara, Tomohiro] Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 804, Japan; [Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Kyushu Institute of Technology; Nagoya University	Kawahara, T (corresponding author), Kyushu Inst Technol, Dept Biol Funct Engn, Wakamatsu Ku, Kitakyushu, Fukuoka 804, Japan.	kawahara@lsse.kyutech.ac.jp	Huang, Wenjing/AAV-9101-2021	Huang, Wenjing/0000-0003-1406-0031	JSPS KAKENHI [23106002, 26630100]; Program to Disseminate Tenure Track System, MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program to Disseminate Tenure Track System, MEXT, Japan	This work was partially supported by JSPS KAKENHI (23106002, 26630100), and the Program to Disseminate Tenure Track System, MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, LAB ANIM SCI, V37, P11; AR A, 1987, RESP PHYSIOL, V68, P377, DOI 10.1016/S0034-5687(87)80022-1; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Bartlett HL, 2004, AM J PHYSIOL-HEART C, V286, pH2035, DOI 10.1152/ajpheart.00807.2003; BAUMANN R, 1992, PHYSIOL REV, V72, P941, DOI 10.1152/physrev.1992.72.4.941; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Busch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053970; CLARK EB, 1984, AM J CARDIOL, V53, P324, DOI 10.1016/0002-9149(84)90447-8; DAVIDSON MK, 1987, ISRAEL J MED SCI, V23, P551; De Bo I, 2003, J MEMBRANE SCI, V215, P303, DOI 10.1016/S0376-7388(03)00024-3; DeSimone Douglas W., 2004, V294, P235; Dohle Daniel S, 2009, J Vis Exp, DOI 10.3791/1620; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; GALLERA J, 1961, EXPERIENTIA, V17, P134, DOI 10.1007/BF02160832; Ghatpande SK, 2008, DEV GROWTH DIFFER, V50, P437, DOI [10.1111/j.1440-169x.2008.01048.x, 10.1111/j.1440-169X.2008.01048.x]; Ghatpande SK, 2008, BIRTH DEFECTS RES A, V82, P121, DOI 10.1002/bdra.20438; GREEN CJ, 1976, P ROY SOC MED, V69, P366, DOI 10.1177/003591577606900529; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hermsen SAB, 2012, TOXICOL SCI, V127, P303, DOI 10.1093/toxsci/kfs092; Hoper J, 1995, INT J MICROCIRC, V15, P186, DOI 10.1159/000178974; Isachenko V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032549; Kamihira M, 1998, DEV GROWTH DIFFER, V40, P449; KAMIYA Y, 1990, J POLYM SCI POL PHYS, V28, P1297, DOI 10.1002/polb.1990.090280808; Kim Byeong Jin, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P20, DOI 10.7461/jcen.2013.15.1.20; KIND C, 1975, ANAT EMBRYOL, V147, P127, DOI 10.1007/BF00306727; Lange N, 2001, INVEST OPHTH VIS SCI, V42, P38; Liu M, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/035028; Loesberg WA, 2005, J BIOMED MATER RES A, V75A, P723, DOI 10.1002/jbm.a.30480; MacDonald JD, 2005, SKULL BASE-INTERD AP, V15, P229, DOI 10.1055/s-2005-872598; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z; MEUER HJ, 1988, RESP PHYSIOL, V71, P331, DOI 10.1016/0034-5687(88)90026-6; Mitsuishi M, 2013, INT J MED ROBOT COMP, V9, P180, DOI 10.1002/rcs.1434; Molenaar R, 2010, POULTRY SCI, V89, P2010, DOI 10.3382/ps.2010-00787; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; ONO T, 1991, DEV BIOL, V144, P167, DOI 10.1016/0012-1606(91)90488-O; Pink DBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033760; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Rao HX, 2007, J MEMBRANE SCI, V303, P132, DOI 10.1016/j.memsci.2007.07.002; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Saito AC, 2014, BIOTECHNOL LETT, V36, P391, DOI 10.1007/s10529-013-1368-2; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schoeffl H, 2013, ARCH PLAST SURG-APS, V40, P104, DOI 10.5999/aps.2013.40.2.104; Seabra R, 2010, IN VIVO, V24, P457; Sedmera D, 1999, ANAT RECORD, V254, P238, DOI 10.1002/(SICI)1097-0185(19990201)254:2<238::AID-AR10>3.0.CO;2-V; Selderslaghs IWT, 2012, REPROD TOXICOL, V33, P142, DOI 10.1016/j.reprotox.2011.08.003; Shiku H, 2006, CHEM LETT, V35, P234, DOI 10.1246/cl.2006.234; Tacon A. G. J., 1982, Agricultural Wastes, V4, P335, DOI 10.1016/0141-4607(82)90030-0; Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; Wallingford JB, 2010, CURR BIOL, V20, pR263, DOI 10.1016/j.cub.2010.01.012; Yalcin Huseyin C, 2010, J Vis Exp, DOI 10.3791/2154	56	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118624	10.1371/journal.pone.0118624	http://dx.doi.org/10.1371/journal.pone.0118624			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768929	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500034
J	Leal, MF; Belangero, PS; Figueiredo, EA; Cohen, C; Loyola, LC; Andreoli, CV; Smith, MC; Pochini, AD; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Smith, Marilia Cardoso; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Gene Expression Studies in Tendons from Patients with Rotator Cuff Tear	PLOS ONE			English	Article							REAL-TIME PCR; ANTERIOR CRUCIATE LIGAMENTS; MESSENGER-RNA LEVELS; HOUSEKEEPING GENES; NORMALIZATION; DEGENERATION; COLLAGEN; TISSUES; SUPRASPINATUS; PUBLICATION	Rotator cuff tear is one of the most common causes of shoulder dysfunction. Gene expression analysis may be a useful tool for understanding tendon tears and the failure of cuff healing, and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) has become an effective method for such studies. However, this technique requires the use of suitable reference genes for data normalization. Here, we evaluate the suitability of six reference genes (18S, ACTB, B2M, GAPDH, HPRT1 and TBP) using samples from the rotator cuff tendons of 28 individuals with tendon tears (3 tendons regions) and 8 controls (2 tendon regions); for the tear patients, we evaluated ruptured and non-ruptured tendon samples. The stability of the candidate reference genes was determined using the NormFinder, geNorm, BestKeeper and DataAssist software packages. Overall, HPRT1 was the best single reference gene, and HPRT1+TBP composed the best pair and HPRT1+TBP+ACTB composed the best trio of reference genes from the analysis of different groups, including the simultaneous analysis of all tissue samples. To identify the optimal combination of reference genes, we evaluated the expression of COL1A1 and COL3A1, and no obvious differences were observed when using 2, 3 or 4 reference genes for most of the analyses. However, COL3A1 expression differed between ruptured and non-ruptured (posterior superior region) tendons of patients only when normalized by HPRT1+TBP+B2M and HPRT1+TBP. On the other hand, the comparison between these two groups using the best trio of reference genes (HPRT1+TBP+ACTB) and 4 reference genes did not revealed a significant difference in COL3A1 expression. Consequently, the use of suitable reference genes for a reliable gene expression evaluation by RT-qPCR should consider the type of tendon samples investigated. HPRT1+TBP+ACTB seems to be the best combination of reference genes for the analysis of involving different tendon samples of individuals with rotator cuff tears.	[Leal, Mariana Ferreira; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Loyola, Leonor Casilla; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Andreoli, Carlos Vicente/AAW-1228-2021; de A. C. Smith, Marilia/C-4397-2012; Leal, Mariana/C-4010-2012; Belangero, Paulo/AAD-8299-2021; Ejnisman, Benno/J-1556-2015	de A. C. Smith, Marilia/0000-0002-1441-1033; Leal, Mariana/0000-0003-4375-2563; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; MC and MCS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; LCL, MC and MFL) as grants and fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Belangero PS, 2014, J ORTHOP RES, V32, P1311, DOI 10.1002/jor.22680; Bramono DS, 2005, CONNECT TISSUE RES, V46, P53, DOI 10.1080/03008200590935556; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; Clements DN, 2008, OSTEOARTHR CARTILAGE, V16, P195, DOI 10.1016/j.joca.2007.06.013; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Fabis J, 2014, J SHOULDER ELBOW SUR; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gotoh M, 2013, KNEE SURG SPORT TR A, V21, P1807, DOI 10.1007/s00167-012-2209-x; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Leal MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105002; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lichtenberg, 2006, CLASSIFICATIONS SCOR; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Robertson CM, 2012, AM J SPORT MED, V40, P1993, DOI 10.1177/0363546512456519; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Taylor SC, 2014, J MOL MICROB BIOTECH, V24, P46, DOI 10.1159/000356189; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118821	10.1371/journal.pone.0118821	http://dx.doi.org/10.1371/journal.pone.0118821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768100	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500046
J	Liu, CJ; Hu, LY; Yeh, CM; Hu, YW; Chen, PM; Chen, TJ; Lu, T				Liu, Chia-Jen; Hu, Li-Yu; Yeh, Chiu-Mei; Hu, Yu-Wen; Chen, Pan-Ming; Chen, Tzeng-Ji; Lu, Ti			Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder	PLOS ONE			English	Article							INFLAMMATORY DISEASE; ANXIETY DISORDER; CO-MORBIDITIES; PREVALENCE; COMORBIDITY; DEPRESSION; MOOD; PATHOPHYSIOLOGY; EPIDEMIOLOGY; ASSOCIATION	Objective We explored the association between IBS and the development of bipolar disorder, and the risk factors for bipolar disorders in patients with IBS. Methods We identified patients who were newly diagnosed with IBS between 2000 and 2010 in the Taiwan National Health Insurance Research Database. We also identified a comparison matched cohort without IBS. The occurrence of new-onset bipolar disorder was evaluated in both cohorts. Results The IBS cohort consisted of 30,796 patients and the comparison cohort consisted of 30,796 matched patients without IBS. The incidence of bipolar disorder (incidence rate ratio, 2.63, 95% confidence interval (CI) 2.10-3.31, P < .001) was higher in the IBS patients than in the matched cohort. Multivariate matched regression models indicated that autoimmune diseases (HR 1.52, 95% CI 1.07-2.17, P = .020), and asthma (HR 1.45, 95% CI 1.08-1.95, P = .013) were independent risk factors for the development of bipolar disorder in the IBS patients. Conclusion IBS may increase the risk of developing subsequent bipolar disorder. Additional prospective studies are required to confirm these findings.	[Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Liu, Chia-Jen; Hu, Yu-Wen] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yeh, Chiu-Mei] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hu, Yu-Wen] Taipei Vet Gen Hosp, Ctr Canc, Taipei, Taiwan; [Chen, Pan-Ming; Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Yuanshan & Suao Branch, Dept Psychiat, Yilan, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Lu, T (corresponding author), Kaohsiung Vet Gen Vet Hosp, Dept Psychiat, Kaohsiung, Taiwan.	tlu@vghks.gov.tw	Chen, TJ/AAH-8430-2021	Hu, Yu-Wen/0000-0002-7983-415X	Taipei Veterans General Hospital [V103B-022, V103E10-001]; Taiwan Clinical Oncology Research Foundation	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taiwan Clinical Oncology Research Foundation	This study is supported in part by grants from Taipei Veterans General Hospital (V103B-022 and V103E10-001) and Taiwan Clinical Oncology Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Bai YM, 2013, J CHIN MED ASSOC, V76, P547, DOI 10.1016/j.jcma.2013.06.013; Chen MH, 2013, J AFFECT DISORD; Crane C, 2003, PSYCHOSOM MED, V65, P919, DOI 10.1097/01.PSY.0000088590.01737.07; De Dios C, 2010, J AFFECT DISORDERS, V125, P74, DOI 10.1016/j.jad.2009.12.006; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; El-Salhy M, 2012, WORLD J GASTROENTERO, V18, P5151, DOI 10.3748/wjg.v18.i37.5151; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; Goldstein BI, 2009, J CLIN PSYCHIAT, V70, P1078, DOI 10.4088/JCP.08r04505; Gwee KA, 2009, J GASTROEN HEPATOL, V24, P1601, DOI 10.1111/j.1440-1746.2009.05984.x; Hamdani Nora, 2012, Front Biosci (Elite Ed), V4, P2170; Hao Jing-xin, 2011, Zhonghua Yi Xue Za Zhi, V91, P1886; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Hsiao CW, 2014, EUR J INTERN MED, V25, P82, DOI 10.1016/j.ejim.2013.11.005; Hu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073057; Huang KL, 2009, PSYCHIAT CLIN NEUROS, V63, P401, DOI 10.1111/j.1440-1819.2009.01974.x; Jerrell JM, 2010, J CLIN PSYCHIAT, V71, P1518, DOI 10.4088/JCP.09m05585ora; Kwan ACP, 2002, J GASTROEN HEPATOL, V17, P1180, DOI 10.1046/j.1440-1746.2002.02871.x; Lai SW, 2014, EUR J EPIDEMIOL, V29, P57, DOI [10.1007/s10654-014-9878-3, 10.1007/s10654-014-9903-6]; Lampa J, 2012, P NATL ACAD SCI USA, V109, P12728, DOI 10.1073/pnas.1118748109; Lau EMC, 2002, DIGEST DIS SCI, V47, P2621, DOI 10.1023/A:1020549118299; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Modabbernia Mohamad-Jafar, 2012, BMC Res Notes, V5, P112, DOI 10.1186/1756-0500-5-112; Mykletun A, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-88; Norgaard M, 2011, BRIT J CANCER, V104, P1202, DOI 10.1038/bjc.2011.65; O'Malley D, 2011, BRAIN BEHAV IMMUN, V25, P1333, DOI 10.1016/j.bbi.2011.04.009; Omagari K, 2013, INTERNAL MED, V52, P1295, DOI 10.2169/internalmedicine.52.0248; Post RM, 2013, J AFFECT DISORD; Post RM, 2013, J AFFECT DISORDERS, V147, P288, DOI 10.1016/j.jad.2012.11.020; Proudfoot J, 2012, J AFFECT DISORDERS, V143, P196, DOI 10.1016/j.jad.2012.05.052; Rege S., 2013, AUST NZ J PSYCHIAT; Robbins Steven E, 2013, Expert Rev Gastroenterol Hepatol, V7, P413, DOI 10.1586/17474124.2013.811043; Rosenblat JD, 2014, PROG NEURO-PSYCHOPH, V53, P23, DOI 10.1016/j.pnpbp.2014.01.013; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sperber AD, 2012, AM J GASTROENTEROL, V107, P1602, DOI 10.1038/ajg.2012.106; Stertz L, 2013, CURR OPIN PSYCHIATR, V26, P19, DOI 10.1097/YCO.0b013e32835aa4b4; Su T.P., 2013, J PSYCHIAT RES; Thomsen AF, 2005, BIPOLAR DISORD, V7, P351, DOI 10.1111/j.1399-5618.2005.00205.x; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu KY, 2013, BIPOLAR DISORD, V15, P787, DOI 10.1111/bdi.12116	43	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118209	10.1371/journal.pone.0118209	http://dx.doi.org/10.1371/journal.pone.0118209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768120	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500022
J	Yao, S; Zhang, JX; Wang, DD; Hou, JJ; Yang, WZ; Da, J; Cai, LY; Yang, M; Jiang, BH; Liu, X; Guo, DA; Wu, WY				Yao, Shuai; Zhang, Jingxian; Wang, Dandan; Hou, Jinjun; Yang, Wenzhi; Da, Juan; Cai, Luying; Yang, Min; Jiang, Baohong; Liu, Xuan; Guo, De-an; Wu, Wanying			Discriminatory Components Retracing Strategy for Monitoring the Preparation Procedure of Chinese Patent Medicines by Fingerprint and Chemometric Analysis	PLOS ONE			English	Article							CARTHAMUS-TINCTORIUS L.; IONIZATION MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; DANHONG INJECTION; RADIX ASTRAGALI; QUALITY-CONTROL; IDENTIFICATION; CONSTITUENTS; CLASSIFICATION; METABOLITES	Chinese patent medicines (CPM), generally prepared from several traditional Chinese medicines (TCMs) in accordance with specific process, are the typical delivery form of TCMs in Asia. To date, quality control of CPMs has typically focused on the evaluation of the final products using fingerprint technique and multi-components quantification, but rarely on monitoring the whole preparation process, which was considered to be more important to ensure the quality of CPMs. In this study, a novel and effective strategy labeling "retracing" way based on HPLC fingerprint and chemometric analysis was proposed with Shenkang injection (SKI) serving as an example to achieve the quality control of the whole preparation process. The chemical fingerprints were established initially and then analyzed by similarity, principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) to evaluate the quality and to explore discriminatory components. As a result, the holistic inconsistencies of ninety-three batches of SKIs were identified and five discriminatory components including emodic acid, gallic acid, caffeic acid, chrysophanol-O-glucoside, and p-coumaroylO- galloyl-glucose were labeled as the representative targets to explain the retracing strategy. Through analysis of the targets variation in the corresponding semi-products (ninety-three batches), intermediates (thirty-three batches), and the raw materials, successively, the origins of the discriminatory components were determined and some crucial influencing factors were proposed including the raw materials, the coextraction temperature, the sterilizing conditions, and so on. Meanwhile, a reference fingerprint was established and subsequently applied to the guidance of manufacturing. It was suggested that the production process should be standardized by taking the concentration of the discriminatory components as the diagnostic marker to ensure the stable and consistent quality for multi-batches of products. It is believed that the effective and practical strategy would play a critical role in the guidance of manufacturing and help improve the safety of the final products.	[Yao, Shuai; Zhang, Jingxian; Wang, Dandan; Hou, Jinjun; Yang, Wenzhi; Da, Juan; Cai, Luying; Yang, Min; Jiang, Baohong; Liu, Xuan; Guo, De-an; Wu, Wanying] Chinese Acad Sci, Natl Engn Lab TCM Standardizat Technol, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Wu, WY (corresponding author), Chinese Acad Sci, Natl Engn Lab TCM Standardizat Technol, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai Inst Mat Med, 501 Haike Rd, Shanghai 201203, Peoples R China.	wanyingwu@simm.ac.cn	Zhang, Jing/GWZ-7332-2022; Hou, Jinjun/GQA-6071-2022; zhou, ju/M-3255-2017	Hou, Jinjun/0000-0003-1470-5127; 	Twelfth Five-Year National Science and Technology Support Program [2012BAI29B06]; Chinese Medicine Industry of State Administration of traditional Chinese Medicine [201307002]	Twelfth Five-Year National Science and Technology Support Program(Chinese Academy of Sciences); Chinese Medicine Industry of State Administration of traditional Chinese Medicine	Funding: This study was financially supported by the Twelfth Five-Year National Science and Technology Support Program (2012BAI29B06), and special scientific research in the Chinese Medicine Industry of State Administration of traditional Chinese Medicine (201307002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts G, 2014, J PHARMACEUT BIOMED, V95, P34, DOI 10.1016/j.jpba.2014.02.006; China Pharmacopoeia Committee, 2002, GUID TCM INJ CHROM F; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Chu C, 2010, CURR ORG CHEM, V14, P1792, DOI 10.2174/138527210792927663; Guo YX, 2007, J PHARMACEUT BIOMED, V43, P1249, DOI 10.1016/j.jpba.2006.10.025; Hakimzadeh N, 2014, J CHROMATOGR A, V1326, P63, DOI 10.1016/j.chroma.2013.12.045; Jin Y, 2008, RAPID COMMUN MASS SP, V22, P1275, DOI 10.1002/rcm.3468; Jin Y, 2008, J PHARMACEUT BIOMED, V46, P418, DOI 10.1016/j.jpba.2007.10.036; Liang J, 2013, J CHROMATOGR A, V1294, P58, DOI 10.1016/j.chroma.2013.04.016; Liu AH, 2007, J CHROMATOGR A, V1161, P170, DOI 10.1016/j.chroma.2007.05.081; Liu HT, 2013, BIOMED CHROMATOGR, V27, P655, DOI 10.1002/bmc.2842; Liu XS, 2013, J PHARMACEUT BIOMED, V76, P70, DOI 10.1016/j.jpba.2012.12.013; Parastar H, 2012, J CHROMATOGR A, V1251, P176, DOI 10.1016/j.chroma.2012.06.011; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Qi LW, 2009, J CHROMATOGR A, V1216, P2087, DOI 10.1016/j.chroma.2008.02.095; Qi Y, 2014, TALANTA, V118, P21, DOI 10.1016/j.talanta.2013.09.054; Sheridan H, 2012, J ETHNOPHARMACOL, V140, P482, DOI 10.1016/j.jep.2012.01.050; Song R, 2008, BIOMED CHROMATOGR, V22, P1230, DOI 10.1002/bmc.1050; Tistaert C, 2009, ANAL CHIM ACTA, V652, P189, DOI 10.1016/j.aca.2009.08.024; Tistaert C, 2011, ANAL CHIM ACTA, V690, P148, DOI 10.1016/j.aca.2011.02.023; Wan JB, 2013, J PHARMACEUT BIOMED, V83, P34, DOI 10.1016/j.jpba.2013.04.019; Wang SF, 2014, J CHROMATOGR A, V1348, P105, DOI 10.1016/j.chroma.2014.04.084; Wu FF, 2011, J SEP SCI, V34, P3194, DOI 10.1002/jssc.201100253; Ye CH, 1997, Patent, Patent No. 96117626; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Zhou WJ, 2013, J PHARMACEUT BIOMED, V84, P59, DOI 10.1016/j.jpba.2013.05.034; Zhou XD, 2014, J ETHNOPHARMACOL, V151, P27, DOI 10.1016/j.jep.2013.10.050; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	28	14	16	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121366	10.1371/journal.pone.0121366	http://dx.doi.org/10.1371/journal.pone.0121366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768096	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500142
J	Zaidi, SH; Smith-Morris, C				Zaidi, Saira H.; Smith-Morris, Carolyn			Diapers in War Zones: Ethnomedical Factors in Acute Childhood Gastroenteritis in Peshawar, Pakistan	PLOS ONE			English	Article							DIARRHEAL DISEASES; CHILDREN; HEALTH; PERCEPTIONS; PATRIARCHY; HYGIENE; SCALE	This article considers ethnomedical knowledge and practices among parents related to contraction of acute gastroenteritis among children in Peshawar, Pakistan. Research methods included analysis of the Emergency Pediatric Services' admission register, a structured interview administered to 47 parents of patients seen in the Khyber Medical College Teaching Hospital, semi-structured interviews of 12 staff, and four home visits among families with children treated at the hospital. The use of native research assistants and participant observation contributed to the reliability of the findings, though the ethnographic, home-visit sample is small. Our research indicated that infection rates are exacerbated in homes through two culturally salient practices and one socioeconomic condition. Various misconceptions propagate the recurrence or perserverance of acute gastroenteritis including assumptions about teething leading to poor knowledge of disease etiology, rehydration solutions leading to increased severity of disease, and diaper usage leading to the spread of disease. In our Discussion, we suggest how hospital structures of authority and gender hierarchy may impact hospital interactions, the flow of information, and its respective importance to the patient's parents leading to possible propagation of disease. These ethnographic data offer a relatively brief but targeted course of action to improve the effectiveness of prevention and treatment efforts.	[Zaidi, Saira H.] Univ Calif Berkeley, Sch Publ Hlth, Dept Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Smith-Morris, Carolyn] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA	University of California System; University of California Berkeley; Southern Methodist University	Zaidi, SH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Dept Infect Dis & Vaccinol, Berkeley, CA 94720 USA.	sairahusain618@gmail.com			Richter Research Fellowship Program by Southern Methodist University	Richter Research Fellowship Program by Southern Methodist University	This research project was funded by the Richter Research Fellowship Program by Southern Methodist University received by SHZ (http://smu.edu/univhonors/Richter%20International%20Fellowships.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2005, MED ANTHROPOL Q, V19, P267, DOI 10.1525/maq.2005.19.3.267; Ahmad N, 2004, PAK J MED RES, V43, P3; Ai AL, 2002, J TRAUMA STRESS, V15, P157, DOI 10.1023/A:1014864225889; Bajolet O, 1998, B SOC PATHOL EXOT, V91, P432; Barrett H, 1996, SOC SCI MED, V43, P1579, DOI 10.1016/S0277-9536(96)00054-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bloomfield SF, 2009, INT SCI FOR HOM HYG, V24; Brown P, 1987, ANTHR INFECT DIS INT; El Katsha S., 1989, Water International, V4, P103, DOI 10.1080/02508068908692072; ELLIOTT EJ, 2008, PAEDIAT CHILD HLTH, V32, P18; Fagundes-Neto U, 1999, J AM COLL NUTR, V18, P303, DOI 10.1080/07315724.1999.10718868; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gupte S, 1983, J Diarrhoeal Dis Res, V1, P109; Halvorson SJ, 2004, HEALTH PLACE, V10, P43, DOI 10.1016/S1353-8292(03)00018-2; Hershey C. L., 2011, CONFL HEALTH, V5, P1; Huda TMN, 2012, SOC SCI MED, V75, P604, DOI 10.1016/j.socscimed.2011.10.042; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kleinman A, 2005, CULTURE PSYCHIAT DIA; Lambert H, 2002, BRIT MED J, V325, P210, DOI 10.1136/bmj.325.7357.210; Macknin ML, 2000, PEDIATRICS, V105, P747, DOI 10.1542/peds.105.4.747; MEEUWISSE GW, 1983, ACTA PAEDIATR SCAND, V72, P161, DOI 10.1111/j.1651-2227.1983.tb09689.x; MOGHADAM VM, 1992, INT SOCIOL, V7, P35, DOI 10.1177/026858092007001002; Moghadam VM, 2004, J COMP FAM STUD, V35, P137, DOI 10.3138/jcfs.35.2.137; Mumtaz S, 2010, AFR J BIOTECHNOL, V9, P1230; Nagamani K, 2007, Indian J Med Microbiol, V25, P133; Parkin PC, 2010, CLIN PEDIATR, V49, P235, DOI 10.1177/0009922809336670; Rabbani F, 2009, INT J HEALTH CARE Q, V22, P498, DOI 10.1108/09526860910975607; Smith-Morris C, 2014, MED ANTHROPOL Q, V28, P141, DOI 10.1111/maq.12093; STAPLETON MC, 1989, SOC SCI MED, V28, P593, DOI 10.1016/0277-9536(89)90254-2; Strand TA, 2012, PLOS ONE, V10, P1371; VAN R, 1991, JAMA-J AM MED ASSOC, V265, P1840, DOI 10.1001/jama.265.14.1840; Vecchiato NL, 1997, MED ANTHROPOL Q, V11, P183, DOI 10.1525/maq.1997.11.2.183; Walker CLF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029151; Wilson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033273; YEN GC, 1995, J AGR FOOD CHEM, V43, P27, DOI 10.1021/jf00049a007; Zwane AP, 2007, WORLD BANK RES OBSER, V22, P1, DOI 10.1093/wbro/lkm002	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119069	10.1371/journal.pone.0119069	http://dx.doi.org/10.1371/journal.pone.0119069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768117	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500062
J	Kajikawa, M; Kinohira, S; Ando, A; Shimoyama, M; Kato, M; Fukuzawa, H				Kajikawa, Masataka; Kinohira, Seiko; Ando, Akira; Shimoyama, Miki; Kato, Misako; Fukuzawa, Hideya			Accumulation of Squalene in a Microalga Chlamydomonas reinhardtii by Genetic Modification of Squalene Synthase and Squalene Epoxidase Genes	PLOS ONE			English	Article							BIOSYNTHESIS PATHWAY; BOTRYOCOCCUS-BRAUNII; EXPRESSION; CLONING; CELLS; CDNA; TRANSFORMATION; OPTIMIZATION; MUTANTS; STRAINS	Several microalgae accumulate high levels of squalene, and as such provide a potentially valuable source of this useful compound. However, the molecular mechanism of squalene biosynthesis in microalgae is still largely unknown. We obtained the sequences of two enzymes involved in squalene synthesis and metabolism, squalene synthase (CrSQS) and squalene epoxidase (CrSQE), from the model green alga Chlamydomonas reinhardtii. CrSQS was functionally characterized by expression in Escherichia coli and CrSQE by complementation of a budding yeast erg1 mutant. Transient expression of CrSQS and CrSQE fused with fluorescent proteins in onion epidermal tissue suggested that both proteins were co-localized in the endoplasmic reticulum. CrSQS-overexpression increased the rate of conversion of C-14-labeled farnesylpyrophosphate into squalene but did not lead to over-accumulation of squalene. Addition of terbinafine caused the accumulation of squalene and suppression of cell survival. On the other hand, in CrSQE-knockdown lines, the expression level of CrSQE was reduced by 59-76% of that in wild-type cells, and significant levels of squalene (0.9-1.1 mu g mg(-1) cell dry weight) accumulated without any growth inhibition. In co-transformation lines with CrSQS-overexpression and CrSQE-knockdown, the level of squalene was not increased significantly compared with that in solitary CrSQE-knockdown lines. These results indicated that partial knockdown of CrSQE is an effective strategy to increase squalene production in C. reinhardtii cells.	[Kajikawa, Masataka; Kinohira, Seiko; Fukuzawa, Hideya] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Ando, Akira; Shimoyama, Miki; Kato, Misako] Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 112, Japan	Kyoto University; Ochanomizu University	Fukuzawa, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.	fukuzawa@lif.kyoto-u.ac.jp	Fukuzawa, Hideya/I-5906-2018	Fukuzawa, Hideya/0000-0003-0963-5662; Kajikawa, Masataka/0000-0003-0361-2769	Advanced Low Carbon Technology Research and Development (ALCA) Program	Advanced Low Carbon Technology Research and Development (ALCA) Program	This study was supported by Advanced Low Carbon Technology Research and Development (ALCA) Program (to H. F. and M. Kato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Bhattacharjee P, 2001, WORLD J MICROB BIOT, V17, P811, DOI 10.1023/A:1013573912952; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Busquets A, 2008, PLANT MOL BIOL, V67, P25, DOI 10.1007/s11103-008-9299-3; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Fan KW, 2010, WORLD J MICROB BIOT, V26, P1303, DOI 10.1007/s11274-009-0301-2; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guevara-Garcia A, 2005, PLANT CELL, V17, P628, DOI 10.1105/tpc.104.028860; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Haubrich BA, 2015, PHYTOCHEMISTRY, V113, P64, DOI 10.1016/j.phytochem.2014.07.019; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hong WK, 2013, J MICROBIOL BIOTECHN, V23, P759, DOI 10.4014/jmb.1212.12023; JANDROSITZ A, 1991, GENE, V107, P155, DOI 10.1016/0378-1119(91)90310-8; JIANG GJ, 1993, J BIOL CHEM, V268, P12818; Jiang Y, 2004, J AGR FOOD CHEM, V52, P1196, DOI 10.1021/jf035004c; Kong F, 2014, J BIOSCI BIOENG, V117, P613, DOI 10.1016/j.jbiosc.2013.10.025; Kribii R, 1997, EUR J BIOCHEM, V249, P61, DOI 10.1111/j.1432-1033.1997.00061.x; Laden BP, 2000, ARCH BIOCHEM BIOPHYS, V374, P381, DOI 10.1006/abbi.1999.1629; Landl KM, 1996, YEAST, V12, P609, DOI 10.1002/(SICI)1097-0061(199605)12:6<609::AID-YEA949>3.0.CO;2-B; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lee HK, 2000, ARCH BIOCHEM BIOPHYS, V381, P43, DOI 10.1006/abbi.2000.1966; Lin HW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001105; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Matsushima D, 2012, PLANT SCI, V185, P309, DOI 10.1016/j.plantsci.2012.01.002; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller MB, 2012, J LIPID RES, V53, P1636, DOI 10.1194/jlr.M027482; Molnar A, 2009, PLANT J, V58, P165, DOI 10.1111/j.1365-313X.2008.03767.x; NAKASHIMA T, 1995, P NATL ACAD SCI USA, V92, P2328, DOI 10.1073/pnas.92.6.2328; Nakazawa A, 2012, BIORESOURCE TECHNOL, V109, P287, DOI 10.1016/j.biortech.2011.09.127; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Nowosieski M, 2011, J CHEM INF MODEL, V51, P455, DOI 10.1021/ci100403b; Ohnishi N, 2010, PLANT CELL, V22, P3105, DOI 10.1105/tpc.109.071811; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; ROBINSON GW, 1993, MOL CELL BIOL, V13, P2706, DOI 10.1128/MCB.13.5.2706; Salimova E, 1999, PLANT PHYSIOL BIOCH, V37, P241, DOI 10.1016/S0981-9428(99)80022-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Spanova M, 2011, EUR J LIPID SCI TECH, V113, P1299, DOI 10.1002/ejlt.201100203; SUMMERS C, 1993, GENE, V136, P185, DOI 10.1016/0378-1119(93)90462-C; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LY, 2014, PHOTOSYNTH RES, V121, P175, DOI 10.1007/s11120-014-9983-x; Wentzinger LF, 2002, PLANT PHYSIOL, V130, P334, DOI 10.1104/pp.004655; Yamano T, 2013, J BIOSCI BIOENG, V115, P691, DOI 10.1016/j.jbiosc.2012.12.020	53	47	49	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120446	10.1371/journal.pone.0120446	http://dx.doi.org/10.1371/journal.pone.0120446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764133	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300041
J	Bell, EH; Kirste, S; Fleming, JL; Stegmaier, P; Drendel, V; Mo, X; Ling, S; Fabian, D; Manring, I; Jilg, CA; Schultze-Seemann, W; McNulty, M; Zynger, DL; Martin, D; White, J; Werner, M; Grosu, AL; Chakravarti, A				Bell, Erica Hlavin; Kirste, Simon; Fleming, Jessica L.; Stegmaier, Petra; Drendel, Vanessa; Mo, Xiaokui; Ling, Stella; Fabian, Denise; Manring, Isabel; Jilg, Cordula A.; Schultze-Seemann, Wolfgang; McNulty, Maureen; Zynger, Debra L.; Martin, Douglas; White, Julia; Werner, Martin; Grosu, Anca L.; Chakravarti, Arnab			A Novel MiRNA-Based Predictive Model for Biochemical Failure Following Post-Prostatectomy Salvage Radiation Therapy	PLOS ONE			English	Article							LOCALIZED-PROSTATE-CANCER; NF-KAPPA-B; LYMPH-NODE METASTASIS; BIOPSY GLEASON SCORE; HUMAN GASTRIC-CANCER; HUMAN BREAST-CANCER; RADICAL PROSTATECTOMY; ANALYTICAL VALIDATION; 10-YEAR PROBABILITY; IONIZING-RADIATION	Purpose To develop a microRNA (miRNA)-based predictive model for prostate cancer patients of 1) time to biochemical recurrence after radical prostatectomy and 2) biochemical recurrence after salvage radiation therapy following documented biochemical disease progression post-radical prostatectomy. Methods Forty three patients who had undergone salvage radiation therapy following biochemical failure after radical prostatectomy with greater than 4 years of follow-up data were identified. Formalin-fixed, paraffin-embedded tissue blocks were collected for all patients and total RNA was isolated from 1mm cores enriched for tumor (> 70%). Eight hundred miRNAs were analyzed simultaneously using the nCounter human miRNA v2 assay (NanoString Technologies; Seattle, WA). Univariate and multivariate Cox proportion hazards regression models as well as receiver operating characteristics were used to identify statistically significant miRNAs that were predictive of biochemical recurrence. Results Eighty eight miRNAs were identified to be significantly (p<0.05) associated with biochemical failure post-prostatectomy by multivariate analysis and clustered into two groups that correlated with early (<= 36 months) versus late recurrence (>36 months). Nine miRNAs were identified to be significantly (p<0.05) associated by multivariate analysis with biochemical failure after salvage radiation therapy. A new predictive model for biochemical recurrence after salvage radiation therapy was developed; this model consisted of miR-4516 and miR-601 together with, Gleason score, and lymph node status. The area under the ROC curve (AUC) was improved to 0.83 compared to that of 0.66 for Gleason score and lymph node status alone. Conclusion miRNA signatures can distinguish patients who fail soon after radical prostatectomy versus late failures, giving insight into which patients may need adjuvant therapy. Notably, two novel miRNAs (miR-4516 and miR-601) were identified that significantly improve prediction of biochemical failure post-salvage radiation therapy compared to clinico-histopathological factors, supporting the use of miRNAs within clinically used predictive models. Both findings warrant further validation studies.	[Bell, Erica Hlavin; Kirste, Simon; Fleming, Jessica L.; Stegmaier, Petra; Ling, Stella; Fabian, Denise; Manring, Isabel; McNulty, Maureen; Martin, Douglas; White, Julia; Chakravarti, Arnab] Ohio State Comprehens Canc Ctr, Arthur G James Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA; [Kirste, Simon; Stegmaier, Petra; Grosu, Anca L.] Univ Med Ctr Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Drendel, Vanessa; Werner, Martin] Univ Med Ctr Freiburg, Dept Pathol, Freiburg, Germany; [Mo, Xiaokui] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA; [Jilg, Cordula A.; Schultze-Seemann, Wolfgang] Univ Med Ctr Freiburg, Dept Urol, Freiburg, Germany; [Zynger, Debra L.] Ohio State Univ, Wexner Med Ctr, Dept Pathol, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Freiburg; University of Freiburg; University System of Ohio; Ohio State University; University of Freiburg; University System of Ohio; Ohio State University	Bell, EH (corresponding author), Ohio State Comprehens Canc Ctr, Arthur G James Hosp, Dept Radiat Oncol, Columbus, OH 43210 USA.	Erica.Bell@osumc.edu	Bell, Erica/J-2950-2015		Ohio State University Comprehensive Cancer Center; NIH/NCI [1U10CA180850-01, 1R01CA188500-01]; NATIONAL CANCER INSTITUTE [R01CA188500, U10CA180850] Funding Source: NIH RePORTER	Ohio State University Comprehensive Cancer Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by funds from The Ohio State University Comprehensive Cancer Center (to AC); NIH/NCI 1U10CA180850-01 and 1R01CA188500-01 (To AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling CL, 2006, UROL CLIN N AM, V33, P147, DOI 10.1016/j.ucl.2005.12.002; Amling CL, 2000, J UROLOGY, V164, P101, DOI 10.1016/S0022-5347(05)67457-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blenkiron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080171; Botticella A, 2014, J CANCER RES CLIN, V140, P1111, DOI 10.1007/s00432-014-1673-8; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Cao Yi-Xiong, 2010, Zhonghua Xue Ye Xue Za Zhi, V31, P361; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Cheng C, 2014, TUMOR BIOL, V35, P4177, DOI 10.1007/s13277-013-1546-9; Chiavacci E, 2014, CYTOTECHNOLOGY; Chowdhari S, 2014, J CELL PHYSL; Cookson MS, 2007, J UROLOGY, V177, P540, DOI 10.1016/j.juro.2006.10.097; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Corcoran C, 2014, PROSTATE, V74, P1320, DOI 10.1002/pros.22848; D'Amico AV, 2000, UROLOGY, V55, P572, DOI 10.1016/S0090-4295(99)00479-3; Den RB, 2014, INT J RADIAT ONCOL, V89, P1038, DOI 10.1016/j.ijrobp.2014.04.052; Dong L, 2014, INT J ONCOL, V45, P746, DOI 10.3892/ijo.2014.2459; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fan YH, 2013, PROTEIN CELL, V4, P176, DOI 10.1007/s13238-013-2084-3; Fendler A, 2011, INT J ONCOL, V39, P1183, DOI 10.3892/ijo.2011.1128; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Gordanpour A, 2012, PROSTATE CANCER P D, V15, P314, DOI 10.1038/pcan.2012.3; Greene FL, 2009, AJCC CANC STAGING MA; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haj-Ahmad TA, 2014, J CANCER, V5, P182, DOI 10.7150/jca.6799; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Larne O, 2013, INT J CANCER, V132, P2867, DOI 10.1002/ijc.27973; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Li AG, 2013, CLIN CANCER RES, V19, P3600, DOI 10.1158/1078-0432.CCR-12-3092; Liang SQ, 2013, TURK NEUROSURG, V23, P721, DOI 10.5137/1019-5149.JTN.7425-12.1; Lichner Z, 2013, CLIN CHEM, V59, P1595, DOI 10.1373/clinchem.2013.205450; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Liu XQ, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/837514; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; May M, 2007, J UROLOGY, V178, P1957, DOI 10.1016/j.juro.2007.07.043; Mazeh H, 2013, J CANCER, V4, P281, DOI 10.7150/jca.5836; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mosakhani N, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-24; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Noto JM, 2013, AM J PHYSIOL-GASTR L, V305, pG786, DOI 10.1152/ajpgi.00279.2013; Nygren MK, 2014, BRIT J CANCER, V110, P2072, DOI 10.1038/bjc.2014.113; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Quek SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045656; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schubert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065064; Shang Y, 2014, ONCOGENE, V33, P3267, DOI 10.1038/onc.2013.297; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sobin L, 2009, TNM CLASSIFICATION M; Srivastava A, 2014, TUMOR BIOL, V35, P4867, DOI 10.1007/s13277-014-1638-1; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang ZS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-76; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Yan H, 2013, PHARMACOLOGY, V92, P167, DOI 10.1159/000354585; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yang Y, 2013, BIOMED REP, V1, P495, DOI 10.3892/br.2013.109; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Yoshino H, 2013, NAT REV UROL, V10, P396, DOI 10.1038/nrurol.2013.113; Yu XT, 2013, TUMOR BIOL, V34, P3501, DOI 10.1007/s13277-013-0928-3; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhao BS, 2013, ASIAN PAC J CANCER P, V14, P139, DOI 10.7314/APJCP.2013.14.1.139; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x; Ziliak D, 2012, MOL CANCER THER, V11, P2054, DOI 10.1158/1535-7163.MCT-12-0221	89	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118745	10.1371/journal.pone.0118745	http://dx.doi.org/10.1371/journal.pone.0118745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760964	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000036
J	Hadas, L; Hermon, D; Boldo, A; Arieli, G; Gafny, R; King, R; Bar-Gal, GK				Hadas, Lia; Hermon, Dalia; Boldo, Amizor; Arieli, Gal; Gafny, Ron; King, Roni; Bar-Gal, Gila Kahila			Wild Gazelles of the Southern Levant: Genetic Profiling Defines New Conservation Priorities	PLOS ONE			English	Article							OVINE MICROSATELLITES; POLYMORPHIC BOVINE; TAXONOMIC STATUS; GENUS GAZELLA; POPULATION; SOFTWARE; DORCAS; MTDNA; DNA; PURIFICATION	The mountain gazelle (Gazella gazelle), Dorcas gazelle (Gazella Dorcas) and acacia gazelle (Gazella arabica acacia) were historically abundant in the southern Levant, and more specifically in Israel. Anthropogenic and natural changes have caused a rapid decline in gazelle populations, raising concerns about their conservation status and future survival. The genetic profile of 111 wild gazelles from Israel was determined based on three regions of mitochondrial DNA (control region, Cytochrome b and 12S ribosomal RNA) and nine nuclear microsatellite markers. Genetic analysis of the mountain gazelle population, the largest known population of this rare species, revealed adequate diversity levels and gene flow between subpopulations. Nevertheless, ongoing habitat degradation and other human effects, such as poaching, suggest the need for drastic measures to prevent species extinction. Dorcas gazelles in Israel displayed inbreeding within subpopulations while still maintaining considerable genetic diversity overall. This stable population, represented by a distinctive genetic profile, is fragmented and isolated from its relatives in neighboring localities. Based on the genetic profile of a newly sampled subpopulation in Israel, we provide an alternative hypothesis for the historic dispersal of Dorcas gazelle, from the Southern Levant to northern Africa. The small acacia gazelle population was closest to gazelles from the Farasan Islands of Saudi Arabia, based on mitochondrial markers. The two populations did not share haplotypes, suggesting that these two populations may be the last remnant wild gazelles of this species worldwide. Only a dozen acacia gazelles survive in Israel, and urgent steps are needed to ensure the survival of this genetically distinctive lineage. The genetic assessments of our study recognize new conservation priorities for each gazelle species in the Southern Levant.	[Hadas, Lia; Bar-Gal, Gila Kahila] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel; [Hermon, Dalia; Gafny, Ron] Israel Police, Natl Headquarters, Div Identificat & Forens Sci, DNA & Forens Biol Lab, Jerusalem, Israel; [Boldo, Amizor; Arieli, Gal] Israel Nat & Parks Author, Supervis & Enforcement Div, Jerusalem, Israel; [King, Roni] Israel Nat & Parks Author, Sci & Conservat Div, Jerusalem, Israel	Hebrew University of Jerusalem	Bar-Gal, GK (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Koret Sch Vet Med, IL-76100 Rehovot, Israel.	gila.kahila@mail.huji.ac.il			Israel Nature and Parks Authority	Israel Nature and Parks Authority	The Israel Nature and Parks Authority provided partial support for the work. AB GA and RK are employees of the Israel Nature and Parks Authority and assisted in the design of the study and contributed to the manuscript.	Barmann EV, 2013, ZOOL J LINN SOC-LOND, V169, P673, DOI 10.1111/zoj.12066; Barmann EV, 2013, MAMM BIOL, V78, P220, DOI 10.1016/j.mambio.2012.07.003; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bar-Oz G, 2004, J ARCHAEOL SCI, V31, P217, DOI 10.1016/j.jas.2003.08.003; BISHOP MD, 1994, GENETICS, V136, P619; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; BUCHANAN FC, 1994, ANIM GENET, V25, P60, DOI 10.1111/j.1365-2052.1994.tb00069.x; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; Danin A, 1998, ATLAS KARTA HA HAI V; Davis S.J.M., 1983, PALEORIENT, V9, P55; Dolev A., 2004, RED BOOK VERTEBRATES; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Geffen H, 1999, J ZOOL, V247, P113, DOI 10.1017/S0952836999001119; Georges M, 1992, Patent, Patent No. [WO 92/13102, 92130102]; Getraida S, 1990, RES REPORT; Gingold G, 2009, ANIM CONSERV, V12, P155, DOI 10.1111/j.1469-1795.2009.00235.x; Godinho R, 2012, CONSERV GENET, V13, P1003, DOI 10.1007/s10592-012-0348-8; Habibi K, 1992, NATL COMMISSION WILD; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; IUCN SSC Antelope Specialist Group, 2008, IUCN 2013 IUCN RED L; Kankilic T, 2012, FOLIA ZOOL, V61, P129, DOI 10.25225/fozo.v61.i2.a6.2012; Kaplan D, 2002, Z JAGDWISS, V48, P167, DOI 10.1007/BF02192405; KEMP SJ, 1995, ANIM GENET, V26, P299, DOI 10.1111/j.1365-2052.1995.tb02663.x; Lerp H, 2013, SPECIATION NATURAL P, P59; Lerp H, 2012, MAMM BIOL, V78, P383; Lerp H, 2011, ORG DIVERS EVOL, V11, P317, DOI 10.1007/s13127-011-0057-z; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorenzen ED, 2010, J BIOGEOGR, V37, P571, DOI 10.1111/j.1365-2699.2009.02207.x; Manor R, 2005, J WILDLIFE MANAGE, V69, P1683, DOI 10.2193/0022-541X(2005)69[1683:EOHDOU]2.0.CO;2; Manor R, 2004, BIOL CONSERV, V119, P231, DOI 10.1016/j.biocon.2003.11.005; Oron T, 2009, ISRAEL NATURE PARKS, P20; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Penty JM, 1993, ANIM GENET, V24, P219, DOI 10.1111/j.1365-2052.1993.tb00295.x; Perktas U, 2011, BIOL J LINN SOC, V104, P710, DOI 10.1111/j.1095-8312.2011.01750.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2012, FIGTREE V142; Rambaut A, 2013, TRACER V1 5; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roca AL, 2004, NATURE, V429, P649, DOI 10.1038/nature02597; SUNDEN SLF, 1993, ANIM GENET, V24, P69, DOI 10.1111/j.1365-2052.1993.tb00924.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernov E., 1987, Journal of Vertebrate Paleontology, V7, P284; TCHERNOV E, 1986, Israel Journal of Zoology, V34, P51; Thieven U, 1997, MAMM GENOME, V8, P52, DOI 10.1007/s003359900348; TOLDO SS, 1993, MAMM GENOME, V4, P720, DOI 10.1007/BF00357796; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; VAIMAN D, 1994, MAMM GENOME, V5, P288, DOI 10.1007/BF00389543; Willard J M, 1998, Methods Mol Biol, V98, P9; Wronski T, 2010, ISLAND GAZELLE NEWS, P20; Wronski T, 2010, SYST BIODIVERS, V8, P119, DOI 10.1080/14772001003613192; Yeshurun R, 2013, MIDDLE PALEOLITHIC P, P45; YOMTOV Y, 1987, BIOL CONSERV, V40, P245, DOI 10.1016/0006-3207(87)90118-2	60	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116401	10.1371/journal.pone.0116401	http://dx.doi.org/10.1371/journal.pone.0116401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760948	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000003
J	Scopel, JF; Queiroz, LD; O'Dowd, FP; Franca, MC; Nucci, A; Honnicke, MG				Scopel, Jonas Francisco; Queiroz, Luciano de Souza; O'Dowd, Francis Pierce; Franca Junior, Marcondes Cavalcante; Nucci, Anamarli; Hoennicke, Marcelo Goncalves			Are Human Peripheral Nerves Sensitive to X-Ray Imaging?	PLOS ONE			English	Article							PHASE-CONTRAST; RADIOGRAPHY; TOMOGRAPHY	Diagnostic imaging techniques play an important role in assessing the exact location, cause, and extent of a nerve lesion, thus allowing clinicians to diagnose and manage more effectively a variety of pathological conditions, such as entrapment syndromes, traumatic injuries, and space-occupying lesions. Ultrasound and nuclear magnetic resonance imaging are becoming useful methods for this purpose, but they still lack spatial resolution. In this regard, recent phase contrast x-ray imaging experiments of peripheral nerve allowed the visualization of each nerve fiber surrounded by its myelin sheath as clearly as optical microscopy. In the present study, we attempted to produce high-resolution x-ray phase contrast images of a human sciatic nerve by using synchrotron radiation propagation-based imaging. The images showed high contrast and high spatial resolution, allowing clear identification of each fascicle structure and surrounding connective tissue. The outstanding result is the detection of such structures by phase contrast x-ray tomography of a thick human sciatic nerve section. This may further enable the identification of diverse pathological patterns, such as Wallerian degeneration, hypertrophic neuropathy, inflammatory infiltration, leprosy neuropathy and amyloid deposits. To the best of our knowledge, this is the first successful phase contrast x-ray imaging experiment of a human peripheral nerve sample. Our long-term goal is to develop peripheral nerve imaging methods that could supersede biopsy procedures.	[Scopel, Jonas Francisco] Univ Fed Goias, Inst Ciencias Saude, BR-75804020 Jatai, Goias, Brazil; [Queiroz, Luciano de Souza] Univ Estadual Campinas, Dept Anat Patol, BR-13083887 Campinas, SP, Brazil; [O'Dowd, Francis Pierce] Lab Nacl Luz Sincrotron, BR-13083970 Campinas, SP, Brazil; [Franca Junior, Marcondes Cavalcante; Nucci, Anamarli] Univ Estadual Campinas, Dept Neurol, BR-13083887 Campinas, SP, Brazil; [Hoennicke, Marcelo Goncalves] Univ Fed Integracao Latino Amer, Inst Latino Amer Ciencias Vida & Nat, BR-85867970 Foz Do Iguacu, Parana, Brazil	Universidade Federal de Goias; Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS); Universidade Estadual de Campinas; Universidade Federal da Integracao Latino-Americana	Scopel, JF (corresponding author), Univ Fed Goias, Inst Ciencias Saude, BR-75804020 Jatai, Goias, Brazil.	jonasscopel@ufg.br	Honnicke, Marcelo G/I-8624-2012	Honnicke, Marcelo G/0000-0003-3276-4323	Conselho Nacional de Desenvolvimento Cientifico eTecnologico [309109/2013-2]; UNILA [23422.010903/2014-47]	Conselho Nacional de Desenvolvimento Cientifico eTecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UNILA	The authors acknowledge Laboratorio Nacional de Luz Sincrotron/Ministerio da Ciencia e Tecnologia (lnls.cnpem.br) for the beamtime (under proposals D09B-Friendly User and D10A-XRD2-16169). MGH thanks Conselho Nacional de Desenvolvimento Cientifico eTecnologico (www.cnpq.br), grant no. 309109/2013-2, for the research fellow. The authors acknowledge UNILA (no. 23422.010903/2014-47) for the publication support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M., 1972, P 6 INT C XRAY OPT M, P63; Antunes A, 2005, NUCL INSTRUM METH B, V238, P28, DOI 10.1016/j.nimb.2005.06.013; Barohn RJ, 1998, SEMIN NEUROL, V18, P7, DOI 10.1055/s-2008-1040857; Bech M, 2009, J SYNCHROTRON RADIAT, V16, P43, DOI 10.1107/S090904950803464X; Beckmann F, 1999, BIOPHYS J, V76, P98, DOI 10.1016/S0006-3495(99)77181-X; Bewer B, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3478018; Chapman D, 2006, NUCL INSTRUM METH A, V562, P461, DOI 10.1016/j.nima.2006.02.185; Cloetens P, 1997, OBSERVATION MICROSTR, V81; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; FORSTER E, 1980, KRIST TECH, V15, P937, DOI 10.1002/crat.19800150812; Giles C, 2003, J SYNCHROTRON RADIAT, V10, P421, DOI 10.1107/S0909049503020144; Honnicke MG, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2814022; Honnicke MG, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4767243; Honnicke MG, 2008, OPT EXPRESS, V16, P9284, DOI 10.1364/OE.16.009284; Honnicke MG, 2008, NUCL INSTRUM METH A, V584, P418, DOI 10.1016/j.nima.2007.10.036; Honnicke MG, 2009, J APPL CRYSTALLOGR, V42, P999, DOI 10.1107/S0021889809040199; Honnicke MG, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2018456; INGAL VN, 1995, J PHYS D APPL PHYS, V28, P2314, DOI 10.1088/0022-3727/28/11/012; Kelly ME, 2007, CAN J OPHTHALMOL, V42, P731, DOI 10.3129/i07-132; Kermarrec E, 2010, SEMIN MUSCULOSKEL R, V14, P463, DOI 10.1055/s-0030-1268067; Kim BI, 2008, MICROSC RES TECHNIQ, V71, P443, DOI 10.1002/jemt.20571; Lareida A, 2009, J MICROSC-OXFORD, V234, P95, DOI 10.1111/j.1365-2818.2009.03143.x; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu R, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/25002; Martinoli C, 2010, SEMIN MUSCULOSKEL R, V14, P461, DOI 10.1055/s-0030-1268395; Martyn C, 1997, J NEUROL NEUROSUR PS, V62, P310, DOI 10.1136/jnnp.62.4.310; Momose A, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0023; Nugent KA, 2007, J OPT SOC AM A, V24, P536, DOI 10.1364/JOSAA.24.000536; Olivo A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772193; Parham C, 2009, ACAD RADIOL, V16, P911, DOI 10.1016/j.acra.2009.02.007; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Podurets K. M., 1989, Soviet Physics - Technical Physics, V34, P654; Rosenberg NR, 2001, J NEUROL NEUROSUR PS, V71, P205, DOI 10.1136/jnnp.71.2.205; Sarapata A, 2014, MED PHYS, V41, DOI 10.1118/1.4860275; Strengell S, 2014, J SYNCHROTRON RADIAT, V21, P1305, DOI 10.1107/S160057751401697X; Suortti P, 2003, PHYS MED BIOL, V48, pR1, DOI 10.1088/0031-9155/48/13/201; Tuohimaa T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2769760; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006; Zhou SA, 2011, NUCL INSTRUM METH A, V648, pS284, DOI 10.1016/j.nima.2010.11.050	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116831	10.1371/journal.pone.0116831	http://dx.doi.org/10.1371/journal.pone.0116831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757086	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700012
J	Kubota, S; Morii, M; Yuki, R; Yamaguchi, N; Yamaguchi, H; Aoyama, K; Kuga, T; Tomonaga, T; Yamaguchi, N				Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Naoto			Role for Tyrosine Phosphorylation of A-kinase Anchoring Protein 8 (AKAP8) in Its Dissociation from Chromatin and the Nuclear Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONDENSATION; OXIDATIVE STRESS; GROWTH-FACTOR; ATM PROTEIN; AURORA-B; SRC; ABL; LYN; ACTIVATION; LOCALIZATION	Protein-tyrosine phosphorylation regulates a wide variety of cellular processes at the plasma membrane. Recently, we showed that nuclear tyrosine kinases induce global nuclear structure changes, which we called chromatin structural changes. However, the mechanisms are not fully understood. In this study we identify protein kinase A anchoring protein 8 (AKAP8/AKAP95), which associates with chromatin and the nuclear matrix, as a nuclear tyrosine-phosphorylated protein. Tyrosine phosphorylation of AKAP8 is induced by several tyrosine kinases, such as Src, Fyn, and c-Abl but not Syk. Nucleus-targeted Lyn and c-Src strongly dissociate AKAP8 from chromatin and the nuclear matrix in a kinase activity-dependent manner. The levels of tyrosine phosphorylation of AKAP8 are decreased by substitution of multiple tyrosine residues on AKAP8 into phenylalanine. Importantly, the phenylalanine mutations of AKAP8 inhibit its dissociation from nuclear structures, suggesting that the association/dissociation of AKAP8 with/from nuclear structures is regulated by its tyrosine phosphorylation. Furthermore, the phenylalanine mutations of AKAP8 suppress the levels of nuclear tyrosine kinase-induced chromatin structural changes. In contrast, AKAP8 knockdown increases the levels of chromatin structural changes. Intriguingly, stimulation with hydrogen peroxide induces chromatin structural changes accompanied by the dissociation of AKAP8 from nuclear structures. These results suggest that AKAP8 is involved in the regulation of chromatin structural changes through nuclear tyrosine phosphorylation.	[Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inahana 1-8-1, Chiba 2608675, Japan; [Kubota, Sho; Morii, Mariko; Yuki, Ryuzaburo; Yamaguchi, Noritaka; Yamaguchi, Hiromi; Aoyama, Kazumasa; Yamaguchi, Naoto] Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Kuga, Takahisa; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Chiba University; Chiba University; National Institute of Health Sciences - Japan	Yamaguchi, N (corresponding author), Chiba Univ, Dept Mol Cell Biol, Grad Sch Pharmaceut Sci, Chuo Ku, Inahana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Kubota, Sho/0000-0001-6119-1259	Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment); Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology;  [25460356];  [264367]; Grants-in-Aid for Scientific Research [15K19545, 26460081] Funding Source: KAKEN	Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research C 25460356 (to N. Y.) and JSPS fellows 264367 (to S. K.), the Global COE Program (Global Center for Education and Research in Immune Regulation and Treatment), and the Program for Leading Graduate Schools (Nurture of Creative Research Leaders in Immune System Regulation and Innovative Therapeutics) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Akileswaran L, 2001, J BIOL CHEM, V276, P17448, DOI 10.1074/jbc.M101171200; Amanchy R, 2008, J PROTEOME RES, V7, P3900, DOI 10.1021/pr800198w; Aoyama K, 2015, CELL BIOL INT, V39, P446, DOI 10.1002/cbin.10413; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Cencioni C, 2013, INT J MOL SCI, V14, P17643, DOI 10.3390/ijms140917643; Chan H. L., 2010, J BIOL CHEM, V285, P4307; Chellappa K, 2012, P NATL ACAD SCI USA, V109, P2302, DOI 10.1073/pnas.1106799109; Chou RH, 2014, DEV CELL, V30, P224, DOI 10.1016/j.devcel.2014.06.008; Eide T, 2003, J BIOL CHEM, V278, P26750, DOI 10.1074/jbc.M300765200; Eide T, 2002, EMBO REP, V3, P426, DOI 10.1093/embo-reports/kvf089; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Gonzalez-Zuniga M, 2014, MOL CELL, V56, P163, DOI 10.1016/j.molcel.2014.08.013; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Guilluy C, 2014, NAT CELL BIOL, V16, P376, DOI 10.1038/ncb2927; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hasegawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116048; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jiang H, 2013, NAT STRUCT MOL BIOL, V20, P1156, DOI 10.1038/nsmb.2656; Kaidi A, 2013, NATURE, V498, P70, DOI 10.1038/nature12201; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kubota S, 2014, J BIOL CHEM, V289, P5730, DOI 10.1074/jbc.M113.546655; LAW CL, 1994, J BIOL CHEM, V269, P12310; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nishibuchi G., 2014, NUCLEIC ACIDS RES, V42, P12498; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Soeda S, 2013, EXP CELL RES, V319, P1382, DOI 10.1016/j.yexcr.2013.02.023; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamaguchi N, 2001, J CELL SCI, V114, P1631; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Yuki R., 2015, J CELL BIOCHEM, DOI [10.1002/icb.25046, DOI 10.1002/ICB.25046]	58	18	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10891	10904		10.1074/jbc.M115.643882	http://dx.doi.org/10.1074/jbc.M115.643882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770215	Green Published, hybrid			2022-12-26	WOS:000353404500028
J	Aeby, GS; Work, TM; Runyon, CM; Shore-Maggio, A; Ushijima, B; Videau, P; Beurmann, S; Callahan, SM				Aeby, Greta S.; Work, Thierry M.; Runyon, Christina M.; Shore-Maggio, Amanda; Ushijima, Blake; Videau, Patrick; Beurmann, Silvia; Callahan, Sean M.			First Record of Black Band Disease in the Hawaiian Archipelago: Response, Outbreak Status, Virulence, and a Method of Treatment	PLOS ONE			English	Article							GREAT-BARRIER-REEF; WHITE SYNDROME; CORAL DISEASE; HANALEI BAY; PREVALENCE; DYNAMICS; GROWTH; IDENTIFICATION; COMMUNITIES; ANOMALIES	A high number of coral colonies, Montipora spp., with progressive tissue loss were reported from the north shore of Kaua'i by a member of the Eyes of the Reef volunteer reporting network. The disease has a distinct lesion (semi-circular pattern of tissue loss with an adjacent dark band) that was first observed in Hanalei Bay, Kaua'i in 2004. The disease, initially termed Montipora banded tissue loss, appeared grossly similar to black band disease (BBD), which affects corals worldwide. Following the initial report, a rapid response was initiated as outlined in Hawai'i's rapid response contingency plan to determine outbreak status and investigate the disease. Our study identified the three dominant bacterial constituents indicative of BBD (filamentous cyanobacteria, sulfate-reducing bacteria, sulfide-oxidizing bacteria) in coral disease lesions from Kaua'i, which provided the first evidence of BBD in the Hawaiian archipelago. A rapid survey at the alleged outbreak site found disease to affect 6-7% of the montiporids, which is higher than a prior prevalence of less than 1% measured on Kaua'i in 2004, indicative of an epizootic. Tagged colonies with BBD had an average rate of tissue loss of 5.7 cm2/day over a two-month period. Treatment of diseased colonies with a double band of marine epoxy, mixed with chlorine powder, effectively reduced colony mortality. Within two months, treated colonies lost an average of 30% less tissue compared to untreated controls.	[Aeby, Greta S.; Runyon, Christina M.; Shore-Maggio, Amanda; Ushijima, Blake; Beurmann, Silvia; Callahan, Sean M.] Hawai Inst Marine Biol, Kneohe, HI 96744 USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA; [Aeby, Greta S.; Runyon, Christina M.; Callahan, Sean M.] Univ Hawaii, Marine Biol Grad Program, Honolulu, HI 96822 USA; [Shore-Maggio, Amanda; Ushijima, Blake; Videau, Patrick; Beurmann, Silvia; Callahan, Sean M.] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA	United States Department of the Interior; United States Geological Survey; University of Hawaii System; University of Hawaii System	Aeby, GS (corresponding author), Hawai Inst Marine Biol, Kneohe, HI 96744 USA.	greta@hawaii.edu	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Ushijima, Blake/0000-0002-1053-5207; Grant, Silvia/0000-0001-5713-9212	Hawai'i Coral Reef Initiative; Hawai'i Division of Aquatic Resources; University of Hawaii	Hawai'i Coral Reef Initiative; Hawai'i Division of Aquatic Resources; University of Hawaii	Funding was provided, in part, by the Hawai'i Coral Reef Initiative and the Hawai'i Division of Aquatic Resources awarded to GSA. Further support was provided by the University of Hawaii. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Aeby G, 2008, HAWAIIS RAPID RESPON; Aeby G, 2007, P HAN WAT WORKSH; Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020370; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Aeby GS, 2011, J MAR BIOL, V2011; Al-Moghrabi SM, 2001, CORAL REEFS, V19, P330, DOI 10.1007/s003380000127; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Barneah O, 2007, ENVIRON MICROBIOL, V9, P1995, DOI 10.1111/j.1462-2920.2007.01315.x; Beeden R, 2012, ENVIRON MANAGE, V49, P1, DOI 10.1007/s00267-011-9770-9; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; Bourne DG, 2011, ISME J, V5, P559, DOI 10.1038/ismej.2010.143; Bruckner AW, 1997, B MAR SCI, V61, P919; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; CARLTON RG, 1995, FEMS MICROBIOL ECOL, V18, P155, DOI 10.1016/0168-6496(95)00052-C; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2010, MAR FRESHWATER RES, V61, P342, DOI 10.1071/MF09060; Derse E, 2007, ENVIRON SCI TECHNOL, V41, P5217, DOI 10.1021/es0700449; DUCKLOW HW, 1979, MICROBIAL ECOL, V5, P215, DOI 10.1007/BF02013528; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Haapkyla J, 2009, DIS AQUAT ORGAN, V87, P105, DOI 10.3354/dao02160; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hudson H., 2000, DIVING SCI 21 CENTUR; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; Kaczmarsky LT, 2005, CARIBB J SCI, V41, P124; Knee KL, 2008, ESTUAR COAST, V31, P607, DOI 10.1007/s12237-008-9055-6; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Maragos James E., 2004, Pacific Science, V58, P211, DOI 10.1353/psc.2004.0020; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller AW, 2011, FEMS MICROBIOL ECOL, V75, P231, DOI 10.1111/j.1574-6941.2010.00991.x; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; NELSON DC, 1983, ARCH MICROBIOL, V136, P262, DOI 10.1007/BF00425214; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Rasoulouniriana D, 2009, DIS AQUAT ORGAN, V87, P91, DOI 10.3354/dao02089; Raymundo L.J., 2008, CORAL DIS HDB GUIDEL, V1st; Raymundo LJ, 2009, P NATL ACAD SCI USA, V106, P17067, DOI 10.1073/pnas.0900365106; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Ross M, 2012, P 12 INT COR REEF S, p16B; ROtzler K., 1983, PSZNI MAR ECOL, V4, P301, DOI DOI 10.1111/J.1439-0485.1983.TB00116.X; Sato Y, 2009, P R SOC B, V276, P2795, DOI 10.1098/rspb.2009.0481; Sokolow S, 2009, DIS AQUAT ORGAN, V87, P5, DOI 10.3354/dao02099; Storlazzi CD, 2009, MAR GEOL, V264, P140, DOI 10.1016/j.margeo.2009.05.002; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2006, DIS AQUAT ORGAN, V69, P111, DOI 10.3354/dao069111; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Vargas-Angel B., 2009, P 11 INT COR REEF S, V1, P175; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Wagner M, 2005, METHOD ENZYMOL, V397, P469, DOI 10.1016/S0076-6879(05)97029-8; Weil E, 2012, DIS AQUAT ORGAN, V98, P163, DOI 10.3354/dao02433; Williams GJ, 2013, DIS AQUAT ORGAN, V106, P181, DOI 10.3354/dao02652; Williams GJ, 2011, DIS AQUAT ORGAN, V94, P89, DOI 10.3354/dao02323; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Woodley CM, 2008, FIELD MANUAL FOR INV	75	31	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120853	10.1371/journal.pone.0120853	http://dx.doi.org/10.1371/journal.pone.0120853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774800	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500194
J	Boerner, JL; Nechiporchik, N; Mueller, KL; Polin, L; Heilbrun, L; Boerner, SA; Zoratti, GL; Stark, K; LoRusso, PM; Burger, A				Boerner, Julie L.; Nechiporchik, Nicole; Mueller, Kelly L.; Polin, Lisa; Heilbrun, Lance; Boerner, Scott A.; Zoratti, Gina L.; Stark, Karri; LoRusso, Patricia M.; Burger, Angelika			Protein Expression of DNA Damage Repair Proteins Dictates Response to Topoisomerase and PARP Inhibitors in Triple-Negative Breast Cancer	PLOS ONE			English	Article							BRCA MUTANT-CELLS; POLY(ADP-RIBOSE) POLYMERASE; PERSPECTIVE; DEFECT; TUMORS; ERCC1	Patients with metastatic triple-negative breast cancer (TNBC) have a poor prognosis. New approaches for the treatment of TNBC are needed to improve patient survival. The concept of synthetic lethality, brought about by inactivating complementary DNA repair pathways, has been proposed as a promising therapeutic option for these tumors. The TNBC tumor type has been associated with BRCA mutations, and inhibitors of Poly (ADP-ribose) polymerase (PARP), a family of proteins that facilitates DNA repair, have been shown to effectively kill BRCA defective tumors by preventing cells from repairing DNA damage, leading to a loss of cell viability and clonogenic survival. Here we present preclinical efficacy results of combining the PARP inhibitor, ABT-888, with CPT-11, a topoisomerase I inhibitor. CPT-11 binds to topoisomerase I at the replication fork, creating a bulky adduct that is recognized as damaged DNA. When DNA damage was stimulated with CPT-11, protein expression of the nucleotide excision repair enzyme ERCC1 inversely correlated with cell viability, but not clonogenic survival. However, 4 out of the 6 TNBC cells were synergistically responsive by cell viability and 5 out of the 6 TNBC cells were synergistically responsive by clonogenic survival to the combination of ABT-888 and CPT-11. In vivo, the BRCA mutant cell line MX-1 treated with CPT-11 alone demonstrated significant decreased tumor growth; this decrease was enhanced further with the addition of ABT-888. Decrease in tumor growth correlated with an increase in double strand DNA breaks as measured by y-H2AX phosphorylation. In summary, inhibiting two arms of the DNA repair pathway simultaneously in TNBC cell lines, independent of BRCA mutation status, resulted in un-repairable DNA damage and subsequent cell death.	[Boerner, Julie L.; Nechiporchik, Nicole; Mueller, Kelly L.; Polin, Lisa; Heilbrun, Lance; Boerner, Scott A.; Zoratti, Gina L.; Stark, Karri; LoRusso, Patricia M.; Burger, Angelika] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA; [Boerner, Scott A.; LoRusso, Patricia M.] Yale Univ, Dept Oncol, New Haven, CT USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Yale University	Boerner, JL (corresponding author), Wayne State Univ, Barbara Ann Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA.	boernerj@karmanos.org		Boerner, Scott/0000-0003-1388-9665	National Institutes of Health [U01 CA-62487, R21 CA135572-02]; NATIONAL CANCER INSTITUTE [R21CA135572, P30CA022453, U01CA062487, R01CA140314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health grants U01 CA-62487 (PML) and R21 CA135572-02 (PML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Anders CK, 2011, CANCER-AM CANCER SOC, V117, P1602, DOI 10.1002/cncr.25746; Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Corbett TH, 1998, INVEST NEW DRUG, V16, P129, DOI 10.1023/A:1006174622061; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gossage L, 2007, CANCER TREAT REV, V33, P565, DOI 10.1016/j.ctrv.2007.07.001; Graziani G, 2005, PHARMACOL RES, V52, P109, DOI 10.1016/j.phrs.2005.02.013; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; HOLM S, 1979, ACTA MED SCAND, V205, P587; Institute NC., PDQ GEN BREAST OV CA; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Littell RC, 2006, STAT ANAL SYSTEM SAS; Murphy CG, 2010, CANCER J, V16, P39, DOI 10.1097/PPO.0b013e3181cf0204; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Santana-Davila R, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-42; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Xu J, 2012, MOL BIOL REP, V39, P3097, DOI 10.1007/s11033-011-1073-y; Zhang YW, 2011, NUCLEIC ACIDS RES, V39, P3607, DOI 10.1093/nar/gkq1304	27	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119614	10.1371/journal.pone.0119614	http://dx.doi.org/10.1371/journal.pone.0119614			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774912	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500105
J	Chappell, JM; Iqbal, A; Gunn, LJ; Abbott, D				Chappell, James M.; Iqbal, Azhar; Gunn, Lachlan J.; Abbott, Derek			Functions of Multivector Variables	PLOS ONE			English	Article								As is well known, the common elementary functions defined over the real numbers can be generalized to act not only over the complex number field but also over the skew (non-commuting) field of the quaternions. In this paper, we detail a number of elementary functions extended to act over the skew field of Clifford multivectors, in both two and three dimensions. Complex numbers, quaternions and Cartesian vectors can be described by the various components within a Clifford multivector and from our results we are able to demonstrate new inter-relationships between these algebraic systems. One key relationship that we discover is that a complex number raised to a vector power produces a quaternion thus combining these systems within a single equation. We also find a single formula that produces the square root, amplitude and inverse of a multivector over one, two and three dimensions. Finally, comparing the functions over different dimension we observe that Cl (R-3) provides a particularly versatile algebraic framework.	[Chappell, James M.; Iqbal, Azhar; Gunn, Lachlan J.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Chappell, JM (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	james.chappell@adelaide.edu.au	Iqbal, Azhar/E-8749-2011; Abbott, Derek/E-8352-2011	Iqbal, Azhar/0000-0002-5221-9384; Abbott, Derek/0000-0002-0945-2674; Gunn, Lachlan/0000-0003-1767-7897				Boudet R, 2009, SPRINGER SER ATOM OP, V52; Carrier G. F., 2005, FUNCTIONS COMPLEX VA, DOI [10.1137/1.9780898719116, DOI 10.1137/1.9780898719116]; Greene R. E., 2006, GRADUATE STUDIES MAT, V40; Hahn A. J., 1994, QUADRATIC ALGEBRAS C; Hestenes D., 1999, NEW FDN CLASSICAL ME, VSecond; Janovska D., 2008, MITT MATH GES HAMBUR, V27, P223; Lam T.Y., 1973, ALGEBRAIC THEORY QUA; Lounesto P., 2001, CLIFFORD ALGEBRAS SP, V2; PORTEOUS IR, 1995, CLIFFORD ALGEBRAS CL; Sangwine SJ, 2006, ADV APPL CLIFFORD AL, V16, P63, DOI 10.1007/s00006-006-0005-8	10	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116943	10.1371/journal.pone.0116943	http://dx.doi.org/10.1371/journal.pone.0116943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774689	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500013
J	Liu, SX; Zhu, WP; Li, SJ; Cui, TX; Li, ZH; Zhang, B; Li, Z; Wu, JX; Liang, XL; Lin, Z; Shi, W				Liu, Shuangxin; Zhu, Weiping; Li, Sijia; Cui, Tongxia; Li, Zhonghe; Zhang, Bin; Li, Zhuo; Wu, Jianxiong; Liang, Xinling; Lin, Zheng; Shi, Wei			The Effect of Bovine Parathyroid Hormone Withdrawal on MC3T3-E1 Cell Proliferation and Phosphorus Metabolism	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HEMODIALYSIS-PATIENTS; SECONDARY HYPERPARATHYROIDISM; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN; MULTIPLE MECHANISMS; DIALYSIS PATIENT; PTH; MANAGEMENT; CINACALCET	Hypocalcemia and hypophosphatemia are common complications after parathyroidectomy (PTX). Sudden removal of high circulating levels of parathyroid hormone (PTH) causes decreased osteoclastic resorption resulting in a decreased bone remodeling space. These phenomena are likely due to an increased influx of calcium and phosphorus into bone. However, there are currently no data to support this hypothesis. In this study, we found that PTX significantly reduced levels of PTH, calcium and phosphate. Compared with preoperative levels, after 1 year, postoperative PTH, calcium and phosphate levels were 295.6 +/- 173.7 pg/mL (P < 0.05), 86.62 +/- 15.98 mg/dL (P < 0.05) and 5.56 +/- 2.03 mg/dL (P < 0.05), respectively. We investigated continuous bovine PTH administration as well as withdrawal of bovine PTH stimulation in the mouse osteoblast precursor cell line MC3T3-E1. MC3T3-E1 cells were cultured with continuous bovine PTH treatment for 20 days or with transient bovine PTH treatment for 10 days. High doses of continuous bovine PTH exposure strongly reduced cell proliferation, alkaline phosphatase activity and the number of mineralized calcium nodules. However, withdrawal of bovine PTH (100 ng/mL) significantly increased the number of mineralized calcium nodules and caused a rapid decline in calcium and phosphorus content of culture medium. In conclusion, continuous exposure to bovine PTH inhibited osteoblast differentiation and reduced the formation of mineralized nodules. However, this inhibition was removed and mineralized nodule formation resumed with withdrawal of bovine PTH. According to the results of our clinical examinations and in vitro experiments, we hypothesize that the sudden removal of high levels of PTH may cause an increased influx of calcium and phosphorus into bone after PTX.	[Liu, Shuangxin; Li, Sijia; Zhang, Bin; Li, Zhuo; Wu, Jianxiong; Liang, Xinling; Lin, Zheng; Shi, Wei] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Zhu, Weiping; Cui, Tongxia; Li, Zhonghe] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Zhuhai, Peoples R China	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Sun Yat Sen University	Shi, W (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Nephrol, 106 Zhongshan 2 Rd, Guangzhou, Guangdong, Peoples R China.	shiwei@139.com	liu, shuangxin/AAS-7429-2020	Zhu, weiping/0000-0002-8856-5609	Guangdong Provincial Science and Technology Foundation [2012B031800164, 2011B031800303]; National Natural Science Foundation [81370808, 81270784, 81170683]; Guangzhou City Science and Technology Project [12A56041537, 2012J4300084, 2012Y2-00028]; National Key Technology RD Program [2011BAI10B06]; National key clinical specialist construction Programs of China; Chinese Society of Nephrology [14050400577]; Medical Scientific Research Foundation of Guangdong Province [A2014259]	Guangdong Provincial Science and Technology Foundation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangzhou City Science and Technology Project; National Key Technology RD Program(National Key Technology R&D Program); National key clinical specialist construction Programs of China; Chinese Society of Nephrology; Medical Scientific Research Foundation of Guangdong Province	This work was supported by Guangdong Provincial Science and Technology Foundation (No. 2012B031800164 and 2011B031800303), the National Natural Science Foundation (No. 81370808, 81270784 and 81170683), Guangzhou City Science and Technology Project (No. 12A56041537, 2012J4300084 and 2012Y2-00028), National Key Technology R&D Program (No. 2011BAI10B06), National key clinical specialist construction Programs of China, Chinese Society of Nephrology (No. 14050400577) and Medical Scientific Research Foundation of Guangdong Province (No.A2014259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan D, 2012, SCAND J CLIN LAB INV, V72, P14, DOI 10.3109/00365513.2011.624631; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Bogazzi F, 2011, J ENDOCRINOL INVEST, V34, pE200, DOI 10.3275/7228; BRASIER AR, 1988, AM J MED, V84, P654, DOI 10.1016/0002-9343(88)90100-3; Cannata-Andia JB, 2013, J NEPHROL, V26, P73, DOI 10.5301/jn.5000212; Cooper K, 2012, NEPHRON CLIN PRACT, V121, pC124, DOI 10.1159/000345164; Cozzolino M, 2004, J NEPHROL, V17, P3; Cruz DN, 1997, AM J KIDNEY DIS, V29, P759, DOI 10.1016/S0272-6386(97)90131-1; Esbrit P, 2013, BIOCHEM PHARMACOL, V85, P1417, DOI 10.1016/j.bcp.2013.03.002; Fukuma S, 2013, KIDNEY INT SUPPL, V3, P436, DOI 10.1038/kisup.2013.91; Goldfarb M, 2012, WORLD J SURG, V36, P1314, DOI 10.1007/s00268-012-1560-x; Greenfield Edward M, 2012, Curr Mol Pharmacol, V5, P127; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Hruska KA, 2011, ADV CHRONIC KIDNEY D, V18, P98, DOI 10.1053/j.ackd.2011.01.001; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2010, J BONE MINER RES, V25, P2427, DOI 10.1002/jbmr.145; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kerschan-Schindl K, 2012, HORM METAB RES, V44, P476, DOI 10.1055/s-0032-1308998; Kousteni Stavroula, 2008, Curr Osteoporos Rep, V6, P72, DOI 10.1007/s11914-008-0013-9; Latus J, 2013, INT J NEPHROL RENOV, V6, P131, DOI 10.2147/IJNRD.S47179; Lazar ES, 2007, SEMIN DIALYSIS, V20, P83, DOI 10.1111/j.1525-139X.2007.00248.x; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Norenstedt S, 2014, J BONE MINER RES, V29, P960, DOI 10.1002/jbmr.2102; Nowack R, 2006, CLIN LAB, V52, P583; PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303; Qin L, 2005, J BIOL CHEM, V280, P3104, DOI 10.1074/jbc.M409846200; Rolighed L, 2013, LANGENBECK ARCH SURG, V398, P113, DOI 10.1007/s00423-012-1026-5; Sabeel A, 2000, AM J NEPHROL, V20, P421, DOI 10.1159/000013630; Sasaki Muneteru, 2013, Clin Calcium, V23, P347, DOI CliCa1303347353; Schaefer F, 2000, Novartis Found Symp, V227, P225; Schaefer F, 2000, NOVARTIS FOUND SYMP, V227, P239; Schmitt CP, 2005, PEDIATR NEPHROL, V20, P346, DOI 10.1007/s00467-004-1767-7; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P407, DOI 10.1097/01.ASN.0000043905.35268.86; Shavit L, 2012, CLIN NEPHROL, V78, P399, DOI 10.5414/CN107031; Song JF, 2014, MED SCI MONITOR, V20, P2624, DOI 10.12659/MSM.892581; Sugimoto T, 2014, OSTEOPOROSIS INT, V25, P1173, DOI 10.1007/s00198-013-2516-1; Tian Y, 2011, MOL CELL BIOCHEM, V355, P211, DOI 10.1007/s11010-011-0856-8; Tsuruta Y, 2013, CLIN EXP NEPHROL, V17, P120, DOI 10.1007/s10157-012-0665-8; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Viaene L, 2008, NEPHRON CLIN PRACT, V110, pC80, DOI 10.1159/000151722; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Witteveen JE, 2013, EUR J ENDOCRINOL, V168, pR45, DOI 10.1530/EJE-12-0528; Yajima A, 2003, AM J KIDNEY DIS, V42, P729, DOI 10.1016/S0272-6386(03)00909-0; Yajima A, 2001, CLIN NEPHROL, V56, P27; Yajima A, 2008, KIDNEY INT, V74, P775, DOI 10.1038/ki.2008.242; Yamanouchi M, 2013, CLIN NEPHROL, V79, P380, DOI 10.5414/CN107661; Yano M, 2012, ENDOCR J, V59, P653, DOI 10.1507/endocrj.EJ12-0022; Yeh SM, 2009, HEMODIAL INT, V13, P163, DOI 10.1111/j.1542-4758.2009.00353.x; Zheng CM, 2012, TOHOKU J EXP MED, V226, P19, DOI 10.1620/tjem.226.19	51	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120402	10.1371/journal.pone.0120402	http://dx.doi.org/10.1371/journal.pone.0120402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775025	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500169
J	Marini, JC; Didelija, IC				Marini, Juan C.; Didelija, Inka Cajo			Arginine Depletion by Arginine Deiminase Does Not Affect Whole Protein Metabolism or Muscle Fractional Protein Synthesis Rate in Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; CANCER-PATIENTS; CITRULLINE; CACHEXIA; GLUTAMINE; DEGRADATION; ENZYMES; BODY; MASS	Due to the absolute need for arginine that certain cancer cells have, arginine depletion is a therapy in clinical trials to treat several types of cancers. Arginine is an amino acids utilized not only as a precursor for other important molecules, but also for protein synthesis. Because arginine depletion can potentially exacerbate the progressive loss of body weight, and especially lean body mass, in cancer patients we determined the effect of arginine depletion by pegylated arginine deiminase (ADI-PEG 20) on whole body protein synthesis and fractional protein synthesis rate in multiple tissues of mice. ADI-PEG 20 successfully depleted circulating arginine (< 1 mu mol/L), and increased citrulline concentration more than tenfold. Body weight and body composition, however, were not affected by ADI-PEG 20. Despite the depletion of arginine, whole body protein synthesis and breakdown were maintained in the ADI-PEG 20 treated mice. The fractional protein synthesis rate of muscle was also not affected by arginine depletion. Most tissues (liver, kidney, spleen, heart, lungs, stomach, small and large intestine, pancreas) were able to maintain their fractional protein synthesis rate; however, the fractional protein synthesis rate of brain, thymus and testicles was reduced due to the ADI-PEG 20 treatment. Furthermore, these results were confirmed by the incorporation of ureido [C-14] citrulline, which indicate the local conversion into arginine, into protein. In conclusion, the intracellular recycling pathway of citrulline is able to provide enough arginine to maintain protein synthesis rate and prevent the loss of lean body mass and body weight.	[Marini, Juan C.] Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA; [Marini, Juan C.; Didelija, Inka Cajo] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Marini, JC (corresponding author), Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA.	marini@bcm.edu			federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement [58-6250-6-001]; National Institutes of Health, National Institute of General Medical Sciences [GM108940]; ARS [ARS-0426348] Funding Source: Federal RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108940] Funding Source: NIH RePORTER	federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by federal funds from the United States Department of Agriculture, Agricultural Research Service under Cooperative Agreement Number 58-6250-6-001 (http://www.ars.usda.gov/main/main.htm) and the National Institutes of Health, National Institute of General Medical Sciences (GM108940; http://www.nigms.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball RO, 2007, J NUTR, V137, p1626S, DOI 10.1093/jn/137.6.1626S; Berk L, 2008, SUPPORT CARE CANCER, V16, P1179, DOI 10.1007/s00520-008-0403-7; Brosnan ME, 2004, J NUTR, V134, p2791S, DOI 10.1093/jn/134.10.2791S; COHEN PP, 1946, J BIOL CHEM, V166, P239; DEWYS WD, 1986, CLINICS ONCOL, V5, P251; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; FEATHERSTON WR, 1973, AM J PHYSIOL, V224, P127, DOI 10.1152/ajplegacy.1973.224.1.127; Feun L, 2008, CURR PHARM DESIGN, V14, P1049, DOI 10.2174/138161208784246199; Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Marini JC, 2014, AM J PHYSIOL-RENAL, V307, pF660, DOI 10.1152/ajprenal.00289.2014; Marini JC, 2012, J NUTR, V142, P572, DOI 10.3945/jn.111.153825; Marini JC, 2011, RAPID COMMUN MASS SP, V25, P1291, DOI 10.1002/rcm.5007; Marini JC, 2010, AM J PHYSIOL-ENDOC M, V299, pE69, DOI 10.1152/ajpendo.00080.2010; Matthews DE, 2007, J NUTR, V137, p1549S, DOI 10.1093/jn/137.6.1549S; Mauldin JP, 2012, TRANSL ONCOL, V5, P26, DOI 10.1593/tlo.11262; Molfino A, 2014, CURR OPIN CLIN NUTR, V17, P471, DOI 10.1097/MCO.0000000000000075; Ott PA, 2013, INVEST NEW DRUG, V31, P425, DOI 10.1007/s10637-012-9862-2; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Phillips MM, 2013, CANCER RES TREAT, V45, P251, DOI 10.4143/crt.2013.45.4.251; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; Roberts BM, 2013, BIOCHEM BIOPH RES CO, V435, P488, DOI 10.1016/j.bbrc.2013.05.018; Shen LJ, 2006, CURR OPIN MOL THER, V8, P240; SMITH KL, 1993, BRIT J CANCER, V67, P680, DOI 10.1038/bjc.1993.126; Synakiewicz A, 2014, EXPERT OPIN INV DRUG, V26, P1; Taskin S, 2014, J CELL MOL MED, V18, P69, DOI 10.1111/jcmm.12165; Taus M, 2014, NUTR THER METAB, V32, P10; Thomas JB, 2002, BIOCHEM J, V363, P581, DOI 10.1042/0264-6021:3630581; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsai SS, 2012, NUTR CLIN PRACT, V27, P593, DOI 10.1177/0884533612457949; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Uster A, 2013, NUTRITION, V29, P1342, DOI 10.1016/j.nut.2013.05.004; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867	36	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119801	10.1371/journal.pone.0119801	http://dx.doi.org/10.1371/journal.pone.0119801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775142	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500125
J	Moratti, E; Vezzalini, M; Tomasello, L; Giavarina, D; Sorio, C				Moratti, Elisabetta; Vezzalini, Marzia; Tomasello, Luisa; Giavarina, Davide; Sorio, Claudio			Identification of Protein Tyrosine Phosphatase Receptor Gamma Extracellular Domain (sPTPRG) as a Natural Soluble Protein in Plasma	PLOS ONE			English	Article							SECRETASE-MEDIATED CLEAVAGE; MASS-SPECTROMETRY; PTP-GAMMA; IN-VITRO; EXPRESSION; GENE; LAR; CELLS; LIVER; BETA	Background PTPRG is a widely expressed protein tyrosine phosphatase present in various isoforms. Peptides from its extracellular domain have been detected in plasma by proteomic techniques. We aim at characterizing the plasmatic PTPRG (sPTPRG) form and to identify its source. Methodology/Principal Findings The expression of sPTPRG was evaluated in human plasma and murine plasma and tissues by immunoprecipitation and Western blotting. The polypeptides identified have an apparent Mr of about 120 kDa (major band) and 90 kDa (minor band) respectively. Full length PTPRG was identified in the 100.000xg pelleted plasma fraction, suggesting that it was present associated to cell-derived vesicles (exosomes). The release of sPTPRG by HepG2 human hepatocellular carcinoma cell line was induced by ethanol and sensitive to metalloproteinase and not to Furin inhibitors. Finally, increased levels of the plasmatic similar to 120 kDa isoform were associated with the occurrence of liver damage. Conclusions These results demonstrate that sPTPRG represent a novel candidate protein biomarker in plasma whose increased expression is associated to hepatocyte damage. This observation could open a new avenue of investigation in this challenging field.	[Moratti, Elisabetta; Vezzalini, Marzia; Tomasello, Luisa; Sorio, Claudio] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy; [Giavarina, Davide] St Bortolo Hosp, Clin Chem & Hematol Lab, Vicenza, Italy	University of Verona; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Sorio, C (corresponding author), Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy.	claudio.sorio@univr.it	Giavarina, Davide/I-7331-2016; Sorio, Claudio/F-2764-2018	Giavarina, Davide/0000-0001-9589-178X; Sorio, Claudio/0000-0003-2739-4014; Vezzalini, Marzia/0000-0002-5476-0844	Associazione Italiana per la Ricerca sul Cancro [AIRC-IG 4667]; NPRP grant from the Qatar National Research Fund (Qatar Foundation) [4-157-3-052]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); NPRP grant from the Qatar National Research Fund (Qatar Foundation)	The authors were supported by Associazione Italiana per la Ricerca sul Cancro (Investigator grant: AIRC-IG 4667 issued to CS) and and NPRP grant 4-157-3-052 from the Qatar National Research Fund (a member of the Qatar Foundation). The statements made herein are solely the responsibility of the author(s). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Boucher CA, 2011, BBA-MOL BASIS DIS, V1812, P1225, DOI 10.1016/j.bbadis.2010.11.006; Cameron A, 2000, J BIOL CHEM, V275, P36741, DOI 10.1074/jbc.M003848200; Campan M, 1996, BIOCHEMISTRY-US, V35, P3797, DOI 10.1021/bi952552d; Cheung AKL, 2008, CANCER RES, V68, P8137, DOI 10.1158/0008-5472.CAN-08-0904; Choi D. S., 2014, MASS SPECTROM REV; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Della Peruta M, 2010, CANCER RES, V70, P8896, DOI 10.1158/0008-5472.CAN-10-0258; Eguchi A, 2014, J HEPATOL; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; GEBBINK MFBG, 1995, J CELL BIOL, V131, P251, DOI 10.1083/jcb.131.1.251; Haapasalo A, 2007, J BIOL CHEM, V282, P9063, DOI 10.1074/jbc.M611324200; Kapp K, 2012, EUR J CELL BIOL, V91, P687, DOI 10.1016/j.ejcb.2012.04.003; Lamprianou S, 2006, MOL CELL BIOL, V26, P5106, DOI 10.1128/MCB.00101-06; Lewis JA, 2010, J PROTEOME RES, V9, P5794, DOI 10.1021/pr1005668; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lorenzetto E, 2013, BRAIN STRUCT FUNCT; Mafficini A, 2007, BIOMARK INSIGHTS, V2, P218; Montes de Oca BP, 2010, CENT NERV SYST AGENT, V10, P337; Pan XP, 2012, HEPATOB PANCREAT DIS, V11, P594, DOI 10.1016/S1499-3872(12)60230-6; Panagopoulos I, 1996, CANCER RES, V56, P4871; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; Shintani T, 1997, BIOCHEM BIOPH RES CO, V230, P419, DOI 10.1006/bbrc.1996.5973; SORIO C, 1995, CANCER RES, V55, P4855; STREULI M, 1992, EMBO J, V11, P897, DOI 10.1002/j.1460-2075.1992.tb05128.x; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Vezzalini M, 2007, HISTOPATHOLOGY, V50, P615, DOI 10.1111/j.1365-2559.2007.02661.x; Wang C, 2010, J CELL BIOCHEM, V109, P113, DOI 10.1002/jcb.22387; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Zhang WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045500	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119110	10.1371/journal.pone.0119110	http://dx.doi.org/10.1371/journal.pone.0119110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775014	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500070
J	Pei, JB; Li, H; Li, SY; An, TT; Farmer, J; Fu, SF; Wang, JK				Pei, Jiubo; Li, Hui; Li, Shuangyi; An, Tingting; Farmer, John; Fu, Shifeng; Wang, Jingkuan			Dynamics of Maize Carbon Contribution to Soil Organic Carbon in Association with Soil Type and Fertility Level	PLOS ONE			English	Article							RESIDUE DECOMPOSITION; FRACTIONATION; FERTILIZATION; FLUXES; RATIOS; STRAW; POOLS	Soil type and fertility level influence straw carbon dynamics in the agroecosystems. However, there is a limited understanding of the dynamic processes of straw-derived and soil-derived carbon and the influence of the addition of straw carbon on soil-derived organic carbon in different soils associated with different fertility levels. In this study, we applied the in-situ carborundum tube method and C-13-labeled maize straw (with and without maize straw) at two cropland (Phaeozem and Luvisol soils) experimental sites in northeast China to quantify the dynamics of maize-derived and soil-derived carbon in soils associated with high and low fertility, and to examine how the addition of maize carbon influences soil-derived organic carbon and the interactions of soil type and fertility level with maize-derived and soil-derived carbon. We found that, on average, the contributions of maize-derived carbon to total organic carbon in maize-soil systems during the experimental period were differentiated among low fertility Luvisol (from 62.82% to 42.90), high fertility Luvisol (from 53.15% to 30.00%), low fertility Phaeozem (from 58.69% to 36.29%) and high fertility Phaeozem (from 41.06% to 16.60%). Furthermore, the addition of maize carbon significantly decreased the remaining soil-derived organic carbon in low and high fertility Luvisols and low fertility Phaeozem before two months. However, the increasing differences in soil-derived organic carbon between both soils with and without maize straw after two months suggested that maize-derived carbon was incorporated into soil-derived organic carbon, thereby potentially offsetting the loss of soil-derived organic carbon. These results suggested that Phaeozem and high fertility level soils would fix more maize carbon over time and thus were more beneficial for protecting soil-derived organic carbon from maize carbon decomposition.	[Pei, Jiubo; Li, Hui; Li, Shuangyi; An, Tingting; Farmer, John; Fu, Shifeng; Wang, Jingkuan] Shenyang Agr Univ, Coll Land & Environm, Minist Agr, Key Lab Northeast Cultivated Land Conservat, Shenyang 110161, Liaoning Provin, Peoples R China	Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University	Wang, JK (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Minist Agr, Key Lab Northeast Cultivated Land Conservat, Shenyang 110161, Liaoning Provin, Peoples R China.	j-kwang@163.com	An, Tingting/V-9666-2017; An, Tingting/M-2186-2017	An, Tingting/0000-0002-5263-7375; An, Tingting/0000-0002-5263-7375	National Science Foundation of China [41171237, 31330011]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA05050501]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences)	Financial support comes from the National Science Foundation of China (41171237 and 31330011) and the Strategic Priority Research Program of Chinese Academy of Sciences (XDA05050501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 1985, PLANT SOIL, V86, P15; An TT, 2015, SOIL BIOL BIOCHEM, V80, P53, DOI 10.1016/j.soilbio.2014.09.024; [Anonymous], 2010, CHINESE AGR SCI B, DOI DOI 10.1007/S11355-019-00403-9; Brady N.C, 2000, NATURE PROPERTIES SO; Bromand S, 2001, PLANT SOIL, V235, P253, DOI 10.1023/A:1011922103323; Casado-Murillo N., 2013, The Open Agriculture Journal, V7, P11, DOI 10.2174/1874331501307010011; Chen Xing-li, 2009, Yingyong Shengtai Xuebao, V20, P314; Coleman D.C., 1991, CARBON ISOTOPE TECHN; Comeau LP, 2013, BIOL FERT SOILS, V49, P1179, DOI 10.1007/s00374-013-0816-4; Conrad R, 2012, SOIL BIOL BIOCHEM, V49, P193, DOI 10.1016/j.soilbio.2012.02.030; Dijkstra FA, 2007, SOIL BIOL BIOCHEM, V39, P2264, DOI 10.1016/j.soilbio.2007.03.026; Dou Sen, 2003, Acta Pedologica Sinica, V40, P328; Follett RF, 1997, SOIL SCI SOC AM J, V61, P1068, DOI 10.2136/sssaj1997.03615995006100040012x; Han FP, 2010, GEODERMA, V154, P261, DOI 10.1016/j.geoderma.2009.10.011; IUSS Working Group WRB, 2014, WORLD SOIL RES REP, V106; Jiang Yong, 2007, Shengtaixue Zazhi, V26, P278; JMP SAS Institute Inc, 2012, JMP 10 BASIC ANAL GR, VSecond; Juarez S, 2013, EUR J SOIL BIOL, V58, P81, DOI 10.1016/j.ejsobi.2013.06.005; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Lal R., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P303, DOI 10.1007/s11027-006-9036-7; Leng YH., 2008, THESIS U SHENYANG AG; Liang Yao, 2011, Scientia Agricultura Sinica, V44, P3565; Lin X. X., 1981, Acta Pedologica Sinica, V18, P97; Liu Min, 2007, Yingyong Shengtai Xuebao, V18, P2503; Liu S, 2013, AFR J AGR RES, V8, P1411; Majumder B, 2008, BIOL FERT SOILS, V44, P451, DOI 10.1007/s00374-007-0226-6; Pineiro G, 2006, GLOBAL CHANGE BIOL, V12, P804, DOI 10.1111/j.1365-2486.2006.01139.x; Rochette P, 1999, SOIL SCI SOC AM J, V63, P1385, DOI 10.2136/sssaj1999.6351385x; Rui JP, 2009, APPL ENVIRON MICROB, V75, P4879, DOI 10.1128/AEM.00702-09; Shen QR, 2000, PLANT NUTR FERT SCI, V6, P98; Studdert GA, 2000, SOIL SCI SOC AM J, V64, P1496, DOI 10.2136/sssaj2000.6441496x; Sylvia D., 2005, PRINCIPLES APPL SOIL, Vsecond; Thuries L, 2001, SOIL BIOL BIOCHEM, V33, P997, DOI 10.1016/S0038-0717(01)00003-7; Vaieretti MV, 2005, PLANT SOIL, V278, P223, DOI 10.1007/s11104-005-8432-1; Wang LiLi, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1073, DOI 10.3724/SP.J.1011.2013.01073; [汪太明 Wang Taiming], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2870; Wang XuDong, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P252; Werth M, 2006, PLANT SOIL, V284, P319, DOI 10.1007/s11104-006-0054-8; Wingeyer AB, 2011, THESIS U NEBRASKA LI; Xu XC, 1985, CHIN J SOIL SCI, V1, P21, DOI DOI 10.19336/J.CNKI.TRTB.1985.01.007; Yu S., 2009, THESIS U SHENYANG AG	41	11	21	9	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120825	10.1371/journal.pone.0120825	http://dx.doi.org/10.1371/journal.pone.0120825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774529	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500192
J	Qin, SS; Ricotta, V; Simon, M; Clark, RAF; Rafailovich, MH				Qin, Sisi; Ricotta, Vincent; Simon, Marcia; Clark, Richard A. F.; Rafailovich, Miriam H.			Continual Cell Deformation Induced via Attachment to Oriented Fibers Enhances Fibroblast Cell Migration	PLOS ONE			English	Article							MYOSIN-IIA; EXTRACELLULAR-MATRIX; ADHESION; NUCLEUS; ROLES	Fibroblast migration is critical to the wound healing process. In vivo, migration occurs on fibrillar substrates, and previous observations have shown that a significant time lag exists before the onset of granulation tissue. We therefore conducted a series of experiments to understand the impact of both fibrillar morphology and migration time. Substrate topography was first shown to have a profound influence. Fibroblasts preferentially attach to fibrillar surfaces, and orient their cytoplasm for maximal contact with the fiber edge. In the case of enmass cell migration out of an agarose droplet, fibroblasts on flat surfaces emerged with an enhanced velocity, v = 52 mu m/h, that decreases to the single cell value, v = 28 mu m/h within 24 hours and remained constant for at least four days. Fibroblasts emerging on fibrillar surfaces emerged with the single cell velocity, which remained constant for the first 24 hours and then increased reaching a plateau with more than twice the initial velocity within the next three days. The focal adhesions were distributed uniformly in cells on flat surfaces, while on the fibrillar surface they were clustered along the cell periphery. Furthermore, the number of focal adhesions for the cells on the flat surfaces remained constant, while it decreased on the fibrillar surface during the next three days. The deformation of the cell nuclei was found to be 50% larger on the fiber surfaces for the first 24 hours. While the mean deformation remained constant on the flat surface, it increased for the next three days by 24% in cells on fibers. On the fourth day, large actin/myosin fibers formed in cells on fibrillar surfaces only and coincided with a change from the standard migration mechanism involving extension of lamellipodia, and retraction of the rear, to one involving strong contractions oriented along the fibers and centered about the nucleus.	[Qin, Sisi; Ricotta, Vincent; Rafailovich, Miriam H.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA; [Simon, Marcia] SUNY Stony Brook, Sch Dent, Stony Brook, NY 11794 USA; [Clark, Richard A. F.] SUNY Stony Brook, Dept Bioengn, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rafailovich, MH (corresponding author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11794 USA.	Miriam.rafailovich@stonybrook.edu			National Science Foundation [1344267]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (Inspire Program Award number: 1344267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Chen CS, 2007, BIOPHYS J, V92, P2984, DOI 10.1529/biophysj.106.100065; Doyle AD, 2012, J CELL SCI, V125, P2244, DOI 10.1242/jcs.098806; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Heissler SM, 2013, CELL MOL LIFE SCI, V70, P1, DOI 10.1007/s00018-012-1002-9; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Jeon H, 2010, BIOMATERIALS, V31, P4286, DOI 10.1016/j.biomaterials.2010.01.103; Jorrisch MH, 2013, BIOL OPEN, V2, P368, DOI 10.1242/bio.20133707; Kaiser JP, 2006, BIOMATERIALS, V27, P5230, DOI 10.1016/j.biomaterials.2006.06.002; Kim DH, 2013, FASEB J, V27, P1351, DOI 10.1096/fj.12-220160; Liu Y, 2009, EXP CELL RES, V315, P2544, DOI 10.1016/j.yexcr.2009.05.013; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; McClain SA, 1996, AM J PATHOL, V149, P1257; Pan Z, 2009, BIOPHYS J, V96, P4286, DOI 10.1016/j.bpj.2009.02.039; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042; Shih WT, 2010, BIOPHYS J, V98, pL29, DOI 10.1016/j.bpj.2010.02.028; SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152	34	14	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119094	10.1371/journal.pone.0119094	http://dx.doi.org/10.1371/journal.pone.0119094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774792	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500068
J	Chen, YL; Lin, HC; Lin, KH; Lin, LS; Hsieh, CE; Ko, CJ; Hung, YJ; Lin, PY				Chen, Yao-Li; Lin, Hui-Chuan; Lin, Kuo-Hua; Lin, Li-Si; Hsieh, Chia-En; Ko, Chih-Jan; Hung, Yu-Ju; Lin, Ping-Yi			Low Hemoglobin Level Is Associated with the Development of Delirium after Hepatectomy for Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							POSTOPERATIVE DELIRIUM; RISK-FACTORS; NONCARDIAC SURGERY; DIAGNOSIS	Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide and liver resection is the only potential curative treatment option for those patients. Postoperative complications specific to elderly surgical patients such as delirium will be increasingly relevant in the coming decades. Herein, we aimed to investigate the risk factors for postoperative delirium in patients who have received hepatectomy for HCC. Methods This is a single medical center observational study and the study subjects comprised 401 individuals who underwent liver resection for hepatocellular carcinoma during January 2009 to October 2013. Multivariate analysis was used to examine whether preoperative, intra-operative, or postoperative variables were associated with the development of delirium. Results Of the 401 patients who underwent hepatectomy, 34 developed postoperative delirium (8.4%). In the majority of those patients, symptoms and signs of the syndrome occurred on postoperative day 2 and the mean duration of symptoms was 3.61 +/- 3.71 days. Multivariate analysis revealed that advanced age (> 71 years) [odds ratio (OR) = 1.133, 95% confidence interval (CI): 1.071-1.200, p< 0.001], prolonged operative time (> 190 minutes) (OR = 1.009, 95% CI: 1.000-1.017, p = 0.038), a decreased postoperative hemoglobin level (< 10.16 g/dL) (OR = 0.777, 95% CI: 0.613-0.983, p = 0.036), and history of hypnotic drug use (OR = 3.074, 95% CI: 1.045-9.039, p = 0.041) were independent risk factors for the development of postoperative delirium after hepatectomy. Conclusions Although the mechanism of postoperative delirium is not well understood, numbers of studies have shown that patients with postoperative delirium tend to have prolonged hospital stay, worse postoperative outcome and an increased risk of short- and long-term mortality. In this study, we found that advanced age, prolonged operative time, postoperative low hemoglobin level and history of hypnotic drug use are independent risk factors for postoperative delirium.	[Chen, Yao-Li; Lin, Kuo-Hua; Lin, Li-Si; Hsieh, Chia-En; Ko, Chih-Jan; Hung, Yu-Ju] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Lin, Ping-Yi] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Lin, Hui-Chuan] Hung Kuang Univ, Dept Senior Citizen Welf & Business, Taichung, Taiwan; [Chen, Yao-Li] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Lin, Ping-Yi] Cent Taiwan Univ Sci & Technol, Dept Nursing, Taichung, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Hungkuang University; Chung Shan Medical University; Kaohsiung Medical University; Central Taiwan University Science & Technology	Hung, YJ (corresponding author), Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan.	149116@cch.org.tw; 69221@cch.org.tw						BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; DeBellis Ronald, 2005, J Intensive Care Med, V20, P164, DOI 10.1177/0885066605275353; DICKSON LR, 1991, PSYCHOSOMATICS, V32, P317, DOI 10.1016/S0033-3182(91)72071-9; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jochum T, 2011, OPEN CRITICAL CARE M, V4, P47; Kawaguchi Yoshiharu, 2006, Spine J, V6, P164, DOI 10.1016/j.spinee.2005.06.010; Lee JK, 2010, SPINE, V35, P1729, DOI 10.1097/BRS.0b013e3181c423fc; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; MULLER WE, 1991, ACTA PSYCHIAT SCAND, V83, P34, DOI 10.1111/j.1600-0447.1991.tb03107.x; National Clinical Guideline Centre, 2010, PAT DEL EXP VID; OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673; RICH MW, 1989, AM J CARDIOL, V63, P714, DOI 10.1016/0002-9149(89)90257-9; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Robinson TN, 2008, CLIN INTERV AGING, V3, P351, DOI 10.2147/CIA.S2759; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Steiner LA, 2011, EUR J ANAESTH, V28, P723, DOI 10.1097/EJA.0b013e328349b7db; Steiner LA, 2011, EUR J ANAESTH, V28, P628, DOI 10.1097/EJA.0b013e328349b7f5; Takeuchi M, 2012, ANN SURG ONCOL, V19, P3963, DOI 10.1245/s10434-012-2432-1; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; Trzepacz P T, 2000, Semin Clin Neuropsychiatry, V5, P132; WHO, 2010, INT STAT CLASS DIS R; Yildizeli B, 2005, ANN THORAC SURG, V79, P1004, DOI 10.1016/j.athoracsur.2004.06.022; Yoshimura Y, 2004, WORLD J SURG, V28, P982, DOI 10.1007/s00268-004-7344-1	26	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119199	10.1371/journal.pone.0119199	http://dx.doi.org/10.1371/journal.pone.0119199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768121	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500070
J	Filipek-Gorniok, B; Carlsson, P; Haitina, T; Habicher, J; Ledin, J; Kjellen, L				Filipek-Gorniok, Beata; Carlsson, Pernilla; Haitina, Tatjana; Habicher, Judith; Ledin, Johan; Kjellen, Lena			The Ndst Gene Family in Zebrafish: Role of Ndst1b in Pharyngeal Arch Formation	PLOS ONE			English	Article							HEPARAN-SULFATE SULFOTRANSFERASES; COMBINATORIAL EXPRESSION PATTERNS; GENOME DUPLICATION; MICE DEFICIENT; HSPG SYNTHESIS; DOMAIN; 6-O-SULFOTRANSFERASE; BIOSYNTHESIS; HYPOPLASIA; MUTATIONS	Heparan sulfate (HS) proteoglycans are ubiquitous components of the extracellular matrix and plasma membrane of metazoans. The sulfation pattern of the HS glycosaminoglycan chain is characteristic for each tissue and changes during development. The glucosaminyl N-deacetylase/N-sulfotransferase (NDST) enzymes catalyze N-deacetylation and N-sulfation during HS biosynthesis and have a key role in designing the sulfation pattern. We here report on the presence of five NDST genes in zebrafish. Zebrafish ndst1a, ndst1b, ndst2a and ndst2b represent duplicated mammalian orthologues of NDST1 and NDST2 that arose through teleost specific genome duplication. Interestingly, the single zebrafish orthologue ndst3, is equally similar to tetrapod Ndst3 and Ndst4. It is likely that a local duplication in the common ancestor of lobe-finned fish and tetrapods gave rise to these two genes. All zebrafish Ndst genes showed distinct but partially overlapping expression patterns during embryonic development. Morpholino knockdown of ndst1b resulted in delayed development, craniofacial cartilage abnormalities, shortened body and pectoral fin length, resembling some of the features of the Ndst1 mouse knockout.	[Filipek-Gorniok, Beata; Carlsson, Pernilla; Kjellen, Lena] Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Haitina, Tatjana; Habicher, Judith; Ledin, Johan] Uppsala Univ, Sci Life Lab, Dept Organismal Biol, SE-75236 Uppsala, Sweden	Uppsala University; Uppsala University	Kjellen, L (corresponding author), Uppsala Univ, Sci Life Lab, Dept Med Biochem & Microbiol, Husargatan 3,POB 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se		Haitina, Tatjana/0000-0002-8754-5534; Ledin, Johan/0000-0002-7319-7735	Knut and Alice Wallenberg Foundation; Swedish Research Council; Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"; Swedish Cancer Society; Stiftelsen for Proteoglykanforskning; Uppsala University	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations"; Swedish Cancer Society(Swedish Cancer Society); Stiftelsen for Proteoglykanforskning; Uppsala University	This work was supported by grants from the Knut and Alice Wallenberg Foundation (to J.L.), the Swedish Research Council (to T.H., J.L., L.K.), the Linnaeus Framework Grant "Genomics of Phenotypic Diversity in Natural Populations" (to J.L.), the Swedish Cancer Society (L.K.), Stiftelsen for Proteoglykanforskning (L.K.), and Uppsala University (to J.L. and L.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; Bink RJ, 2003, J BIOL CHEM, V278, P31118, DOI 10.1074/jbc.M213124200; Cadwallader AB, 2007, DEV DYNAM, V236, P581, DOI 10.1002/dvdy.21051; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Cadwallader AB, 2006, DEV DYNAM, V235, P3423, DOI 10.1002/dvdy.20991; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Clement A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000136; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Filipek-Gorniok B, 2013, DEV DYN; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Ghiselli G, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-19; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Kakuta Y, 1998, TRENDS BIOCHEM SCI, V23, P129, DOI 10.1016/S0968-0004(98)01182-7; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ledin J, 2004, J BIOL CHEM; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309; Maccarana M, 1996, J BIOL CHEM, V271, P17804, DOI 10.1074/jbc.271.30.17804; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Monnich M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020051; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Neugebauer JM, 2013, DEVELOPMENT, V140, P3892, DOI 10.1242/dev.096388; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Nusslein-Volhard C, 2005, ZEBRAFISH, P1, DOI [10.1089/zeb.2005.2.1, DOI 10.1089/ZEB.2005.2.1]; Ohno S., 1970, EVOLUTION GENE DUPLI; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pallerla SR, 2008, J BIOL CHEM, V283, P16885, DOI 10.1074/jbc.M709774200; Pallerla SR, 2007, DEV DYNAM, V236, P556, DOI 10.1002/dvdy.21038; Pan Y, 2013, MATRIX BIOL; Reuter MS, 2014, AM J MED GENET A; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Samson SC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001727; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Warda M, 2006, GLYCOCONJUGATE J, V23, P555, DOI 10.1007/s10719-006-7668-1; Wei Z, 1999, J BIOL CHEM, V274, P1966, DOI 10.1074/jbc.274.4.1966	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119040	10.1371/journal.pone.0119040	http://dx.doi.org/10.1371/journal.pone.0119040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767878	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500060
J	Ligthart, S; de Vries, PS; Uitterlinden, AG; Hofman, A; Franco, OH; Chasman, DI; Dehghan, A				Ligthart, Symen; de Vries, Paul S.; Uitterlinden, Andre G.; Hofman, Albert; Franco, Oscar H.; Chasman, Daniel I.; Dehghan, Abbas		CHARGE Inflammation Working Grp	Pleiotropy among Common Genetic Loci Identified for Cardiometabolic Disorders and C-Reactive Protein	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MENDELIAN RANDOMIZATION; ASSOCIATION ANALYSES; PLASMA-CONCENTRATION; ARTERY-DISEASE; RISK; HEALTH	Pleiotropic genetic variants have independent effects on different phenotypes. C-reactive protein (CRP) is associated with several cardiometabolic phenotypes. Shared genetic backgrounds may partially underlie these associations. We conducted a genome-wide analysis to identify the shared genetic background of inflammation and cardiometabolic phenotypes using published genome-wide association studies (GWAS). We also evaluated whether the pleiotropic effects of such loci were biological or mediated in nature. First, we examined whether 283 common variants identified for 10 cardiometabolic phenotypes in GWAS are associated with CRP level. Second, we tested whether 18 variants identified for serum CRP are associated with 10 cardiometabolic phenotypes. We used a Bonferroni corrected p-value of 1.1x10(-04) (0.05/463) as a threshold of significance. We evaluated the independent pleiotropic effect on both phenotypes using individual level data from the Women Genome Health Study. Evaluating the genetic overlap between inflammation and cardiometabolic phenotypes, we found 13 pleiotropic regions. Additional analyses showed that 6 regions (APOC1, HNF1A, IL6R, PPP1R3B, HNF4A and IL1F10) appeared to have a pleiotropic effect on CRP independent of the effects on the cardiometabolic phenotypes. These included loci where individuals carrying the risk allele for CRP encounter higher lipid levels and risk of type 2 diabetes. In addition, 5 regions (GCKR, PABPC4, BCL7B, FTO and TMEM18) had an effect on CRP largely mediated through the cardiometabolic phenotypes. In conclusion, our results show genetic pleiotropy among inflammation and cardiometabolic phenotypes. In addition to reverse causation, our data suggests that pleiotropic genetic variants partially underlie the association between CRP and cardiometabolic phenotypes.	[Ligthart, Symen; de Vries, Paul S.; Uitterlinden, Andre G.; Hofman, Albert; Franco, Oscar H.; Dehghan, Abbas] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital	Dehghan, A (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.	a.dehghan@erasmusmc.nl	Franco, Óscar H/ABE-2305-2020; Alizadeh, Behrooz Z Ziad/J-2921-2017; Dehghan, Abbas/ABE-7377-2020; Jamshidi, Yalda/AAL-1377-2020; Benjamin, Emelia/E-7103-2011; Ligthart, Symen/AAF-7185-2020; Ramachandran, Vasan/Y-2527-2019; Naitza, Silvia/D-5620-2017; Dehghan, Abbas/B-9896-2008; Smith, Albert Vernon/K-5150-2015; Aspelund, Thor/C-5983-2008; Sijbrands, Eric/A-1065-2009	Franco, Óscar H/0000-0002-4606-4929; Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; Jamshidi, Yalda/0000-0003-0151-6482; Benjamin, Emelia/0000-0003-4076-2336; Ramachandran, Vasan/0000-0001-7357-5970; de Vries, Paul/0000-0003-0964-0111; Koenig, Wolfgang/0000-0002-2064-9603; Soranzo, Nicole/0000-0003-1095-3852; Pramstaller, Peter P/0000-0002-9831-8302; Dehghan, Abbas/0000-0001-6403-016X; Bandinelli, Stefania/0000-0002-6491-0850; Smith, Albert Vernon/0000-0003-1942-5845; Keaney, John/0000-0002-0866-1837; Gieger, Christian/0000-0001-6986-9554; Pankow, James/0000-0001-7076-483X; Kuss, Oliver/0000-0003-3301-5869; Aspelund, Thor/0000-0002-7998-5433; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Shuldiner, Alan/0000-0001-9921-4305; Hoogeveen, Ron/0000-0003-2399-4653; Fuchsberger, Christian/0000-0002-5918-8947; Sijbrands, Eric/0000-0001-8857-7389	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [916.12.154]; National Heart, Lung, and Blood Institute [HL043851, HL080467]; National Cancer Institute, the Donald W. Reynolds Foundation [CA047988]; Fondation Leducq; Amgen; National Institutes of Health (NIH) [N01-HC 25195 1, RO1 HL64753, R01 HL076784, 1 R01 AG028321]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784, R01HL064753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute, the Donald W. Reynolds Foundation; Fondation Leducq(Leducq Foundation); Amgen(Amgen); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek grant [916.12.154 to A.D.]. The WGHS is supported by [HL043851] and [HL080467] from the National Heart, Lung, and Blood Institute and [CA047988] from the National Cancer Institute, the Donald W. Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The CRP GWAS meta-analysis was supported by the National Institutes of Health (NIH) ([N01-HC 25195 1]; [RO1 HL64753]; [R01 HL076784]; [1 R01 AG028321]). Part of the funding for genotyping in the WGHS was provided by Amgen. Amgen has not been involved in the design, analysis and interpretation of the study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Blake GJ, 2003, CIRCULATION, V108, P2993, DOI 10.1161/01.CIR.0000104566.10178.AF; Carter AJR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-160; Collaboration CRPCHDG, 2011, BMJ BRITISH MEDICAL, V342; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Hindorff LA, 2008, ATHEROSCLEROSIS, V197, P922, DOI 10.1016/j.atherosclerosis.2007.08.012; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Olden M, 2013, AM J KIDNEY DIS, V61, P889, DOI 10.1053/j.ajkd.2012.12.024; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Reiner AP, 2009, CIRC-CARDIOVASC GENE, V2, P244, DOI 10.1161/CIRCGENETICS.108.839506; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 1998, CIRCULATION, V97, P425; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Team RC, 2012, R LANG ENV STAT COMP; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Timpson NJ, 2011, INT J OBESITY, V35, P300, DOI 10.1038/ijo.2010.137; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Williams GC, 2001, SCI AGING KNOWLEDGE, V2001, pcp13	36	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118859	10.1371/journal.pone.0118859	http://dx.doi.org/10.1371/journal.pone.0118859			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768928	Green Published, Green Accepted, gold			2022-12-26	WOS:000351277500050
J	Singh, V; Kaul, SC; Wadhwa, R; Pati, PK				Singh, Varinder; Kaul, Sunil C.; Wadhwa, Renu; Pati, Pratap Kumar			Evaluation and Selection of Candidate Reference Genes for Normalization of Quantitative RT-PCR in Withania somnifera (L.) Dunal	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; LIPID-PEROXIDATION; EXPRESSION; VALIDATION; IDENTIFICATION; CANCER; MODEL; LEAF	Quantitative real-time PCR (qRT-PCR) is now globally used for accurate analysis of transcripts levels in plants. For reliable quantification of transcripts, identification of the best reference genes is a prerequisite in qRT-PCR analysis. Recently, Withania somnifera has attracted lot of attention due to its immense therapeutic potential. At present, biotechnological intervention for the improvement of this plant is being seriously pursued. In this background, it is important to have comprehensive studies on finding suitable reference genes for this high valued medicinal plant. In the present study, 11 candidate genes were evaluated for their expression stability under biotic (fungal disease), abiotic (wounding, salt, drought, heat and cold) stresses, in different plant tissues and in response to various plant growth regulators (methyl jasmonate, salicylic acid, abscisic acid). The data as analyzed by various software packages (geNorm, NormFinder, Bestkeeper and Delta Ct method) suggested that cyclophilin (CYP) is a most stable gene under wounding, heat, methyl jasmonate, different tissues and all stress conditions. T-SAND was found to be a best reference gene for salt and salicylic acid (SA) treated samples, while 26S ribosomal RNA (26S), ubiquitin (UBQ) and beta-tubulin (TUB) were the most stably expressed genes under drought, biotic and cold treatment respectively. For abscisic acid (ABA) treated samples 18S-rRNA was found to stably expressed gene. Finally, the relative expression level of the three genes involved in the withanolide biosynthetic pathway was detected to validate the selection of reliable reference genes. The present work will significantly contribute to gene analysis studies in W. somnifera and facilitate in improving the quality of gene expression data in this plant as well as and other related plant species.	[Singh, Varinder; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India; [Kaul, Sunil C.; Wadhwa, Renu] AIST, Natl Inst Adv Ind Sci & Technol, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Kaul, Sunil C.; Wadhwa, Renu] AIST, Natl Inst Adv Ind Sci & Technol, DBT AIST Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan	Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar 143005, Punjab, India.	pkpati@yahoo.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; pati, pratap/0000-0001-9017-7608	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), New Delhi; University Grants Commission (UGC), New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	Authors thanks the Department of Biotechnology, Government of India, Council of Scientific and Industrial Research (CSIR), New Delhi and University Grants Commission (UGC), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Barua A, 2013, AM J REPROD IMMUNOL, V70, P538, DOI 10.1111/aji.12172; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; CHAPPELL J, 1995, PLANT PHYSIOL, V107, P1, DOI 10.1145/224057.224059; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaudhary G, 2003, CLIN EXP PHARMACOL P, V30, P399, DOI 10.1046/j.1440-1681.2003.03849.x; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cruz F, 2009, MOL BREEDING, V23, P607, DOI 10.1007/s11032-009-9259-x; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Dhar N, 2014, J BIOL CHEM; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jayaprakasam B, 2004, TETRAHEDRON, V60, P3109, DOI 10.1016/j.tet.2004.01.016; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Khazal KF, 2013, ANTICANCER RES, V33, P1519; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kim OT, 2010, PLANT CELL REP, V29, P403, DOI 10.1007/s00299-010-0831-y; Kushwaha AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074777; Lee MH, 2004, PLANT CELL PHYSIOL, V45, P976, DOI 10.1093/pcp/pch126; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Mishra MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063064; Misra L, 2012, J ASIAN NAT PROD RES, V14, P39, DOI 10.1080/10286020.2011.622719; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Pati PK, 2008, INDIAN J MICROBIOL, V48, P432, DOI 10.1007/s12088-008-0053-y; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Sabir F, 2013, PROTOPLASMA, V250, P539, DOI 10.1007/s00709-012-0438-y; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sharma A, 2011, PHYTOPHARMACOL, V1, P54; Sharma P, 2010, ASSAM U J SCI TECHNO, V6, P37; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Szic KSV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087850; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Zhang K, 2013, J BIOTECHNOL, V168, P7, DOI 10.1016/j.jbiotec.2013.08.008; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	58	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118860	10.1371/journal.pone.0118860	http://dx.doi.org/10.1371/journal.pone.0118860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769035	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500051
J	Hauser, B; Zhao, Y; Pang, XW; Ling, ZQ; Myers, E; Wang, P; Califano, J; Gu, XB				Hauser, Belinda; Zhao, Yuan; Pang, Xiaowu; Ling, Zhiqiang; Myers, Ernest; Wang, Paul; Califano, Joseph; Gu, Xinbin			Functions of MiRNA-128 on the Regulation of Head and Neck Squamous Cell Carcinoma Growth and Apoptosis	PLOS ONE			English	Article							SALVIANOLIC ACID B; IN-VIVO; CANCER STATISTICS; SELF-RENEWAL; LUNG-CANCER; BMI-1; MICRORNAS; PROLIFERATION; TUMORIGENESIS; MECHANISM	Background Incidence of head and neck squamous cell carcinoma (HNSCC) has continuously increased in past years while its survival rate has not been significantly improved. There is a critical need to better understand the genetic regulation of HNSCC tumorigenesis and progression. In this study, we comprehensively analyzed the function of miRNA-128 (miR-128) in the regulation of HNSCC growth and its putative targets in vitro and in vivo systems. Methods The function and targets of miR-128 were investigated in human HNSCC cell lines (JHU-13 and JHU-22), which were stably transfected with the miR-128 gene using a lentiviral delivery system. The expression levels of miR-128 and its targeted proteins were analyzed with qRT-PCR, Western blotting and flow cytometry. The binding capacity of miRNA-128 to its putative targets was determined using a luciferase report assay. MTT, colony formation, and a tumor xenograft model further evaluated the effects of miR-128 on HNSCC growth. Results We generated two miR-128 stably transfected human HNSCC cell lines (JHU-13miR-128 and JHU-22miR-128). Enforced expression of miR-128 was detected in both cultured JHU-13miR128 and JHU-22miR-128 cell lines, approximately seventeen to twenty folds higher than in vector control cell lines. miRNA-128 was able to bind with the 30-untranslated regions of BMI-1, BAG-2, BAX, H3f3b, and Paip2 mRNAs, resulting in significant reduction of the targeted protein levels. We found that upregulated miR-128 expression significantly inhibited both JHU-13miR-128 and JHU-22miR-128 cell viability approximately 20 to 40%, and the JHU-22miR128 tumor xenograft growth compared to the vector control groups. Conclusions miR-128 acted as a tumor suppressor inhibiting the HNSCC growth by directly mediating the expression of putative targets. Our results provide a better understanding of miRNA-128 function and its potential targets, which may be valuable for developing novel diagnostic markers and targeted therapy.	[Hauser, Belinda; Gu, Xinbin] Howard Univ, Dept Genet & Human Genet, Washington, DC 20059 USA; [Zhao, Yuan; Pang, Xiaowu; Gu, Xinbin] Howard Univ, Dept Oral Pathol, Washington, DC 20059 USA; [Ling, Zhiqiang] Zhejiang Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Myers, Ernest] Howard Univ, Dept Otolaryngol Head & Neck Surg, Washington, DC 20059 USA; [Wang, Paul] Howard Univ, Dept Radiol, Washington, DC 20059 USA; [Wang, Paul; Gu, Xinbin] Howard Univ, Ctr Canc, Washington, DC 20059 USA; [Califano, Joseph] Johns Hopkins Univ, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Califano, Joseph] Johns Hopkins Univ, Dept Head & Neck Res Div, Baltimore, MD USA	Howard University; Howard University; Zhejiang Cancer Hospital; Howard University; Howard University; Howard University; Johns Hopkins University; Johns Hopkins University	Gu, XB (corresponding author), Howard Univ, Dept Genet & Human Genet, Washington, DC 20059 USA.	xgu@howard.edu			National Cancer Institute, NIH [P20 CA118770, CA192989-01]; National Institute of Minority Health Disparity, NIH [RCMI-NIH 2G12RR003048]; National Dental Association Foundation/Colgate Palmolive Research Fund; NATIONAL CANCER INSTITUTE [P20CA118770, P20CA192989] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003048] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Minority Health Disparity, NIH; National Dental Association Foundation/Colgate Palmolive Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported in part by funding P20 CA118770 and CA192989-01 from National Cancer Institute, NIH; RCMI-NIH 2G12RR003048 from National Institute of Minority Health Disparity, NIH; and National Dental Association Foundation/Colgate Palmolive Research Fund.	Adlakha YK aSN, 2013, CELL DEATH DIS, P4; Adlakha YK, 2011, CELL MOL LIFE SCI, V68, P1415, DOI 10.1007/s00018-010-0528-y; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cui JG, 2010, J NEURO-ONCOL, V98, P297, DOI 10.1007/s11060-009-0077-0; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Farnebo L, 2009, INT J MOL MED, V24, P549, DOI 10.3892/ijmm_00000264; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hao YB, 2009, INT J CANCER, V124, P2200, DOI 10.1002/ijc.24160; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Karim MM, 2006, P NATL ACAD SCI USA, V103, P9494, DOI 10.1073/pnas.0603701103; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lippman SM, 2005, J CLIN ONCOL, V23, P346, DOI 10.1200/JCO.2005.09.128; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rapidis AD, 2009, J ONCOL, V2009, DOI 10.1155/2009/346345; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Tran N, 2010, HEAD NECK-J SCI SPEC, V32, P1099, DOI 10.1002/hed.21356; Voncken JW, 1999, J CELL SCI, V112, P4627; Wangpermtam P, 2011, ASIAN PAC J CANCER P, V12, P2081; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhao YA, 2010, CANCER PREV RES, V3, P787, DOI 10.1158/1940-6207.CAPR-09-0243	38	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116321	10.1371/journal.pone.0116321	http://dx.doi.org/10.1371/journal.pone.0116321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764126	Green Submitted, gold, Green Published			2022-12-26	WOS:000351276300005
J	Colli, CM; Bezagio, RC; Nishi, L; Bignotto, TS; Ferreira, EC; Falavigna-Guilherme, AL; Gomes, ML				Colli, Cristiane Maria; Bezagio, Renata Coltro; Nishi, Leticia; Bignotto, Thais Souto; Ferreira, Erika Cristina; Falavigna-Guilherme, Ana Lucia; Gomes, Monica Lucia			Identical Assemblage of Giardia duodenalis in Humans, Animals and Vegetables in an Urban Area in Southern Brazil Indicates a Relationship among Them	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SEQUENCE-ANALYSIS; SAO-PAULO; WATER; TRANSMISSION; INFECTION; CHILDREN; STATE; CRYPTOSPORIDIUM; IDENTIFICATION	Background Giardia duodenalis infects humans and other mammals by ingestion of cysts in contaminated water or food, or directly in environments with poor hygiene. Eight assemblages, designated A-H, are described for this species. Methodology/Principal Findings We investigated by microscopy or by direct immunofluorescence technique the occurrence of G. duodenalis in 380 humans, 34 animals, 44 samples of water and 11 of vegetables. G. duodenalis cysts present in samples were genotyped through PCR-RFLP of beta giardin and glutamate dehydrogenase (gdh) genes and sequencing of gdh. The gdh gene was amplified in 76.5%(26/34) of the human faeces samples with positive microscopy and in 2.9% (1/34) of negative samples. In 70.4%(19/27) of the positive samples were found BIV assemblage. In two samples from dogs with positive microscopy and one negative sample, assemblages BIV, C, and D were found. Cysts of Giardia were not detected in water samples, but three samples used for vegetable irrigation showed total coliforms above the allowed limit, and Escherichia coli was observed in one sample. G. duodenalis BIV was detected in two samples of Lactuca sativa irrigated with this sample of water. BIV was a common genotype, with 100% similarity, between different sources or hosts (humans, animals and vegetables), and the one most often found in humans. Conclusions/Significance This is the first study in Brazil that reports the connection among humans, dogs and vegetables in the transmission dynamics of G. duodenalis in the same geographic area finding identical assemblage. BIV assemblage was the most frequently observed among these different links in the epidemiological chain.	[Colli, Cristiane Maria; Bezagio, Renata Coltro; Falavigna-Guilherme, Ana Lucia; Gomes, Monica Lucia] State Univ Maring uem, Environm & Food Parasitol Lab, Maringa, Parana, Brazil; [Nishi, Leticia] Univ Estadual Maringa, Dept Chem Engn, Maringa, Parana, Brazil; [Bignotto, Thais Souto] State Univ West Parana, Engn & Exact Sci Ctr, Maringa, Parana, Brazil; [Ferreira, Erika Cristina] Univ Estadual Maringa, Dept Stat, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Oeste do Parana; Universidade Estadual de Maringa	Colli, CM (corresponding author), State Univ Maring uem, Environm & Food Parasitol Lab, Maringa, Parana, Brazil.	criscolli@yahoo.com.br	Nishi, Leticia/G-3746-2010; Colli, Cristiane Maria/G-4974-2013; Colli, Cristiane Maria/ABH-9857-2020	Nishi, Leticia/0000-0001-8796-5769; Colli, Cristiane Maria/0000-0002-6899-7519; Falavigna-Guilherme, Ana Lucia/0000-0001-7361-5223	Coordination for the Improvement of Higher Education Personnel (CAPES); Support for scientific and technological development of the Parana (Fundacao Araucaria)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Support for scientific and technological development of the Parana (Fundacao Araucaria)	1. Coordination for the Improvement of Higher Education Personnel (CAPES): www.capes.gov.br, CMC. 2. Support for scientific and technological development of the Parana (Fundacao Araucaria): www.fappr.pr.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; APHA, 2012, 3120 APHA, V22nd; Pereira Maria das Graças Cabral, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P139; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007; Cantusio Neto N, 2004, HIG ALIMENT, V18, P52; Christenson E, 2014, SCI TOTAL ENVIRON, V490, P301, DOI 10.1016/j.scitotenv.2014.05.010; CONAMA (Conselho Nacional do Meio Ambiente), 2005, DIARIO OFICIAL UNIAO; Coradi ST, 2011, J VENOM ANIM TOXINS, V17, P353, DOI 10.1590/S1678-91992011000300016; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Fernandes LN, 2011, J WATER HEALTH, V9, P361, DOI 10.2166/wh.2011.098; Ferreira FS, 2012, PARASITOL RES, V111, P2173, DOI 10.1007/s00436-012-3068-6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoque M. Ekramul, 2002, International Journal of Infectious Diseases, V6, P191, DOI 10.1016/S1201-9712(02)90110-4; Hunter PR, 2005, INT J PARASITOL, V35, P1181, DOI 10.1016/j.ijpara.2005.07.009; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Karon AE, 2011, EPIDEMIOL INFECT, V139, P713, DOI 10.1017/S0950268810001573; Kohli Anita, 2008, Trans R Soc Trop Med Hyg, V102, P718, DOI 10.1016/j.trstmh.2008.03.002; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Molina N, 2011, ANN TROP MED PARASIT, V105, P299, DOI 10.1179/136485911X12987676649665; Mota A, 2009, J FOOD PROTECT, V72, P2184, DOI 10.4315/0362-028X-72.10.2184; Nishi L, 2009, ZOONOSES PUBLIC HLTH, V56, P221, DOI 10.1111/j.1863-2378.2008.01189.x; Oliveira-Rocha M, 2011, PARASITOLOGIA HUMANA, P514; Otenio MH, 2007, SALUSVITA, V26, P197; Pupulin ART, 2004, PR RBAC, V36, P147; Ratanapo S, 2008, AM J TROP MED HYG, V78, P611, DOI 10.4269/ajtmh.2008.78.611; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Sorensen JP, 2014, WATER RES IN PRESS; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5; Uda-Shimoda CF, 2014, DIAGN MICR INFEC DIS, V78, P53, DOI 10.1016/j.diagmicrobio.2013.09.008; Volotao AC, 2007, ACTA TROP, V102, P10, DOI 10.1016/j.actatropica.2007.02.010; Zhang Ping, 2012, Parasitol Res, V111, P2157, DOI 10.1007/s00436-012-3064-x	39	42	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118065	10.1371/journal.pone.0118065	http://dx.doi.org/10.1371/journal.pone.0118065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761119	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275000017
J	Verhulst, A; Sun, S; McKenna, CE; D'Haese, PC				Verhulst, Anja; Sun, Shuting; McKenna, Charles E.; D'Haese, Patrick C.			Endocytotic Uptake of Zoledronic Acid by Tubular Cells May Explain Its Renal Effects in Cancer Patients Receiving High Doses of the Compound	PLOS ONE			English	Article							NITROGEN-CONTAINING BISPHOSPHONATES; FLOW-CYTOMETRIC IMMUNODISSECTION; RECEPTOR-MEDIATED ENDOCYTOSIS; GTP-BINDING PROTEINS; DOUBLE-BLIND; PHARMACOKINETICS; PHARMACODYNAMICS; ACIDIFICATION; LOCALIZATION; RISEDRONATE	Zoledronic acid, a highly potent nitrogen-containing bisphosphonate used for the treatment of pathological bone loss, is excreted unmetabolized via the kidney if not bound to the bone. In cancer patients receiving high doses of the compound renal excretion may be associated with acute tubular necrosis. The question of how zoledronic acid is internalized by renal tubular cells has not been answered until now. In the current work, using a primary human tubular cell culture system, the pathway of cellular uptake of zoledronic acid (fluorescently/radiolabeled) and its cytotoxicity were investigated. Previous studies in our laboratory have shown that this primary cell culture model consistently mimics the physiological characteristics of molecular uptake/transport of the epithelium in vivo. Zoledronic acid was found to be taken up by tubular cells via fluid-phase-endocytosis (from apical and basolateral side) as evidenced by its co-localization with dextran. Cellular uptake and the resulting intracellular level was twice as high from the apical side compared to the basolateral side. Furthermore, the intracellular zoledronic acid level was found to be dependent on the administered concentration and not saturable. Cytotoxic effects however, were only seen at higher administration doses and/or after longer incubation times. Although zoledronic acid is taken up by tubular cells, no net tubular transport could be measured. It is concluded that fluidphase-endocytosis of zoledronic acid and cellular accumulation at high doses may be responsible for the acute tubular necrosis observed in some cancer patients receiving high doses of the compound.	[Verhulst, Anja; D'Haese, Patrick C.] Univ Antwerp, Lab Pathophysiol, Antwerp, Belgium; [Sun, Shuting; McKenna, Charles E.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	University of Antwerp; University of Southern California	Verhulst, A (corresponding author), Univ Antwerp, Lab Pathophysiol, Antwerp, Belgium.	anja.verhulst@uantwerpen.be	D'Haese, Patrick C/C-9599-2019	Sun, Shuting/0000-0002-3635-9029	Novartis	Novartis(Novartis)	AV is a postdoctoral fellow of the Fund for Scientific Research Flanders (www.fwo.be). PD received a research Grant from Novartis. Staff members of Novartis did read the manuscript and gave the permission for publication of the data but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript	Asselman M, 2005, KIDNEY INT, V68, P71, DOI 10.1111/j.1523-1755.2005.00382.x; Barrett J, 2004, J CLIN PHARMACOL, V44, P951, DOI 10.1177/0091270004267594; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; Burckhardt G, 2012, PHARMACOL THERAPEUT, V136, P106, DOI 10.1016/j.pharmthera.2012.07.010; Chen TL, 2002, J CLIN PHARMACOL, V42, P1228, DOI 10.1177/009127002762491316; Coxon FP, 2003, CALCIFIED TISSUE INT, V72, P80, DOI 10.1007/s00223-002-2017-2; DAVIS BH, 1986, CYTOMETRY, V7, P251, DOI 10.1002/cyto.990070305; Deng JT, 1996, HEPATOLOGY, V23, P445; Gibson d'Ambrosio RE, 1983, IN VITRO, V23, P279; Gorvin CM, 2013, P NATL ACAD SCI USA, V110, P7014, DOI 10.1073/pnas.1302063110; Helbert MJF, 2001, KIDNEY INT, V59, P554, DOI 10.1046/j.1523-1755.2001.059002554.x; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Helbert MJF, 1999, EXP NEPHROL, V7, P360; Kashemirov BA, 2008, BIOCONJUGATE CHEM, V19, P2308, DOI 10.1021/bc800369c; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; Kim MY, 2014, BIOMOL THER, V22, P295, DOI 10.4062/biomolther.2014.055; LACAVE R, 1993, J CELL SCI, V104, P705; Lepist EI, 2012, EXPERT OPIN DRUG MET, V8, P433, DOI 10.1517/17425255.2012.667401; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; Luhe A, 2008, TOXICOL IN VITRO, V22, P899, DOI 10.1016/j.tiv.2008.01.006; Markowitz GS, 2003, KIDNEY INT, V64, P281, DOI 10.1046/j.1523-1755.2003.00071.x; Martin D, 2007, BBA-MOL CELL RES, V1773, P419, DOI 10.1016/j.bbamcr.2006.11.015; Michaelson D, 2002, JNCI-J NATL CANCER I, V94, P1458; Mitchell DY, 2000, J CLIN PHARMACOL, V40, P258, DOI 10.1177/00912700022008928; Perazella MA, 2008, KIDNEY INT, V74, P1385, DOI 10.1038/ki.2008.356; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Roelofs AJ, 2009, BRIT J HAEMATOL, V144, P245, DOI 10.1111/j.1365-2141.2008.07435.x; Rogers Maurice, 2011, Scottish Forestry, V65, P34; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Rosen LS, 2003, J CLIN ONCOL, V21, P3150, DOI 10.1200/JCO.2003.04.105; Rosen LS, 2003, CANCER-AM CANCER SOC, V98, P1735, DOI 10.1002/cncr.11701; Sato K, 2009, LIFE SCI, V85, P800, DOI 10.1016/j.lfs.2009.10.012; Skerjanec A, 2003, J CLIN PHARMACOL, V43, P154, DOI 10.1177/0091270002239824; Sun ST, 2011, PHOSPHORUS SULFUR, V186, P970, DOI 10.1080/10426507.2010.526674; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; Thompson K, 2006, MOL PHARMACOL, V69, P1624, DOI 10.1124/mol.105.020776; Verhulst A, 2004, J AM SOC NEPHROL, V15, P2249, DOI 10.1097/01.ASN.0000136778.32499.05; Verhulst A, 2002, J AM SOC NEPHROL, V13, P1210, DOI 10.1681/ASN.V1351210; Verhulst A, 2002, J AM SOC NEPHROL, V14, P107; Verhulst A, 2008, MOL PHARMACOL, V74, P1084, DOI 10.1124/mol.108.047647	42	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121861	10.1371/journal.pone.0121861	http://dx.doi.org/10.1371/journal.pone.0121861			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756736	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700079
J	El Bcheraoui, C; Basulaiman, M; Wilson, S; Daoud, F; Tuffaha, M; AlMazroa, MA; Memish, ZA; Al Saeedi, M; Mokdad, AH				El Bcheraoui, Charbel; Basulaiman, Mohammed; Wilson, Shelley; Daoud, Farah; Tuffaha, Marwa; AlMazroa, Mohammad A.; Memish, Ziad A.; Al Saeedi, Mohammed; Mokdad, Ali H.			Breast Cancer Screening in Saudi Arabia: Free but Almost No Takers	PLOS ONE			English	Article							PROGRAM; HEALTH; BURDEN	Introduction Mammography ensures early diagnosis and a better chance for treatment and recovery from breast cancer. We conducted a national survey to investigate knowledge and practices of breast cancer screening among Saudi women aged 50 years or older in order to inform the breast cancer national health programs. Materials and Methods The Saudi Health Interview Survey is a national multistage survey of individuals aged 15 years or older. The survey included questions on socio-demographic characteristics, tobacco consumption, diet, physical activity, health-care utilization, different health-related behaviors, and self-reported chronic conditions. Female respondents were asked about knowledge and practices of self and clinical breast exams, as well as mammography. Results Between April and June 2013, a total of 10,735 participants completed the survey. Among respondents, 1,135 were women aged 50 years or older and were included in this analysis. About 89% of women reported not having a clinical breast exam in the past year, and 92% reported never having a mammogram. Women living in Al Sharqia had the highest rate of mammography use. Women who were educated, those who had received a routine medical exam within the last two years, and those who were diagnosed with hypertension were more likely to have had a mammogram in the past two years. Discussion Our results show very low rates of breast cancer screening in the Kingdom of Saudi Arabia, a country with free health services. This calls for educational campaigns to improve breast cancer screening. Addressing the barriers for breast cancer screening is a public health imperative.	[El Bcheraoui, Charbel; Wilson, Shelley; Daoud, Farah; Tuffaha, Marwa; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Basulaiman, Mohammed; AlMazroa, Mohammad A.; Memish, Ziad A.; Al Saeedi, Mohammed] Minist Hlth Kingdom Saudi Arabia, Assadah, Al Murabba Riya, Saudi Arabia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mokdad, AH (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Suite 600, Seattle, WA 98195 USA.	mokdaa@uw.edu	Mokdad, Ali H./AAD-1232-2022; Memish, Ziad Ahmed/AEJ-9424-2022	Mokdad, Ali H./0000-0002-4994-3339; Memish, Ziad Ahmed/0000-0002-5099-0714	Saudi ministry of health	Saudi ministry of health	The study was funded by the Saudi ministry of health who managed the data collection. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aa A, 2005, ANN SAUDI MED, V26, P272; Abulkhair OA, 2010, ANN SAUDI MED, V30, P350, DOI 10.4103/0256-4947.67078; Adib S M, 2009, East Mediterr Health J, V15, P6; Akhtar S. S., 2010, Eastern Mediterranean Health Journal, V16, P1025; Alkhenizan A, 2013, J CLIN ONCOL, V31; Amin TT, 2009, ASIAN PAC J CANCER P, V10, P133; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chouchane L, 2013, LANCET ONCOL, V14, pE417, DOI 10.1016/S1470-2045(13)70165-7; Hagi SK, 2013, AM J RES COMMUNICATI, V1; Ibrahim EM, 2008, MED ONCOL, V25, P387, DOI 10.1007/s12032-008-9051-5; King S., 2008, BREAST CANC POLITICS; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Memish ZA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140176; Milaat W A, 2000, East Mediterr Health J, V6, P338; Miles A, 2004, CANCER-AM CANCER SOC, V101, P1201, DOI 10.1002/cncr.20505; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Ramady MA, 2010, SAUDI ARABIAN ECONOMY: POLICIES, ACHIEVEMENTS, AND CHALLENGES, SECOND EDITION, P1, DOI 10.1007/978-1-4419-5987-4; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954; Saudi arabian monetary agency (SAMA), 2013, 49 SAMA; Soni A, 2007, USE BREAST CANC DETE; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; VERBEEK ALM, 1984, LANCET, V1, P1222	22	73	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119051	10.1371/journal.pone.0119051	http://dx.doi.org/10.1371/journal.pone.0119051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774520	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500066
J	Pariona-Llanos, R; Pavani, RS; Reis, M; Noel, V; Silber, AM; Armelin, HA; Cano, MIN; Elias, MC				Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Silber, Ariel Mariano; Armelin, Hugo Aguirre; Cano, Maria Isabel Nogueira; Elias, Maria Carolina			Glyceraldehyde 3-Phosphate Dehydrogenase-Telomere Association Correlates with Redox Status in Trypanosoma cruzi	PLOS ONE			English	Article							PROTEIN; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; INHIBITION; PARALLEL; HOMOLOG; BINDING; CYCLE; DNA	Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a classical metabolic enzyme involved in energy production and plays a role in additional nuclear functions, including transcriptional control, recognition of misincorporated nucleotides in DNA and maintenance of telomere structure. Here, we show that the recombinant protein T. cruzi GAPDH (rTcGAPDH) binds single-stranded telomeric DNA. We demonstrate that the binding of GAPDH to telomeric DNA correlates with the balance between oxidized and reduced forms of nicotinamide adenine dinucleotides (NAD+/NADH). We observed that GAPDH-telomere association and NAD+/NADH balance changed throughout the T. cruzi life cycle. For example, in replicative epimastigote forms of T. cruzi, which show similar intracellular concentrations of NAD+ and NADH, GAPDH binds to telomeric DNA in vivo and this binding activity is inhibited by exogenous NAD+. In contrast, in the T. cruzi non-proliferative trypomastigote forms, which show higher NAD+ concentration, GAPDH was absent from telomeres. In addition, NAD+ abolishes physical interaction between recombinant GAPDH and synthetic telomere oligonucleotide in a cell free system, mimicking exogenous NAD+ that reduces GAPDH-telomere interaction in vivo. We propose that the balance in the NAD+/NADH ratio during T. cruzi life cycle homeostatically regulates GAPDH telomere association, suggesting that in trypanosomes redox status locally modulates GAPDH association with telomeric DNA.	[Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Armelin, Hugo Aguirre; Elias, Maria Carolina] Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil; [Pariona-Llanos, Ricardo; Pavani, Raphael Souza; Reis, Marcelo; Noel, Vincent; Armelin, Hugo Aguirre; Elias, Maria Carolina] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling CeTIC, Sao Paulo, Brazil; [Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Unit Drug Discovery, BR-05508 Sao Paulo, Brazil; [Armelin, Hugo Aguirre] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Cano, Maria Isabel Nogueira] Univ Estadual Paulista Julio de Mesquita Filho UN, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil	Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	Elias, MC (corresponding author), Inst Butantan, Lab Especial Ciclo Celular, Sao Paulo, Brazil.	carolina.eliassabbaga@butantan.gov.br	Elias, Maria QB/AAW-9284-2021; Cano, Maria Isabel/M-7691-2019; Noël, Vincent/P-5803-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Cano, Maria Isabel/A-4020-2008; Elias, Maria Carolina/E-9197-2015; Reis, Marcelo S./K-4075-2012; Armelin, Hugo/P-4390-2015; Silber, Ariel/O-6951-2015	Cano, Maria Isabel/0000-0001-9798-6627; Noël, Vincent/0000-0003-3448-291X; Elias, Maria Carolina/0000-0002-0501-8280; Reis, Marcelo S./0000-0002-3754-9115; Armelin, Hugo/0000-0001-9557-0804; pariona, ricardo/0000-0001-9836-6526; Silber, Ariel/0000-0003-4528-4732; Pavani, Raphael/0000-0002-7187-2995	FAPESP [05/00154-1, 2013/07467-1, 11/50631-1]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Support was provided by FAPESP Nr. 05/00154-1 to MCE, Nr. 2013/07467-1 to MCE and HAA and Nr 11/50631-1 to AMS. RPLl and RSP are FAPESP fellows (2009/50488-4 and 2011/16670-0). AMS, HAA, MINC and MCE are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANGS JD, 1993, J CELL SCI, V105, P1101; Benabdellah K, 2007, MOL MICROBIOL, V65, P1559, DOI 10.1111/j.1365-2958.2007.05892.x; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; da Cunha JPC, 2006, MOL BIOCHEM PARASIT, V150, P268, DOI 10.1016/j.molbiopara.2006.08.012; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chu KW, 1999, J COMPUT PHYS, V148, P646, DOI 10.1006/jcph.1998.6134; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; Das A, 2004, CURR MOL MED, V4, P577, DOI 10.2174/1566524043360267; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Demarse NA, 2009, J MOL BIOL, V394, P789, DOI 10.1016/j.jmb.2009.09.062; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Freitas RF, 2009, BIOORGAN MED CHEM, V17, P2476, DOI 10.1016/j.bmc.2009.01.079; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Greenall A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r146; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; KARPEL RL, 1981, BIOCHIM BIOPHYS ACTA, V654, P256, DOI 10.1016/0005-2787(81)90180-5; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Manning-Cela R, 2002, INFECT IMMUN, V70, P4726, DOI 10.1128/IAI.70.8.4726-4728.2002; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Silva JJN, 2010, BRIT J PHARMACOL, V160, P260, DOI 10.1111/j.1476-5381.2009.00524.x; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Neto JLS, 2007, BIOCHEM BIOPH RES CO, V358, P417, DOI 10.1016/j.bbrc.2007.04.144; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Sundararaj KP, 2004, J BIOL CHEM, V279, P6152, DOI 10.1074/jbc.M310549200; Teixeira SMR, 1998, BRAZ J MED BIOL RES, V31, P1503, DOI 10.1590/S0100-879X1998001200001; Yu FX, 2009, CELL CYCLE, V8, P773, DOI 10.4161/cc.8.5.7880; Zhang QH, 2002, SCIENCE, V295, P1895	35	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120896	10.1371/journal.pone.0120896	http://dx.doi.org/10.1371/journal.pone.0120896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775131	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500197
J	Xu, WP; Morris, U; Aydin-Schmidt, B; Msellem, MI; Shakely, D; Petzold, M; Bjorkman, A; Martensson, A				Xu, Weiping; Morris, Ulrika; Aydin-Schmidt, Berit; Msellem, Mwinyi I.; Shakely, Deler; Petzold, Max; Bjorkman, Anders; Martensson, Andreas			SYBR Green Real-Time PCR-RFLP Assay Targeting the Plasmodium Cytochrome B Gene - A Highly Sensitive Molecular Tool for Malaria Parasite Detection and Species Determination	PLOS ONE			English	Article							DRIED BLOOD; RNA; DNA; SEQUENCES	A prerequisite for reliable detection of low-density Plasmodium infections in malaria pre-elimination settings is the availability of ultra-sensitive and high-throughput molecular tools. We developed a SYBR Green real-time PCR restriction fragment length polymorphism assay (cytb-qPCR) targeting the cytochrome b gene of the four major human Plasmodium species (P. falciparum, P. vivax, P. malariae, and P. ovale) for parasite detection and species determination with DNA extracted from dried blood spots collected on filter paper. The performance of cytb-qPCR was first compared against four reference PCR methods using serially diluted Plasmodium samples. The detection limit of the cytb-qPCR was 1 parasite/mu l (p/mu l) for P. falciparum and P. ovale, and 2 p/mu l for P. vivax and P. malariae, while the reference PCRs had detection limits of 0.5-10 p/mu l. The ability of the PCR methods to detect low-density Plasmodium infections was then assessed using 2977 filter paper samples collected during a cross-sectional survey in Zanzibar, a malaria pre-elimination setting in sub-Saharan Africa. Field samples were defined as 'final positive' if positive in at least two of the five PCR methods. Cytb-qPCR preformed equal to or better than the reference PCRs with a sensitivity of 100% (65/65; 95% CI 94.5-100%) and a specificity of 99.9%(2910/2912; 95% CI 99.7-100%) when compared against 'final positive' samples. The results indicate that the cytb-qPCR may represent an opportunity for improved molecular surveillance of low-density Plasmodium infections in malaria pre-elimination settings.	[Xu, Weiping; Morris, Ulrika; Aydin-Schmidt, Berit; Shakely, Deler; Bjorkman, Anders; Martensson, Andreas] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Div Malaria Res, Stockholm, Sweden; [Msellem, Mwinyi I.] Zanzibar Malaria Eliminat Programme, Zanzibar, Tanzania; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Martensson, Andreas] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Martensson, Andreas] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden	Karolinska Institutet; University of Gothenburg; Karolinska Institutet; Uppsala University	Xu, WP (corresponding author), Dalian Univ Technol, Sch Food & Environm, Panjin Campus, Liaoning 124221, Peoples R China.	Weiping.Xu@ki.se	Morris, Ulrika/AAY-8512-2020	Morris, Ulrika/0000-0003-4734-5754	Swedish International Development Agency (SIDA) [SWE 2009-193]; Swedish Civil Contingencies Agency (MSB) [2010-7991]; Swedish Medical Research Council (VR) [2009-3785]; Goljes foundation	Swedish International Development Agency (SIDA); Swedish Civil Contingencies Agency (MSB); Swedish Medical Research Council (VR)(Swedish Medical Research Council (SMRC)Swedish Research Council); Goljes foundation	Funding provided by Swedish International Development Agency (SIDA) [grant number SWE 2009-193], http://www.sida.se, AM, The Swedish Civil Contingencies Agency (MSB) [grant number 2010-7991], http://www.msb.se, AM, The Swedish Medical Research Council (VR) [grant number 2009-3785], http://www.vr.se, AB and Goljes foundation, http://www.lindhes.se/stiftelseforvaltning/ansokan-ombidrag, UM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemayehu S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-277; Baidjoe A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-272; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Costa DC, 2014, MEM I OSWALDO CRUZ, V109, P21, DOI 10.1590/0074-0276140102; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hasan AU, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-182; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Hsiang MS, 2010, J CLIN MICROBIOL, V48, P3539, DOI 10.1128/JCM.00522-10; Hwang J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-339; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Kamau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071539; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Qari SH, 1996, MOL PHYLOGENET EVOL, V6, P157, DOI 10.1006/mpev.1996.0068; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Shakely D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072912; Sharma I, 2001, INT J PARASITOL, V31, P1107, DOI 10.1016/S0020-7519(01)00218-1; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Snounou Georges, 2002, Methods Mol Med, V72, P189, DOI 10.1385/1-59259-271-6:189; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; Strom GEA, 2014, T ROY SOC TROP MED H, V108, P488, DOI 10.1093/trstmh/tru084; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WOODEN J, 1993, PARASITOL TODAY, V9, P303, DOI 10.1016/0169-4758(93)90131-X	32	23	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120210	10.1371/journal.pone.0120210	http://dx.doi.org/10.1371/journal.pone.0120210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774805	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500158
J	Trepanier, JC; Ellis, KN; Tucker, CS				Trepanier, Jill C.; Ellis, Kelsey N.; Tucker, Clay S.			Hurricane Risk Variability along the Gulf of Mexico Coastline	PLOS ONE			English	Article							TROPICAL CYCLONE INTENSITY; SEA-SURFACE TEMPERATURE; RETURN PERIODS; MAXIMUM INTENSITY; SENSITIVITY; ATLANTIC; WINDS	Hurricane risk characteristics are examined across the U.S. Gulf of Mexico coastline using a hexagonal tessellation. Using an extreme value model, parameters are collected representing the rate or lambda (frequency), the scale or sigma (range), and the shape or xi (intensity) of the extreme wind distribution. These latent parameters and the 30-year return level are visualized across the grid. The greatest 30-year return levels are located toward the center of the Gulf of Mexico, and for inland locations, along the borders of Louisiana, Mississippi, and Alabama. Using a geographically weighted regression model, the relationship of these parameters to sea surface temperature (SST) is found to assess sensitivity to change. It is shown that as SSTs increase near the coast, the frequency of hurricanes in these grids decrease significantly. This reinforces the importance of SST in areas of likely tropical cyclogenesis in determining the number of hurricanes near the coast, along with SSTs along the lifespan of the storm, rather than simply local SST. The range of hurricane wind speeds experienced near Florida is shown to increase with increasing SSTs (insignificant), suggesting that increased temperatures may allow hurricanes to maintain their strength as they pass over the Florida peninsula. The modifiable areal unit problem is assessed using multiple grid sizes. Moran's I and the local statistic G are calculated to examine spatial autocorrelation in the parameters. This research opens up future questions regarding rapid intensification and decay close to the coast and the relationship to changing SSTs.	[Trepanier, Jill C.; Tucker, Clay S.] Louisiana State Univ, Dept Geog & Anthropol, Baton Rouge, LA 70803 USA; [Ellis, Kelsey N.] Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA	Louisiana State University System; Louisiana State University; University of Tennessee System; University of Tennessee Knoxville	Ellis, KN (corresponding author), Univ Tennessee, Dept Geog, Knoxville, TN 37996 USA.	ellis@utk.edu		Ellis, Kelsey/0000-0003-1699-6132				BIVAND R., 2014, SPDEP SPATIAL DEPEND; Blake E.S., 2011, DEADLIEST COSTLIEST; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Chu PS, 1998, J APPL METEOROL, V37, P951, DOI 10.1175/1520-0450(1998)037<0951:MRPOTC>2.0.CO;2; Cohen AE, 2010, NATL WEATHER DIGEST, V34, P99; Coles S., 2001, INTRO STAT MODELING; DEMARIA M, 1994, J CLIMATE, V7, P1324, DOI 10.1175/1520-0442(1994)007<1324:SSTATM>2.0.CO;2; Ellis KN, 2015, NAT HAZARDS, V75, P2733, DOI 10.1007/s11069-014-1461-4; Elsner JB, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053002; Elsner J.B., 2013, HURRICANE CLIMATOLOG; Elsner JB, 2013, J CLIMATE, V26, P5949, DOI 10.1175/JCLI-D-12-00433.1; Elsner JB, 2012, CLIM DYNAM, V39, P21, DOI 10.1007/s00382-011-1066-5; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2004, J ATMOS SCI, V61, P843, DOI 10.1175/1520-0469(2004)061<0843:ECOTCI>2.0.CO;2; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; Emanuel KA, 1999, NATURE, V401, P665, DOI 10.1038/44326; EVANS JL, 1993, J CLIMATE, V6, P1133, DOI 10.1175/1520-0442(1993)006<1133:SOTCIT>2.0.CO;2; Fotheringham AS, 2000, QUANTITATIVE GEOGRAP; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Haining R., 2003, SPATIAL DATA ANAL TH; Jagger TH, 2006, J CLIMATE, V19, P3220, DOI 10.1175/JCLI3913.1; Jarvinen B.R., 1984, TECHNICAL REPORT; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Keim BD, 2007, J CLIMATE, V20, P3498, DOI 10.1175/JCLI4187.1; Knabb RD, 2005, TECHNICAL B NATL HUR; Kotz S., 2000, EXTREME VALUE DISTRI; Malmstadt JC, 2010, J APPL METEOROL CLIM, V49, P2121, DOI 10.1175/2010JAMC2420.1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Parisi F, 2008, J CLIMATE, V21, P403, DOI 10.1175/2007JCLI1772.1; Scheitlin KN, 2011, THEOR APPL CLIMATOL, V105, P287, DOI 10.1007/s00704-010-0386-4; Trepanier JC, 2014, NAT HAZARDS, V71, P1733, DOI 10.1007/s11069-013-0985-3; Trepanier JC, 2014, NAT HAZARDS, V70, P1181, DOI 10.1007/s11069-013-0869-6; Vickery P, 2009, J WIND ENG IND AEROD, P1; Webster PJ, 2005, SCIENCE, V309, P1844, DOI 10.1126/science.1116448	35	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118196	10.1371/journal.pone.0118196	http://dx.doi.org/10.1371/journal.pone.0118196			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767885	Green Published, gold			2022-12-26	WOS:000351277500020
J	Anselmino, M; Scarsoglio, S; Camporeale, C; Saglietto, A; Gaita, F; Ridolfi, L				Anselmino, Matteo; Scarsoglio, Stefania; Camporeale, Carlo; Saglietto, Andrea; Gaita, Fiorenzo; Ridolfi, Luca			Rate Control Management of Atrial Fibrillation: May a Mathematical Model Suggest an Ideal Heart Rate?	PLOS ONE			English	Article							STRICT RATE CONTROL; RATE CONTROL EFFICACY; RHYTHM CONTROL; RACE II; LENIENT; INTERVALS; VOLUME	Background Despite the routine prescription of rate control therapy for atrial fibrillation (AF), clinical evidence demonstrating a heart rate target is lacking. Aim of the present study was to run a mathematical model simulating AF episodes with a different heart rate (HR) to predict hemodynamic parameters for each situation. Methods The lumped model, representing the pumping heart together with systemic and pulmonary circuits, was run to simulate AF with HR of 50, 70, 90, 110 and 130 bpm, respectively. Results Left ventricular pressure increased by 57%, from 33.92 +/- 37.56 mmHg to 53.15 +/- 47.56 mmHg, and mean systemic arterial pressure increased by 27%, from 82.66 +/- 14.04 mmHg to 105.3 +/- 7.6 mmHg, at the 50 and 130 bpm simulations, respectively. Stroke volume (from 77.45 +/- 8.50 to 39.09 +/- 8.08 mL), ejection fraction (from 61.10 +/- 4.40 to 39.32 +/- 5.42%) and stroke work (SW, from 0.88 +/- 0.04 to 0.58 +/- 0.09 J) decreased by 50, 36 and 34%, at the 50 and 130 bpm simulations, respectively. In addition, oxygen consumption indexes (rate pressure product - RPP, tension time index per minute - TTI/min, and pressure volume area per minute - PVA/min) increased from the 50 to the 130 bpm simulation, respectively, by 186% (from 5598 +/- 1939 to 15995 +/- 3219 mmHg/min), 56% (from 2094 +/- 265 to 3257 +/- 301 mmHg s/min) and 102% (from 57.99 +/- 17.90 to 117.4 +/- 26.0 J/min). In fact, left ventricular efficiency (SW/PVA) decreased from 80.91 +/- 2.91% at 50 bpm to 66.43 +/- 3.72% at the 130 bpm HR simulation. Conclusion Awaiting compulsory direct clinical evidences, the present mathematical model suggests that lower HRs during permanent AF relates to improved hemodynamic parameters, cardiac efficiency, and lower oxygen consumption.	[Anselmino, Matteo; Saglietto, Andrea; Gaita, Fiorenzo] Univ Turin, Citta Salute & Sci Hosp, Div Cardiol, Dept Med Sci, Turin, Italy; [Scarsoglio, Stefania] Politecn Torino, DIMEAS Dept Mech & Aerosp Engn, Turin, Italy; [Camporeale, Carlo; Ridolfi, Luca] Politecn Torino, DIATI Dept Environm Land & Infrastruct Engn, Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Polytechnic University of Turin; Polytechnic University of Turin	Ridolfi, L (corresponding author), Politecn Torino, DIATI Dept Environm Land & Infrastruct Engn, Turin, Italy.	luca.ridolfi@polito.it	Scarsoglio, Stefania/ABC-4325-2020; Saglietto, Andrea/E-2184-2015; Scarsoglio, Stefania/E-8067-2015; Camporeale, Carlo/I-1247-2019	Scarsoglio, Stefania/0000-0002-9427-6491; Saglietto, Andrea/0000-0001-9475-1507; Scarsoglio, Stefania/0000-0002-9427-6491; Camporeale, Carlo/0000-0002-7311-6018; RIDOLFI, Luca/0000-0003-2947-8641; Gaita, Fiorenzo/0000-0003-3178-6205; Anselmino, Matteo/0000-0002-6311-4270				Andrade J, 2014, CIRC RES, V114, P1453, DOI 10.1161/CIRCRESAHA.114.303211; [Anonymous], 2014, MATLAB 42014A; Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875; ERBEL R, 1984, AM J CARDIOL, V53, P590, DOI 10.1016/0002-9149(84)90036-5; Go Orson, 2009, Curr Cardiol Rep, V11, P430; Groenveld HF, 2011, J AM COLL CARDIOL, V58, P1795, DOI 10.1016/j.jacc.2011.06.055; Hennig T, 2006, J BIOL PHYS, V32, P383, DOI 10.1007/s10867-006-9022-z; January CT, 2014, J AM COLL CARDIOL, DOI [10.1016/j.jacc.2014,03,022, DOI 10.1016/J.JACC.2014,03,022]; Lip GYH, 2015, EUROPACE, V17, P194, DOI 10.1093/europace/euu201; NISHIKAWA Y, 1994, J PHYSIOL-LONDON, V481, P457, DOI 10.1113/jphysiol.1994.sp020454; Scaglione M, 2014, HEART RHYTHM, V11, P777, DOI 10.1016/j.hrthm.2014.02.018; Scarsoglio S, 2014, MED BIOL ENG COMPUT, V52, P905, DOI 10.1007/s11517-014-1192-4; Smit MD, 2011, J AM COLL CARDIOL, V58, P942, DOI 10.1016/j.jacc.2011.04.030; Suga H, 2003, CLIN EXP PHARMACOL P, V30, P580, DOI 10.1046/j.1440-1681.2003.03879.x; TAKAOKA H, 1993, CIRCULATION, V87, P59, DOI 10.1161/01.CIR.87.1.59; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Van Gelder IC, 2006, AM HEART J, V152, P420, DOI 10.1016/j.ahj.2006.02.033; Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-6363-5; Wyse DG, 2011, J AM COLL CARDIOL, V58, P950, DOI 10.1016/j.jacc.2011.04.028; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	22	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119868	10.1371/journal.pone.0119868	http://dx.doi.org/10.1371/journal.pone.0119868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764321	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300033
J	Berger, Z; Perkins, S; Ambroise, C; Oborski, C; Calabrese, M; Noell, S; Riddell, D; Hirst, WD				Berger, Zdenek; Perkins, Sarah; Ambroise, Claude; Oborski, Christine; Calabrese, Matthew; Noell, Stephen; Riddell, David; Hirst, Warren D.			Tool Compounds Robustly Increase Turnover of an Artificial Substrate by Glucocerebrosidase in Human Brain Lysates	PLOS ONE			English	Article							ACID-BETA-GLUCOSIDASE; GAUCHER-DISEASE; CEREBROSPINAL-FLUID; ISOFAGOMINE INCREASES; MUTATIONS; MULTICENTER; CHAPERONES; PROTOTYPE; VARIANTS; DEMENTIA	Mutations in glucocerebrosidase (GBA1) cause Gaucher disease and also represent a common risk factor for Parkinson's disease and Dementia with Lewy bodies. Recently, new tool molecules were described which can increase turnover of an artificial substrate 4MUG when incubated with mutant N370S GBA1 from human spleen. Here we show that these compounds exert a similar effect on the wild-type enzyme in a cell-free system. In addition, these tool compounds robustly increase turnover of 4MUG by GBA1 derived from human cortex, despite substantially lower glycosylation of GBA1 in human brain, suggesting that the degree of glycosylation is not important for compound binding. Surprisingly, these tool compounds failed to robustly alter GBA1 turnover of 4MUG in the mouse brain homogenate. Our data raise the possibility that in vivo models with humanized glucocerebrosidase may be needed for efficacy assessments of such small molecules.	[Berger, Zdenek; Perkins, Sarah; Ambroise, Claude; Oborski, Christine; Riddell, David; Hirst, Warren D.] Pfizer, Neurosci Res Unit, Cambridge, MA 02140 USA; [Calabrese, Matthew] Pfizer Inc, Struct Biol Grp, Groton, CT 06340 USA; [Noell, Stephen] Pfizer Inc, Primary Pharmacol Grp, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer	Berger, Z (corresponding author), Pfizer, Neurosci Res Unit, 610 Main St, Cambridge, MA 02140 USA.	zdenek.berger@pfizer.com		Hirst, Warren/0000-0003-0389-8891				Balducci C, 2007, MOVEMENT DISORD, V22, P1481, DOI 10.1002/mds.21399; Deegan PB, 2012, DRUG DES DEV THER, V6, DOI 10.2147/DDDT.S14395; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Goldin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029861; Grabowski GA, 1996, CRIT REV ONCOL HEMAT, V23, P25, DOI 10.1016/1040-8428(96)00199-0; Khanna R, 2010, FEBS J, V277, P1618, DOI 10.1111/j.1742-4658.2010.07588.x; Kurzawa-Akanbi M, 2012, J NEUROCHEM, V123, P298, DOI 10.1111/j.1471-4159.2012.07879.x; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Motabar O, 2012, ANAL BIOANAL CHEM, V402, P731, DOI 10.1007/s00216-011-5496-z; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Parnetti L, 2009, NEUROBIOL DIS, V34, P484, DOI 10.1016/j.nbd.2009.03.002; Parnetti L, 2014, MOV DISORD; Patnaik S, 2012, J MED CHEM, V55, P5734, DOI 10.1021/jm300063b; Premkumar L, 2007, GAUCHER DIS; Ron I, 2005, BLOOD CELL MOL DIS, V35, P57, DOI 10.1016/j.bcmd.2005.03.006; Sanders A, 2013, BLOOD CELL MOL DIS, V51, P109, DOI 10.1016/j.bcmd.2013.03.006; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2012, J BIOL CHEM, V287, P4275, DOI 10.1074/jbc.M111.280016; Sun Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019037; van de Berg WDJ, 2013, AD PD M FLOR IT; van Dijk KD, 2013, MOVEMENT DISORD, V28, P747, DOI 10.1002/mds.25495; Westbroek W, 2011, TRENDS MOL MED, V17, P485, DOI 10.1016/j.molmed.2011.05.003; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Zhao H, 2002, CELL MOL LIFE SCI, V59, P694, DOI 10.1007/s00018-002-8458-y; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104	29	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119141	10.1371/journal.pone.0119141	http://dx.doi.org/10.1371/journal.pone.0119141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763858	gold, Green Submitted, Green Published			2022-12-26	WOS:000351276300020
J	Tansiri, Y; Rowland-Jones, SL; Ananworanich, J; Hansasuta, P				Tansiri, Yada; Rowland-Jones, Sarah L.; Ananworanich, Jintanat; Hansasuta, Pokrath			Clinical Outcome of HIV Viraemic Controllers and Noncontrollers with Normal CD4 Counts Is Exclusively Determined by Antigen-Specific CD8(+) T-Cell-Mediated HIV Suppression	PLOS ONE			English	Article							VIRUS TYPE-1 REPLICATION; VIRAL LOAD; NASOPHARYNGEAL CARCINOMA; IMMUNE CONTROL; EX-VIVO; INFECTION; RESPONSES; GAG; LYMPHOCYTES; ACTIVATION	In this cross-sectional study we evaluated T-cell responses using several assays to determine immune correlates of HIV control that distinguish untreated viraemic controllers (VC) from noncontrollers (NC) with similar CD4 counts. Samples were taken from 65 ART-naive chronically HIV-infected VC and NC from Thailand with matching CD4 counts in the normal range (>450 cells/mu l). We determined HIVp24-specific T-cell responses using standard Interferon- gamma (IFN gamma) ELISpot assays, and compared the functional quality of HIVp24-specific CD8(+) T-cell responses using polychromatic flow cytometry. Finally, in vitro HIV suppression assays were performed to evaluate directly the activity of CD8(+) T cells in HIV control. Autologous CD4(+) T cells were infected with primary patient-derived HIV isolates and the HIV suppressive activity of CD8(+) T cells was determined after co-culture, measuring production of HIVp24 Ag by ELISA. The HIVp24-specific T-cell responses of VC and NC could not completely be differentiated through measurement of IFN gamma-producing cells using ELISpot assays, nor by the absolute cell numbers of polyfunctional HIVp24-specific CD8(+) T cells. However, in vitro HIV suppression assays showed clear differences between VC and NC. HIV suppressive activity, mediated by either ex vivo unstimulated CD8(+) T cells or HIVp24-specific T-cell lines, was significantly greater using cells from VC than NC cells. Additionally, we were able to demonstrate a significant correlation between the level of HIV suppressive activity mediated by ex vivo unstimulated CD8(+) T cells and plasma viral load (pVL) (Spearman r = -0.7345, p = 0.0003). This study provides evidence that in vitro HIV suppression assays are the most informative in the functional evaluation of CD8(+) T-cell responses and can distinguish between VC and NC.	[Tansiri, Yada; Hansasuta, Pokrath] Chulalongkorn Univ, Fac Med, Div Virol, Dept Microbiol, Bangkok 10330, Thailand; [Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England; [Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Bangkok 10330, Thailand	Chulalongkorn University; University of Oxford; Chulalongkorn University	Hansasuta, P (corresponding author), Chulalongkorn Univ, Fac Med, Div Virol, Dept Microbiol, Bangkok 10330, Thailand.	Pokrath.H@Chula.ac.th	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Tansiri, Yada/0000-0002-0329-0133	Government Grant through National Research Council of Thailand (NRCT); Chulalongkorn University, Bangkok, Thailand [GRB_BSS_49_55_30_08]; Thailand Research Fund (TRF) through TRF Senior Research Scholar; Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program [PHD/0148/2549]	Government Grant through National Research Council of Thailand (NRCT); Chulalongkorn University, Bangkok, Thailand(Chulalongkorn University); Thailand Research Fund (TRF) through TRF Senior Research Scholar; Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This study was financial supported by Government Grant through National Research Council of Thailand (NRCT) and Chulalongkorn University, Bangkok, Thailand (GRB_BSS_49_55_30_08). PH was partially supported by the Thailand Research Fund (TRF) through TRF Senior Research Scholar; YT was also supported by the Thailand Research Fund (TRF) through the Royal Golden Jubilee Ph.D. Program (PHD/0148/2549). The funders had no role in study design, data collection, data analysis, decision to publish, and manuscript preparation.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Berger CT, 2011, J VIROL, V85, P9334, DOI 10.1128/JVI.00460-11; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; COFFIN J, 1986, SCIENCE, V232, P697, DOI 10.1126/science.3008335; Comoli P, 2005, J CLIN ONCOL, V23, P8942, DOI 10.1200/JCO.2005.02.6195; Dong T, 2004, J EXP MED, V200, P1547, DOI 10.1084/jem.20032044; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fogg MH, 2009, P NATL ACAD SCI USA, V106, P3318, DOI 10.1073/pnas.0813320106; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Julg B, 2010, J VIROL, V84, P5540, DOI 10.1128/JVI.02031-09; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kottilil S, 2000, J CLIN IMMUNOL, V20, P175, DOI 10.1023/A:1006633429087; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lecuroux C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059767; Luo XH, 2010, BIOL BLOOD MARROW TR, V16, P994, DOI 10.1016/j.bbmt.2010.02.007; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poropatich K, 2011, J GEN VIROL, V92, P247, DOI 10.1099/vir.0.027102-0; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Spentzou A, 2010, J INFECT DIS, V201, P720, DOI 10.1086/650492; Sriwanthana B, 2001, AIDS RES HUM RETROV, V17, P719, DOI 10.1089/088922201750236997; Streeck H, 2009, NAT PROTOC, V4, P461, DOI 10.1038/nprot.2009.7; Techakriengkrai N, 2013, AIDS, V27, P17, DOI 10.1097/QAD.0b013e32835ac0e1; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; Yang HB, 2012, J INFECT DIS, V206, P552, DOI 10.1093/infdis/jis379; Zhang YH, 2011, J IMMUNOL, V187, P684, DOI 10.4049/jimmunol.1100316	45	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118871	10.1371/journal.pone.0118871	http://dx.doi.org/10.1371/journal.pone.0118871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764310	gold, Green Published, Green Submitted			2022-12-26	WOS:000351276300016
J	Nishikawa, N; Shimo, Y; Wada, M; Hattori, N; Kitazawa, S				Nishikawa, Natsuko; Shimo, Yasushi; Wada, Makoto; Hattori, Nobutaka; Kitazawa, Shigeru			Effects of Aging and Idiopathic Parkinson's Disease on Tactile Temporal Order Judgment	PLOS ONE			English	Article							DISCRIMINATION; STIMULATION; PERCEPTION; HANDEDNESS; MOVEMENTS; PARIETAL; SACCADES; MODEL; AGE	It is generally accepted that the basal ganglia play an important role in interval timing that requires the measurement of temporal durations. By contrast, it remains controversial whether the basal ganglia play an essential role in temporal order judgment (TOJ) of successive stimuli, a behavior that does not necessarily require the measurement of durations in time. To address this issue, we compared the effects of idiopathic Parkinson's disease (PD) on the TOJ of two successive taps delivered to each hand, with the arms uncrossed in one condition and crossed in another. In addition to age-matched elderly participants without PD (non-PD), we examined young healthy participants so that the effect of aging could serve as a control for evaluating the effects of PD. There was no significant difference between PD and non-PD participants in any parameter of TOJ under either arm posture, although reaction time was significantly longer in PD compared with non-PD participants. By contrast, the effect of aging was apparent in both conditions. With their arms uncrossed, the temporal resolution (the interstimulus interval that yielded 84% correct responses) in elderly participants was significantly worse compared with young participants. With their arms crossed, elderly participants made more errors at longer intervals (similar to 1 s) than young participants, although both age groups showed similar judgment reversal at moderately short intervals (similar to 200 ms). These results indicate that the basal ganglia and dopaminergic systems do not play essential roles in tactile TOJ involving both hands and that the effect of aging on TOJ is mostly independent of the dopaminergic systems.	[Nishikawa, Natsuko; Shimo, Yasushi; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138421, Japan; [Wada, Makoto; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan; [Wada, Makoto] Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Dev Disorders Sect, Tokorozawa, Saitama, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka, Japan; [Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontiers Biosci, Dynam Brain Network Lab, Osaka, Japan	Juntendo University; Juntendo University; Osaka University; Osaka University	Kitazawa, S (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo, Japan.	kitazawa@fbs.osaka-u.ac.jp	Hattori, Nobutaka/ACR-0069-2022		 [21240029];  [25119002]	; 	This work was supported by Grants-in-Aid for Scientific Research (A) 21240029, and Grants-in-Aid for Scientific Research on Innovative Areas 25119002 to S.K. (http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; AXELROD S, 1968, J GERONTOL, V23, P191, DOI 10.1093/geronj/23.2.191; Azanon E, 2008, CURR BIOL, V18, P1044, DOI 10.1016/j.cub.2008.06.045; Brown LN, 2000, J CLIN EXP NEUROPSYC, V22, P587, DOI 10.1076/1380-3395(200010)22:5;1-9;FT587; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Conte A, 2010, BRAIN, V133, P2656, DOI 10.1093/brain/awq191; Coppinger NW, 1955, J GERONTOL, V10, P48, DOI 10.1093/geronj/10.1.48; Craig JC, 2010, ATTEN PERCEPT PSYCHO, V72, P226, DOI 10.3758/APP.72.1.226; Davis B, 2009, J NEUROSCI, V29, P3182, DOI 10.1523/JNEUROSCI.5793-08.2009; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; DESMEDT JE, 1980, ELECTROEN CLIN NEURO, V50, P404, DOI 10.1016/0013-4694(80)90007-3; Fiorio M, 2008, J NEUROL, V255, P1372, DOI 10.1007/s00415-008-0923-6; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujisaki W., 2012, NEW HDB MULTISENSORY, P301; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; Haggard P, 2008, SENSORIMOTOR FDN HIG; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Heed T, 2010, J COGNITIVE NEUROSCI, V22, P184, DOI 10.1162/jocn.2008.21168; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jahanshahi M, 2006, J NEUROSCI, V26, P12266, DOI 10.1523/JNEUROSCI.2540-06.2006; JASKOWSKI P, 1991, PERCEPT PSYCHOPHYS, V50, P76, DOI 10.3758/BF03212206; Kitazawa S, 2002, CONSCIOUS COGN, V11, P475, DOI 10.1016/S1053-8100(02)00031-4; Laasonen M, 2002, NEUROREPORT, V13, P1111, DOI 10.1097/00001756-200207020-00008; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Nakano T, 2011, I-PERCEPTION, V2, P800; Nelson AJ, 2012, CAN J NEUROL SCI, V39, P52, DOI 10.1017/S0317167100012683; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overvliet KE, 2011, NEUROPSYCHOLOGIA, V49, P3046, DOI 10.1016/j.neuropsychologia.2011.07.005; Oyama G, 2011, PARKINSONISM RELAT D, V17, P189, DOI 10.1016/j.parkreldis.2010.12.004; PASTOR MA, 1992, BRAIN, V115, P875, DOI 10.1093/brain/115.3.875; PASTOR MA, 1992, BRAIN, V115, P211, DOI 10.1093/brain/115.1.211; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; Poliakoff E, 2006, NEUROSCI LETT, V396, P207, DOI 10.1016/j.neulet.2005.11.034; Rigato S, 2013, EUR J NEUROSCI, V38, P2884, DOI 10.1111/ejn.12292; Shore DI, 2002, COGNITIVE BRAIN RES, V14, P153, DOI 10.1016/S0926-6410(02)00070-8; Soto-Faraco S, 2013, NEUROPSYCHOLOGIA, V51, P1584, DOI 10.1016/j.neuropsychologia.2013.04.012; Takahashi T, 2013, CEREB CORTEX, V23, P1952, DOI 10.1093/cercor/bhs179; Wada M, 2004, NEUROPSYCHOLOGIA, V42, P1887, DOI 10.1016/j.neuropsychologia.2004.05.009; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118331	10.1371/journal.pone.0118331	http://dx.doi.org/10.1371/journal.pone.0118331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760621	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000022
J	Sun, WL; Valero, MC; Seong, KM; Steele, LD; Huang, IT; Lee, CH; Clark, JM; Qiu, XH; Pittendrigh, BR				Sun, Weilin; Valero, M. Carmen; Seong, Keon Mook; Steele, Laura D.; Huang, I-Ting; Lee, Chien-Hui; Clark, John M.; Qiu, Xinghui; Pittendrigh, Barry R.			A Glycine Insertion in the Estrogen-Related Receptor (ERR) Is Associated with Enhanced Expression of Three Cytochrome P450 Genes in Transgenic Drosophila melanogaster	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; DDT RESISTANCE; TRANSCRIPTIONAL CONTROL; METABOLIC RESISTANCE; RESPONSES; CYP6A2; DATABASE; STRAINS; CYP12D1; NRF2	Insecticide-resistant Drosophila melanogaster strains represent a resource for the discovery of the underlying molecular mechanisms of cytochrome P450 constitutive overexpression, even if some of these P450s are not directly involved in the resistance phenotype. For example, in select 4,4'-dichlorodiphenyltrichloroethane (DDT) resistant strains the glucocorticoid receptor-like (GR-like) potential transcription factor binding motifs (TFBMs) have previously been shown to be associated with constitutively differentially-expressed cytochrome P450s, Cyp12d1, Cyp6g2 and Cyp9c1. However, insects are not known to have glucocorticoids. The only ortholog to the mammalian glucocorticoid receptor (GR) in D. melanogaster is an estrogen-related receptor (ERR) gene, which has two predicted alternative splice isoforms (ERRa and ERRb). Sequencing of ERRa and ERRb in select DDT susceptible and resistant D. melanogaster strains has revealed a glycine (G) codon insertion which was only observed in the ligand binding domain of ERR from the resistant strains tested (ERR-G). Transgenic flies, expressing the ERRa-G allele, constitutively over-expressed Cyp12d1, Cyp6g2 and Cyp9c1. Only Cyp12d1 and Cyp6g2 were over-expressed in the ERRb-G transgenic flies. Phylogenetic studies show that the G-insertion appeared to be located in a less conserved domain in ERR and this insertion is found in multiple species across the Sophophora subgenera.	[Sun, Weilin; Valero, M. Carmen; Seong, Keon Mook; Steele, Laura D.; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Huang, I-Ting; Lee, Chien-Hui] Chung Hwa Univ Med Technol, Tainan, Taiwan; [Clark, John M.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Chung Hua University; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Sciences; Institute of Zoology, CAS	Sun, WL (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	wsn@illinois.edu			C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment	C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment	This work was primarily funded by the C. W. Kearns, C. L. Metcalf and W. P. Flint Endowment. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x; Ansell PJ, 2005, MOL CELL ENDOCRINOL, V243, P27, DOI 10.1016/j.mce.2005.08.002; Ariazi EA, 2002, CANCER RES, V62, P6510; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bardet PL, 2006, TRENDS ENDOCRIN MET, V17, P166, DOI 10.1016/j.tem.2006.03.005; Brandt A, 2002, INSECT MOL BIOL, V11, P337, DOI 10.1046/j.1365-2583.2002.00344.x; Catania F, 2004, MOL ECOL, V13, P2491, DOI 10.1111/j.1365-294X.2004.02263.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Dvorak Z, 2010, DRUG METAB REV, V42, P621, DOI 10.3109/03602532.2010.484462; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Giraudo M, 2010, PESTIC BIOCHEM PHYS, V97, P115, DOI 10.1016/j.pestbp.2009.06.009; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kazemian M, 2011, NUCLEIC ACIDS RES, V39, pW79, DOI 10.1093/nar/gkr291; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Kuruganti S, 2007, GENE, V388, P43, DOI 10.1016/j.gene.2006.09.019; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Maitra S, 2000, GENE, V248, P147, DOI 10.1016/S0378-1119(00)00129-3; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McDonnell CM, 2012, J MOL EVOL, V74, P281, DOI 10.1007/s00239-012-9506-3; McKenzie JA, 1998, PHILOS T ROY SOC B, V353, P1729, DOI 10.1098/rstb.1998.0325; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Ostberg T, 2003, BIOCHEMISTRY-US, V42, P6427, DOI 10.1021/bi027279b; Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PLAPP FW, 1984, PESTIC BIOCHEM PHYS, V22, P194, DOI 10.1016/0048-3575(84)90089-0; Qiu XH, 2013, PEST MANAG SCI, V69, P930, DOI 10.1002/ps.3454; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Sullivan AA, 2003, MOL ENDOCRINOL, V17, P2125, DOI 10.1210/me.2002-0430; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Tremblay Annie M, 2007, Nucl Recept Signal, V5, pe009, DOI 10.1621/nrs.05009; Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645; Zhou W, 2007, MOL CELL ENDOCRINOL, V278, P52, DOI 10.1016/j.mce.2007.08.011	48	12	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118779	10.1371/journal.pone.0118779	http://dx.doi.org/10.1371/journal.pone.0118779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761142	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000039
J	Szymanska, P; Martin, KR; MacKeigan, JP; Hlavacek, WS; Lipniacki, T				Szymanska, Paulina; Martin, Katie R.; MacKeigan, Jeffrey P.; Hlavacek, William S.; Lipniacki, Tomasz			Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEPENDENT PHOSPHORYLATION; MAMMALIAN TARGET; MAINTAINS ENERGY; BINDING PARTNER; CELL-GROWTH; S6 KINASE; AUTOPHAGY; COMPLEX; RAPTOR	We constructed a mechanistic, computational model for regulation of (macro) autophagy and protein synthesis (at the level of translation). The model was formulated to study the system-level consequences of interactions among the following proteins: two key components of MTOR complex 1 (MTORC1), namely the protein kinase MTOR (mechanistic target of rapamycin) and the scaffold protein RPTOR; the autophagy-initiating protein kinase ULK1; and the multimeric energy-sensing AMP-activated protein kinase (AMPK). Inputs of the model include intrinsic AMPK kinase activity, which is taken as an adjustable surrogate parameter for cellular energy level or AMP: ATP ratio, and rapamycin dose, which controls MTORC1 activity. Outputs of the model include the phosphorylation level of the translational repressor EIF4EBP1, a substrate of MTORC1, and the phosphorylation level of AMBRA1 (activating molecule in BECN1-regulated autophagy), a substrate of ULK1 critical for autophagosome formation. The model incorporates reciprocal regulation of mTORC1 and ULK1 by AMPK, mutual inhibition of MTORC1 and ULK1, and ULK1-mediated negative feedback regulation of AMPK. Through analysis of the model, we find that these processes may be responsible, depending on conditions, for graded responses to stress inputs, for bistable switching between autophagy and protein synthesis, or relaxation oscillations, comprising alternating periods of autophagy and protein synthesis. A sensitivity analysis indicates that the prediction of oscillatory behavior is robust to changes of the parameter values of the model. The model provides testable predictions about the behavior of the AMPK-MTORC1-ULK1 network, which plays a central role in maintaining cellular energy and nutrient homeostasis.	[Szymanska, Paulina] Univ Warsaw, Coll Inter, Fac Individual Studies Math & Nat Sci, Warsaw, Poland; [Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Inst, Grand Rapids, MI USA; [Hlavacek, William S.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA; [Hlavacek, William S.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Lipniacki, Tomasz] Inst Fundamental Technol Res, PL-00049 Warsaw, Poland	University of Warsaw; Van Andel Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Hlavacek, WS (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87544 USA.	wish@lanl.gov; tlipnia@ippt.pan.pl	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Martin, Katie/0000-0002-3689-4814; Szymanska-Rozek, Paulina/0000-0002-2527-5081; Hlavacek, William/0000-0003-4383-8711; MacKeigan, Jeffrey/0000-0002-0198-5679	National Institutes of Health/National Institute of General Medical Science [P50GM085273]; US Department of Energy through the Los Alamos Center for Nonlinear Studies [DE-AC52-06NA25396]; Laboratory-directed Research and Development (LDRD) Program; National Science Center (Poland) [2011/03/B/NZ2/00281]; EU through the European Social Fund [UDA-POKL.04.01.01-00-072/09-00]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy through the Los Alamos Center for Nonlinear Studies(United States Department of Energy (DOE)); Laboratory-directed Research and Development (LDRD) Program; National Science Center (Poland)(National Science Centre, Poland); EU through the European Social Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	WSH is supported by National Institutes of Health/National Institute of General Medical Science grant P50GM085273, (www.nih.gov/www.nigms.nih.gov) and US Department of Energy Contract DE-AC52-06NA25396 through the Los Alamos Center for Nonlinear Studies and the Laboratory-directed Research and Development (LDRD) Program, (www.energy.gov). TL is supported by National Science Center (Poland) Grant No. 2011/03/B/NZ2/00281, (www.ncn.gov.pl). PS is supported by EU through the European Social Fund, contract number UDA-POKL.04.01.01-00-072/09-00, (http://ec.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Bach M, 2011, BIOCHEM J, V440, P283, DOI 10.1042/BJ20101894; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chylek LA, 2014, WIRES SYST BIOL MED, V6, P13, DOI 10.1002/wsbm.1245; Chylek LA, 2011, MOL BIOSYST, V7, P2779, DOI 10.1039/c1mb05077j; Coffman K, 2014, J BIOL CHEM, V289, P4723, DOI 10.1074/jbc.M113.482067; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dunlop EA, 2013, BIOCHEM SOC T, V41, P939, DOI 10.1042/BST20130030; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kapuy O, 2009, PROG BIOPHYS MOL BIO, V100, P47, DOI 10.1016/j.pbiomolbio.2009.06.004; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuznetsov, 2013, ELEMENTS APPL BIFURC; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Loffler AS, 2011, AUTOPHAGY, V7, P696, DOI 10.4161/auto.7.7.15451; Lomnitz JG, 2014, ACS SYNTH BIOL; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu W, 2011, BIOINFORMATICS, V27, P1721, DOI 10.1093/bioinformatics/btr197; Xu YQ, 2013, AUTOPHAGY, V9, P1418, DOI 10.4161/auto.25080; Yang J, 2011, MATH BIOSCI, V232, P164, DOI 10.1016/j.mbs.2011.06.003; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2006, MOL BIOL CELL, V17, P5094, DOI 10.1091/mbc.E06-06-0479; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116550	10.1371/journal.pone.0116550	http://dx.doi.org/10.1371/journal.pone.0116550			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761126	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000006
J	Muuronen, AT; Taina, M; Hedman, M; Marttila, J; Kuusisto, J; Onatsu, J; Vanninen, R; Jakala, P; Sipola, P; Mustonen, P				Muuronen, Antti T.; Taina, Mikko; Hedman, Marja; Marttila, Jarkko; Kuusisto, Johanna; Onatsu, Juha; Vanninen, Ritva; Jakala, Pekka; Sipola, Petri; Mustonen, Pirjo			Increased Visceral Adipose Tissue as a Potential Risk Factor in Patients with Embolic Stroke of Undetermined Source (ESUS)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; COMPUTED-TOMOGRAPHY; ISCHEMIC-STROKE; FAT MASS; INFLAMMATION; ECHOCARDIOGRAPHY; CLASSIFICATION; ASSOCIATION	Purpose The etiology of an ischemic stroke remains undetermined in 20-35% of cases and many patients do not have any of the conventional risk factors. Increased visceral adipose tissue (VAT) is a suggested new risk factor for both carotid artery atherosclerosis (CAA) and atrial fibrillation (AF), but its role in the remaining stroke population is unknown. We assessed the amount of VAT in patients with embolic stroke of undetermined source (ESUS) after excluding major-risk cardioembolic sources, occlusive atherosclerosis, and lacunar stroke. Methods Altogether 58 patients (mean age 57.7 +/- 10.2 years, 44 men) with ischemic stroke of unknown etiology but without CAA, known AF or small vessel disease underwent computed tomography angiography and assessment of VAT. For comparison VAT values from three different reference populations were used. Conventional risk factors (smoking, hypertension, diabetes, increased total and LDL-cholesterol, decreased HDL-cholesterol) were also registered. Results Mean VAT area was significantly higher in stroke patients (205 +/- 103 cm(2) for men and 168 +/- 99 cm(2) for women) compared to all reference populations (P<0.01). 50% of male and 57% of female patients had an increased VAT area. In male patients, VAT was significantly higher despite similar body mass index (BMI). Increased VAT was more common than any of the conventional risk factors. Conclusion Increased VAT was found in over half of our patients with ESUS suggesting it may have a role in the pathogenesis of thromboembolism in this selected group of patients.	[Muuronen, Antti T.; Taina, Mikko; Hedman, Marja; Marttila, Jarkko; Vanninen, Ritva; Sipola, Petri] Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Hedman, Marja] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Kuusisto, Johanna] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Jakala, Pekka] Kuopio Univ Hosp, Neuro Ctr, SF-70210 Kuopio, Finland; [Vanninen, Ritva; Sipola, Petri] Univ Eastern Finland, Inst Clin Med, Radiol Unit, Kuopio, Finland; [Jakala, Pekka] Univ Eastern Finland, Inst Clin Med, Neurol Unit, Kuopio, Finland; [Mustonen, Pirjo] Keski Suomi Cent Hosp, Dept Cardiol, Jyvaskyla, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital	Muuronen, AT (corresponding author), Kuopio Univ Hosp, Diagnost Imaging Ctr, Dept Clin Radiol, SF-70210 Kuopio, Finland.	Antti.Muuronen@kuh.fi			Kuopio University Hospital [5063519]	Kuopio University Hospital	This study was supported by the Kuopio University Hospital (grant number 5063519-URL: http://www.psshp.fi/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860; Arboix A, 2010, CURR CARDIOL REV, V6, P150, DOI 10.2174/157340310791658730; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Berker D, 2010, DIAGN INTERV RADIOL, V16, P99, DOI 10.4261/1305-3825.DIR.2749-09.1; Bodenant M, 2011, STROKE, V42, P2872, DOI 10.1161/STROKEAHA.111.614099; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; CHOWDHURY B, 1994, INT J OBESITY, V18, P219; Cohen J, 1998, STAT POWER ANAL BEHA, P273; Davi G, 2002, JAMA-J AM MED ASSOC, V288, P2008, DOI 10.1001/jama.288.16.2008; DiTomasso D, 2010, ATHEROSCLEROSIS, V208, P531, DOI 10.1016/j.atherosclerosis.2009.08.015; Gautier A, 2013, CLIN ENDOCRINOL, V78, P373, DOI 10.1111/j.1365-2265.2012.04401.x; Guercini F, 2008, J THROMB HAEMOST, V6, P549, DOI 10.1111/j.1538-7836.2008.02903.x; Hanzu FA, 2011, J THROMB HAEMOST, V9, P1236, DOI 10.1111/j.1538-7836.2011.04285.x; Hart RG, 2014, LANCET NEUROL, V13, P429, DOI 10.1016/S1474-4422(13)70310-7; Jensky NE, 2011, OBESITY, V19, P2418, DOI 10.1038/oby.2011.70; Karcher HS, 2013, CEREBROVASC DIS, V35, P341, DOI 10.1159/000348703; Karttunen V, 2002, EUR J NEUROL, V9, P625, DOI 10.1046/j.1468-1331.2002.00464.x; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; KUHNS LR, 1978, AM J ROENTGENOL, V131, P115, DOI 10.2214/ajr.131.1.115; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mazzoccoli G, 2012, ATHEROSCLEROSIS, V223, P378, DOI 10.1016/j.atherosclerosis.2012.05.033; Mertens I, 2001, HORM METAB RES, V33, P602, DOI 10.1055/s-2001-17907; Mosteller RD, 1987, NEW ENGL J MED, V317, P1098; Nicklas BJ, 2003, DIABETES CARE, V26, P1413, DOI 10.2337/diacare.26.5.1413; Nieuwdorp M, 2005, CURR OPIN PHARMACOL, V5, P155, DOI 10.1016/j.coph.2004.10.003; Pepi M, 2010, EUR J ECHOCARDIOGR, V11, P461, DOI 10.1093/ejechocard/jeq045; Quetelet L A, 1994, Obes Res, V2, P72; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; ROSSNER S, 1990, INT J OBESITY, V14, P893; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Salmenniemi U, 2005, INT J OBESITY, V29, P1464, DOI 10.1038/sj.ijo.0803041; Salmenniemi U, 2004, CIRCULATION, V110, P3842, DOI 10.1161/01.CIR.0000150391.38660.9B; Schoen RE, 1998, INT J OBESITY, V22, P338, DOI 10.1038/sj.ijo.0800591; Shen W, 2004, AM J CLIN NUTR, V80, P271, DOI 10.1093/ajcn/80.2.271; Sipola P, 2013, CEREBROVASC DIS, V35, P521, DOI 10.1159/000350734; SJOSTROM L, 1986, AM J PHYSIOL, V250, pE736, DOI 10.1152/ajpendo.1986.250.6.E736; Starr ME, 2013, AGING CELL, V12, P194, DOI 10.1111/acel.12040; Taina M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079519; THAETE FL, 1995, INT J OBESITY, V19, P464; Toss F, 2011, INT J OBESITY, V35, P1427, DOI 10.1038/ijo.2011.9; Uchida Y, 2012, DIABETES, V61, P1552, DOI 10.2337/db11-0828; United Nations Scientific Committee on the Effects of Atomic Radiation, 2010, SOURCES AND EFFECTS, V1; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wiklund P, 2008, J CLIN ENDOCR METAB, V93, P4360, DOI 10.1210/jc.2008-0804; World Health Organization, 2012, WORLD HLTH STAT 2012; Yoshizumi T, 1999, RADIOLOGY, V211, P283; Yudkin JS, 2004, METABOLISM, V53, P852, DOI 10.1016/j.metabol.2004.02.004	55	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120598	10.1371/journal.pone.0120598	http://dx.doi.org/10.1371/journal.pone.0120598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756793	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700069
J	Nielsen, LA; Bojsoe, C; Kloppenborg, JT; Trier, C; Gamborg, M; Holm, JC				Nielsen, Louise A.; Bojsoe, Christine; Kloppenborg, Julie T.; Trier, Caecilie; Gamborg, Michael; Holm, Jens-Christian			The Influence of Familial Predisposition to Cardiovascular Complications upon Childhood Obesity Treatment	PLOS ONE			English	Article							BODY-MASS INDEX; CHRONIC CARE TREATMENT; PARENTAL OBESITY; CHILDREN; OVERWEIGHT; RISK; PROGRAM; HISTORY; DISEASE; WEIGHT	Introduction The aim was to investigate whether a familial predisposition to obesity related cardiovascular complications was associated with the degree of obesity at baseline and/or changes in the degree of obesity during a multidisciplinary childhood obesity treatment program. Methods The study included 1421 obese children (634 boys) with a median age of 11.5 years (range 3.1-17.9 years), enrolled in treatment for 0.04 to 5.90 years (median 1.3 years) at the Children's Obesity Clinic, Denmark. At baseline, weight and height were measured, body mass index (BMI) standard deviation score (SDS) calculated, and self-reported information on familial predisposition to obesity, hypertension, type 2 diabetes mellitus (T2DM), thromboembolic events, and dyslipidaemia were obtained. A familial predisposition included events in biological parents, siblings, grandparents, uncles, and aunts. The treatment outcomes were categorically analysed according to the prevalence of familial predispositions. Results The median BMI SDS at enrolment was 3.2 in boys and 2.8 in girls. One-thousand-and-forty-one children had obesity in their family, 773 had hypertension, 551 had T2DM, 568 had thromboembolic events, and 583 had dyslipidaemia. Altogether, 733 had three or more predispositions. At baseline, familial T2DM was associated with a higher mean BMI SDS (p = 0.03), but no associations were found between the other predispositions and the children's degree of obesity. During treatment, girls with familial obesity lost more weight, compared to girls without familial obesity (p = 0.04). No other familial predispositions were associated with changes in BMI SDS during treatment. Conclusion Obese children with a familial predisposition to T2DM showed a significantly higher degree of obesity at baseline and girls with familial obesity responded better to treatment. Besides these findings, no other associations were found between the occurrence of familial predispositions and the degree of obesity or changes herein during multidisciplinary childhood obesity treatment.	[Nielsen, Louise A.; Bojsoe, Christine; Kloppenborg, Julie T.; Trier, Caecilie; Holm, Jens-Christian] Copenhagen Univ Hosp Holbaek, Dept Paediat, Childrens Obes Clin, DK-4300 Holbaek, Denmark; [Kloppenborg, Julie T.] Copenhagen Univ Hosp Herlev, Dept Paediat, DK-2730 Herlev, Denmark; [Trier, Caecilie] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, DK-2200 Copenhagen, Denmark; [Gamborg, Michael] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Capital Reg, DK-2000 Copenhagen, Denmark; [Holm, Jens-Christian] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Nielsen, LA (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Paediat, Childrens Obes Clin, DK-4300 Holbaek, Denmark.	loani@regionsjaelland.dk	Holm, Louise Aas/GOG-8527-2022; Holm, Jens-Christian/T-4594-2017	Holm, Louise Aas/0000-0002-5439-5429; Holm, Jens-Christian/0000-0003-4653-342X	Region Zealand Health Scientific Research Foundation; Danish Council for Strategic Research [11-115917, 11-116714]	Region Zealand Health Scientific Research Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study is part of research activities in TARGET (The impact of our genomes on individual treatment response in obese children, see www.target.ku.dk) and BIOCHILD (Genetics and systems biology of childhood obesity in India and Denmark, see (www.biochild.ku.dk)) consortia supported by the Region Zealand Health Scientific Research Foundation (see, http://www.regionsjaelland.dk/Sundhed/forskning/forskningsfinansiering/Sider/oekonomi.aspx) and the Danish Council for Strategic Research (grant 11-115917 and 11-116714) (see, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-strategic-research). Funding was received by J-CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altinli S, 2011, J PEDIAT ENDOCRINOL, V20, P431, DOI [10.1515/JPEM.2007.20.3.431, DOI 10.1515/JPEM.2007.20.3.431]; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; BLONDE CV, 1981, PREV MED, V10, P25, DOI 10.1016/0091-7435(81)90003-7; Cook S, 2011, PEDIATR CLIN N AM, V58, P1363, DOI 10.1016/j.pcl.2011.09.003; Danielsson P, 2012, ARCH PEDIAT ADOL MED, V166, P1103, DOI 10.1001/2013.jamapediatrics.319; Danielzik S, 2004, INT J OBESITY, V28, P1494, DOI 10.1038/sj.ijo.0802756; Davis MM, 2008, J AM BOARD FAM MED, V21, P549, DOI 10.3122/jabfm.2008.06.070140; Davison KK, 2001, INT J OBESITY, V25, P1834, DOI 10.1038/sj.ijo.0801835; Eliakim A, 2004, J PEDIATR ENDOCR MET, V17, P1055; Glowinska B, 2002, EUR J PEDIATR, V161, P511, DOI 10.1007/s00431-002-1040-7; Holm JC, 2011, INT J PEDIATR OBES, V6, P188, DOI 10.3109/17477166.2011.575157; Morgen CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069860; Neef M, 2013, BEST PRACT RES CL EN, V27, P229, DOI 10.1016/j.beem.2013.02.007; Nielsen TRH, 2012, CHILD OBES, V8, P533, DOI 10.1089/chi.2011.0098; Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Polley DC, 2005, J AM DIET ASSOC, V105, P262, DOI 10.1016/j.jada.2004.11.004; Pott W, 2009, INT J EAT DISORDER, V42, P284, DOI 10.1002/eat.20655; Pulgaron ER, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0508-y; Reinehr T, 2009, INT J OBESITY, V33, P418, DOI 10.1038/ijo.2009.50; Reinehr T, 2013, NAT REV ENDOCRINOL, V9, P607, DOI 10.1038/nrendo.2013.149; Sabin MA, 2007, J EVAL CLIN PRACT, V13, P364, DOI 10.1111/j.1365-2753.2006.00706.x; Weiss R, 2003, LANCET, V362, P951, DOI 10.1016/S0140-6736(03)14364-4	23	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120177	10.1371/journal.pone.0120177	http://dx.doi.org/10.1371/journal.pone.0120177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756875	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700060
J	Boyle, ST; Ingman, WV; Poltavets, V; Faulkner, JW; Whitfield, RJ; McColl, SR; Kochetkova, M				Boyle, S. T.; Ingman, W. V.; Poltavets, V.; Faulkner, J. W.; Whitfield, R. J.; McColl, S. R.; Kochetkova, M.			The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells	ONCOGENE			English	Article							LYMPH-NODE METASTASIS; BREAST-CANCER CELLS; TUMOR-GROWTH; EXPRESSION; CXCR4; MODEL; DISEASE; ACTIVATION; INCREASES; PREDICTS	The chemokine receptor CCR7 is widely implicated in breast cancer pathobiology. Although recent reports correlated high CCR7 levels with more advanced tumor grade and poor prognosis, limited in vivo data are available regarding its specific function in mammary gland neoplasia and the underlying mechanisms involved. To address these questions we generated a bigenic mouse model of breast cancer combined with CCR7 deletion, which revealed that CCR7 ablation results in a considerable delay in tumor onset as well as significantly reduced tumor burden. Importantly, CCR7 was found to exert its function by regulating mammary cancer stem-like cells in both murine and human tumors. In vivo experiments showed that loss of CCR7 activity either through deletion or pharmacological antagonism significantly decreased functional pools of stem-like cells in mouse primary mammary tumors, providing a mechanistic explanation for the tumor-promoting role of this chemokine receptor. These data characterize the oncogenic properties of CCR7 in mammary epithelial neoplasia and point to a new route for therapeutic intervention to target evasive cancer stem cells.	[Boyle, S. T.; Poltavets, V.; Faulkner, J. W.; McColl, S. R.; Kochetkova, M.] Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia; [Ingman, W. V.] Univ Adelaide, Robinson Inst, Adelaide, SA 5005, Australia; [Ingman, W. V.] Univ Adelaide, Queen Elizabeth Hosp, Sch Med, Discipline Surg, Adelaide, SA 5005, Australia; [Whitfield, R. J.] Royal Adelaide Hosp, Breast Endocrine & Surg Oncol Unit, Adelaide, SA 5000, Australia; [Whitfield, R. J.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia; [McColl, S. R.] Univ Adelaide, Ctr Mol Pathol, Adelaide, SA 5005, Australia	University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide; Royal Adelaide Hospital; University of Adelaide; University of Adelaide	Kochetkova, M (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	marina.kochetkova@adelaide.edu.au	Kochetkova, Marina/ABE-9538-2021; Boyle, Sarah/B-3048-2019	Kochetkova, Marina/0000-0002-0599-7378; Ingman, Wendy/0000-0003-3116-2902; Poltavets, Valentina/0000-0003-1976-7765; Boyle, Sarah/0000-0001-6143-9285	NHMRC; The Hospital Research Foundation [RF2011/2] Funding Source: researchfish; National Breast Cancer Foundation [ECF-11-06] Funding Source: researchfish	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); The Hospital Research Foundation; National Breast Cancer Foundation	We are grateful to Dr Timothy Proudman and Dr Pallave Dasari from the Queen Elizabeth Hospital for supply of normal human breast tissue and Dr Deepak Dhatrak of the Department of Anatomical Pathology at SA Pathology for procurement of human breast cancer samples. We would also like to sincerely thank Professor Angel Lopez for critical reading of the manuscript, and Dr Michael Samuel and Ms Natasha Pyne for assistance with immunohistochemistry. This work was supported by an NHMRC project grant. WVI is a National Breast Cancer Foundation/The QEH Research Foundation Fellow.	Ablett MP, 2014, ONCOTARGET, V5, P599, DOI 10.18632/oncotarget.1169; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Biswas S, 2014, BREAST CANCER RES TR, V143, P265, DOI 10.1007/s10549-013-2811-8; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Cassier PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-213; Chin AR, 2014, MOL CELL ENDOCRINOL, V382, P598, DOI 10.1016/j.mce.2013.03.024; Cunningham HD, 2010, TRANSL ONCOL, V3, P354, DOI 10.1593/tlo.10178; Desgrosellier JS, 2014, DEV CELL, V30, P295, DOI 10.1016/j.devcel.2014.06.005; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Giordano A, 2013, ANN ONCOL, V24, P2515, DOI 10.1093/annonc/mdt223; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Iwanaga R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3219; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lavergne E, 2004, J IMMUNOL, V173, P3755, DOI 10.4049/jimmunol.173.6.3755; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Ma J, 2012, TUMOR BIOL, V33, P1983, DOI 10.1007/s13277-012-0458-4; Ma XR, 2009, MOL CANCER THER, V8, P490, DOI 10.1158/1535-7163.MCT-08-0485; Maglione JE, 2001, CANCER RES, V61, P8298; Maxmen A, 2012, NATURE, V485, pS50, DOI 10.1038/485S50a; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pilkington KR, 2004, J BIOL CHEM, V279, P40276, DOI 10.1074/jbc.M405808200; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Sharma S, 2000, J IMMUNOL, V164, P4558, DOI 10.4049/jimmunol.164.9.4558; Smalley MJ, 2012, J MAMMARY GLAND BIOL, V17, P91, DOI 10.1007/s10911-012-9257-1; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Weninger W, 2003, J IMMUNOL, V170, P4638, DOI 10.4049/jimmunol.170.9.4638; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	39	29	30	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					105	115		10.1038/onc.2015.66	http://dx.doi.org/10.1038/onc.2015.66			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25772241	Green Published			2022-12-26	WOS:000367812400010
J	Chen, L; Xu, S; Xu, Y; Lu, W; Liu, L; Yue, D; Teng, J; Chen, J				Chen, L.; Xu, S.; Xu, Y.; Lu, W.; Liu, L.; Yue, D.; Teng, J.; Chen, J.			Cab45S promotes cell proliferation through SERCA2b inhibition and Ca2+ signaling	ONCOGENE			English	Article							INTESTINAL EPITHELIAL-CELLS; THERAPEUTIC TARGET; ER STRESS; STORE; STIM1; CANCER; CALCINEURIN; APOPTOSIS; FAMILY; TRPC1	Cytosolic Ca2+, closely related to endoplasmic reticulum (ER) Ca2+, plays a critical role in regulating cell proliferation and tumorigenesis. However, the role of ER lumen proteins in regulating cytosolic Ca2+ level remains poorly understood. Here, we find that the Cab45S, localizes in the ER lumen, inhibits sarco/ER Ca2+-ATPase 2b (SERCA2b) activity through its first EF-hand domain directly binding to the intra-lumenal loop 4 of SERCA2b, and reduces ER Ca2+. STIM1 activation, induced by the Cab45S-dependent drop in ER Ca2+, together with the upregulation of the plasma membrane Ca2+ channel TRPC1 ultimately increases extracellular Ca2+ influx. Furthermore, increased cytosolic Ca2+ level elicits Ca2+-NFAT signaling and promotes cell proliferation. Consistently, in cervical carcinoma patients, Cab45S is upregulated. Thus, our data reveal that the ability of Cab45S to inhibit SERCA2b activity is crucial for its role as a modulator of cell proliferation and tumor growth.	[Chen, L.; Xu, S.; Xu, Y.; Lu, W.; Liu, L.; Yue, D.; Teng, J.; Chen, J.] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Chen, J.] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China	Peking University; Peking University	Teng, J (corresponding author), Peking Univ, Coll Life Sci, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	junlinteng@pku.edu.cn; chenjg@pku.edu.cn		Chen, Liang/0000-0002-4875-5811	National Natural Science Foundation of China [31471280, 31271424]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Weizhong Zhu (Nantong University) for providing with the Adenovirus containing GFP-tagged NFATc3; Zhili Li (Peking University Medical College), Xiaogai Yang (Peking University Medical College) and Weiguo Zhu (Peking University Medical College) for providing us with Panc1, SW1990, PC3 and SW480 cell lines, respectively. We also extend our thanks to Zhen Cai and Chuanmao Zhang (Peking University) for assistance with instruments and antibodies. This work was supported by the National Natural Science Foundation of China (31471280, 31271424).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Baggott RR, 2012, CARCINOGENESIS, V33, P2362, DOI 10.1093/carcin/bgs282; BEELER TJ, 1979, J BIOL CHEM, V254, P6229; Bergner A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-25; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Brochet DXP, 2005, P NATL ACAD SCI USA, V102, P3099, DOI 10.1073/pnas.0500059102; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.193; Chen QQ, 2012, CAN J PHYSIOL PHARM, V90, P1611, DOI 10.1139/y2012-133; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Dhitavat J, 2003, J INVEST DERMATOL, V121, P486, DOI 10.1046/j.1523-1747.2003.12410.x; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hovnanian A., 2007, V45, P337; John LM, 1998, J CELL BIOL, V142, P963, DOI 10.1083/jcb.142.4.963; Kang YK, 2005, MOL CELLS, V19, P268; Kurosaki T, 2010, PROG BIOPHYS MOL BIO, V103, P51, DOI 10.1016/j.pbiomolbio.2010.02.004; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Lechleiter JD, 1998, BIOPHYS CHEM, V72, P123, DOI 10.1016/S0301-4622(98)00128-8; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Li GL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-20; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; LYTTON J, 1992, J BIOL CHEM, V267, P14483; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Malli R, 2008, J CELL SCI, V121, P3133, DOI 10.1242/jcs.034496; Marasa BS, 2008, AM J PHYSIOL-CELL PH, V294, pC1277, DOI 10.1152/ajpcell.90635.2007; Marasa BS, 2006, BIOCHEM J, V397, P77, DOI 10.1042/BJ20060124; Mikoshiba K, 2007, BIOCHEM SOC SYMP, V74, P9, DOI 10.1042/BSS2007c02; Pacifico F, 2003, J MOL ENDOCRINOL, V30, P399, DOI 10.1677/jme.0.0300399; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Stokke MK, 2010, CARDIOVASC RES, V86, P63, DOI 10.1093/cvr/cvp401; Tsuji A, 2006, BIOCHEM J, V396, P51, DOI 10.1042/BJ20051524; Tsukamoto T, 2001, PSYCHOPHARMACOLOGY, V158, P107, DOI 10.1007/s002130100870; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; von Blume J, 2012, J CELL BIOL, V199, P1057, DOI 10.1083/jcb.201207180; Wang Qiao, 2012, Front Biosci (Elite Ed), V4, P998, DOI 10.2741/E435; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu YF, 2008, J GENET GENOMICS, V35, P153, DOI 10.1016/S1673-8527(08)60021-1	59	19	19	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					35	46		10.1038/onc.2015.56	http://dx.doi.org/10.1038/onc.2015.56			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25772237				2022-12-26	WOS:000367812400004
J	Morante, K; Caaveiro, JMM; Tanaka, K; Gonzalez-Manas, JM; Tsumoto, K				Morante, Koldo; Caaveiro, Jose M. M.; Tanaka, Koji; Manuel Gonzalez-Manas, Juan; Tsumoto, Kouhei			A Pore-Forming Toxin Requires a Specific Residue for Its Activity in Membranes with Particular Physicochemical Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANEMONE ACTINIA-EQUINA; DETERGENT-RESISTANT MEMBRANES; LIPID PHASE COEXISTENCE; AMINO-ACID-SEQUENCE; SEA-ANEMONE; STICHOLYSIN-II; STICHODACTYLA-HELIANTHUS; PERFRINGOLYSIN-O; MODEL MEMBRANES; FUNCTIONAL EXPRESSION	The physicochemical landscape of the bilayer modulates membrane protein function. Actinoporins are a family of potent hemolytic proteins from sea anemones acting at the membrane level. This family of cytolysins preferentially binds to target membranes containing sphingomyelin, where they form lytic pores giving rise to cell death. Although the cytolytic activity of the actinoporin fragaceatoxin C (FraC) is sensitive to vesicles made of various lipid compositions, it is far from clear how this toxin adjusts its mechanism of action to a broad range of physiochemical landscapes. Herein, we show that the conserved residue Phe-16 of FraC is critical for pore formation in cholesterol-rich membranes such as those of red blood cells. The interaction of a panel of muteins of Phe-16 with model membranes composed of raft-like lipid domains is inactivated in cholesterol-rich membranes but not in cholesterol-depleted membranes. These results indicate that actinoporins recognize different membrane environments, resulting in a wider repertoire of susceptible target membranes (and preys) for sea anemones. In addition, this study has unveiled promising candidates for the development of protein-based biosensors highly sensitive to the concentration of cholesterol within the membrane.	[Morante, Koldo; Caaveiro, Jose M. M.; Tsumoto, Kouhei] Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Tanaka, Koji; Tsumoto, Kouhei] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Morante, Koldo; Manuel Gonzalez-Manas, Juan] Univ Basque Country, Dept Biochem & Mol Biol, Leioa 48940, Spain; [Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo; University of Tokyo; University of Basque Country; University of Tokyo	Caaveiro, JMM (corresponding author), Univ Tokyo, Dept Bioengn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan.	jose@bioeng.t.u-tokyo.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp	Caaveiro, Jose/J-2790-2013	Caaveiro, Jose/0000-0001-5568-2369; GONZALEZ MANAS, JUAN MANUEL/0000-0002-1833-6982; Morante, Koldo/0000-0002-9877-9168	Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Spanish Ministerio de Ciencia e Innovacion; Grants-in-Aid for Scientific Research [14J07513] Funding Source: KAKEN	Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science; Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology of the Japan Society for the Promotion of Science and by the Platform for Drug Discovery, Informatics, and Structural Life Science of the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Recipient of a fellowship from the Spanish Ministerio de Ciencia e Innovacion.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Alegre-Cebollada J, 2008, J MOL BIOL, V382, P920, DOI 10.1016/j.jmb.2008.07.053; Alm I, 2015, BBA-BIOMEMBRANES, V1848, P925, DOI 10.1016/j.bbamem.2014.12.017; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; Anderluh G, 1999, TOXICON, V37, P1391, DOI 10.1016/S0041-0101(99)00082-3; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bellomio A, 2009, TOXICON, V54, P869, DOI 10.1016/j.toxicon.2009.06.022; BELMONTE G, 1994, BBA-BIOMEMBRANES, V1192, P197, DOI 10.1016/0005-2736(94)90119-8; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caaveiro JMM, 2001, BIOPHYS J, V80, P1343, DOI 10.1016/S0006-3495(01)76107-3; de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5; De los Rios V, 1998, EUR J BIOCHEM, V252, P284, DOI 10.1046/j.1432-1327.1998.2520284.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FORTI S, 1989, EUR J BIOCHEM, V181, P767, DOI 10.1111/j.1432-1033.1989.tb14790.x; Garcia-Ortega L, 2011, BBA-BIOMEMBRANES, V1808, P2275, DOI 10.1016/j.bbamem.2011.05.012; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Goni FM, 2014, BBA-BIOMEMBRANES, V1838, P1467, DOI 10.1016/j.bbamem.2014.01.006; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Il'ina A, 2006, TOXICON, V47, P517, DOI 10.1016/j.toxicon.2005.12.014; Jiang XY, 2003, BIOCHEM BIOPH RES CO, V312, P562, DOI 10.1016/j.bbrc.2003.10.159; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Lin QQ, 2014, J BIOL CHEM, V289, P5467, DOI 10.1074/jbc.M113.533943; Litman BJ, 1996, LIPIDS, V31, pS193, DOI 10.1007/BF02637075; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Maula T, 2013, BBA-BIOMEMBRANES, V1828, P1390, DOI 10.1016/j.bbamem.2013.01.018; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechaly AE, 2012, J STRUCT BIOL, V180, P312, DOI 10.1016/j.jsb.2012.06.003; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; MICHAEL SF, 1994, BIOTECHNIQUES, V16, P410; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P2621, DOI 10.1271/bbb.66.2621; Nelson LD, 2010, BIOPHYS J, V99, P3255, DOI 10.1016/j.bpj.2010.09.028; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; Oscarsson J, 1999, MOL MICROBIOL, V32, P1226, DOI 10.1046/j.1365-2958.1999.01435.x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Pedrera L, 2014, BBA-BIOMEMBRANES, V1838, P1752, DOI 10.1016/j.bbamem.2014.03.011; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Pungercar J, 1997, BBA-PROTEIN STRUCT M, V1341, P105, DOI 10.1016/S0167-4838(97)00083-6; Ray S, 2012, J BIOL CHEM, V287, P30395, DOI 10.1074/jbc.M112.385575; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; SCHWARZ G, 1992, BIOCHIM BIOPHYS ACTA, V1110, P97, DOI 10.1016/0005-2736(92)90299-2; Shogomori H, 2005, J BIOL CHEM, V280, P18931, DOI 10.1074/jbc.M500247200; SIMPSON RJ, 1990, EUR J BIOCHEM, V190, P319, DOI 10.1111/j.1432-1033.1990.tb15579.x; Skocaj M, 2013, CURR MED CHEM, V20, P491; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Tejuca M, 2004, INT IMMUNOPHARMACOL, V4, P731, DOI 10.1016/j.intimp.2004.02.010; Tejuca M, 1996, BIOCHEMISTRY-US, V35, P14947, DOI 10.1021/bi960787z; Tziakas DN, 2011, INT J CARDIOL, V150, P22, DOI 10.1016/j.ijcard.2010.02.022; Uechi GI, 2005, TOXICON, V45, P761, DOI 10.1016/j.toxicon.2005.01.015; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Uitert I, 2010, SOFT MATTER, V6, P4420, DOI 10.1039/c0sm00181c; Wang YW, 2000, BBA-PROTEIN STRUCT M, V1478, P9, DOI 10.1016/S0167-4838(99)00289-7; Wong E. V., 2009, CELLS MOL MECH; Yasuda T, 2014, BIOPHYS J, V106, P631, DOI 10.1016/j.bpj.2013.12.034; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375	74	28	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10850	10861		10.1074/jbc.M114.615211	http://dx.doi.org/10.1074/jbc.M114.615211			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759390	hybrid, Green Published			2022-12-26	WOS:000353404500025
J	Halpern, BS; Longo, C; Lowndes, JSS; Best, BD; Frazier, M; Katona, SK; Kleisner, KM; Rosenberg, AA; Scarborough, C; Selig, ER				Halpern, Benjamin S.; Longo, Catherine; Lowndes, Julia S. Stewart; Best, Benjamin D.; Frazier, Melanie; Katona, Steven K.; Kleisner, Kristin M.; Rosenberg, Andrew A.; Scarborough, Courtney; Selig, Elizabeth R.			Patterns and Emerging Trends in Global Ocean Health	PLOS ONE			English	Article							INDEX; FISHERIES	International and regional policies aimed at managing ocean ecosystem health need quantitative and comprehensive indices to synthesize information from a variety of sources, consistently measure progress, and communicate with key constituencies and the public. Here we present the second annual global assessment of the Ocean Health Index, reporting current scores and annual changes since 2012, recalculated using updated methods and data based on the best available science, for 221 coastal countries and territories. The Index measures performance of ten societal goals for healthy oceans on a quantitative scale of increasing health from 0 to 100, and combines these scores into a single Index score, for each country and globally. The global Index score improved one point (from 67 to 68), while many country-level Index and goal scores had larger changes. Per-country Index scores ranged from 41-95 and, on average, improved by 0.06 points (range -8 to +12). Globally, average scores increased for individual goals by as much as 6.5 points (coastal economies) and decreased by as much as 1.2 points (natural products). Annual updates of the Index, even when not all input data have been updated, provide valuable information to scientists, policy makers, and resource managers because patterns and trends can emerge from the data that have been updated. Changes of even a few points indicate potential successes (when scores increase) that merit recognition, or concerns (when scores decrease) that may require mitigative action, with changes of more than 10-20 points representing large shifts that deserve greater attention. Goal scores showed remarkably little covariance across regions, indicating low redundancy in the Index, such that each goal delivers information about a different facet of ocean health. Together these scores provide a snapshot of global ocean health and suggest where countries have made progress and where a need for further improvement exists.	[Halpern, Benjamin S.; Longo, Catherine; Lowndes, Julia S. Stewart; Best, Benjamin D.; Frazier, Melanie; Scarborough, Courtney] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Imperial Coll London, Ascot, Berks, England; [Best, Benjamin D.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Katona, Steven K.; Selig, Elizabeth R.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Kleisner, Kristin M.] Univ British Columbia, Sea Us Project, Vancouver, BC V5Z 1M9, Canada; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; Duke University; Conservation International; University of British Columbia	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	halpern@bren.ucsb.edu	Frazier, Melanie R/A-2367-2012	Scarborough, Courtney/0000-0001-7270-9228; Lowndes, Julia/0000-0003-1682-3872	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; University of California Santa Barbara's National Center for Ecological Analysis and Synthesis - David and Lucile Packard Foundation; New England Aquarium; National Geographic	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; University of California Santa Barbara's National Center for Ecological Analysis and Synthesis - David and Lucile Packard Foundation; New England Aquarium; National Geographic(National Geographic Society)	Beau and Heather Wrigley generously provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the University of California Santa Barbara's National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AGR OC HLTH ACT PLAN; Branch TA, 2013, NATURE, V495, pE5, DOI 10.1038/nature11974; *COMM AUSTR, 1998, AUSTR OC POL; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Elfes CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092589; Halpern BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098995; Halpern BS, 2013, NATURE, V495, pE7, DOI 10.1038/nature11975; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; KIMURA DK, 1982, CAN J FISH AQUAT SCI, V39, P1467, DOI 10.1139/f82-198; Kleisner KM, 2013, AMBIO, V42, P910, DOI 10.1007/s13280-013-0447-x; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; *PEW OC COMM, 2003, AM LIV OC CHART COUR; Puget Sound Partnership, 2008, PUG SOUND ACT AG PRO; Rosenberg A.A., 2014, FAO FISHERIES AQUACU, P175; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Selig ER, 2015, ECOSYSTEM S IN PRESS; Srinivasan U. Thara, 2010, Journal of Bioeconomics, V12, P183, DOI 10.1007/s10818-010-9090-9; Thorson JT, 2013, CAN J FISH AQUAT SCI, V70, P1829, DOI 10.1139/cjfas-2013-0280; Thorson JT, 2012, CAN J FISH AQUAT SCI, V69, P645, DOI 10.1139/F2012-016; United Nations Development Programme, 2012, RIS S HUM PROGR DIV; United States National Ocean Council, 2013, NAT OC POL IMPL PLAN; World Bank, 2013, WORLD DEV IND 2013, DOI [10.1596/978-0-8213-9824-1, DOI 10.1596/978-0-8213-9824-1]; Worldwide Governance Indicators, 2013, WORLDWIDE GOVERNANCE	25	65	66	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117863	10.1371/journal.pone.0117863	http://dx.doi.org/10.1371/journal.pone.0117863			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774678	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500022
J	Mamiya, H; Jeyadevan, B				Mamiya, Hiroaki; Jeyadevan, Balachandran			Nonequilibrium Magnetic Response of Anisotropic Superparamagnetic Nanoparticles and Possible Artifacts in Magnetic Particle Imaging	PLOS ONE			English	Article							SYSTEM; PHASE; SPIN; MPI	Magnetic responses of superparamagnetic nanoparticles to high-frequency AC magnetic fields with sufficiently large amplitudes are numerically simulated to exactly clarify the phenomena occurring in magnetic particle imaging. When the magnetic anisotropy energy inevitable in actual nanoparticles is taken into account in considering the magnetic potential, larger nanoparticles exhibit a delayed response to alternations of the magnetic fields. This kind of delay is rather remarkable in the lower-amplitude range of the field, where the assistance by the Zeeman energy to thermally activated magnetization reversal is insufficient. In some cases, a sign inversion of the third-order harmonic response was found to occur at some specific amplitude, despite the lack in DC bias magnetic field strength. Considering the attenuation of the AC magnetic field generated in the human body, it is possible that the phases of the signals from nanoparticles deep inside the body and those near the body surface are completely different. This may lead to artifacts in the reconstructed image. Furthermore, when the magnetic/thermal torque-driven rotation of the anisotropic nanoparticles as well as the magnetic anisotropy energy are taken into account, the simulated results show that, once the easy axes are aligned toward the direction of the DC bias magnetic field, it takes time to randomize them at the field-free point. During this relaxation, the third-order harmonic response depends highly upon the history of the magnetic field. This is because non-linearity of the anhysteretic magnetization curve for the superparamagnetic nanoparticles varies with the orientations of the easy axes. This history dependence may also lead to another artifact in magnetic particle imaging, when the scanning of the field-free point is faster than the Brownian relaxations.	[Mamiya, Hiroaki] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan; [Jeyadevan, Balachandran] Univ Shiga Prefecture, Hikone 5228533, Japan	National Institute for Materials Science; University Shiga Prefecture	Mamiya, H (corresponding author), Natl Inst Mat Sci, Tsukuba, Ibaraki 3050047, Japan.	MAMIYA.Hiroaki@nims.go.jp	MAMIYA, Hiroaki/H-2520-2011	MAMIYA, Hiroaki/0000-0002-7840-3008	Japan Society for the Promotion of Science (JSPS) KAKENHI (B) [24310071]	Japan Society for the Promotion of Science (JSPS) KAKENHI (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (B) Grant Number 24310071 (H. M. and B. J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arelaro AD, 2005, J APPL PHYS, V97, DOI 10.1063/1.1853931; Carrey J, 2011, J APPL PHYS, V109, DOI 10.1063/1.3551582; Chevry L, 2013, BIOMATERIALS, V34, P6299, DOI 10.1016/j.biomaterials.2013.05.002; Cimurs J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062315; Du YM, 2013, INT J MOL SCI, V14, P18682, DOI 10.3390/ijms140918682; Ferguson RM, 2011, MED PHYS, V38, P1619, DOI 10.1118/1.3554646; Franke J, 2013, INT WORKSH MAGN PART, P98041; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Ichiyanagi K, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4819305; Knopp T, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/1/012002; Konkle JJ, 2013, BIOMED ENG-BIOMED TE, V58, P565, DOI 10.1515/bmt-2012-0062; Krishnan KM, 2010, IEEE T MAGN, V46, P2523, DOI 10.1109/TMAG.2010.2046907; Kuimova MK, 2012, PHYS CHEM CHEM PHYS, V14, P12671, DOI 10.1039/c2cp41674c; Ludwig F, 2013, BIOMED ENG-BIOMED TE, V58, P535, DOI 10.1515/bmt-2013-0013; Mamiya H, 1998, IEEE T MAGN, V34, P1126, DOI 10.1109/20.706406; Mamiya H, 2000, PHYS REV LETT, V84, P6106, DOI 10.1103/PhysRevLett.84.6106; Mamiya H, 1999, PHYS REV LETT, V82, P4332, DOI 10.1103/PhysRevLett.82.4332; Mamiya H, 2013, J NANOMATER, V2013, DOI 10.1155/2013/752973; Mamiya H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00157; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0; Ruckert MA, 2013, BIOMED ENG-BIOMED TE, V58, P593, DOI 10.1515/bmt-2013-0015; Sagawa T, 2007, BIOCHEM BIOPH RES CO, V355, P770, DOI 10.1016/j.bbrc.2007.02.031; Yoshida T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.127002	24	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118156	10.1371/journal.pone.0118156	http://dx.doi.org/10.1371/journal.pone.0118156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775017	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500025
J	O'Donnell, KM; Thompson, FR; Semlitsch, RD				O'Donnell, Katherine M.; Thompson, Frank R., III; Semlitsch, Raymond D.			Partitioning Detectability Components in Populations Subject to Within-Season Temporary Emigration Using Binomial Mixture Models	PLOS ONE			English	Article							RED-BACKED SALAMANDER; DETECTION PROBABILITIES; ESTIMATING ABUNDANCE; TERRESTRIAL SALAMANDERS; PLETHODON-CINEREUS; ECOLOGY; COUNTS; COVER	Detectability of individual animals is highly variable and nearly always < 1; imperfect detection must be accounted for to reliably estimate population sizes and trends. Hierarchical models can simultaneously estimate abundance and effective detection probability, but there are several different mechanisms that cause variation in detectability. Neglecting temporary emigration can lead to biased population estimates because availability and conditional detection probability are confounded. In this study, we extend previous hierarchical binomial mixture models to account for multiple sources of variation in detectability. The state process of the hierarchical model describes ecological mechanisms that generate spatial and temporal patterns in abundance, while the observation model accounts for the imperfect nature of counting individuals due to temporary emigration and false absences. We illustrate our model's potential advantages, including the allowance of temporary emigration between sampling periods, with a case study of southern red-backed salamanders Plethodon serratus. We fit our model and a standard binomial mixture model to counts of terrestrial salamanders surveyed at 40 sites during 3-5 surveys each spring and fall 2010-2012. Our models generated similar parameter estimates to standard binomial mixture models. Aspect was the best predictor of salamander abundance in our case study; abundance increased as aspect became more northeasterly. Increased time-since-rainfall strongly decreased salamander surface activity (i.e. availability for sampling), while higher amounts of woody cover objects and rocks increased conditional detection probability (i.e. probability of capture, given an animal is exposed to sampling). By explicitly accounting for both components of detectability, we increased congruence between our statistical modeling and our ecological understanding of the system. We stress the importance of choosing survey locations and protocols that maximize species availability and conditional detection probability to increase population parameter estimate reliability.	[O'Donnell, Katherine M.; Semlitsch, Raymond D.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Thompson, Frank R., III] US Forest Serv, USDA, No Res Stn, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service; University of Missouri System; University of Missouri Columbia	O'Donnell, KM (corresponding author), Univ Missouri, Div Biol Sci, 105 Tucker Hall, Columbia, MO 65211 USA.	odonnell.katie.m@gmail.com	O'Donnell, Katherine/AAG-1106-2020	O'Donnell, Katherine/0000-0001-9023-174X	GAANN Fellowship; U.S. Forest Service [09-JV-11242311-064]	GAANN Fellowship(US Department of Education); U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This project was funded by GAANN Fellowship (KMO) and U.S. Forest Service, Joint Venture Agreement 09-JV-11242311-064. U.S. Forest Service was responsible for overall study design, but was not involved in data collection or analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2010, SALAMANDERS US CANAD; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P14, DOI 10.2193/0022-541X(2004)068[0014:SATVID]2.0.CO;2; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Bolker BM, 2013, METHODS ECOL EVOL, V4, P501, DOI 10.1111/2041-210X.12044; Buderman FE, 2012, POPUL ECOL, V54, P157, DOI 10.1007/s10144-011-0294-1; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Dodd CK, 2004, HERPETOLOGICA, V60, P468, DOI 10.1655/03-60; Dodd Jr CK, 2003, MONITORING AMPHIBIAN; Donnelly M. A., 1994, MEASURING MONITORING, P183; FEDER ME, 1983, HERPETOLOGICA, V39, P291; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Grover MC, 1998, J HERPETOL, V32, P489, DOI 10.2307/1565202; Halstead BJ, 2012, ANIM CONSERV, V15, P133, DOI 10.1111/j.1469-1795.2012.00540.x; Herbeck LA, 2000, J HERPETOL, V34, P341, DOI 10.2307/1565354; Jaeger R.G., 1994, MEASURING MONITORING, P97; JAEGER RG, 1980, COPEIA, P265, DOI 10.2307/1444003; Jung RE, 2000, ENVIRON MONIT ASSESS, V63, P65, DOI 10.1023/A:1006413603057; Kabrick JM, 2014, FOR SCI, V60; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; MacKenzie DI, 2002, ECOLOGY, V83, P2387, DOI 10.2307/3071800; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; O'Donnell KM, 2014, HERPETOLOGICA, V70, P259, DOI 10.1655/HERPETOLOGICA-D-13-00036; Peterman WE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062184; Plummer M., 2003, P 3 INT WORKSH DISTR; Pollock Kenneth H., 2004, P43; POLLOCK KH, 1990, WILDLIFE MONOGR, P1; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; Price SJ, 2012, HYDROBIOLOGIA, V679, P205, DOI 10.1007/s10750-011-0882-2; R Core Team, 2021, R LANGUAGE ENV STAT; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Semlitsch RD, 2014, CAN J ZOOL; Slobodkin L. B., 1980, GROWTH REGULATION AN; Smith CK, 2000, J HERPETOL, V34, P547, DOI 10.2307/1565270; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; Su Y.-S., 2013, R2JAGS PACKAGE RUNNI; TAUB FB, 1961, ECOLOGY, V42, P681, DOI 10.2307/1933498; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Williams AK, 2004, J WILDLIFE MANAGE, V68, P418, DOI 10.2193/0022-541X(2004)068[0418:RFAISD]2.0.CO;2; Williams B. K., 2002, ANAL MANAGEMENT ANIM	56	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117216	10.1371/journal.pone.0117216	http://dx.doi.org/10.1371/journal.pone.0117216			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775182	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500017
J	Zhao, QP; Xiong, T; Xu, XJ; Jiang, MS; Dong, HF				Zhao, Qin Ping; Xiong, Tao; Xu, Xing Jian; Jiang, Ming Sen; Dong, Hui Fen			De Novo Transcriptome Analysis of Oncomelania hupensis after Molluscicide Treatment by Next-Generation Sequencing: Implications for Biology and Future Snail Interventions	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; SCHISTOSOMA-JAPONICUM; INTERMEDIATE HOST; NICLOSAMIDE; IDENTIFICATION; INFECTION	The freshwater snail Oncomelania hupensis is the only intermediate host of Schistosoma japonicum, which causes schistosomiasis. This disease is endemic in the Far East, especially in mainland China. Because niclosamide is the only molluscicide recommended by the World Health Organization, 50% wettable powder of niclosamide ethanolamine salt (WPN), the only chemical molluscicide available in China, has been widely used as the main snail control method for over two decades. Recently, a novel molluscicide derived from niclosamide, the salt of quinoid-2',5-dichloro-4'-nitro-salicylanilide (Liu Dai Shui Yang An, LDS), has been developed and proven to have the same molluscicidal effect as WPN, with lower cost and significantly lower toxicity to fish than WPN. The mechanism by which these molluscicides cause snail death is not known. Here, we report the next-generation transcriptome sequencing of O. hupensis; 145,008,667 clean reads were generated and assembled into 254,286 unigenes. Using GO and KEGG databases, 14,860 unigenes were assigned GO annotations and 4,686 unigenes were mapped to 250 KEGG pathways. Many sequences involved in key processes associated with biological regulation and innate immunity have been identified. After the snails were exposed to LDS and WPN, 254 unigenes showed significant differential expression. These genes were shown to be involved in cell structure defects and the inhibition of neurohumoral transmission and energy metabolism, which may cause snail death. Gene expression patterns differed after exposure to LDS and WPN, and these differences must be elucidated by the identification and annotation of these unknown unigenes. We believe that this first large-scale transcriptome dataset for O. hupensis will provide an opportunity for the in-depth analysis of this biomedically important freshwater snail at the molecular level and accelerate studies of the O. hupensis genome. The data elucidating the molluscicidal mechanism will be of great benefit in future snail control efforts.	[Zhao, Qin Ping; Xiong, Tao; Jiang, Ming Sen; Dong, Hui Fen] Wuhan Univ, Sch Basic Med Sci, Dept Parasitol, Wuhan 430072, Hubei Province, Peoples R China; [Xu, Xing Jian] Hubei Prov Ctr Dis Control & Prevent, Inst Schistosomiasis Control, Wuhan, Hubei Province, Peoples R China	Wuhan University	Dong, HF (corresponding author), Wuhan Univ, Sch Basic Med Sci, Dept Parasitol, Wuhan 430072, Hubei Province, Peoples R China.	hfdong@whu.edu.cn			National Science and Technology Major Project [2012ZX10004909]; Schistosomiasis control Project of Hubei Province [XF2012-3]	National Science and Technology Major Project; Schistosomiasis control Project of Hubei Province	The present study was supported by the National Science and Technology Major Project (grant 2012ZX10004909) and the Schistosomiasis control Project of Hubei Province (XF2012-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergquist R, 2010, ADV PARASIT, V72, P109, DOI 10.1016/S0065-308X(10)72005-4; Dai JR, 2008, PARASITOL RES, V103, P405, DOI 10.1007/s00436-008-0988-2; Dai JR, 2015, PARASITOLOGY, V142, P332, DOI 10.1017/S0031182014000870; Dheilly NM, 2014, DEV COMP IMMUNOL, V45, P56, DOI 10.1016/j.dci.2014.01.022; Graebing PW, 2004, J AGR FOOD CHEM, V52, P5924, DOI 10.1021/jf0401524; Gray DJ, 2014, INT J PARASITOL, V44, P659, DOI 10.1016/j.ijpara.2014.05.005; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Li Hongjun, 2006, Zhongguo Xuexichongbing Fangzhi Zazhi, V18, P427; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Li WenGui, 1997, Chinese Journal of Parasitic Disease Control, V10, P42; Liu R, 2013, PARASITOL RES, V112, P1483, DOI 10.1007/s00436-013-3295-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McManus DP, 2009, EXPERT REV ANTI-INFE, V7, P473, DOI [10.1586/eri.09.17, 10.1586/ERI.09.17]; MOH, 2000, HDB SCHIST CONTR, P204; Oliveira EC, 2000, ECOTOX ENVIRON SAFE, V46, P342, DOI 10.1006/eesa.2000.1924; OSTROSKYWEGMAN P, 1986, MUTAT RES, V173, P81, DOI 10.1016/0165-7992(86)90015-1; Park SJ, 2011, BMB REP, V44, P517, DOI 10.5483/BMBRep.2011.44.8.517; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; Shrivastava J, 2005, MOL ECOL, V14, P839, DOI 10.1111/j.1365-294X.2005.02443.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang H, 2012, EXP PARASITOL, V130, P374, DOI 10.1016/j.exppara.2012.02.004; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; WHO, 1993, WHO TECH REP SER, V830, P51; WHO, 1985, WHO TECH REP SER, V728, P58; WHO Expert Committee, 2002, WHO TECH REP SER, V912, P7; Xing YunTian, 2010, Chinese Journal of Schistosomiasis Control, V22, P504; Yang GJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-260; Yang JinSun, 2007, Chinese Journal of Schistosomiasis Control, V19, P311; Yi YA, 2005, ACTA TROP, V96, P191, DOI 10.1016/j.actatropica.2005.07.014; Yuan Y, 2011, MALACOLOGIA, V53, P217, DOI 10.4002/040.053.0202; Zhang L, 2012, INT J MOL SCI, V13, P5844, DOI 10.3390/ijms13055844; Zhang SH, 2010, MALACOLOGIA, V53, P147, DOI 10.4002/040.053.0107; Zhang Tao, 2002, Chinese Journal of Schistosomiasis Control, V14, P234; Zhao QP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000611; Zhao QP, 2010, MOL PHYLOGENET EVOL, V57, P215, DOI 10.1016/j.ympev.2010.05.026; Zhou XN, 2010, ADV PARASIT, V72, P145, DOI 10.1016/S0065-308X(10)72006-6; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhu Dan-Dan, 2011, Acta Hydrobiologica Sinica, V35, P672	39	27	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118673	10.1371/journal.pone.0118673	http://dx.doi.org/10.1371/journal.pone.0118673			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775015	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500034
J	Pardo, LM; Rosas, Y; Fuentes, JP; Riveros, MP; Chaparro, OR				Miguel Pardo, Luis; Rosas, Yenifer; Pablo Fuentes, Juan; Paz Riveros, Marcela; Roberto Chaparro, Oscar			Fishery Induces Sperm Depletion and Reduction in Male Reproductive Potential for Crab Species under Male-Biased Harvest Strategy	PLOS ONE			English	Article							SPINY KING CRAB; MALE-MALE COMPETITION; CALLINECTES-SAPIDUS; BLUE-CRAB; PARALITHODES-BREVIPES; MALE SIZE; UNNATURAL SELECTION; MATING HISTORY; BIRGUS-LATRO; LIMITATION	Sperm depletion in males can occur when polygynous species are intensively exploited under a male-biased management strategy. In fisheries involving crabs species, the effects of this type of management on the reproductive potential is far from being understood. This study tests whether male-biased management of the principal Chilean crab fishery is able to affect the potential capacity of Metacarcinus edwardsii males to transfer sperm to females. Five localities in southern Chile, recording contrasting crab fishery landing, were selected to assess the potential of sperm depletion triggered by fishery. Seasonally, male crabs from each locality were obtained. Dry weight and histological condition of vasa deferentia and the Vaso-Somatic Index (VSI) were determined in order to use them as proxies for sperm depletion and male reproductive condition. A manipulative experiment was performed in the laboratory to estimate vasa deferentia weight and VSI from just-mated males in order to obtain a reference point for the potential effects of the fishery on sperm reserves. Sperm storage capacity is significantly affected by fisheries; during the mating season vasa deferentia from localities with low fishery intensity were heavier than those from high intensity fisheries, and these differences were even more evident in large males. Histological section showed that this disparity in vasa deferentia weight was explained principally by differences in the quantity of spermatophores rather than other seminal material. VSI was always higher in males from localities with low fishery intensity. Males from localities with high fishery intensity showed little capacity to recover sperm reserves and the VSI of these males remained below the values of the just-mated males. Detriment in the capacity of males to transfer sperm is the first step to sperm limitation in an exploited population, thus detection of sperm depletion can be an alert to introduce changes in the current management of crabs.	[Miguel Pardo, Luis; Rosas, Yenifer; Pablo Fuentes, Juan; Paz Riveros, Marcela; Roberto Chaparro, Oscar] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile	Pardo, LM (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	luispardo@uach.cl	Pardo, L M/A-3178-2008; Chaparro, Oscar R/A-5070-2009	Pardo, L M/0000-0003-2005-4922; Pardo, Luis Miguel/0000-0002-8179-5057	FONDECYT [1110445]; DID Universidad Austral de Chile	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DID Universidad Austral de Chile	LMP acknowledges funding from FONDECYT project 1110445 and DID Universidad Austral de Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockerhoff AM, 2005, MAR ECOL PROG SER, V290, P179, DOI 10.3354/meps290179; Carver AM, 2005, J EXP MAR BIOL ECOL, V319, P29, DOI 10.1016/j.jembe.2004.06.013; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Gardner C, 2002, MAR FRESHWATER RES, V53, P661, DOI 10.1071/MF01097; Gosselin T, 2003, BEHAV ECOL SOCIOBIOL, V55, P151, DOI 10.1007/s00265-003-0695-z; Hines AH, 2003, B MAR SCI, V72, P287; Hinojosa I, 2003, ANIM BEHAV, V66, P449, DOI 10.1006/anbe.2003.2220; Jivoff P, 2003, B MAR SCI, V72, P273; Kendall MS, 1999, J EXP MAR BIOL ECOL, V239, P23, DOI 10.1016/S0022-0981(99)00022-2; Kendall MS, 2002, MAR ECOL PROG SER, V230, P235, DOI 10.3354/meps230235; Kendall MS, 2001, CAN J FISH AQUAT SCI, V58, P1168, DOI 10.1139/cjfas-58-6-1168; Krol R.M., 1992, DECAPOD CRUSTACEA MI, V10, P295; Pardo LM, 2013, INVERTEBR BIOL, V132, P386, DOI 10.1111/ivb.12038; Pardo LM, 2009, J MAR BIOL ASSOC UK, V89, P1627, DOI 10.1017/S0025315409000010; Olguin A, 2006, FIPIT0416; Olguin A, 2011, TECHNICAL REPORT; Pillans S, 2005, MAR ECOL PROG SER, V295, P201, DOI 10.3354/meps295201; Pool H, 1998, FIPIT9635; Rondeau A, 2001, BIOL BULL-US, V201, P204, DOI 10.2307/1543335; Rubolini D, 2007, FRESHWATER BIOL, V52, P1898, DOI 10.1111/j.1365-2427.2007.01814.x; Sainte-Marie Bernard, 2007, P191; Sainte-Marie B, 2008, B MAR SCI, V83, P131; Sato T, 2005, MAR ECOL PROG SER, V296, P251, DOI 10.3354/meps296251; Sato T, 2007, CAN J FISH AQUAT SCI, V64, P735, DOI 10.1139/F07-044; Sato T, 2006, MAR ECOL PROG SER, V312, P189, DOI 10.3354/meps312189; Sato T, 2011, AQUAT BIOL, V13, P11, DOI 10.3354/ab00350; Sato T, 2010, AQUAT BIOL, V10, P23, DOI 10.3354/ab00263; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Xuan FJ, 2014, AQUAT BIOL, V20, P145, DOI 10.3354/ab00555; Zar JH, 1999, BIOSTATISTICAL ANAL	31	27	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115525	10.1371/journal.pone.0115525	http://dx.doi.org/10.1371/journal.pone.0115525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768728	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500001
J	Nemeckova, I; Serwadczak, A; Oujo, B; Jezkova, K; Rathouska, J; Fikrova, P; Varejckova, M; Bernabeu, C; Lopez-Novoa, JM; Chlopicki, S; Nachtigal, P				Nemeckova, Ivana; Serwadczak, Agnieszka; Oujo, Barbara; Jezkova, Katerina; Rathouska, Jana; Fikrova, Petra; Varejckova, Michala; Bernabeu, Carmelo; Lopez-Novoa, Jose M.; Chlopicki, Stefan; Nachtigal, Petr			High Soluble Endoglin Levels Do Not Induce Endothelial Dysfunction in Mouse Aorta	PLOS ONE			English	Article							OXIDATIVE STRESS; ATHEROSCLEROSIS; HYPERTENSION; PATHWAYS; ADHESION; PROTEIN; MICE	Increased levels of a soluble form of endoglin (sEng) circulating in plasma have been detected in various pathological conditions related to cardiovascular system. High concentration of sEng was also proposed to contribute to the development of endothelial dysfunction, but there is no direct evidence to support this hypothesis. Therefore, in the present work we analyzed whether high sEng levels induce endothelial dysfunction in aorta by using transgenic mice with high expression of human sEng. Transgenic mice with high expression of human sEng on CBAxC57BI/6J background (Sol-Eng(+)) and age-matched transgenic littermates that do not develop high levels of human soluble endoglin (control animals in this study) on chow diet were used. As expected, male and female Sol-Eng(+) transgenic mice showed higher levels of plasma concentrations of human sEng as well as increased blood arterial pressure, as compared to control animals. Functional analysis either in vivo or ex vivo in isolated aorta demonstrated that the endothelium-dependent vascular function was similar in Sol-Eng(+) and control mice. In addition, Western blot analysis showed no differences between Sol-Eng(+) and control mice in the protein expression levels of endoglin, endothelial NO-synthase (eNOS) and pro-inflammatory ICAM-1 and VCAM-1 from aorta. Our results demonstrate that high levels of soluble endoglin alone do not induce endothelial dysfunction in Sol-Eng(+) mice. However, these data do not rule out the possibility that soluble endoglin might contribute to alteration of endothelial function in combination with other risk factors related to cardiovascular disorders.	[Nemeckova, Ivana; Jezkova, Katerina; Rathouska, Jana; Fikrova, Petra; Varejckova, Michala; Nachtigal, Petr] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Hradec Kralove 50005, Czech Republic; [Serwadczak, Agnieszka; Chlopicki, Stefan] JCET, PL-30348 Krakow, Poland; [Chlopicki, Stefan] Jagiellonian Univ, Coll Med, Dept Expt Pharmacol, Chair Pharmacol, PL-31531 Krakow, Poland; [Oujo, Barbara; Lopez-Novoa, Jose M.] Univ Salamanca, Dept Physiol & Pharmacol, Renal & Cardiovasc Physiopathol Unit, Salamanca 37007, Spain; [Bernabeu, Carmelo] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Bernabeu, Carmelo] CIBERER, Madrid 28040, Spain	Charles University Prague; Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Nachtigal, P (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biol & Med Sci, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic.	petr.nachtigal@faf.cuni.cz	Bernabeu, Carmelo/P-4662-2019; Fikrova, Petra/T-7875-2017; Lopez-Novoa, Jose M/A-3672-2008; Bernabeu, Carmelo/L-3226-2014; Nachtigal, Petr/S-8022-2017; Blazickova, Katerina/T-1215-2017; Nemeckova, Ivana/T-6610-2017; Rathouska, Jana/Q-2796-2016	Bernabeu, Carmelo/0000-0002-1563-6162; Fikrova, Petra/0000-0003-0484-6049; Bernabeu, Carmelo/0000-0002-1563-6162; Nachtigal, Petr/0000-0001-9568-7295; Blazickova, Katerina/0000-0002-1654-0277; Nemeckova, Ivana/0000-0002-9795-8471; Chlopicki, Stefan/0000-0002-2878-3858; Rathouska, Jana/0000-0001-6363-9715	Grant Agency of Charles University in Prague [300811/C, 1284214/C]; Charles University in Prague [SVV/2014/260064]; European Regional Development Fund under the Innovative Economy Program of the European Union [POIG.01.01.02-00-069/09]; Ministerio de Economia y Competitividad of Spain [SAF2010-19222, SAF2013-43421-R, SAF2010-15881]; Junta de Castilla y Leon [GR100]; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB); Red de Investigacion Cooperativa en Enfermedades Renales [RD12/0021/0032]; FEDER funds; Ministerio de Economia y Competitividad [BES-2008-005550]; European Social Fund; state budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]	Grant Agency of Charles University in Prague; Charles University in Prague; European Regional Development Fund under the Innovative Economy Program of the European Union; Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB); Red de Investigacion Cooperativa en Enfermedades Renales; FEDER funds(European Commission); Ministerio de Economia y Competitividad(Spanish Government); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic	This work was supported by grants from the Grant Agency of Charles University in Prague (300811/C and 1284214/C), Charles University in Prague (SVV/2014/260064), European Regional Development Fund under the Innovative Economy Program of the European Union (grant coordinated by JCET-UJ, No POIG.01.01.02-00-069/09), Ministerio de Economia y Competitividad of Spain (SAF2010-19222 and SAF2013-43421-R to CB and SAF2010-15881 to JML-N), Junta de Castilla y Leon (GR100 to JML-N), Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER, CB), and Red de Investigacion Cooperativa en Enfermedades Renales (RD12/0021/0032; REDINREN, JML-N). CIBERER and REDINREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The Cardiovascular Phenotyping Unit of the University of Salamanca, including the telemetry equipment, was acquired with the support of the European Regional Development Funds (FEDER). BO is supported by a fellowship from Ministerio de Economia y Competitividad (BES-2008-005550). The publication is co-financed by the European Social Fund and the state budget of the Czech Republic (Project No. CZ.1.07/2.3.00/30.0061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernabeu C, 2007, J CELL BIOCHEM, V102, P1375, DOI 10.1002/jcb.21594; Blaha M, 2008, ATHEROSCLEROSIS, V197, P264, DOI 10.1016/j.atherosclerosis.2007.04.022; Blann AD, 1996, ATHEROSCLEROSIS, V120, P221, DOI 10.1016/0021-9150(95)05713-7; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chamorro-Jorganes A, 2010, HYPERTENSION, V56, P484, DOI 10.1161/HYPERTENSIONAHA.110.152587; Cui S, 2008, CHINESE MED J-PEKING, V121, P128, DOI 10.1097/00029330-200801020-00007; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Gregory AL, 2014, PLACENTA, V35, pS93, DOI 10.1016/j.placenta.2013.10.020; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Ikemoto T, 2012, HEART VESSELS, V27, P344, DOI 10.1007/s00380-011-0163-z; Jerkic M, 2004, FASEB J, V18, P609, DOI 10.1096/fj.03-0197fje; Joseph-Silverstein J, 1998, CANCER INVEST, V16, P176, DOI 10.3109/07357909809050034; Keaney John F. Jr., 2000, Molecular Aspects of Medicine, V21, P99, DOI 10.1016/S0098-2997(00)00005-4; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Najemnik C, 1999, ACTA MED AUST, V26, P148; Rathouska J, 2011, PHARMACOL RES, V64, P53, DOI 10.1016/j.phrs.2011.03.008; Rossi E, 2013, BLOOD, V121, P403, DOI 10.1182/blood-2012-06-435347; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Strasky Z, 2011, CIRC J, V75, P1747, DOI 10.1253/circj.CJ-10-1285; Tornavaca O, 2009, CIRCULATION, V119, P1908, DOI 10.1161/CIRCULATIONAHA.108.808543; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; Valdivielso JM, 2001, AM J PHYSIOL-REG I, V280, pR771, DOI 10.1152/ajpregu.2001.280.3.R771; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Walshe TE, 2009, ARTERIOSCL THROM VAS, V29, P1185, DOI 10.1161/ATVBAHA.109.186742	27	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119665	10.1371/journal.pone.0119665	http://dx.doi.org/10.1371/journal.pone.0119665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768936	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500090
J	Ozaki, K; Chikashige, Y; Hiraoka, Y; Matsumoto, T				Ozaki, Kanako; Chikashige, Yuji; Hiraoka, Yasushi; Matsumoto, Tomohiro			Fission Yeast Scp3 Potentially Maintains Microtubule Orientation through Bundling	PLOS ONE			English	Article							ISOPROPYL N-3-CHLOROPHENYL CARBAMATE; GAMMA-TUBULIN COMPLEXES; N-PHENYL CARBAMATE; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; CELL-DIVISION; MUTATION; TRANSFORMATION; MORPHOGENESIS; NUCLEAR	Microtubules play important roles in organelle transport, the maintenance of cell polarity and chromosome segregation and generally form bundles during these processes. The fission yeast gene scp3(+) was identified as a multicopy suppressor of the cps3-81 mutant, which is hypersensitive to isopropyl N-3-chlorophenylcarbamate (CIPC), a poison that induces abnormal multipolar spindle formation in higher eukaryotes. In this study, we investigated the function of Scp3 along with the effect of CIPC in the fission yeast Schizosaccharomyces pombe. Microscopic observation revealed that treatment with CIPC, cps3-81 mutation and scp3+ gene deletion disturbed the orientation of microtubules in interphase cells. Overexpression of scp3+ suppressed the abnormal orientation of microtubules by promoting bundling. Functional analysis suggested that Scp3 functions independently from Ase1, a protein largely required for the bundling of the mitotic spindle. A strain lacking the ase1(+) gene was more sensitive to CIPC, with the drug affecting the integrity of the mitotic spindle, indicating that CIPC has a mitotic target that has a role redundant with Ase1. These results suggested that multiple systems are independently involved to ensure microtubule orientation by bundling in fission yeast.	[Ozaki, Kanako; Matsumoto, Tomohiro] Kyoto Univ, Grad Sch Biostudies, Kyoto, Kyoto, Japan; [Chikashige, Yuji; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo, Japan; [Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Matsumoto, Tomohiro] Kyoto Univ, Ctr Radiat Biol, Kyoto, Kyoto 606, Japan	Kyoto University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Kyoto University	Matsumoto, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Kyoto, Japan.	tmatsumo@house.rbc.kyoto-u.ac.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228	Ministry of Education, Culture, Sports, Science and Technology [22019020]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: The authors received funding from Ministry of Education, Culture, Sports, Science and Technology, [http://www.mext.go.jp/] grant number: 22019020 (Tokutei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BOKROS CL, 1993, BIOCHEMISTRY-US, V32, P3437, DOI 10.1021/bi00064a030; Carvalho P, 2003, TRENDS CELL BIOL, V13, P229, DOI 10.1016/S0962-8924(03)00074-6; Chikashige Y, 2014, CELL STRUCT FUNCT, V39, P93, DOI 10.1247/csf.14007; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; COSS RA, 1974, J CELL BIOL, V63, P84, DOI 10.1083/jcb.63.1.84; COSS RA, 1975, EXP CELL RES, V92, P394, DOI 10.1016/0014-4827(75)90393-6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; DOONAN JH, 1985, J CELL SCI, V75, P131; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hashimoto T, 2013, CURR OPIN PLANT BIOL, V16, P698, DOI 10.1016/j.pbi.2013.09.002; Iimori M, 2012, EXP CELL RES, V318, P262, DOI 10.1016/j.yexcr.2011.11.006; Ishiguro J, 1996, FEBS LETT, V392, P237, DOI 10.1016/0014-5793(96)00819-8; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; ISHIGURO J, 1992, JPN J GENET, V67, P97, DOI 10.1266/jjg.67.97; ISHIGURO J, 1994, JPN J GENET, V69, P671, DOI 10.1266/jjg.69.671; ISHIGURO J, 1993, JPN J GENET, V68, P265, DOI 10.1266/jjg.68.265; Ishijima SA, 1999, FEMS MICROBIOL LETT, V180, P31, DOI 10.1111/j.1574-6968.1999.tb08774.x; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; LIU B, 1995, CELL MOTIL CYTOSKEL, V31, P113, DOI 10.1002/cm.970310204; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Masuda H, 2006, GENES CELLS, V11, P319, DOI 10.1111/j.1365-2443.2006.00946.x; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; MOREJOHN LC, 1991, PHARMACOL THERAPEUT, V51, P217, DOI 10.1016/0163-7258(91)90078-Z; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moritz M, 2001, CURR OPIN STRUC BIOL, V11, P174, DOI 10.1016/S0959-440X(00)00187-1; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; OLIVER JM, 1978, EXP CELL RES, V116, P229, DOI 10.1016/0014-4827(78)90079-4; Sato M, 2007, NATURE, V447, P334, DOI 10.1038/nature05773; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Subramanian R, 2012, DEV CELL, V23, P874, DOI 10.1016/j.devcel.2012.10.011; Takeshita N, 2014, CURR OPIN MICROBIOL, V20, P34, DOI 10.1016/j.mib.2014.04.005; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Warner SL, 2008, CURR ONCOL REP, V10, P122, DOI 10.1007/s11912-008-0020-0; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Young DH, 2000, PLANT PHYSIOL, V124, P115, DOI 10.1104/pp.124.1.115	50	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120109	10.1371/journal.pone.0120109	http://dx.doi.org/10.1371/journal.pone.0120109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767875	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500108
J	Salazar-Pelaez, LM; Abraham, T; Herrera, AM; Correa, MA; Ortega, JE; Pare, PD; Seow, CY				Salazar-Pelaez, Lina M.; Abraham, Thomas; Herrera, Ana M.; Correa, Mario A.; Ortega, Jorge E.; Pare, Peter D.; Seow, Chun Y.			Vitronectin Expression in the Airways of Subjects with Asthma and Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							SERUM SPREADING FACTOR; BRONCHOALVEOLAR LAVAGE FLUID; HEPARIN-BINDING PEPTIDES; S-PROTEIN; EPITHELIAL-CELLS; GENE-EXPRESSION; MESSENGER-RNA; ORGANISM ATTACHMENT; BIOLOGICAL ROLE; LUNG-DISEASE	Vitronectin, a multifunctional glycoprotein, is involved in coagulation, inhibition of the formation of the membrane attack complex (MAC), cell adhesion and migration, wound healing, and tissue remodeling. The primary cellular source of vitronectin is hepatocytes; it is not known whether resident cells of airways produce vitronectin, even though the glycoprotein has been found in exhaled breath condensate and bronchoalveolar lavage from healthy subjects and patients with interstitial lung disease. It is also not known whether vitronectin expression is altered in subjects with asthma and COPD. In this study, bronchial tissue from 7 asthmatic, 10 COPD and 14 control subjects was obtained at autopsy and analyzed by immunohistochemistry to determine the percent area of submucosal glands occupied by vitronectin. In a separate set of experiments, quantitative colocalization analysis was performed on tracheobronchial tissue sections obtained from donor lungs (6 asthmatics, 4 COPD and 7 controls). Vitronectin RNA and protein expressions in bronchial surface epithelium were examined in 12 subjects who undertook diagnostic bronchoscopy. Vitronectin was found in the tracheobronchial epithelium from asthmatic, COPD, and control subjects, although its expression was significantly lower in the asthmatic group. Colocalization analysis of 3D confocal images indicates that vitronectin is expressed in the glandular serous epithelial cells and in respiratory surface epithelial cells other than goblet cells. Expression of the 65-kDa vitronectin isoform was lower in bronchial surface epithelium from the diseased subjects. The cause for the decreased vitronectin expression in asthma is not clear, however, the reduced concentration of vitronectin in the epithelial/submucosal layer of airways may be linked to airway remodeling.	[Salazar-Pelaez, Lina M.; Herrera, Ana M.; Seow, Chun Y.] Univ CES, Sch Med, Medellin, Colombia; [Abraham, Thomas] Penn State Hershey Coll Med, Penn State Microscopy Imaging Core, Hershey, PA USA; [Correa, Mario A.] Inst Nacl Med Legal & Ciencias Forenses, Medellin, Colombia; [Ortega, Jorge E.] Clin Cardio VID, Medellin, Colombia; [Pare, Peter D.; Seow, Chun Y.] Univ British Columbia, James Hogg Res Ctr, Vancouver, BC V5Z 1M9, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of British Columbia	Seow, CY (corresponding author), Univ CES, Sch Med, Medellin, Colombia.	chun.seow@hli.ubc.ca	Abraham, Thomas/AAJ-7950-2020; Salazar-Pelaéz, Lina/AAH-2360-2021; Seow, Chun/AAQ-4099-2020; Ortega, Jorge Emilio/U-7558-2019; Abraham, Thomas/J-7080-2014; Pare, Peter D/C-7425-2011	Ortega, Jorge Emilio/0000-0001-8188-874X; Abraham, Thomas/0000-0003-0750-8774; Herrera-Gonzalez, Ana M/0000-0002-7534-7004; Salazar-Pelaez, Lina/0000-0001-6224-1078	Knowledge Management Division and School of Medicine at Universidad CES [2011CI09]; Canadian Institutes of Health Research (CIHR) [MOP-13271, MOP-37924]; Colciencias Doctoral Fellowship [494/2009]	Knowledge Management Division and School of Medicine at Universidad CES; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Colciencias Doctoral Fellowship	This work was supported by Knowledge Management Division and School of Medicine at Universidad CES (Grant code 2011CI09) and operating grants from the Canadian Institutes of Health Research (CIHR grant number MOP-13271, MOP-37924). Lina M. Salazar-Pelaez was supported by Colciencias Doctoral Fellowship (Becas Francisco Jose de Caldas, Contract 494/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; Anderson DH, 1999, INVEST OPHTH VIS SCI, V40, P3305; Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Bari M R, 2010, Mymensingh Med J, V19, P576; BARNES DW, 1983, J BIOL CHEM, V258, P2548; BARNES DW, 1983, P NATL ACAD SCI-BIOL, V80, P1362, DOI 10.1073/pnas.80.5.1362; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; BeruBe K, 2010, TOXICOLOGY, V278, P311, DOI 10.1016/j.tox.2010.04.004; Boublil L, 2013, TOXICOL IN VITRO, V27, P533, DOI 10.1016/j.tiv.2012.11.008; Carpagnano GE, 2003, RESPIRATION, V70, P154, DOI 10.1159/000070062; Chin LYM, 2012, EUR RESPIR J, V40, P45, DOI 10.1183/09031936.00065411; Contoli M, 2009, MINERVA MED, V100, P467; EKLUND AG, 1992, AM REV RESPIR DIS, V145, P646, DOI 10.1164/ajrccm/145.3.646; FINK TM, 1992, HUM GENET, V88, P569, DOI 10.1007/BF00219346; Francois PP, 1999, J BIOL CHEM, V274, P37611, DOI 10.1074/jbc.274.53.37611; Hageman GS, 1999, FASEB J, V13, P477, DOI 10.1096/fasebj.13.3.477; Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HETLAND G, 1989, SCAND J IMMUNOL, V29, P15, DOI 10.1111/j.1365-3083.1989.tb01094.x; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Husain A.N, 2010, ROBBINS COTRAN PATHO, P677; INUZUKA S, 1994, PATHOL RES PRACT, V190, P903; Jackson DJ, 2011, J ALLERGY CLIN IMMUN, V128, P1165, DOI 10.1016/j.jaci.2011.10.024; Johnston Neil W, 2007, Proc Am Thorac Soc, V4, P591, DOI 10.1513/pats.200706-064TH; Kelsen SG, 2000, ASTHMA MECH PROTOCOL, P41; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; LIMPER AH, 1994, IMMUNOL LETT, V42, P139, DOI 10.1016/0165-2478(94)90077-9; LIMPER AH, 1993, INFECT IMMUN, V61, P4302, DOI 10.1128/IAI.61.10.4302-4309.1993; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Malmsten M, 2006, MATRIX BIOL, V25, P294, DOI 10.1016/j.matbio.2006.04.003; Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006; MANDERS EMM, 1992, J CELL SCI, V103, P857; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; McDonald VM, 2012, CLIN EXP ALLERGY, V42, P670, DOI 10.1111/j.1365-2222.2012.03981.x; NICULESCU F, 1987, ATHEROSCLEROSIS, V65, P1, DOI 10.1016/0021-9150(87)90002-5; OHRN MB, 1995, RESPIRATION, V62, P136; Ozaki S, 1999, BIOCHEM BIOPH RES CO, V258, P524, DOI 10.1006/bbrc.1999.0672; Papi A, 2007, CURR OPIN PHARMACOL, V7, P259, DOI 10.1016/j.coph.2006.11.015; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POHL WR, 1991, AM REV RESPIR DIS, V143, P1369, DOI 10.1164/ajrccm/143.6.1369; PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P123; PREISSNER KT, 1991, ANNU REV CELL BIOL, V7, P275, DOI 10.1146/annurev.cellbio.7.1.275; Preissner KT, 1998, THROMB RES, V89, P1, DOI 10.1016/S0049-3848(97)00298-3; PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063; REILLY JT, 1988, J CLIN PATHOL, V41, P1269, DOI 10.1136/jcp.41.12.1269; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; SEIFFERT D, 1991, P NATL ACAD SCI USA, V88, P9402, DOI 10.1073/pnas.88.21.9402; SEIFFERT D, 1994, J BIOL CHEM, V269, P19836; SEIFFERT D, 1995, J IMMUNOL, V155, P3180; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Singh B, 2010, MOL MICROBIOL, V75, P1426, DOI 10.1111/j.1365-2958.2010.07066.x; Skold CM, 2010, CLIN RESPIR J, V4, P20, DOI 10.1111/j.1752-699X.2010.00193.x; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TESCHLER H, 1993, AM REV RESPIR DIS, V147, P332, DOI 10.1164/ajrccm/147.2.332; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P4103, DOI 10.1021/bi00411a029; Yamada S, 1996, CLIN CHIM ACTA, V252, P95, DOI 10.1016/0009-8981(96)06320-6; Zhang DZ, 2011, AM J PHYSIOL-RENAL, V300, pF475, DOI 10.1152/ajprenal.00407.2010	64	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119717	10.1371/journal.pone.0119717	http://dx.doi.org/10.1371/journal.pone.0119717			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768308	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500095
J	Schmid, D; Ricci, C; Leitzmann, MF				Schmid, Daniela; Ricci, Cristian; Leitzmann, Michael F.			Associations of Objectively Assessed Physical Activity and Sedentary Time with All-Cause Mortality in US Adults: The NHANES Study	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; TELEVISION VIEWING TIME; BODY-MASS INDEX; ENERGY-EXPENDITURE; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; UNITED-STATES; SITTING TIME; CANCER-RISK; LIFE-STYLE	Background Sedentary behavior is related to increased mortality risk. Whether such elevated risk can be offset by enhanced physical activity has not been examined using accelerometry data. Materials and Methods We examined the relations of sedentary time and physical activity to mortality from any cause using accelerometry data among 1,677 women and men aged 50 years or older from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 cycle with follow-up through December 31, 2006. Results During an average follow-up of 34.67 months and 4,845.42 person-years, 112 deaths occurred. In multivariate Cox proportional hazard models, greater sedentary time (>= median of 8.60 hours/day) was associated with increased risk of mortality from any cause (relative risk (RR) = 2.03; 95% confidence interval (CI) = 1.09-3.81). Low level of moderate to vigorous physical activity (< median of 6.60 minutes/day) was also related to enhanced allcause mortality risk (RR = 3.30; 95% CI = 1.33-8.17). In combined analyses, greater time spent sedentary and low levels of moderate to vigorous physical activity predicted a substantially elevated all-cause mortality risk. As compared with the combination of a low sedentary level and a high level of moderate to vigorous physical activity, the risks of mortality from all causes were 4.38 (95% CI = 1.26-15.16) for low levels of both sedentary time and physical activity, 2.79 (95% CI = 0.77-10.12) for greater time spent sedentary and high physical activity level, and 7.79 (95% CI = 2.26-26.82) for greater time spent sedentary and low physical activity level. The interaction term between sedentary time and moderate to vigorous physical activity was not statistically significant (p = 0.508). Conclusions Both high levels of sedentary time and low levels of moderate to vigorous physical activity are strong and independent predictors of early death from any cause. Whether a high physical activity level removes the increased risk of all-cause mortality related to sedentariness requires further investigation.	[Schmid, Daniela; Ricci, Cristian; Leitzmann, Michael F.] Univ Regensburg, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany	University of Regensburg	Schmid, D (corresponding author), Univ Regensburg, Dept Epidemiol & Prevent Med, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	daniela.schmid@klinik.uni-regensburg.de	Ricci, Cristian/AAV-3315-2021; Schmid, Daniela/GPG-1151-2022	Ricci, Cristian/0000-0003-4113-8682; 				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Arem H, 2014, INT J CANCER, V135, P423, DOI 10.1002/ijc.28659; Australian Government. Department of Health, AUSTRALIAS PHYSICAL; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Blanck HM, 2007, OBESITY, V15, P1578, DOI 10.1038/oby.2007.187; Bowman Shanthy A, 2006, Prev Chronic Dis, V3, pA38; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Canadian Society for Exercise Physiology, CAN PHYS ACT GUID CA; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Centers for Disease Control and Prevention, 2012, FACTS PHYS ACT; Centers for Disease control and Prevention/National Center for Health Statistics/U.S. Department of Health and Human Services, NAT HLTH NUTR EX SUR; Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dhaliwal SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083435; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Ferrari P, 2007, AM J EPIDEMIOL, V166, P832, DOI 10.1093/aje/kwm148; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2004, EXERC SPORT SCI REV, V32, P161; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Klenk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084817; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Krogh-Madsen R, 2010, J APPL PHYSIOL, V108, P1034, DOI 10.1152/japplphysiol.00977.2009; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lavie CJ, 2011, J CARDIOPULM REHABIL, V31, P137, DOI 10.1097/HCR.0b013e3182122827; Leenders NYJM, 2003, INT J SPORTS MED, V24, P43, DOI 10.1055/s-2003-37196; Leenders NYJM, 2001, MED SCI SPORT EXER, V33, P1233; Lukanova A, 2003, INT J CANCER, V104, P636, DOI 10.1002/ijc.10990; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Mathews CE, 2012, EXERC SPORT SCI REV, V40, P118, DOI 10.1097/JES.0b013e31825b34a0; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; McTiernan A, 2004, CANCER EPIDEM BIOMAR, V13, P1099; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mitchell JA, 2014, MED SCI SPORT EXER, V46, P2244, DOI 10.1249/MSS.0000000000000366; Neilson HK, 2009, CANCER EPIDEM BIOMAR, V18, P11, DOI 10.1158/1055-9965.EPI-08-0756; NHANES, 1999, LINK MORT FIL; O'Keefe JH, 2008, J AM COLL CARDIOL, V51, P249, DOI 10.1016/j.jacc.2007.10.016; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Panagiotakos Demosthenes B, 2004, Prev Cardiol, V7, P190, DOI 10.1111/j.1520-037X.2004.03539.x; Parker L, 2014, CLIN PHYSIOL FUNCT I, V34, P377, DOI 10.1111/cpf.12108; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Pavey TG, 2012, BRIT J SPORT MED, V0, P1, DOI DOI 10.1136/BJSP0RTS-2012-091676; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schatzkin A, 2009, CANCER EPIDEM BIOMAR, V18, P1026, DOI 10.1158/1055-9965.EPI-08-1129; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Tambalis K, 2009, ANGIOLOGY, V60, P614, DOI 10.1177/0003319708324927; Thomson CA, 2014, CANCER PREV RES, V7, P42, DOI 10.1158/1940-6207.CAPR-13-0258; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	74	102	106	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119591	10.1371/journal.pone.0119591	http://dx.doi.org/10.1371/journal.pone.0119591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768112	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500086
J	Son, SJ; Lee, KS; Chung, JH; Chang, KJ; Roh, HW; Kim, SH; Jin, T; Back, JH; Kim, HJ; Lee, Y; Choi, SH; Noh, JS; Lim, KY; Chung, YK; Hong, CH; Oh, BH				Son, Sang Joon; Lee, Kang Soo; Chung, Ji Hyung; Chang, Ki Jung; Roh, Hyun Woong; Kim, Soo Hyun; Jin, Taewon; Back, Joung Hwan; Kim, Hyun Jung; Lee, Yunhwan; Choi, Seong Hye; Noh, Jai Sung; Lim, Ki Young; Chung, Young Ki; Hong, Chang Hyung; Oh, Byoung Hoon			Increased Plasma Levels of Heat Shock Protein 70 Associated with Subsequent Clinical Conversion to Mild Cognitive Impairment in Cognitively Healthy Elderly	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; VASCULAR-DISEASE; NERVOUS-SYSTEM; BRAIN PROTEINS; RISK-FACTORS; HSP70; PROTECTION	Background and Aims Heat shock proteins (HSPs) have been regarded as cytoprotectants that protect brain cells during the progression of neurodegenerative diseases and from damage resulting from cerebral ischemia. In this study, we assessed the association between plasma HSP 70/27 levels and cognitive decline. Methods Among participants in the community-based cohort study of dementia called the Gwangju Dementia and Mild Cognitive Impairment Study, subjects without cognitive impairment at baseline, who then either remained without impairment (non-conversion group), or suffered mild cognitive impairment (MCI) (conversion group) (non-conversion group, N = 36; conversion group, N = 30) were analyzed. Results After a five to six year follow-up period, comparison of the plasma HSP 70 and HSP 27 levels of the two groups revealed that only the plasma HSP 70 level was associated with a conversion to MCI after adjustments for age, gender, years of education, follow-up duration, APOE e4, hypertension, and diabetes (repeated measure analysis of variance: F = 7.59, p = 0.008). Furthermore, an increase in plasma HSP 70 level was associated with cognitive decline in language and executive function (linear mixed model: Korean Boston Naming Test, -0.426 [-0.781, -0.071], p = 0.019; Controlled Oral Word Association Test, -0.176 [-0.328, -0.023], p = 0.024; Stroop Test, -0.304 [-0.458, -0.150], p< 0.001). Conclusions These findings suggest that the plasma HSP 70 level may be related to cognitive decline in the elderly.	[Son, Sang Joon; Chang, Ki Jung; Roh, Hyun Woong; Noh, Jai Sung; Lim, Ki Young; Chung, Young Ki; Hong, Chang Hyung] Ajou Univ, Sch Med, Dept Psychiat, Suwon 443380, Gyeonggi Do, South Korea; [Lee, Kang Soo] CHA Univ, Gangnam Med Ctr, Dept Psychiat, Seoul 135081, South Korea; [Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Appl Biosci, Songnam 463400, Gyeonggi Do, South Korea; [Kim, Soo Hyun; Jin, Taewon] Yonsei Univ, Grad Program Sci Aging, Seoul 120752, South Korea; [Back, Joung Hwan] Hlth Insurance Policy Res Inst, Natl Hlth Insurance Serv, Seoul 121749, South Korea; [Kim, Hyun Jung] Natl Med Ctr, Dept Psychiat, Seoul 100799, South Korea; [Lee, Yunhwan] Ajou Univ, Sch Med, Dept Prevent Med & Publ Hlth, Suwon 443380, Gyeonggi Do, South Korea; [Choi, Seong Hye] Inha Univ, Coll Med, Dept Neurol, Inchon 400711, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Dept Psychiat, Seoul 120752, South Korea; [Oh, Byoung Hoon] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul 120752, South Korea	Ajou University; Pochon Cha University; Pochon Cha University; Yonsei University; National Health Insurance Service; National Medical Center - Korea; Ajou University; Inha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Hong, CH (corresponding author), Ajou Univ, Sch Med, Dept Psychiat, 164 Worldcup Ro, Suwon 443380, Gyeonggi Do, South Korea.	antiaging@ajou.ac.kr; drobh@yuhs.ac	Lee, Yunhwan/F-4967-2010	Lee, Yunhwan/0000-0001-8484-4750	Faculty Research Grant of Yonsei University College of Medicine [2011(6-2011-0151)]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI10C2020]	Faculty Research Grant of Yonsei University College of Medicine; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a Faculty Research Grant of Yonsei University College of Medicine for 2011(6-2011-0151) and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI C, 1995, CANCER RES, V55, P4452; Arawaka S, 2010, CURR PHARM BIOTECHNO, V11, P158, DOI 10.2174/138920110790909713; BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Bjorkdahl C, 2008, J NEUROSCI RES, V86, P1343, DOI 10.1002/jnr.21589; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Calabrese V, 2002, J NEUROSCI RES, V68, P65, DOI 10.1002/jnr.10177; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Franklin TB, 2005, INT J HYPERTHER, V21, P379, DOI 10.1080/02656730500069955; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Kang Y., 2012, SEOUL NEUROPSYCHOLOG, V2nd; Kang Y., 1997, J KOREAN NEUROL ASS, V15, P300; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kim E, 2012, PSYCHONEUROENDOCRINO, V37, P358, DOI 10.1016/j.psyneuen.2011.07.005; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Lee KS, 2008, NEUROSCI LETT, V436, P223, DOI 10.1016/j.neulet.2008.03.025; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; Maineri ND, 2007, ARQ BRAS CARDIOL, V89, P158, DOI 10.1590/S0066-782X2007001500003; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Njemini R, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-24; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Reed T, 2008, NEUROBIOL DIS, V30, P107, DOI 10.1016/j.nbd.2007.12.007; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P511; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Son SJ, 2012, J CLIN PSYCHIAT, V73, P1555, DOI 10.4088/JCP.12m07702; Sultana R, 2009, J BIOENERG BIOMEMBR, V41, P441, DOI 10.1007/s10863-009-9241-7; Tervo S, 2004, DEMENT GERIATR COGN, V17, P196, DOI 10.1159/000076356; Wang BW, 2012, CAN J NEUROL SCI, V39, P592, DOI 10.1017/S0317167100015316; Wright BH, 2000, HEART VESSELS, V15, P18, DOI 10.1007/s003800070043	40	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119180	10.1371/journal.pone.0119180	http://dx.doi.org/10.1371/journal.pone.0119180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768018	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500069
J	Wijemanne, P; Xing, J; Berberov, EM; Marx, DB; Francis, DH; Moxley, RA				Wijemanne, Prageeth; Xing, Jun; Berberov, Emil M.; Marx, David B.; Francis, David H.; Moxley, Rodney A.			Relationship between Heat-Labile Enterotoxin Secretion Capacity and Virulence in Wild Type Porcine-Origin Enterotoxigenic Escherichia coli Strains	PLOS ONE			English	Article							PROTEIN MODEL QUALITY; SCORING FUNCTION; VIBRIO-CHOLERAE; COLIBACILLOSIS; IDENTIFICATION; PATHOGENICITY; PREVALENCE; RELEASE; PATHWAY; RABBIT	Heat-labile enterotoxin (LT) is an important virulence factor secreted by some strains of enterotoxigenic Escherichia coli (ETEC). The prototypic human-origin strain H10407 secretes LT via a type II secretion system(T2SS). We sought to determine the relationship between the capacity to secrete LT and virulence in porcine-origin wild type (WT) ETEC strains. Sixteen WT ETEC strains isolated from cases of severe diarrheal disease were analyzed by GM1ganglioside enzyme- linked immunosorbent assay tomeasure LT concentrations in culture supernatants. All strains had detectable LT in supernatants by 2 h of culture and 1 strain, which was particularly virulent in gnotobiotic piglets (3030-2), had the highest LT secretion level all porcine-origin WT strains tested (P<0.05). The level of LT secretion (concentration in supernatants at 6-h culture) explained 92% of the variation in time-to-a-moribund-condition (R-2 = 0.92, P<0.0001) in gnotobiotic piglets inoculated with either strain 3030-2, or an ETEC strain of lesser virulence (2534-86), or a non-enterotoxigenicWT strain (G58-1). All 16 porcine ETEC strains were positive by PCR analysis for the T2SS genes, gspD and gspK, and bioinformatic analysis of 4 porcine-origin strains for which complete genomic sequences were available revealed a T2SS with a high degree of homology to that of H10407. MaximumLikelihood phylogenetic trees constructed using T2SS genes gspC, gspD, gspE and homologs showed that strains 2534-86 and 3030-2 clustered together in the same clade with other porcine-origin ETEC strains in the database, UMNK88 and UMN18. Protein modeling of the ATPase gene (gspE) further revealed a direct relationship between the predicted ATP-binding capacities and LT secretion levels as follows: H10407, -8.8 kcal/mol and 199 ng/ml; 3030-2, -8.6 kcal/mol and 133 ng/ml; and 2534-86, -8.5 kcal/mol and 80 ng/ml. This study demonstrated a direct relationship between predicted ATP-binding capacity of GspE and LT secretion, and between the latter and virulence.	[Wijemanne, Prageeth; Xing, Jun; Berberov, Emil M.; Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Xing, Jun] Canada Immunoassay Dev, Windsor, ON, Canada; [Berberov, Emil M.] Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Ctr, Saskatoon, SK, Canada; [Marx, David B.] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Francis, David H.] S Dakota State Univ, Dept Vet Sci, Brookings, SD 57007 USA	University of Nebraska System; University of Nebraska Lincoln; University of Saskatchewan; University of Nebraska System; University of Nebraska Lincoln; South Dakota State University	Moxley, RA (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	rmoxley1@unl.edu		Moxley, Rodney/0000-0002-5377-7716	United States Department of Agriculture Multi-State Research [NC1202, NEB-39-167]	United States Department of Agriculture Multi-State Research	Support was provided by the United States Department of Agriculture Multi-State Research Project NC1202, NEB-39-167. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35; Berberov EM, 2004, INFECT IMMUN, V72, P3914, DOI 10.1128/IAI.72.7.3914-3924.2004; Bodero MD, 2009, INFECT IMMUN, V77, P791, DOI 10.1128/IAI.00928-08; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; CHEN TM, 1985, INFECT IMMUN, V47, P5, DOI 10.1128/IAI.47.1.5-10.1985; Erume J, 2010, VET MICROBIOL, V144, P160, DOI 10.1016/j.vetmic.2009.12.043; Erume J, 2008, INFECT IMMUN, V76, P3141, DOI 10.1128/IAI.01743-07; Erume J, 2013, VET MICROBIOL, V161, P315, DOI 10.1016/j.vetmic.2012.07.048; EVANS DG, 1973, INFECT IMMUN, V7, P873, DOI 10.1128/IAI.7.6.873-880.1973; FRANCIS DH, 1991, AM J VET RES, V52, P1051; Francis DH, 2002, J SWINE HEALTH PROD, V10, P171; GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979; Gonzales L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074069; GUINEE PAM, 1977, INFECT IMMUN, V15, P549; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hegde A, 2009, INDIAN J MED MICROBI, V27, P325, DOI 10.4103/0255-0857.55446; KUNKEL SL, 1979, INFECT IMMUN, V23, P652, DOI 10.1128/IAI.23.3.652-659.1979; McVeigh A, 2000, INFECT IMMUN, V68, P5710, DOI 10.1128/IAI.68.10.5710-5715.2000; MOON HW, 1971, LAB INVEST, V25, P133; MOON HW, 1980, INFECT IMMUN, V27, P222, DOI 10.1128/IAI.27.1.222-230.1980; Moxley RA, 1998, INFECT IMMUN, V66, P5031, DOI 10.1128/IAI.66.10.5031-5035.1998; MUNDELL DH, 1976, INFECT IMMUN, V14, P383, DOI 10.1128/IAI.14.2.383-388.1976; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; RISTAINO PA, 1983, J CLIN MICROBIOL, V18, P808, DOI 10.1128/JCM.18.4.808-815.1983; SACK DA, 1975, INFECT IMMUN, V11, P334, DOI 10.1128/IAI.11.2.334-336.1975; Shepard SM, 2012, J BACTERIOL, V194, P395, DOI 10.1128/JB.06225-11; Lasaro MAS, 2006, FEMS IMMUNOL MED MIC, V48, P123, DOI 10.1111/j.1574-695X.2006.00134.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Walker RI, 2007, VACCINE, V25, P2545, DOI 10.1016/j.vaccine.2006.12.028; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018; Zhang WP, 2006, INFECT IMMUN, V74, P3107, DOI 10.1128/IAI.01338-05	37	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117663	10.1371/journal.pone.0117663	http://dx.doi.org/10.1371/journal.pone.0117663			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768732	Green Published, gold			2022-12-26	WOS:000351277500017
J	Zhang, T; Nie, SP; Liu, BQ; Yu, YD; Zhang, Y; Liu, JB				Zhang, Ting; Nie, Shaoping; Liu, Boqun; Yu, Yiding; Zhang, Yan; Liu, Jingbo			Activity Prediction and Molecular Mechanism of Bovine Blood Derived Angiotensin I-Converting Enzyme Inhibitory Peptides	PLOS ONE			English	Article							BIOACTIVE PEPTIDES; IDENTIFICATION; PROTEIN; QSAR; DIGESTION; PURIFICATION; HEMOGLOBIN; MODEL; MILK; MEAT	Development of angiotensin I-converting enzyme (ACE, EC 3.4.15.1) inhibitory peptides from food protein is under extensive research as alternative for the prevention of hypertension. However, it is difficult to identify peptides released from food sources. To accelerate the progress of peptide identification, a three layer back propagation neural network model was established to predict the ACE-inhibitory activity of pentapeptides derived from bovine hemoglobin by simulated enzyme digestion. The pentapeptide WTQRF has the best predicted value with experimental IC50 23.93 mu M. The potential molecular mechanism of the WTQRF / ACE interaction was investigated by flexible docking.	[Zhang, Ting; Liu, Boqun; Yu, Yiding; Zhang, Yan; Liu, Jingbo] Jilin Univ, Lab Nutr & Funct Food, Changchun 130023, Jilin, Peoples R China; [Nie, Shaoping] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China	Jilin University; Nanchang University	Liu, JB (corresponding author), Jilin Univ, Lab Nutr & Funct Food, Changchun 130023, Jilin, Peoples R China.	ljb168@sohu.com	Liu, Boqun/V-9297-2019; Nie, S/K-1124-2019	Nie, Shao-Ping/0000-0002-2412-4679; zhang, ting/0000-0003-4229-6332	National Natural Science Foundation of China [31271907, 31471597]; Specialized Research Fund for the Doctoral Program of Higher [20130061110088]; Project of National Key Technology Research and Development Program for the 12th Five-year Plan [2012BAD33B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher; Project of National Key Technology Research and Development Program for the 12th Five-year Plan	This work was supported by the Grant 31271907 and 31471597 of the National Natural Science Foundation of China, the Specialized Research Fund for the Doctoral Program of Higher (No. 20130061110088), and the Project of National Key Technology Research and Development Program for the 12th Five-year Plan (NO. 2012BAD33B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catiau L, 2011, PEPTIDES, V32, P1463, DOI 10.1016/j.peptides.2011.05.021; Catiau L, 2011, PEPTIDES, V32, P633, DOI 10.1016/j.peptides.2010.12.016; Chen JR, 2002, J FOOD BIOCHEM, V26, P543, DOI 10.1111/j.1745-4514.2002.tb00772.x; Cu YC, 2011, FOOD RES INT, V44, P2465, DOI 10.1016/j.foodres.2011.01.051; Contreras MD, 2009, INT DAIRY J, V19, P566, DOI 10.1016/j.idairyj.2009.05.004; Donkor ON, 2007, INT DAIRY J, V17, P1321, DOI 10.1016/j.idairyj.2007.02.009; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Escudero E, 2010, J AGR FOOD CHEM, V58, P2895, DOI 10.1021/jf904204n; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Gomez-Ruiz JA, 2007, ELECTROPHORESIS, V28, P4202, DOI 10.1002/elps.200700324; Gomez-Ruiz JA, 2006, EUR FOOD RES TECHNOL, V223, P595, DOI 10.1007/s00217-005-0238-0; Gouda KGM, 2006, J AGR FOOD CHEM, V54, P4568, DOI 10.1021/jf060264q; Guang C, 2009, J AGR FOOD CHEM, V57, P5113, DOI 10.1021/jf900494d; Hanif K, 2010, HYPERTENS RES, V33, P11, DOI 10.1038/hr.2009.184; Hasan F, 2006, FOOD BIOPROD PROCESS, V84, P135, DOI 10.1205/fbp.05152; He R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091051; Hernandez-Ledesma B, 2007, INT DAIRY J, V17, P42, DOI 10.1016/j.idairyj.2005.12.012; Hernandez-Ledesma B, 2006, J CHROMATOGR A, V1116, P31, DOI 10.1016/j.chroma.2006.03.006; Hernandez-Ledesma B, 2011, ADV COLLOID INTERFAC, V165, P23, DOI 10.1016/j.cis.2010.11.001; Jalali-Heravi M, 2008, EUR J MED CHEM, V43, P548, DOI 10.1016/j.ejmech.2007.04.014; Jang A, 2005, MEAT SCI, V69, P653, DOI 10.1016/j.meatsci.2004.10.014; Kodera T, 2006, J FOOD SCI, V71, pC164, DOI 10.1111/j.1365-2621.2006.tb15612.x; Kuba M, 2005, PROCESS BIOCHEM, V40, P2191, DOI 10.1016/j.procbio.2004.08.010; Kuba M, 2003, BIOSCI BIOTECH BIOCH, V67, P1278, DOI 10.1271/bbb.67.1278; Lavoie JL, 2003, ENDOCRINOLOGY, V144, P2179, DOI 10.1210/en.2003-0150; Lee DH, 2004, PEPTIDES, V25, P621, DOI 10.1016/j.peptides.2004.01.015; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Liu B., 2013, QUANTITATIVE STRUCTU; Liu JB, 2010, FOOD CHEM, V122, P1159, DOI 10.1016/j.foodchem.2010.03.108; Lu J, 2011, J AGR FOOD CHEM, V59, P559, DOI 10.1021/jf104126a; Majumder K, 2009, J AGR FOOD CHEM, V57, P471, DOI 10.1021/jf8028557; Majumder K, 2010, FOOD RES INT, V43, P1371, DOI 10.1016/j.foodres.2010.04.027; MATERSON BJ, 1994, ARCH INTERN MED, V154, P513, DOI 10.1001/archinte.154.5.513; Matsui T, 1999, J PEPT SCI, V5, P289, DOI 10.1002/(SICI)1099-1387(199907)5:7<289::AID-PSC196>3.0.CO;2-6; Motoi H, 2003, NAHRUNG, V47, P354, DOI 10.1002/food.200390081; Muguruma M, 2009, FOOD CHEM, V114, P516, DOI 10.1016/j.foodchem.2008.09.081; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nedjar-Arroume N, 2008, PEPTIDES, V29, P969, DOI 10.1016/j.peptides.2008.01.011; Nedjar-Arroume N, 2006, PEPTIDES, V27, P2082, DOI 10.1016/j.peptides.2006.03.033; Ni H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037077; Peng WJ, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-54; Ren Y., 2011, SCI RES ESSAYS, V6, P6262; Sagardia I, 2013, FOOD CHEM, V136, P1370, DOI 10.1016/j.foodchem.2012.09.092; Shen Q, 2004, EUR J PHARM SCI, V22, P145, DOI 10.1016/j.ejps.2004.03.002; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Sturrock ED, 2004, CELL MOL LIFE SCI, V61, P2677, DOI 10.1007/s00018-004-4239-0; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Udenigwe CC, 2014, TRENDS FOOD SCI TECH, V36, P137, DOI 10.1016/j.tifs.2014.02.004; Vermeirssen V, 2004, BRIT J NUTR, V92, P357, DOI 10.1079/BJN20041189; Watermeyer JM, 2008, STRUCTURAL DETERMINA; Wu H, 2008, PROCESS BIOCHEM, V43, P457, DOI 10.1016/j.procbio.2008.01.018; Wu JP, 2007, J PEPT SCI, V13, P63, DOI 10.1002/psc.800; Wu JP, 2006, QSAR COMB SCI, V25, P873, DOI 10.1002/qsar.200630005; Wu JP, 2002, FOOD RES INT, V35, P367, DOI 10.1016/S0963-9969(01)00131-4; Yu ZP, 2012, FOOD CHEM, V133, P315, DOI 10.1016/j.foodchem.2012.01.032; Yu ZP, 2011, FOOD CHEM, V129, P1376, DOI 10.1016/j.foodchem.2011.05.067; Yu ZP, 2011, J SCI FOOD AGR, V91, P921, DOI 10.1002/jsfa.4266; Zhong M, 2013, J FOOD SCI, V78, pS1445, DOI 10.1111/1750-3841.12199	60	10	11	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119598	10.1371/journal.pone.0119598	http://dx.doi.org/10.1371/journal.pone.0119598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768442	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500088
J	Hirotsu, T; Sonoda, H; Uozumi, T; Shinden, Y; Mimori, K; Maehara, Y; Ueda, N; Hamakawa, M				Hirotsu, Takaaki; Sonoda, Hideto; Uozumi, Takayuki; Shinden, Yoshiaki; Mimori, Koshi; Maehara, Yoshihiko; Ueda, Naoko; Hamakawa, Masayuki			A Highly Accurate Inclusive Cancer Screening Test Using Caenorhabditis elegans Scent Detection	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; LUNG-CANCER; C-ELEGANS; OLFACTORY BEHAVIOR; GUANYLYL CYCLASE; SENSORY NEURONS; RECEPTORS; RESPONSES; BREATH; CHEMOTAXIS	Early detection and treatment are of vital importance to the successful eradication of various cancers, and development of economical and non-invasive novel cancer screening systems is critical. Previous reports using canine scent detection demonstrated the existence of cancer-specific odours. However, it is difficult to introduce canine scent recognition into clinical practice because of the need to maintain accuracy. In this study, we developed a Nematode Scent Detection Test (NSDT) using Caenorhabditis elegans to provide a novel highly accurate cancer detection system that is economical, painless, rapid and convenient. We demonstrated wild-type C. elegans displayed attractive chemotaxis towards human cancer cell secretions, cancer tissues and urine from cancer patients but avoided control urine; in parallel, the response of the olfactory neurons of C. elegans to the urine from cancer patients was significantly stronger than to control urine. In contrast, G protein a mutants and olfactory neurons-ablated animals were not attracted to cancer patient urine, suggesting that C. elegans senses odours in urine. We tested 242 samples to measure the performance of the NSDT, and found the sensitivity was 95.8%; this is markedly higher than that of other existing tumour markers. Furthermore, the specificity was 95.0%. Importantly, this test was able to diagnose various cancer types tested at the early stage (stage 0 or 1). To conclude, C. elegans scent-based analyses might provide a new strategy to detect and study disease-associated scents.	[Hirotsu, Takaaki; Uozumi, Takayuki; Hamakawa, Masayuki] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Hirotsu, Takaaki] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 812, Japan; [Sonoda, Hideto; Uozumi, Takayuki] Kyushu Univ, Res & Dev Ctr Taste & Odor Sensing, Div Appl Med Sensing, Fukuoka 812, Japan; [Hirotsu, Takaaki; Ueda, Naoko] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Sonoda, Hideto] Imari Arita Kyoritsu Hosp, Dept Gen Surg, Saga, Japan; [Shinden, Yoshiaki; Mimori, Koshi] Kyushu Univ, Beppu Hosp, Dept Surg, Oita, Japan; [Sonoda, Hideto; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University; Kyushu University; Kyushu University	Hirotsu, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	hirotsu.takaaki.056@m.kyushu-u.ac.jp; sonoda-hideto@imari-arita-hp.or.jp		Mimori, Koshi/0000-0003-3897-9974	JSPS; Senri Life Science Foundation; Inamori Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Health Foundation; Mishima Kaiun Memorial Foundation; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development [Type E-4, 24425]; Grants-in-Aid for Scientific Research [26430019] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senri Life Science Foundation; Inamori Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Japan Health Foundation(Japan Health Foundation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a JSPS Grant-in-aid for Young Scientists (A), Grant-in-Aid for Scientific Research (C), Senri Life Science Foundation, Inamori Foundation, The Kurata Memorial Hitachi Science and Technology Foundation, The Japan Health Foundation, Mishima Kaiun Memorial Foundation and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (Type E-4, 24425). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bargmann CI., 2006, WORMBOOK, P1, DOI [10.1895/wormbook.1.123.1, DOI 10.1895/WORMBOOK.1.123.1]; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; Bianchi Laura, 2006, WormBook, P1; Bijland LR, 2013, NETH J MED, V71, P300; Boyle P., 2008, World Cancer Report 2008; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chen X, 2007, CANCER-AM CANCER SOC, V110, P835, DOI 10.1002/cncr.22844; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; D'Amico Arnaldo, 2012, Expert Opin Med Diagn, V6, P175, DOI 10.1517/17530059.2012.665870; Di Natale C, 2003, BIOSENS BIOELECTRON, V18, P1209, DOI 10.1016/S0956-5663(03)00086-1; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Hanai Y, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-7; Hirotsu T, 2005, GENES CELLS, V10, P517, DOI 10.1111/j.1365-2443.2005.00856.x; Horvath G, 2008, INTEGR CANCER THER, V7, P76, DOI 10.1177/1534735408319058; Kajikawa J, 2010, JPN J MED PHARM SCI, V63, P523; Kawakita M, 2011, METHODS MOL BIOL, V720, P367, DOI 10.1007/978-1-61779-034-8_23; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Luo L, 2008, J NEUROPHYSIOL, V99, P2617, DOI 10.1152/jn.00053.2008; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nuttley WM, 2001, LEARN MEMORY, V8, P170, DOI 10.1101/lm.36501; Phillips M, 1999, LANCET, V353, P1930, DOI 10.1016/S0140-6736(98)07552-7; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robertson Hugh M, 2006, WormBook, P1; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shinkai Y, 2011, J NEUROSCI, V31, P3007, DOI 10.1523/JNEUROSCI.4691-10.2011; Sonoda H, 2014, SURG TODAY, P17, DOI [10.1007/s00595-014-0850-3, DOI 10.1007/S00595-014-0850-3]; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; Suzuki N, 2006, JPN J MED PHARM SCI, V56, P897; Taniguchi G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005136; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Uozumi T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00500; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Yoshida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1750; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	42	41	46	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118699	10.1371/journal.pone.0118699	http://dx.doi.org/10.1371/journal.pone.0118699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760772	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000034
J	Matsue, Y; Tsutsumi, M; Hayashi, N; Saito, T; Tsuchishima, M; Toshikuni, N; Arisawa, T; George, J				Matsue, Yasuhiro; Tsutsumi, Mikihiro; Hayashi, Nobuhiko; Saito, Takashi; Tsuchishima, Mutsumi; Toshikuni, Nobuyuki; Arisawa, Tomiyasu; George, Joseph			Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection	PLOS ONE			English	Article							MOLECULAR PATHOGENESIS; FIBROTIC LIVER; CIRRHOSIS; ENGAGEMENT; TESTS	Background & Aims Osteopontin (OPN) is a matricellular protein that upregulates during pathogenesis of hepatic fibrosis. The present study was aimed to evaluate whether serum OPN could be used as a biomarker to assess the degree of hepatic fibrosis in patients with hepatitis C virus (HCV) infection. Methods Needle biopsy was performed on HCV patients and scored as zero fibrosis (F0), mild fibrosis (F1), moderate fibrosis (F2), severe fibrosis (F3) and liver cirrhosis (F4) based on Masson's trichrome and a-smooth muscle actin (alpha-SMA) staining. Serum OPN levels were measured using ELISA and correlated with the degree of fibrosis. Furthermore, the OPN values were correlated and evaluated with platelets count, serum hyaluronic acid (HA), and collagen type IV and subjected to receiver operating characteristic (ROC) curve analysis. Results Serum OPN levels were remarkably increased from F0 through F4 in a progressive manner and the differences were significant (P < 0.001) between each group. The data were highly correlated with the degree of hepatic fibrosis. The ROC curve analysis depicted that serum OPN is an independent risk factor and an excellent biomarker and a prognostic index in HCV patients. Conclusions The results of the present study indicate that serum OPN levels reflect the degree of hepatic fibrosis and could be used as a biomarker to assess the stage of fibrosis in HCV patients which would help to reduce the number of liver biopsies. Furthermore, serum OPN serves as a prognostic index towards the progression of hepatic fibrosis to cirrhosis and hepatocellular carcinoma.	[Matsue, Yasuhiro; Tsutsumi, Mikihiro; Hayashi, Nobuhiko; Saito, Takashi; Tsuchishima, Mutsumi; Toshikuni, Nobuyuki; George, Joseph] Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan; [Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Uchinada, Ishikawa 92002, Japan	Kanazawa Medical University; Kanazawa Medical University	George, J (corresponding author), Kanazawa Med Univ, Dept Hepatol, Uchinada, Ishikawa 92002, Japan.	georgej@kanazawa-med.ac.jp	George, Joseph/P-8447-2018	George, Joseph/0000-0001-5354-7884	Kanazawa Medical University [SR2012-04]; Ministry of Health, Labor, and Welfare of Japan	Kanazawa Medical University; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant for Specially Promoted Research from Kanazawa Medical University (SR2012-04) and the Ministry of Health, Labor, and Welfare of Japan to M. Tsutsumi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El Makarem MA, 2011, ANN HEPATOL, V10, P296, DOI 10.1016/S1665-2681(19)31541-8; Arai M, 2006, SCAND J GASTROENTERO, V41, P102, DOI 10.1080/00365520510024061; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bose SK, 2014, WORLD J DIABETES, V5, P52, DOI 10.4239/wjd.v5.i1.52; CHICHIBU K, 1989, CLIN CHIM ACTA, V181, P317, DOI 10.1016/0009-8981(89)90237-4; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; George J, 2004, CLIN CHIM ACTA, V348, P189, DOI 10.1016/j.cccn.2004.05.018; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; George J, 1996, BBA-PROTEIN STRUCT M, V1292, P215, DOI 10.1016/0167-4838(95)00202-2; Gotoh M, 2002, PATHOL INT, V52, P19, DOI 10.1046/j.1440-1827.2002.01316.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huang WB, 2010, CLIN CHIM ACTA, V411, P675, DOI 10.1016/j.cca.2010.01.029; Lee SH, 2004, BIOCHEM PHARMACOL, V68, P2367, DOI 10.1016/j.bcp.2004.08.022; Lorena D, 2006, J HEPATOL, V44, P383, DOI 10.1016/j.jhep.2005.07.024; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; MISAKI M, 1990, CLIN CHEM, V36, P522; Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Nagoshi S, 2014, HEPATOL RES, V44, P22, DOI 10.1111/hepr.12166; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Patouraux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035612; Ramaiah SK, 2008, TOXICOL SCI, V103, P4, DOI 10.1093/toxsci/kfm246; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Vezali E, 2010, CLIN THER, V32, P2117, DOI 10.1016/S0149-2918(11)00022-1; Wong N, 2000, CLIN CANCER RES, V6, P4000; Zhao L, 2008, INT J CLIN PRACT, V62, P1056, DOI 10.1111/j.1742-1241.2007.01368.x; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	40	39	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118744	10.1371/journal.pone.0118744	http://dx.doi.org/10.1371/journal.pone.0118744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760884	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000035
J	Boas, IMV; Pidde-Queiroz, G; Magnoli, FC; Goncalves-de-Andrade, RM; van den Berg, CW; Tambourgi, DV				Villas Boas, Isadora Maria; Pidde-Queiroz, Giselle; Magnoli, Fabio Carlos; Goncalves-de-Andrade, Rute M.; van den Berg, Carmen W.; Tambourgi, Denise V.			A Serine Protease Isolated from the Bristles of the Amazonic Caterpillar, Premolis semirufa, Is a Potent Complement System Activator	PLOS ONE			English	Article							LOXOSCELES-INTERMEDIA; VENOM; C5A; METALLOPROTEINASE; ANAPHYLATOXINS; ENVENOMATION; IMMUNOLOGY; COMPONENT; PROTEINS; CLEAVAGE	Background The caterpillar of the moth Premolis semirufa, commonly named pararama, is found in the Brazilian Amazon region. Accidental contact with the caterpillar bristles causes an intense itching sensation, followed by symptoms of an acute inflammation, which last for three to seven days after the first incident. After multiple accidents a chronic inflammatory reaction, called "Pararamose", characterized by articular synovial membrane thickening with joint deformities common to chronic synovitis, frequently occurs. Although complement mediated inflammation may aid the host defense, inappropriate or excessive activation of the complement system and generation of anaphylatoxins can lead to inflammatory disorder and pathologies. The aim of the present study was to evaluate, in vitro, whether the Premolis semirufa's bristles extract could interfere with the human complement system. Results The bristles extract was able to inhibit the haemolytic activity of the alternative pathway, as well as the activation of the lectin pathway, but had no effect on the classical pathway, and this inhibition seemed to be caused by activation and consumption of complement components. The extract induced the production of significant amounts of all three anaphylatoxins, C3a, C4a and C5a, promoted direct cleavage of C3, C4 and C5 and induced a significant generation of terminal complement complexes in normal human serum. By using molecular exclusion chromatography, a serine protease of 82 kDa, which activates complement, was isolated from P. semirufa bristles extract. The protease, named here as Ps82, reduced the haemolytic activity of the alternative and classical pathways and inhibited the lectin pathway. In addition, Ps82 induced the cleavage of C3, C4 and C5 and the generation of C3a and C4a in normal human serum and it was capable to cleave human purified C5 and generate C5a. The use of Phenanthroline, metalloprotease inhibitor, in the reactions did not significantly interfere with the activity of the Ps82, whereas the presence of PMSF, serine protease inhibitor, totally blocked the activity. Conclusion These data show that a serine protease present in the Premolis semirufa's bristles extract has the ability to activate the complement system, which may contribute to the inflammatory process presented in humans after envenomation.	[Villas Boas, Isadora Maria; Pidde-Queiroz, Giselle; Magnoli, Fabio Carlos; Goncalves-de-Andrade, Rute M.; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, SP, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, SP, Brazil.	denise.tambourgi@butantan.gov.br	Tambourgi, Denise/H-7114-2016; Boas, Isadora Maria Villas/H-3499-2013; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Tambourgi, Denise/0000-0003-1896-9074; Villas Boas, Isadora/0000-0001-6034-9544	FAPESP; CNPq; Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX)	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX)	This study was supported by grants from FAPESP, CNPq and Instituto Nacional de Ciencia e Tecnologia em Toxinas (INCTTOX).	Addis-Lieser E, 2005, J IMMUNOL, V175, P1894, DOI 10.4049/jimmunol.175.3.1894; Bertazzi DT, 2005, INT IMMUNOPHARMACOL, V5, P1077, DOI 10.1016/j.intimp.2005.02.007; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Costa R M, 1993, Rev Paul Med, V111, P462; Costa RM, 2003, ANIMAIS PECONHENTOS, P233, DOI [10.1016/j.ttbdis.2014.03.010, DOI 10.1016/J.TTBDIS.2014.03.010]; Dias LB, 1997, DOENCAS INFECCIOSAS; EGGERTSEN G, 1980, TOXICON, V18, P87, DOI 10.1016/0041-0101(80)90034-3; EMBER JA, 1998, HUMAN COMPLEMENT SYS, P241; Farsky SHP, 2000, MEDIAT INFLAMM, V9, P213, DOI 10.1080/09629350020025728; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; HUGLI T E, 1986, Complement, V3, P111; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jusko M, 2014, J INNATE IMMUN, V6, P31, DOI 10.1159/000351458; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Ministerio da Saude, 1992, MAN DIAGN TRAT AC AN; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MULLEREBERHARD HJ, 1985, J INVEST DERMATOL, V85, pS47; Nataf S, 1999, J IMMUNOL, V162, P4018; Ottonello L, 1999, J IMMUNOL, V162, P6510; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Pidde-Queiroz G, 2010, MOL IMMUNOL, V47, P2537, DOI 10.1016/j.molimm.2010.07.003; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Tambourgi DV, 2014, MOL IMMUNOL, V61, P153, DOI 10.1016/j.molimm.2014.06.020; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; TAMBOURGI DV, 1995, J IMMUNOL, V155, P4459; Tambourgi DV, 2000, BLOOD, V95, P683, DOI 10.1182/blood.V95.2.683; TAMBOURGI DV, 1994, BRIT J PHARMACOL, V112, P723, DOI 10.1111/j.1476-5381.1994.tb13137.x; Tanaka GD, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-4; Villas-Boas IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071938; Villas-Boas IM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001531; Vogel CW, 2010, TOXICON, V56, P1198, DOI 10.1016/j.toxicon.2010.04.007; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118615	10.1371/journal.pone.0118615	http://dx.doi.org/10.1371/journal.pone.0118615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760458	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000032
J	Ohtsuki, H; Awano, T; Tsugeki, NK; Ishida, S; Oda, H; Makino, W; Urabe, J				Ohtsuki, Hajime; Awano, Tamotsu; Tsugeki, Narumi K.; Ishida, Seiji; Oda, Hirotaka; Makino, Wataru; Urabe, Jotaro			Historical Changes in the Ecosystem Condition of a Small Mountain Lake over the Past 60 Years as Revealed by Plankton Remains and Daphnia Ephippial Carapaces Stored in Lake Sediments	PLOS ONE			English	Article							WHOLE-LAKE; ZOOPLANKTON COMMUNITY; NITROGEN SATURATION; LARGEMOUTH BASS; FISH ABUNDANCE; RESTING EGGS; LONG-TERM; EUTROPHICATION; DEPOSITION; JAPAN	To examine if changes in species composition of a plankton community in the past due to anthropogenic activities can be clarified in lakes without any monitoring data, we analyzed genetically ephippial carapaces of Daphnia with plankton remains stored in the bottom sediments of Lake Hataya Ohunma in Japan. In the lake, abundance of most plankton remains in the sediments was limited and TP flux was at low levels (2-4 mg/m(2)/y) before 1970. However TP flux increased two-fold during the period from 1980s to 1990s. In parallel with this increase, abundance of most plankton remains increased although abundance of benthic testate amoebae's remains decreased, indicating that the lake trophic condition had changed from oligo-to mesotrophic for the past 60 years. According to cluster analysis, the stratigraphic sediments were divided into two periods with different features of the phytoplankton composition. Chronological comparison with events in the watershed suggested that eutrophication occurred because of an increase in visitors to the watershed and deposition of atmospheric dust. In this lake more than 50% of resting eggs produced by Daphnia over the past 60 years hatched. However, genetic analysis of the ephippial carapaces (remains) showed that the Daphnia population was originally composed of D. dentifera but that D. galeata, or its hybrid with D. dentifera, invaded and increased the population density when the lake was eutrophied. Subsequently, large D. pulex established populations in the 1980s when largemouth bass were anonymously introduced. These results indicated that the Lake Hataya Ohunma plankton community underwent significant changes despite the fact that there were no notable changes in land cover or land use in the watershed. Since increases in atmospheric deposition and release of fish have occurred in many Japanese lakes, the changes in the plankton community described here may be widespread in these lakes.	[Ohtsuki, Hajime; Awano, Tamotsu; Tsugeki, Narumi K.; Ishida, Seiji; Makino, Wataru; Urabe, Jotaro] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan; [Oda, Hirotaka] Nagoya Univ, Chronol Res, Nagoya, Aichi 4648601, Japan	Tohoku University; Nagoya University	Ohtsuki, H (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	ohtsuki-hajime@m.tohoku.ac.jp	Tsugeki, Narumi/AAV-2862-2021; Urabe, Jotaro/ABI-7692-2020; Urabe, Jotaro/A-6256-2012	Tsugeki, Narumi/0000-0003-1236-906X; Urabe, Jotaro/0000-0001-5111-687X; Urabe, Jotaro/0000-0001-5111-687X	MEXT Japan [19207003]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [D-1002]; Global COE (Centers of Excellence) Program of MEXT, Japan [J03, E07]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Global COE (Centers of Excellence) Program of MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research A (no. 19207003) from MEXT Japan, by the Environment Research and Technology Development Fund (D-1002) of the Ministry of the Environment, Japan, and by the Global COE (Centers of Excellence) Program (J03, E07) of MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association A. W. W. A. Water Environment Federation APHA AWWA and WEF, 1998, STANDARD METHODS EXA; ANDERSON NJ, 1993, TRENDS ECOL EVOL, V8, P356; Azuma M, 1998, ENVIRON BIOL FISH, V52, P379, DOI 10.1023/A:1007476104352; Bennice CO, 2009, AQUAC RES, V40, P582, DOI 10.1111/j.1365-2109.2008.02134.x; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; Caceres CE, 2004, OECOLOGIA, V141, P425, DOI 10.1007/s00442-004-1657-5; Carpenter S. R., 1996, TROPHIC CASCADE LAKE; Catalan J, 2013, J PALEOLIMNOL, V49, P513, DOI 10.1007/s10933-013-9681-2; Davidson TA, 2010, FRESHWATER BIOL, V55, P584, DOI 10.1111/j.1365-2427.2009.02391.x; DEMOTT WR, 1982, ECOLOGY, V63, P1949, DOI 10.2307/1940132; Escobar J, 2008, J PALEOLIMNOL, V40, P715, DOI 10.1007/s10933-008-9195-5; Fitzsimmons JM, 2006, HYDROBIOLOGIA, V568, P187, DOI 10.1007/s10750-006-0104-5; Frey D.G., 1986, P667; Frisch D, 2014, ECOL LETT, V17, P360, DOI 10.1111/ele.12237; Gliwicz M., 1989, P253; GOULDEN CE, 1982, ECOLOGY, V63, P1780, DOI 10.2307/1940120; Han BP, 2008, HYDROBIOLOGIA, V596, P197, DOI 10.1007/s10750-007-9096-z; Hanazato Takayuki, 2001, Japanese Journal of Limnology, V62, P151; Hariston NG, 1999, LIMNOL OCEANOGR, V44, P477; Ishida S, 2012, LIMNOLOGY, V13, P261, DOI 10.1007/s10201-012-0380-x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Jankowski T, 2003, LIMNOL OCEANOGR, V48, P1948, DOI 10.4319/lo.2003.48.5.1948; Jeppesen E, 2001, TRENDS ECOL EVOL, V16, P191, DOI 10.1016/S0169-5347(01)02100-0; Jeppesen E, 2003, HYDROBIOLOGIA, V491, P321, DOI 10.1023/A:1024488525225; Jeppesen E, 2002, J PALEOLIMNOL, V27, P133, DOI 10.1023/A:1013561208488; Kanai Y., 1995, BULL GEOL SURV JPN, V46, P225; KOHATA K, 1991, J CHROMATOGR, V558, P131, DOI 10.1016/0021-9673(91)80118-Z; KOMEIJI T, 1990, ATMOS ENVIRON A-GEN, V24, P2099, DOI 10.1016/0960-1686(90)90243-G; Lampert KP, 2014, FRESHWATER BIOL, V59, P1735, DOI 10.1111/fwb.12378; LAMPERT W, 1996, LIMNOECOLOGY ECOLOGY; Leavitt PR, 1994, J PALEOLIMNOL, V11, P133, DOI 10.1007/BF00686862; Leavitt PR, 1999, LIMNOL OCEANOGR, V44, P757, DOI 10.4319/lo.1999.44.3_part_2.0757; Makino W, 2001, HYDROBIOLOGIA, V442, P309, DOI 10.1023/A:1017532717135; Markova S, 2006, BIOLOGIA, V61, pS135, DOI 10.2478/s11756-006-0126-5; MEDIOLI FS, 1988, PALAEOGEOGR PALAEOCL, V62, P361, DOI 10.1016/0031-0182(88)90062-4; Mergeay J, 2005, HYDROBIOLOGIA, V542, P261, DOI 10.1007/s10750-004-4952-6; MITTELBACH GG, 1995, ECOLOGY, V76, P2347, DOI 10.2307/2265812; Neff JC, 2008, NAT GEOSCI, V1, P189, DOI 10.1038/ngeo133; Nykanen M, 2009, J PALEOLIMNOL, V42, P551, DOI 10.1007/s10933-008-9304-5; Ohrui K, 1997, ECOL APPL, V7, P391, DOI 10.1890/1051-0761(1997)007[0391:NSIJFW]2.0.CO;2; Ohte N, 2001, WATER AIR SOIL POLL, V130, P649, DOI 10.1023/A:1013804728336; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Pollard HG, 2003, AMBIO, V32, P214, DOI 10.1639/0044-7447(2003)032[0214:ROCDCI]2.0.CO;2; R Core Team, R LANG ENV STAT COMP; Reid VA, 2002, J PALEOLIMNOL, V27, P481, DOI 10.1023/A:1020380918518; Rellstab C, 2011, LIMNOL OCEANOGR, V56, P292, DOI 10.4319/lo.2011.56.1.0292; SCOTT DB, 1983, J PALEONTOL, V57, P809; Shiraishi Y., 1961, B FRESHWATER FISH RE, V10, P1; Sorf M, 2014, ANN LIMNOL-INT J LIM, V50, P71, DOI 10.1051/limn/2014001; Takamura K, 2007, ECOL RES, V22, P940, DOI 10.1007/s11284-007-0415-7; TAKAMURA N, 1992, ARCH HYDROBIOL, V124, P129; Takamura N, 2012, ECOL RES, V27, P837, DOI 10.1007/s11284-012-0971-3; Tsugeki N, 2003, LIMNOLOGY, V4, P101, DOI 10.1007/s10201-003-0097-y; Tsugeki NK, 2014, J LIMNOL, V73, P191, DOI 10.4081/jlimnol.2014.569; Tsugeki NK, 2012, ECOL RES, V27, P1041, DOI 10.1007/s11284-012-0984-y; Tsugeki NK, 2010, J PALEOLIMNOL, V44, P69, DOI 10.1007/s10933-009-9386-8; Tsugeki NK, 2009, J PALEOLIMNOL, V42, P155, DOI 10.1007/s10933-008-9268-5; URABE J, 1990, LIMNOL OCEANOGR, V35, P1703, DOI 10.4319/lo.1990.35.8.1703; Wakamatsu Shinji, 2013, Asian Journal of Atmospheric Environment, V7, P177, DOI 10.5572/ajae.2013.7.4.177; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yamagata Prefecture, 1968, HIST YAMAGATA PREFEC, V1	62	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119767	10.1371/journal.pone.0119767	http://dx.doi.org/10.1371/journal.pone.0119767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757090	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700052
J	Sheikh, BN; Phipson, B; El-Saafin, F; Vanyai, HK; Downer, NL; Bird, MJ; Kueh, AJ; May, RE; Smyth, GK; Voss, AK; Thomas, T				Sheikh, B. N.; Phipson, B.; El-Saafin, F.; Vanyai, H. K.; Downer, N. L.; Bird, M. J.; Kueh, A. J.; May, R. E.; Smyth, G. K.; Voss, A. K.; Thomas, T.			MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway	ONCOGENE			English	Article							LEUKEMIA ZINC-FINGER; LEUCINE-ZIPPER KINASE; ACUTE MYELOID-LEUKEMIA; MONOCYTIC LEUKEMIA; GENE-EXPRESSION; TRANSLOCATION T(8/16)(P11,P13); GENOME EXPRESSION; CELL-DEATH; PROTEIN; PROLIFERATION	Cellular senescence is an important mechanism that restricts tumour growth. The Ink4a-Arf locus (also known as Cdkn2a), which encodes p16(INK4A) and p19(ARF), has a central role in inducing and maintaining senescence. Given the importance of cellular senescence in restraining tumour growth, great emphasis is being placed on the identification of novel factors that can modulate senescence. The MYST-family histone acetyltransferase MOZ (MYST3, KAT6A), first identified in recurrent translocations in acute myeloid leukaemia, has been implicated in both the promotion and inhibition of senescence. In this study, we investigate the role of MOZ in cellular senescence and show that MOZ is a potent inhibitor of senescence via the INK4A-ARF pathway. Primary mouse embryonic fibroblasts (MEFs) isolated from Moz-deficient embryos exhibit premature senescence, which was rescued on the Ink4a-Arf(-/-) background. Importantly, senescence resulting from the absence of MOZ was not accompanied by DNA damage, suggesting that MOZ acts independently of the DNA damage response. Consistent with the importance of senescence in cancer, expression profiling revealed that genes overexpressed in aggressive and highly proliferative cancers are expressed at low levels in Mozdeficient MEFs. We show that MOZ is required to maintain normal levels of histone 3 lysine 9 (H3K9) and H3K27 acetylation at the transcriptional start sites of at least four genes, Cdc6, Ezh2, E2f2 and Melk, and normal mRNA levels of these genes. CDC6, EZH2 and E2F2 are known inhibitors of the INK4A-ARF pathway. Using chromatin immunoprecipitation, we show that MOZ occupies the Cdc6, Ezh2 and Melk loci, thereby providing a direct link between MOZ, H3K9 and H3K27 acetylation, and normal transcriptional levels at these loci. This work establishes that MOZ is an upstream inhibitor of the INK4A-ARF pathway, and suggests that inhibiting MOZ may be one way to induce senescence in proliferative tumour cells.	[Sheikh, B. N.; El-Saafin, F.; Vanyai, H. K.; Downer, N. L.; Kueh, A. J.; May, R. E.; Voss, A. K.; Thomas, T.] Walter & Eliza Hall Inst Med Res, Div Dev & Canc, Melbourne, Vic 3052, Australia; [Sheikh, B. N.; El-Saafin, F.; Vanyai, H. K.; Voss, A. K.; Thomas, T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Phipson, B.; Smyth, G. K.] Walter & Eliza Hall Inst Med Res, Div Bioinformat, Melbourne, Vic 3052, Australia; [Phipson, B.; Bird, M. J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bird, M. J.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Smyth, G. K.] Univ Melbourne, Dept Math & Stat, Melbourne, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Thomas, T (corresponding author), Walter & Eliza Hall Inst Med Res, Div Dev & Canc, 1G Royal Parade, Melbourne, Vic 3052, Australia.	avoss@wehi.edu.au; tthomas@wehi.edu.au	Smyth, Gordon/B-5276-2008; Voss, Anne K/F-5110-2013; Phipson, Belinda/AAP-2213-2020	Smyth, Gordon/0000-0001-9221-2892; Voss, Anne K/0000-0002-3853-9381; Phipson, Belinda/0000-0002-1711-7454; Bird, Matthew/0000-0003-3185-0780; Sheikh, Bilal/0000-0002-1970-6236; Thomas, Tim/0000-0002-7623-8344	Australian National Health and Medical Research Council; Australian Mitochondrial Disease Foundation; Australian Postgraduate Awards; Australian Federal Government (IRISS); Victorian State Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Mitochondrial Disease Foundation; Australian Postgraduate Awards(Australian Government); Australian Federal Government (IRISS)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government	We thank Carmen Gatt and Faye Dabrowski for technical support. We thank Andreas Strasser for helpful discussions and Liz Valente for the provision of the anti-p21<SUP>CIP1</SUP> antibody. This work was supported by the Australian National Health and Medical Research Council (senior research fellowships to AKV and TT; scholarship to BNS), the Australian Mitochondrial Disease Foundation (MJB), Australian Postgraduate Awards (to MJB, FE and HKV) and operational infrastructure grants from the Australian Federal Government (IRISS) and the Victorian State Government (OIS).	Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Azzam G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074297; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Camos M, 2006, CANCER RES, V66, P6947, DOI 10.1158/0008-5472.CAN-05-4601; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; Champagne N, 2001, ONCOGENE, V20, P404, DOI 10.1038/sj.onc.1204114; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Esteyries S, 2008, LEUKEMIA, V22, P663, DOI 10.1038/sj.leu.2404930; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; Haferlach T, 2009, LEUKEMIA, V23, P934, DOI 10.1038/leu.2008.388; Hayama S, 2007, CANCER RES, V67, P4113, DOI 10.1158/0008-5472.CAN-06-4705; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kig C, 2013, J BIOL CHEM, V288, P24200, DOI 10.1074/jbc.M113.471433; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Ohta S, 2001, ONCOL REP, V8, P1063; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Perez-Campo FM, 2014, STEM CELLS, V32, P1591, DOI 10.1002/stem.1606; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; QUELLE DE, 1995, CELL, V83, P993; Reimann M, 2010, CANCER CELL, V17, P262, DOI 10.1016/j.ccr.2009.12.043; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rokudai S, 2013, P NATL ACAD SCI USA, V110, P3895, DOI 10.1073/pnas.1300490110; Rokudai S, 2009, J BIOL CHEM, V284, P237, DOI 10.1074/jbc.M805101200; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; STARK B, 1995, LEUKEMIA RES, V19, P367, DOI 10.1016/0145-2126(94)00150-9; Sun T, 2001, AM J HEMATOL, V66, P207, DOI 10.1002/1096-8652(200103)66:3<207::AID-AJH1046>3.0.CO;2-Q; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vasseur Sophie, 2003, Mol Cancer, V2, P19, DOI 10.1186/1476-4598-2-19; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Voss AK, 2012, METHODS MOL BIOL, V809, P335, DOI 10.1007/978-1-61779-376-9_23; Voss AK, 2009, DEV CELL, V17, P674, DOI 10.1016/j.devcel.2009.10.006; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu D, 2010, BIOINFORMATICS, V26, P2176, DOI 10.1093/bioinformatics/btq401; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603	75	46	49	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 19	2015	34	47					5807	5820		10.1038/onc.2015.33	http://dx.doi.org/10.1038/onc.2015.33			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW5KV	25772242				2022-12-26	WOS:000365035200004
J	Maric, G; Annis, MG; Dong, Z; Rose, AAN; Ng, S; Perkins, D; MacDonald, PA; Ouellet, V; Russo, C; Siegel, PM				Maric, G.; Annis, M. G.; Dong, Z.; Rose, A. A. N.; Ng, S.; Perkins, D.; MacDonald, P. A.; Ouellet, V.; Russo, C.; Siegel, P. M.			GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin alpha(5)beta(1) for efficient breast cancer metastasis	ONCOGENE			English	Article							GLYCOPROTEIN NONMETASTATIC B; THERAPEUTIC TARGET; DC-HIL; EXPRESSION; OSTEOACTIVIN; PROTEIN; CELLS; ADHESION; ANGIOGENESIS; SIGNATURE	Glycoprotein nmb (GPNMB) promotes breast tumor growth and metastasis and its expression in tumor epithelium correlates with poor prognosis in breast cancer patients. Despite its biological and clinical significance, little is known regarding the molecular mechanisms engaged by GPNMB. Herein, we show that GPNMB engages distinct functional domains and mechanisms to promote primary tumor growth and metastasis. We demonstrate that neuropilin-1 (NRP-1) expression is increased in breast cancer cells that overexpress GPNMB. Interestingly, the GPNMB-driven increase in NRP-1 expression potentiated vascular endothelial growth factor signaling in breast cancer cells and was required for the growth, but not metastasis, of these cells in vivo. Interrogation of RNAseq data sets revealed a positive correlation between GPNMB and NRP-1 levels in human breast tumors. Furthermore, we ascribe pro-growth and pro-metastatic functions of GPNMB to its ability to bind alpha(5)beta(1) integrin and increase downstream signaling in breast cancer cells. We show that GPNMB enhances breast cancer cell adhesion to fibronectin, increases alpha(5)beta(1) expression and associates with this receptor through its RGD motif. GPNMB recruitment into integrin complexes activates Src and Fak signaling pathways in an RGD-dependent manner. Importantly, both the RGD motif and cytoplasmic tail of GPNMB are required to promote primary mammary tumor growth; however, only mutation of the RGD motif impaired the formation of lung metastases. Together, these findings identify novel and distinct molecular mediators of GPNMB-induced breast cancer growth and metastasis.	[Maric, G.; Annis, M. G.; Dong, Z.; Rose, A. A. N.; Ng, S.; Perkins, D.; MacDonald, P. A.; Ouellet, V.; Russo, C.; Siegel, P. M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Maric, G.; Annis, M. G.; Dong, Z.; Rose, A. A. N.; MacDonald, P. A.; Ouellet, V.; Russo, C.; Siegel, P. M.] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Ng, S.; Perkins, D.; Siegel, P. M.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Siegel, P. M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Siegel, PM (corresponding author), McGill Univ, Goodman Canc Res Ctr, 1160 Pine Ave West,Room 513, Montreal, PQ H3A 1A3, Canada.	peter.siegel@mcgill.ca	Rose, April/AAR-8222-2020	Rose, April/0000-0002-9845-4603; Annis, Matthew/0000-0002-8776-004X	Canadian Institutes for Health Research (CIHR); Fonds de recherche en sante du Quebec (FRSQ) research scholar program; CIHR [MOP-119401]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec (FRSQ) research scholar program; CIHR(Canadian Institutes of Health Research (CIHR))	We thank members of the Siegel laboratory for their thoughtful discussions regarding the current work and are also grateful to Dr Josie Ursini-Siegel for her critical reading of the manuscript. We acknowledge the Goodman Cancer Research Centre histology core facility (McGill University) for routine histological services. GM acknowledges studentship support from the Canadian Institutes for Health Research (CIHR). PMS was supported by the Fonds de recherche en sante du Quebec (FRSQ) research scholar program (Junior 2) and is currently a McGill University William Dawson Scholar. This research was supported solely by a grant from the CIHR (MOP-119401).	Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Bachelder RE, 2001, CANCER RES, V61, P5736; Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bendell J, 2013, J CLIN ONCOL, V32, P3619; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chung JS, 2009, J IMMUNOL, V183, P5190, DOI 10.4049/jimmunol.0901319; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Keir CH, 2012, EXPERT OPIN BIOL TH, V12, P259, DOI 10.1517/14712598.2012.642357; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Le Borgne R, 2001, J CELL SCI, V114, P2831; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309, DOI 10.1615/CritRevEukarGeneExpr.v22.i4.50; Moussa FM, 2014, J CELL BIOCHEM, V115, P1243, DOI 10.1002/jcb.24760; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; Northey JJ, 2013, J BIOL CHEM, V288, P5210, DOI 10.1074/jbc.M112.424804; Parikh AA, 2003, CANCER, V98, P720, DOI 10.1002/cncr.11560; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rose AAN, 2007, MOL CANCER RES, V5, P1001, DOI 10.1158/1541-7786.MCR-07-0119; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Sondag GR, 2014, J CELL PHYSIOL, V229, P955, DOI 10.1002/jcp.24512; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Theos AC, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12084; Tomihari M, 2009, EXP DERMATOL, V18, P586, DOI 10.1111/j.1600-0625.2008.00830.x; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Vaklavas C, 2014, BIODRUGS; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Xu H, 2014, CLIN CHEM, V60, P122, DOI 10.1373/clinchem.2013.207167; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	49	47	51	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	2015	34	43					5494	5504		10.1038/onc.2015.8	http://dx.doi.org/10.1038/onc.2015.8			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU4EM	25772243				2022-12-26	WOS:000363479700009
J	Castrillo, M; Avalos, J				Castrillo, Marta; Avalos, Javier			The Flavoproteins CryD and VvdA Cooperate with the White Collar Protein WcoA in the Control of Photocarotenogenesis in Fusarium fujikuroi	PLOS ONE			English	Article							DEPENDENT CAROTENOID SYNTHESIS; NEUROSPORA-CRASSA; SCLEROTINIA-SCLEROTIORUM; LIGHT REGULATION; GENE-CLUSTER; BIOSYNTHESIS; MUTANTS; PHOTOLYASE; ENZYMES; DNA	Light stimulates carotenoid biosynthesis in the ascomycete fungus Fusarium fujikuroi through transcriptional activation of the structural genes of the pathway carRA, carB, and cart, but the molecular basis of this photoresponse is unknown. The F. fujikuroi genome contains genes for different predicted photoreceptors, including the WC protein WcoA, the DASH cryptochrome CryD and the Vivid-like flavoprotein VvdA. We formerly found that null mutants of wcoA, cryD or vvdA exhibit carotenoid photoinduction under continuous illumination. Here we show that the wild type exhibits a biphasic response in light induction kinetics experiments, with a rapid increase in carotenoid content in the first hours, a transient arrest and a subsequent slower increase. The mutants of the three photoreceptors show different kinetic responses: the wcoA mutants are defective in the rapid response, the cryD mutants are affected in the slower response, while the fast and slow responses were respectively enhanced and attenuated in the vvdA mutants. Transcriptional analyses of the car genes revealed a strong reduction of dark and light-induced transcript levels in the wcoA mutants, while minor or no reductions were found in the cryD mutants. Formerly, we found no change on carRA and carB photoinduction in vvdA mutants. Taken together, our data suggest a cooperative participation of WcoA and CryD in early and late stages of photoinduction of carotenoid biosynthesis in F. fujikuroi, and a possible modulation of WcoA activity by VvdA. An unexpected transcriptional induction by red light of vvdA, cryD and carRA genes suggest the participation of an additional red light-absorbing photoreceptor.	[Castrillo, Marta; Avalos, Javier] Univ Seville, Dept Genet, Seville, Spain	University of Sevilla	Avalos, J (corresponding author), Univ Seville, Dept Genet, Seville, Spain.	avalos@us.es	Avalos, Javier/B-4218-2011	Avalos, Javier/0000-0001-5484-2893	European funds (European Regional Development Fund, ERDF); Spanish Government (Ministerio de Economia y Competitividad) [BIO2006-01323, BIO2009-11131]; Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo) [P07-CVI-02813, CTS-6638]	European funds (European Regional Development Fund, ERDF); Spanish Government (Ministerio de Economia y Competitividad)(Spanish Government); Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo)	This work was supported by European funds (European Regional Development Fund, ERDF), the Spanish Government (Ministerio de Economia y Competitividad, projects BIO2006-01323 and BIO2009-11131), and Andalusian Government (Consejeria de Economia, Innovacion, Ciencia y Empleo, projects P07-CVI-02813 and CTS-6638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URLs: European Regional Development Fund: http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm, Ministerio de Economia y Competitividad: http://www.mineco.gob.es/, Consejeria de Economia, Innovacion, Ciencia y Empleo: http://www.juntadeandalucia.es/organismos/economiainnovacioncienciayempleo.html.	Adam AL, 2011, FEMS MICROBIOL LETT, V318, P76, DOI 10.1111/j.1574-6968.2011.02241.x; Alejandre-Duran E, 2003, FUNGAL GENET BIOL, V40, P159, DOI 10.1016/S1087-1845(03)00089-6; Arrach N, 2002, MOL GENET GENOMICS, V266, P914, DOI 10.1007/s00438-001-0626-5; Avalos J, 2007, CURR ORG CHEM, V11, P721, DOI 10.2174/138527207780598729; AVALOS J, 1985, APPL ENVIRON MICROB, V49, P187, DOI 10.1128/AEM.49.1.187-191.1985; AVALOS J, 1990, FEMS MICROBIOL LETT, V66, P295; Avalos J., 1987, CURR GENET, V25, P1837, DOI DOI 10.1007/BF00384613; Avalos Javier, 2012, Methods Mol Biol, V898, P263, DOI 10.1007/978-1-61779-918-1_18; Avalos J, 2014, FUNG BIOL-US, P149, DOI 10.1007/978-1-4939-1191-2_8; Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; BEJARANO ER, 1991, PLANTA, V183, P1, DOI 10.1007/BF00197560; BINDL E, 1970, PLANTA, V94, P156, DOI 10.1007/BF00387760; Castellanos F, 2010, FUNGAL GENET BIOL, V47, P468, DOI 10.1016/j.fgb.2010.02.001; Castrillo M, 2014, FUNGAL GENET BIOL, V71, P9, DOI 10.1016/j.fgb.2014.08.004; Castrillo M, 2013, APPL ENVIRON MICROB, V79, P2777, DOI 10.1128/AEM.03110-12; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Corrochano LM, 2007, PHOTOCH PHOTOBIO SCI, V6, P725, DOI 10.1039/b702155k; Corrochano LM, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P417; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Diaz-Sanchez V, 2012, APPL ENVIRON MICROB, V78, P7258, DOI 10.1128/AEM.01552-12; Diaz-Sanchez V, 2011, FEBS J, V278, P3164, DOI 10.1111/j.1742-4658.2011.08242.x; Estrada AF, 2008, FUNGAL GENET BIOL, V45, P705, DOI 10.1016/j.fgb.2007.12.003; Froehlich AC, 2010, EUKARYOT CELL, V9, P738, DOI 10.1128/EC.00380-09; Georgiou CD, 2001, MYCOL RES, V105, P1110, DOI 10.1016/S0953-7562(08)61974-7; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; KLITTICH CJR, 1988, GENETICS, V118, P417; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; LOPEZDIAZ I, 1980, PLANTA, V150, P134, DOI 10.1007/BF00582356; Malzahn E, 2010, CELL, V142, P762, DOI 10.1016/j.cell.2010.08.010; Navarro-Sampedro L, 2008, GENETICS, V178, P171, DOI 10.1534/genetics.107.079582; Pokorny R, 2008, P NATL ACAD SCI USA, V105, P21023, DOI 10.1073/pnas.0805830106; Prado MM, 2004, CURR GENET, V46, P47, DOI 10.1007/s00294-004-0508-6; Prado-Cabrero A, 2007, MOL MICROBIOL, V64, P448, DOI 10.1111/j.1365-2958.2007.05665.x; Proctor RH, 1997, MICROBIOL-SGM, V143, P2583, DOI 10.1099/00221287-143-8-2583; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rademacher W., 1997, FUNGAL BIOTECHNOLOGY, P193; RAU W, 1967, PLANTA, V72, P14, DOI 10.1007/BF00388141; RAU W, 1968, PLANTA, V80, P309, DOI 10.1007/BF00392400; Rodriguez-Ortiz R, 2013, MOL GENET GENOMICS, V288, P157, DOI 10.1007/s00438-013-0739-7; Rodriguez-Ortiz R, 2012, FUNGAL GENET BIOL, V49, P684, DOI 10.1016/j.fgb.2012.06.007; Rodriguez-Ortiz R, 2009, APPL ENVIRON MICROB, V75, P405, DOI 10.1128/AEM.01089-08; Ruiz-Roldan MC, 2008, EUKARYOT CELL, V7, P1227, DOI 10.1128/EC.00072-08; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; SCHROTT EL, 1980, PLANTA, V150, P174, DOI 10.1007/BF00582363; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shrode LB, 2001, FUNGAL GENET BIOL, V32, P169, DOI 10.1006/fgbi.2001.1264; Thewes S, 2005, MOL GENET GENOMICS, V274, P217, DOI 10.1007/s00438-005-0015-6; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Veluchamy S, 2008, FUNGAL GENET BIOL, V45, P1265, DOI 10.1016/j.fgb.2008.06.004; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Youssar L, 2005, MOL MICROBIOL, V55, P828, DOI 10.1111/j.1365-2958.2004.04424.x	57	21	24	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119785	10.1371/journal.pone.0119785	http://dx.doi.org/10.1371/journal.pone.0119785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774802	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500122
J	Chen, M; Hu, P; Ling, N; Peng, H; Lei, Y; Hu, HD; Zhang, DZ; Ren, H				Chen, Min; Hu, Peng; Ling, Ning; Peng, Hui; Lei, Yu; Hu, Huaidong; Zhang, Dazhi; Ren, Hong			Enhanced Functions of Peripheral gamma delta T Cells in Chronic Hepatitis B Infection during Interferon alpha Treatment In Vivo and In Vitro	PLOS ONE			English	Article							VIRUS; RECEPTOR; THERAPY; REPLICATION; ACTIVATION; PLASTICITY; RESPONSES; SUBSETS; INNATE; INJURY	Background gamma delta T cells play an important role in infectious, autoimmune, or neoplastic diseases. Here, a study was conducted to investigate the dynamic changes in phenotype and function of peripheral gamma delta T cells in patients with chronic hepatitis B (CHB) during pegylated-interferon (pegIFN)-alpha treatment, and to explore their roles in IFN-alpha therapy. Methods Total 15 CHB patients with pegIFN-alpha therapy and 6 healthy controls (HC) were enrolled in this study. Flow cytometry was used for the study of frequency of peripheral gamma delta T cells, subtypes, effector or memory gamma delta T cells, and also the IFN-gamma+, TNF-alpha+, CD107a+ or Granzyme B+ gamma delta T cells in 10 patients at week 0, 4, 8, 12, 24, 36 and 48 of treatment. Another 5 CHB patients and 6 HC were recruited for the gamma delta T cell isolation, and gene expression in gamma delta T cells was evaluated before or after IFN-alpha treatment in vitro. Results Although gamma delta T cells decreased in CHB patients during pegIFN-alpha therapy, their capacities to produce TNF-alpha and to express CD107a were enhanced. More effector gamma delta T cells (CD27-CD45RA+) were found in the response group than in non-response group. Furthermore, IFN-alpha boosted the expression of Mx2 and cytokine genes in gamma delta T cells from CHB patients in vitro. Conclusion IFN-alpha could enhance the cytokine production or cytotoxicity potential of gamma delta T cells in vivo and in vitro. The enhanced function of gamma delta T cells might contribute to the effect of IFN-alpha treatment.	[Chen, Min; Hu, Peng; Ling, Ning; Lei, Yu; Hu, Huaidong; Zhang, Dazhi; Ren, Hong] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis,Minist Educ, Chongqing, Peoples R China; [Peng, Hui] Chongqing Med Univ, Affiliated Hosp 2, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, M (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Inst Viral Hepatitis,Minist Educ, Chongqing, Peoples R China.	chenggming@aliyun.com; renhong0531@vip.sina.com.cn	Ling, Ning/AAF-3633-2019	Ling, Ning/0000-0003-1250-4073	National Natural Science Foundation of China [30901264]; National Science and Technology Major Project of China [2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003]; Medical Science Foundation Project of Health Bureau of Chongqing Province [2011-2-152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; Medical Science Foundation Project of Health Bureau of Chongqing Province	This work was supported by the National Natural Science Foundation of China (30901264), http://www.nsfc.gov.cn/, to Min Chen; the National Science and Technology Major Project of China (2012ZX1002007001, 2011ZX09302005, 2012ZX09303001-001, 2012ZX10002003), http://www.nmp.gov.cn/, to Hong Ren, and the Medical Science Foundation Project of Health Bureau of Chongqing Province (2011-2-152), http://www.cqwsjsw.gov.cn/, to Hui Peng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2011, GASTROENTEROLOGY, V141, P1231, DOI 10.1053/j.gastro.2011.06.069; Ajuebor MN, 2008, J VIROL, V82, P9564, DOI 10.1128/JVI.00927-08; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331; Barcy S, 2008, J IMMUNOL, V180, P3417, DOI 10.4049/jimmunol.180.5.3417; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen CY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003501; Chen M, 2008, J INFECT DIS, V198, P1643, DOI 10.1086/593065; Chen M, 2012, J CLIN IMMUNOL, V32, P877, DOI 10.1007/s10875-012-9678-z; CHRISTMAS SE, 1990, IMMUNOLOGY, V71, P486; Cimini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037014; Craxi A, 2003, ANTIVIR RES, V60, P87, DOI 10.1016/j.antiviral.2003.08.015; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Gioia C, 2002, J IMMUNOL, V168, P1484, DOI 10.4049/jimmunol.168.3.1484; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Li N, 2012, HEPATOLOGY, V56, P803, DOI 10.1002/hep.25608; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Pinheiro MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050923; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Siegers GM, 2014, MOL THER, V22, P1416, DOI 10.1038/mt.2014.104; Tan AT, 2008, J GASTROEN HEPATOL, V23, P833, DOI 10.1111/j.1440-1746.2008.05385.x; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977	35	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120086	10.1371/journal.pone.0120086	http://dx.doi.org/10.1371/journal.pone.0120086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774808	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500149
J	Munyai, TC; Foord, SH				Munyai, Thinandavha Caswell; Foord, Stefan Hendrik			Temporal Patterns of Ant Diversity across a Mountain with Climatically Contrasting Aspects in the Tropics of Africa	PLOS ONE			English	Article							SPECIES RICHNESS; ELEVATIONAL GRADIENTS; LATITUDINAL GRADIENTS; ECOLOGICAL DATA; BETA DIVERSITY; SCALE; AREA; TEMPERATURE; ASSEMBLAGE; ALTITUDE	Factors that drive species richness over space and time are still poorly understood and are often context specific. Identifying these drivers for ant diversity has become particularly relevant within the context of contemporary global change events. We report on a long-term biannual (wet and dry seasons), standardized sampling of epigeal ants over a five year period on the mesic and arid aspects of an inselberg (Soutpansberg Mountain Range) in the tropics of Africa. We detail seasonal, annual and long-term trends of species density, test the relative contribution of geometric constraints, energy, available area, climate, local environmental variables, time, and space in explaining ant species density patterns through Generalized Linear Mixed Models (GLMM) where replicates were included as random factors to account for temporal pseudo-replication. Seasonal patterns were very variable and we found evidence of decreased seasonal variation in species density with increased elevation. The extent and significance of a decrease in species density with increased elevation varied with season. Annual patterns point to an increase in ant diversity over time. Ant density patterns were positively correlated with mean monthly temperature but geometric constraints dominated model performance while soil characteristics were minor correlates. These drivers and correlates accounted for all the spatio-temporal variability in the database. Ant diversity was therefore mainly determined by geometric constraints and temperature while soil characteristics (clay and carbon content) accounted for smaller but significant amounts of variation. This study documents the role of season, elevation and their interaction in affecting ant species densities while highlighting the importance of neutral processes and temperature in driving these patterns.	[Munyai, Thinandavha Caswell; Foord, Stefan Hendrik] Univ Venda, Ctr Invas Biol, Thohoyandou, Limpopo Provinc, South Africa; [Munyai, Thinandavha Caswell] Univ Venda, Dept Ecol & Resource Management, Thohoyandou, Limpopo Provinc, South Africa; [Foord, Stefan Hendrik] Univ Venda, South African Res Chair Biodivers Value & Change, Thohoyandou, Limpopo Provinc, South Africa; [Foord, Stefan Hendrik] Univ Venda, Dept Zool, Thohoyandou, Limpopo Provinc, South Africa	University of Venda; University of Venda; University of Venda; University of Venda	Munyai, TC (corresponding author), Univ Venda, Ctr Invas Biol, Thohoyandou, Limpopo Provinc, South Africa.	caswell.munyai@gmail.com	Munyai, Caswell/AAD-3110-2020; Munyai, Caswell TC/F-9919-2013; Foord, Stefan Hendrik/F-3282-2018	Munyai, Caswell/0000-0002-1562-2385; Foord, Stefan Hendrik/0000-0002-9195-2562	Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology; University of Venda	Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology(Department of Science & Technology (India)); University of Venda	This work was financially supported by the Department of Science and Technology- National Research Foundation Centre of Excellence for Invasion Biology and the University of Venda to TCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABENSPERGTRAUN M, 1995, AUST J ECOL, V20, P282, DOI 10.1111/j.1442-9993.1995.tb00540.x; ADIS J, 1979, ZOOL ANZ, V202, P177; Andersen Alan N., 2000, P25; [Anonymous], [No title captured]; Araujo Luzia Marcia, 2003, Lundiana, V4, P103; ATKIN L, 1988, J TROP ECOL, V4, P307, DOI 10.1017/S026646740000287X; Beck J, 2010, BASIC APPL ECOL, V11, P714, DOI 10.1016/j.baae.2010.08.009; Berger K, 2003, 1 SYNTHESIS ENV BIOL; Bestelmeyer BT, 2003, ECOL APPL, V13, P1750, DOI 10.1890/02-5089; Bishop TR, 2014, J BIOGEOGR, V41, P2256, DOI 10.1111/jbi.12368; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Botes A, 2006, J BIOGEOGR, V33, P71, DOI 10.1111/j.1365-2699.2005.01336.x; Boulton AM, 2005, ENVIRON ENTOMOL, V34, P96, DOI 10.1603/0046-225X-34.1.96; Braschler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031463; Cerda X, 1997, J ANIM ECOL, V66, P363, DOI 10.2307/5982; Chaladze G, 2012, J INSECT CONSERV, V16, P791, DOI 10.1007/s10841-012-9464-5; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2006, RANGEMODEL MONTE COR; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; Cowling RM, 1995, BIODIVERSITY LETT, V2, P127; Crous CJ, 2014, INSECT CONSERV DIVER, V7, P185, DOI 10.1111/icad.12044; de Juan S, 2014, ECOGRAPHY, V37, P183, DOI 10.1111/j.1600-0587.2013.00048.x; Del Toro I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067973; Delsinne T, 2010, J ARID ENVIRON, V74, P1149, DOI 10.1016/j.jaridenv.2010.03.014; Dunn RR, 2006, ECOGRAPHY, V29, P251, DOI 10.1111/j.2006.0906-7590.04259.x; Ellison AM, 2002, TREES-STRUCT FUNCT, V16, P181, DOI 10.1007/s00468-001-0133-7; Fisher Brian L., 1998, Fieldiana Zoology, V90, P39; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Foord SH, 2015, J ARID ENVIRON, V113, P114, DOI 10.1016/j.jaridenv.2014.10.006; Hahn N, 2006, THESIS U PRETORIA; Hahn N., 2002, THESIS U KWAZULU NAT; Jacquemin J, 2012, APPL SOIL ECOL, V62, P163, DOI 10.1016/j.apsoil.2012.08.008; Jayatilaka P, 2011, J EXP BIOL, V214, P2730, DOI 10.1242/jeb.053710; Jocque R, 2008, ZOOKEYS, P59, DOI 10.3897/zookeys.1.10; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kerr JT, 2006, ECOL LETT, V9, P149, DOI 10.1111/j.1461-0248.2005.00860.x; Kirchhof S, 2010, SALAMANDRA, V46, P147; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leal IR, 2014, BIOTROPICA, V46, P516, DOI 10.1111/btp.12126; Lobo JM, 2000, CAN ENTOMOL, V132, P307, DOI 10.4039/Ent132307-3; Lyons SK, 2002, ECOLOGY, V83, P47; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2007, ECOLOGY, V88, P76, DOI 10.1890/0012-9658(2007)88[76:AAMED]2.0.CO;2; Munyai TC, 2012, J INSECT CONSERV, V16, P677, DOI 10.1007/s10841-011-9449-9; Munyai TC, KOEDOE IN PRESS; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Paknia O, 2014, MYRMECOL NEWS, V20, P15; Parr CL, 2008, J ANIM ECOL, V77, P1191, DOI 10.1111/j.1365-2656.2008.01450.x; Parr CL, 2004, J APPL ECOL, V41, P630, DOI 10.1111/j.0021-8901.2004.00920.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Ramon Giovanni, 2013, Metodos en Ecologia y Sistematica, V8, P37; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Sabu TK, 2008, J INSECT SCI, V8, P1536; Samson DA, 1997, BIOTROPICA, V29, P349, DOI 10.1111/j.1744-7429.1997.tb00436.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Wielgoss A, 2010, AGR ECOSYST ENVIRON, V135, P253, DOI 10.1016/j.agee.2009.10.003; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	16	19	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122035	10.1371/journal.pone.0122035	http://dx.doi.org/10.1371/journal.pone.0122035			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774670	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500220
J	Lee, M; Kim, MK; Kim, SM; Park, H; Park, CG; Park, HK				Lee, Myoungsook; Kim, Mi Kyung; Kim, Seon-Mee; Park, Hyesoon; Park, Chang Gyu; Park, Hye Kyung			Gender-Based Differences on the Association between Salt-Sensitive Genes and Obesity in Korean Children Aged between 8 and 9 Years	PLOS ONE			English	Article							METABOLIC SYNDROME; SODIUM-INTAKE; HYPERTENSION; POLYMORPHISMS; ADOLESCENTS; PREVALENCE; DISEASE; LEPTIN; RISK; MASS	Background High sodium intake is associated with the development of chronic diseases such as obesity. Although its role in obesity remains controversial, there may be a correlation between salt sensitivity and the early onset of chronic diseases in obese children. Methods In all, 2,163 Korean children (1,106 boys and 1,057 girls) aged 8-9 years were recruited from seven elementary schools in Seoul. To evaluate whether obesity risk was modulated by the salt sensitivity, 11 SNPs related to salt sensitive genes (SSG) became the target of sodium intakes in obese children. Results BP, HOMA-IR, LDLc, TG, and the girls' sodium intake significantly increased, but HDLc significantly decreased with increase in BMI. Regardless of sex, the obesity risk was 5.27-fold (CI; 1.320-27.560) higher in the Q2 to Q5 of sodium intake adjusted by energy (4044.9-5058.9 mg/day) than in the lowest Q1 level (2287.6 mg/day) in obese children. BP was sensitively dependent on insulin resistance and lipid accumulation in all subjects; however, sodium intake may be an independent risk factor of obesity without increasing BP in girls. GRK4 A486V mutant homozygote was highly distributed in the obese group, but other SNPs had no impact. The obesity risk increased 7.06, 16.8, and 46.09-fold more in boys with GRK4 A486V, ACE, and SLC12A3 mutants as sodium intake increased. Among girls, the obesity risk increased in GRK4 A486V heterozygote and CYP11 beta-2 mutant homozygote although sodium intake was relatively lower, implying that ACE, SLC12A, CYP11 beta-2, and GRK4 A486V polymorphisms showed gender-based differences with regard to interaction between sodium intake and obesity. Conclusion A high sodium intake markedly increased the obesity risk in variants of GRK4 A486V regardless of sex. The obesity risk increased with GRK4 A486V, ACE, and SLC12A3 variants in boys, whereas it increased with GRK4 A486V and CYP11B2 variants in girls as sodium intake increased. Obese children with the specific gene variants are recommended to reduce their sodium intake.	[Lee, Myoungsook] Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Lee, Myoungsook] Sungshin Womens Univ, Res Inst Obes Sci, Seoul, South Korea; [Kim, Mi Kyung] Natl Canc Ctr, Dept Epidemiol, Ilsan, South Korea; [Kim, Seon-Mee] Korea Univ, Guro Hosp, Dept Internal Med, Div Family Med, Seoul, South Korea; [Park, Hyesoon] Univ Ulsan, Asan Hosp, Sch Med, Dept Family Med, Seoul, South Korea; [Park, Chang Gyu] Korea Univ, Guro Hosp, Dept Internal Med, Div Cardiovasc Dis, Seoul, South Korea; [Park, Hye Kyung] Korean Food & Drug Adm, Div Nutr Policy, Cheongju, South Korea	Sungshin Women's University; Sungshin Women's University; National Cancer Center - Korea (NCC); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Korea University; Korea University Medicine (KU Medicine)	Lee, M (corresponding author), Sungshin Womens Univ, Dept Food & Nutr, Seoul, South Korea.	mlee@sungshin.ac.kr		Lee, Myoungsook/0000-0003-1344-6979; Kim, Seon Mee/0000-0002-1957-2928; Park, Chang/0000-0001-9654-9257	Korea Food & Drug Administration [11162KFDA162]; Korea Food Research Institute; National Research Foundation of Korea [MSIP: 2014R1A2A1A11049611/1]	Korea Food & Drug Administration(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Korea Food Research Institute; National Research Foundation of Korea(National Research Foundation of Korea)	Funding: This study was funded by Korea Food & Drug Administration (11162KFDA162), Korea Food Research Institute, and National Research Foundation of Korea grant (MSIP: 2014R1A2A1A11049611/1).	Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Calo LA, 2011, HYPERTENS RES, V34, P1017, DOI 10.1038/hr.2011.72; Calson SH, 2010, HYPERTENSION, V35, P403; Chen J, 2009, LANCET, V373, P829, DOI 10.1016/S0140-6736(09)60144-6; Deji N, 2012, BIOCHEM BIOPH RES CO, V418, P559, DOI 10.1016/j.bbrc.2012.01.070; Delles C, 2012, CAN J CARDIOL, V28, P296, DOI 10.1016/j.cjca.2012.02.004; ELLIOTT P, 1988, BRIT MED J, V297, P319; Felder RA, 2006, NAT CLIN PRACT NEPHR, V2, P637, DOI 10.1038/ncpneph0301; Felder RA, 2013, CURR OPIN NEPHROL HY, V22, P65, DOI 10.1097/MNH.0b013e32835b3693; Fonseca-Alaniz MH, 2007, OBESITY, V15, P2200, DOI 10.1038/oby.2007.261; Han JY, 2008, LUNG CANCER, V59, P69, DOI 10.1016/j.lungcan.2007.07.019; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; Kim JH, 2006, DIABETES, V55, P843, DOI 10.2337/diabetes.55.03.06.db05-1013; Kim TH, 2008, EXP MOL MED, V40, P418, DOI 10.3858/emm.2008.40.4.418; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Li K, 2010, AM J PHYSIOL-REG I, V299, pR590, DOI 10.1152/ajpregu.00207.2009; Morrison AC, 2005, AM J HYPERTENS, V18, P653, DOI 10.1016/j.amjhyper.2004.11.030; Olson JE, 2007, BREAST CANCER RES TR, V102, P237, DOI 10.1007/s10549-006-9324-7; Pan XQ, 2010, EUR J EPIDEMIOL, V25, P813, DOI 10.1007/s10654-010-9504-y; Park J, 2010, J KOREAN MED SCI, V25, P75, DOI 10.3346/jkms.2010.25.1.75; Park SJ, 2013, NUTR RES PRACT, V7, P139, DOI 10.4162/nrp.2013.7.2.139; Poch E, 2001, HYPERTENSION, V38, P1204, DOI 10.1161/hy1101.099479; Radin MJ, 2003, MOL CELL BIOCHEM, V242, P57, DOI 10.1023/A:1021181527060; Ramachandran V, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-11; Republic of Korea: Ministry of Health & Welfare, 2010, KOR NAT HLTH NUTR EX; Sanada H, 2006, CLIN CHEM, V52, P352, DOI 10.1373/clinchem.2005.059139; Seo JY, 2013, OBES RES CLIN PRACT, V7, pE182, DOI 10.1016/j.orcp.2011.12.001; Speirs HJL, 2004, J HYPERTENS, V22, P931, DOI 10.1097/00004872-200405000-00014; Tanaka N, 2003, DIABETES, V52, P2848, DOI 10.2337/diabetes.52.11.2848; Trivedi M, 2005, AM J PHYSIOL-RENAL, V289, pF298, DOI 10.1152/ajprenal.00362.2004; Wang XF, 2008, CLIN CHIM ACTA, V388, P95, DOI 10.1016/j.cca.2007.10.017; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Willett W, 1998, EPIDEMIOLOGY, P273; Yang SJ, 2013, NUTRITION, V29, P525, DOI 10.1016/j.nut.2012.09.001	34	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120111	10.1371/journal.pone.0120111	http://dx.doi.org/10.1371/journal.pone.0120111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768006	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500109
J	Zub, KA; de Sousa, MML; Sarno, A; Sharma, A; Demirovic, A; Rao, S; Young, C; Aas, PA; Ericsson, I; Sundan, A; Jensen, ON; Slupphaug, G				Zub, Kamila Anna; de Sousa, Mirta Mittelstedt Leal; Sarno, Antonio; Sharma, Animesh; Demirovic, Aida; Rao, Shalini; Young, Clifford; Aas, Per Arne; Ericsson, Ida; Sundan, Anders; Jensen, Ole Norregaard; Slupphaug, Geir			Modulation of Cell Metabolic Pathways and Oxidative Stress Signaling Contribute to Acquired Melphalan Resistance in Multiple Myeloma Cells	PLOS ONE			English	Article							ALDO-KETO REDUCTASES; CANCER-CELLS; CYCLOOXYGENASE ISOZYMES; LACTATE-DEHYDROGENASE; URSODEOXYCHOLIC ACID; INDUCED APOPTOSIS; MAMMALIAN TARGET; PROTEIN-KINASE; BREAST-CANCER; INHIBITOR	Alkylating agents are widely used chemotherapeutics in the treatment of many cancers, including leukemia, lymphoma, multiple myeloma, sarcoma, lung, breast and ovarian cancer. Melphalan is the most commonly used chemotherapeutic agent against multiple myeloma. However, despite a 70-80% initial response rate, virtually all patients eventually relapse due to the emergence of drug-resistant tumour cells. By using global proteomic and transcriptomic profiling on melphalan sensitive and resistant RPMI8226 cell lines followed by functional assays, we discovered changes in cellular processes and pathways not previously associated with melphalan resistance in multiple myeloma cells, including a metabolic switch conforming to the Warburg effect (aerobic glycolysis), and an elevated oxidative stress response mediated by VEGF/IL8-signaling. In addition, up-regulated aldo-keto reductase levels of the AKR1C family involved in prostaglandin synthesis contribute to the resistant phenotype. Finally, selected metabolic and oxidative stress response enzymes were targeted by inhibitors, several of which displayed a selective cytotoxicity against the melphalan-resistant cells and should be further explored to elucidate their potential to overcome melphalan resistance.	[Zub, Kamila Anna; de Sousa, Mirta Mittelstedt Leal; Sarno, Antonio; Sharma, Animesh; Demirovic, Aida; Rao, Shalini; Aas, Per Arne; Ericsson, Ida; Sundan, Anders; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Sharma, Animesh; Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, PROMEC Core Facil Prote & Metabol, Trondheim, Norway; [Young, Clifford; Jensen, Ole Norregaard] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Southern Denmark	Slupphaug, G (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway.	geir.slupphaug@ntnu.no	Slupphaug, Geir/AAN-3794-2020; Jensen, Ole Norregaard/J-1763-2012	Slupphaug, Geir/0000-0002-7498-3500; Jensen, Ole Norregaard/0000-0003-1862-8528; Sarno, Antonio/0000-0002-9308-8018; Young, Clifford/0000-0002-3945-286X	Research Council of Norway [183423, 183432]; Norwegian Cancer Society [TS-02-2008-0185]; Cancer Fund at St. Olavs Hospital, Trondheim [47063403]; Liaison Committee [81133200]; Villum Fonden [00007292] Funding Source: researchfish	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Cancer Fund at St. Olavs Hospital, Trondheim; Liaison Committee; Villum Fonden(Villum Fonden)	Funding was provided by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906), grant no. 183423 and 183432; the Norwegian Cancer Society (https://kreftforeningen.no/en/), grant no. TS-02-2008-0185; the Cancer Fund at St. Olavs Hospital, Trondheim (http://www.stolav.no/en/), grant no. 47063403; the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) (http://www.ntnu.no/dmf/rad/samorg), grant no. 81133200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED AE, 1982, CANCER CHEMOTH PHARM, V8, P271; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bauman DR, 2005, MOL PHARMACOL, V67, P60, DOI 10.1124/mol.104.006569; BELLAMY WT, 1991, CANCER RES, V51, P995; Birtwistle L, 2009, MUTAT RES-FUND MOL M, V662, P67, DOI 10.1016/j.mrfmmm.2008.12.010; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Byrns MC, 2010, J STEROID BIOCHEM, V118, P177, DOI 10.1016/j.jsbmb.2009.12.009; Byrns MC, 2009, CHEM-BIOL INTERACT, V178, P221, DOI 10.1016/j.cbi.2008.10.024; Chen Q, 2005, BLOOD, V106, P698, DOI 10.1182/blood-2004-11-4286; Chi Y, 2011, J PHARMACOL EXP THER, V339, P257, DOI 10.1124/jpet.111.183020; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Das GC, 2006, MOL CARCINOGEN, V45, P635, DOI 10.1002/mc.20184; DeBerardinis RJ, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31818b0d9b; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Ding J, 2006, MOL CARCINOGEN, V45, P250, DOI 10.1002/mc.20175; Dowell JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070163; el Dein OS, 2012, BIOCHEM PHARMACOL, V83, P1172, DOI 10.1016/j.bcp.2012.01.017; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Homolya L, 2003, BIOFACTORS, V17, P103, DOI 10.1002/biof.5520170111; Hu T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05810; Ikegami T, 2006, MOL CANCER THER, V5, P68, DOI 10.1158/1535-7163.MCT-05-0107; Khanim F, 2014, BRIT J CANCER, V110, P1506, DOI 10.1038/bjc.2014.83; Kim HS, 2014, PATHOBIOLOGY, V81, P78, DOI 10.1159/000357017; Kluza J, 2012, CANCER RES, V72, P5035, DOI 10.1158/0008-5472.CAN-12-0979; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Leseux L, 2006, BLOOD, V108, P4156, DOI 10.1182/blood-2006-05-026203; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Lonial S, 2009, BRIT J HAEMATOL, V145, P681, DOI 10.1111/j.1365-2141.2009.07649.x; Lyon RC, 2013, NEUROCHEM INT, V62, P113, DOI 10.1016/j.neuint.2012.10.007; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; Masui K, 2013, CELL METAB, V18, P726, DOI 10.1016/j.cmet.2013.09.013; Mohamed D, 2008, ANAL BIOANAL CHEM, V392, P805, DOI 10.1007/s00216-008-2236-0; Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891; Niewisch MR, 2012, CELL PHYSIOL BIOCHEM, V29, P373, DOI 10.1159/000338492; Oancea M, 2004, INT J HEMATOL, V80, P224, DOI 10.1532/IJH97.04107; Ouellet M, 2004, BIOCHEM J, V377, P675, DOI 10.1042/BJ20030969; Page BDG, 2013, J MED CHEM, V56, P7190, DOI 10.1021/jm3017255; Penning T. M., 2014, CHEM BIOL INTERACT; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pizzuto R, 2012, BBA-BIOENERGETICS, V1817, P1679, DOI 10.1016/j.bbabio.2012.05.010; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Podar K, 2005, BLOOD, V105, P1383, DOI 10.1182/blood-2004-07-2909; POVIRK LF, 1994, MUTAT RES-REV GENET, V318, P205, DOI 10.1016/0165-1110(94)90015-9; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Reed TT, 2011, FREE RADICAL BIO MED, V51, P1302, DOI 10.1016/j.freeradbiomed.2011.06.027; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rothbarth J, 2002, CHEM-BIOL INTERACT, V140, P93, DOI 10.1016/S0009-2797(02)00014-5; Saeki T, 2012, NUTR CANCER, V64, P617, DOI 10.1080/01635581.2012.669876; Sanchez WY, 2013, BRIT J CANCER, V108, P1624, DOI 10.1038/bjc.2013.120; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi Y, 2005, INT J INF TECH DECIS, V4, P1; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sousa MML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055493; Spanswick VJ, 2002, BLOOD, V100, P224, DOI 10.1182/blood.V100.1.224; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Verrax J, 2011, BIOCHEM PHARMACOL, V82, P1540, DOI 10.1016/j.bcp.2011.07.102; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wlodarski P, 2005, CANCER RES, V65, P7800, DOI 10.1158/0008-5472.CAN-04-4180; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xie JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-11; Yarde DN, 2009, CANCER RES, V69, P9367, DOI 10.1158/0008-5472.CAN-09-2616; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	78	40	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119857	10.1371/journal.pone.0119857	http://dx.doi.org/10.1371/journal.pone.0119857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769101	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000351277500099
J	Xu, XY; Nakazawa, N; Yanagida, M				Xu, Xingya; Nakazawa, Norihiko; Yanagida, Mitsuhiro			Condensin HEAT Subunits Required for DNA Repair, Kinetochore/Centromere Function and Ploidy Maintenance in Fission Yeast	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; MAD2-DEPENDENT SPINDLE CHECKPOINT; MITOTIC CHROMOSOME CONDENSATION; NUCLEOTIDE EXCISION-REPAIR; UBIQUITOUS PROTEIN FAMILY; SCHIZOSACCHAROMYCES-POMBE; CENTROMERE PROTEIN; NUCLEAR PROTEASOME; ESCHERICHIA-COLI; REPEAT PROTEINS	Condensin, a central player in eukaryotic chromosomal dynamics, contains five evolutionarily-conserved subunits. Two SMC (structural maintenance of chromosomes) subunits contain ATPase, hinge, and coiled-coil domains. One non-SMC subunit is similar to bacterial kleisin, and two other non-SMC subunits contain HEAT (similar to armadillo) repeats. Here we report isolation and characterization of 21 fission yeast (Schizosaccharomyces pombe) mutants for three non-SMC subunits, created using error-prone mutagenesis that resulted in single-amino acid substitutions. Beside condensation, segregation, and DNA repair defects, similar to those observed in previously isolated SMC and cnd2 mutants, novel phenotypes were observed for mutants of HEAT-repeats containing Cnd1 and Cnd3 subunits. cnd3-L269P is hypersensitive to the microtubule poison, thiabendazole, revealing defects in kinetochore/centromere and spindle assembly checkpoints. Three cnd1 and three cnd3 mutants increased cell size and doubled DNA content, thereby eliminating the haploid state. Five of these mutations reside in helix B of HEAT repeats. Two non-SMC condensin subunits, Cnd1 and Cnd3, are thus implicated in ploidy maintenance.	[Xu, Xingya; Nakazawa, Norihiko; Yanagida, Mitsuhiro] Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan; [Xu, Xingya] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka, Japan	Okinawa Institute of Science & Technology Graduate University; Osaka University	Yanagida, M (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Onna Son, Okinawa, Japan.	myanagid@gmail.com			JSPS fellowship; JSPS [25840013]	JSPS fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	X.X. was a recipient of the JSPS fellowship (1979) and was supported by a Grant-in-Aid for JSPS fellows from JSPS. N.N. was supported by a Grantin- Aid for Young Scientists (B) 25840013 from JSPS. The JSPS URL is http://www.jsps.go.jp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1989, EMBO J, V8, P3997, DOI 10.1002/j.1460-2075.1989.tb08582.x; ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; Al-Bassam J, 2007, STRUCTURE, V15, P355, DOI 10.1016/j.str.2007.01.012; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Britton RA, 1998, GENE DEV, V12, P1254, DOI 10.1101/gad.12.9.1254; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Cuylen S, 2011, TRENDS CELL BIOL, V21, P552, DOI 10.1016/j.tcb.2011.06.003; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Garcia MA, 2001, EMBO J, V20, P3389, DOI 10.1093/emboj/20.13.3389; George Carolyn M, 2014, Cells, V3, P865, DOI 10.3390/cells3030865; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hayashi T, 2014, GENES CELLS, V19, P541, DOI 10.1111/gtc.12152; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kimata Y, 2008, J CELL SCI, V121, P1107, DOI 10.1242/jcs.024224; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; Kitayama C, 1997, J CELL BIOL, V137, P1309, DOI 10.1083/jcb.137.6.1309; Koshland D, 1996, ANNU REV CELL DEV BI, V12, P305, DOI 10.1146/annurev.cellbio.12.1.305; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Malik HS, 1997, P NATL ACAD SCI USA, V94, P13738, DOI 10.1073/pnas.94.25.13738; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mitchison JM, 1970, METHOD CELL PHYSIOL, V4, P131; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; NABESHIMA K, 1995, GENE DEV, V9, P1572, DOI 10.1101/gad.9.13.1572; NAKASEKO Y, 1984, J BACTERIOL, V157, P334, DOI 10.1128/JB.157.1.334-336.1984; Nakaseko Y, 2001, CURR BIOL, V11, P537, DOI 10.1016/S0960-9822(01)00155-5; Nakazawa N, 2008, J CELL BIOL, V180, P1115, DOI 10.1083/jcb.200708170; Nakazawa N, 2011, J CELL SCI, V124, P1795, DOI 10.1242/jcs.078733; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; NIKI H, 1991, EMBO J, V10, P183, DOI 10.1002/j.1460-2075.1991.tb07935.x; NIWA O, 1988, NATURE, V336, P430, DOI 10.1038/336430a0; OHKURA H, 1988, EMBO J, V7, P1465, DOI 10.1002/j.1460-2075.1988.tb02964.x; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; Perche O, 2013, EUR J MED GENET, V56, P635, DOI 10.1016/j.ejmg.2013.07.007; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Petrova B, 2013, MOL CELL BIOL, V33, P984, DOI 10.1128/MCB.01400-12; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Robellet X, 2014, G3-GENES GENOM GENET, V4, P373, DOI 10.1534/g3.113.009621; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Saitoh S, 2005, MOL BIOL CELL, V16, P3666, DOI 10.1091/mbc.E05-01-0014; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SAMEJIMA I, 1994, MOL CELL BIOL, V14, P6361, DOI 10.1128/MCB.14.9.6361; SAMEJIMA I, 1993, J CELL SCI, V105, P135; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2011, P NATL ACAD SCI USA, V108, P16950, DOI 10.1073/pnas.1103617108; Toyoda Y, 2002, CURR BIOL, V12, P347, DOI 10.1016/S0960-9822(02)00692-9; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Yamamoto A, 2003, EMBO J, V22, P2284, DOI 10.1093/emboj/cdg222; Yamanaka K, 1996, MOL GEN GENET, V250, P241; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005	79	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119347	10.1371/journal.pone.0119347	http://dx.doi.org/10.1371/journal.pone.0119347			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764183	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300023
J	Kim, SB; Lee, HY; Seo, S; Lee, JH; Choi, D				Kim, Saet-Byul; Lee, Hye-Young; Seo, Seungyeon; Lee, Joo Hyun; Choi, Doil			RNA-Dependent RNA Polymerase (NIb) of the Potyviruses Is an Avirulence Factor for the Broad-Spectrum Resistance Gene Pvr4 in Capsicum annuum cv. CM334	PLOS ONE			English	Article							POTATO-VIRUS-Y; HELPER COMPONENT PROTEINASE; TOBACCO ETCH POTYVIRUS; COAT PROTEIN; MUTATIONAL ANALYSIS; PLANTA EXPRESSION; GENOME SEQUENCE; PEPPER; IDENTIFICATION; INFECTION	Potyviruses are one of the most destructive viral pathogens of Solanaceae plants. In Capsicum annuum landrace CM334, a broad-spectrum gene, Pvr4 is known to be involved in resistance against multiple potyviruses, including Pepper mottle virus (PepMoV), Pepper severe mosaic virus (PepSMV), and Potato virus Y (PVY). However, a potyvirus avirulence factor against Pvr4 has not been identified. To identify the avirulence factor corresponding to Pvr4 in potyviruses, we performed Agrobacterium-mediated transient expressions of potyvirus protein coding regions in potyvirus-resistant (Pvr4) and -susceptible (pvr4) pepper plants. Hypersensitive response (HR) was observed only when a RNA-dependent RNA polymerase (NIb) of PepMoV, PepSMV, or PVY was expressed in Pvr4-bearing pepper leaves in a genotype-specific manner. In contrast, HR was not observed when the NIb of Tobacco etch virus (TEV), a virulent potyvirus, was expressed in Pvr4-bearing pepper leaves. Our results clearly demonstrate that NIbs of PepMoV, PepSMV, and PVY serve as avirulence factors for Pvr4 in pepper plants.	[Kim, Saet-Byul; Lee, Hye-Young; Seo, Seungyeon; Lee, Joo Hyun; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU)	Choi, D (corresponding author), Seoul Natl Univ, Dept Plant Sci, Plant Genom & Breeding Inst, Seoul, South Korea.	doil@snu.ac.kr	Kim, Saet-Byul/AAK-7920-2021; Choi, Doil/F-5002-2011	Kim, Saet-Byul/0000-0001-8826-6265; 	National Research Foundation of Korea, Ministry of Science, ICT and Future Planning [2010-0015105]; Vegetable Breeding Research Center of an ARC from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government [PJ710001-05]	National Research Foundation of Korea, Ministry of Science, ICT and Future Planning; Vegetable Breeding Research Center of an ARC from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government	This work was supported by a grant from National Research Foundation of Korea, Ministry of Science, ICT and Future Planning (Project No. 2010-0015105) and a Vegetable Breeding Research Center of an ARC Grant (PJ710001-05) from the Ministry for Food, Agriculture, Forestry, and Fisheries of the Korean government to DC.	ABDALLA OA, 1991, PLANT DIS, V75, P1019, DOI 10.1094/PD-75-1019; Ahn HI, 2006, ARCH VIROL, V151, P2037, DOI 10.1007/s00705-006-0776-1; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Arnedo-Andres MS, 2002, THEOR APPL GENET, V105, P1067, DOI 10.1007/s00122-002-1058-2; ATREYA PL, 1995, J GEN VIROL, V76, P265, DOI 10.1099/0022-1317-76-2-265; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Bae C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063533; Baldauf PM, 2006, PLANT DIS, V90, P559, DOI 10.1094/PD-90-0559; Caranta C, 1999, GENOME, V42, P1111, DOI 10.1139/gen-42-6-1111; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; Chung BYW, 2008, P NATL ACAD SCI USA, V105, P5897, DOI 10.1073/pnas.0800468105; Elena SF, 2012, CURR OPIN VIROL, V2, P719, DOI 10.1016/j.coviro.2012.09.004; Grube RC, 2000, THEOR APPL GENET, V101, P852, DOI 10.1007/s001220051552; Hong YL, 1996, VIROLOGY, V226, P146, DOI 10.1006/viro.1996.0639; HONG YL, 1995, VIROLOGY, V214, P159, DOI 10.1006/viro.1995.9944; Ivanov KI, 2014, J GEN VIROL, V95, P1415, DOI 10.1099/vir.0.064220-0; Janzac B, 2009, PLANT PATHOL, V58, P443, DOI 10.1111/j.1365-3059.2008.01992.x; Janzac B, 2010, MOL PLANT MICROBE IN, V23, P823, DOI 10.1094/MPMI-23-6-0823; Kim HJ, 2011, THEOR APPL GENET, V122, P1051, DOI 10.1007/s00122-010-1510-7; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Lee MY, 2011, VIRUS RES, V155, P487, DOI 10.1016/j.virusres.2010.12.004; Mestre P, 2000, PLANT J, V23, P653, DOI 10.1046/j.1365-313x.2000.00834.x; Moury B, 2011, MOL PLANT MICROBE IN, V24, P787, DOI 10.1094/MPMI-10-10-0246; Oh SK, 2010, MOL CELLS, V30, P557, DOI 10.1007/s10059-010-0156-2; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Quenouille J, 2013, MOL PLANT PATHOL, V14, P439, DOI 10.1111/mpp.12024; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Szittya G, 2001, J VIROL, V75, P2411, DOI 10.1128/JVI.75.5.2411-2420.2001; Tian YP, 2013, MOL PLANT MICROBE IN, V26, P297, DOI 10.1094/MPMI-09-12-0219-R; Valkonen JPT, 1996, ANN APPL BIOL, V129, P25, DOI 10.1111/j.1744-7348.1996.tb05728.x; VERCHOT J, 1992, VIROLOGY, V190, P298, DOI 10.1016/0042-6822(92)91216-H; Vijayapalani P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002639; Wei TY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000962; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; ZITTER TA, 1972, PLANT DIS REP, V56, P586	39	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119639	10.1371/journal.pone.0119639	http://dx.doi.org/10.1371/journal.pone.0119639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760376	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000064
J	Zorb, C; Muhling, KH; Kutschera, U; Geilfus, CM				Zoerb, Christian; Muehling, Karl H.; Kutschera, Ulrich; Geilfus, Christoph-Martin			Salinity Stiffens the Epidermal Cell Walls of Salt-Stressed Maize Leaves: Is the Epidermis Growth-Restricting?	PLOS ONE			English	Article							DEEP-WATER RICE; ZEA-MAYS L.; VICIA-FABA L.; LEAF ELONGATION; NACL STRESS; STEM ELONGATION; PLANT-GROWTH; ACID-GROWTH; TOLERANCE; EXPANSINS	As a result of salt (NaCl)-stress, sensitive varieties of maize (Zea mays L.) respond with a strong inhibition of organ growth. The reduction of leaf elongation investigated here has several causes, including a modification of the mechanical properties of the cell wall. Among the various tissues that form the leaf, the epidermis plays a special role in controlling organ growth, because it is thought to form a rigid outer leaf coat that can restrict elongation by interacting with the inner cell layers. This study was designed to determine whether growthrelated changes in the leaf epidermis and its cell wall correspond to the overall reduction in cell expansion of maize leaves during an osmotic stress-phase induced by salt treatment. Two different maize varieties contrasting in their degree of salt resistance (i.e., the hybrids Lector vs. SR03) were compared in order to identify physiological features contributing to resistance towards salinity. Wall loosening-related parameters, such as the capacity of the epidermal cell wall to expand, beta-expansin abundance and apoplastic pH values, were analysed. Our data demonstrate that, in the salt-tolerant maize hybrid which maintained leaf growth under salinity, the epidermal cell wall was more extensible under salt stress. This was associated with a shift of the epidermal apoplastic pH into a range more favourable for acid growth. The more sensitive hybrid that displayed a pronounced leaf growth-reduction was shown to have stiffer epidermal cell walls under stress. This may be attributable to the reduced abundance of cell wall-loosening beta-expansin proteins following a high salinity-treatment in the nutrient solution (100 mM NaCl, 8 days). This study clearly documents that salt stress impairs epidermal wall-loosening in growth-reduced maize leaves.	[Zoerb, Christian] Univ Hohenheim, Qual Plant Prod, Inst Crop Sci, Stuttgart, Germany; [Muehling, Karl H.; Geilfus, Christoph-Martin] Univ Kiel, Inst Plant Nutr & Soil Sci, Kiel, Germany; [Kutschera, Ulrich] Univ Kassel, Inst Biol, D-34125 Kassel, Germany	University Hohenheim; University of Kiel; Universitat Kassel	Zorb, C (corresponding author), Univ Hohenheim, Qual Plant Prod, Inst Crop Sci, Stuttgart, Germany.	Christian.zoerb@uni-hohenheim.de	Mühling, Karl H./L-6443-2014	Mühling, Karl H./0000-0002-9922-6581	Deutsche Forschungsgemeinschaft (DFG) [ZO118/6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a research grant (ZO118/6) of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Plant, Cell and Environment, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; BERNSTEIN N, 1993, PLANTA, V191, P433, DOI 10.1007/BF00195744; Cho HT, 1998, PLANT J, V15, P805, DOI 10.1046/j.1365-313X.1998.00258.x; Cho HT, 1997, PLANT PHYSIOL, V113, P1137, DOI 10.1104/pp.113.4.1137; Colmer TD, 2006, J EXP BOT, V57, P1059, DOI 10.1093/jxb/erj124; CRAMER GR, 1991, J EXP BOT, V42, P1417, DOI 10.1093/jxb/42.11.1417; De Costa W, 2007, PHYSIOL PLANTARUM, V131, P311, DOI 10.1111/j.1399-3054.2007.00962.x; Fan L, 2004, PLANT PHYSIOL, V135, P2291, DOI 10.1104/pp.104.041426; Geilfus C.-M., 2011, THESIS CHRISTIAN ALB; Geilfus CM, 2014, PLANT SCI, V223, P109, DOI 10.1016/j.plantsci.2014.03.012; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; Geilfus CM, 2011, J PLANT GROWTH REGUL, V30, P387, DOI 10.1007/s00344-011-9201-4; Geilfus CM, 2010, PLANT PHYSIOL BIOCH, V48, P993, DOI 10.1016/j.plaphy.2010.09.011; Geilfus CM, 2010, J IMMUNOL METHODS, V362, P89, DOI 10.1016/j.jim.2010.09.006; GREEN PB, 1980, ANNU REV PLANT PHYS, V31, P51, DOI 10.1146/annurev.pp.31.060180.000411; Hu YC, 2000, INT J PLANT SCI, V161, P575, DOI 10.1086/314280; Kohler W., 1984, EINFUHRUNG STAT BIOL, P101; Kutschera U, 2008, TRENDS PLANT SCI, V13, P105, DOI 10.1016/j.tplants.2007.12.002; Kutschera U, 2008, ANN BOT-LONDON, V101, P615, DOI 10.1093/aob/mcn015; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; KUTSCHERA U, 1988, PLANT PHYSIOL, V88, P361, DOI 10.1104/pp.88.2.361; Kutschera U, 2006, SCIENCE, V311, P952; KUTSCHERA U, 1992, BOT ACTA, V105, P246, DOI 10.1111/j.1438-8677.1992.tb00294.x; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; Kutschera U, 2001, PLANT BIOLOGY, V3, P466, DOI 10.1055/s-2001-17731; Marcotrigiano M, 2010, AM J BOT, V97, P224, DOI 10.3732/ajb.0900102; Moll S, 2002, PLANT PHYSIOL, V130, P47, DOI 10.1104/pp.004259; Muhling KH, 2010, P INT PLANT NUTR C 1; Muller B, 2007, PLANT PHYSIOL, V143, P278, DOI 10.1104/pp.106.087494; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; MUNNS R, 1993, PLANT CELL ENVIRON, V16, P15, DOI 10.1111/j.1365-3040.1993.tb00840.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Pitann B, 2009, J PLANT NUTR SOIL SC, V172, P535, DOI 10.1002/jpln.200800349; PYEE J, 1994, ARCH BIOCHEM BIOPHYS, V311, P460, DOI 10.1006/abbi.1994.1263; PYKE KA, 1991, J EXP BOT, V42, P1407, DOI 10.1093/jxb/42.11.1407; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Schubert S, 2009, PLANT SCI, V177, P196, DOI 10.1016/j.plantsci.2009.05.011; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; VANVOLKENBURGH E, 1985, PLANT PHYSIOL, V77, P190, DOI 10.1104/pp.77.1.190; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yeats TH, 2010, J EXP BOT, V61, P3759, DOI 10.1093/jxb/erq194; Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012; Zorb C, 2004, PLANT SCI, V167, P91, DOI [10.1016/S0168-9452(04)00111-6, 10.1016/j.plantsci.2004.03.004]	47	43	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118406	10.1371/journal.pone.0118406	http://dx.doi.org/10.1371/journal.pone.0118406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760715	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000023
J	Digiacomo, G; Ziche, M; Dello Sbarba, P; Donnini, S; Rovida, E				Digiacomo, Graziana; Ziche, Marina; Dello Sbarba, Persio; Donnini, Sandra; Rovida, Elisabetta			Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2	FASEB JOURNAL			English	Article						monocytes/macrophages; cytokine receptors; signal transduction; inflammation	DENDRITIC CELLS; GROWTH; ANGIOGENESIS; PROLIFERATION; ENHANCEMENT; MOTILITY; ADHESION; ACID; INOS; EP4	Prostaglandin E2 (PGE2), a key mediator of immunity, inflammation, and cancer, acts through 4 G-protein-coupled E-prostanoid receptors (EPs 1-4). Crosstalk between EPs and receptor tyrosine kinases also occurs. Colony-stimulating factor-1 receptor (CSF-1R) is an RTK that sustains the survival, proliferation, and motility of monocytes/macrophages, which are an essential component of innate immunity and cancer development. The aim of this study was to investigate on a possible crosstalk between EP and CSF-1R. In BAC1.2F5 and RAW264.7 murine macrophages, CSF-1 (EC50 = 18.1 and 10.2 ng/ml, respectively) and PGE2 (EC50 = 1.5 and 5.5 nM, respectively) promoted migration. PGE2 induced rapid CSF-1R phosphorylation that was dependent on Src family kinases (SFKs). CSF-1R inhibition reduced PGE2-elicited ERK1/2 phosphorylation and macrophage migration, indicating that CSF-1R plays a role in PGE2-mediated immunoregulation. EP4 appeared responsible for functional PGE2/CSF-1R crosstalk. Furthermore, PGE2 synergized with CSF-1 in inducing ERK1/2 phosphorylation and macrophage migration. ERK1/2 inhibition completely blocked migration induced by the combination CSF-1/PGE2. CSF-1/PGE2 functional interaction with respect to migration also occurred in bone marrow-derived murine macrophages (EC50 CSF-1, 6.7 ng/ml; EC50 PGE2, 16.7 nM). These results indicated that PGE2 transactivates CSF-1R and synergizes with its signaling at ERK1/2 level in promoting macrophage migration.	[Digiacomo, Graziana; Dello Sbarba, Persio; Rovida, Elisabetta] Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin Mario, I-50134 Florence, Italy; [Digiacomo, Graziana; Ziche, Marina; Dello Sbarba, Persio; Donnini, Sandra; Rovida, Elisabetta] Univ Siena, Dipartimento Sci Vita, I-53100 Siena, Italy; [Ziche, Marina; Donnini, Sandra] Ist Toscano Tumori, Florence, Italy	University of Florence; University of Siena; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Rovida, E (corresponding author), Univ Florence, Dipartimento Sci Biomed Sperimentali & Clin Mario, Sez Patol & Oncol Sperimentali, Viale GB Morgagni 50, I-50134 Florence, Italy.	erovida@unifi.it	Rovida, Elisabetta/F-3565-2015; Donnini, Sandra/K-9252-2019; Dello Sbarba, Persio/AAX-9887-2020	Rovida, Elisabetta/0000-0002-5949-3239; Donnini, Sandra/0000-0001-6617-1644; Ziche, Marina/0000-0002-9564-214X	Associazione Italiana per la Ricerca sul Cancro [IG5220, IG13466, IG15282, IG10731]; Istituto Toscano Tumori; Ministero della Salute (Ricerca Finalizzata) [RF-TOS-2008-1163728]; Regione Toscana (Programma per la Ricerca in Materia di Salute); Fondazione Cassa di Risparmio di Volterra	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Toscano Tumori; Ministero della Salute (Ricerca Finalizzata)(Ministry of Health, Italy); Regione Toscana (Programma per la Ricerca in Materia di Salute)(Regione Toscana); Fondazione Cassa di Risparmio di Volterra	The authors are grateful to Dr. Ignazia Tusa for her help in performing the experiments. This work was supported by Associazione Italiana per la Ricerca sul Cancro (Grants IG5220 and IG13466 to P.D.S., IG15282 to E.R., and IG10731 to M.Z.), Istituto Toscano Tumori (to P.D.S. and M.Z.), Ministero della Salute (Ricerca Finalizzata, Grant RF-TOS-2008-1163728, to P.D.S.), Regione Toscana (Programma per la Ricerca in Materia di Salute, to P.D.S.), and Fondazione Cassa di Risparmio di Volterra (to P.D.S.).	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alexander LD, 2014, AM J PHYSIOL-RENAL, V307, pF287, DOI 10.1152/ajprenal.00094.2014; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Barbetti V, 2014, ONCOGENE, V33, P4359, DOI 10.1038/onc.2013.542; Barbetti V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.49; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; Han C, 2006, J CELL PHYSIOL, V207, P261, DOI 10.1002/jcp.20560; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kim JI, 2010, MOL CANCER RES, V8, P569, DOI 10.1158/1541-7786.MCR-09-0511; Korade-Mirnics Z, 2000, J LEUKOCYTE BIOL, V68, P603; Li XL, 2007, ARCH BIOCHEM BIOPHYS, V467, P20, DOI 10.1016/j.abb.2007.08.005; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; MacDonald KPA, 2005, J IMMUNOL, V175, P1399, DOI 10.4049/jimmunol.175.3.1399; Majumder M, 2014, CANCER SCI, V105, P1142, DOI 10.1111/cas.12475; Mayoral R, 2005, CARCINOGENESIS, V26, P753, DOI 10.1093/carcin/bgi022; Medeiros A, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/327568; Morandi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027450; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; RALPH P, 1977, J IMMUNOL, V119, P950; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Rovida E, 2005, BIOL CHEM, V386, P919, DOI 10.1515/BC.2005.107; Rovida E, 2008, J IMMUNOL, V180, P4166, DOI 10.4049/jimmunol.180.6.4166; Sampaio NG, 2011, J CELL SCI, V124, P2021, DOI 10.1242/jcs.075309; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Tajima T, 2012, AM J PHYSIOL-GASTR L, V302, pG524, DOI 10.1152/ajpgi.00264.2011; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Zaslona Z, 2012, BLOOD, V119, P2358, DOI 10.1182/blood-2011-08-374207	37	21	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2545	2554		10.1096/fj.14-258939	http://dx.doi.org/10.1096/fj.14-258939			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757564				2022-12-26	WOS:000355209500031
J	Lau, G; Labrecque, J; Metz, M; Vaz, R; Fricker, SP				Lau, Gloria; Labrecque, Jean; Metz, Markus; Vaz, Roy; Fricker, Simon P.			Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue ROLE OF ILE198	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CCR5; SMALL-MOLECULE CCR5; BICYCLAM NONPEPTIDE ANTAGONISTS; HIV-1 INFECTION; ACCURATE DOCKING; ENTRY INHIBITORS; BINDING; MARAVIROC; CXCR4; TYPE-1	The chemokine receptors CCR5 and CCR2b share 89% amino acid homology. CCR5 is a co-receptor for HIV and CCR5 antagonists have been investigated as inhibitors of HIV infection. We describe the use of two CCR5 antagonists, Schering-C (SCH-C), which is specific for CCR5, and TAK-779, a dual inhibitor of CCR5 and CCR2b, to probe the CCR5 inhibitor binding site using CCR5/CCR2b chimeric receptors. Compound inhibition in the different chimeras was assessed by inhibition of chemokine-induced calcium flux. SCH-C inhibited RANTES (regulated on activation, normal T cell expressed and secreted) (CCL5)-mediated calcium flux on CCR5 with an IC50 of 22.8 nM but was inactive against monocyte chemoattractant protein-1 (CCL2)-mediated calcium flux on CCR2b. However, SCH-C inhibited CCL2-induced calcium flux against a CCR5/CCR2b chimera consisting of transmembrane domains IV-VI of CCR5 with an IC50 of 55 nM. A sequence comparison of CCR5 and CCR2b identified a divergent amino acid sequence located at the junction of transmembrane domain V and second extracellular loop. Transfer of the CCR5 sequence KNFQTLKIV into CCR2b conferred SCH-C inhibition (IC50 of 122 nM) into the predominantly CCR2b chimera. Furthermore, a single substitution, R206I, conferred partial but significant inhibition (IC50 of 1023 nM) by SCH-C. These results show that a limited amino acid sequence is responsible for SCH-C specificity to CCR5, and we propose a model showing the interaction with CCR5 Ile(198).	Anormed Inc, Langley, BC V2Y 1N5, Canada; [Metz, Markus; Vaz, Roy] Sanofi, Lead Generat Candidate Realizat, Waltham, MA 02451 USA; [Fricker, Simon P.] Sanofi Genzyme R&D Ctr, Framingham, MA 01701 USA	AnorMED Inc; Sanofi-Aventis; Sanofi-Aventis; Genzyme Corporation	Fricker, SP (corresponding author), Sanofi Genzyme R&D Ctr, 49 New York Ave, Framingham, MA 01701 USA.	simonpfricker@gmail.com						Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Billick E., 2004, J VIROL, V78, P4134; Calandra G, 2010, CURR TOP MICROBIOL, V341, P173, DOI 10.1007/82_2010_26; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DiPersio JF, 2009, J CLIN ONCOL, V27, P4767, DOI 10.1200/JCO.2008.20.7209; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; Doranz BJ, 1997, IMMUNOL RES, V16, P15, DOI 10.1007/BF02786321; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Filer A. D., 2004, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V3, P103, DOI 10.2174/1568014043355393; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fricker SP, 2014, FUTURE MED CHEM, V6, P91, DOI [10.4155/FMC.13.194, 10.4155/fmc.13.194]; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Ghorban K, 2013, INFLAMMATION, V36, P633, DOI 10.1007/s10753-012-9585-8; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kothandan G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032864; Kromdijk W, 2010, EXPERT OPIN PHARMACO, V11, P1215, DOI 10.1517/14656561003801081; Labrecque J, 2011, VIROLOGY, V413, P231, DOI 10.1016/j.virol.2011.02.016; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Metz M, 2011, J AM CHEM SOC, V133, P16477, DOI 10.1021/ja2043722; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Moyle G, 2009, CLIN INFECT DIS, V48, P798, DOI 10.1086/597097; Mueller A, 2004, INT J BIOCHEM CELL B, V36, P35, DOI 10.1016/S1357-2725(03)00172-9; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Perry CM, 2010, DRUGS, V70, P1189, DOI 10.2165/11203940-000000000-00000; Rosenkilde MM, 2007, J BIOL CHEM, V282, P27354, DOI 10.1074/jbc.M704739200; Rucker J, 1996, CELL, V87, P437, DOI 10.1016/S0092-8674(00)81364-1; Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934; Sayana S, 2009, EXPERT REV ANTI-INFE, V7, P9, DOI 10.1586/14787210.7.1.9; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Shiraishi M, 2000, J MED CHEM, V43, P2049, DOI 10.1021/jm9906264; Skerlj R, 2013, J MED CHEM, V56, P8049, DOI 10.1021/jm401101p; Skerlj RT, 2010, J MED CHEM, V53, P3376, DOI 10.1021/jm100073m; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wong RSY, 2008, MOL PHARMACOL, V74, P1485, DOI 10.1124/mol.108.049775; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Yamasaki R., 2012, CLIN EXP NEUROIMMUNO, V3, P16, DOI [DOI 10.1111/J.1759-1961.2011.00024.X, 10.1111/j.1759-1961.2011.00024.x]; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	52	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11041	11051		10.1074/jbc.M115.640169	http://dx.doi.org/10.1074/jbc.M115.640169			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767113	Green Published, hybrid			2022-12-26	WOS:000353404500040
J	Calluso, C; Tosoni, A; Pezzulo, G; Spadone, S; Committeri, G				Calluso, Cinzia; Tosoni, Annalisa; Pezzulo, Giovanni; Spadone, Sara; Committeri, Giorgia			Interindividual Variability in Functional Connectivity as Long-Term Correlate of Temporal Discounting	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; DEFAULT-MODE NETWORK; DECISION-MAKING; DELAYED REWARDS; SELF-CONTROL; FRONTOPARIETAL NETWORKS; BRAIN ACTIVITY; LIFE-SPAN; IMPULSIVITY; FUTURE	During intertemporal choice (IT) future outcomes are usually devaluated as a function of the delay, a phenomenon known as temporal discounting (TD). Based on task-evoked activity, previous neuroimaging studies have described several networks associated with TD. However, given its relevance for several disorders, a critical challenge is to define a specific neural marker able to predict TD independently of task execution. To this aim, we used resting-state functional connectivity MRI (fcMRI) and measured TD during economic choices several months apart in 25 human subjects. We further explored the relationship between TD, impulsivity and decision uncertainty by collecting standard questionnaires on individual trait/state differences. Our findings indicate that fcMRI within and between critical nodes of task-evoked neural networks associated with TD correlates with discounting behavior measured a long time afterwards, independently of impulsivity. Importantly, the nodes form an intrinsic circuit that might support all the mechanisms underlying TD, from the representation of subjective value to choice selection through modulatory effects of cognitive control and episodic prospection.	[Calluso, Cinzia; Tosoni, Annalisa; Spadone, Sara; Committeri, Giorgia] Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, I-66013 Chieti, Italy; [Calluso, Cinzia; Tosoni, Annalisa; Spadone, Sara; Committeri, Giorgia] G DAnnunzio Fdn, Inst Adv Biomed Technol, I-66013 Chieti, Italy; [Pezzulo, Giovanni] CNR, Inst Cognit Sci & Technol, I-00185 Rome, Italy	G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Calluso, C (corresponding author), Univ G DAnnunzio, Dept Neurosci Imaging & Clin Sci, Via Vestini 33, I-66013 Chieti, Italy.	cinzia.calluso@unich.it	Tosoni, Annalisa/J-7410-2016; Committeri, Giorgia/AAC-1035-2022; Spadone, Sara/GZL-0599-2022; Calluso, Cinzia/B-9662-2017; Pezzulo, Giovanni/AAY-3586-2020	Tosoni, Annalisa/0000-0001-9004-2623; Spadone, Sara/0000-0002-2304-4984; Calluso, Cinzia/0000-0001-6693-0786; Pezzulo, Giovanni/0000-0001-6813-8282	University G. d'Annunzio; EU's FP7 [FP7-ICT-270108]; HFSP [RGY0088/2014]	University G. d'Annunzio; EU's FP7; HFSP(Human Frontier Science Program)	This work was supported by University G. d'Annunzio grants to GC and by the EU's FP7 under grant agreement no FP7-ICT-270108 and the HFSP under grant agreement RGY0088/2014 to GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2006, SUPERLAB STIMULUS PR; Ainslie G, 1975, PSYCHOL BULL, V59, P257; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Beck RC, 2009, EXP CLIN PSYCHOPHARM, V17, P345, DOI 10.1037/a0017078; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V90, P1; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Boettiger CA, 2007, J NEUROSCI, V27, P14383, DOI 10.1523/JNEUROSCI.2551-07.2007; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bretteville-Jensen AL, 1999, J HEALTH ECON, V18, P393, DOI 10.1016/S0167-6296(98)00057-5; Camchong J, 2011, BIOL PSYCHIAT, V69, P1117, DOI 10.1016/j.biopsych.2011.01.008; CAPRARA GV, 1993, PERS INDIV DIFFER, V15, P281, DOI 10.1016/0191-8869(93)90218-R; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2009, PHARMACOPSYCHIATRY, V42, pS56, DOI 10.1055/s-0028-1124107; Dixon MR, 2006, J APPL BEHAV ANAL, V39, P413, DOI 10.1901/jaba.2006.173-05; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P449, DOI 10.1901/jaba.2003.36-449; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gianotti LRR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00054; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Goudriaan AE, 2008, PSYCHOL MED, V38, P41, DOI 10.1017/S0033291707000694; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Han SD, 2013, EXP GERONTOL, V48, P1489, DOI 10.1016/j.exger.2013.10.003; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; HAXBY JV, 1993, BEHAV RES METH INSTR, V25, P400, DOI 10.3758/BF03204531; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Joreskog K, 2013, LISREL 9 0 STUDENT E; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Kirby KN, 2009, PSYCHON B REV, V16, P457, DOI 10.3758/PBR.16.3.457; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Li N, 2013, J NEUROSCI, V33, P4886, DOI 10.1523/JNEUROSCI.1342-12.2013; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; Loo R, 2000, PERS INDIV DIFFER, V29, P895, DOI 10.1016/S0191-8869(99)00241-X; Madden GJ, 1997, EXP CLIN PSYCHOPHARM, V5, P256, DOI 10.1037/1064-1297.5.3.256; Mazur JE, 1987, QUANTITATIVE ANAL BE, V5, P57; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCrae R.R., 1984, EMERGING LIVES ENDUR; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Monterosso J, 1999, PSYCHOPHARMACOLOGY, V146, P339, DOI 10.1007/PL00005480; Odum AL, 2011, BEHAV PROCESS, V87, P1, DOI 10.1016/j.beproc.2011.02.007; Patton J.H., 1995, J CLIN PSYCHOL; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pennartz CMA, 2011, TRENDS NEUROSCI, V34, P548, DOI 10.1016/j.tins.2011.08.001; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Pezzulo G, 2014, TRENDS COGN SCI, P1; Pezzulo G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0470; Pezzulo G, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00092; Pezzulo G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00079; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Scheres A, 2010, BIOL PSYCHIAT, V67, P641, DOI 10.1016/j.biopsych.2009.10.033; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shulman GL, 2009, J NEUROSCI, V29, P4392, DOI 10.1523/JNEUROSCI.5609-08.2009; Talairach J., 1988, COPLANAR STEREOTAXIC; The Mathworks Inc, 2009, MATL R2009A; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wilson VB, 2011, J CHILD PSYCHOL PSYC, V52, P256, DOI 10.1111/j.1469-7610.2010.02347.x; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	93	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119710	10.1371/journal.pone.0119710	http://dx.doi.org/10.1371/journal.pone.0119710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774886	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500113
J	Magierowski, RH; Read, SM; Carter, SJB; Warfe, DM; Cook, LS; Lefroy, EC; Davies, PE				Magierowski, Regina H.; Read, Steve M.; Carter, Steven J. B.; Warfe, Danielle M.; Cook, Laurie S.; Lefroy, Edward C.; Davies, Peter E.			Inferring Landscape-Scale Land-Use Impacts on Rivers Using Data from Mesocosm Experiments and Artificial Neural Networks	PLOS ONE			English	Article							DEPOSITED FINE SEDIMENT; DISSOLVED NUTRIENTS; STRESSOR GRADIENTS; AQUATIC INSECTS; SUBSIDY-STRESS; STREAMS; RESPONSES; COMMUNITIES; REDUNDANCY; MICROCOSMS	Identifying land-use drivers of changes in river condition is complicated by spatial scale, geomorphological context, land management, and correlations among responding variables such as nutrients and sediments. Furthermore, variations in standard metrics, such as substratum composition, do not necessarily relate causally to ecological impacts. Consequently, the absence of a significant relationship between a hypothesised driver and a dependent variable does not necessarily indicate the absence of a causal relationship. We conducted a gradient survey to identify impacts of catchment-scale grazing by domestic livestock on river macroinvertebrate communities. A standard correlative approach showed that community structure was strongly related to the upstream catchment area under grazing. We then used data from a stream mesocosm experiment that independently quantified the impacts of nutrients and fine sediments on macroinvertebrate communities to train artificial neural networks (ANNs) to assess the relative influence of nutrients and fine sediments on the survey sites from their community composition. The ANNs developed to predict nutrient impacts did not find a relationship between nutrients and catchment area under grazing, suggesting that nutrients were not an important factor mediating grazing impacts on community composition, or that these ANNs had no generality or insufficient power at the landscape-scale. In contrast, ANNs trained to predict the impacts of fine sediments indicated a significant relationship between fine sediments and catchment area under grazing. Macro-invertebrate communities at sites with a high proportion of land under grazing were thus more similar to those resulting from high fine sediments in a mesocosm experiment than to those resulting from high nutrients. Our study confirms that 1) fine sediment is an important mediator of land-use impacts on river macroinvertebrate communities, 2) ANNs can successfully identify subtle effects and separate the effects of correlated variables, and 3) data from small-scale experiments can generate relationships that help explain landscape-scale patterns.	[Magierowski, Regina H.; Cook, Laurie S.; Davies, Peter E.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Magierowski, Regina H.; Warfe, Danielle M.; Lefroy, Edward C.; Davies, Peter E.] Univ Tasmania, Ctr Environm, Hobart, Tas, Australia; [Read, Steve M.] Forestry Tasmania, Hobart, Tas, Australia; [Read, Steve M.] Univ Melbourne, Dept Forest & Ecosyst Sci, Creswick, Vic, Australia; [Carter, Steven J. B.] Univ Tasmania, Sch Math & Phys, Hobart, Tas, Australia; [Warfe, Danielle M.] Univ Tasmania, Tasmanian Sch Business & Econ, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Melbourne; University of Tasmania; University of Tasmania	Magierowski, RH (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	reginam@utas.edu.au	Magierowski, Regina/B-4588-2013; Davies, Peter/J-7713-2014; Lefroy, Ted/J-7144-2014	Magierowski, Regina/0000-0002-7547-8549; Davies, Peter/0000-0003-2651-4061; Lefroy, Ted/0000-0002-3164-8948	Australian Government Department of the Environment, Commonwealth Environmental Research Facilities; Australian Government Department of the Environment, National Environment Research Program	Australian Government Department of the Environment, Commonwealth Environmental Research Facilities(Australian Government); Australian Government Department of the Environment, National Environment Research Program(Australian Government)	The Australian Government Department of the Environment, Commonwealth Environmental Research Facilities (http://www.environment.gov.au/science/nerp) funded the Landscape Logic Research Hub-Directed by ECL. The Australian Government Department of the Environment, National Environment Research Program (http://www.environment.gov.au/science/nerp) funded the Landscapes and Policy Research Hub-Directed by ECL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna V, 2004, FRESHWATER BIOL, V49, P960, DOI 10.1111/j.1365-2427.2004.01239.x; Allan JD, 2012, FRESHWATER BIOL, V57, P58, DOI 10.1111/j.1365-2427.2011.02683.x; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allan JD, 1997, FRESHWATER BIOL, V37, P149, DOI 10.1046/j.1365-2427.1997.d01-546.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2009, DPIPWE CART TASM LAN; BARBOUR MT, 1992, ENVIRON TOXICOL CHEM, V11, P437, DOI [10.1897/1552-8618(1992)11[437:EOERBB]2.0.CO;2, 10.1002/etc.5620110401]; Bende-Michl U, 2013, ENVIRON MONIT ASSESS, V185, P9191, DOI 10.1007/s10661-013-3246-8; Bergstrom U, 2006, AM NAT, V167, P246, DOI 10.1086/499372; Beyers DW, 1998, J N AM BENTHOL SOC, V17, P367, DOI 10.2307/1468339; Bond NR, 2003, FRESHWATER BIOL, V48, P455, DOI 10.1046/j.1365-2427.2003.01016.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brown LE, 2011, J ANIM ECOL, V80, P884, DOI 10.1111/j.1365-2656.2011.01814.x; BRS, 2006, TECHN HDB SUPP AUSTR, V3; Burcher CL, 2007, ECOLOGY, V88, P228, DOI 10.1890/0012-9658(2007)88[228:TLCRCL]2.0.CO;2; Campbell I.C., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P3250; CAMPBELL IC, 1989, AUST J MAR FRESH RES, V40, P519; Campbell IC, 1998, INT VER THEOR ANGEW, V26, P986; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; CHESSMAN BC, 1986, AUST J MAR FRESH RES, V37, P129, DOI 10.1071/MF9860129; Clapcott JE, 2011, FRESHWATER BIOL, DOI 101111/j.1365-2427.2011.02696.x; Cooper SD, 1993, FRESHWATER BIOMONITO; CROSSLAND NO, 1992, TOXICOL LETT, V64-5, P511, DOI 10.1016/0378-4274(92)90226-A; DAVIES AL, 1993, FRESHWATER BIOL, V30, P47, DOI 10.1111/j.1365-2427.1993.tb00787.x; DAVIES PE, 1993, J HYDROL, V150, P481, DOI 10.1016/0022-1694(93)90122-P; Demuth H. B., 2014, NEURAL NETWORK DESIG; Downes B.J., 2002, MONITORING ECOLOGICA; DPIPWE, 2015, WAT INF SYST TASM; DPIPWE, 2005, CFEV DAT V1 0 CONS F; Drake JA, 1996, ECOLOGY, V77, P670, DOI 10.2307/2265489; Englund G, 2003, ADV ECOL RES, V33, P161, DOI 10.1016/S0065-2504(03)33011-9; Gravelle JA, 2009, FOREST ECOL MANAG, V257, P1663, DOI 10.1016/j.foreco.2009.01.017; Greet J, 2011, FRESHWATER BIOL, V56, P1231, DOI 10.1111/j.1365-2427.2011.02564.x; HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697; Hagan MT., 1997, NEURAL NETWORK DESIG; Harris GP, 2012, FRESHWATER BIOL, V57, P91, DOI 10.1111/j.1365-2427.2011.02640.x; Hauer F.R., 2007, METHODS STREAM ECOLO; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Ives AR, 1996, ECOLOGY, V77, P681, DOI 10.2307/2265491; Karle IM, 2007, J EXP MAR BIOL ECOL, V353, P265, DOI 10.1016/j.jembe.2007.09.014; King RS, 2005, ECOL APPL, V15, P137, DOI 10.1890/04-0481; Krasnicki T, 2001, AUSTR WIDE ASSESSMEN; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; LENAT DR, 1994, HYDROBIOLOGIA, V294, P185, DOI 10.1007/BF00021291; Leprieur F, 2006, J APPL ECOL, V43, P930, DOI 10.1111/j.1365-2664.2006.01201.x; Lindenmayer D. B., 2011, B ECOL SOC AM, V92, P245, DOI DOI 10.1890/0012-9623-92.3.245; Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004; Magierowski RH, 2006, ECOL APPL, V16, P2264, DOI 10.1890/1051-0761(2006)016[2264:ROSOBI]2.0.CO;2; Magierowski RH, 2012, MAR FRESHWATER RES, V63, P762, DOI 10.1071/MF11267; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; McNie EC, 2007, ENVIRON SCI POLICY, V10, P17, DOI 10.1016/j.envsci.2006.10.004; Moore JC, 1996, ECOLOGY, V77, P694, DOI 10.2307/2265494; Mosisch TD, 2001, FRESHWATER BIOL, V46, P1269, DOI 10.1046/j.1365-2427.2001.00747.x; ODUM EP, 1979, BIOSCIENCE, V29, P349, DOI 10.2307/1307690; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Ozesmi SL, 2006, ECOL MODEL, V195, P83, DOI 10.1016/j.ecolmodel.2005.11.012; Park YS, 2003, ECOL MODEL, V160, P265, DOI 10.1016/S0304-3800(02)00258-2; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ransom G., 2002, 23 COMM AUSTR U CANB; South NRM, 2009, TASMANIAN RIVER COND; Spivak AC, 2011, FRESHWATER BIOL, V56, P279, DOI 10.1111/j.1365-2427.2010.02495.x; Sponseller RA, 2001, FRESHWATER BIOL, V46, P1409, DOI 10.1046/j.1365-2427.2001.00758.x; STRAHLER AN, 1952, GEOL SOC AM BULL, V63, P923, DOI 10.1130/0016-7606(1952)63[923:DBOG]2.0.CO;2; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; UNDERWOOD AJ, 1988, MAR ECOL PROG SER, V46, P227, DOI 10.3354/meps046227; Wagenhoff A, 2013, FRESHWATER BIOL, V58, P1849, DOI 10.1111/fwb.12174; Wagenhoff A, 2012, J APPL ECOL, V49, P892, DOI 10.1111/j.1365-2664.2012.02162.x; Wagenhoff A, 2011, FRESHWATER BIOL, V56, P1916, DOI 10.1111/j.1365-2427.2011.02619.x; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; YULE C, 1986, AUST J MAR FRESH RES, V37, P121	74	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120901	10.1371/journal.pone.0120901	http://dx.doi.org/10.1371/journal.pone.0120901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775245	Green Published, Green Accepted, gold			2022-12-26	WOS:000351183500198
J	Yassine, S; Escoffier, J; Nahed, RA; Pierre, V; Karaouzene, T; Ray, PF; Arnoult, C				Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe			Dynamics of Sun5 Localization during Spermatogenesis in Wild Type and Dpy19l2 Knock-Out Mice Indicates That Sun5 Is Not Involved in Acrosome Attachment to the Nuclear Envelope	PLOS ONE			English	Article							MEMBRANE PROTEIN; SPERM PROTEIN; GLOBOZOOSPERMIA; IDENTIFICATION; SPAG4; HEAD	The acrosome is an organelle that is central to sperm physiology and a defective acrosome biogenesis leads to globozoospermia, a severe male infertility. The identification of the actors involved in acrosome biogenesis is therefore particularly important to decipher the molecular pathogeny of globozoospermia. We recently showed that a defect in the DPY19L2 gene is present in more than 70% of globozoospermic men and demonstrated that Dpy19l2, located in the inner nuclear membrane, is the first protein involved in the attachment of the acrosome to the nuclear envelope (NE). SUN proteins serve to link the nuclear envelope to the cytoskeleton and are therefore good candidates to participate in acrosome-nucleus attachment, potentially by interacting with DPY19L2. In order to characterize new actors of acrosomal attachment, we focused on Sun5 (also called Spag4l), which is highly expressed in male germ cells, and investigated its localization during spermatogenesis. Using immunohistochemistry and Western blot experiments in mice, we showed that Sun5 transits through different cellular compartments during meiosis. In pachytene spermatocytes, it is located in a membranous compartment different to the reticulum. In round spermatids, it progresses to the Golgi and the NE before to be located to the tail/head junction in epididymal sperm. Interestingly, we demonstrate that Sun5 is not, as initially reported, facing the acrosome but is in fact excluded from this zone. Moreover, we show that in Dpy19l2 KO spermatids, upon the detachment of the acrosome, Sun5 relocalizes to the totality of the NE suggesting that the acrosome attachment excludes Sun5 from the NE facing the acrosome. Finally, Western-blot experiments demonstrate that Sun5 is glycosylated. Overall, our work, associated with other publications, strongly suggests that the attachment of the acrosome to the nucleus does not likely depend on the formation of SUN complexes.	[Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe] Univ Grenoble Alpes, F-38000 Grenoble, France; [Yassine, Sandra; Escoffier, Jessica; Nahed, Roland Abi; Pierre, Virginie; Karaouzene, Thomas; Ray, Pierre F.; Arnoult, Christophe] INSERM U823, Equipe Genet Epigenet & Therapies Infertil, Inst Albert Bonniot, F-38000 Grenoble, France; [Karaouzene, Thomas; Ray, Pierre F.] CHU Grenoble, UF Biochim & Genet Mol, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Arnoult, C (corresponding author), Univ Grenoble Alpes, F-38000 Grenoble, France.	Christophe.arnoult@ujf-grenoble.fr	Escoffier, jessica/E-9498-2017; Escoffier, jessica/T-9857-2019; Abi Nahed, Roland/GNP-4140-2022; Ray, Pierre F/D-7315-2019; ARNOULT, christophe/E-8312-2013	Escoffier, jessica/0000-0001-8166-5845; Abi Nahed, Roland/0000-0002-8767-6462; Ray, Pierre F/0000-0003-1544-7449; ARNOULT, christophe/0000-0002-3753-5901	Gravit Foundation; Agence National de la Recherche [ICG2I]	Gravit Foundation; Agence National de la Recherche(French National Research Agency (ANR))	This study was supported by grants from Gravit Foundation (to CA), from the Agence National de la Recherche (Grant ICG2I to PR and CA).	Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Chi YH, 2012, NUCLEUS-PHILA, V3, P418, DOI 10.4161/nucl.21714; Coutton C, 2012, HUM REPROD, V27, P2549, DOI 10.1093/humrep/des160; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Frohnert C, 2011, MOL HUM REPROD, V17, P207, DOI 10.1093/molehr/gaq099; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Gronborg M, 2002, MOL CELL PROTEOMICS, V1, P517, DOI 10.1074/mcp.M200010-MCP200; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Ho HC, 2003, BIOL REPROD, V68, P1590, DOI 10.1095/biolreprod.102.011320; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Jiang XZ, 2011, DNA CELL BIOL, V30, P875, DOI 10.1089/dna.2010.1161; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Korfali Nadia, 2009, V528, P201, DOI 10.1007/978-1-60327-310-7_15; Kracklauer MP, 2010, J CELL SCI, V123, P2763, DOI 10.1242/jcs.066589; Li B, 2014, TRAFFIC, V15, P347, DOI 10.1111/tra.12150; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Yassine S, 2014, MOL HUM REPROD	26	31	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118698	10.1371/journal.pone.0118698	http://dx.doi.org/10.1371/journal.pone.0118698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775128	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500035
J	Bertoldo, MJ; Guibert, E; Faure, M; Rame, C; Foretz, M; Viollet, B; Dupont, J; Froment, P				Bertoldo, Michael J.; Guibert, Edith; Faure, Melanie; Rame, Christelle; Foretz, Marc; Viollet, Benoit; Dupont, Joelle; Froment, Pascal			Specific Deletion of AMP-Activated Protein Kinase (alpha 1AMPK) in Murine Oocytes Alters Junctional Protein Expression and Mitochondrial Physiology	PLOS ONE			English	Article							IN-VITRO MATURATION; MOUSE OOCYTES; DEVELOPMENTAL COMPETENCE; MEIOTIC RESUMPTION; GRANULOSA-CELLS; PROGESTERONE SECRETION; HISTONE DEACETYLATION; PORCINE OOCYTES; FOLLICLE CELLS; COMMUNICATION	Oogenesis and folliculogenesis are dynamic processes that are regulated by endocrine, paracrine and autocrine signals. These signals are exchanged between the oocyte and the somatic cells of the follicle. Here we analyzed the role of AMP-activated protein kinase (AMPK), an important regulator of cellular energy homeostasis, by using transgenic mice deficient in alpha 1AMPK specifically in the oocyte. We found a decrease of 27% in litter size was observed in ZP3-alpha 1AMPK(-/-)(ZP3-KO) female mice. Following in vitro fertilization, where conditions are stressful for the oocyte and embryo, ZP3-KO oocytes were 68% less likely to pass the 2-cell stage. In vivo and in cumulus-oocyte complexes, several proteins involved in junctional communication, such as connexin37 and N-cadherin were downregulated in the absence of alpha 1AMPK. While the two signalling pathways (PKA and MAPK) involved in the junctional communication between the cumulus/granulosa cells and the oocyte were stimulated in control oocytes, ZP3-KO oocytes exhibited only low phosphorylation of MAPK or CREB proteins. In addition, MII oocytes deficient in alpha 1AMPK had a 3-fold lower ATP concentration, an increase in abnormal mitochondria, and a decrease in cytochrome C and PGC1 alpha levels, suggesting perturbed energy production by mitochondria. The absence of alpha 1AMPK also induced a reduction in histone deacetylase activity, which was associated with an increase in histone H3 acetylation (K9/K14 residues). Together, the results of the present study suggest that absence of AMPK, modifies oocyte quality through energy processes and oocyte/somatic cell communication. The limited effect observed in vivo could be partly due to a favourable follicle microenvironment where nutrients, growth factors, and adequate cell interaction were present. Whereas in a challenging environment such as that of in vitro culture following IVF, the phenotype is revealed.	[Bertoldo, Michael J.; Guibert, Edith; Faure, Melanie; Rame, Christelle; Dupont, Joelle; Froment, Pascal] Univ Tours, CNRS, Haras Nationaux Physiol Reprod & Comportements, INRA,UMR 7247, F-37380 Nouzilly, France; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Dupont, Joelle] CNRS, UMR8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bertoldo, Michael J.] Univ New S Wales, Discipline Obstet & Gynaecol, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of New South Wales Sydney	Froment, P (corresponding author), Univ Tours, CNRS, Haras Nationaux Physiol Reprod & Comportements, INRA,UMR 7247, F-37380 Nouzilly, France.	pascal.froment@tours.inra.fr	FORETZ, Marc/O-7334-2017; Viollet, Benoit/O-6927-2017; Viollet, Benoit/N-2397-2019	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Froment, Pascal/0000-0002-7388-9598	Region Centre; Institut National de la Recherche Agronomique; French National Research Agency (ANR)	Region Centre(Region Centre-Val de Loire); Institut National de la Recherche Agronomique; French National Research Agency (ANR)(French National Research Agency (ANR))	Melanie Faure was supported by the Region Centre and Institut National de la Recherche Agronomique (Ph.D Grant). The national FERTiNERGY programme funded by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, P NATL ACAD SCI USA, V103, P7339, DOI 10.1073/pnas.0510946103; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Alesutan I, 2011, J MEMBRANE BIOL, V240, P151, DOI 10.1007/s00232-011-9353-y; Araki K, 1996, BIOL REPROD, V55, P1315, DOI 10.1095/biolreprod55.6.1315; Bendale DS, 2013, BRIT J PHARMACOL, V170, P779, DOI 10.1111/bph.12290; Bertoldo MJ, 2014, CRYOBIOLOGY, V68, P262, DOI 10.1016/j.cryobiol.2014.02.006; Bertoldo MJ, 2014, REPRODUCTION FERTILI; BROWER PT, 1982, DEV BIOL, V90, P144, DOI 10.1016/0012-1606(82)90219-6; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cerda J, 1999, BIOL REPROD, V61, P692, DOI 10.1095/biolreprod61.3.692; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; Chen J, 2008, DEV BIOL, V313, P47, DOI 10.1016/j.ydbio.2007.09.043; Chi Y, 2014, J CELL SCI, V127, P1487, DOI 10.1242/jcs.139089; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DOWNS SM, 1994, DEV BIOL, V162, P154, DOI 10.1006/dbio.1994.1075; Downs SM, 2006, MOL REPROD DEV, V73, P1159, DOI 10.1002/mrd.20439; Dugan LL, 2013, J CLIN INVEST, V123, P4888, DOI 10.1172/JCI66218; Edry I, 2006, MOL CELL ENDOCRINOL, V252, P102, DOI 10.1016/j.mce.2006.03.009; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Frank LA, 2014, HUM REPROD, V29, P1292, DOI 10.1093/humrep/deu066; Froment P, 2004, ENDOCRINOLOGY, V145, P2080, DOI 10.1210/en.2003-0956; Froment P, 2008, CELL CYCLE, V7, P3098, DOI 10.4161/cc.7.19.6807; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Gabriel AM, 2009, INT J BIOCHEM CELL B, V41, P2062, DOI 10.1016/j.biocel.2009.02.002; Gharibi S, 2013, THERIOGENOLOGY, V80, P302, DOI 10.1016/j.theriogenology.2013.04.012; Gittens JEI, 2005, J CELL SCI, V118, P5071, DOI 10.1242/jcs.02624; Hardie DG, 1999, BIOCHEM SOC SYMP, P13; Hernandez M, 2006, PROSTATE, V66, P1151, DOI 10.1002/pros.20451; Jennings PC, 2011, HUM REPROD, V26, P878, DOI 10.1093/humrep/deq393; Jorgensen JS, 2013, MOL REPROD DEV, V80, P960, DOI 10.1002/mrd.22232; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalma Y, 2004, ENDOCRINOLOGY, V145, P1617, DOI 10.1210/en.2003-1051; Kidder GM, 2010, CAN J PHYSIOL PHARM, V88, P399, DOI [10.1139/Y10-009, 10.1139/y10-009]; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; LaRosa C, 2006, BIOL REPROD, V74, P585, DOI 10.1095/biolreprod.105.046524; LaRosa C, 2007, BIOL REPROD, V76, P476, DOI 10.1095/biolreprod.106.057422; Li L, 2011, DIABETES, V60, P157, DOI 10.2337/db10-0331; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Machell NH, 2003, REPRODUCTION, V125, P791, DOI 10.1530/rep.0.1250791; Mayes MA, 2007, BIOL REPROD, V76, P589, DOI 10.1095/biolreprod.106.057828; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Nakano A, 2012, GENES CELLS, V17, P737, DOI 10.1111/j.1365-2443.2012.01629.x; Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011; Ogawa T, 2005, CANCER RES, V65, P9771, DOI 10.1158/0008-5472.CAN-05-0227; Peluso JJ, 2006, REPRODUCTION, V131, P429, DOI 10.1530/rep.1.00863; Perez GI, 2000, NATURE, V403, P500, DOI 10.1038/35000651; QUINN P, 1973, J REPROD FERTIL, V35, P301, DOI 10.1530/jrf.0.0350301; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ratchford AM, 2008, MOL ENDOCRINOL, V22, P2643, DOI 10.1210/me.2007-0495; Reverchon M, 2013, MOL HUM REPROD, V19, P313, DOI 10.1093/molehr/gat002; Rufas O, 2000, MOL HUM REPROD, V6, P163, DOI 10.1093/molehr/6.2.163; Schelbach CJ, 2010, REPROD FERT DEVELOP, V22, P771, DOI 10.1071/RD09193; Silvestre MFP, 2014, LIFE SCI, V100, P55, DOI 10.1016/j.lfs.2014.01.080; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Tartarin P, 2012, ENDOCRINOLOGY, V153, P3468, DOI 10.1210/en.2011-1911; Thomas RE, 2004, BIOL REPROD, V70, P548, DOI 10.1095/biolreprod.103.021204; Thouas GA, 2004, BIOL REPROD, V71, P1936, DOI 10.1095/biolreprod.104.033589; Tosca L, 2005, ENDOCRINOLOGY, V146, P4500, DOI 10.1210/en.2005-0301; Tosca L, 2007, BIOL REPROD, V77, P452, DOI 10.1095/biolreprod.107.060848; Tosca L, 2006, J ENDOCRINOL, V190, P85, DOI 10.1677/joe.1.06828; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Ya R, 2014, ZYGOTE, V22, P91, DOI 10.1017/S0967199412000457; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zheng HX, 2013, EUR J CANCER, V49, P2734, DOI 10.1016/j.ejca.2013.03.014; Ziv S, 2002, MOL REPROD DEV, V62, P547, DOI 10.1002/mrd.10149	74	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119680	10.1371/journal.pone.0119680	http://dx.doi.org/10.1371/journal.pone.0119680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767884	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500092
J	Ferru-Clement, R; Fresquet, F; Norez, C; Metaye, T; Becq, F; Kitzis, A; Thoreau, V				Ferru-Clement, Romain; Fresquet, Fleur; Norez, Caroline; Metaye, Thierry; Becq, Frederic; Kitzis, Alain; Thoreau, Vincent			Involvement of the Cdc42 Pathway in CFTR Post-Translational Turnover and in Its Plasma Membrane Stability in Airway Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE-CONDUCTANCE-REGULATOR; CYSTIC-FIBROSIS GENE; RHO-GTPASES; ENDOCYTIC TRAFFICKING; FUNCTIONAL EXPRESSION; VESICLE TRAFFICKING; ACTIN CYTOSKELETON; CHLORIDE CHANNEL; QUALITY-CONTROL; N-WASP	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel that is expressed on the apical plasma membrane (PM) of epithelial cells. The most common deleterious allele encodes a trafficking-defective mutant protein undergoing endoplasmic reticulum-associated degradation (ERAD) and presenting lower PM stability. In this study, we investigated the involvement of the Cdc42 pathway in CFTR turnover and trafficking in a human bronchiolar epithelial cell line (CFBE41o-) expressing wild-type CFTR. Cdc42 is a small GTPase of the Rho family that fulfils numerous cell functions, one of which is endocytosis and recycling process via actin cytoskeleton remodelling. When we treated cells with chemical inhibitors such as ML141 against Cdc42 and wiskostatin against the downstream effector N-WASP, we observed that CFTR channel activity was inhibited, in correlation with a decrease in CFTR amount at the cell surface and an increase in dynamin-dependent CFTR endocytosis. Anchoring of CFTR to the cortical cytoskeleton was then presumably impaired by actin disorganization. When we performed siRNA-mediated depletion of Cdc42, actin polymerization was not impacted, but we observed actin-independent consequences upon CFTR. Total and PM CFTR amounts were increased, resulting in greater activation of CFTR. Pulse-chase experiments showed that while CFTR degradation was slowed, CFTR maturation through the Golgi apparatus remained unaffected. In addition, we observed increased stability of CFTR in PM and reduction of its endocytosis. This study highlights the involvement of the Cdc42 pathway at several levels of CFTR biogenesis and trafficking: (i) Cdc42 is implicated in the first steps of CFTR biosynthesis and processing; (ii) it contributes to the stability of CFTR in PM via its anchoring to cortical actin; (iii) it promotes CFTR endocytosis and presumably its sorting toward lysosomal degradation.	[Ferru-Clement, Romain; Fresquet, Fleur; Kitzis, Alain; Thoreau, Vincent] Univ Poitiers, Lab Genet Malad Rares, Poitiers, France; [Fresquet, Fleur; Kitzis, Alain] Ctr Hosp Univ Poitiers, Serv Genet, Poitiers, France; [Norez, Caroline; Becq, Frederic] Univ Poitiers, CNRS, Lab Signalisat & Transports Ion Membranaires, Poitiers, France; [Metaye, Thierry] Ctr Hosp Univ Poitiers, Lab Biophys Med, Poitiers, France	Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Thoreau, V (corresponding author), Univ Poitiers, Lab Genet Malad Rares, Poitiers, France.	vincent.thoreau@univ-poitiers.fr	Becq, Frederic/P-9233-2016; Norez, Caroline/P-9567-2016	Becq, Frederic/0000-0003-3915-0973; Ferru-Clement, Romain/0000-0001-5309-0861	University of Poitiers; French Ministry of Higher Education and Research; Vaincre la Mucoviscidose	University of Poitiers; French Ministry of Higher Education and Research; Vaincre la Mucoviscidose	This work was supported by the University of Poitiers, the French Ministry of Higher Education and Research and Vaincre la Mucoviscidose (www.vaincrelamuco.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen N, 2007, J CYST FIBROS, V6, P1, DOI 10.1016/j.jcf.2006.09.002; Aspenstrom P, 2014, BIOL CHEM, V395, P477, DOI 10.1515/hsz-2013-0296; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Benharouga M, 2003, J BIOL CHEM, V278, P22079, DOI 10.1074/jbc.M301030200; Bilan F, 2008, EXP CELL RES, V314, P2199, DOI 10.1016/j.yexcr.2008.04.012; Bompard G, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-42; Bu WY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012153; Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140; Cheng J, 2005, J BIOL CHEM, V280, P3731, DOI 10.1074/jbc.M410026200; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fischer H, 1995, J PHYSIOL-LONDON, V489, P745, DOI 10.1113/jphysiol.1995.sp021088; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Ganeshan R, 2007, BBA-MOL CELL RES, V1773, P192, DOI 10.1016/j.bbamcr.2006.09.031; Guerra L, 2005, J BIOL CHEM, V280, P40925, DOI 10.1074/jbc.M505103200; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; HOOGEVEEN AT, 1991, EXP CELL RES, V193, P435, DOI 10.1016/0014-4827(91)90118-E; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; Norez Caroline, 2004, J Cyst Fibros, V3 Suppl 2, P119, DOI 10.1016/j.jcf.2004.05.025; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Padrick SB, 2010, ANNU REV BIOCHEM, V79, P707, DOI 10.1146/annurev.biochem.77.060407.135452; PRAT AG, 1995, AM J PHYSIOL-CELL PH, V268, pC1552, DOI 10.1152/ajpcell.1995.268.6.C1552; Prat AG, 1999, AM J PHYSIOL-CELL PH, V277, pC1160, DOI 10.1152/ajpcell.1999.277.6.C1160; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sun F, 2000, J BIOL CHEM, V275, P29539, DOI 10.1074/jbc.M004961200; Surviladze Z., 2010, PROBE REPORTS NIH MO; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tang BL, 2011, TRAFFIC, V12, P364, DOI 10.1111/j.1600-0854.2011.01161.x; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118943	10.1371/journal.pone.0118943	http://dx.doi.org/10.1371/journal.pone.0118943			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768293	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500055
J	Perroni, F; Guidetti, L; Cignitti, L; Baldari, C				Perroni, Fabrizio; Guidetti, Laura; Cignitti, Lamberto; Baldari, Carlo			Absolute vs. Weight-Related Maximum Oxygen Uptake in Firefighters: Fitness Evaluation with and without Protective Clothing and Self-Contained Breathing Apparatus among Age Group	PLOS ONE			English	Article							COLLEGE STEP TEST; PHYSIOLOGICAL-RESPONSES; METABOLIC DEMANDS; PHYSICAL-FITNESS; SIMULATED RESCUE; AEROBIC CAPACITY; FIRE FIGHTERS; RISK-FACTORS; PERFORMANCE; VALIDITY	During fire emergencies, firefighters wear personal protective devices (PC) and a self-contained breathing apparatus (S.C.B.A.) to be protected from injuries. The purpose of this study was to investigate the differences of aerobic level in 197 firefighters (age: 34 +/- 7 yr; BMI: 24.4 +/- 2.3 kg.m(-2)), evaluated by a Queen's College Step field Test (QCST), performed with and without fire protective garments, and to analyze the differences among age groups (<25 yr; 26-30 yr, 31-35 yr, 36-40 yr and >40 yr). Variance analysis was applied to assess differences (p < 0.05) between tests and age groups observed in absolute and weight-related values, while a correlation was examined between QCST with and without PC+S.C.B.A. The results have shown that a 13% of firefighters failed to complete the test with PC+S.C.B.A. and significant differences between QCST performed with and without PC+S.C.B.A. in absolute (F(1,169) = 42.6, p < 0.0001) and weight-related (F(1,169) = 339.9, p < 0.0001) terms. A better correlation has been found in L.min(-1) (r=0.67) than in ml.kg(-1).min(-1) (r=0.54). Moreover, we found significant differences among age groups both in absolute and weightrelated values. The assessment of maximum oxygen uptake of firefighters in absolute term can be a useful tool to evaluate the firefighters' cardiovascular strain.	[Perroni, Fabrizio] Univ Turin, Dept Med Sci, Sch Exercise & Sport Sci SUISM, Turin, Italy; [Guidetti, Laura; Baldari, Carlo] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Cignitti, Lamberto] Italian Fire Fighter Corp, Rome, Italy	University of Turin; Foro Italico University of Rome	Baldari, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	carlo.baldari@uniroma4.it	Guidetti, Laura/K-1142-2014; Baldari, Carlo/N-6756-2014	Guidetti, Laura/0000-0002-1419-4550; Perroni, Fabrizio/0000-0003-2094-4351; Baldari, Carlo/0000-0001-6227-3571	Italian Firefighters Corp	Italian Firefighters Corp	The authors would like to express their gratitude to the Italian Firefighters Corp for the support in carrying out the experimental sessions.	ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Bakri I, 2012, ERGONOMICS, V55, P782, DOI 10.1080/00140139.2012.663506; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bilzon JLJ, 2001, ERGONOMICS, V44, P766, DOI 10.1080/00140130118253; Chatterjee S, 2005, INDIAN J MED RES, V121, P32; Chatterjee S, 2004, BRIT J SPORT MED, V38, P289, DOI 10.1136/bjsm.2002.002212; Cohen J.E., 1988, STAT POWER ANAL BEHA; Donovan R, 2009, OCCUP MED-OXFORD, V59, P487, DOI 10.1093/occmed/kqp095; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Eglin CM, 2004, ERGONOMICS, V47, P483, DOI 10.1080/0014013031000107568; Elsner KL, 2008, ERGONOMICS, V51, P1418, DOI 10.1080/00140130802120259; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; Griefahn B, 2003, APPL ERGON, V34, P157, DOI 10.1016/S0003-6870(02)00143-6; Hammer RL, 2013, J STRENGTH COND RES, V27, P1435, DOI 10.1519/JSC.0b013e318265aaf7; Holmer I, 2007, APPL ERGON, V38, P45, DOI 10.1016/j.apergo.2006.01.004; Hopkins WG, 2013, NEW VIEW STAT; HOROWITZ MR, 1993, CAN J PUBLIC HEALTH, V84, P50; Knapik JJ, 2001, MED SCI SPORT EXER, V33, P946, DOI 10.1097/00005768-200106000-00014; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Mattila VM, 2007, MED SCI SPORT EXER, V39, P1061, DOI 10.1249/01.mss.0b013e318053721d; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; National Fire Protection Association, 2007, NFPA ASS 1500 STAND; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Oldham JA, 2000, OCCUP MED-OXFORD, V50, P599, DOI 10.1093/occmed/50.8.599; Perroni F, 2009, ERGONOMICS, V52, P484, DOI 10.1080/00140130802707873; Perroni F., 2014, OPEN SPORTS SCI J, V7, P8, DOI [DOI 10.2174/1875399X01407010008, 10.2174/1875399X01407010008]; Perroni F, 2008, SPORT SCI HLTH, V4, P27; Perroni F, 2014, APPL ERGON, V45, P456, DOI 10.1016/j.apergo.2013.06.005; Perroni F, 2010, J STRENGTH COND RES, V24, P3457, DOI 10.1519/JSC.0b013e3181b2c7ff; Portney LG, 2009, FDN CLIN RES APPL PR; Punakallio A, 1997, EXPERIENCE INNOVATIO; Punakallio A, 2012, J OCCUP ENVIRON MED, V54, P1133, DOI 10.1097/JOM.0b013e3182554b11; Qu XD, 2011, J BIOMECH, V44, P1259, DOI 10.1016/j.jbiomech.2011.02.016; Rhea MR, 2004, J STRENGTH COND RES, V18, P348; Richmond VL, 2008, ERGONOMICS, V51, P1023, DOI 10.1080/00140130801939709; Rodriguez-Marroyo JA, 2011, ERGONOMICS, V54, P1101, DOI 10.1080/00140139.2011.611895; SAUPE K, 1991, AM J PUBLIC HEALTH, V81, P1192, DOI 10.2105/AJPH.81.9.1192; Smith DL, 1997, ERGONOMICS, V40, P500, DOI 10.1080/001401397188125; Smith DL, 2005, ERGONOMICS, V48, P55, DOI 10.1080/00140130412331303911; SOTHMANN MS, 1992, J OCCUP ENVIRON MED, V34, P797, DOI 10.1097/00043764-199208000-00014; Swank AM, 2000, J STRENGTH COND RES, V14, P170; TRAFIMOW JH, 1993, SPINE, V18, P364, DOI 10.1097/00007632-199303000-00011; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; von Heimburg E, 2013, INT J OCCUP SAF ERGO, V19, P227, DOI 10.1080/10803548.2013.11076981; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; Williford HN, 1999, ERGONOMICS, V42, P1179, DOI 10.1080/001401399185063	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119757	10.1371/journal.pone.0119757	http://dx.doi.org/10.1371/journal.pone.0119757			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764201	gold, Green Published			2022-12-26	WOS:000351276300032
J	Segura, J; Marin-Lopez, MA; Jones, PF; Oliva, B; Fernandez-Fuentes, N				Segura, Joan; Alejandro Marin-Lopez, Manuel; Jones, Pamela F.; Oliva, Baldo; Fernandez-Fuentes, Narcis			VORFFIP-Driven Dock: V-(DOCK)-O-2, a Fast and Accurate Protein Docking Strategy	PLOS ONE			English	Article							SERVER; INFORMATION; COMPLEXES; ALGORITHM; DIAGRAMS	The experimental determination of the structure of protein complexes cannot keep pace with the generation of interactomic data, hence resulting in an ever-expanding gap. As the structural details of protein complexes are central to a full understanding of the function and dynamics of the cell machinery, alternative strategies are needed to circumvent the bottleneck in structure determination. Computational protein docking is a valid and valuable approach to model the structure of protein complexes. In this work, we describe a novel computational strategy to predict the structure of protein complexes based on data-driven docking: VORFFIP-driven dock (V-D2OCK). This new approach makes use of our newly described method to predict functional sites in protein structures, VORFFIP, to define the region to be sampled during docking and structural clustering to reduce the number of models to be examined by users. V-D2OCK has been benchmarked using a validated and diverse set of protein complexes and compared to a state-of-art docking method. The speed and accuracy compared to contemporary tools justifies the potential use of (VDOCK)-O-2 for high-throughput, genome-wide, protein docking. Finally, we have developed a web interface that allows users to browser and visualize V-D2OCK predictions from the convenience of their web-browsers.	[Segura, Joan; Jones, Pamela F.; Fernandez-Fuentes, Narcis] Univ Leeds, Sch Med, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Alejandro Marin-Lopez, Manuel; Oliva, Baldo] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Struct Bioinformat Lab GRIB IMIM, Barcelona 08003, Catalonia, Spain	University of Leeds; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University	Fernandez-Fuentes, N (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3EB, Dyfed, Wales.	narcis.fernandez@gmail.com	Gasull, Martina/J-4076-2019; Oliva, Baldomero/A-2690-2009	Oliva, Baldomero/0000-0003-0702-0250; Segura, Joan/0000-0001-5593-735X; Fernandez-Fuentes, Narcis/0000-0002-6421-1080; Marin Lopez, Manuel Alejandro/0000-0003-0833-3574	Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF); University of Leeds; Spanish Ministry of Economy and Competitiveness; Generalitat of Catalonia [FI-DGR2012];  [BIO2011-22568]; BBSRC [BBS/E/W/10962A01D] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10962A01D] Funding Source: researchfish	Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF); University of Leeds; Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat of Catalonia; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Research Councils UK (RCUK) under the RCUK Academic Fellowship program (NFF) and a PhD scholarship awarded by the University of Leeds (JS). BO acknowledges support from the Spanish Ministry of Economy and Competitiveness; grant number BIO2011-22568 and MAML a PhD scholarship awarded by the Generalitat of Catalonia (FI-DGR2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Feliu E, 2011, PROTEIN SCI, V20, P529, DOI 10.1002/pro.585; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Kirby TW, 2006, J BIOL CHEM, V281, P38466, DOI 10.1074/jbc.M606917200; Kummel D, 2006, J MOL BIOL, V361, P22, DOI 10.1016/j.jmb.2006.06.012; Lesk VI, 2008, BIOINFORMATICS, V24, P1137, DOI 10.1093/bioinformatics/btn093; Li B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-7; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Ofran Y, 2003, J MOL BIOL, V325, P377, DOI 10.1016/S0022-2836(02)01223-8; Pierce B, 2007, PROTEINS, V67, P1078, DOI 10.1002/prot.21373; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Ritchie DW, 2010, BIOINFORMATICS, V26, P2398, DOI 10.1093/bioinformatics/btq444; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Segura J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-352; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118107	10.1371/journal.pone.0118107	http://dx.doi.org/10.1371/journal.pone.0118107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763838	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300011
J	Glaser, T; Lewandowski, J; Dusing, J				Glaser, Tina; Lewandowski, Joshua; Duesing, Jessica			The Long and Winding Road to Uncertainty: The Link between Spatial Distance and Feelings of Uncertainty	PLOS ONE			English	Article							PSYCHOLOGICAL DISTANCE; CONSTRUAL-LEVEL; PROBABILITY; INFORMATION; FOREST	Construal Level Theory (CLT) [1] defines psychological distance as any object, event, or person that cannot be experienced by the self in the here and now. The goal of the present research was to demonstrate that feelings of uncertainty are closely linked to the concept of psychological distance. Two experiments tested the assumption that spatial distance and uncertainty are bidirectionally related. In the first experiment, we show that perceived spatial distance leads to a feeling of uncertainty. The second experiment revealed that a feeling of uncertainty leads to a perception of greater distance. By demonstrating that distance is closely tied to uncertainty, the present research extends previous research on both distance and uncertainty by incorporating previously unexplained findings within CLT. Implications of these findings such as the role of uncertainty within CLT are discussed.	[Glaser, Tina] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Lewandowski, Joshua] Claremont Grad Univ, Sch Behav & Org Sci, Claremont, CA USA; [Duesing, Jessica] Univ Trier, Dept Psychol, Trier, Germany	University of Bielefeld; Claremont Colleges; Claremont Graduate School; Universitat Trier	Glaser, T (corresponding author), Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany.	tina.glaser@uni-bielefeld.de		Glaser, Tina/0000-0003-2955-6910	young academics of the University of Bielefeld	young academics of the University of Bielefeld	The work was funded by a research grant for young academics of the University of Bielefeld, awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Anan Y, 2007, J EXP PSYCHOL GEN, V136, P610, DOI 10.1037/0096-3445.136.4.610; Bar-Anan Y, 2009, EMOTION, V9, P123, DOI 10.1037/a0014607; BERLYNE DE, 1962, BRIT J PSYCHOL, V53, P27, DOI 10.1111/j.2044-8295.1962.tb00811.x; CLORE GL, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P133; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; de Bruin WB, 2000, ORGAN BEHAV HUM DEC, V81, P115, DOI 10.1006/obhd.1999.2868; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Forster J, 2004, J PERS SOC PSYCHOL, V87, P177, DOI 10.1037/0022-3514.87.2.177; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; GILBERT DT, 1990, J PERS SOC PSYCHOL, V59, P601, DOI 10.1037/0022-3514.59.4.601; Hansen J, 2010, PERS SOC PSYCHOL B, V36, P1576, DOI 10.1177/0146167210386238; Helzer EG, 2012, SOC COGNITION, V30, P519, DOI 10.1521/soco.2012.30.5.519; Hogg MA, 2007, ADV EXP SOC PSYCHOL, V39, P69, DOI 10.1016/S0065-2601(06)39002-8; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; KAGAN J, 1972, J PERS SOC PSYCHOL, V22, P51, DOI 10.1037/h0032356; Karelitz TM, 2004, J EXP PSYCHOL-APPL, V10, P25, DOI 10.1037/1076-898X.10.1.25; Knight, 1933, RISK UNCERTAINTY PRO; Liberman N, 2002, J EXP SOC PSYCHOL, V38, P523, DOI 10.1016/S0022-1031(02)00535-8; Liberman N., 2007, SOCIAL PSYCHOL HDB B, P353; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Maglio SJ, 2013, J EXP PSYCHOL GEN, V142, P644, DOI 10.1037/a0030258; Marguc J, 2011, J PERS SOC PSYCHOL, V101, P883, DOI 10.1037/a0025013; Namkoong JE, 2014, SOC PSYCHOL PERS SCI, V5, P352, DOI 10.1177/1948550613499240; Nussbaum S, 2006, J EXP PSYCHOL GEN, V135, P152, DOI 10.1037/0096-3445.135.2.152; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Smith PK, 2006, J PERS SOC PSYCHOL, V90, P578, DOI 10.1037/0022-3514.90.4.578; Snodgrass JG, 1975, EXPT SENSORY PSYCHOL, P17; Tormala ZL, 2007, SOC PERSONAL PSYCHOL, V1, P469, DOI 10.1111/j.1751-9004.2007.00025.x; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2011, HDB THEORIES SOCIAL, P118, DOI DOI 10.4135/9781446249215.N7; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van den Bos K, 2009, PSYCHOL INQ, V20, P197, DOI 10.1080/10478400903333411; VELTEN E, 1968, BEHAV RES THER, V6, P473, DOI 10.1016/0005-7967(68)90028-4; Wakslak C, 2009, PSYCHOL SCI, V20, P52, DOI 10.1111/j.1467-9280.2008.02250.x; Wakslak CJ, 2006, J EXP PSYCHOL GEN, V135, P641, DOI 10.1037/0096-3445.135.4.641; Wakslak CJ, 2012, ORGAN BEHAV HUM DEC, V117, P150, DOI 10.1016/j.obhdp.2011.10.004; WEARY G, 1994, J PERS SOC PSYCHOL, V67, P308, DOI 10.1037/0022-3514.67.2.308; Wichman AL, 2008, J EXP SOC PSYCHOL, V44, P1106, DOI 10.1016/j.jesp.2007.12.002; Windschitl PD, 1999, J EXP PSYCHOL LEARN, V25, P1514, DOI 10.1037/0278-7393.25.6.1514	40	2	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119108	10.1371/journal.pone.0119108	http://dx.doi.org/10.1371/journal.pone.0119108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756619	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700038
J	Grieshaber, NA; Tattersall, JS; Liguori, J; Lipat, JN; Runac, J; Grieshaber, SS				Grieshaber, Nicole A.; Tattersall, Jeremiah S.; Liguori, Johella; Lipat, Joseph N.; Runac, Justin; Grieshaber, Scott S.			Identification of the Base-Pairing Requirements for Repression of hctA Translation by the Small RNA IhtA Leads to the Discovery of a New mRNA Target in Chlamydia trachomatis	PLOS ONE			English	Article							HISTONE H1-LIKE PROTEIN; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; DEVELOPMENTAL CYCLE; GENE-EXPRESSION; NONCODING RNAS; HC1; DNA; REGULATOR; FEATURES	The non-coding small RNA, IhtA expressed by the obligate intracellular human pathogen Chlamydia trachomatis modulates the translation of HctA, a key protein involved in replicative to infectious cell type differentiation. Using a combination of bioinformatics and mutagenesis we sought to identify the base pairing requirement for functional repression of HctA protein expression, with an eye to applying our findings towards the identification of additional targets. IhtA is predicted to fold into a three stem: loop structure. We found that loop 1 occludes the initiation codon of hctA, while loop 2 and 3 are not required for function. This 7 nucleotide region forms G/C rich interactions surrounding the AUG of hctA. Two additional genes in the chlamydial genome, CTL0322 and CTL0097, contained some elements of the hctA: IhtA recognition sequence. The mRNA of both CTL0322and CTL0097 interacted with IhtA in vitro as measured by biolayer interferometry. However, using a CheZ reporter expression system, IhtA only inhibited the translation of CTL0322. The proposed IhtA recognition site in the CTL0322message contains significant G/C base pairing on either side of the initiation codon while CTL0097 only contains G/C base pairing 3' to the AUG initiation codon. These data suggest that as the functional interacting region is only 6-7nt in length that full translation repression is dependent on the degree of G/C base pairing. Additionally our results indicate that IhtA may regulate multiple mRNAs involved in the chlamydial infectious cycle.	[Grieshaber, Nicole A.; Grieshaber, Scott S.] Univ Idaho, Coll Sci, Dept Biol Sci, Moscow, ID 83843 USA; [Tattersall, Jeremiah S.; Liguori, Johella; Lipat, Joseph N.; Runac, Justin] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA	Idaho; University of Idaho; State University System of Florida; University of Florida	Grieshaber, SS (corresponding author), Univ Idaho, Coll Sci, Dept Biol Sci, Moscow, ID 83843 USA.	scottg@uidaho.edu			National Institutes of Health, National Institutes of Allergy and Infectious Diseases [AI079193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079193, R21AI113617] Funding Source: NIH RePORTER	National Institutes of Health, National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health, National Institutes of Allergy and Infectious Diseases, http://www.niaid.nih.gov/Pages/default.aspx, grant AI079193 to NAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2011, NUCLEIC ACIDS RES, V39, P1843, DOI 10.1093/nar/gkq1065; Albrecht M, 2010, NUCLEIC ACIDS RES, V38, P868, DOI 10.1093/nar/gkp1032; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BARRY CE, 1992, SCIENCE, V256, P377, DOI 10.1126/science.256.5055.377; BARRY CE, 1993, MOL MICROBIOL, V9, P273, DOI 10.1111/j.1365-2958.1993.tb01689.x; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; CHRISTIANSEN G, 1993, J BACTERIOL, V175, P1785, DOI 10.1128/JB.175.6.1785-1795.1993; Coornaert A, 2010, MOL MICROBIOL, V76, P467, DOI 10.1111/j.1365-2958.2010.07115.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FAHR MJ, 1995, J BACTERIOL, V177, P4252, DOI 10.1128/jb.177.15.4252-4260.1995; Grieshaber NA, 2006, MOL MICROBIOL, V59, P541, DOI 10.1111/j.1365-2958.2005.04949.x; Grieshaber NA, 2004, P NATL ACAD SCI USA, V101, P7451, DOI 10.1073/pnas.0400754101; Grieshaber NA, 2006, J BACTERIOL, V188, P5289, DOI 10.1128/JB.00526-06; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HACKSTADT T, 1991, P NATL ACAD SCI USA, V88, P3937, DOI 10.1073/pnas.88.9.3937; HUANG CX, 1993, BIOCHIM BIOPHYS ACTA, V1202, P297, DOI 10.1016/0167-4838(93)90019-N; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; KUO SC, 1987, J BACTERIOL, V169, P1307, DOI 10.1128/jb.169.3.1307-1314.1987; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, CURR OPIN MICROBIOL, V6, P120, DOI 10.1016/S1369-5274(03)00027-4; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Papenfort K, 2009, RES MICROBIOL, V160, P278, DOI 10.1016/j.resmic.2009.03.004; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PEDERSEN LB, 1994, MOL MICROBIOL, V11, P1085, DOI 10.1111/j.1365-2958.1994.tb00385.x; PERARA E, 1992, P NATL ACAD SCI USA, V89, P2125, DOI 10.1073/pnas.89.6.2125; Richter AS, 2012, RNA BIOL, V9, P954, DOI 10.4161/rna.20294; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Skipp P, 2005, PROTEOMICS, V5, P1558, DOI 10.1002/pmic.200401044; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; TAO S, 1991, J BACTERIOL, V173, P2818, DOI 10.1128/JB.173.9.2818-2822.1991; Tattersall J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047439; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; WHO, 2001, GLOBAL PREVALENCE AN	49	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116593	10.1371/journal.pone.0116593	http://dx.doi.org/10.1371/journal.pone.0116593			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756658	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700008
J	Iaccarino, L; Crespi, C; Della Rosa, PA; Catricala, E; Guidi, L; Marcone, A; Tagliavini, F; Magnani, G; Cappa, SF; Perani, D				Iaccarino, Leonardo; Crespi, Chiara; Della Rosa, Pasquale Anthony; Catricala, Eleonora; Guidi, Lucia; Marcone, Alessandra; Tagliavini, Fabrizio; Magnani, Giuseppe; Cappa, Stefano F.; Perani, Daniela			The Semantic Variant of Primary Progressive Aphasia: Clinical and Neuroimaging Evidence in Single Subjects	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; CEREBRAL GLUCOSE-METABOLISM; ANTERIOR TEMPORAL-LOBE; WHITE-MATTER DAMAGE; BEHAVIORAL FEATURES; ALZHEIMERS-DISEASE; DEMENTIA; ATROPHY; LANGUAGE; PATTERNS	Background/Aim We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semantic variant of primary progressive aphasia (svPPA), with the aim to provide clinical-functional correlations of the cognitive and behavioral manifestations at the single-subject level. Methods We performed neuropsychological investigations, F-18-FDG-PET single-subject and group analysis, with an optimized SPM voxel-based approach, and correlation analyses. A measurement of white matter integrity by means of diffusion tensor imaging (DTI) was also available for a subgroup of patients. Results Cognitive assessment confirmed the presence of typical semantic memory deficits in all patients, with a relative sparing of executive, attentional, visuo-constructional, and episodic memory domains. F-18-FDG-PET showed a consistent pattern of cerebral hypometabolism across all patients, which correlated with performance in semantic memory tasks. In addition, a majority of patients also presented with behavioral disturbances associated with metabolic dysfunction in limbic structures. In a subgroup of cases the DTI analysis showed FA abnormalities in the inferior longitudinal and uncinate fasciculi. Discussion Each svPPA individual had functional derangement involving an extended, connected system within the left temporal lobe, a crucial part of the verbal semantic network, as well as an involvement of limbic structures. The latter was associated with behavioral manifestations and extended beyond the area of atrophy shown by CT scan. Conclusion Single-subject F-18-FDG-PET analysis can account for both cognitive and behavioral alterations in svPPA. This provides useful support to the clinical diagnosis.	[Iaccarino, Leonardo; Crespi, Chiara; Perani, Daniela] Univ Vita Salute San Raffaele, Milan, Italy; [Iaccarino, Leonardo; Crespi, Chiara; Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Crespi, Chiara; Cappa, Stefano F.; Perani, Daniela] Univ Vita Salute San Raffaele, CERMAC, Milan, Italy; [Della Rosa, Pasquale Anthony; Perani, Daniela] CNR, Ist Bioimmagini & Fisiol Mol, Segrate, Italy; [Catricala, Eleonora; Guidi, Lucia; Cappa, Stefano F.] IUSS, Pavia, Italy; [Marcone, Alessandra] Hosp San Raffaele, Dept Clin Neurosci, I-20132 Milan, Italy; [Tagliavini, Fabrizio] IRCCS Fdn, Carlo Besta Neurol Inst, Milan, Italy; [Magnani, Giuseppe] Hosp San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Perani, Daniela] Hosp San Raffaele, Nucl Med Unit, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); IUSS PAVIA; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Perani, D (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	perani.daniela@hsr.it	Cappa, Stefano/B-1874-2014; Rosa, Pasquale Anthony Della/AAC-3459-2019; Crespi, Chiara/H-5251-2018; Perani, Daniela/AAN-3221-2020; Crespi, Chiara/M-9039-2019; Crespi, Chiara/K-6484-2016; Tagliavini, Fabrizio/AAO-7891-2021; Magnani, Giuseppe/AAN-2242-2020	Cappa, Stefano/0000-0003-1003-3925; Rosa, Pasquale Anthony Della/0000-0002-3137-1731; Crespi, Chiara/0000-0002-7851-9887; Crespi, Chiara/0000-0002-7851-9887; Crespi, Chiara/0000-0002-7851-9887; Tagliavini, Fabrizio/0000-0003-1039-7315; Magnani, Giuseppe/0000-0001-8436-2903; catricala, eleonora/0000-0003-1622-4415	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This research was supported by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2011, BRAIN, V134, P2025, DOI 10.1093/brain/awr119; Agosta F, 2012, CEREB CORTEX, V22, P2705, DOI 10.1093/cercor/bhr288; Agosta F, 2014, NEUROBIOL AGING, V35, P2646, DOI 10.1016/j.neurobiolaging.2014.05.017; Agosta F, 2010, BRAIN, V133, P286, DOI 10.1093/brain/awp233; Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Ash S, 2006, NEUROLOGY, V66, P1405, DOI 10.1212/01.wnl.0000210435.72614.38; Basso A, 1987, Funct Neurol, V2, P189; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binney RJ, 2010, CEREB CORTEX, V20, P2728, DOI 10.1093/cercor/bhq019; Blaizot X, 2010, CEREB CORTEX, V20, P2198, DOI 10.1093/cercor/bhp289; Bozeat S, 2000, J NEUROL NEUROSUR PS, V69, P178, DOI 10.1136/jnnp.69.2.178; Brambati SM, 2009, NEUROBIOL AGING, V30, P103, DOI 10.1016/j.neurobiolaging.2007.05.014; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Carlesimo GA, 1995, ARCH NEUROLOGIA PSIC, P1; Catani M, 2012, ATLAS OF HUMAN BRAIN; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Catricala E, 2013, NEUROL SCI, V34, P985, DOI 10.1007/s10072-012-1181-z; Cerami C, 2013, J ALZHEIMERS DIS, V36, P415, DOI 10.3233/JAD-130317; Chan D, 2001, ANN NEUROL, V49, P433, DOI 10.1002/ana.92.abs; Chare L, 2014, J NEUROL NEUROSUR PS, V85, P866, DOI 10.1136/jnnp-2013-306948; Chen KHM, 2010, BRAIN COGNITION, V72, P400, DOI 10.1016/j.bandc.2009.11.007; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Davies RR, 2009, NEUROBIOL AGING, V30, P2043, DOI 10.1016/j.neurobiolaging.2008.02.005; de Zubicaray GI, 2011, NEUROIMAGE, V54, P1488, DOI 10.1016/j.neuroimage.2010.08.058; Della Rosa PA, 2014, NEUROINFORMATICS, V12, P575, DOI 10.1007/s12021-014-9235-4; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Desgranges B, 2007, NEUROBIOL AGING, V28, P1904, DOI 10.1016/j.neurobiolaging.2006.08.006; Diehl J, 2004, NEUROBIOL AGING, V25, P1051, DOI 10.1016/j.neurobiolaging.2003.10.007; Diehl-Schmid J, 2006, DEMENT GERIATR COGN, V22, P346, DOI 10.1159/000095624; Drzezga A, 2008, NEUROIMAGE, V39, P619, DOI 10.1016/j.neuroimage.2007.09.020; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; Fan L, 2013, CEREB CORTEX, P1; Farias ST, 2005, AM J NEURORADIOL, V26, P2492; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Galton CJ, 2001, NEUROLOGY, V57, P216, DOI 10.1212/WNL.57.2.216; Gamboz N, 2009, NEUROL SCI, V30, P453, DOI 10.1007/s10072-009-0130-y; Gefen T, 2013, NEUROLOGY, V81, P658, DOI 10.1212/WNL.0b013e3182a08f83; GOLOMB J, 1993, ARCH NEUROL-CHICAGO, V50, P967, DOI 10.1001/archneur.1993.00540090066012; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Guo CC, 2013, BRAIN, V136, P2979, DOI 10.1093/brain/awt222; Hodges JR, 2007, LANCET NEUROL, V6, P1004, DOI 10.1016/S1474-4422(07)70266-1; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Howard D, 1992, PURAMIDS PALM TREES; Kertesz A, 2003, J INT NEUROPSYCH SOC, V9, P710, DOI 10.1017/S1355617703950041; Kertesz A, 2010, ARCH NEUROL-CHICAGO, V67, P483, DOI 10.1001/archneurol.2010.55; Kim EJ, 2012, DEMENT GERIATR COGN, V34, P300, DOI 10.1159/000345506; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; Lauro-Grotto R, 1997, CORTEX, V33, P593, DOI 10.1016/S0010-9452(08)70720-2; Liljestrom M, 2009, HUM BRAIN MAPP, V30, P1845, DOI 10.1002/hbm.20785; LUDERS H, 1991, BRAIN, V114, P743, DOI 10.1093/brain/114.2.743; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marczinski CA, 2006, BRAIN LANG, V97, P258, DOI 10.1016/j.bandl.2005.11.001; MCCARTHY R, 1990, NATURE, V343, P599, DOI 10.1038/343599a0; MCCARTHY RA, 1988, NATURE, V334, P428, DOI 10.1038/334428a0; Mesulam MM, 2013, NEUROLOGY, V81, P456, DOI 10.1212/WNL.0b013e31829d87df; Miceli G., 1994, BATTERIA LANALISI DE; Mion M, 2010, BRAIN, V133, P3256, DOI 10.1093/brain/awq272; Mummery CJ, 2000, ANN NEUROL, V47, P36; Mummery CJ, 1999, BRAIN, V122, P61, DOI 10.1093/brain/122.1.61; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nestor PJ, 2006, NEUROIMAGE, V30, P1010, DOI 10.1016/j.neuroimage.2005.10.008; Noppeney U, 2007, BRAIN, V130, P1138, DOI 10.1093/brain/awl344; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Pascual B, 2013, CEREB CORTEX, P1; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Pijnenburg YAL, 2004, DEMENT GERIATR COGN, V17, P302, DOI 10.1159/000077159; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Rankin KP, 2003, NEUROLOGY, V60, P266, DOI 10.1212/01.WNL.0000041497.07694.D2; Rohrer JD, 2010, NEUROLOGY, V75, P2204, DOI 10.1212/WNL.0b013e318202038c; Rohrer JD, 2009, NEUROLOGY, V72, P1562, DOI 10.1212/WNL.0b013e3181a4124e; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Rosen HJ, 2002, BRAIN, V125, P2286, DOI 10.1093/brain/awf225; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schwindt GC, 2013, HUM BRAIN MAPP, V34, P973, DOI 10.1002/hbm.21484; Seeley WW, 2005, NEUROLOGY, V64, P1384, DOI 10.1212/01.WNL.0000158425.46019.5C; Snowden J., 1989, BEHAV NEUROL, V2, P167, DOI [DOI 10.1093/NEUCAS/1.1.39-Y, https://doi.org/10.1155/1989/124043, DOI 10.1155/1989/124043]; Snowden JS, 2004, BRAIN, V127, P860, DOI 10.1093/brain/awh099; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Spinnler H, 1987, ITALIAN J NEUROLOGIC, P1; Tan LH, 2011, P NATL ACAD SCI USA, V108, P2540, DOI 10.1073/pnas.0909623108; Tan RH, 2014, BRAIN, P1; Tettamanti M, 2005, NEUROREPORT, V16, P397, DOI 10.1097/00001756-200503150-00018; Thompson SA, 2003, NEUROLOGY, V61, P1196, DOI 10.1212/01.WNL.0000091868.28557.B8; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; TYRRELL PJ, 1990, BRAIN, V113, P1321, DOI 10.1093/brain/113.5.1321; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Visser M, 2011, J COGNITIVE NEUROSCI, V23, P3121, DOI 10.1162/jocn_a_00007; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Vitali P, 2005, BRAIN LANG, V93, P32, DOI 10.1016/j.bandl.2004.08.005; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Whitwell JL, 2010, NEUROLOGY, V74, P1279, DOI 10.1212/WNL.0b013e3181d9edde; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910	104	33	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120197	10.1371/journal.pone.0120197	http://dx.doi.org/10.1371/journal.pone.0120197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756991	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700061
J	Vassallo, I; Zinn, P; Lai, M; Rajakannu, P; Hamou, MF; Hegi, ME				Vassallo, I.; Zinn, P.; Lai, M.; Rajakannu, P.; Hamou, M-F; Hegi, M. E.			WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1	ONCOGENE			English	Article							TYROSINE KINASE ROR2; GLIOMA-CELL LINES; COLORECTAL-CANCER; TUMOR-SUPPRESSOR; COLON-CANCER; SELF-RENEWAL; BETA-CATENIN; STEM-CELLS; EXPRESSION; PATHWAY	Glioblastoma is the most aggressive primary brain tumor in adults and due to the invasive nature cannot be completely removed. The WNT inhibitory factor 1 (WIF1), a secreted inhibitor of WNTs, is systematically downregulated in glioblastoma and acts as strong tumor suppressor. The aim of this study was the dissection of WIF1-associated tumor-suppressing effects mediated by canonical and non-canonical WNT signaling. We found that WIF1 besides inhibiting the canonical WNT pathway selectively downregulates the WNT/calcium pathway associated with significant reduction of p38-MAPK (p38-mitogen-activated protein kinase) phosphorylation. Knockdown of WNT5A, the only WNT ligand overexpressed in glioblastoma, phenocopied this inhibitory effect. WIF1 expression inhibited cell migration in vitro and in an orthotopic brain tumor model, in accordance with the known regulatory function of the WNT/Ca2+ pathway on migration and invasion. In search of a mediator for this function differential gene expression profiles of WIF1-expressing cells were performed. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA and key positive regulator of invasion, emerged as the top downregulated gene. Indeed, knockdown of MALAT1 reduced migration in glioblastoma cells, without effect on proliferation. Hence, loss of WIF1 enhances the migratory potential of glioblastoma through WNT5A that activates the WNT/Ca2+ pathway and MALAT1. These data suggest the involvement of canonical and non-canonical WNT pathways in glioblastoma promoting key features associated with this deadly disease, proliferation on one hand and invasion on the other. Successful targeting will require a dual strategy affecting both canonical and non-canonical WNT pathways.	[Vassallo, I.; Rajakannu, P.; Hamou, M-F; Hegi, M. E.] Lausanne Univ Hosp CHUV, Neurosurg NCH, Lausanne, Switzerland; [Vassallo, I.; Rajakannu, P.; Hamou, M-F; Hegi, M. E.] Lausanne Univ Hosp CHUV, Neurosci Res Ctr CRN, Dept Clin Neurosci, CH-1066 Epalinges, Switzerland; [Zinn, P.] Baylor Coll Med, Dept Neurol Surg, Houston, TX 77030 USA; [Lai, M.] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging LIFMET, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Baylor College of Medicine; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hegi, ME (corresponding author), Lausanne Univ Hosp CHUV, Neurosci Res Ctr CRN, Dept Clin Neurosci, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	Monika.Hegi@chuv.ch	Hegi, Monika/O-4796-2015	Hegi, Monika/0000-0003-0855-6495	Swiss National Science Foundation [31003A_138116/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The presented work was supported by the Swiss National Science Foundation (31003A_138116/1). The results published here are in part based on data generated by The Cancer TCGA Genome Atlas pilot project established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov/.	Andreeff M, 2008, LEUKEMIA, V22, P2041, DOI 10.1038/leu.2008.198; Bady P, 2012, NEURO-ONCOLOGY, V14, P701, DOI 10.1093/neuonc/nos072; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; Bitler BG, 2011, CANCER RES, V71, P6184, DOI 10.1158/0008-5472.CAN-11-1341; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cawthorne Christopher, 2007, J Biomol Tech, V18, P120; Cheng RF, 2014, J CELL PHYSIOL, V229, P1908, DOI 10.1002/jcp.24566; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gotze S, 2010, INT J CANCER, V126, P2584, DOI 10.1002/ijc.24981; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Habu M, 2014, J BIOCHEM, V156, P29, DOI 10.1093/jb/mvu015; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kamino M, 2011, CANCER SCI, V102, P540, DOI 10.1111/j.1349-7006.2010.01815.x; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lambiv WL, 2011, NEURO-ONCOLOGY, V13, P736, DOI 10.1093/neuonc/nor036; Li GB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780521; Li XY, 2013, MOL PHARMACEUT, V10, P307, DOI 10.1021/mp300445a; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Ma L, 2007, J BIOL CHEM, V282, P28980, DOI 10.1074/jbc.M702840200; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; O'Connell MP, 2009, J INVEST DERMATOL, V129, P1782, DOI 10.1038/jid.2008.433; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Polakis P, 2012, COLD SPRING HARB PER, V4; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sciuscio D, 2011, CLIN CANCER RES, V17, P255, DOI 10.1158/1078-0432.CCR-10-1931; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wang Y, 2012, CANC LETT, V331, P139; Wick W, 2008, NEURO-ONCOLOGY, V10, P1019, DOI 10.1215/15228517-2008-058; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Yu JM, 2007, CANCER LETT, V257, P172, DOI 10.1016/j.canlet.2007.07.011; Zhang ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090318	59	96	98	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					12	21		10.1038/onc.2015.61	http://dx.doi.org/10.1038/onc.2015.61			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25772239	Green Submitted, Green Accepted			2022-12-26	WOS:000367812400002
J	Robinson, RJ; Hensel, EC; Morabito, PN; Roundtree, KA				Robinson, R. J.; Hensel, E. C.; Morabito, P. N.; Roundtree, K. A.			Electronic Cigarette Topography in the Natural Environment	PLOS ONE			English	Article							SMOKING TOPOGRAPHY; NICOTINE; TOBACCO; STANDARDS	This paper presents the results of a clinical, observational, descriptive study to quantify the use patterns of electronic cigarette users in their natural environment. Previously published work regarding puff topography has been widely indirect in nature, and qualitative rather than quantitative, with the exception of three studies conducted in a laboratory environment for limited amounts of time. The current study quantifies the variation in puffing behaviors among users as well as the variation for a given user throughout the course of a day. Puff topography characteristics computed for each puffing session by each subject include the number of subject puffs per puffing session, the mean puff duration per session, the mean puff flow rate per session, the mean puff volume per session, and the cumulative puff volume per session. The same puff topography characteristics are computed across all puffing sessions by each single subject and across all subjects in the study cohort. Results indicate significant inter-subject variability with regard to puffing topography, suggesting that a range of representative puffing topography patterns should be used to drive machine-puffed electronic cigarette aerosol evaluation systems.	[Robinson, R. J.; Hensel, E. C.; Morabito, P. N.; Roundtree, K. A.] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA	Rochester Institute of Technology	Robinson, RJ (corresponding author), Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA.	rjreme@rit.edu	Hensel, Edward/Q-6753-2019	Hensel, Edward/0000-0002-2682-0766	Rochester Institute of Technology, Rochester NY; FSI, Inc., Farmington, NY	Rochester Institute of Technology, Rochester NY; FSI, Inc., Farmington, NY	This work was funded by an internal grant from the Rochester Institute of Technology, Rochester NY. Additional support was provided by FSI, Inc., Farmington, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ahijevych K, 1997, RES NURS HEALTH, V20, P505, DOI 10.1002/(SICI)1098-240X(199712)20:6<505::AID-NUR5>3.0.CO;2-Q; Aung AT, 2004, ADDICT BEHAV, V29, P699, DOI 10.1016/j.addbeh.2004.02.012; Bialous SA, 2001, TOB CONTROL, V10, P96, DOI 10.1136/tc.10.2.96; Blank MD, 2009, NICOTINE TOB RES, V11, P896, DOI 10.1093/ntr/ntp083; Brauer LH, 1996, ADDICT BEHAV, V21, P233, DOI 10.1016/0306-4603(95)00054-2; BRIDGES RB, 1990, PHARMACOL BIOCHEM BE, V37, P29, DOI 10.1016/0091-3057(90)90037-I; Burling TA, 1996, J SUBST ABUSE, V8, P445, DOI 10.1016/S0899-3289(96)90005-X; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Evans SE, 2014, TOB CONTROL, V23, P23, DOI 10.1136/tobaccocontrol-2013-051489; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; Goniewicz ML, 2014, ADDICTION, V109, P500, DOI 10.1111/add.12410; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Hammond D, 2005, CANCER EPIDEM BIOMAR, V14, P1370, DOI 10.1158/1055-9965.EPI-04-0498; Hammond D., 2005, HUMAN SMOKING BEHAV; HATSUKAMI D, 1987, INT J ADDICT, V22, P719, DOI 10.3109/10826088709027453; HATSUKAMI DK, 1988, ADDICT BEHAV, V13, P91, DOI 10.1016/0306-4603(88)90031-7; Hua M, 2013, TOB CONTROL, V22, P103, DOI 10.1136/tobaccocontrol-2011-050226; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Sazonov E, 2013, J STUD ALCOHOL DRUGS, V74, P956, DOI 10.15288/jsad.2013.74.956; Tan L., 2013, FUNDAMENTALS APPL, V2nd ed.; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213; Trtchounian A, 2010, NICOTINE TOB RES, V12, P905, DOI 10.1093/ntr/ntq114; Westenberger BJ, 2009, EVALUATION E CIGARAT; Williams M, 2011, NICOTINE TOB RES, V13, P1276, DOI 10.1093/ntr/ntr164	26	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129296	10.1371/journal.pone.0129296	http://dx.doi.org/10.1371/journal.pone.0129296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	25775238	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300112
J	Meyer, MB; Benkusky, NA; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley			Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; KAPPA-B LIGAND; 1,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTION FACTOR; OSTEOBLASTIC CELLS; PARATHYROID-HORMONE; BONE-FORMATION; BINDING-SITES; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTERSTITIAL COLLAGENASE	Matrix metalloproteinase 13 (Mmp13, collagenase-3) plays an essential role in bone metabolism and mineral homeostasis. It is regulated by numerous factors, including BMP-2, parathyroid hormone, and 1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3), through transcription factors such as Runt-related transcription factor 2 (RUNX2), CCAAT/enhancer-binding protein beta (C/EBP beta), OSX, and vitamin D receptor (VDR). During osteoblast maturation, the basal expression of Mmp13 and its sensitivity to 1,25(OH)(2)D-3 are strikingly increased. In this report, ChIP-sequencing analysis in mouse preosteoblasts revealed that the Mmp13 gene was probably regulated by three major enhancers located -10, -20, and -30 kb upstream of the gene promoter, occupied by activated VDR and prebound C/EBP beta and RUNX2, respectively. Initially, bacterial artificial chromosome clone recombineering and traditional mutagenesis defined binding sites for VDR and RUNX2. We then employed a CRISPR/Cas9 gene editing approach to delete the -10 and -30 kb Mmp13 enhancers, a region proximal to the promoter, and VDR or RUNX2. VDR-mediated up-regulation of Mmp13 transcription was completely abrogated upon removal of the -10 kb enhancer, resulting in a 1,25(OH)(2)D-3-directed repression of Mmp13. Deletion of either the -30 kb enhancer or RUNX2 resulted in a complete loss of basal transcript activity and a ChIP-identified destabilization of the chromatin enhancer environment and factor binding. Whereas enhancer deletions only affected Mmp13 expression, the RUNX2 deletion led to changes in gene expression, a reduction in cellular proliferation, and an inability to differentiate. We conclude that the Mmp13 gene is regulated via at least three specific distal enhancers that display independent activities yet are able to integrate response from multiple signaling pathways in a model of activation and suppression.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health, NIDDK [DK-072281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant DK-072281 (to J. W. P.).	Achari Y, 2009, BBA-MOL BASIS DIS, V1792, P211, DOI 10.1016/j.bbadis.2009.01.002; Benderdour M, 2002, BIOCHEM BIOPH RES CO, V291, P1151, DOI 10.1006/bbrc.2002.6580; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Chimge NO, 2012, CLIN CANCER RES, V18, P901, DOI 10.1158/1078-0432.CCR-11-1530; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Etoh T, 2000, GUT, V47, P50, DOI 10.1136/gut.47.1.50; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Gao P, 2014, TUMOR BIOL, V35, P10137, DOI 10.1007/s13277-014-2309-y; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grumbles RM, 1996, J CELL BIOCHEM, V63, P395; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lian JB, 2013, J BONE MINER RES, V28, P2060, DOI 10.1002/jbmr.2076; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Brien CA, 1999, J BIOL CHEM, V274, P19301, DOI 10.1074/jbc.274.27.19301; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Peeters-Joris C, 1998, BBA-MOL CELL RES, V1405, P14, DOI 10.1016/S0167-4889(98)00094-9; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rydziel S, 1997, J CELL BIOCHEM, V67, P176, DOI 10.1002/(SICI)1097-4644(19971101)67:2<176::AID-JCB3>3.0.CO;2-U; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2006, J CELL BIOCHEM, V99, P545, DOI 10.1002/jcb.20878; Stein GS, 2010, ADV ENZYME REGUL, V50, P160, DOI 10.1016/j.advenzreg.2009.10.026; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Tsuji K, 2001, BBA-MOL CELL RES, V1539, P122, DOI 10.1016/S0167-4889(01)00099-4; Uchida M, 2001, J BONE MINER RES, V16, P221, DOI 10.1359/jbmr.2001.16.2.221; Uria JA, 1998, AM J PATHOL, V153, P91, DOI 10.1016/S0002-9440(10)65549-6; Varghese S, 1997, ENDOCRINOLOGY, V138, P1035, DOI 10.1210/en.138.3.1035; Walling HW, 1998, J CELL PHYSIOL, V177, P563, DOI 10.1002/(SICI)1097-4652(199812)177:4<563::AID-JCP7>3.0.CO;2-B; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Winchester SK, 1999, J CELL PHYSIOL, V181, P479, DOI 10.1002/(SICI)1097-4652(199912)181:3<479::AID-JCP12>3.0.CO;2-D; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zanotti S, 2009, J ENDOCRINOL, V201, P263, DOI 10.1677/JOE-08-0514; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015	53	38	40	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11093	11107		10.1074/jbc.M115.648394	http://dx.doi.org/10.1074/jbc.M115.648394			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25773540	hybrid, Green Published			2022-12-26	WOS:000353404500044
J	Arizmendi-Mejia, R; Linares, C; Garrabou, J; Antunes, A; Ballesteros, E; Cebrian, E; Diaz, D; Ledoux, JB				Arizmendi-Mejia, Rosana; Linares, Cristina; Garrabou, Joaquim; Antunes, Agostinho; Ballesteros, Enric; Cebrian, Emma; Diaz, David; Ledoux, Jean-Baptiste			Combining Genetic and Demographic Data for the Conservation of a Mediterranean Marine Habitat-Forming Species	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MULTILOCUS GENOTYPE DATA; MASS MORTALITY; EVOLUTIONARY PROCESSES; ENVIRONMENTAL-FACTORS; PARAMURICEA-CLAVATA; ECOLOGICAL CHANGE; COMPUTER-PROGRAM; F-STATISTICS; DIVERSITY	The integration of ecological and evolutionary data is highly valuable for conservation planning. However, it has been rarely used in the marine realm, where the adequate design of marine protected areas (MPAs) is urgently needed. Here, we examined the interacting processes underlying the patterns of genetic structure and demographic strucuture of a highly vulnerable Mediterranean habitat-forming species (i.e. Paramuricea clavata (Risso, 1826)), with particular emphasis on the processes of contemporary dispersal, genetic drift, and colonization of a new population. Isolation by distance and genetic discontinuities were found, and three genetic clusters were detected; each submitted to variations in the relative impact of drift and gene flow. No founder effect was found in the new population. The interplay of ecology and evolution revealed that drift is strongly impacting the smallest, most isolated populations, where partial mortality of individuals was highest. Moreover, the eco-evolutionary analyses entailed important conservation implications for P. clavata. Our study supports the inclusion of habitat-forming organisms in the design of MPAs and highlights the need to account for genetic drift in the development of MPAs. Moreover, it reinforces the importance of integrating genetic and demographic data in marine conservation.	[Arizmendi-Mejia, Rosana; Linares, Cristina] Univ Barcelona, Fac Biol, Dept Ecol, E-08028 Barcelona, Spain; [Arizmendi-Mejia, Rosana; Garrabou, Joaquim; Ledoux, Jean-Baptiste] CSIC, ICM, E-08003 Barcelona, Spain; [Antunes, Agostinho; Ledoux, Jean-Baptiste] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4050123 Oporto, Portugal; [Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4169007 Oporto, Portugal; [Ballesteros, Enric; Cebrian, Emma] CSIC, Ctr Estudis Avancats Blanes, Blanes 17300, Spain; [Diaz, David] Inst Espanol Oceanog, Palma De Mallorca 07015, Spain	University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Spanish Institute of Oceanography	Arizmendi-Mejia, R (corresponding author), Univ Barcelona, Fac Biol, Dept Ecol, Avinguda Diagonal 643, E-08028 Barcelona, Spain.	r.arizmendi@icm.csic.es	DIAZ, DAVID/AAS-8722-2021; Linares, Cristina/A-5244-2018; Cebrian, Emma/J-9640-2012	DIAZ, DAVID/0000-0003-0611-2516; Linares, Cristina/0000-0003-3855-2743; Ledoux, Jean-Baptiste/0000-0001-8796-6163; Cebrian, Emma/0000-0001-7588-0135; Antunes, Agostinho/0000-0002-1328-1732	Espais de Natura Balear; Spanish Ministry of Science and Innovation; Spanish Ministry of Economy and Competitivity [CTM2009-08045, CGL2012-32194]; Ramon y Cajal research contract [RyC-2011-08134]; CUR-DIUE-Generalitat de Catalunya and the European Social Fund [FI-DGR 2011]; JAE doc; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/74400/2010]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT [PEst-C/MAR/ LA0015/2013, PTDC/AAC-AMB/121301/2010, FCOMP-01-0124-FEDER-019490]	Espais de Natura Balear; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitivity(Spanish Government); Ramon y Cajal research contract(Spanish Government); CUR-DIUE-Generalitat de Catalunya and the European Social Fund; JAE doc; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially funded by the Espais de Natura Balear (http://en.balearsnatura.com), the Spanish Ministry of Science and Innovation (http://www.micinn.es) and the Spanish Ministry of Economy and Competitivity (http://www.mineco.gob.es) through the Biorock (CTM2009-08045) and the Smart (CGL2012-32194) projects. Additional funding was provided by a Ramon y Cajal research contract (RyC-2011-08134) to CL, a PhD grant from the CUR-DIUE- Generalitat de Catalunya and the European Social Fund (FI-DGR 2011) (http://www.gencat.cat/ agaur) to RAM, and a JAE doc to EC. JBL was funded by a Postdoctoral grant (SFRH/BPD/74400/2010) from Fundacao para a Ciencia e a Tecnologia (FCT) (http://www.fct.pt) and AA was partially supported by the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT, under the projects PEst-C/MAR/ LA0015/2013 and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell G, 2009, CONSERV GENET, V10, P2025, DOI 10.1007/s10592-009-9885-1; Allendorf F., 2007, CONSERVATION GENETIC; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Ardren WR, 2003, MOL ECOL, V12, P35, DOI 10.1046/j.1365-294X.2003.01705.x; Aurelle D, 2011, GENETICA, V139, P855, DOI 10.1007/s10709-011-9589-6; Aurelle D, 2010, MOL ECOL RESOUR, V10, P751, DOI 10.1111/j.1755-0998.2010.02871.x; Aurelle D, 2013, CONSERV GENET, V14, P705, DOI 10.1007/s10592-013-0464-0; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Beaumont MA, 2MOD; Beger M, 2003, BIOL CONSERV, V111, P53, DOI 10.1016/S0006-3207(02)00249-5; Belkhir K., 2004, GENETIX 4 05 LOGICIE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodkin JL, 1999, CONSERV BIOL, V13, P1378, DOI 10.1046/j.1523-1739.1999.98124.x; Castric V, 2004, MOL ECOL, V13, P1299, DOI 10.1111/j.1365-294X.2004.02129.x; Cerrano C, 2010, BIODIVERS CONSERV, V19, P153, DOI 10.1007/s10531-009-9712-5; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Coma R, 1998, ESTUAR COAST SHELF S, V47, P459, DOI 10.1006/ecss.1998.0375; COMA R, 1995, MAR ECOL PROG SER, V117, P185, DOI 10.3354/meps117185; COMA R, 1995, MAR ECOL PROG SER, V117, P173, DOI 10.3354/meps117173; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cornuet JM, 1999, GENETICS, V153, P1989; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Cupido R, 2009, MAR ECOL PROG SER, V394, P195, DOI 10.3354/meps08260; Dailianis T, 2011, MOL ECOL, V20, P3757, DOI 10.1111/j.1365-294X.2011.05222.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Farkas TE, 2013, CURR BIOL, V23, P1835, DOI 10.1016/j.cub.2013.07.067; Ferriere R., 2004, EVOLUTIONARY CONSERV; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Foster KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071049; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Gori A, 2011, MAR BIOL, V158, P1721, DOI 10.1007/s00227-011-1686-7; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hardy O, 2013, SPAGEDI 1 4 USERS MA; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Hendry A, 2013, CURR BIOL, V23, pR869, DOI 10.1016/j.cub.2013.08.023; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; HUSBAND BC, 1992, EVOLUTION, V46, P1875, DOI 10.1111/j.1558-5646.1992.tb01175.x; Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kelleher G., 1999, GUIDELINES MARINE PR; Knaepkens G, 2004, BIOL CONSERV, V115, P403, DOI 10.1016/S0006-3207(03)00156-3; Lamy T, 2012, MOL ECOL, V21, P1394, DOI 10.1111/j.1365-294X.2012.05478.x; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; Mokhtar-Jamai K, 2013, ECOL EVOL, V3, P1765, DOI 10.1002/ece3.588; Mora MS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-9; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Niklas KJ, 2003, ECOL LETT, V6, P405, DOI 10.1046/j.1461-0248.2003.00440.x; Oostermeijer JGB, 2003, BIOL CONSERV, V113, P389, DOI 10.1016/S0006-3207(03)00127-7; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Palkovacs EP, 2014, EVOL APPL, V7, P212, DOI 10.1111/eva.12111; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rannala B., 2007, BAYESASS VERSION 3 0; Roberts C, 2012, CURR BIOL, V22, pR444, DOI 10.1016/j.cub.2012.04.030; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Serbezov D, 2012, GENETICS, V191, P579, DOI 10.1534/genetics.111.136580; SLOBODKIN LAWRENCE B., 1961; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Toonen RJ, 2001, BIOTECHNIQUES, V31, P1320; Underwood JN, 2013, J NAT CONSERV, V21, P163, DOI 10.1016/j.jnc.2012.12.001; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wesseling I, 2001, INT REV HYDROBIOL, V86, P77, DOI 10.1002/1522-2632(200101)86:1<77::AID-IROH77>3.0.CO;2-7; Wilson GA, 2003, GENETICS, V163, P1177	100	28	28	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119585	10.1371/journal.pone.0119585	http://dx.doi.org/10.1371/journal.pone.0119585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774522	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500102
J	Chandra, V; Das, T; Gulati, P; Biswas, NK; Rote, S; Chatterjee, U; Ghosh, SN; Deb, S; Saha, SK; Chowdhury, AK; Ghosh, S; Rudin, CM; Mukherjee, A; Basu, A; Dhara, S				Chandra, Vikas; Das, Tapojyoti; Gulati, Puneet; Biswas, Nidhan K.; Rote, Sarang; Chatterjee, Uttara; Ghosh, Samarendra N.; Deb, Sumit; Saha, Suniti K.; Chowdhury, Anup K.; Ghosh, Subhashish; Rudin, Charles M.; Mukherjee, Ankur; Basu, Analabha; Dhara, Surajit			Hedgehog Signaling Pathway Is Active in GBM with GLI1 mRNA Expression Showing a Single Continuous Distribution Rather than Discrete High/Low Clusters	PLOS ONE			English	Article							HUMAN HOMOLOG; PHASE-II; CANCER; GENE; VISMODEGIB; ACTIVATION; MUTATIONS; PLACEBO; ROLES; PTCH2	Hedgehog (Hh) signaling pathway is a valid therapeutic target in a wide range of malignancies. We focus here on glioblastoma multiforme (GBM), a lethal malignancy of the central nervous system (CNS). By analyzing RNA-sequencing based transcriptomics data on 149 clinical cases of TCGA-GBM database we show here a strong correlation (r = 0.7) between GLI1 and PTCH1 mRNA expression-as a hallmark of the canonical Hh-pathway activity in this malignancy. GLI1 mRNA expression varied in 3 orders of magnitude among the GBM patients of the same cohort showing a single continuous distribution-unlike the discrete high/low-GLI1 mRNA expressing clusters of medulloblastoma (MB). When compared with MB as a reference, the median GLI1 mRNA expression in GBM appeared 14.8 fold lower than that of the "high-Hh" cluster of MB but 5.6 fold higher than that of the " low-Hh" cluster of MB. Next, we demonstrated statistically significant up-and down-regulation of GLI1 mRNA expressions in GBM patient-derived low-passage neurospheres in vitro by sonic hedgehog ligand-enriched conditioned media (shh-CM) and by Hh-inhibitor drug vismodegib respectively. We also showed clinically achievable dose (50 ae M) of vismodegib alone to be sufficient to induce apoptosis and cell cycle arrest in these low-passage GBM neurospheres in vitro. Vismodegib showed an effect on the neurospheres, both by down-regulating GLI1 mRNA expression and by inducing apoptosis/cell cycle arrest, irrespective of their relative endogenous levels of GLI1 mRNA expression. We conclude from our study that this single continuous distribution pattern of GLI1 mRNA expression technically puts almost all GBM patients in a single group rather than discrete high-or low-clusters in terms of Hh-pathway activity. That is suggestive of therapies with Hh-pathway inhibitor drugs in this malignancy without a need for further stratification of patients on the basis of relative levels of Hh-pathway activity among them.	[Chandra, Vikas; Das, Tapojyoti; Biswas, Nidhan K.; Mukherjee, Ankur; Basu, Analabha; Dhara, Surajit] Natl Inst Biomed Genom, Kalyani 741251, W Bengal, India; [Gulati, Puneet; Rote, Sarang; Ghosh, Samarendra N.; Deb, Sumit; Chowdhury, Anup K.; Ghosh, Subhashish] Bangur Inst Neurol, Kolkata 700098, India; [Chatterjee, Uttara] Inst Post Grad Med Educ & Res, Kolkata 700020, India; [Saha, Suniti K.] Nil Ratan Sarkar Med Coll & Hosp, Kolkata 700014, India; [Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Memorial Sloan Kettering Cancer Center	Dhara, S (corresponding author), Natl Inst Biomed Genom, PO NSS, Kalyani 741251, W Bengal, India.	sd1@nibmg.ac.in	Das, Tapojyoti/AAX-3858-2021; Rudin, Charles/R-2530-2019; biswas, Nidhan Kumar K/A-4383-2009	Rudin, Charles/0000-0001-5204-3465; biswas, Nidhan Kumar K/0000-0001-7960-3290; Das, Tapojyoti/0000-0002-4644-1499	National Institute of Biomedical Genomics (NIBMG), India; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institute of Biomedical Genomics (NIBMG), India; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors received no specific funding for this work. This work was supported by an intramural fund of National Institute of Biomedical Genomics (NIBMG), India.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113, DOI 10.1016/S0733-8635(18)30114-1; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hu ZL, 2003, CANCER RES, V63, P923; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kaye SB, 2012, CLIN CANCER RES, V18, P6509, DOI 10.1158/1078-0432.CCR-12-1796; Li X, 2006, ONCOGENE, V25, P609, DOI 10.1038/sj.onc.1209077; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Raffel C, 1997, CANCER RES, V57, P842; Rahnama F, 2004, BIOCHEM J, V378, P325, DOI 10.1042/BJ20031200; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2012, CLIN CANCER RES, V18, P3218, DOI 10.1158/1078-0432.CCR-12-0568; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zaphiropoulos PG, 1999, CANCER RES, V59, P787	28	20	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116390	10.1371/journal.pone.0116390	http://dx.doi.org/10.1371/journal.pone.0116390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775002	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500007
J	Jacobus, AP; Gross, J				Jacobus, Ana Paula; Gross, Jeferson			Optimal Cloning of PCR Fragments by Homologous Recombination in Escherichia coli	PLOS ONE			English	Article							DNA CLONING; IN-VITRO; EFFICIENT	PCR fragments and linear vectors containing overlapping ends are easily assembled into a propagative plasmid by homologous recombination in Escherichia coli. Although this gaprepair cloning approach is straightforward, its existence is virtually unknown to most molecular biologists. To popularize this method, we tested critical parameters influencing the efficiency of PCR fragments cloning into PCR-amplified vectors by homologous recombination in the widely used E. coli strain DH5 alpha. We found that the number of positive colonies after transformation increases with the length of overlap between the PCR fragment and linear vector. For most practical purposes, a 20 bp identity already ensures high-cloning yields. With an insert to vector ratio of 2:1, higher colony forming numbers are obtained when the amount of vector is in the range of 100 to 250 ng. An undesirable cloning background of empty vectors can be minimized during vector PCR amplification by applying a reduced amount of plasmid template or by using primers in which the 50 termini are separated by a large gap. DpnI digestion of the plasmid template after PCR is also effective to decrease the background of negative colonies. We tested these optimized cloning parameters during the assembly of five independent DNA constructs and obtained 94% positive clones out of 100 colonies probed. We further demonstrated the efficient and simultaneous cloning of two PCR fragments into a vector. These results support the idea that homologous recombination in E. coli might be one of the most effective methods for cloning one or two PCR fragments. For its simplicity and high efficiency, we believe that recombinational cloning in E. coli has a great potential to become a routine procedure in most molecular biologyoriented laboratories.	[Jacobus, Ana Paula; Gross, Jeferson] Univ Sao Paulo, Dept Biol Sci, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Gross, J (corresponding author), Univ Sao Paulo, Dept Biol Sci, Luiz de Queiroz Coll Agr, Piracicaba, SP, Brazil.	jgross@usp.br	Jacobus, Ana/M-4114-2019; Ibrahim, Essam Hassan/G-1960-2018; Jacobus, Ana P/C-3159-2011	Jacobus, Ana/0000-0002-9092-931X; Ibrahim, Essam Hassan/0000-0003-0130-2257; Jacobus, Ana P/0000-0002-9092-931X	Sao Paulo research foundation [2013/15743-9]	Sao Paulo research foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Sao Paulo research foundation (http://www.fapesp.br/en/, Grant number 2013/15743-9 to JG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Casali Nicola, 2003, Methods Mol Biol, V235, P27; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; Eckert-Boulet N, 2012, YEAST, V29, P323, DOI 10.1002/yea.2912; Furuya K, 2012, YEAST, V29, P241, DOI 10.1002/yea.2907; Furuya K, 2009, YEAST, V26, P221, DOI 10.1002/yea.1662; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Grundemann D, 1996, BIOTECHNIQUES, V21, P898; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079979; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lovett ST, 2002, GENETICS, V160, P851; Maniatis T., 1982, MOL CLONING; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Parrish JR, 2004, J PROTEOME RES, V3, P582, DOI 10.1021/pr0341134; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288	26	84	108	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119221	10.1371/journal.pone.0119221	http://dx.doi.org/10.1371/journal.pone.0119221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774528	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500075
J	Yanagisawa, S; Sakurada, Y; Miki, A; Matsumiya, W; Imoto, I; Honda, S				Yanagisawa, Suiho; Sakurada, Yoichi; Miki, Akiko; Matsumiya, Wataru; Imoto, Issei; Honda, Shigeru			The Association of Elastin Gene Variants with Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy	PLOS ONE			English	Article							FACTOR-H CFH; MACULAR DEGENERATION; SUSCEPTIBILITY; ARMS2; POLYMORPHISM; FEATURES	Objective To compare the association of elastin (ELN) gene variants between two different angiographic phenotypes of polypoidal choroidal vasculopathy (PCV). Methods We included 411 treatment-naive PCV patients and 350 controls in the present study. PCV was classified into two phenotypes (152 Type 1 and 259 Type 2) according to the presence or absence of feeding vessels found in indocyanine-green angiography. Single nucleotide polymorphisms (SNPs) in the ELN region including rs868005, rs884843, rs2301995, rs13239907 and rs2856728 were genotyped using TaqMan Genotyping Assays. Results In the allelic association analyses, rs868005 showed the strongest association with Type 2 PCV (allelic odds ratio 1.56; p = 7.4x10(-6)), while no SNP was significantly associated with Type 1 PCV. Genotype association analyses revealed the significant association of rs868005 with Type 2 PCV in log additive model and predominant model (odds ratio 1.75; p = 1.5x10(-6) and odds ratio 1.60; p = 0.0044, respectively), but not with Type 1 PCV. These findings were further corroborated by another control group in the literature. Conclusions There may be significantly different associations in genetic variants of elastin between two angiographic phenotypes of PCV.	[Yanagisawa, Suiho; Miki, Akiko; Matsumiya, Wataru; Honda, Shigeru] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sakurada, Yoichi] Univ Yamanashi, Fac Med, Dept Ophthalmol, Chuo Ku, Kofu, Yamanashi 4093898, Japan; [Imoto, Issei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Human Genet, Tokushima 7708503, Japan	Kobe University; University of Yamanashi; Tokushima University	Honda, S (corresponding author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sighonda@med.kobe-u.ac.jp	Honda, Shigeru/W-4761-2019; Imoto, Issei/AAD-5799-2020	Imoto, Issei/0000-0002-4150-7938	Ministry of Education, Science and Culture, Tokyo, Japan [23592567]; Takeda Science Foundation, Osaka, Japan	Ministry of Education, Science and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation, Osaka, Japan(Takeda Science Foundation (TSF))	This study was supported by a Grant-in Aid (C) 23592567 from the Ministry of Education, Science and Culture, Tokyo, Japan (S.H.), and by a grant from the Takeda Science Foundation, Osaka, Japan (S.H.). The funding organization had no role in the design or conduct of this research.	Akagawa H, 2006, HUM MOL GENET, V15, P1722, DOI 10.1093/hmg/ddl096; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fuse N, 2011, AM J OPHTHALMOL, V151, P550, DOI 10.1016/j.ajo.2010.08.048; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Honda S, 2014, OPHTHALMOLOGICA, V231, P59, DOI 10.1159/000355488; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, Nippon Ganka Gakkai Zasshi, V109, P417; Kawamura A, 2013, ACTA OPHTHALMOL, V91, pe474, DOI 10.1111/aos.12110; Kondo N, 2008, INVEST OPHTH VIS SCI, V49, P1101, DOI 10.1167/iovs.07-1145; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kuroiwa S, 2004, CLIN EXP OPHTHALMOL, V32, P297, DOI 10.1111/j.1442-9071.2004.00827.x; Liang XY, 2012, INVEST OPHTH VIS SCI, V53, P3175, DOI 10.1167/iovs.11-8135; Lim TH, 2010, EYE, V24, P483, DOI 10.1038/eye.2009.323; Lima LH, 2011, OPHTHALMIC GENET, V32, P80, DOI 10.3109/13816810.2010.544362; Miki A, 2013, OPHTHALMIC GENET, V34, P146, DOI 10.3109/13816810.2012.749288; Nakajima M, 2004, JPN J OPHTHALMOL, V48, P249, DOI 10.1007/s10384-003-0057-4; Nakashizuka H, 2008, INVEST OPHTH VIS SCI, V49, P4729, DOI 10.1167/iovs.08-2134; Okubo A, 2002, BRIT J OPHTHALMOL, V86, P1093, DOI 10.1136/bjo.86.10.1093; Tanaka K, 2011, MOL VIS, V17, P2751; Tanaka K, 2011, INVEST OPHTH VIS SCI, V52, P7441, DOI 10.1167/iovs.11-7546; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Tsujikawa A, 2011, AM J OPHTHALMOL, V151, P961, DOI 10.1016/j.ajo.2011.01.002; Yamashiro K, 2011, INVEST OPHTH VIS SCI, V52, P8780, DOI 10.1167/iovs.11-8205; Yanagisawa S, 2011, MOL VIS, V17, P3574; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Yannuzzi LA, 1997, ARCH OPHTHALMOL-CHIC, V115, P478, DOI 10.1001/archopht.1997.01100150480005; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Zhang XZ, 2013, EXP EYE RES, V108, P16, DOI 10.1016/j.exer.2012.12.005	28	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120643	10.1371/journal.pone.0120643	http://dx.doi.org/10.1371/journal.pone.0120643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775011	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500187
J	Chu, XM; Yu, H; Sun, XX; An, Y; Li, B; Li, XB				Chu, Xian-Ming; Yu, Hua; Sun, Xue-Xia; An, Yi; Li, Bing; Li, Xue-Bin			Identification of Bacteriology and Risk Factor Analysis of Asymptomatic Bacterial Colonization in Pacemaker Replacement Patients	PLOS ONE			English	Article							RHYTHM MANAGEMENT DEVICES; PERMANENT PACEMAKER; CARDIOVERTER-DEFIBRILLATORS; STAPHYLOCOCCUS-AUREUS; INFECTION; DIAGNOSIS; ENDOCARDITIS; PREVENTION; PREVALENCE; SONICATION	Background Recent researches revealed that asymptomatic bacterial colonization on PMs might be ubiquitous and increase the risk of clinical PM infection. Early diagnosis of patients with asymptomatic bacterial colonization could provide opportunity for targeted preventive measures. Objective The present study explores the incidence of bacterial colonization of generator pockets in pacemaker replacement patients without signs of infection, and to analyze risk factors for asymptomatic bacterial colonization. Methods From June 2011 to December 2013, 118 patients underwent pacemaker replacement or upgrade. Identification of bacteria was carried out by bacterial culture and 16S rRNA sequencing. Clinical risk characteristics were analyzed. Results The total bacterial positive rate was 37.3% (44 cases), and the coagulase-negative Staphylococcus aureus detection rate was the highest. Twenty two (18.6%) patients had positive bacterial culture results, of which 50% had coagulase-negative staphylococcus. The bacterial DNA detection rate was 36.4 %(43 cases). Positive bacterial DNA results from pocket tissues and the surface of the devices were 22.0% and 29.7%, respectively. During followup (median, 27.0 months), three patients (6.8%, 3/44) became symptomatic with the same genus of microorganism, S. aureus (n= 2) and S. epidermidis (n= 1). Multivariable logistic regression analysis showed that history of bacterial infection, use of antibiotics, application of antiplatelet drugs, replacement frequency were independent risk factors for asymptomatic bacterial colonization. Conclusion There was a high incidence of asymptomatic bacterial colonization in pacemaker patients with independent risk factors. Bacterial culture combined genetic testing could improve the detection rate.	[Chu, Xian-Ming; Sun, Xue-Xia; An, Yi] Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao 266100, Peoples R China; [Li, Bing] Qingdao Univ, Coll Med, Dept Biol, Qingdao 266021, Peoples R China; [Yu, Hua] Qingdao Univ, Affiliated Cardiovasc Hosp, Qingdao 266000, Peoples R China; [Li, Xue-Bin] Peking Univ, Peoples Hosp, Dept Cardiac Electrophysiol, Beijing 100044, Peoples R China	Qingdao University; Qingdao University; Qingdao University; Peking University	Chu, XM (corresponding author), Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao 266100, Peoples R China.	chuxianming@medmail.com.cn; cxm19782001@sina.com		Li, Bing/0000-0002-5545-9674	National Natural Science Foundation of China [81471546]; Capital Project [Z121107001012016]; Shandong Project [2014WS0173, 2012YD18035, J12LL59]; Hospital Project [47-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Capital Project; Shandong Project; Hospital Project	This project is supported by the National Natural Science Foundation of China (No. 81471546), Capital Project (No. Z121107001012016), Shandong Project (No. 2014WS0173, No. 2012YD18035, J12LL59), and Hospital Project (No. 47-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Sarina Maciel Braga, 2012, Gen Dent, V60, pe123; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bak J, 2011, PHOTOCHEM PHOTOBIOL, V87, P1123, DOI 10.1111/j.1751-1097.2011.00962.x; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Bongiorni MG, 2012, EUROPACE, V14, P1666, DOI 10.1093/europace/eus350; Borer A, 2004, INFECT CONT HOSP EP, V25, P492, DOI 10.1086/502428; Chua JD, 2005, PACE, V28, P1276, DOI 10.1111/j.1540-8159.2005.00268.x; Dasgupta A, 2007, AM J KIDNEY DIS, V49, P656, DOI 10.1053/j.ajkd.2007.02.272; EMLEN W, 1982, J EXP MED, V155, P1210, DOI 10.1084/jem.155.4.1210; Gould PA, 2008, HEART RHYTHM, V5, P1675, DOI 10.1016/j.hrthm.2008.09.020; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Harcombe AA, 1998, HEART, V80, P240, DOI 10.1136/hrt.80.3.240; Jost GF, 2013, J CLIN NEUROSCI; Justesen US, 2010, J CLIN MICROBIOL, V48, P946, DOI 10.1128/JCM.02075-09; Kanaan N, 2013, OTOL NEUROTOL, V34, P539, DOI 10.1097/MAO.0b013e3182829792; Kleemann T, 2010, EUROPACE, V12, P58, DOI 10.1093/europace/eup334; Klug D, 2003, PACE, V26, P1489, DOI 10.1046/j.1460-9592.2003.t01-1-00215.x; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Klug D, 2010, EUROPACE, V12, P5, DOI 10.1093/europace/eup402; Lo Ronald, 2006, J Invasive Cardiol, V18, P599; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lower SK, 2011, P NATL ACAD SCI USA, V108, P18372, DOI 10.1073/pnas.1109071108; Margey R, 2010, EUROPACE, V12, P64, DOI 10.1093/europace/eup362; Martin A, 2014, PACE, V37, P242, DOI 10.1111/pace.12274; Mason PK, 2011, PACE, V34, P143, DOI 10.1111/j.1540-8159.2010.02820.x; Massoure PL, 2007, PACE, V30, P12; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Oliva A, 2010, J CLIN MICROBIOL, V48, P4669, DOI 10.1128/JCM.01532-10; Pichlmaier M, 2008, EUROPACE, V10, P1067, DOI 10.1093/europace/eun191; Pichlmaier M, 2013, TECHNOL HEALTH CARE, V21, P87, DOI 10.3233/THC-120711; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Sohail MR, 2007, INTERN MED J, V37, DOI 10.1111/j.1445-5994.2007.01415.x; Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Sohal M, 2014, EUROPACE, V16, P81, DOI 10.1093/europace/eut163; Uslan DZ, 2006, CLIN INFECT DIS, V43, P731, DOI 10.1086/506942; Vergidis P, 2012, INFECT DIS CLIN N AM, V26, P173, DOI 10.1016/j.idc.2011.09.012; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020	39	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119232	10.1371/journal.pone.0119232	http://dx.doi.org/10.1371/journal.pone.0119232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768661	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500072
J	Miyazaki, M; Ouyang, C; Zhou, XZ; Murdoch, JB; Fushimi, Y; Okada, T; Fujimoto, K; Kido, A; Arakawa, Y; Miyamoto, S; Togashi, K				Miyazaki, Mitsue; Ouyang, Cheng; Zhou, Xiangzhi; Murdoch, James B.; Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Kido, Aki; Arakawa, Yoshiki; Miyamoto, Susumu; Togashi, Kaori			Z-Spectrum Analysis Provides Proton Environment Data (ZAPPED): A New Two-Pool Technique for Human Gray and White Matter	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; IN-VIVO; MRI; RELAXATION; CONTRAST; BRAIN; EXCHANGE; TISSUE; POOL; 3T	A new technique - Z-spectrum Analysis Provides Proton Environment Data (ZAPPED) - was used to map cross-relaxing free and restricted protons in nine healthy subjects plus two brain tumor patients at 3T. First, MT data were acquired over a wide symmetric range of frequency offsets, and then a trio of quantitative biomarkers, i. e., the apparent spin-spin relaxation times (T-2,T-f, T-2,T-r) in both free and restricted proton pools as well as the restricted pool fraction F-r, were mapped by fitting the measured Z-spectra to a simple two-Lorentzian compartment model on a voxel-by-voxel basis. The mean restricted exchangeable proton fraction, Fr, was found to be 0.17 in gray matter (GM) and 0.28 in white matter (WM) in healthy subjects. Corresponding mean values for apparent spin-spin relaxation times were 785 mu s (T-2,T-f) and 17.7 mu s (T-2,T-r) in GM, 672 mu s (T-2,T-f) and 23.4 mu s (T-2,T-r) in WM. The percentages of F-f and F-r in GM are similar for all ages, whereas Fr shows a tendency to decrease with age in WM among healthy subjects. The patient ZAPPED images show higher contrast between tumor and normal tissues than traditional T-2-weighted and T-1-weighted images. The ZAPPED method provides a simple phenomenological approach to estimating fractions and apparent T-2 values of free and restricted MT-active protons, and it may offer clinical useful information.	[Miyazaki, Mitsue; Ouyang, Cheng; Zhou, Xiangzhi; Murdoch, James B.] Toshiba Med Res Inst, MR Res, Vernon Hills, IL 60061 USA; [Fushimi, Yasutaka; Okada, Tomohisa; Fujimoto, Koji; Kido, Aki; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Arakawa, Yoshiki; Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan	Toshiba Corporation; Kyoto University; Kyoto University	Miyazaki, M (corresponding author), Toshiba Med Res Inst, MR Res, Vernon Hills, IL 60061 USA.	mmiyazaki@tmriusa.com	Okada, Tomohisa/C-5939-2008; Arakawa, Yoshiki/H-6067-2017; Fushimi, Yasutaka/L-8922-2017	Arakawa, Yoshiki/0000-0003-4626-4645; Fushimi, Yasutaka/0000-0002-1982-3168; Okada, Tomohisa/0000-0003-2312-5677; Kido, Aki/0000-0001-5131-2870	Toshiba Medical Systems Corporation, Japan [150100700014]	Toshiba Medical Systems Corporation, Japan	Toshiba Medical Systems Corporation, Japan, provided a sponsored research program, "Researches for improvement of MR visualization (No. 150100700014)" to one of the authors, Professor Kaori Togashi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; BALABAN R S, 1992, Magnetic Resonance Quarterly, V8, P116; BOTTOMLEY PA, 1984, RADIOLOGY, V150, P441, DOI 10.1148/radiology.150.2.6691099; Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023; Ge Y, 2000, AM J NEURORADIOL, V23, P1327; Guttmann CRG, 1998, NEUROLOGY, V50, P972, DOI 10.1212/WNL.50.4.972; KOENIG SH, 1990, MAGNET RESON MED, V14, P482, DOI 10.1002/mrm.1910140306; KOENIG SH, 1991, MAGNET RESON MED, V20, P285, DOI 10.1002/mrm.1910200210; MIYAZAKI M, 1994, MAGNET RESON MED, V32, P52, DOI 10.1002/mrm.1910320108; MORRISON C, 1995, J MAGN RESON SER B, V108, P103, DOI 10.1006/jmrb.1995.1111; Okuchi S, 2014, ACAD RADIOL, V21, P812, DOI 10.1016/j.acra.2014.03.007; PIKE GB, 1992, MAGNET RESON MED, V25, P372, DOI 10.1002/mrm.1910250217; Pirpamer L, 2014, P JOINT ANN M ISMRM, P206; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Soellinger M, 2011, MAGN RESON MED, V66, P717, DOI 10.1002/mrm.22846; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yarnykh VL, 2012, MAGN RESON MED, V68, P166, DOI 10.1002/mrm.23224; Yarnykh VL, 2002, MAGNET RESON MED, V47, P929, DOI 10.1002/mrm.10120	24	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119915	10.1371/journal.pone.0119915	http://dx.doi.org/10.1371/journal.pone.0119915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768108	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500102
J	Rzem, R; Achouri, Y; Marbaix, E; Schakman, O; Wiame, E; Marie, S; Gailly, P; Vincent, MF; Veiga-da-Cunha, M; Van Schaftingen, E				Rzem, Rim; Achouri, Younes; Marbaix, Etienne; Schakman, Olivier; Wiame, Elsa; Marie, Sandrine; Gailly, Philippe; Vincent, Marie-Francoise; Veiga-da-Cunha, Maria; Van Schaftingen, Emile			A Mouse Model of L-2-Hydroxyglutaric Aciduria, a Disorder of Metabolite Repair	PLOS ONE			English	Article							NEUROPATHOLOGICAL FINDINGS; LYSINE METABOLISM; GENE; DEHYDROGENASE; IDENTIFICATION; BRAIN; KETOGLUTARATE; DEGENERATION; TRANSPORTERS; ASTROCYTES	The purpose of the present work was to progress in our understanding of the pathophysiology of L-2-hydroxyglutaric aciduria, due to a defect in L-2-hydroxyglutarate dehydrogenase, by creating and studying a mouse model of this disease. L-2-hydroxyglutarate dehydrogenase-deficient mice (l2hgdh(-/-)) accumulated L-2-hydroxyglutarate in tissues, most particularly in brain and testis, where the concentration reached approximate to 3.5 mu mol/g. Male mice showed a 30% higher excretion of L-2-hydroxyglutarate compared to female mice, supporting that this dicarboxylic acid is partially made in males by lactate dehydrogenase C, a poorly specific form of this enzyme exclusively expressed in testes. Involvement of mitochondrial malate dehydrogenase in the formation of L-2-hydroxyglutarate was supported by the commensurate decrease in the formation of this dicarboxylic acid when down-regulating this enzyme in mouse l2hgdh(-/-) embryonic fibroblasts. The concentration of lysine and arginine was markedly increased in the brain of l2hgdh(-/-) adult mice. Saccharopine was depleted and glutamine was decreased by approximate to 40%. Lysine-alpha-ketoglutarate reductase, which converts lysine to saccharopine, was inhibited by L-2-hydroxyglutarate with a Ki of approximate to 0.8 mM. As low but significant activities of the bifunctional enzyme lysine-alpha-ketoglutarate reductase/saccharopine dehydrogenase were found in brain, these findings suggest that the classical lysine degradation pathway also operates in brain and is inhibited by the high concentrations of L-2-hydroxyglutarate found in l2hgdh(-/-) mice. Pathological analysis of the brain showed significant spongiosis. The vacuolar lesions mostly affected oligodendrocytes and myelin sheats, as in other dicarboxylic acidurias, suggesting that the pathophysiology of this model of leukodystrophy may involve irreversible pumping of a dicarboxylate in oligodendrocytes. Neurobehavioral testing indicated that the mice mostly suffered from a deficit in learning capacity. In conclusion, the findings support the concept that L-2-hydroxyglutaric aciduria is a disorder of metabolite repair. The accumulation of L-2-hydroxyglutarate exerts toxic effects through various means including enzyme inhibition and glial cell swelling.	[Rzem, Rim; Achouri, Younes; Wiame, Elsa; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Welbio & Lab Physiol Chem, de Duve Inst, B-1200 Brussels, Belgium; [Marbaix, Etienne] Catholic Univ Louvain, Cell Unit, de Duve Inst, B-1200 Brussels, Belgium; [Schakman, Olivier; Gailly, Philippe] Catholic Univ Louvain, Lab Cell Physiol, Inst Neurosci, B-1200 Brussels, Belgium; [Marie, Sandrine; Vincent, Marie-Francoise] Catholic Univ Louvain, Lab Metab Dis, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, Welbio & Lab Physiol Chem, de Duve Inst, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be; emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	ACHOURI, Younes/0000-0001-7409-1441; Van Schaftingen, Emile/0000-0002-6199-7647	Fonds National de la Recherche Scientifique (FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy [P7/43, P7/13]	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) and the Interuniversity Attraction Poles Programme, Belgian Science Policy (Networks P7/43 and P7/13). Maria Veiga-da-Cunha is Chercheur Qualifie of the Belgian Fonds National de la Recherche Scientifique (FRS-FNRS). The Desordres Inflammatoires dans les Affections Neurologiques (DIANE) Centre of Excellence programme of the Region Wallonne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouri Y, 2004, BIOCHEM J, V381, P35, DOI 10.1042/BJ20031933; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Audouard E, 2013, MOL CELL NEUROSCI, V56, P159, DOI 10.1016/j.mcn.2013.05.001; Barbot C, 1997, BRAIN DEV-JPN, V19, P268, DOI 10.1016/S0387-7604(97)00574-3; BARTH PG, 1992, ANN NEUROL, V32, P66, DOI 10.1002/ana.410320111; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Brauburger K, 2011, J INHERIT METAB DIS, V34, P477, DOI 10.1007/s10545-010-9268-2; Chabli A, 2007, CLIN BIOCHEM, V40, P692, DOI 10.1016/j.clinbiochem.2007.02.005; Chen E, 1996, J INHERIT METAB DIS, V19, P335, DOI 10.1007/BF01799264; Chevronnay HPG, 2014, J AM SOC NEPHROL, V25, P1256, DOI 10.1681/ASN.2013060598; Cox RP, 2001, THE METABOLIC MOLECU, V2, P1965; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; Deguil J, 2010, NEUROTOX RES, V17, P142, DOI 10.1007/s12640-009-9091-4; Dombret C, 2012, HUM MOL GENET, V21, P4703, DOI 10.1093/hmg/dds310; Duran M, 1980, J Inherit Metab Dis, V3, P109, DOI 10.1007/BF02312543; Fujita T, 2005, J NEUROCHEM, V93, P706, DOI 10.1111/j.1471-4159.2005.03067.x; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Hagos Y, 2008, PFLUG ARCH EUR J PHY, V457, P223, DOI 10.1007/s00424-008-0489-2; Hallen A, 2013, AMINO ACIDS, V45, P1249, DOI 10.1007/s00726-013-1590-1; Hallen A, 2011, J NEUROCHEM, V118, P379, DOI 10.1111/j.1471-4159.2011.07220.x; Houten SM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-57; Ishida N, 1997, NEUROSCIENCE, V81, P1183, DOI 10.1016/S0306-4522(97)00220-0; Kamoun P, 2002, J INHERIT METAB DIS, V25, P1, DOI 10.1023/A:1015195009330; Kolker S, 2006, J INHERIT METAB DIS, V29, P701, DOI 10.1007/s10545-006-0415-8; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; LARNAOUT A, 1994, ACTA NEUROPATHOL, V88, P367, DOI 10.1007/BF00310381; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Louis DN, 2009, 1 NONNEOPLASTIC DIS, P345; Mignion L, 2013, MAGN RESON MED, V69, P248, DOI 10.1002/mrm.24245; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Papes F, 2001, FEBS LETT, V488, P34, DOI 10.1016/S0014-5793(00)02401-7; RAO VV, 1992, COMP BIOCHEM PHYS B, V103, P221, DOI 10.1016/0305-0491(92)90435-T; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Sadilkova K, 2009, J NEUROSCI METH, V184, P136, DOI 10.1016/j.jneumeth.2009.07.019; Sauer SW, 2011, BRAIN, V134, P157, DOI 10.1093/brain/awq269; SCHATZ L, 1969, J BIOL CHEM, V244, P4393; Scurrell E, 2008, J COMP PATHOL, V138, P160, DOI 10.1016/j.jcpa.2007.11.005; Seijo-Martinez M, 2005, ARCH NEUROL-CHICAGO, V62, P666, DOI 10.1001/archneur.62.4.666; Struys EA, 2007, J INHERIT METAB DIS, V30, P690, DOI 10.1007/s10545-007-0697-5; Sztriha L, 2002, PEDIATR NEUROL, V27, P141, DOI 10.1016/S0887-8994(02)00405-8; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Topcu M, 2005, TURKISH J PEDIATR, V47, P1; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Traka M, 2008, J NEUROSCI, V28, P11537, DOI 10.1523/JNEUROSCI.1490-08.2008; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Weil-Malherbe H, 1937, BIOCHEM J, V31, P2080, DOI 10.1042/bj0312080; Weimar C, 2013, CLIN NEUROL NEUROSUR, V115, P765, DOI 10.1016/j.clineuro.2012.06.040; Yodoya E, 2006, J NEUROCHEM, V97, P162, DOI 10.1111/j.1471-4159.2006.03720.x; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	54	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119540	10.1371/journal.pone.0119540	http://dx.doi.org/10.1371/journal.pone.0119540			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763823	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300028
J	Li, XJ; Fliegel, L				Li, Xiuju; Fliegel, Larry			A Novel Human Mutation in the SLC9A1 Gene Results in Abolition of Na+/H+ Exchanger Activity	PLOS ONE			English	Article							TRANSMEMBRANE SEGMENT-VII; NHE1 ISOFORM; FUNCTIONAL-ANALYSIS; AMINO-ACIDS; INSIGHTS; MODEL; TAIL; IV	The SLC9A1 gene, the Na+/H+ exchanger isoform 1 is the principal plasma membrane Na+/H+ exchanger of mammalian cells and functions by exchanging one intracellular proton for one extracellular sodium. The human protein is 815 amino acids in length. Five hundred N-terminal amino acids make up the transport domain of the protein and are believed to form 12 transmembrane segments. Recently, a genetic mutation of the Na+/H+ exchanger isoform 1, N266H, was discovered in a human patient through exome sequencing. We examined the effect of this mutation on expression, targeting and activity of the Na+/H+ exchanger. Mutant N266H protein was expressed in AP-1 cells, which lack their endogenous Na+/H+ exchanger protein. Targeting of the mutant protein to the cell surface was normal and expression levels were only slightly reduced relative to the wild type protein. However, the N266H mutant protein had no detectable Na+/H+ exchanger activity. A histidine residue at this location may disrupt the cation binding site or the pore of the Na+/H+ exchanger protein.	[Li, Xiuju; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	lfliegel@ualberta.ca			Canadian Institute of Health Sciences [MOP 114876]	Canadian Institute of Health Sciences	Funded by the Canadian Institute of Health Sciences (MOP 114876). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves C, 2014, BIOCHEM CELL BIOL, V92, P524, DOI 10.1139/bcb-2014-0071; Alves C, 2014, BIOCHEMISTRY-US, V53, P3658, DOI 10.1021/bi500392y; Amith SR, 2013, CANCER RES, V73, P1259, DOI 10.1158/0008-5472.CAN-12-4031; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; Ding J, 2007, CAN J PHYSIOL PHARM, V85, P319, DOI 10.1139/Y06-081; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Guissart C, 2014, HUM MOL GEN IN PRESS; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Kemp G, 2008, CHANNELS, V2, P329, DOI 10.4161/chan.2.5.6898; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Lee BL, 2013, J MOL CELL CARDIOL, V61, P60, DOI 10.1016/j.yjmcc.2012.11.019; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Ndayizeye M, 2009, BBA-BIOMEMBRANES, V1788, P983, DOI 10.1016/j.bbamem.2009.01.001; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Tzeng J, 2011, BBA-BIOMEMBRANES, V1808, P2327, DOI 10.1016/j.bbamem.2011.05.004; Tzeng J, 2010, J BIOL CHEM, V285, P36656, DOI 10.1074/jbc.M110.161471; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Zhu X, 2015, GENETICS ME IN PRESS	22	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119453	10.1371/journal.pone.0119453	http://dx.doi.org/10.1371/journal.pone.0119453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760855	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000057
J	Yang, YH; Tsai, IJ; Chang, CJ; Chuang, YH; Hsu, HY; Chiang, BL				Yang, Yao-Hsu; Tsai, I-Jung; Chang, Chun-Jung; Chuang, Ya-Hui; Hsu, Hui-Yao; Chiang, Bor-Luen			The Interaction between Circulating Complement Proteins and Cutaneous Microvascular Endothelial Cells in the Development of Childhood Henoch-Schonlein Purpura	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; ACUTE STAGE; IGA; CHILDREN; C5A; EXPRESSION; C3A; HYPOCOMPLEMENTEMIA; CLASSIFICATION; ANAPHYLATOXINS	Objective In addition to IgA, the deposition of complement (C)3 in dermal vessels is commonly found in Henoch-Schnlein purpura (HSP). The aim of this study is to elucidate the role of circulating complement proteins in the pathogenesis of childhood HSP. Methods Plasma levels of C3a, C4a, C5a, and Bb in 30 HSP patients and 30 healthy controls were detected by enzyme-linked immunosorbent assay (ELISA). The expression of C3a receptor (C3aR), C5a receptor (CD88), E-selectin, intercellular adhesion molecule 1 (ICAM-1), C3, C5, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, and RANTES by human dermal microvascular endothelial cells (HMVEC-d) was evaluated either by flow cytometry or by ELISA. Results At the acute stage, HSP patients had higher plasma levels of C3a (359.5 +/- 115.3 vs. 183.3 +/- 94.1 ng/ml, p < 0.0001), C5a (181.4 +/- 86.1 vs. 33.7 +/- 26.3 ng/ml, p < 0.0001), and Bb (3.7 +/- 2.6 vs. 1.0 +/- 0.6 mu g/ml, p < 0.0001), but not C4a than healthy controls. Although HSP patient-derived acute phase plasma did not alter the presentation of C3aR and CD88 on HMVEC-d, it enhanced the production of endothelial C3 and C5. Moreover, C5a was shown in vitro to up-regulate the expression of IL-8, MCP-1, E-selectin, and ICAM-1 by HMVEC-d with a dose-dependent manner. Conclusion In HSP, the activation of the complement system in part through the alternative pathway may have resulted in increased plasma levels of C3a and C5a, which, especially C5a, may play a role in the disease pathogenesis by activating endothelium of cutaneous small vessels.	[Yang, Yao-Hsu; Tsai, I-Jung; Hsu, Hui-Yao] Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan; [Chang, Chun-Jung] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chiang, Bor-Luen] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, YH (corresponding author), Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Coll Med, Taipei 10764, Taiwan.	yan0126@ms15.hinet.net	; Yang, Yao-Hsu/A-3450-2019	CHUANG, YA-HUI/0000-0003-0857-0035; Yang, Yao-Hsu/0000-0002-6266-9864; Yang, Yao-Hsu/0000-0002-8080-0504; CHIANG, BOR-LUEN/0000-0002-6705-0286; Tsai, I-Jung/0000-0003-3967-9412	National Science Council of Taiwan [NSC 103-2314-B-002 -069 -]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan (grant number: NSC 103-2314-B-002 -069 -). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Aktas B, 2009, ANN PHARMACOTHER, V43, P792, DOI 10.1345/aph.1L608; Albrecht EA, 2004, AM J PATHOL, V164, P849, DOI 10.1016/S0002-9440(10)63173-2; Cines DB, 1998, BLOOD, V91, P3527; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; Gardner-Medwin JMM, 2002, LANCET, V360, P1197, DOI 10.1016/S0140-6736(02)11279-7; Goldberg EI, 1999, INT J DERMATOL, V38, P706, DOI 10.1046/j.1365-4362.1999.00741.x; HIEMSTRA PS, 1987, EUR J IMMUNOL, V17, P321, DOI 10.1002/eji.1830170304; Hisano S, 2005, AM J KIDNEY DIS, V45, P295, DOI 10.1053/j.ajkd.2004.10.020; Jagels MA, 2000, IMMUNOPHARMACOLOGY, V46, P209, DOI 10.1016/S0162-3109(99)00178-2; Jariwala S, 2011, ANN ALLERG ASTHMA IM, V107, P180, DOI 10.1016/j.anai.2011.05.006; Jen HY, 2011, PEDIAT ALLERG IMM-UK, V22, P862, DOI 10.1111/j.1399-3038.2011.01198.x; JOHNSON E, 1991, SCAND J IMMUNOL, V33, P667, DOI 10.1111/j.1365-3083.1991.tb02539.x; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Lambert EM, 2003, PEDIATRICS, V112, pE491, DOI 10.1542/peds.112.6.e491; Langeggen H, 2000, CLIN EXP IMMUNOL, V121, P69, DOI 10.1046/j.1365-2249.2000.01238.x; Laufer J, 2001, MOL IMMUNOL, V38, P221, DOI 10.1016/S0161-5890(01)00044-X; Lin Q, 2012, PEDIATR NEPHROL, V27, P801, DOI 10.1007/s00467-011-2070-z; Motoyama O, 2005, PEDIATR INT, V47, P39, DOI 10.1111/j.1442-200x.2005.02005.x; Murphy K, 2012, JANEWAYS IMMUNOBIOLO, P48; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; Rolle AS, 2013, JCR-J CLIN RHEUMATOL, V19, P90, DOI 10.1097/RHU.0b013e3182863027; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Saulsbury FT, 1999, MEDICINE, V78, P395, DOI 10.1097/00005792-199911000-00005; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Skeie JM, 2010, INVEST OPHTH VIS SCI, V51, P5336, DOI 10.1167/iovs.10-5322; Watanabe T, 2011, PEDIATR NEPHROL, V26, P795, DOI 10.1007/s00467-010-1722-8; Yang YH, 2008, AUTOIMMUN REV, V7, P179, DOI 10.1016/j.autrev.2007.11.012; Yang YH, 2014, AUTOIMMUN REV, V13, P355, DOI 10.1016/j.autrev.2014.01.031; Yang YH, 2012, BRIT J DERMATOL, V167, P874, DOI 10.1111/j.1365-2133.2012.11068.x; Yang YH, 2000, CLIN EXP IMMUNOL, V122, P285, DOI 10.1046/j.1365-2249.2000.01361.x; Yang YH, 2006, CLIN EXP IMMUNOL, V144, P247, DOI 10.1111/j.1365-2249.2006.03076.x; Yang YH, 2005, RHEUMATOLOGY, V44, P618, DOI 10.1093/rheumatology/keh544	37	29	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120411	10.1371/journal.pone.0120411	http://dx.doi.org/10.1371/journal.pone.0120411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760949	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275000069
J	Heidrich, E; Carattino, MD; Hughey, RP; Pilewski, JM; Kleyman, TR; Myerburg, MM				Heidrich, Elisa; Carattino, Marcelo D.; Hughey, Rebecca P.; Pilewski, Joseph M.; Kleyman, Thomas R.; Myerburg, Mike M.			Intracellular Na+ Regulates Epithelial Na+ Channel Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCONVENTIONAL PROTEIN SECRETION; SODIUM-CHANNEL; CYSTIC-FIBROSIS; FEEDBACK INHIBITION; CYTOSOLIC NA+; GAMMA-SUBUNIT; MEMBRANE; TRAFFICKING; CELLS	Epithelial Na+ channel (ENaC) function is regulated by the intracellular Na+ concentration ([Na+](i)) through a process known as Na+ feedback inhibition. Although this process is known to decrease the expression of proteolytically processed active channels on the cell surface, it is unknown how [Na+](i) alters ENaC cleavage. We show here that [Na+](i) regulates the posttranslational processing of ENaC subunits during channel biogenesis. At times when [Na+](i) is low, ENaC subunits develop mature N-glycans and are processed by proteases. Conversely, glycan maturation and sensitivity to proteolysis are reduced when [Na+](i) is relatively high. Surface channels with immature N-glycans were not processed by endogenous channel activating proteases, nor were they sensitive to cleavage by exogenous trypsin. Biotin chase experiments revealed that the immature surface channels were not converted into mature cleaved channels following a reduction in [Na+](i). The hypothesis that [Na+](i) regulates ENaC maturation within the biosynthetic pathways is further supported by the finding that Brefeldin A prevented the accumulation of processed surface channels following a reduction in [Na+](i). Therefore, increased [Na+](i) interferes with ENaC N-glycan maturation and prevents the channel from entering a state that allows proteolytic processing.	[Heidrich, Elisa; Hughey, Rebecca P.; Pilewski, Joseph M.; Myerburg, Mike M.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Carattino, Marcelo D.; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Renal Electrolyte Div, Pittsburgh, PA 15213 USA; [Carattino, Marcelo D.; Pilewski, Joseph M.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Myerburg, MM (corresponding author), NW628 Montefiore Hosp, Div Pulm Allergy & Crit Care Med, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	myerburgm@upmc.edu	Pilewski, Joseph/AAF-5149-2021; Regan, Clinton/E-6250-2012		National Institutes of Health [K08 HL087932, R01 HL112863, R01 DK051391, P30 DK079307, P30 DK072506]; Cystic Fibrosis Foundation [MYERBU07Q0, RDP]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL087932, R01HL112863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, P30DK072506, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HL087932, R01 HL112863, R01 DK051391, P30 DK079307, and P30 DK072506. This work was also supported by Cystic Fibrosis Foundation Grants MYERBU07Q0 and RDP (to The University of Pittsburgh).	Abriel H, 1999, J PHYSIOL-LONDON, V516, P31, DOI 10.1111/j.1469-7793.1999.031aa.x; Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Awayda MS, 1999, AM J PHYSIOL-CELL PH, V277, pC216, DOI 10.1152/ajpcell.1999.277.2.C216; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Dinudom A, 1998, P NATL ACAD SCI USA, V95, P7169, DOI 10.1073/pnas.95.12.7169; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; Myerburg M. M., 2010, AM J RESP CELL MOL B, V45, P592; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Patel AB, 2013, AM J PHYSIOL-RENAL, V304, pF222, DOI 10.1152/ajprenal.00596.2012; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200	27	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11569	11577		10.1074/jbc.M115.640763	http://dx.doi.org/10.1074/jbc.M115.640763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767115	hybrid, Green Published			2022-12-26	WOS:000353719400032
J	Akopian, T; Kandror, O; Tsu, C; Lai, JH; Wu, WG; Liu, YX; Zhao, P; Park, A; Wolf, L; Dick, LR; Rubin, EJ; Bachovchin, W; Goldberg, AL				Akopian, Tatos; Kandror, Olga; Tsu, Christopher; Lai, Jack H.; Wu, Wengen; Liu, Yuxin; Zhao, Peng; Park, Annie; Wolf, Lisa; Dick, Lawrence R.; Rubin, Eric J.; Bachovchin, William; Goldberg, Alfred L.			Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; ESCHERICHIA-COLI; CLP PROTEASE; PROCESSIVE DEGRADATION; PROTEINS; DISTINCT; TRANSLOCATION; TETRADECAMER; COMPONENT; CONTAINS	The ClpP1P2 protease complex is essential for viability in Mycobacteria tuberculosis and is an attractive drug target. Using a fluorogenic tripeptide library (Ac-X3X2X1-aminomethylcoumarin) and by determining specificity constants (k(cat)/K-m), we show that ClpP1P2 prefers Met >> Leu > Phe > Ala in the X-1 position, basic residues or Trp in the X-2 position, and Pro >> Ala > Trp in the X-3 position. We identified peptide substrates that are hydrolyzed up to 1000 times faster than the standard ClpP substrate. These positional preferences were consistent with cleavage sites in the protein GFPssrA by ClpXP1P2. Studies of ClpP1P2 with inactive ClpP1 or ClpP2 indicated that ClpP1 was responsible for nearly all the peptidase activity, whereas both ClpP1 and ClpP2 contributed to protein degradation. Substrate-based peptide boronates were synthesized that inhibit ClpP1P2 peptidase activity in the submicromolar range. Some of them inhibited the growth of Mtb cells in the low micromolar range indicating that cleavage specificity of Mtb ClpP1P2 can be used to design novel anti-bacterial agents.	[Akopian, Tatos; Kandror, Olga; Wolf, Lisa; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tsu, Christopher; Dick, Lawrence R.] Takeda Pharmaceut Int Co, Dept Biochem, Cambridge, MA 02139 USA; [Lai, Jack H.; Wu, Wengen; Liu, Yuxin; Zhao, Peng; Bachovchin, William] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02711 USA; [Park, Annie; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Goldberg, AL (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	Alfred_Goldberg@hms.harvard.edu	liu, yuxin/GRY-3592-2022; Dick, Lawrence/ABA-8831-2021; william.bachovchin@tufts.edu/AAA-3538-2022	Dick, Larry/0000-0002-6880-0405	National Institutes of Health [R01GM051923-17A1]; Harvard Catalyst Grant; Roche Applied Science; Bill and Melinda Gates Foundation [OPP1024065]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst Grant; Roche Applied Science; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM051923-17A1. This work was also supported by a Harvard Catalyst Grant, a grant from Roche Applied Science (to A. L. G.), and by Bill and Melinda Gates Foundation Grant OPP1024065 (to E. J. R.).	Akopian T, 2012, EMBO J, V31, P1529, DOI 10.1038/emboj.2012.5; Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Butler SM, 2006, MOL MICROBIOL, V60, P553, DOI 10.1111/j.1365-2958.2006.05128.x; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Coutts SJ, 1996, J MED CHEM, V39, P2087, DOI 10.1021/jm950732f; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; FLANAGAN JM, 1995, BIOCHEMISTRY-US, V34, P10910, DOI 10.1021/bi00034a025; Frase H, 2007, BIOCHEMISTRY-US, V46, P6647, DOI 10.1021/bi7002789; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; Ingallinella P, 2000, BIOCHEMISTRY-US, V39, P12898, DOI 10.1021/bi001590g; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Kang SG, 2005, J BIOL CHEM, V280, P35424, DOI 10.1074/jbc.M507240200; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; MAURIZI MR, 1991, BIOCHEM SOC T, V19, P719, DOI 10.1042/bst0190719; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Raju RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002511; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Sheppeck JE, 2000, BIOORG MED CHEM LETT, V10, P2639, DOI 10.1016/S0960-894X(00)00545-X; Smoum R, 2012, CHEM REV, V112, P4156, DOI 10.1021/cr608202m; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Zeiler E, 2013, P NATL ACAD SCI USA, V110, P11302, DOI 10.1073/pnas.1219125110	45	37	37	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11008	11020		10.1074/jbc.M114.625640	http://dx.doi.org/10.1074/jbc.M114.625640			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759383	hybrid, Green Published			2022-12-26	WOS:000353404500037
J	Bai, J; Lei, Y; An, GL; He, L				Bai, Jun; Lei, Yun; An, Gai-li; He, Li			Down-Regulation of Deacetylase HDAC6 Inhibits the Melanoma Cell Line A375.S2 Growth through ROS-Dependent Mitochondrial Pathway	PLOS ONE			English	Article							CYTOCHROME-C; APOPTOSIS; CARDIOLIPIN; DYSFUNCTION; BIOGENESIS; GENERATION	Previous studies have shown that histone deacetylase 6 (HDAC6) plays critical roles in many cellular processes related to cancer. However, its biological roles in the development of melanoma remain unexplored. Our aim was to investigate whether HDAC6 has a biological role in human melanoma development and to understand its underlying mechanism. In the present study, HDAC6 expression was up-regulated in melanoma tissues and cell lines. Knockdown of HDAC6 significantly inhibited the proliferation and colony formation ability of A375. S2 cells, promoted cell arrest at G0/G1 phase and apoptosis. Additionally, western blotting assay showed that HDAC6 silencing suppressed Bcl-2 level and enhanced Bax level, then activated caspase-9 and caspase-3, and further activated the release of cytochrome c from mitochondria to cytoplasm, finally induced cell apoptosis involving the mitochondrial pathway. Knockdown of HDAC6 triggered a significant generation of ROS and disruption of mitochondrial membrane potential (MMP). Furthermore, ROS inhibitor, NAC reduced HDAC6 siRNA-induced ROS production, and blocked HDAC6 siRNA-induced loss of MMP and apoptosis. NAC also significantly blocked HDAC6 siRNA-induced mtDNA copy number decrease and mitochondrial biogenesis and degradation imbalance. In conclusion, the results showed that knockdown of HDAC6 induced apoptosis in human melanoma A375.S2 cells through a ROS-dependent mitochondrial pathway.	[Bai, Jun; Lei, Yun; An, Gai-li; He, Li] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Dept Med Oncol,Shaanxi Prov Peoples Hosp, Xian 710049, Peoples R China	Xi'an Jiaotong University; Xi'an Medical University	Bai, J (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Dept Med Oncol,Shaanxi Prov Peoples Hosp, Xian 710049, Peoples R China.	baijun1155@163.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Bo H, 2010, ANN NY ACAD SCI, V1201, P121, DOI 10.1111/j.1749-6632.2010.05618.x; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Huang SH, 2012, J AGR FOOD CHEM, V60, P665, DOI 10.1021/jf204193v; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kamemura K, 2012, FEBS LETT, V586, P1379, DOI 10.1016/j.febslet.2012.03.060; Kang J, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/896751; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Larisa P.M., 2007, FOCUS CELL APOPTOSIS, V1, P233; Lee W, 2013, BIOCHEM BIOPH RES CO, V430, P406, DOI 10.1016/j.bbrc.2012.11.030; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Liu MJ, 2004, TOXICOL APPL PHARM, V194, P141, DOI 10.1016/j.taap.2003.08.017; Ma Y, 2014, BIOCHEM BIOPH RES CO, V448, P8, DOI 10.1016/j.bbrc.2014.04.007; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236; Petrosillo G, 2003, FASEB J, V17, P2202, DOI 10.1096/fj.03-0012com; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Shen W, 2008, DIABETOLOGIA, V51, P165, DOI 10.1007/s00125-007-0852-4; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Yoboue Edgar D, 2012, Int J Cell Biol, V2012, P403870, DOI 10.1155/2012/403870; Yoon DH, 2013, TOXICOL APPL PHARM, V273, P659, DOI 10.1016/j.taap.2013.10.015; Zuckerman JE, 2011, J INVEST DERMATOL, V131, P453, DOI 10.1038/jid.2010.310	27	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121247	10.1371/journal.pone.0121247	http://dx.doi.org/10.1371/journal.pone.0121247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774669	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500211
J	Cedres, S; Ponce-Aix, S; Zugazagoitia, J; Sansano, I; Enguita, A; Navarro-Mendivil, A; Martinez-Marti, A; Martinez, P; Felip, E				Cedres, Susana; Ponce-Aix, Santiago; Zugazagoitia, Jon; Sansano, Irene; Enguita, Ana; Navarro-Mendivil, Alejandro; Martinez-Marti, Alex; Martinez, Pablo; Felip, Enriqueta			Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)	PLOS ONE			English	Article							B7-H1 EXPRESSION; EXTRAPLEURAL PNEUMONECTOMY; INDUCTION CHEMOTHERAPY; SPONTANEOUS REGRESSION; T-CELLS; SURVIVAL; ANTIBODY; SAFETY; INFILTRATION; LYMPHOCYTES	Background The increasing incidence and poor outcome associated with MPM requires finding effective treatment for this disease. PD1/PD-L1 pathway plays a central role in tumor immune evasion and appears to be predictive and prognostic marker. PD-L1 is expressed in many different human cancers but its role in MPM has yet to be established. The aim of this study is to evaluate the expression of PD-L1 in MPM. Methods 119 MPM patients (p) from two institutions between November 2002 and February 2014 were reviewed. Formalin-fixed, paraffin-embedded tissue was stained with anti-PD-L1 (clone E1L3N). Cases showing more than 1% of tumor cells expression of PD-L1 were considered positive. Results PD-L1 was analyzed in 77 p with tumor tissue available and was positive in 20.7% p (14 samples in membrane, 16 in cytoplasm and 4 in immune infiltrate). PD-L1 intensity was weak in 56.2%, moderate in 25% and strong in 18.7% p. There was a significant relationship between PD-L1 expression and histology (PD-L1 expression 37.5% in no-epithelioid tumor and 13.2% in epithelioid; p=0.033). The median survival in p PD-L1 positive was 4.79 vs 16.3 months in p PD-L1 negative (p=0.012). Conclusions We have shown PD-L1 is expressed in 20% of patients, associated with no epithelioid histology and poor prognostic in MPM. Our results suggest PD-L1 warrants further exploration in selecting p for immunotherapy.	[Cedres, Susana; Navarro-Mendivil, Alejandro; Martinez-Marti, Alex; Martinez, Pablo; Felip, Enriqueta] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain; [Ponce-Aix, Santiago; Zugazagoitia, Jon] 12 Octubre Univ Hosp, Med Oncol Serv, Madrid, Spain; [Sansano, Irene] Vall dHebron Univ Hosp, Dept Pathol, Barcelona, Spain; [Enguita, Ana] 12 Octubre Univ Hosp, Dept Pathol, Madrid, Spain	Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitario 12 de Octubre; Hospital Universitari Vall d'Hebron; Hospital Universitario 12 de Octubre	Cedres, S (corresponding author), Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain.	scedres@vhebron.net	FELIP, ENRIQUETA/AAG-6316-2019; Sansano, Irene/AAH-9731-2021	Sansano, Irene/0000-0003-0188-5210; FELIP, ENRIQUETA/0000-0002-7620-0098; MARTINEZ-MARTI, ALEX/0000-0002-6714-9526; Balmana, Judith/0000-0002-0762-6415				Allen RKA, 2007, MED J AUSTRALIA, V187, P413, DOI 10.5694/j.1326-5377.2007.tb01315.x; Anraku M, 2008, J THORAC CARDIOV SUR, V135, P823, DOI 10.1016/j.jtcvs.2007.10.026; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Calabro L, 2013, LANCET ONCOL, V14, P1104, DOI 10.1016/S1470-2045(13)70381-4; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Currie AJ, 2009, J IMMUNOL, V183, P7898, DOI 10.4049/jimmunol.0901060; de Perrot M, 2009, J CLIN ONCOL, V27, P1413, DOI 10.1200/JCO.2008.17.5604; Flores RM, 2005, LUNG CANCER-J IASLC, V49, pS71, DOI 10.1016/j.lungcan.2005.03.015; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gandhi L, 2014, AACR ANN M APRIL6; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hassan R, 2010, CLIN CANCER RES, V16, P6132, DOI 10.1158/1078-0432.CCR-10-2275; Herbst RS, 2013, J CLIN ONCOL S, V31; Inami K, 2010, CANCER SCI, V101, P969, DOI 10.1111/j.1349-7006.2009.01463.x; International Union Against Cancer, 2009, TNM CLASSIFICATION M; Jackaman C, 2009, EUR RESPIR J, V34, P162, DOI 10.1183/09031936.00101008; Karim R, 2009, CLIN CANCER RES, V15, P6341, DOI 10.1158/1078-0432.CCR-09-1652; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Krug LM, 2010, CANCER IMMUNOL IMMUN, V59, P1467, DOI 10.1007/s00262-010-0871-8; LEIGH RA, 1982, S AFR MED J, V61, P1007; Mansfield AS, 2014, J THORAC ONCOL, V9, P1036, DOI 10.1097/JTO.0000000000000177; MARTINI N, 1987, ANN THORAC SURG, V43, P113, DOI 10.1016/S0003-4975(10)60182-8; Neragi-Miandoab Siyamek, 2008, Int J Surg, V6, P293, DOI 10.1016/j.ijsu.2008.04.004; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Opitz I, 2008, EUR J CARDIO-THORAC, V33, P501, DOI 10.1016/j.ejcts.2007.09.045; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pilling JE, 2007, ANN THORAC SURG, V83, P314, DOI 10.1016/j.athoracsur.2006.05.070; Rena O, 2011, J SURG ONCOL, V104, P701, DOI 10.1002/jso.21901; Robinson BWS, 2001, LUNG CANCER-J IASLC, V32, P197, DOI 10.1016/S0169-5002(00)00217-8; Schalper K, 2014, CLIN CANCER RES, V20, P5064, DOI [10.1158/1078-0432.CCR-13-3271, DOI 10.1158/1078-0432.CCR-13-3271]; Seiwert TY, 2015, J CLIN ONCOL, V33; Soliman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088557; Strome SE, 2003, CANCER RES, V63, P6501; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Velcheti V, 2014, LAB INVEST, V94, P107, DOI 10.1038/labinvest.2013.130; Velcheti V, 2013, J THORAC ONCOL, V8, P803, DOI 10.1097/JTO.0b013e318292be18; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weber JS, 2013, J CLIN ONCOL, V31; Yamada N, 2010, CANCER IMMUNOL IMMUN, V59, P1543, DOI 10.1007/s00262-010-0881-6; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	46	143	147	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e121071	10.1371/journal.pone.0121071	http://dx.doi.org/10.1371/journal.pone.0121071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774992	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500205
J	Ma, L; Jeffery, WR; Essner, JJ; Kowalko, JE				Ma, Li; Jeffery, William R.; Essner, Jeffrey J.; Kowalko, Johanna E.			Genome Editing Using TALENs in Blind Mexican Cavefish, Astyanax mexicanus	PLOS ONE			English	Article							PINK-EYED-DILUTION; AGGRESSIVE-BEHAVIOR; EVOLUTION; EFFICIENT; GENE; DNA; CONVERGENCE; FISH; STICKLEBACKS; ALBINISM	Astyanax mexicanus, a teleost fish that exists in a river-dwelling surface form and multiple cave-dwelling forms, is an excellent system for studying the genetic basis of evolution. Cavefish populations, which independently evolved from surface fish ancestors multiple times, have evolved a number of morphological and behavioral traits. Quantitative trait loci (QTL) analyses have been performed to identify the genetic basis of many of these traits. These studies, combined with recent sequencing of the genome, provide a unique opportunity to identify candidate genes for these cave-specific traits. However, tools to test the requirement of these genes must be established to evaluate the role of candidate genes in generating cave-specific traits. To address this need, we designed transcription activator-like effector nucleases (TALENs) to target two genes that contain coding changes in cavefish relative to surface fish and map to the same location as QTL for pigmentation, oculocutaneous albinism 2 (oca2) and melanocortin 1 receptor (mc1r). We found that surface fish genes can be mutated using this method. TALEN-induced mutations in oca2 result in mosaic loss of melanin pigmentation visible as albino patches in F-0 founder fish, suggesting biallelic gene mutations in F(0)s and allowing us to evaluate the role of this gene in pigmentation. The pigment cells in the albino patches can produce melanin upon treatment with L-DOPA, behaving similarly to pigment cells in albino cavefish and providing additional evidence that oca2 is the gene within the QTL responsible for albinism in cavefish. This technology has the potential to introduce a powerful tool for studying the role of candidate genes responsible for the evolution of cavefish traits.	[Ma, Li; Jeffery, William R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Essner, Jeffrey J.; Kowalko, Johanna E.] Iowa State Univ, Genet Dev & Cell Biol Dept, Ames, IA 50011 USA	University System of Maryland; University of Maryland College Park; Iowa State University	Essner, JJ (corresponding author), Iowa State Univ, Genet Dev & Cell Biol Dept, Ames, IA 50011 USA.	jessner@iastate.edu		Essner, Jeffrey/0000-0001-8816-3848; Ma, Li/0000-0003-0233-3039	Department of Genetics, Development and Cell Biology at Iowa State University; National Institute of Health grant [R01-EY014619]; National Science Foundation grant [IBN-0542384]; NATIONAL EYE INSTITUTE [R01EY024941, R01EY014619] Funding Source: NIH RePORTER	Department of Genetics, Development and Cell Biology at Iowa State University; National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation grant(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the Department of Genetics, Development and Cell Biology at Iowa State University and by National Institute of Health grant R01-EY014619 (WRJ) and National Science Foundation grant IBN-0542384 (WRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Bannister S, 2014, GENETICS, V197, P77, DOI 10.1534/genetics.113.161091; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bilandzija H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080823; Bilandzija H, 2012, EVOL DEV, V14, P196, DOI 10.1111/j.1525-142X.2012.00535.x; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Blackburn PR, 2013, ZEBRAFISH, V10, P116, DOI 10.1089/zeb.2013.9999; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; BRILLIANT MH, 1994, PIGM CELL RES, V7, P398, DOI 10.1111/j.1600-0749.1994.tb00068.x; BURCHARDS H, 1985, BEHAV PROCESS, V11, P225, DOI 10.1016/0376-6357(85)90017-8; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Dong ZJ, 2014, ZEBRAFISH, V11, P265, DOI 10.1089/zeb.2014.0974; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Duboue ER, 2011, CURR BIOL, V21, P671, DOI 10.1016/j.cub.2011.03.020; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Elipot Y, 2013, CURR BIOL, V23, P1, DOI 10.1016/j.cub.2012.10.044; Espinasa L, 2005, BEHAV PROCESS, V70, P144, DOI 10.1016/j.beproc.2005.06.003; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gross JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055659; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; Hinaux H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053553; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kowalko JE, 2013, P NATL ACAD SCI USA, V110, P16933, DOI 10.1073/pnas.1317192110; Kowalko JE, 2013, CURR BIOL, V23, P1874, DOI 10.1016/j.cub.2013.07.056; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Li MH, 2013, ENDOCRINOLOGY, V154, P4814, DOI 10.1210/en.2013-1451; Liu JY, 2012, J GENET GENOMICS, V39, P209, DOI 10.1016/j.jgg.2012.04.003; Liu Y, 2014, METHODS; McCauley DW, 2004, EVOL DEV, V6, P209, DOI 10.1111/j.1525-142X.2004.04026.x; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Menuet A, 2007, DEVELOPMENT, V134, P845, DOI 10.1242/dev.02780; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; O'Quin KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057281; Parzefall J., 1991, MEM BIOSPEL, V18, P29; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Protas M, 2007, CURR BIOL, V17, P452, DOI 10.1016/j.cub.2007.01.051; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; ROSEMBLAT S, 1994, P NATL ACAD SCI USA, V91, P12071, DOI 10.1073/pnas.91.25.12071; SCHEMMEL C, 1980, Z TIERPSYCHOL, V53, P9; SCHEMMEL C, 1974, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V12, P196; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; TEYKE T, 1990, BRAIN BEHAV EVOLUT, V35, P23, DOI 10.1159/000115853; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; WILKENS H, 1988, EVOL BIOL, V23, P271; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yoshizawa M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-108; Yoshizawa M, 2010, CURR BIOL, V20, P1631, DOI 10.1016/j.cub.2010.07.017	58	33	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119370	10.1371/journal.pone.0119370	http://dx.doi.org/10.1371/journal.pone.0119370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774757	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500086
J	Vogl, S; Lutz, RW; Schonfelder, G; Lutz, WK				Vogl, Silvia; Lutz, Roman W.; Schoenfelder, Gilbert; Lutz, Werner K.			CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing-A Correlation Analysis Using Flurbiprofen as Probe Drug	PLOS ONE			English	Article							CYTOCHROME-P450 2C9; ALLELIC VARIANT; WARFARIN; POLYMORPHISMS; TOLBUTAMIDE; PHARMACOGENETICS; 4-HYDROXYLATION; ASSOCIATION; IMPACT; RISK	Currently, genotyping of patients for polymorphic enzymes responsible for metabolic elimination is considered a possibility to adjust drug dose levels. For a patient to profit from this procedure, the interindividual differences in drug metabolism within one genotype should be smaller than those between different genotypes. We studied a large cohort of healthy young adults (283 subjects), correlating their CYP2C9 genotype to a simple phenotyping metric, using flurbiprofen as probe drug. Genotyping was conducted for CYP2C9*1, *2, *3. The urinary metabolic ratio MR (concentration of CYP2C9-dependent metabolite divided by concentration of flurbiprofen) determined two hours after flurbiprofen (8.75 mg) administration served as phenotyping metric. Linear statistical models correlating genotype and phenotype provided highly significant allele-specific MR estimates of 0.596 for the wild type allele CYP2C9*1, 0.405 for CYP2C9*2 (68 % of wild type), and 0.113 for CYP2C9*3 (19 % of wild type). If these estimates were used for flurbiprofen dose adjustment, taking 100 % for genotype *1/*1, an average reduction to 84 %, 60 %, 68 %, 43 %, and 19% would result for genotype *1/*2, *1/*3, *2/*2, *2/*3, and *3/*3, respectively. Due to the large individual variation within genotypes with coefficients of variation >= 20% and supposing the normal distribution, one in three individuals would be out of the average optimum dose by more than 20 %, one in 20 would be 40% off. Whether this problem also applies to other CYPs and other drugs has to be investigated case by case. Our data for the given example, however, puts the benefit of individual drug dosing to question, if it is exclusively based on genotype.	[Vogl, Silvia; Schoenfelder, Gilbert; Lutz, Werner K.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Schoenfelder, Gilbert] Charite, Dept Clin Pharmacol & Toxicol, D-13353 Berlin, Germany; [Lutz, Roman W.] Swiss Fed Inst Technol, Seminar Stat, Zurich, Switzerland; [Schoenfelder, Gilbert] BfR Fed Inst Risk Assessment, Berlin, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; Federal Institute for Risk Assessment	Vogl, S (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany.	silvia.vogl@charite.de		Schonfelder, Gilbert/0000-0001-6134-1990				Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; Bosilkovska M, 2014, BASIC CLIN PHARMACOL, V115, P465, DOI 10.1111/bcpt.12231; Castellan AC, 2013, CLIN PHARMACOKINET, V52, P199, DOI 10.1007/s40262-013-0031-3; Conrado DJ, 2013, PHARMACOGENOMICS, V14, P215, DOI [10.2217/PGS.12.203, 10.2217/pgs.12.203]; Daali Y, 2012, CLIN PHARMACOL THER, V91, P489, DOI 10.1038/clpt.2011.247; Greenblatt DJ, 2006, J CLIN PHARMACOL, V46, P214, DOI 10.1177/0091270005283465; Greenblatt DJ, 2006, CLIN PHARMACOL THER, V79, P125, DOI 10.1016/j.clpt.2005.09.014; Herman D, 2005, PHARMACOGENOMICS J, V5, P193, DOI 10.1038/sj.tpj.6500308; Kirchheiner J, 2005, CLIN PHARMACOL THER, V77, P1, DOI 10.1016/j.clpt.2004.08.009; Kirchheiner J, 2002, PHARMACOGENETICS, V12, P101, DOI 10.1097/00008571-200203000-00004; Kirchheiner Julia, 2004, Per Med, V1, P63, DOI 10.1517/17410541.1.1.63; Lee CR, 2003, EUR J CLIN PHARMACOL, V58, P791, DOI 10.1007/s00228-003-0574-6; Lee CR, 2003, J CLIN PHARMACOL, V43, P84, DOI 10.1177/0091270002239710; MAGDALOU J, 1990, DRUG METAB DISPOS, V18, P692; Ramsden Diane, 2014, Drug Metab Dispos, V42, P1940, DOI 10.1124/dmd.114.057901; Sanderson S, 2005, GENET MED, V7, P97, DOI 10.1097/01.GIM.0000153664.65759.CF; Sistonen J, 2009, PHARMACOGENET GENOM, V19, P170, DOI 10.1097/FPC.0b013e32831ebb30; Stehle S, 2008, CLIN PHARMACOKINET, V47, P565, DOI 10.2165/00003088-200847090-00002; Subramanian M, 2010, DRUG METAB DISPOS, V38, P1003, DOI 10.1124/dmd.109.030155; Subramanian M, 2009, DRUG METAB DISPOS, V37, P1682, DOI 10.1124/dmd.109.026500; SullivanKlose TH, 1996, PHARMACOGENETICS, V6, P341, DOI 10.1097/00008571-199608000-00007; Temesvari M, 2012, J PHARMACOL EXP THER, V341, P294, DOI 10.1124/jpet.111.189597; Topic E, 2004, CLIN CHEM LAB MED, V42, P72, DOI 10.1515/CCLM.2004.014; TRACY TS, 1995, BIOCHEM PHARMACOL, V49, P1269, DOI 10.1016/0006-2952(95)00048-5; Tracy TS, 1996, BIOCHEM PHARMACOL, V52, P1305, DOI 10.1016/0006-2952(96)00501-1; Tracy TS, 2002, DRUG METAB DISPOS, V30, P385, DOI 10.1124/dmd.30.4.385; Verhoef TI, 2014, BRIT J CLIN PHARMACO, V77, P626, DOI 10.1111/bcp.12220; Wadelius M, 2004, PHARMACOGENOMICS J, V4, P40, DOI 10.1038/sj.tpj.6500220; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Yamazaki H, 1998, BIOCHEM PHARMACOL, V56, P243, DOI 10.1016/S0006-2952(98)00133-6; Zgheib NK, 2007, BRIT J CLIN PHARMACO, V63, P477, DOI 10.1111/j.1365-2125.2006.02781.x; Zgheib NK, 2006, CLIN PHARMACOL THER, V80, P257, DOI 10.1016/j.clpt.2006.06.005; Zhang SY, 2012, MOL PHARMACOL, V82, P529, DOI 10.1124/mol.112.078386; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302; Zhou SF, 2010, TOXICOLOGY, V278, P165, DOI 10.1016/j.tox.2009.08.013; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	36	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120403	10.1371/journal.pone.0120403	http://dx.doi.org/10.1371/journal.pone.0120403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775139	Green Published, gold			2022-12-26	WOS:000351183500170
J	Zhang, Q; Sun, TJ; Zhang, YL				Zhang, Qian; Sun, Tongjun; Zhang, Yuelin			ER Quality Control Components UGGT and STT3a Are Required for Activation of Defense Responses in Bir1-1	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; DEFECTIVE BRASSINOSTEROID RECEPTOR; ENDOPLASMIC-RETICULUM; INNATE IMMUNITY; PLANT IMMUNITY; ARABIDOPSIS; CHAPERONES; RESISTANCE; PROTEINS; BIOGENESIS	The receptor-like kinase SUPPRESSOR OF BIR1, 1 (SOBIR1) functions as a critical regulator in plant immunity. It is required for activation of cell death and defense responses in Arabidopsis bak1-interacting receptor-like kinase 1,1 (bir1-1) mutant plants. Here we report that the ER quality control component UDP-glucose:glycoprotein glucosyltransferase (UGGT) is required for the biogenesis of SOBIR1 and mutations in UGGT suppress the spontaneous cell death and constitutive defense responses in bir1-1. Loss of function of STT3a, which encodes a subunit of the oligosaccharyltransferase complex, also suppresses the autoimmune phenotype in bir1-1. However, it has no effect on the accumulation of SOBIR1, suggesting that additional signaling components other than SOBIR1 may be regulated by ER quality control. Our study provides clear evidence that ER quality control play critical roles in regulating defense activation in bir1-1.	[Zhang, Qian; Sun, Tongjun; Zhang, Yuelin] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Zhang, YL (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	yuelin.zhang@ubc.ca	Sun, Tongjun/AGV-6839-2022		Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca/index_eng.asp) provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Bi DL, 2010, PLANT PHYSIOL, V153, P1771, DOI 10.1104/pp.110.158501; Caplan JL, 2009, CELL HOST MICROBE, V6, P457, DOI 10.1016/j.chom.2009.10.005; Dejgaard S, 2004, CURR ISSUES MOL BIOL, V6, P29; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2014, MOL PLANT PATHOL, V15, P109, DOI 10.1111/mpp.12071; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; Liebrand TWH, 2012, PLANT PHYSIOL, V159, P1819, DOI 10.1104/pp.112.196741; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Sun TJ, 2014, PLANT J, V77, P748, DOI 10.1111/tpj.12425; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zhang YL, 2003, PLANT CELL, V15, P2647, DOI 10.1105/tpc.014894	20	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120245	10.1371/journal.pone.0120245	http://dx.doi.org/10.1371/journal.pone.0120245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775181	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500161
J	Matsuno, H; Ohi, K; Hashimoto, R; Yamamori, H; Yasuda, Y; Fujimoto, M; Yano-Umeda, S; Saneyoshi, T; Takeda, M; Hayashi, Y				Matsuno, Hitomi; Ohi, Kazutaka; Hashimoto, Ryota; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Yano-Umeda, Satomi; Saneyoshi, Takeo; Takeda, Masatoshi; Hayashi, Yasunori			A Naturally Occurring Null Variant of the NMDA Type Glutamate Receptor NR3B Subunit Is a Risk Factor of Schizophrenia	PLOS ONE			English	Article							ACOUSTIC STARTLE RESPONSE; HIGH-ACTIVITY ALLELE; GRIN1 GENE PROMOTER; SCHIZOTYPAL PERSONALITY; PREPULSE INHIBITION; CALCIUM PERMEABILITY; G1001C POLYMORPHISM; AMPA RECEPTORS; EXPRESSION; ASPARTATE	Hypofunction of the N-methyl-D-aspartate type glutamate receptor (NMDAR) has been implicated in the pathogenesis of schizophrenia. Here, we investigated the significance of a common human genetic variation of the NMDAR NR3B subunit that inserts 4 bases within the coding region (insCGTT) in the pathogenesis of schizophrenia. The cDNA carrying this polymorphism generates a truncated protein, which is electrophysiologically non-functional in heterologous expression systems. Among 586 schizophrenia patients and 754 healthy controls, insCGTT was significantly overrepresented in patients compared to controls (odds ratio = 1.37, p = 0.035). Among 121 schizophrenia patients and 372 healthy controls, genetic analyses of normal individuals revealed that those carrying insCGTT have a predisposition to schizotypal personality traits (F-1,F-356 = 4.69, p = 0.031). Furthermore, pre-pulse inhibition, a neurobiological trait disturbed in patients with schizophrenia, was significantly impaired in patients carrying insCGTT compared with those with the major allele (F-1,F-116 = 5.72, p = 0.018, F-1,F-238 = 4.46, p = 0.036, respectively). These results indicate that a naturally occurring null variant in NR3B could be a risk factor of schizophrenia.	[Matsuno, Hitomi; Saneyoshi, Takeo; Hayashi, Yasunori] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Ohi, Kazutaka; Hashimoto, Ryota; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka 5650871, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Osaka 5650871, Japan; [Yamamori, Hidenaga; Yano-Umeda, Satomi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka 5650871, Japan; [Hayashi, Yasunori] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan	RIKEN; Osaka University; Osaka University; Osaka University; Saitama University	Hashimoto, R (corresponding author), Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka 5650871, Japan.	hashimor@psy.med.osaka-u.ac.jp; yhayashi@brain.riken.jp	Hayashi, Yasunori/C-2249-2008; Hashimoto, Ryota/P-8572-2014; Saneyoshi, Takeo/AAF-5170-2019; Ohi, Kazutaka/J-7851-2019; Hashimoto, Ryota/AAE-3200-2019; Hayashi, Yasunori/AAF-1408-2019	Hayashi, Yasunori/0000-0002-7560-3004; Hashimoto, Ryota/0000-0002-5941-4238; Ohi, Kazutaka/0000-0001-9577-9640; Hashimoto, Ryota/0000-0002-5941-4238; Hayashi, Yasunori/0000-0002-7560-3004	RIKEN; National Institutes of Health [R21NS46421]; Ministry of Education, Culture, Sports, Science and Technology, Japan [90466037, 22110006, 22390225, 23659565, 221S0003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS046421] Funding Source: NIH RePORTER	RIKEN; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by RIKEN [to Y.H.]; National Institutes of Health grant [R21NS46421 to Y.H.]; Grant-in-Aid for Scientific Research A [grant number 90466037 to Y.H.]; Grant-in-Aid for Scientific Research on Innovative Area "Foundation of Synapse and Neurocircuit Pathology" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [22110006 to Y.H.]; a Grant-in-Aid for Scientific Research B [22390225 to R.H.]; Grant-in-Aid for Challenging Exploratory Research [23659565 to R.H.]; and Grant-in-Aid for Scientific Research on Innovative Areas "Comprehensive Brain Science Network" from the Ministry of Education, Culture, Sports, Science and Technology, Japan [221S0003 to R.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarian S, 1996, J NEUROSCI, V16, P19; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Andersson O, 2001, GENOMICS, V78, P178, DOI 10.1006/geno.2001.6666; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Avramopoulos D, 2002, MOL PSYCHIATR, V7, P706, DOI 10.1038/sj.mp.4001070; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Banno M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028929; Begni S, 2003, BIOL PSYCHIAT, V53, P617, DOI 10.1016/S0006-3223(02)01783-3; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Bendel O, 2005, NEUROSCI LETT, V377, P31, DOI 10.1016/j.neulet.2004.11.064; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Cioffi CL, 2013, BIOORG MED CHEM LETT, V23, P5034, DOI 10.1016/j.bmcl.2013.07.019; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fukaya M, 2005, EUR J NEUROSCI, V21, P1432, DOI 10.1111/j.1460-9568.2005.03957.x; Fukumori R, 2010, NEUROCHEM INT, V57, P730, DOI 10.1016/j.neuint.2010.08.009; Galehdari H, 2009, J MOL NEUROSCI, V38, P178, DOI 10.1007/s12031-008-9148-5; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hashimoto R, 2011, NEUROPSYCHOPHARMACOL, V36, P1921, DOI 10.1038/npp.2011.78; Hong LE, 2008, BIOL PSYCHIAT, V63, P17, DOI 10.1016/j.biopsych.2007.05.011; IIJIMA Y, 2010, KOUDOURYOUHOUKENKYU, V36, P29; INTERNATIONAL S, 2009, NATURE, V460, P748, DOI DOI 10.1038/NATURE08185; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Kircher T, 2009, PSYCHOL MED, V39, P1657, DOI 10.1017/S0033291709005388; Koide T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036836; Lin YT, 2014, PSYCHIAT RES, V218, P356, DOI 10.1016/j.psychres.2014.04.032; Low CM, 2010, MOL PHARMACOL, V78, P1, DOI 10.1124/mol.110.064006; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; Matsuda K, 2003, J NEUROSCI, V23, P10064; Matsuda K, 2002, MOL BRAIN RES, V100, P43, DOI 10.1016/S0169-328X(02)00173-0; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moriwaki M, 2009, NEUROSCI RES, V65, P259, DOI 10.1016/j.neures.2009.07.009; Niemann S, 2008, NEUROLOGY, V70, P666, DOI 10.1212/01.wnl.0000271078.51280.17; Niemann S, 2007, EUR J NEUROSCI, V26, P1407, DOI 10.1111/j.1460-9568.2007.05774.x; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pulay Attila J, 2009, Prim Care Companion J Clin Psychiatry, V11, P53; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Quednow BB, 2008, BIOL PSYCHIAT, V64, P434, DOI 10.1016/j.biopsych.2008.02.019; Quednow BB, 2010, SCHIZOPHRENIA BULL, V36, P341, DOI 10.1093/schbul/sbn088; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Riley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571; Schurhoff F, 2007, AM J MED GENET B, V144B, P64, DOI 10.1002/ajmg.b.30395; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smothers CT, 2009, J PHARMACOL EXP THER, V331, P975, DOI 10.1124/jpet.109.158493; Snyder MA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00031; Someya T, 1994, P 32 SCI M U HLTH CA, P286; Stefanis NC, 2007, BIOL PSYCHIAT, V62, P784, DOI 10.1016/j.biopsych.2006.11.015; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Takahashi H, 2008, NEUROSCI RES, V62, P187, DOI 10.1016/j.neures.2008.08.006; Takahashi H, 2010, PSYCHOPHYSIOLOGY, V47, P831, DOI 10.1111/j.1469-8986.2010.01000.x; Takata A, 2013, BIOL PSYCHIAT, V73, P532, DOI 10.1016/j.biopsych.2012.10.024; Tarabeux J, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.52; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wee KSL, 2008, J COMP NEUROL, V509, P118, DOI 10.1002/cne.21747; Wee KSL, 2010, NEUROCHEM INT, V57, P97, DOI 10.1016/j.neuint.2010.05.003; Yasuda Y, 2011, NEUROSCI LETT, V495, P216, DOI 10.1016/j.neulet.2011.03.069	64	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116319	10.1371/journal.pone.0116319	http://dx.doi.org/10.1371/journal.pone.0116319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768306	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500007
J	Bronchalo-Vicente, L; Rodriguez-Del Rio, E; Freire, J; Calderon-Gonzalez, R; Frande-Cabanes, E; Gomez-Roman, JJ; Fernandez-Llaca, H; Yanez-Diaz, S; Alvarez-Dominguez, C				Bronchalo-Vicente, Lucia; Rodriguez-Del Rio, Estela; Freire, Javier; Calderon-Gonzalez, Ricardo; Frande-Cabanes, Elisabet; Javier Gomez-Roman, Jose; Fernandez-Llaca, Hector; Yanez-Diaz, Sonsoles; Alvarez-Dominguez, Carmen			A Novel Therapy for Melanoma Developed in Mice: Transformation of Melanoma into Dendritic Cells with Listeria monocytogenes	PLOS ONE			English	Article							ANTIGEN-EXPRESSION; ENHANCEMENT; VACCINATION; INFECTION; RESPONSES; EPITOPES; VACCINES	Listeria monocytogenes is a gram-positive bacteria and human pathogen widely used in cancer immunotherapy because of its capacity to induce a specific cytotoxic T cell response in tumours. This bacterial pathogen strongly induces innate and specific immunity with the potential to overcome tumour induced tolerance and weak immunogenicity. Here, we propose a Listeria based vaccination for melanoma based in its tropism for these tumour cells and its ability to transform in vitro and in vivo melanoma cells into matured and activated dendritic cells with competent microbicidal and antigen processing abilities. This Listeria based vaccination using low doses of the pathogen caused melanoma regression by apoptosis as well as bacterial clearance. Vaccination efficacy is LLO dependent and implies the reduction of LLO-specific CD4+ T cell responses, strong stimulation of innate pro-inflammatory immune cells and a prevalence of LLO-specific CD8+ T cells involved in tumour regression and Listeria elimination. These results support the use of low doses of pathogenic Listeria as safe melanoma therapeutic vaccines that do not require antibiotics for bacterial removal.	[Bronchalo-Vicente, Lucia; Rodriguez-Del Rio, Estela; Calderon-Gonzalez, Ricardo; Frande-Cabanes, Elisabet; Yanez-Diaz, Sonsoles; Alvarez-Dominguez, Carmen] Inst Invest Marques Valdecilla IDIVAL, Grp Genom Proteom & Vacunas, Santander, Spain; [Bronchalo-Vicente, Lucia; Fernandez-Llaca, Hector; Yanez-Diaz, Sonsoles] Hosp Univ Marques Valdecilla, Serv Dermatol, Santander, Spain; [Freire, Javier; Javier Gomez-Roman, Jose] Hosp Univ Marques Valdecilla, Serv Anat Patol, Santander, Cantabria, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Alvarez-Dominguez, C (corresponding author), Inst Invest Marques Valdecilla IDIVAL, Grp Genom Proteom & Vacunas, Santander, Spain.	calvarez@humv.es	Alvarez-Dominguez, Carmen/J-4675-2014; José Javier, Gómez-Román/AAC-8156-2021; González, Ricardo Calderón/N-6863-2013; Frande-Cabanes, Elisabet/F-9889-2016	Alvarez-Dominguez, Carmen/0000-0002-4585-6959; José Javier, Gómez-Román/0000-0002-2849-9435; González, Ricardo Calderón/0000-0003-0841-3814; Frande-Cabanes, Elisabet/0000-0003-1748-0584	 [SAF2009-08695];  [SAF2012-34203]	; 	This work was supported by grants SAF2009-08695 and SAF2012-34203. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-4; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Boyano Maria Dolores, 1998, Invasion and Metastasis, V18, P122, DOI 10.1159/000024505; BOYANO MD, 1994, PATHOBIOLOGY, V62, P186, DOI 10.1159/000163909; Calderon-Gonzalez R, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00022; Carrasco-Marin E, 2012, J BIOL CHEM, V287, P14310, DOI 10.1074/jbc.M112.348615; Carrasco-Marin E, 2011, J BIOL CHEM, V286, P3332, DOI 10.1074/jbc.M110.146761; Coley W B, 1910, Proc R Soc Med, V3, P1; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Elkadi OA, 2013, MED HYPOTHESES, V81, P207, DOI 10.1016/j.mehy.2013.05.001; Forschner A, 2004, CLIN MICROBIOL INFEC, V10, P86, DOI 10.1111/j.1469-0691.2004.00808.x; Frande-Cabanes E, 2014, GLIA, V62, P233, DOI 10.1002/glia.22602; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gonzalez A, 1992, 21 NAT C DERM VEN LA; Gonzalez-Vela MC, 2008, ACTA DERM-VENEREOL, V88, P92, DOI 10.2340/00015555-0334; Guirnalda PD, 2012, ONCOIMMUNOLOGY, V1, P822, DOI 10.4161/onci.20491; Kim SH, 2009, CANCER RES, V69, P5860, DOI 10.1158/0008-5472.CAN-08-4855; Klarquist JS, 2012, ONCOIMMUNOLOGY, V1, P1584, DOI 10.4161/onci.22660; Kono M, 2012, VACCINE, V30, P2633, DOI 10.1016/j.vaccine.2012.02.026; Maciag PC, 2009, VACCINE, V27, P3975, DOI 10.1016/j.vaccine.2009.04.041; Mitchell LM, 2011, CELL IMMUNOL, V268, P79, DOI 10.1016/j.cellimm.2011.03.001; Oshita C, 2012, ONCOL REP, V28, P1131, DOI 10.3892/or.2012.1956; Pan ZK, 1999, CANCER RES, V59, P5264; Patyar S, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-21; Prevost G, 2003, CURR OPIN INFECT DIS, V16, P71, DOI 10.1097/00001432-200304000-00002; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; Shahabi Vafa, 2010, Bioeng Bugs, V1, P235, DOI 10.4161/bbug.1.4.11243; Skoberne M, 2008, J CLIN INVEST, V118, P3990, DOI 10.1172/JCI31350; Wood LM, 2008, IMMUNOL RES, V42, P233, DOI 10.1007/s12026-008-8087-0; ZALOUDIK J, 1988, J CLIN PATHOL, V41, P1078, DOI 10.1136/jcp.41.10.1078; Zelenik K, 2014, ZOONOSES PUBLIC HLTH, V61, P238, DOI 10.1111/zph.12075	31	11	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117923	10.1371/journal.pone.0117923	http://dx.doi.org/10.1371/journal.pone.0117923			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760947	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275000014
J	Damodaran, SP; Eberhard, S; Boitard, L; Rodriguez, JG; Wang, Y; Bremond, N; Baudry, J; Bibette, J; Wollman, FA				Damodaran, Shima P.; Eberhard, Stephan; Boitard, Laurent; Rodriguez, Jairo Garnica; Wang, Yuxing; Bremond, Nicolas; Baudry, Jean; Bibette, Jerome; Wollman, Francis-Andre			A Millifluidic Study of Cell-to-Cell Heterogeneity in Growth-Rate and Cell-Division Capability in Populations of Isogenic Cells of Chlamydomonas reinhardtii	PLOS ONE			English	Article							SINGLE-CELL; ESCHERICHIA-COLI; GENE-EXPRESSION; ENVIRONMENTAL MICROBIOLOGY; NONGENETIC HETEROGENEITY; SACCHAROMYCES-CEREVISIAE; BACTERIAL PERSISTENCE; GENOME INSTABILITY; FLOW-CYTOMETRY; FISSION YEAST	To address possible cell-to-cell heterogeneity in growth dynamics of isogenic cell populations of Chlamydomonas reinhardtii, we developed a millifluidic drop-based device that not only allows the analysis of populations grown from single cells over periods of a week, but is also able to sort and collect drops of interest, containing viable and healthy cells, which can be used for further experimentation. In this study, we used isogenic algal cells that were first synchronized in mixotrophic growth conditions. We show that these synchronized cells, when placed in droplets and kept in mixotrophic growth conditions, exhibit mostly homogeneous growth statistics, but with two distinct subpopulations: a major population with a short doubling-time (fast-growers) and a significant subpopulation of slowly dividing cells (slow-growers). These observations suggest that algal cells from an isogenic population may be present in either of two states, a state of restricted division and a state of active division. When isogenic cells were allowed to propagate for about 1000 generations on solid agar plates, they displayed an increased heterogeneity in their growth dynamics. Although we could still identify the original populations of slow-and fast-growers, drops inoculated with a single progenitor cell now displayed a wider diversity of doubling-times. Moreover, populations dividing with the same growth-rate often reached different cell numbers in stationary phase, suggesting that the progenitor cells differed in the number of cell divisions they could undertake. We discuss possible explanations for these cell-to-cell heterogeneities in growth dynamics, such as mutations, differential aging or stochastic variations in metabolites and macromolecules yielding molecular switches, in the light of single-cell heterogeneities that have been reported among isogenic populations of other eu- and prokaryotes.	[Damodaran, Shima P.; Boitard, Laurent; Rodriguez, Jairo Garnica; Wang, Yuxing; Bremond, Nicolas; Baudry, Jean; Bibette, Jerome] PSL Res Univ, ParisTech, CNRS,UMR 8231, Inst Chem Biol & Innovat ESPCI,Lab Colloides & Ma, Paris, France; [Eberhard, Stephan; Wollman, Francis-Andre] UPMC, CNRS, Inst Biol Phys Chim, Lab Physiol Membranaire & Mol Chloroplaste, Paris, France; [Wang, Yuxing] Shanghai Jiao Tong Univ, Opt Sci & Engn Res Ctr, Dept Phys & Astron, Shanghai 200030, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Shanghai Jiao Tong University	Bibette, J (corresponding author), PSL Res Univ, ParisTech, CNRS,UMR 8231, Inst Chem Biol & Innovat ESPCI,Lab Colloides & Ma, Paris, France.	jerome.bibette@espci.fr; wollman@ibpc.fr	Baudry, Jean/A-7344-2016; Damodaran, Shima P/D-3737-2019; Baudry, Jean/AAX-6267-2020	Baudry, Jean/0000-0002-5526-499X; Damodaran, Shima P/0000-0002-7344-3545; Baudry, Jean/0000-0002-5526-499X; Eberhard, Stephan/0000-0002-1445-3110; Bremond, Nicolas/0000-0003-3724-7050	Unite Mixte de Recherche [7141]; CNRS; Universite Pierre et Marie Curie, Paris 06; DEFI CNRS Milli_Oil project; Agence Nationale de la Recherche (ANR) [13-BSV7-0001-01]; "Initiative d'Excellence" program [ANR-11-LABX-0011-01]; Fondation Pierre-Gilles de Gennes pour la Recherche [FPGG035]	Unite Mixte de Recherche; CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie, Paris 06; DEFI CNRS Milli_Oil project; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); "Initiative d'Excellence" program; Fondation Pierre-Gilles de Gennes pour la Recherche	This work was supported by Unite Mixte de Recherche 7141, CNRS and Universite Pierre et Marie Curie, Paris 06, by the DEFI CNRS Milli_Oil project, by the Agence Nationale de la Recherche (ANR) contract 13-BSV7-0001-01, by the "Initiative d'Excellence" program (Grant "DYNAMO," ANR-11-LABX-0011-01), and by Fondation Pierre-Gilles de Gennes pour la Recherche contract FPGG035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Bae S, 2013, ANAL BIOANAL CHEM, V405, P9365, DOI 10.1007/s00216-013-7389-9; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Blaby IK, 2014, TRENDS PLANT SCI; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Boitard L, 2012, P NATL ACAD SCI USA, V109, P7181, DOI 10.1073/pnas.1200894109; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capp JP, 2010, GENETICS, V185, P395, DOI 10.1534/genetics.110.118190; Claudi B, 2014, CELL, V158, P722, DOI 10.1016/j.cell.2014.06.045; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cooper VS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001790; Czechowska K, 2008, CURR OPIN MICROBIOL, V11, P205, DOI 10.1016/j.mib.2008.04.006; DEMETS R, 1985, J GEN MICROBIOL, V131, P2919; Dewan A, 2012, BIOTECHNOL BIOENG, V109, P2987, DOI 10.1002/bit.24568; Dichosa AEK, 2014, NAT PROTOC, V9, P608, DOI 10.1038/nprot.2014.034; Eberhard S, 2008, ANNU REV GENET, V42, P463, DOI 10.1146/annurev.genet.42.110807.091452; Esquivel MG, 2011, TRENDS BIOTECHNOL, V29, P595, DOI 10.1016/j.tibtech.2011.06.008; Eun YJ, 2011, ACS CHEM BIOL, V6, P260, DOI 10.1021/cb100336p; Fischer BB, 2006, PLANT CELL PHYSIOL, V47, P1135, DOI 10.1093/pcp/pcj085; Flatscher R, 2012, GENET RES INT, V2012, DOI 10.1155/2012/698421; Fulneckova J, 2013, GENOME BIOL EVOL, V5, P468, DOI 10.1093/gbe/evt019; Garay LA, 2014, J AGR FOOD CHEM; Garz A, 2012, BIOPHYS J, V103, P1078, DOI 10.1016/j.bpj.2012.07.026; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Ghosh S, 2014, CURR OPIN GENET DEV, V26, P41, DOI 10.1016/j.gde.2014.05.003; Ghysels B, 2010, PHOTOSYNTH RES, V106, P145, DOI 10.1007/s11120-010-9582-4; Gimpel JA, 2013, CURR OPIN CHEM BIOL, V17, P489, DOI 10.1016/j.cbpa.2013.03.038; Grossman AR, 2000, CURR OPIN PLANT BIOL, V3, P132, DOI 10.1016/S1369-5266(99)00053-9; Grossman AR, 2003, EUKARYOT CELL, V2, P1137, DOI 10.1128/EC.2.6.1137-1150.2003; Grunberger A, 2014, CURR OPIN BIOTECH, V29, P15, DOI 10.1016/j.copbio.2014.02.008; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; HAILS T, 1995, CURR GENET, V28, P437, DOI 10.1007/BF00310812; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Helaine S, 2013, CURR OPIN MICROBIOL, V16, P184, DOI 10.1016/j.mib.2012.12.004; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; Hippler M, 1998, BBA-BIOENERGETICS, V1367, P1, DOI 10.1016/S0005-2728(98)00136-4; Hoeck C, 1995, ALGAE INTRO PHYCOLOG; Hofer U, 2013, NAT REV MICROBIOL, V11, P598, DOI 10.1038/nrmicro3095; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Joers A, 2010, J BACTERIOL, V192, P3379, DOI 10.1128/JB.00056-10; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; Kursten D, 2011, ENG LIFE SCI, V11, P580, DOI 10.1002/elsc.201100023; Kupiec M, 2014, FEMS MICROBIOL REV, V38, P144, DOI 10.1111/1574-6976.12054; Lee DH, 2013, ANAL CHEM, V85, P8749, DOI 10.1021/ac401836j; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Lemaire SD, 1999, EUR J PHYCOL, V34, P279, DOI 10.1080/09670269910001736332; Leon R, 2007, TRANSGENIC MICROALGA; Levchenko A, 2014, CURR OPIN BIOTECH, V28, P156, DOI 10.1016/j.copbio.2014.05.002; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/nchembio.436, 10.1038/NCHEMBIO.436]; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Longo VD, 2012, SUBCELL BIOCHEM, V57, P101, DOI 10.1007/978-94-007-2561-4_5; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Maklakov AA, 2013, CURR BIOL, V23, pR1003, DOI 10.1016/j.cub.2013.10.002; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; Mason PJ, 2013, TRANSL RES, V162, P333, DOI 10.1016/j.trsl.2013.08.009; Matsumura Kazunori, 2010, Journal of Nanobiotechnology, V8, P23, DOI 10.1186/1477-3155-8-23; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Misumi O, 2001, J PLANT RES, V114, P125, DOI 10.1007/PL00013975; Morgan AD, 2014, SPONTANEOUS MUTATION; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Ness RW, 2012, GENETICS, V192, P1447, DOI 10.1534/genetics.112.145078; Pan J, 2011, INTEGR BIOL-UK, V3, P1043, DOI 10.1039/c1ib00033k; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan Y, 2011, EXP GERONTOL, V46, P847, DOI 10.1016/j.exger.2011.08.007; Perrineau MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092533; PETRACEK ME, 1990, P NATL ACAD SCI USA, V87, P8222, DOI 10.1073/pnas.87.21.8222; PETRACEK ME, 1994, EMBO J, V13, P3648, DOI 10.1002/j.1460-2075.1994.tb06672.x; PETRACEK ME, 1992, NUCLEIC ACIDS RES, V20, P89, DOI 10.1093/nar/20.1.89; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Rando TA, 2013, ANNU REV PHYSIOL, V75, P617, DOI 10.1146/annurev-physiol-092712-103439; Rang CU, 2011, CURR BIOL, V21, P1813, DOI 10.1016/j.cub.2011.09.018; Ratcliff WC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3742; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Richmond A, 2008, HDB MICROALGAL CULTU; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rochaix JD, 2002, PHOTOSYNTH RES, V73, P285, DOI 10.1023/A:1020484105601; Rochaix JD, 1995, ANNU REV GENET, V29, P209, DOI 10.1146/annurev.ge.29.120195.001233; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Rupprecht J, 2009, J BIOTECHNOL, V142, P10, DOI 10.1016/j.jbiotec.2009.02.008; Saeed H, 2013, J BIOSCIENCES, V38, P641, DOI 10.1007/s12038-013-9346-3; Sanchez A, 2013, ANNU REV BIOPHYS, V42, P469, DOI 10.1146/annurev-biophys-083012-130401; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Silflow CD, 2001, PLANT PHYSIOL, V127, P1500, DOI 10.1104/pp.127.4.1500; Skjanes K, 2013, CRIT REV BIOTECHNOL, V33, P172, DOI 10.3109/07388551.2012.681625; Skommer J, 2011, FRONT BIOSCI-LANDMRK, V16, P307, DOI 10.2741/3689; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Specht EA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00060; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; SPUDICH JL, 1980, J CELL BIOL, V85, P136, DOI 10.1083/jcb.85.1.136; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stepanauskas R, 2012, CURR OPIN MICROBIOL, V15, P613, DOI 10.1016/j.mib.2012.09.001; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Strenkert D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-35; Strenkert D, 2011, PLANT CELL, V23, P2285, DOI 10.1105/tpc.111.085266; Strovas TJ, 2007, J BACTERIOL, V189, P7127, DOI 10.1128/JB.00746-07; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; Vachova L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/601836; Velmurugan N, 2013, BIORESOURCE TECHNOL, V138, P30, DOI 10.1016/j.biortech.2013.03.078; Vijg J, 2013, ANNU REV PHYSIOL, V75, P645, DOI 10.1146/annurev-physiol-030212-183715; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682; Wu B, 2014, J THEOR BIOL, V347, P1, DOI 10.1016/j.jtbi.2013.12.001; Wu JC, 2013, BIOTECHNOL ADV, V31, P1047, DOI 10.1016/j.biotechadv.2013.09.001; Yin HB, 2012, CURR OPIN BIOTECH, V23, P110, DOI 10.1016/j.copbio.2011.11.002; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91	124	36	37	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118987	10.1371/journal.pone.0118987	http://dx.doi.org/10.1371/journal.pone.0118987			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760649	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000045
J	Neumann, B; Vafeidis, AT; Zimmermann, J; Nicholls, RJ				Neumann, Barbara; Vafeidis, Athanasios T.; Zimmermann, Juliane; Nicholls, Robert J.			Future Coastal Population Growth and Exposure to Sea-Level Rise and Coastal Flooding - A Global Assessment	PLOS ONE			English	Article							CLIMATE-CHANGE; PORT CITIES; SCENARIOS; IMPACT; 21ST-CENTURY; PROJECTIONS; MIGRATION; LOSSES	Coastal zones are exposed to a range of coastal hazards including sea-level rise with its related effects. At the same time, they are more densely populated than the hinterland and exhibit higher rates of population growth and urbanisation. As this trend is expected to continue into the future, we investigate how coastal populations will be affected by such impacts at global and regional scales by the years 2030 and 2060. Starting from baseline population estimates for the year 2000, we assess future population change in the low-elevation coastal zone and trends in exposure to 100-year coastal floods based on four different sea-level and socio-economic scenarios. Our method accounts for differential growth of coastal areas against the land-locked hinterland and for trends of urbanisation and expansive urban growth, as currently observed, but does not explicitly consider possible displacement or out-migration due to factors such as sea-level rise. We combine spatially explicit estimates of the baseline population with demographic data in order to derive scenario-driven projections of coastal population development. Our scenarios show that the number of people living in the low-elevation coastal zone, as well as the number of people exposed to flooding from 1-in-100 year storm surge events, is highest in Asia. China, India, Bangladesh, Indonesia and Viet Nam are estimated to have the highest total coastal population exposure in the baseline year and this ranking is expected to remain largely unchanged in the future. However, Africa is expected to experience the highest rates of population growth and urbanisation in the coastal zone, particularly in Egypt and sub-Saharan countries in Western and Eastern Africa. The results highlight countries and regions with a high degree of exposure to coastal flooding and help identifying regions where policies and adaptive planning for building resilient coastal communities are not only desirable but essential. Furthermore, we identify needs for further research and scope for improvement in this kind of scenario-based exposure analysis.	[Neumann, Barbara; Vafeidis, Athanasios T.; Zimmermann, Juliane] Univ Kiel, Inst Geog, Kiel, Germany; [Nicholls, Robert J.] Univ Southampton, Fac Engn Environm, Southampton, Hants, England; [Nicholls, Robert J.] Univ Southampton, Tyndall Ctr Climate Change Res, Southampton, Hants, England	University of Kiel; University of Southampton; University of Southampton	Neumann, B (corresponding author), Univ Kiel, Inst Geog, Kiel, Germany.	neumann@geographie.uni-kiel.de	Nicholls, Robert James/ABD-1481-2020; Vafeidis, Athanasios Thomas/Z-6053-2019; Neumann, Barbara/B-5232-2009; Nicholls, Robert James/G-3898-2010	Nicholls, Robert James/0000-0002-9715-1109; Vafeidis, Athanasios Thomas/0000-0002-3906-5544; Neumann, Barbara/0000-0003-0015-2314; Nicholls, Robert James/0000-0002-9715-1109	UK Government Office for Science; German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean"	UK Government Office for Science; German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean"(German Research Foundation (DFG))	Financial support has been provided by the UK Government Office for Science and by the German Science Foundation (DFG) via the Kiel Cluster of Excellence "The Future Ocean". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk D., 2009, POPULATION DYNAMICS, P80; Balk D., 2009, POPULATION DYNAMICS, P206; Black R, 2011, GLOBAL ENVIRON CHANG, V21, pS3, DOI 10.1016/j.gloenvcha.2011.10.001; Brown S., 2013, COASTAL HAZARDS, P117, DOI [10.1007/978-94-007-5234-4, DOI 10.1007/978-94-007-5234-4_5]; [Center for International Earth Science Information Network (CIESIN) Columbia University Centro Internacional de Agricultura Tropical (CIAT)], 2005, GRIDD POP WORLD VERS; Center for International Earth Science Information Network-CIESIN-Columbia University International Food Policy Research Institute-IFPRI, 2004, GLOB RUR URB MAPP PR; Church, 2010, UNDERSTANDING SEA LE, P17, DOI [10.1002/9781444323276.ch2, DOI 10.1002/9781444323276.CH2]; Church JA, 2013, CLIMATECHANGE 2013 P; Curtis KJ, 2011, POPUL ENVIRON, V33, P28, DOI 10.1007/s11111-011-0136-2; Dasgupta S, 2011, CLIMATIC CHANGE, V106, P567, DOI 10.1007/s10584-010-9959-6; Dasgupta S, 2009, CLIMATIC CHANGE, V93, P379, DOI 10.1007/s10584-008-9499-5; de Sherbinin A, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045602; Ericson JP, 2006, GLOBAL PLANET CHANGE, V50, P63, DOI 10.1016/j.gloplacha.2005.07.004; ESRI, 2008, ESRI DAT MAPS 9 3; Esteban M, 2013, INT J DISAST RISK RE, V5, P84, DOI 10.1016/j.ijdrr.2013.07.002; Foresight, 2011, MIGR GLOB ENV CHANG; Fragkias M, 2012, GLOBAL CHANGE MAGAZI, V78, P16; Gaffin SR, 2004, GLOBAL ENVIRON CHANG, V14, P105, DOI 10.1016/j.gloenvcha.2004.02.004; Gerland P, 2014, SCIENCE, V346, P234, DOI 10.1126/science.1257469; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hallegatte S, 2011, CLIMATIC CHANGE, V104, P1, DOI 10.1007/s10584-010-9981-8; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; Hijmans R, 2008, GLOBAL ADM AREAS GAD; Hinkel J, 2011, REG ENV CHANG, V12, P1; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Hinkel J, 2010, MITIG ADAPT STRAT GL, V15, P703, DOI 10.1007/s11027-010-9237-y; Hugo G, 2011, GLOBAL ENVIRON CHANG, V21, pS21, DOI 10.1016/j.gloenvcha.2011.09.008; IPCC, 2012, MAN RISKS EXTR EV DI; ISciences L.L.C, 2003, ENH GLOB MAP EL SLOP; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Lichter M, 2011, J COASTAL RES, V27, P757, DOI 10.2112/JCOASTRES-D-10-00072.1; Lindeboom H., 2005, GLO CH IGBP, P1, DOI 10.1007/3-540-27851-6_1; Lutz W, 2014, SCIENCE, V346, P560, DOI 10.1126/science.346.6209.561-a; Lutz W, 2010, PHILOS T R SOC B, V365, P2779, DOI 10.1098/rstb.2010.0133; Maloney MC, 2014, CLIMATE RISK MANAGEM, V2, P26, DOI [10.5339/gcsp.2014.20, DOI 10.5339/GCSP.2014.20]; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Mcleod E, 2010, SUSTAIN SCI, V5, P207, DOI 10.1007/s11625-010-0105-1; Mimura N, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P687; Mondal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048191; Nicholls RJ, 1999, GLOBAL ENVIRON CHANG, V9, pS69, DOI 10.1016/S0959-3780(99)00019-9; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Nicholls RJ, 2014, METRICS ASSESSING EC; Nicholls RJ, 2008, CLIMATIC CHANGE, V91, P171, DOI 10.1007/s10584-008-9424-y; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; Nicholls RJ, 2010, SCIENCE, V328, P1517, DOI 10.1126/science.1185782; Nicholls RJ, 2008, SUSTAIN SCI, V3, P89, DOI 10.1007/s11625-008-0050-4; OECD, 2010, CIT CLIM CHANG; Patterson M., 2008, ECOLOGICAL EC OCEANS, P187; Potere D, 2007, GEOJOURNAL, V69, P55, DOI 10.1007/s10708-007-9102-z; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Salvatore M., 2005, MAPPING GLOBAL URBAN; Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Seto KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023777; Seto KC, 2011, GLOBAL ENVIRON CHANG, V21, pS94, DOI 10.1016/j.gloenvcha.2011.08.005; Seto KC, 2010, ANNU REV ENV RESOUR, V35, P167, DOI 10.1146/annurev-environ-100809-125336; Small C, 2003, J COASTAL RES, V19, P584; Smith K, 2011, NAT CLIM CHANGE, V1, P331; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Tacoli  C., 2009, POPULATION DYNAMICS, P104; The Government Office for Science, 2011, MIGR GLOB ENV CHANG; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2011, ESAPWP220 UN; United Nations, 2010, 12 UN DEP EC SOC AFF; Vafeidis A, 2011, MR9 ANAL LAND AREA P; Vafeidis AT, 2005, DIVA DATABASE DOCUME; Vafeidis AT, 2008, J COASTAL RES, V24, P917, DOI 10.2112/06-0725.1; Visbeck M, 2014, MAR POLICY, V48, P184, DOI 10.1016/j.marpol.2014.03.005; Warner K, 2010, GLOBAL ENVIRON CHANG, V20, P402, DOI 10.1016/j.gloenvcha.2009.12.001; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Woodroffe C. D, 2002, COASTS FORM PROCESS	75	1073	1081	47	525	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118571	10.1371/journal.pone.0118571	http://dx.doi.org/10.1371/journal.pone.0118571			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760037	gold, Green Accepted, Green Published			2022-12-26	WOS:000351275000029
J	Warrener, AG; Lewton, KL; Pontzer, H; Lieberman, DE				Warrener, Anna G.; Lewton, Kristi L.; Pontzer, Herman; Lieberman, Daniel E.			A Wider Pelvis Does Not Increase Locomotor Cost in Humans, with Implications for the Evolution of Childbirth	PLOS ONE			English	Article							ENERGY-COST; METABOLIC COST; BRAIN SIZE; BODY-MASS; BIRTH; ENCEPHALIZATION; WALKING; MEN; PLEISTOCENE; ENERGETICS	The shape of the human female pelvis is thought to reflect an evolutionary trade-off between two competing demands: a pelvis wide enough to permit the birth of large-brained infants, and narrow enough for efficient bipedal locomotion. This trade-off, known as the obstetrical dilemma, is invoked to explain the relative difficulty of human childbirth and differences in locomotor performance between men and women. The basis for the obstetrical dilemma is a standard static biomechanical model that predicts wider pelves in females increase the metabolic cost of locomotion by decreasing the effective mechanical advantage of the hip abductor muscles for pelvic stabilization during the single-leg support phase of walking and running, requiring these muscles to produce more force. Here we experimentally test this model against a more accurate dynamic model of hip abductor mechanics in men and women. The results show that pelvic width does not predict hip abductor mechanics or locomotor cost in either women or men, and that women and men are equally efficient at both walking and running. Since a wider birth canal does not increase a woman's locomotor cost, and because selection for successful birthing must be strong, other factors affecting maternal pelvic and fetal size should be investigated in order to help explain the prevalence of birth complications caused by a neonate too large to fit through the birth canal.	[Warrener, Anna G.; Lieberman, Daniel E.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Lewton, Kristi L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Pontzer, Herman] Hunter Coll, Dept Anthropol, New York, NY 10065 USA	Harvard University; Boston University; City University of New York (CUNY) System; Hunter College (CUNY)	Warrener, AG (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Div Ave, Cambridge, MA 02138 USA.	awarrener@fas.harvard.edu	Lewton, Kristi/AAC-2766-2022; Warrener, Anna/AAC-5225-2020	Lewton, Kristi/0000-0003-0674-2454; Pontzer, Herman/0000-0003-2397-6543	National Science Foundation; BSN [0850841]; Leakey Foundation; Wenner-Gren Foundation	National Science Foundation(National Science Foundation (NSF)); BSN; Leakey Foundation; Wenner-Gren Foundation	This research was supported by grants from the National Science Foundation (www.nsf.gov), BSN # 0850841, The Leakey Foundation (www.leakeyfoundation.org) and The Wenner-Gren Foundation (www.wennergren.org). Grants were obtained by AGW. Institutional support was provided by Washington University in St. Louis and obtained by AGW and HP. Institutional support for Harvard University was obtained by DEL and KLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano CJ, 2012, J APPL PHYSIOL, V112, P427, DOI 10.1152/japplphysiol.00554.2011; Arsuaga JL, 1999, NATURE, V399, P255, DOI 10.1038/20430; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BOURDIN M, 1993, EUR J APPL PHYSIOL O, V66, P439, DOI 10.1007/BF00599618; Briese V, 2010, HOMO, V61, P64, DOI 10.1016/j.jchb.2009.11.002; Brown KM, 2013, INT UROGYNECOL J, V24, P431, DOI 10.1007/s00192-012-1876-y; Brown KM., 2012, THESIS J HOPKINS U; BUNC V, 1989, EUR J APPL PHYSIOL, V59, P178, DOI 10.1007/BF02386184; Correia H, 2005, HOMO, V56, P153, DOI 10.1016/j.jchb.2005.05.003; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; DeSilva JM, 2008, J HUM EVOL, V55, P1064, DOI 10.1016/j.jhevol.2008.07.008; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; Grabowski MW, 2013, EVOL BIOL, V40, P57, DOI 10.1007/s11692-012-9174-7; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hilton CE, 2008, CURR ANTHROPOL, V49, P144, DOI 10.1086/524760; HOLM S, 1979, SCAND J STAT, V6, P65; INMAN VT, 1947, J BONE JOINT SURG, V29, P607; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kurki HK, 2007, AM J PHYS ANTHROPOL, V133, P1152, DOI 10.1002/ajpa.20636; Kurki HK, 2011, INT J PALEOPATHOL, V1, P138, DOI 10.1016/j.ijpp.2011.10.004; Larkin JC, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.068; LEUTENEGGER W, 1974, J HUM EVOL, V3, P207, DOI 10.1016/0047-2484(74)90179-1; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; LOVEJOY CO, 1973, AM J PHYS ANTHROPOL, V38, P757, DOI 10.1002/ajpa.1330380315; Marlowe FW, 2010, THE HADZA; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P79, DOI 10.1002/ajpa.1330680108; MERCHANT AC, 1965, J BONE JOINT SURG AM, VA 47, P462, DOI 10.2106/00004623-196547030-00003; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; MILLER JF, 1987, J APPL PHYSIOL, V62, P1497, DOI 10.1152/jappl.1987.62.4.1497; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nuger RL., 2008, THESIS CITY U NEW YO; O'Brien TD, 2010, EXP PHYSIOL, V95, P202, DOI 10.1113/expphysiol.2009.048967; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Pontzer H, 2005, J EXP BIOL, V208, P1513, DOI 10.1242/jeb.01549; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rightmire GP, 2004, AM J PHYS ANTHROPOL, V124, P109, DOI 10.1002/ajpa.10346; Roberston D.G., 2004, RES METHODS BIOMECHA, P143; Roberts TJ, 1998, J EXP BIOL, V201, P2745; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; Rosenberg KR., 1994, AM J PHYS ANTHROPOL, V35, P89; Rubenson J, 2007, J EXP BIOL, V210, P3513, DOI 10.1242/jeb.000992; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Larsen CS, 2006, QUATERN INT, V150, P12, DOI 10.1016/j.quaint.2006.01.004; Stalberg K, 2012, ACTA OBSTET GYNECOL, V85, P821; Strickland SS, 2010, NOMADIC PEOPLES, V33, P231; Thibault V, 2010, J SPORT SCI MED, V9, P214; Voigt M, 2008, Z Geburtshilfe Neonatol, V212, P201, DOI 10.1055/s-2008-1076995; Walrath D, 2003, CURR ANTHROPOL, V44, P5, DOI 10.1086/344489; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wittman AB, 2007, OBSTET GYNECOL SURV, V62, P739, DOI 10.1097/01.ogx.0000286584.04310.5c	61	82	82	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118903	10.1371/journal.pone.0118903	http://dx.doi.org/10.1371/journal.pone.0118903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760381	Green Published, gold			2022-12-26	WOS:000351275000043
J	Huang, CM; Chen, SY; Huang, PH; Tsai, FJ				Huang, Chung-Ming; Chen, Shih-Yin; Huang, Po-Hao; Tsai, Fuu-Jen			Effect of MPG Gene rs2858056 Polymorphism, Copy Number Variation, and Level of Serum MPG Protein on the Risk for Rheumatoid Arthritis	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN GENOME; COLORECTAL-CANCER; SUSCEPTIBILITY; ASSOCIATION; DISEASE; PTPN22; PADI4	Objective This study examined the role of SNP rs2858056 of the MPG gene on the incidence and severity of rheumatoid arthritis (RA). Methods This cohort study enrolled 365 RA patients and 375 age-and gender-matched healthy controls, all of whom had Han Chinese ethnicity and were from Taiwan. Gene polymorphism of the SNP rs2858056 of MPG was determined from genomic DNA. Allelic frequencies and genotypes were compared among cases and controls. Quantitation of rs2858056 copy number variation (CNV) was determined. Serum samples from RA patients and controls were analyzed to determine serum levels of MPG. The relationship between rs2858056 polymorphism and clinical manifestations of RA was evaluated. Results Our results indicated a statistically significant difference in genotype frequency distributions at rs2858056 for RA patients and controls (p = 0.05) and a significant difference in allelic frequency in patients and controls (p = 0.04). Furthermore, there was a significantly greater level of serum MPG protein in patients than controls (p < 0.001). However, the cases and controls had no significant differences in MPG CNV (p = 0.12). We also did not detect any association of the MPG rs2858056 with rheumatoid factor (RF), extraarticular involvement, or bone erosion in the RA patients. Conclusion Our study suggests that RA is associated with a polymorphism in the MPG gene (rs2858056) and increased serum level of the MPG protein.	[Huang, Chung-Ming; Huang, Po-Hao] China Med Univ Hosp, Div Rheumatol & Immunol, Dept Internal Med, Taichung, Taiwan; [Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Huang, Chung-Ming; Huang, Po-Hao] China Med Univ, Grad Inst Integrated Med, Coll Chinese Med, Taichung, Taiwan; [Chen, Shih-Yin; Tsai, Fuu-Jen] China Med Univ, Grad Inst Chinese Med Sci, Coll Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Tsai, FJ (corresponding author), China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan.	d0704@mail.cmuh.org.tw	Tsai, Fuu-Jen/J-4140-2015		National Science Council in Taiwan [NSC99-2314-B-039-005]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by the National Science Council in Taiwan (NSC99-2314-B-039-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Broderick P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-243; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Cerda SR, 1998, FEBS LETT, V431, P12, DOI 10.1016/S0014-5793(98)00697-8; Chen HM, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-269; Chen SY, 2010, J APPL GENET, V51, P519, DOI 10.1007/BF03208883; Chen SY, 2012, RHEUMATOL INT, V32, P1165, DOI 10.1007/s00296-010-1738-1; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; GOMOLKA M, 1995, J MOL MED-JMM, V73, P19, DOI 10.1007/BF00203615; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013; Lo SF, 2012, RHEUMATOL INT, V32, P3723, DOI 10.1007/s00296-011-2185-3; Lo SF, 2012, RHEUMATOL INT, V32, P2301, DOI 10.1007/s00296-011-1961-4; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rusin M, 1999, Hum Mutat, V14, P269, DOI 10.1002/(SICI)1098-1004(1999)14:3<269::AID-HUMU13>3.0.CO;2-6; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Sliwinski T., 2009, Experimental Oncology, V31, P57; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; WORDSWORTH P, 1991, ANN RHEUM DIS, V50, P343, DOI 10.1136/ard.50.6.343; Zhang YY, 2006, INT J CANCER, V119, P2592, DOI 10.1002/ijc.22206; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	31	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120699	10.1371/journal.pone.0120699	http://dx.doi.org/10.1371/journal.pone.0120699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757089	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700072
J	Hung, TH; Hsieh, TT				Hung, Tai-Ho; Hsieh, T'sang-T'ang			The Effects of Implementing the International Association of Diabetes and Pregnancy Study Groups Criteria for Diagnosing Gestational Diabetes on Maternal and Neonatal Outcomes	PLOS ONE			English	Article							RISK-FACTORS; MELLITUS; RECOMMENDATIONS; CLASSIFICATION; HYPERGLYCEMIA; PREVALENCE; IADPSG; WOMEN; AGE	Background In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommended a new strategy for the screening and diagnosis of gestational diabetes mellitus (GDM). However, no study has indicated that adopting the IADPSG recommendations improves perinatal outcomes. The objective of this study was to evaluate the effects of implementing the IADPSG criteria for diagnosing GDM on maternal and neonatal outcomes. Methodology/Principal Findings Previously, we used a two-step approach (a 1-h, 50-g glucose challenge test followed by a 3-h, 100-g glucose tolerance test when indicated) to screen for and diagnose GDM. In July 2011, we adopted the IADPSG recommendations in our routine obstetric care. In this study, we retrospectively compared the rates of various maternal and neonatal outcomes in all women who delivered after 24 weeks of gestation during the periods before (P1, between January 1, 2009 and December 31, 2010) and after (P2, between January 1, 2012 and December 31, 2013) the IADPSG criteria were implemented. Pregnancies complicated by multiple gestations, fetal chromosomal or structural anomalies, and pre-pregnancy diabetes mellitus were excluded. Our results showed that the incidence of GDM increased from 4.6% using the two-step method to 12.4% using the IADPSG criteria. Compared to the women in P1, the women in P2 experienced less weight gain during pregnancy, lower birth weights, shorter labor courses, and lower rates of macrosomia (< 4000 g) and large-for-gestational age (LGA) infants. P2 was a significant independent factor against macrosomia (adjusted odds ratio [OR] 0.63, 95% confidence interval [CI] 0.43-0.90) and LGA (adjusted OR 0.74, 95% CI 0.61-0.89) after multivariable logistic regression analysis. Conclusions/Significance The adoption of the IADPSG criteria for diagnosis of GDM was associated with significant reductions in maternal weight gain during pregnancy, birth weights, and the rates of macrosomia and LGA.	[Hung, Tai-Ho; Hsieh, T'sang-T'ang] Chang Gung Mem Hosp Taipei, Dept Obstet & Gynecol, Taipei, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp Taipei, Dept Obstet & Gynecol, Taipei, Taiwan.	thh20@cgmh.org.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020	Hung, Tai-Ho/0000-0003-2354-7060; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2011, Obstet Gynecol, V118, P751, DOI 10.1097/AOG.0b013e3182310cc3; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Benhalima K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/248121; Bodmer-Roy S, 2012, OBSTET GYNECOL, V120, P746, DOI 10.1097/AOG.0b013e31826994ec; Cheng YKY, 2013, INT J GYNECOL OBSTET, V120, P249, DOI 10.1016/j.ijgo.2012.10.019; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Fok TF, 2009, NEONATOLOGY, V95, P23, DOI 10.1159/000151752; Hadar E, 2013, CLIN OBSTET GYNECOL, V56, P758, DOI 10.1097/GRF.0b013e3182a8e08e; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Hung TH, 2013, INT J GYNECOL OBSTET, V122, P212, DOI 10.1016/j.ijgo.2013.03.033; Landon MB, 2011, OBSTET GYNECOL, V118, P1379, DOI 10.1097/AOG.0b013e31823974e2; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lapolla A, 2011, DIABETIC MED, V28, P1074, DOI 10.1111/j.1464-5491.2011.03351.x; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Mission JF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.048; O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4; Reece EA, 2013, AM J OBSTET GYNECOL, V208, P255, DOI 10.1016/j.ajog.2012.10.887; Sevket O, 2014, J MATERN-FETAL NEO M, V27, P36, DOI 10.3109/14767058.2013.799656; Visser GHA, 2013, AM J OBSTET GYNECOL, V208, P260, DOI 10.1016/j.ajog.2012.10.881; Wei YM, 2012, CHINESE MED J-PEKING, V125, P1206, DOI 10.3760/cma.j.issn.0366-6999.2012.07.002; Werner EF, 2012, DIABETES CARE, V35, P529, DOI 10.2337/dc11-1643	26	47	49	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0122261	10.1371/journal.pone.0122261	http://dx.doi.org/10.1371/journal.pone.0122261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756838	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700080
J	Fan, YH; Ding, J; Nguyen, S; Liu, XJ; Xu, G; Zhou, HY; Duan, NN; Yang, SM; Zern, MA; Wu, J				Fan, Y-H; Ding, J.; Nguyen, S.; Liu, X-J; Xu, G.; Zhou, H-Y; Duan, N-N; Yang, S-M; Zern, M. A.; Wu, J.			Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; GENE DELIVERY; TARGET GENES; MOUSE MODEL; PATHWAY; METASTASIS; MECHANISMS; COMPONENTS; LDE225	Hepatoma exhibits a series of heterogeneous subpopulations in its cell surface markers, tumorigenicity, invasion and metastatic capability. We previously demonstrated that the CD133(-)/EpCAM(-) hepatoma subpopulation was more metastatic than its counterpart; however, the controlling mechanisms are unexplored. The present study aimed to delineate the significance of aberrant hedgehog (Hh) signaling in the mediation of metastases. Fluorescence-activated cell sorting-enriched CD133(-)/EpCAM(-) (double negative, DN), Huh-7 cells underwent a transwell selection for metastatic cells (transwell-selected, TS). The TS cells displayed much greater metastatic activity as evidenced by an increased invasion rate, extremely upregulated expression of matrix metalloproteinase (MMP)-1/2/9 genes compared with DN and double-positive (DP) subpopulations. In contrast to DP cells, TS cells lost E-cadherin and were all vimentin-positive as shown by immunocytochemistry. There was a transitional increase in Gli-1/2 gene expression levels from DP, DN to TS subpopulations, which was consistent with elevated Gli-1/2 or Twist-1 protein levels in the nuclear fraction. Furthermore, truncated Gli-1 (tGli-1), which transactivates molecules involved in metastasis, was detected in the highly invasive Huh-7 cell subpopulation, but not in less metastatic hepatoma cells or normal hepatocytes. The enhanced metastatic features with increased expression of MMPs as well as the presence of twist and snail genes in TS Huh-7 cells were reversed by LDE225, a potent Smoothened antagonist. In conclusion, the highly metastatic capability of a unique TS subpopulation was highly attributed to significant epithelial-mesenchymal transition, enhanced Hh activity and aberrant occurrence of a tGli-1 variant, which appears to be responsible for the highly invasive behavior.	[Fan, Y-H; Nguyen, S.; Zern, M. A.; Wu, J.] Univ Calif Davis, Med Ctr, Div Gastroenterol & Hepatol, Dept Internal Med, Sacramento, CA 95817 USA; [Fan, Y-H; Yang, S-M] Third Mil Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Ding, J.; Liu, X-J; Xu, G.; Zhou, H-Y; Duan, N-N; Wu, J.] Fudan Univ, Shanghai Med Coll, Key Lab Mol Virol, Shanghai 200032, Peoples R China; [Ding, J.] Shanghai Jingan Dist Cent Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Zern, M. A.; Wu, J.] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Sacramento, CA 95817 USA; [Wu, J.] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai Inst Liver Dis, Shanghai 200032, Peoples R China; [Wu, J.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; Army Medical University; Fudan University; University of California System; University of California Davis; Fudan University; University of California System; University of California Davis	Wu, J (corresponding author), Fudan Univ, Shanghai Med Coll, Key Lab Mol Virol, 138 Yixue Yuan Rd,POB 228, Shanghai 200032, Peoples R China.	jdwu@ucdavis.edu	Liu, Xuejing/AAB-5617-2022; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Ding, Jia/0000-0002-7391-8520; Zou, Haoyu/0000-0003-0778-4920	Natural Science Foundation of China [81272436]; California Institute of Regenerative Medicine [TR0-01857]; China Scholarship Council Award [201207610003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); China Scholarship Council Award(China Scholarship Council)	This study is partially supported by the Natural Science Foundation of China to Dr Jian Wu (#81272436). Dr Mark A Zern was supported by the California Institute of Regenerative Medicine (#TR0-01857). Ya-Han Fan is the recipient of China Scholarship Council Award (201207610003). The authors are grateful to Bridget McLaughlin for her technical support in the FACS enrichment of hepatoma cell subpopulations at the UC Davis Flow Cytometry Shared Resource, and to Mrs Shu-Hui Sun from Fudan University Shanghai Medical College for her technical assistance in flow cytometric analysis. The abstract of this work was presented in the 64th Annual Meeting of the American Association for the Study of Liver Diseases, Washington, DC, USA, 1-5 November 2013, and published in Hepatology (2013;59:1081A).	Adkins Y, 2013, LAB INVEST, V93, P1313, DOI 10.1038/labinvest.2013.123; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Chen XL, 2010, ARCH MED RES, V41, P315, DOI 10.1016/j.arcmed.2010.06.003; Chen XL, 2011, J HEPATOL, V55, P838, DOI 10.1016/j.jhep.2010.12.043; Chen XL, 2011, TRANSPLANTATION, V91, P293, DOI 10.1097/TP.0b013e318204756c; Eichenmuller M, 2009, HEPATOLOGY, V49, P482, DOI 10.1002/hep.22649; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fendrich V, 2011, ANN SURG, V254, P818, DOI 10.1097/SLA.0b013e318236bc0f; Fouzas I, 2008, TRANSPL P, V40, P3806, DOI 10.1016/j.transproceed.2008.09.050; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Lingala S, 2010, EXP MOL PATHOL, V89, P27, DOI 10.1016/j.yexmp.2010.05.005; Liu L, 2003, GENE THER, V10, P180, DOI 10.1038/sj.gt.3301861; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McNeill B, 2012, MOL CELL NEUROSCI, V49, P333, DOI 10.1016/j.mcn.2011.12.008; NICOLSON GL, 1984, CANCER METAST REV, V3, P25, DOI 10.1007/BF00047691; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Philips GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023943; Price John T, 2002, Expert Opin Ther Targets, V6, P217; Riedlinger D, 2014, J HEPATO-BIL-PAN SCI, V21, P607, DOI 10.1002/jhbp.107; Rodon J, 2014, CLIN CANCER RES, V20, P1900, DOI 10.1158/1078-0432.CCR-13-1710; Ruiz I, 2007, TRENDS CELL BIOL, V17, P438, DOI DOI 10.1016/J.TCB.2007.06.007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki K, 2014, WORLD J SURG, V38, P1147, DOI 10.1007/s00268-013-2374-1; Shimokawa T, 2008, J BIOL CHEM, V283, P14345, DOI 10.1074/jbc.M800299200; Steg AD, 2012, MOL CANCER THER, V11, P1587, DOI 10.1158/1535-7163.MCT-11-1058; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wege H, 2003, GASTROENTEROLOGY, V124, P432, DOI 10.1053/gast.2003.50064; Wu J, 2004, HEPATOLOGY, V40, P195, DOI 10.1002/hep.20288; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; You N, 2012, ONCOL REP, V28, P2091, DOI 10.3892/or.2012.2035	39	27	29	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					116	124		10.1038/onc.2015.67	http://dx.doi.org/10.1038/onc.2015.67			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25772244	Green Published			2022-12-26	WOS:000367812400011
J	Wimmer, P; Berscheminski, J; Blanchette, P; Groitl, P; Branton, PE; Hay, RT; Dobner, T; Schreiner, S				Wimmer, P.; Berscheminski, J.; Blanchette, P.; Groitl, P.; Branton, P. E.; Hay, R. T.; Dobner, T.; Schreiner, S.			PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53	ONCOGENE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; NUCLEAR-BODY FORMATION; REGION-1B 55-KDA ONCOPROTEIN; E1B 55-KILODALTON PROTEIN; HUMAN-EMBRYO RETINOBLASTS; SUMO-1 MODIFICATION; E1B-55K ONCOPROTEIN; INFECTED-CELLS; RAR-ALPHA; PREMATURE SENESCENCE	Although modulation of the cellular tumor-suppressor p53 is considered to have the major role in E1A/E1B-55K-mediated tumorigenesis, other promyelocytic leukemia nuclear body (PML-NB)/PML oncogenic domain (POD)-associated factors including SUMO, Mre11, Daxx, as well as the integrity of these nuclear bodies contribute to the transformation process. However, the biochemical consequences and oncogenic alterations of PML-associated E1B-55K by SUMO-dependent PML-IV and PML-V interaction have so far remained elusive. We performed mutational analysis to define a PML interaction motif within the E1B-55K polypeptide. Our results showed that E1B-55K/PML binding is not required for p53, Mre11 and Daxx interaction. We also observed that E1B-55K lacking subnuclear PML localization because of either PML-IV or PML-V-binding deficiency was no longer capable of mediating E1B-55K-dependent SUMOylation of p53, inhibition of p53-mediated transactivation or efficiently transforming primary rodent cells. These results together with the observation that E1B-55K-dependent SUMOylation of p53 is required for efficient cell transformation, provides evidence for the idea that the SUMO ligase activity of the E1B-55K viral oncoprotein is intimately linked to its growth-promoting oncogenic activities.	[Wimmer, P.; Berscheminski, J.; Groitl, P.; Dobner, T.; Schreiner, S.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Transformat, D-20251 Hamburg, Germany; [Blanchette, P.; Branton, P. E.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Branton, P. E.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Branton, P. E.] McGill Univ, Dept Goodman Canc Ctr, Montreal, PQ, Canada; [Hay, R. T.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	Heinrich Pette Institute; McGill University; McGill University; McGill University; University of Dundee	Schreiner, S (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Viral Transformat, Martinistr 52, D-20251 Hamburg, Germany.	sabrina.schreiner@tum.de	Hay, Ronald/S-3233-2019; Hay, Ronald T/F-9338-2011	Hay, Ronald/0000-0001-7113-9024; Hay, Ronald T/0000-0001-7113-9024; Schreiner, Sabrina/0000-0002-5744-7159	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Peter und Traudl Engelhorn Stiftung; Erich und Gertrud Roggenbuck Stiftung; Else Kroner-Fresenius-Stiftung; Deutsche Krebshilfe e. V.; Deutsche Forschungsgemeinschaft (DFG); Wilhelm Sander-Stiftung; B Braun Stiftung; Drager Stiftung; Fonds der Chemischen Industrie; Canadian Institutes of Health Research; Canadian Foundation for Innovation (CFI); Ministere du Developpement economique, innovation et exportation Quebec (MDEIE); Cancer Research UK [13067] Funding Source: researchfish	Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG); Peter und Traudl Engelhorn Stiftung; Erich und Gertrud Roggenbuck Stiftung; Else Kroner-Fresenius-Stiftung; Deutsche Krebshilfe e. V.(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; B Braun Stiftung; Drager Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ministere du Developpement economique, innovation et exportation Quebec (MDEIE); Cancer Research UK(Cancer Research UK)	We thank Roger D Everett for providing reagents, and greatly appreciate the critical comments and very helpful advise from Thomas Sternsdorf. We thank Ellis Jaffray, Gabriele Dobner and Thomas Speiseder for technical support and Hannah Staege for animal work. The Heinrich Pette Institute, Leibniz Institute for Experimental Virology is supported by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). SS was supported by the Peter und Traudl Engelhorn Stiftung and additional grants from the Erich und Gertrud Roggenbuck Stiftung, the Else Kroner-Fresenius-Stiftung and the Deutsche Krebshilfe e. V. TD is supported by the Deutsche Forschungsgemeinschaft (DFG) and the Wilhelm Sander-Stiftung. Part of this work was supported by the B Braun Stiftung, the Drager Stiftung and the Fonds der Chemischen Industrie. PB and PEB were supported by grants from the Canadian Institutes of Health Research. Image collection for the manuscript was performed in the McGill University Life Sciences Complex Imaging Facility. Purchase of equipment in the facility was made possible with funding from the Canadian Foundation for Innovation (CFI) and the Ministere du Developpement economique, innovation et exportation Quebec (MDEIE).	ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Berscheminski J, 2013, J VIROL, V87, P965, DOI 10.1128/JVI.02023-12; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Blanchette P, 2004, MOL CELL BIOL, V24, P9619, DOI 10.1128/MCB.24.21.9619-9629.2004; Brand Peter, 2010, PMC Biophys, V3, P3, DOI 10.1186/1757-5036-3-3; BRANTON PE, 1984, BIOCHIM BIOPHYS ACTA, V780, P67, DOI 10.1016/0304-419X(84)90007-6; BYRD P, 1982, NATURE, V298, P69, DOI 10.1038/298069a0; Carbone R, 2002, ONCOGENE, V21, P1633, DOI 10.1038/sj.onc.1205227; CARVALHO T, 1995, J CELL BIOL, V131, P45, DOI 10.1083/jcb.131.1.45; CHANG KS, 1992, MOL CELL BIOL, V12, P800, DOI 10.1128/MCB.12.2.800; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Dosch T, 2001, J VIROL, V75, P5677, DOI 10.1128/JVI.75.12.5677-5683.2001; Duprez E, 1999, J CELL SCI, V112, P381; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; Endter C, 2005, ONCOGENE, V24, P55, DOI 10.1038/sj.onc.1208170; Endter C, 2004, CURR TOP MICROBIOL, V273, P163; Endter C, 2001, P NATL ACAD SCI USA, V98, P11312, DOI 10.1073/pnas.191361798; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Fallaux FJ, 1998, HUM GENE THER, V9, P1909, DOI 10.1089/hum.1998.9.13-1909; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; GALLIMORE PH, 1986, ANTICANCER RES, V6, P499; Gallimore PH, 2001, ONCOGENE, V20, P7824, DOI 10.1038/sj.onc.1204913; Geng YY, 2012, J BIOL CHEM, V287, P30729, DOI 10.1074/jbc.M112.374769; GODDARD AD, 1995, MAMM GENOME, V6, P732, DOI 10.1007/BF00354296; GODDARD AD, 1992, LEUKEMIA, V6, pS117; Goodrum FD, 1996, J VIROL, V70, P6323, DOI 10.1128/JVI.70.9.6323-6335.1996; Gostissa M, 2003, CURR OPIN CELL BIOL, V15, P351, DOI 10.1016/S0955-0674(03)00038-3; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Graham F.L., 1984, ADENOVIRUSES, P339; GRAHAM FL, 1984, J CELL PHYSIOL, P151; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRAND RJA, 1994, VIROLOGY, V203, P229, DOI 10.1006/viro.1994.1480; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, BLOOD, V103, P2358, DOI 10.1182/blood-2003-07-2200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; HALEY KP, 1984, P NATL ACAD SCI-BIOL, V81, P5734, DOI 10.1073/pnas.81.18.5734; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Ishov AM, 1996, J CELL BIOL, V134, P815, DOI 10.1083/jcb.134.4.815; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAO CC, 1990, VIROLOGY, V179, P806, DOI 10.1016/0042-6822(90)90148-K; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P667, DOI 10.1073/pnas.012317299; Kindsmuller K, 2007, P NATL ACAD SCI USA, V104, P6684, DOI 10.1073/pnas.0702158104; Kindsmuller K, 2009, J VIROL, V83, P9045, DOI 10.1128/JVI.00728-09; KOKEN MHM, 1995, ONCOGENE, V10, P1315; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; Konig C, 1999, J VIROL, V73, P2253; Kratzer F, 2000, ONCOGENE, V19, P850, DOI 10.1038/sj.onc.1203395; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lethbridge KJ, 2003, J GEN VIROL, V84, P259, DOI 10.1099/vir.0.18820-0; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Logan J, 1984, CANCER CELL, V2, P527; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Martin MED, 1999, MOL CELL BIOL, V19, P3403; Martin MED, 1998, J VIROL, V72, P3146, DOI 10.1128/JVI.72.4.3146-3154.1998; Maul GG, 1998, BIOESSAYS, V20, P660, DOI 10.1002/(SICI)1521-1878(199808)20:8<660::AID-BIES9>3.0.CO;2-M; MCLORIE W, 1991, J GEN VIROL, V72, P1467, DOI 10.1099/0022-1317-72-6-1467; Melnick A, 1999, LEUKEMIA, V13, P1534, DOI 10.1038/sj.leu.2401513; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MORAN E, 1986, J VIROL, V57, P765, DOI 10.1128/JVI.57.3.765-775.1986; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 2008, CELL CYCLE, V7, P754, DOI 10.4161/cc.7.6.5495; Nevels M, 2006, ADENOVIRUS METHODS P, P187; Nevins JR, 1996, VIROLOGY, P301; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; Owerbach D, 2005, BIOCHEM BIOPH RES CO, V337, P517, DOI 10.1016/j.bbrc.2005.09.090; PANDOLFI PP, 1992, EMBO J, V11, P1397, DOI 10.1002/j.1460-2075.1992.tb05185.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Pearson M, 2001, ONCOGENE, V20, P7250, DOI 10.1038/sj.onc.1204856; Pennella MA, 2010, J VIROL, V84, P12210, DOI 10.1128/JVI.01442-10; Querido E, 1997, J VIROL, V71, P3526, DOI 10.1128/JVI.71.5.3526-3533.1997; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Querido E, 1997, J VIROL, V71, P3788, DOI 10.1128/JVI.71.5.3788-3798.1997; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Ricciardi R, 1995, DNA TUMOR VIRUSES ON, P195; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SABBATINI P, 1995, GENE DEV, V9, P2184, DOI 10.1101/gad.9.17.2184; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; SARNOW P, 1982, VIROLOGY, V120, P510, DOI 10.1016/0042-6822(82)90054-X; SARNOW P, 1984, J VIROL, V49, P692, DOI 10.1128/JVI.49.3.692-700.1984; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schiedner G, 2000, HUM GENE THER, V11, P2105, DOI 10.1089/104303400750001417; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Schreiner S, 2011, J VIROL, V85, P8752, DOI 10.1128/JVI.00440-11; Schreiner S, 2010, J VIROL, V84, P7029, DOI 10.1128/JVI.00074-10; Sieber T, 2007, J VIROL, V81, P95, DOI 10.1128/JVI.01608-06; Stadler M, 1995, ONCOGENE, V11, P2565; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Torok D, 2009, FRONT BIOSCI-LANDMRK, V14, P1325, DOI 10.2741/3311; TRENTIN JJ, 1962, SCIENCE, V137, P835, DOI 10.1126/science.137.3533.835; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Ullman AJ, 2007, J VIROL, V81, P4744, DOI 10.1128/JVI.02385-06; Van Damme E, 2011, FRONT BIOSCI-LANDMRK, V16, P2910, DOI 10.2741/3889; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; VANDENHEUVEL SJL, 1992, J VIROL, V66, P591, DOI 10.1128/JVI.66.1.591-595.1992; Wang ZG, 1998, SCIENCE, V279, P1547; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; WHITE E, 1993, P SOC EXP BIOL MED, V204, P30; White E, 2001, ONCOGENE, V20, P7836, DOI 10.1038/sj.onc.1204861; WHITTAKER JL, 1984, MOL CELL BIOL, V4, P110, DOI 10.1128/MCB.4.1.110; Wienzek S, 2000, J VIROL, V74, P193, DOI 10.1128/JVI.74.1.193-202.2000; Wimmer P, 2013, ONCOGENE, V32, P1626, DOI 10.1038/onc.2012.187; Wimmer P, 2010, ONCOGENE, V29, P5511, DOI 10.1038/onc.2010.284; Wimmer P, 2012, J VIROL, V86, P642, DOI 10.1128/JVI.06227-11; YEW PR, 1994, GENE DEV, V8, P190, DOI 10.1101/gad.8.2.190; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0; ZANTEMA A, 1985, MOL CELL BIOL, V5, P3084, DOI 10.1128/MCB.5.11.3084; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	139	15	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2016	35	1					69	82		10.1038/onc.2015.63	http://dx.doi.org/10.1038/onc.2015.63			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DA4ZT	25772236				2022-12-26	WOS:000367812400007
J	Wu, YD; Gunst, SJ				Wu, Yidi; Gunst, Susan J.			Vasodilator-stimulated Phosphoprotein (VASP) Regulates Actin Polymerization and Contraction in Airway Smooth Muscle by a Vinculin-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FOCAL-ADHESION; FILAMENT ELONGATION; TENSION DEVELOPMENT; PROXIMITY LIGATION; ENA/VASP PROTEINS; HUMAN PLATELETS; ARP2/3 COMPLEX; CELL-MIGRATION; BARBED END	Vasodilator-stimulated phosphoprotein (VASP) can catalyze actin polymerization by elongating actin filaments. The elongation mechanism involves VASP oligomerization and its binding to profilin, a G-actin chaperone. Actin polymerization is required for tension generation during the contraction of airway smooth muscle (ASM); however, the role of VASP in regulating actin dynamics in ASM is not known. We stimulated ASM cells and tissues with the contractile agonist acetylcholine (ACh) or the adenylyl cyclase activator, forskolin (FSK), a dilatory agent. ACh and FSK stimulated VASP Ser(157) phosphorylation by different kinases. Inhibition of VASP Ser(157) phosphorylation by expression of the mutant VASP S157A in ASM tissues suppressed VASP phosphorylation and membrane localization in response to ACh, and also inhibited contraction and actin polymerization. ACh but not FSK triggered the formation of VASPVASP complexes as well as VASP-vinculin and VASP-profilin complexes at membrane sites. VASP-VASP complex formation and the interaction of VASP with vinculin and profilin were inhibited by expression of the inactive vinculin mutant, vinculin Y1065F, but VASP phosphorylation and membrane localization were unaffected. We conclude that VASP phosphorylation at Ser(157) mediates its localization at the membrane, but that VASP Ser(157) phosphorylation and membrane localization are not sufficient to activate its actin catalytic activity. The interaction of VASP with activated vinculin at membrane adhesion sites is a necessary prerequisite for VASP-mediated molecular processes necessary for actin polymerization. Our results show that VASP is a critical regulator of actin dynamics and tension generation during the contractile activation of ASM.	[Wu, Yidi; Gunst, Susan J.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunst, SJ (corresponding author), 635 Barnhill Dr, Indianapolis, IN 46202 USA.	sgunst@iupui.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 HL29289, HL074099, R01HL109629]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109629, R01HL048522, R01HL029289, R01HL074099] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL29289, HL074099, and R01HL109629.	Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Blume C, 2007, J BIOL CHEM, V282, P4601, DOI 10.1074/jbc.M608866200; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Brindle NPJ, 1996, BIOCHEM J, V318, P753, DOI 10.1042/bj3180753; BUTT E, 1994, J BIOL CHEM, V269, P14509; Chitaley K, 2004, FEBS LETT, V556, P211, DOI 10.1016/S0014-5793(03)01435-2; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Doppler H, 2013, CELL ADHES MIGR, V7, P482, DOI 10.4161/cam.27351; Dominguez R, 2009, CRIT REV BIOCHEM MOL, V44, P351, DOI 10.3109/10409230903277340; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; HAFFNER C, 1995, EMBO J, V14, P19, DOI 10.1002/j.1460-2075.1995.tb06971.x; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HATHAWAY DR, 1985, AM J PHYSIOL, V249, pC345; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Huang YL, 2014, J BIOL CHEM, V289, P3677, DOI 10.1074/jbc.M113.508077; Huang YL, 2011, J BIOL CHEM, V286, P3630, DOI 10.1074/jbc.M110.139923; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim HR, 2010, AM J PHYSIOL-CELL PH, V298, pC559, DOI 10.1152/ajpcell.00431.2009; Kuhnel K, 2004, P NATL ACAD SCI USA, V101, P17027, DOI 10.1073/pnas.0403069101; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Quinlan MP, 2004, J CELL PHYSIOL, V200, P277, DOI 10.1002/jcp.20009; Reinhard M, 1996, FEBS LETT, V399, P103, DOI 10.1016/S0014-5793(96)01295-1; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tang DD, 2003, J PHYSIOL-LONDON, V553, P21, DOI 10.1113/jphysiol.2003.045047; Wentworth JKI, 2006, BIOCHEM J, V393, P555, DOI 10.1042/BJ20050796; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang WW, 2012, J BIOL CHEM, V287, P33996, DOI 10.1074/jbc.M112.369603; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004; Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x	46	18	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11403	11416		10.1074/jbc.M115.645788	http://dx.doi.org/10.1074/jbc.M115.645788			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25759389	Green Published, hybrid			2022-12-26	WOS:000353719400017
J	Denis, M; Mehrmohammadi, M; Song, PF; Meixner, DD; Fazzio, RT; Pruthi, S; Whaley, DH; Chen, SG; Fatemi, M; Alizad, A				Denis, Max; Mehrmohammadi, Mohammad; Song, Pengfei; Meixner, Duane D.; Fazzio, Robert T.; Pruthi, Sandhya; Whaley, Dana H.; Chen, Shigao; Fatemi, Mostafa; Alizad, Azra			Comb-Push Ultrasound Shear Elastography of Breast Masses: Initial Results Show Promise	PLOS ONE			English	Article							WAVE ELASTOGRAPHY; DIFFERENTIATING BENIGN; US; MAMMOGRAPHY; TISSUE; PERFORMANCE; TECHNOLOGY; DIAGNOSIS; MODULUS; LESIONS	Purpose or Objective To evaluate the performance of Comb-push Ultrasound Shear Elastography (CUSE) for classification of breast masses. Materials and Methods CUSE is an ultrasound-based quantitative two-dimensional shear wave elasticity imaging technique, which utilizes multiple laterally distributed acoustic radiation force (ARF) beams to simultaneously excite the tissue and induce shear waves. Female patients who were categorized as having suspicious breast masses underwent CUSE evaluations prior to biopsy. An elasticity estimate within the breast mass was obtained from the CUSE shear wave speed map. Elasticity estimates of various types of benign and malignant masses were compared with biopsy results. Results Fifty-four female patients with suspicious breast masses from our ongoing study are presented. Our cohort included 31 malignant and 23 benign breast masses. Our results indicate that the mean shear wave speed was significantly higher in malignant masses (6 +/- 1.58 m/s) in comparison to benign masses (3.65 +/- 1.36 m/s). Therefore, the stiffness of the mass quantified by the Young's modulus is significantly higher in malignant masses. According to the receiver operating characteristic curve (ROC), the optimal cut-off value of 83 kPa yields 87.10% sensitivity, 82.61% specificity, and 0.88 for the area under the curve (AUC). Conclusion CUSE has the potential for clinical utility as a quantitative diagnostic imaging tool adjunct to B-mode ultrasound for differentiation of malignant and benign breast masses.	[Denis, Max; Mehrmohammadi, Mohammad; Song, Pengfei; Chen, Shigao; Fatemi, Mostafa; Alizad, Azra] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Meixner, Duane D.; Fazzio, Robert T.; Whaley, Dana H.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN USA; [Pruthi, Sandhya; Alizad, Azra] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Alizad, A (corresponding author), Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	Alizad.azra@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Song, Pengfei/0000-0002-9103-6345; Mehrmohammadi, Mohammad/0000-0002-9264-9354	National Institutes of Health-National Cancer Institute [R01CA148994-04S1, R01CA148994, R01CA168575]; NATIONAL CANCER INSTITUTE [R01CA168575, R01CA148994] Funding Source: NIH RePORTER	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants R01CA148994-04S1, R01CA148994, and R01CA168575 from the National Institutes of Health-National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2010, RADIOLOGY, V256, P297, DOI 10.1148/radiol.10090385; Bai M, 2012, J ULTRAS MED, V31, P289, DOI 10.7863/jum.2012.31.2.289; Barr RG, 2012, J ULTRAS MED, V31, P895, DOI 10.7863/jum.2012.31.6.895; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bercoff J, 2003, ULTRASOUND MED BIOL, V29, P1387, DOI 10.1016/S0301-5629(03)00978-5; Berg WA, 2008, JAMA-J AM MED ASSOC, V299, P2151, DOI 10.1001/jama.299.18.2151; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Chang JM, 2011, BREAST CANCER RES TR, V129, P89, DOI 10.1007/s10549-011-1627-7; Chang JM, 2011, RADIOLOGY, V259, P59, DOI 10.1148/radiol.10101414; Chen SC, 2004, ULTRASOUND OBST GYN, V23, P188, DOI 10.1002/uog.930; Cohn NA, 1997, IEEE T ULTRASON FERR, V44, P1304, DOI 10.1109/58.656634; Correas J-M, 2013, Diagn Interv Imaging, V94, P551, DOI 10.1016/j.diii.2013.01.017; Corsetti V, 2011, EUR J CANCER, V47, P1021, DOI 10.1016/j.ejca.2010.12.002; Cosgrove DO, 2012, EUR RADIOL, V22, P1023, DOI 10.1007/s00330-011-2340-y; Evans A, 2012, BRIT J CANCER, V107, P224, DOI 10.1038/bjc.2012.253; Evans A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2787; Fink M, 2010, PHYS TODAY, V63, P28, DOI 10.1063/1.3326986; Gennisson JL, 2007, J ACOUST SOC AM, V122, P3211, DOI 10.1121/1.2793605; GORDON PB, 1995, CANCER, V76, P626, DOI 10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z; Ianculescu V, 2014, EUR J RADIOL, V83, P773, DOI 10.1016/j.ejrad.2014.01.021; KASAI C, 1985, IEEE T SON ULTRASON, V32, P458, DOI 10.1109/T-SU.1985.31615; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Latorre-Ossa H, 2012, IEEE T ULTRASON FERR, V59, P833, DOI 10.1109/TUFFC.2012.2262; Lee SH, 2014, RADIOLOGY, V270, P344, DOI 10.1148/radiol.13130561; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076322; Mehrmohammadi M, 2014, COMB PUSH ULTRASOUND; Montaldo G, 2009, IEEE T ULTRASON FERR, V56, P489, DOI 10.1109/TUFFC.2009.1067; Nightingale K, 2002, ACOUSTIC RAD FORCE I, P525; Ohlinger R, 2004, ULTRASCHALL MED, V25, P48, DOI 10.1055/s-2003-45244; Plecha DM, 2014, RADIOLOGY; Rahbar G, 1999, RADIOLOGY, V213, P889, DOI 10.1148/radiology.213.3.r99dc20889; Sandrin L., 2002, ACOUST IMAGING, P485, DOI 10.1007/0-306-47107-8_68.; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Sarvazyan A, 2011, CURR MED IMAGING, V7, P255, DOI 10.2174/157340511798038684; Schaefer FKW, 2011, EUR J RADIOL, V77, P450, DOI 10.1016/j.ejrad.2009.08.026; SEWELL CW, 1995, RADIOL CLIN N AM, V33, P1067; Song PF, 2014, ULTRASOUND MED BIOL, V40, P1343, DOI 10.1016/j.ultrasmedbio.2013.12.026; Song PF, 2013, IEEE T MED IMAGING, V32, P1435, DOI 10.1109/TMI.2013.2257831; Song PF, 2012, IEEE T MED IMAGING, V31, P1821, DOI 10.1109/TMI.2012.2205586; STAVROS AT, 1995, RADIOLOGY, V196, P123, DOI 10.1148/radiology.196.1.7784555; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Teh W, 1998, EUR J CANCER, V34, P449, DOI 10.1016/S0959-8049(97)10066-1; Varghese T, 2000, ULTRASOUND MED BIOL, V26, P839, DOI 10.1016/S0301-5629(00)00199-X; Yao MH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/142504	47	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119398	10.1371/journal.pone.0119398	http://dx.doi.org/10.1371/journal.pone.0119398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774978	Green Published, gold			2022-12-26	WOS:000351183500088
J	Storch, TT; Pegoraro, C; Finatto, T; Quecini, V; Rombaldi, CV; Girardi, CL				Storch, Tatiane Timm; Pegoraro, Camila; Finatto, Taciane; Quecini, Vera; Rombaldi, Cesar Valmor; Girardi, Cesar Luis			Identification of a Novel Reference Gene for Apple Transcriptional Profiling under Postharvest Conditions	PLOS ONE			English	Article							REAL-TIME; RT-PCR; ETHYLENE BIOSYNTHESIS; EXPRESSION; FRUIT; NORMALIZATION; ARABIDOPSIS; VALIDATION; PERCEPTION; SELECTION	Reverse Transcription quantitative PCR (RT-qPCR) is one of the most important techniques for gene expression profiling due to its high sensibility and reproducibility. However, the reliability of the results is highly dependent on data normalization, performed by comparisons between the expression profiles of the genes of interest against those of constitutively expressed, reference genes. Although the technique is widely used in fruit postharvest experiments, the transcription stability of reference genes has not been thoroughly investigated under these experimental conditions. Thus, we have determined the transcriptional profile, under these conditions, of three genes commonly used as reference-ACTIN (MdACT), PROTEIN DISULPHIDE ISOMERASE (MdPDI) and UBIQUITIN-CONJUGATING ENZYME E2 (MdUBC)-along with two novel candidates-HISTONE 1 (MdH1) and NUCLEOSSOME ASSEMBLY 1 PROTEIN (MdNAP1). The expression profile of the genes was investigated throughout five experiments, with three of them encompassing the postharvest period and the other two, consisting of developmental and spatial phases. The transcriptional stability was comparatively investigated using four distinct software packages: BestKeeper, Norm-Finder, geNorm and DataAssist. Gene ranking results for transcriptional stability were similar for the investigated software packages, with the exception of BestKeeper. The classic reference gene MdUBC ranked among the most stably transcribed in all investigated experimental conditions. Transcript accumulation profiles for the novel reference candidate gene MdH1 were stable throughout the tested conditions, especially in experiments encompassing the postharvest period. Thus, our results present a novel reference gene for postharvest experiments in apple and reinforce the importance of checking the transcription profile of reference genes under the experimental conditions of interest.	[Storch, Tatiane Timm; Pegoraro, Camila; Finatto, Taciane; Quecini, Vera; Girardi, Cesar Luis] Empresa Brasileira Pesquisa Agr Uva & Vinho, Bento Goncalves, Brazil; [Storch, Tatiane Timm; Rombaldi, Cesar Valmor] Univ Fed Pelotas, Pelotas, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Pelotas	Girardi, CL (corresponding author), Empresa Brasileira Pesquisa Agr Uva & Vinho, Bento Goncalves, Brazil.	cesar.girardi@embrapa.br	Pegoraro, Camila/P-2940-2015; Rombaldi, Cesar/T-2940-2019; Pegoraro, Camila/L-2265-2019; Finatto, Taciane/O-9510-2014; Quecini, Vera/AAM-7724-2020	Pegoraro, Camila/0000-0003-1376-9751; Pegoraro, Camila/0000-0003-1376-9751; Finatto, Taciane/0000-0002-6873-3783; Quecini, Vera/0000-0001-7806-3309; Rombaldi, Cesar/0000-0002-6995-2937	Embrapa/SEG [02.10.01.002]; CNPq Productivity Research Grant; CAPES Institutional Doctorate Grant;  [02986/9]	Embrapa/SEG; CNPq Productivity Research Grant; CAPES Institutional Doctorate Grant; 	The work was supported by the following: Research Grant 02.10.01.002 from Embrapa/SEG to CLG (https://sistemas.sede.embrapa.br/ideare); CNPq Productivity Research Grant to CVR (http://www.cnpq.br/); CAPES Institutional Doctorate Grant to TTS (http://www.capes.gov.br/bolsas/bolsas-nopais/ds-e-proap); and Post Doctoral Grant 02986/9 to CP (www.capes.gov.br/bolsas/bolsas-no-pais/pnpd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Embrapa, the funding agency with which one or more of the authors is affiliated, is a government research institution (https://www.embrapa.br/en/home) similar to the United States Department of Agriculture (USDA) and provides competitive funding to research projects without playing a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ay N, 2014, J EXP BOT, V65, P3875, DOI 10.1093/jxb/eru132; Bapat VA, 2010, BIOTECHNOL ADV, V28, P94, DOI 10.1016/j.biotechadv.2009.10.002; Bennett AB, 2008, PLANT SCI, V175, P130, DOI 10.1016/j.plantsci.2008.03.004; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Dal Cin V, 2005, J EXP BOT, V56, P2995, DOI 10.1093/jxb/eri296; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dong MT, 2012, CURR GENET, V58, P13, DOI 10.1007/s00294-011-0361-3; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Goulao LF, 2008, TRENDS FOOD SCI TECH, V19, P4, DOI 10.1016/j.tifs.2007.07.002; Gu CS, 2014, SCI WORLD J, DOI 10.1155/2014/532713; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Harb J, 2012, POSTHARVEST BIOL TEC, V64, P94, DOI 10.1016/j.postharvbio.2011.10.001; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Ling H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097469; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Mann HS, 2008, J AM SOC HORTIC SCI, V133, P152, DOI 10.21273/JASHS.133.1.152; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nobile PM, 2011, J EXP BOT, V62, P4309, DOI 10.1093/jxb/err146; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rios G, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00247; Saha G. C., 2012, American Journal of Plant Sciences, V3, P235, DOI 10.4236/ajps.2012.32028; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vimolmangkang S, 2014, GENE, V534, P78, DOI 10.1016/j.gene.2013.10.007; Wei JM, 2010, POSTHARVEST BIOL TEC, V56, P147, DOI 10.1016/j.postharvbio.2009.12.003; Yang XT, 2013, POSTHARVEST BIOL TEC, V78, P55, DOI 10.1016/j.postharvbio.2012.11.012; Yi H, 2006, PLANT CELL, V18, P1575, DOI 10.1105/tpc.105.039719; ZENG Y, 2002, PLANT MOL BIOL REP, V20, pA417, DOI DOI 10.1007/BF02772130; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	43	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120599	10.1371/journal.pone.0120599	http://dx.doi.org/10.1371/journal.pone.0120599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774904	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500186
J	Xu, YD; Fu, WJ; Wang, ZX; Li, G; Zhang, X				Xu, Yongde; Fu, Weijun; Wang, Zhongxin; Li, Gang; Zhang, Xu			A Tissue-Specific Scaffold for Tissue Engineering-Based Ureteral Reconstruction	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX; IN-VITRO; UROTHELIAL CELLS; DIFFERENTIATION; PROLIFERATION; UROPLAKIN; MEMBRANE; CULTURE; MODEL	Terminally differentiated somatic cells can rapidly change phenotypes when they are isolated from their native tissue and cultured in vitro. This problem may become a barrier to tissue engineering-based organ reconstruction, which utilizes somatic cells. The present study was designed to validate the feasibility of maintaining the urothelial cell phenotype in a tissue-specific ureteral scaffold. The tissue-specific scaffold was fabricated by blending poly (L-lactic acid) (PLLA) and ureteral extracellular matrix (UECM) using electrostatic spinning technology. PLLA was used to enhance the mechanical properties, and UECM was used to mimic the natural components of the ureter. Primary urothelial cells (UCs), derived from ureteral mucosa, were seeded onto the tissue-specific scaffold to assess cell adhesion, proliferation and phenotypes at designated time points. The results showed that UCs in the tissue-specific scaffold exhibited better proliferation compared to cells in pure PLLA or a PLLA-small intestinal submucosa (PLLA-SIS) scaffold (p<0.05). At different time points, the expression of a UC-specific marker (UroplakinIII) in the tissue-specific scaffold was significantly higher than its expression in pure PLLA or a PLLA-SIS scaffold (p<0.05). Therefore, the tissue-specific scaffold appears to be an ideal substrate for promoting UC survival and phenotype maintenance.	[Xu, Yongde; Fu, Weijun; Wang, Zhongxin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Urol, Sanya, Peoples R China; [Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China; [Li, Gang] 309th Hosp PLA, Inst Organ Transplantat PLA, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Fu, WJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Urol, Sanya, Peoples R China.	fuweijun@hotmail.com			Beijing Natural Science Foundation [7142145]	Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Beijing Natural Science Foundation (No. 7142145) (PI Weijun Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Chen Y, 2008, J MATER SCI-MATER M, V19, P2261, DOI 10.1007/s10856-007-3335-8; Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Fu WJ, 2012, J BIOMED MATER RES A, V100A, P1725, DOI 10.1002/jbm.a.34134; Fu WJ, 2009, BJU INT, V104, P263, DOI 10.1111/j.1464-410X.2009.08366.x; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Hoganson DM, 2010, BIOMATERIALS, V31, P6934, DOI 10.1016/j.biomaterials.2010.05.026; Hu JA, 2010, BIOMATERIALS, V31, P7971, DOI 10.1016/j.biomaterials.2010.07.028; Huet C, 2001, J ENDOCRINOL, V169, P347, DOI 10.1677/joe.0.1690347; Lindberg K, 2001, BURNS, V27, P254, DOI 10.1016/S0305-4179(00)00113-3; Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017; McClelland R, 2008, TISSUE ENG PT A, V14, P59, DOI 10.1089/ten.a.2007.0058; Pietrzak WS, 2010, J CRANIOFAC SURG, V21, P177, DOI 10.1097/SCS.0b013e3181c50e9c; Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0; Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017; SOUTHGATE J, 1994, LAB INVEST, V71, P583; TEOFILI L, 1992, ANN HEMATOL, V65, P22, DOI 10.1007/BF01715121; Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068; WU XR, 1990, J BIOL CHEM, V265, P19170; YU J, 1990, J CELL BIOL, V111, P1207, DOI 10.1083/jcb.111.3.1207; Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005; Zhang YY, 2004, TISSUE ENG, V10, P181, DOI 10.1089/107632704322791835; Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5	25	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120244	10.1371/journal.pone.0120244	http://dx.doi.org/10.1371/journal.pone.0120244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775033	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500160
J	Zhang, CL; Zhao, HY; Li, J; Liu, HB; Wang, F; Wei, YJ; Su, JZ; Zhang, DW; Liu, TF; Zhang, Y				Zhang, Chunlong; Zhao, Hongyan; Li, Jie; Liu, Hongbo; Wang, Fang; Wei, Yanjun; Su, Jianzhong; Zhang, Dongwei; Liu, Tiefu; Zhang, Yan			The Identification of Specific Methylation Patterns across Different Cancers	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; PROTEIN INTERACTION DATABASE; BREAST-CANCER; DNA METHYLATION; GASTRIC-CANCER; COLORECTAL-CANCER; PROMOTER METHYLATION; EXPRESSION; CELLS; GENES	Abnormal DNA methylation is known as playing an important role in the tumorgenesis. It is helpful for distinguishing the specificity of diagnosis and therapeutic targets for cancers based on characteristics of DNA methylation patterns across cancers. High throughput DNA methylation analysis provides the possibility to comprehensively filter the epigenetics diversity across various cancers. We integrated whole-genome methylation data detected in 798 samples from seven cancers. The hierarchical clustering revealed the existence of cancer-specific methylation pattern. Then we identified 331 differentially methylated genes across these cancers, most of which (266) were specifically differential methylation in unique cancer. A DNA methylation correlation network (DMCN) was built based on the methylation correlation between these genes. It was shown the hubs in the DMCN were inclined to cancer-specific genes in seven cancers. Further survival analysis using the part of genes in the DMCN revealed high-risk group and low-risk group were distinguished by seven biomarkers (PCDHB15, WBSCR17, IGF1, GYPC, CYGB, ACTG2, and PRRT1) in breast cancer and eight biomarkers (ZBTB32, OR51B4, CCL8, TMEFF2, SALL3, GPSM1, MAGEA8, and SALL1) in colon cancer, respectively. At last, a protein-protein interaction network was introduced to verify the biological function of differentially methylated genes. It was shown that MAP3K14, PTN, ACVR1 and HCK sharing different DNA methylation and gene expression across cancers were relatively high degree distribution in PPI network. The study suggested that not only the identified cancer-specific genes provided reference for individual treatment but also the relationship across cancers could be explained by differential DNA methylation.	[Zhang, Chunlong; Li, Jie; Liu, Hongbo; Wang, Fang; Wei, Yanjun; Su, Jianzhong; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Zhao, Hongyan; Liu, Tiefu] Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Peoples R China; [Zhang, Dongwei] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Liu, TF (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Harbin, Peoples R China.	liutiefu2014@sina.com; tyozhang@ems.hrbmu.edu.cn	Liu, Hongbo/M-2162-2015	Liu, Hongbo/0000-0002-0733-8616	National Natural Science Foundation of China [31371334, 61203262, 61403112, 61402139]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by the National Natural Science Foundation of China [no. 31371334, 61203262, 61403112, 61402139]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Magid AF, 2014, ACS MED CHEM LETT, V5, P456, DOI [10.1021/ml5000838, 10.1021/ml500276a]; Antony P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-901; Anwar S, 2000, EUR J SURG ONCOL, V26, P635, DOI 10.1053/ejso.2000.0974; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Armendariz BG, 2014, EUR J NEUROSCI; Asiaf A, 2014, ASIAN PAC J CANCER P, V15, P6397, DOI 10.7314/APJCP.2014.15.15.6397; Barchitta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109478; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Choo Kong-Bung, 2011, Malays J Pathol, V33, P61; Correa Candace R, 2009, Eur J Cancer, V45 Suppl 1, P420, DOI 10.1016/S0959-8049(09)70073-5; Dallol A, 2003, CANCER RES, V63, P1054; Daniunaite K, 2014, J UROL; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Delgado-Cruzata L, 2012, EPIGENETICS-US, V7, P868, DOI 10.4161/epi.20830; Deng JY, 2014, AM J CANCER RES, V4, P518; Gallagher WM, 2001, FEBS LETT, V489, P59, DOI 10.1016/S0014-5793(00)02389-9; Ghasemi R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.31; Giani C, 1996, J CLIN ENDOCR METAB, V81, P990, DOI 10.1210/jc.81.3.990; Gokul Gopinathan, 2013, Subcell Biochem, V61, P597, DOI 10.1007/978-94-007-4525-4_26; Greten FR, 2004, CANCER LETT, V206, P193, DOI 10.1016/j.canlet.2003.08.029; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guardiola M, 2014, ATHEROSCLEROSIS, V237, P528, DOI 10.1016/j.atherosclerosis.2014.10.029; Guerrero-Setas D, 2013, MODERN PATHOL, V26, P1111, DOI 10.1038/modpathol.2013.32; Isserlin R, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq037; Kang C, 2014, WORLD J GASTROENTERO, V20, P6433, DOI 10.3748/wjg.v20.i21.6433; Kawano H, 2014, ANN SURG ONCOL, V21, pS696, DOI 10.1245/s10434-014-3818-z; Kiga K, 2014, RNA BIOL; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krupp M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-53; Li G, 2013, GENE; Li YX, 2014, DNA CELL BIOL, V33, P455, DOI 10.1089/dna.2013.2291; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Litovkin K, 2014, J CANCER RES CLIN, V140, P1849, DOI 10.1007/s00432-014-1738-8; Liu ZQ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00194; Mahon KL, 2014, BR J CANC; Miura D, 2014, J NIPPON MED SCH, V81, P211, DOI 10.1272/jnms.81.211; MURRAY TI, 1992, CANCER, V69, P2232, DOI 10.1002/1097-0142(19920501)69:9<2232::AID-CNCR2820690904>3.0.CO;2-0; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura J, 2014, WORLD J GASTROENTERO, V20, P11991, DOI 10.3748/wjg.v20.i34.11991; Oh JH, 2014, CANCER PREV RES, V7, P585, DOI 10.1158/1940-6207.CAPR-13-0320; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Pu H, 2014, CARCINOGENESIS; Sadr-Nabavi A, 2009, INT J CANCER, V124, P1727, DOI 10.1002/ijc.24108; Sakoda LC, 2008, CANCER EPIDEM BIOMAR, V17, P1066, DOI 10.1158/1055-9965.EPI-07-2680; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Schreiber G, 2010, CURR OPIN CHEM BIOL, V14, P511, DOI 10.1016/j.cbpa.2010.06.165; Soreide K, 2006, BRIT J SURG, V93, P395, DOI 10.1002/bjs.5328; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Broek AJ, 2014, EUR J HUM GENET; Varisli L, 2013, GENET TEST MOL BIOMA, V17, P562, DOI 10.1089/gtmb.2012.0524; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vidigal JA, 2014, TRENDS CELL BIOL; Vivanco I, 2014, BR J CANC; Wang L, 2014, ACTA BIOCH BIOPHYS S; Wang WQ, 2010, EXP CELL RES, V316, P2456, DOI 10.1016/j.yexcr.2010.05.027; Wei Z, 2007, BIOINFORMATICS, V23, P1537, DOI 10.1093/bioinformatics/btm129; Wu BK, 2014, CELL CYCLE, V13, P3222, DOI 10.4161/15384101.2014.950886; Wu MC, 2014, EPIGENETICS-US, V9, P318, DOI 10.4161/epi.27119; Yu XP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-79	69	35	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120361	10.1371/journal.pone.0120361	http://dx.doi.org/10.1371/journal.pone.0120361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774687	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500166
J	Zhang, YT; Zhang, DL; Jiang, YR; Sun, WQ; Wang, Y; Chen, WJ; Li, SH; Shi, L; Shen, XM; Zhang, J; Jiang, F				Zhang, Yunting; Zhang, Donglan; Jiang, Yanrui; Sun, Wanqi; Wang, Yan; Chen, Wenjuan; Li, Shenghui; Shi, Lu; Shen, Xiaoming; Zhang, Jun; Jiang, Fan			Association between Physical Activity and Teacher-Reported Academic Performance among Fifth-Graders in Shanghai: A Quantile Regression	PLOS ONE			English	Article							ACHIEVEMENT; EDUCATION; CHILDREN; INTERVENTIONS; EXERCISE; INCREASE; FITNESS; YOUTH	Introduction A growing body of literature reveals the causal pathways between physical activity and brain function, indicating that increasing physical activity among children could improve rather than undermine their scholastic performance. However, past studies of physical activity and scholastic performance among students often relied on parent-reported grade information, and did not explore whether the association varied among different levels of scholastic performance. Our study among fifth-grade students in Shanghai sought to determine the association between regular physical activity and teacher-reported academic performance scores (APS), with special attention to the differential associational patterns across different strata of scholastic performance. Method A total of 2,225 students were chosen through a stratified random sampling, and a complete sample of 1470 observations were used for analysis. We used a quantile regression analysis to explore whether the association between physical activity and teacher-reported APS differs by distribution of APS. Results Minimal-intensity physical activity such as walking was positively associated with academic performance scores (beta = 0.13, SE = 0.04). The magnitude of the association tends to be larger at the lower end of the APS distribution (beta = 0.24, SE = 0.08) than in the higher end of the distribution (beta = 0.00, SE = 0.07). Conclusion Based upon teacher-reported student academic performance, there is no evidence that spending time on frequent physical activity would undermine student's APS. Those students who are below the average in their academic performance could be worse off in academic performance if they give up minimal-intensity physical activity. Therefore, cutting physical activity time in schools could hurt the scholastic performance among those students who were already at higher risk for dropping out due to inadequate APS.	[Zhang, Yunting; Li, Shenghui; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Zhang, Yunting] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Child Hlth Advocacy Inst, Shanghai 200030, Peoples R China; [Zhang, Donglan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Jiang, Yanrui; Sun, Wanqi; Wang, Yan; Chen, Wenjuan; Shen, Xiaoming; Jiang, Fan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Dev & Behav Pediat, Shanghai 200030, Peoples R China; [Shi, Lu] Clemson Univ, Dept Publ Hlth Sci, Clemson, SC USA; [Shen, Xiaoming; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Minist E, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of California System; University of California Los Angeles; Shanghai Jiao Tong University; Clemson University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China.	zhangjunjim@gmail.com; fanjiang@shsmu.edu.cn	Shi, Lu/AAG-5414-2021; Jiang, Fan/AGX-9052-2022; Jiang, Fan/AHA-6297-2022; Meijer, Anna/K-5118-2016	Jiang, Fan/0000-0003-0634-101X; 	Chinese National Natural Science Foundation [81422040, 81172685]; MOE New Century Excellent Talents [NCET-13-0362]; Ministry of Science and Technology [2010CB535000]; Ministry of Health [201002006]; Shanghai Science and Technology Commission [12411950405, 13QH1401800]; Shanghai Municipal Committee of Education [11SG19]; Shanghai Key Discipline of Public Health	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); MOE New Century Excellent Talents; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Committee of Education; Shanghai Key Discipline of Public Health	The study was supported by Chinese National Natural Science Foundation (81422040, 81172685); MOE New Century Excellent Talents (NCET-13-0362); Ministry of Science and Technology (2010CB535000); Ministry of Health (201002006), Shanghai Science and Technology Commission (12411950405, 13QH1401800); Shanghai Municipal Committee of Education (11SG19), Shanghai Key Discipline of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonell C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3078; Bruni O, 2006, SLEEP MED, V7, P43, DOI 10.1016/j.sleep.2005.09.003; Centers For Disease Control, 2013, MAK DIFF YOUR SCH CH; Chomitz VR, 2009, J SCHOOL HEALTH, V79, P30, DOI 10.1111/j.1746-1561.2008.00371.x; Coe DP, 2006, MED SCI SPORT EXER, V38, P1515, DOI 10.1249/01.mss.0000227537.13175.1b; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Cooper H, 2007, BATTLE HOMEWORK; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Drollette ES, 2012, MED SCI SPORT EXER, V44, P2017, DOI 10.1249/MSS.0b013e318258bcd5; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; Good T. L., 2003, LOOKING CLASSROOMS, V9th; Griew P, 2010, PREV MED, V51, P282, DOI 10.1016/j.ypmed.2010.06.009; Group of China Obesity Task Force, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P97; Jago R, 2004, PREV MED, V39, P157, DOI 10.1016/j.ypmed.2004.01.014; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; [姜艳蕊 JIANG YanRui], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P444; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Lai X., 2007, J PHYS ED, V14, P125; Law M, 2006, DEV MED CHILD NEUROL, V48, P337, DOI 10.1017/S0012162206000740; Ministry of Education of PRC, 2010, OUTL CHIN MED LONG T; Ministry of Education of PRC, 2007, HEALTH MEDICINE RESE, V4, P5; Ministry of Education of PRC, 2011, REG ENS ONE HOUR PHY; Ministry of Health of PRC, 1998, STAND DAIL STUD TIM; Perry JC, 2010, COUNS PSYCHOL, V38, P269, DOI 10.1177/0011000009349272; Ploughman M, 2008, DEV NEUROREHABIL, V11, P236, DOI 10.1080/17518420801997007; Poropat AE, 2009, PSYCHOL BULL, V135, P322, DOI 10.1037/a0014996; Rasberry CN, 2011, PREV MED, V52, pS10, DOI 10.1016/j.ypmed.2011.01.027; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Roger Koenker, 2005, QUANTILEREGRESSION; Sallis JF, 1999, RES Q EXERCISE SPORT, V70, P127, DOI 10.1080/02701367.1999.10608030; Sektnan M, 2010, EARLY CHILD RES Q, V25, P464, DOI 10.1016/j.ecresq.2010.02.005; Shanghai Bureau of Statistics, 2010, SHANGH STAT YB; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2000, ED RES, V12, P30; Tremblay MS, 2000, PEDIATR EXERC SCI, V12, P312, DOI 10.1123/pes.12.3.312; Trudeau F, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-10; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; Xu Y, 2002, J PHYS ED, V9, P116	40	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0115483	10.1371/journal.pone.0115483	http://dx.doi.org/10.1371/journal.pone.0115483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774525	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500003
J	Bao, LD; Peng, R; Wang, Y; Ma, RL; Ren, XH; Meng, WB; Sun, FS; Fang, JX; Chen, P; Wang, Y; Chen, QH; Cai, J; Jin, J; Guo, JH; Yang, SC; Mo, XM; Zhang, EJ; Zhang, YR; Lu, ZX; Chen, BB; Yue, XJ; Zhu, MJ; Wang, YY; Li, XC; Bian, Y; Kong, SS; Pan, WF; Ding, Q; Cao, J; Liu, RP; Chen, N; Huang, XL; Agula, B; Lyu, HJ				Bao, Lidao; Peng, Rui; Wang, Yi; Ma, Ruilian; Ren, Xianhua; Meng, Wenbin; Sun, Fusheng; Fang, Junxia; Chen, Ping; Wang, Yang; Chen, Qiuhong; Cai, Jian; Jin, Jian; Guo, Jinhui; Yang, Shucheng; Mo, Xiaomei; Zhang, Enjing; Zhang, Yuerong; Lu, Zhaoxin; Chen, Binbin; Yue, Xiujuan; Zhu, Meijun; Wang, Yingying; Li, Xinchao; Bian, Yuan; Kong, Shaoshan; Pan, Wenfei; Ding, Qian; Cao, Jun; Liu, Rupin; Chen, Nan; Huang, Xuelian; Agula, B.; Lyu, Haijun			Significant Reduction of Antibiotic Consumption and Patients' Costs after an Action Plan in China, 2010-2014	PLOS ONE			English	Article							RESISTANCE	Introduction On July 1, 2011, the Chinese government launched a national Action Plan for antibiotic stewardship targeting antibiotic misuse in public hospitals. The aim of this study was to evaluate the impacts of the Action Plan in terms of frequency and intensity of antibiotic utilization and patients costs in public general hospitals. Methods Administrative pharmacy data from July 2010 to June 2014 were sampled from 65 public general hospitals and divided into three segments: (1) July 2010 to June 2011 as the preparation period; (2) July 2011 to June 2012 as the intervention period; and (3) July 2012 to June 2014 as the assessment period. The outcome measures included (1) antibiotic prescribing rates; (2) intensity of antibiotic consumption; (3) patients costs; and (4) duration of peri-operative antibiotic treatment in clean surgeries of thyroidectomy, breast, hernia, and orthopedic procedures. Longitudinal and cross-sectional analyses were conducted. Results Longitudinal analyses showed significant trend changes in the frequency and intensity of antibiotic consumption, the patients' costs on antibiotics, and the duration of antibiotic treatment received by surgical patients undergoing the 4 clean procedures during the intervention period. Cross-sectional analyses showed that the antibiotic prescribing rates were reduced to 35.3% and 12.9% in inpatient and outpatient settings, that the intensity of antibiotic consumption was reduced to 35.9 DDD/100 bed-days, that patients' costs on antibiotics were reduced significantly, and that the duration of peri-operative antibiotic treatment received by surgical patients undergoing the 4 types of clean procedures decreased to less than 24 hour during the assessment period. Conclusion The Action Plan, as a combination of managerial and professional strategies, was effective in reducing the frequency and intensity of antibiotic consumption, patients' costs on antibiotics, and the duration of peri-operative antibiotic treatment in the 4 clean surgeries.	[Bao, Lidao; Peng, Rui; Wang, Yi; Ma, Ruilian; Ren, Xianhua] Inner Mongolia Med Univ, Dept Pharm, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Meng, Wenbin] Inner Mongolia Med Univ, Dept Obstet, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China; [Sun, Fusheng] Peoples Hosp, Dept Pharm, Qingdao, Shandong, Peoples R China; [Fang, Junxia] Third Peoples Hosp, Dept Pharm, Fuyang, Zhejiang, Peoples R China; [Chen, Ping] Cent Hosp, Dept Pharm, Zibo, Shandong, Peoples R China; [Wang, Yang] Women & Childrens Hosp, Dept Pharm, Maanshan, Henan, Peoples R China; [Chen, Qiuhong] Peoples Liberat Army, Mil Hosp 175, Dept Pharm, Zhangzhou, Fujian, Peoples R China; [Cai, Jian] Fengxian Dist Psychiat Ctr, Dept Pharm, Shanghai, Peoples R China; [Jin, Jian] Shanghai Transport Univ, Affiliated Peoples Hosp 9, Dept Pharm, Shanghai, Peoples R China; [Guo, Jinhui] TB Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China; [Yang, Shucheng] Women & Childrens Hosp, Dept Pharm, Taiyuan, Shanxi, Peoples R China; [Mo, Xiaomei] Women & Childrens Hosp, Dept Pharm, Qingdao, Shandong, Peoples R China; [Zhang, Enjing] Third Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China; [Zhang, Yuerong] Huli Dist Women & Childrens Hosp, Dept Pharm, Xiamen, Fujian, Peoples R China; [Lu, Zhaoxin] Haici Med Grp, Dept Emergency, Qingdao, Shandong, Peoples R China; [Chen, Binbin] Ctr Psychiat, Dept Pharm, Xiamen, Fujian, Peoples R China; [Yue, Xiujuan] Capital Med Univ, Beijing Youan Hosp, Dept Pharm, Beijing, Peoples R China; [Zhu, Meijun] Minhang Dist Psychiat Ctr, Dept Pharm, Shanghai, Peoples R China; [Wang, Yingying] Dongchangfu Dist Women & Childrens Hosp, Dept Pharm, Liaocheng, Shandong, Peoples R China; [Li, Xinchao] Lintong Dist Chinese Med Hosp, Dept Pharm, Xian, Shanxi, Peoples R China; [Bian, Yuan] Peoples Hosp, Dept Pharm, Chengdu, Sichuan, Peoples R China; [Kong, Shaoshan] Women & Childrens Hosp, Dept Pharm, Zhuhai, Guangdong, Peoples R China; [Pan, Wenfei] Buwai Cardiol Hosp, Dept Pharm, Beijing, Peoples R China; [Ding, Qian] Capital Pediat Res Ctr, Affiliated Childrens Hosp, Dept Pharm, Beijing, Peoples R China; [Cao, Jun] Fifth Peoples Hosp, Dept Pharm, Suzhou, Zhejiang, Peoples R China; [Liu, Rupin] Cent Hosp, Dept Pharm, Xinyang, Henan, Peoples R China; [Chen, Nan] Southern China Med Univ, Peoples Hosp, Dept Pharm, Zhengzhou, Henan, Peoples R China; [Huang, Xuelian] Peoples Hosp, Dept Pharm, Luo Cty, Guangdong, Peoples R China; [Agula, B.] Inner Mongolia Med Univ, Dept Mongolian Med, Hohhot, Inner Mongolia, Peoples R China; [Lyu, Haijun] Inner Mongolia Med Univ, Ctr Sci Res, Affiliated Hosp, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Medical University; Inner Mongolia Medical University; Capital Medical University; Inner Mongolia Medical University; Inner Mongolia Medical University	Agula, B (corresponding author), Inner Mongolia Med Univ, Dept Mongolian Med, Hohhot, Inner Mongolia, Peoples R China.	agulab@163.com; haijunlyu@outlook.com	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Chen, QH/GXH-3158-2022		Nature Science Fund from Inner Mongolia Autonomous Region [2013MS1224]; Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University [NYFY2010YB006]; Youth Innovation Fund from Inner Mongolia Medical University [NY2010QN002]; Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University [NYFYZD20130158]	Nature Science Fund from Inner Mongolia Autonomous Region; Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University; Youth Innovation Fund from Inner Mongolia Medical University; Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University	This study was financially supported by Nature Science Fund from Inner Mongolia Autonomous Region to Lidao Bao (2013MS1224), Scientific Project Fund from Affiliated Hospital of Inner Mongolia Medical University to Yi Wang (NYFY2010YB006), Youth Innovation Fund from Inner Mongolia Medical University to Lidao Bao (NY2010QN002), and Key Scientific Fund from Affiliated Hospital of Inner Mongolia Medical University to Ruilian Ma (NYFYZD20130158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2013, INDIAN J PHARM SCI, V75, P11, DOI 10.4103/0250-474X.113531; Chinese Ministry of Health, 2012, CHIN HEALTHC ALM; Chinese Ministry of Health, 2010, REG PRESCR MAN; Chinese Ministry of Health, 2011, ACT PLAN ANT STEW CL; Chinese Ministry of Health, 2011, REG PHARM ADM MED I; Chinese Ministry of Heath, 2012, REG CLIN APPL ANT; Costelloe C., 2010, BMJ, V340; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Knobler SL, 2003, WHO GLOBAL STRATEGY; Li F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-353; Tao D, 2010, VOLUME, V2, P8; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wang JF, 2013, CURR TOP MED CHEM, V13, P1242, DOI 10.2174/15680266113139990011; WHO, 2020, WHO COLLABORATING CT; Xiao YH, 2011, DRUG RESIST UPDATE, V14, P236, DOI 10.1016/j.drup.2011.07.001; Yezli S, 2012, INT J ANTIMICROB AG, V40, P389, DOI 10.1016/j.ijantimicag.2012.07.009	17	44	47	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118868	10.1371/journal.pone.0118868	http://dx.doi.org/10.1371/journal.pone.0118868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767891	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500052
J	Crisan, AF; Oancea, C; Timar, B; Fira-Mladinescu, O; Tudorache, V				Crisan, Alexandru Florian; Oancea, Cristian; Timar, Bogdan; Fira-Mladinescu, Ovidiu; Tudorache, Voicu			Balance Impairment in Patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PREDICTING FALLS; POSTURAL CONTROL; ELDERLY-PEOPLE; RISK-FACTORS; DEPRESSION; COMMUNITY; FEAR; INDIVIDUALS; PREVENTION	Background/Purpose Chronic obstructive pulmonary disease (COPD) is a respiratory disease that results in progressive airflow limitation and respiratory distress. Physiopathological features of COPD suggest that people who suffer from this disease have many risk factors for falls that have been identified in older individuals. The aim of the study was to compare and quantify functional balance between COPD patients and healthy subjects; to investigate the risk of falls in acute stages of the disease and to identify risk factors that could lead to falls. Methods We studied 46 patients with moderate-severe COPD (29 stable and 17 in acute exacerbation - AECOPD) and 17 healthy subjects (control group) having similar demographic data. We analyzed the difference in Berg Balance Scale (BBS), Single Leg Stance (SLS) and Timed Up and Go test (TUG) between these three groups and the correlation of these scores with a number of incriminatory factors. Results The presence of COPD was associated with significant worsening of balance tests: BBS (55 control, vs. 53 COPD, vs. 44 AECOPD points p<0.001), TUG (8.6 control vs. 12.3 COPD vs. 15.9 AECOPD seconds. p<0.001), SLS (31.1 control vs. 17.7 COPD vs. 7.2 AECOPD seconds p<0.001) which may be associated with an increased risk of falls. Anxiety and depression were significantly associated with decreased balance test scores; anxiety (2 control vs. 6 COPD vs. 9 AECOPD points p<0.001) depression (2 control vs. 7 COPD vs. 12 AECOPD points p<0.001). Conclusions According to our results COPD patients in moderate-severe stages and especially those in exacerbation have a high risk of falls.	[Crisan, Alexandru Florian; Oancea, Cristian; Fira-Mladinescu, Ovidiu; Tudorache, Voicu] Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania; [Timar, Bogdan] Univ Med & Farm Timisoara, Dept Biostat & Med Informat, Timisoara, Romania	Victor Babes University of Medicine & Pharmacy, Timisoara; Victor Babes University of Medicine & Pharmacy, Timisoara	Oancea, C (corresponding author), Univ Med & Farm Timisoara, Dept Pulmonol, Timisoara, Romania.	oancea@umft.ro	Fira-Mladinescu, Ovidiu/C-5736-2011; Crișan, Alexandru/AHE-4031-2022	Fira-Mladinescu, Ovidiu/0000-0002-9034-5218; 				ALEXANDER NB, 1994, J AM GERIATR SOC, V42, P93, DOI 10.1111/j.1532-5415.1994.tb06081.x; [Anonymous], AM J RESP CRI CARE M, V166, P111; ARFKEN CL, 1994, AM J PUBLIC HEALTH, V84, P565, DOI 10.2105/AJPH.84.4.565; Barry E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-14; Bean JF, 2002, J GERONTOL A-BIOL, V57, pM751, DOI 10.1093/gerona/57.11.M751; Beauchamp MK, 2010, MULTIDISCIP RESP MED, V5, P417, DOI 10.1186/2049-6958-5-6-417; Beauchamp MK, 2012, CHEST, V141, P1496, DOI 10.1378/chest.11-1708; Berg K, 1996, CLIN GERIATR MED, V12, P705; Biderman A, 2002, J EPIDEMIOL COMMUN H, V56, P631, DOI 10.1136/jech.56.8.631; Bohannon RW, 2006, TOP GERIATR REHABIL, V22, P70; Brown AP, 1999, PHYSIOTHER THEORY PR, V15, P59; Butcher Scott J, 2004, J Cardiopulm Rehabil, V24, P274, DOI 10.1097/00008483-200407000-00013; Casaburi R, 2000, CHEST, V118, P1294, DOI 10.1378/chest.118.5.1294; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Evans RA, 2014, CHEST; Gianjoppe-Santos J., 2013, Fisioter Pesqui, V20, P379, DOI 10.1590/S1809-29502013000400013; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Lachman ME, 1998, J GERONTOL B-PSYCHOL, V53, pP43, DOI 10.1093/geronb/53B.1.P43; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Langley FA, 2007, INTERNET J ALLIED HE, V5; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Maltais F, 2000, CLIN CHEST MED, V21, P665, DOI 10.1016/S0272-5231(05)70176-3; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mikkelsen RL, 2004, NORD J PSYCHIAT, V58, P65, DOI 10.1080/08039480310000824; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Oga T, 2007, RESP MED, V101, P146, DOI 10.1016/j.rmed.2006.04.001; Ozge A, 2001, Electromyogr Clin Neurophysiol, V41, P185; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roig M, 2011, RESP MED, V105, P461, DOI 10.1016/j.rmed.2010.08.015; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022; Spruit MA, 2003, THORAX, V58, P752, DOI 10.1136/thorax.58.9.752; STUDENSKI S, 1994, J AM GERIATR SOC, V42, P297, DOI 10.1111/j.1532-5415.1994.tb01755.x; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1994, J GERONTOL, V49, pM140, DOI 10.1093/geronj/49.3.M140; Turcu A, 2004, GERONTOLOGY, V50, P303, DOI 10.1159/000079128; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289	40	46	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120573	10.1371/journal.pone.0120573	http://dx.doi.org/10.1371/journal.pone.0120573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768731	Green Published, gold			2022-12-26	WOS:000351277500129
J	Kalaiarasan, P; Kumar, B; Chopra, R; Gupta, V; Subbarao, N; Bamezai, RNK				Kalaiarasan, Ponnusamy; Kumar, Bhupender; Chopra, Rupali; Gupta, Vibhor; Subbarao, Naidu; Bamezai, Rameshwar N. K.			In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2	PLOS ONE			English	Article							TUMOR M2-PYRUVATE KINASE; AMINO-ACID SUBSTITUTIONS; MISSENSE MUTATIONS; CANCER; PROTEIN; GROWTH; PKM2; METABOLISM; EXPRESSION; ISOFORM	Role of, 29-non-synonymous, 15-intronic, 3-close to UTR, single nucleotide polymorphisms (SNPs) and 2 mutations of Human Pyruvate Kinase (PK) M2 were investigated by in-silico and in-vitro functional studies. Prediction of deleterious substitutions based on sequence homology and structure based servers, SIFT, PANTHER, SNPs&GO, PhD-SNP, SNAP and PolyPhen, depicted that 19% emerged common between all the mentioned programs. SNPeffect and HOPE showed three substitutions (C31F, Q310P and S437Y) in-silico as deleterious and functionally important. In-vitro activity assays showed C31F and S437Y variants of PKM2 with reduced activity, while Q310P variant was catalytically inactive. The allosteric activation due to binding of fructose 1-6 bisphosphate (FBP) was compromised in case of S437Y nsSNP variant protein. This was corroborated through molecular dynamics (MD) simulation study, which was also carried out in other two variant proteins. The 5 intronic SNPs of PKM2, associated with sporadic breast cancer in a case-control study, when subjected to different computational analyses, indicated that 3 SNPs (rs2856929, rs8192381 and rs8192431) could generate an alternative transcript by influencing splicing factor binding to PKM2. We propose that these, potentially functional and important variations, both within exons and introns, could have a bearing on cancer metabolism, since PKM2 has been implicated in cancer in the recent past.	[Kalaiarasan, Ponnusamy; Chopra, Rupali] Shri Mata Vaishno Devi Univ, Sch Biotechnol, Katra, Jammu & Kashmir, India; [Kumar, Bhupender; Gupta, Vibhor; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India; [Subbarao, Naidu; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India	Shri Mata Vaishno Devi University; Jawaharlal Nehru University, New Delhi; Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India.	bamezai@hotmail.com	Kumar, Bhupender/GLR-8413-2022; Subbarao, Prof Naidu/AAZ-1832-2020	Kumar, Bhupender/0000-0003-3887-5040; Subbarao, Prof Naidu/0000-0002-1720-2165; Bamezai, R.N.K/0000-0002-5128-2859	JK DST	JK DST	P.K thanks J&K DST for providing Senior Research Fellowship.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brunham LR, 2005, PLOS GENET, V1, P739, DOI 10.1371/journal.pgen.0010083; Calabrese R, 2009, HUM MUTAT, V30, P1237, DOI 10.1002/humu.21047; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Harris I, 2012, CELL RES, V22, P447, DOI 10.1038/cr.2011.203; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Huang CS, 2007, CLIN CHIM ACTA, V384, P69, DOI 10.1016/j.cca.2007.06.001; Hulleman E, 2009, HAEMATOL-HEMATOL J, V94, P1322, DOI 10.3324/haematol.2009.011437; Iqbal MA, 2014, FEBS LETT; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2002, BRIT J NUTR, V87, pS23, DOI [10.1079/BJN2001455, 10.1079/BJN2001454]; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rabbani G, 2014, APPL MICROBIOL BIOT, V98, P2533, DOI 10.1007/s00253-013-5123-3; Schneider J, 2002, ANTICANCER RES, V22, P311; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie JY, 2014, BBA-BIOMEMBRANES, V1838, P994, DOI 10.1016/j.bbamem.2013.12.011; YAMADA K, 1990, J BIOL CHEM, V265, P19885; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang B, 2004, WORLD J GASTROENTERO, V10, P1643, DOI 10.3748/wjg.v10.i11.1643	45	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120469	10.1371/journal.pone.0120469	http://dx.doi.org/10.1371/journal.pone.0120469			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768091	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500126
J	Nishimura, T; Hosoi, H; Saito, O; Miyamae, R; Shimokura, R; Yamanaka, T; Kitahara, T; Levitt, H				Nishimura, Tadashi; Hosoi, Hiroshi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Yamanaka, Toshiaki; Kitahara, Tadashi; Levitt, Harry			Cartilage Conduction Is Characterized by Vibrations of the Cartilaginous Portion of the Ear Canal	PLOS ONE			English	Article							BONE-CONDUCTION; HEARING; SOUND; TRANSMISSION; STIMULATION; THRESHOLDS; HEAD	Cartilage conduction (CC) is a new form of sound transmission which is induced by a transducer being placed on the aural cartilage. Although the conventional forms of sound transmission to the cochlea are classified into air or bone conduction (AC or BC), previous study demonstrates that CC is not classified into AC or BC (Laryngoscope 124: 1214-1219). Next interesting issue is whether CC is a hybrid of AC and BC. Seven volunteers with normal hearing participated in this experiment. The threshold-shifts by water injection in the ear canal were measured. AC, BC, and CC thresholds at 0.5-4 kHz were measured in the 0%-, 40%-, and 80%-water injection conditions. In addition, CC thresholds were also measured for the 20%-, 60%-, 100%-, and overflowing-water injection conditions. The contributions of the vibrations of the cartilaginous portion were evaluated by the threshold-shifts. For AC and BC, the threshold-shifts by the water injection were 22.6-53.3 dB and within 14.9 dB at the frequency of 0.5-4 kHz, respectively. For CC, when the water was filled within the bony portion, the thresholds were elevated to the same degree as AC. When the water was additionally injected to reach the cartilaginous portion, the thresholds at 0.5 and 1 kHz dramatically decreased by 27.4 and 27.5 dB, respectively. In addition, despite blocking AC by the injected water, the CC thresholds in force level were remarkably lower than those for BC. The vibration of the cartilaginous portion contributes to the sound transmission, particularly in the low frequency range. Although the airborne sound is radiated into the ear canal in both BC and CC, the mechanism underlying its generation is different between them. CC generates airborne sound in the canal more efficiently than BC. The current findings suggest that CC is not a hybrid of AC and BC.	[Nishimura, Tadashi; Saito, Osamu; Miyamae, Ryosuke; Shimokura, Ryota; Yamanaka, Toshiaki; Kitahara, Tadashi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan; [Hosoi, Hiroshi] Nara Med Univ, Kashihara, Nara 634, Japan; [Levitt, Harry] CUNY, New York, NY 10021 USA	Nara Medical University; Nara Medical University; City University of New York (CUNY) System	Nishimura, T (corresponding author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Kashihara, Nara 634, Japan.	t-nishim@naramed-u.ac.jp			Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI [26462564]	Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This research was supported by a Health and Labour Science Research Grants for the Sensory and Communicative Disorders from the Ministry of Health, Labour and Welfare, Japan. This study was also supported by JSPS KAKENHI Grant Number 26462564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dillon H., 2001, HEARING AIDS; Donaldson JA, 1980, OTOLARYNGOLOGY, V1, P26; FARRIOR JB, 1983, LARYNGOSCOPE, V93, P75; Hosoi H., 2004, Japanese Patent, Patent No. [4541111, 4541111, 17]; Hosoi H., 2010, ARCH MAT SCI ENG, V42, P104; Ito T, 2011, AUDIOL NEURO-OTOL, V16, P12, DOI 10.1159/000314282; LAU C C, 1986, British Journal of Audiology, V20, P261, DOI 10.3109/03005368609079025; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lightfoot G R, 1979, Br J Audiol, V13, P53, DOI 10.3109/03005367909078877; Morimoto C, 2014, J REHABIL RES DEV, V51, P325, DOI 10.1682/JRRD.2013.05.0128; NILO ER, 1968, J SPEECH HEAR RES, V11, P805, DOI 10.1044/jshr.1104.805; Nishimura T, 2015, AURIS NASUS LARYNX, V42, P15, DOI 10.1016/j.anl.2014.08.001; Nishimura T, 2014, LARYNGOSCOPE, V124, P1214, DOI 10.1002/lary.24485; Nishimura T, 2013, AURIS NASUS LARYNX, V40, P440, DOI 10.1016/j.anl.2012.12.003; Shimokura R, 2015, J SOUND VIB, V335, P261, DOI 10.1016/j.jsv.2014.09.021; Shimokura R, 2014, J ACOUST SOC AM, V135, P1959, DOI 10.1121/1.4868372; Shimokura R, 2013, APPL ACOUST, V74, P1234, DOI 10.1016/j.apacoust.2013.04.013; Shipton M S, 1980, Br J Audiol, V14, P86, DOI 10.3109/03005368009078908; Sohmer H, 2000, HEARING RES, V146, P81, DOI 10.1016/S0378-5955(00)00099-X; Stenfelt S, 2005, OTOL NEUROTOL, V26, P1245, DOI 10.1097/01.mao.0000187236.10842.d5; Stenfelt S, 2003, J ACOUST SOC AM, V113, P902, DOI 10.1121/1.1534606; Watanabe T, 2008, EAR HEARING, V29, P667, DOI 10.1097/AUD.0b013e3181775dde; Williams P, 1980, GRAYS ANATOMY, P1190	23	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120135	10.1371/journal.pone.0120135	http://dx.doi.org/10.1371/journal.pone.0120135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768088	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500110
J	Wang, WM; Zhang, Y; Lu, WY; Liu, KY				Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan			Mitochondrial Reactive Oxygen Species Regulate Adipocyte Differentiation of Mesenchymal Stem Cells in Hematopoietic Stress Induced by Arabinosylcytosine	PLOS ONE			English	Article							BONE-MARROW ADIPOCYTES; OXIDATIVE STRESS; COMPLEX III; PPAR-GAMMA; ADIPOGENESIS; CHEMOTHERAPY; ENGRAFTMENT; OSTEOBLASTOGENESIS; BIOGENESIS; METABOLISM	Objective The increase in adipocytes induced by chemotherapeutic drugs may play a negative role in hematopoietic recovery. However, the mechanism underlying adipocyte differentiation of mesenchymal stem cells (MSCs) in hematopoietic stress is still unknown. Hence, the involvement of reactive oxygen species (ROS) in adipocyte differentiation under hematopoietic stress was investigated in vitro and in vivo. Methods The roles of cellular ROS in adipogenesis were investigated in vivo through an adipocyte hyperplasia marrow model under hematopoietic stress induced by arabinosylcytosine (AraC) and in vitro via adipocyte differentiation of human MSCs. ROS levels were detected using the CM-H(2)DCFDA probe and Mito-SOX dye. Adipogenesis was evaluated by histopathology and oil red O staining, whereas detection of mRNA levels of antioxidant enzymes and adipogenesis markers was performed using quantitative real-time polymerase chain reaction analysis. Results ROS were found to play an important role in regulating adipocyte differentiation of MSCs by activating peroxisome proliferator-activated receptor gamma (PPAR.,) while the antioxidant N-acetyl-L-cysteine acts through ROS to inhibit adipocyte differentiation. The elevated ROS levels induced by Ara-C were caused by both over-generation of mitochondrial ROS and reduction of antioxidant enzymes (Cu/Zn Superoxide dismutase and catalase). Our findings suggest that a mitochondrial-targeted antioxidant could diminish adipocyte differentiation.	[Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan] Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China; [Wang, Weimin; Zhang, Yao; Lu, Wenyi; Liu, Kaiyan] Peking Univ, Inst Hematol, Beijing 100871, Peoples R China	Peking University; Peking University	Liu, KY (corresponding author), Peking Univ, Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China.	liukaiyan@medmail.com.cn			National Natural Science Foundation of China [81270572]; National Basic Research 973 Program [2013CB733701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program(National Basic Research Program of China)	Funding: The authors were supported by fundings from National Natural Science Foundation of China (Grant Number: 81270572) and National Basic Research 973 Program (Grant Number: 2013CB733701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; Bethel M, 2013, CURR OSTEOPOROS REP, V11, P99, DOI 10.1007/s11914-013-0135-6; Calzadilla P, 2011, INT J MOL SCI, V12, P6936, DOI 10.3390/ijms12106936; Carew JS, 2003, LEUKEMIA, V17, P1437, DOI 10.1038/sj.leu.2403043; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Carriere A, 2009, ARTERIOSCL THROM VAS, V29, P1093, DOI 10.1161/ATVBAHA.109.188318; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; DAMON LE, 1994, LEUKEMIA, V8, P535; del Canizo C, 1999, BONE MARROW TRANSPL, V23, P901; del Canizo MC, 1999, HAEMATOLOGICA, V84, P511; DOMENECH J, 1994, BRIT J HAEMATOL, V88, P488, DOI 10.1111/j.1365-2141.1994.tb05064.x; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Hole PS, 2011, BLOOD, V117, P5816, DOI 10.1182/blood-2011-01-326025; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hu LP, 2014, BLOOD, V124, pE45, DOI 10.1182/blood-2014-03-559369; Imhoff BR, 2010, DIFFERENTIATION, V80, P31, DOI 10.1016/j.diff.2010.04.005; Jitschin R, 2014, BLOOD, V123, P2663, DOI 10.1182/blood-2013-10-532200; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; Kim JH, 2014, CELL BIOL INT, V38, P32, DOI 10.1002/cbin.10170; Kong Y, 2013, BIOL BLOOD MARROW TR, V19, P1465, DOI 10.1016/j.bbmt.2013.07.014; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee KH, 2004, BONE MARROW TRANSPL, V33, P729, DOI 10.1038/sj.bmt.1704428; Lee OH, 2012, PHYTOTHER RES, V26, P403, DOI 10.1002/ptr.3568; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Regina Jitschin ADH, 2014, BLOOD; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhu RJ, 2013, INT J HEMATOL, V97, P58, DOI 10.1007/s12185-012-1233-4	40	64	67	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120629	10.1371/journal.pone.0120629	http://dx.doi.org/10.1371/journal.pone.0120629			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768922	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500130
J	Wang, XH; Yang, J; Ai, DN; Zheng, YC; Tang, SY; Wang, YT				Wang, Xuehu; Yang, Jian; Ai, Danni; Zheng, Yongchang; Tang, Songyuan; Wang, Yongtian			Adaptive Mesh Expansion Model (AMEM) for Liver Segmentation from CT Image	PLOS ONE			English	Article							REPRESENTATION	This study proposes a novel adaptive mesh expansion model (AMEM) for liver segmentation from computed tomography images. The virtual deformable simplex model (DSM) is introduced to represent the mesh, in which the motion of each vertex can be easily manipulated. The balloon, edge, and gradient forces are combined with the binary image to construct the external force of the deformable model, which can rapidly drive the DSM to approach the target liver boundaries. Moreover, tangential and normal forces are combined with the gradient image to control the internal force, such that the DSM degree of smoothness can be precisely controlled. The triangular facet of the DSM is adaptively decomposed into smaller triangular components, which can significantly improve the segmentation accuracy of the irregularly sharp corners of the liver. The proposed method is evaluated on the basis of different criteria applied to 10 clinical data sets. Experiments demonstrate that the proposed AMEM algorithm is effective and robust and thus outperforms six other up-to-date algorithms. Moreover, AMEM can achieve a mean overlap error of 6.8% and a mean volume difference of 2.7%, whereas the average symmetric surface distance and the root mean square symmetric surface distance can reach 1.3 mm and 2.7 mm, respectively.	[Wang, Xuehu; Yang, Jian; Ai, Danni; Tang, Songyuan; Wang, Yongtian] Beijing Inst Technol, Beijing Engn Res Ctr Mixed Real & Adv Display, Sch Opt & Elect, Beijing 100081, Peoples R China; [Zheng, Yongchang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China; [Zheng, Yongchang] Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, J (corresponding author), Beijing Inst Technol, Beijing Engn Res Ctr Mixed Real & Adv Display, Sch Opt & Elect, Beijing 100081, Peoples R China.	jyang@bit.edu.cn			National Basic Research Program of China [2010CB732505, 2013CB328806]; Key Projects in the National Science & Technology Pillar Program [2013BAI01B01]; National Hi-Tech Research and Development Program [2013AA013703]	National Basic Research Program of China(National Basic Research Program of China); Key Projects in the National Science & Technology Pillar Program; National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (2010CB732505, 2013CB328806), the Key Projects in the National Science & Technology Pillar Program (2013BAI01B01) and the National Hi-Tech Research and Development Program (2013AA013703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anter AM, 2013, FED CONF COMPUT SCI, P193; Baghdadi L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-237; Belaid A, 2011, IEEE T INF TECHNOL B, V15, P138, DOI 10.1109/TITB.2010.2090889; Chen Y, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2667; Chen Y, 2011, EUR J RADIOL, V80, pE42, DOI 10.1016/j.ejrad.2010.07.003; Chi Y, 2007, P MICCAI WORKSH 3D S, P167; Ciecholewski M, 2014, J SIGNAL PROCESS SYS, V74, P151, DOI 10.1007/s11265-013-0755-1; Delingette H., 1994, Proceedings of the 1994 IEEE Workshop on Motion of Non-Rigid and Articulated Objects (Cat. No.94TH0671-8), P152, DOI 10.1109/MNRAO.1994.346242; Delingette H, 1999, INT J COMPUT VISION, V32, P111, DOI 10.1023/A:1008157432188; DELINGETTE H, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P856, DOI 10.1109/CVPR.1994.323913; Gao Y, 2012, MED IMAGE ANAL, V16, P1216, DOI 10.1016/j.media.2012.06.002; Goldenstein S, 2005, COMPUT GRAPH FORUM, V24, P729, DOI 10.1111/j.1467-8659.2005.00898.x; HEBERT M, 1995, IEEE T PATTERN ANAL, V17, P681, DOI 10.1109/34.391410; Heimann T., 2007, 3D SEGMENTATION CLIN, P161; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Heimann T, 2009, MED IMAGE ANAL, V13, P543, DOI 10.1016/j.media.2009.05.004; Kainmuller D., 2007, P MICCAI WORKSHOP 3D, V109, P116; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Ling H., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587393; Mainenti PP, 2010, ABDOM IMAGING, V35, P511, DOI 10.1007/s00261-009-9555-2; McInerney T., 1993, [1993] Proceedings Fourth International Conference on Computer Vision, P518, DOI 10.1109/ICCV.1993.378169; Mohamadnejad M, 2011, GASTROINTEST ENDOSC, V73, P71, DOI 10.1016/j.gie.2010.08.050; Montagnat J, 1997, LECT NOTES COMPUT SC, V1205, P13, DOI 10.1007/BFb0029220; Muller M, 2007, J VIS COMMUN IMAGE R, V18, P109, DOI 10.1016/j.jvcir.2007.01.005; Okada T, 2008, ACAD RADIOL, V15, P1390, DOI 10.1016/j.acra.2008.07.008; Oliveira DAB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-30; Rikxoort E., 2007, P MICCAI WORKSH 3 D, P101; Rusko L, 2009, MED IMAGE ANAL, V13, P871, DOI 10.1016/j.media.2009.07.009; Saddi M., 2007, P MICCAI WORKSH 3D S, P207; Seghers D., 2007, P MICCAI WORKSH 3 D, P135; Soler L, 2001, Comput Aided Surg, V6, P131, DOI 10.1002/igs.1016; Zhang ST, 2012, MED IMAGE ANAL, V16, P1385, DOI 10.1016/j.media.2012.07.007; Zhang X, 2010, IEEE T BIO-MED ENG, V57, P2622, DOI 10.1109/TBME.2010.2056369; Zheng CX, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185594	34	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118064	10.1371/journal.pone.0118064	http://dx.doi.org/10.1371/journal.pone.0118064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769030	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500019
J	Debeb, BG; Smith, DL; Li, L; Larson, R; Xu, W; Woodward, WA				Debeb, Bisrat G.; Smith, Daniel L.; Li, Li; Larson, Richard; Xu, Wei; Woodward, Wendy A.			Differential Effect of Phosphorylation-Defective Survivin on Radiation Response in Estrogen Receptor-Positive and -Negative Breast Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; INITIATING CELLS; DOWN-REGULATION; EXPRESSION; APOPTOSIS; RESISTANCE; RADIORESISTANCE; GENE; RADIOSENSITIVITY; SENSITIZATION	Survivin is a key member of the inhibitor of apoptosis protein family, and is considered a promising therapeutic target due to its universal overexpression in cancers. Survivin is implicated in cellular radiation response through its role in apoptosis, cell division, and DNA damage response. In the present study, analysis of publically available data sets showed that survivin gene expression increased with breast cancer stage (p < 0.00001) and was significantly higher in estrogen receptor-negative cancers as compared to estrogen receptor-positive cancers (p = 9e-46). However, survivin was prognostic in estrogen receptor-positive tumors (p = 0.03) but not in estrogen receptor-negative tumors (p = 0.28). We assessed the effect of a survivin dominant-negative mutant on colony-formation (2D) and mammosphere-formation (3D) efficiency, and radiation response in the estrogen receptor-positive MCF7 and estrogen receptor-negative SUM149 breast cancer cell lines. The colony-formation efficiency was significantly lower in the dominant-negative survivin-transduced cells versus control MCF7 cells (0.42 vs. 0.58, p < 0.01), but it was significantly higher in dominant-negative population versus control-transduced SUM149 cells (0.29 vs. 0.20, p < 0.01). A similar, non-significant, trend in mammosphere-formation efficiency was observed. We compared the radiosensitivity of cells stably expressing dominant-negative survivin with their controls in both cell lines under 2D and 3D culture conditions following exposure to increasing doses of radiation. We found that the dominant-negative populations were radioprotective in MCF7 cells but radiosensitive in SUM149 cells compared to the control-transduced population; further, Taxol was synergistic with the survivin mutant in SUM149 but not MCF7. Our data suggests that survivin modulation influences radiation response differently in estrogen receptor-positive and estrogen receptor-negative breast cancer subtypes, warranting further investigation.	[Debeb, Bisrat G.; Smith, Daniel L.; Li, Li; Larson, Richard; Xu, Wei; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020	Woodward, Wendy/0000-0002-7935-739X; Smith, Daniel/0000-0002-2440-1349	National Institutes of Health [R01CA138239-01]; State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; Susan G. Komen [KG101478, KG111387]; M.D. Anderson Cancer Center; Center for Stem Cell and Developmental Biology; Estate of CW Johnson; NATIONAL CANCER INSTITUTE [R01CA138239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas Grant for Rare and Aggressive Breast Cancer Research Program; Susan G. Komen(Susan G. Komen Breast Cancer Foundation); M.D. Anderson Cancer Center; Center for Stem Cell and Developmental Biology; Estate of CW Johnson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R01CA138239-01; and The State of Texas Grant for Rare and Aggressive Breast Cancer Research Program. Bisrat G. Debeb and Wei Xu are recipients of Susan G. Komen for the cure (R) Postdoctoral Fellowships, KG101478 and KG111387, respectively. Daniel L. Smith is a recipient of a fellowship from the M.D. Anderson Cancer Center, Center for Stem Cell and Developmental Biology and the Estate of CW Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Asanuma K, 2000, JPN J CANCER RES, V91, P1204, DOI 10.1111/j.1349-7006.2000.tb00906.x; Cao C, 2004, ONCOGENE, V23, P7047, DOI 10.1038/sj.onc.1207929; Capalbo G, 2010, INT J RADIAT ONCOL, V77, P226, DOI 10.1016/j.ijrobp.2009.12.001; Chakravarti A, 2004, ONCOGENE, V23, P7494, DOI 10.1038/sj.onc.1208049; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chen XJ, 2009, MODERN PATHOL, V22, P699, DOI 10.1038/modpathol.2009.25; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Debeb BG, 2012, STEM CELLS, V30, P2366, DOI 10.1002/stem.1219; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kami K, 2005, SURGERY, V138, P299, DOI 10.1016/j.surg.2005.05.009; Kennedy SM, 2003, BRIT J CANCER, V88, P1077, DOI 10.1038/sj.bjc.6600776; Lee CW, 2008, CANCER RES, V68, P5273, DOI 10.1158/0008-5472.CAN-07-6673; Lee CW, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2200; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu B, 2004, CANCER RES, V64, P2840, DOI 10.1158/0008-5472.CAN-03-3547; Mamounas EP, 2012, J CLIN ONCOL, V30, P3960, DOI 10.1200/JCO.2011.40.8369; Mamounas EP, 2010, J CLIN ONCOL, V28, P1677, DOI 10.1200/JCO.2009.23.7610; Mesri M, 2001, J CLIN INVEST, V108, P981, DOI 10.1172/JCI12983; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Peng XC, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-46; Pennati M, 2003, J INVEST DERMATOL, V120, P648, DOI 10.1046/j.1523-1747.2003.12082.x; Petrarca CR, 2011, CLIN BREAST CANCER, V11, P129, DOI 10.1016/j.clbc.2011.03.002; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Rodel C, 2003, INT J RADIAT ONCOL, V55, P1341, DOI 10.1016/S0360-3016(02)04618-7; Rodel F, 2011, CURR MED CHEM, V18, P191, DOI 10.2174/092986711794088362; Rodel F, 2008, INT J RADIAT ONCOL, V71, P247, DOI 10.1016/j.ijrobp.2008.02.011; Sah NK, 2006, INT J RADIAT ONCOL, V66, P852, DOI 10.1016/j.ijrobp.2006.06.049; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Span PN, 2004, CLIN CHEM, V50, P1986, DOI 10.1373/clinchem.2004.039149; Tanaka K, 2000, CLIN CANCER RES, V6, P127; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Woodward WA, 2010, CANCER-AM CANCER SOC, V116, P2840, DOI 10.1002/cncr.25173; Woodward WA, 2009, SEMIN RADIAT ONCOL, V19, P87, DOI 10.1016/j.semradonc.2008.11.003; Yamanaka K, 2011, INT J ONCOL, V39, P569, DOI 10.3892/ijo.2011.1077	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120719	10.1371/journal.pone.0120719	http://dx.doi.org/10.1371/journal.pone.0120719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763854	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300047
J	Heiman-Patterson, TD; Blankenhorn, EP; Sher, RB; Jiang, J; Welsh, P; Dixon, MC; Jeffrey, JI; Wong, P; Cox, GA; Alexander, GM				Heiman-Patterson, Terry D.; Blankenhorn, Elizabeth P.; Sher, Roger B.; Jiang, Juliann; Welsh, Priscilla; Dixon, Meredith C.; Jeffrey, Jeremy I.; Wong, Philip; Cox, Gregory A.; Alexander, Guillermo M.			Genetic Background Effects on Disease Onset and Lifespan of the Mutant Dynactin p150(Glued) Mouse Model of Motor Neuron Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SOD1; MUTATIONS; TRANSPORT	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease primarily affecting motor neurons in the central nervous system. Although most cases of ALS are sporadic, about 5-10% of cases are familial (FALS) with approximately 20% of FALS caused by mutations in the Cu/Zn superoxide dismutase (SOD1) gene. We have reported that hSOD1G93A transgenic mice modeling this disease show a more severe phenotype when the transgene is bred on a pure SJL background and a milder phenotype when bred on a pure B6 background and that these phenotype differences link to a region on mouse Chromosome 17. To examine whether other models of motor neuron degeneration are affected by genetic background, we bred the mutant human dynactin p150Glued (G59S-hDCTN1) transgene onto inbred SJL and B6 congenic lines. This model is based on an autosomal dominant lower motor neuron disease in humans linked to a mutation in the p150Glued subunit of the dynactin complex. As seen in hSOD1-G93A mice, we observed a more severe phenotype with earlier disease onset (p<0.001) and decreased survival (p<0.00001) when the G59S-hDCTN1 transgene was bred onto the SJL background and delayed onset (p<0.0001) with increased survival (p<0.00001) when bred onto the B6 background. Furthermore, B6 mice with an SJL derived chromosome 17 interval previously shown to delay disease onset in hSOD1-G93A mice also showed delays onset in G59S-hDCTN1 mice suggesting that at least some genetic modifiers are shared. We have shown that genetic background influences phenotype in G59S-hDCTN1 mice, in part through a region of chromosome 17 similar to the G93-hSOD1 ALS mouse model. These results support the presence of genetic modifiers in both these models some of which may be shared. Identification of these modifiers will highlight intracellular pathways involved in motor neuron disease and provide new therapeutic targets that may be applicable to motor neuron degeneration.	[Heiman-Patterson, Terry D.; Jiang, Juliann; Welsh, Priscilla; Dixon, Meredith C.; Jeffrey, Jeremy I.; Alexander, Guillermo M.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Blankenhorn, Elizabeth P.] Drexel Univ, Coll Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Cox, Gregory A.] Jackson Lab, Bar Harbor, ME USA; [Wong, Philip] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Sher, Roger B.] Univ Maine, Dept Mol & Biomed Sci, Orono, ME USA	Drexel University; Drexel University; Jackson Laboratory; Johns Hopkins University; University of Maine System; University of Maine Orono	Heiman-Patterson, TD (corresponding author), Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.	theiman@drexelmed.edu			ALS Hope Foundation	ALS Hope Foundation	This work was funded by the ALS Hope Foundation. All of the funding was from the ALS Hope Foundation and the foundation played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The ALS Hope Foundation provides funds for ALS related projects in the lab and maintenance of the animal colonies.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Blankenhorn EP, 2011, ANN NEUROL, V70, P887, DOI 10.1002/ana.22642; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Langefeld CD, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Ludolph AC, 2012, CURR OPIN NEUROL, V25, P530, DOI 10.1097/WCO.0b013e328356d328; Magrane J, 2014, HUM MOL GENET, V23, P1413, DOI 10.1093/hmg/ddt528; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Peviani M, 2010, CNS NEUROL DISORD-DR, V9, P491, DOI 10.2174/187152710791556096; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sasaki S, 2005, ACTA NEUROPATHOL, V110, P48, DOI 10.1007/s00401-005-1021-9; Sher R, 2014, AMYOTROPH LATERAL SC, V10, P1; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Swarup V, 2011, PROG NEURO-PSYCHOPH, V35, P363, DOI 10.1016/j.pnpbp.2010.08.006; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117848	10.1371/journal.pone.0117848	http://dx.doi.org/10.1371/journal.pone.0117848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763819	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300010
J	Li, GW; Thabane, L; Ioannidis, G; Kennedy, C; Papaioannou, A; Adachi, JD				Li, Guowei; Thabane, Lehana; Ioannidis, George; Kennedy, Courtney; Papaioannou, Alexandra; Adachi, Jonathan D.			Comparison between Frailty Index of Deficit Accumulation and Phenotypic Model to Predict Risk of Falls: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) Hamilton Cohort	PLOS ONE			English	Article							CANADIAN MULTICENTER OSTEOPOROSIS; OLDER-PEOPLE; HEALTH; EPIDEMIOLOGY; FRACTURES; ADULTS; DISABILITY; RATIONALE; MORTALITY; VALIDITY	Objectives To compare the predictive accuracy of the frailty index (FI) of deficit accumulation and the phenotypic frailty (PF) model in predicting risks of future falls, fractures and death in women aged >= 55 years. Methods Based on the data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) 3- year Hamilton cohort (n = 3,985), we compared the predictive accuracy of the FI and PF in risks of falls, fractures and death using three strategies: (1) investigated the relationship with adverse health outcomes by increasing per one-fifth (i.e., 20%) of the FI and PF; (2) trichotomized the FI based on the overlap in the density distribution of the FI by the three groups (robust, pre-frail and frail) which were defined by the PF; (3) categorized the women according to a predicted probability function of falls during the third year of follow-up predicted by the FI. Logistic regression models were used for falls and death, while survival analyses were conducted for fractures. Results The FI and PF agreed with each other at a good level of consensus (correlation coefficients >= 0.56) in all the three strategies. Both the FI and PF approaches predicted adverse health outcomes significantly. The FI quantified the risks of future falls, fractures and death more precisely than the PF. Both the FI and PF discriminated risks of adverse outcomes in multivariable models with acceptable and comparable area under the curve (AUCs) for falls (AUCs >= 0.68) and death (AUCs >= 0.79), and c-indices for fractures (c-indices >= 0.69) respectively. Conclusions The FI is comparable with the PF in predicting risks of adverse health outcomes. These findings may indicate the flexibility in the choice of frailty model for the elderly in the population-based settings.	[Li, Guowei; Thabane, Lehana; Kennedy, Courtney] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Thabane, Lehana; Adachi, Jonathan D.] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada; [Ioannidis, George; Papaioannou, Alexandra; Adachi, Jonathan D.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University; McMaster University	Adachi, JD (corresponding author), McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada.	lig28@mcmaster.ca; jd.adachi@sympatico.ca	Li, Guowei/HCH-8923-2022		Father Sean O'Sullivan Research Award; Warner Chilcott Company, LLC; Sanofi-Aventis; Research Institute of St. Joe's Hamilton; China Scholarship Council	Father Sean O'Sullivan Research Award; Warner Chilcott Company, LLC; Sanofi-Aventis(Sanofi-Aventis); Research Institute of St. Joe's Hamilton; China Scholarship Council(China Scholarship Council)	Financial support for the GLOW study was provided by Warner Chilcott Company, LLC and Sanofi-Aventis to the Center for Outcomes Research, University of Massachusetts Medical School. This work was supported in part by a Father Sean O'Sullivan Research Award, the Research Institute of St. Joe's Hamilton [GL]; and the China Scholarship Council [GL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Aama T, 2011, CAN FAM PHYSICIAN, V57, P771; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Cesari M, 2014, AGE AGEING, V43, P10, DOI 10.1093/ageing/aft160; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dent E, 2013, AGE AGEING, DOI [10.1093/ageing/aft059, DOI 10.1093/AGEING/AFT059]; Diez-Perez A, 2013, J BONE MINER RES; Ensrud KE, 2008, ARCH INTERN MED, V168, P382, DOI 10.1001/archinternmed.2007.113; Forti P, 2012, ARCH GERONTOL GERIAT, V54, P16, DOI 10.1016/j.archger.2011.01.007; FRAX&REG;, WHO FRACT RISK ASS T; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gobbens RJ, 2010, NURS OUTLOOK, V58, P76, DOI 10.1016/j.outlook.2009.09.005; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gregson CL, 2014, OSTEOPOROSIS INT, V25, P85, DOI 10.1007/s00198-013-2438-y; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hooven FH, 2009, OSTEOPOROSIS INT, V20, P1107, DOI 10.1007/s00198-009-0958-2; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Hundrup YA, 2004, SCAND J PUBLIC HEALT, V32, P136, DOI 10.1080/14034940310017490; Jung HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087958; Karlsson MK, 2013, SCAND J PUBLIC HLTH; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; Kulminski AM, 2008, J AM GERIATR SOC, V56, P898, DOI 10.1111/j.1532-5415.2008.01656.x; Li GW, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-185; Malmstrom TK, 2014, J AM GERIATR SOC, V62, P721, DOI 10.1111/jgs.12735; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Papaioannou A, 2005, OSTEOPOROSIS INT, V16, P568, DOI 10.1007/s00198-004-1735-x; Peel NM, 2011, CAN J AGING, V30, P7, DOI 10.1017/S071498081000070X; Rahman A, 2005, AM J EPIDEMIOL, V162, P491, DOI 10.1093/aje/kwi215; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Siminoski K, 2005, CAN ASSOC RADIOL J, V56, P178; Sternberg SA, 2011, J AM GERIATR SOC, V59, P2129, DOI 10.1111/j.1532-5415.2011.03597.x; Tom SE, 2013, J AM GERIATR SOC, V61, P327, DOI 10.1111/jgs.12146; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; Whitson HE, 2007, J GERONTOL A-BIOL, V62, P728, DOI 10.1093/gerona/62.7.728; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x	48	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120144	10.1371/journal.pone.0120144	http://dx.doi.org/10.1371/journal.pone.0120144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764521	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300035
J	Zhou, T; Chen, BM; Liu, G; Huang, FF; Liu, JG; Liao, WB; Wang, YY; Ren, SJ; Chen, CQ; Peng, SL				Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Chen, Chun-Quan; Peng, Shao-Lin			Biodiversity of Jinggangshan Mountain: The Importance of Topography and Geographical Location in Supporting Higher Biodiversity	PLOS ONE			English	Article							BUTTERFLY SPECIES RICHNESS; ALTITUDINAL GRADIENT; REGIONAL-SCALE; DIVERSITY; CLIMATE; PATTERNS; DETERMINANTS; PROVINCE; FORESTS	Diversity is mainly determined by climate and environment. In addition, topography is a complex factor, and the relationship between topography and biodiversity is still poorly understood. To understand the role of topography, i.e., altitude and slope, in biodiversity, we selected Jinggangshan Mountain (JGM), an area with unique topography, as the study area. We surveyed plant and animal species richness of JGM and compared the biodiversity and the main geographic characteristics of JGM with the adjacent 4 mountains. Gleason's richness index was calculated to assess the diversity of species. In total, 2958 spermatophyte species, 418 bryophyte species, 355 pteridophyte species and 493 species of vertebrate animals were recorded in this survey. In general, the JGM biodiversity was higher than that of the adjacent mountains. Regarding topographic characteristics, 77% of JGM's area was in the mid-altitude region and approximately 40% of JGM's area was in the 10 degrees-20 degrees slope range, which may support more vegetation types in JGM area and make it a biodiversity hotspot. It should be noted that although the impact of topography on biodiversity was substantial, climate is still a more general factor driving the formation and maintenance of higher biodiversity. Topographic conditions can create microclimates, and both climatic and topographic conditions contribute to the formation of high biodiversity in JGM.	[Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Peng, Shao-Lin] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China; [Zhou, Ting; Chen, Bao-Ming; Liu, Gang; Huang, Fang-Fang; Liu, Jin-Gang; Liao, Wen-Bo; Wang, Ying-Yong; Ren, Si-Jie; Peng, Shao-Lin] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China; [Chen, Chun-Quan] Adm Bur Jinggangshan, Jian 343600, Jiangxi, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Peng, SL (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 51027, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn	Chen, Bao-Ming/H-9024-2016	Chen, Bao-Ming/0000-0003-1891-8752	National Natural Science Foundation of China [31300401]; study of Ecological Process and World Heritage application of Jinggangshan Mount [71020047]; Mount Jinggangshan region, China [71020993, 2013FY111500]; Guangdong Natural Science Foundation [S2012040007896]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); study of Ecological Process and World Heritage application of Jinggangshan Mount; Mount Jinggangshan region, China; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (31300401), the study of Ecological Process and World Heritage application of Jinggangshan Mount (71020047), a comprehensive scientific survey of the biodiversity from Mount Jinggangshan region, China (71020993, 2013FY111500), Guangdong Natural Science Foundation (S2012040007896), the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RB, 1991, J BIOGEOGR, V18, P123, DOI 10.2307/2845287; [Anonymous], 2005, FLORA CHINA; BEALS EW, 1969, SCIENCE, V165, P981, DOI 10.1126/science.165.3897.981; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Borges PAV, 2001, ECOGRAPHY, V24, P68, DOI 10.1034/j.1600-0587.2001.240109.x; Burke IC, 1999, ECOSYSTEMS, V2, P422, DOI 10.1007/s100219900091; Chang H, 2003, STUDIES BIODIVERSITY, P418; [陈宝明 Chen Baoming], 2012, [生态学报, Acta Ecologica Sinica], V32, P6326; [陈功锡 Chen Gongxi], 2004, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V24, P865; Cheng S, 2011, AVIAN RESOURCE WUYIS, P239; Coblentz DD, 2004, J BIOGEOGR, V31, P1125, DOI 10.1111/j.1365-2699.2004.00981.x; Conord C, 2012, ECOL EVOL, V2, P2595, DOI 10.1002/ece3.350; Costanza JK, 2011, LANDSCAPE ECOL, V26, P851, DOI 10.1007/s10980-011-9613-3; Cui BS, 2009, CAN J PLANT SCI, V89, P209, DOI 10.4141/CJPS08013; Curran M, 2012, J TROP ECOL, V28, P243, DOI 10.1017/S0266467412000193; Danz NP, 2011, ECOGRAPHY, V34, P402, DOI 10.1111/j.1600-0587.2010.06561.x; Duan S, 2004, J JINAGGANGSHAN NORM, V25, P12; Editorial Board of Physical Science, 1985, PHYS GEOGR CHIN BOT, P104; Fei Liang, 2012, P1; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; GOSZ JR, 1993, ECOL APPL, V3, P369, DOI 10.2307/1941905; Grytnesn J, 2007, ENCY BIODIVERSITY; Gu J, 2005, RESOURCE TRAGOPAN TE, P15; Illan JG, 2010, J BIOGEOGR, V37, P1706, DOI 10.1111/j.1365-2699.2010.02314.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Huang Zu-hao, 2007, Sichuan Journal of Zoology, V26, P368; Itoh A, 2003, ECOL RES, V18, P307, DOI 10.1046/j.1440-1703.2003.00556.x; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT CR; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Jimenez-Valverde A, 2007, ECOL ENTOMOL, V32, P113, DOI 10.1111/j.1365-2311.2006.00848.x; Kerr JT, 2001, P NATL ACAD SCI USA, V98, P11365, DOI 10.1073/pnas.201398398; Kong Ling-Jie, 2012, Plant Science Journal, V30, P584, DOI 10.3724/SP.J.1142.2012.60584; Korner C., 2002, MOUNTAIN BIODIVERSIT; Leuschner C, 2007, BASIC APPL ECOL, V8, P219, DOI 10.1016/j.baae.2006.02.004; Li Z, 2003, STUDY BIODIVERSITY N, P163; Li Z., 2001, SUBTROPICAL PLANT SC, V30, P28; Li ZuoZhou, 2005, Journal of Wuhan Botanical Research, V23, P592; Liang Q., 2003, STUDY BIODIVERSITY N, P402; Liao B, 2009, SHANDONG FORESTRY SC, V185, P8; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Liu X, 2005, SCI INVESTIGATION RE, P150; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; MacRinnon J, 2000, FIELD GUIDE BIRDS CH, P571; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Miao R, 2003, STUDY BIODIVERSITY N, P176; Ouyang Shan, 2012, Chinese Journal of Zoology, V47, P59; Parviainen M, 2008, J BIOGEOGR, V35, P1888, DOI 10.1111/j.1365-2699.2008.01922.x; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Peng S, 2011, STUDY BIODIVERSITY M; Peng S.L., 2008, STUDY BIODIVERSITY M; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Shen You-Hui, 2008, Acta Zoologica Sinica, V54, P645; Smith AT, 2009, FIELD GUIDE MAMMALS, P1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Wang Lei, 2013, Shengwu Duoyangxing, V21, P163, DOI 10.3724/SP.J.1003.2013.07210; Wang S, 2004, CHINA SPECIES RED LI, VI; Wang Y, 2013, ASIAN HERPETOL RES, P4; Wang YY, 2012, ZOOTAXA, P53; Wang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093075; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; Wu S, 2002, B BOT RES, V22, P284; Wu Z Y, 1979, ACTA BOT YUNNANICA, V1, P1; Xu Zhongxian, 2013, Sichuan Journal of Zoology, V32, P263; Yamaura Y, 2011, OIKOS, V120, P427, DOI 10.1111/j.1600-0706.2010.18764.x; Yang Jian-Huan, 2013, Chinese Journal of Zoology, V48, P129; Yang Li-Jun, 2014, Huanjing Kunchong Xuebao, V36, P679; Yang W, 2010, EEO COMPENSATION BIO, P7; [叶张煌 Ye Zhanghuang], 2013, [山地学报, Journal of Mountain Science], V31, P250; Yu YF, 1999, PLANTS, V151, P3; Yuan X, 2003, STUDY BIODIVERSITY N, P445; Zhang ZH, 2013, J MT SCI-ENGL, V10, P95, DOI 10.1007/s11629-013-2429-7; Zhao J, 2012, SICHUAN J ZOOLOGY, V31, P447; Zheng C, 2003, J FUJIAN FORESTRY SC, V30, P54; Zong Y, 1983, J AMPHIBIANS REPTILE, V2, P61; Zuo C. X., 2008, ENTOMOLOGICAL J E CH, V17, P220	86	4	7	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120208	10.1371/journal.pone.0120208	http://dx.doi.org/10.1371/journal.pone.0120208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763820	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300037
J	Derraik, JGB; Rowe, DL; Cutfield, WS; Hofman, PL				Derraik, Jose G. B.; Rowe, Deborah L.; Cutfield, Wayne S.; Hofman, Paul L.			Decreasing Birth Weight Is Associated with Adverse Metabolic Profile and Lower Stature in Childhood and Adolescence	PLOS ONE			English	Article							INSULIN-RESISTANCE; BLOOD-PRESSURE; BORN SMALL; ADULT HYPERTENSION; GESTATIONAL-AGE; PRETERM BIRTH; GROWTH; SENSITIVITY; STANDARDS; CHILDREN	Objective We aimed to evaluate the association of birth weight SDS with insulin resistance, blood pressure, and auxology in children and adolescents born 23-42 weeks of gestation. Methods We studied 143 singleton children and adolescents aged 9.3 +/- 3.3 years (range 2.0-17.9 years). Clinical assessments included insulin resistance measured by HOMA2-IR, auxology, and blood pressure from sphygmomanometer measurements. Continuous associations were examined, and stratified analyses carried out. For the latter, participants were divided into those of below-average birth weight (BABW, <0 SDS) and above-average birth weight (AABW, >= 0 SDS). Results Irrespective of gestational age, lower birth weight SDS was associated with progressively greater HOMA2-IR (p<0.0001) and higher fasting insulin concentrations (p<0.0001). Decreasing birth weight SDS was associated with higher systolic (p = 0.011) and diastolic (p = 0.006) blood pressure. Lower birth weight SDS was also associated with decreasing stature (p<0.010). The BABW group was similar to 40% more insulin resistant than AABW participants (p = 0.004), with the former also displaying fasting insulin concentrations 37% higher (p = 0.004). BABW participants were 0.54 SDS shorter than those of higher birth weight (p = 0.002). On average, BABW participants had not met their genetic potential, tending to be shorter than their parents (p = 0.065). As a result, when corrected for parents' heights, BABW participants were 0.62 SDS shorter than those born of higher birth weight (p = 0.001). Sub-group analyses on participants born appropriate-for-gestational-age (n = 128) showed that associations of birth weight SDS with both insulin resistance and stature remained (although attenuated). Conclusion Decreasing birth weight SDS (even within the normal range) is associated with adverse metabolic profile and lower stature in children and adolescents.	[Derraik, Jose G. B.; Rowe, Deborah L.; Cutfield, Wayne S.; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Rowe, Deborah L.] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand	University of Auckland; University of Auckland	Hofman, PL (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	p.hofman@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was supported by an unrestricted grant from Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker D. J. P., 1994, MOTHERS BABIES DIS L; Chiavaroli V, 2009, PEDIATRICS, V124, P695, DOI 10.1542/peds.2008-3056; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Doyle LW, 2004, ARCH DIS CHILD, V89, P347, DOI 10.1136/adc.2002.025924; Doyle LW, 2003, PEDIATRICS, V111, P252, DOI 10.1542/peds.111.2.252; ELLIMAN A, 1992, ACTA PAEDIATR, V81, P311, DOI 10.1111/j.1651-2227.1992.tb12232.x; Hack M, 2003, PEDIATRICS, V112, pE30, DOI 10.1542/peds.112.1.e30; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Hofman PL, 1997, J CLIN ENDOCR METAB, V82, P402, DOI 10.1210/jc.82.2.402; Law CM, 1996, J HYPERTENS, V14, P935; Loomba-Albrecht LA, 2009, CURR OPIN ENDOCRINOL, V16, P10, DOI 10.1097/MED.0b013e328320d54c; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Mathai S, 2012, DIABETES, V61, P2479, DOI 10.2337/db11-1672; Moore VM, 1999, J HYPERTENS, V17, P883, DOI 10.1097/00004872-199917070-00003; Moran A, 2002, J CLIN ENDOCR METAB, V87, P4817, DOI 10.1210/jc.2002-020517; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Pandolfi C, 2008, METABOLISM, V57, P999, DOI 10.1016/j.metabol.2008.02.018; RichEdwards JW, 1997, BRIT MED J, V315, P396, DOI 10.1136/bmj.315.7105.396; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rowe DL, 2011, CLIN ENDOCRINOL, V75, P661, DOI 10.1111/j.1365-2265.2011.04116.x; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TANNER JM, 1975, ARCH DIS CHILD, V50, P14, DOI 10.1136/adc.50.1.14; Tinnion R, 2014, ARCH DIS CHILD, V99, P362, DOI 10.1136/archdischild-2013-304615; WHINCUP P, 1995, BRIT MED J, V311, P773, DOI 10.1136/bmj.311.7008.773	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119433	10.1371/journal.pone.0119433	http://dx.doi.org/10.1371/journal.pone.0119433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760717	Green Published, gold			2022-12-26	WOS:000351275000056
J	Amat-ur-Rasool, H; Saghir, A; Idrees, M				Amat-ur-Rasool, Hafsa; Saghir, Anam; Idrees, Muhammad			Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development	PLOS ONE			English	Article							WEST-NILE-VIRUS; NEUTRALIZING EPITOPES; DOMAIN-III; ORGANIZATION; EXPRESSION; PROTEINS	Dengue fever of tropics is a mosquito transmitted devastating disease caused by dengue virus (DENV). There is no effective vaccine available, so far, against any of its four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4). There is a need for the development of preventive and therapeutic vaccines against DENV to decrease the prevalence of dengue fever, especially in Pakistan. In this research, linear and conformational B-cell epitopes of envelope glycoprotein of DENV-2 and DENV-3 (the most prevalent serotypes in Pakistan) were predicted. We used Kolaskar and Tongaonkar method for linear epitope prediction, Emini's method for surface accessibility prediction and Karplus and Schulz's algorithm for flexibility determination. To propose three dimensional epitopes, the E proteins for both serotypes were homology modeled by using Phyre2 V 2.0 server, and ElliPro was used for the prediction of surface epitopes on their globular structure. Total 21 and 19 linear epitopes were predicted for DENV-2 and DENV-3 Pakistani isolates respectively. Whereas, 5 and 4 discontinuous epitopes were proposed for DENV-2 and DENV-3 Pakistani isolates respectively. Moreover, the values of surface accessibility, flexibility and solvent-accessibility can be helpful in analyzing vaccines against DENV-2 and DENV-3. In conclusion, the proposed continuous and discontinuous antigenic peptides can be valuable candidates for diagnostic and therapeutics of DENV.	[Amat-ur-Rasool, Hafsa; Saghir, Anam; Idrees, Muhammad] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Idrees, M (corresponding author), Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan.	idreeskhan@cemb.edu.pk	Idrees, Muhammad/K-6032-2012	Idrees, Muhammad/0000-0002-3081-7631; Amat Ur Rasool, D. Hafsa/0000-0001-9664-3796; Idrees, Muhammad/0000-0001-5783-1372				BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; HAYES CG, 1982, T ROY SOC TROP MED H, V76, P431, DOI 10.1016/0035-9203(82)90130-4; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; Hua Zhong, 2009, Journal of Biomedical Science & Engineering, V2, P123, DOI 10.4236/jbise.2009.22022; Idrees S, 2012, GENET VACCINES THER, V10, DOI [10.1186/1479-0556-10-10, DOI 10.1186/1479-0556-10-10]; Jahan Fridous, 2011, Asia Pac Fam Med, V10, P1, DOI 10.1186/1447-056X-10-1; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Khan E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012505; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Koo C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-275; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Li L, 2005, VIROLOGY, V335, P99, DOI 10.1016/j.virol.2005.02.011; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Qureshi Jazibeh A., 1997, JPMA (Journal of the Pakistan Medical Association), V47, P178; Seema, 2005, INDIAN J CLIN BIOCHE, V20, P92, DOI 10.1007/BF02867407; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zamudio-Meza H, 2009, J GEN VIROL, V90, P2902, DOI 10.1099/vir.0.014159-0	28	7	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119854	10.1371/journal.pone.0119854	http://dx.doi.org/10.1371/journal.pone.0119854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775090	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500134
J	Brison, CM; Mullen, SM; Wuerth, ME; Podolsky, K; Cook, M; Herman, JA; Walter, JD; Meeks, SL; Spiegel, PC				Brison, Caileen M.; Mullen, Steven M.; Wuerth, Michelle E.; Podolsky, Kira; Cook, Matthew; Herman, Jacob A.; Walter, Justin D.; Meeks, Shannon L.; Spiegel, P. Clint			The 1.7 angstrom X-Ray Crystal Structure of the Porcine Factor VIII C2 Domain and Binding Analysis to Anti-Human C2 Domain Antibodies and Phospholipid Surfaces	PLOS ONE			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; HEMOPHILIA-A PATIENTS; MEMBRANE-BINDING; VONWILLEBRAND-FACTOR; MONOCLONAL-ANTIBODY; TERNARY COMPLEX; LIGHT-CHAIN; C1 DOMAIN; FACTOR-V	The factor VIII C2 domain is essential for binding to activated platelet surfaces as well as the cofactor activity of factor VIII in blood coagulation. Inhibitory antibodies against the C2 domain commonly develop following factor VIII replacement therapy for hemophilia A patients, or they may spontaneously arise in cases of acquired hemophilia. Porcine factor VIII is an effective therapeutic for hemophilia patients with inhibitor due to its low cross-reactivity; however, the molecular basis for this behavior is poorly understood. In this study, the X-ray crystal structure of the porcine factor VIII C2 domain was determined, and superposition of the human and porcine C2 domains demonstrates that most surface-exposed differences cluster on the face harboring the "non-classical" antibody epitopes. Furthermore, antibody-binding results illustrate that the "classical" 3E6 antibody can bind both the human and porcine C2 domains, although the inhibitory titer to human factor VIII is 41 Bethesda Units (BU)/mg IgG versus 0.8 BU/mg IgG to porcine factor VIII, while the non-classical G99 antibody does not bind to the porcine C2 domain nor inhibit porcine factor VIII activity. Further structural analysis of differences between the electrostatic surface potentials suggest that the C2 domain binds to the negatively charged phospholipid surfaces of activated platelets primarily through the 3E6 epitope region. In contrast, the G99 face, which contains residue 2227, should be distal to the membrane surface. Phospholipid binding assays indicate that both porcine and human factor VIII C2 domains bind with comparable affinities, and the human K2227A and K2227E mutants bind to phospholipid surfaces with similar affinities as well. Lastly, the G99 IgG bound to PS-immobilized factor VIII C2 domain with an apparent dissociation constant of 15.5 nM, whereas 3E6 antibody binding to PS-bound C2 domain was not observed.	[Brison, Caileen M.; Mullen, Steven M.; Wuerth, Michelle E.; Podolsky, Kira; Cook, Matthew; Herman, Jacob A.; Walter, Justin D.; Spiegel, P. Clint] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Meeks, Shannon L.] Emory Univ, Dept Pediat, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA	Western Washington University; Emory University	Spiegel, PC (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.	Paul.Spiegel@wwu.edu		Herman, Jacob/0000-0002-2069-5810; Meeks, Shannon/0000-0002-3683-8644; Podolsky, Kira/0000-0003-3152-6593	National Institutes of Health [R15 HL103518]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL103518, U54HL112309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health R15 HL103518 (P.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAI M, 1989, J CLIN INVEST, V83, P1978, DOI 10.1172/JCI114107; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrow RT, 2006, J THROMB HAEMOST, V4, P2223, DOI 10.1111/j.1538-7836.2006.02135.x; Bloem E, 2013, J BIOL CHEM, V288, P29670, DOI 10.1074/jbc.M113.473116; BRAY GL, 1994, BLOOD, V83, P2428; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeFrates SR, 2013, PHARMACOTHERAPY, V33, P157, DOI 10.1002/phar.1173; Dimitrov JD, 2010, J THROMB HAEMOST, V8, P1524, DOI 10.1111/j.1538-7836.2010.03878.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FOSTER PA, 1987, J BIOL CHEM, V262, P8443; Franchini M, 2008, BLOOD, V112, P250, DOI 10.1182/blood-2008-03-143586; Giangrande PLF, 2012, HAEMOPHILIA, V18, P305, DOI 10.1111/j.1365-2516.2012.02803.x; Gilbert GE, 2012, BLOOD, V120, P1923, DOI 10.1182/blood-2012-01-408245; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; Hay Charles R. M., 2000, Haematologica, V85, P21; Hay CR, 2000, HAEMATOLOGICA, V85, P4; HILLEUBANKS DC, 1989, P NATL ACAD SCI USA, V86, P6508, DOI 10.1073/pnas.86.17.6508; Hoots WK, 2001, HAEMOPHILIA, V7, P4, DOI 10.1046/j.1365-2516.2001.00099.x; Hsu TC, 2008, BLOOD, V111, P200, DOI 10.1182/blood-2007-01-068957; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KANE WH, 1988, BLOOD, V71, P539; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kempton CL, 2012, HAEMOPHILIA, V18, P798, DOI 10.1111/j.1365-2516.2012.02789.x; Kreuz W, 2002, SEMIN THROMB HEMOST, V28, P285, DOI 10.1055/s-2002-32664; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Liu Z, 2010, J BIOL CHEM, V285, P8824, DOI 10.1074/jbc.M109.080168; LOLLAR P, 1989, BIOCHEMISTRY-US, V28, P666, DOI 10.1021/bi00428a038; Lu JH, 2011, BLOOD, V117, P3181, DOI 10.1182/blood-2010-08-301663; Lusher JM, 2003, HAEMOPHILIA, V9, P38, DOI 10.1046/j.1365-2516.2003.00708.x; Markovitz RC, 2013, BLOOD, V121, P2785, DOI 10.1182/blood-2012-09-456582; Mauser-Bunschoten EP, 2001, HAEMOPHILIA, V7, P364, DOI 10.1046/j.1365-2516.2001.00513.x; Meeks SL, 2009, J THROMB HAEMOST, V7, P658, DOI 10.1111/j.1538-7836.2009.03299.x; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Mei BS, 2010, BLOOD, V116, P270, DOI 10.1182/blood-2009-11-254755; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Nirnjee SM, 2005, TRENDS CARDIOVAS MED, V15, P41, DOI 10.1016/j.tcm.2005.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker ET, 2004, J THROMB HAEMOST, V2, P605, DOI 10.1111/j.1538-7836.2004.00685.x; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Saenko EL, 1997, J BIOL CHEM, V272, P18007, DOI 10.1074/jbc.272.29.18007; SAENKO EL, 1994, J BIOL CHEM, V269, P11601; Scharrer I, 1999, HAEMOPHILIA, V5, P145; Scott DW, 2014, HAEMOPHILIA, V20, P80, DOI 10.1111/hae.12407; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; SHIMA M, 1995, BRIT J HAEMATOL, V91, P714, DOI 10.1111/j.1365-2141.1995.tb05374.x; SHIMA M, 1993, THROMB HAEMOSTASIS, V69, P240; Soucie JM, 2000, TRANSFUSION, V40, P708, DOI 10.1046/j.1537-2995.2000.40060708.x; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Spiegel PC, 2004, J BIOL CHEM, V279, P53691, DOI 10.1074/jbc.M409389200; Spiegel PC, 2002, BRIT J HAEMATOL, V119, P310, DOI 10.1046/j.1365-2141.2002.03845.x; Stennicke HR, 2013, BLOOD, V121, P2108, DOI 10.1182/blood-2012-01-407494; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Toschi V, 2010, CURR OPIN MOL THER, V12, P617; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; Wakabayashi H, 2013, J BIOL CHEM, V288, P31289, DOI 10.1074/jbc.M113.497289; Wakabayashi H, 2010, J BIOL CHEM, V285, P25176, DOI 10.1074/jbc.M110.106906; Walter JD, 2013, BLOOD, V122, P4270, DOI 10.1182/blood-2013-08-519124; Walter JD, 2013, J BIOL CHEM, V288, P9905, DOI 10.1074/jbc.M112.424564	63	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122447	10.1371/journal.pone.0122447	http://dx.doi.org/10.1371/journal.pone.0122447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775247	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500225
J	Gomez, GF; Bickersmith, SA; Gonzalez, R; Conn, JE; Correa, MM				Gomez, Giovan F.; Bickersmith, Sara A.; Gonzalez, Ranulfo; Conn, Jan E.; Correa, Margarita M.			Molecular Taxonomy Provides New Insights into Anopheles Species of the Neotropical Arribalzagia Series	PLOS ONE			English	Article							RIBOSOMAL DNA; DIPTERA-CULICIDAE; GENETIC DIVERSITY; MALARIA VECTOR; POPULATION-STRUCTURE; NUNEZTOVARI DIPTERA; CONCERTED EVOLUTION; MAXIMUM-LIKELIHOOD; MOSQUITOS DIPTERA; COMPLEX DIPTERA	Phylogenetic analysis of partial mitochondrial cytochrome oxidase c subunit I (COI) and nuclear internal transcribed spacer 2 (ITS2) sequences were used to evaluate initial identification and to investigate phylogenetic relationships of seven Anopheles morphospecies of the Arribalzagia Series from Colombia. Phylogenetic trees recovered highly supported clades for An. punctimaculas. s., An. calderoni, An. malefactor s. l., An. neomaculipalpus, An. apicimacula s. l., An. mattogrossensis and An. peryassui. This study provides the first molecular confirmation of An. malefactorfrom Colombia and discovered conflicting patterns of divergence for the molecular markers among specimens from northeast and northern Colombia suggesting the presence of two previously unrecognized Molecular Operational Taxonomic Units (MOTUs). Furthermore, two highly differentiated An. apicimacula MOTUs previously found in Panama were detected. Overall, the combined molecular dataset facilitated the detection of known and new Colombian evolutionary lineages, and constitutes the baseline for future research on their bionomics, ecology and potential role as malaria vectors.	[Gomez, Giovan F.; Correa, Margarita M.] Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Antioquia, Colombia; [Bickersmith, Sara A.; Conn, Jan E.] New York State Dept Hlth, Wadsworth Ctr, Griffin Lab, Singerlands, NY USA; [Gonzalez, Ranulfo] Univ Valle, Fac Ciencias Nat & Exactas, Cali, Valle Del Cauca, Colombia; [Conn, Jan E.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	Universidad de Antioquia; Wadsworth Center; Universidad del Valle; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Correa, MM (corresponding author), Univ Antioquia, Grp Microbiol Mol, Escuela Microbiol, Medellin, Antioquia, Colombia.	margaritcorrea@gmail.com	Gómez, Giovan F./AAN-8904-2021	Gómez, Giovan F./0000-0003-2277-6953; Conn, Jan/0000-0002-5301-7020; Gonzalez, Ranulfo/0000-0003-4047-8677; Bickersmith, Sara/0000-0002-2748-0425	Comite para el Desarrollo de la Investigacion-CODI [8700-689]; Estrategia para la Sostenibilidad de Grupos, Universidad de Antioquia [E01719]; US National Institutes of Health [2R01 A154139]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria [511-2010]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054139] Funding Source: NIH RePORTER	Comite para el Desarrollo de la Investigacion-CODI; Estrategia para la Sostenibilidad de Grupos, Universidad de Antioquia; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Comite para el Desarrollo de la Investigacion-CODI, Grant No. 8700-689 to MMC, Estrategia para la Sostenibilidad de Grupos 2013-2014, Universidad de Antioquia Grant No. E01719, and US National Institutes of Health grant 2R01 A154139 to JEC. GFG received financial support for his doctoral studies from Departamento Administrativo de Ciencia, Tecnologia e Innovacion-COLCIENCIAS, Colombia, Convocatoria 511-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1906, P BIOL SOC WASH; [Anonymous], MAL ENT VECT CONTR L; [Anonymous], REV PERU EPIDEMOLOGI; [Anonymous], ENTOMOLOGIA MED FACU; [Anonymous], GENEIOUS VERSION 6 0; [Anonymous], 1987, COLOMB MED; [Anonymous], 1922, AM J HYG; [Anonymous], 2002, CULICIDOLOGIA MED; [Anonymous], REV BIOMEDICA; [Anonymous], 2018, SANTIAGO CALI U VALL, DOI DOI 10.25100/PEU.309; Bourke BP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-111; Brochero H, 2008, BIOMEDICA, V28, P18, DOI 10.7705/biomedica.v28i1.105; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Castelo AT, 2002, BIOINFORMATICS, V18, P634, DOI 10.1093/bioinformatics/18.4.634; Chaparro P, 2012, BIOMEDICA, V32, P29, DOI 10.1590/S0120-41572012000500005; Choochote W, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-36; Cienfuegos AV, 2011, ACTA TROP, V118, P128, DOI 10.1016/j.actatropica.2011.02.004; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054063; FRITZ GN, 1994, MOL BIOL EVOL, V11, P406; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gonzalez R, 2010, MEM I OSWALDO CRUZ, V105, P1001, DOI 10.1590/S0074-02762010000800009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Harbach R. E., 2013, MOSQUITO TAXONOMIC I; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HEINEMANN S J, 1978, Mosquito Systematics, V10, P493; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Khalin A. V., 2012, Parazitologiya (St. Petersburg), V46, P253; Li C, 2007, J HERED, V98, P51, DOI 10.1093/jhered/esl037; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Loaiza JR, 2012, INFECT GENET EVOL, V12, P1, DOI 10.1016/j.meegid.2011.08.004; Loaiza JR, 2013, ACTA TROP, V128, P61, DOI 10.1016/j.actatropica.2013.06.012; Lucumi-Aragon D, 2011, REV COLOMB ENTOMOL, V37, P256; Manguin S, 1999, AM J TROP MED HYG, V60, P364, DOI 10.4269/ajtmh.1999.60.364; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Matson R, 2008, AM J TROP MED HYG, V78, P492, DOI 10.4269/ajtmh.2008.78.492; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya-Lerma J, 2011, MEM I OSWALDO CRUZ, V106, P223, DOI 10.1590/S0074-02762011000900028; Myers Norman, 2000, Nature (London), V403, P853, DOI 10.1038/35002501; Onyabe DY, 1999, INSECT MOL BIOL, V8, P435, DOI 10.1046/j.1365-2583.1999.00134.x; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Rodriguez JCP, 2011, MEM I OSWALDO CRUZ, V106, P114, DOI 10.1590/S0074-02762011000900015; Paskewitz S.M., 1993, Insect Molecular Biology, V2, P247, DOI 10.1111/j.1365-2583.1994.tb00144.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ramos MF, 2008, MEM I OSWALDO CRUZ, V103, P85, DOI 10.1590/S0074-02762008000100013; REY H, 1945, AM J TROP MED, V25, P501; Rona LDP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-207; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Rosero DA, 2010, REV COLOMB ENTOMOL, V36, P260; Ruiz F, 2005, MEM I OSWALDO CRUZ, V100, P155, DOI 10.1590/S0074-02762005000200008; Sallum MAM, 2000, ANN ENTOMOL SOC AM, V93, P745, DOI 10.1603/0013-8746(2000)093[0745:POADCB]2.0.CO;2; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulrich JN, 2013, TRENDS PARASITOL, V29, P104, DOI 10.1016/j.pt.2013.01.002; Walton C, 1999, MED VET ENTOMOL, V13, P24, DOI 10.1046/j.1365-2915.1999.00142.x; Walton C, 2000, MOL BIOL EVOL, V17, P962, DOI 10.1093/oxfordjournals.molbev.a026377; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WILKERSON R C, 1991, Mosquito Systematics, V23, P25; WILKERSON RC, 1990, J MED ENTOMOL, V27, P207, DOI 10.1093/jmedent/27.2.207; Wilkerson RC, 2004, J MED ENTOMOL, V41, P392, DOI 10.1603/0022-2585-41.3.392; Wilkerson RC, 1999, J MED ENTOMOL, V36, P345, DOI 10.1093/jmedent/36.3.345; WILKERSON RC, 1990, J AM MOSQUITO CONTR, V6, P7; Wilkerson RC, 1997, P ENTOMOL SOC WASH, V99, P461; WILKERSON RC, 1990, J MED ENTOMOL, V27, P225, DOI 10.1093/jmedent/27.2.225; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wong J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-143; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zapata MA, 2007, AM J TROP MED HYG, V77, P67, DOI 10.4269/ajtmh.2007.77.67; Zarowiecki M, 2011, PARASITOLOGY, V138, P1723, DOI 10.1017/S003118201100062X	87	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119488	10.1371/journal.pone.0119488	http://dx.doi.org/10.1371/journal.pone.0119488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774795	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500095
J	Gresa-Arribas, N; Arino, H; Martinez-Hernandez, E; Petit-Pedrol, M; Sabater, L; Saiz, A; Dalmau, J; Graus, F				Gresa-Arribas, Nuria; Arino, Helena; Martinez-Hernandez, Eugenia; Petit-Pedrol, Mar; Sabater, Lidia; Saiz, Albert; Dalmau, Josep; Graus, Francesc			Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity	PLOS ONE			English	Article							STIFF-PERSON-SYNDROME; DEPENDENT DIABETES-MELLITUS; LIMBIC ENCEPHALITIS; CEREBELLAR-ATAXIA; RECEPTOR ANTIBODIES; GABA(A) RECEPTOR; AUTOANTIBODIES; DISORDERS; GEPHYRIN; SPECTRUM	Antibodies to glutamic acid decarboxylase (GAD-ab) associate to different neurological syndromes. It is unknown if the diversity in syndrome association represents epitopes in different immunodominant domains or co-existence of antibodies to other proteins of the inhibitory synapsis. We examined the serum and CSF of 106 patients with anti-GAD related syndromes (39 cerebellar ataxia, 32 stiff-person syndrome [SPS], 18 epilepsy, and 17 limbic encephalitis [LE]). GAD65-ab titres were quantified by ELISA. Immunoblot was used to determine if the antibody-targeted epitopes of GAD65 and GAD67 were linear. A cell-based assay (CBA) with HEK293 cells expressing the GAD65 N-terminal, central catalytic domain, or C-terminal was used to investigate the immunodominant domains. Antibodies to GAD67, gamma-aminobutyric acid A receptor (GABAaR), glycine receptor (GlyR), GABAaR-associated protein (GABARAP), and gephyrin were determined with CBA. GAD-ab internalization was investigated using cultured rat hippocampal neurons. CSF GAD65-ab titres were higher in patients with cerebellar ataxia and LE compared to those with SPS (p = 0.02). GAD67-ab were identified in 81% of sera and 100% of CSF. GAD65-ab recognized linear epitopes in 98% of the patients and GAD67-ab in 42% (p < 0.001). The GAD65 catalytic domain was recognized by 93% of sera, and the three domains by 22% of sera and 74% of CSF (p < 0.001). Six patients had GABAaR-ab and another 6 had GlyR-ab without association to distinctive symptoms. None of the patients had gephyrin-or GABARAP-ab. GAD65-ab were not internalized by live neurons. Overall, these findings show that regardless of the neurological syndrome, the CSF immune response against GAD is more widespread than that of the serum and that there is no specific association between clinical phenotype and the presence of antibodies against other proteins of the inhibitory synapsis.	[Gresa-Arribas, Nuria; Arino, Helena; Martinez-Hernandez, Eugenia; Petit-Pedrol, Mar; Sabater, Lidia; Saiz, Albert; Dalmau, Josep; Graus, Francesc] IDIBAPS, Neuroimmunol Program, Barcelona, Spain; [Arino, Helena; Martinez-Hernandez, Eugenia; Saiz, Albert; Graus, Francesc] Univ Barcelona, Hosp Clin, Serv Neurol, Barcelona, Spain; [Dalmau, Josep] ICREA, Barcelona, Spain; [Dalmau, Josep] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; ICREA; University of Pennsylvania	Graus, F (corresponding author), IDIBAPS, Neuroimmunol Program, Barcelona, Spain.	fgraus@clinic.ub.es	Sabater, Lidia/U-7570-2019; Martinez-Hernandez, Eugenia/L-3310-2014; Ariño, Helena/C-3248-2018; Petit-Pedrol, Mar MPP/K-9657-2015; Graus, Francesc/K-9904-2018; Sabater, Lidia/C-7627-2018	Martinez-Hernandez, Eugenia/0000-0002-8317-7068; Ariño, Helena/0000-0003-4036-1671; Petit-Pedrol, Mar MPP/0000-0002-3220-9488; Graus, Francesc/0000-0002-8924-8322; Dalmau, Josep/0000-0001-5856-2813; Sabater, Lidia/0000-0001-8556-6166	NIH [RO1NS077851, RO1MH094741]; Fondo Investigaciones Sanitarias, Spain [11/01780, 12/00611]; Fundacio la Marato TV3; Hospital Clinic, Barcelona; EMH by a grant of Instituto Carlos III, Madrid, Spain [CM12/00055]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077851] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondo Investigaciones Sanitarias, Spain(Instituto de Salud Carlos III); Fundacio la Marato TV3; Hospital Clinic, Barcelona; EMH by a grant of Instituto Carlos III, Madrid, Spain; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ICREA(ICREA)	This work was supported by NIH grants RO1NS077851, RO1MH094741 (JD); grants 11/01780 (JD) and 12/00611 (FG) from the Fondo Investigaciones Sanitarias, Spain; and Fundacio la Marato TV3 (JD). HA is supported by a post-residency grant of Hospital Clinic, Barcelona, and EMH by a grant of Instituto Carlos III (CM12/00055), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos H, 2013, NEUROLOGY, V81, P1962, DOI 10.1212/01.wnl.0000436617.40779.65; Alexopoulos H, 2013, EXPERT REV CLIN IMMU, V9, P1043, DOI 10.1586/1744666X.2013.845527; Ali F, 2011, J AUTOIMMUN, V37, P79, DOI 10.1016/j.jaut.2011.05.005; Ances BM, 2005, BRAIN, V128, P1764, DOI 10.1093/brain/awh526; Arino H, 2014, JAMA NEUROL, V71, P1009, DOI 10.1001/jamaneurol.2014.1011; Bernal F, 2003, NEUROLOGY, V60, P230, DOI 10.1212/01.WNL.0000041495.87539.98; Boronat A, 2011, NEUROLOGY, V76, P795, DOI 10.1212/WNL.0b013e31820e7b8d; Burbelo PD, 2008, BIOCHEM BIOPH RES CO, V366, P1, DOI 10.1016/j.bbrc.2007.11.077; BUTLER MH, 1993, J EXP MED, V178, P2097, DOI 10.1084/jem.178.6.2097; Butler MH, 2000, NEURON, V26, P307, DOI 10.1016/S0896-6273(00)81165-4; Chang TS, 2013, JAMA NEUROL, V70, P1140, DOI 10.1001/jamaneurol.2013.3499; Chang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072921; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Dalakas MC, 2001, NEW ENGL J MED, V345, P1870, DOI 10.1056/NEJMoa01167; Dalakas MC, 2001, NEUROLOGY, V57, P780, DOI 10.1212/WNL.57.5.780; Dinkel K, 1998, ANN NEUROL, V44, P194, DOI 10.1002/ana.410440209; Fenalti G, 2008, DIABETES, V57, P1293, DOI 10.2337/db07-1461; Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447; Gultekin SH, 2000, BRAIN, V123, P1481, DOI 10.1093/brain/123.7.1481; Hampe CS, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-82; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Hansen N, 2013, EXP NEUROL, V239, P202, DOI 10.1016/j.expneurol.2012.10.013; Honnorat J, 2001, ARCH NEUROL-CHICAGO, V58, P225, DOI 10.1001/archneur.58.2.225; Hughes EG, 2010, J NEUROSCI, V30, P5866, DOI 10.1523/JNEUROSCI.0167-10.2010; Ishida K, 2007, J NEUROL NEUROSUR PS, V78, P190, DOI 10.1136/jnnp.2006.091116; Jarius S, 2010, J NEUROIMMUNOL, V229, P219, DOI 10.1016/j.jneuroim.2010.07.019; KIM J, 1994, J EXP MED, V180, P595, DOI 10.1084/jem.180.2.595; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Leypoldt F, 2014, ANN NEW YORK ACAD SC; Malter MP, 2010, ANN NEUROL, V67, P470, DOI 10.1002/ana.21917; Manto MU, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-3; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; McKeon A, 2013, JAMA NEUROL, V70, P44, DOI 10.1001/jamaneurol.2013.574; McKeon A, 2012, ARCH NEUROL-CHICAGO, V69, P230, DOI 10.1001/archneurol.2011.991; Petit-Pedrol M, 2014, LANCET NEUROL, V13, P276, DOI 10.1016/S1474-4422(13)70299-0; Planaguma J, 2015, BRAIN, V138, P94, DOI 10.1093/brain/awu310; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Raju R, 2006, BRAIN, V129, P3270, DOI 10.1093/brain/awl245; Rakocevic G, 2006, NEUROLOGY, V67, P1068, DOI 10.1212/01.wnl.0000237558.83349.d0; RICHTER W, 1993, P NATL ACAD SCI USA, V90, P2832, DOI 10.1073/pnas.90.7.2832; Sabater L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060438; Saiz A, 1997, NEUROLOGY, V49, P1026, DOI 10.1212/WNL.49.4.1026; Saiz A, 2008, BRAIN, V131, P2553, DOI 10.1093/brain/awn183; Skorstad G, 2008, EUR J NEUROL, V15, P973, DOI 10.1111/j.1468-1331.2008.02221.x; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Vega-Flores G, 2014, CEREB CORTEX, V24, P2093, DOI 10.1093/cercor/bht060	47	95	103	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121364	10.1371/journal.pone.0121364	http://dx.doi.org/10.1371/journal.pone.0121364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774787	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500212
J	Healy, GN; Winkler, EAH; Brakenridge, CL; Reeves, MM; Eakin, EG				Healy, Genevieve N.; Winkler, Elisabeth A. H.; Brakenridge, Charlotte L.; Reeves, Marina M.; Eakin, Elizabeth G.			Accelerometer-Derived Sedentary and Physical Activity Time in Overweight/Obese Adults with Type 2 Diabetes: Cross-Sectional Associations with Cardiometabolic Biomarkers	PLOS ONE			English	Article							DELIVERED WEIGHT-LOSS; ACTIVITY INTERVENTION; RANDOMIZED-TRIAL; LIVING WELL; BEHAVIOR; RISK; INTENSITY; VALIDITY; OUTCOMES; GLUCOSE	Objective To examine the associations of sedentary time and physical activity with biomarkers of cardiometabolic health, including the potential collective impact of shifting mean time use from less-to more-active behaviours (cross-sectionally, using isotemporal substitution), in adults with type 2 diabetes. Methods Participants with overweight/obese body mass index (BMI; >= 25 kg/m(2)) (n = 279; 158 men, mean [SD] age = 58.2 [8.6] years) wore Actigraph GT1M accelerometers (waking hours; seven days) to assess moderate-to vigorous-intensity physical activity (MVPA), light-intensity activity, and sedentary time (segregated into non-prolonged [accumulated in bouts <30min] and prolonged [accumulated in bouts >= 30 min]). Cross-sectional associations with waist circumference, BMI, fasting blood (HbA(1c), glucose, triacylglycerols, high-density lipoprotein cholesterol), and blood pressure of these activity variables (30 min/day increments) were examined adjusted for confounders and wear then, if significant, examined using isotemporal substitution modelling. Results Waist circumference and BMI were significantly (p<0.05) associated with more prolonged sedentary time and less light-intensity activity. Light intensity activity was also significantly associated with lower fasting plasma glucose (relative rate: 0.98, 95% CI: 0.97, 1.00; p<0.05). No biomarker was significantly associated with non-prolonged sedentary time or MVPA. Lower mean prolonged sedentary time (-30 min/day) with higher mean light intensity time (+30 min/day) was significantly associated with lower waist circumference (beta = -0.77, 95% CI: -1.33, -0.22 cm). Lower mean prolonged sedentary time (-30 min/day) with either 30 min/day higher mean non-prolonged sedentary time (beta = -0.35, 95% CI: -0.70, -0.01 kg/m(2)) or light-intensity time (beta = -0.36, -0.61, -0.11 kg/m(2)) was associated with significantly lower average BMI. Conclusions Significantly improved mean levels of waist circumference and BMI were observed when shifting time from prolonged sedentary to non-prolonged sedentary or light-intensity activity (cross-sectionally). Lifestyle interventions in overweight/obese adults with type 2 diabetes might consider targeting shifts in these non-MVPA activities to more rigorously evaluate their potential cardiometabolic benefit in this population.	[Healy, Genevieve N.; Winkler, Elisabeth A. H.; Brakenridge, Charlotte L.; Reeves, Marina M.; Eakin, Elizabeth G.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Healy, Genevieve N.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Healy, Genevieve N.] Curtin Univ, Sch Physiotherapy, Perth, WA 6845, Australia	University of Queensland; Baker Heart and Diabetes Institute; Curtin University	Healy, GN (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	g.healy@uq.edu.au	Winkler, Elisabeth/AAD-7153-2022; Brakenridge, Charlotte/A-1589-2015; Eakin, Elizabeth G/F-7918-2010; Healy, Genevieve/A-7408-2008; Reeves, Marina M/B-3813-2009	Winkler, Elisabeth/0000-0003-1452-6102; Brakenridge, Charlotte/0000-0003-4540-7659; Eakin, Elizabeth G/0000-0002-8835-9995; Healy, Genevieve/0000-0001-7093-7892; Reeves, Marina M/0000-0003-3052-2013	National Health and Medical Research Council (NHMRC) project grant; ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young; NHMRC Training Fellowship [569861]; Heart Foundation Postdoctoral Fellowship [PH 12B 7054]; NHMRC Senior Research Fellowship [511001]; National Breast Cancer Foundation Early Career Fellowship [ECF-13-09]	National Health and Medical Research Council (NHMRC) project grant(National Health and Medical Research Council (NHMRC) of Australia); ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young; NHMRC Training Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation Postdoctoral Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation Early Career Fellowship	This study was supported by a National Health and Medical Research Council (NHMRC) project grant. The accelerometer collection was supported by an ADS-Servier National Diabetes Strategy Grant in Memory of Barry Young. GNH is supported by a NHMRC [#569861] Training Fellowship and a Heart Foundation Postdoctoral Fellowship [PH 12B 7054]. EGE is supported by a NHMRC Senior Research Fellowship [#511001]. MMR is supported by a National Breast Cancer Foundation Early Career Fellowship [ECF-13-09]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Avery L, 2012, DIABETES CARE, V35, P2681, DOI 10.2337/dc11-2452; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011; Buman MP, 2014, AM J EPIDEMIOL, V179, P323, DOI 10.1093/aje/kwt292; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cichosz SL, 2013, DIABETIC MED, V30, P1063, DOI 10.1111/dme.12199; Colberg SR, 2010, MED SCI SPORT EXER, V42, P2282, DOI 10.1249/MSS.0b013e3181eeb61c; Cooper AR, 2012, DIABETOLOGIA, V55, P589, DOI 10.1007/s00125-011-2408-x; Department of Health and Ageing, 1999, NAT PHYS ACT GUID AU; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Eakin EG, 2013, ANN BEHAV MED, V46, P193, DOI 10.1007/s12160-013-9498-2; Eakin EG, 2014, DIABETES CARE, V37, P2177, DOI 10.2337/dc13-2427; Eakin EG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-452; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gando Y, 2014, J PHYS ACT HEALTH, V11, P266, DOI 10.1123/jpah.2012-0071; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Henson J, 2013, DIABETOLOGIA, V56, P1012, DOI 10.1007/s00125-013-2845-9; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Lewis J, 1995, NUTTAB95 NUTR DAT TA; Loprinzi PD, 2013, AGING MENT HEALTH, V17, P801, DOI 10.1080/13607863.2013.801066; Loprinzi PD, 2013, J DIABETES COMPLICAT, V27, P134, DOI 10.1016/j.jdiacomp.2012.09.004; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Newby PK, 2003, AM J CLIN NUTR, V78, P941, DOI 10.1093/ajcn/78.5.941; SCHMIDT FH, 1961, KLIN WOCHENSCHR, V39, P1244, DOI 10.1007/BF01506150; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Strath SJ, 2003, INT J SPORTS MED, V24, P298, DOI 10.1055/s-2003-39504; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Trost SG, 2012, MED SCI SPORT EXER, V44, P1801, DOI 10.1249/MSS.0b013e318258ac11	35	74	74	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119140	10.1371/journal.pone.0119140	http://dx.doi.org/10.1371/journal.pone.0119140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775249	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500072
J	Nishihara, H; Shimizu, F; Sano, Y; Takeshita, Y; Maeda, T; Abe, M; Koga, M; Kanda, T				Nishihara, Hideaki; Shimizu, Fumitaka; Sano, Yasuteru; Takeshita, Yukio; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi			Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis	PLOS ONE			English	Article							ORAL FINGOLIMOD; WHITE-MATTER; RAT MODEL; FTY720; EXPRESSION; LESIONS; INTERFERON; THERAPY	Objective Effect of fingolimod in multiple sclerosis (MS) is thought to involve the prevention of lymphocyte egress from lymphoid tissues, thereby reducing autoaggressive lymphocyte infiltration into the central nervous system across blood-brain barrier (BBB). However, brain microvascular endothelial cells (BMECs) represent a possible additional target for fingolimod in MS patients by directly repairing the function of BBB, as S1P receptors are also expressed by BMECs. In this study, we evaluated the effects of fingolimod on BMECs and clarified whether fingolimod-phosphate restores the BBB function after exposure to MS sera. Methods Changes in tight junction proteins, adhesion molecules and transendothelial electrical resistance (TEER) in BMECs were evaluated following incubation in conditioned medium with or without fingolimod/fingolimod-phosphate. In addition, the effects of sera derived from MS patients, including those in the relapse phase of relapse-remitting (RR) MS, stable phase of RRMS and secondary progressive MS (SPMS), on the function of BBB in the presence of fingolimod-phosphate were assessed. Results Incubation with fingolimod-phosphate increased the claudin-5 protein levels and TEER values in BMECs, although it did not change the amount of occludin, ICAM-1 or MelCAM proteins. Pretreatment with fingolimod-phosphate restored the changes in the claudin-5 and VCAM-1 protein/mRNA levels and TEER values in BMECs after exposure to MS sera. Conclusions Pretreatment with fingolimod-phosphate prevents BBB disruption caused by both RRMS and SPMS sera via the upregulation of claudin-5 and downregulation of VCAM-1 in BMECs, suggesting that fingolimod-phosphate is capable of directly modifying the BBB. BMECs represent a possible therapeutic target for fingolimod in MS patients.	[Nishihara, Hideaki; Shimizu, Fumitaka; Sano, Yasuteru; Takeshita, Yukio; Maeda, Toshihiko; Abe, Masaaki; Koga, Michiaki; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan	Yamaguchi University	Kanda, T (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Ube, Yamaguchi 755, Japan.	tkanda@yamaguchi-u.ac.jp	Koga, Michiaki/L-4825-2019; Nishihara, Hideaki/AAJ-7563-2021	Koga, Michiaki/0000-0002-1356-955X; Nishihara, Hideaki/0000-0002-2990-835X	Japan Society for the Promotion of Science, Tokyo, Japan [24790886, 22790821, 23659457, 25293203, 26670443]; Ministry of Health, Labour and Welfare of Japan [K2002528]; National Center of Neurology and Psychiatry [25-4]; Yamaguchi University Hospital; Novartis Pharma K.K.; Mitsubishi Tanabe Pharma; Grants-in-Aid for Scientific Research [26461271] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Yamaguchi University Hospital; Novartis Pharma K.K.(Novartis); Mitsubishi Tanabe Pharma(Mitsubishi Tanabe Pharma Corporation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TK received the funding. This work was supported in part by research grants (Nos. 24790886, Nos. 22790821, Nos. 23659457, Nos. 25293203 and Nos. 26670443) from the Japan Society for the Promotion of Science, Tokyo, Japan (https://www.jsps.go.jp/english/), a research grant (K2002528) from Health and Labor Sciences Research Grants for research on intractable diseases (Neuroimmunological Disease Research Committee) from the Ministry of Health, Labour and Welfare of Japan (http://www.mhlw.go.jp/english/index.html), an Intramural Research Grant (25-4) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry and a Translational Research Promotion Grant from Yamaguchi University Hospital. This study was sponsored by Novartis Pharma K.K. and Mitsubishi Tanabe Pharma and conducted as collaborative research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balatoni B, 2007, BRAIN RES BULL, V74, P307, DOI 10.1016/j.brainresbull.2007.06.023; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; BROSNAN CF, 1995, NEUROLOGY, V45, pS16, DOI 10.1212/WNL.45.6_Suppl_6.S16; Calabresi PA, 2014, LANCET NEUROL, V13, P545, DOI 10.1016/S1474-4422(14)70049-3; Choi YS, 2012, BIOCHEM BIOPH RES CO, V421, P305, DOI 10.1016/j.bbrc.2012.04.005; Chun J, 2010, CLIN NEUROPHARMACOL, V33, P91, DOI 10.1097/WNF.0b013e3181cbf825; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Engelhardt B, 2010, CLIN EXP NEUROIMMUNO, V1, P79, DOI DOI 10.1111/J.1759-1961.2010.009.X; Engelhardt B, 2008, NEURODEGENER DIS, V5, P16, DOI 10.1159/000109933; Foster CA, 2009, BRAIN PATHOL, V19, P254, DOI 10.1111/j.1750-3639.2008.00182.x; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; Khatri B, 2011, LANCET NEUROL, V10, P520, DOI 10.1016/S1474-4422(11)70099-0; Kira J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-21; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Leech S, 2007, NEUROPATH APPL NEURO, V33, P86, DOI 10.1111/j.1365-2990.2006.00781.x; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; McQuaid S, 2009, BIOCHEM SOC T, V37, P329, DOI 10.1042/BST0370329; Mehling M, 2011, NEUROLOGY, V76, pS20, DOI 10.1212/WNL.0b013e31820db341; Miron VE, 2008, J NEUROL SCI, V274, P13, DOI 10.1016/j.jns.2008.06.031; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Plumb J, 2002, BRAIN PATHOL, V12, P154; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sano Y., 2013, CLIN EXP NEUROIMMUNO, V4, P92, DOI [10.1111/cen3.12001, DOI 10.1111/CEN3.12001, 10.1111]; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimizu F, 2013, THE BLOOD BRAIN BARR; Shimizu F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092872; Shimizu F, 2012, J NEUROL NEUROSUR PS, V83, P288, DOI 10.1136/jnnp-2011-300434; Soliven B, 2011, NEUROLOGY, V76, pS9, DOI 10.1212/WNL.0b013e31820d9507; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tasaki A, 2014, J NEUROL NEUROSUR PS, V85, P419, DOI 10.1136/jnnp-2013-305907; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Wang L, 2011, EUR RESPIR J, V38, P78, DOI 10.1183/09031936.00047810; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang ZL, 2006, WORLD J GASTROENTERO, V12, P4241, DOI 10.3748/wjg.v12.i26.4241	38	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121488	10.1371/journal.pone.0121488	http://dx.doi.org/10.1371/journal.pone.0121488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774903	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500213
J	Perera, BPU; Teruyama, R; Kim, J				Perera, Bambarendage P. U.; Teruyama, Ryoichi; Kim, Joomyeong			Yy1 Gene Dosage Effect and Bi-Allelic Expression of Peg3	PLOS ONE			English	Article							TRANSCRIPTION FACTOR YY1; IMPRINTED GENE; EVOLUTION; BINDING; SEQUENCE; CELLS	In the current study, we tested the in vivo effects of Yy1 gene dosage on the Peg3 imprinted domain with various breeding schemes utilizing two sets of mutant alleles. The results indicated that a half dosage of Yy1 coincides with the up-regulation of Peg3 and Zim1, suggesting a repressor role of Yy1 in this imprinted domain. This repressor role of Yy1 is consistent with the observations derived from previous in vitro studies. The current study also provided an unexpected observation that the maternal allele of Peg3 is also normally expressed, and thus the expression of Peg3 is bi-allelic in the specific areas of the brain, including the choroid plexus, the PVN (Paraventricular Nucleus) and the SON (Supraoptic Nucleus) of the hypothalamus. The exact roles of the maternal allele of Peg3 in these cell types are currently unknown, but this new finding confirms the previous prediction that the maternal allele may be functional in specific cell types based on the lethality associated with the homozygotes for several mutant alleles of the Peg3 locus. Overall, these results confirm the repressor role of Yy1 in the Peg3 domain and also provide a new insight regarding the bi-allelic expression of Peg3 in mouse brain.	[Perera, Bambarendage P. U.; Teruyama, Ryoichi; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Perera, Bambarendage/0000-0002-7774-0985; Teruyama, Ryoichi/0000-0002-9356-8310	National Institute of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066225, R01GM097074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institute of Health (J. K. R01-GM066225, R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Alfieri C, 2013, GENE DEV, V27, P2367, DOI 10.1101/gad.226621.113; Basu A, 2014, NUCLEIC ACIDS RES, V42, P2208, DOI 10.1093/nar/gkt1187; Broad KD, 2011, P NATL ACAD SCI USA, V108, P15237, DOI 10.1073/pnas.1106022108; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Calame K, 2007, GENE DEV, V21, P1145, DOI 10.1101/gad.1559007; Charalambous M, 2004, DEV BIOL, V271, P488, DOI 10.1016/j.ydbio.2004.04.022; Choo JH, 2008, GENE, V409, P28, DOI 10.1016/j.gene.2007.10.036; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Do Kim J, 2009, NUCLEIC ACIDS RES, V37, P5656, DOI 10.1093/nar/gkp613; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Karam R, 2013, BBA-GENE REGUL MECH, V1829, P624, DOI 10.1016/j.bbagrm.2013.03.002; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kim J, 2004, GENOMICS, V84, P47, DOI 10.1016/j.ygeno.2004.02.007; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 2001, GENOMICS, V77, P91, DOI 10.1006/geno.2001.6621; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; KIM J, 2013, NATL GEOGR, V224, P8; Kim J, 2005, RAPIDLY EVOLVING IMF; Kim J, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY, VOLS 1-3, PROCEEDINGS, P16; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; Kim J, 2008, EPIGENETICS-US, V3, P115, DOI 10.4161/epi.3.3.6176; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Lucifero D, 2002, GENOMICS, V79, P530, DOI 10.1006/geno.2002.6732; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Oei SL, 2004, GENOMICS, V83, P873, DOI 10.1016/j.ygeno.2003.11.001; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Schlesinger S, 2013, CELL REP, V4, P50, DOI 10.1016/j.celrep.2013.06.003; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119493	10.1371/journal.pone.0119493	http://dx.doi.org/10.1371/journal.pone.0119493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774914	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500096
J	Romero, M; Caniffi, C; Bouchet, G; Costa, MA; Elesgaray, R; Arranz, C; Tomat, AL				Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Costa, Maria A.; Elesgaray, Rosana; Arranz, Cristina; Tomat, Analia L.			Chronic Treatment with Atrial Natriuretic Peptide in Spontaneously Hypertensive Rats: Beneficial Renal Effects and Sex Differences	PLOS ONE			English	Article							NITRIC-OXIDE; BLOOD-PRESSURE; OXIDATIVE STRESS; ANTIOXIDANT THERAPY; GENDER-DIFFERENCES; CELL-DEATH; ESTROGEN; DISEASE; KIDNEY; EXPRESSION	Objective The aim of this study was to investigate the effects of chronic treatment with atrial natriuretic peptide (ANP) on renal function, nitric oxide (NO) system, oxidative stress, collagen content and apoptosis in kidneys of spontaneously hypertensive rats (SHR), as well as sex-related differences in the response to the treatment. Methods 10 week-old male and female SHR were infused with ANP (100 ng/h/rat) or saline (NaCl 0.9%) for 14 days (subcutaneous osmotic pumps). Systolic blood pressure (SBP) was recorded and diuresis and natriuresis were determined. After treatment, renal NO synthase (NOS) activity and eNOS expression were evaluated. Thiobarbituric acid-reactive substances (TBARS), glutathione concentration and glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities were determined in the kidney. Collagen was identified in renal slices by Sirius red staining and apoptosis by Tunel assay. Results Female SHR showed lower SBP, oxidative stress, collagen content and apoptosis in kidney, and higher renal NOS activity and eNOS protein content, than males. ANP lowered SBP, increased diuresis, natriuresis, renal NOS activity and eNOS expression in both sexes. Renal response to ANP was more marked in females than in males. In kidney, ANP reduced TBARS, renal collagen content and apoptosis, and increased glutathione concentration and activity of GPx and SOD enzymes in both sexes. Conclusions Female SHR exhibited less organ damage than males. Chronic ANP treatment would ameliorate hypertension and end-organ damage in the kidney by reducing oxidative stress, increasing NO-system activity, and diminishing collagen content and apoptosis, in both sexes.	[Romero, Mariana; Caniffi, Carolina; Bouchet, Gonzalo; Costa, Maria A.; Elesgaray, Rosana; Arranz, Cristina; Tomat, Analia L.] Univ Buenos Aires, IQUIMEFA CONICET, Catedra Fisiol, Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Tomat, AL (corresponding author), Univ Buenos Aires, IQUIMEFA CONICET, Catedra Fisiol, Fac Farm & Bioquim, Junin 956,Piso 7, RA-1113 Buenos Aires, DF, Argentina.	atomat@ffyb.uba.ar			UBACYT from Universidad de Buenos Aires, Argentina, MAC [20020100100060 (2011-2014)]; CONICET, Argentina, CA [PIP-112-200801-01121]	UBACYT from Universidad de Buenos Aires, Argentina, MAC; CONICET, Argentina, CA	This study was partially supported by grants: UBACYT No 20020100100060 (2011-2014) from Universidad de Buenos Aires, Argentina, MAC; and PIP-112-200801-01121 from CONICET, Argentina, CA.	Antus B, 2003, NEPHROL DIAL TRANSPL, V18, P54, DOI 10.1093/ndt/18.1.54; Baldini PM, 2005, MOL CELL BIOCHEM, V272, P19, DOI 10.1007/s11010-005-4779-0; Baylis C, 2012, CURR OPIN NEPHROL HY, V21, P1, DOI 10.1097/MNH.0b013e32834d54ca; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSNIHAN KB, 1994, AM J HYPERTENS, V7, P576, DOI 10.1093/ajh/7.7.576; Buege J A, 1978, Methods Enzymol, V52, P302; Chang HR, 2005, CHINESE J PHYSIOL, V48, P15; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Costa MA, 2006, LIFE SCI, V78, P1543, DOI 10.1016/j.lfs.2005.07.024; Costa MA, 2004, J HYPERTENS, V22, pS183, DOI 10.1097/00004872-200406002-00634; Costa MA, 2010, AM J PHYSIOL-HEART C, V298, pH778, DOI 10.1152/ajpheart.00488.2009; Costa MD, 2004, REGUL PEPTIDES, V118, P151, DOI 10.1016/j.regpep.2003.12.009; Costa MD, 2000, HYPERTENSION, V35, P1119, DOI 10.1161/01.HYP.35.5.1119; Dantas APV, 2004, CARDIOVASC RES, V61, P22, DOI 10.1016/j.cardiores.2003.10.010; Das S, 2010, ENDOCRINOLOGY, V151, P5841, DOI 10.1210/en.2010-0655; De Vito P, 2010, PEPTIDES, V31, P1412, DOI 10.1016/j.peptides.2010.04.001; Dubey RK, 2002, CARDIOVASC RES, V53, P688, DOI 10.1016/S0008-6363(01)00527-2; Elesgaray R, 2012, AM J PHYSIOL-RENAL, V302, pF1385, DOI 10.1152/ajprenal.00624.2011; Filippatos GS, 2001, AM J PHYSIOL-LUNG C, V281, pL749, DOI 10.1152/ajplung.2001.281.4.L749; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Fukai T, 2002, CARDIOVASC RES, V55, P239, DOI 10.1016/S0008-6363(02)00328-0; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Hall JE, 2008, HYPERTENSION, V51, P951, DOI 10.1161/HYPERTENSIONAHA.107.009813; Huang A, 1997, AM J PHYSIOL-HEART C, V272, pH1804, DOI 10.1152/ajpheart.1997.272.4.H1804; Iseki K, 1997, KIDNEY INT, V51, P850, DOI 10.1038/ki.1997.119; Ji H, 2007, GENDER MED, V4, P56, DOI 10.1016/S1550-8579(07)80009-X; Kishimoto I, 1996, P NATL ACAD SCI USA, V93, P6215, DOI 10.1073/pnas.93.12.6215; Koeners MP, 2007, HYPERTENSION, V50, P1077, DOI 10.1161/HYPERTENSIONAHA.107.095794; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; Tomat AL, 2008, AM J PHYSIOL-REG I, V295, pR543, DOI 10.1152/ajpregu.00050.2008; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Nishikimi T, 2009, REGUL PEPTIDES, V154, P44, DOI 10.1016/j.regpep.2009.02.006; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Ortiz A, 2001, J CELL MOL MED, V5, P18, DOI 10.1111/j.1582-4934.2001.tb00135.x; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Pelzer T, 2000, BIOCHEM BIOPH RES CO, V268, P192, DOI 10.1006/bbrc.2000.2073; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Rakhit RD, 2001, HEART, V86, P368, DOI 10.1136/heart.86.4.368; Reckelhoff JF, 1998, HYPERTENSION, V31, P435, DOI 10.1161/01.HYP.31.1.435; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Romero M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071992; Schnackenberg CG, 1999, HYPERTENSION, V33, P424, DOI 10.1161/01.HYP.33.1.424; Shono M, 2007, CIRC J, V71, P1040, DOI 10.1253/circj.71.1040; Smith RS, 2005, LIFE SCI, V76, P2457, DOI 10.1016/j.lfs.2004.11.028; Sullivan JC, 2007, AM J PHYSIOL-REG I, V292, pR764, DOI 10.1152/ajpregu.00322.2006; Tain YL, 2010, J PINEAL RES, V49, P390, DOI 10.1111/j.1600-079X.2010.00806.x; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tomat AL, 2007, LIFE SCI, V80, P1292, DOI 10.1016/j.lfs.2006.12.035; Vaziri ND, 2004, CURR OPIN NEPHROL HY, V13, P93, DOI 10.1097/00041552-200401000-00013; Vaziri ND, 2000, HYPERTENSION, V36, P957, DOI 10.1161/01.HYP.36.6.957; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005; Yang SM, 2000, J CARDIOVASC PHARM, V36, P242, DOI 10.1097/00005344-200008000-00015	58	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120362	10.1371/journal.pone.0120362	http://dx.doi.org/10.1371/journal.pone.0120362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774801	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500167
J	Dong, GY; Peng, C; Luo, J; Wang, CM; Han, L; Wu, B; Ji, GJ; He, HX				Dong, Guoying; Peng, Chao; Luo, Jing; Wang, Chengmin; Han, Le; Wu, Bin; Ji, Guangju; He, Hongxuan			Adamantane-Resistant Influenza A Viruses in the World (1902-2013): Frequency and Distribution of M2 Gene Mutations	PLOS ONE			English	Article							A(H3N2) VIRUSES; AMANTADINE-RESISTANCE; RIMANTADINE; A(H1N1); SEASON; SURVEILLANCE; PROPHYLAXIS; AUSTRALIA; EMERGENCE	Adamantanes (amantadine and rimantadine) have been used to prevent and treat influenza A virus infections for many years; however, resistance to these drugs has been widely reported in the world. To investigate the frequency and distribution of M2 gene mutations in adamantane-resistant influenza variants circulated in the world between 1902 and 2013, 31251 available M2 protein sequences from different HA-subtype influenza A viruses (H1-H17) were analyzed and adamantane resistance-associated mutations were compared (L26F, V27A, A30T, A30V, S31N, G34E, and L38F). We find that 45.2% (n = 14132) of influenza A (H1-H17) viruses circulating globally were resistant to adamantanes, and the vast majority of resistant viruses (95%) bear S31N mutations. Whereas, only about 1% have V27A mutations and other mutations (L26F, A30T, G34E, and L38F) were extremely rare (their prevalence appeared to be < 0.2%). Our results confirm that H1, H3, H5, H7, H9, and H17 subtype influenza A viruses exhibit high-level resistance to adamantanes. In contrast, the appearance of adamantane-resistant mutants in H2, H4, H6, H10, and H11 subtypes was rare. However, no adamantane resistance viruses were identified among other HA subtypes (H8, H12-H16). Our findings indicate that the frequency and distribution of adamantane- resistant influenza variants varied among different HA subtypes, host species, years of isolation, and geographical areas. This comprehensive study raises concerns about the increasing prevalence of adamantane-resistant influenza A viruses and highlights the importance of monitoring the emergence and worldwide spread of adamantaneresistant variants.	[Dong, Guoying; Peng, Chao; Han, Le] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Dong, Guoying; Luo, Jing; Wang, Chengmin; Wu, Bin; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Dong, GY (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China.	dongguoying88@aliyun.com; gj28@ibp.ac.cn; hehx@ioz.ac.cn		Ji, Guangju/0000-0001-8626-3490	National High Technology Research and Development Program (863 Program) of China [2012AA12A407]; National Key Basic Research and Development Program (973 Program) of China [2010CB530302]	National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China)	This work was supported by grants from the National High Technology Research and Development Program (863 Program) of China (2012AA12A407) and the National Key Basic Research and Development Program (973 Program) of China (2010CB530302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2005, ANTIMICROB AGENTS CH, V49, P556, DOI 10.1128/AAC.49.2.556-559.2005; Astrahan P, 2004, PROTEINS, V55, P251, DOI 10.1002/prot.20018; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Barr IG, 2007, ANTIVIR RES, V75, P173, DOI 10.1016/j.antiviral.2007.01.006; Barr IG, 2007, ANTIVIR RES, V73, P112, DOI 10.1016/j.antiviral.2006.08.002; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; BELSHE RB, 1989, J INFECT DIS, V159, P430, DOI 10.1093/infdis/159.3.430; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; COX NJ, 1994, EUR J EPIDEMIOL, V10, P467, DOI 10.1007/BF01719678; Deyde VM, 2008, J INFECT DIS, V197, P632, DOI 10.1086/525056; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Englund Janet A, 2002, Semin Pediatr Infect Dis, V13, P120, DOI 10.1053/spid.2002.122999; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; HAY AJ, 1986, J ANTIMICROB CHEMOTH, V18, P19, DOI 10.1093/jac/18.Supplement_B.19; Hayden FG, 2006, NEW ENGL J MED, V354, P785, DOI 10.1056/NEJMp068030; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Hayden FG, 1996, ANTIVIRAL DRUG RESIS, P59; He GM, 2008, ANTIVIR RES, V77, P72, DOI 10.1016/j.antiviral.2007.08.007; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Ilyushina NA, 2007, ANTIVIR THER, V12, P363; REUMAN PD, 1989, ANTIVIR RES, V11, P27, DOI 10.1016/0166-3542(89)90018-1; Saito R, 2008, J INFECT DIS, V197, P630, DOI 10.1086/525055; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Tang JW, 2008, J MED VIROL, V80, P895, DOI 10.1002/jmv.21155; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wu B, 2009, CHINESE SCI BULL, V54, P2179, DOI 10.1007/s11434-009-0421-y; Ziegler T, 1999, J INFECT DIS, V180, P935, DOI 10.1086/314994	32	98	107	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119115	10.1371/journal.pone.0119115	http://dx.doi.org/10.1371/journal.pone.0119115			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768797	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500065
J	Haas, BW; Brook, M; Remillard, L; Ishak, A; Anderson, IW; Filkowski, MM				Haas, Brian W.; Brook, Michael; Remillard, Laura; Ishak, Alexandra; Anderson, Ian W.; Filkowski, Megan M.			I Know How You Feel: The Warm-Altruistic Personality Profile and the Empathic Brain	PLOS ONE			English	Article							RIGHT TEMPOROPARIETAL JUNCTION; PERSPECTIVE-TAKING; SOCIAL COGNITION; 5-FACTOR MODEL; FACET SCALES; BIG 5; METAANALYSIS; NEUROSCIENCE; INVENTORY; ACCURACY	The ability to empathize with other people is a critical component of human social relationships. Empathic processing varies across the human population, however it is currently unclear how personality traits are associated with empathic processing. This study was designed to test the hypothesis that specific personality traits are associated with behavioral and biological indicators of improved empathy. Extraversion and Agreeableness are personality traits designed to measure individual differences in social-cognitive functioning, however each trait-dimension includes elements that represent interpersonal social functioning and elements that do not represent interpersonal social functioning. We tested the prediction that interpersonal elements of Extraversion (Warmth) and Agreeableness (Altruism) are associated with empathy and non-interpersonal elements of Extraversion and Agreeableness are not associated with empathy. We quantified empathic processing behaviorally (empathic accuracy task using video vignettes) and within the brain (fMRI and an emotional perspective taking task) in 50 healthy subjects. Converging evidence shows that highly warm and altruistic people are well skilled in recognizing the emotional states of other people and exhibit greater activity in brain regions important for empathy (temporoparietal junction and medial prefrontal cortex) during emotional perspective taking. A mediation analysis further supported the association between warm-altruistic personality and empathic processing; indicating that one reason why highly warm-altruistic individuals may be skilled empathizers is that they engage the temporoparietal junction and medial prefrontal cortex more. Together, these findings advance the way the behavioral and neural basis of empathy is understood and demonstrates the efficacy of personality scales to measure individual differences in interpersonal social function.	[Haas, Brian W.; Remillard, Laura; Ishak, Alexandra; Anderson, Ian W.; Filkowski, Megan M.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Haas, Brian W.] Univ Georgia, Interdisciplinary Neurosci Grad Program, Athens, GA 30602 USA; [Brook, Michael] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Northwestern University; Feinberg School of Medicine	Haas, BW (corresponding author), Univ Georgia, Dept Psychol, Athens, GA 30602 USA.	bhaas@uga.edu			University of Georgia, Office of the Vice President for Research	University of Georgia, Office of the Vice President for Research	Funding: This study was funded by the University of Georgia, Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A., 1964, SOCIAL INTEREST CHAL; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; [Anonymous], 2001, EMOTIONS SOCIAL PSYC; Ashton MC, 2002, J PERS SOC PSYCHOL, V83, P245, DOI 10.1037//0022-3514.83.1.245; Bastian VA, 2005, PERS INDIV DIFFER, V39, P1135, DOI 10.1016/j.paid.2005.04.006; BATSON CD, 1988, J PERS SOC PSYCHOL, V55, P52, DOI 10.1037/0022-3514.55.1.52; Martos MPB, 2013, SCAND J PSYCHOL, V54, P407, DOI 10.1111/sjop.12058; Brook M, 2013, J ABNORM PSYCHOL, V122, P156, DOI 10.1037/a0030261; Christov-Moore L, 2014, NEUROSCI BIOBEHAV R, V46, P604, DOI 10.1016/j.neubiorev.2014.09.001; Costa A, 2008, BEHAV NEUROL, V19, P71, DOI 10.1155/2008/694632; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Costa P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089254, 10.1371/journal.pone.0094842]; COSTA PT, 1991, PERS INDIV DIFFER, V12, P887, DOI 10.1016/0191-8869(91)90177-D; COSTA PT, 1995, J PERS ASSESS, V64, P21, DOI 10.1207/s15327752jpa6401_2; Cote S, 2011, J PERS SOC PSYCHOL, V101, P217, DOI 10.1037/a0023171; Davis M.H., 1997, EMPATHIC ACCURACY, P144; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Decety J, 2011, EMOT REV, V3, P92, DOI 10.1177/1754073910374662; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; DEPUE RA, 2005, BEHAV BRAIN SCI, V28, P350, DOI DOI 10.1017/S0140525X05000063; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; DeYoung CG, 2007, J PERS SOC PSYCHOL, V93, P880, DOI 10.1037/0022-3514.93.5.880; DeYoung CG, 2013, J PERS, V81, P465, DOI 10.1111/jopy.12020; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Giardina A, 2011, NEUROSCI LETT, V495, P150, DOI 10.1016/j.neulet.2011.03.059; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Graziano W., 2013, HDB COGNITION EMOTIO, P347; Grezes J, 2002, NEUROPSYCHOLOGIA, V40, P212, DOI 10.1016/S0028-3932(01)00089-6; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Hall JA, 2009, J NONVERBAL BEHAV, V33, P149, DOI 10.1007/s10919-009-0070-5; Ickes W.J., 1997, EMPATHIC ACCURACY; Jang KL, 2002, PERS INDIV DIFFER, V33, P83, DOI 10.1016/S0191-8869(01)00137-4; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Kraus MW, 2010, PSYCHOL SCI, V21, P1716, DOI 10.1177/0956797610387613; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Mars RB, 2012, CEREB CORTEX, V22, P1894, DOI 10.1093/cercor/bhr268; McBride C, 2005, PERS INDIV DIFFER, V38, P129, DOI 10.1016/j.paid.2004.03.014; MCCRAE RR, 1989, J PERS SOC PSYCHOL, V56, P586, DOI 10.1037/0022-3514.56.4.586; McCrae RR, 2005, J PERS ASSESS, V84, P261, DOI 10.1207/s15327752jpa8403_05; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mooradian TA, 2011, AM J PSYCHOL, V124, P99, DOI 10.5406/amerjpsyc.124.1.0099; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Morishima Y, 2012, NEURON, V75, P73, DOI 10.1016/j.neuron.2012.05.021; Oswald PA, 1996, J SOC PSYCHOL, V136, P613, DOI 10.1080/00224545.1996.9714045; PIEDMONT RL, 1993, J PERS ASSESS, V60, P302, DOI 10.1207/s15327752jpa6002_8; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Preston SD, 2012, EMOT REV, V4, P24, DOI 10.1177/1754073911421378; Realo A, 2002, TRAMES-J HUMANIT SOC, V16, P205; RICHENDOLLER NR, 1994, PERS INDIV DIFFER, V17, P303, DOI 10.1016/0191-8869(94)90278-X; Sanfey AG, 2007, SCIENCE, V318, P598, DOI 10.1126/science.1142996; Sollberger M, 2009, NEUROPSYCHOLOGIA, V47, P2812, DOI 10.1016/j.neuropsychologia.2009.06.006; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; UNDERWOOD B, 1982, PSYCHOL BULL, V91, P143, DOI 10.1037/0033-2909.91.1.143; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Watson D., 1997, HDB PERSONALITY PSYC; WIGGINS JS, 1979, J PERS SOC PSYCHOL, V37, P395, DOI 10.1037/0022-3514.37.3.395; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	59	17	17	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120639	10.1371/journal.pone.0120639	http://dx.doi.org/10.1371/journal.pone.0120639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25769028	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500131
J	Sibley, KM; Howe, T; Lamb, SE; Lord, SR; Maki, BE; Rose, DJ; Scott, V; Stathokostas, L; Straus, SE; Jaglal, SB				Sibley, Kathryn M.; Howe, Tracey; Lamb, Sarah E.; Lord, Stephen R.; Maki, Brian E.; Rose, Debra J.; Scott, Vicky; Stathokostas, Liza; Straus, Sharon E.; Jaglal, Susan B.			Recommendations for a Core Outcome Set for Measuring Standing Balance in Adult Populations: A Consensus-Based Approach	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; EVALUATION SYSTEMS TEST; MINI-BESTEST; PSYCHOMETRIC PROPERTIES; DETECTABLE CHANGE; CLINICAL UTILITY; CHRONIC STROKE; OLDER-PEOPLE; SHORT-FORM; SCALE	Background Standing balance is imperative for mobility and avoiding falls. Use of an excessive number of standing balance measures has limited the synthesis of balance intervention data and hampered consistent clinical practice. Objective To develop recommendations for a core outcome set (COS) of standing balance measures for research and practice among adults. Methodology A combination of scoping reviews, literature appraisal, anonymous voting and face-to-face meetings with fourteen invited experts from a range of disciplines with international recognition in balance measurement and falls prevention. Consensus was sought over three rounds using pre-established criteria. Data sources The scoping review identified 56 existing standing balance measures validated in adult populations with evidence of use in the past five years, and these were considered for inclusion in the COS. Results Fifteen measures were excluded after the first round of scoring and a further 36 after round two. Five measures were considered in round three. Two measures reached consensus for recommendation, and the expert panel recommended that at a minimum, either the Berg Balance Scale or Mini Balance Evaluation Systems Test be used when measuring standing balance in adult populations. Limitations Inclusion of two measures in the COS may increase the feasibility of potential uptake, but poses challenges for data synthesis. Adoption of the standing balance COS does not constitute a comprehensive balance assessment for any population, and users should include additional validated measures as appropriate. Conclusions The absence of a gold standard for measuring standing balance has contributed to the proliferation of outcome measures. These recommendations represent an important first step towards greater standardization in the assessment and measurement of this critical skill and will inform clinical research and practice internationally.	[Sibley, Kathryn M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Sibley, Kathryn M.; Maki, Brian E.; Jaglal, Susan B.] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Howe, Tracey] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Lamb, Sarah E.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Rehabil Res Ctr, Oxford, England; [Lord, Stephen R.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Maki, Brian E.; Straus, Sharon E.; Jaglal, Susan B.] Univ Toronto, Toronto, ON, Canada; [Rose, Debra J.] Calif State Univ Fullerton, Fullerton, CA 92634 USA; [Scott, Vicky] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Scott, Vicky] British Columbia Injury Res & Prevent Unit, Clayton, Vic, Australia; [Scott, Vicky] Minist Hlth, Clayton, Vic, Australia; [Stathokostas, Liza] Univ Western Ontario, Canadian Ctr Act & Aging, London, ON, Canada	University of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; Glasgow Caledonian University; University of Oxford; Neuroscience Research Australia; University of New South Wales Sydney; University of Toronto; California State University System; California State University Fullerton; University of British Columbia; Western University (University of Western Ontario)	Sibley, KM (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada.	kathryn.sibley@umanitoba.ca		Howe, Tracey/0000-0003-4382-0407; Lamb, Sarah/0000-0003-4349-7195; Jaglal, Susan/0000-0002-2930-1443; Lord, Stephen R/0000-0002-7111-8802	Canadian Institutes of Health Research (CIHR) [MAG133935]; STIHR-CIHR Fellowship from Knowledge Translation Canada; Toronto Rehabilitation Institute; NIHR Oxford CLARHC; BRU; Canadian Foundation for Innovation; Ontario Innovation Trust; Ministry of Research and Innovation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); STIHR-CIHR Fellowship from Knowledge Translation Canada; Toronto Rehabilitation Institute(University of Toronto); NIHR Oxford CLARHC; BRU; Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	Funding: The project was funded by a Canadian Institutes of Health Research (CIHR) planning grant (# MAG133935) - http://www.cihr-irsc.gc.ca/e/193.html. KMS was supported by a STIHR-CIHR Fellowship from Knowledge Translation Canada and the Toronto Rehabilitation Institute. SEL is supported by the NIHR Oxford CLARHC and BRU awards. SES holds a Canada Research Chair in Knowledge Translation and Quality of Care. SBJ holds the Toronto Rehabilitation Institute Chair in Rehabilitation Research at the University of Toronto. Infrastructure support was provided by the Toronto Rehabilitation Institute, with grants from the Canadian Foundation for Innovation, the Ontario Innovation Trust and the Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beaupre LA, 2005, J GEN INTERN MED, V20, P1019, DOI 10.1111/j.1525-1497.2005.00219.x; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Bergstrom M, 2012, TRANSLATION VALIDATI, P1532, DOI [doi: 10.3109/ 09593985.2011.653707 PMID: 22288658, DOI 10.3109/09593985.2011.653707]; Bland DC, 2011, BRAIN INJURY, V25, P664, DOI 10.3109/02699052.2011.576306; Boers M, 2014, J RHEUMATOL, V41, P978, DOI 10.3899/jrheum.131307; Boulgarides LK, 2003, PHYS THER, V83, P328, DOI 10.1093/ptj/83.4.328; Brusse KJ, 2005, PHYS THER, V85, P134, DOI 10.1093/ptj/85.2.134; Canadian Agency for Drugs and Technologies in Health, 2013, GREY MATT PRACT SEAR; Chou CY, 2006, PHYS THER, V86, P195, DOI 10.1093/ptj/86.2.195; Conradsson M, 2007, PHYS THER, V87, P1155, DOI 10.2522/ptj.20060343; Crocker T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004294.pub3; Dillon CF, 2010, VISION HEARING BALAN; Donoghue D, 2009, J REHABIL MED, V41, P343, DOI 10.2340/16501977-0337; Duncan RP, 2011, ARCH PHYS MED REHAB, V92, P1431, DOI 10.1016/j.apmr.2011.04.008; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fitch K., 2001, RAND UCLA APPROPRIAT; Flansbjer UB, 2012, PM&R, V4, P165, DOI 10.1016/j.pmrj.2011.11.004; Franchignoni F, 2005, ARCH PHYS MED REHAB, V86, P2225, DOI 10.1016/j.apmr.2005.09.006; Franchignoni F, 2010, J REHABIL MED, V42, P323, DOI 10.2340/16501977-0537; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haas R, 2012, PHYS THER; Hiengkaew V, 2012, ARCH PHYS MED REHAB, V93, P1201, DOI 10.1016/j.apmr.2012.01.014; Holbein-Jenny MA, 2007, ERGONOMICS, V50, P631, DOI 10.1080/00140130601154814; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Howe TE, 2011, COCHRANE DATABASE SY, V11; Howe TE, 2011, AGE AGEING, V40, P532, DOI 10.1093/ageing/afr082; Jogi P, 2011, PHYSIOTHER CAN, V63, P107, DOI 10.3138/ptc.2009-26; King LA, 2012, COMP MINI BESTEST BE, DOI [10.1155/2012/375419, DOI 10.1155/2012/375419]; La Porta F, 2011, J REHABIL MED, V43, P445, DOI 10.2340/16501977-0800; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Learmonth YC, 2012, INT J REHABIL RES, V35, P69, DOI 10.1097/MRR.0b013e328350b65f; Leddy AL, 2011, J NEUROL PHYS THER, V35, P90, DOI 10.1097/NPT.0b013e31821a620c; Leddy AL, 2011, PHYS THER, V91, P102, DOI 10.2522/ptj.20100113; Lemay JF, 2010, SPINAL CORD, V48, P245, DOI 10.1038/sc.2009.119; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; Lofgren N, 2014, MINI BESTEST CLIN RE; Mao HF, 2002, STROKE, V33, P1022, DOI 10.1161/01.STR.0000012516.63191.C5; McGlynn M, 2007, PHYSIOTHER CAN, V59, P241, DOI DOI 10.3138/ptc.59.4.241; McNeely ME, 2012, GAIT POSTURE, V36, P144, DOI 10.1016/j.gaitpost.2012.02.009; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; O'Hoski S, 2014, PHYS THER, V94, P334, DOI 10.2522/ptj.20130104; Orr R, 2008, SPORTS MED, V38, P317, DOI 10.2165/00007256-200838040-00004; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Qutubuddin AA, 2005, ARCH PHYS MED REHAB, V86, P789, DOI 10.1016/j.apmr.2004.11.005; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Saunders DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub5; Scalzo PL, 2009, ARQ NEURO-PSIQUIAT, V67, P831, DOI 10.1590/S0004-282X2009000500010; Schlenstedt C, 2014, COMP FULLERTON ADV B; Shumway-Cook A., 2007, MOTOR CONTROL TRANSL; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Sibley KM, 2015, ARCH PHYS MED REHAB, V96, P122, DOI 10.1016/j.apmr.2014.06.021; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; Steffen T, 2008, PHYS THER, V88, P733, DOI 10.2522/ptj.20070214; Stevenson TJ, 2001, AUST J PHYSIOTHER, V47, P29, DOI 10.1016/S0004-9514(14)60296-8; Sturnieks DL, 2004, J RHEUMATOL, V31, P2272; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tran D, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-249; Tsang CSL, 2013, PHYS THER, V93, P1102, DOI 10.2522/ptj.20120454; Tyson SF, 2009, CLIN REHABIL, V23, P824, DOI 10.1177/0269215509335018; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; Wang CH, 2004, PHYS THER, V84, P430, DOI 10.1093/ptj/84.5.430; Whitney Susan, 2003, Physiother Res Int, V8, P178, DOI 10.1002/pri.288; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132; Wirz M, 2010, NEUROREHAB NEURAL RE, V24, P70, DOI 10.1177/1545968309341059; Wood-Dauphinee S, 1997, CAN J REHABIL, V10, P35	74	55	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120568	10.1371/journal.pone.0120568	http://dx.doi.org/10.1371/journal.pone.0120568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768435	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500128
J	Tiedeken, EJ; Stout, JC				Tiedeken, Erin Jo; Stout, Jane C.			Insect-Flower Interaction Network Structure Is Resilient to a Temporary Pulse of Floral Resources from Invasive Rhododendron ponticum	PLOS ONE			English	Article							PLANT-POLLINATOR NETWORKS; ANIMAL MUTUALISTIC NETWORKS; ALIEN PLANT; RELATIVE ABUNDANCE; SEED PRODUCTION; NEST DENSITY; IMPACTS; CONSERVATION; INTEGRATION; TOLERANCE	Invasive alien plants can compete with native plants for resources, and may ultimately decrease native plant diversity and/or abundance in invaded sites. This could have consequences for native mutualistic interactions, such as pollination. Although invasive plants often become highly connected in plant- pollinator interaction networks, in temperate climates they usually only flower for part of the season. Unless sufficient alternative plants flower outside this period, whole- season floral resources may be reduced by invasion. We hypothesized that the cessation of flowering of a dominant invasive plant would lead to dramatic, seasonal compositional changes in plant- pollinator communities, and subsequent changes in network structure. We investigated variation in floral resources, flower- visiting insect communities, and interaction networks during and after the flowering of invasive Rhododendron ponticum in four invaded Irish woodland sites. Floral resources decreased significantly after R. ponticum flowering, but the magnitude of the decrease varied among sites. Neither insect abundance nor richness varied between the two periods (during and after R. ponticum flowering), yet insect community composition was distinct, mostly due to a significant reduction in Bombus abundance after flowering. During flowering R. ponticum was frequently visited by Bombus; after flowering, these highly mobile pollinators presumably left to find alternative floral resources. Despite compositional changes, however, network structural properties remained stable after R. ponticum flowering ceased: generality increased, but quantitative connectance, interaction evenness, vulnerability, H'(2) and network size did not change. This is likely because after R. ponticum flowering, two to three alternative plant species became prominent in networks and insects increased their diet breadth, as indicated by the increase in network- level generality. We conclude that network structure is robust to seasonal changes in floral abundance at sites invaded by alien, massflowering plant species, as long as alternative floral resources remain throughout the season to support the flower- visiting community.	[Tiedeken, Erin Jo; Stout, Jane C.] Univ Dublin Trinity Coll, Dept Bot, Sch Nat Sci, Dublin 2, Ireland; [Tiedeken, Erin Jo; Stout, Jane C.] Univ Dublin Trinity Coll, Trinity Ctr Biodivers Res, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Tiedeken, EJ (corresponding author), Univ Dublin Trinity Coll, Dept Bot, Sch Nat Sci, Dublin 2, Ireland.	tiedekee@tcd.ie	Stout, Jane C/B-1631-2010; borba, jared/D-6810-2015; Stout, Jane/AAS-8867-2020	Stout, Jane C/0000-0002-2027-0863; Stout, Jane/0000-0002-2027-0863	Science Foundation Ireland [10/RFP/EOB2842]; Irish Research Council's EMBARK Postgraduate Scholarship Scheme [RS/2010/2147]; National Science Foundation Graduate Research Fellowship [2010097514]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council's EMBARK Postgraduate Scholarship Scheme(Irish Research Council for Science, Engineering and Technology); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This project was funded by Science Foundation Ireland (http://www.sfi.ie/, grant number 10/RFP/EOB2842 to JCS) and the Irish Research Council's EMBARK Postgraduate Scholarship Scheme (http://research.ie/, grant number RS/2010/2147 to EJT). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (http://www.nsfgrfp.org/, under Grant No. 2010097514 to EJT). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation or other funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Albrecht M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0773; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bartomeus I, 2010, J ECOL, V98, P440, DOI 10.1111/j.1365-2745.2009.01629.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bjerknes AL, 2007, BIOL CONSERV, V138, P1, DOI 10.1016/j.biocon.2007.04.015; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Byrne E, 2010, THESIS TRINITY COLL; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Clout M, 2002, TURNING TIDE BIOL IN; CROSS J R, 1975, Journal of Ecology, V63, P345, DOI 10.2307/2258859; CROSS JR, 1981, J ECOL, V69, P807, DOI 10.2307/2259638; Dicks LV, 2002, J ANIM ECOL, V71, P32, DOI 10.1046/j.0021-8790.2001.00572.x; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Dietzsch AC., 2009, THESIS TRINITY COLL; Dietzsch AC, 2011, OECOLOGIA, V167, P469, DOI 10.1007/s00442-011-1987-z; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Ferrero V, 2013, BIOL INVASIONS, V15, P2347, DOI 10.1007/s10530-013-0457-4; Ghazoul J, 2002, ECOL ENTOMOL, V27, P638, DOI 10.1046/j.1365-2311.2002.00438.x; Gibson RH, 2011, OIKOS, V120, P822, DOI 10.1111/j.1600-0706.2010.18927.x; Goulson D, 2000, OIKOS, V88, P547, DOI 10.1034/j.1600-0706.2000.880311.x; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaiser-Bunbury CN, 2011, J ECOL, V99, P202, DOI 10.1111/j.1365-2745.2010.01732.x; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Kaiser-Bunbury CN, 2009, PERSPECT PLANT ECOL, V11, P241, DOI 10.1016/j.ppees.2009.04.001; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Martin P. H., 1999, Biological Invasions, V1, P215, DOI 10.1023/A:1010084421858; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Memmott J, 2002, P ROY SOC B-BIOL SCI, V269, P2395, DOI 10.1098/rspb.2002.2174; Morales CL, 2006, J ECOL, V94, P171, DOI 10.1111/j.1365-2745.2005.01069.x; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; National Biodiversity Data Centre, 2010, ID GUID IR BUMBL; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Padron B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006275; Parnell J, 2011, WEBBS IRISH FLORA; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Power EF, 2011, J APPL ECOL, V48, P561, DOI 10.1111/j.1365-2664.2010.01949.x; PYSEK P, 1995, J VEG SCI, V6, P711, DOI 10.2307/3236442; R Core Team, 2016, R FDN STAT COMP; Rose F., 2006, WILD FLOWER KEY IDEN; Stanley DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065516; Stout JC, 2007, BOT J LINN SOC, V155, P373, DOI 10.1111/j.1095-8339.2007.00719.x; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Stout JC, 2014, ACTA OECOL, V55, P78, DOI 10.1016/j.actao.2013.12.002; Stout JC, 2007, APIDOLOGIE, V38, P198, DOI 10.1051/apido:2006071; Stout JC, 2006, BIODIVERS CONSERV, V15, P755, DOI 10.1007/s10531-004-1065-5; Stubbs AE, 1983, BRIT HOVERFLIES ILLU; Sugiura N, 1996, ECOL RES, V11, P249, DOI 10.1007/BF02347782; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; USHER MB, 1986, PHILOS T ROY SOC B, V314, P695, DOI 10.1098/rstb.1986.0081; Vance NC, 2004, AM J BOT, V91, P2060, DOI 10.3732/ajb.91.12.2060; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vila M, 2009, P ROY SOC B-BIOL SCI, V276, P3887, DOI 10.1098/rspb.2009.1076; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x	76	27	29	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119733	10.1371/journal.pone.0119733	http://dx.doi.org/10.1371/journal.pone.0119733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764085	gold, Green Published, Green Submitted			2022-12-26	WOS:000351276300031
J	Calderon-Rivera, A; Sandoval, A; Gonzalez-Ramirez, R; Gonzalez-Billault, C; Felix, R				Calderon-Rivera, Aida; Sandoval, Alejandro; Gonzalez-Ramirez, Ricardo; Gonzalez-Billault, Christian; Felix, Ricardo			Regulation of Neuronal Ca(v)3.1 Channels by Cyclin-Dependent Kinase 5 (Cdk5)	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; SURFACE EXPRESSION; ACTIVATOR P35; CELLS; PAIN; PHOSPHORYLATION; DIFFERENTIATION; EPILEPSY; CLONING; ROLES	Low voltage-activated (LVA) T-type Ca2+ channels activate in response to subthreshold membrane depolarizations and therefore represent an important source of Ca2+ influx near the resting membrane potential. In neurons, these proteins significantly contribute to control relevant physiological processes including neuronal excitability, pacemaking and post-inhibitory rebound burst firing. Three subtypes of T-type channels (Ca(v)3.1 to Ca(v)3.3) have been identified, and using functional expression of recombinant channels diverse studies have validated the notion that T-type Ca2+ channels can be modulated by various endogenous ligands as well as by second messenger pathways. In this context, the present study reveals a previously unrecognized role for cyclin-dependent kinase 5 (Cdk5) in the regulation of native T-type channels in N1E-115 neuroblastoma cells, as well as recombinant Ca(v)3.1channels heterologously expressed in HEK-293 cells. Cdk5 and its co-activators play critical roles in the regulation of neuronal differentiation, cortical lamination, neuronal cell migration and axon outgrowth. Our results show that overexpression of Cdk5 causes a significant increase in whole cell patch clamp currents through T-type channels in N1E-115 cells, while siRNA knockdown of Cdk5 greatly reduced these currents. Consistent with this, overexpression of Cdk5 in HEK-293 cells stably expressing Ca(v)3.1channels upregulates macroscopic currents. Furthermore, using site-directed mutagenesis we identified a major phosphorylation site at serine 2234 within the C-terminal region of the Ca(v)3.1subunit. These results highlight a novel role for Cdk5 in the regulation of T-type Ca2+ channels.	[Calderon-Rivera, Aida; Sandoval, Alejandro] UNAM, FES Iztacala, Sch Med, Tlalnepantla, Mexico; [Gonzalez-Ramirez, Ricardo] Dr Manuel Gea Gonzalez Gen Hosp, Dept Mol Biol & Histocompatibil, Minist Hlth, Mexico City, DF, Mexico; [Gonzalez-Billault, Christian] Univ Chile, Fac Sci, Dept Biol, Santiago, Chile; [Felix, Ricardo] IPN, CINVESTAV, Ctr Res & Adv Studies, Natl Polytech Inst,Dept Cell Biol, Mexico City 07738, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad de Chile; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Felix, R (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Natl Polytech Inst,Dept Cell Biol, Mexico City 07738, DF, Mexico.	rfelix@cell.cinvestav.mx	Gonzalez-Billault, Christian/P-2393-2019; González-Ramírez, Ricardo/O-1792-2014; Felix, Ricardo/A-6989-2008; Gonzalez-Billault, Christian/K-9622-2013	González-Ramírez, Ricardo/0000-0003-1399-8036; Felix, Ricardo/0000-0002-5383-7176; Sandoval, Alejandro/0000-0002-8558-6033; Gonzalez-Billault, Christian/0000-0003-0335-1482	Conacyt Mexico [128707-Q]; PAPIIT; UNAM [IN-221011]; CONICYT Chile [ACT114]	Conacyt Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT; UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work received funding from the following sources: 128707-Q, Conacyt Mexico, http://www.conacyt.mx/; IN-221011, PAPIIT; UNAM, http://dgapa.unam.mx/html/papiit/papit.html; and ACT114, CONICYT Chile, http://www.conicyt.cl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila G, 2004, CELL MOL NEUROBIOL, V24, P317, DOI 10.1023/B:CEMN.0000022765.52109.26; Avila T, 2006, J CELL PHYSIOL, V209, P448, DOI 10.1002/jcp.20743; Borquez DA, 2013, GENOMICS, V101, P221, DOI 10.1016/j.ygeno.2013.01.003; Bourinet E, 2014, PHYSIOL REV, V94, P81, DOI 10.1152/physrev.00023.2013; Buraei Z, 2005, BIOPHYS J, V89, P1681, DOI 10.1529/biophysj.104.052837; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chemin J, 2007, J BIOL CHEM, V282, P32710, DOI 10.1074/jbc.M702746200; Cheung ZH, 2006, NEURON, V50, P13, DOI 10.1016/j.neuron.2006.02.024; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Francois A, 2014, PFLUG ARCH EUR J PHY, V466, P707, DOI 10.1007/s00424-014-1484-4; Gandini Maria A, 2014, Cold Spring Harb Protoc, V2014, P389, DOI 10.1101/pdb.prot073205; Gonzalez-Ramirez R, 2014, J CELL PHYSIOL, V229, P551, DOI 10.1002/jcp.24432; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Hu CL, 2009, J BIOL CHEM, V284, P7465, DOI 10.1074/jbc.M808049200; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kesavapany S, 2001, EUR J NEUROSCI, V13, P241, DOI 10.1046/j.1460-9568.2001.01376.x; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lai KO, 2009, BBA-MOL BASIS DIS, V1792, P741, DOI 10.1016/j.bbadis.2009.05.001; Lee JH, 1999, J NEUROSCI, V19, P1912; Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Matsushita M, 1996, BRAIN RES, V734, P319, DOI 10.1016/S0006-8993(96)00702-0; Mor M, 2012, AM J PHYSIOL-CELL PH, V303, pC192, DOI 10.1152/ajpcell.00427.2011; NARAHASHI T, 1987, J PHYSIOL-LONDON, V383, P231; Nelson MT, 2006, CURR PHARM DESIGN, V12, P2189, DOI 10.2174/138161206777585184; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Panner A, 2005, CELL CALCIUM, V37, P105, DOI 10.1016/j.ceca.2004.07.002; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Su SC, 2012, NEURON, V75, P675, DOI 10.1016/j.neuron.2012.06.023; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Toledo A, 2012, CELL CALCIUM, V52, P377, DOI 10.1016/j.ceca.2012.06.005; Tomizawa K, 2002, J NEUROSCI, V22, P2590, DOI 10.1523/JNEUROSCI.22-07-02590.2002; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Weiss N, 2013, PFLUG ARCH EUR J PHY, V465, P1159, DOI 10.1007/s00424-013-1259-3; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Yarotskyy V, 2012, J NEUROPHYSIOL, V107, P1942, DOI 10.1152/jn.00993.2011; YOSHII M, 1988, BIOPHYS J, V54, P885, DOI 10.1016/S0006-3495(88)83025-X; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x	44	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119134	10.1371/journal.pone.0119134	http://dx.doi.org/10.1371/journal.pone.0119134			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760945	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000048
J	Leles, B; Chaves, AV; Russo, P; Batista, JAN; Lovato, MB				Leles, Bruno; Chaves, Anderson V.; Russo, Philip; Batista, Joao A. N.; Lovato, Maria Bernadete			Genetic Structure Is Associated with Phenotypic Divergence in Floral Traits and Reproductive Investment in a High-Altitude Orchid from the Iron Quadrangle, Southeastern Brazil	PLOS ONE			English	Article							LOCAL ADAPTATION; POPULATION-GENETICS; LANDSCAPE GENETICS; FLOW; VARIABILITY; DIFFERENTIATION; SPECIATION; EVOLUTION; SOFTWARE; PHYLOGEOGRAPHY	Knowledge of the role of Neotropical montane landscapes in shaping genetic connectivity and local adaptation is essential for understanding the evolutionary processes that have shaped the extraordinary species diversity in these regions. In the present study, we examined the landscape genetics, estimated genetic diversity, and explored genetic relationships with morphological variability and reproductive strategies in seven natural populations of Cattleya liliputana (Orchidaceae). Nuclear microsatellite markers were used for genetic analyses. Spatial Bayesian clustering and population-based analyses revealed significant genetic structuring and high genetic diversity (He = 0.733 +/- 0.03). Strong differentiation was found between populations over short spatial scales (FST = 0.138, p < 0.001), reflecting the landscape discontinuity and isolation. Monmonier's maximum difference algorithm, Bayesian analysis on STRUCTURE and principal component analysis identified one major genetic discontinuity between populations. Divergent genetic groups showed phenotypic divergence in flower traits and reproductive strategies. Increased sexual reproductive effort was associated with rock outcrop type and may be a response to adverse conditions for growth and vegetative reproduction. Here we discuss the effect of restricted gene flow, local adaptation and phenotypic plasticity as drivers of population differentiation in Neotropical montane rock outcrops.	[Leles, Bruno; Chaves, Anderson V.; Russo, Philip; Lovato, Maria Bernadete] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Batista, Joao A. N.] Univ Fed Minas Gerais, Dept Bot, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Leles, B (corresponding author), Univ Estadual Paulista UNESP, Programa Posgrad Ecol & Biodiversidade, Dept Ecol, Rio Claro, SP, Brazil.	lovatomb@icb.ufmg.br; brunopleles@gmail.com	Lovato, Maria B/D-5303-2018; Chaves, Anderson Vieira/AAB-2717-2019; Batista, Joao A N/I-3389-2015; Lovato, Maria B/C-2126-2013; Russo, Philip/P-8784-2015	Lovato, Maria B/0000-0001-7009-3079; Chaves, Anderson Vieira/0000-0002-0934-1763; Batista, Joao A N/0000-0003-4640-0942; Russo, Philip/0000-0002-1607-0009	Fundacao Boticario; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); CNPq	Fundacao Boticario; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by the Fundacao Boticario and by the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The Pro-Reitoria de Pesquisa of the Universidade Federal de Minas Gerais provided resources for editing the language of the manuscript. MBL received research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; Antonelli A, 2010, BIOL J LINN SOC, V100, P597, DOI 10.1111/j.1095-8312.2010.01438.x; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Armbruster WS, 2009, EVOL ECOL, V23, P159, DOI 10.1007/s10682-008-9259-z; Ashman TL, 2006, HEREDITY, V96, P343, DOI 10.1038/sj.hdy.6800815; Azevedo MTA, 2007, BOT J LINN SOC, V153, P33, DOI 10.1111/j.1095-8339.2007.00589.x; Barbosa AR, 2012, AM J BOT, V99, P1477, DOI 10.3732/ajb.1200070; Barros FD, 2012, PLANT BIOLOGY, V14, P208, DOI 10.1111/j.1438-8677.2011.00474.x; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Bendahmane M, 2013, J EXP BOT, V64, P847, DOI 10.1093/jxb/ers387; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Borba EL, 2007, PLANT SYST EVOL, V267, P129, DOI 10.1007/s00606-007-0555-9; Borba EL, 2001, ANN BOT-LONDON, V88, P89, DOI 10.1006/anbo.2001.1435; Burke A, 2003, DIVERS DISTRIB, V9, P375, DOI 10.1046/j.1472-4642.2003.00035.x; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Caro LM, 2013, J EVOLUTION BIOL, V26, P357, DOI 10.1111/jeb.12055; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Collevatti RG, 2009, ANN BOT-LONDON, V104, P655, DOI 10.1093/aob/mcp157; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; da Cruz DT, 2011, PLANT SYST EVOL, V294, P87, DOI 10.1007/s00606-011-0444-0; Darwin C., 1859, ORIGINS SPECIES MEAN; Development Core Team R, 2012, R LANG ENV STAT COMP; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; DNPM, 2005, FERR; Doyle J. J., 1987, PHYTOCHEM B, P11; Echternacht L, 2011, FLORA, V206, P782, DOI 10.1016/j.flora.2011.04.003; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 2006, PHYLIP PHYLOGENY INF; Friedman J, 2013, NEW PHYTOL, V199, P571, DOI 10.1111/nph.12260; Gaston A, 2013, J EXP BOT, V64, P1837, DOI 10.1093/jxb/ert047; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Gentry AH, 1995, P NEOTR MONT FOR BIO; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Gomez JM, 2009, EVOLUTION, V63, P1820, DOI 10.1111/j.1558-5646.2009.00667.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/nclimate1329, 10.1038/NCLIMATE1329]; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goulart MF, 2011, BIOTROPICA, V43, P695, DOI 10.1111/j.1744-7429.2011.00760.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2012, SYST BIOL, V61, P897, DOI 10.1093/sysbio/sys038; Gumbert A, 2000, BEHAV ECOL SOCIOBIOL, V48, P36, DOI 10.1007/s002650000213; Gutierrez-Pinto N, 2012, MOL PHYLOGENET EVOL, V64, P156, DOI 10.1016/j.ympev.2012.03.011; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HENDERSON A, 1991, NATURE, V351, P21, DOI 10.1038/351021e0; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2008, AMBIO, V37, P324, DOI 10.1579/0044-7447(2008)37[324:TCOIOT]2.0.CO;2; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Juillet N, 2010, PERSPECT PLANT ECOL, V12, P317, DOI 10.1016/j.ppees.2010.05.001; Kaczorowski RL, 2008, EVOLUTION, V62, P1738, DOI 10.1111/j.1558-5646.2008.00400.x; Kartzinel TR, 2013, MOL ECOL, V22, P6048, DOI 10.1111/mec.12551; Knauer LG, 2007, GEONOMOS, V15, P8190, DOI [DOI 10.18285/GEONOMOS.V15I1.109, 10.18285/geonomos.v15i1.109]; Krizek BA, 2013, J EXP BOT, V64, P1427, DOI 10.1093/jxb/ert025; Leal B, 2013, THESIS U FEDERAL MIN; Lousada JM, 2013, BRAZ J BOT, V36, P45, DOI 10.1007/s40415-013-0001-x; Lousada JM, 2011, GENETICA, V139, P431, DOI 10.1007/s10709-011-9561-5; MAC ARTHUR ROBERT H., 1967; Magurran AE, 1998, PHILOS T R SOC B, V353, P275, DOI 10.1098/rstb.1998.0209; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Mota RC, 2006, THESIS U FEDEAL MINA; Nosil P, 2005, EVOLUTION, V59, P705; Nosil P, 2008, MOL ECOL, V17, P2103, DOI 10.1111/j.1365-294X.2008.03715.x; Novello M, 2013, GENET MOL RES, V12, P3274, DOI 10.4238/2013.September.3.3; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Osborne OG, 2013, GENOME BIOL EVOL, V5, P1704, DOI 10.1093/gbe/evt127; Pabst G.F.J., 1975, ORCHIDACEAE BRASILIE, V1; Palma-Silva C, 2011, MOL ECOL, V20, P3185, DOI 10.1111/j.1365-294X.2011.05143.x; Papadopulos AST, 2011, P NATL ACAD SCI USA, V108, P13188, DOI 10.1073/pnas.1106085108; Pfennig DW, 2014, MOL ECOL, V23, P4438, DOI 10.1111/mec.12887; Phillips RD, 2012, MOL ECOL, V21, P5208, DOI 10.1111/mec.12036; Pinheiro F, 2011, J BIOGEOGR, V38, P1923, DOI 10.1111/j.1365-2699.2011.02539.x; Pinheiro F, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-49; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pritchard JK, 2000, GENETICS, V155, P945; Rapini A., 2008, MEGADIVERSIDADE, V4, P15; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Safford HD, 2007, J BIOGEOGR, V34, P1701, DOI 10.1111/j.1365-2699.2007.01732.x; Salzmann CC, 2007, ANN BOT-LONDON, V100, P757, DOI 10.1093/aob/mcm161; Sambatti JBM, 2006, EVOLUTION, V60, P696, DOI 10.1111/j.0014-3820.2006.tb01149.x; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Silva-Pereira V, 2007, PLANT SYST EVOL, V269, P171, DOI 10.1007/s00606-007-0583-5; Smidt EC, 2006, PLANT SPEC BIOL, V21, P85, DOI 10.1111/j.1442-1984.2006.00154.x; Sork VL, 2010, MOL ECOL, V19, P3489, DOI 10.1111/j.1365-294X.2010.04786.x; Spier CA, 2003, MINER DEPOSITA, V38, P751, DOI 10.1007/s00126-003-0371-2; *STATSOFT INC, 2003, STATISTICA DAT AN SO; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Turner TL, 2010, NAT GENET, V42, P260, DOI 10.1038/ng.515; Van den Berg C, 2014, PHYTOTAXA, V186, P75, DOI 10.11646/phytotaxa.186.2.2; van den Berg C, 2009, ANN BOT-LONDON, V104, P417, DOI 10.1093/aob/mcp101; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verola CF, 2008, THESIS U CAMPINAS; Willi Y, 2007, J EVOLUTION BIOL, V20, P534, DOI 10.1111/j.1420-9101.2006.01263.x; Withner C., 1990, CATTLEYAS THEIR RELA, V3; Wright JW, 2007, PLANT SOIL, V293, P209, DOI 10.1007/s11104-006-9181-5; Zitari A, 2012, HEREDITY, V108, P219, DOI 10.1038/hdy.2011.61	108	11	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120645	10.1371/journal.pone.0120645	http://dx.doi.org/10.1371/journal.pone.0120645			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756994	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700071
J	Hadi, T; Bardou, M; Mace, G; Sicard, P; Wendremaire, M; Barrichon, M; Richaud, S; Demidov, O; Sagot, P; Garrido, C; Lirussi, F				Hadi, Tarik; Bardou, Marc; Mace, Guillaume; Sicard, Pierre; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Sagot, Paul; Garrido, Carmen; Lirussi, Frederic			Glutathione prevents preterm parturition and fetal death by targeting macrophage-induced reactive oxygen species production in the myometrium	FASEB JOURNAL			English	Article						inflammation; preterm labor; antioxidant; chorioamnionitis	SMOOTH-MUSCLE-CELLS; KAPPA-B ACTIVATION; OXIDATIVE STRESS; SIGNAL-TRANSDUCTION; COCULTURE MODEL; NADPH OXIDASE; LABOR; INFLAMMATION; PREGNANCY; BIRTH	Preterm birth is an inflammatory process resulting from the massive infiltration of innate immune cells and the production of proinflammatory cytokines in the myometrium. However, proinflammatory cytokines, which induce labor in vivo, fail to induce labor-associated features in humanmyometrial cells (MCs). We thus aimed to investigate if reactive oxygen species (ROS) production could be the missing step between immune cell activation and MC response. Indeed, we found that ROS production is increased in the human preterm laboring myometrium (27% ROS producing cells, respectively, versus 2% in nonlaboring controls), with 90% ROS production in macrophages. Using LPS-stimulated myometrial samples and cell coculture experiments, we demonstrated that ROS production is required for labor onset. Furthermore, we showed that ROS are required first in the NADPH oxidase (NADPHox)-2/NF-kappa B-dependent macrophage response to inflammatory stimuli but, more importantly, to trigger macrophage-inducedMCs transactivation. Remarkably, in a murine model of LPS-induced preterm labor (inducing delivery within 17 hours, with no pup survival), cotreatment with glutathione delayed labor onset up to 94 hours and prevented in utero fetal distress, allowing 46% pups to survive. These results suggest that targeting ROS production with the macrophage-permeable antioxidant glutathione could constitute a promising strategy to prevent preterm birth.	[Hadi, Tarik; Bardou, Marc; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Garrido, Carmen; Lirussi, Frederic] INSERM, U866, Lipides Nutr Canc, Dijon, France; [Hadi, Tarik; Bardou, Marc; Wendremaire, Maeva; Barrichon, Marina; Richaud, Sarah; Demidov, Oleg; Garrido, Carmen; Lirussi, Frederic] Univ Bourgogne, Dijon, France; [Bardou, Marc; Mace, Guillaume; Wendremaire, Maeva; Sagot, Paul; Lirussi, Frederic] Ctr Hosp Univ Dijon, Dijon, France; [Bardou, Marc; Lirussi, Frederic] INSERM, Ctr Invest Clin 1432, Dijon, France; [Mace, Guillaume; Sagot, Paul] Serv Gynecol & Obstet, Dijon, France; [Sicard, Pierre] Fac Med Toulouse, INSERM, Unite Mixte Rech 1048, Inst Metab & Cardiovasc Dis, F-31073 Toulouse, France; [Sicard, Pierre] Univ Toulouse 3, Ctr Hosp Univ Toulouse, Claudius Regaud Inst, F-31062 Toulouse, France; [Garrido, Carmen] Ctr Georges Francois Leclerc, Anticanc Ctr George Francois Leclerc, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Centre Georges-Francois Leclerc	Lirussi, F (corresponding author), CHU Dijon, CRI U866, Fac Med, 7 Bd Jeanne dArc,BP 87900, F-21079 Dijon, France.	frederic.lirussi@u-bourgogne.fr	Demidov, Oleg/U-2050-2017; Demidov, Oleg/AAC-4462-2021; Lirussi, Frederic/AAM-8186-2020; Garrido, carmen/G-1633-2018; Sicard, Pierre/N-7310-2018; Garrido, Carolina/GWM-5557-2022	Demidov, Oleg/0000-0003-4323-7174; Demidov, Oleg/0000-0003-4323-7174; Lirussi, Frederic/0000-0002-0649-6719; Garrido, carmen/0000-0003-1368-1493; Sicard, Pierre/0000-0001-5837-3916; Wendremaire, Maeva/0000-0001-9532-5702	French Regional Council of Burgundy (Conseil Regional de Bourgogne) [AOI STRESSOX]	French Regional Council of Burgundy (Conseil Regional de Bourgogne)(Region Bourgogne-Franche-Comte)	This work was funded in part by the French Regional Council of Burgundy (Conseil Regional de Bourgogne, Grant AOI STRESSOX).	Al-Gubory KH, 2010, INT J BIOCHEM CELL B, V42, P1634, DOI 10.1016/j.biocel.2010.06.001; ANDERSON ME, 1990, FASEB J, V4, P3251, DOI 10.1096/fasebj.4.14.2227215; Asikainen TM, 2006, FASEB J, V20, P1698, DOI 10.1096/fj.06-5887fje; Bartfai L, 2012, J MATERN-FETAL NEO M, V25, P575, DOI 10.3109/14767058.2011.587060; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beloosesky R, 2006, AM J OBSTET GYNECOL, V194, P268, DOI 10.1016/j.ajog.2005.06.082; Bevilacqua E, 2012, REPROD BIOMED ONLINE, V25, P31, DOI 10.1016/j.rbmo.2012.03.016; Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Chai M, 2012, PLACENTA, V33, P604, DOI 10.1016/j.placenta.2012.04.014; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Chevillard G, 2007, REPRODUCTION, V134, P811, DOI 10.1530/REP-07-0289; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clerici G, 2012, J OBSTET GYNAECOL, V32, P124, DOI 10.3109/01443615.2011.637139; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Daneshmand SS, 2002, AM J OBSTET GYNECOL, V187, P1131, DOI 10.1067/mob.2002.127145; Elnakish MT, 2013, J PATHOL, V231, P290, DOI 10.1002/path.4255; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Esplin MS, 2005, J MATERN-FETAL NEO M, V17, P365, DOI 10.1080/14767050500141329; FAN YY, 1995, IN VITRO CELL DEV-AN, V31, P492; Fetalvero Kristina M, 2008, J Clin Invest, V118, P3966, DOI 10.1172/JCI33800; Fidel PL, 1997, J SOC GYNECOL INVEST, V4, P22, DOI 10.1016/S1071-5576(96)00060-3; Finkel T, 2001, IUBMB LIFE, V52, P3, DOI 10.1080/15216540252774694; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fruhwirth Gilbert O., 2008, V49, P351, DOI 10.1007/978-1-4020-8831-5_13; Gandhirajan RK, 2013, J CLIN INVEST, V123, P887, DOI 10.1172/JCI65647; Gloire G, 2009, ANTIOXID REDOX SIGN, V11, P2209, DOI [10.1089/ars.2009.2463, 10.1089/ARS.2009.2463]; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gross G, 2000, AM J PHYSIOL-REG I, V278, pR1415, DOI 10.1152/ajpregu.2000.278.6.R1415; Hadi T, 2013, BBA-MOL CELL RES, V1833, P1041, DOI 10.1016/j.bbamcr.2013.01.019; Han YM, 2007, J PATHOL, V211, P489, DOI 10.1002/path.2131; Hauth JC, 2010, OBSTET GYNECOL, V116, P653, DOI 10.1097/AOG.0b013e3181ed721d; Heller DS, 2012, J LOW GENIT TRACT DI, V16, P4, DOI 10.1097/LGT.0b013e31822bb004; Helmer H, 2002, J SOC GYNECOL INVEST, V9, P15, DOI 10.1016/S1071-5576(01)00142-3; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hutchinson JL, 2014, FASEB J, V28, P94, DOI 10.1096/fj.13-237040; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Kimura T, 1999, REV REPROD, V4, P73, DOI 10.1530/ror.0.0040073; Kindzelskii AL, 2004, J IMMUNOL, V172, P6373, DOI 10.4049/jimmunol.172.10.6373; Kolls JK, 2006, J CLIN INVEST, V116, P860, DOI 10.1172/JCI28111; LEE E, 1995, ARTERIOSCL THROM VAS, V15, P2284, DOI 10.1161/01.ATV.15.12.2284; Lehner C, 2011, ANTIOXID REDOX SIGN, V15, P1305, DOI 10.1089/ars.2011.3923; Lin CC, 2010, FREE RADICAL BIO MED, V48, P240, DOI 10.1016/j.freeradbiomed.2009.10.047; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Lirussi F, 2010, BRIT J PHARMACOL, V159, P1354, DOI 10.1111/j.1476-5381.2009.00616.x; Lirussi F, 2008, BIOL REPROD, V78, P497, DOI 10.1095/biolreprod.107.064444; LUFT BJ, 1984, CELL IMMUNOL, V85, P94, DOI 10.1016/0008-8749(84)90281-8; MacIntyre DA, 2014, FASEB J, V28, P2358, DOI 10.1096/fj.13-247783; Mensink A, 1998, ENVIRON TOXICOL PHAR, V5, P197, DOI 10.1016/S1382-6689(98)00002-7; Moore RM, 2009, BIOL REPROD, V80, P781, DOI 10.1095/biolreprod.108.073205; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Ogge G, 2011, J PATHOL, V223, P553, DOI 10.1002/path.2825; Oliveira-Marques V, 2009, ANTIOXID REDOX SIGN, V11, P2223, DOI [10.1089/ars.2009.2601, 10.1089/ARS.2009.2601]; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Scirocco A, 2010, J CELL PHYSIOL, V223, P442, DOI 10.1002/jcp.22053; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Shynlova O, 2010, REPRODUCTION, V139, P247, DOI 10.1530/REP-09-0260; Sundrani DP, 2011, MED HYPOTHESES, V77, P878, DOI 10.1016/j.mehy.2011.08.001; Taggart MJ, 2008, J CLIN INVEST, V118, P3829, DOI 10.1172/JCI37785; Tinkel J, 2012, CARDIOL REV, V20, P77, DOI 10.1097/CRD.0b013e31823dbbad; Trollmann R, 2008, AM J PHYSIOL-REG I, V295, pR1973, DOI 10.1152/ajpregu.00053.2008; Ustun C, 2001, INT J GYNECOL OBSTET, V72, P109, DOI 10.1016/S0020-7292(00)00280-0; Wong BW, 2012, CAN J CARDIOL, V28, P631, DOI 10.1016/j.cjca.2012.06.023; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Yuan M, 2009, MOL HUM REPROD, V15, P713, DOI 10.1093/molehr/gap054	69	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2653	2666		10.1096/fj.14-266783	http://dx.doi.org/10.1096/fj.14-266783			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757563				2022-12-26	WOS:000355209500040
J	Kuusk, S; Sorlie, M; Valjamae, P				Kuusk, Silja; Sorlie, Morten; Valjamae, Priit			The Predominant Molecular State of Bound Enzyme Determines the Strength and Type of Product Inhibition in the Hydrolysis of Recalcitrant Polysaccharides by Processive Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; FAMILY 18 CHITINASE; SERRATIA-MARCESCENS; CRYSTALLINE CELLULOSE; INSOLUBLE CELLULOSE; AROMATIC RESIDUES; KINETIC-MODEL; SUBSTRATE; BINDING; CELLULASES	Processive enzymes are major components of the efficient enzyme systems that are responsible for the degradation of the recalcitrant polysaccharides cellulose and chitin. Despite intensive research, there is no consensus on which step is rate-limiting for these enzymes. Here, we performed a comparative study of two well characterized enzymes, the cellobiohydrolase Cel7A from Hypocrea jecorina and the chitinase ChiA from Serratia marcescens. Both enzymes were inhibited by their disaccharide product, namely chitobiose for ChiA and cellobiose for Cel7A. The products behaved as noncompetitive inhibitors according to studies using the C-14-labeled crystalline polymeric substrates C-14 chitin nanowhiskers and C-14-labeled bacterial microcrystalline cellulose for ChiA and Cel7A, respectively. The resulting observed K-i(obs) values were 0.45 +/- 0.08 mM for ChiA and 0.17 +/- 0.02 mM for Cel7A. However, in contrast to ChiA, the K-i(obs) of Cel7A was an order of magnitude higher than the true K-i value governed by the thermodynamic stability of the enzyme-inhibitor complex. Theoretical analysis of product inhibition suggested that the inhibition strength and pattern can be accounted for by assuming different rate-limiting steps for ChiA and Cel7A. Measuring the population of enzymes whose active site was occupied by a polymer chain revealed that Cel7A was bound predominantly via its active site. Conversely, the active-site-mediated binding of ChiA was slow, and most ChiA exhibited a free active site, even when the substrate concentration was saturating for the activity. Collectively, our data suggest that complexation with the polymer chain is rate-limiting for ChiA, whereas Cel7A is limited by dissociation.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Tartu; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism Grant [EMP171]; Estonian Science Foundation [9227]	Norwegian Financial Mechanism Grant; Estonian Science Foundation	This work was supported by Norwegian Financial Mechanism Grant EMP171 and Estonian Science Foundation Grant 9227.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Baumann MJ, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-45; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BHIKHABHAI R, 1984, Journal of Applied Biochemistry, V6, P336; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Brurberg MB, 1996, MICROBIOL-SGM, V142, P1581, DOI 10.1099/13500872-142-7-1581; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Chen L, 2014, J BIOL CHEM, V289, P17932, DOI 10.1074/jbc.M114.564534; Chundawat SPS, 2011, J AM CHEM SOC, V133, P11163, DOI 10.1021/ja2011115; CLAEYSSENS M, 1989, BIOCHEM J, V261, P819, DOI 10.1042/bj2610819; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2014, ANAL BIOCHEM, V447, P162, DOI 10.1016/j.ab.2013.11.024; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Dybvik AI, 2011, ANAL CHEM, V83, P4030, DOI 10.1021/ac1031308; Fox JM, 2012, BIOCHEMISTRY-US, V51, P442, DOI 10.1021/bi2011543; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gruno M, 2004, BIOTECHNOL BIOENG, V86, P503, DOI 10.1002/bit.10838; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; HOLTZAPPLE M, 1990, BIOTECHNOL BIOENG, V36, P275, DOI 10.1002/bit.260360310; Honda Y, 2003, J BIOCHEM, V133, P253, DOI 10.1093/jb/mvg031; HORMANN H, 1962, LIEBIGS ANN CHEM, V655, P178; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kont R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-135; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kostylev M, 2012, BIOTECHNOL BIOENG, V109, P295, DOI 10.1002/bit.23299; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Macdonald JM, 2010, ANGEW CHEM INT EDIT, V49, P2599, DOI 10.1002/anie.200906644; Murphy L, 2013, ENZYME MICROB TECH, V52, P163, DOI 10.1016/j.enzmictec.2013.01.002; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nelson N, 1944, J BIOL CHEM, V153, P375; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Pereira AGB, 2014, CARBOHYD POLYM, V107, P158, DOI 10.1016/j.carbpol.2014.02.046; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; Qi F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-238; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Shang BZ, 2014, ACS CATAL, V4, P2216, DOI 10.1021/cs500126q; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sipos B, 2010, APPL BIOCHEM BIOTECH, V161, P347, DOI 10.1007/s12010-009-8824-4; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-104; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Valjamae P, 2003, BIOTECHNOL BIOENG, V84, P254, DOI 10.1002/bit.10775; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zakariassen H, 2010, CARBOHYD POLYM, V82, P779, DOI 10.1016/j.carbpol.2010.05.051; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	75	38	38	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11678	11691		10.1074/jbc.M114.635631	http://dx.doi.org/10.1074/jbc.M114.635631			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767120	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000353719400041
J	Curci, PL; De Paola, D; Danzi, D; Vendramin, GG; Sonnante, G				Curci, Pasquale L.; De Paola, Domenico; Danzi, Donatella; Vendramin, Giovanni G.; Sonnante, Gabriella			Complete Chloroplast Genome of the Multifunctional Crop Globe Artichoke and Comparison with Other Asteraceae	PLOS ONE			English	Article							DNA; GENE; SEQUENCE; MICROSATELLITES; IDENTIFICATION; EVOLUTION; TOOLS; WILD; MITOCHONDRIAL; ORGANIZATION	With over 20,000 species, Asteraceae is the second largest plant family. High-throughput sequencing of nuclear and chloroplast genomes has allowed for a better understanding of the evolutionary relationships within large plant families. Here, the globe artichoke chloroplast (cp) genome was obtained by a combination of whole-genome and BAC clone high-throughput sequencing. The artichoke cp genome is 152,529 bp in length, consisting of two single-copy regions separated by a pair of inverted repeats (IRs) of 25,155 bp, representing the longest IRs found in the Asteraceae family so far. The large (LSC) and the small (SSC) single-copy regions span 83,578 bp and 18,641 bp, respectively. The artichoke cp sequence was compared to the other eight Asteraceae complete cp genomes available, revealing an IR expansion at the SSC/IR boundary. This expansion consists of 17 bp of the ndhF gene generating an overlap between the ndhF and ycf1 genes. A total of 127 cp simple sequence repeats (cpSSRs) were identified in the artichoke cp genome, potentially suitable for future population studies in the Cynara genus. Parsimony-informative regions were evaluated and allowed to place a Cynara species within the Asteraceae family tree. The eight most informative coding regions were also considered and tested for "specific barcode" purpose in the Asteraceae family. Our results highlight the usefulness of cp genome sequencing in exploring plant genome diversity and retrieving reliable molecular resources for phylogenetic and evolutionary studies, as well as for specific barcodes in plants.	[Curci, Pasquale L.; De Paola, Domenico; Danzi, Donatella; Sonnante, Gabriella] CNR, Inst Biosci & Bioresources, Bari, Italy; [Vendramin, Giovanni G.] CNR, Inst Biosci & Bioresources, Sesto Fiorentino, FI, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Sonnante, G (corresponding author), CNR, Inst Biosci & Bioresources, Bari, Italy.	gabriella.sonnante@ibbr.cnr.it	Vendramin, Giovanni G/K-9731-2014	Vendramin, Giovanni G/0000-0001-9921-7872; Danzi, Donatella/0000-0003-4393-5087; SONNANTE, GABRIELLA/0000-0003-0993-6828; Curci, Pasquale Luca/0000-0002-5780-3029; De Paola, Domenico/0000-0001-5667-3114	Italian Ministry of Economy and Finance [191/2009]; BiodiverSO - PSR Puglia	Italian Ministry of Economy and Finance; BiodiverSO - PSR Puglia	This research was supported by a dedicated grant from the Italian Ministry of Economy and Finance to the National Research Council for the project Innovazione e Sviluppo del Mezzogiorno - Conoscenze Integrate per Sostenibilita ed Innovazione del Made in Italy Agroalimentare (C.I.S.I. A.)-Legge n. 191/2009, and by the project BiodiverSO - PSR Puglia 2007-2013 Mis. 214/4 subaz. a), http://biodiversitapuglia.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, MOL ECOL RESOUR, V13, P929, DOI 10.1111/1755-0998.12128; Barres L, 2013, AM J BOT, V100, P867, DOI 10.3732/ajb.1200058; Bausher MG, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-21; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bremer K., 1994, ASTERACEAE CLADISTIC; Calabrese N, 2012, ACTA HORTIC, V942, P153, DOI 10.17660/ActaHortic.2012.942.18; Chung HJ, 2006, PLANT CELL REP, V25, P1369, DOI 10.1007/s00299-006-0196-4; Dempewolf H, 2010, MOL ECOL RESOUR, V10, P1048, DOI 10.1111/j.1755-0998.2010.02859.x; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drescher A, 2000, PLANT J, V22, P97, DOI 10.1046/j.1365-313x.2000.00722.x; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gatto A, 2013, ANN BOT-LONDON, V112, P855, DOI 10.1093/aob/mct150; Gebhardt R, 1997, TOXICOL APPL PHARM, V144, P279, DOI 10.1006/taap.1997.8130; Grassi F, 2002, VITIS, V41, P157; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Kode V, 2005, PLANT J, V44, P237, DOI 10.1111/j.1365-313X.2005.02533.x; Kraft K, 1997, PHYTOMEDICINE, V4, P369, DOI 10.1016/S0944-7113(97)80049-9; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078568; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057533; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martin G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067350; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; Melotto-Passarin DM, 2011, GENET MOL RES, V10, P2024, DOI 10.4238/vol10-3gmr1019; MILLIGAN BG, 1989, MOL BIOL EVOL, V6, P355; Mudunuri SB, 2007, BIOINFORMATICS, V23, P1181, DOI 10.1093/bioinformatics/btm097; Negro D, 2012, J FOOD SCI, V77, pC244, DOI 10.1111/j.1750-3841.2011.02531.x; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Odintsova MS, 2006, BIOTECHNOL INTELL UN, P57, DOI 10.1007/978-0-387-36672-2_6; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Ortiz S., 2009, SYSTEMATICS EVOLUTIO, P193; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Panero JL, 2008, MOL PHYLOGENET EVOL, V47, P757, DOI 10.1016/j.ympev.2008.02.011; Provan J, 2001, TRENDS ECOL EVOL, V16, P142, DOI 10.1016/S0169-5347(00)02097-8; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Ravi V, 2008, PLANT SYST EVOL, V271, P101, DOI 10.1007/s00606-007-0608-0; ROHDE W, 1994, J GEN VIROL, V75, P2141, DOI 10.1099/0022-1317-75-9-2141; Rottenberg A, 1996, GENET RESOUR CROP EV, V43, P53, DOI 10.1007/BF00126940; Sasaki T, 2003, MOL BIOL EVOL, V20, P1028, DOI 10.1093/molbev/msg098; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Sonnante G, 2002, GENET RESOUR CROP EV, V49, P247, DOI 10.1023/A:1015574627621; Sonnante G, 2007, ANN BOT-LONDON, V100, P1095, DOI 10.1093/aob/mcm127; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Umashankar V, 2007, BIOINFORMATION, V2, P62; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053939, 10.1371/journal.pone.0073053]; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872	67	87	91	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120589	10.1371/journal.pone.0120589	http://dx.doi.org/10.1371/journal.pone.0120589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774672	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500184
J	Itagaki, K; Kaczmarek, E; Lee, YT; Tang, IT; Isal, B; Adibnia, Y; Sandler, N; Grimm, MJ; Segal, BH; Otterbein, E; Hauser, CJ				Itagaki, Kiyoshi; Kaczmarek, Elzbieta; Lee, Yen Ting; Tang, I. Tien; Isal, Burak; Adibnia, Yashar; Sandler, Nicola; Grimm, Melissa J.; Segal, Brahm H.; Otterbein, E.; Hauser, Carl J.			Mitochondrial DNA Released by Trauma Induces Neutrophil Extracellular Traps	PLOS ONE			English	Article							NADPH OXIDASE; MAP KINASE; INFLAMMATION; THROMBOSIS; IMMUNITY; INJURY	Neutrophil extracellular traps (NETs) are critical for anti-bacterial activity of the innate immune system. We have previously shown that mitochondrial damage-associated molecular patterns (mtDAMPs), including mitochondrial DNA (mtDNA), are released into the circulation after injury. We therefore questioned whether mtDNA is involved in trauma-induced NET formation. Treatment of human polymorphoneutrophils (PMN) with mtDNA induced robust NET formation, though in contrast to phorbol myristate acetate (PMA) stimulation, no NADPH-oxidase involvement was required. Moreover, formation of mtDNA-induced NETs was completely blocked by TLR9 antagonist, ODN-TTAGGG. Knowing that infective outcomes of trauma in elderly people are more severe than in young people, we measured plasma mtDNA and NET formation in elderly and young trauma patients and control subjects. MtDNA levels were significantly higher in the plasma of elderly trauma patients than young patients, despite lower injury severity scores in the elderly group. NETs were not visible in circulating PMN isolated from either young or old control subjects. NETs were however, detected in PMN isolated from young trauma patients and to a lesser extent from elderly patients. Stimulation by PMA induced widespread NET formation in PMN from both young volunteers and young trauma patients. NET response to PMA was much less pronounced in both elderly volunteers' PMN and in trauma patients' PMN. We conclude that mtDNA is a potent inducer of NETs that activates PMN via TLR9 without NADPH-oxidase involvement. We suggest that decreased NET formation in the elderly regardless of higher mtDNA levels in their plasma may result from decreased levels of TLR9 and/or other molecules, such as neutrophil elastase and myeloperoxidase that are involved in NET generation. Further study of the links between circulating mtDNA and NET formation may elucidate the mechanisms of trauma-related organ failure as well as the greater susceptibility to secondary infection in elderly trauma patients.	[Itagaki, Kiyoshi; Kaczmarek, Elzbieta; Lee, Yen Ting; Tang, I. Tien; Isal, Burak; Adibnia, Yashar; Sandler, Nicola; Otterbein, E.; Hauser, Carl J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Kaczmarek, Elzbieta] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Grimm, Melissa J.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Grimm, Melissa J.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Segal, Brahm H.] SUNY Buffalo, Sch Med, Dept Med, Buffalo, NY 14260 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Itagaki, K (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.	kitagaki@bidmc.harvard.edu; chauser@bidmc.harvard.edu	Segal, Brahm/AAW-2706-2020; Hauser, Carl J./Y-1189-2019; Itagaki, Kiyoshi/M-5501-2015	Itagaki, Kiyoshi/0000-0002-6033-1122; Adibnia, Yashar/0000-0001-9298-6150; Hauser, Carl/0000-0003-3167-1846	 [5 R01 GM089711 04]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089711] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 5 R01 GM089711 04 to CJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Arai Y, 2014, BIOCHEM BIOPH RES CO, V443, P556, DOI 10.1016/j.bbrc.2013.12.007; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V., 2010, JOVE-J VIS EXP, V36, P1724, DOI [10.3791/1724, DOI 10.3791/1724/J0VE.C0M/VIDE0/1724]; Brinkmann V, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00413; Fuchs TA, 2012, ARTERIOSCL THROM VAS, V32, P1777, DOI 10.1161/ATVBAHA.111.242859; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gaszner Peter, 2004, Neuropsychopharmacol Hung, V6, P90; Ginde AA, 2014, SHOCK, V42, P99, DOI 10.1097/SHK.0000000000000182; Grassle S, 2014, ARTERIOSCL THROM VAS, V34, P1382, DOI 10.1161/ATVBAHA.113.303016; Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991; Itagaki K, 2002, J IMMUNOL, V168, P4063, DOI 10.4049/jimmunol.168.8.4063; Knudson M Margaret, 2004, Curr Opin Crit Care, V10, P539, DOI 10.1097/01.ccx.0000144941.09650.9f; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Sapey E, 2014, BLOOD, V123, P239, DOI 10.1182/blood-2013-08-519520; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Sun SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059989; Tseng CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041454; van Kessel KPM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00467; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Zhang Q, 2010, SHOCK, V34, P55, DOI 10.1097/SHK.0b013e3181cd8c08; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	114	117	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120549	10.1371/journal.pone.0120549	http://dx.doi.org/10.1371/journal.pone.0120549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774524	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500183
J	Kadowaki, T; Nishiyama, Y; Hisabori, T; Hihara, Y				Kadowaki, Taro; Nishiyama, Yoshitaka; Hisabori, Toru; Hihara, Yukako			Identification of OmpR-Family Response Regulators Interacting with Thioredoxin in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							HIGH-LIGHT; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REDOX; RPAB; SYSTEM; PHOTOSYNTHESIS; MECHANISM; PROTEINS; STRESS	The redox state of the photosynthetic electron transport chain is known to act as a signal to regulate the transcription of key genes involved in the acclimation responses to environmental changes. We hypothesized that the protein thioredoxin (Trx) acts as a mediator connecting the redox state of the photosynthetic electron transport chain and transcriptional regulation, and established a screening system to identify transcription factors (TFs) that interact with Trx. His-tagged TFs and S-tagged mutated form of Trx, TrxM(C35S), whose active site cysteine 35 was substituted with serine to trap the target interacting protein, were co-expressed in E. coli cells and Trx-TF complexes were detected by immuno-blotting analysis. We examined the interaction between Trx and ten OmpR family TFs encoded in the chromosome of the cyanobacterium Synechocystis sp. PCC 6803 (S.6803). Although there is a highly conserved cysteine residue in the receiver domain of all OmpR family TFs, only three, RpaA (Slr0115), RpaB (Slr0946) and ManR (Slr1837), were identified as putative Trx targets. The recombinant forms of wild-type TrxM, RpaA, RpaB and ManR proteins from S.6803 were purified following over-expression in E. coli and their interaction was further assessed by monitoring changes in the number of cysteine residues with free thiol groups. An increase in the number of free thiols was observed after incubation of the oxidized TFs with Trx, indicating the reduction of cysteine residues as a consequence of interaction with Trx. Our results suggest, for the first time, the possible regulation of OmpR family TFs through the supply of reducing equivalents from Trx, as well as through the phospho-transfer from its cognate sensor histidine kinase.	[Kadowaki, Taro; Nishiyama, Yoshitaka; Hihara, Yukako] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Hisabori, Toru; Hihara, Yukako] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Saitama University; Tokyo Institute of Technology; Japan Science & Technology Agency (JST)	Hihara, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	hihara@molbiol.saitama-u.ac.jp	Hihara, Yukako/E-3461-2010; Hihara, Yukako/AAX-2065-2020; Hisabori, Toru/E-5205-2014; Hihara, Yukako/AAO-6742-2020	Hisabori, Toru/0000-0003-2046-0277; Hihara, Yukako/0000-0003-1916-2053	Network Joint Research Center for Materials and Devices [2014243]; Ministry of Education, Culture, Sports, Science and Technology [23570047]; Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25119704] Funding Source: KAKEN	Network Joint Research Center for Materials and Devices; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Network Joint Research Center for Materials and Devices (No. 2014243) (to Y.H.), Grant-in-Aid for Scientific Research (C) (No. 23570047) from the Ministry of Education, Culture, Sports, Science and Technology (to Y.H.), and Core Research of Evolutional Science & Technology program from the Japan Science and Technology Agency (to Y.H.).	Ansong C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00325; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Carroll RK, 2009, J BIOL CHEM, V284, P12008, DOI 10.1074/jbc.M806261200; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Perez-Perez ME, 2006, PROTEOMICS, V6, pS186, DOI 10.1002/pmic.200500215; Fey V, 2005, J EXP BOT, V56, P1491, DOI 10.1093/jxb/eri180; Guo J, 2014, MOL CELL PROTEOMICS, V13, P3270, DOI 10.1074/mcp.M114.041160; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Hanaoka M, 2012, J BIOL CHEM, V287, P26321, DOI 10.1074/jbc.M111.338251; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Hisabori T, 2007, PHOTOCHEM PHOTOBIOL, V83, P145, DOI 10.1562/2006-02-27-IR-816; Hishiya S, 2008, PLANT CELL PHYSIOL, V49, P11, DOI 10.1093/pcp/pcm158; Horiuchi M, 2010, BIOCHEM J, V431, P135, DOI 10.1042/BJ20100789; Hosoya-Matsuda N, 2005, J BIOL CHEM, V280, P840, DOI 10.1074/jbc.M411493200; Husain M, 2010, P NATL ACAD SCI USA, V107, P14396, DOI 10.1073/pnas.1005299107; Itou H, 2001, J BIOCHEM-TOKYO, V129, P343, DOI 10.1093/oxfordjournals.jbchem.a002863; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lawlor DW, 2009, ANN BOT-LONDON, V103, P561, DOI [10.1093/aob/mcn244, 10.1093/aob/mcn256]; Lindahl M, 2003, P NATL ACAD SCI USA, V100, P16107, DOI 10.1073/pnas.2534397100; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Majeed W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045139; Menon S, 2001, BIOCHEMISTRY-US, V50, P5948; Moronta-Barrios F, 2012, MICROBIOL-SGM, V158, P1229, DOI 10.1099/mic.0.057679-0; Muramatsu M, 2012, J PLANT RES, V125, P11, DOI 10.1007/s10265-011-0454-6; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Ogawa T, 2002, J BIOL CHEM, V277, P28981, DOI 10.1074/jbc.M204175200; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Seino Y, 2009, J BACTERIOL, V191, P1581, DOI 10.1128/JB.01588-08; Seki A, 2007, J BIOL CHEM, V282, P36887, DOI 10.1074/jbc.M707582200; Shumskaya MA, 2005, J BIOL CHEM, V280, P21531, DOI 10.1074/jbc.m412174200; Sippola K, 1999, PLANT MOL BIOL, V41, P425, DOI 10.1023/A:1006347808475; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Yamaguchi K, 2002, PLANT CELL, V14, P2901, DOI 10.1105/tpc.006262	38	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119107	10.1371/journal.pone.0119107	http://dx.doi.org/10.1371/journal.pone.0119107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774906	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500069
J	Magierowski, M; Jasnos, K; Kwiecien, S; Drozdowicz, D; Surmiak, M; Strzalka, M; Ptak-Belowska, A; Wallace, JL; Brzozowski, T				Magierowski, Marcin; Jasnos, Katarzyna; Kwiecien, Slawomir; Drozdowicz, Danuta; Surmiak, Marcin; Strzalka, Malgorzata; Ptak-Belowska, Agata; Wallace, John L.; Brzozowski, Tomasz			Endogenous Prostaglandins and Afferent Sensory Nerves in Gastroprotective Effect of Hydrogen Sulfide against Stress-Induced Gastric Lesions	PLOS ONE			English	Article							LIPID-PEROXIDATION; INJURY; DAMAGE; NEUROPEPTIDES; PATHOGENESIS; INVOLVEMENT; INHIBITION; ULCERATION; RESOLUTION; MUCOSA	Hydrogen sulfide (H2S) plays an important role in human physiology, exerting vasodilatory, neuromodulatory and anti-inflammatory effects. H2S has been implicated in the mechanism of gastrointestinal integrity but whether this gaseous mediator can affect hemorrhagic lesions induced by stress has been little elucidated. We studied the effect of the H2S precursor L-cysteine, H2S-donor NaHS, the H2S synthesizing enzyme (CSE) activity inhibitor-D, L-propargylglycine (PAG) and the gastric H2S production by CSE/CBS/3-MST activity in water immersion and restraint stress (WRS) ulcerogenesis and the accompanying changes in gastric blood flow (GBF). The role of endogenous prostaglandins (PGs) and sensory afferent nerves releasing calcitonin gene-related peptide (CGRP) in the mechanism of gastroprotection induced by H2S was examined in capsaicin-denervated rats and those pre-treated with capsazepine to inhibit activity of vanilloid receptors (VR-1). Rats were pre-treated with vehicle, NaHS, the donor of H2S and or L-cysteine, the H2S precursor, with or without the concurrent treatment with 1) nonselective (indomethacin) and selective cyclooxygenase (COX)-1 (SC-560) or COX-2 (rofecoxib) inhibitors. The expression of mRNA and protein for COX-1 and COX-2 were analyzed in gastric mucosa pretreated with NaHS with or without PAG. Both NaHS and L-cysteine dose-dependently attenuated severity of WRS-induced gastric lesions and significantly increased GBF. These effects were significantly reduced by pretreatment with PAG and capsaicin denervation. NaHS increased gastric H2S production via CSE/CBS but not 3-MST activity. Inhibition of COX-1 and COX-2 activity significantly diminished NaHS-and L-cysteine-induced protection and hyperemia. NaHS increased expression of COX-1, COX-2 mRNAs and proteins and raised CGRP mRNA expression. These effects of NaHS on COX-1 and COX-2 protein contents were reversed by PAG and capsaicin denervation. We conclude that H2S exerts gastroprotection against WRS-induced gastric lesions by the mechanism involving enhancement in gastric	[Magierowski, Marcin; Jasnos, Katarzyna; Kwiecien, Slawomir; Drozdowicz, Danuta; Surmiak, Marcin; Strzalka, Malgorzata; Ptak-Belowska, Agata; Brzozowski, Tomasz] Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	Jagiellonian University; Collegium Medicum Jagiellonian University; University of Calgary	Brzozowski, T (corresponding author), Jagiellonian Univ, Coll Med, Dept Physiol, Krakow, Poland.	mpbrzozo@cyf-kr.edu.pl	Wallace, John/AAL-3763-2021; Surmiak, Marcin/GYU-3390-2022	Surmiak, Marcin/0000-0001-8396-1488; Magierowski, Marcin/0000-0003-0175-5600; Kwiecien, Slawomir/0000-0002-4806-8042	Jagiellonian University Medical College for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland [K/DSC/001380]; Malopolskie Centre of Entrepreneurship	Jagiellonian University Medical College for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland; Malopolskie Centre of Entrepreneurship	This study was supported by a grant from the Jagiellonian University Medical College (No. K/DSC/001380) for Marcin Magierowski, Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. Marcin Magierowski is supported by a scholarship for PhD candidates from Malopolskie Centre of Entrepreneurship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboubakr EM, 2013, ARCH PHARM RES, V36, P1507, DOI 10.1007/s12272-013-0194-3; Bhatia V, 2005, J GASTROEN HEPATOL, V20, P332, DOI 10.1111/j.1440-1746.2004.03508.x; Biernat J, 2005, J PHYSIOL PHARMACOL, V56, P133; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; Brzozowski T, 2001, MICROSC RES TECHNIQ, V53, P343, DOI 10.1002/jemt.1102; Brzozowski T, 2008, REGUL PEPTIDES, V148, P6, DOI 10.1016/j.regpep.2008.02.003; Brzozowski T, 2008, J PHARMACOL EXP THER, V326, P105, DOI 10.1124/jpet.108.136457; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chavez-Pina AE, 2010, EUR J PHARMACOL, V630, P131, DOI 10.1016/j.ejphar.2009.12.017; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Flannigan KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071962; HAWKEY CJ, 1986, GUT, V27, P1484, DOI 10.1136/gut.27.12.1484; Konturek PC, 2000, SCAND J GASTROENTERO, V35, P452; KONTUREK PC, 2009, J PHYSIOL PHARMACOL, V60, P41; KONTUREK SJ, 1982, DIGEST DIS SCI, V27, P967, DOI 10.1007/BF01391740; Kwiecien S, 2007, J PHYSIOL PHARMACOL, V58, P149; Kwiecien S, 2004, J PHYSIOL PHARMACOL, V55, P337; Kwiecien S, 2012, J PHYSIOL PHARMACOL, V63, P143; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Kwiecien S, 2010, GASTROENTEROL POL, V17, P234; Lou LX, 2008, CLIN EXP PHARMACOL P, V35, P223, DOI 10.1111/j.1440-1681.2007.04812.x; Magierowski M, 2013, J PHARMACOL EXP THER, V347, P717, DOI 10.1124/jpet.113.207233; Magierowski M, 2013, POSTEP HIG MED DOSW, V67, P150, DOI 10.5604/17322693.1038356; Mard SA, 2012, DIGEST DIS SCI, V57, P1496, DOI 10.1007/s10620-012-2051-5; Mok YYP, 2008, INFLAMM RES, V57, P512, DOI 10.1007/s00011-008-7231-6; Morsy MA, 2010, LIFE SCI, V87, P692, DOI 10.1016/j.lfs.2010.10.004; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; SWAROOP M, 1992, J BIOL CHEM, V267, P11455; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Wang R, 2003, ANTIOXID REDOX SIGN, V5, P493, DOI 10.1089/152308603768295249; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zanardo RC, 1996, FASEB J, V20, P2118; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118972	10.1371/journal.pone.0118972	http://dx.doi.org/10.1371/journal.pone.0118972			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774496	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500057
J	Zhang, CQ; Zhao, XQ; Wang, CX; Liu, LP; Ding, YC; Akbary, F; Pu, YH; Zou, XY; Du, WL; Jing, J; Pan, YS; Wong, KS; Wang, YJ; Wang, YL				Zhang, Changqing; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Ding, Yuchuan; Akbary, Fauzia; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Jing, Jing; Pan, Yuesong; Wong, Ka Sing; Wang, Yongjun; Wang, Yilong		Chinese IntraCranial	Prediction Factors of Recurrent Ischemic Events in One Year after Minor Stroke	PLOS ONE			English	Article							CAROTID-ARTERY-DISEASE; HIGH EARLY RISK; CEREBRAL INFARCTION; VASCULAR EVENTS; ATTACK; STENOSIS; SCORE; EDUCATION; PERFUSION; PATTERNS	Background The risk of a subsequent stroke following a minor stroke is high. However, there are no effective rating scales to predict recurrent stroke following a minor one. Therefore, we assessed the risk factors associated with recurrent ischemic stroke or transient ischemic attack (TIA) within one year of minor stroke onset in order to identify possible risk factors. Methods Eight hundred and sixty-three non-cardioembolic ischemic stroke patients in the Chinese IntraCranial AtheroSclerosis Study that presented with minor stroke, defined as an admission National Institutes of Health stroke scale (NIHSS) score of <= 3, were consecutively enrolled in our study. Clinical information and imaging features upon admission, and any recurrent ischemic stroke or TIA within one year was recorded. Cox regression was used to identify risk factors associated with recurrent ischemic stroke or TIA within the year following stroke onset. Results A total of 50 patients (6.1%) experienced recurrent ischemic stroke or TIA within one year of minor stroke onset. Multivariate Cox regression model identified lower admission NIHSS score (HR, 1.75; 95% CI, 1.32 to 2.33; P<0.0001), history of coronary heart disease (HR, 2.62; 95% CI, 1.17 to 5.86; P = 0.02), severe stenosis or occlusion of large cerebral artery (HR, 4.68; 95% CI, 1.87 to 11.7; P = 0.001), and multiple acute cerebral infarcts (HR, 2.61; 95% CI, 1.01 to 6.80; P = 0.05) as independent risk factors for recurrent ischemic stroke or TIA within one year. Conclusions Some minor stroke patients are at higher risk for recurrent ischemic stroke or TIA. Urgent and intensified therapy may be reasonable in these patients.	[Zhang, Changqing; Zhao, Xingquan; Wang, Chunxue; Liu, Liping; Pu, Yuehua; Zou, Xinying; Du, Wanliang; Jing, Jing; Pan, Yuesong; Wang, Yongjun; Wang, Yilong] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China; [Ding, Yuchuan; Akbary, Fauzia] Wayne State Univ, Sch Med, Detroit, MI USA; [Wong, Ka Sing] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Wayne State University; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com; yilong528@gmail.com	liu, li/HGC-0900-2022; Pan, Yuesong/AAI-6303-2020; Wong, Ka Sing Lawrence/N-3434-2015; Ding, yu/GWV-1732-2022	Pan, Yuesong/0000-0003-3082-6789; Wong, Ka Sing Lawrence/0000-0002-2031-9866; 	Ministry of Science and Technology [2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02]; Ministry of Health of the People's Republic of China [2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02]; Beijing Municipal Science & Technology Commission [Z131100002613005]; S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China, grant no. National S&T Major Project of China (2013BAI09B03, 2012ZX09303-005-001, 2011BAI08B02), Beijing Municipal Science & Technology Commission (Z131100002613005), and in part by the S.H. Ho Cardiovascular Disease and Stroke Center of the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2013, STROKE, V44, P1505, DOI 10.1161/STROKEAHA.111.000142; Amarenco P, 2011, STROKE, V42, P22, DOI 10.1161/STROKEAHA.110.584086; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Ay H, 2010, NEUROLOGY, V74, P128, DOI 10.1212/WNL.0b013e3181ca9cff; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Chandratheva A, 2011, STROKE, V42, P632, DOI 10.1161/STROKEAHA.110.593301; Chaves CJ, 2003, ARCH NEUROL-CHICAGO, V60, P237, DOI 10.1001/archneur.60.2.237; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Coutts SB, 2008, INT J STROKE, V3, P3, DOI 10.1111/j.1747-4949.2008.00182.x; D'Amore C, 2012, FRONT NEUROL NEUROSC, V30, P181, DOI 10.1159/000333638; Foerster M, 2009, AM J CARDIOL, V103, P361, DOI 10.1016/j.amjcard.2008.09.089; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2010, STROKE, V41, P1907, DOI 10.1161/STROKEAHA.110.578971; Grant Edward G, 2003, Ultrasound Q, V19, P190, DOI 10.1097/00013644-200312000-00005; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2003, STROKE, V34, P2446, DOI 10.1161/01.STR.0000090842.81076.68; Kim JM, 2012, ARCH NEUROL-CHICAGO, V69, P1470, DOI 10.1001/archneurol.2012.1018; Lin HJ, 2007, J CLIN NEUROSCI, V14, P17, DOI 10.1016/j.jocn.2005.07.026; Lindsay AC, 2012, JACC-CARDIOVASC IMAG, V5, P388, DOI 10.1016/j.jcmg.2011.10.007; Merwick A, 2010, LANCET NEUROL, V9, P1060, DOI 10.1016/S1474-4422(10)70240-4; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Ois A, 2008, STROKE, V39, P1717, DOI 10.1161/STROKEAHA.107.505438; Pu YH, 2013, STROKE, V44, P2109, DOI 10.1161/STROKEAHA.113.001522; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Szabo K, 2001, STROKE, V32, P1323, DOI 10.1161/01.STR.32.6.1323; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250	33	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120105	10.1371/journal.pone.0120105	http://dx.doi.org/10.1371/journal.pone.0120105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774939	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500150
J	Brenner, E; Smeets, JBJ				Brenner, Eli; Smeets, Jeroen B. J.			How Moving Backgrounds Influence Interception	PLOS ONE			English	Article							CONTINUOUS VISUAL FEEDBACK; REACHING MOVEMENTS; HAND; MOTION; TARGETS; PERCEPTION; PREDICTION; POSITION; INFORMATION; RESPONSES	Reaching movements towards an object are continuously guided by visual information about the target and the arm. Such guidance increases precision and allows one to adjust the movement if the target unexpectedly moves. On-going arm movements are also influenced by motion in the surrounding. Fast responses to motion in the surrounding could help cope with moving obstacles and with the consequences of changes in one's eye orientation and vantage point. To further evaluate how motion in the surrounding influences interceptive movements we asked subjects to tap a moving target when it reached a second, static target. We varied the direction and location of motion in the surrounding, as well as details of the stimuli that are known to influence eye movements. Subjects were most sensitive to motion in the background when such motion was near the targets. Whether or not the eyes were moving, and the direction of the background motion in relation to the direction in which the eyes were moving, had very little influence on the response to the background motion. We conclude that the responses to background motion are driven by motion near the target rather than by a global analysis of the optic flow and its relation with other information about self-motion.	[Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Brenner, E (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Fac Human Movement Sci, Amsterdam, Netherlands.	e.brenner@fbw.vu.nl	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Netherlands Organisation for Scientific Research (NWO) [464-13-169]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The Netherlands Organisation for Scientific Research (NWO) grant 464-13-169; http://www.nwo.nl/en; EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekawa N, 2010, J NEUROPHYSIOL, V103, P2717, DOI 10.1152/jn.91133.2008; Aivar MP, 2008, EXP BRAIN RES, V190, P251, DOI 10.1007/s00221-008-1475-9; Amano K, 2009, J NEUROPHYSIOL, V101, P888, DOI 10.1152/jn.90993.2008; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Brenner E, 2003, SPATIAL VISION, V16, P365, DOI 10.1163/156856803322467581; BRENNER E, 1994, EXP BRAIN RES, V99, P316, DOI 10.1007/BF00239598; Brenner E, 2013, EXP BRAIN RES, V230, P207, DOI 10.1007/s00221-013-3645-7; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Brenner E, 2009, EXP BRAIN RES, V196, P375, DOI 10.1007/s00221-009-1857-7; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; CARLTON LG, 1981, J EXP PSYCHOL HUMAN, V7, P1019, DOI 10.1037/0096-1523.7.5.1019; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; de Lussanet MHE, 2001, EXP BRAIN RES, V137, P246, DOI 10.1007/s002210000607; de Rugy A, 2012, J NEUROPHYSIOL, V107, P766, DOI 10.1152/jn.00854.2011; Desmurget M, 1996, EXP BRAIN RES, V110, P265; Diaz G, 2013, J VISION, V13, DOI 10.1167/13.1.20; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Gomi H, 2006, J NEUROSCI, V26, P5301, DOI 10.1523/JNEUROSCI.0340-06.2006; Gomi H, 2013, J NEUROSCI, V33, P16502, DOI 10.1523/JNEUROSCI.4741-12.2013; Gomi H, 2008, CURR OPIN NEUROBIOL, V18, P558, DOI 10.1016/j.conb.2008.11.002; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; Greenwald HS, 2005, VISION RES, V45, P1975, DOI 10.1016/j.visres.2005.01.025; MERGNER T, 1992, EXP BRAIN RES, V89, P655; MOHRMANNLENDLA H, 1991, ERGONOMICS, V34, P353, DOI 10.1080/00140139108967319; PAILHOUS J, 1990, BEHAV BRAIN RES, V38, P275, DOI 10.1016/0166-4328(90)90181-D; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; Pisella L, 1998, EXP BRAIN RES, V121, P270, DOI 10.1007/s002210050460; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Saunders JA, 2005, EXP BRAIN RES, V162, P458, DOI 10.1007/s00221-004-2064-1; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; SMEETS JBJ, 1995, BIOL CYBERN, V73, P519, DOI 10.1007/BF00199544; Soechting JF, 2008, J NEUROPHYSIOL, V99, P2956, DOI 10.1152/jn.90308.2008; van Mierlo CM, 2009, J VISION, V9, DOI 10.1167/9.3.25; Voudouris D, 2013, J NEUROPHYSIOL, V110, P1484, DOI 10.1152/jn.00066.2013; Warren PA, 2007, J VISION, V7, DOI 10.1167/7.11.2; Warren PA, 2009, CURR BIOL, V19, P1555, DOI 10.1016/j.cub.2009.07.057; Whitney D, 2005, EXP BRAIN RES, V162, P394, DOI 10.1007/s00221-004-2154-0; Whitney D, 2003, NATURE, V423, P869, DOI 10.1038/nature01693; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119903	10.1371/journal.pone.0119903	http://dx.doi.org/10.1371/journal.pone.0119903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25767873	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500100
J	Doorakkers, E; Konings, P; Mattsson, F; Lagergren, J; Brusselaers, N				Doorakkers, Eva; Konings, Peter; Mattsson, Fredrik; Lagergren, Jesper; Brusselaers, Nele			Early Complications Following Oesophagectomy for Cancer in Relation to Long-Term Healthcare Utilisation: A Prospective Population-Based Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SURGICAL COMPLICATIONS; PERSISTING SYMPTOMS; SURVIVORS; SURGERY; COSTS	Background Little is known about how early postoperative complications after oesophagectomy for cancer influence healthcare utilisation in the long-term. We hypothesised that these complications also increase healthcare utilisation long after the recovery period. Methods This was a prospective, nationwide Swedish population-based cohort study of patients who underwent curatively intended oesophagectomy for cancer in 2001-2005 and survived at least 1 year postoperatively (n = 390). Total days of in-hospitalisation, number of hospitalisations and number of visits to the outpatient clinic within 5 years of surgery were analysed using quasi-Poisson models with adjustment for patient, tumour and treatment characteristics and are expressed as incidence rate ratios (IRR) and 95% confidence intervals (CI). Results There was an increased in-hospitalisation period 1-5 years after surgery in patients with more than 1 complication (IRR 1.5, 95% CI 1.0-2.4). The IRR for the number of hospitalisations by number of complications was 1.1 (95% CI 0.7-1.6), and 1.2 (95% CI 0.9-1.6) for number of outpatient visits in patients with more than 1 complication. The IRR for in-hospitalisation period 1-5 years following oesophagectomy was 1.8 (95% CI 1.0-3.0) for patients with anastomotic insufficiency and 1.5 (95% CI 0.9-2.5) for patients with cardiovascular or cerebrovascular complications. We found no association with number of hospitalisations (IRR 1.2, 95% CI 0.7-2.0) or number of outpatient visits (IRR 1.3, 95% CI 0.9-1.7) after anastomotic insufficiency, or after cardiovascular or cerebrovascular complications (IRR 1.2, 95% CI 0.7-1.9) and (IRR 1.1, 95% CI 0.8-1.5) respectively. Conclusion This study showed an increased total in-hospitalisation period 1-5 years after oesophagectomy for cancer in patients with postoperative complications, particularly following anastomotic insufficiency.	[Doorakkers, Eva; Konings, Peter; Mattsson, Fredrik; Lagergren, Jesper; Brusselaers, Nele] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Doorakkers, Eva] Radboud Univ Nijmegen, Dept Surg, NL-6525 ED Nijmegen, Netherlands; [Lagergren, Jesper] Kings Coll London, Div Canc Studies, London, England	Karolinska Institutet; Radboud University Nijmegen; University of London; King's College London	Brusselaers, N (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden.	nele.brusselaers@ki.se	Brusselaers, Nele/I-3501-2012	Brusselaers, Nele/0000-0003-0137-447X; Konings, Peter/0000-0002-8637-5916	Swedish Research Council (SIMSAM); Swedish Cancer Society	Swedish Research Council (SIMSAM)(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society)	Funding: This work was supported by the Swedish Research Council (SIMSAM) and Swedish Cancer Society (non-restricted educational grants). www.simsam.nu; www.cancerfonden.se. The funding sources had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, or preparation, review or approval of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Brusselaers N, 2013, GUT; Carrott PW, 2012, J AM COLL SURGEONS, V215, P331, DOI 10.1016/j.jamcollsurg.2012.04.030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Derogar M, 2013, J CLIN ONCOL, V31, P551, DOI 10.1200/JCO.2012.46.1517; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Dimick JB, 2003, J AM COLL SURGEONS, V196, P671, DOI 10.1016/S1072-7515(03)00122-4; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Gordon LG, 2011, BRIT J SURG, V98, P1589, DOI 10.1002/bjs.7599; Issa DE, 2014, EUR J CANC CARE; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; Lang K, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-227; Mols F, 2007, EUR J CANCER, V43, P2211, DOI 10.1016/j.ejca.2007.06.022; Mols F, 2007, INT J CANCER, V121, P871, DOI 10.1002/ijc.22739; Peuckmann V, 2009, EUR J CANCER, V45, P625, DOI 10.1016/j.ejca.2008.09.027; Rutegard M, 2012, EJSO-EUR J SURG ONC, V38, P555, DOI 10.1016/j.ejso.2012.02.177; Sobin, 2009, UICC TNM CLASSIFICAT; Treanor C, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-316; van der Schaaf M, 2012, BRIT J SURG, V99, P95, DOI 10.1002/bjs.7750; van der Schaaf M, 2013, ANN SURG ONCOL, V20, P1639, DOI 10.1245/s10434-012-2690-y; Viklund P, 2006, ANN SURG, V243, P204, DOI 10.1097/01.sla.0000197698.17794.eb; Viklund P, 2005, WORLD J SURG, V29, P841, DOI 10.1007/s00268-005-7887-9	24	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121080	10.1371/journal.pone.0121080	http://dx.doi.org/10.1371/journal.pone.0121080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768921	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500138
J	Lu, JY; Cheung, MLM; Huang, BT; Wu, LL; Xie, WJ; Chen, ZJ; Li, DR; Xie, LX				Lu, Jia-Yang; Cheung, Michael Lok-Man; Huang, Bao-Tian; Wu, Li-Li; Xie, Wen-Jia; Chen, Zhi-Jian; Li, De-Rui; Xie, Liang-Xi			Improving Target Coverage and Organ-at-Risk Sparing in Intensity-Modulated Radiotherapy for Cervical Oesophageal Cancer Using a Simple Optimisation Method	PLOS ONE			English	Article							SIMULTANEOUS INTEGRATED BOOST; DIRECT APERTURE OPTIMIZATION; 3D CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; LUNG-CANCER; IMRT; PLANS; HEAD; NECK; CHEMORADIOTHERAPY	Purpose To assess the performance of a simple optimisation method for improving target coverage and organ-at-risk (OAR) sparing in intensity-modulated radiotherapy (IMRT) for cervical oesophageal cancer. Methods For 20 selected patients, clinically acceptable original IMRT plans (Original plans) were created, and two optimisation methods were adopted to improve the plans: 1) a base dose function (BDF)-based method, in which the treatment plans were re-optimised based on the original plans, and 2) a dose-controlling structure (DCS)-based method, in which the original plans were re-optimised by assigning additional constraints for hot and cold spots. The Original, BDF-based and DCS-based plans were compared with regard to target dose homogeneity, conformity, OAR sparing, planning time and monitor units (MUs). Dosimetric verifications were performed and delivery times were recorded for the BDF-based and DCS-based plans. Results The BDF-based plans provided significantly superior dose homogeneity and conformity compared with both the DCS-based and Original plans. The BDF-based method further reduced the doses delivered to the OARs by approximately 1-3%. The re-optimisation time was reduced by approximately 28%, but the MUs and delivery time were slightly increased. All verification tests were passed and no significant differences were found. Conclusion The BDF-based method for the optimisation of IMRT for cervical oesophageal cancer can achieve significantly better dose distributions with better planning efficiency at the expense of slightly more MUs.	[Lu, Jia-Yang; Huang, Bao-Tian; Wu, Li-Li; Xie, Wen-Jia; Chen, Zhi-Jian; Li, De-Rui; Xie, Liang-Xi] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China; [Cheung, Michael Lok-Man] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China	Shantou University; Chinese University of Hong Kong; Prince of Wales Hospital	Xie, LX (corresponding author), Shantou Univ, Dept Radiat Oncol, Canc Hosp, Coll Med, Shantou, Peoples R China.	xieliangxi1@qq.com			National Natural Science Foundation of China [81171994]; Shantou University Medical College Clinical Research Enhancement Initiative [201425]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shantou University Medical College Clinical Research Enhancement Initiative	Funding: This work was sponsored in part by both National Natural Science Foundation of China (Grant No. 81171994) and Shantou University Medical College Clinical Research Enhancement Initiative (Grant No. 201425). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2005, INT J RADIAT ONCOL, V61, P335, DOI 10.1016/j.ijrobp.2004.06.014; Broderick M, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-8; Budrukkar Ashwini N, 2004, Australas Radiol, V48, P45, DOI 10.1111/j.1440-1673.2004.01241.x; Cao CN, 2014, JAMA OTOLARYNGOL, V140, P918, DOI 10.1001/jamaoto.2014.2013; Cheng MC, 2014, MED DOSIM, V39, P246, DOI 10.1016/j.meddos.2014.03.003; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Dobler B, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-33; Dogan N, 2006, MED PHYS, V33, P4033, DOI 10.1118/1.2357835; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Fenkell L, 2008, RADIOTHER ONCOL, V89, P287, DOI 10.1016/j.radonc.2008.08.008; Freilich J, 2014, DIS ESOPHAG IN PRESS; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jeraj R, 2002, PHYS MED BIOL, V47, P391, DOI 10.1088/0031-9155/47/3/303; Jones S, 2008, MED DOSIM, V33, P86, DOI 10.1016/j.meddos.2007.04.002; Kumar G, 2012, JPN J RADIOL, V30, P18, DOI 10.1007/s11604-011-0002-2; Kwint M, 2012, INT J RADIAT ONCOL, V84, pE223, DOI 10.1016/j.ijrobp.2012.03.027; Lin SH, 2012, INT J RADIAT ONCOL, V84, P1078, DOI 10.1016/j.ijrobp.2012.02.015; Lu JY, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140654; Nicolini G, 2012, INT J RADIAT ONCOL, V84, P553, DOI 10.1016/j.ijrobp.2011.12.041; Nutting CM, 2001, RADIOTHER ONCOL, V61, P157, DOI 10.1016/S0167-8140(01)00438-8; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Shridhar R, 2012, J RADIOL ONCOL, V1, P347, DOI 10.1007/s13566-012-0048-5; Shridhar R, 2013, CANCER CONTROL, V20, P97, DOI 10.1177/107327481302000203; Suss P, 2013, PHYS MED BIOL, V58, P1855, DOI 10.1088/0031-9155/58/6/1855; Tucker SL, 2006, INT J RADIAT ONCOL, V66, P754, DOI 10.1016/j.ijrobp.2006.06.002; Verbakel WFAR, 2012, INT J RADIAT ONCOL, V83, pE297, DOI 10.1016/j.ijrobp.2011.12.059; Vineberg KA, 2002, INT J RADIAT ONCOL, V52, P1159, DOI 10.1016/S0360-3016(01)02800-0; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Xhaferllari I, 2013, J APPL CLIN MED PHYS, V14, P176, DOI 10.1120/jacmp.v14i1.4052; Yu WW, 2014, STRAHLENTHER ONKOL, V190, P979, DOI 10.1007/s00066-014-0636-y	33	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121679	10.1371/journal.pone.0121679	http://dx.doi.org/10.1371/journal.pone.0121679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768733	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500145
J	Zhou, FW; Fortin, JM; Chen, HX; Martinez-Diaz, H; Chang, LJ; Reynolds, BA; Roper, SN				Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Chang, Lung-Ji; Reynolds, Brent A.; Roper, Steven N.			Functional Integration of Human Neural Precursor Cells in Mouse Cortex	PLOS ONE			English	Article							EXPERIMENTAL CORTICAL DYSPLASIA; EMBRYONIC STEM-CELLS; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; NEONATAL-RAT-BRAIN; PROGENITOR CELLS; PARKINSONS-DISEASE; PYRAMIDAL NEURONS; SPINAL-CORD; SYNAPTIC ACTIVITY	This study investigates the electrophysiological properties and functional integration of different phenotypes of transplanted human neural precursor cells (hNPCs) in immunodeficient NSG mice. Postnatal day 2 mice received unilateral injections of 100,000 GFP+hNPCs into the right parietal cortex. Eight weeks after transplantation, 1.21% of transplanted hNPCs survived. In these hNPCs, parvalbumin (PV)-, calretinin (CR)-, somatostatin (SS)-positive inhibitory interneurons and excitatory pyramidal neurons were confirmed electrophysiologically and histologically. All GFP+ hNPCs were immunoreactive with antihuman specific nuclear protein. The proportions of PV-, CR-, and SS-positive cells among GFP+cells were 35.5%, 15.7%, and 17.1%, respectively; around 15% of GFP+ cells were identified as pyramidal neurons. Those electrophysiologically and histological identified GFP+hNPCs were shown to fire action potentials with the appropriate firing patterns for different classes of neurons and to display spontaneous excitatory and inhibitory postsynaptic currents (sEPSCs and sIPSCs). The amplitude, frequency and kinetic properties of sEPSCs and sIPSCs in different types of hNPCs were comparable to host cells of the same type. In conclusion, GFP+ hNPCs produce neurons that are competent to integrate functionally into host neocortical neuronal networks. This provides promising data on the potential for hNPCs to serve as therapeutic agents in neurological diseases with abnormal neuronal circuitry such as epilepsy.	[Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Reynolds, Brent A.; Roper, Steven N.] Univ Florida, Dept Neurosurg, Gainesville, FL 32611 USA; [Zhou, Fu-Wen; Fortin, Jeff M.; Chen, Huan-Xin; Martinez-Diaz, Hildabelis; Reynolds, Brent A.; Roper, Steven N.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Chang, Lung-Ji] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhou, FW (corresponding author), Univ Florida, Dept Neurosurg, Gainesville, FL 32611 USA.	fuwen.zhou@neurosurgery.ufl.edu		Tilahin, Shimelis/0000-0001-8975-8026; Zhou, Fuwen/0000-0002-3500-666X	Wells Foundation; Densch Foundation	Wells Foundation; Densch Foundation	Funding provided by Wells Foundation and Densch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrova MA, 2002, DEV BRAIN RES, V134, P143, DOI 10.1016/S0165-3806(02)00273-0; Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson AJ, 2011, REGEN MED, V6, P367, DOI [10.2217/RME.11.22, 10.2217/rme.11.22]; Bachoud-Levi A, 2000, LANCET, V356, P1975, DOI 10.1016/S0140-6736(00)03310-9; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Brederlau A, 2006, STEM CELLS, V24, P1433, DOI 10.1634/stemcells.2005-0393; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; Chang L.-J., 2001, Current Gene Therapy, V1, P237, DOI 10.2174/1566523013348634; Chu K, 2004, BRAIN RES, V1023, P213, DOI 10.1016/j.brainres.2004.07.045; Collier TJ, 1999, J NEUROSCI, V19, P5563; Condic ML, 2001, J NEUROSCI, V21, P4782, DOI 10.1523/JNEUROSCI.21-13-04782.2001; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; GAGE FH, 1983, SCIENCE, V221, P966, DOI 10.1126/science.6879196; Gilani AI, 2014, P NATL ACAD SCI USA, V111, P7450, DOI 10.1073/pnas.1316488111; Glass JD, 2012, STEM CELLS, V30, P1144, DOI 10.1002/stem.1079; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guo FZ, 2010, J NEUROSCI, V30, P12036, DOI 10.1523/JNEUROSCI.1360-10.2010; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hammad M, 2014, CEREB CORTEX; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Ideguchi M, 2010, J NEUROSCI, V30, P894, DOI 10.1523/JNEUROSCI.4318-09.2010; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Larsson LC, 2001, CELL TRANSPLANT, V10, P295, DOI 10.3727/000000001783986765; Liker MA, 2003, BRAIN RES, V971, P168, DOI 10.1016/S0006-8993(03)02337-0; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mendez I, 2005, BRAIN, V128, P1498, DOI 10.1093/brain/awh510; Mendez I, 2002, J NEUROSURG, V96, P589, DOI 10.3171/jns.2002.96.3.0589; Mukhida K, 2007, STEM CELLS, V25, P2874, DOI 10.1634/stemcells.2007-0326; Ourednik V, 2001, SCIENCE, V293, P1820, DOI 10.1126/science.1060580; Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roper SN, 1999, EPILEPSY RES, V37, P63, DOI 10.1016/S0920-1211(99)00035-2; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Southwell DG, 2014, SCIENCE, V344, P167, DOI 10.1126/science.1240622; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Taub AH, 2013, J NEUROSCI, V33, P14359, DOI 10.1523/JNEUROSCI.1748-13.2013; Thompson KW, 2004, EPILEPSIA, V45, P4, DOI 10.1111/j.0013-9580.2004.29503.x; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Tyson JA, 2014, TRENDS NEUROSCI, V37, P169, DOI 10.1016/j.tins.2014.01.003; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Valente MF, 2013, CELL TRANSPLANT, V22, P1237, DOI 10.3727/096368912X657422; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou FW, 2011, CEREB CORTEX, V21, P1645, DOI 10.1093/cercor/bhq234; Zhou FW, 2009, J NEUROPHYSIOL, V102, P2514, DOI 10.1152/jn.00557.2009; Zietlow R, 2012, EXP NEUROL, V235, P563, DOI 10.1016/j.expneurol.2012.03.010; Zigova T, 1996, DEV BIOL, V173, P459, DOI 10.1006/dbio.1996.0040; Zipancic I, 2010, CELL TRANSPLANT, V19, P549, DOI 10.3727/096368910X491383	66	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120281	10.1371/journal.pone.0120281	http://dx.doi.org/10.1371/journal.pone.0120281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763840	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300038
J	Guo, YJ; Rong, Y; Huang, XJ; Lai, HP; Luo, X; Zhang, ZH; Liu, YW; He, MA; Wu, TC; Chen, WH				Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong			Shift Work and the Relationship with Metabolic Syndrome in Chinese Aged Workers	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CHRONIC DISEASE; SLEEP DURATION; RISK; ASSOCIATION	Background Shift work is indicated to be associated with adverse metabolic disorders. However, potential effects of shift work on metabolic syndrome (MetS) and its components have not been well established. Methods In total, 26,382 workers from Dongfeng-Tongji Cohort were included in this study. Information on shift work history was gathered through questionnaires and metabolic traits were measured. Logistic regression models were used to calculate the odds ratio (OR) and 95% confidence interval (CI) for long-term shift work related with MetS and each component, respectively. Further stratification analysis was performed to detect the differences on MetS between female and male shift workers. Results Long-term shift work was associated with MetS without adjusting for any confounders. Compared with the group of non-shift work, the multivariate-adjusted ORs (95% CI) of MetS associated with 1-10, 11 -20, and >= 20y of shift work were 1.05 (0.95-1.16), 1.14 (1.03-1.26), 1.16 (1.01-1.31), respectively. In female workers, we found a dose-response relationship that every 10 years increase in shift work was associated with a 10% (95% CI: 1%-20%) elevated OR of MetS, while no significant dose-response trend was found among male workers. Furthermore, shift work duration was significantly associated with ORs of high blood pressure (1.07, 1.01-1.13), long waist circumference (1.10, 1.01-1.20) and high glucose levels (1.09, 1.04-1.15). No significant association was observed between shift work and low HDL cholesterol) and raised triglyceride levels. Conclusions Long-term shift work was associated with metabolic syndrome and the association might differ by gender in retired workers. Applicable intervention strategies are needed for prevention of metabolic disorders for shift workers.	[Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth,Minist Educ, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Minist Environm Protect, Wuhan 430074, Peoples R China; [Guo, Yanjun; Rong, Yi; Huang, Xiji; Lai, Hanpeng; Luo, Xin; Zhang, Zhihong; Liu, Yuewei; He, Meian; Wu, Tangchun; Chen, Weihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430074, Peoples R China.	wchen@mails.tjmu.edu.cn	Chen, Weihong/D-2177-2011; Liu, Yuewei/J-5147-2019	Chen, Weihong/0000-0001-8689-7311; Liu, Yuewei/0000-0001-5970-4262	National Basic Research Program of China [2011CB503804]; 111 project; Program for Changjiang Scholars; Innovative Research Team in University; China Medical Board 12-13; Graduates' Innovation Fund of Huazhong University of Science Technology	National Basic Research Program of China(National Basic Research Program of China); 111 project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); China Medical Board 12-13; Graduates' Innovation Fund of Huazhong University of Science Technology	The authors gratefully acknowledge the financial support provided by the National Basic Research Program of China (2011CB503804); The 111 project; the Program for Changjiang Scholars; Innovative Research Team in University; China Medical Board 12-13; and Graduates' Innovation Fund of Huazhong University of Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykan AC, 2014, CARDIOL J, V21, P245, DOI 10.5603/CJ.a2013.0126; Bjorvatn B, 2009, SLEEP MED REV, V13, P47, DOI 10.1016/j.smrv.2008.04.009; Chang CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038874; Cooper DC, 2013, CARDIOVASC PSYCHIAT; Copertaro A, 2011, IND HEALTH, V49, P597; David Mika Kivimaki G Batty, 2011, PLOS MED, V8, DOI [10.1371/journal.pmed.1001138, DOI 10.1371/JOURNAL.PMED.1001138]; de Assis MAA, 2003, J HUM NUTR DIET, V16, P283, DOI 10.1046/j.1365-277X.2003.00448.x; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Gumenyuk V, 2012, CHRONOBIOL INT, V29, P928, DOI 10.3109/07420528.2012.699356; Guo YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071107; Hanley AJG, 2005, CIRCULATION, V112, P3713, DOI 10.1161/CIRCULATIONAHA.105.559633; Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003; Hublin C, 2010, EUR J EPIDEMIOL, V25, P315, DOI 10.1007/s10654-010-9439-3; Ioja S, 2012, POSTGRAD MED, V124, P119, DOI 10.3810/pgm.2012.07.2573; Itoh H, 2011, IND HEALTH, V49, P658, DOI 10.2486/indhealth.MS1271; Juda M, 2013, J BIOL RHYTHM, V28, P141, DOI 10.1177/0748730412475042; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Kawada T, 2014, ARCH ENVIRON OCCUP H, V69, P55, DOI 10.1080/19338244.2012.732123; Khabour OF, 2013, CLIN EXP HYPERTENS, V35, P361, DOI 10.3109/10641963.2012.732645; Kurl S, 2006, STROKE, V37, P806, DOI 10.1161/01.STR.0000204354.06965.44; Lieu SJ, 2012, J HYPERTENS, V30, P61, DOI 10.1097/HJH.0b013e32834e1ea3; Lin YC, 2009, CHRONOBIOL INT, V26, P740, DOI 10.1080/07420520902929029; Maki KC, 2012, METAB SYNDR RELAT D, V10, P363, DOI 10.1089/met.2012.0020; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; Monk TH, 2012, J SLEEP RES, V17, P273; Nicholson PJ, 2011, OCCUP MED-OXFORD, V61, P443, DOI 10.1093/occmed/kqr078; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Pilcher JJ, 2000, SLEEP, V23, P155; Rabaeus M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-196; Ramin C, 2015, OCCUP ENVIRON MED, V72, P100, DOI 10.1136/oemed-2014-102292; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Stefani KM, 2013, DIABETES RES CLIN PR, V102, P250, DOI 10.1016/j.diabres.2013.10.003; Ulas T, 2012, EUR REV MED PHARMACO, V16, P594; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang F, 2014, OBES REV, V15, P709, DOI 10.1111/obr.12194; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Xu SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078270; Ye HH, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-33; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	44	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120632	10.1371/journal.pone.0120632	http://dx.doi.org/10.1371/journal.pone.0120632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761114	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000071
J	Sierra-Corona, R; Davidson, A; Fredrickson, EL; Luna-Soria, H; Suzan-Azpiri, H; Ponce-Guevara, E; Ceballos, G				Sierra-Corona, Rodrigo; Davidson, Ana; Fredrickson, Ed L.; Luna-Soria, Hugo; Suzan-Azpiri, Humberto; Ponce-Guevara, Eduardo; Ceballos, Gerardo			Black-Tailed Prairie Dogs, Cattle, and the Conservation of North America's Arid Grasslands	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; LIVESTOCK; BISON; ECOSYSTEM; PATTERNS; CHALLENGES; COMMUNITIES; COMPETITION	Prairie dogs (Cynomys spp.) have been eliminated from over 95% of their historic range in large part from direct eradication campaigns to reduce their purported competition with cattle for forage. Despite the longstanding importance of this issue to grassland management and conservation, the ecological interactions between cattle and prairie dogs have not been well examined. We address this issue through two complementary experiments to determine if cattle and prairie dogs form a mutualistic grazing association similar to that between prairie dogs and American bison. Our experimental results show that cattle preferentially graze along prairie dog colony edges and use their colony centers for resting, resembling the mutualistic relationship prairie dogs have with American bison. Our results also show that prairie dog colonies are not only an important component of the grassland mosaic for maintaining biodiversity, but also provide benefits to cattle, thereby challenging the longstanding view of prairie dogs as an undesirable pest species in grasslands.	[Sierra-Corona, Rodrigo; Ponce-Guevara, Eduardo; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Davidson, Ana] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Fredrickson, Ed L.] Eastern Kentucky Univ, Dept Agr, Richmond, KY 40475 USA; [Luna-Soria, Hugo; Suzan-Azpiri, Humberto] Univ Autonoma Queretaro, Fac Ciencias Nat, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidad Autonoma de Queretaro	Sierra-Corona, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	rsierra@iecologia.unam.mx		Ceballos, Gerardo/0000-0001-8374-2656	Consejo Nacional de Ciencia y Tecnologia (CONACyT); J.M. Kaplan Fund; Whithley Fund for Nature; Rufford Fundation; Fundacion Carlos Slim A. C.	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); J.M. Kaplan Fund; Whithley Fund for Nature; Rufford Fundation; Fundacion Carlos Slim A. C.	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT), http://www.conacyt.gob.mx, J.M. Kaplan Fund, http://www.jmkfund.org, The Whithley Fund for Nature, http://whitleyaward.org, Rufford Fundation, http://www.rufford.org, and the Fundacion Carlos Slim A. C., http://fundacioncarlosslim.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCHER S, 1987, VEGETATIO, V72, P159; Augustine DJ, 2013, ECOL APPL, V23, P850, DOI 10.1890/12-0890.1; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Bergstrom BJ, 2013, CONSERV LETT, V11, P1; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Cheng E, 2006, OECOLOGIA, V147, P546, DOI 10.1007/s00442-005-0286-y; CID MS, 1991, J RANGE MANAGE, V44, P100, DOI 10.2307/4002305; COPPOCK DL, 1986, J WILDLIFE MANAGE, V50, P452, DOI 10.2307/3801103; COPPOCK DL, 1983, OECOLOGIA, V56, P10, DOI 10.1007/BF00378211; COTECOCA, 2002, COEF AG ENT FED 1 HE; Curtin Charles, 2006, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V40, P57; Davidson AD, 2012, FRONT ECOL ENVIRON, V10, P477, DOI 10.1890/110054; Davidson AD, 2010, ECOLOGY, V91, P3189, DOI 10.1890/09-1277.1; Delibes-Mateos M, 2011, BIOL CONSERV, V144, P1335, DOI 10.1016/j.biocon.2011.02.012; Derner JD, 2006, FRONT ECOL ENVIRON, V4, P459, DOI 10.1890/1540-9295(2006)4[459:ALWGAB]2.0.CO;2; Derner JD, 2009, RANGELAND ECOL MANAG, V62, P111, DOI 10.2111/08-008.1; Fahnestock JT, 2002, OECOLOGIA, V132, P86, DOI 10.1007/s00442-002-0930-8; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Frank DA, 1998, BIOSCIENCE, V48, P513, DOI 10.2307/1313313; Fuhlendorf SD, 2001, BIOSCIENCE, V51, P625, DOI 10.1641/0006-3568(2001)051[0625:RHOREM]2.0.CO;2; Ganskopp D, 2006, RANGELAND ECOL MANAG, V59, P189, DOI 10.2111/04-152R1.1; Guenther DA, 2003, J RANGE MANAGE, V56, P410, DOI 10.2307/4003830; Hartnett D.C., 1997, Ecological Studies, V125, P72; HERBEL CH, 1967, J RANGE MANAGE, V20, P296, DOI 10.2307/3895975; Holechek BJL, 2006, RANGELANDS, V28, P7; Howard JL, 2014, FIRE EFFECTS INFORM; HUNTLY N, 1991, ANNU REV ECOL SYST, V22, P477, DOI 10.1146/annurev.ecolsys.22.1.477; IMTA, 2008, EXTR RAP INF CLIM ER; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jones S, 1999, ENVIRON HIST, V4, P531, DOI 10.2307/3985400; Knapp AK, 2010, BIOSCIENCE, V49, P39; KNOWLES CJ, 1986, GREAT BASIN NAT, V46, P198; Koford C. B., 1958, WILDLIFE MONOGR, V3, P3; Kotliar NB, 2000, CONSERV BIOL, V14, P1715, DOI 10.1111/j.1523-1739.2000.98384.x; KRUEGER K, 1986, ECOLOGY, V67, P760, DOI 10.2307/1937699; Laliberte AS, 2007, PHOTOGRAMM ENG REM S, V73, P197, DOI 10.14358/PERS.73.2.197; Launchbaugh KL, 2005, RANGELAND ECOL MANAG, V58, P99, DOI 10.2111/03-146.1; Lemaire G, 2011, GRASSLAND PRODUCTIVITY AND ECOSYSTEM SERVICES, pXIII, DOI 10.1079/9781845938093.A; List R, 2010, INT J WILDERNESS, V16, P35; List R, 2007, CONSERV BIOL, V21, P1487, DOI 10.1111/j.1523-1739.2007.00810.x; Martinez-Estevez L, 2013, P 19 C COMP EL FIELD, P1; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; MCCOLLUM FT, 1985, J RANGE MANAGE, V38, P539, DOI 10.2307/3899748; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; NEUENSCHWANDER L F, 1975, Southwestern Naturalist, V20, P255, DOI 10.2307/3670443; Oki G.S., 2002, GLOBAL DESERTIFICATI, P95; OMEILIA ME, 1982, J RANGE MANAGE, V35, P580, DOI 10.2307/3898641; OSBORN B, 1949, ECOLOGY, V30, P322, DOI 10.2307/1932613; Peinetti HR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00021.1; Pinedo AC, 2013, DIAGNOSTICO ACTUAL S, P126; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RIEGEL ANDREW, 1941, TRANS KANSAS ACAD SCI, V44, P76, DOI 10.2307/3624869; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; SENFT RL, 1985, J RANGE MANAGE, V38, P82, DOI 10.2307/3899341; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Towne EG, 2005, ECOL APPL, V15, P1550, DOI 10.1890/04-1958; Vanderhye AVR, 1985, INTERSPECIFIC NUTR F, P44; Weltzin JF, 1997, SOUTHWEST NAT, V42, P251; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; Wiken E, 1998, PARKS, V8, P9	62	15	15	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118602	10.1371/journal.pone.0118602	http://dx.doi.org/10.1371/journal.pone.0118602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760377	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000031
J	Yamato, M; Pyenson, ND				Yamato, Maya; Pyenson, Nicholas D.			Early Development and Orientation of the Acoustic Funnel Provides Insight into the Evolution of Sound Reception Pathways in Cetaceans	PLOS ONE			English	Article							POSTNATAL-GROWTH; MIDDLE EOCENE; FETAL GROWTH; BLUE WHALE; ANATOMY; MORPHOLOGY; MAMMALIA; BALEEN; SKULL; ALLOMETRY	Whales receive underwater sounds through a fundamentally different mechanism than their close terrestrial relatives. Instead of hearing through the ear canal, cetaceans hear through specialized fatty tissues leading to an evolutionarily novel feature: an acoustic funnel located anterior to the tympanic aperture. We traced the ontogenetic development of this feature in 56 fetal specimens from 10 different families of toothed (odontocete) and baleen (mysticete) whales, using X-ray computed tomography. We also charted ear ossification patterns through ontogeny to understand the impact of heterochronic developmental processes. We determined that the acoustic funnel arises from a prominent V-shaped structure established early in ontogeny, formed by the malleus and the goniale. In odontocetes, this V-formation develops into a cone-shaped funnel facing anteriorly, directly into intramandibular acoustic fats, which is likely functionally linked to the anterior orientation of sound reception in echolocation. In contrast, the acoustic funnel in balaenopterids rotates laterally, later in fetal development, consistent with a lateral sound reception pathway. Balaenids and several fossil mysticetes retain a somewhat anteriorly oriented acoustic funnel in the mature condition, indicating that a lateral sound reception pathway in balaenopterids may be a recent evolutionary innovation linked to specialized feeding modes, such as lunge-feeding.	[Yamato, Maya] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Yamato, Maya; Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Mammal, Washington, DC 20560 USA; [Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Palaeontol, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Yamato, M (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA.	yamatom@si.edu		Pyenson, Nicholas/0000-0003-4678-5782	NMNH Peter Buck Postdoctoral Fellowship; NMNH Remington Kellogg Fund	NMNH Peter Buck Postdoctoral Fellowship; NMNH Remington Kellogg Fund	Support for this work came from a NMNH Peter Buck Postdoctoral Fellowship to MY, and the NMNH Remington Kellogg Fund to NDP (http://www.mnh.si.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU WWL, 1984, J ACOUST SOC AM, V75, P255, DOI 10.1121/1.390403; Bajpai S, 2011, J PALEONTOL, V85, P703, DOI 10.1666/10-128.1; Bisconti M, 2001, ITAL J ZOOL, V68, P87, DOI 10.1080/11250000109356390; BOENNINGHAUS G, 1904, ZOOL JB A, V19, P189; Cozzi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037110; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011927; CUMMINGS WC, 1971, J ACOUST SOC AM, V50, P1193, DOI 10.1121/1.1912752; de Buffrenil V, 2004, J ZOOL, V262, P371, DOI 10.1017/S0952836903004758; Demere TA, 2008, ZOOL J LINN SOC-LOND, V154, P308, DOI 10.1111/j.1096-3642.2008.00414.x; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; EALES NB, 1950, PHILOS T ROY SOC B, V235, P1, DOI 10.1098/rstb.1950.0013; Ekdale EG, 2015, J ANAT, V226, P22, DOI 10.1111/joa.12253; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Fordyce R.E., 2009, THERIAN SKULL LEXICO; FRAZER JFD, 1973, J ZOOL, V169, P111; Galatius A, 2010, BIOL J LINN SOC, V99, P278, DOI 10.1111/j.1095-8312.2009.01357.x; Gatesy J, 2013, MOL PHYLOGENET EVOL, V66, P479, DOI 10.1016/j.ympev.2012.10.012; Gingerich PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004366; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haddad D, 2012, ZOOL ANZ, V251, P115, DOI 10.1016/j.jcz.2011.06.004; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; Kasuya T., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P1; KELLOGG WN, 1958, SCIENCE, V128, P982, DOI 10.1126/science.128.3330.982; Kesteven H. L., 1941, Records of the Australian Museum, V21, P59; Kinkel MD, 2001, J MORPHOL, V249, P126, DOI 10.1002/jmor.1044; Lancaster WC, 2014, MARINE MAMMAL SCI; Laws R. M., 1959, Discovery Reports, V29, P281; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Marx FG, 2011, J MAMM EVOL, V18, P77, DOI 10.1007/s10914-010-9148-4; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; MCNAMARA KJ, 1986, J PALEONTOL, V60, P4, DOI 10.1017/S0022336000021454; Mooney TA, 2012, ADV MAR BIOL, V63, P197, DOI 10.1016/B978-0-12-394282-1.00004-1; Moran MM, 2011, ANAT REC, V294, P1743, DOI 10.1002/ar.21388; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Norris K. S., 1964, P317; NORRIS KS, 1961, BIOL BULL, V120, P163, DOI 10.2307/1539374; Nummela S, 2004, NATURE, V430, P776, DOI 10.1038/nature02720; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; OELSCHLAGER HA, 1986, AM J ANAT, V177, P353, DOI 10.1002/aja.1001770306; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; PERRIN WF, 1976, FISH B-NOAA, V74, P229; Pyenson ND, 2013, BIOL J LINN SOC, V108, P586, DOI 10.1111/j.1095-8312.2012.02032.x; Pyenson ND, 2012, NATURE, V485, P498, DOI 10.1038/nature11135; Pyenson ND, 2011, J MAMM EVOL, V18, P269, DOI 10.1007/s10914-011-9170-1; Rauschmann MA, 2006, J MORPHOL, V267, P1295, DOI 10.1002/jmor.10477; Reese CS, 2001, J AM STAT ASSOC, V96, P915, DOI 10.1198/016214501753208618; Reidenberg J., 2008, ENCY MARINE MAMMALS, P220; REYSENBACH DE HAAN F W, 1957, Acta Otolaryngol Suppl, V134, P1; Ridewood WG, 1923, PHILOS T R SOC LON B, V211, P209, DOI 10.1098/rstb.1923.0005; Roston RA, 2013, ANAT REC, V296, P709, DOI 10.1002/ar.22678; Sterba O, 1999, EMBRYOLOGY DOLPHINS; Sumich James L., 2013, Journal of Cetacean Research and Management, V13, P89; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; Tsai CH, 2014, EVOL BIOL, V41, P299, DOI 10.1007/s11692-014-9269-4; Wartzok Douglas, 1999, P117; Yamada M., 1953, Scientific Reports of the Whales Research Institute Tokyo, V8, P1; Yamato M, 2012, ANAT REC, V295, P991, DOI 10.1002/ar.22459	61	13	13	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118582	10.1371/journal.pone.0118582	http://dx.doi.org/10.1371/journal.pone.0118582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760328	gold, Green Published			2022-12-26	WOS:000351275000030
J	Richardson, SL; Mao, YF; Zhang, G; Hanjra, P; Peterson, DL; Huang, R				Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Peterson, Darrell L.; Huang, Rong			Kinetic Mechanism of Protein N-terminal Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLATION; DNA; IDENTIFICATION; SPECIFICITY; CHROMATIN; PEPTIDES; BINDING; ASSAY; NRMT; RCC1	The protein N-terminal methyltransferase 1 (NTMT1) catalyzes the transfer of the methyl group from the S-adenosyl-L-methionine to the protein alpha-amine, resulting in formation of S-adenosyl-L-homocysteine and alpha-N-methylated proteins. NTMT1 is an interesting potential anticancer target because it is overexpressed in gastrointestinal cancers and plays an important role in cell mitosis. To gain insight into the biochemical mechanism of NTMT1, we have characterized the kinetic mechanism of recombinant NTMT1 using a fluorescence assay and mass spectrometry. The results of initial velocity, product, and dead-end inhibition studies indicate that methylation by NTMT1 proceeds via a random sequential Bi Bi mechanism. In addition, our processivity studies demonstrate that NTMT1 proceeds via a distributive mechanism for multiple methylations. Together, our studies provide new knowledge about the kinetic mechanism of NTMT1 and lay the foundation for the development of mechanism-based inhibitors.	[Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Huang, Rong] Virginia Commonwealth Univ, Dept Med Chem, Richmond, VA 23219 USA; [Richardson, Stacie L.; Mao, Yunfei; Zhang, Gang; Hanjra, Pahul; Peterson, Darrell L.; Huang, Rong] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23219 USA; [Peterson, Darrell L.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23219 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Huang, R (corresponding author), Inst Struct Biol & Drug Discovery, Dept Med Chem, 800 East Leigh St,Suite 212, Richmond, VA 23219 USA.	rhuang@vcu.edu	Zhang, Gang/J-3328-2019; Huang, Rong/AAL-3276-2020; Zhang, Gang/A-3292-2016	Zhang, Gang/0000-0003-0774-5710; Huang, Rong/0000-0002-1477-3165; Zhang, Gang/0000-0003-0774-5710	National Institutes of Health, National Center for Advancing Translational Sciences [UL1TR000058]; Virginia Commonwealth University School of Pharmacy; A. D. Williams Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Advancing Translational Sciences; Virginia Commonwealth University School of Pharmacy; A. D. Williams Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health, National Center for Advancing Translational Sciences, Grant UL1TR000058 (to the Virginia Commonwealth University Center for Clinical and Translational Research). This work was also supported by the startup funds from the Virginia Commonwealth University School of Pharmacy and the A. D. Williams Fund.	Bailey AO, 2013, P NATL ACAD SCI USA, V110, P11827, DOI 10.1073/pnas.1300325110; Biron E, 2006, J PEPT SCI, V12, P213, DOI 10.1002/psc.711; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Cai Q, 2014, J BIOL CHEM, V289, P16046, DOI 10.1074/jbc.M114.558510; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P352; Copeland RA, 2010, CURR OPIN CHEM BIOL, V14, P505, DOI 10.1016/j.cbpa.2010.06.174; Ctrnacta V, 2007, FEMS MICROBIOL LETT, V273, P87, DOI 10.1111/j.1574-6968.2007.00795.x; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Petkowski JJ, 2013, BIOCHEM J, V456, P453, DOI 10.1042/BJ20131163; Petkowski JJ, 2012, BIOCHEMISTRY-US, V51, P5942, DOI 10.1021/bi300278f; Pu D, 2008, RAPID COMMUN MASS SP, V22, P91, DOI 10.1002/rcm.3337; Rechthaler J, 2013, J AM SOC MASS SPECTR, V24, P701, DOI 10.1007/s13361-013-0614-0; Reid GE, 2000, J AM SOC MASS SPECTR, V11, P1047, DOI 10.1016/S1044-0305(00)00189-6; Santhiya D, 2009, LANGMUIR, V25, P13770, DOI 10.1021/la901546t; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; Tooley CES, 2010, NATURE, V466, P1125, DOI 10.1038/nature09343; Villar-Garea A, 2012, NUCLEIC ACIDS RES, V40, P1536, DOI 10.1093/nar/gkr935; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Yost Julianne M, 2011, Curr Chem Genomics, V5, P72, DOI 10.2174/1875397301005010072; Zhu Xiangping, 2003, J Biomol Tech, V14, P298	27	26	26	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11601	11610		10.1074/jbc.M114.626846	http://dx.doi.org/10.1074/jbc.M114.626846			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25771539	Green Published, hybrid			2022-12-26	WOS:000353719400035
J	Li, LY; Homan, KT; Vishnivetskiy, SA; Manglik, A; Tesmer, JJG; Gurevich, VV; Gurevich, EV				Li, Lingyong; Homan, Kristoff T.; Vishnivetskiy, Sergey A.; Manglik, Aashish; Tesmer, John J. G.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.			G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; LIGHT-DEPENDENT PHOSPHORYLATION; RHODOPSIN KINASE; BETA(2)-ADRENERGIC RECEPTOR; VISUAL ARRESTIN; CONSTITUTIVE ACTIVITY; DIFFERENTIALLY AFFECT; VASOPRESSIN RECEPTOR; NONVISUAL ARRESTINS; SIGNALING PATHWAYS	G protein-coupled receptor (GPCR) kinases (GRKs) play a key role in homologous desensitization of GPCRs. It is widely assumed that most GRKs selectively phosphorylate only active GPCRs. Here, we show that although this seems to be the case for the GRK2/3 subfamily, GRK5/6 effectively phosphorylate inactive forms of several GPCRs, including beta 2-adrenergic and M2 muscarinic receptors, which are commonly used as representative models for GPCRs. Agonist-independent GPCR phosphorylation cannot be explained by constitutive activity of the receptor or membrane association of the GRK, suggesting that it is an inherent ability of GRK5/6. Importantly, phosphorylation of the inactive beta(2)-adrenergic receptor enhanced its interactions with arrestins. Arrestin-3 was able to discriminate between phosphorylation of the same receptor by GRK2 and GRK5, demonstrating preference for the latter. Arrestin recruitment to inactive phosphorylated GPCRs suggests that not only agonist activation but also the complement of GRKs in the cell regulate formation of the arrestin-receptor complex and thereby G protein-independent signaling.	[Li, Lingyong; Vishnivetskiy, Sergey A.; Gurevich, Vsevolod V.; Gurevich, Eugenia V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Homan, Kristoff T.; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Manglik, Aashish] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Vanderbilt University; University of Michigan System; University of Michigan; Stanford University	Gurevich, EV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Preston Res Bldg,Rm 454, Nashville, TN 37232 USA.	Eugenia.Gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Li, Lingyong/D-7493-2016; Regan, Clinton/E-6250-2012; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [NS065868, R21DA030103, GM077561, EY011500, HL071818, HL086865]; American Heart Association [N014938]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109955, R01GM077561, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS065868 and R21DA030103 (to E V. G.), GM077561 and EY011500 (to V. V. G.), and HL071818 and HL086865 (to J. J. G. T.). This work was also supported by American Heart Association Grant N014938 (to K. T. H.).	Ahmed MR, 2008, J NEUROCHEM, V104, P1622, DOI 10.1111/j.1471-4159.2007.05104.x; Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Ahmed MR, 2008, J PHARMACOL EXP THER, V325, P276, DOI 10.1124/jpet.107.131987; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Baameur F, 2010, MOL PHARMACOL, V77, P405, DOI 10.1124/mol.109.058115; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BINDER BM, 1990, J BIOL CHEM, V265, P15333; Binder BM, 1996, J BIOL CHEM, V271, P19826, DOI 10.1074/jbc.271.33.19826; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; BOWNDS D, 1972, NATURE-NEW BIOL, V237, P125, DOI 10.1038/newbio237125a0; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Bychkov ER, 2008, NEUROBIOL AGING, V29, P379, DOI 10.1016/j.neurobiolaging.2006.10.012; Bychkov ER, 2011, NEUROBIOL DIS, V44, P248, DOI 10.1016/j.nbd.2011.07.009; Bychkov E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048912; Bychkov E, 2011, INT J NEUROPSYCHOPH, V14, P1, DOI 10.1017/S1461145710000118; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chanrion B, 2008, MOL PHARMACOL, V73, P748, DOI 10.1124/mol.107.041574; CHEN CY, 1993, J BIOL CHEM, V268, P7825; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Daaka Y, 1997, P NATL ACAD SCI USA, V94, P2180, DOI 10.1073/pnas.94.6.2180; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Gimenez LE, 2014, CELL SIGNAL, V26, P1523, DOI 10.1016/j.cellsig.2014.03.019; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Hisatomi O, 1998, FEBS LETT, V424, P159, DOI 10.1016/S0014-5793(98)00162-8; Homan KT, 2014, CURR OPIN CELL BIOL, V27, P25, DOI 10.1016/j.ceb.2013.10.009; Huang CC, 2011, BIOCHEMISTRY-US, V50, P1940, DOI 10.1021/bi101606e; Huang CC, 2011, J BIOL CHEM, V286, P7715, DOI 10.1074/jbc.R109.051847; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; KUHN H, 1972, FEBS LETT, V20, P1, DOI 10.1016/0014-5793(72)80002-4; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; LORENZ W, 1991, P NATL ACAD SCI USA, V88, P8715, DOI 10.1073/pnas.88.19.8715; Loudon RP, 1997, J BIOL CHEM, V272, P27422, DOI 10.1074/jbc.272.43.27422; Mushegian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033806; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHTA T, 1991, J MOL EVOL, V33, P34, DOI 10.1007/BF02100193; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; STERNEMARR R, 1993, J BIOL CHEM, V268, P15640; STOFFEL RH, 1994, J BIOL CHEM, V269, P27791; Stoffel RH, 1998, BIOCHEMISTRY-US, V37, P16053, DOI 10.1021/bi981432d; Tesmer JJG, 2012, ACTA CRYSTALLOGR F, V68, P622, DOI 10.1107/S1744309112017435; Tesmer JJG, 2010, J MED CHEM, V53, P1867, DOI 10.1021/jm9017515; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Thiyagarajan MM, 2004, J BIOL CHEM, V279, P17989, DOI 10.1074/jbc.M310738200; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Walther C, 2010, J BIOL CHEM, V285, P41578, DOI 10.1074/jbc.M110.162156; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Woollard Alison, 2005, WormBook, P1, DOI 10.1895/wormbook.1.2.1; Yang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082072; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	95	40	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10775	10790		10.1074/jbc.M115.644773	http://dx.doi.org/10.1074/jbc.M115.644773			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770216	Green Published, hybrid			2022-12-26	WOS:000353404500019
J	Bick, MJ; Malik, S; Mustaev, A; Darst, SA				Bick, Matthew J.; Malik, Sohail; Mustaev, Arkady; Darst, Seth A.			TFIIB Is Only similar to 9 angstrom Away from the 5 '-End of a Trimeric RNA Primer in a Functional RNA Polymerase II Preinitiation Complex	PLOS ONE			English	Article							TRANSCRIPTION FACTOR TFIIF; CORE PROMOTER ELEMENT; STRUCTURAL BASIS; ACTIVE-CENTER; DEPENDENT TRANSCRIPTION; CRYSTAL-STRUCTURE; INITIATION-FACTOR; LARGEST SUBUNIT; DNA; HOLOENZYME	Recent X-ray crystallographic studies of Pol II in complex with the general transcription factor (GTF) IIB have begun to provide insights into the mechanism of transcription initiation. These structures have also shed light on the architecture of the transcription preinitiation complex (PIC). However, structural characterization of a functional PIC is still lacking, and even the topological arrangement of the GTFs in the Pol II complex is a matter of contention. We have extended our activity-based affinity crosslinking studies, initially developed to investigate the interaction of bacterial RNA polymerase with s, to the eukaryotic transcription machinery. Towards that end, we sought to identify GTFs that are within the Pol II active site in a functioning PIC. We provide biochemical evidence that TFIIB is located within similar to 9 angstrom of the -2 site of promoter DNA, where it is positioned to play a role in de novo transcription initiation.	[Bick, Matthew J.; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; [Malik, Sohail] Rockefeller Univ, Lab Biochem & Mol Biol, New York, NY 10021 USA; [Mustaev, Arkady] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	Rockefeller University; Rockefeller University; New Jersey Institute of Technology	Darst, SA (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	darst@mail.rockefeller.edu		Bick, Matthew/0000-0002-9585-859X	National Institutes of Health [GM081697]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, grant number GM081697; http://nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Elsby LM, 2006, EMBO REP, V7, P898, DOI 10.1038/sj.embor.7400767; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fishburn J, 2012, MOL CELL BIOL, V32, P12, DOI 10.1128/MCB.06242-11; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Ge H, 1996, METHOD ENZYMOL, V274, P57; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GRACHEV MA, 1987, EUR J BIOCHEM, V163, P113, DOI 10.1111/j.1432-1033.1987.tb10743.x; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOLSTEGE FCP, 1995, EMBO J, V14, P810, DOI 10.1002/j.1460-2075.1995.tb07059.x; Iyer L. M., 2011, J STRUCT BIOL; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Kulbachinskiy A, 2006, J BIOL CHEM, V281, P18273, DOI 10.1074/jbc.C600060200; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lane WJ, 2010, J MOL BIOL, V395, P671, DOI 10.1016/j.jmb.2009.10.062; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Liu X, 2011, CELL, V147, P1218, DOI 10.1016/j.cell.2011.11.033; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malik S, 1998, P NATL ACAD SCI USA, V95, P2192, DOI 10.1073/pnas.95.5.2192; MALIK S, 1993, MOL CELL BIOL, V13, P6253, DOI 10.1128/MCB.13.10.6253; Malik S, 2003, METHOD ENZYMOL, V364, P257; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murakami KS, 2003, METHOD ENZYMOL, V370, P42; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PAN GH, 1994, J BIOL CHEM, V269, P30101; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SCHMIDT MC, 1986, FEBS LETT, V194, P305, DOI 10.1016/0014-5793(86)80106-5; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SUN ZW, 1995, P NATL ACAD SCI USA, V92, P3127, DOI 10.1073/pnas.92.8.3127; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Thompson NE, 2009, J BIOL CHEM, V284, P24754, DOI 10.1074/jbc.M109.030486; TYREE CM, 1993, GENE DEV, V7, P1254, DOI 10.1101/gad.7.7a.1254; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786	63	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119007	10.1371/journal.pone.0119007	http://dx.doi.org/10.1371/journal.pone.0119007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774659	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500058
J	Hohwu, L; Zhu, JL; Graversen, L; Li, J; Sorensen, TIA; Obel, C				Hohwu, Lena; Zhu, Jin Liang; Graversen, Lise; Li, Jiong; Sorensen, Thorkild I. A.; Obel, Carsten			Prenatal Parental Separation and Body Weight, Including Development of Overweight and Obesity Later in Childhood	PLOS ONE			English	Article							DIVORCE; STRESS; ASSOCIATION; ADIPOSITY; BMI	Background Early parental separation may be a stress factor causing a long-term alteration in the hypothalamic-pituitary-adrenal-axis activity possibly impacting on the susceptibility to develop overweight and obesity in offspring. We aimed to examine the body mass index (BMI) and the risk of overweight and obesity in children whose parents lived separately before the child was born. Methods A follow-up study was conducted using data from the Aarhus Birth Cohort in Denmark and included 2876 children with measurements of height and weight at 9-11-years-of-age, and self-reported information on parental cohabitation status at child birth and at 9-11-years-of-age. Quantile regression was used to estimate the difference in median BMI between children whose parents lived separately (n = 124) or together (n = 2752) before the birth. We used multiple logistic regression to calculate odds ratio (OR) for overweight and obesity, adjusted for gender, parity, breast feeding status, and maternal pre-pregnancy BMI, weight gain during pregnancy, age and educational level at child birth; with and without possible intermediate factors birth weight and maternal smoking during pregnancy. Due to a limited number of obese children, OR for obesity was adjusted for the a priori confounder maternal pre-pregnancy BMI only. Results The difference in median BMI was 0.54 kg/m(2) (95% confidence intervals (CI): 0.10; 0.98) between children whose parents lived separately before birth and children whose parents lived together. The risk of overweight and obesity was statistically significantly increased in children whose parents lived separately before the birth of the child; OR 2.29 (95% CI: 1.18; 4.45) and OR 2.81 (95% CI: 1.05; 7.51), respectively. Additional, adjustment for possible intermediate factors did not substantially change the estimates. Conclusion Parental separation before child birth was associated with higher BMI, and increased risk of overweight and obesity in 9-11-year-old children; this may suggest a fetal programming effect or unmeasured difference in psychosocial factors between separated and nonseparated parents.	[Hohwu, Lena; Zhu, Jin Liang; Graversen, Lise; Li, Jiong; Obel, Carsten] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksbjerg Hosp, Inst Prevent Med, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Aarhus University; Novo Nordisk Foundation; University of Copenhagen	Hohwu, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	lena.hohwu@ph.au.dk	li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	li, jiong/0000-0002-1716-8067; Hohwu, Lena/0000-0002-9887-7745; Obel, Carsten/0000-0001-5004-1933; li, jiong/0000-0003-1125-026X	European Research Council [ERC-StG-2010- 260242-PROGEURO]; Danish Medical Research Council [09-072986]; full PhD fellowship at Aarhus University, Denmark	European Research Council(European Research Council (ERC)European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); full PhD fellowship at Aarhus University, Denmark	This work was supported by European Research Council (ERC-StG-2010- 260242-PROGEURO to JL; the Danish Medical Research Council (project no. 09-072986). LH is supported by a full PhD fellowship at Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; Amato PR, 2000, J MARRIAGE FAM, V62, P1269, DOI 10.1111/j.1741-3737.2000.01269.x; Arkes J, 2012, OBESITY, V20, P1696, DOI 10.1038/oby.2012.84; Bloch M, 2007, HORM BEHAV, V51, P516, DOI 10.1016/j.yhbeh.2007.01.009; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; Gluckman PD, 2008, INT J OBESITY, V32, pS62, DOI 10.1038/ijo.2008.240; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Huffman FG, 2010, INT J ENV RES PUB HE, V7, P2800, DOI 10.3390/ijerph7072800; Ingstrup KG, 2012, J OBES, V2012, DOI 10.1155/2012/462845; Li JO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011896; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Mack KY, 2001, DEATH STUD, V25, P419, DOI 10.1080/074811801750257527; Mairesse J, 2007, AM J PHYSIOL-ENDOC M, V292, pE1526, DOI 10.1152/ajpendo.00574.2006; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; O'Donnell KJ, 2012, PSYCHONEUROENDOCRINO, V37, P818, DOI 10.1016/j.psyneuen.2011.09.014; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Pesonen AK, 2010, PSYCHONEUROENDOCRINO, V35, P758, DOI 10.1016/j.psyneuen.2009.10.017; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Reynolds RM, 2010, J STEROID BIOCHEM, V122, P3, DOI 10.1016/j.jsbmb.2010.01.009; Schmeer KK, 2012, SOC SCI RES, V41, P820, DOI 10.1016/j.ssresearch.2012.01.007; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; SKODOL AE, 1989, AM J PSYCHIAT, V146, P61; Sun SMS, 2006, HANDBOOK OF PEDIATRIC OBESITY: ETIOLOGY, PATHOPHYSIOLOGY, AND PREVENTION, P19; Watt TT, 2013, J COMMUN HEALTH, V38, P513, DOI 10.1007/s10900-012-9641-1; Welberg LAM, 2005, J ENDOCRINOL, V186, pR7, DOI 10.1677/joe.1.06374; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Yannakoulia M, 2008, OBESITY, V16, P1382, DOI 10.1038/oby.2008.70	34	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119138	10.1371/journal.pone.0119138	http://dx.doi.org/10.1371/journal.pone.0119138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775129	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500071
J	Lecroisey, C; Le Petillon, Y; Escriva, H; Lammert, E; Laudet, V				Lecroisey, Claire; Le Petillon, Yann; Escriva, Hector; Lammert, Eckhard; Laudet, Vincent			Identification, Evolution and Expression of an Insulin-Like Peptide in the Cephalochordate Branchiostoma lanceolatum	PLOS ONE			English	Article							II GENE-EXPRESSION; GROWTH-FACTOR; AMPHIOXUS; FAMILY; VERTEBRATE; INSIGHTS; GENOME; DUPLICATION; PHYLOGENY; RECEPTORS	Insulin is one of the most studied proteins since it is central to the regulation of carbohydrate and fat metabolism in vertebrates and its expression and release are disturbed in diabetes, the most frequent human metabolic disease worldwide. However, the evolution of the function of the insulin protein family is still unclear. In this study, we present a phylogenetic and developmental analysis of the Insulin Like Peptide (ILP) in the cephalochordate amphioxus. We identified an ILP in the European amphioxus Branchiostoma lanceolatum that displays structural characteristics of both vertebrate insulin and Insulin-like Growth Factors (IGFs). Our phylogenetic analysis revealed that amphioxus ILP represents the sister group of both vertebrate insulin and IGF proteins. We also characterized both temporal and spatial expression of ILP in amphioxus. We show that ilp is highly expressed in endoderm and paraxial mesoderm during development, and mainly expressed in the gut of both the developing embryo and adult. We hypothesize that ILP has critical implications in both developmental processes and metabolism and could display IGF-and insulin-like functions in amphioxus supporting the idea of a common ancestral protein.	[Lecroisey, Claire; Laudet, Vincent] Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France; [Le Petillon, Yann; Escriva, Hector] Observ Oceanol, BIOM, CNRS, UMR 7232, F-66650 Banyuls Sur Mer, France; [Lammert, Eckhard] Univ Dusseldorf, Inst Metab Physiol, D-40225 Dusseldorf, Germany	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf	Laudet, V (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, Mol Zool Team,Inst Genom Fonct Lyon, Lyon, France.	Vincent.Laudet@ens-lyon.fr	Escriva, Hector/K-8325-2013	Escriva, Hector/0000-0001-7577-5028; Laudet, Vincent/0000-0003-4022-4175	Agence Nationale de la Recherche [ANR-2010-BLAN-1234 01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche (http://www.agence- nationale-recherche. fr). Grant number: ANR-2010-BLAN-1234 01 (CL HE VL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Benitez CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012401; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; Chan SJ, 2000, AM ZOOL, V40, P213; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; DEVASKAR SU, 1993, REGUL PEPTIDES, V48, P55, DOI 10.1016/0167-0115(93)90335-6; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Fuentes M, 2007, J EXP ZOOL PART B, V308B, P484, DOI 10.1002/jez.b.21179; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo B, 2009, CELL TISSUE RES, V338, P67, DOI 10.1007/s00441-009-0824-8; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Holland ND, 2009, ACTA ZOOL-STOCKHOLM, V90, P372, DOI 10.1111/j.1463-6395.2008.00379.x; Holland PWH, 1997, ADVANCES IN COMPARATIVE ENDOCRINOLOGY, TOMES 1 AND 2, P247; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; LEE JE, 1990, DEVELOPMENT, V110, P151; Li H, 2006, INVERTEBR BIOL, V125, P172, DOI 10.1111/j.1744-7410.2006.00050.x; Liu MY, 2011, MOL CELL ENDOCRINOL, V343, P45, DOI 10.1016/j.mce.2011.06.004; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Murphy Coleen T, 2013, WormBook, P1, DOI 10.1895/wormbook.1.164.1; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; OLIVA AA, 1995, P NATL ACAD SCI USA, V92, P3591, DOI 10.1073/pnas.92.8.3591; Oulion S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036554; Penn O, 2010, MOL BIOL EVOL, V27, P1759, DOI 10.1093/molbev/msq066; Perillo M, 2014, GEN COMP ENDOCR, V205, P68, DOI 10.1016/j.ygcen.2014.06.014; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieler T, 2006, BIOL CELL, V98, P79, DOI 10.1042/BC20050069; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Reinecke M, 1998, INT REV CYTOL, V183, P1, DOI 10.1016/S0074-7696(08)60142-4; REINECKE M, 1981, CELL TISSUE RES, V219, P445; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Theodosiou M, 2011, J EXP ZOOL PART B, V316B, P263, DOI 10.1002/jez.b.21397; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Villasenor A, 2012, SEMIN CELL DEV BIOL, V23, P685, DOI 10.1016/j.semcdb.2012.06.003; Wang S, 2003, BIOCHEMISTRY-US, V42, P9687, DOI 10.1021/bi0346289; Wang YF, 2012, FISH SHELLFISH IMMUN, V32, P1068, DOI 10.1016/j.fsi.2012.03.001; Welsch U., 1975, S ZOOLOGICAL SOC LON, V36, P17; Wilkinson TN, 2005, ANN NY ACAD SCI, V1041, P530, DOI 10.1196/annals.1282.079; Wilkinson TN, 2007, ADV EXP MED BIOL, V612, P1; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Zhou JF, 2013, ENDOCRINOLOGY, V154, P3753, DOI 10.1210/en.2013-1201	47	19	19	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119461	10.1371/journal.pone.0119461	http://dx.doi.org/10.1371/journal.pone.0119461			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774519	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500093
J	Lindberg, AS; Oksa, J; Antti, H; Malm, C				Lindberg, Ann-Sofie; Oksa, Juha; Antti, Henrik; Malm, Christer			Multivariate Statistical Assessment of Predictors of Firefighters' Muscular and Aerobic Work Capacity	PLOS ONE			English	Article							CONTAINED BREATHING APPARATUS; PERSONAL PROTECTIVE EQUIPMENT; PHYSICAL-FITNESS; PHYSIOLOGICAL DEMANDS; FIRE-FIGHTERS; ABILITY TEST; PERFORMANCE; TASKS; RESPONSES; BALANCE	Physical capacity has previously been deemed important for firefighters physical work capacity, and aerobic fitness, muscular strength, and muscular endurance are the most frequently investigated parameters of importance. Traditionally, bivariate and multivariate linear regression statistics have been used to study relationships between physical capacities and work capacities among firefighters. An alternative way to handle datasets consisting of numerous correlated variables is to use multivariate projection analyses, such as Orthogonal Projection to Latent Structures. The first aim of the present study was to evaluate the prediction and predictive power of field and laboratory tests, respectively, on firefighters' physical work capacity on selected work tasks. Also, to study if valid predictions could be achieved without anthropometric data. The second aim was to externally validate selected models. The third aim was to validate selected models on firefighters' and on civilians'. A total of 38 (26 men and 12 women) + 90 (38 men and 52 women) subjects were included in the models and the external validation, respectively. The best prediction (R-2) and predictive power (Q(2)) of Stairs, Pulling, Demolition, Terrain, and Rescue work capacities included field tests (R-2 = 0.73 to 0.84, Q(2) = 0.68 to 0.82). The best external validation was for Stairs work capacity (R-2 = 0.80) and worst for Demolition work capacity (R-2 = 0.40). In conclusion, field and laboratory tests could equally well predict physical work capacities for fire-fighting work tasks, and models excluding anthropometric data were valid. The predictive power was satisfactory for all included work tasks except Demolition.	[Lindberg, Ann-Sofie; Malm, Christer] Umea Univ, Sports Med Unit, Umea, Sweden; [Lindberg, Ann-Sofie; Malm, Christer] Winternet, Boden, Sweden; [Oksa, Juha] Finnish Inst Occupat Hlth, Phys Work Capac Team, Oulu, Finland; [Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Finnish Institute of Occupational Health; Umea University	Lindberg, AS (corresponding author), Umea Univ, Sports Med Unit, Umea, Sweden.	ann-sofie.lindberg@winter-net.se	Malm, Christer B/O-3458-2014	Malm, Christer B/0000-0002-8436-2476	Swedish Civil Contingencies Agency	Swedish Civil Contingencies Agency	Funders of the work were the Swedish Civil Contingencies Agency, https://www.msb.se/en/?ResetTargetNavigation=true. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ARB MED KONTR ARB AR, P18; Bakri I, 2012, ERGONOMICS, V55, P782, DOI 10.1080/00140139.2012.663506; Barr D, 2010, APPL ERGON, V41, P161, DOI 10.1016/j.apergo.2009.07.001; Bergkvist M, 1992, UTVARDERING TEST BED; Brown LE, 2001, J EXERC PHYSL ONLINE, V4; DAVIS PO, 1982, MED SCI SPORT EXER, V14, P65, DOI 10.1249/00005768-198201000-00013; Deblasi F., 2003, ISOKINETIC TESTING D; Dreger RW, 2007, APPL PHYSIOL NUTR ME, V32, P454, DOI 10.1139/H07-020; Dreger RW, 2006, ERGONOMICS, V49, P911, DOI 10.1080/00140130600667451; Eriksson L., 2013, MULTI MEGAVARIATE DA; Garver JN, 2005, J STRENGTH COND RES, V19, P310; GAVHED DCE, 1989, EUR J APPL PHYSIOL O, V59, P115, DOI 10.1007/BF02396588; Gentzler M, 2010, WORK, V37, P227, DOI 10.3233/WOR-2010-1075; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P207; GLEDHILL N, 1992, CAN J SPORT SCI, V17, P199; Harvey DG, 2008, EUR J APPL PHYSIOL, V103, P89, DOI 10.1007/s00421-008-0673-2; Henderson ND, 2007, PERS PSYCHOL, V60, P431, DOI 10.1111/j.1744-6570.2007.00079.x; Henderson ND, 2010, PERS PSYCHOL, V63, P999, DOI 10.1111/j.1744-6570.2010.01196.x; Hooper AJ, 2001, APPL ERGON, V32, P399, DOI 10.1016/S0003-6870(01)00007-2; Huang CJ, 2010, INT J PSYCHOPHYSIOL, V75, P312, DOI 10.1016/j.ijpsycho.2009.12.013; Kluth K, 2004, OCCUPATIONAL ERGONOM, V4, P89; Kong PW, 2012, RES Q EXERCISE SPORT, V83, P546; Koopmans L, 2011, J OCCUP ENVIRON MED, V53, P856, DOI 10.1097/JOM.0b013e318226a763; Levels K, 2014, APPL ERGON, V45, P1504, DOI 10.1016/j.apergo.2014.04.011; Lindberg AS, 2014, INT J OCCUP SAF ERGO, V20, P309, DOI 10.1080/10803548.2014.11077042; Lindberg AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091215; Lindberg AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068047; Lord C, 2012, APPL ERGON, V43, P191, DOI 10.1016/j.apergo.2011.05.003; LOUHEVAARA V, 1994, INT J IND ERGONOM, V13, P139, DOI 10.1016/0169-8141(94)90080-9; Lund A, 2013, TESTING NORMALITY LA; Lusa S, 2006, INT ARCH OCC ENV HEA, V79, P419, DOI 10.1007/s00420-005-0059-2; LUSA S, 1994, J OCCUP ENVIRON MED, V36, P70; Malm C, 2005, 2 RADD; McArdle WD., 2001, EXERCISE PHYSL ENERG; Michaelides MA, 2011, J STRENGTH COND RES, V25, P956, DOI 10.1519/JSC.0b013e3181cc23ea; Michaelides MA, 2008, RES Q EXERCISE SPORT, V79, P468, DOI 10.1080/02701367.2008.10599513; OCONNELL ER, 1986, J OCCUP ENVIRON MED, V28, P282; Oksa J, 2013, APPL PHYSIOL NUTR ME, V38, P292, DOI 10.1139/apnm-2012-0180; Perroni F, 2014, APPL ERGON, V45, P456, DOI 10.1016/j.apergo.2013.06.005; Phillips M, 2011, APPL ERGON, V42, P411, DOI 10.1016/j.apergo.2010.08.020; Phillips M, 2012, APPL ERGON, V43, P435, DOI 10.1016/j.apergo.2011.06.018; Punakallio A, 2005, SAFETY SCI, V43, P455, DOI 10.1016/j.ssci.2005.08.009; Punakallio A, 2003, AVIAT SPACE ENVIR MD, V74, P1151; Rhea MR, 2004, J STRENGTH COND RES, V18, P348; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Sharkey BJ., 2008, HARD WORK DEFINING P; Sheaff AK, 2010, J STRENGTH COND RES, V24, P3112, DOI 10.1519/JSC.0b013e3181f0a8d5; SJODIN B, 1981, INT J SPORTS MED, V2, P166, DOI 10.1055/s-2008-1034605; Son SY, 2014, APPL ERGON, V45, P1019, DOI 10.1016/j.apergo.2013.12.006; Sonnentag, 2002, PSYCHOL MANAGEMENT I; Sothmann MS, 2004, ERGONOMICS, V47, P864, DOI 10.1080/00140130410001670372; Sothmann MS., 1990, HUM PERFORM, V3, P217; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; ┼strand PO., 2003, TXB WORK PHYSL PHYSL; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P2913, DOI 10.1007/s00421-011-2267-7; Tokmakidis S, 1995, COACHING SPORT SCI J, V1, P19; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; United States Department of Agriculture US Forest Service, 2002, PACK TEST WORK CAP T; von Heimburg ED, 2006, ERGONOMICS, V49, P111, DOI 10.1080/00140130500435793; Williams-Bell FM, 2009, MED SCI SPORT EXER, V41, P653, DOI 10.1249/MSS.0b013e31818ad117; Williford HN, 1999, ERGONOMICS, V42, P1179, DOI 10.1080/001401399185063; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	62	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118945	10.1371/journal.pone.0118945	http://dx.doi.org/10.1371/journal.pone.0118945			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775243	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500054
J	Martin, JR; Kosem, A; van Wassenhove, V				Martin, Jean-Remy; Koesem, Anne; van Wassenhove, Virginie			Hysteresis in Audiovisual Synchrony Perception	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENT; SIMULTANEITY; ADAPTATION; SPEECH; TIME; RECALIBRATION; INTEGRATION; ASYNCHRONY; RECOGNITION; PLASTICITY	The effect of stimulation history on the perception of a current event can yield two opposite effects, namely: adaptation or hysteresis. The perception of the current event thus goes in the opposite or in the same direction as prior stimulation, respectively. In audiovisual (AV) synchrony perception, adaptation effects have primarily been reported. Here, we tested if perceptual hysteresis could also be observed over adaptation in AV timing perception by varying different experimental conditions. Participants were asked to judge the synchrony of the last (test) stimulus of an AV sequence with either constant or gradually changing AV intervals (constant and dynamic condition, respectively). The onset timing of the test stimulus could be cued or not (prospective vs. retrospective condition, respectively). We observed hysteretic effects for AV synchrony judgments in the retrospective condition that were independent of the constant or dynamic nature of the adapted stimuli; these effects disappeared in the prospective condition. The present findings suggest that knowing when to estimate a stimulus property has a crucial impact on perceptual simultaneity judgments. Our results extend beyond AV timing perception, and have strong implications regarding the comparative study of hysteresis and adaptation phenomena.	[Martin, Jean-Remy] Univ Paris 06, IEC, Paris, France; [Martin, Jean-Remy] CNRS, EHESS, ENS, IJN, Paris, France; [Koesem, Anne; van Wassenhove, Virginie] Univ Paris 11, INSERM, U992, CEA,DSV,I2BM,Cognit Neuroimaging Unit,NeuroSpin, F Gif Yvette, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Martin, JR (corresponding author), Univ Paris 06, IEC, Paris, France.	jeanremy08@gmail.com	van Wassenhove, Virginie/F-4129-2010; Kosem, Anne/M-2344-2019	van Wassenhove, Virginie/0000-0002-2569-5502; Kosem, Anne/0000-0002-2692-9999	Marie Curie International Reintegration Grant (IRG) [249222]; European Research Council-Starting Grant (ERC-YStG) [263584]; National Funding Agency for Research Grant (ANR) [R10JCJC-1904]; doctoral school Cerveau Cognition Comportement (ED3C, Paris, France); Direction Generale de l'Armement (DGA); Commissariat a l'Energie Atomique (CEA)	Marie Curie International Reintegration Grant (IRG)(European Commission); European Research Council-Starting Grant (ERC-YStG); National Funding Agency for Research Grant (ANR)(French National Research Agency (ANR)); doctoral school Cerveau Cognition Comportement (ED3C, Paris, France); Direction Generale de l'Armement (DGA); Commissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission)	This work was supported by a Marie Curie International Reintegration Grant (IRG)-249222, an European Research Council-Starting Grant (ERC-YStG)-263584 and an National Funding Agency for Research Grant (ANR)-R10JCJC-1904 to V.vW, a scholarship from the doctoral school Cerveau Cognition Comportement (ED3C, Paris, France) to J.R.M. and from the Direction Generale de l'Armement (DGA) and the Commissariat a l'Energie Atomique (CEA) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstis S, 1998, TRENDS COGN SCI, V2, P111, DOI 10.1016/S1364-6613(98)01142-5; Barlow H, 1990, VISION CODING EFFICI; Buckthought A, 2008, VISION RES, V48, P819, DOI 10.1016/j.visres.2007.12.013; Cai MB, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00470; Chopin A, 2012, CURR BIOL, V22, P622, DOI 10.1016/j.cub.2012.02.021; Di Luca M, 2009, J VISION, V9, DOI 10.1167/9.12.7; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Fujisaki W, 2009, EXP BRAIN RES, V198, P245, DOI 10.1007/s00221-009-1870-x; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; Gepshtein S, 2005, EXP BRAIN RES, V160, P487, DOI 10.1007/s00221-004-2038-3; Gibson JJ, 1937, PSYCHOL REV, V44, P222, DOI 10.1037/h0061358; Heron J, 2010, EUR J NEUROSCI, V31, P1755, DOI 10.1111/j.1460-9568.2010.07194.x; HIRSH I J, 1964, Annee Psychol, V64, P1; Hock HS, 2010, SEEING PERCEIVING, V23, P173, DOI 10.1163/187847510X503597; Hock HS, 2005, SPATIAL VISION, V18, P317, DOI 10.1163/1568568054089393; Hock HS, 1997, PERCEPT PSYCHOPHYS, V59, P1077, DOI 10.3758/BF03205522; Kleinschmidt A, 2002, NEURON, V34, P659, DOI 10.1016/S0896-6273(02)00694-3; Kosem A, 2014, NEUROIMAGE, V92, P274, DOI 10.1016/j.neuroimage.2014.02.010; Kosem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040936; Kopinska A, 2004, PERCEPTION, V33, P1049, DOI 10.1068/p5169; Large ME, 2005, J NEUROPHYSIOL, V93, P3453, DOI 10.1152/jn.00934.2004; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Melloni L, 2011, J NEUROSCI, V31, P1386, DOI 10.1523/JNEUROSCI.4570-10.2011; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Muller T, 2014, ANN NY ACAD SCI, V1326, P60, DOI 10.1111/nyas.12545; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Noppeney U, 2008, CEREB CORTEX, V18, P598, DOI 10.1093/cercor/bhm091; Prinzmetal W, 1998, J EXP PSYCHOL HUMAN, V24, P261, DOI 10.1037/0096-1523.24.1.261; Roach NW, 2011, P ROY SOC B-BIOL SCI, V278, P1314, DOI 10.1098/rspb.2010.1737; Roseboom W, 2011, PSYCHOL SCI, V22, P872, DOI 10.1177/0956797611413293; Sanchez-Garcia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025198; Sato Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019377; Schwiedrzik CM, 2014, CEREB CORTEX, V24, P1152, DOI 10.1093/cercor/bhs396; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Stocker AA, 2005, J VIS, V5, P928, DOI [10.1167/5.8.928, DOI 10.1167/5.8.928]; Stromeyer CF., 1978, FORM COLOR AFTEREFFE, P97; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; van Wassenhove V, 2009, PHILOS T R SOC B, V364, P1815, DOI 10.1098/rstb.2009.0023; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Yamamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040379; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329; Zilber N, 2014, NEUROIMAGE, V93, P32, DOI 10.1016/j.neuroimage.2014.02.017	53	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119365	10.1371/journal.pone.0119365	http://dx.doi.org/10.1371/journal.pone.0119365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774653	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500085
J	Kim, JO; Song, DW; Kwon, EJ; Hong, SE; Song, HK; Min, CK; Kim, DH				Kim, Jin Ock; Song, Dong Woo; Kwon, Eun Jeong; Hong, Seong-Eui; Song, Hong Ki; Min, Choon Kee; Kim, Do Han			miR-185 Plays an Anti-Hypertrophic Role in the Heart via Multiple Targets in the Calcium-Signaling Pathways	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; GUINEA-PIG MYOCARDIUM; PROTEIN-KINASE-II; FACTOR 1 RECEPTOR; NA+-CA2+ EXCHANGER; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; IN-VITRO; MICRORNAS; FAILURE	MicroRNA (miRNA) is an endogenous non-coding RNA species that either inhibits RNA translation or promotes degradation of target mRNAs. miRNAs often regulate cellular signaling by targeting multiple genes within the pathways. In the present study, using Gene Set Analysis, a useful bioinformatics tool to identify miRNAs with multiple target genes in the same pathways, we identified miR-185 as a key candidate regulator of cardiac hypertrophy. Using a mouse model, we found that miR-185 was significantly down-regulated in myocardial cells during cardiac hypertrophy induced by transverse aortic constriction. To confirm that miR-185 is an anti-hypertrophic miRNA, genetic manipulation studies such as overexpression and knock-down of miR-185 in neonatal rat ventricular myocytes were conducted. The results showed that up-regulation of miR-185 led to anti-hypertrophic effects, while down-regulation led to pro-hypertrophic effects, suggesting that miR-185 has an anti-hypertrophic role in the heart. Our study further identified Camk2d, Ncx1, and Nfatc3 as direct targets of miR-185. The activity of Nuclear Factor of Activated T-cell (NFAT) and calcium/calmodulin-dependent protein kinase II delta (CaMKII delta) was negatively regulated by miR-185 as assessed by NFAT-luciferase activity and western blotting. The expression of phospho-phospholamban (Thr-17), a marker of CaMKII delta activity, was also significantly reduced by miR-185. In conclusion, miR-185 effectively blocked cardiac hypertrophy signaling through multiple targets, rendering it a potential drug target for diseases such as heart failure.	[Kim, Do Han] GIST, Sch Life Sci, Kwangju, South Korea; GIST, Syst Biol Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Kim, DH (corresponding author), GIST, Sch Life Sci, Kwangju, South Korea.	dhkim@gist.ac.kr		Kim, Jin Ock/0000-0002-5323-7808	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning [2013M3A9A7046297]	GIST Systems Biology Infrastructure Establishment Grant; National Research Foundation of Korea (NRF) - Korea Government, the Ministry of Science, ICT & Future Planning	This work was supported by the 2014 GIST Systems Biology Infrastructure Establishment Grant and the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2013M3A9A7046297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2014, J CLIN INVEST, V124, P2651, DOI 10.1172/JCI73579; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belkaya S, 2013, J BIOL CHEM, V288, P30752, DOI 10.1074/jbc.M113.503532; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252; Cha H, 2008, J MOL CELL CARDIOL, V45, P796, DOI 10.1016/j.yjmcc.2008.09.124; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; de la Morena MT, 2013, CLIN IMMUNOL, V147, P11, DOI 10.1016/j.clim.2013.01.011; Ding SL, 2011, WIRES RNA, V2, P124, DOI 10.1002/wrna.61; Dulce RA, 2006, J MOL CELL CARDIOL, V41, P807, DOI 10.1016/j.yjmcc.2006.05.016; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Gladka MM, 2012, J MOL CELL CARDIOL, V52, P74, DOI 10.1016/j.yjmcc.2011.09.015; Gray RP, 2001, PFLUG ARCH EUR J PHY, V442, P117, DOI 10.1007/s004240000512; Hagemann D, 2000, J BIOL CHEM, V275, P22532, DOI 10.1074/jbc.C000253200; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Knezevic I, 2012, J BIOL CHEM, V287, P12913, DOI 10.1074/jbc.M111.331751; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; Leite-Moreira AM, 2013, DRUG DISCOV TODAY, V18, P1243, DOI 10.1016/j.drudis.2013.07.025; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li QL, 2014, J CELL MOL MED, V18, P919, DOI 10.1111/jcmm.12242; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Liu M, 2011, CANCER LETT, V301, P151, DOI 10.1016/j.canlet.2010.11.009; Lu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024724; Luo M, 2013, SURGERY, V153, P836, DOI 10.1016/j.surg.2012.12.004; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Magee WP, 2003, AM J PHYSIOL-HEART C, V284, pH903, DOI 10.1152/ajpheart.00784.2002; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Namekata I, 2005, LIFE SCI, V77, P312, DOI 10.1016/j.lfs.2004.10.065; Oka T, 2008, CIRC J, V72, P1359, DOI 10.1253/circj.72.1359; Roos KP, 2007, J CARD FAIL, V13, P318, DOI 10.1016/j.cardfail.2007.01.004; Saito T, 2003, J MOL CELL CARDIOL, V35, P1153, DOI 10.1016/S0022-2828(03)00234-7; Shen K, 2012, BIOCHEM PHARMACOL, V84, P320, DOI 10.1016/j.bcp.2012.04.017; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Shimoyama M, 1999, CIRCULATION, V100, P2449, DOI 10.1161/01.CIR.100.24.2449; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Song DW, 2014, BIOCHEM J, V457, P151, DOI 10.1042/BJ20130833; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Verdonck F, 2003, CARDIOVASC RES, V57, P1035, DOI 10.1016/S0008-6363(02)00734-4; Wang CX, 2012, J CELL BIOCHEM, V113, P2040, DOI 10.1002/jcb.24075; Wang J, 2012, CELL RES, V22, P516, DOI 10.1038/cr.2011.132; Wang J, 2013, J BIOL CHEM, V288, P10418, DOI 10.1074/jbc.M112.444463; Wang Yaosheng, 2011, HEART, V97, pA49; Wang ZY, 2001, J BIOL CHEM, V276, P17706, DOI 10.1074/jbc.M100544200; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang Z, ONCOGENE IN PRESS	68	48	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0122509	10.1371/journal.pone.0122509	http://dx.doi.org/10.1371/journal.pone.0122509			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767890	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500148
J	Wei, WZ; Giessler, S; Wolinska, J; Ma, XL; Yang, Z; Hu, W; Yin, MB				Wei, Wenzhi; Giessler, Sabine; Wolinska, Justyna; Ma, Xiaolin; Yang, Zhong; Hu, Wei; Yin, Mingbo			Genetic Structure of Daphnia galeata Populations in Eastern China	PLOS ONE			English	Article							INTERSPECIFIC HYBRIDIZATION; SOFTWARE; DISPERSAL; CRUSTACEA; DIFFERENTIATION; COLONIZATION; EVOLUTIONARY; ZOOPLANKTON; DISTINCTION; DIVERSITY	This study presents the first examination of the genetic structure of Daphnia longispina complex populations in Eastern China. Only one species, D. galeata, was present across the eight investigated lakes; as identified by taxon assignment using allelic variation at 15 microsatellite loci. Three genetically differentiated D. galeata subgroups emerged independent of the type of statistical analysis applied. Thus, Bayesian clustering, discriminant analysis based on results from factorial correspondence analysis, and UPGMA clustering consistently showed that populations from two neighbouring lakes were genetically separated from a mixture of genotypes found in other lakes, which formed another two subgroups. Clonal diversity was high in all D. galeata populations, and most samples showed no deviation from Hardy-Weinberg equilibrium, indicating that clonal selection had little effect on the genetic diversity. Overall, populations did not cluster by geographical origin. Further studies will show if the observed pattern can be explained by natural colonization processes or by recent anthropogenic impact on predominantly artificial lakes.	[Wei, Wenzhi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Giessler, Sabine] Univ Munich, Dept Biol 2, Evolut Okol, Planegg Martinsried, Germany; [Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Berlin, Germany; [Ma, Xiaolin; Yang, Zhong; Hu, Wei; Yin, Mingbo] Fudan Univ, Sch Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Yangzhou University; University of Munich; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Fudan University	Yin, MB (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	yinm@fudan.edu.cn	Wolinska, Justyna/N-6455-2014; Yin, Mingbo/E-3677-2017	Yin, Mingbo/0000-0002-0742-5031	National Natural Science Foundation of China [31200284]; Priority Academic Program Development of Jiangsu Higher Education Institutions; German Science Foundation [WO 1587/4-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; German Science Foundation(German Research Foundation (DFG))	Funding: This research was funded by the National Natural Science Foundation of China grant to MY (31200284), the Priority Academic Program Development of Jiangsu Higher Education Institutions to WW, and the German Science Foundation grant to JW (WO 1587/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Belkhir K., 5000 CNRS UMR; Benzie JAH, 2005, CLADOCERA GENUS DAPH; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Brede N, 2006, MOL ECOL NOTES, V6, P536, DOI 10.1111/j.1471-8286.2005.01218.x; Brede N, 2009, P NATL ACAD SCI USA, V106, P4758, DOI 10.1073/pnas.0807187106; BROOKS JOHN L., 1957, MEM CONNECTICUT ACAD ARTS AND SCI, V13, P1; Caceres CE, 1998, OECOLOGIA, V115, P233, DOI 10.1007/s004420050512; Chao A., 2010, PROGRAM SPADE SPECIE; Chiang SC, 1979, FAUNA INCA; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356; DEMOTT WR, 1983, ECOL MONOGR, V53, P321, DOI 10.2307/1942534; Dlouha S, 2010, HYDROBIOLOGIA, V643, P107, DOI 10.1007/s10750-010-0128-8; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; EDMONDSON WT, 1982, LIMNOL OCEANOGR, V27, P272, DOI 10.4319/lo.1982.27.2.0272; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Figuerola J, 2005, AM NAT, V165, P274, DOI 10.1086/427092; FRYER G, 1985, ZOOL J LINN SOC-LOND, V84, P165, DOI 10.1111/j.1096-3642.1985.tb01797.x; Giessler S, 2001, HYDROBIOLOGIA, V442, P55, DOI 10.1023/A:1017504803506; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; Hebert PDN, 1988, MEMORIE I IDROBIOLOG, P439; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Keller B, 2008, PHILOS T R SOC B, V363, P2943, DOI 10.1098/rstb.2008.0044; Keller B, 2007, LIMNOL OCEANOGR, V52, P984, DOI 10.4319/lo.2007.52.3.0984; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Lampert W, 2011, DAPHNIA DEV MODEL OR; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; MORT MA, 1986, EVOLUTION, V40, P756, DOI 10.1111/j.1558-5646.1986.tb00535.x; MORT MA, 1985, HEREDITY, V55, P27, DOI 10.1038/hdy.1985.68; NEI M, 1974, GENETICS, V76, P379; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petrusek A, 2008, ZOOL SCR, V37, P507, DOI 10.1111/j.1463-6409.2008.00336.x; Petrusek A, 2007, FUND APPL LIMNOL, V169, P279, DOI 10.1127/1863-9135/2007/0169-0279; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Pijanowska J, 1996, J PLANKTON RES, V18, P1407, DOI 10.1093/plankt/18.8.1407; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rellstab C, 2011, LIMNOL OCEANOGR, V56, P292, DOI 10.4319/lo.2011.56.1.0292; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; SCHWENK K, 1995, EXPERIENTIA, V51, P465, DOI 10.1007/BF02143199; Schwenk K, 2000, P ROY SOC B-BIOL SCI, V267, P1833, DOI 10.1098/rspb.2000.1218; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Spaak P, 2012, P ROY SOC B-BIOL SCI, V279, P2936, DOI 10.1098/rspb.2012.0280; Stenberg P, 2003, MOL ECOL NOTES, V3, P329, DOI 10.1046/j.1471-8286.2003.00408.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thielsch A, 2012, MOL ECOL RESOUR, V12, P697, DOI 10.1111/j.1755-0998.2012.03142.x; Thielsch A, 2009, MOL ECOL, V18, P1616, DOI 10.1111/j.1365-294X.2009.04130.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WOLF HG, 1987, HYDROBIOLOGIA, V145, P213, DOI 10.1007/BF02530282; Yin MB, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-80; Yin MB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-12; Yin MB, 2010, MOL ECOL, V19, P4168, DOI 10.1111/j.1365-294X.2010.04807.x	58	8	8	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120168	10.1371/journal.pone.0120168	http://dx.doi.org/10.1371/journal.pone.0120168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768727	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500113
J	Yu, Q; Lou, XM; He, Y				Yu, Qing; Lou, Xiang-ming; He, Yan			Preferential Recruitment of Th17 Cells to Cervical Cancer via CCR6-CCL20 Pathway	PLOS ONE			English	Article							REGULATORY T-CELLS; HEPATOCELLULAR-CARCINOMA; PHENOTYPE; INFLAMMATION; GENERATION; RELEVANCE; ARTHRITIS; SURVIVAL; IMMUNITY; DISEASE	Our previous studies suggest that Th17 cells accumulate within tumor tissues and correlate with recurrence of cervical cancer patients. However, the source of the increased tumor-infiltrating Th17 cells remains poorly understood. We investigated the prevalence, phenotype and trafficking property of Th17 cells in patients with cervical cancer. Our results showed that Th17 cells highly aggregated within tumor tissues in an activated phenotype with markedly increased expression of CCR6. Correspondingly, level of CCL20 in the tumor tissues was significantly higher than that in non-tumor and normal control tissues, and strongly positively associated with Th17 cells. Further, in vitro migration assay showed CCL20 had effective chemotaxis to circulating Th17 cells. In conclusion, Th17 cells are recruited into tumor tissues preferentially through CCR6-CCL20 pathway, which can serve as a novel therapeutic target for cervical cancer.	[Yu, Qing; Lou, Xiang-ming] Hangzhou First Peoples Hosp, Hangzhou Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China; [He, Yan] Yiwu Matern & Child Care Hosp, Dept Pathol, Yiwu, Zhejiang, Peoples R China		Yu, Q (corresponding author), Hangzhou First Peoples Hosp, Hangzhou Obstet & Gynecol Hosp, Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China.	yuqing790226@163.com	yu, qing/HGC-4611-2022					Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chen DY, 2012, HUM IMMUNOL, V73, P1068, DOI 10.1016/j.humimm.2012.07.333; Chen DY, 2012, CELL IMMUNOL, V272, P166, DOI 10.1016/j.cellimm.2011.10.015; Chen KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024671; Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013; Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lee JJ, 2011, HEAD NECK-J SCI SPEC, V33, P1301, DOI 10.1002/hed.21607; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Maruyama T, 2010, CANCER SCI, V101, P1947, DOI 10.1111/j.1349-7006.2010.01624.x; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yu Q, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0795-1; Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	33	33	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120855	10.1371/journal.pone.0120855	http://dx.doi.org/10.1371/journal.pone.0120855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768730	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500137
J	Ano, Y; Kutsukake, T; Hoshi, A; Yoshida, A; Nakayama, H				Ano, Yasuhisa; Kutsukake, Toshiko; Hoshi, Ayaka; Yoshida, Aruto; Nakayama, Hiroyuki			Identification of a Novel Dehydroergosterol Enhancing Microglial Anti-Inflammatory Activity in a Dairy Product Fermented with Penicillium candidum	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MACROPHAGES; NEUROINFLAMMATION; INFLAMMATION; DEPOSITION; ORIGIN; CELLS; RISK; MICE; CNS	Despite the ever-increasing number of dementia patients worldwide, fundamental therapeutic approaches to treat this disease remain to be established. Preventive approaches such as diet, exercise and learning attract attention. Several epidemiological studies suggest that ingestion of fermented dairy products prevents cognitive decline in the elderly. These reports indicate that specific ingredients in the fermented dairy products elicit an anti-inflammatory or anti-oxidative activity that facilitates neuroprotection. The responsible components remain to be investigated. A number of studies have shown that inflammation caused by microglia is closely related to exaggeration of the pathology and cognitive decline seen in the elderly. Many researchers have proposed that controlling microglial activities could be effective in preventing and possibly curing dementia. In the present study, to elucidate specific compounds that regulate microglial activity from dairy products, repeated purification by HPLC, combined with evaluation using primary microglia, facilitated the identification of dehydroergosterol (DHE) as a novel component of the extract that enhances microglial anti-inflammatory activity. DHE contains three conjugated double bonds in a steroid ring system and is an analogue of ergosterol. Despite their related chemical structures, the anti-inflammatory activity of DHE is markedly stronger than that of ergosterol. P. candidum for camembert cheese produces DHE, but P. Roqueforti for blue cheese and Aspergillus do not. DHE also induces CD11b-positive microglia cells into CD206-positive M2 type microglia. Neurotoxicity and neuronal cell death induced by excessively activated microglia is suppressed by treatment with DHE. Thus, this is the first report to demonstrate that DHE, identified as a responsible compound in dairy products, can induce microglia into a preferable phenotype for our brain environment and can be safely introduced into the body by consumption of dairy products. We believe the uptake of DHE might help to prevent the onset of dementia.	[Ano, Yasuhisa; Kutsukake, Toshiko; Hoshi, Ayaka; Yoshida, Aruto] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan; [Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Ano, Y (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp			Kirin Company Ltd.	Kirin Company Ltd.	The authors received no specific funding for this work. Kirin Company Ltd. provided support in the form of salaries for authors Yasuhisa Ano, Toshiko Kutsukake, Ayaka Hoshi and Aruto Yoshida but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Crichton GE, 2010, ASIA PAC J CLIN NUTR, V19, P161; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Dumont M, 2011, FREE RADICAL BIO MED, V51, P1014, DOI 10.1016/j.freeradbiomed.2010.11.026; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Jiang ZL, 2014, IMMUNOL LETT, V160, P17, DOI 10.1016/j.imlet.2014.03.006; Li ZL, 2014, BRAIN BEHAV IMMUN, V38, P237, DOI 10.1016/j.bbi.2014.02.008; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; McIntosh A, 2008, LIPIDS, V43, P1185, DOI 10.1007/s11745-008-3194-1; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Naert G, 2011, CURR ALZHEIMER RES, V8, P151, DOI 10.2174/156720511795256035; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sugama Shuei, 2009, Inflammation & Allergy Drug Targets, V8, P277; Tachibana Y, 2006, YAKUGAKU ZASSHI, V126, P1139, DOI 10.1248/yakushi.126.1139; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; Weekman EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-127; Welberg L, 2014, NAT REV NEUROSCI, V15, DOI 10.1038/nrn3678; Wustner D, 2007, CHEM PHYS LIPIDS, V146, P1, DOI 10.1016/j.chemphyslip.2006.12.004	34	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116598	10.1371/journal.pone.0116598	http://dx.doi.org/10.1371/journal.pone.0116598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760331	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275000008
J	Strohecker, AM; Joshi, S; Possemato, R; Abraham, RT; Sabatini, D; White, E				Strohecker, A. M.; Joshi, S.; Possemato, R.; Abraham, R. T.; Sabatini, D. M.; White, E.			Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening	ONCOGENE			English	Article							ADVANCED SOLID TUMORS; PHASE-I TRIAL; SIRNA SCREEN; TARGETING AUTOPHAGY; PROTEIN-DEGRADATION; SELECTIVE AUTOPHAGY; HUNTINGTONS-DISEASE; BODY FORMATION; CELL-DEATH; CANCER	Deregulation of autophagy has been linked to multiple degenerative diseases and cancer, thus the identification of novel autophagy regulators for potential therapeutic intervention is important. To meet this need, we developed a high content image-based short hairpin RNA screen monitoring levels of the autophagy substrate p62/SQSTM1. We identified 186 genes whose loss caused p62 accumulation indicative of autophagy blockade, and 67 genes whose loss enhanced p62 elimination indicative of autophagy stimulation. One putative autophagy stimulator, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), drives flux through pentose phosphate pathway. Knockdown of PFKFB4 in prostate cancer cells increased p62 and reactive oxygen species (ROS), but surprisingly increased autophagic flux. Addition of the ROS scavenger N-acetyl cysteine prevented p62 accumulation in PFKFB4-depleted cells, suggesting that the upregulation of p62 and autophagy was a response to oxidative stress caused by PFKFB4 elimination. Thus, PFKFB4 suppresses oxidative stress and p62 accumulation, without which autophagy is stimulated likely as a ROS detoxification response.	[Strohecker, A. M.; Joshi, S.; White, E.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Strohecker, A. M.; Joshi, S.; White, E.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Strohecker, A. M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Strohecker, A. M.] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA; [Strohecker, A. M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Strohecker, A. M.] Ohio State Univ, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Strohecker, A. M.] Ohio State Univ, Richard J Solove Res Inst, Columbus, OH 43210 USA; [Possemato, R.; Sabatini, D. M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Possemato, R.; Sabatini, D. M.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Sabatini, D. M.] MIT, Dept Biol, Cambridge, MA USA; [Possemato, R.] NYU, Dept Pathol, New York, NY 10016 USA; [Abraham, R. T.] Pfizer, Oncol Res Unit, San Diego, CA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); New York University; Pfizer	White, E (corresponding author), Rutgers Canc Inst New Jersey, 195 Little Albany St, New Brunswick, NJ 08903 USA.	eileenpwhite@gmail.com	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065; Possemato, Richard/0000-0002-2401-0030; /0000-0002-1446-7256	NIH [R37 CA53370, RC1 CA147961, R01 CA163591, R01 CA130893]; Rutgers Cancer Institute of New Jersey [P30 CA072720]; Johnson Johnson; New Jersey Commission on Cancer Research [09-2406-CCR-E0, DFHS13PPCO24]; NATIONAL CANCER INSTITUTE [R01CA130893, R01CA163591, R37CA053370, P30CA072720, RC1CA147961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Cancer Institute of New Jersey; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); New Jersey Commission on Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Komatsu (conditional Atg7 mice) and Z Yue (Beclin1<SUP>+/-</SUP>) for mice and T Yoshimori for providing the ptf-LC3 plasmid. We also thank the staff of the Genetic Perturbation Platform of the Broad Institute (formerly the RNAi Platform) particularly S Silver and O Alkan for assistance with execution and analysis of screen data, The Genome Core of the Whitehead Institute for assistance with the Arrayscan, A Roberts for fluorescence-activated cell sorting (FACS) analysis, P Chin for technical assistance and members of the White and Sabatini laboratories for helpful discussions. This work was supported by NIH grants R37 CA53370, RC1 CA147961, R01 CA163591, R01 CA130893, the Rutgers Cancer Institute of New Jersey (P30 CA072720), Johnson & Johnson, and a gift to DMS and EW from Pfizer. AMS and SJ were supported by postdoctoral fellowships from the New Jersey Commission on Cancer Research (09-2406-CCR-E0 to AMS, DFHS13PPCO24 to SJ).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Bernardi P, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011387; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Fallon L, 2002, J BIOL CHEM, V277, P486, DOI 10.1074/jbc.M109806200; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Goidts V, 2012, ONCOGENE, V31, P3235, DOI 10.1038/onc.2011.490; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; He PF, 2009, AUTOPHAGY, V5, P52, DOI 10.4161/auto.5.1.7247; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huo YY, 2013, CANCER DISCOV, V3, P894, DOI 10.1158/2159-8290.CD-13-0011; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jeon YK, 2011, BBA-PROTEINS PROTEOM, V1814, P1340, DOI 10.1016/j.bbapap.2011.05.015; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Law BYK, 2010, MOL CANCER THER, V9, P718, DOI 10.1158/1535-7163.MCT-09-0700; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li L, 2013, J BIOL CHEM, V288, P703, DOI 10.1074/jbc.C112.396903; Li LJ, 2013, CANCER CELL, V24, P738, DOI 10.1016/j.ccr.2013.10.025; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Mahalingam D, 2014, AUTOPHAGY, V10, P1403, DOI 10.4161/auto.29231; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; McKnight NC, 2012, EMBO J, V31, P1931, DOI 10.1038/emboj.2012.36; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Minchenko OH, 2005, BIOCHIMIE, V87, P1005, DOI 10.1016/j.biochi.2005.04.007; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; Ros S, 2012, CANCER DISCOV, V2, P328, DOI 10.1158/2159-8290.CD-11-0234; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shanmugam M, 2009, J BIOL CHEM, V284, P26816, DOI 10.1074/jbc.M109.000646; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Szyniarowski P, 2011, AUTOPHAGY, V7, P892, DOI 10.4161/auto.7.8.15770; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; Warmoes MO, 2014, BIOCHEM PHARMACOL, V92, P12, DOI 10.1016/j.bcp.2014.07.019; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang Z, 2014, AUTOPHAGY, V10, P382, DOI 10.4161/auto.27345; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	97	41	41	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 5	2015	34	45					5662	5676		10.1038/onc.2015.23	http://dx.doi.org/10.1038/onc.2015.23			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CV9GA	25772235	Green Submitted, Green Accepted			2022-12-26	WOS:000364594300007
J	Liu, C; Tan, FCK; Xiao, ZC; Dawe, GS				Liu, Chao; Tan, Francis Chee Kuan; Xiao, Zhi-Cheng; Dawe, Gavin S.			Amyloid Precursor Protein Enhances Nav1.6 Sodium Channel Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein (APP); JNK; G Protein; Membrane Protein; Sodium Channel; Trafficking; Duolink; G(o) Protein; Nav1; 6 Sodium Channels; Cell Surface Expression	N-TERMINAL KINASE; CYTOPLASMIC DOMAIN; EPILEPTIC ENCEPHALOPATHY; SCN8A; NA(V)1.6; PHOSPHORYLATION; NEURONS; MUTATION; MICE; G(O)	Background: Loss-of-function amyloid precursor protein (APP) and Nav1.6 transgenic mice share similar phenotypes. Results: APP interacts with Nav1.6 and enhances its cell surface expression through a G(o)-coupled JNK pathway. Conclusion: APP regulates Nav1.6 function, likely through a G(o)-coupled JNK pathway. Significance: This finding advances the current understanding of APP functions and has implications for novel therapies for neurodegenerative disorders. Amyloid precursor protein (APP) is commonly associated with Alzheimer disease, but its physiological function remains unknown. Nav1.6 is a key determinant of neuronal excitability in vivo. Because mouse models of gain of function and loss of function of APP and Nav1.6 share some similar phenotypes, we hypothesized that APP might be a candidate molecule for sodium channel modulation. Here we report that APP colocalized and interacted with Nav1.6 in mouse cortical neurons. Knocking down APP decreased Nav1.6 sodium channel currents and cell surface expression. APP-induced increases in Nav1.6 cell surface expression were G(o) protein-dependent, enhanced by a constitutively active G(o) protein mutant, and blocked by a dominant negative G(o) protein mutant. APP also regulated JNK activity in a G(o) protein-dependent manner. JNK inhibition attenuated increases in cell surface expression of Nav1.6 sodium channels induced by overexpression of APP. JNK, in turn, phosphorylated APP. Nav1.6 sodium channel surface expression was increased by T668E and decreased by T668A, mutations of APP695 mimicking and preventing Thr-668 phosphorylation, respectively. Phosphorylation of APP695 at Thr-668 enhanced its interaction with Nav1.6. Therefore, we show that APP enhances Nav1.6 sodium channel cell surface expression through a G(o)-coupled JNK pathway.	[Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Neurobiol & Ageing Programme, Inst Life Sci, Singapore 117456, Singapore; [Liu, Chao; Tan, Francis Chee Kuan; Dawe, Gavin S.] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, Singapore 117456, Singapore; [Xiao, Zhi-Cheng] Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Peoples R China; [Xiao, Zhi-Cheng] Monash Univ, Dept Anat & Dev Biol, Shunxi Monash Immune Regenerat & Neurosci Lab, Melbourne, Vic 3800, Australia	National University of Singapore; National University of Singapore; National University of Singapore; Kunming Medical University; Monash University	Xiao, ZC (corresponding author), Kunming Med Coll, Inst Mol & Clin Med, Key Lab Stem Cell & Regenerat Med, Kunming 650031, Peoples R China.	zhicheng.xiao@monash.edu; gavindawe@nus.edu.sg	Liu, Chao/AAL-6454-2021	Dawe, Gavin/0000-0001-6119-701X; xiao, zhicheng/0000-0001-5172-762X; Tan, Francis Chee Kuan/0000-0002-5272-9990	National Medical Research Council, Ministry of Health, Singapore; NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre [NMRC/CG/013/2013]; Monash University, Australia; Talent Program of Yunnan Province, China;  [NMRC/1059/2006]	National Medical Research Council, Ministry of Health, Singapore(National Medical Research Council, Singapore); NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre; Monash University, Australia(Monash University); Talent Program of Yunnan Province, China; 	This work was supported by the National Medical Research Council, Ministry of Health, Singapore with NMRC NUHS Centre Grant-Memory, Aging, and Cognition Centre Seed Funding, NMRC/CG/013/2013 (to G. S. D.) and in collaboration with Z. C. X. (Grant NMRC/1059/2006). This work was also supported by grants from the Professorial Fellowship of Monash University, Australia, and by the Talent Program of Yunnan Province, China (to Z. C. X.).	Aman TK, 2007, BIOPHYS J, V92, P1938, DOI 10.1529/biophysj.106.093500; Aplin AE, 1996, J NEUROCHEM, V67, P699; Biffi E, 2012, BIOTECHNOL BIOENG, V109, P166, DOI 10.1002/bit.23310; Black JA, 2012, EXP NEUROL, V234, P302, DOI 10.1016/j.expneurol.2011.09.030; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brouillet E, 1999, J NEUROSCI, V19, P1717; Burbidge SA, 2002, MOL BRAIN RES, V103, P80, DOI 10.1016/S0169-328X(02)00188-2; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gullberg M., 2010, NAT METHODS, DOI [10.1038/nmeth.f.1306, DOI 10.1038/NMETH.F.1306]; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hashimoto Y, 2003, J NEUROCHEM, V84, P864, DOI 10.1046/j.1471-4159.2003.01585.x; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; ICHIKAWA M, 1993, NEUROSCI RES, V16, P95, DOI 10.1016/0168-0102(93)90076-3; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Komwatana P, 1996, P NATL ACAD SCI USA, V93, P8107, DOI 10.1073/pnas.93.15.8107; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lee A, 2009, CHANNELS, V3, P171, DOI 10.4161/chan.3.3.8854; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Liu C, 2010, TRAFFIC, V11, P405, DOI 10.1111/j.1600-0854.2009.01027.x; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lu T, 1999, J PHYSIOL-LONDON, V518, P371, DOI 10.1111/j.1469-7793.1999.0371p.x; Ma JY, 1997, NEURON, V19, P443, DOI 10.1016/S0896-6273(00)80952-6; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Meisler MH, 2004, GENETICA, V122, P37, DOI 10.1007/s10709-004-1441-9; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; O'Brien Janelle E., 2013, Frontiers in Genetics, V4, P213, DOI 10.3389/fgene.2013.00213; O'Brien JE, 2012, J BIOL CHEM, V287, P18459, DOI 10.1074/jbc.M111.336024; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Sharkey LM, 2009, J NEUROSCI, V29, P2733, DOI 10.1523/JNEUROSCI.6026-08.2009; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Standen CL, 2001, J NEUROCHEM, V76, P316, DOI 10.1046/j.1471-4159.2001.00102.x; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Veeraraghavalu K, 2014, J NEUROSCI, V34, P3668, DOI 10.1523/JNEUROSCI.5079-13.2014; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Xu DE, 2014, CELL ADHES MIGR, V8, P396, DOI 10.4161/cam.28802; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	61	18	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12048	12057		10.1074/jbc.M114.617092	http://dx.doi.org/10.1074/jbc.M114.617092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25767117	Green Published, hybrid			2022-12-26	WOS:000354388600020
J	Moon, C; Zhang, WQ; Ren, AX; Arora, K; Sinha, C; Yarlagadda, S; Woodrooffe, K; Schuetz, JD; Valasani, KR; de Jonge, HR; Shanmukhappa, SK; Shata, MTM; Buddington, RK; Parthasarathi, K; Naren, AP				Moon, Changsuk; Zhang, Weiqiang; Ren, Aixia; Arora, Kavisha; Sinha, Chandrima; Yarlagadda, Sunitha; Woodrooffe, Koryse; Schuetz, John D.; Valasani, Koteswara Rao; de Jonge, Hugo R.; Shanmukhappa, Shiva Kumar; Shata, Mohamed Tarek M.; Buddington, Randal K.; Parthasarathi, Kaushik; Naren, Anjaparavanda P.			Compartmentalized Accumulation of cAMP near Complexes of Multidrug Resistance Protein 4 (MRP4) and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Contributes to Drug-induced Diarrhea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; IN-VITRO; CONFERS RESISTANCE; SMALL-INTESTINE; IRINOTECAN; CAMPTOTHECINS; MECHANISMS; TRANSPORT; CULTURES; EFFLUX	Diarrhea is one of the most common adverse side effects observed in similar to 7% of individuals consuming Food and Drug Administration (FDA)-approved drugs. The mechanism of how these drugs alter fluid secretion in the gut and induce diarrhea is not clearly understood. Several drugs are either substrates or inhibitors of multidrug resistance protein 4 (MRP4), such as the anti-colon cancer drug irinotecan and an anti-retroviral used to treat HIV infection, 3'-azido-3'-deoxythymidine (AZT). These drugs activate cystic fibrosis transmembrane conductance regulator (CFTR)-mediated fluid secretion by inhibiting MRP4-mediated cAMP efflux. Binding of drugs to MRP4 augments the formation of MRP4-CFTR-containing macromolecular complexes that is mediated via scaffolding protein PDZK1. Importantly, HIV patients on AZT treatment demonstrate augmented MRP4-CFTR complex formation in the colon, which defines a novel paradigm of drug-induced diarrhea.	[Moon, Changsuk; Arora, Kavisha; Yarlagadda, Sunitha; Woodrooffe, Koryse; Shanmukhappa, Shiva Kumar; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Moon, Changsuk; Zhang, Weiqiang; Ren, Aixia; Arora, Kavisha; Sinha, Chandrima; Yarlagadda, Sunitha; Parthasarathi, Kaushik; Naren, Anjaparavanda P.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA; [Zhang, Weiqiang] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN 38163 USA; [Ren, Aixia] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Valasani, Koteswara Rao] Univ Kansas, Dept Pharmacol & Toxicol, Sch Pharm, Lawrence, KS 66047 USA; [Valasani, Koteswara Rao] Univ Kansas, Higuchi Biosci Ctr, Sch Pharm, Lawrence, KS 66047 USA; [de Jonge, Hugo R.] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-3000 CA Rotterdam, Netherlands; [Shata, Mohamed Tarek M.] Univ Cincinnati, Med Ctr, Div Digest Dis, Cincinnati, OH 45267 USA; [Buddington, Randal K.] Univ Memphis, Dept Hlth & Sport Sci, Memphis, TN 38152 USA	Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Kansas; University of Kansas; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; University of Cincinnati; University of Memphis	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Pediat, 3333 Burnet Ave,S-6322, Cincinnati, OH 45229 USA.	anaren@cchmc.org	Buddington, Randal/ABH-2011-2021; Regan, Clinton/E-6250-2012; Schuetz, John D/N-2692-2018; Shata, Mohamed/ABB-3392-2021	Shata, Mohamed Tarek/0000-0003-1907-0570; Buddington, Randal/0000-0001-5790-0593	National Institutes of Health [DK080834, DK093045, GM060904]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK080834, R01DK093045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060904, R56GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grants DK080834 and DK093045 (to A. P. N.) and GM060904 (to J. D. S.).	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Blandizzi C, 2001, TOXICOL APPL PHARM, V177, P149, DOI 10.1006/taap.2001.9293; Blandizzi C, 2001, BRIT J PHARMACOL, V132, P73, DOI 10.1038/sj.bjp.0703766; Chassany O, 2000, DRUG SAFETY, V22, P53, DOI 10.2165/00002018-200022010-00005; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dallas S, 2004, J PHARMACOL EXP THER, V309, P1221, DOI 10.1124/jpet.103.063966; Damu AG, 1998, PHYTOCHEMISTRY, V49, P1811, DOI 10.1016/S0031-9422(98)00342-2; Kool M, 1997, CANCER RES, V57, P3537; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Leggas M, 2004, MOL CELL BIOL, V24, P7612, DOI 10.1128/MCB.24.17.7612-7621.2004; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Liu JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1492, DOI 10.1152/ajpcell.00392.2011; Maroun J A, 2007, Curr Oncol, V14, P13, DOI 10.3747/co.2007.96; McCracken KW, 2011, NAT PROTOC, V6, P1920, DOI 10.1038/nprot.2011.410; Nieto N, 2000, DIGEST DIS SCI, V45, P2044, DOI 10.1023/A:1005603019800; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; PAVLOV O G, 1987, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V73, P517; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pizzolato JF, 2003, LANCET, V361, P2235, DOI 10.1016/S0140-6736(03)13780-4; Ratnaike RN, 1998, DRUG AGING, V13, P245, DOI 10.2165/00002512-199813030-00007; Ren AX, 2012, DIGEST DIS SCI, V57, P99, DOI 10.1007/s10620-011-1821-9; Riedl KM, 2001, J AGR FOOD CHEM, V49, P4917, DOI 10.1021/jf010683h; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schaaf LJ, 2006, CLIN CANCER RES, V12, P3782, DOI 10.1158/1078-0432.CCR-05-2152; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sparreboom A, 1998, CLIN CANCER RES, V4, P2747; Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Tian Q, 2005, PHARM RES-DORDR, V22, P1837, DOI 10.1007/s11095-005-7595-z; Vilar S, 2008, J COMPUT CHEM, V29, P2613, DOI 10.1002/jcc.21016; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Zeng WZ, 1997, AM J PHYSIOL-CELL PH, V273, pC442, DOI 10.1152/ajpcell.1997.273.2.C442	40	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11246	11257		10.1074/jbc.M114.605410	http://dx.doi.org/10.1074/jbc.M114.605410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25762723	Green Published, hybrid			2022-12-26	WOS:000353719400004
J	Li, PY; Chen, XL; Ji, P; Li, CY; Wang, P; Zhang, Y; Xie, BB; Qin, QL; Su, HN; Zhou, BC; Zhang, YZ; Zhang, XY				Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying			Interdomain Hydrophobic Interactions Modulate the Thermostability of Microbial Esterases from the Hormone-Sensitive Lipase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; THERMOPHILIC ESTERASE; SEQUENCE SIMILARITY; FUNCTIONAL-ANALYSIS; BACTERIAL HOMOLOG; SUBFAMILY; CARBOXYLESTERASE; ACIDOCALDARIUS; STABILITY; RESIDUES	Microbial hormone-sensitive lipases (HSLs) contain a CAP domain and a catalytic domain. However, it remains unclear how the CAP domain interacts with the catalytic domain to maintain the stability of microbial HSLs. Here, we isolated an HSL esterase, E40, from a marine sedimental metagenomic library. E40 exhibited the maximal activity at 45 degrees C and was quite thermolabile, with a half-life of only 2 min at 40 degrees C, which may be an adaptation of E40 to the permanently cold sediment environment. The structure of E40 was solved to study its thermolability. Structural analysis showed that E40 lacks the interdomain hydrophobic interactions between loop 1 of the CAP domain and alpha 7 of the catalytic domain compared with its thermostable homologs. Mutational analysis showed that the introduction of hydrophobic residues Trp(202) and Phe(203) in alpha 7 significantly improved E40 stability and that a further introduction of hydrophobic residues in loop 1 made E40 more thermostable because of the formation of interdomain hydrophobic interactions. Altogether, the results indicate that the absence of interdomain hydrophobic interactions between loop 1 and alpha 7 leads to the thermolability of E40. In addition, a comparative analysis of the structures of E40 and other thermolabile and thermostable HSLs suggests that the interdomain hydrophobic interactions between loop 1 and alpha 7 are a key element for the thermostability of microbial HSLs. Therefore, this study not only illustrates the structural element leading to the thermolability of E40 but also reveals a structural determinant for HSL thermostability.	[Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Li, Ping-Yi; Chen, Xiu-Lan; Ji, Peng; Li, Chun-Yang; Wang, Peng; Zhang, Yi; Xie, Bin-Bin; Qin, Qi-Long; Su, Hai-Nan; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Zhang, XY (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangxiying@sdu.edu.cn	WANG, Peng/GSN-5263-2022	Li, Chun-Yang/0000-0002-1151-4897; Zhang, Yu-Zhong/0000-0002-2017-1005	National Natural Science Foundation of China [91228210, 31290230, 31290231, 31170055, 91328208]; Hi-Tech Research and Development Program of China [2012AA092103]; China Ocean Mineral Resources R&D Association Special Foundation [DY125-15-T-05]; Fundamental Research Funds of Shandong University [2014QY006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R&D Association Special Foundation; Fundamental Research Funds of Shandong University	This work was supported by National Natural Science Foundation of China Grants 91228210, 31290230, 31290231, 31170055, and 91328208; Hi-Tech Research and Development Program of China Grant 2012AA092103; China Ocean Mineral Resources R&D Association Special Foundation Grant DY125-15-T-05; and Fundamental Research Funds of Shandong University Grant 2014QY006.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; De Simone G, 2000, J MOL BIOL, V303, P761, DOI 10.1006/jmbi.2000.4195; De Simone G, 2004, J BIOL CHEM, V279, P6815, DOI 10.1074/jbc.M307738200; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; Dou S, 2014, BIOCHEM BIOPH RES CO, V446, P1145, DOI 10.1016/j.bbrc.2014.03.072; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jensen LH, 1997, METHOD ENZYMOL, V277, P353, DOI 10.1016/S0076-6879(97)77020-4; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Ma BD, 2013, BIORESOURCE TECHNOL, V133, P354, DOI 10.1016/j.biortech.2013.01.089; Manco G, 2000, ARCH BIOCHEM BIOPHYS, V373, P182, DOI 10.1006/abbi.1999.1497; Manco G, 1998, BIOCHEM J, V332, P203, DOI 10.1042/bj3320203; Manco G, 2001, J BIOL CHEM, V276, P37482, DOI 10.1074/jbc.M103017200; Mandrich L, 2005, J MOL BIOL, V345, P501, DOI 10.1016/j.jmb.2004.10.035; Mandrich L, 2008, PROTEINS, V71, P1721, DOI 10.1002/prot.21877; Nam KH, 2009, PROTEINS, V74, P1036, DOI 10.1002/prot.22313; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; Ohara K, 2014, J BIOL CHEM, V289, P24499, DOI 10.1074/jbc.M113.521856; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pezzullo M, 2013, PROTEIN ENG DES SEL, V26, P47, DOI 10.1093/protein/gzs066; Rhee JK, 2006, APPL ENVIRON MICROB, V72, P3021, DOI 10.1128/AEM.72.4.3021-3025.2006; Suzuki Y, 2004, FEMS MICROBIOL LETT, V236, P97, DOI 10.1016/j.femsle.2004.05.026; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Xia YZ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1189; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	37	51	51	0	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11188	11198		10.1074/jbc.M115.646182	http://dx.doi.org/10.1074/jbc.M115.646182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25771540	hybrid, Green Published			2022-12-26	WOS:000353404500051
J	Li, TL; Su, L; Lei, YJ; Liu, XF; Zhang, YJ; Liu, XG				Li, Tianliang; Su, Ling; Lei, Yuanjiu; Liu, Xianfang; Zhang, Yajing; Liu, Xiangguo			DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH RECEPTOR 5; NF-KAPPA-B; CCAAT/ENHANCER-BINDING PROTEIN; TRAIL-INDUCED APOPTOSIS; HOMOLOGOUS PROTEIN; CARCINOMA-CELLS; UP-REGULATION; DR5 EXPRESSION; CHOP; TRANSCRIPTION	TNFRSF10A and TNFRSF10B are cell surface receptors that bind to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and mediate the extrinsic pathway of apoptosis. However, the mechanisms of transcriptional regulation of TNFRSF10A and TNFRSF10B remain largely uncharacterized. In this study, two putative DDIT3 binding sites (-1636/-1625; -374/-364) and a putative AP-1 binding site (-304/-298) were identified in the TNFRSF10A promoter region. We found that DDIT3 interacts with phospho-JUN, and the DDIT3-phospho-JUN complex binds to the AP-1 binding site (-304/-298) within the TNFRSF10A promoter region. In addition, we confirmed that KAT2A physically interacts with the N-terminal region (amino acids 1-26) of DDIT3. Importantly, knockdown of KAT2A down-regulated TNFRSF10A and TNFRSF10B and dramatically decreased promoter activity of cells transfected with luciferase reporter plasmid containing the AP-1 binding site (-304/-298) of the TNFRSF10A promoter, as well as cells transfected with luciferase reporter plasmid containing DDIT3 binding site (-276/- 264) of the TNFRSF10B promoter. ChIP results suggest that KAT2 A may participate in a KAT2A center dot DDIT3 center dot phospho-JUN complex, or may participate in a KAT2A center dot DDIT3 complex and acetylate H3K9/K14, respectively. Moreover, we verified that TNFRSF10A mediates apoptosis triggered by endoplasmic reticulum stress in human lung cancer cells. Collectively, we demonstrate that DDIT3 and KAT2A cooperatively up-regulate TNFRSF10A and TNFRSF10B. Our findings highlight novel mechanisms underlying endoplasmic reticulum stress-induced TNFRSF10A and TNFRSF10B expressions and apoptosis. These findings will be helpful for elucidating mechanisms related to anticancer drugs in mediating apoptosis.	[Li, Tianliang; Su, Ling; Lei, Yuanjiu; Liu, Xianfang; Zhang, Yajing; Liu, Xiangguo] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China	Shandong University	Liu, XG (corresponding author), Shandong Univ, Sch Life Sci, Rm 103,South Bldg,27 Shanda South Rd, Jinan 250100, Peoples R China.	xgliu@sdu.edu.cn	Liu, Xiangguo/G-1091-2010	Liu, Xiangguo/0000-0002-1879-3817; Lei, Yuanjiu/0000-0002-7486-4261; Su, Ling/0000-0001-7008-0550	National Natural Science Foundation of China [31371402, 31171332, 81472686, 30971479]; National Key Basic Research Program of China [2013CB910900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (31371402, 31171332, 81472686, 30971479), National Key Basic Research Program of China (2013CB910900, project 3).	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Guan BX, 2002, ONCOGENE, V21, P3121, DOI 10.1038/sj.onc.1205430; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jin XH, 2007, J UROLOGY, V177, P1894, DOI 10.1016/j.juro.2007.01.018; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Lee BS, 2013, ENDOCR-RELAT CANCER, V20, P283, DOI 10.1530/ERC-12-0405; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lim JH, 2009, CARCINOGENESIS, V30, P729, DOI 10.1093/carcin/bgn265; Liu GB, 2012, J CELL MOL MED, V16, P1618, DOI 10.1111/j.1582-4934.2011.01401.x; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Marmorstein R, 2001, J MOL BIOL, V311, P433, DOI 10.1006/jmbi.2001.4859; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Mendoza FJ, 2008, APOPTOSIS, V13, P756, DOI 10.1007/s10495-008-0210-0; Miyagi Satoru, 2011, Rinsho Ketsueki, V52, P490; Ohoka N, 2007, J BIOL CHEM, V282, P35687, DOI 10.1074/jbc.M703735200; Pino SC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005468; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tsai JY, 2010, ONCOL REP, V24, P1169, DOI 10.3892/or_00000969; Ubeda M, 1996, MOL CELL BIOL, V16, P1479; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Verfaillie T, 2013, CANCER LETT, V332, P249, DOI 10.1016/j.canlet.2010.07.016; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang A, 2010, CURR OPIN CELL BIOL, V22, P837, DOI 10.1016/j.ceb.2010.08.001; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yoshida T, 2007, ONCOL REP, V18, P1239; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	51	61	62	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11108	11118		10.1074/jbc.M115.645333	http://dx.doi.org/10.1074/jbc.M115.645333			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25770212	Green Published, hybrid			2022-12-26	WOS:000353404500045
J	Liang, J; Suhandynata, RT; Zhou, HL				Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin			Phosphorylation of Sae2 Mediates Forkhead-associated (FHA) Domain-specific Interaction and Regulates Its DNA Repair Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; BUDDING YEAST SAE2; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINT; GENOME REARRANGEMENTS; END RESECTION; ATM; PROTEIN; RAD53; MEC1	Saccharomyces cerevisiae Sae2 and its ortholog CtIP in higher eukaryotes have a conserved role in the initial processing of DNA lesions and influencing their subsequent repair pathways. Sae2 is phosphorylated by the ATR/ATM family kinases Mec1 and Tel1 in response to DNA damage. Among the Mec1/Tel1 consensus phosphorylation sites of Sae2, we found that mutations of Thr-90 and Thr-279 of Sae2 into alanine caused a persistent Rad53 activation in response to a transient DNA damage, similar to the loss of Sae2. To gain insight into the function of this phosphorylation of Sae2, we performed a quantitative proteomics analysis to identify its associated proteins. We found that phosphorylation of Thr-90 of Sae2 mediates its interaction with Rad53, Dun1, Xrs2, Dma1, and Dma2, whereas Rad53 and Dun1 additionally interact with phosphorylated Thr-279 of Sae2. Mutations of the ligand-binding residues of Forkhead-associated (FHA) domains of Rad53, Dun1, Xrs2, Dma1, and Dma2 abolished their interactions with Sae2, revealing the involvement of FHA-specific interactions. Mutations of Thr-90 and Thr-279 of Sae2 caused a synergistic defect when combined with sgs1 Delta and exo1 Delta and elevated gross chromosomal rearrangements. Likewise, mutations of RAD53 and DUN1 caused a synthetic growth defect with sgs1 Delta and elevated gross chromosomal rearrangements. These findings suggest that threonine-specific phosphorylation of Sae2 by Mec1 and Tel1 contributes to DNA repair and genome maintenance via its interactions with Rad53 and Dun1.	[Liang, Jason; Suhandynata, Raymond T.; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Liang, Jason; Zhou, Huilin] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu	Regan, Clinton/E-6250-2012	Liang, Jason/0000-0001-8742-8824; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [GM080469]; Ludwig Cancer Research; National Institutes of Health, NCI [T32 CA009523]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Research; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080469 (to H. Z. and R. S.). This work was also supported by Ludwig Cancer Research (to H. Z. and R. S.).; Supported by National Institutes of Health, NCI, Training Grant T32 CA009523.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bashkirov VI, 2003, MOL CELL BIOL, V23, P1441, DOI 10.1128/MCB.23.4.1441-1452.2003; Brush GS, 1996, P NATL ACAD SCI USA, V93, P15075, DOI 10.1073/pnas.93.26.15075; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Chen SH, 2007, J BIOL CHEM, V282, P986, DOI 10.1074/jbc.M609322200; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Craven RJ, 2002, GENETICS, V161, P493; Deng CC, 2005, GENETICS, V170, P591, DOI 10.1534/genetics.104.028795; Dodson GE, 2010, CELL CYCLE, V9, P1516, DOI 10.4161/cc.9.8.11260; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Fu Q, 2014, MOL CELL BIOL, V34, P778, DOI 10.1128/MCB.00963-13; Gatei M, 2000, NAT GENET, V25, P115, DOI 10.1038/75508; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Li S, 2000, NATURE, V406, P210, DOI 10.1038/35018134; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Peterson SE, 2013, MOL CELL, V49, P657, DOI 10.1016/j.molcel.2012.11.020; Putnam CD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004277; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Vialard JE, 1998, EMBO J, V17, P5679, DOI 10.1093/emboj/17.19.5679; Wang HL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003277; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	44	23	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10751	10763		10.1074/jbc.M114.625293	http://dx.doi.org/10.1074/jbc.M114.625293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762720	hybrid, Green Published			2022-12-26	WOS:000353404500017
J	Vaque, JP; Martinez, N; Varela, I; Fernandez, F; Mayorga, M; Derdak, S; Beltran, S; Moreno, T; Almaraz, C; De las Heras, G; Bayes, M; Gut, I; Crespo, J; Piris, MA				Vaque, Jose P.; Martinez, Nerea; Varela, Ignacio; Fernandez, Fidel; Mayorga, Marta; Derdak, Sophia; Beltran, Sergi; Moreno, Thaidy; Almaraz, Carmen; De las Heras, Gonzalo; Bayes, Monica; Gut, Ivo; Crespo, Javier; Piris, Miguel A.			Colorectal Adenomas Contain Multiple Somatic Mutations That Do Not Coincide with Synchronous Adenocarcinoma Specimens	PLOS ONE			English	Article							HUMAN COLON; GENOME; CANCER; ALIGNMENT; PROTEIN	We have performed a comparative ultrasequencing study of multiple colorectal lesions obtained simultaneously from four patients. Our data show that benign lesions (adenomatous or hyperplastic polyps) contain a high mutational load. Additionally multiple synchronous colorectal lesions show non overlapping mutational signatures highlighting the degree of heterogeneity between multiple specimens in the same patient. Observations in these cases imply that considering not only the number of mutations but an effective oncogenic combination of mutations can determine the malignant progression of colorectal lesions.	[Vaque, Jose P.; Martinez, Nerea; Almaraz, Carmen; Piris, Miguel A.] Inst Invest Marques de Valdecilla, IDIVAL, Canc Genom Grp, Santander, Spain; [Varela, Ignacio; Moreno, Thaidy] IBBTEC UC CSIC SODERCAN Inst Biomed & Biotecnol C, Santander, Spain; [Fernandez, Fidel; Mayorga, Marta; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain; [Derdak, Sophia; Beltran, Sergi; Bayes, Monica; Gut, Ivo] CNAG, Barcelona, Spain; [De las Heras, Gonzalo; Crespo, Javier] Hosp Univ Marques de Valdecilla, Gastroenterol & Hepatol Unit, Santander, Spain; [Crespo, Javier] IFIMAV, Infect Immun & Digest Pathol Grp, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV)	Vaque, JP (corresponding author), Inst Invest Marques de Valdecilla, IDIVAL, Canc Genom Grp, Santander, Spain.	jpvaque@idival.org	Magunacelaya, Nerea Martinez/M-5040-2016; Gut, Ivo/ABF-3188-2020; Varela, Ignacio/G-1699-2016; Beltran, Sergi/I-3408-2015; Varela, Ignacio/AAA-7680-2021; Piris, Miguel A/B-7067-2008; Vaqué, José P/H-8413-2015; Piris, Miguel A/AAP-1445-2020	Magunacelaya, Nerea Martinez/0000-0002-3983-0867; Gut, Ivo/0000-0001-7219-632X; Varela, Ignacio/0000-0002-0969-506X; Beltran, Sergi/0000-0002-2810-3445; Varela, Ignacio/0000-0002-0969-506X; Piris, Miguel A/0000-0001-5839-3634; Vaqué, José P/0000-0002-3913-2495; Piris, Miguel A/0000-0001-5839-3634; Moreno Rodriguez, Thaidy/0000-0003-3588-3889; Crespo, Javier/0000-0001-8248-0172	isciii, FEDER [PI12/00357]; Grant Fundacion Aecc; Grant SODERCAN-Gobierno de Cantabria; Spanish "Ministerio de Ciencia e Innovacion" (RETICS) [SAF2008-03871]; Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal	isciii, FEDER; Grant Fundacion Aecc; Grant SODERCAN-Gobierno de Cantabria; Spanish "Ministerio de Ciencia e Innovacion" (RETICS); Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal	Funding provided by Grant PI12/00357 (isciii, FEDER funds) to JPV, Grant Fundacion Aecc to MAP, Grant SODERCAN-Gobierno de Cantabria to MAP and Grant from the Spanish "Ministerio de Ciencia e Innovacion" (RETICS, SAF2008-03871) to MAP. IV is funded by Spanish Ministerio de Economia y Competitividad subprograma Ramon y Cajal. The authors would like to thank Servicio Santander Supercomputacion for their IT support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Martinez N, 2014, LEUKEMIA, V28, P1334, DOI 10.1038/leu.2013.365; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nikolaev SI, 2012, CANCER RES, V72, P6279, DOI 10.1158/0008-5472.CAN-12-3869; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Zhou DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053310	16	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119946	10.1371/journal.pone.0119946	http://dx.doi.org/10.1371/journal.pone.0119946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775023	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500142
J	Arndt, S; Landthaler, M; Zimmermann, JL; Unger, P; Wacker, E; Shimizu, T; Li, YF; Morfill, GE; Bosserhoff, AK; Karrer, S				Arndt, Stephanie; Landthaler, Michael; Zimmermann, Julia L.; Unger, Petra; Wacker, Eva; Shimizu, Tetsuji; Li, Yang-Fang; Morfill, Gregor E.; Bosserhoff, Anja-Katrin; Karrer, Sigrid			Effects of Cold Atmospheric Plasma (CAP) on beta-Defensins, Inflammatory Cytokines, and Apoptosis-Related Molecules in Keratinocytes In Vitro and In Vivo	PLOS ONE			English	Article							ARGON PLASMA; ANTIMICROBIAL PEPTIDES; PRESSURE PLASMA; CHRONIC WOUNDS; EXPRESSION; BARRIER; GENE; DECONTAMINATION; TISSUE; CELLS	Cold atmospheric plasma (CAP) has been gaining increasing interest as a new approach for the treatment of skin diseases or wounds. Although this approach has demonstrated promising antibacterial activity, its exact mechanism of action remains unclear. This study explored in vitro and in vivo whether CAP influences gene expression and molecular mechanisms in keratinocytes. Our results revealed that a 2 min CAP treatment using the MicroPlaSter beta in analogy to the performed clinical studies for wound treatment induces expression of IL-8, TGF-beta 1, and TGF-beta 2. In vitro and in vivo assays indicated that keratinocyte proliferation, migration, and apoptotic mechanisms were not affected by the CAP treatment under the applied conditions. Further, we observed that antimicrobial peptides of the beta-defensin family are upregulated after CAP treatment. In summary, our results suggest that a 2 min application of CAP induces gene expression of key regulators important for inflammation and wound healing without causing proliferation, migration or cell death in keratinocytes. The induction of beta-defensins in keratinocytes describes an absolutely new plasma strategy. Activation of antimicrobial peptides supports the well-known antibacterial effect of CAP treatment, whereas the mechanism of beta-defensin activation by CAP is not investigated so far.	[Arndt, Stephanie; Wacker, Eva] Univ Regensburg, Inst Pathol, D-93042 Regensburg, Germany; [Landthaler, Michael; Unger, Petra; Karrer, Sigrid] Univ Hosp Regensburg, Dept Dermatol, D-93042 Regensburg, Germany; [Zimmermann, Julia L.; Shimizu, Tetsuji; Li, Yang-Fang; Morfill, Gregor E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Bosserhoff, Anja-Katrin] Univ Erlangen Nurnberg, Inst Biochem & Mol Med, D-91054 Erlangen, Germany	University of Regensburg; University of Regensburg; Max Planck Society; University of Erlangen Nuremberg	Karrer, S (corresponding author), Univ Hosp Regensburg, Dept Dermatol, D-93042 Regensburg, Germany.	sigrid.karrer@klinik.uni-regensburg.de	Shimizu, Tetsuji/L-1478-2018; Bosserhoff, Anja/GNH-4801-2022	Shimizu, Tetsuji/0000-0001-9432-1152; Bosserhoff, Anja/0000-0001-8147-394X; Li, Yangfang/0000-0002-5346-3741				Afshar M, 2013, VET DERMATOL, V24, P32, DOI 10.1111/j.1365-3164.2012.01082.x; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Brown Rebeccah L., 1995, Wound Repair and Regeneration, V3, P25, DOI 10.1046/j.1524-475X.1995.30108.x; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Clausen ML, 2013, BRIT J DERMATOLOGY; Daeschlein G, 2012, J HOSP INFECT, V81, P177, DOI 10.1016/j.jhin.2012.02.012; Daeschlein G, 2012, J DTSCH DERMATOL GES, V10, P509, DOI 10.1111/j.1610-0387.2012.07857.x; Deilmann M, 2009, PLASMA PROCESSES S1, pi; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Gethin Georgina, 2012, Br J Community Nurs, VSuppl, pS17; Gibson AL, 2012, WOUND REPAIR REGEN, V20, P414, DOI 10.1111/j.1524-475X.2012.00786.x; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Grose R, 2004, MOL BIOTECHNOL, V28, P147, DOI 10.1385/MB:28:2:147; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2011, EXP DERMATOL, V20, P282, DOI 10.1111/j.1600-0625.2010.01159.x; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Heinlin J, 2013, J EUR ACAD DERMATOL, V27, P324, DOI 10.1111/j.1468-3083.2011.04395.x; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2013, RANDOMIZED PLACEBOCO; Heinlin J, 2013, WOUND REPAIR REGENER; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Kalghatgi SU, 2008, IEEE ENG MED BIO, P3578, DOI 10.1109/IEMBS.2008.4649979; Kalghatgi SU, 2009, C P ANN INT C IEEE E, P6030, DOI DOI 10.1109/IEMBS.2009.5333168; KAPPELMANN M, 2012, ONCOGENE; Kieft IE, 2005, IEEE T PLASMA SCI, V33, P771, DOI 10.1109/TPS.2005.844528; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; KONDO S, 1993, J INVEST DERMATOL, V101, P690, DOI 10.1111/1523-1747.ep12371677; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lademann O, 2011, SKIN PHARMACOL PHYS, V24, P284, DOI 10.1159/000329913; Levine JH, 1993, AM J PATHOL, V143, P368; Lupu Andreea-Roxana, 2009, Roum Arch Microbiol Immunol, V68, P136; Maisch T, 2012, J IND MICROBIOL BIOT, V39, P1367, DOI 10.1007/s10295-012-1137-6; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Maisch T, 2012, APPL ENVIRON MICROB, V78, P4242, DOI 10.1128/AEM.07235-11; Portugal M, 2007, BIOMED PHARMACOTHER, V61, P412, DOI 10.1016/j.biopha.2007.05.010; Roberts Anita B., 1995, Wound Repair and Regeneration, V3, P408, DOI 10.1046/j.1524-475X.1995.30405.x; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08; Yu Y, 2011, J HUAZHONG U SCI-MED, V31, P390, DOI 10.1007/s11596-011-0387-2	51	82	84	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120041	10.1371/journal.pone.0120041	http://dx.doi.org/10.1371/journal.pone.0120041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768736	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500105
J	Bialas, J; Groettrup, M; Aichem, A				Bialas, Johanna; Groettrup, Marcus; Aichem, Annette			Conjugation of the Ubiquitin Activating Enzyme UBE1 with the Ubiquitin-Like Modifier FAT10 Targets It for Proteasomal Degradation	PLOS ONE			English	Article							PROTEIN FAT10; CELLULAR-RESPONSE; E1; IDENTIFICATION; CANCERS; E2; FAT10YLATION; SUMO-1; SIGNAL; ALPHA	The ubiquitin-like modifier HLA-F adjacent transcript 10 (FAT10) directly targets its substrates for proteasomal degradation by becoming covalently attached via its C-terminal diglycine motif to internal lysine residues of its substrate proteins. The conjugation machinery consists of the bispecific E1 activating enzyme Ubiquitin-like modifier activating enzyme 6 (UBA6), the likewise bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1 (USE1), and possibly E3 ligases. By mass spectrometry analysis the ubiquitin E1 activating enzyme ubiquitin-activating enzyme 1 (UBE1) was identified as putative substrate of FAT10. Here, we confirm that UBE1 and FAT10 form a stable non-reducible conjugate under overexpression as well as under endogenous conditions after induction of endogenous FAT10 expression with proinflammatory cytokines. FAT10ylation of UBE1 depends on the diglycine motif of FAT10. By specifically downregulating FAT10, UBA6 or USE1 with siRNAs, we show that UBE1 modification depends on the FAT10 conjugation pathway. Furthermore, we confirm that UBE1 does not act as a second E1 activating enzyme for FAT10 but that FAT10ylation of UBE1 leads to its proteasomal degradation, implying a putative regulatory role of FAT10 in the ubiquitin conjugation pathway.	[Bialas, Johanna; Groettrup, Marcus; Aichem, Annette] Univ Konstanz, Biotechnol Inst Thurgau, CH-8280 Kreuzlingen, Switzerland; [Bialas, Johanna; Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, D-78457 Constance, Germany	University of Konstanz	Aichem, A (corresponding author), Univ Konstanz, Biotechnol Inst Thurgau, Unterseestr 47, CH-8280 Kreuzlingen, Switzerland.	Annette.Aichem@bitg.ch	Groettrup, Marcus/AAT-2623-2020		Konstanz Research School "Chemical Biology" at the University of Konstanz; German Research Foundation (DFG) Collaborative Research Centre [SFB969]; DFG [SPP1365, GR1517/10-1]; Velux Foundation [855]; Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education and Research	Konstanz Research School "Chemical Biology" at the University of Konstanz; German Research Foundation (DFG) Collaborative Research Centre(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Velux Foundation(Velux Fonden); Thurgauische Stiftung fur Wissenschaft und Forschung; Swiss State Secretariat for Education and Research	Funding: JB was funded by the Konstanz Research School "Chemical Biology" at the University of Konstanz; This work was supported by the German Research Foundation (DFG) Collaborative Research Centre SFB969 (Project C01), the DFG Priority Program "SPP1365 Ubiquitin Family Network" (grant GR1517/10-1), the Velux Foundation (grant 855), the Thurgauische Stiftung fur Wissenschaft und Forschung, the Swiss State Secretariat for Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichem A, 2014, FEBS J, V281, P1848, DOI 10.1111/febs.12745; Aichem A, 2012, J CELL SCI, V125, P4576, DOI 10.1242/jcs.107789; Aichem A, 2012, METHODS MOL BIOL, V832, P125, DOI 10.1007/978-1-61779-474-2_7; Aichem A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1012; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Bett JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030866; Buchsbaum S, 2012, BIOCHEM BIOPH RES CO, V428, P11, DOI 10.1016/j.bbrc.2012.09.110; Canaan A, 2006, MOL CELL BIOL, V26, P5180, DOI 10.1128/MCB.00966-05; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; CIECHANOVER A, 1981, P NATL ACAD SCI-BIOL, V78, P761, DOI 10.1073/pnas.78.2.761; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2443, DOI 10.1007/s00018-012-0933-5; Fan WF, 1996, IMMUNOGENETICS, V44, P97, DOI 10.1007/s002510050095; Gavin JM, 2012, J BIOL CHEM, V287, P15512, DOI 10.1074/jbc.M111.336198; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Leidecker O, 2012, CELL CYCLE, V11, P1142, DOI 10.4161/cc.11.6.19559; Li TW, 2011, ARCH BIOCHEM BIOPHYS, V509, P164, DOI 10.1016/j.abb.2011.02.017; Lim CB, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-20; Liu YC, 1999, P NATL ACAD SCI USA, V96, P4313, DOI 10.1073/pnas.96.8.4313; Lukasiak S, 2008, ONCOGENE, V27, P6068, DOI 10.1038/onc.2008.201; Merbl Y, 2013, CELL, V152, P1160, DOI 10.1016/j.cell.2013.02.007; Moudry P, 2012, CELL CYCLE, V11, P1573, DOI 10.4161/cc.19978; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Raasi S, 1999, EUR J IMMUNOL, V29, P4030, DOI 10.1002/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; Ren JW, 2011, J CELL SCI, V124, P3665, DOI 10.1242/jcs.087403; Ross MJ, 2006, J AM SOC NEPHROL, V17, P996, DOI 10.1681/ASN.2005070692; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schmidtke G, 2014, BBA-MOL CELL RES, V1843, P97, DOI 10.1016/j.bbamcr.2013.01.009; Schmidtke G, 2009, FEBS LETT, V583, P591, DOI 10.1016/j.febslet.2009.01.006; SCHWARTZ AL, 1992, P NATL ACAD SCI USA, V89, P5542, DOI 10.1073/pnas.89.12.5542; Szczepanowski RH, 2005, J BIOL CHEM, V280, P22006, DOI 10.1074/jbc.M502583200; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985	47	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120329	10.1371/journal.pone.0120329	http://dx.doi.org/10.1371/journal.pone.0120329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768649	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500120
J	Carrick, RT; Bates, ORJ; Benson, BE; Habel, N; Bates, JHT; Spector, PS				Carrick, Richard T.; Bates, Oliver R. J.; Benson, Bryce E.; Habel, Nicole; Bates, Jason H. T.; Spector, Peter S.			Prospectively Quantifying the Propensity for Atrial Fibrillation: A Mechanistic Formulation	PLOS ONE			English	Article							CRITICAL MASS HYPOTHESIS; IMPULSE PROPAGATION; REFRACTORY PERIOD; CATHETER ABLATION; HEART; MODEL; SUSCEPTIBILITY; INSIGHTS; DENSITY; IMPACT	The goal of this study was to determine quantitative relationships between electrophysiologic parameters and the propensity of cardiac tissue to undergo atrial fibrillation. We used a computational model to simulate episodes of fibrillation, which we then characterized in terms of both their duration and the population dynamics of the electrical waves which drove them. Monte Carlo sampling revealed that episode durations followed an exponential decay distribution and wave population sizes followed a normal distribution. Half-lives of reentrant episodes increased exponentially with either increasing tissue area to boundary length ratio (A/BL) or decreasing action potential duration (APD), resistance (R) or capacitance (C). We found that the qualitative form of fibrillatory activity (e.g., multi-wavelet reentry (MWR) vs. rotors) was dependent on the ratio of resistance and capacitance to APD; MWR was reliably produced below a ratio of 0.18. We found that a composite of these electrophysiologic parameters, which we term the fibrillogenicity index (Fb = A/(BL*APD*R*C)), reliably predicted the duration of MWR episodes (r(2) = 0.93). Given that some of the quantities comprising Fb are amenable to manipulation (via either pharmacologic treatment or catheter ablation), these findings provide a theoretical basis for the development of titrated therapies of atrial fibrillation.	[Carrick, Richard T.; Benson, Bryce E.; Bates, Jason H. T.] Univ Vermont, Coll Engn & Math Sci, Dept Bioengn, Burlington, VT USA; [Bates, Oliver R. J.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Habel, Nicole; Spector, Peter S.] Univ Vermont, Coll Med, Dept Med Cardiol, Burlington, VT 05405 USA; [Bates, Jason H. T.] Univ Vermont, Coll Med, Dept Med Pulm Dis & Crit Care Med, Burlington, VT USA	University of Vermont; Boston University; University of Vermont; University of Vermont	Spector, PS (corresponding author), Univ Vermont, Coll Med, Dept Med Cardiol, Burlington, VT 05405 USA.	peter.spector@uvm.edu		Carrick, Richard/0000-0001-5589-1216	Evslin Family Foundation, Inc.	Evslin Family Foundation, Inc.	The Peter Spector laboratory at the University of Vermont received funding from the Evslin Family Foundation, Inc., a non-profit angel donor group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Allessie M, 1985, CARDIAC ELECTROPHYSI, P265, DOI DOI 10.1016/J.HRTHM.2012.03.008; Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; Byrd GD, 2005, CIRCULATION, V112, pI7, DOI 10.1161/CIRCULATIONAHA.104.526210; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Carrick RT, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1229, DOI 10.1161/CIRCEP.113.000759; Charitos EI, 2014, J AM COLL CARDIOL, V63, P2840, DOI 10.1016/j.jacc.2014.04.019; COX JL, 1991, J THORAC CARDIOV SUR, V101, P584; de Groot NMS, 2010, CIRCULATION, V122, P1674, DOI 10.1161/CIRCULATIONAHA.109.910901; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Go AS, 2014, JAMA-J AM MED ASSOC, V285, P2370; Jacquemet V, 2005, EUROPACE, V7, pS83, DOI 10.1016/j.eupc.2005.03.017; Jacquemet V, 2008, AM J PHYSIOL-HEART C, V294, pH2040, DOI 10.1152/ajpheart.01298.2007; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kojodjojo P, 2007, J CARDIOVASC ELECTR, V18, P269, DOI 10.1111/j.1540-8167.2007.00723.x; Lee AM, 2013, J THORAC CARDIOV SUR, V146, P593, DOI 10.1016/j.jtcvs.2012.04.021; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; McDowell KS, 2011, BIOPHYS J, V101, P1307, DOI 10.1016/j.bpj.2011.08.009; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Oral H, 2002, CIRCULATION, V105, P1077, DOI 10.1161/hc0902.104712; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; Sanoski CA, 2009, J MANAGE CARE PHARM, V15, pS4; Spector PS, 2012, EUROPACE, V14, pV106, DOI 10.1093/europace/eus278; Spector PS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P586, DOI 10.1161/CIRCEP.110.961524; Tilz RR, 2012, J AM COLL CARDIOL, V60, P1921, DOI 10.1016/j.jacc.2012.04.060; WANG JJ, 1993, CIRCULATION, V88, P1030, DOI 10.1161/01.CIR.88.3.1030; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wright M, 2008, J CARDIOVASC ELECTR, V19, P583, DOI 10.1111/j.1540-8167.2008.01187.x	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118746	10.1371/journal.pone.0118746	http://dx.doi.org/10.1371/journal.pone.0118746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768978	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500042
J	Gonzalez, A; Shimobayashi, M; Eisenberg, T; Merle, DA; Pendl, T; Hall, MN; Moustafa, T				Gonzalez, Asier; Shimobayashi, Mitsugu; Eisenberg, Tobias; Merle, David Adrian; Pendl, Tobias; Hall, Michael N.; Moustafa, Tarek			TORC1 Promotes Phosphorylation of Ribosomal Protein S6 via the AGC Kinase Ypk3 in Saccharomyces cerevisiae	PLOS ONE			English	Article							GROWTH-CONTROL; FISSION YEAST; BUDDING YEAST; RAPAMYCIN; PATHWAY; TARGET; SCH9; METABOLISM; EQUIVALENT; RESISTANCE	The target of rapamycin complex 1 (TORC1) is an evolutionarily conserved sensor of nutrient availability. Genetic and pharmacological studies in the yeast Saccharomyces cerevisiae have provided mechanistic insights on the regulation of TORC1 signaling in response to nutrients. Using a highly specific antibody that recognizes phosphorylation of the bona fide TORC1 target ribosomal protein S6 (Rps6) in yeast, we found that nutrients rapidly induce Rps6 phosphorylation in a TORC1-dependent manner. Moreover, we demonstrate that Ypk3, an AGC kinase which exhibits high homology to human S6 kinase (S6K), is required for the phosphorylation of Rps6 in vivo. Rps6 phosphorylation is completely abolished in cells lacking Ypk3 (ypk3 Delta), whereas Sch9, previously reported to be the yeast ortholog of S6K, is dispensable for Rps6 phosphorylation. Phosphorylation-deficient mutations in regulatory motifs of Ypk3 abrogate Rps6 phosphorylation, and complementation of ypk3. cells with human S6 kinase restores Rps6 phosphorylation in a rapamycin-sensitive manner. Our findings demonstrate that Ypk3 is a critical component of the TORC1 pathway and that the use of a phospho-S6 specific antibody offers a valuable tool to identify new nutrient-dependent and rapamycin-sensitive targets in vivo.	[Gonzalez, Asier; Shimobayashi, Mitsugu; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland; [Eisenberg, Tobias; Merle, David Adrian; Pendl, Tobias; Moustafa, Tarek] Graz Univ, Inst Mol Biosci, Graz, Austria	University of Basel; University of Graz	Moustafa, T (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	tarek.moustafa@uni-graz.at	González, Asier/A-7064-2012; Moustafa, Tarek/P-9509-2016; Eisenberg, Tobias/AAV-7806-2021	Moustafa, Tarek/0000-0002-6755-4687; Shimobayashi, Mitsugu/0000-0002-6936-0990; Hall, Michael N/0000-0002-2998-0757; Eisenberg, Tobias/0000-0003-3559-1130	FEBS Long-Term Fellowship; APART-fellowship of the Austrian Academy of Sciences; SystemsX.ch; Swiss National Science Foundation; Canton of Basel; SFB LIPOTOX - Austrian Science Fund (FWF) [F30]; Austrian Science Fund (FWF) [F 3002] Funding Source: researchfish	FEBS Long-Term Fellowship; APART-fellowship of the Austrian Academy of Sciences; SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Basel; SFB LIPOTOX - Austrian Science Fund (FWF); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: A. G. was the recipient of a FEBS Long-Term Fellowship. T.E. is recipient of an APART-fellowship of the Austrian Academy of Sciences. This work was supported by SystemsX.ch, Swiss National Science Foundation, the Canton of Basel (M.N.H) and by the SFB LIPOTOX F30 funded by the Austrian Science Fund (FWF) to T.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Brachmann CB, 1998, YEAST, V14, P115; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; Canelas AB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1150; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Iesmantavicius V, 2014, MOL CELL PROTEOMICS, V13, P1979, DOI 10.1074/mcp.O113.035683; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; JOHNSON SP, 1987, MOL CELL BIOL, V7, P1338, DOI 10.1128/MCB.7.4.1338; KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Stracka D, 2014, J BIOL CHEM, V289, P25010, DOI 10.1074/jbc.M114.574335; Su B, 2011, CRIT REV BIOCHEM MOL, V46, P527, DOI 10.3109/10409238.2011.618113; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Dam TJP, 2011, J MOL EVOL, V73, P209, DOI 10.1007/s00239-011-9469-9; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamane-Sando Y, 2014, MICROBIOLOGYOPEN, V3, P196, DOI 10.1002/mbo3.160	34	59	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120250	10.1371/journal.pone.0120250	http://dx.doi.org/10.1371/journal.pone.0120250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767889	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500116
J	Li, CL; Zhou, LZ; Xu, L; Zhao, NN; Beauchamp, G				Li, Chunlin; Zhou, Lizhi; Xu, Li; Zhao, Niannian; Beauchamp, Guy			Vigilance and Activity Time-Budget Adjustments of Wintering Hooded Cranes, Grus monacha, in Human-Dominated Foraging Habitats	PLOS ONE			English	Article							GROUP-SIZE; PREDATION RISK; FLOCK SIZE; BEHAVIORAL PLASTICITY; SHENGJIN LAKE; BIRDS; AGE; ELK; CONSERVATION; WATERBIRDS	Due to loss and degradation of natural wetlands, waterbirds increasingly rely on surrounding human-dominated habitats to obtain food. Quantifying vigilance patterns, investigating the trade-off among various activities, and examining the underlying mechanisms will help us understand how waterbirds adapt to human-caused disturbances. During two successive winters (November-February of 2012-13 and 2013-14), we studied the hooded crane, Grus monacha, in the Shengjin Lake National Nature Reserve (NNR), China, to investigate how the species responds to human disturbances through vigilance and activity time-budget adjustments. Our results showed striking differences in the behavior of the cranes when foraging in the highly disturbed rice paddy fields found in the buffer zone compared with the degraded natural wetlands in the core area of the NNR. Time spent vigilant decreased with flock size and cranes spent more time vigilant in the human-dominated buffer zone. In the rice paddy fields, the birds were more vigilant but also fed more at the expense of locomotion and maintenance activities. Adult cranes spent more time vigilant and foraged less than juveniles. We recommend habitat recovery in natural wetlands and community co-management in the surrounding human-dominated landscape for conservation of the hooded crane and, generally, for the vast numbers of migratory waterbirds wintering in the middle and lower reaches of the Yangtze River floodplain.	[Li, Chunlin; Zhou, Lizhi; Xu, Li] Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China; [Zhao, Niannian] Shengjin Lake Natl Nat Reserve Management Ctr, Chizhou, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Vet Med, Montreal, PQ H3C 3J7, Canada	Anhui University; Universite de Montreal	Zhou, LZ (corresponding author), Anhui Univ, Sch Resources & Environm Engn, Hefei 230039, Peoples R China.	zhoulz@ahu.edu.cn	Zhou, Lizhi/AAF-4535-2021	Zhou, Lizhi/0000-0002-5702-4658	National Natural Sciences Foundation of China [31301897, 31172117]; Ph.D. Programs Foundation of Ministry of Education of China [20133401120014]; Anhui Provincial Natural Science Foundation [1308085QC64]; Anhui Postdoctoral Science Foundation [023033200025]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Postdoctoral Science Foundation	Funding to CL from National Natural Sciences Foundation of China (No. 31301897), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20133401120014), the Anhui Provincial Natural Science Foundation (No. 1308085QC64) and the Anhui Postdoctoral Science Foundation (No. 023033200025). Funding to LZ from National Natural Sciences Foundation of China (No. 31172117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, WATERBIRD SURVEY MID; Arenz CL, 2000, ANIM BEHAV, V59, P535, DOI 10.1006/anbe.1999.1345; Aviles JM, 2007, J AVIAN BIOL, V38, P690, DOI 10.1111/j.2007.0908-8857.04002.x; Barri FR, 2012, EMU, V112, P67, DOI 10.1071/MU10090; Barter M., 2004, WATERBIRD SURVEY MID; Barter Mark, 2005, Forktail, V21, P1; Beauchamp G., 2014, SOCIAL PREDATION GRO; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Beauchamp G, 2010, ETHOLOGY, V116, P645, DOI 10.1111/j.1439-0310.2010.01778.x; Beauchamp G, 2009, ANIM BEHAV, V78, P223, DOI 10.1016/j.anbehav.2009.04.029; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; Benoist S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082960; BirdLife International, 2014, IUCN 2014 IUCN RED L; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Boukhriss J, 2007, ETHOLOGY, V113, P377, DOI 10.1111/j.1439-0310.2007.01335.x; Cameron EZ, 2005, ANIM BEHAV, V69, P1337, DOI 10.1016/j.anbehav.2004.08.015; Cangjue Z., 2007, CHINESE J WILDLIFE, V29, P15; Cao Lei, 2011, Chinese Birds, V2, P1; Cao L, 2009, NATURE, V460, P173, DOI 10.1038/460173b; Caro Tim, 2005, pXIII; Cezilly F, 2012, IBIS, V154, P161, DOI 10.1111/j.1474-919X.2011.01173.x; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Czech HA, 2002, WATERBIRDS, V25, P56; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Elphick CS, 2010, WATERBIRDS, V33, P1, DOI 10.1675/063.033.s101; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; Fox AD, 2011, AQUAT CONSERV, V21, P82, DOI 10.1002/aqc.1154; Fraser L.H., 2005, WORLDS LARGEST WETLA, DOI [10.1017/cbo9780511542091, DOI 10.1017/CBO9780511542091]; Frid A, 2002, CONSERV ECOL, V6; Fritz H, 2002, ETHOL ECOL EVOL, V14, P91; Gosselin-Ildari AD, 2012, AM J PRIMATOL, V74, P613, DOI 10.1002/ajp.22013; Gross K, 2010, AM NAT, V176, P456, DOI 10.1086/655428; HART A, 1984, ANIM BEHAV, V32, P1216, DOI 10.1016/S0003-3472(84)80239-0; Hope DD, 2014, BEHAV ECOL SOCIOBIOL, V68, P827, DOI 10.1007/s00265-014-1695-x; Johnsgard P.A., 1983, CRANES OF THE WORLD; Kuang FL, 2014, WATERBIRDS, V37, P94, DOI 10.1675/063.037.0112; Lee SD, 2007, BIOL CONSERV, V138, P286, DOI 10.1016/j.biocon.2007.04.007; Li CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032607; Li Herng-Chein, 2012, Taiwania, V57, P99; Li Z, 2009, J ZOOL, V277, P302, DOI 10.1111/j.1469-7998.2008.00541.x; Li ZQ, 2013, WETLANDS, V33, P227, DOI 10.1007/s13157-012-0371-z; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Ma ZJ, 2010, WETLANDS, V30, P15, DOI 10.1007/s13157-009-0001-6; Ma ZJ, 2003, ECOL RES, V18, P321, DOI 10.1046/j.1440-1703.2003.00557.x; Mathot KJ, 2011, ECOL LETT, V14, P1254, DOI 10.1111/j.1461-0248.2011.01698.x; McCormick MI, 2013, ECOL EVOL, V3, P4221, DOI 10.1002/ece3.793; Murray CG, 2013, HYDROBIOLOGIA, V716, P131, DOI 10.1007/s10750-013-1558-x; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2012, ETHOLOGY, V118, P1, DOI 10.1111/j.1439-0310.2011.01974.x; Robinson BG, 2013, ANIM BEHAV, V85, P849, DOI 10.1016/j.anbehav.2013.02.004; TACHA TC, 1988, WILDLIFE MONOGR, P1; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Wang Q, 2002, CRANES RAILS BUSTARD; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Wolff JO, 2003, CAN J ZOOL, V81, P266, DOI 10.1139/Z03-011; Wood C, 2010, WATERBIRDS, V33, P30, DOI 10.1675/063.033.s103; Xu Li-Lin, 2008, Wuhan Zhiwuxue Yanjiu, V26, P264; Zhou B, 2009, CHINA J WILDL, V30, P133; Zhou B, 2010, WATERBIRDS, V33, P110, DOI 10.1675/063.033.0114; Zimmer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018977	63	29	38	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118928	10.1371/journal.pone.0118928	http://dx.doi.org/10.1371/journal.pone.0118928			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768111	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500054
J	Ma, J; Kanakala, S; He, YH; Zhang, JL; Zhong, XL				Ma, Jun; Kanakala, S.; He, Yehua; Zhang, Junli; Zhong, Xiaolan			Transcriptome Sequence Analysis of an Ornamental Plant, Ananas comosus var. bracteatus, Revealed the Potential Unigenes Involved in Terpenoid and Phenylpropanoid Biosynthesis	PLOS ONE			English	Article							RNA-SEQ; EXPRESSION; GENOME; L.; DISCOVERY	Background Ananas comosus var. bracteatus (Red Pineapple) is an important ornamental plant for its colorful leaves and decorative red fruits. Because of its complex genome, it is difficult to understand the molecular mechanisms involved in the growth and development. Thus high-throughput transcriptome sequencing of Ananas comosus var. bracteatus is necessary to generate large quantities of transcript sequences for the purpose of gene discovery and functional genomic studies. Results The Ananas comosus var. bracteatus transcriptome was sequenced by the Illumina paired-end sequencing technology. We obtained a total of 23.5 million high quality sequencing reads, 1,555,808 contigs and 41,052 unigenes. In total 41,052 unigenes of Ananas comosus var. bracteatus, 23,275 unigenes were annotated in the NCBI non-redundant protein database and 23,134 unigenes were annotated in the Swiss-Port database. Out of these, 17,748 and 8,505 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. Functional annotation against Kyoto Encyclopedia of Genes and Genomes Pathway database identified 5,825 unigenes which were mapped to 117 pathways. The assembly predicted many unigenes that were previously unknown. The annotated unigenes were compared against pineapple, rice, maize, Arabidopsis, and sorghum. Unigenes that did not match any of those five sequence datasets are considered to be Ananas comosus var. bracteatus unique. We predicted unigenes encoding enzymes involved in terpenoid and phenylpropanoid biosynthesis. Conclusion The sequence data provide the most comprehensive transcriptomic resource currently available for Ananas comosus var. bracteatus. To our knowledge; this is the first report on the de novo transcriptome sequencing of the Ananas comosus var. bracteatus. Unigenes obtained in this study, may help improve future gene expression, genetic and genomics studies in Ananas comosus var. bracteatus.	[Ma, Jun; Zhang, Junli; Zhong, Xiaolan] Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China; [Kanakala, S.] Agr Res Org, Volcani Ctr, Inst Plant Protect, IL-50250 Bet Dagan, Israel; [He, Yehua] South China Agr Univ, Hort Biotechnol Coll, Guangzhou, Guangdong, Peoples R China	Sichuan Agricultural University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; South China Agricultural University	Ma, J (corresponding author), Sichuan Agr Univ, Coll Landscape Architecture, Chengdu, Sichuan, Peoples R China.	junma365@hotmail.com	Surapathrudu, Kanakala/I-3791-2019	Surapathrudu, Kanakala/0000-0003-4702-3990	Natural Science Foundation of China [31300585]; Sichuan Agricultural University, China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Agricultural University, China	This work was funded by the Natural Science Foundation of China (31300585) and special funds by Sichuan Agricultural University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Collins JL, 1960, PINEAPPLE BOT UTILIS; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; d'Eeckenbrugge Geo Coppens, 2003, P13, DOI 10.1079/9780851995038.0013; Dewick, 2002, MED NATURAL PRODUCTS; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, p1e15; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Ito Y, 2006, J PHARMACOL SCI, V102, P196, DOI 10.1254/jphs.FP0060711; Kai T, 2005, DEV BIOL, V283, P486, DOI 10.1016/j.ydbio.2005.04.018; Kalaiselvi M., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS1341; Koia JH, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-240; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Montinola LR, 1991, PINA; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moyle R, 2005, J EXP BOT, V56, P101, DOI 10.1093/jxb/eri015; Moyle RL, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-21; Neuteboom LW, 2002, PLANT SCI, V163, P1021, DOI 10.1016/S0168-9452(02)00277-7; Ong WD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046937; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha FD, 2000, AN ACAD BRAS CIENC, V72, P295; TAKATA RH, 1976, LLOYDIA, V39, P409; TAUSSIG SJ, 1988, J ETHNOPHARMACOL, V22, P191, DOI 10.1016/0378-8741(88)90127-4; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang GY, 2005, NATURAL PRODUCTS: DRUG DISCOVERY AND THERAPEUTIC MEDICINE, P197, DOI 10.1007/978-1-59259-976-9_9; Wen L, 1999, J AGR FOOD CHEM, V47, P850, DOI 10.1021/jf9808067	36	19	21	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119153	10.1371/journal.pone.0119153	http://dx.doi.org/10.1371/journal.pone.0119153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769053	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500067
J	Shabani, P; Khaledi, HN; Beigy, M; Emamgholipour, S; Parvaz, E; Poustchi, H; Doosti, M				Shabani, Parisa; Khaledi, Hassan Naeimi; Beigy, Maani; Emamgholipour, Solaleh; Parvaz, Eskandar; Poustchi, Hossein; Doosti, Mahmood			Circulating Level of CTRP1 in Patients with Nonalcoholic Fatty Liver Disease (NAFLD): Is It through Insulin Resistance?	PLOS ONE			English	Article							ADIPOSE-TISSUE; STEATOHEPATITIS; ADIPONECTIN; FAMILY; OBESE; PATHOGENESIS; INFLAMMATION; PROGRESSION; EXPRESSION; CYTOKINES	Nonalcoholic fatty liver disease (NAFLD) is considered as one of the most common liver diseases. It is robustly linked to obesity and insulin resistance and is regarded as hepatic manifestation of metabolic syndrome (MetS). Adipokines are involved in the pathophysiology of liver diseases. The aim of this study was to evaluate the plasma concentrations of CTRP1 (complement-C1q TNF-related protein 1) in 22 patients with NAFLD, 22 patients with type 2 diabetes mellitus (T2DM), 22 patients with NAFLD+T2DM and 21 healthy controls, as well as their correlation with the level of metabolic and hepatic parameters. Plasma concentration of CTRP1 was measured with ELISA method. Plasma concentration of CTRP1 in patients with NAFLD, T2DM and NAFLD+T2DM were significantly higher than healthy subjects (p<0.0001). Moreover, we observed significant positive correlations between plasma level of CTRP1 and fasting blood glucose (FBG) (p<0.001), homeostasis model assessment of insulin resistance (HOMA-IR) (p<0.001), body mass index (BMI) (p = 0.001), alanine amino transferase (ALT) (p = 0.002), gamma glutamyl transferase (gamma-GT) (p<0.001) and liver stiffness (LS) (p<0.001). Our results indicate the strong association of CTRP1 with insulin resistance in NAFLD. Also, it seems that CTRP1 can be considered as an emerging biomarker for NAFLD, however, more studies are necessary to unravel the role of CTRP1 in NAFLD pathogenesis.	[Shabani, Parisa; Khaledi, Hassan Naeimi; Emamgholipour, Solaleh; Doosti, Mahmood] Univ Tehran Med Sci, Fac Med, Dept Biochem, Tehran, Iran; [Beigy, Maani] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran; [Parvaz, Eskandar] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran; [Poustchi, Hossein] Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tarbiat Modares University; Tehran University of Medical Sciences	Poustchi, H (corresponding author), Univ Tehran Med Sci, Digest Dis Res Inst, Liver & Pancreatobiliary Dis Res Ctr, Tehran, Iran.	h.poustchi@gmail.com; doostimd@sina.tums.ac.ir	Beigy, Maani/S-4091-2019; Emamgholipour, Solaleh/T-6035-2017	Beigy, Maani/0000-0003-2963-3533; Doosti, Mahmood/0000-0003-3011-065X; Emamgholipour, Solaleh/0000-0002-9949-5773				Alam S, 2013, WORLD J HEPATOL, V5, P281, DOI 10.4254/wjh.v5.i5.281; Angulo P, 2004, J HEPATOL, V41, P943, DOI 10.1016/j.jhep.2004.08.020; Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Du J, 2014, WORLD J GASTROENTERO, V20, P569, DOI 10.3748/wjg.v20.i2.569; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Jarrar MH, 2008, ALIMENT PHARM THER, V27, P412, DOI 10.1111/j.1365-2036.2007.03586.x; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Krawczyk K, 2009, J PHYSIOL PHARMACOL, V60, P71; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Pagano C, 2005, EUR J ENDOCRINOL, V152, P113, DOI 10.1530/eje.1.01821; Pan XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094478; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Podrini C, 2013, CURR PHARM DESIGN, V19, P2737, DOI 10.2174/1381612811319150009; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Schaffler A, 2012, TRENDS ENDOCRIN MET, V23, P194, DOI 10.1016/j.tem.2011.12.003; Schwenger KJP, 2014, WORLD J GASTROENTERO, V20, P1712, DOI 10.3748/wjg.v20.i7.1712; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Semba T, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-120; Sonsuz A, 2002, AM J GASTROENTEROL, V97, P495; Stefan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092238; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wree A, 2014, METABOLISM, V63, P1542, DOI 10.1016/j.metabol.2014.09.001; Xin YP, 2014, ENDOCR J, V61, P841, DOI 10.1507/endocrj.EJ14-0016; Yuasa D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099846	36	26	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118650	10.1371/journal.pone.0118650	http://dx.doi.org/10.1371/journal.pone.0118650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767880	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500036
J	Yousfi, N; Pruvot, B; Lopez, T; Magadoux, L; Franche, N; Pichon, L; Salvadori, F; Solary, E; Garrido, C; Laurens, V; Chluba, J				Yousfi, Nadhir; Pruvot, Benoist; Lopez, Tatiana; Magadoux, Lea; Franche, Nathalie; Pichon, Laurent; Salvadori, Francoise; Solary, Eric; Garrido, Carmen; Laurens, Veronique; Chluba, Johanna			The Impact of Tumor Nitric Oxide Production on VEGFA Expression and Tumor Growth in a Zebrafish Rat Glioma Xenograft Model	PLOS ONE			English	Article							FLUORESCENT INDICATORS; IN-VIVO; CELLS; TRANSPLANTATION; SYNTHASE; ANGIOGENESIS; PROGRESSION; EMBRYOS; STRESS; CANCER	To investigate the effect of nitric oxide on tumor development, we established a rat tumor xenograft model in zebrafish embryos. The injected tumor cells formed masses in which nitric oxide production could be detected by the use of the cell-permeant DAF-FM-DA (diaminofluorophore 4-amino-5-methylamino-2'-7'-difluorofluorescein diacetate) and DAR-4M-AM (diaminorhodamine-4M). This method revealed that nitric oxide production could be co-localized with the tumor xenograft in 46% of the embryos. In 85% of these embryos, tumors were vascularized and blood vessels were observed on day 4 post injection. Furthermore, we demonstrated by qRT-PCR that the transplanted glioma cells highly expressed Nos2, Vegfa and Cyclin D1 mRNA. In the xenografted embryos we also found increased zebrafish vegfa expression. Glioma and zebrafish derived Vegfa and tumor Cyclin D1 expression could be down regulated by the nitric oxide scavenger 2-(4-Carboxyphenyl)-4,4,5,5-tetra-methylimidazoline-1-oxyl-3-oxide or CPTIO. We conclude that even if there is a heterogeneous nitric oxide production by the xenografted glioma cells that impacts Vegfa and Cyclin D1 expression levels, our results suggest that reduction of nitric oxide levels by nitric oxide scavenging could be an efficient approach to treat glioma.	[Yousfi, Nadhir; Lopez, Tatiana; Garrido, Carmen; Chluba, Johanna] INSERM, UMR 866, Equipe Labellisee Ligue Canc, Dijon, France; [Yousfi, Nadhir; Pruvot, Benoist; Lopez, Tatiana; Pichon, Laurent; Salvadori, Francoise; Laurens, Veronique; Chluba, Johanna] Univ Burgundy, UFR SVTE, Dijon, France; [Magadoux, Lea; Franche, Nathalie; Laurens, Veronique] Ecole Prat Hautes Etud, EA 7269, Dijon, France; [Solary, Eric] Inst Gustave Roussy, INSERM, U1009, Paris, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Chluba, J (corresponding author), INSERM, UMR 866, Equipe Labellisee Ligue Canc, Dijon, France.	Johanna.Chluba@u-bourgogne.fr	Garrido, carmen/G-1633-2018; Garrido, Carolina/GWM-5557-2022; Chluba, Johanna/D-1224-2012	Garrido, carmen/0000-0003-1368-1493; Laurens, Veronique/0000-0002-7841-628X; Solary, Eric/0000-0002-8629-1341; Chluba, Johanna/0000-0001-8779-8016; Lopez, Tatiana/0000-0002-3658-682X	INSERM; Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer; University of Burgundy; Conseil Regional de Bourgogne; Conseil Regional de Bourgogne [34324]; Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche; Ligue Contre le Cancer(Ligue nationale contre le cancer); University of Burgundy; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	Funding: This work was supported by the INSERM, the Ministere de l'Education Nationale et de l'Enseignement Superieur et de la Recherche, the Ligue Contre le Cancer, the University of Burgundy, and the Conseil Regional de Bourgogne. NY was supported by the Conseil Regional de Bourgogne by a fellowship of the Feder Program Jeunes chercheurs entreprenneurs (ref. no. 34324) and a fellowship of the Ligue Nationale Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Burke AJ, 2013, CARCINOGENESIS, V34, P503, DOI 10.1093/carcin/bgt034; Corkery DP, 2011, BRIT J HAEMATOL, V153, P786, DOI 10.1111/j.1365-2141.2011.08661.x; CORNAIN S, 1975, INT J CANCER, V16, P301, DOI 10.1002/ijc.2910160213; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; Danilova N, 2004, DEV COMP IMMUNOL, V28, P755, DOI 10.1016/j.dci.2003.12.003; Duvillard C, 1999, INT J CANCER, V81, P779, DOI 10.1002/(SICI)1097-0215(19990531)81:5<779::AID-IJC19>3.0.CO;2-I; Flitney FW, 2001, MOL CANCER THER, V10, P1571; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frerart F, 2009, MOL CANCER RES, V7, P1056, DOI 10.1158/1541-7786.MCR-08-0388; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Geiger GA, 2008, CANCER RES, V68, P3396, DOI 10.1158/0008-5472.CAN-07-6396; Ghotra VPS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031281; Gosgnach W, 2000, AM J PHYSIOL-CELL PH, V279, pC1880, DOI 10.1152/ajpcell.2000.279.6.C1880; Haldi Maryann, 2006, Angiogenesis, V9, P139, DOI 10.1007/s10456-006-9040-2; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Kojima H, 2001, ANAL CHEM, V73, P1967, DOI 10.1021/ac001136i; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Lepiller S, 2007, FREE RADICAL BIO MED, V43, P619, DOI 10.1016/j.freeradbiomed.2007.05.025; Lepiller S, 2009, GENE, V445, P58, DOI 10.1016/j.gene.2009.05.016; Li PL, 2011, METHOD CELL BIOL, V105, P403, DOI 10.1016/B978-0-12-381320-6.00017-5; Marques IJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-128; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Ozawa N, 2004, HYPERTENS RES, V27, P93, DOI 10.1291/hypres.27.93; Poon KL, 2008, DEV DYNAM, V237, P1662, DOI 10.1002/dvdy.21566; Poon KL, 2003, GENE EXPR PATTERNS, V3, P463, DOI 10.1016/S1567-133X(03)00063-2; Pruvot B, 2011, HAEMATOL-HEMATOL J, V96, P612, DOI 10.3324/haematol.2010.031401; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Stoletov K, 2007, P NATL ACAD SCI USA, V104, P17406, DOI 10.1073/pnas.0703446104; Taylor AM, 2009, ZEBRAFISH, V6, P339, DOI 10.1089/zeb.2009.0607; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wink DA, 2008, NITRIC OXIDE-BIOL CH, V19, P65, DOI 10.1016/j.niox.2008.05.003; Yang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085759; Zhao CJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021768, 10.1371/journal.pone.0023925]; Zhao H, 2009, J NEUROSURG, V111, P238, DOI 10.3171/2008.8.JNS08644	44	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120435	10.1371/journal.pone.0120435	http://dx.doi.org/10.1371/journal.pone.0120435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768009	gold, Green Published			2022-12-26	WOS:000351277500125
J	Liu, XL; Wang, JS; Liu, Q; Zhao, PF; Hou, Y; Ma, Y; Guo, QY				Liu, Xingli; Wang, Jingshi; Liu, Qin; Zhao, Pengfei; Hou, Yang; Ma, Yue; Guo, Qiyong			Determination of the Optimal Dose Reduction Level via Iterative Reconstruction Using 640-Slice Volume Chest CT in a Pig Model	PLOS ONE			English	Article							Z-AXIS MODULATION; MULTIDETECTOR CT; IMAGE QUALITY; PEDIATRIC CT; ROW CT; CHILDREN; OPTIMIZATION; ABDOMEN	Aim To determine the optimal dose reduction level of iterative reconstruction technique for paediatric chest CT in pig models. Materials and Methods 27 infant pigs underwent 640-slice volume chest CT with 80kVp and different mAs. Automatic exposure control technique was used, and the index of noise was set to SD10 (Group A, routine dose), SD12.5, SD15, SD17.5, SD20 (Groups from B to E) to reduce dose respectively. Group A was reconstructed with filtered back projection (FBP), and Groups fromB to E were reconstructed using iterative reconstruction (IR). Objective and subjective image quality (IQ) among groups were compared to determine an optimal radiation reduction level. Results The noise and signal-to-noise ratio (SNR) in Group D had no significant statistical difference from that in Group A (P = 1.0). The scores of subjective IQ in Group A were not significantly different from those in Group D (P > 0.05). There were no obvious statistical differences in the objective and subjective index values among the subgroups (small, medium and large subgroups) of Group D. The effective dose (ED) of Group D was 58.9% lower than that of Group A (0.20 +/- 0.05mSv vs 0.48 +/- 0.10mSv, p < 0.001). Conclusions In infant pig chest CT, using iterative reconstruction can provide diagnostic image quality; furthermore, it can reduce the dosage by 58.9%.	[Liu, Qin; Zhao, Pengfei; Hou, Yang; Ma, Yue; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang 36, Liaoning, Peoples R China; [Liu, Xingli] China Med Univ, Shengjing Hosp, Dept Cardiol, Shenyang 110004, Liaoning, Peoples R China; [Wang, Jingshi] Dalian Municipal Women & Childrens Med Cent, Dept Radiol, Dalian 116033, Liaoning, Peoples R China	China Medical University	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, 36 Sanhao St, Shenyang 36, Liaoning, Peoples R China.	houyang1973@163.com	Yang, Aliza/HGU-3681-2022	Hou, Yang/0000-0002-9184-5441	government funds-Liaoning Science Public Research Funds	government funds-Liaoning Science Public Research Funds	The presented work was supported by government funds-Liaoning Science Public Research Funds [2011] no. 49. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousily F, 2011, PEDIATR CARDIOL, V32, P426, DOI 10.1007/s00246-010-9873-8; [Anonymous], 2009, 16262 EUR; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Fricke BL, 2003, AM J ROENTGENOL, V180, P407, DOI 10.2214/ajr.180.2.1800407; Greess H, 2004, EUR RADIOL, V14, P995, DOI 10.1007/s00330-004-2301-9; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056295; Kalra MK, 2005, RADIOLOGY, V237, P303, DOI 10.1148/radiol.2371041227; Kalra MK, 2004, RADIOLOGY, V233, P241, DOI 10.1148/radiol.2331031505; Kalra MK, 2004, RADIOLOGY, V232, P347, DOI 10.1148/radiol.2322031304; Katsura M, 2012, EUR RADIOL, V22, P1613, DOI 10.1007/s00330-012-2452-z; Khong P-L, 2012, Annals of the ICRP, V41, P170, DOI 10.1016/j.icrp.2012.06.017; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Lee SH, 2012, EUR J RADIOL, V81, pE938, DOI 10.1016/j.ejrad.2012.06.013; Mieville FA, 2013, PEDIATR RADIOL, V43, P558, DOI 10.1007/s00247-012-2554-4; Mulkens TH, 2005, RADIOLOGY, V237, P213, DOI 10.1148/radiol.2363041220; Nievelstein RAJ, 2010, PEDIATR RADIOL, V40, P1324, DOI 10.1007/s00247-010-1714-7; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Singh S, 2011, RADIOLOGY, V259, P565, DOI 10.1148/radiol.11101450; Singh S, 2009, RADIOLOGY, V252, P200, DOI 10.1148/radiol.2521081554; Tack D, 2003, AM J ROENTGENOL, V181, P331, DOI 10.2214/ajr.181.2.1810331; Thomas KE, 2008, PEDIATR RADIOL, V38, P645, DOI 10.1007/s00247-008-0794-0; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013; Yoo RE, 2013, INT J CARDIOVAS IMAG, V29, P669, DOI 10.1007/s10554-012-0113-6	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117213	10.1371/journal.pone.0117213	http://dx.doi.org/10.1371/journal.pone.0117213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764485	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300008
J	Yang, XR; Killian, JK; Hammond, S; Burke, LS; Bennett, H; Wang, Y; Davis, SR; Strong, LC; Neglia, J; Stovall, M; Weathers, RE; Robison, LL; Bhatia, S; Mabuchi, K; Inskip, PD; Meltzer, P				Yang, Xiaohong R.; Killian, J. Keith; Hammond, Sue; Burke, Laura S.; Bennett, Hunter; Wang, Yonghong; Davis, Sean R.; Strong, Louise C.; Neglia, Joseph; Stovall, Marilyn; Weathers, Rita E.; Robison, Leslie L.; Bhatia, Smita; Mabuchi, Kiyohiko; Inskip, Peter D.; Meltzer, Paul			Characterization of Genomic Alterations in Radiation-Associated Breast Cancer among Childhood Cancer Survivors, Using Comparative Genomic Hybridization (CGH) Arrays	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; SUBTYPES; TUMORS; INSTABILITY; RISK	Ionizing radiation is an established risk factor for breast cancer. Epidemiologic studies of radiation- exposed cohorts have been primarily descriptive; molecular events responsible for the development of radiation-associated breast cancer have not been elucidated. In this study, we used array comparative genomic hybridization (array-CGH) to characterize genome- wide copy number changes in breast tumors collected in the Childhood Cancer Survivor Study (CCSS). Array-CGH data were obtained from 32 cases who developed a second primary breast cancer following chest irradiation at early ages for the treatment of their first cancers, mostly Hodgkin lymphoma. The majority of these cases developed breast cancer before age 45 (91%, n = 29), had invasive ductal tumors (81%, n = 26), estrogen receptor (ER)-positive staining (68%, n = 19 out of 28), and high proliferation as indicated by high Ki67 staining (77%, n = 17 out of 22). Genomic regions with low-copy number gains and losses and high-level amplifications were similar to what has been reported in sporadic breast tumors, however, the frequency of amplifications of the 17q12 region containing human epidermal growth factor receptor 2 (HER2) was much higher among CCSS cases (38%, n = 12). Our findings suggest that second primary breast cancers in CCSS were enriched for an "amplifier" genomic subgroup with highly proliferative breast tumors. Future investigation in a larger irradiated cohort will be needed to confirm our findings.	[Yang, Xiaohong R.; Burke, Laura S.; Bennett, Hunter; Mabuchi, Kiyohiko; Inskip, Peter D.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Killian, J. Keith; Wang, Yonghong; Davis, Sean R.; Meltzer, Paul] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hammond, Sue] Childrens Hosp, Dept Lab Med & Pathol, Columbus, OH 43205 USA; [Hammond, Sue] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Strong, Louise C.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Neglia, Joseph] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Stovall, Marilyn; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Robison, Leslie L.] St Jude Childrens Res Hosp, Epidemiol & Canc Control, Memphis, TN 38105 USA; [Bhatia, Smita] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; St Jude Children's Research Hospital; University of Alabama System; University of Alabama Birmingham	Yang, XR (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	royang@mail.nih.gov	Robison, Leslie/N-8122-2018; Davis, Sean/AAD-1801-2021	Davis, Sean/0000-0002-8991-6458; Neglia, Joseph/0000-0002-5525-0598; Bennett, Hunter/0000-0002-8495-1545	Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology Genetics [U24 CA55727]; NATIONAL CANCER INSTITUTE [P30CA016672, ZICBC011040, ZIABC011091, U24CA055727] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the NIH, NCI, Division of Cancer Epidemiology & Genetics and grant for the CCSS (U24 CA55727).	Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Castiglioni F, 2007, CLIN CANCER RES, V13, P46, DOI 10.1158/1078-0432.CCR-06-1490; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Choi DH, 2003, CANCER-AM CANCER SOC, V98, P1587, DOI 10.1002/cncr.11703; Clemons M, 2000, CANCER TREAT REV, V26, P291, DOI 10.1053/ctrv.2000.0174; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Holm K, 2012, BREAST CANCER RES TR, V133, P583, DOI 10.1007/s10549-011-1817-3; Horst KC, 2014, ANN ONCOL, V25, P848, DOI 10.1093/annonc/mdu017; Inskip PD, 2009, J CLIN ONCOL, V27, P3901, DOI 10.1200/JCO.2008.20.7738; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Keegan THM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3156; Kenney LB, 2004, ANN INTERN MED, V141, P590, DOI 10.7326/0003-4819-141-8-200410190-00006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Land CE, 2003, RADIAT RES, V160, P707, DOI 10.1667/RR3082; Miura S, 2008, CANCER-AM CANCER SOC, V112, P2143, DOI 10.1002/cncr.23414; Morrison DH, 2012, BRIT J CANCER, V107, P382, DOI 10.1038/bjc.2012.219; Moskowitz CS, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.18_suppl.cra9513; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Pronzato P, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/534256; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; TOKUNAGA M, 1994, RADIAT RES, V138, P209, DOI 10.2307/3578591	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116078	10.1371/journal.pone.0116078	http://dx.doi.org/10.1371/journal.pone.0116078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764003	Green Submitted, gold, Green Published			2022-12-26	WOS:000351276300004
J	Zhu, MM; Huang, JN; Zhu, BJ; Sun, Q; Xu, X; Miao, YY; Zou, HD				Zhu, Mingming; Huang, Jiannan; Zhu, Bijun; Sun, Qian; Xu, Xian; Miao, Yuyu; Zou, Haidong			Changes of Vision-Related Quality of Life in Retinal Detachment Patients after Cataract Surgery	PLOS ONE			English	Article							VISUAL FUNCTION; POPULATION; OUTCOMES; PHACOEMULSIFICATION; RISK; QUESTIONNAIRE; ACUITY; EYES	Rhegmatenous retinal detachment (RRD) is one of the most serious complications after phacoemulsification combined with intraocular lens implantation surgery. It has been reported that vision-related quality of life (VRQoL), as well as visual acuity rapidly decreased when RRD developed. However, little is known of the VRQoL in those RRD patients after anatomical retinal re-attachment, especially whether or not the VRQoL is higher than that before cataract surgery. In this prospective case series study, we use the Chinese-version low vision quality of life questionnaire (CLVQOL) to assess the changes of VRQoL in age-related cataract patients who suffered from RRD after phacoemulsification with intraocular lens (phaco-IOL) implantation. All participants were asked to complete questionnaires in face-to-face interviews one day before and two weeks after cataract surgery, as well as one day before and three months after RRD surgery. A total of 10,127 consecutive age-related cataract patients were followed up to one year after phaco-IOL implantation; among these patients, 17 were diagnosed as RRD. The total CLVQOL scores and subscale scores except "Mobility" decreased significantly when RRD developed. After retinal surgery, only the score of "General vision and lighting" in the CLVQOL questionnaires improved when compared to the scores two weeks after cataract surgery, although the best corrected visual acuity of all patients significantly raised up. However, the mean CLVQOL scores and subscale scores were still considerably higher than the level prior to cataract surgery. Our study suggests that cataract patients at high risk of postoperative RRD should not deny the opportunity to undergo phaco-IOL implantation, even though potential VRQoL impairment induced by RRD exists.	[Zhu, Mingming; Huang, Jiannan; Zhu, Bijun; Sun, Qian; Xu, Xian; Miao, Yuyu; Zou, Haidong] Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Huang, Jiannan; Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China.	zouhaidong@hotmail.com		Zou, Haidong/0000-0002-6831-7560				Bhagwandien ACE, 2006, OPHTHALMOLOGY, V113, P643, DOI 10.1016/j.ophtha.2005.10.056; Boberg-Ans G, 2006, ACTA OPHTHALMOL SCAN, V84, P613, DOI 10.1111/j.1600-0420.2006.00719.x; Clark A, 2012, ARCH OPHTHALMOL-CHIC, V130, P882, DOI 10.1001/archophthalmol.2012.164; Desai P, 1996, BRIT J OPHTHALMOL, V80, P868, DOI 10.1136/bjo.80.10.868; Erie JC, 2006, OPHTHALMOLOGY, V113, P2026, DOI 10.1016/j.ophtha.2006.05.054; Gothwal VK, 2010, J CATARACT REFR SURG, V36, P1181, DOI 10.1016/j.jcrs.2010.01.029; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; HOLLADAY JT, 1991, AM J OPHTHALMOL, V111, P372, DOI 10.1016/S0002-9394(14)72328-1; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Monestam E, 1999, J CATARACT REFR SURG, V25, P1127, DOI 10.1016/S0886-3350(99)00135-2; Neuhann IM, 2008, J CATARACT REFR SURG, V34, P1644, DOI 10.1016/j.jcrs.2008.06.022; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Ranta P, 2002, OPHTHALMOLOGY, V109, P1432, DOI 10.1016/S0161-6420(02)01111-9; Saw SM, 2002, J CATARACT REFR SURG, V28, P445, DOI 10.1016/S0886-3350(01)01016-1; Scott IU, 1998, OPHTHALMOLOGY, V105, P795, DOI 10.1016/S0161-6420(98)95017-5; Sheu Shwu-Jiuan, 2005, J Chin Med Assoc, V68, P321, DOI 10.1016/S1726-4901(09)70168-6; STEINBERG EP, 1994, ARCH OPHTHALMOL-CHIC, V112, P630, DOI 10.1001/archopht.1994.01090170074026; Tuft SJ, 2006, OPHTHALMOLOGY, V113, P650, DOI 10.1016/j.ophtha.2006.01.001; Wolffsohn JS, 2000, AM J OPHTHALMOL, V130, P793, DOI 10.1016/S0002-9394(00)00610-3; Zou H, 2005, QUAL LIFE RES, V14, P1633, DOI 10.1007/s11136-004-0026-5; Zou HD, 2008, OPHTHAL EPIDEMIOL, V15, P212, DOI 10.1080/09286580701843804; Zou HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028597	22	1	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120505	10.1371/journal.pone.0120505	http://dx.doi.org/10.1371/journal.pone.0120505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764367	gold, Green Submitted, Green Published			2022-12-26	WOS:000351276300043
J	Amer, S; Helal, IB; Kamau, E; Feng, YY; Xiao, LH				Amer, Said; Helal, Ibrahim B.; Kamau, Evelyne; Feng, Yaoyu; Xiao, Lihua			Molecular Characterization of Echinococcus granulosus Sensu Lato from Farm Animals in Egypt	PLOS ONE			English	Article							HUMAN CYSTIC ECHINOCOCCOSIS; IDENTIFICATION; STRAINS; EPIDEMIOLOGY; HUMANS; SHEEP; DOGS; G1	Little is known on the diversity and public health significance of Echinococcus species in livestock in Egypt. In this study, 37 individual hydatid cysts were collected from dromedary camels (n=28), sheep (n=7) and buffalos (n=2). DNA was extracted from protoscoleces/germinal layer of individual cysts and amplified by PCR targeting nuclear (actin II) and mitochondrial (COX1 and NAD1) genes. Direct sequencing of amplicons indicated the presence of Echinococcus canadenesis (G6 genotype) in 26 of 28 camel cysts, 3 of 7 sheep cysts and the 2 buffalo derived cysts. In contrast, Echinococcus granulosus sensu stricto (G1 genotype) was detected in one cyst from a camel and 4 of 7 cysts from sheep, whereas Echinococcus ortleppi (G5 genotype) was detected in one cyst from a camel. This is the first identification of E. ortleppi in Egypt.	[Amer, Said; Xiao, Lihua] Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot Infect Dis, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Amer, Said] Kafr El Sheikh Univ, Fac Sci, Dept Zool, Kafr Al Sheikh, Egypt; [Helal, Ibrahim B.] Tanta Univ, Fac Sci, Dept Zool, Tanta, Egypt; [Kamau, Evelyne] Univ Evry Val Essonne, ISSB, Evry, France; [Feng, Yaoyu] E China Univ Sci & Technol, Sch Resources & Environm Engn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Centers for Disease Control & Prevention - USA; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Tanta University; UDICE-French Research Universities; Universite Paris Saclay; East China University of Science & Technology	Feng, YY (corresponding author), E China Univ Sci & Technol, Sch Resources & Environm Engn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	yyfeng@ecust.edu.cn; lxiao@cdc.gov	Helal, Ibrahim/AAF-7342-2019; Feng, Yaoyu/S-1979-2019; Xiao, Lihua/B-1704-2013; Feng, Yaoyu/B-3076-2014	Helal, Ibrahim/0000-0003-3932-5665; Feng, Yaoyu/0000-0002-8380-1246; Xiao, Lihua/0000-0001-8532-2727; Feng, Yaoyu/0000-0002-8380-1246	Arab Fund for Economic & Social Development "Zamalat Program"; National Natural Science Foundation of China [31110103901]	Arab Fund for Economic & Social Development "Zamalat Program"(Arab Fund for Economic and Social Development); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Arab Fund for Economic & Social Development "Zamalat Program" and the National Natural Science Foundation of China (Project No. 31110103901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaty HEA, 2012, ACTA TROP, V121, P125, DOI 10.1016/j.actatropica.2011.10.014; Abd El Baki Mohammad H., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P711; Aboelhadid SM, 2013, VET PARASITOL, V193, P292, DOI 10.1016/j.vetpar.2012.11.019; Abushhewa MH, 2010, MOL CELL PROBE, V24, P346, DOI 10.1016/j.mcp.2010.07.005; Adwan G, 2013, EXP PARASITOL, V134, P195, DOI 10.1016/j.exppara.2013.03.024; Ahmed ME, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-127; Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Atkinson JAM, 2013, GLOBAL CHANGE BIOL, V19, P677, DOI 10.1111/gcb.12088; Azab Magda E., 2004, Journal of the Egyptian Society of Parasitology, V34, P83; Bart JM, 2006, PARASITOL RES, V98, P130, DOI 10.1007/s00436-005-0015-9; Bart JM, 2004, PARASITOLOGY, V128, P229, DOI [10.1017/S0031182003004359, 10.1017/s0031182003004359]; Beato S, 2010, PARASITOL INT, V59, P638, DOI 10.1016/j.parint.2010.08.004; BOWLES J, 1993, INT J PARASITOL, V23, P969, DOI 10.1016/0020-7519(93)90065-7; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Carmena D, 2014, VET PARASITOL, V202, P69, DOI 10.1016/j.vetpar.2014.03.009; Casulli A, 2010, T ROY SOC TROP MED H, V104, P29, DOI 10.1016/j.trstmh.2009.08.001; da Silva AM, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/583297; DASILVA CMD, 1993, MOL BIOCHEM PARASIT, V60, P209, DOI 10.1016/0166-6851(93)90132-H; Dowling PM, 2000, ANN TROP MED PARASIT, V94, P69, DOI 10.1080/00034980057626; Dyab Kamal A., 2005, Journal of the Egyptian Society of Parasitology, V35, P157; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; El Shazly Atef M., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P483; Farjallah S., 2007, Parassitologia (Rome), V49, P239; Guarnera EA, 2004, ACTA TROP, V92, P153, DOI 10.1016/j.actatropica.2004.06.008; Hailemariam Z, 2012, PARASITOL INT, V61, P375, DOI 10.1016/j.parint.2012.01.007; Haridy Fouad M., 2006, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V36, P1087; Ibrahim K, 2011, CHINESE MED J-PEKING, V124, P2829, DOI 10.3760/cma.j.issn.0366-6999.2011.18.006; Ito A, 2007, FUTURE MICROBIOL, V2, P439, DOI 10.2217/17460913.2.4.439; Jabbar A, 2011, MOL CELL PROBE, V25, P49, DOI 10.1016/j.mcp.2010.11.001; Maillard S, 2007, PARASITOL RES, V100, P495, DOI 10.1007/s00436-006-0286-9; Mazyad Said A. M., 2007, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V37, P523; McManus DP, 2010, ADV PARASIT, V72, P267, DOI 10.1016/S0065-308X(10)72010-8; McManus DP, 2003, PARASITOLOGY, V127, pS37, DOI 10.1017/S0031182003003524; Moro PL, 2009, PARASITOL INT, V58, P184, DOI 10.1016/j.parint.2009.01.005; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nakao M, 2013, INT J PARASITOL, V43, P1017, DOI 10.1016/j.ijpara.2013.06.002; Nejad MR, 2012, J HELMINTHOL, V86, P485, DOI 10.1017/S0022149X1100071X; Omer RA, 2010, VET PARASITOL, V169, P340, DOI 10.1016/j.vetpar.2010.01.004; Piccoli L, 2013, CLIN MICROBIOL INFEC, V19, P578, DOI 10.1111/j.1469-0691.2012.03993.x; Sadjadi SM, 2006, PARASITOL INT, V55, pS197, DOI 10.1016/j.parint.2005.11.030; Shahnazi M, 2011, ACTA TROP, V117, P47, DOI 10.1016/j.actatropica.2010.09.002; Sharafi Seyedeh Maryam, 2014, Gastroenterol Hepatol Bed Bench, V7, P82; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Taha HA, 2012, PARASITOL RES, V111, P1993, DOI 10.1007/s00436-012-3046-z; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; THOMPSON RCA, 1990, INT J PARASITOL, V20, P457, DOI 10.1016/0020-7519(90)90193-Q; Yan N, 2013, VET PARASITOL, V196, P179, DOI 10.1016/j.vetpar.2013.02.010; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014	49	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118509	10.1371/journal.pone.0118509	http://dx.doi.org/10.1371/journal.pone.0118509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760944	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275000025
J	Garcia, SM; Marinho, LSR; Lunardelli, PA; Seneda, MM; Meirelles, FV				Garcia, Sheila Merlo; Rafagnin Marinho, Luciana Simoes; Lunardelli, Paula Alvares; Seneda, Marcelo Marcondes; Meirelles, Flavio Vieira			Developmental Block and Programmed Cell Death in Bos indicus Embryos: Effects of Protein Supplementation Source and Developmental Kinetics	PLOS ONE			English	Article							IN-VITRO; BOVINE EMBRYOS; DNA-DAMAGE; APOPTOSIS; PATTERN; VIVO; MITOCHONDRIAL; CLEAVAGE; TAURUS; SERUM	The aims of this study were to determine if the protein source of the medium influences zebu embryo development and if developmental kinetics, developmental block and programmed cell death are related. The culture medium was supplemented with either fetal calf serum or bovine serum albumin. The embryos were classified as Fast (n = 1,235) or Slow (n = 485) based on the time required to reach the fourth cell cycle (48 h and 90 h post insemination - hpi -, respectively). The Slow group was further separated into two groups: those presenting exactly 4 cells at 48 hpi (Slow/4 cells) and those that reached the fourth cell cycle at 90 hpi (Slow). Blastocyst quality, DNA fragmentation, mitochondrial membrane potential and signs of apoptosis or necrosis were evaluated. The Slow group had higher incidence of developmental block than the Fast group. The embryos supplemented with fetal calf serum had lower quality. DNA fragmentation and mitochondrial membrane potential were absent in embryos at 48 hpi but present at 90 hpi. Early signs of apoptosis were more frequent in the Slow and Slow/4 cell groups than in the Fast group. We concluded that fetal calf serum reduces blastocyst development and quality, but the mechanism appears to be independent of DNA fragmentation. The apoptotic cells detected at 48 hpi reveal a possible mechanism of programmed cell death activation prior to genome activation. The apoptotic cells observed in the slow-developing embryos suggested a relationship between programmed cell death and embryonic developmental kinetics in zebu in vitro-produced embryos.	[Garcia, Sheila Merlo; Meirelles, Flavio Vieira] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Pirassununga, SP, Brazil; [Rafagnin Marinho, Luciana Simoes; Lunardelli, Paula Alvares; Seneda, Marcelo Marcondes] State Univ Londrina UEL, DCV, CCA, Lab Reprod Anim, Londrina, PR, Brazil	Universidade de Sao Paulo; Universidade Estadual de Londrina	Seneda, MM (corresponding author), State Univ Londrina UEL, DCV, CCA, Lab Reprod Anim, Londrina, PR, Brazil.	mseneda@uel.br	Marinho, Luciana Rafagnin/AAZ-4903-2021; Seneda, Marcelo/AAP-9031-2020; Meirelles, Flavio V/B-5048-2010; CTC USP, CEPID 13 18/J-8951-2014	Marinho, Luciana Rafagnin/0000-0002-5816-6076; Meirelles, Flavio V/0000-0003-0372-4920; Merlo Garcia Firetti, Sheila/0000-0003-4076-6265; CTC USP, CEPID 13 18/0000-0002-7123-9524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): U$ 7000,00 (http://www.fapesp.br/), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): U$ 3000,00 (http://www.cnpq.br/). Authors who recieved the funding: SMG and FVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2000, J ANIM SCI, V78, P1291; Bastos GM, 2008, MOL REPROD DEV, V75, P282, DOI 10.1002/mrd.20798; Bo GA, 2003, ANIM REPROD SCI, V78, P307, DOI 10.1016/S0378-4320(03)00097-6; Bohrer RC, 2013, REPRODUCTION, V146, P325, DOI 10.1530/REP-13-0271; Brad AM, 2007, REPRODUCTION, V134, P789, DOI 10.1530/REP-07-0146; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Carvalho JBP, 2008, THERIOGENOLOGY, V69, P167, DOI 10.1016/j.theriogenology.2007.08.035; Chaudhari M, 2009, TOXICOLOGY, V262, P153, DOI 10.1016/j.tox.2009.06.002; Crosier AE, 2000, BIOL REPROD, V62, P1459, DOI 10.1095/biolreprod62.5.1459; Fox J., 2019, R COMPANION APPL REG, V.; GARDNER DK, 1994, BIOL REPROD, V50, P390, DOI 10.1095/biolreprod50.2.390; Gjorret JO, 2007, MOL REPROD DEV, V74, P961, DOI 10.1002/mrd.20714; Gutierrez-Adan A, 2004, MOL REPROD DEV, V68, P441, DOI 10.1002/mrd.20113; Hwang IS, 2013, J VET SCI, V14, P235, DOI 10.4142/jvs.2013.14.3.235; Jousan FD, 2007, MOL REPROD DEV, V74, P189, DOI 10.1002/mrd.20527; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; Leivas FG, 2011, THERIOGENOLOGY, V75, P429, DOI 10.1016/j.theriogenology.2010.08.017; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Pers-Kamczyc E, 2012, REPROD DOMEST ANIM, V47, P899, DOI 10.1111/j.1439-0531.2012.01987.x; Pons I, 2013, J ASSIST REPROD GEN, V30, P1211, DOI 10.1007/s10815-013-0089-8; Pontes JHF, 2011, THERIOGENOLOGY, V75, P1640, DOI 10.1016/j.theriogenology.2010.12.026; Pontes JHF, 2010, THERIOGENOLOGY, V74, P1349, DOI 10.1016/j.theriogenology.2010.06.004; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; R Core Team, 2018, R LANG ENV STAT COMP; Rooke JA, 2007, THERIOGENOLOGY, V67, P639, DOI 10.1016/j.theriogenology.2006.09.040; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Stigliani S, 2013, HUM REPROD, P1; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Sugimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036627; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; VanSoom A, 1997, MOL REPROD DEV, V47, P47, DOI 10.1002/(SICI)1098-2795(199705)47:1&lt;47::AID-MRD7&gt;3.0.CO;2-Q; Velker BAM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096602; Walser CB, 2011, CURR OPIN GENET DEV, V21, P431, DOI 10.1016/j.gde.2011.03.003; Zheng Wenjing, 2012, Results Probl Cell Differ, V55, P115, DOI 10.1007/978-3-642-30406-4_7	39	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119463	10.1371/journal.pone.0119463	http://dx.doi.org/10.1371/journal.pone.0119463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760989	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000059
J	Mirzaei, MK; Nilsson, AS				Mirzaei, Mohammadali Khan; Nilsson, Anders S.			Isolation of Phages for Phage Therapy: A Comparison of Spot Tests and Efficiency of Plating Analyses for Determination of Host Range and Efficacy	PLOS ONE			English	Article							ESCHERICHIA-COLI; REFERENCE COLLECTION; BACTERIOPHAGE; STRAINS; IDENTIFICATION; P2	Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to antibiotic treatment of bacterial infections. There are, however, several problems to be solved, mainly associated to the biology of phages, the interaction between phages and their bacterial hosts, but also to the vast variation of pathogenic bacteria which implies that large numbers of different phages are going to be needed. All of these phages must under present regulation of medical products undergo extensive clinical testing before they can be applied. It will consequently be of great economic importance that effective and versatile phages are selected and collected into phage libraries, i.e., the selection must be carried out in a way that it results in highly virulent phages with broad host ranges. We have isolated phages using the Escherichia coli reference (ECOR) collection and compared two methods, spot testing and efficiency of plating (EOP), which are frequently used to identify phages suitable for phage therapy. The analyses of the differences between the two methods show that spot tests often overestimate both the overall virulence and the host range and that the results are not correlated to the results of EOP assays. The conclusion is that single dilution spot tests cannot be used for identification and selection of phages to a phage library and should be replaced by EOP assays. The difference between the two methods can be caused by many factors. We have analysed if the differences and lack of correlation could be caused by lysis from without, bacteriocins in the phage lysate, or by the presence of pro-phages harbouring genes coding for phage resistance systems in the genomes of the bacteria in the ECOR collection.	[Mirzaei, Mohammadali Khan; Nilsson, Anders S.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Nilsson, AS (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	anders.s.nilsson@su.se	Khan Mirzaei, Mohammadali/ABB-9778-2021	Khan Mirzaei, Mohammadali/0000-0003-2801-4474	Olle Engqvist Foundation	Olle Engqvist Foundation	This work was funded by the Olle Engqvist Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasifar R, 2014, ARCH VIROL, V159, P2253, DOI 10.1007/s00705-014-2055-x; Abedon Stephen T, 2011, Bacteriophage, V1, P66; Abedon Stephen T, 2011, Bacteriophage, V1, P46, DOI 10.4161/bact.1.1.13980; Abedon ST, 2010, CURR PHARM BIOTECHNO, V11, P28, DOI 10.2174/138920110790725410; Ackermann HW, 2001, ARCH VIROL, V146, P843, DOI 10.1007/s007050170120; Al-Fendi A, 2014, J BASIC MICROB, V54, P1036, DOI 10.1002/jobm.201300458; BELTRAN P, 1991, J GEN MICROBIOL, V137, P601, DOI 10.1099/00221287-137-3-601; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BERTANI LE, 1971, ADV GENET, V16, P199, DOI 10.1016/S0065-2660(08)60359-4; Bourdin G, 2014, MICROB BIOTECHNOL, V7, P165, DOI 10.1111/1751-7915.12113; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Brussow H, 2014, CLIN INFECT DIS, V58, P535, DOI 10.1093/cid/cit776; Calendar Richard, 1998, P241; Carlson K, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P437; Castillo D, 2014, MICROB ECOL, V67, P748, DOI 10.1007/s00248-014-0375-8; Cavanagh D, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00417; CLARK WA, 1962, APPL MICROBIOL, V10, P466, DOI 10.1128/AEM.10.5.466-471.1962; Di Lallo G, 2014, J BASIC MICROB, V54, P1210, DOI 10.1002/jobm.201300951; Dziewit L, 2014, J VIROL, V88, P13111, DOI 10.1128/JVI.01875-14; Frampton RA, 2014, APPL ENVIRON MICROB, V80, P2216, DOI 10.1128/AEM.00062-14; Gill JJ, 2010, CURR PHARM BIOTECHNO, V11, P2, DOI 10.2174/138920110790725311; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Keen EC, BACTERIOPHAGE, V4; Kim M, 2014, APPL ENVIRON MICROB, V80, P1026, DOI 10.1128/AEM.03494-13; Kleppen HP, 2012, APPL ENVIRON MICROB, V78, P7299, DOI 10.1128/AEM.00031-12; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kutter E, 2010, CURR PHARM BIOTECHNO, V11, P69, DOI 10.2174/138920110790725401; Kutter Elizabeth, 2009, V501, P141, DOI 10.1007/978-1-60327-164-6_14; Matsushita K, 2009, FEMS MICROBIOL LETT, V291, P201, DOI 10.1111/j.1574-6968.2008.01455.x; Mirzaei MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116294; Mosig G, 1997, VIROLOGY, V230, P72, DOI 10.1006/viro.1997.8464; Nilsson AS, 2014, UPSALA J MED SCI, V119, P192, DOI 10.3109/03009734.2014.902878; Nilsson AS, 2004, MOL BIOL EVOL, V21, P1, DOI 10.1093/molbev/msg223; Nilsson AS, 2006, BACTERIOPHAGES, P365; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Odegrip R, 2006, J BACTERIOL, V188, P1643, DOI 10.1128/JB.188.4.1643-1647.2006; PIERONI P, 1994, J MED MICROBIOL, V41, P423, DOI 10.1099/00222615-41-6-423; Pirnay JP, 2011, PHARM RES-DORDR, V28, P934, DOI 10.1007/s11095-010-0313-5; RILEY MA, 1992, J GEN MICROBIOL, V138, P1345, DOI 10.1099/00221287-138-7-1345; Sambrook J., 2001, MOL CLONING LAB MANU; Silva YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114197; Tsonos J, 2014, VET MICROBIOL, V171, P470, DOI 10.1016/j.vetmic.2013.10.021; Verbeken G, 2014, ARCH IMMUNOL THER EX, V62, P117, DOI 10.1007/s00005-014-0269-y; Viazis S, 2011, J APPL MICROBIOL, V110, P1323, DOI 10.1111/j.1365-2672.2011.04989.x; Wittmann J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086935; Wongsuntornpoj S, 2014, VET MICROBIOL, V172, P345, DOI 10.1016/j.vetmic.2014.05.023	47	173	179	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118557	10.1371/journal.pone.0118557	http://dx.doi.org/10.1371/journal.pone.0118557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761060	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000027
J	Peterson, JM; Bell, SS				Peterson, Jennifer M.; Bell, Susan S.			Saltmarsh Boundary Modulates Dispersal of Mangrove Propagules: Implications for Mangrove Migration with Sea-Level Rise	PLOS ONE			English	Article							AVICENNIA-MARINA PROPAGULES; CLIMATE-CHANGE; FRAGMENTED LANDSCAPES; ECOLOGICAL BOUNDARIES; SOUTH FLORIDA; IMPACTS; ECOTONE; LIMITATIONS; GERMINANS; EXPANSION	Few studies have empirically examined the suite of mechanisms that underlie the distributional shifts displayed by organisms in response to changing climatic condition. Mangrove forests are expected to move inland as sea-level rises, encroaching on saltmarsh plants inhabiting higher elevations. Mangrove propagules are transported by tidal waters and propagule dispersal is likely modified upon encountering the mangrove-saltmarsh ecotone, the implications of which are poorly known. Here, using an experimental approach, we record landward and seaward dispersal and subsequent establishment of mangrove propagules that encounter biotic boundaries composed of two types of saltmarsh taxa: succulents and grasses. Our findings revealed that propagules emplaced within saltmarsh vegetation immediately landward of the extant mangrove fringe boundary frequently dispersed in the seaward direction. However, propagules moved seaward less frequently and over shorter distances upon encountering boundaries composed of saltmarsh grasses versus succulents. We uniquely confirmed that the small subset of propagules dispersing landward displayed proportionately higher establishment success than those transported seaward. Although impacts of ecotones on plant dispersal have rarely been investigated in situ, our experimental results indicate that the interplay between tidal transport and physical attributes of saltmarsh vegetation influence boundary permeability to propagules, thereby directing the initial phase of shifting mangrove distributions. The incorporation of tidal inundation information and detailed data on landscape features, such as the structure of saltmarsh vegetation at mangrove boundaries, should improve the accuracy of models that are being developed to forecast mangrove distributional shifts in response to sea-level rise.	[Peterson, Jennifer M.; Bell, Susan S.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Bell, SS (corresponding author), Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA.	sbell@usf.edu			US Department of Commerce, National Oceanic and Atmospheric Administration [NA09NOS4200033]	US Department of Commerce, National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was supported by a grant from the US Department of Commerce, National Oceanic and Atmospheric Administration (http://www.noaa.gov) #NA09NOS4200033 to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Alleman LK, 2011, ESTUAR COAST, V34, P1068, DOI 10.1007/s12237-011-9404-8; Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Berger U, 2008, AQUAT BOT, V89, P260, DOI 10.1016/j.aquabot.2007.12.015; Breitfuss MJ, 2003, ESTUAR COAST SHELF S, V56, P573, DOI 10.1016/S0272-7714(02)00207-X; Breshears DD, 2008, P NATL ACAD SCI USA, V105, P11591, DOI 10.1073/pnas.0806579105; Cadenasso ML, 2003, BIOSCIENCE, V53, P717, DOI 10.1641/0006-3568(2003)053[0717:AIASAT]2.0.CO;2; Cadenasso ML, 2003, BIOSCIENCE, V53, P750, DOI 10.1641/0006-3568(2003)053[0750:AFFATO]2.0.CO;2; Cadenasso ML, 2001, CONSERV BIOL, V15, P91, DOI 10.1046/j.1523-1739.2001.99309.x; Castro J, 2002, J VEG SCI, V13, P725, DOI 10.1658/1100-9233(2002)013[0725:MBPSCO]2.0.CO;2; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; CLARKE PJ, 1993, AQUAT BOT, V45, P195, DOI 10.1016/0304-3770(93)90021-N; Cohen MCL, 2003, WETL ECOL MANAG, V11, P223, DOI 10.1023/A:1025007331075; De Ryck DJR, 2012, AQUAT BOT, V103, P66, DOI 10.1016/j.aquabot.2012.06.005; DELANGE WP, 1994, J COASTAL RES, V10, P539; Donnelly M, 2014, ESTUAR COAST, V37, P1562, DOI 10.1007/s12237-014-9789-2; Ellison JC, 2008, AQUAT BOT, V89, P93, DOI 10.1016/j.aquabot.2008.02.007; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Gaiser EE, 2006, HYDROBIOLOGIA, V569, P237, DOI 10.1007/s10750-006-0135-y; Gilman E, 2007, ENVIRON MONIT ASSESS, V124, P105, DOI 10.1007/s10661-006-9212-y; Grinnell J., 1936, Condor, V38, P80, DOI 10.2307/1363554; Guo HY, 2013, GLOBAL CHANGE BIOL, V19, P2765, DOI 10.1111/gcb.12221; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; Jiang J, 2014, ESTUAR COAST, V37, P24, DOI 10.1007/s12237-013-9666-4; Keith SA, 2011, DIVERS DISTRIB, V17, P275, DOI 10.1111/j.1472-4642.2010.00734.x; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Krauss KW, 2011, J COAST CONSERV, V15, P629, DOI 10.1007/s11852-011-0153-4; Lopez-Medellin X, 2011, J VEG SCI, V22, P143, DOI 10.1111/j.1654-1103.2010.01232.x; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pepino M, 2012, ECOL APPL, V22, P1435; Peterson JM, 2012, ECOLOGY, V93, P1648, DOI 10.1890/11-1430.1; Renton M, 2013, ECOL MODEL, V249, P50, DOI 10.1016/j.ecolmodel.2012.07.005; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Schultz CB, 2001, ECOLOGY, V82, P1879, DOI 10.1890/0012-9658(2001)082[1879:EMDBIA]2.0.CO;2; Sousa WP, 2007, ECOL MONOGR, V77, P53, DOI 10.1890/05-1935; Teh SY, 2008, ECOL MODEL, V213, P245, DOI 10.1016/j.ecolmodel.2007.12.007; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wasson K, 2013, ESTUAR COAST, V36, P654, DOI 10.1007/s12237-013-9601-8; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	46	24	24	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119128	10.1371/journal.pone.0119128	http://dx.doi.org/10.1371/journal.pone.0119128			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760867	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000047
J	Park, JM; Wu, T; Cyr, AR; Woodfield, GW; De Andrade, JP; Spanheimer, PM; Li, T; Sugg, SL; Lal, G; Domann, FE; Zhang, W; Weigel, RJ				Park, J. M.; Wu, T.; Cyr, A. R.; Woodfield, G. W.; De Andrade, J. P.; Spanheimer, P. M.; Li, T.; Sugg, S. L.; Lal, G.; Domann, F. E.; Zhang, W.; Weigel, R. J.			The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis	ONCOGENE			English	Article							TRANSCRIPTION FACTOR AP-2-GAMMA; PATHOLOGICAL COMPLETE RESPONSE; NEGATIVE BREAST-CANCER; FACTOR RECEPTOR; EXPRESSION PATTERNS; CELL-LINES; GENE; TUMORS; AP-2; OVEREXPRESSION	TFAP2C/AP-2 gamma influences development of the mammary gland and regulates patterns of gene expression in luminal and HER2-amplified breast cancer. The roles of TFAP2C in mammary gland tumorigenesis and in pathways critical to cancer progression remain poorly understood. To gain greater insight into oncogenic mechanisms regulated by TFAP2C, we examined mammary tumorigenesis in MMTV-Neu transgenic female mice with or without conditional knockout (KO) of Tcfap2c, the mouse homolog of TFAP2C. Loss of Tcfap2c increased the latency of tumorigenesis and tumors that formed demonstrated reduced proliferative index and increased apoptosis. In addition, tumors formed in Tcfap2c KO animals had a significant reduction in Egfr levels without a change in the expression of the Neu oncogene. The MMneu-flAP2C cell line was established from tumor tissue derived from MMTV-Neu/Tcfap2c(L/L) control animals and parallel cell lines with and without expression of Tcfap2c were created by transduction with adenovirus-empty and adenovirus-Cre, respectively. KO of Tcfap2c in vitro reduced activated phosphorylated-Erk, decreased cell viability, repressed tumor growth and was associated with attenuation of Egfr expression. Chromatin immunoprecipitation and direct sequencing and expression analysis confirmed that Egfr was a Tcfap2c target gene in murine, as well as human, mammary carcinoma cells. Furthermore, decreased viability of mammary cancer cells was directly related to Egfr functional blockade. We conclude that TFAP2C regulates tumorigenesis, cell growth and survival in HER2-amplified breast cancer through transcriptional regulation of EGFR. The findings have important implications for targeting the EGFR pathway in breast cancer.	[Park, J. M.; Wu, T.; Cyr, A. R.; Woodfield, G. W.; De Andrade, J. P.; Spanheimer, P. M.; Sugg, S. L.; Lal, G.; Domann, F. E.; Weigel, R. J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; [Park, J. M.; Weigel, R. J.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Li, T.] Washington Univ, Genome Inst, St Louis, MO USA; [Domann, F. E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Domann, F. E.; Zhang, W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Weigel, R. J.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Washington University (WUSTL); University of Iowa; University of Iowa; University of Iowa	Weigel, RJ (corresponding author), Univ Iowa, Dept Surg, 200 Hawkins Dr,1516 JCP, Iowa City, IA 52242 USA.	Ronald-Weigel@uiowa.edu	Li, Tiandao/F-4039-2012	Li, Tiandao/0000-0003-1650-0555; Lal, Geeta/0000-0001-6471-6479; De Andrade, James/0000-0001-7357-9322; Sugg, Sonia/0000-0001-7530-8526; Weigel, Ronald/0000-0002-9249-0793; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health [R01CA109294, T32CA148062]; NATIONAL CANCER INSTITUTE [R01CA109294, T32CA078586, R01CA115438, T32CA148062, K08CA151658, R00CA158055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alicia Olivier from University of Iowa Pathology Core Lab for her assistance in IHC. This work was supported by the National Institutes of Health grants R01CA109294 (PI: RJW), T32CA148062 (PI: RJW) and by a generous gift from the Kristen Olewine Milke Breast Cancer Research Fund.	Allouche A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1851; Auman HJ, 2002, DEVELOPMENT, V129, P2733; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Bos M, 1997, CLIN CANCER RES, V3, P2099; Bosher JM, 1996, ONCOGENE, V13, P1701; Bria E, 2014, CANCER TREAT REV, V40, P847, DOI 10.1016/j.ctrv.2014.05.001; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Cyr AR, 2015, ONCOGENE, V34, P436, DOI 10.1038/onc.2013.569; DeFazio-Eli L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2866; Delacroix L, 2005, DNA CELL BIOL, V24, P582, DOI 10.1089/dna.2005.24.582; Friedrichs N, 2007, HISTOPATHOLOGY, V51, P814, DOI 10.1111/j.1365-2559.2007.02887.x; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Huang SX, 2008, NEOPLASIA, V10, P118, DOI 10.1593/neo.07637; Jager R, 2010, DEV DYNAM, V239, P1027, DOI 10.1002/dvdy.22239; Jager R, 2005, BREAST CANCER RES TR, V90, P273, DOI 10.1007/s10549-004-4815-x; Jager R, 2003, MOL CANCER RES, V1, P921; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kulak MV, 2013, ONCOGENE, V32, P4043, DOI 10.1038/onc.2012.400; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; MELLENTINMICHELOTTI J, 1994, J BIOL CHEM, V269, P31983; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Nieto Y, 2007, J CLIN ONCOL, V25, P4405, DOI 10.1200/JCO.2006.09.8822; Pegram MD, 1998, BREAST CANCER RES TR, V52, P65, DOI 10.1023/A:1006111117877; Pellikainen J, 2004, EUR J CANCER, V40, P1485, DOI 10.1016/j.ejca.2004.02.020; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sale S, 2013, NAT CELL BIOL, V15, P451, DOI 10.1038/ncb2725; Shiu KK, 2014, ONCOGENE, V33, P619, DOI 10.1038/onc.2012.625; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spanheimer PM, 2013, J SURG RES, V184, P519, DOI 10.1016/j.jss.2013.04.042; Turner BC, 1998, CANCER RES, V58, P5466; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2013, ONCOGENE, V32, P1338, DOI 10.1038/onc.2012.452; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woodfield GW, 2007, CANCER RES, V67, P8439, DOI 10.1158/0008-5472.CAN-07-2293; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Zhang J, 2003, DEV BIOL, V256, P127, DOI 10.1016/S0012-1606(02)00119-7	42	16	17	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2015	34	50					6105	6114		10.1038/onc.2015.59	http://dx.doi.org/10.1038/onc.2015.59			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CY0RQ	25772240	Green Accepted			2022-12-26	WOS:000366113800007
J	Plessner, M; Melak, M; Chinchilla, P; Baarlink, C; Grosse, R				Plessner, Matthias; Melak, Michael; Chinchilla, Pilar; Baarlink, Christian; Grosse, Robert			Nuclear F-actin Formation and Reorganization upon Cell Spreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORCE TRANSMISSION; TRANSCRIPTION; DYNAMICS; FILAMENTS; SRF; MECHANOTRANSDUCTION; CYTOSKELETON; COMPLEXES; PROTEINS; NETWORK	We recently discovered signal-regulated nuclear actin network assembly. However, in contrast to cytoplasmic actin regulation, polymeric nuclear actin structures and functions remain only poorly understood. Here we describe a novel molecular tool to visualize real-time nuclear actin dynamics by targeting the Actin-Chromobody-TagGFP to the nucleus, thus establishing a nuclear Actin-Chromobody. Interestingly, we observe nuclear actin polymerization into dynamic filaments upon cell spreading and fibronectin stimulation, both of which appear to be triggered by integrin signaling. Furthermore, we show that nucleoskeletal proteins such as the LINC (linker of nucleoskeleton and cytoskeleton) complex and components of the nuclear lamina couple cell spreading or integrin activation by fibronectin to nuclear actin polymerization. Spreading-induced nuclear actin polymerization results in serum response factor (SRF)-mediated transcription through nuclear retention of myocardin-related transcription factor A (MRTF-A). Our results reveal a signaling pathway, which links integrin activation by extracellular matrix interaction to nuclear actin polymerization through the LINC complex, and therefore suggest a role for nuclear actin polymerization in the context of cellular adhesion and mechanosensing.	[Plessner, Matthias; Melak, Michael; Chinchilla, Pilar; Baarlink, Christian; Grosse, Robert] Univ Marburg, Inst Pharmacol, BPC, D-35043 Marburg, Germany	Philipps University Marburg	Grosse, R (corresponding author), Univ Marburg, Inst Pharmacol, BPC, Karl von Frisch Str 1, D-35043 Marburg, Germany.	robert.grosse@staff.uni-marburg.de		Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft (DFG) [GR 2111/7-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (GR 2111/7-1).	Baarlink C, 2014, NUCLEUS-PHILA, V5, P15, DOI 10.4161/nucl.28066; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; Brandt DT, 2009, NAT CELL BIOL, V11, P557, DOI 10.1038/ncb1862; de Lanerolle P, 2011, NAT CELL BIOL, V13, P1282, DOI 10.1038/ncb2364; Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Floch AG, 2014, METHOD CELL BIOL, V122, P1, DOI 10.1016/B978-0-12-417160-2.00001-1; Gama-Carvalho M, 2001, FEBS LETT, V498, P157, DOI 10.1016/S0014-5793(01)02487-5; Grosse R, 2013, NAT REV MOL CELL BIO, V14, P693, DOI 10.1038/nrm3681; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Hendzel MJ, 2014, CURR OPIN CELL BIOL, V28, P84, DOI 10.1016/j.ceb.2014.04.003; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kaminski A, 2014, PROG MOL BIOL TRANSL, V126, P157, DOI 10.1016/B978-0-12-394624-9.00007-5; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Lombardi ML, 2011, J BIOL CHEM, V286, P26743, DOI 10.1074/jbc.M111.233700; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rocchetti A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-12; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Skarp KP, 2010, CYTOSKELETON, V67, P487, DOI 10.1002/cm.20464; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Treisman R, 2013, TRENDS BIOCHEM SCI, V38, P376, DOI 10.1016/j.tibs.2013.06.004; Vartiainen MK, 2008, FEBS LETT, V582, P2033, DOI 10.1016/j.febslet.2008.04.010; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Weston L, 2012, J CELL SCI, V125, P3519, DOI 10.1242/jcs.099523	32	151	154	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11209	11216		10.1074/jbc.M114.627166	http://dx.doi.org/10.1074/jbc.M114.627166			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25759381	Green Published, hybrid			2022-12-26	WOS:000353719400001
J	Barbour, SE; Nguyen, PT; Park, M; Emani, B; Lei, XY; Kambalapalli, M; Shultz, JC; Wijesinghe, D; Chalfant, CE; Ramanadham, S				Barbour, Suzanne E.; Nguyen, Phuong T.; Park, Margaret; Emani, Bhargavi; Lei, Xiaoyong; Kambalapalli, Mamatha; Shultz, Jacqueline C.; Wijesinghe, Dayanjan; Chalfant, Charles E.; Ramanadham, Sasanka			Group VIA Phospholipase A(2) (iPLA(2)beta) Modulates Bcl-x 5 '-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; PRE-MESSENGER-RNA; ARACHIDONIC-ACID METABOLISM; INSULIN-SECRETING CELLS; HUMAN PANCREATIC-ISLETS; ER STRESS; CERAMIDE GENERATION; PROTEIN; EXPRESSION; 12-LIPOXYGENASE	Diabetes is a consequence of reduced beta-cell function and mass, due to beta-cell apoptosis. Endoplasmic reticulum (ER) stress is induced during beta-cell apoptosis due to various stimuli, and our work indicates that group VIA phospholipase A(2)beta (iPLA(2)beta) participates in this process. Delineation of underlying mechanism(s) reveals that ER stress reduces the anti-apoptotic Bcl-x(L) protein in INS-1 cells. The Bcl-x pre-mRNA undergoes alternative pre-mRNA splicing to generate Bcl-x(L) or Bcl-x(S) mature mRNA. We show that both thapsigargin-induced and spontaneous ER stress are associated with reductions in the ratio of Bcl-x(L)/Bcl-x(S) mRNA in INS-1 and islet beta-cells. However, chemical inactivation or knockdown of iPLA(2)beta augments the Bcl-x(L)/Bcl-x(S) ratio. Furthermore, the ratio is lower in islets from islet-specific RIP-iPLA(2)beta transgenic mice, whereas islets from global iPLA(2)beta(-/-) mice exhibit the opposite phenotype. In view of our earlier reports that iPLA(2)beta induces ceramide accumulation through neutral sphingomyelinase 2 and that ceramides shift the Bcl-x 5'-splice site (5'SS) selection in favor of Bcl-x(S), we investigated the potential link between Bcl-x splicing and the iPLA(2)beta/ceramide axis. Exogenous C-6-ceramide did not alter Bcl-x 5'SS selection in INS-1 cells, and neutral sphingomyelinase 2 inactivation only partially prevented the ER stress-induced shift in Bcl-x splicing. In contrast, 5(S)-hydroxytetraenoic acid augmented the ratio of Bcl-x(L)/Bcl-x(S) by 15.5-fold. Taken together, these data indicate that beta-cell apoptosis is, in part, attributable to the modulation of 5'SS selection in the Bcl-x pre-mRNA by bioactive lipids modulated by iPLA(2)beta.	[Barbour, Suzanne E.; Nguyen, Phuong T.; Park, Margaret; Emani, Bhargavi; Kambalapalli, Mamatha; Shultz, Jacqueline C.; Wijesinghe, Dayanjan; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Lei, Xiaoyong; Ramanadham, Sasanka] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Lei, Xiaoyong; Ramanadham, Sasanka] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Wijesinghe, Dayanjan; Chalfant, Charles E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA 23249 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Med Coll Virginia, Massey Canc Ctr, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Reanimat Engn Sci Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Ramanadham, S (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	sramvem@uab.edu			National Institutes of Health from NIDDK [DK-69455]; National Institutes of Health from NHLBI [HL91388]; National Institutes of Health from NCI Cancer Center [HL072925, CA154314, NH1C06-RR17393, P30 CA016059]; American Diabetes Association; National Science Foundation [MCB 0544068]; Virginia Commonwealth University Presidential Research Incentive Program; Veterans Affairs Merit Award [BX001792]; Research Career Scientist Award; United States Israel Bi-National Science Foundation [2011380]; NATIONAL CANCER INSTITUTE [R01CA154314, P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058, KL2TR000057] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072925, R01HL125353, R21HL091388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069455] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010641] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NCI Cancer Center; American Diabetes Association(American Diabetes Association); National Science Foundation(National Science Foundation (NSF)); Virginia Commonwealth University Presidential Research Incentive Program; Veterans Affairs Merit Award(US Department of Veterans Affairs); Research Career Scientist Award(US Department of Veterans Affairs); United States Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant DK-69455 from NIDDK (to S. R.), Grant HL91388 from NHLBI (to S. E. B.), Grants HL072925 (to C. E C.), CA154314 (to C. E. C.), and NH1C06-RR17393 (to Virginia Commonwealth University), and P30 CA016059 from NCI Cancer Center. This work was also supported by the American Diabetes Association (to S. R.), National Science Foundation Grant MCB 0544068 (to S. E. B.), Virginia Commonwealth University Presidential Research Incentive Program (to S. E. B.), Veterans Affairs Merit Award BX001792 (to C. E. C.), a Research Career Scientist Award (to C. E. C.), and Grant BSF#2011380 from the United States Israel Bi-National Science Foundation (to C. E. C.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Atsumi G, 1998, J BIOL CHEM, V273, P13870, DOI 10.1074/jbc.273.22.13870; Bao S, 2008, AM J PHYSIOL-ENDOC M, V294, pE217, DOI 10.1152/ajpendo.00474.2007; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bauman JA, 2010, NUCLEIC ACIDS RES, V38, P8348, DOI 10.1093/nar/gkq731; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Bone RN, 2015, DIABETES, V64, P541, DOI 10.2337/db14-0097; Braun T, 2003, MOL CANCER RES, V1, P186; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Carrington EM, 2009, DIABETES, V58, P2316, DOI 10.2337/db08-1602; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Ealovega MW, 1996, CANCER RES, V56, P1965; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gijon MA, 1997, SEMIN CELL DEV BIOL, V8, P297, DOI 10.1006/scdb.1997.0151; Green-Mitchell SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056763; GROSS RW, 1993, BIOCHEMISTRY-US, V32, P327, DOI 10.1021/bi00052a041; Han JS, 1998, SPRINGER SEMIN IMMUN, V19, P279, DOI 10.1007/BF00787225; Holohan C, 2008, J CELL MOL MED, V12, P591, DOI 10.1111/j.1582-4934.2007.00191.x; HUGHES JH, 1989, DIABETES, V38, P1251, DOI 10.2337/diabetes.38.10.1251; Hui HX, 2005, DIABETES, V54, P424, DOI 10.2337/diabetes.54.2.424; Iwawaki T, 2013, SEMIN IMMUNOPATHOL, V35, P333, DOI 10.1007/s00281-013-0369-5; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Klein D, 2004, BIOCHEM BIOPH RES CO, V323, P473, DOI 10.1016/j.bbrc.2004.08.116; Lei XY, 2007, BIOCHEMISTRY-US, V46, P10170, DOI 10.1021/bi700017z; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lei XY, 2013, ISLETS, V5, P29, DOI 10.4161/isl.23758; Lei XY, 2012, AM J PHYSIOL-ENDOC M, V303, pE1386, DOI 10.1152/ajpendo.00234.2012; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Leu S, 2012, J CELL SCI, V125, P3164, DOI 10.1242/jcs.100859; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Ma ZM, 2001, J BIOL CHEM, V276, P13198, DOI 10.1074/jbc.M010423200; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Michels J., 2013, INT J CELL BIOL, V2013; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Nowatzke W, 1998, ENDOCRINOLOGY, V139, P4073, DOI 10.1210/en.139.10.4073; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Persaud SJ, 2007, DIABETES, V56, P197, DOI 10.2337/db06-0490; Prasad KMR, 2003, BIOCHEM BIOPH RES CO, V308, P427, DOI 10.1016/S0006-291X(03)01418-9; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P5339, DOI 10.1021/bi00071a009; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P337, DOI 10.1021/bi00052a042; Ramanadham S, 2004, BIOCHEMISTRY-US, V43, P918, DOI 10.1021/bi035536m; RAMANADHAM S, 1994, BIOCHEMISTRY-US, V33, P7442, DOI 10.1021/bi00189a052; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Sesti G, 2002, ANN MED, V34, P444, DOI 10.1080/078538902321012397; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Socha L, 2003, ANN NY ACAD SCI, V1005, P178, DOI 10.1196/annals.1288.022; Tao HM, 2002, J BIOL CHEM, V277, P31270, DOI 10.1074/jbc.M203196200; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; TURK J, 1988, DIABETES, V37, P992, DOI 10.2337/diabetes.37.7.992; TURK J, 1992, BIOCHIM BIOPHYS ACTA, V1125, P280, DOI 10.1016/0005-2760(92)90057-3; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Wijesinghe DS, 2014, J LIPID RES, V55, P1298, DOI 10.1194/jlr.M048207; Xiao QL, 2012, J NEUROSCI, V32, P13587, DOI 10.1523/JNEUROSCI.2617-12.2012; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081; Yang HP, 2004, HEPATOLOGY, V40, P221, DOI 10.1002/hep.20274; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	81	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11021	11031		10.1074/jbc.M115.648956	http://dx.doi.org/10.1074/jbc.M115.648956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762722	hybrid, Green Published			2022-12-26	WOS:000353404500038
J	Tokarski, JS; Zupa-Fernandez, A; Tredup, JA; Pike, K; Chang, CY; Xie, DL; Cheng, LH; Pedicord, D; Muckelbauer, J; Johnson, SR; Wu, S; Edavettal, SC; Hong, Y; Witmer, MR; Elkin, LL; Blat, Y; Pitts, WJ; Weinstein, DS; Burke, JR				Tokarski, John S.; Zupa-Fernandez, Adriana; Tredup, Jeffrey A.; Pike, Kristen; Chang, ChiehYing; Xie, Dianlin; Cheng, Lihong; Pedicord, Donna; Muckelbauer, Jodi; Johnson, Stephen R.; Wu, Sophie; Edavettal, Suzanne C.; Hong, Yang; Witmer, Mark R.; Elkin, Lisa L.; Blat, Yuval; Pitts, William J.; Weinstein, David S.; Burke, James R.			Tyrosine Kinase 2-mediated Signal Transduction in T Lymphocytes Is Blocked by Pharmacological Stabilization of Its Pseudokinase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V617F JAK2; TYK2; ACTIVATION; INHIBITOR; MUTATION; EFFICACY; SAFETY; ANTIBODY; THERAPY; PLACEBO	Inhibition of signal transduction downstream of the IL-23 receptor represents an intriguing approach to the treatment of autoimmunity. Using a chemogenomics approach marrying kinome-wide inhibitory profiles of a compound library with the cellular activity against an IL-23-stimulated transcriptional response in T lymphocytes, a class of inhibitors was identified that bind to and stabilize the pseudokinase domain of the Janus kinase tyrosine kinase 2 (Tyk2), resulting in blockade of receptor-mediated activation of the adjacent catalytic domain. These Tyk2 pseudokinase domain stabilizers were also shown to inhibit Tyk2-dependent signaling through the Type I interferon receptor but not Tyk2-independent signaling and transcriptional cellular assays, including stimulation through the receptors for IL-2 (JAK1- and JAK3-dependent) and thrombopoietin (JAK2-dependent), demonstrating the high functional selectivity of this approach. A crystal structure of the pseudokinase domain liganded with a representative example showed the compound bound to a site analogous to the ATP-binding site in catalytic kinases with features consistent with high ligand selectivity. The results support a model where the pseudokinase domain regulates activation of the catalytic domain by forming receptor-regulated inhibitory interactions. Tyk2 pseudokinase stabilizers, therefore, represent a novel approach to the design of potent and selective agents for the treatment of autoimmunity.	[Tokarski, John S.; Chang, ChiehYing; Muckelbauer, Jodi; Johnson, Stephen R.] Bristol Myers Squibb Res & Dev, Dept Mol Struct & Design, Princeton, NJ 08543 USA; [Zupa-Fernandez, Adriana; Cheng, Lihong; Burke, James R.] Bristol Myers Squibb Res & Dev, Dept Immunosci Biol, Princeton, NJ 08543 USA; [Tredup, Jeffrey A.; Xie, Dianlin; Wu, Sophie; Edavettal, Suzanne C.; Witmer, Mark R.] Bristol Myers Squibb Res & Dev, Dept Prot Sci, Princeton, NJ 08543 USA; [Pedicord, Donna; Blat, Yuval] Bristol Myers Squibb Res & Dev, Dept Leads Discovery & Optimizat, Princeton, NJ 08543 USA; [Hong, Yang; Pitts, William J.; Weinstein, David S.] Bristol Myers Squibb Res & Dev, Dept Discovery Chem, Princeton, NJ 08543 USA; [Pike, Kristen; Elkin, Lisa L.] Bristol Myers Squibb Res & Dev, Dept Leads Discovery & Optimizat, Wallingford, CT 06492 USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Burke, JR (corresponding author), Bristol Myers Squibb Res & Dev, Immunosci Biol, Mail Stop K24-03,POB 4000, Princeton, NJ 08543 USA.	james.burke@bms.com		Pitts, William/0000-0002-1034-6043				Ban M, 2009, EUR J HUM GENET, V17, P1309, DOI 10.1038/ejhg.2009.41; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Bricogne G., 2011, BUSTER; Constantinescu SN, 2013, BIOCHEM SOC T, V41, P1048, DOI 10.1042/BST20130084; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Doyle ML, 1995, METHOD ENZYMOL, V259, P183; Dyckman A., 2008, United States Patent, Patent No. 7456194; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Geremia A, 2011, J EXP MED, V208, P1127, DOI 10.1084/jem.20101712; Gillooly KM, 2009, J PHARMACOL EXP THER, V331, P349, DOI 10.1124/jpet.109.156018; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Kempson J, 2009, J MED CHEM, V52, P1994, DOI 10.1021/jm8015816; Liang J, 2013, J MED CHEM, V56, P4521, DOI 10.1021/jm400266t; Longbrake EE, 2009, EXPERT REV NEUROTHER, V9, P319, DOI 10.1586/14737175.9.3.319; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1233, DOI 10.1517/13543776.2012.723693; Ortmann R, 2001, J IMMUNOL, V166, P5712, DOI 10.4049/jimmunol.166.9.5712; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oyamada A, 2009, J IMMUNOL, V183, P7539, DOI 10.4049/jimmunol.0902740; Percy MJ, 2005, HEMATOL ONCOL, V23, P91, DOI 10.1002/hon.761; Pieri L, 2009, HAEMATOL-HEMATOL J, V94, P1537, DOI 10.3324/haematol.2009.007047; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Purandare AV, 2012, LEUKEMIA, V26, P280, DOI 10.1038/leu.2011.292; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Shide K, 2007, LEUKEMIA RES, V31, P1077, DOI 10.1016/j.leukres.2006.08.018; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strober BE, 2011, BRIT J DERMATOL, V165, P661, DOI 10.1111/j.1365-2133.2011.10419.x; Toms AV, 2013, NAT STRUCT MOL BIOL, V20, P1221, DOI 10.1038/nsmb.2673; Vincenti F, 2012, AM J TRANSPLANT, V12, P2446, DOI 10.1111/j.1600-6143.2012.04127.x; Vollmer TL, 2011, MULT SCLER J, V17, P181, DOI 10.1177/1352458510384496; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001	44	64	64	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11061	11074		10.1074/jbc.M114.619502	http://dx.doi.org/10.1074/jbc.M114.619502			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762719	Green Published, hybrid			2022-12-26	WOS:000353404500042
J	Moradi, S; Berry, R; Pymm, P; Hitchen, C; Beckham, SA; Wilce, MCJ; Walpole, NG; Clements, CS; Reid, HH; Perugini, MA; Brooks, AG; Rossjohn, J; Vivian, JP				Moradi, Shoeib; Berry, Richard; Pymm, Phillip; Hitchen, Corinne; Beckham, Simone A.; Wilce, Matthew C. J.; Walpole, Nicholas G.; Clements, Craig S.; Reid, Hugh H.; Perugini, Matthew A.; Brooks, Andrew G.; Rossjohn, Jamie; Vivian, Julian P.			The Structure of the Atypical Killer Cell Immunoglobulin-like Receptor, KIR2DL4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Immunoglobulin Fold; Natural Killer Cells (NK Cells); Protein Structure; Receptor Structure-Function; Small Angle X-ray Scattering (SAXS)	SIZE-DISTRIBUTION ANALYSIS; CRYSTAL-STRUCTURE; HLA-G; ACTIVATING RECEPTOR; CUTTING EDGE; NK CELLS; RECOGNITION; CD158D; EXPRESSION; ULTRACENTRIFUGATION	Background: KIR2DL4 is an important natural killer cell receptor with properties distinct from other KIRs. Results: The D0 domain of KIR2DL4 drove self-association of the receptor. Conclusion: Among KIRs, the self-association of KIR2DL4 is unique and a result of discrete differences in its D0 domain. Significance: The self-association of KIR2DL4 has implications for its unique signaling and function. The engagement of natural killer cell immunoglobulin-like receptors (KIRs) with their target ligands, human leukocyte antigen (HLA) molecules, is a critical component of innate immunity. Structurally, KIRs typically have either two (D1-D2) or three (D0-D1-D2) extracellular immunoglobulin domains, with the D1 and D2 domain recognizing the 1 and 2 helices of HLA, respectively, whereas the D0 domain of the KIR3DLs binds a loop region flanking the 1 helix of the HLA molecule. KIR2DL4 is distinct from other KIRs (except KIR2DL5) in that it does not contain a D1 domain and instead has a D0-D2 arrangement. Functionally, KIR2DL4 is also atypical in that, unlike all other KIRs, KIR2DL4 has both activating and inhibitory signaling domains. Here, we determined the 2.8 angstrom crystal structure of the extracellular domains of KIR2DL4. Structurally, KIR2DL4 is reminiscent of other KIR2DL receptors, with the D0 and D2 adopting the C2-type immunoglobulin fold arranged with an acute elbow angle. However, KIR2DL4 self-associated via the D0 domain in a concentration-dependent manner and was observed as a tetramer in the crystal lattice by size exclusion chromatography, dynamic light scattering, analytical ultracentrifugation, and small angle x-ray scattering experiments. The assignment of residues in the D0 domain to forming the KIR2DL4 tetramer precludes an interaction with HLA akin to that observed for KIR3DL1. Accordingly, no interaction was observed to HLA by direct binding studies. Our data suggest that the unique functional properties of KIR2DL4 may be mediated by self-association of the receptor.	[Moradi, Shoeib; Berry, Richard; Pymm, Phillip; Hitchen, Corinne; Beckham, Simone A.; Wilce, Matthew C. J.; Walpole, Nicholas G.; Clements, Craig S.; Reid, Hugh H.; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Berry, Richard; Rossjohn, Jamie; Vivian, Julian P.] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic 3086, Australia; [Brooks, Andrew G.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; La Trobe University; University of Melbourne; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	Jamie.rossjohn@monash.edu; Julian.vivian@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; berry, richard/0000-0001-7043-0469; Moradi, Shoeib/0000-0003-2808-4579; Pymm, Phillip/0000-0003-2722-4621; Vivian, Julian/0000-0002-9400-4437; Brooks, Andrew/0000-0002-4085-9683	Australian Research Council (ARC) [DE130101504]; National Health and Medical Research Council (NHMRC) of Australia [1046685]; NHMRC Peter Doherty Fellowship [GNT1035636]; NHMRC Australia Fellowship; ARC DECRA Fellowship	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC DECRA Fellowship(Australian Research Council)	This work was supported by Australian Research Council (ARC) Grant DE130101504 and by National Health and Medical Research Council (NHMRC) of Australia Grant 1046685.; Supported by NHMRC Peter Doherty Fellowship GNT1035636.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. E-mail: Jamie.rossjohn@monash.edu.; Supported by an ARC DECRA Fellowship. To whom correspondence may be addressed. E-mail: Julian.vivian@monash.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; Brown PH, 2007, BIOMACROMOLECULES, V8, P2011, DOI 10.1021/bm070193j; Brusilovsky M, 2013, J IMMUNOL, V191, P5256, DOI 10.4049/jimmunol.1302079; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; Cantoni C, 1998, EUR J IMMUNOL, V28, P1980, DOI 10.1002/(SICI)1521-4141(199806)28:06<1980::AID-IMMU1980>3.0.CO;2-F; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clements CS, 2006, ACTA CRYSTALLOGR F, V62, P70, DOI 10.1107/S1744309105041473; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Finton KA, 2012, IMMUNOL REV, V250, P239, DOI 10.1111/j.1600-065X.2012.01168.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goding J.W., 1996, MONOCLONAL ANTIBODIE, Vthird, P234; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Graef T, 2009, J EXP MED, V206, P2557, DOI 10.1084/jem.20091010; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hecht ML, 2009, J PROTEOME RES, V8, P712, DOI 10.1021/pr800747c; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Kikuchi-Maki A, 2003, J IMMUNOL, V171, P3415, DOI 10.4049/jimmunol.171.7.3415; Laue T. M., 1991, ANAL ULTRACENTRIFUGA, P90; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Page MEL, 2014, J IMMUNOL, V192, P732, DOI 10.4049/jimmunol.1301748; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu JX, 2014, P NATL ACAD SCI USA, V111, P2662, DOI 10.1073/pnas.1322052111; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McVicar D W, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.75.re1; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; O'Connor GM, 2014, J IMMUNOL, V192, P2875, DOI 10.4049/jimmunol.1303142; PARHAM P, 1979, J IMMUNOL, V123, P342; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 2001, J IMMUNOL, V167, P1877, DOI 10.4049/jimmunol.167.4.1877; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Rajagopalan S, 2012, P NATL ACAD SCI USA, V109, P20596, DOI 10.1073/pnas.1208248109; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rajagopalan S, 2010, TRAFFIC, V11, P1381, DOI 10.1111/j.1600-0854.2010.01112.x; Saulquin X, 2003, J EXP MED, V197, P933, DOI 10.1084/jem.20021624; Saunders PM, 2015, J IMMUNOL, V194, P781, DOI 10.4049/jimmunol.1402542; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sivori S, 2010, BLOOD, V116, P1637, DOI 10.1182/blood-2009-12-256586; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517	58	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10460	10471		10.1074/jbc.M114.612291	http://dx.doi.org/10.1074/jbc.M114.612291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759384	Green Published, hybrid			2022-12-26	WOS:000353241100045
J	Chung, S; Spruston, N; Koh, S				Chung, Sungkwon; Spruston, Nelson; Koh, Sookyong			Age-Dependent Changes in Intrinsic Neuronal Excitability in Subiculum after Status Epilepticus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SPONTANEOUS RECURRENT SEIZURES; EARLY-LIFE SEIZURES; PYRAMIDAL NEURONS; KAINIC ACID; IN-VITRO; LONG-TERM; INTERICTAL ACTIVITY; ENTORHINAL CORTEX; RAT HIPPOCAMPUS	Kainic acid-induced status epilepticus (KA-SE) in mature rats results in the development of spontaneous recurrent seizures and a pattern of cell death resembling hippocampal sclerosis in patients with temporal lobe epilepsy. In contrast, KA-SE in young animals before postnatal day (P) 18 is less likely to cause cell death or epilepsy. To investigate whether changes in neuronal excitability occur in the subiculum after KA-SE, we examined the age-dependent effects of SE on the bursting neurons of subiculum, the major output region of the hippocampus. Patch-clamp recordings were used to monitor bursting in pyramidal neurons in the subiculum of rat hippocampal slices. Neurons were studied either one or 2-3 weeks following injection of KA or saline (control) in immature (P15) or more mature (P30) rats, which differ in their sensitivity to KA as well as the long-term sequelae of the KA-SE. A significantly greater proportion of subicular pyramidal neurons from P15 rats were strong-bursting neurons and showed increased frequency-dependent bursting compared to P30 animals. Frequency-dependent burst firing was enhanced in P30, but not in P15 rats following KA-SE. The enhancement of bursting induced by KA-SE in more mature rats suggests that the frequency-dependent limitation of repetitive burst firing, which normally occurs in the subiculum, is compromised following SE. These changes could facilitate the initiation of spontaneous recurrent seizures or their spread from the hippocampus to other parts of the brain.	[Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon, South Korea; [Spruston, Nelson] Janelia Res Campus, Sci Program, Ashburn, VA USA; [Koh, Sookyong] Northwestern Univ, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60611 USA	Sungkyunkwan University (SKKU); Northwestern University; Feinberg School of Medicine	Koh, S (corresponding author), Northwestern Univ, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Neurobiol Program, Chicago, IL 60611 USA.	skoh@luriechildrens.org	CHUNG, SUNGKWON/ABF-8293-2021	Spruston, Nelson/0000-0003-3118-1636	NIH/NINDS [R01 NS073768, NS35180]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073768] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH/NINDS R01 NS073768 (SK) and NS35180 (NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala B.J., 1984, BRAIN RES, V315, P139; Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029; Behr J, 2000, BRAIN RES, V867, P259, DOI 10.1016/S0006-8993(00)02324-6; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2001, EPILEPSIA, V42, P5, DOI 10.1046/j.1528-1157.2001.042suppl.3005.x; Benini R, 2005, J PHYSIOL-LONDON, V566, P885, DOI 10.1113/jphysiol.2005.088708; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bulinski JC, 1998, PROG NEUROBIOL, V55, P641, DOI 10.1016/S0301-0082(98)00023-9; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; Cooper DC, 2005, PLOS BIOL, V3, P1123, DOI 10.1371/journal.pbio.0030175; de Guzman P, 2006, HIPPOCAMPUS, V16, P843, DOI 10.1002/hipo.20215; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; Drexel M, 2011, NEUROSCIENCE, V189, P316, DOI 10.1016/j.neuroscience.2011.05.021; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Elliott RC, 2003, J NEUROSCI, V23, P2218; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Graef JD, 2009, J NEUROSCI, V29, P4430, DOI 10.1523/JNEUROSCI.0198-09.2009; Graves AR, 2012, NEURON, V76, P776, DOI 10.1016/j.neuron.2012.09.036; Hargus NJ, 2011, NEUROBIOL DIS, V41, P361, DOI 10.1016/j.nbd.2010.10.004; HEINEMANN U, 1993, HIPPOCAMPUS, V3, P89; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; Huang L, 2012, BRAIN BEHAV, V2, P532, DOI 10.1002/brb3.70; JENSEN FE, 1992, EPILEPSIA, V33, P971, DOI 10.1111/j.1528-1157.1992.tb01746.x; Jung HY, 2001, J NEUROSCI, V21, P3312, DOI 10.1523/JNEUROSCI.21-10-03312.2001; Knopp A, 2005, J COMP NEUROL, V483, P476, DOI 10.1002/cne.20460; Knopp A, 2008, BRAIN, V131, P1516, DOI 10.1093/brain/awn095; Koh S, 1999, NEUROLOGY, V53, P915, DOI 10.1212/WNL.53.5.915; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mlsna LM, 2013, EPILEPSY BEHAV, V29, P190, DOI 10.1016/j.yebeh.2013.07.018; Moore SJ, 2009, NEURON, V61, P287, DOI 10.1016/j.neuron.2008.12.013; MOSHE SL, 1983, ANN NEUROL, V13, P552, DOI 10.1002/ana.410130514; Naber PA, 1998, J COMP NEUROL, V393, P284; NADLER JV, 1981, LIFE SCI, V29, P2031; NITECKA L, 1984, NEUROSCIENCE, V13, P1073, DOI 10.1016/0306-4522(84)90289-6; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Palma E, 2006, P NATL ACAD SCI USA, V103, P8465, DOI 10.1073/pnas.0602979103; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Raol YSH, 2003, ANN NEUROL, V53, P503, DOI 10.1002/ana.10490; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Sanchez RM, 2001, EPILEPSIA, V42, P577, DOI 10.1046/j.1528-1157.2001.12000.x; Schwarcz R, 2002, EPILEPSY RES, V50, P161, DOI 10.1016/S0920-1211(02)00077-3; Schwarcz R, 2000, ANN NY ACAD SCI, V911, P328; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; SPERBER EF, 1991, DEV BRAIN RES, V60, P88, DOI 10.1016/0165-3806(91)90158-F; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; WASTERLAIN CG, 1976, NEUROLOGY, V26, P975, DOI 10.1212/WNL.26.10.975; Wellmer J, 2002, EUR J NEUROSCI, V16, P259, DOI 10.1046/j.1460-9568.2002.02086.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wittenberg GM, 2006, J NEUROSCI, V26, P6610, DOI 10.1523/JNEUROSCI.5388-05.2006; Witter MP, 2006, BEHAV BRAIN RES, V174, P251, DOI 10.1016/j.bbr.2006.06.022; Wozny C, 2005, EPILEPSIA, V46, P17, DOI 10.1111/j.1528-1167.2005.01066.x; Wozny C, 2003, SCIENCE, V301, P463; Zhang X, 2002, J NEUROSCI, V22, P6052	60	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119411	10.1371/journal.pone.0119411	http://dx.doi.org/10.1371/journal.pone.0119411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775210	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500090
J	Dyer, KD; Rosenberg, HF				Dyer, Kimberly D.; Rosenberg, Helene F.			Physiologic Concentrations of HMGB1 Have No Impact on Cytokine-Mediated Eosinophil Survival or Chemotaxis in Response to Eotaxin-2 (CCL24)	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; MOLECULAR-PATTERN MOLECULES; SERUM-LEVELS; PROTEIN; EXPRESSION; INFLAMMATION; ACTIVATION; RECEPTORS; RAGE	HMGB1 is an alarmin that can stimulate the innate immune system alone or in a complex with other inflammatory mediators. Given the recent interest in HMGB1 with respect to the pathogenesis of eosinophil-associated disorders, including asthmatic inflammation and chronic rhinosinusitis, we have explored the role of this mediator and in promoting eosinophil activation. HMGB1 receptors RAGE and TLR4 but not TLR2 were detected on freshly isolated human eosinophils from healthy donors. Physiologic and relevant pathophysiologic levels of biologically-active HMGB1 had no effect on survival of human eosinophils alone or in combination with pro-survival cytokines IL-5, IL-3, or GM-CSF, and increasing concentrations of HMGB1 had no impact on surface expression of RAGE, TLR2 or TLR4. Similarly, HMGB1 did not elicit chemotaxis of human eosinophils alone and had no effect in combination with the eosinophil chemotactic agent, eotaxin-2 (CCL24). However, surface expression of TLR2 and TLR4 increased in response to cell stress, notably on eosinophils that remain viable after 48 hours without IL-5. As such, HMGB1 signaling on eosinophils may be substantially more detailed, and may involve complex immunostimulatory pathways other than or in addition to those evaluated here.	[Dyer, Kimberly D.; Rosenberg, Helene F.] NIAID, Inflammat Immunobiol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Dyer, KD (corresponding author), NIAID, Inflammat Immunobiol Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kdyer@niaid.nih.gov			NIAID Division of Intramural Research [AI000941]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000941] Funding Source: NIH RePORTER	NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the NIAID Division of Intramural Research #AI000941 to HFR. Funding supported the design, execution and interpretation of the results. Source of funding did not play a role in the performance, decision to publish or preparation of the manuscript.	Bellussi LM, 2013, J BIOL REG HOMEOS AG, V27, P791; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Calogero S, 1999, NAT GENET, V22, P276, DOI 10.1038/10338; Chen DS, 2014, INT FORUM ALLERGY RH, V4, P453, DOI 10.1002/alr.21294; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen T, 2014, EXP DERMATOL, V23, P419, DOI 10.1111/exd.12422; Chen T, 2013, ARCH DERMATOL RES, V305, P263, DOI 10.1007/s00403-013-1330-0; Curran CS, 2011, INT IMMUNOL, V23, P713, DOI 10.1093/intimm/dxr083; Dyer KD, 2013, METHODS MOL BIOL, V1032, P59, DOI 10.1007/978-1-62703-496-8_5; Gero D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065994; Goldstein RS, 2007, MOL MED, V13, P210, DOI 10.2119/2006-00108.Goldstein; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hou CC, 2011, MOL MED, V17, P807, DOI 10.2119/molmed.2010.00173; Ilmarinen Pinja, 2014, J Cell Death, V7, P1, DOI 10.4137/JCD.S13588; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Keyel PA, 2014, CYTOKINE, V69, P136, DOI 10.1016/j.cyto.2014.03.007; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Lotfi R, 2009, J IMMUNOL, V183, P5023, DOI 10.4049/jimmunol.0900504; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Musumeci D, 2014, PHARMACOL THERAPEUT, V141, P347, DOI 10.1016/j.pharmthera.2013.11.001; Nagase H, 2003, J IMMUNOL, V171, P3977, DOI 10.4049/jimmunol.171.8.3977; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Percopo CM, 2010, EXP DERMATOL, V19, P467, DOI 10.1111/j.1600-0625.2009.00974.x; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Salpietro C, 2013, INT ARCH ALLERGY IMM, V161, P116, DOI 10.1159/000345246; Schleimer RP, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P508; Shim EJ, 2012, CLIN EXP ALLERGY, V42, P958, DOI 10.1111/j.1365-2222.2012.03998.x; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; Ueno H, 2004, AM J RESP CRIT CARE, V170, P1310, DOI 10.1164/rccm.200402-188OC; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wibisono D, 2010, ANN RHEUM DIS, V69, P1888, DOI 10.1136/ard.2009.119172; Wong CK, 2007, AM J RESP CELL MOL, V37, P85, DOI 10.1165/rcmb.2006-0457OC; Yanai H, 2014, J INTERN MED, V276, P444, DOI 10.1111/joim.12285; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zickert A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3747	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118887	10.1371/journal.pone.0118887	http://dx.doi.org/10.1371/journal.pone.0118887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774667	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500049
J	Gu, LQ; Robinson, RAS				Gu, Liqing; Robinson, Rena A. S.			Multiple Proteases to Localize Oxidation Sites	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; TOP-DOWN PROTEOMICS; MASS-SPECTROMETRY; PROTEIN CARBONYLATION; METHIONINE RESIDUES; ION MOBILITY; IDENTIFICATION; PEPTIDES; PHENYLALANINE; PATHWAY	Proteins present in cellular environments with high levels of reactive oxygen and nitrogen species and/or low levels of antioxidants are highly susceptible to oxidative post-translational modification (PTM). Irreversible oxidative PTMs can generate a complex distribution of modified protein molecules, recently termed as proteoforms. Using ubiquitin as a model system, we mapped oxidative modification sites using trypsin, Lys-C, and Glu-C peptides. Several M+16 Da proteoforms were detected as well as proteoforms that include other previously unidentified oxidative modifications. This work highlights the use of multiple protease digestions to give insights to the complexity of oxidative modifications possible in bottom-up analyses.	[Gu, Liqing; Robinson, Rena A. S.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Robinson, RAS (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	rena@pitt.edu	Hensel, Edward/Q-6753-2019	Hensel, Edward/0000-0002-2682-0766	University of Pittsburgh Start-Up Funds (RASR)	University of Pittsburgh Start-Up Funds (RASR)	This research was supported by the University of Pittsburgh Start-Up Funds (RASR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye TT, 2005, ANAL CHEM, V77, P5814, DOI 10.1021/ac050353m; BACARESEHAMILTON AJ, 1985, PEPTIDES, V6, P17, DOI 10.1016/0196-9781(85)90069-5; Bakhtiar R, 2005, BIOCHEM BIOPH RES CO, V334, P1, DOI 10.1016/j.bbrc.2005.05.138; Borazjani A, 2011, CHEM-BIOL INTERACT, V194, P1, DOI 10.1016/j.cbi.2011.08.007; Brodbelt JS, 2009, MASS SPECTROM REV, V28, P390, DOI 10.1002/mas.20216; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chalkley RJ, 2005, METHOD ENZYMOL, V402, P289, DOI 10.1016/S0076-6879(05)02009-4; Ciechanover A, 2000, J CELL BIOCHEM, P40; Dekker L, 2014, PROTEOMICS, V14, P1239, DOI 10.1002/pmic.201300366; Deterding LJ, 2007, ANAL CHEM, V79, P6236, DOI 10.1021/ac070935z; Downard KM, 2012, RAPID COMMUN MASS SP, V26, P226, DOI 10.1002/rcm.5320; Fedorova M, 2014, MASS SPECTROM REV, V33, P79, DOI 10.1002/mas.21381; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ge Y, 2003, PROTEIN SCI, V12, P2320, DOI 10.1110/ps.03244403; Gregorich ZR, 2014, PROTEOMICS, V14, P1195, DOI 10.1002/pmic.201300432; Hartmer RG, 2009, RAPID COMMUN MASS SP, V23, P2273, DOI 10.1002/rcm.4145; Hayes CS, 1998, J BACTERIOL, V180, P2694, DOI 10.1128/JB.180.10.2694-2700.1998; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kastle M, 2011, CURR PHARM DESIGN, V17, P4007, DOI 10.2174/138161211798764898; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Li H., 2014, J AM SOC MASS SPECTR; Liu H, 2014, ASMS ANNUAL CONFEREN; Lourette N, 2010, J AM SOC MASS SPECTR, V21, P930, DOI 10.1016/j.jasms.2010.02.027; Madian AG, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010892; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; Madian AG, 2010, J PROTEOME RES, V9, P1330, DOI 10.1021/pr900890k; Maleknia SD, 1999, ANAL CHEM, V71, P3965, DOI 10.1021/ac990500e; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P521, DOI 10.1016/0003-9861(92)90606-W; McClintock C, 2008, ANAL CHEM, V80, P3304, DOI 10.1021/ac702493a; Mikesh LM, 2006, BBA-PROTEINS PROTEOM, V1764, P1811, DOI 10.1016/j.bbapap.2006.10.003; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Moradian A, 2014, PROTEOMICS, V14, P489, DOI 10.1002/pmic.201300256; Ntai I, 2014, ANAL CHEM, V86, P4961, DOI 10.1021/ac500395k; Peng Y, 2014, MOL CELL PROTEOMICS, V13, P2752, DOI 10.1074/mcp.M114.040675; Robinson RAS, 2012, ANAL CHEM, V84, P4677, DOI 10.1021/ac202000v; Rogowska-Wrzesinska A, 2014, FREE RADICAL RES, P1; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sharp JS, 2003, ANAL BIOCHEM, V313, P216, DOI 10.1016/S0003-2697(02)00612-7; Shi HL, 2013, J PHYS CHEM B, V117, P164, DOI 10.1021/jp3099544; Smith LM, 2013, NAT METHODS, V10, P186, DOI 10.1038/nmeth.2369; SOLAR S, 1985, RADIAT PHYS CHEM, V26, P103, DOI 10.1016/0146-5724(85)90039-1; STADTMAN ER, 1991, J BIOL CHEM, V266, P2005; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stadtman ER, 1997, CHEM RES TOXICOL, V10, P485, DOI 10.1021/tx960133r; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Sze SK, 2003, ANAL CHEM, V75, P1599, DOI 10.1021/ac020446t; Sze SK, 2002, P NATL ACAD SCI USA, V99, P1774, DOI 10.1073/pnas.251691898; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wells JM, 2005, METHOD ENZYMOL, V402, P148, DOI 10.1016/S0076-6879(05)02005-7; Wiesner J, 2008, PROTEOMICS, V8, P4466, DOI 10.1002/pmic.200800329; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yi Donghui, 2005, J Biomol Tech, V16, P364; Yuan ZF, 2014, ANNU REV ANAL CHEM, V7, P113, DOI 10.1146/annurev-anchem-071213-015959; Zhao C, 2006, ANAL CHEM, V78, P5134, DOI 10.1021/ac060525v	55	45	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116606	10.1371/journal.pone.0116606	http://dx.doi.org/10.1371/journal.pone.0116606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775238	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000351183500009
J	Hayat, T; Anwar, MS; Farooq, M; Alsaedi, A				Hayat, Tasawar; Anwar, Muhammad Shoaib; Farooq, Muhammad; Alsaedi, Ahmad			Mixed Convection Flow of Viscoelastic Fluid by a Stretching Cylinder with Heat Transfer	PLOS ONE			English	Article							POWER-LAW FLUID; STAGNATION-POINT FLOW; BOUNDARY-LAYER-FLOW; MASS-TRANSFER; INCLINED PLATE; MAXWELL FLUID; SURFACE; SHEET	Flow of viscoelastic fluid due to an impermeable stretching cylinder is discussed. Effects of mixed convection and variable thermal conductivity are present. Thermal conductivity is taken temperature dependent. Nonlinear partial differential system is reduced into the nonlinear ordinary differential system. Resulting nonlinear system is computed for the convergent series solutions. Numerical values of skin friction coefficient and Nusselt number are computed and discussed. The results obtained with the current method are in agreement with previous studies using other methods as well as theoretical ideas. Physical interpretation reflecting the contribution of influential parameters in the present flow is presented. It is hoped that present study serves as a stimulus for modeling further stretching flows especially in polymeric and paper production processes.	[Hayat, Tasawar; Anwar, Muhammad Shoaib; Farooq, Muhammad] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmad] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Farooq, M (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	hfarooq99@yahoo.com	Hayat, Tasawar/E-9449-2015; Farooq, Muhammad/AAX-3841-2020; Hayat, Tasawar/A-3853-2013; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/Y-2524-2019; Anwar, Muhammad Shoaib/AAU-8840-2021	Farooq, Muhammad/0000-0002-5481-6393; Alsaedi, Ahmed/0000-0003-3452-8922; Anwar, Muhammad Shoaib/0000-0001-5141-9838	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia	This paper was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia. The funder has no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Andersson HI, 2006, INT J NONLIN MECH, V41, P1228, DOI 10.1016/j.ijnonlinmec.2006.12.006; Dalir N, 2014, ALEX ENG J, V53, P769, DOI 10.1016/j.aej.2014.08.005; Das K, 2012, COMPUT MATH APPL, V63, P255, DOI 10.1016/j.camwa.2011.11.018; El-Aziz M. Abd, 2013, J EGYPTIAN MATH SOC, V21, P385, DOI DOI 10.1016/J.JOEMS.2013.02.010; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2011, CHEM ENG SCI, V66, P2660, DOI 10.1016/j.ces.2011.03.008; Hakeem A.K.A., 2014, J KING SAUDI U ENG S, V26, P168; Hassanien IA, 1998, MATH COMPUT MODEL, V28, P105, DOI 10.1016/S0895-7177(98)00148-4; Hayat T, 2013, COMPUT FLUIDS, V86, P103, DOI 10.1016/j.compfluid.2013.07.003; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2014, INT J NUMER METHOD H, V24, P760, DOI 10.1108/HFF-09-2012-0219; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090038; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Kumar BR, 2013, INT J HEAT MASS TRAN, V56, P370, DOI 10.1016/j.ijheatmasstransfer.2012.09.001; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S., 2012, HOMOTOPY ANAL METHOD; Lok YY, 2012, INT J THERM SCI, V59, P186, DOI 10.1016/j.ijthermalsci.2012.04.008; Moradi A, 2013, INT J THERM SCI, V64, P129, DOI 10.1016/j.ijthermalsci.2012.08.014; Mukhopadhyay S, 2013, AIN SHAMS ENG J, V4, P933, DOI 10.1016/j.asej.2013.04.004; Mukhopadhyay S, 2014, CHINESE PHYS B, V23, DOI 10.1088/1674-1056/23/4/044702; Nadeem S, 2012, MATH PROBL ENG, V2012, DOI 10.1155/2012/640289; Pal D, 2014, J EGYPT MATH SOC, V22, P123, DOI [10.1016/j.joems.2013.05.010, DOI 10.1016/J.JOEMS.2013.05.010]; Pal D, 2013, APPL MATH COMPUT, V219, P7556, DOI 10.1016/j.amc.2012.10.119; Panigrahi S, 2014, APPL MATH MECH-ENGL, V35, P1525, DOI 10.1007/s10483-014-1888-6; Patil PM, 2012, COMPUT FLUIDS, V56, P17, DOI 10.1016/j.compfluid.2011.11.008; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rashidi MM, 2014, ARAB J SCI ENG, V39, P5113, DOI 10.1007/s13369-014-1140-5; Rashidi M. M, 2014, ADV MECH ENG, V2014, DOI DOI 10.1155/2014/735939; Seshadri R, 2014, J APPL ANAL COMPUT, V4, P389; Shehzad SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068139; Singh V., 2012, INT J APPL MATH MECH, V8, P41; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2013, INT J HEAT MASS TRAN, V57, P82, DOI 10.1016/j.ijheatmasstransfer.2012.10.006; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Vajravelu K, 2012, APPL MATH COMPUT, V219, P3993, DOI 10.1016/j.amc.2012.10.034; Vajravelu K, 2013, NONLINEAR ANAL-REAL, V14, P455, DOI 10.1016/j.nonrwa.2012.07.008; Vajravelu K, 2011, COMPUT MATH APPL, V62, P93, DOI 10.1016/j.camwa.2011.04.055	37	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118815	10.1371/journal.pone.0118815	http://dx.doi.org/10.1371/journal.pone.0118815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775032	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500043
J	Kleppa, E; Klinge, KF; Galaphaththi-Arachchige, HN; Holmen, SD; Lillebo, K; Onsrud, M; Gundersen, SG; Taylor, M; Ndhlovu, P; Kjetland, EF				Kleppa, Elisabeth; Klinge, Kari F.; Galaphaththi-Arachchige, Hashini Nilushika; Holmen, Sigve D.; Lillebo, Kristine; Onsrud, Mathias; Gundersen, Svein Gunnar; Taylor, Myra; Ndhlovu, Patricia; Kjetland, Eyrun F.			Schistosoma haematobium Infection and CD4+T-Cell Levels: A Cross-Sectional Study of Young South African Women	PLOS ONE			English	Article							RURAL ZIMBABWEAN WOMEN; HIV-1 INFECTION; GENITAL SCHISTOSOMIASIS; HELMINTH INFECTION; IMMUNE ACTIVATION; COINFECTION; PROGRESSION; EXCRETION; COUNTS; CD4	Schistosoma (S.) haematobiumcauses urogenital schistosomiasis and has been hypothesized to adversely impact HIV transmission and progression. On the other hand it has been hypothesized that HIV could influence the manifestations of schistosomiasis. In this cross-sectional study, we explored the association between urogenital S. haematobium infection and CD4 cell counts in 792 female high-school students from randomly selected schools in rural KwaZulu-Natal, South Africa. We also investigated the association between low CD4 cell counts in HIV positive women and the number of excreted schistosome eggs in urine. Sixteen percent were HIV positive and 31% had signs of urogenital schistosomiasis (as determined by genital sandy patches and / or abnormal blood vessels on ectocervix / vagina by colposcopy or presence of eggs in urine). After stratifying for HIV status, participants with and without urogenital schistosomiasis had similar CD4 cell counts. Furthermore, there was no significant difference in prevalence of urogenital schistosomiasis in HIV positive women with low and high CD4 cell counts. There was no significant difference in the number of eggs excreted in urine when comparing HIV positive and HIV negative women. Our findings indicate that urogenital schistosomiasis do not influence the number of circulating CD4 cells.	[Kleppa, Elisabeth; Klinge, Kari F.; Galaphaththi-Arachchige, Hashini Nilushika; Holmen, Sigve D.; Lillebo, Kristine; Kjetland, Eyrun F.] Oslo Univ Hosp, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway; [Kleppa, Elisabeth; Holmen, Sigve D.; Lillebo, Kristine] Univ Oslo, Fac Med, Oslo, Norway; [Onsrud, Mathias] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway; [Gundersen, Svein Gunnar] Sorlandet Hosp, Res Unit, Kristiansand, Norway; [Gundersen, Svein Gunnar] Univ Agder, Dept Global Dev & Planning, Kristiansand, Norway; [Taylor, Myra; Kjetland, Eyrun F.] Univ KwaZulu Natal, Coll Hlth Sci, Nelson R Mandela Sch Med, Discipline Publ Hlth Med, Durban, South Africa; [Ndhlovu, Patricia] Univ London Imperial Coll Sci Technol & Med, London, England	University of Oslo; University of Oslo; University of Oslo; University of Agder; University of Kwazulu Natal; Imperial College London	Kleppa, E (corresponding author), Oslo Univ Hosp, Dept Infect Dis, Norwegian Ctr Imported & Trop Dis, Oslo, Norway.	elisabeth.kleppa@medisin.uio.no		Kjetland, Eyrun Floerecke/0000-0002-5552-1095	South-Eastern Norway Regional Health Authority; Research Council of Norway; European Research Council under the European Union's Seventh Framework Programme (FP7) /ERC Grant [PIRSES-GA-2010-269245]	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); European Research Council under the European Union's Seventh Framework Programme (FP7) /ERC Grant(European Research Council (ERC))	The research project was funded by grants from the South-Eastern Norway Regional Health Authority, The Research Council of Norway and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) /ERC Grant agreement no. PIRSES-GA-2010-269245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuye C, 2005, J CLIN IMMUNOL, V25, P127, DOI 10.1007/s10875-005-2818-y; [Anonymous], 2011, 2011 NATL ANTENATAL; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; BRAUNMUNZINGER RA, 1992, TROP MED PARASITOL, V43, P149; Brown M, 2005, J INFECT DIS, V191, P1648, DOI 10.1086/429668; Brown M, 2004, J INFECT DIS, V190, P1869, DOI 10.1086/425042; Colley DG, LANCET; DOEHRING E, 1985, KIDNEY INT, V27, P667, DOI 10.1038/ki.1985.62; Downs JA, 2011, AM J TROP MED HYG, V84, P364, DOI 10.4269/ajtmh.2011.10-0585; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hegertun IEA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002104; Jourdan PM, 2011, AM J TROP MED HYG, V85, P1060, DOI 10.4269/ajtmh.2011.11-0135; Kalinkovich A, 1998, CLIN EXP IMMUNOL, V114, P414; Kallestrup P, 2006, CLIN INFECT DIS, V42, P1781, DOI 10.1086/504380; Kallestrup P, 2005, J INFECT DIS, V192, P1956, DOI 10.1086/497696; Kallestrup P, 2005, J INFECT DIS, V191, P1311, DOI 10.1086/428907; Karanja DMS, 1997, AM J TROP MED HYG, V56, P515, DOI 10.4269/ajtmh.1997.56.515; Karim QA, 2014, SEX TRANSM INFECT, V90, P620, DOI 10.1136/sextrans-2014-051548; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kjetland EF, 2005, AM J TROP MED HYG, V72, P311, DOI 10.4269/ajtmh.2005.72.311; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Kleppa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098593; Lawn SD, 2004, J INFECTION, V48, P1, DOI 10.1016/j.jinf.2003.09.001; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Mwanakasale V, 2003, AM J TROP MED HYG, V69, P420, DOI 10.4269/ajtmh.2003.69.420; Nausch N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00472; Ndeffo Mbah ML, 2013, TROP MED INT HLTH; [Republic of South Africa Department of Health], 2008, STAND TREATM GUID ES; Sangare LR, 2011, PARASITOLOGY, V138, P1546, DOI 10.1017/S0031182011000357; Secor WE, 2007, CURR OPIN INFECT DIS, V20, P519, DOI 10.1097/QCO.0b013e3282e9ac03; Secor WE, 2012, CURR OPIN HIV AIDS, V7, P254, DOI 10.1097/COH.0b013e328351b9e3; van Lieshout L, 2000, ACTA TROP, V77, P69, DOI 10.1016/S0001-706X(00)00115-7; Walson JL, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub2; Walson JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006419.pub3; Weintrob AC, 2010, INT J STD AIDS, V21, P57, DOI 10.1258/ijsa.2009.009164; Wolday D, 2002, JAIDS-J ACQ IMM DEF, V31, P56, DOI 10.1097/00126334-200209010-00008	37	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119326	10.1371/journal.pone.0119326	http://dx.doi.org/10.1371/journal.pone.0119326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768005	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000351277500077
J	Munjal, N; Jawed, K; Wajid, S; Yazdani, SS				Munjal, Neha; Jawed, Kamran; Wajid, Saima; Yazdani, Syed Shams			A Constitutive Expression System for Cellulase Secretion in Escherichia coli and Its Use in Bioethanol Production	PLOS ONE			English	Article							FERMENTATIVE LACTATE-DEHYDROGENASE; HETEROLOGOUS PROTEIN EXPRESSION; BETA-GLUCOSIDASE; OXYGEN AVAILABILITY; CELL-SURFACE; CELLOBIOSE; GENE; STRATEGIES; PATHWAYS; BIOMASS	The production of biofuels from lignocellulosic biomass appears to be attractive and viable due to the abundance and availability of this biomass. The hydrolysis of this biomass, however, is challenging because of the complex lignocellulosic structure. The ability to produce hydrolytic cellulase enzymes in a cost-effective manner will certainly accelerate the process of making lignocellulosic ethanol production a commercial reality. These cellulases may need to be produced aerobically to generate large amounts of protein in a short time or anaerobically to produce biofuels from cellulose via consolidated bioprocessing. Therefore, it is important to identify a promoter that can constitutively drive the expression of cellulases under both aerobic and anaerobic conditions without the need for an inducer. Using lacZ as reporter gene, we analyzed the strength of the promoters of four genes, namely lacZ, gapA, ldhA and pflB, and found that the gapA promoter yielded the maximum expression of the beta-galactosidase enzyme under both aerobic and anaerobic conditions. We further cloned the genes for two cellulolytic enzymes, beta-1,4-endoglucanase and beta-1,4-glucosidase, under the control of the gapA promoter, and we expressed these genes in Escherichia coli, which secreted the products into the extracellular medium. An ethanologenic E. colistrain transformed with the secretory beta-glucosidase gene construct fermented cellobiose in both defined and complex medium. This recombinant strain also fermented wheat straw hydrolysate containing glucose, xylose and cellobiose into ethanol with an 85% efficiency of biotransformation. An ethanologenic strain that constitutively secretes a cellulolytic enzyme is a promising platform for producing lignocellulosic ethanol.	[Munjal, Neha; Jawed, Kamran; Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, Synthet Biol & Biofuels Grp, New Delhi, India; [Yazdani, Syed Shams] Int Ctr Genet Engn & Biotechnol, DBT ICGEB Ctr Adv Bioenergy Res, New Delhi, India; [Wajid, Saima] Jamia Hamdard, Ctr Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; DBT-ICGEB Centre for Advanced Bioenergy Research, New Delhi; Jamia Hamdard University	Yazdani, SS (corresponding author), Int Ctr Genet Engn & Biotechnol, Synthet Biol & Biofuels Grp, Aruna Asaf Ali Marg, New Delhi, India.	shams@icgeb.res.in			Department of Biotechnology, Govt. of India, through Bioenergy Centre [BT/PB/Center/03/2011]	Department of Biotechnology, Govt. of India, through Bioenergy Centre	This work was supported by Department of Biotechnology, Govt. of India, through Bioenergy Centre Grant no. BT/PB/Center/03/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlakha N, 2012, APPL ENVIRON MICROB, V78, P7447, DOI 10.1128/AEM.01386-12; Adlakha N, 2011, APPL ENVIRON MICROB, V77, P4859, DOI 10.1128/AEM.02808-10; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Belien T, 2006, MOL PLANT MICROBE IN, V19, P1072, DOI 10.1094/MPMI-19-1072; Bunch PK, 1997, MICROBIOL-UK, V143, P187, DOI 10.1099/00221287-143-1-187; Claassen PAM, 1999, APPL MICROBIOL BIOT, V52, P741, DOI 10.1007/s002530051586; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Gupta S, 2013, PROTEIN EXPRES PURIF, V88, P20, DOI 10.1016/j.pep.2012.11.006; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Hannig G, 1998, TRENDS BIOTECHNOL, V16, P54, DOI 10.1016/S0167-7799(97)01155-4; Hoyer K, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-14; Ingram LO, 1999, BIOTECHNOL PROGR, V15, P855, DOI 10.1021/bp9901062; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Jiang GRJ, 2001, MICROBIOL-SGM, V147, P2437, DOI 10.1099/00221287-147-9-2437; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; la Grange DC, 2010, APPL MICROBIOL BIOT, V87, P1195, DOI 10.1007/s00253-010-2660-x; Lai XK, 1997, APPL ENVIRON MICROB, V63, P355, DOI 10.1128/AEM.63.2.355-363.1997; Liu L, 2013, BIOENGINEERED, V4, P212, DOI 10.4161/bioe.24761; Lynd LR, 1999, BIOTECHNOL PROGR, V15, P777, DOI 10.1021/bp990109e; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Maki M, 2009, INT J BIOL SCI, V5, P500; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; Moniruzzaman M, 1997, APPL ENVIRON MICROB, V63, P4633, DOI 10.1128/AEM.63.12.4633-4637.1997; Munjal N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-145; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; SAWERS G, 1988, J BACTERIOL, V170, P5330, DOI 10.1128/jb.170.11.5330-5336.1988; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Shin HD, 2014, METAB ENG, V24, P9, DOI 10.1016/j.ymben.2014.04.002; Soma Y, 2012, J BIOSCI BIOENG, V114, P80, DOI 10.1016/j.jbiosc.2012.02.019; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Tabor S., 1990, CURR PROTOC MOL BIOL; Tanaka T, 2011, APPL ENVIRON MICROB, V77, P6265, DOI 10.1128/AEM.00459-11; Tegel H, 2011, FEBS J, V278, P729, DOI 10.1111/j.1742-4658.2010.07991.x; Thouvenot B, 2004, BIOCHEM J, V383, P371, DOI 10.1042/BJ20040792; Zerbs S, 2009, METHOD ENZYMOL, V463, P149, DOI 10.1016/S0076-6879(09)63012-3; Zhou S, 2008, BIOTECHNOL LETT, V30, P335, DOI 10.1007/s10529-007-9544-x	45	16	18	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119917	10.1371/journal.pone.0119917	http://dx.doi.org/10.1371/journal.pone.0119917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768292	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500103
J	Singla, DK; Singla, RD; Abdelli, LS; Glass, C				Singla, Dinender K.; Singla, Reetu D.; Abdelli, Latifa S.; Glass, Carley			Fibroblast Growth Factor-9 Enhances M2 Macrophage Differentiation and Attenuates Adverse Cardiac Remodeling in the Infarcted Diabetic Heart	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY MEDIATORS; FGF9; MONOCYTES; PATHOPHYSIOLOGY; INTERLEUKIN-6; APOPTOSIS; AFFINITY; ALPHA	Inflammation has been implicated as a perpetrator of diabetes and its associated complications. Monocytes, key mediators of inflammation, differentiate into pro-inflammatory M1 macrophages and anti-inflammatory M2 macrophages upon infiltration of damaged tissue. However, the inflammatory cell types, which propagate diabetes progression and consequential adverse disorders, remain unclear. The current study was undertaken to assess monocyte infiltration and the role of fibroblast growth factor-9 (FGF-9) on monocyte to macrophage differentiation and cardioprotection in the diabetic infarcted heart. Db/db diabetic mice were assigned to sham, myocardial infarction (MI), and MI+FGF-9 groups. MI was induced by permanent coronary artery ligation and animals were subjected to 2D transthoracic echocardiography two weeks post-surgery. Immunohistochemical and immunoassay results from heart samples collected suggest significantly increased infiltration of monocytes (Mean +/- SEM; MI: 2.02% +/- 0.23% vs. Sham 0.75% +/- 0.07%; p<0.05) and associated pro-inflammatory cytokines (TNF-alpha, MCP-1, and IL-6), adverse cardiac remodeling (Mean +/- SEM; MI: 33% +/- 3.04% vs. Sham 2.2% +/- 0.33%; p<0.05), and left ventricular dysfunction (Mean +/- SEM; MI: 35.4% +/- 1.25% vs. Sham 49.19% +/- 1.07%; p<0.05) in the MI group. Importantly, treatment of diabetic infarcted myocardium with FGF-9 resulted in significantly decreased monocyte infiltration (Mean +/- SEM; MI+FGF-9: 1.39% +/- 0.1% vs. MI: 2.02% +/- 0.23%; p<0.05), increased M2 macrophage differentiation (Mean +/- SEM; MI+FGF-9: 4.82% +/- 0.86% vs. MI: 0.85% +/- 0.3%; p<0.05) and associated anti-inflammatory cytokines (IL-10 and IL-1RA), reduced adverse remodeling (Mean +/- SEM; MI+FGF-9: 11.59% +/- 1.2% vs. MI: 33% +/- 3.04%; p<0.05), and improved cardiac function (Fractional shortening, Mean +/- SEM; MI+FGF-9: 41.51% +/- 1.68% vs. MI: 35.4% +/- 1.25%; p<0.05). In conclusion, our data suggest FGF-9 possesses novel therapeutic potential in its ability to mediate monocyte to M2 differentiation and confer cardiac protection in the post-MI diabetic heart.	[Singla, Dinender K.; Singla, Reetu D.; Abdelli, Latifa S.; Glass, Carley] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Singla, DK (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA.	dsingla@ucf.edu		Glass, Carley/0000-0001-9875-1125	national institute of health [RO1 HL090646, R01HL117241]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117241, R01HL090646] Funding Source: NIH RePORTER	national institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This paper is supported in part by the grants from national institute of health grants; RO1 HL090646, and R01HL117241 to Dr. Singla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no additional funding sources for this study.	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Bardini G, 2010, DIABETES CARE, V33, P411, DOI 10.2337/dc09-1342; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Glass C, 2012, CELL TRANSPLANT, V21, P1931, DOI 10.3727/096368911X627561; Glass C, 2011, AM J PHYSIOL-HEART C, V301, pH2038, DOI 10.1152/ajpheart.00271.2011; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; HECHT D, 1995, GROWTH FACTORS, V12, P223, DOI 10.3109/08977199509036882; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Kumar D, 2003, J LAB CLIN MED, V142, P288, DOI 10.1016/S0022-2143(03)00148-3; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Leavy O, 2011, NAT REV IMMUNOL, V11, P715, DOI 10.1038/nri3096; Li SL, 2006, DIABETES, V55, P2611, DOI 10.2337/db06-0164; Lin YS, 2009, DEV BIOL, V329, P44, DOI 10.1016/j.ydbio.2009.02.011; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Meng L, 2010, AM J PHYSIOL-HEART C, V298, pH736, DOI 10.1152/ajpheart.00935.2009; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Tarr Joanna M, 2013, ISRN Ophthalmol, V2013, P343560, DOI 10.1155/2013/343560; Van Dam PS, 2013, EUR J PHARMACOL, V719, P180, DOI 10.1016/j.ejphar.2013.07.017; van der Laan AM, 2012, HEART, V98, P1384, DOI 10.1136/heartjnl-2012-301623	36	41	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120739	10.1371/journal.pone.0120739	http://dx.doi.org/10.1371/journal.pone.0120739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768089	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500134
J	Andronic, J; Shirakashi, R; Pickel, SU; Westerling, KM; Klein, T; Holm, T; Sauer, M; Sukhorukov, VL				Andronic, Joseph; Shirakashi, Ryo; Pickel, Simone U.; Westerling, Katherine M.; Klein, Teresa; Holm, Thorge; Sauer, Markus; Sukhorukov, Vladimir L.			Hypotonic Activation of the Myo-Inositol Transporter SLC5A3 in HEK293 Cells Probed by Cell Volumetry, Confocal and Super-Resolution Microscopy	PLOS ONE			English	Article							NA+/MYO-INOSITOL COTRANSPORTER; DOMAIN POTASSIUM CHANNELS; ORGANIC OSMOLYTE CHANNELS; HUMAN T-LYMPHOCYTES; INTRACELLULAR DELIVERY; NUCLEAR-LOCALIZATION; CULTURED ASTROCYTES; FLUORESCENT-PROBES; MECHANISMS; PERMEABILITY	Swelling-activated pathways for myo-inositol, one of the most abundant organic osmolytes in mammalian cells, have not yet been identified. The present study explores the SLC5A3 protein as a possible transporter of myo-inositol in hyponically swollen HEK293 cells. To address this issue, we examined the relationship between the hypotonicity-induced changes in plasma membrane permeability to myo-inositol P-ino [m/s] and expression/localization of SLC5A3. P-ino values were determined by cell volumetry over a wide tonicity range (100-275 mOsm) in myo-inositol-substituted solutions. While being negligible under mild hypotonicity (200-275 mOsm), P-ino grew rapidly at osmolalities below 200 mOsm to reach a maximum of similar to 3 nm/s at 100-125 mOsm, as indicated by fast cell swelling due to myo-inositol influx. The increase in P-ino resulted most likely from the hypotonicity-mediated incorporation of cytosolic SLC5A3 into the plasma membrane, as revealed by confocal fluorescence microscopy of cells expressing EGFP-tagged SLC5A3 and super-resolution imaging of immunostained SLC5A3 by direct stochastic optical reconstruction microscopy (dSTORM). dSTORM in hypotonic cells revealed a surface density of membrane-associated SLC5A3 proteins of 200-2000 localizations/mu m(2). Assuming SLC5A3 to be the major path for myoinositol, a turnover rate of 80-800 myo-inositol molecules per second for a single transporter protein was estimated from combined volumetric and dSTORM data. Hypotonic stress also caused a significant upregulation of SLC5A3 gene expression as detected by semi-quantitative RT-PCR and Western blot analysis. In summary, our data provide first evidence for swelling-mediated activation of SLC5A3 thus suggesting a functional role of this transporter in hypotonic volume regulation of mammalian cells.	[Andronic, Joseph; Pickel, Simone U.; Westerling, Katherine M.; Klein, Teresa; Holm, Thorge; Sauer, Markus; Sukhorukov, Vladimir L.] Univ Wurzburg, Biozentrum, Dept Biotechnol & Biophys, Wurzburg, Germany; [Shirakashi, Ryo] Univ Tokyo, Inst Ind Sci, Tokyo, Japan	University of Wurzburg; University of Tokyo	Sukhorukov, VL (corresponding author), Univ Wurzburg, Biozentrum, Dept Biotechnol & Biophys, Hubland, Wurzburg, Germany.	sukhorukov@biozentrum.uni-wuerzburg.de	Sukhorukov, Vladimir L/ACO-0333-2022; Sauer, Markus/C-4378-2017	Sauer, Markus/0000-0002-1692-3219; Klein, Teresa/0000-0002-1155-0361	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronic J, 2013, BBA-BIOMEMBRANES, V1828, P699, DOI 10.1016/j.bbamem.2012.09.028; Bitoun M, 2000, ADV EXP MED BIOL, V483, P239; Bobak N, 2011, BBA-BIOMEMBRANES, V1808, P2036, DOI 10.1016/j.bbamem.2011.04.013; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; Chauvin TR, 2004, BIOL REPROD, V70, P744, DOI 10.1095/biolreprod.103.022731; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Djuzenova CS, 2009, MOL MED REP, V2, P633, DOI 10.3892/mmr_00000149; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Fenili D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024032; Fernandez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057268; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; GRINSTEIN S, 1982, J GEN PHYSIOL, V80, P801, DOI 10.1085/jgp.80.6.801; HAGER K, 1995, J MEMBRANE BIOL, V143, P103; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Isaacks RE, 1999, J NEUROSCI RES, V57, P866, DOI 10.1002/(SICI)1097-4547(19990915)57:6<866::AID-JNR12>3.3.CO;2-B; Junankar PR, 2000, CELL PHYSIOL BIOCHEM, V10, P355, DOI 10.1159/000016368; Kempson SA, 2004, PFLUG ARCH EUR J PHY, V449, P227, DOI 10.1007/s00424-004-1338-6; Kempson SA, 2003, AM J PHYSIOL-CELL PH, V285, pC1091, DOI 10.1152/ajpcell.00021.2003; Kiesel M, 2006, BIOPHYS J, V90, P4720, DOI 10.1529/biophysj.105.078725; Kinne RKH, 1998, CONTRIB NEPHROL, V123, P34, DOI 10.1159/000059927; Kinne RKH, 2000, CELL PHYSIOL BIOCHEM, V10, P371, DOI 10.1159/000016376; Kirk K, 1997, J MEMBRANE BIOL, V158, P1, DOI 10.1007/s002329900239; Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135; KWON HM, 1992, J BIOL CHEM, V267, P6297; KWON HM, 1995, CURR OPIN CELL BIOL, V7, P465, DOI 10.1016/0955-0674(95)80002-6; Kwon MS, 2008, J BIOL CHEM, V283, P22400, DOI 10.1074/jbc.M710550200; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lang F, 2007, J AM COLL NUTR, V26, p613S, DOI 10.1080/07315724.2007.10719667; Lang F, 2011, NESTLE NUTR WORKS SE, V69, P115, DOI 10.1159/000329290; Loschberger A, 2012, J CELL SCI, V125, P570, DOI 10.1242/jcs.098822; Loveday D, 2003, J NEUROCHEM, V87, P476, DOI 10.1046/j.1471-4159.2003.02021.x; MCMANUS ML, 1995, NEW ENGL J MED, V333, P1260, DOI 10.1056/NEJM199511093331906; Memmel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087052; Pasantes-Morales H, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.05.002; PASANTESMORALES H, 1994, AM J PHYSIOL, V266, pC172, DOI 10.1152/ajpcell.1994.266.1.C172; Reuss R, 2004, J MEMBRANE BIOL, V200, P67, DOI 10.1007/s00232-004-0694-7; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Shirakashi R, 2004, INT J HEAT MASS TRAN, V47, P4517, DOI 10.1016/j.ijheatmasstransfer.2004.04.007; Snapp EL, 2011, COLD SPRING HARB PRO, V2011, DOI [10.1101/pdb.top066548, DOI 10.1101/PDB.TOP066548]; Sukhorukov VL, 2006, BIOCHEM BIOPH RES CO, V346, P829, DOI 10.1016/j.bbrc.2006.05.193; Sukhorukov VL, 2009, BBA-BIOMEMBRANES, V1788, P1841, DOI 10.1016/j.bbamem.2009.06.016; Tong EHY, 2006, J BIOL CHEM, V281, P23870, DOI 10.1074/jbc.M602556200; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; van de Linde S, 2013, CHEM BIOL, V20, P8, DOI 10.1016/j.chembiol.2012.11.004; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Wehner F, 2004, REV PHYSIOL BIOCH P, V148, P1, DOI 10.1007/s10254-003-0009-x; Wolter S, 2010, J MICROSC-OXFORD, V237, P12, DOI 10.1111/j.1365-2818.2009.03287.x; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Woo SK, 2000, AM J PHYSIOL-RENAL, V278, pF1006; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004	52	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119990	10.1371/journal.pone.0119990	http://dx.doi.org/10.1371/journal.pone.0119990			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756525	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700057
J	Duarri, A; Nibbeling, EAR; Fokkens, MR; Meijer, M; Boerrigter, M; Verschuuren-Bemelmans, CC; Kremer, BPH; van de Warrenburg, BP; Dooijes, D; Boddeke, E; Sinke, RJ; Verbeek, DS				Duarri, Anna; Nibbeling, Esther A. R.; Fokkens, Michiel R.; Meijer, Michel; Boerrigter, Melissa; Verschuuren-Bemelmans, Corien C.; Kremer, Berry P. H.; van de Warrenburg, Bart P.; Dooijes, Dennis; Boddeke, Erik; Sinke, Richard J.; Verbeek, Dineke S.			Functional Analysis Helps to Define KCNC3 Mutational Spectrum in Dutch Ataxia Cases	PLOS ONE			English	Article							DOMINANT CEREBELLAR-ATAXIA; SPINOCEREBELLAR ATAXIA; POTASSIUM CHANNELS; KV3.3 CHANNELS	Spinocerebellar ataxia type 13 (SCA13) is an autosomal dominantly inherited neurodegenerative disorder of the cerebellum caused by mutations in the voltage gated potassium channel KCNC3. To identify novel pathogenic SCA13 mutations in KCNC3 and to gain insights into the disease prevalence in the Netherlands, we sequenced the entire coding region of KCNC3 in 848 Dutch cerebellar ataxia patients with familial or sporadic origin. We evaluated the pathogenicity of the identified variants by co-segregation analysis and in silico prediction followed by biochemical and electrophysiological studies. We identified 19 variants in KCNC3 including 2 non-coding, 11 missense and 6 synonymous variants. Two missense variants did not co-segregate with the disease and were excluded as potentially disease-causing mutations. We also identified the previously reported p.R420H and p. R423H mutations in our cohort. Of the remaining 7 missense variants, functional analysis revealed that 2 missense variants shifted Kv3.3 channel activation to more negative voltages. These variations were associated with early disease onset and mild intellectual disability. Additionally, one other missense variant shifted channel activation to more positive voltages and was associated with spastic ataxic gait. Whereas, the remaining missense variants did not change any of the channel characteristics. Of these three functional variants, only one variant was in silico predicted to be damaging and segregated with disease. The other two variants were in silico predicted to be benign and co-segregation analysis was not optimal or could only be partially confirmed. Therefore, we conclude that we have identified at least one novel pathogenic mutation in KCNC3 that cause SCA13 and two additionally potential SCA13 mutations. This leads to an estimate of SCA13 prevalence in the Netherlands to be between 0.6% and 1.3%.	[Duarri, Anna; Nibbeling, Esther A. R.; Fokkens, Michiel R.; Boerrigter, Melissa; Verschuuren-Bemelmans, Corien C.; Sinke, Richard J.; Verbeek, Dineke S.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Meijer, Michel; Boddeke, Erik] Univ Groningen, Univ Med Ctr Groningen, Dept Med Physiol, Groningen, Netherlands; [Kremer, Berry P. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van de Warrenburg, Bart P.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Dooijes, Dennis] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands	University of Groningen; University of Groningen; University of Groningen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Verbeek, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	d.s.verbeek@umcg.nl	Boerrigter, Melissa Maria/ABC-6057-2020; Nibbeling, Esther/AAC-3537-2022; van de Warrenburg, Bart PC/D-1935-2010; Duarri, Anna/K-2811-2017	Boerrigter, Melissa Maria/0000-0002-7583-6991; Nibbeling, Esther/0000-0001-8818-3232; van de Warrenburg, Bart PC/0000-0003-4412-1616; Duarri, Anna/0000-0003-4075-5478	Dutch Brain Foundation [2011(1)-105]; University of Groningen, Groningen, the Netherlands; NWO [40-00506-98-9021, 175-010-2009-023]	Dutch Brain Foundation; University of Groningen, Groningen, the Netherlands(Netherlands Government); NWO(Netherlands Organization for Scientific Research (NWO))	This work received financial support from the Dutch Brain Foundation (2011(1)-105) and a Rosalind Franklin Fellowship from the University of Groningen, Groningen, the Netherlands. Part of the work was performed at the UMCG Imaging and Microscopy Center (UMIC), which is sponsored by NWO grants 40-00506-98-9021and 175-010-2009-023.	Bauer P, 2010, J NEUROL NEUROSUR PS, V81, P1229, DOI 10.1136/jnnp.2009.202150; Burk K, 2013, INT J NEUROSCI, V123, P278, DOI 10.3109/00207454.2012.755180; Cagnoli C, 2010, HUM MUTAT, V31, P1117, DOI 10.1002/humu.21342; Chang SY, 2007, J COMP NEUROL, V502, P953, DOI 10.1002/cne.21353; Deng QW, 2005, J NEUROSCI, V25, P11531, DOI 10.1523/JNEUROSCI.3672-05.2005; Duarri A, 2013, NEUROGENETICS, V14, P257, DOI 10.1007/s10048-013-0370-0; Duarri A, 2012, ANN NEUROL, V72, P870, DOI 10.1002/ana.23700; Fawcett K, 2013, J NEUROL, V260, P856, DOI 10.1007/s00415-012-6721-1; Figueroa KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017811; Figueroa KP, 2010, HUM MUTAT, V31, P191, DOI 10.1002/humu.21165; Gallego-Iradi C, 2014, NEUROBIOL DIS, V71, P270, DOI 10.1016/j.nbd.2014.08.020; GOLDMANWOHL DS, 1994, J NEUROSCI, V14, P511; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Irie T, 2014, J PHYSIOL-LONDON, V592, P229, DOI 10.1113/jphysiol.2013.264309; Issa FA, 2012, DIS MODEL MECH; Issa FA, 2011, J NEUROSCI, V31, P6831, DOI 10.1523/JNEUROSCI.6572-10.2011; Jezierska J, 2013, J NEUROL, V260, P1807, DOI 10.1007/s00415-013-6882-6; Joho RH, 2009, CEREBELLUM, V8, P323, DOI 10.1007/s12311-009-0098-4; Martina M, 2003, J NEUROSCI, V23, P5698; Matsukawa H, 2003, J NEUROSCI, V23, P7677; Middlebrooks JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076749; Minassian NA, 2012, J PHYSIOL-LONDON, V590, P1599, DOI 10.1113/jphysiol.2012.228205; Mock AF, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-99; Peng L, 2013, INT J NEUROSCI, V123, P450, DOI 10.3109/00207454.2013.763254; Rajakulendran S, 2007, NEUROTHERAPEUTICS, V4, P258, DOI 10.1016/j.nurt.2007.01.010; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Veys K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00205; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; Zagha E, 2008, J NEUROSCI, V28, P1291, DOI 10.1523/JNEUROSCI.4358-07.2008; Zhao J, 2013, BIOCHEM J, V454, P259, DOI 10.1042/BJ20130034	32	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116599	10.1371/journal.pone.0116599	http://dx.doi.org/10.1371/journal.pone.0116599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756792	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700009
J	Widdows, KL; Panitchob, N; Crocker, IP; Please, CP; Hanson, MA; Sibley, CP; Johnstone, ED; Sengers, BG; Lewis, RM; Glazier, JD				Widdows, Kate L.; Panitchob, Nuttanont; Crocker, Ian P.; Please, Colin P.; Hanson, Mark A.; Sibley, Colin P.; Johnstone, Edward D.; Sengers, Bram G.; Lewis, Rohan M.; Glazier, Jocelyn D.			Integration of computational modeling with membrane transport studies reveals new insights into amino acid exchange transport mechanisms	FASEB JOURNAL			English	Article						antiporters; facilitated transport; LAT2 (SLC7A8); overshoot phenomena	PLASMA-MEMBRANE; HUMAN-PLACENTA; SYSTEM L; ACTIVE-TRANSPORT; BRUSH-BORDER; HEAVY-CHAIN; IN-VITRO; VESICLES; EXPRESSION; LAT2	Uptake of system L amino acid substrates into isolated placental plasma membrane vesicles in the absence of opposing side amino acid (zero-trans uptake) is incompatible with the concept of obligatory exchange, where influx of amino acid is coupled to efflux. We therefore hypothesized that system L amino acid exchange transporters are not fully obligatory and/or that amino acids are initially present inside the vesicles. To address this, we combined computational modeling with vesicle transport assays and transporter localization studies to investigate the mechanisms mediating [C-14] L-serine (a system L substrate) transport into human placental microvillous plasma membrane (MVM) vesicles. The carrier model provided a quantitative framework to test the 2 hypotheses that L-serine transport occurs by either obligate exchange or nonobligate exchange coupled with facilitated transport (mixed transport model). The computational model could only account for experimental [C-14] L-serine uptake data when the transporter was not exclusively in exchange mode, best described by the mixed transport model. MVM vesicle isolates contained endogenous amino acids allowing for potential contribution to zerotrans uptake. Both L-type amino acid transporter (LAT) 1 and LAT2 subtypes of system L were distributed to MVM, with L-serine transport attributed to LAT2. These findings suggest that exchange transporters do not function exclusively as obligate exchangers.	[Widdows, Kate L.; Crocker, Ian P.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Widdows, Kate L.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Widdows, Kate L.; Sibley, Colin P.; Johnstone, Edward D.; Glazier, Jocelyn D.] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Panitchob, Nuttanont; Sengers, Bram G.] Univ Southampton, Fac Engn & Environm, Bioengn Sci Res Grp, Southampton, Hants, England; [Please, Colin P.] Univ Oxford, Math Inst, Oxford, England; [Hanson, Mark A.; Lewis, Rohan M.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Sengers, Bram G.; Lewis, Rohan M.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England	University of Manchester; University of Manchester; University of Manchester; University of Southampton; University of Oxford; University of Southampton; University of Southampton	Lewis, RM (corresponding author), Univ Southampton, Southampton Gen Hosp, Fac Med, Inst Dev Sci MP887, Southampton SO16 6YD, Hants, England.	rohan.lewis@soton.ac.uk	Hanson, Mark/AAE-8236-2019; Lewis, Rohan/C-9350-2011	Hanson, Mark/0000-0002-6907-613X; Lewis, Rohan/0000-0003-4044-9104; Johnstone, Ed/0000-0001-9732-8544; Sengers, Bram/0000-0001-5859-6984; Please, Colin/0000-0001-8917-8574	Biotechnology and Biological Sciences Research Council [BB/I011315/1, BB/I011250/1]; British Heart Foundation; BBSRC [BB/I011315/1, BB/I011250/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Claire McGuire (Research Practitioner), the midwives, and participating women at St Mary's Hospital (Manchester, United Kingdom), for generous assistance in obtaining placentas for our study. The authors also thank Teresa Wu-Hoyee at Genetic Medicine (Manchester, United Kingdom), who kindly performed the HPLC analyses. This study was supported by Biotechnology and Biological Sciences Research Council Grants BB/I011315/1 and BB/I011250/1. M.A.H. was supported by the British Heart Foundation. The authors declare no conflicts of interest.	Ayuk PTY, 2000, AM J PHYSIOL-CELL PH, V278, pC1162, DOI 10.1152/ajpcell.2000.278.6.C1162; Baird FE, 2009, AM J PHYSIOL-ENDOC M, V297, pE822, DOI 10.1152/ajpendo.00330.2009; Berman MC, 2001, BBA-BIOMEMBRANES, V1513, P95, DOI 10.1016/S0005-2736(01)00356-X; Brand AP, 2010, PLACENTA, V31, P456, DOI 10.1016/j.placenta.2010.01.016; Broer S, 2011, BIOCHEM J, V436, P193, DOI 10.1042/BJ20101912; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Broer S, 2002, PFLUG ARCH EUR J PHY, V444, P457, DOI 10.1007/s00424-002-0840-y; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; CHRISTENSEN HN, 1969, J BIOL CHEM, V244, P1510; Chrostowski MK, 2010, PLACENTA, V31, P528, DOI 10.1016/j.placenta.2009.12.010; Chrostowski MK, 2009, PLACENTA, V30, P270, DOI 10.1016/j.placenta.2008.12.015; Cleal JK, 2008, J NEUROENDOCRINOL, V20, P419, DOI 10.1111/j.1365-2826.2008.01662.x; Cleal JK, 2007, J PHYSIOL-LONDON, V582, P871, DOI 10.1113/jphysiol.2007.130690; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P13231, DOI 10.1021/bi961208t; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Fotiadis D, 2013, MOL ASPECTS MED, V34, P139, DOI 10.1016/j.mam.2012.10.007; GANAPATHY ME, 1986, BIOCHEM J, V238, P201, DOI 10.1042/bj2380201; GLAZIER JD, 1988, BIOCHIM BIOPHYS ACTA, V945, P127, DOI 10.1016/0005-2736(88)90475-0; Glazier JD, 2006, METH MOLEC MED, V122, P241; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; HEINZ E, 1984, BIOCHIM BIOPHYS ACTA, V776, P83, DOI 10.1016/0005-2736(84)90253-0; HOELTZLI SD, 1989, AM J PHYSIOL, V256, pC630, DOI 10.1152/ajpcell.1989.256.3.C630; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kim CS, 2008, BIOL PHARM BULL, V31, P1096, DOI 10.1248/bpb.31.1096; KRUPKA RM, 1993, BIOCHIM BIOPHYS ACTA, V1183, P105, DOI 10.1016/0005-2728(93)90009-5; Kudo Y, 2001, J PHYSIOL-LONDON, V531, P405, DOI 10.1111/j.1469-7793.2001.0405i.x; KURUVILLA AG, 1994, J CLIN INVEST, V94, P689, DOI 10.1172/JCI117386; Lewis RM, 2007, PLACENTA, V28, P445, DOI 10.1016/j.placenta.2006.06.014; Lewis RM, 2013, PLACENTA, V34, pS46, DOI 10.1016/j.placenta.2012.10.010; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHENDRAN D, 1993, PEDIATR RES, V34, P661; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MURER H, 1980, J MEMBRANE BIOL, V55, P81, DOI 10.1007/BF01871151; Okamoto Y, 2002, AM J PHYSIOL-CELL PH, V282, pC196, DOI 10.1152/ajpcell.2002.282.1.C196; Panitchob N, 2015, J THEOR BIOL, V365, P352, DOI 10.1016/j.jtbi.2014.10.042; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Sengers BG, 2010, EXP PHYSIOL, V95, P829, DOI 10.1113/expphysiol.2010.052902; Tsitsiou E, 2009, J PHYSIOL-LONDON, V587, P4001, DOI 10.1113/jphysiol.2009.173393; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Verrey F, 2003, PFLUG ARCH EUR J PHY, V445, P529, DOI 10.1007/S00424-002-0973-Z; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z	46	23	23	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2583	2594		10.1096/fj.14-267773	http://dx.doi.org/10.1096/fj.14-267773			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25761365	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000355209500034
J	Pfister, AS; Keil, M; Kuhl, M				Pfister, Astrid S.; Keil, Marina; Kuehl, Michael			The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME BIOGENESIS; DOWN-REGULATION; TRANSCRIPTION; APOPTOSIS; P53; NUCLEOPHOSMIN; BCL-2; BAX; DNA; SUPERFAMILY	Proper ribosome formation is a prerequisite for cell growth and proliferation. Failure of this process results in nucleolar stress and p53-mediated apoptosis. The Wnt target Peter Pan (PPAN) is required for 45 S rRNA maturation. So far, the role of PPAN in nucleolar stress response has remained elusive. We demonstrate that PPAN localizes to mitochondria in addition to its nucleolar localization and inhibits the mitochondrial apoptosis pathway in a p53-independent manner. Loss of PPAN induces BAX stabilization, depolarization of mitochondria, and release of cytochrome c, demonstrating its important role as an anti-apoptotic factor. Staurosporine-induced nucleolar stress and apoptosis disrupt nucleolar PPAN localization and induce its accumulation in the cytoplasm. This is accompanied by phosphorylation and subsequent cleavage of PPAN by caspases. Moreover, we show that PPAN is a novel interaction partner of the anti-apoptotic protein nucleophosmin (NPM). PPAN depletion induces NPM and upstream-binding factor (UBF) degradation, which is independent of caspases. In summary, we provide evidence for a novel nucleolar stress-response pathway involving PPAN, NPM, and BAX to guarantee cell survival in a p53 independent manner.	[Pfister, Astrid S.; Keil, Marina; Kuehl, Michael] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany	Ulm University	Kuhl, M (corresponding author), Univ Ulm, Inst Biochem & Mol Biol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	michael.kuehl@uni-ulm.de			German Federal Ministry of Research and Technology within SyStaR Grant [BMF0315894A]; State of Baden-Wurttemberg Perspektivforderung; Medical Faculty of Ulm University Baustein [3.2, LSBN0101]	German Federal Ministry of Research and Technology within SyStaR Grant; State of Baden-Wurttemberg Perspektivforderung; Medical Faculty of Ulm University Baustein	This work was supported by German Federal Ministry of Research and Technology within SyStaR Grant BMF0315894A (to M. Kuhl), State of Baden-Wurttemberg Perspektivforderung (to M. Kuhl), and Medical Faculty of Ulm University Baustein 3.2, LSBN0101 (to A. S. P.).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Bogengruber E, 2003, FEMS YEAST RES, V3, P35, DOI 10.1111/j.1567-1364.2003.tb00136.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bugner V, 2011, DEVELOPMENT, V138, P2369, DOI 10.1242/dev.060160; Burger K, 2013, BIOL CHEM, V394, P1133, DOI 10.1515/hsz-2013-0153; Cain K, 2003, DRUG METAB REV, V35, P337, DOI 10.1081/DMR-120026497; Casiano CA, 1996, J EXP MED, V184, P765, DOI 10.1084/jem.184.2.765; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chou CC, 2001, MOL PHARMACOL, V59, P38, DOI 10.1124/mol.59.1.38; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Geng Y, 2010, J HISTOCHEM CYTOCHEM, V58, P265, DOI 10.1369/jhc.2009.954024; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hirsch T, 1998, J IMMUNOL, V161, P35; Holmberg Olausson Karl, 2012, Cells, V1, P774, DOI 10.3390/cells1040774; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Kanellis D. C., 2014, ONCOGENE, DOI [10.1038/onc.2014.183, DOI 10.1038/0NC.2014.183]; Kim J, 1998, GENETICS, V149, P795; Lindenboim L, 2011, BBA-MOL CELL RES, V1813, P584, DOI 10.1016/j.bbamcr.2010.11.016; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu ML, 2007, J CELL BIOCHEM, V100, P1154, DOI 10.1002/jcb.21103; Lo SJ, 2013, HEPATOLOGY, V57, P1893, DOI 10.1002/hep.26209; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marquez-Lona EM, 2012, BIOCHEM BIOPH RES CO, V417, P514, DOI 10.1016/j.bbrc.2011.11.152; Migeon JC, 1999, MOL BIOL CELL, V10, P1733, DOI 10.1091/mbc.10.6.1733; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Torres-Montaner A, 2000, J HISTOCHEM CYTOCHEM, V48, P1521, DOI 10.1177/002215540004801109; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Wehner KA, 2002, MOL CELL, V9, P329, DOI 10.1016/S1097-2765(02)00438-0; Westphal D, 2014, CELL DEATH DIFFER, V21, P196, DOI 10.1038/cdd.2013.139; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042253; Zhang JH, 2009, ACTA BIOCH BIOPH SIN, V41, P991, DOI 10.1093/abbs/gmp096; Zhu JB, 2007, CELL RES, V17, P441, DOI 10.1038/cr.2007.36	51	31	32	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10905	10918		10.1074/jbc.M114.634246	http://dx.doi.org/10.1074/jbc.M114.634246			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759387	hybrid, Green Published			2022-12-26	WOS:000353404500029
J	Griffiths, S; Wingen, L; Pietragalla, J; Garcia, G; Hasan, A; Miralles, D; Calderini, DF; Ankleshwaria, JB; Waite, ML; Simmonds, J; Snape, J; Reynolds, M				Griffiths, Simon; Wingen, Luzie; Pietragalla, Julian; Garcia, Guillermo; Hasan, Ahmed; Miralles, Daniel; Calderini, Daniel F.; Ankleshwaria, Jignaben Bipinchandra; Waite, Michelle Leverington; Simmonds, James; Snape, John; Reynolds, Matthew			Genetic Dissection of Grain Size and Grain Number Trade-Offs in CIMMYT Wheat Germplasm	PLOS ONE			English	Article							SPRING WHEAT; SEED SIZE; 1BL/1RS TRANSLOCATION; QTL ANALYSIS; BREAD WHEAT; YIELD; ENVIRONMENTS; WEIGHT; POPULATION; TRAITS	Grain weight (GW) and number per unit area of land (GN) are the primary components of grain yield in wheat. In segregating populations both yield components often show a negative correlation among themselves. Here we use a recombinant doubled haploid population of 105 individuals developed from the CIMMYT varieties Weebill and Bacanora to understand the relative contribution of these components to grain yield and their interaction with each other. Weebill was chosen for its high GW and Bacanora for high GN. The population was phenotyped in Mexico, Argentina, Chile and the UK. Two loci influencing grain yield were indicated on 1B and 7B after QTL analysis. Weebill contributed the increasing alleles. The 1B effect, which is probably caused by to the 1BL. 1RS rye introgression in Bacanora, was a result of increased GN, whereas, the 7B QTL controls GW. We concluded that increased in GW from Weebill 7B allele is not accompanied by a significant reduction in grain number. The extent of the GW and GN trade-off is reduced. This makes this locus an attractive target for marker assisted selection to develop high yielding bold grain varieties like Weebill. AMMI analysis was used to show that the 7B Weebill allele appears to contribute to yield stability.	[Griffiths, Simon; Wingen, Luzie; Ankleshwaria, Jignaben Bipinchandra; Waite, Michelle Leverington; Simmonds, James; Snape, John] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Pietragalla, Julian; Reynolds, Matthew] CIMMYT Int, Mexico City 06600, DF, Mexico; [Garcia, Guillermo; Miralles, Daniel] Univ Buenos Aires, Fac Agron, Dept Prod Vegetal, Catedra Cerealicultura, Buenos Aires, DF, Argentina; [Garcia, Guillermo; Miralles, Daniel] Univ Buenos Aires, Fac Agron, IFEVA CONICET, Buenos Aires, DF, Argentina; [Hasan, Ahmed; Calderini, Daniel F.] Univ Austral Chile, Plant Prod & Plant Protect Inst, Valdivia, Chile	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad Austral de Chile	Griffiths, S (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	simon.griffiths@jic.ac.uk	Reynolds, Matthew M/S-3578-2016; Calderini, Daniel F/D-7922-2015; hasan, ahmed/B-3788-2010; Wingen, Luzie/AAF-3703-2019	Reynolds, Matthew M/0000-0002-4291-4316; Calderini, Daniel F/0000-0001-7873-5101; Wingen, Luzie/0000-0002-4682-4764; Snape, john/0000-0002-9241-3931; Simmonds, James/0000-0003-4936-1694; Garcia, Guillermo/0000-0001-7690-4100; Hasan, Ahmed/0000-0001-6762-9098	UK by the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/J/000C0617] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0617] Funding Source: researchfish	UK by the Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in the UK by the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2001, THEOR APPL GENET, V102, P726, DOI 10.1007/s001220051703; Breseghello F, 2007, FIELD CROP RES, V101, P172, DOI 10.1016/j.fcr.2006.11.008; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bustos DV, 2013, FIELD CROP RES, V145, P106, DOI 10.1016/j.fcr.2013.01.015; Calderini DF, 2001, EUPHYTICA, V119, P199, DOI 10.1023/A:1017597923568; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Garcia GA, 2013, CROP SCI, V53, P2577, DOI 10.2135/cropsci2012.11.0669; Gauch HG, 2008, CROP SCI, V48, P866, DOI 10.2135/cropsci2007.09.0513; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; GOLLOB HF, 1968, PSYCHOMETRIKA, V33, P73, DOI 10.1007/BF02289676; GRIEVE CM, 1992, PLANT SOIL, V147, P197, DOI 10.1007/BF00029071; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; LAURIE DA, 1988, THEOR APPL GENET, V76, P393, DOI 10.1007/BF00265339; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; MARSHALL DR, 1986, AUST J AGR RES, V37, P331, DOI 10.1071/AR9860331; Monneveux P, 2003, CEREAL RES COMMUN, V31, P371; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Peake AS, 2011, CROP PASTURE SCI, V62, P276, DOI 10.1071/CP10219; RDevelopmentCoreTeam, 2008, R LANG ENV STAT COMP; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; Singh R, 2009, CEREAL RES COMMUN, V37, P441, DOI 10.1556/CRC.37.2009.3.13; Tsilo TJ, 2010, THEOR APPL GENET, V121, P717, DOI 10.1007/s00122-010-1343-4; Wang Y, 2012, MOL BREEDING, V29, P661, DOI 10.1007/s11032-011-9580-z; Wiersma JJ, 2001, CROP SCI, V41, P999, DOI 10.2135/cropsci2001.414999x; Wu X., 2012, P ACM SIGCOMM, P7; Xiao YG, 2011, CROP PASTURE SCI, V62, P625, DOI 10.1071/CP11037; Zhao CH, 2012, FIELD CROP RES, V127, P79, DOI 10.1016/j.fcr.2011.11.008	32	69	73	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118847	10.1371/journal.pone.0118847	http://dx.doi.org/10.1371/journal.pone.0118847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775191	Green Published, gold			2022-12-26	WOS:000351183500044
J	Liao, XF; Ren, JJ; Wei, CH; Ross, AC; Cecere, TE; Jortner, BS; Ahmed, SA; Luo, XM				Liao, Xiaofeng; Ren, Jingjing; Wei, Cheng-Hsin; Ross, A. Catharine; Cecere, Thomas E.; Jortner, Bernard S.; Ahmed, S. Ansar; Luo, Xin M.			Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model	PLOS ONE			English	Article							REGULATORY T-CELLS; B-CELLS; DENDRITIC CELLS; VITAMIN-A; X-RECEPTOR; TGF-BETA; IN-VITRO; PATHOGENESIS; ACTIVATION; TISSUE	Roles of all-trans-retinoic acid (tRA), a metabolite of vitamin A (VA), in both tolerogenic and immunogenic responses are documented. However, how tRA affects the development of systemic autoimmunity is poorly understood. Here we demonstrate that tRA have paradoxical effects on the development of autoimmune lupus in the MRL/lpr mouse model. We administered, orally, tRA or VA mixed with 10% of tRA (referred to as VARA) to female mice starting from 6 weeks of age. At this age, the mice do not exhibit overt clinical signs of lupus. However, the immunogenic environment preceding disease onset has been established as evidenced by an increase of total IgM/IgG in the plasma and expansion of lymphocytes and dendritic cells in secondary lymphoid organs. After 8 weeks of tRA, but not VARA treatment, significantly higher pathological scores in the skin, brain and lung were observed. These were accompanied by a marked increase in B-cell responses that included autoantibody production and enhanced expression of plasma cell-promoting cytokines. Paradoxically, the number of lymphocytes in the mesenteric lymph node decreased with tRA that led to significantly reduced lymphadenopathy. In addition, tRA differentially affected renal pathology, increasing leukocyte infiltration of renal tubulointerstitium while restoring the size of glomeruli in the kidney cortex. In contrast, minimal induction of inflammation with tRA in the absence of an immunogenic environment in the control mice was observed. Altogether, our results suggest that under a predisposed immunogenic environment in autoimmune lupus, tRA may decrease inflammation in some organs while generating more severe disease in others.	[Liao, Xiaofeng; Ren, Jingjing; Cecere, Thomas E.; Jortner, Bernard S.; Ahmed, S. Ansar; Luo, Xin M.] Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Wei, Cheng-Hsin; Ross, A. Catharine] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Luo, XM (corresponding author), Virginia Tech, Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	xinluo@vt.edu	Cecere, Thomas E/N-9266-2016; Luo, Xin M/J-6544-2016	Luo, Xin M/0000-0002-2809-5836	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041479] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK041479] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adamson, 1996, Oncologist, V1, P305; Ait-Azzouzene D, 2010, J IMMUNOL, V185, P1015, DOI 10.4049/jimmunol.1000698; Anolik JH, 2013, LUPUS, V22, P342, DOI 10.1177/0961203312471576; Apostolidis SA, 2011, LUPUS, V20, P120, DOI 10.1177/0961203310389100; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Chen F, 2010, J CLIN INVEST, V120, P2040, DOI 10.1172/JCI40253; Chen Q, 2007, CELL IMMUNOL, V249, P37, DOI 10.1016/j.cellimm.2007.11.001; Chen QY, 2011, CLIN VACCINE IMMUNOL, V18, P1015, DOI 10.1128/CVI.00004-11; Chen QY, 2005, P NATL ACAD SCI USA, V102, P14142, DOI 10.1073/pnas.0505018102; Ching KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032001; Clark AG, 2013, AUTOIMMUNITY, V46, P188, DOI 10.3109/08916934.2012.746671; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crispin JC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/943254; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; de Lema GP, 2004, KIDNEY INT, V66, P1018, DOI 10.1111/j.1523-1755.2004.00850.x; Degos L, 2001, ONCOGENE, V20, P7140, DOI 10.1038/sj.onc.1204763; DRICKAMER LC, 1974, DEV PSYCHOBIOL, V7, P257, DOI 10.1002/dev.420070310; Elias KM, 2008, BLOOD, V111, P1013, DOI 10.1182/blood-2007-06-096438; Fehr EM, 2013, J AUTOIMMUN, V40, P86, DOI 10.1016/j.jaut.2012.08.003; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Hellman P, 2007, HUM IMMUNOL, V68, P324, DOI 10.1016/j.humimm.2007.01.018; Hochheiser K, 2013, J CLIN INVEST, V123, P4242, DOI 10.1172/JCI70143; Iikuni N, 2009, J IMMUNOL, V183, P1518, DOI 10.4049/jimmunol.0901163; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; James ML, 2010, PEDIATR RES, V67, P591, DOI 10.1203/PDR.0b013e3181dbac3d; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; KALIN JR, 1981, DRUG METAB DISPOS, V9, P196; Kinoshita K, 2003, J IMMUNOL, V170, P5793, DOI 10.4049/jimmunol.170.11.5793; Kinoshita K, 2010, AM J KIDNEY DIS, V55, P344, DOI 10.1053/j.ajkd.2009.06.012; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kreft B, 1996, J AUTOIMMUN, V9, P463, DOI 10.1006/jaut.1996.0063; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Lech M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020118; Liu J, 2006, GENES IMMUN, V7, P156, DOI 10.1038/sj.gene.6364286; Liu Z, 2012, NAT MED, V18, P871, DOI 10.1038/nm.2752; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marill J, 2003, CURR DRUG METAB, V4, P1, DOI 10.2174/1389200033336900; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nacionales DC, 2009, J IMMUNOL, V182, P4226, DOI 10.4049/jimmunol.0800771; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; Nozaki Y, 2005, CLIN EXP IMMUNOL, V139, P74, DOI 10.1111/j.1365-2249.2005.02654.x; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Perry D, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/271694; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rodriguez W, 2006, ARTHRITIS RHEUM-US, V54, P325, DOI 10.1002/art.21556; Ross AC, 2007, NEONATOLOGY, V92, P26, DOI 10.1159/000100083; Ross AC, 2006, J LIPID RES, V47, P1844, DOI 10.1194/jlr.M600061-JLR200; Rottman JB, 2010, VET PATHOL, V47, P664, DOI 10.1177/0300985810370005; Sawalha AH, 2012, J AUTOIMMUN, V38, pJ216, DOI 10.1016/j.jaut.2011.11.008; Shima Y, 2005, NEPHRON EXP NEPHROL, V100, pE54, DOI 10.1159/000084655; Sobel ES, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3387; Stephensen CB, 2002, J IMMUNOL, V168, P4495, DOI 10.4049/jimmunol.168.9.4495; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; WALSH SJ, 1995, J RHEUMATOL, V22, P1663; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Zhang Z, 2009, J IMMUNOL, V183, P3160, DOI 10.4049/jimmunol.0900385; Zhou WD, 2001, KIDNEY INT, V59, P1227, DOI 10.1046/j.1523-1755.2001.0590041227.x	75	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118176	10.1371/journal.pone.0118176	http://dx.doi.org/10.1371/journal.pone.0118176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775135	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500026
J	Tyc, O; Wolf, AB; Garbeva, P				Tyc, Olaf; Wolf, Alexandra B.; Garbeva, Paolina			The Effect of Phylogenetically Different Bacteria on the Fitness of Pseudomonas fluorescens in Sand Microcosms	PLOS ONE			English	Article							SOIL; DIVERSITY; COMPETITION; EVOLUTION; GROWTH	In most environments many microorganisms live in close vicinity and can interact in various ways. Recent studies suggest that bacteria are able to sense and respond to the presence of neighbouring bacteria in the environment and alter their response accordingly. This ability might be an important strategy in complex habitats such as soils, with great implications for shaping the microbial community structure. Here, we used a sand microcosm approach to investigate how Pseudomonas fluorescens Pf0-1 responds to the presence of monocultures or mixtures of two phylogenetically different bacteria, a Gram-negative (Pedobacter sp. V48) and a Gram-positive (Bacillus sp. V102) under two nutrient conditions. Results revealed that under both nutrient poor and nutrient rich conditions confrontation with the Gram-positive Bacillus sp. V102 strain led to significant lower cell numbers of Pseudomonas fluorescens Pf0-1, whereas confrontation with the Gram-negative Pedobacter sp. V48 strain did not affect the growth of Pseudomonas fluorescens Pf0-1. However, when Pseudomonas fluorescens Pf0-1 was confronted with the mixture of both strains, no significant effect on the growth of Pseudomonas fluorescens Pf0-1 was observed. Quantitative real-time PCR data showed up-regulation of genes involved in the production of a broad-spectrum antibiotic in Pseudomonas fluorescens Pf0-1 when confronted with Pedobacter sp. V48, but not in the presence of Bacillus sp. V102. The results provide evidence that the performance of bacteria in soil depends strongly on the identity of neighbouring bacteria and that inter-specific interactions are an important factor in determining microbial community structure.	[Tyc, Olaf; Wolf, Alexandra B.; Garbeva, Paolina] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, NL-6700 AB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Tyc, O (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, POB 50, NL-6700 AB Wageningen, Netherlands.	o.tyc@nioo.knaw.nl	Garbeva, Paolina/C-3727-2011; Tyc, Olaf/AAQ-1262-2021; KNAW, NIOO-KNAW/A-4320-2012	Garbeva, Paolina/0000-0002-2359-5719; Tyc, Olaf/0000-0001-9949-0975; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant [836.09.004]	Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant	This work is supported by the Netherlands Organization for Scientific Research (NWO) MEERVOUD personal grant issued to Paolina Garbeva (836.09.004).	Allen B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001549; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; COMPEAU G, 1988, APPL ENVIRON MICROB, V54, P2432, DOI 10.1128/AEM.54.10.2432-2438.1988; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Czaran T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006655; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; de Boer W, 2007, FEMS MICROBIOL ECOL, V59, P177, DOI 10.1111/j.1574-6941.2006.00197.x; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Garbeva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027266; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Inglis RF, 2012, EVOLUTION, V66, P3472, DOI 10.1111/j.1558-5646.2012.01706.x; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Mitri S, 2013, ANNU REV GENET, V47, P247, DOI 10.1146/annurev-genet-111212-133307; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Traxler MF, 2013, MBIO, V4, DOI 10.1128/mBio.00459-13; Tyc O, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00567; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; van den Berg H. A., 2008, Computational Mathematics and Modeling, V19, P406, DOI 10.1007/s10598-008-9013-y; van Wezel GP, 2011, NAT PROD REP, V28, P1311, DOI 10.1039/c1np00003a; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685	26	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119838	10.1371/journal.pone.0119838	http://dx.doi.org/10.1371/journal.pone.0119838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774766	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500131
J	Alvarez, J; Sarradell, J; Morrison, R; Perez, A				Alvarez, Julio; Sarradell, Javier; Morrison, Robert; Perez, Andres			Impact of Porcine Epidemic Diarrhea on Performance of Growing Pigs	PLOS ONE			English	Article							UNITED-STATES; MORTALITY	The impact of porcine epidemic diarrhea virus (PEDv) infection on the US pork industry has mainly been attributed to the mortality that it causes in suckling piglets, and, consequently, much effort has been invested in the quantification of its effect in sow farms. However, no information on the performance of surviving pigs that were exposed to the PEDv as piglets is available. Here, a retrospective cohort study to evaluate the impact of porcine epidemic diarrhea virus (PEDv) infection on growing pigs' performance, as indicated by mortality, average daily gain (ADG), average daily feed intake (ADFI), and feed conversion ratio (FCR) was performed using production records from weaned pigs in nursery and wean-to-finish sites from sow farms that became PEDv-infected between May 2013 and June 2014. Production records from the first batch of growing pigs weaned in infected flows after the PEDv outbreak ("infected batches") were compared with those from pigs weaned within the previous 14 to 120 days ("control batches"). Performance records from infected and control batches, paired by flow, were compared using non-parametric paired tests. Mortality, ADG and FCR were significantly different in PEDv-positive (infected) compared with PEDv-negative (control) batches, with a mean increase of mortality and FCR of 11% and 0.5, respectively, and a decrease of ADG of 0.16 lb/day. Our results demonstrate a poorer performance of growing pigs weaned after a PEDv outbreak compared with those weaned within the previous 14-120 days, suggesting that in addition to the mortality induced by PEDv in suckling pigs, the disease also impairs the performance of surviving pig. These findings help to quantify the impact of PEDv infection in the US and, ultimately, contribute to efforts to quantify the cost-effectiveness of disease prevention and control measures.	[Alvarez, Julio; Morrison, Robert; Perez, Andres] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sarradell, Javier] Natl Univ Rosario, Fac Vet, Dept Gen & Syst Pathol Sarradell, Casilda, Argentina	University of Minnesota System; University of Minnesota Twin Cities; National University of Rosario	Alvarez, J (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	jalvarez@umn.edu	Alvarez, Julio/H-8292-2013; Perez, Andres/HGD-8377-2022	Alvarez, Julio/0000-0002-8999-9417; 				Campbell E., 2014, BLOOMBERG NEWS; Department of Economics ISU, 2014, EST LIV RET WEAN FEE; Geiger JO, 2013, PORCINE EPIDEMIC DIA; Goede D., 2014, PRODUCTION IMPACT ST; Hill C, 2014, EMERGENCE PORCINE EP, P9; HOLDEN PJ, 1991, AGRI-PRACTICE, V12, P46; Lange de FM, 2009, DIS SWINE, P1055; Losinger WC, 1998, PREV VET MED, V33, P121, DOI 10.1016/S0167-5877(97)00052-4; Maes D, 2001, J SWINE HEALTH PROD, V9, P267; Sawyer W., 2014, THIS LITTLE PIGGY CR, P8; Stein T, 2014, FEEDSTUFFS; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675	12	55	57	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120532	10.1371/journal.pone.0120532	http://dx.doi.org/10.1371/journal.pone.0120532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768287	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500127
J	Chen, L; Chu, C; Kong, XY; Huang, GH; Huang, T; Cai, YD				Chen, Lei; Chu, Chen; Kong, Xiangyin; Huang, Guohua; Huang, Tao; Cai, Yu-Dong			A Hybrid Computational Method for the Discovery of Novel Reproduction-Related Genes	PLOS ONE			English	Article							MITOTIC CELL-DIVISION; TGF-BETA; GERM-CELL; MALE-INFERTILITY; CONSERVED ROLE; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION; NETWORK; WALKING	Uncovering the molecular mechanisms underlying reproduction is of great importance to infertility treatment and to the generation of healthy offspring. In this study, we discovered novel reproduction-related genes with a hybrid computational method, integrating three different types of method, which offered new clues for further reproduction research. This method was first executed on a weighted graph, constructed based on known protein-protein interactions, to search the shortest paths connecting any two known reproduction-related genes. Genes occurring in these paths were deemed to have a special relationship with reproduction. These newly discovered genes were filtered with a randomization test. Then, the remaining genes were further selected according to their associations with known reproduction-related genes measured by protein-protein interaction score and alignment score obtained by BLAST. The in-depth analysis of the high confidence novel reproduction genes revealed hidden mechanisms of reproduction and provided guidelines for further experimental validations.	[Huang, Guohua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Chu, Chen] Chinese Acad Sci, State Key Lab Mol Biol, Shanghai Key Lab Mol Androl, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Huang, Guohua/A-2215-2019; Chen, Lei/A-2275-2011; Chu, Chen/J-6527-2019	Huang, Guohua/0000-0001-6954-3933; Chen, Lei/0000-0003-3068-1583; Chu, Chen/0000-0001-8084-0867; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [31371335, 61202021, 61373028, 11371008, 61303099]; Innovation Program of the Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Educational Development Foundation	National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (31371335, 61202021, 61373028, 11371008, 61303099), the Innovation Program of the Shanghai Municipal Education Commission (12YZ120, 12ZZ087) and the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aston KI, 2014, ANDROLOGY-US, V2, P315, DOI 10.1111/j.2047-2927.2014.00188.x; Attaman JA, 2012, HUM REPROD, V27, P1466, DOI 10.1093/humrep/des065; Attari F, 2014, STEM CELLS DEV, V23, P1050, DOI 10.1089/scd.2013.0438; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Ben-Shushan E, 2014, NOTCH SIGNALING REGU; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Besnard V, 2005, AM J PHYSIOL-LUNG C, V289, pL750, DOI 10.1152/ajplung.00151.2005; Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Boulet AM, 2012, DEV BIOL, V371, P235, DOI 10.1016/j.ydbio.2012.08.017; Cabaton NJ, 2011, ENVIRON HEALTH PERSP, V119, P547, DOI 10.1289/ehp.1002559; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Craven J, 2005, ADV NEURAL INFORM PR, V17, P193; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; Dechanet C, 2011, HUM REPROD UPDATE, V17, P76, DOI 10.1093/humupd/dmq033; deKretser DM, 1997, LANCET, V349, P787, DOI 10.1016/S0140-6736(96)08341-9; Dobashi M, 2002, ASIAN J ANDROL, V4, P105; Dong YL, 2007, BIOL REPROD, V76, P892, DOI 10.1095/biolreprod.106.059089; Doronin K, 2012, SCIENCE, V338, P795, DOI 10.1126/science.1226625; Feng YM, 2014, CELL CYCLE, V13, P782, DOI 10.4161/cc.27708; Gormen T. H., 1990, INTRO ALGORITHMS; Hasegawa K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121012; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Hutson LD, 2003, DEV DYNAM, V228, P358, DOI 10.1002/dvdy.10386; Izzi L, 2007, EMBO J, V26, P3132, DOI 10.1038/sj.emboj.7601753; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Kawamura S, 2004, INTERNAL MED, V43, P218, DOI 10.2169/internalmedicine.43.218; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Kofron M, 2004, DEVELOPMENT, V131, P5065, DOI 10.1242/dev.01396; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li GD, 2010, MOL ENDOCRINOL, V24, P1404, DOI 10.1210/me.2010-0014; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Managbanag JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003802; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Mori S, 2003, DEV GROWTH DIFFER, V45, P7, DOI 10.1046/j.1440-169X.2003.00670.x; Morris RS, 1996, LANCET, V347, P1277, DOI 10.1016/S0140-6736(96)90934-4; Moulos P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-235; Moussad EEDA, 2002, J CLIN PATHOL-MOL PA, V55, P186, DOI 10.1136/mp.55.3.186; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Nusinow DP, 2012, BIOINFORMATICS, V28, P3115, DOI 10.1093/bioinformatics/bts594; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Ouvrier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026966; Park YY, 2010, MOL CELLS, V30, P485, DOI 10.1007/s10059-010-0136-6; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piao J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03022; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Sanchez A, 2010, GOPROFILES R PACKAGE; Sanchez A, 2007, J STAT PLAN INFER, V137, P3975, DOI 10.1016/j.jspi.2007.04.015; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharpe RM, 2002, NAT CELL BIOL, V4, pS33, DOI 10.1038/ncb-nm-fertilityS33; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Shooner C, 2005, REPROD BIOL ENDOCRIN, V3, P1, DOI 10.1186/1477-7827-3-20; Smedley D, 2014, BIOINFORMATICS, V30, P3215, DOI 10.1093/bioinformatics/btu508; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strazzabosco M, 2010, J HEPATOL, V52, P765, DOI 10.1016/j.jhep.2009.12.022; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Vachias C, 2010, DEVELOPMENT, V137, P2703, DOI 10.1242/dev.052183; VANDUIN M, 1994, BIOL REPROD, V51, P607, DOI 10.1095/biolreprod51.4.607; Wang CH, 2014, CELL RES, V24, P610, DOI 10.1038/cr.2014.27; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Wang WG, 2012, DEVELOPMENT, V139, P601, DOI 10.1242/dev.069575; Wang XC, 2010, BIOCHEM BIOPH RES CO, V394, P29, DOI 10.1016/j.bbrc.2010.02.061; Woodhoo A, 2009, NAT NEUROSCI, V12, P839, DOI 10.1038/nn.2323; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu YE, 2000, P NATL ACAD SCI USA, V97, P4683, DOI 10.1073/pnas.97.9.4683; Zhang J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/523415	90	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117090	10.1371/journal.pone.0117090	http://dx.doi.org/10.1371/journal.pone.0117090			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768094	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500014
J	Chung, NC; Huang, YH; Chang, CH; Liao, JC; Yang, CH; Chen, CC; Liu, IY				Chung, Ni-Chun; Huang, Ying-Hsueh; Chang, Chuan-Hsiung; Liao, James C.; Yang, Chih-Hsien; Chen, Chien-Chang; Liu, Ingrid Y.			Behavior Training Reverses Asymmetry in Hippocampal Transcriptome of the Ca(v)3.2 Knockout Mice	PLOS ONE			English	Article							CHILDHOOD ABSENCE EPILEPSY; GENE-EXPRESSION; GLUTAMATE RECEPTORS; PARKINSONS-DISEASE; CALCIUM-CHANNELS; BRAIN ASYMMETRY; CA2+ CHANNELS; MEMORY; CACNA1H; FEAR	Homozygous Ca(v)3.2 knockout mice, which are defective in the pore-forming subunit of a low voltage activated T-type calcium channel, have been documented to show impaired maintenance of late-phase long-term potentiation (L-LTP) and defective retrieval of contextassociated fear memory. To investigate the role of Ca(v)3.2 in global gene expression, we performed a microarray transcriptome study on the hippocampi of the Ca(v)3.2(-/-) mice and their wild-type littermates, either naive (untrained) or trace fear conditioned. We found a significant left-right asymmetric effect on the hippocampal transcriptome caused by the Ca(v)3.2 knockout. Between the naive Ca(v)3.2(-/-) and the naive wild-type mice, 3522 differentially expressed genes (DEGs) were found in the left hippocampus, but only 4 DEGs were found in the right hippocampus. Remarkably, the effect of Ca(v)3.2 knockout was partially reversed by trace fear conditioning. The number of DEGs in the left hippocampus was reduced to 6 in the Ca(v)3.2 knockout mice after trace fear conditioning, compared with the wild-type naive mice. To our knowledge, these results demonstrate for the first time the asymmetric effects of the Ca(v)3.2 and its partial reversal by behavior training on the hippocampal transcriptome.	[Chung, Ni-Chun; Liu, Ingrid Y.] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Huang, Ying-Hsueh; Chang, Chuan-Hsiung; Yang, Chih-Hsien] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Chen, Chien-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liu, Ingrid Y.] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	Tzu Chi University; National Yang Ming Chiao Tung University; University of California System; University of California Los Angeles; Academia Sinica - Taiwan; Tzu Chi University	Liu, IY (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	ycliu@mail.tcu.edu.tw	Chen, Chien-Chang/D-2023-2015; Liu, Ingrid Y/AAN-2606-2021	Chen, Chien-Chang/0000-0001-8850-4278; Liao, James/0000-0002-4580-7276	National Science Council, Taiwan [98-2314-B-320-001-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by National Science Council, Taiwan (#98-2314-B-320-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Arnold OH, 1999, NEUROPSYCHOBIOLOGY, V40, P21, DOI 10.1159/000026593; Bading H, 2013, NAT REV NEUROSCI, V14, P593, DOI 10.1038/nrn3531; Barnes P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003248; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; BIANKI VL, 1981, INT J NEUROSCI, V15, P37, DOI 10.3109/00207458108985844; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Carbon M, 2006, J NEUROL SCI, V248, P72, DOI 10.1016/j.jns.2006.05.005; Chan KFY, 2004, EXP NEUROL, V190, P328, DOI 10.1016/j.expneurol.2004.08.001; Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029384; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x; Chioza B, 2006, EPILEPSY RES, V69, P177, DOI 10.1016/j.eplepsyres.2006.01.009; Costanzo MJ, 2008, BIOORG MED CHEM LETT, V18, P2114, DOI 10.1016/j.bmcl.2008.01.093; Cribbs LL, 2000, FEBS LETT, V466, P54, DOI 10.1016/S0014-5793(99)01756-1; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; Alvares LD, 2013, NEUROSCIENCE, V244, P42, DOI 10.1016/j.neuroscience.2013.04.005; Dong SZ, 2007, EUR J NEUROSCI, V26, P101, DOI 10.1111/j.1460-9568.2007.05641.x; Dreosti E, 2014, CURR BIOL, V24, P440, DOI 10.1016/j.cub.2014.01.016; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Gafford GM, 2011, NEUROSCIENCE, V182, P98, DOI 10.1016/j.neuroscience.2011.03.023; Gao ZY, 1998, EUR J NEUROSCI, V10, P2416, DOI 10.1046/j.1460-9568.1998.00252.x; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Hanlon FM, 2005, BEHAV NEUROSCI, V119, P863, DOI 10.1037/0735-7044.119.4.863; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hou GL, 2013, NEUROCHEM RES, V38, P453, DOI 10.1007/s11064-012-0954-3; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; Jellinger KA, 2002, J NEURAL TRANSM-SUPP, P347; Johnson CM, 1997, J NEUROSCI, V17, P6189; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Li BX, 2014, NAT NEUROSCI, V17, P1055, DOI 10.1038/nn.3744; Li L, 2007, MOL CELL NEUROSCI, V35, P76, DOI 10.1016/j.mcn.2007.02.004; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Liang JM, 2006, NEUROSCI LETT, V406, P27, DOI 10.1016/j.neulet.2006.06.073; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Maguire EA, 2003, J NEUROSCI, V23, P5302; Mei B, 2005, BRAIN RES BULL, V67, P1, DOI 10.1016/j.brainresbull.2005.03.023; Moskal JR, 2006, HIPPOCAMPUS, V16, P629, DOI 10.1002/hipo.20198; Palmer AR, 2004, SCIENCE, V306, P828, DOI 10.1126/science.1103707; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Raftogianni A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048337; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Son WY, 2002, DEV GROWTH DIFFER, V44, P181, DOI 10.1046/j.1440-169X.2002.00633.x; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Steenland HW, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-16; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; Szapiro G, 2003, HIPPOCAMPUS, V13, P53, DOI 10.1002/hipo.10043; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; TRANEL D, 1991, BRAIN COGNITION, V15, P187, DOI 10.1016/0278-2626(91)90025-4; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118832	10.1371/journal.pone.0118832	http://dx.doi.org/10.1371/journal.pone.0118832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768289	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500047
J	Kim, S; Sung, J; Foo, M; Jin, YS; Kim, PJ				Kim, Seunghyeon; Sung, Jaeyun; Foo, Mathias; Jin, Yong-Su; Kim, Pan-Jun			Uncovering the Nutritional Landscape of Food	PLOS ONE			English	Article							CHILDHOOD; NUTRIENT; NETWORK	Recent progresses in data-driven analysis methods, including network-based approaches, are revolutionizing many classical disciplines. These techniques can also be applied to food and nutrition, which must be studied to design healthy diets. Using nutritional information from over 1,000 raw foods, we systematically evaluated the nutrient composition of each food in regards to satisfying daily nutritional requirements. The nutrient balance of a food was quantified and termed nutritional fitness; this measure was based on the food's frequency of occurrence in nutritionally adequate food combinations. Nutritional fitness offers a way to prioritize recommendable foods within a global network of foods, in which foods are connected based on the similarities of their nutrient compositions. We identified a number of key nutrients, such as choline and alpha-linolenic acid, whose levels in foods can critically affect the nutritional fitness of the foods. Analogously, pairs of nutrients can have the same effect. In fact, two nutrients can synergistically affect the nutritional fitness, although the individual nutrients alone may not have an impact. This result, involving the tendency among nutrients to exhibit correlations in their abundances across foods, implies a hidden layer of complexity when exploring for foods whose balance of nutrients within pairs holistically helps meet nutritional requirements. Interestingly, foods with high nutritional fitness successfully maintain this nutrient balance. This effect expands our scope to a diverse repertoire of nutrient-nutrient correlations, which are integrated under a common network framework that yields unexpected yet coherent associations between nutrients. Our nutrient-profiling approach combined with a network-based analysis provides a more unbiased, global view of the relationships between foods and nutrients, and can be extended towards nutritional policies, food marketing, and personalized nutrition.	[Kim, Seunghyeon; Sung, Jaeyun; Foo, Mathias; Kim, Pan-Jun] Asia Pacific Ctr Theoret Phys, Pohang, South Korea; [Kim, Seunghyeon; Kim, Pan-Jun] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Jin, Yong-Su] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA; [Jin, Yong-Su] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kim, PJ (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, South Korea.	pjkim@apctp.org	Foo, Mathias/AAR-9549-2021; Foo, Mathias/GSO-3501-2022; Jin, Yong-Su/L-4530-2013	Foo, Mathias/0000-0003-1400-2659; Sung, Jaeyun/0000-0002-3005-2798	Basic Science Research Program through the National Research Foundation of Korea [NRF-2012R1A1A2008925]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF-2012R1A1A2008925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Babic Z, 2011, INT J PROD ECON, V130, P218, DOI 10.1016/j.ijpe.2010.12.016; Barrat A., 2009, DYNAMICAL PROCESSES; Boon CS, 2005, CRIT REV FOOD SCI, V45, P511, DOI 10.1080/10408690590957160; Church SM, 2006, NUTR BULL, V31, P15, DOI 10.1111/j.1467-3010.2006.00538.x; Crawford I.M., 1997, AGR FOOD MARKETING M; De Irala-Estevez J, 2000, EUR J CLIN NUTR, V54, P706, DOI 10.1038/sj.ejcn.1601080; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; GOLDSMITH GA, 1958, AM J CLIN NUTR, V6, P479, DOI 10.1093/ajcn/6.5.479; Keen C. L., 2006, MINERAL REQUIREMENTS, P304; Kennedy E, 2008, NUTR REV, V66, P703, DOI 10.1111/j.1753-4887.2008.00124.x; Kim SW, 2013, SUSTAINABLE SWINE NU, P217; Kittler P.G., 2008, FOOD CULTURE; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036439; Lu S, 2008, J INTEGR PLANT BIOL, V50, P778, DOI 10.1111/j.1744-7909.2008.00708.x; Menaa F, 2013, J FOOD SCI, V78, pR377, DOI 10.1111/1750-3841.12055; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; National Health and Medical Research Council (NHMRC), 2013, AUSTR DIET GUID; National Research Council, 2005, DIET REF INT EN CARB; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Otten JJ, 2006, DIETARY REFERENCE IN, P219; Santika O, 2009, J NUTR, V139, P135, DOI 10.3945/jn.108.092270; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Wardle J, 2000, APPETITE, V34, P269, DOI 10.1006/appe.1999.0311; Yang Y, 2013, P NATL ACAD SCI USA, V110, P4545, DOI 10.1073/pnas.1216075110; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x	29	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118697	10.1371/journal.pone.0118697	http://dx.doi.org/10.1371/journal.pone.0118697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768022	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500037
J	Lizunov, VA; Stenkula, KG; Blank, PS; Troy, A; Lee, JP; Skarulis, MC; Cushman, SW; Zimmerberg, J				Lizunov, Vladimir A.; Stenkula, Karin G.; Blank, Paul S.; Troy, Aaron; Lee, Jo-Ping; Skarulis, Monica C.; Cushman, Samuel W.; Zimmerberg, Joshua			Human Adipose Cells In Vitro Are Either Refractory or Responsive to Insulin, Reflecting Host Metabolic State	PLOS ONE			English	Article							GLUT4 VESICLES; FAT-CELLS; SENSITIVITY; FUSION; TISSUE; HETEROGENEITY; RESISTANCE; OBESITY	While intercellular communication processes are frequently characterized by switch-like transitions, the endocrine system, including the adipose tissue response to insulin, has been characterized by graded responses. Yet here individual cells from adipose tissue biopsies are best described by a switch-like transition between the basal and insulin-stimulated states for the trafficking of the glucose transporter GLUT4. Two statistically-defined populations best describe the observed cellular heterogeneity, representing the fractions of refractive and responsive adipose cells. Furthermore, subjects exhibiting high systemic insulin sensitivity indices (SI) have high fractions of responsive adipose cells in vitro, while subjects exhibiting decreasing SI have increasing fractions of refractory cells in vitro. Thus, a two-component model best describes the relationship between cellular refractory fraction and subject SI. Since isolated cells exhibit these different response characteristics in the presence of constant culture conditions and milieu, we suggest that a physiological switching mechanism at the adipose cellular level ultimately drives systemic SI.	[Lizunov, Vladimir A.; Blank, Paul S.; Troy, Aaron; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA; [Stenkula, Karin G.; Lee, Jo-Ping; Cushman, Samuel W.] NIDDK, Expt Diabet Metab & Nutr Sect, NIH, Bethesda, MD 20892 USA; [Skarulis, Monica C.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Stenkula, Karin G.] Lund Univ, Expt Med Sci, Lund, Sweden	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Lund University	Zimmerberg, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD USA.	joshz@mail.nih.gov	Blank, Paul/Q-9673-2019	Stenkula, Karin/0000-0002-0739-1150; Troy, Aaron/0000-0001-9844-5718	Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075007] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF13OC0004953] Funding Source: researchfish	Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Intramural Research Programs of Eunice Kennedy Shriver National Institute of Child Health and Human Development and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Bluher M, 2004, J BIOL CHEM, V279, P31891, DOI 10.1074/jbc.M404569200; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Cantley JL, 2013, P NATL ACAD SCI USA, V110, P1869, DOI 10.1073/pnas.1219456110; Cizmeci D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083640; Crivat G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077953; Franck N, 2007, DIABETOLOGIA, V50, P1716, DOI 10.1007/s00125-007-0713-1; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; GLIEMANN J, 1972, ISRAEL J MED SCI, V8, P807; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Khalifeh-Soltani A, 2014, NAT MED, V20, P175, DOI 10.1038/nm.3450; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Lee YK, 2013, NAT CELL BIOL, V15, P568, DOI 10.1038/ncb2776; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; Lizunov VA, 2009, J BIOL CHEM, V284, P7914, DOI 10.1074/jbc.M806460200; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Pekkurnaz G, 2014, CELL IN PRESS, V158, P1, DOI [10.1182/asheducation-2014.1.158, DOI 10.1182/ASHEDUCATION-2014.1.158]; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smith U, 1999, ANN NY ACAD SCI, V892, P119, DOI 10.1111/j.1749-6632.1999.tb07790.x; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Stenkula KG, 2010, CELL METAB, V12, P250, DOI 10.1016/j.cmet.2010.08.005; Thompson D, 2012, PHYSIOL REV, V92, P157, DOI 10.1152/physrev.00012.2011; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119291	10.1371/journal.pone.0119291	http://dx.doi.org/10.1371/journal.pone.0119291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768970	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500074
J	Mourits, DL; Hartong, DT; Bosscha, MI; Kloos, RJHM; Moll, AC				Mourits, Daphne L.; Hartong, Dyonne T.; Bosscha, Machteld I.; Kloos, Roel J. H. M.; Moll, Annette C.			Worldwide Enucleation Techniques and Materials for Treatment of Retinoblastoma: An International Survey	PLOS ONE			English	Article							ORBITAL IMPLANTS; ANOPHTHALMIC SOCKET; HYDROXYAPATITE; EVISCERATION; MOTILITY; PTOSIS; TRENDS	Purpose To investigate the current practice of enucleation with or without orbital implant for retinoblastoma in countries across the world. Methods A digital survey identifying operation techniques and material used for orbital implants after enucleation in patients with retinoblastoma. Results We received a response of 58 surgeons in 32 different countries. A primary artificial implant is routinely inserted by 42 (72.4%) surgeons. Ten (17.2%) surgeons leave the socket empty, three (5.2%) decide per case. Other surgeons insert a dermis fat graft as a standard primary implant (n=1), or fill the socket in a standard secondary procedure (n=2; one uses dermis fat grafts and one artificial implants). The choice for porous implants was more frequent than for non-porous implants: 27 (58.7%) and 15 (32.6%), respectively. Both porous and non-porous implant types are used by 4 (8.7%) surgeons. Twenty-five surgeons (54.3%) insert bare implants, 11 (23.9%) use separate wrappings, eight (17.4%) use implants with prefab wrapping and two insert implants with and without wrapping depending on type of implant. Attachment of the muscles to the wrapping or implant (at various locations) is done by 31 (53.4%) surgeons. Eleven (19.0%) use a myoconjunctival technique, nine (15.5%) suture the muscles to each other and seven (12.1%) do not reattach the muscles. Measures to improve volume are implant exchange at an older age (n=4), the use of Restylane SQ (n=1) and osmotic expanders (n=1). Pegging is done by two surgeons. Conclusion No (worldwide) consensus exists about the use of material and techniques for enucleation for the treatment of retinoblastoma. Considerations for the use of different techniques are discussed.	[Mourits, Daphne L.; Hartong, Dyonne T.; Bosscha, Machteld I.; Moll, Annette C.] Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Kloos, Roel J. H. M.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Mourits, DL (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands.	d.mourits@vumc.nl	Bosscha, Machteld/T-2808-2019		ODAS Foundation, Delft, the Netherlands	ODAS Foundation, Delft, the Netherlands(Netherlands Government)	Funding: This study was financially supported by a grant from the ODAS Foundation, Delft, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN L, 1983, OPHTHALMOLOGY, V90, P1116; Baino F, 2014, ACTA BIOMATER, V10, P1064, DOI 10.1016/j.actbio.2013.12.014; Carroll WL, 2010, CANC CHILDREN ADOLES; Choi YJ, 2013, BRIT J OPHTHALMOL, V97, P1530, DOI 10.1136/bjophthalmol-2013-303481; Chojniak MM, 2012, PEDIATR HEMAT ONCOL, V34, P102; Cleres B, 2014, OPHTHALMOLOGE, V111, P572, DOI 10.1007/s00347-013-2950-7; Colen TP, 2000, OPHTHALMOLOGY, V107, P1889, DOI 10.1016/S0161-6420(00)00348-1; Custer PL, 1999, OPHTHALMOLOGY, V106, P513, DOI 10.1016/S0161-6420(99)90109-4; Custer PL, 2003, OPHTHALMOLOGY, V110, P2054, DOI 10.1016/S0161-6420(03)00857-1; Fountain TR, 1999, OPHTHALMIC PLAST REC, V15, P32, DOI 10.1097/00002341-199901000-00008; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Jordan DR, 1999, OPHTHALMOLOGY, V106, P505, DOI 10.1016/S0161-6420(99)90108-2; Kaltreider SA, 2003, OPHTHAL PLAST RECONS, V19, P421, DOI 10.1097/01.IOP.0000092799.82563.D7; Kaltreider SA, 2001, ARCH OPHTHALMOL-CHIC, V119, P379, DOI 10.1001/archopht.119.3.379; Kim NJ, 2008, OPHTHALMOLOGICA, V222, P351, DOI 10.1159/000146896; Moshfeghi DM, 2000, SURV OPHTHALMOL, V44, P277, DOI 10.1016/S0039-6257(99)00112-5; Mourits MP, 2012, ORBIT, P1, DOI [10.3109/01676830.2011.638098, DOI 10.3109/01676830.2011.638098]; Mules PH., 1885, T OPHTHAL SOC UK, V5, P200; NUNERY WR, 1993, OPHTHALMIC PLAST REC, V9, P96, DOI 10.1097/00002341-199306000-00004; Peylan-Ramu N, 2001, MED PEDIATR ONCOL, V37, P465, DOI 10.1002/mpo.1231; Sami D, 2007, SURV OPHTHALMOL, V52, P244, DOI 10.1016/j.survophthal.2007.02.007; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Shildkrot Y, 2011, OPHTHALMOLOGY, V118, P2480, DOI 10.1016/j.ophtha.2011.05.024; Shome D, 2010, OPHTHALMOLOGY, V117, P1638, DOI 10.1016/j.ophtha.2009.12.035; SMIT TJ, 1991, BRIT J OPHTHALMOL, V75, P667, DOI 10.1136/bjo.75.11.667; SMIT TJ, 1990, OPHTHALMOLOGY, V97, P1347; Su GW, 2004, OPHTHAL PLAST RECONS, V20, P274, DOI 10.1097/01.IOP.0000129528.16938.1E; Trichopoulos N, 2005, OPHTHAL PLAST RECONS, V21, P331, DOI 10.1097/01.iop.0000175034.88019.a5; TYERS AG, 1982, T OPHTHAL SOC UK, V102, P90; VISTNES LM, 1976, PLAST RECONSTR SURG, V58, P539, DOI 10.1097/00006534-197611000-00002; Viswanathan P, 2007, BRIT J OPHTHALMOL, V91, P616, DOI 10.1136/bjo.2006.103937; Wells TS, 2011, OPHTHAL PLAST RECONS, V27, P364, DOI 10.1097/IOP.0b013e31821c1298; Yadava Usha, 2004, Indian Journal of Ophthalmology, V52, P221	33	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121292	10.1371/journal.pone.0121292	http://dx.doi.org/10.1371/journal.pone.0121292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767872	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500140
J	Nakayama, J; Raines, TA; Lynch, KR; Slack-Davis, JK				Nakayama, John; Raines, Timothy A.; Lynch, Kevin R.; Slack-Davis, Jill K.			Decreased Peritoneal Ovarian Cancer Growth in Mice Lacking Expression of Lipid Phosphate Phosphohydrolase 1	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; CELL-MIGRATION; SIGNALING PATHWAY; IN-VIVO; INVASION; METASTASIS; ACTIVATION; AUTOTAXIN; ADHESION; MOUSE	Lysophosphatidic acid (LPA) is a bioactive lipid that enhances ovarian cancer cell proliferation, migration and invasion in vitro and stimulates peritoneal metastasis in vivo. LPA is generated through the action of autotaxin or phospholipases, and degradation begins with lipid phosphate phosphohydrolase (LPP)-dependent removal of the phosphate. While the effects of LPA on ovarian cancer progression are clear, the effects of LPA metabolism within the tumor microenvironment on peritoneal metastasis have not been reported. We examined the contribution of lipid phosphatase activity to ovarian cancer peritoneal metastasis using mice deficient in LPP1 expression. Homozygous deletion of LPP1 (LPP1 KO) results in elevated levels and decreased turnover of LPA in vivo. Within 2 weeks of intraperitoneal injection of syngeneic mouse ovarian cancer cells, we observed enhanced tumor seeding in the LPP1 KO mice compared to wild type. However, tumor growth plateaued in the LPP1 KO mice by 3 weeks while tumors continued to grow in wild type mice. The decreased tumor burden was accompanied by increased apoptosis and no change in proliferation or angiogenesis. Tumor growth was restored and apoptosis reversed with exogenous administration of LPA. Together, these observations demonstrate that the elevated levels of LPA per se in LPP1 KO mice do not inhibit tumor growth. Rather, the data support the notion that either elevated LPA concentration or altered LPA metabolism affects other growth-promoting contributions of the tumor microenvironment.	[Nakayama, John] Univ Virginia, Ctr Canc, Dept Obstet & Gynecol, Charlottesville, VA 22908 USA; [Raines, Timothy A.; Slack-Davis, Jill K.] Univ Virginia, Ctr Canc, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Lynch, Kevin R.] Univ Virginia, Ctr Canc, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lynch, Kevin R.; Slack-Davis, Jill K.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Slack-Davis, JK (corresponding author), Univ Virginia, Ctr Canc, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	jks6a@virginia.edu			National Institutes of Health/National Cancer Institute [CA142783]; National Institutes of Health General Medical Sciences [GM067958-09]; University of Virginia Gynecologic Oncology Fellowship Program; NATIONAL CANCER INSTITUTE [T32CA009109, R01CA142783, P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067958] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Virginia Gynecologic Oncology Fellowship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by the National Institutes of Health/National Cancer Institute grant CA142783 supported JKS-D and KRL, who was also supported by National Institutes of Health General Medical Sciences grant GM067958-09. TAR was supported by a diversity supplement to CA142783. JN was supported by the University of Virginia Gynecologic Oncology Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Bian DF, 2004, CANCER RES, V64, P4209, DOI 10.1158/0008-5472.CAN-04-0060; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Cai QC, 2012, FASEB J, V26, P3306, DOI 10.1096/fj.12-207597; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Fang XJ, 2000, BIOCHEM J, V352, P135, DOI 10.1042/0264-6021:3520135; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Fishman DA, 2001, CANCER RES, V61, P3194; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Hong GY, 1999, FEBS LETT, V460, P513, DOI 10.1016/S0014-5793(99)01400-3; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Koh JS, 1998, J CLIN INVEST, V102, P716, DOI 10.1172/JCI1002; Lagadari M, 2009, INT IMMUNOL, V21, P667, DOI 10.1093/intimm/dxp035; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Mishra RS, 2008, J EXP MED, V205, P347, DOI 10.1084/jem.20071243; Oda SK, 2013, CANCER IMMUNOL RES, V1, P245, DOI 10.1158/2326-6066.CIR-13-0043-T; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Prewett M, 1999, CANCER RES, V59, P5209; Ptaszynska MM, 2008, MOL CANCER RES, V6, P352, DOI 10.1158/1541-7786.MCR-07-0143; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; So J, 2004, GYNECOL ONCOL, V95, P314, DOI 10.1016/j.ygyno.2004.08.001; Sutphen R, 2004, CANCER EPIDEM BIOMAR, V13, P1185; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Tanyi JL, 2003, CANCER RES, V63, P1073; Tokumura A, 2007, LIFE SCI, V80, P1641, DOI 10.1016/j.lfs.2006.12.041; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Xiao YJ, 2001, ANAL BIOCHEM, V290, P302, DOI 10.1006/abio.2001.5000; Xu Y, 1995, CLIN CANCER RES, V1, P1223; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604	36	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120071	10.1371/journal.pone.0120071	http://dx.doi.org/10.1371/journal.pone.0120071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769037	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500107
J	Peters, MAK; Balzer, J; Shams, L				Peters, Megan A. K.; Balzer, Jonathan; Shams, Ladan			Smaller = Denser, and the Brain Knows It: Natural Statistics of Object Density Shape Weight Expectations	PLOS ONE			English	Article							VISUAL SIZE CUES; MANIPULATIVE FORCES; PRECISION GRIP; INTEGRATION; PERCEPTION; HEAVINESS; EXPERIENCE; ILLUSIONS; MODELS; MEMORY	If one nondescript object's volume is twice that of another, is it necessarily twice as heavy? As larger objects are typically heavier than smaller ones, one might assume humans use such heuristics in preparing to lift novel objects if other informative cues (e.g., material, previous lifts) are unavailable. However, it is also known that humans are sensitive to statistical properties of our environments, and that such sensitivity can bias perception. Here we asked whether statistical regularities in properties of liftable, everyday objects would bias human observers' predictions about objects' weight relationships. We developed state-of-the-art computer vision techniques to precisely measure the volume of everyday objects, and also measured their weight. We discovered that for liftable man-made objects, "twice as large" doesn't mean "twice as heavy": Smaller objects are typically denser, following a power function of volume. Interestingly, this "smaller is denser" relationship does not hold for natural or unliftable objects, suggesting some ideal density range for objects designed to be lifted. We then asked human observers to predict weight relationships between novel objects without lifting them; crucially, these weight predictions quantitatively match typical weight relationships shown by similarly-sized objects in everyday environments. These results indicate that the human brain represents the statistics of everyday objects and that this representation can be quantitatively abstracted and applied to novel objects. Finally, that the brain possesses and can use precise knowledge of the nonlinear association between size and weight carries important implications for implementation of forward models of motor control in artificial systems.	[Peters, Megan A. K.; Shams, Ladan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Balzer, Jonathan] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90095 USA; [Shams, Ladan] Univ Calif Los Angeles, Dept Bioengn, Engn 5 5121, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Peters, MAK (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	meganakpeters@ucla.edu		Peters, Megan/0000-0002-0248-0816	National Science Foundation Graduate Research Fellowship Program; National Science Foundation [BCS-1057625]; Office of Naval Research (ONR) [N00014-13-1-0563]; Air Force Research Laboratory (AFRL) [FA8650-11-1-7156:P00004]; Division Of Behavioral and Cognitive Sci [1057969] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research (ONR)(Office of Naval Research); Air Force Research Laboratory (AFRL)(United States Department of DefenseUS Air Force Research Laboratory); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. M. A. K. P. was supported by the National Science Foundation Graduate Research Fellowship Program. L. S. was supported by National Science Foundation grant BCS-1057625. This research was also supported in part by ongoing Office of Naval Research (ONR) N00014-13-1-0563 and Air Force Research Laboratory (AFRL) FA8650-11-1-7156:P00004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; ANDERSON NH, 1970, PERCEPT PSYCHOPHYS, V8, P1, DOI 10.3758/BF03208919; Aslin RN, 2012, CURR DIR PSYCHOL SCI, V21, P170, DOI 10.1177/0963721412436806; Balzer J, 2013, IEEE WORKSH APPL COM; Baugh LA, 2012, J NEUROPHYSIOL, V108, P1262, DOI 10.1152/jn.00263.2012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Brayanov JB, 2010, J NEUROPHYSIOL, V103, P1518, DOI 10.1152/jn.00814.2009; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2010, EXP BRAIN RES, V205, P283, DOI 10.1007/s00221-010-2353-9; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Craje C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076855; CROSS DV, 1975, PERCEPT PSYCHOPHYS, V18, P79, DOI 10.3758/BF03204091; Fiser J, 2009, LEARN BEHAV, V37, P141, DOI 10.3758/LB.37.2.141; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flanagan JR, 2001, CAN J EXP PSYCHOL, V55, P87, DOI 10.1037/h0087355; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Geisler WS, 2009, VISUAL NEUROSCI, V26, P109, DOI 10.1017/S0952523808080875; Gekas N, 2013, J VISION, V13, DOI 10.1167/13.4.8; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Goldreich D, 2012, SEEING PERCEIVING, V25, P365, DOI 10.1163/187847612X634445; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1992, EXP BRAIN RES, V90, P399; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Hadjiosif AM, 2011, IEEE ENG MED BIO, P4057, DOI 10.1109/IEMBS.2011.6091008; Hedges JH, 2011, J VISION, V11, DOI 10.1167/11.6.14; Huang I, 1945, J GEN PSYCHOL, V33, P65, DOI 10.1080/00221309.1945.10544495; Hunt RH, 2001, J EXP PSYCHOL GEN, V130, P658, DOI 10.1037//0096-3445.130.4.658; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitchel AD, 2011, J EXP PSYCHOL LEARN, V37, P1081, DOI 10.1037/a0023700; Mon-Williams M, 2000, EXP BRAIN RES, V135, P405, DOI 10.1007/s002210000538; ROSS HE, 1982, PERCEPT PSYCHOPHYS, V31, P429, DOI 10.3758/BF03204852; ROSS J, 1970, PERCEPT PSYCHOPHYS, V7, P161, DOI 10.3758/BF03208648; Sanborn AN, 2013, PSYCHOL REV, V120, P411, DOI 10.1037/a0031912; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seitz AR, 2007, PERCEPTION, V36, P1445, DOI 10.1068/p5843; Series P, 2011, FRONT HUM NEUROSCI, V7, P1; Soatto S., 2011, STEPS THEORY VISUAL; STEVENS JC, 1970, PERCEPT PSYCHOPHYS, V8, P225, DOI 10.3758/BF03210210; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	49	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119794	10.1371/journal.pone.0119794	http://dx.doi.org/10.1371/journal.pone.0119794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7NO	25768977	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500098
J	Vaagenes, IC; Tsai, SY; Ton, ST; Husak, VA; McGuire, SO; O'Brien, TE; Kartje, GL				Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; O'Brien, Timothy E.; Kartje, Gwendolyn L.			Binge Ethanol Prior to Traumatic Brain Injury Worsens Sensorimotor Functional Recovery in Rats	PLOS ONE			English	Article							COGNITIVE RECOVERY; ADULT-RATS; STROKE; NEUROGENESIS; PREVALENCE; PLASTICITY; DRINKING; THERAPY; TRENDS; DAMAGE	A significant number of patients suffering from traumatic brain injury (TBI) have a high blood alcohol level at the time of injury. Furthermore, drinking alcohol in a binge-like pattern is now recognized as a national problem, leading to a greater likelihood of being injured. Our objective was to determine the consequences of a binge paradigm of alcohol intoxication at the time of TBI on long-term functional outcome using a sensitive test of sensorimotor function. We trained adult, male, Sprague Dawley rats on the skilled forelimb reaching task and then administered a single binge dose of ethanol (2g/kg, i.p.) or saline for three consecutive days (for a total of 3 doses). One hour after the final ethanol dose, rats underwent a TBI to the sensorimotor cortex corresponding to the preferred reaching forelimb. Animals were then tested for seven weeks on the skilled forelimb reaching task to assess the profile of recovery. We found that the group given ethanol prior to TBI displayed a slower recovery curve with a lower recovery plateau as compared to the control group. Therefore, even a relatively short (3 day) episode of binge alcohol exposure can negatively impact long-term recovery from a TBI, underscoring this significant public health problem.	[Vaagenes, Ian C.; Tsai, Shih-Yen; Ton, Son T.; Husak, Vicki A.; McGuire, Susan O.; Kartje, Gwendolyn L.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA; [Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ton, Son T.; Kartje, Gwendolyn L.] Loyola Univ, Med Ctr, Neurosci Res Inst, Maywood, IL 60153 USA; [O'Brien, Timothy E.] Loyola Univ, Dept Math & Stat, Chicago, IL 60611 USA; [McGuire, Susan O.] Univ Illinois, Coll Med, Dept Anesthesiol, Chicago, IL 60680 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Vaagenes, IC (corresponding author), Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.	Ian.Vaagenes@va.gov	McGuire, Susan O/AAD-8582-2020		National Institute of Health [R21 AA020951]; National Institute on Alcohol Abuse and Alcoholism [T32 AA013526]; Department of Veterans Affairs; Office of Academic Affiliations; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA020951, T32AA013526] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Veterans Affairs(US Department of Veterans Affairs); Office of Academic Affiliations(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding: This research was supported by a grant from the National Institute of Health R21 AA020951, an National Institute on Alcohol Abuse and Alcoholism training grant T32 AA013526, the Department of Veterans Affairs and the Office of Academic Affiliations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EM, 2008, EXP NEUROL, V211, P588, DOI 10.1016/j.expneurol.2008.02.027; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Gillani RL, 2010, BEHAV BRAIN RES, V208, P415, DOI 10.1016/j.bbr.2009.12.015; Hansson AC, 2010, INT J NEUROPSYCHOPH, V13, P583, DOI 10.1017/S1461145710000246; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; Hingson RW, 2009, J STUD ALCOHOL DRUGS, P12, DOI 10.15288/jsads.2009.s16.12; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; ODONOGHUE DL, 1986, BRAIN RES, V385, P311, DOI 10.1016/0006-8993(86)91078-4; Olthuis JV, 2011, J AM COLL HEALTH, V59, P239, DOI 10.1080/07448481.2010.497523; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ostrovskaya O, 2011, J PHARMACOL EXP THER, V337, P171, DOI 10.1124/jpet.110.176990; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Prasad RM, 2001, J NEUROTRAUM, V18, P1019, DOI 10.1089/08977150152693719; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Seymour AB, 2005, J CEREBR BLOOD F MET, V25, P1366, DOI 10.1038/sj.jcbfm.9600134; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thurman V DJC, 2007, BRAIN INJURY MED; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Wainwright PE, 2007, DEV PSYCHOBIOL, V49, P664, DOI 10.1002/dev.20245; Wolf WA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108031; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Young ME, 2009, LEARN MOTIV, V40, P160, DOI 10.1016/j.lmot.2008.10.004; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120356	10.1371/journal.pone.0120356	http://dx.doi.org/10.1371/journal.pone.0120356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768795	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500121
J	Westhrin, M; Xie, ML; Olderoy, MO; Sikorski, P; Strand, BL; Standal, T				Westhrin, Marita; Xie, Minli; Olderoy, Magnus O.; Sikorski, Pawel; Strand, Berit L.; Standal, Therese			Osteogenic Differentiation of Human Mesenchymal Stem Cells in Mineralized Alginate Matrices	PLOS ONE			English	Article							COLLAGEN FIBRIL; BONE-FORMATION; IN-VIVO; MICROSPHERES; IMMOBILIZATION; HYDROXYAPATITE; MICROCAPSULES; BIOMATERIALS; SCLEROSTIN; SCAFFOLDS	Mineralized biomaterials are promising for use in bone tissue engineering. Culturing osteogenic cells in such materials will potentially generate biological bone grafts that may even further augment bone healing. Here, we studied osteogenic differentiation of human mesenchymal stem cells (MSC) in an alginate hydrogel system where the cells were co-immobilized with alkaline phosphatase (ALP) for gradual mineralization of the microenvironment. MSC were embedded in unmodified alginate beads and alginate beads mineralized with ALP to generate a polymer/hydroxyapatite scaffold mimicking the composition of bone. The initial scaffold mineralization induced further mineralization of the beads with nanosized particles, and scanning electron micrographs demonstrated presence of collagen in the mineralized and unmineralized alginate beads cultured in osteogenic medium. Cells in both types of beads sustained high viability and metabolic activity for the duration of the study (21 days) as evaluated by live/dead staining and alamar blue assay. MSC in beads induced to differentiate in osteogenic direction expressed higher mRNA levels of osteoblast-specific genes (RUNX2, COL1AI, SP7, BGLAP) than MSC in traditional cell cultures. Furthermore, cells differentiated in beads expressed both sclerostin (SOST) and dental matrix protein-1 (DMP1), markers for late osteoblasts/osteocytes. In conclusion, Both ALP-modified and unmodified alginate beads provide an environment that enhance osteogenic differentiation compared with traditional 2D culture. Also, the ALP-modified alginate beads showed profound mineralization and thus have the potential to serve as a bone substitute in tissue engineering.	[Westhrin, Marita; Standal, Therese] Norwegian Univ Sci & Technol, Kristian Gerhard Jebsen Ctr Myeloma Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Standal, Therese] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Xie, Minli; Olderoy, Magnus O.; Sikorski, Pawel] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway; [Strand, Berit L.] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Standal, T (corresponding author), Norwegian Univ Sci & Technol, Kristian Gerhard Jebsen Ctr Myeloma Res, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	therese.standal@ntnu.no	Strand, Berit Løkensgard/O-3999-2015; Sikorski, Pawel/A-2304-2009	Strand, Berit Løkensgard/0000-0002-9951-0355; Sikorski, Pawel/0000-0001-9413-1623; Standal, Therese/0000-0003-3314-8522	Research Council of Norway [193072, 182047, 182695-I40, 217708/O10]; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); K. G. Jebsen Center for Myeloma Research; Norwegian Cancer Society	Research Council of Norway(Research Council of Norway); Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); K. G. Jebsen Center for Myeloma Research; Norwegian Cancer Society(Norwegian Cancer Society)	Funding: This work has been supported by the Research Council of Norway project numbers 193072, 182047, 182695-I40 and 217708/O10, the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), the K. G. Jebsen Center for Myeloma Research and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a; Chan G, 2001, TRENDS BIOTECHNOL, V26, P382; CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N; Cohen J, 2011, J BIOMED MATER RES A, V96A, P93, DOI 10.1002/jbm.a.32961; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9; COX R. W., 1967, J ROY MICROSC SOC, V87, P123; Evangelista MB, 2007, BIOMATERIALS, V28, P3644, DOI 10.1016/j.biomaterials.2007.04.028; Gamie Z, 2012, EXPERT OPIN BIOL TH, V12, P713, DOI 10.1517/14712598.2012.679652; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Johnson AJ, 2010, ACTA BIOMATERIALIA, V1; Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Malaval L, 1999, J CELL BIOCHEM, V74, P616; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McMahon RE, 2013, J BIOMED MATER RES B, V101B, P387, DOI 10.1002/jbm.b.32823; Morch YA, 2007, BIOMACROMOLECULES, V8, P2809, DOI 10.1021/bm700502b; Moshaverinia A, 2013, BIOMATERIALS, V34, P6572, DOI 10.1016/j.biomaterials.2013.05.048; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Ohyama Y, 2004, ENDOCRINOLOGY, V145, P4685, DOI 10.1210/en.2003-1492; Olderoy MO, 2012, J MATER SCI-MATER M, V23, P1619, DOI 10.1007/s10856-012-4655-x; OYAAS J, 1995, BIOTECHNOL BIOENG, V47, P492, DOI 10.1002/bit.260470411; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qi MRG, 2012, XENOTRANSPLANTATION, V19, P355, DOI 10.1111/xen.12009; Qiao PY, 2013, MAT SCI ENG C-MATER, V33, P4633, DOI 10.1016/j.msec.2013.07.022; Rokstad AM, 2013, BIOMATERIALS, V34, P621, DOI 10.1016/j.biomaterials.2012.10.012; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O; Starborg T, 2008, METHOD CELL BIOL, V88, P319, DOI 10.1016/S0091-679X(08)00417-2; Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5; Strand BL, 2003, J BIOMED MATER RES A, V64A, P540, DOI 10.1002/jbm.a.10337; Strand BL, 2002, J MICROENCAPSUL, V19, P615, DOI 10.1080/02652040210144243; Suarez-Gonzalez D, 2010, J BIOMED MATER RES A, V95A, P222, DOI 10.1002/jbm.a.32833; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Wang J, 2014, BIO-MED MATER ENG, V24, P835, DOI 10.3233/BME-130875; Weir MD, 2010, ACTA BIOMATER, V6, P4118, DOI 10.1016/j.actbio.2010.04.029; Xie ML, 2012, RSC ADV, V2, P1457, DOI 10.1039/c1ra00750e; Xie ML, 2010, ACTA BIOMATER, V6, P3665, DOI 10.1016/j.actbio.2010.03.034; Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017	43	72	72	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120374	10.1371/journal.pone.0120374	http://dx.doi.org/10.1371/journal.pone.0120374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769043	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500123
J	Yan, CA; Zhang, WC; Zhang, ZJ; Liu, YM; Deng, C; Nie, N				Yan, Chang-An; Zhang, Wanchang; Zhang, Zhijie; Liu, Yuanmin; Deng, Cai; Nie, Ning			Assessment of Water Quality and Identification of Polluted Risky Regions Based on Field Observations & GIS in the Honghe River Watershed, China	PLOS ONE			English	Article							SYSTEMS; INDEX; BASIN; INDIA	Water quality assessment at the watershed scale requires not only an investigation of water pollution and the recognition of main pollution factors, but also the identification of polluted risky regions resulted in polluted surrounding river sections. To realize this objective, we collected water samplings from 67 sampling sites in the Honghe River watershed of China with Grid GIS method to analyze six parameters including dissolved oxygen (DO), ammonia nitrogen (NH3-N), nitrate nitrogen (NO3-N), nitrite nitrogen (NO2-N), total nitrogen (TN) and total phosphorus (TP). Single factor pollution index and comprehensive pollution index were adopted to explore main water pollutants and evaluate water quality pollution level. Based on two evaluate methods, Geo-statistical analysis and Geographical Information System (GIS) were used to visualize the spatial pollution characteristics and identifying potential polluted risky regions. The results indicated that the general water quality in the watershed has been exposed to various pollutants, in which TP, NO2-N and TN were the main pollutants and seriously exceeded the standard of Category III. The zones of TP, TN, DO, NO2-N and NH3-N pollution covered 99.07%, 62.22%, 59.72%, 37.34% and 13.82% of the watershed respectively, and they were from medium to serious polluted. 83.27% of the watershed in total was polluted by comprehensive pollutants. These conclusions may provide useful and effective information for watershed water pollution control and management.	[Yan, Chang-An; Liu, Yuanmin; Deng, Cai; Nie, Ning] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, Nanjing 210093, Jiangsu, Peoples R China; [Yan, Chang-An] Kunming Inst Environm Sci, Kunming 650032, Peoples R China; [Zhang, Wanchang; Liu, Yuanmin; Deng, Cai; Nie, Ning] Chinese Acad Sci, Inst Remote Sensing & Digital Earth RADI, Key Lab Digital Earth Sci, Beijing 100094, Peoples R China; [Zhang, Zhijie] Nanjing Univ Posts & Telecommun, Coll Automat, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Nanjing University of Posts & Telecommunications	Zhang, WC (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth RADI, Key Lab Digital Earth Sci, Beijing 100094, Peoples R China.	wchzhang@126.com			National Basic Research Program of China (973) [2010CB951404]; National Natural Science Foundation of China [41175088, 40971024]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973, Grant No. 2010CB951404) and the National Natural Science Foundation of China (No. 41175088 and No. 40971024) to W.C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; [Anonymous], 1990, GB124091990 NAT SMC; [Anonymous], 2011, CHIN ENV QUAL COMM; Chang H, 2005, HYDROBIOLOGIA, V544, P321, DOI 10.1007/s10750-005-1894-6; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Deutsch CV, 1996, COMPUT GEOSCI, V22, P765, DOI 10.1016/0098-3004(96)00005-2; Donohue I, 2006, WATER RES, V40, P91, DOI 10.1016/j.watres.2005.10.027; Facchinelli A, 2001, ENVIRON POLLUT, V114, P313, DOI 10.1016/S0269-7491(00)00243-8; Gong C. L., 2007, CHONGQING ENV SCI, V10, P910; Gong X, 2014, RSC ADV, V4, P54494, DOI 10.1039/c4ra09979f; Henan Provincial Bureau of Statistics, 2012, HEN STAT YB 2012; Jasmin I, 2014, ENVIRON MONIT ASSESS, V186, P935, DOI 10.1007/s10661-013-3425-7; Jiang H.H., 1999, ENV MONIT CHINA, V15, P46; Jiang WJ, 2014, ENVIRON SCI TECHNOL, V48, P8078, DOI 10.1021/es405804m; Jiang YP, 2006, PROCEEDINGS OF THE CONFERENCE OF GLOBAL CHINESE SCHOLARS ON HYDRODYNAMICS, P528; Jonnalagadda SB, 2001, WATER RES, V35, P2371, DOI 10.1016/S0043-1354(00)00533-9; Li T, 2007, ENVIRON ENG SCI, V26, P451; [刘聚涛 Liu Jutao], 2010, [环境污染与防治, Environmental Pollution & Control], V32, P20; Liu Q, 2012, THESIS NANJING U; Meng W, 2009, J ENVIRON SCI, V21, P1017, DOI 10.1016/S1001-0742(08)62377-3; Ministry of Environmental Protection of the People's Republic of China, 2002, MON AN METH WAT WAST, P200; Ministry of Environmental Protection of the People's Republic of China, 2002, 912002 HJT MIN ENV P; Ministry of Environmental Protection of the People's Republic of China State Administration for Quality Supervision and Inspection and Quarantine of China, 1999, GHZB11999 MIN ENV PR; Ministry of Environmental Protection of the People's Republic of China State Administration for Quality Supervision and Inspection and Quarantine of China, 2002, 38382002 GB MIN ENV, DOI [10.1016/j.chemosphere.2011.07.064, DOI 10.1016/J.CHEMOSPHERE.2011.07.064]; NIEMI GJ, 1990, ENVIRON MANAGE, V14, P571, DOI 10.1007/BF02394710; Ouyang Y, 2005, WATER RES, V39, P2621, DOI 10.1016/j.watres.2005.04.024; [庞振凌 PANG ZhenLing], 2008, [生态学报, Acta Ecologica Sinica], V28, P1810; Shankar BS, 2008, ENVIRON ENG SCI, V25, P911, DOI 10.1089/ees.2007.0231; Vairavamoorthy K, 2007, ENVIRON MODELL SOFTW, V22, P951, DOI 10.1016/j.envsoft.2006.05.027; Varol M, 2012, RIVER RES APPL, V28, P1428, DOI 10.1002/rra.1533; Wan W, 2013, INT J CHEM PETROLEUM, V2, P1; Xu Zu-xin, 2005, Journal of Tongji University (Natural Science), V33, P482; Yao JY, 2009, ENV SCI MANAGEMENT, V34, P172; Zhang C.X., 2007, RATIONAL ALLOCATION	34	47	49	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119130	10.1371/journal.pone.0119130	http://dx.doi.org/10.1371/journal.pone.0119130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768942	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500066
J	Storti, B; Di Rienzo, C; Cardarelli, F; Bizzarri, R; Beltram, F				Storti, Barbara; Di Rienzo, Carmine; Cardarelli, Francesco; Bizzarri, Ranieri; Beltram, Fabio			Unveiling TRPV1 Spatio-Temporal Organization in Live Cell Membranes	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; RESONANCE ENERGY-TRANSFER; FLUORESCENT PROTEIN; CAPSAICIN RECEPTOR; IN-VIVO; CHANNEL SUBUNITS; LIPID RAFTS; ION-CHANNEL; MICROTUBULES; BINDING	Transient Receptor Potential Vanilloid 1 (TRPV1) is a non-selective cation channel that integrates several stimuli into nociception and neurogenic inflammation. Here we investigated the subtle TRPV1 interplay with candidate membrane partners in live cells by a combination of spatio-temporal fluctuation techniques and fluorescence resonance energy transfer (FRET) imaging. We show that TRPV1 is split into three populations with fairly different molecular properties: one binding to caveolin-1 and confined into caveolar structures, one actively guided by microtubules through selective binding, and one which diffuses freely and is not directly implicated in regulating receptor functionality. The emergence of caveolin- 1 as a new interactor of TRPV1 evokes caveolar endocytosis as the main desensitization pathway of TRPV1 receptor, while microtubule binding agrees with previous data suggesting the receptor stabilization in functional form by these cytoskeletal components. Our results shed light on the hitherto unknown relationships between spatial organization and TRPV1 function in live-cell membranes.	[Storti, Barbara; Di Rienzo, Carmine; Bizzarri, Ranieri; Beltram, Fabio] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Storti, Barbara; Di Rienzo, Carmine; Bizzarri, Ranieri; Beltram, Fabio] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Di Rienzo, Carmine; Cardarelli, Francesco; Beltram, Fabio] Ist Italiano Tecnol, NEST, Ctr Nanotechnol Innovat, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Bizzarri, R (corresponding author), Scuola Normale Super Pisa, NEST, Pisa, Italy.	ranieri.bizzarri@nano.cnr.it	Bizzarri, Ranieri/ABH-8343-2020; Storti, Barbara/AAB-7791-2019; Beltram, Fabio/L-9486-2019; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011	Storti, Barbara/0000-0002-2758-0426; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672	Italian Ministry for University and Research (MiUR) under the framework of the FIRB project [RBPR05JH2P]; PRIN [010BJ23MN_004]	Italian Ministry for University and Research (MiUR) under the framework of the FIRB project(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Italian Ministry for University and Research (MiUR) under the framework of the FIRB project RBPR05JH2P and PRIN project 010BJ23MN_004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bucci M, 2000, NAT MED, V6, P1362, DOI 10.1038/82176; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Digman MA, 2009, MICROSC RES TECHNIQ, V72, P323, DOI 10.1002/jemt.20655; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gallego-Sandin S, 2009, J BIOL CHEM, V284, P32591, DOI 10.1074/jbc.M109.019687; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2012, J NEUROCHEM, V123, P1, DOI 10.1111/j.1471-4159.2012.07892.x; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hellmich UA, 2014, HANDB EXP PHARMACOL, V223, P991, DOI 10.1007/978-3-319-05161-1_11; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Holzer P, 2014, BRIT J PHARMACOL, V171, P2469, DOI 10.1111/bph.12723; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Kohler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023798; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Patterson G, 2001, J CELL SCI, V114, P837; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rienzo C Di, 2013, P NATL ACAD SCI US; Ries J, 2009, BIOPHYS J, V96, P1999, DOI 10.1016/j.bpj.2008.12.3888; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schneckenburger H, 2005, CURR OPIN BIOTECH, V16, P13, DOI 10.1016/j.copbio.2004.12.004; Sowa G, 2001, P NATL ACAD SCI USA, V98, P14072, DOI 10.1073/pnas.241409998; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Storti B, 2012, J BIOL CHEM, V287, P7803, DOI 10.1074/jbc.M111.332296; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Wang Y, 2008, NEUROCHEM RES, V33, P2008, DOI 10.1007/s11064-008-9750-5; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	47	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116900	10.1371/journal.pone.0116900	http://dx.doi.org/10.1371/journal.pone.0116900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764349	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300007
J	Lecube, A; Sampol, G; Hernandez, C; Romero, O; Ciudin, A; Simo, R				Lecube, Albert; Sampol, Gabriel; Hernandez, Cristina; Romero, Odile; Ciudin, Andreea; Simo, Rafael			Characterization of Sleep Breathing Pattern in Patients with Type 2 Diabetes: Sweet Sleep Study	PLOS ONE			English	Article							APNEA; RISK; MELLITUS	Background Although sleep apnea-hypopnea syndrome (SAHS) is highly prevalent in patients with type 2 diabetes (T2D), it is unknown whether or not subjects with and without T2D share the same sleep breathing pattern. Methodology/Principal findings A cross-sectional study in patients with SAHS according to the presence (n = 132) or not (n = 264) of T2D. Both groups were matched by age, gender, BMI, and waist and neck circumferences. A subgroup of 125 subjects was also matched by AHI. The exclusion criteria included chronic respiratory disease, alcohol abuse, use of sedatives, and heart failure. A higher apnea hypopnea index (AHI) was observed in T2D patients [32.2 (10.2-114.0) vs. 25.6 (10.2-123.4) events/hours; p = 0.002). When sleep events were evaluated separately, patients with T2D showed a significant increase in apnea events [8.4 (0.1-87.7) vs. 6.3 (0.0-105.6) e/h; p = 0.044), as well as a two-fold increase in the percentage of time spent with oxygen saturation <90% [15.7 (0.0-97.0) vs. 7.9 (0.0-95.6) %; <0.001)], higher rates of oxygen desaturation events, and also higher daily sleepiness [7.0 (0.0-21.0) vs. 5.0 (0.0-21.0); p = 0.006)] than subjects without T2D. Significant positive correlations between fasting plasma glucose and AHI, the apnea events, and CT90 were observed. Finally, multiple linear regression analyses showed that T2D was independently associated with AHI (R-2 = 0.217), the apnea index (R-2 = 0.194), CT90 (R-2 = 0.222), and desaturation events. Conclusions/significance T2D patients present a different pattern of sleep breathing than subject without diabetes. The most important differences are the severity of hypoxemia and the number of apneas whereas the incidence of hypopnea episodes is similar.	[Lecube, Albert; Hernandez, Cristina; Ciudin, Andreea; Simo, Rafael] Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, ISCIII,Endocrinol Dept, E-08193 Barcelona, Spain; [Lecube, Albert] Univ Lleida, IRB Lleida, Hosp Univ Arnau de Vilanova, Endocrinol & Nutr Dept, Lleida, Spain; [Sampol, Gabriel; Romero, Odile] Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBERES, ISCIII,Dept Neurophysiol,Sleep Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Lecube, A (corresponding author), Univ Autonoma Barcelona, Inst Recerca & Hosp Univ Vall dHebron VHIR, CIBER Diabet Enfermedades Metab Asociadas CIBERDE, ISCIII,Endocrinol Dept, E-08193 Barcelona, Spain.	alecube@gmail.com	Romero, Odile/N-8109-2015; CIUDIN, ANDREEA/O-5250-2016; Lecube, Albert/H-3813-2019	Romero, Odile/0000-0002-0147-596X; CIUDIN, ANDREEA/0000-0001-5622-0203; Lecube, Albert/0000-0001-9684-0183; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria) [PI 12/00803]; Sociedad Espanola Endocrinologia y Nutricion	Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); Sociedad Espanola Endocrinologia y Nutricion	This study was supported by grants from the Instituto de Salud Carlos III (Fondo de Investigacion Sanitaria, PI 12/00803), and the Sociedad Espanola Endocrinologia y Nutricion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; [Anonymous], 2011, Adv Cardiol, V46, P139, DOI 10.1159/000325108; Campo A, 2007, EUR RESPIR J, V30, P223, DOI 10.1183/09031936.00115006; Ficker JH, 1998, EUR RESPIR J, V11, P14, DOI 10.1183/09031936.98.11010014; Hartge MM, 2008, DIABETES VASC DIS RE, V4, P84; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Lecube A, 2011, CYTOKINE, V54, P121, DOI 10.1016/j.cyto.2011.01.010; Lecube A, 2010, DIABETOLOGIA, V53, P1210, DOI 10.1007/s00125-010-1700-5; Lecube A, 2010, DIABETES-METAB RES, V26, P639, DOI 10.1002/dmrr.1131; Lecube A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004692; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Muraki I, 2010, DIABETOLOGIA, V53, P481, DOI 10.1007/s00125-009-1616-0; Nieto FJ, 2004, AM J RESP CRIT CARE, V169, P354, DOI 10.1164/rccm.200306-756OC; Peltier AC, 2007, SLEEP MED, V8, P149, DOI 10.1016/j.sleep.2006.06.010; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Ramadan W, 2007, OBESITY, V15, P1409, DOI 10.1038/oby.2007.169; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Sampol Gabriel, 2012, Endocrinol Nutr, V59, P95, DOI 10.1016/j.endonu.2011.12.003; Tasali E, 2008, CHEST, V133, P496, DOI 10.1378/chest.07-0828; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P4409, DOI 10.1210/jc.2003-031929; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1	23	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119073	10.1371/journal.pone.0119073	http://dx.doi.org/10.1371/journal.pone.0119073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760760	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000046
J	Yu, H; Jiang, WZ; Liu, Q; Zhang, H; Piao, MX; Chen, ZD; Bian, MD				Yu, Hui; Jiang, Wenzhu; Liu, Qing; Zhang, Hui; Piao, Mingxin; Chen, Zhengdao; Bian, Mingdi			Expression Pattern and Subcellular Localization of the Ovate Protein Family in Rice	PLOS ONE			English	Article							BRASSINOSTEROID SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR FAMILY; GENE-EXPRESSION; HOMEOBOX GENE; DOMAIN PROTEIN; PLANT-GROWTH; ARABIDOPSIS; CELL; MUTANT; IDENTIFICATION	The Arabidopsis ovate family proteins (AtOFPs) have been shown to function as transcriptional repressors and regulate multiple aspects of plant growth and development. There are 31 genes that encode the full-length OVATE-domain containing proteins in the rice genome. In this study, the gene structure analysis revealed that OsOFPs are intron poor. Phylogenetic analysis suggested that OVATE proteins from rice, Arabidopsis and tomato can be divided into 4 groups (I-IV). Real-time quantitative polymerase chain reaction (RT-qPCR) analysis identified OsOFPs with different tissue-specific expression patterns at all stages of development in the rice plant. Interestingly, nearly half of the total number of OsOFP family was more highly expressed during the seed developmental stage. In addition, seed developmental cis-elements were found in the promoter region of the OsOFPs. Subcellular localization analysis revealed that YFP-OsOFP fusion proteins predominantly localized in the nucleus. Our results suggest that OsOFPs may act as regulatory proteins and play pivotal roles in the growth and development of rice.	[Yu, Hui; Jiang, Wenzhu; Liu, Qing; Zhang, Hui; Piao, Mingxin; Chen, Zhengdao; Bian, Mingdi] Jilin Univ, Coll Plant Sci, Lab Soil & Plant Mol Genet, Changchun 130062, Peoples R China	Jilin University	Bian, MD (corresponding author), Jilin Univ, Coll Plant Sci, Lab Soil & Plant Mol Genet, Changchun 130062, Peoples R China.	bianmd@jlu.edu.cn	Jiang, Wenzhu/AAD-7561-2022		National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor [2010ZX08010-002]	National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor	This work was supported by the National Major Project, Crop Yield Improvement Using Synthetic Transcription Factor (2010ZX08010-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinsug MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030846; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Century K, 2008, PLANT PHYSIOL, V147, P20, DOI 10.1104/pp.108.117887; Dai MQ, 2007, PLANT PHYSIOL, V144, P380, DOI 10.1104/pp.107.095737; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hay A, 2010, DEVELOPMENT, V137, P3153, DOI 10.1242/dev.030049; Heang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031325; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Hong Z, 2005, PLANT CELL, V17, P2243, DOI 10.1105/tpc.105.030973; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Jiang YH, 2012, PLANT J, V70, P398, DOI 10.1111/j.1365-313X.2011.04877.x; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; Kuijt SJH, 2004, PLANT MOL BIOL, V55, P781, DOI 10.1007/s11103-005-1967-y; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Liu D, 2014, ANN BOT-LONDON, V113, P1219, DOI 10.1093/aob/mcu061; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MULLER M, 1993, PLANT J, V4, P343, DOI 10.1046/j.1365-313X.1993.04020343.x; Nagamura Y, 2011, PLANT CELL PHYSIOL, V52, P230, DOI 10.1093/pcp/pcq197; Nakagawa H, 2012, PLANT PHYSIOL, V158, P1208, DOI 10.1104/pp.111.187567; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Scott MP, 2000, CELL, V100, P27, DOI 10.1016/S0092-8674(00)81681-5; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; Vollbrecht E, 2000, DEVELOPMENT, V127, P3161; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023896; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xue LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031081; Yaish MW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001098; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Yoshihara T, 1996, PLANT SCI, V121, P63, DOI 10.1016/S0168-9452(96)04511-6; Yoshii M, 2009, PLANT J, V57, P615, DOI 10.1111/j.1365-313X.2008.03712.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang C, 2012, PLOS GENET, V8, P651, DOI 10.1371/journal.pgen.1002686; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu QH, 2004, PLANT PHYSIOL, V135, P1514, DOI 10.1104/pp.104.041459	58	32	39	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118966	10.1371/journal.pone.0118966	http://dx.doi.org/10.1371/journal.pone.0118966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760462	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000044
J	Ioannou, D; Kandukuri, L; Quadri, A; Becerra, V; Simpson, JL; Tempest, HG				Ioannou, Dimitrios; Kandukuri, Lakshmi; Quadri, Ameer; Becerra, Victor; Simpson, Joe Leigh; Tempest, Helen G.			Spatial Positioning of All 24 Chromosomes in the Lymphocytes of Six Subjects: Evidence of Reproducible Positioning and Spatial Repositioning following DNA Damage with Hydrogen Peroxide and Ultraviolet B	PLOS ONE			English	Article							ORDER CHROMATIN ARRANGEMENTS; NUCLEAR ARCHITECTURE; TERRITORY ARRANGEMENTS; SEGMENTAL DUPLICATIONS; GENOME; ORGANIZATION; REPAIR; CELLS; CYTOTOXICITY; GENOTOXICITY	The higher-order organization of chromatin is well-established, with chromosomes occupying distinct positions within the interphase nucleus. Chromatin is susceptible to, and constantly assaulted by both endogenous and exogenous threats. However, the effects of DNA damage on the spatial topology of chromosomes are hitherto, poorly understood. This study investigates the organization of all 24 human chromosomes in lymphocytes from six individuals prior to- and following in-vitro exposure to genotoxic agents: hydrogen peroxide and ultraviolet B. This study is the first to report reproducible distinct hierarchical radial organization of chromosomes with little inter-individual differences between subjects. Perturbed nuclear organization was observed following genotoxic exposure for both agents; however a greater effect was observed for hydrogen peroxide including: 1) More peripheral radial organization; 2) Alterations in the global distribution of chromosomes; and 3) More events of chromosome repositioning (18 events involving 10 chromosomes vs. 11 events involving 9 chromosomes for hydrogen peroxide and ultraviolet B respectively). Evidence is provided of chromosome repositioning and altered nuclear organization following in-vitro exposure to genotoxic agents, with notable differences observed between the two investigated agents. Repositioning of chromosomes following genotoxicity involved recurrent chromosomes and is most likely part of the genomes inherent response to DNA damage. The variances in nuclear organization observed between the two agents likely reflects differences in mobility and/or decondensation of chromatin as a result of differences in the type of DNA damage induced, chromatin regions targeted, and DNA repair mechanisms.	[Ioannou, Dimitrios; Kandukuri, Lakshmi; Quadri, Ameer; Becerra, Victor; Simpson, Joe Leigh; Tempest, Helen G.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA; [Simpson, Joe Leigh] March Dimes Fdn, White Plains, NY USA; [Tempest, Helen G.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Tempest, HG (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Human & Mol Genet, Miami, FL 33199 USA.	htempest@fiu.edu		Tempest, Helen/0000-0002-2369-4127	Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization" [W81XWh-10-1-0732]; Herbert Wertheim College of Medicine at Florida International University (startup funds)	Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization"(United States Department of Defense); Herbert Wertheim College of Medicine at Florida International University (startup funds)	This study was funded in part by a Department of Defense grant "Mass Scale Biosensor Threat Diagnostic for In-Theater Defense Utilization" W81XWh-10-1-0732 for the assessment of chromosomal aberrations following genotoxicity exposure, and supported the following authors DI, LK, JLS and HGT. The authors would also like to acknowledge the financial support for the chromosome territory organization studies provided by the Herbert Wertheim College of Medicine at Florida International University (startup funds awarded to HGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bourne G., 2013, HUMAN INTERPHASE CHR, P9; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Bridger JM, 2014, ADV EXP MED BIOL, V773, P263, DOI 10.1007/978-1-4899-8032-8_12; Buyukleyla M, 2009, ECOTOX ENVIRON SAFE, V72, P943, DOI 10.1016/j.ecoenv.2008.10.005; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Celik A, 2011, INT J HUM GENET, V11, P23, DOI 10.1080/09723757.2011.11886119; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2006, EUR J HISTOCHEM, V50, P223; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Elcock LS, 2010, BIOCHEM SOC T, V38, P263, DOI 10.1042/BST0380263; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; ESTERVIG D, 1984, PHOTOCHEM PHOTOBIOL, V40, P333, DOI 10.1111/j.1751-1097.1984.tb04595.x; Folle GA, 2008, MUTAT RES-REV MUTAT, V658, P172, DOI 10.1016/j.mrrev.2007.08.005; Foster HA, 2005, CHROMOSOMA, V114, P212, DOI 10.1007/s00412-005-0016-6; Gazave E, 2005, CHROMOSOME RES, V13, P377, DOI 10.1007/s10577-005-3254-9; Ghosal G, 2013, TRANSL CANCER RES, V2, P107, DOI 10.3978/j.issn.2218-676X.2013.04.01; Gopalakrishnan Kalpana, 2010, Genome Integr, V1, P16, DOI 10.1186/2041-9414-1-16; Green M H, 1999, J Epidemiol, V9, pS48; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Houtgraaf JH, 2006, CARDIOVASC REVASCULA, V7, P165, DOI 10.1016/j.carrev.2006.02.002; HSU TC, 1975, GENETICS, V79, P137; Ioannou D, 2011, CHROMOSOME RES, V19, P741, DOI 10.1007/s10577-011-9238-z; Kasurka CB, 2011, TOXICOL IN VITRO, V25, P1480, DOI 10.1016/j.tiv.2011.05.002; Khalil A, 2007, CHROMOSOME RES, V15, P899, DOI 10.1007/s10577-007-1172-8; Koehler D, 2009, EXP CELL RES, V315, P2053, DOI 10.1016/j.yexcr.2009.02.016; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Wei-Feng, 2006, Acta Genetica Sinica, V33, P381, DOI 10.1016/S0379-4172(06)60064-4; MANUELIDIS L, 1990, SCIENCE, V250, P1533, DOI 10.1126/science.2274784; Marella NV, 2009, J CELL PHYSIOL, V221, P130, DOI 10.1002/jcp.21836; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Meaburn KJ, 2005, BIOCHEM SOC T, V33, P1438, DOI 10.1042/BST0331438; Mehta IS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r135; Millan NM, 2012, CHROMOSOME RES, V20, P875, DOI 10.1007/s10577-012-9323-y; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Naidoo Nasheen, 2011, Human Genomics, V5, P577; Oliver B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-214; PARSHAD R, 1980, MUTAT RES, V73, P115, DOI 10.1016/0027-5107(80)90140-2; Postberg J, 2010, ESSAYS BIOCHEM, V48, P1, DOI [10.1042/BSE0480001, 10.1042/bse0480001]; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sanders MH, 2004, CYTOGENET GENOME RES, V104, P35, DOI 10.1159/000077464; SEGUIN LR, 1988, AM J HUM GENET, V42, P468; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Szczerbal I, 2009, CHROMOSOMA, V118, P647, DOI 10.1007/s00412-009-0225-5; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tanabe H, 2005, CYTOGENET GENOME RES, V108, P255, DOI 10.1159/000080824; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Verschure PJ, 2004, BIOL CELL, V96, P569, DOI 10.1016/j.biolcel.2004.07.001; Wijeratne SSK, 2005, J AGR FOOD CHEM, V53, P8768, DOI 10.1021/jf0512003	61	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118886	10.1371/journal.pone.0118886	http://dx.doi.org/10.1371/journal.pone.0118886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756782	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700029
J	Li, LP; Zhou, LX; Wang, LH; Xue, HP; Zhao, X				Li, Longping; Zhou, Luoxiong; Wang, Lihong; Xue, Huping; Zhao, Xin			Characterization of Methicillin-Resistant and -Susceptible Staphylococcal Isolates from Bovine Milk in Northwestern China	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; ANTIMICROBIAL RESISTANCE; AUREUS; MASTITIS; GENE; IDENTIFICATION; MUTATIONS; SODA; FOOD	Emergence of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative staphylococci (MR-CoNS) in bovine milk is a major public health concern. The primary purpose of this research was to determine molecular genetic characteristics and antibiotic resistance of staphylococcal isolates recovered from milk of mastitic cows in the Shaanxi Province in Northwestern China. One hundred and thirteen methicillin-susceptible Staphylococcus aureus (MSSA), one mecA-positive and phenotype-positive MRSA, seven mecA-and mecC-negative but phenotype-positive MRSA and two MR-CoNS including one oxacillin-susceptible mecA-positive Staphylococcus haemolyticus (OS-MRSH) and one mecA-positive and methicillin-resistant Staphylococcus epidermidis (MRSE) isolates were recovered from 214 quarter milk samples on 4 dairy farms. All above 123 isolates were subjected to antibiotic resistance profiling. S. aureus isolates were also genotyped using the spa typing and the multilocus sequence typing (MLST). Eight MRSA and 2 MR-CoNS isolates were additionally tested for SCCmec types. Resistance was common among isolates against ampicillin or penicillin (80.5%), kanamycin (68.3%), gentamicin (67.5%), tetracycline (43.9%) and chloramphenicol (30.1%). However, no isolate was resistant to vancomycin or teicoplanin. Twenty, 29 and 58 isolates showed resistance to 1, 2 or more than 2 antibiotics, respectively. The predominant multidrug resistance profile was penicillin/ampicillin/kanamycin/gentamicin/tetracycline (46 isolates). Most S. aureus isolates belonged to spa types t524 (n = 63), t11772 (a new type, n = 31) and t4207 (n = 15). At the same time, MLST types ST71 (n = 67) and ST2738 (a new type, n = 45) were identified as dominant sequence types. The mecA-positive and phenotype-positive MRSA isolate had a composite genotype t524-ST71-SCCmecIVa, while 7 mecA-negative but phenotype-positive MRSA isolates were all t524-ST71. The OS-MRSH isolate contained a type V SCCmec cassette, while the MRSE isolate possessed a non-typeable SCCmec. The spa-MLST types t11772-ST2738 (n = 27), t11807-ST2683 (n = 4) and t11771-ST2738 (n = 3) were newly identified genotypes of S. aureus. These new genotypes and multidrug-resistant staphylococci could pose additional threat to animal and human health.	[Li, Longping; Zhou, Luoxiong; Wang, Lihong; Xue, Huping; Zhao, Xin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhao, Xin] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Northwest A&F University - China; McGill University	Zhao, X (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zhaoxin@nwsuaf.edu.cn	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332; Li, Longoing/0000-0001-5500-5018	National Science Foundation of China [31372282]; China Thousand Talents Program; University Scientific Research Fund project [Z111021305]; Natural Science and Engineering Research Council of Canada	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Thousand Talents Program; University Scientific Research Fund project; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was financially supported by a grant from the National Science Foundation of China (31372282), the China Thousand Talents Program and a University Scientific Research Fund project (Fund No. Z111021305). This work was also partially supported from a discovery grant by Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XL, 2014, J ANTIMICROB CHEMOTH, V69, P594, DOI 10.1093/jac/dkt418; Bal EBB, 2010, J MICROBIOL, V48, P267, DOI 10.1007/s12275-010-9373-9; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Brody T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003074; Clinical and Laboratory Standards Institute, 2004, CLSI DOCUMENT M31 S1; Clinical and Laboratory Standards Institute, 2011, CLSI DOCUMENT M100 S; De Buyser ML, 2001, INT J FOOD MICROBIOL, V67, P1, DOI 10.1016/S0168-1605(01)00443-3; Erskine RJ, 2002, J DAIRY SCI, V85, P1111, DOI 10.3168/jds.S0022-0302(02)74172-6; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Fournier C, 2008, RES VET SCI, V85, P439, DOI 10.1016/j.rvsc.2008.01.010; Frey Y, 2013, J DAIRY SCI, V96, P2247, DOI 10.3168/jds.2012-6091; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Ghebremedhin B, 2008, J CLIN MICROBIOL, V46, P1019, DOI 10.1128/JCM.02058-07; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Huber H, 2010, EURO SURVEILL, V15; Ikawaty R, 2009, VET MICROBIOL, V136, P277, DOI 10.1016/j.vetmic.2008.10.034; Kumar R, 2010, CURR MICROBIOL, V60, P379, DOI 10.1007/s00284-009-9553-1; Lovseth A, 2004, J CLIN MICROBIOL, V42, P3869, DOI 10.1128/JCM.42.8.3869-3872.2004; Martineau F, 2000, ANTIMICROB AGENTS CH, V44, P231, DOI 10.1128/AAC.44.2.231-238.2000; Moon JS, 2007, J DAIRY SCI, V90, P1176, DOI 10.3168/jds.S0022-0302(07)71604-1; Oliver SP, 2012, VET CLIN N AM-FOOD A, V28, P165, DOI 10.1016/j.cvfa.2012.03.005; Poyart C, 2001, J CLIN MICROBIOL, V39, P4296, DOI 10.1128/JCM.39.12.4296-4301.2001; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; Turutoglu H, 2009, VET RES COMMUN, V33, P945, DOI 10.1007/s11259-009-9313-5; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; Wang X, 2014, LETT APPL MICROBIOL, V58, P527, DOI 10.1111/lam.12221; Wang X, 2012, FOODBORNE PATHOG DIS, V9, P95, DOI 10.1089/fpd.2011.0987; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	30	31	33	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116699	10.1371/journal.pone.0116699	http://dx.doi.org/10.1371/journal.pone.0116699			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756992	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700011
J	Wilson, GC; Kuboki, S; Freeman, CM; Nojima, H; Schuster, RM; Edwards, MJ; Lentsch, AB				Wilson, Gregory C.; Kuboki, Satoshi; Freeman, Christopher M.; Nojima, Hiroyuki; Schuster, Rebecca M.; Edwards, Michael J.; Lentsch, Alex B.			CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration	PLOS ONE			English	Article							MICE; ISCHEMIA/REPERFUSION; HEPATECTOMY; NEUTROPHILS; RECEPTOR-2; RECOVERY	Background Our previous in vitro studies have demonstrated dose-dependent effects of CXCR2 ligands on hepatocyte cell death and proliferation. In the current study, we sought to determine if CXCR2 ligand concentration is responsible for the divergent effects of these mediators on liver regeneration after ischemia/reperfusion injury and partial hepatectomy. Methods Murine models of partial ischemia/reperfusion injury and hepatectomy were used to study the effect of CXCR2 ligands on liver regeneration. Results We found that hepatic expression of the CXCR2 ligands, macrophage inflammatory protein-2 (MIP-2) and keratinocyte-derived chemokine (KC), was significantly increased after both I/R injury and partial hepatectomy. However, expression of these ligands after I/R injury was 30-100-fold greater than after hepatectomy. Interestingly, the same pattern of expression was found in ischemic versus non-ischemic liver lobes following I/R injury with expression significantly greater in the ischemic liver lobes. In both systems, lower ligand expression was associated with increased hepatocyte proliferation and liver regeneration in a CXCR2-dependent fashion. To confirm that these effects were related to ligand concentration, we administered exogenous MIP-2 and KC to mice undergoing partial hepatectomy. Mice received a "high" dose that replicated serum levels found after I/R injury and a "low" dose that was similar to that found after hepatectomy. Mice receiving the "high" dose had reduced levels of hepatocyte proliferation and regeneration whereas the "low" dose promoted hepatocyte proliferation and regeneration. Conclusions Together, these data demonstrate that concentrations of CXC chemokines regulate the hepatic proliferative response and subsequent liver regeneration.	[Wilson, Gregory C.; Kuboki, Satoshi; Freeman, Christopher M.; Nojima, Hiroyuki; Schuster, Rebecca M.; Edwards, Michael J.; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Lentsch, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45220 USA.	alex.lentsch@uc.edu	NOJIMA, HIROYUKI/E-3782-2017	NOJIMA, HIROYUKI/0000-0003-3983-2501; Wilson, Gregory/0000-0001-6237-0136	National Institutes of Health [DK56029, AG025881, GM08478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK056029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grants DK56029, AG025881, and GM08478. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Clarke C, 2011, HEPATOLOGY, V53, P261, DOI 10.1002/hep.24028; Clarke CN, 2010, FASEB J, V24, p[749, 743]; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; Colletti LM, 1998, SHOCK, V10, P248, DOI 10.1097/00024382-199810000-00004; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; Hogaboam CM, 1999, FASEB J, V13, P1565, DOI 10.1096/fasebj.13.12.1565; Kuboki S, 2008, HEPATOLOGY, V48, P1213, DOI 10.1002/hep.22471; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Ren XD, 2003, AM J PATHOL, V163, P563, DOI 10.1016/S0002-9440(10)63684-X; Sakai N, 2011, TRANSPL P, V43, P1967, DOI 10.1016/j.transproceed.2011.03.028; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Van Sweringen HL, 2013, HEPATOLOGY, V57, P331, DOI 10.1002/hep.26049; Van Sweringen HL, 2011, HEPATOLOGY, V54, P1445, DOI 10.1002/hep.24457	15	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120092	10.1371/journal.pone.0120092	http://dx.doi.org/10.1371/journal.pone.0120092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756662	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700058
J	Cheung, KG; Cole, LK; Xiang, B; Chen, KY; Ma, XL; Myal, Y; Hatch, GM; Tong, Q; Dolinsky, VW				Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Chen, Keyun; Ma, Xiuli; Myal, Yvonne; Hatch, Grant M.; Tong, Qiang; Dolinsky, Vernon W.			Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRIAMYCIN-INDUCED CARDIOMYOPATHY; MANGANESE SUPEROXIDE-DISMUTASE; AEROBIC EXERCISE; BREAST-CANCER; RAT-HEART; ELECTRON-TRANSPORT; SKELETAL-MUSCLE; COMPLEX-I; ANTHRACYCLINE; DEACETYLASE	Doxorubicin (DOX) is a chemotherapeutic agent effective in the treatment of many cancers. However, cardiac dysfunction caused by DOX limits its clinical use. DOX is believed to be harmful to cardiomyocytes by interfering with the mitochondrial phospholipid cardiolipin and causing inefficient electron transfer resulting in the production of reactive oxygen species (ROS). Sirtuin-3 (SIRT3) is a class III lysine deacetylase that is localized to the mitochondria and regulates mitochondrial respiration and oxidative stress resistance enzymes such as superoxide dismutase-2 (SOD2). The purpose of this study was to determine whether SIRT3 prevents DOX-induced mitochondrial ROS production. Administration of DOX to mice suppressed cardiac SIRT3 expression, and DOX induced a dose-dependent decrease in SIRT3 and SOD2 expression in H9c2 cardiomyocytes. SIRT3-null mouse embryonic fibroblasts produced significantly more ROS in the presence of DOX compared with wild-type cells. Overexpression of wildtype SIRT3 increased cardiolipin levels and rescued mitochondrial respiration and SOD2 expression in DOX-treated H9c2 cardiomyocytes and attenuated the amount of ROS produced following DOX treatment. These effects were absent when a deacetylase-deficient SIRT3 was expressed in H9c2 cells. Our results suggest that overexpression of SIRT3 attenuates DOX-induced ROS production, and this may involve increased SOD2 expression and improved mitochondrial bioenergetics. SIRT3 activation could be a potential therapy for DOX-induced cardiac dysfunction.	[Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 3P4, Canada; [Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Diabet Res Envisioned & Accomplished Manitoba DRE, Winnipeg, MB R3E 3P4, Canada; [Cheung, Kyle G.; Cole, Laura K.; Xiang, Bo; Ma, Xiuli; Hatch, Grant M.; Dolinsky, Vernon W.] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada; [Myal, Yvonne] Univ Manitoba, Dept Pathol, Winnipeg, MB R3E 3P4, Canada; [Chen, Keyun; Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Baylor College of Medicine	Dolinsky, VW (corresponding author), Univ Manitoba, 601 John Buhler Res Ctr,715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	vdolinsky@chrim.ca			Heart and Stroke Foundation [000402]; Manitoba Health Research Council; Canadian Breast Cancer Foundation; American Heart Association [0665162Y]; United States Department of Agriculture [6250-51000-055]; Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Manitoba Health Research Council; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); American Heart Association(American Heart Association); United States Department of Agriculture(United States Department of Agriculture (USDA)); Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship	This work was supported in part by the Heart and Stroke Foundation Grant 000402 and a research grant the Manitoba Health Research Council (to V. W. D.), a Canadian Breast Cancer Foundation grant (to Y. M.), a Heart and Stroke Foundation grant (to G. M. H.), and American Heart Association Grant 0665162Y and United States Department of Agriculture Grant 6250-51000-055 (to Q. T.).; Recipient of a Canadian Institutes of Health Research/Heart and Stroke Foundation of Canada Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT) fellowship.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ascensao A, 2011, CLIN SCI, V120, P37, DOI 10.1042/CS20100254; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; BARTLETT GR, 1959, J BIOL CHEM, V234, P469; BIANCHI C, 1987, EXP MOL PATHOL, V46, P123, DOI 10.1016/0014-4800(87)90036-0; Carvalho C, 2009, CURR MED CHEM, V16, P3267, DOI 10.2174/092986709788803312; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dolinsky VW, 2014, MOLECULES, V19, P14919, DOI 10.3390/molecules190914919; Dolinsky VW, 2013, AM J PHYSIOL-ENDOC M, V305, pE243, DOI 10.1152/ajpendo.00044.2013; Dolinsky VW, 2012, J PHYSIOL-LONDON, V590, P2783, DOI 10.1113/jphysiol.2012.230490; DOROSHOW JH, 1983, CANCER RES, V43, P460; Eidenschink AB, 2000, CARDIOL YOUNG, V10, P610; Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827; GOORMAGHTIGH E, 1983, BIOCHEM PHARMACOL, V32, P889, DOI 10.1016/0006-2952(83)90593-2; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haykowsky MJ, 2009, CLIN CANCER RES, V15, P4963, DOI 10.1158/1078-0432.CCR-09-0628; Hequet O, 2004, J CLIN ONCOL, V22, P1864, DOI 10.1200/JCO.2004.06.033; Hostetler K. Y., 1982, PHOSPHOLIPIDS, V4, P215; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jones LW, 2007, J AM COLL CARDIOL, V50, P1435, DOI 10.1016/j.jacc.2007.06.037; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kuznetsov AV, 2011, BBA-MOL CELL RES, V1813, P1144, DOI 10.1016/j.bbamcr.2011.03.002; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Law IKM, 2009, PROTEOMICS, V9, P2444, DOI 10.1002/pmic.200800738; Marques-Aleixo I, 2015, MITOCHONDRION, V20, P22, DOI 10.1016/j.mito.2014.10.008; MUHAMMED H, 1983, BIOCHIM BIOPHYS ACTA, V722, P43, DOI 10.1016/0005-2728(83)90155-X; Mutter T, 2000, BIOCHEM J, V346, P403, DOI 10.1042/0264-6021:3460403; Ohkura K, 2003, MOL CELL BIOCHEM, V248, P203, DOI 10.1023/A:1024161024231; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pereira GC, 2011, CURR PHARM DESIGN, V17, P2113; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Sack MN, 2011, AM J PHYSIOL-HEART C, V301, pH2191, DOI 10.1152/ajpheart.00199.2011; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Yen HC, 1999, ARCH BIOCHEM BIOPHYS, V362, P59, DOI 10.1006/abbi.1998.1011; Zhang C, 2011, CARDIOVASC RES, V90, P538, DOI 10.1093/cvr/cvr022	49	113	117	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10981	10993		10.1074/jbc.M114.607960	http://dx.doi.org/10.1074/jbc.M114.607960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759382	Green Published, hybrid			2022-12-26	WOS:000353404500035
J	Blanchard, MG; de Baaij, JHF; Verkaart, SAJ; Lameris, AL; Basmadjian, C; Zhao, Q; Desaubry, L; Bindels, RJM; Hoenderop, JGJ				Blanchard, Maxime G.; de Baaij, Jeroen H. F.; Verkaart, Sjoerd A. J.; Lameris, Anke L.; Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent; Bindels, Rene J. M.; Hoenderop, Joost G. J.			Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity	PLOS ONE			English	Article							INSULIN-RECEPTOR; KINASE DOMAIN; LIPID RAFTS; PROTEIN; PHOSPHORYLATION; HYPOMAGNESEMIA; PROHIBITINS; ACTIVATION; SURVIVAL; PODOCIN	Magnesium (Mg2+) is essential for enzymatic activity, brain function and muscle contraction. Blood Mg2+ concentrations are tightly regulated between 0.7 and 1.1 mM by Mg2+ (re) absorption in kidney and intestine. The apical entry of Mg2+ in (re) absorbing epithelial cells is mediated by the transient receptor potential melastatin type 6 (TRPM6) ion channel. Here, flavaglines are described as a novel class of stimulatory compounds for TRPM6 activity. Flavaglines are a group of natural and synthetic compounds that target the ubiquitously expressed prohibitins and thereby affect cellular signaling. By whole-cell patch clamp analyses, it was demonstrated that nanomolar concentrations of flavaglines increases TRPM6 activity by similar to 2 fold. The stimulatory effects were dependent on the presence of the alpha-kinase domain of TRPM6, but did not require its phosphotransferase activity. Interestingly, it was observed that two natural occurring TRPM6 mutants with impaired insulin-sensitivity, TRPM6-p. Val1393Ile and TRPM6-p.Lys1584Glu, are not sensitive to flavagline stimulation. In conclusion, we have identified flavaglines as potent activators of TRPM6 activity. Our results suggest that flavaglines stimulate TRPM6 via the insulin receptor signaling pathway.	[Blanchard, Maxime G.; de Baaij, Jeroen H. F.; Verkaart, Sjoerd A. J.; Lameris, Anke L.; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Basmadjian, Christine; Zhao, Qian; Desaubry, Laurent] Univ Strasbourg, Lab Therapeut Innovat UMR7200, CNRS, Fac Pharm, Illkirch Graffenstaden, France	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Radboud Inst Mol Life Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Desaubry, Laurent G/R-5446-2017; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Desaubry, Laurent G/0000-0002-1192-2970; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Blanchard, Maxime/0000-0001-8955-2239	Netherlands Organization for Scientific Research [ZonMW 9120.8026, NWO Vici 016.130.668]; EURenOmics project from the European Union seventh framework programme (FP7) [305608]; Association Nationale Recherche Technologie (ANRT); Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EURenOmics project from the European Union seventh framework programme (FP7); Association Nationale Recherche Technologie (ANRT)(French National Research Agency (ANR)); Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research)	This work was supported by grants from the Netherlands Organization for Scientific Research (ZonMW 9120.8026, NWO Vici 016.130.668) and the EURenOmics project from the European Union seventh framework programme (FP7/2007-2013, agreement no. 305608). The authors also thank the Association Nationale Recherche Technologie (ANRT) and the Association d'Aide a la Recherche et a l'Enseignement en Cancerologie (AAREC Filia Research) for fellowships to C. Basmadjian and Q. Zhao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Anderson M, 2013, AM J PHYSIOL-CELL PH, V305, pC276, DOI 10.1152/ajpcell.00095.2013; Basmadjian C, 2013, FUTURE MED CHEM, V5, P2185, DOI 10.4155/fmc.13.177; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brandao K, 2014, CELL MOL LIFE SCI, V71, P4853, DOI 10.1007/s00018-014-1647-7; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Cao G, 2010, J BIOL CHEM, V285, P26081, DOI 10.1074/jbc.M110.103655; Cao G, 2009, J BIOL CHEM, V284, P14788, DOI 10.1074/jbc.M808752200; Chowdhury I, 2014, J CELL PHYSIOL, V229, P998, DOI 10.1002/jcp.24531; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; de Baaij JHF, 2012, CLIN KIDNEY J, V5, P15, DOI 10.1093/ndtplus/sfr164; Huber TB, 2007, NEPHRON EXP NEPHROL, V106, pE27, DOI 10.1159/000101789; Morino-Koga S, 2013, J CELL PHYSIOL, V228, P439, DOI 10.1002/jcp.24149; Nair AV, 2012, P NATL ACAD SCI USA, V109, P11324, DOI 10.1073/pnas.1113811109; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Pan L, 2014, NAT PROD REP, V31, P924, DOI 10.1039/c4np00006d; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Song YQ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-4; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Thuaud F, 2011, J MED CHEM, V54, P411, DOI 10.1021/jm101318b; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; van der Wijst J, 2014, BIOCHEM J, V460, P165, DOI 10.1042/BJ20131639; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Xie J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00146; Yogi A, 2009, AM J PHYSIOL-REG I, V296, pR201, DOI 10.1152/ajpregu.90602.2008; Zhang Z, 2014, J BIOL CHEM, V289, P5217, DOI 10.1074/jbc.M113.512285	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119028	10.1371/journal.pone.0119028	http://dx.doi.org/10.1371/journal.pone.0119028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774985	gold, Green Published			2022-12-26	WOS:000351183500061
J	Kassavou, A; Turner, A; French, DP				Kassavou, Aikaterini; Turner, Andrew; French, David P.			The Role of Walkers' Needs and Expectations in Supporting Maintenance of Attendance at Walking Groups: A Longitudinal Multi-Perspective Study of Walkers and Walk Group Leaders	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; INTERVENTIONS	Background There is good evidence that when people's needs and expectations regarding behaviour change are met, they are satisfied with that change, and maintain those changes. Despite this, there is a dearth of research on needs and expectations of walkers when initially attending walking groups and whether and how these needs and expectations have been satisfied after a period of attendance. Equally, there is an absence of research on how people who lead these groups understand walkers' needs and walk leaders' actions to address them. The present study was aimed at addressing both of these gaps in the research. Methods Two preliminary thematic analyses were conducted on face-to-face interviews with ( a) eight walkers when they joined walking groups, five of whom were interviewed three months later, and (b) eight walk leaders. A multi-perspective analysis building upon these preliminary analyses identified similarities and differences within the themes that emerged from the interviews with walkers and walk leaders. Results Walkers indicated that their main needs and expectations when joining walking groups were achieving long-term social and health benefits. At the follow up interviews, walkers indicated that satisfaction with meeting similar others within the groups was the main reason for continued attendance. Their main source of dissatisfaction was not feeling integrated in the existing walking groups. Walk leaders often acknowledged the same reasons for walkers joining and maintaining attendance at walking. However, they tended to attribute dissatisfaction and drop out to uncontrollable environmental factors and/or walkers' personalities. Walk leaders reported a lack of efficacy to effectively address walkers' needs. Conclusions Interventions to increase retention of walkers should train walk leaders with the skills to help them modify the underlying psychological factors affecting walkers' maintenance at walking groups. This should result in greater retention of walkers in walking groups, thereby allowing walkers to receive the long-term social and health benefits of participation in these groups.	[Kassavou, Aikaterini] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Behav Sci Grp,Primary Care Unit, Cambridge, England; [Turner, Andrew] Coventry Univ, Appl Res Ctr Hlth & Lifestyle Intervent, Coventry, W Midlands, England; [French, David P.] Univ Manchester, Sch Psychol Sci, Manchester Ctr Hlth Psychol, Manchester, Lancs, England	University of Cambridge; Coventry University; University of Manchester	Kassavou, A (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Behav Sci Grp,Primary Care Unit, Cambridge, England.	kk532@medschl.cam.ac.uk	French, David P/K-7283-2012	French, David P/0000-0002-7663-7804; Kassavou, Aikaterini/0000-0002-6562-4143; Turner, Andrew/0000-0001-6538-4242	Coventry University (Faculty of Health and Life Sciences)	Coventry University (Faculty of Health and Life Sciences)	AK was funded with a PhD studentship by Coventry University (Faculty of Health and Life Sciences). DF and AT acted as supervisors. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allender S, 2008, HEALTH PROMOT INT, V23, P160, DOI 10.1093/heapro/dan012; American Volkssport Association, 2011, AM VOLKSSP ASS FUN F; Ashley A, 2011, HLTH ED J, V60, P265; Ashley A, 2001, PRIM HEALTH CARE RES, V2, P98; Bandura A, 1997, SELF EFFICACY EXERCI, DOI [10.1080/08870440802254597, DOI 10.1080/08870440802254597]; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CHAMBERLAIN K, 2004, RES METHODS CLIN HLT, V0005, P00069; Chief Medical Officers of England Scotland Wales and Northern Ireland, 2011, START ACT STAY ACT R; Coleman RJ, 2011, NATURAL ENGLAND COMM; Dillman D. A., 2000, MAIL INTERNET SURVEY, V2; DUNCAN HH, 1995, J APPL GERONTOL, V14, P64, DOI 10.1177/073346489501400105; Duncan HH., 1993, THESIS VIRGINIA POLY; Foster G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005108.pub2; Hynds H, 2009, PRIMARY HLTH CARE RE; Jancey J, 2006, AM J HEALTH BEHAV, V30, P626, DOI 10.5993/AJHB.30.6.9; Jancey JM, 2008, GERONTOLOGIST, V48, P251, DOI 10.1093/geront/48.2.251; Jancey JM, 2008, AM J HEALTH PROMOT, V22, P318, DOI 10.4278/ajhp.22.5.318; Kassavou A., 2012, THESIS COVENTRY U; Kassavou A, 2015, J HEALTH PSYCHOL, V20, P1328, DOI 10.1177/1359105313511839; Kassavou A, 2014, HEALTH PSYCHOL, V33, P752, DOI 10.1037/hea0000015; Kassavou A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-18; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Knox PR, 2011, EVALUATION WALKING S; Krieger James, 2009, Am J Public Health, V99 Suppl 3, pS593, DOI 10.2105/AJPH.2009.164384; Michie S, 2008, ADDICTION, V103, P886, DOI 10.1111/j.1360-0443.2007.02112.x; OBrien L, 2009, PRIMARY HLTH CARE RE; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Rothman AJ, 2011, HDB SELF REGULATION, P106; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Walking for Health, 2013, WALK HLTH SUPP YOU G; Yardley L., 2004, RES METHODS CLIN HLT, P39, DOI DOI 10.4135/9781849209793	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118754	10.1371/journal.pone.0118754	http://dx.doi.org/10.1371/journal.pone.0118754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25774527	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500039
J	Kollndorfer, K; Kowalczyk, K; Frasnelli, J; Hoche, E; Unger, E; Mueller, CA; Krajnik, J; Trattnig, S; Schopf, V				Kollndorfer, Kathrin; Kowalczyk, Ksenia; Frasnelli, Johannes; Hoche, Elisabeth; Unger, Ewald; Mueller, Christian A.; Krajnik, Jacqueline; Trattnig, Siegfried; Schoepf, Veronika			Same Same but Different. Different Trigeminal Chemoreceptors Share the Same Central Pathway	PLOS ONE			English	Article							INDEPENDENT COMPONENTS; ODOR IDENTIFICATION; OLFACTORY FUNCTION; CHEMICAL SENSES; HUMAN AWARENESS; IMAGING DATA; ION-CHANNEL; TRP CHANNEL; PAIN; STIMULI	Intranasal trigeminal sensations are important in everyday life of human beings, as they play a governing role in protecting the airways from harm. Trigeminal sensations arise from the binding of a ligand to various sub-types of transient receptor potential (TRP) channels located on mucosal branches of the trigeminal nerve. Which underlying neural networks are involved in the processing of various trigeminal inputs is still unknown. To target this unresolved question fourteen healthy human subjects were investigated by completing three functional magnetic resonance imaging (fMRI) scanning sessions during which three trigeminal substances, activating varying sub-types of chemoreceptors and evoking different sensations in the nose were presented: CO2, menthol and cinnamaldehyde. We identified similar functional networks responding to all stimuli: an olfactory network, a somatosensory network and an integrative network. The processing pathway of all three stimulants was represented by the same functional networks, although CO2 evokes painful but virtually odor-less sensations, and the two other stimulants, menthol and cinnamaldehyde are perceived as mostly non painful with a clear olfactory percept. Therefore, our results suggest a common central processing pathway for trigeminal information regardless of the trigeminal chemoreceptor and sensation type.	[Kollndorfer, Kathrin; Kowalczyk, Ksenia; Hoche, Elisabeth; Krajnik, Jacqueline; Schoepf, Veronika] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Kollndorfer, Kathrin] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Frasnelli, Johannes] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; [Frasnelli, Johannes] Hop Sacre Coeur, Ctr Rech, Montreal, PQ H4J 1C5, Canada; [Unger, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Mueller, Christian A.] Med Univ Vienna, Dept Otorhinolaryngol, Vienna, Austria; [Trattnig, Siegfried] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, High Field MR Ctr, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Universite de Montreal; Universite de Montreal; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Schopf, V (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	veronika.schoepf@uni-graz.at	Frasnelli, Johannes/D-9206-2018	Frasnelli, Johannes/0000-0002-8863-3982; Kollndorfer, Kathrin/0000-0002-5983-5307; Unger, Ewald/0000-0003-0275-9988; Schopf, Veronika/0000-0003-1937-4216; Trattnig, Siegfried/0000-0003-1623-3303	Austrian Science Fund (FWF) [P23205-B09]; Austrian Science Fund (FWF) [P 23205] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	K. Kollndorfer and JK were funded by a grant of the Austrian Science Fund (FWF; P23205-B09) to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 2010, BRAIN RES REV, V62, P183, DOI 10.1016/j.brainresrev.2009.11.001; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Baykara RA, 2013, J BACK MUSCULOSKELET, V26, P367, DOI 10.3233/BMR-130393; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Brass M, 2010, BRAIN STRUCT FUNCT, V214, P603, DOI 10.1007/s00429-010-0269-6; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carlson KS, 2013, J NEUROSCI, V33, P13873, DOI 10.1523/JNEUROSCI.0422-13.2013; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Frasnelli J, 2007, INT J PSYCHOPHYSIOL, V65, P177, DOI 10.1016/j.ijpsycho.2007.03.007; Frasnelli J, 2006, NEUROSCIENCE, V142, P541, DOI 10.1016/j.neuroscience.2006.06.005; Frasnelli J, 2011, NEUROSCIENCE, V189, P377, DOI 10.1016/j.neuroscience.2011.04.065; Frasnelli J, 2010, NEUROSCI LETT, V468, P259, DOI 10.1016/j.neulet.2009.11.008; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Frasnelli J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00288; Frasnelli J, 2009, CHEM SENSES, V34, P139, DOI 10.1093/chemse/bjn068; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2009, ANN NY ACAD SCI, V1170, P190, DOI 10.1111/j.1749-6632.2009.03910.x; Iannilli E, 2008, PAIN, V139, P376, DOI 10.1016/j.pain.2008.05.007; Iannilli E, 2007, BRAIN RES, V1139, P235, DOI 10.1016/j.brainres.2006.12.082; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kleemann AM, 2009, PHYSIOL BEHAV, V97, P401, DOI 10.1016/j.physbeh.2009.03.013; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2001, EUR ARCH OTO-RHINO-L, V258, P168, DOI 10.1007/s004050100328; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Salas MM, 2009, EUR J NEUROSCI, V29, P1568, DOI 10.1111/j.1460-9568.2009.06702.x; Schopf V, 2011, NEUROIMAGE, V55, P185, DOI 10.1016/j.neuroimage.2010.11.010; Seidel S, 2011, ROFO-FORTSCHR RONTG, V183, P1051, DOI 10.1055/s-0031-1281768; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stuck BA, 2011, NEUROSCIENCE, V176, P442, DOI 10.1016/j.neuroscience.2011.01.009; Tedeschi G, 2013, NEUROL SCI, V34, pS47, DOI 10.1007/s10072-013-1383-z; THURAUF N, 1991, NEUROSCI LETT, V128, P297, DOI 10.1016/0304-3940(91)90283-Y; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; von Skramlik E, 1924, Z SINNESPHYSIOL, V56, P69, DOI DOI 10.1107/S0108767309007235; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wiesmann M, 2006, NEUROIMAGE, V32, P293, DOI 10.1016/j.neuroimage.2006.03.022; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	54	23	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121091	10.1371/journal.pone.0121091	http://dx.doi.org/10.1371/journal.pone.0121091			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775237	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500207
J	Li, DY; Wan, JQ; Ma, YW; Wang, Y; Huang, MZ; Chen, YM				Li, Dongya; Wan, Jinquan; Ma, Yongwen; Wang, Yan; Huang, Mingzhi; Chen, Yangmei			Stormwater Runoff Pollutant Loading Distributions and Their Correlation with Rainfall and Catchment Characteristics in a Rapidly Industrialized City	PLOS ONE			English	Article							1ST FLUSH LOAD; SURFACE RUNOFF; URBAN; QUALITY; WATERSHEDS; AREA	Fast urbanization and industrialization in developing countries result in significant stormwater runoff pollution, due to drastic changes in land-use, from rural to urban. A three-year study on the stormwater runoff pollutant loading distributions of industrial, parking lot and mixed commercial and residential catchments was conducted in the Tongsha reservoir watershed of Dongguan city, a typical, rapidly industrialized urban area in China. This study presents the changes in concentration during rainfall events, event mean concentrations (EMCs) and event pollution loads per unit area (EPLs). The first flush criterion, namely the mass first flush ratio (MFFn), was used to identify the first flush effects. The impacts of rainfall and catchment characterization on EMCs and pollutant loads percentage transported by the first 40% of runoff volume (FF40) were evaluated. The results indicated that the pollutant wash-off process of runoff during the rainfall events has significant temporal and spatial variations. The mean rainfall intensity (I), the impervious rate (IMR) and max 5-min intensity (I-max5) are the critical parameters of EMCs, while I-max5, antecedent dry days (ADD) and rainfall depth (RD) are the critical parameters of FF40. Intercepting the first 40% of runoff volume can remove 55% of TSS load, 53% of COD load, 58% of TN load, and 61% of TP load, respectively, according to all the storm events. These results may be helpful in mitigating stormwater runoff pollution for many other urban areas in developing countries.	[Li, Dongya; Wan, Jinquan; Ma, Yongwen; Wang, Yan; Huang, Mingzhi; Chen, Yangmei] S China Univ Technol, Coll Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China; [Wan, Jinquan] Minist Educ, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Guangzhou 510006, Guangdong, Peoples R China; [Ma, Yongwen] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou 510640, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Wan, JQ (corresponding author), S China Univ Technol, Coll Environm & Energy, Guangzhou 510006, Guangdong, Peoples R China.	ppjqwan@scut.edu.cn	wang, yan/AAS-9297-2021	Huang, Mingzhi/0000-0002-2592-3544	National Natural Science Foundation of China [51208206]; Guangdong Provincial Department of Science [2012A032300015]; Guangdong Natural Science Foundation [S2011040000389]; China Postdoctoral Science Foundation [2012M511570, 2013T60807]; High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China [201213]; Fundamental Research Funds for the Central Universities [2013ZZ0031]; national water pollution control and management major projects [2008ZX07211006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Department of Science; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); national water pollution control and management major projects	This research has been supported by National Natural Science Foundation of China (No. 51208206), Guangdong Provincial Department of Science (No. 2012A032300015), Guangdong Natural Science Foundation (No. S2011040000389), China Postdoctoral Science Foundation (2012M511570, 2013T60807), High-level Personnel Foundation of Guangdong Higher Education Institutions, State key laboratory of Pulp and Paper Engineering in China (201213), the Fundamental Research Funds for the Central Universities (2013ZZ0031) and the national water pollution control and management major projects (2008ZX07211006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Batroney T, 2010, J HYDROL ENG, V15, P123, DOI 10.1061/(ASCE)HE.1943-5584.0000167; Bertrand-Krajewski JL, 1998, WATER RES, V32, P2341, DOI 10.1016/S0043-1354(97)00420-X; Brezonik PL, 2002, WATER RES, V36, P1743, DOI 10.1016/S0043-1354(01)00375-X; Chang MT, 2004, J ENVIRON MANAGE, V73, P307, DOI 10.1016/j.jenvman.2004.06.014; Chow MF, 2013, ENVIRON MONIT ASSESS, V185, P8321, DOI 10.1007/s10661-013-3175-6; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Deletic A, 1998, WATER RES, V32, P2462, DOI 10.1016/S0043-1354(97)00470-3; Francey M, 2010, J ENVIRON ENG, V136, P381, DOI 10.1061/(ASCE)EE.1943-7870.0000038; Geiger F.W., 1987, INT C URB STORM DRAI, P40; Gupta K, 1996, WATER RES, V30, P1244, DOI 10.1016/0043-1354(95)00282-0; Han YH, 2006, WATER SCI TECHNOL, V53, P235, DOI 10.2166/wst.2006.057; Kang JH, 2006, WATER RES, V40, P3820, DOI 10.1016/j.watres.2006.09.007; Kim LH, 2007, SCI TOTAL ENVIRON, V376, P178, DOI 10.1016/j.scitotenv.2006.12.053; Kleinman PJA, 2006, J ENVIRON QUAL, V35, P1248, DOI 10.2134/jeq2006.0015; Lee JH, 2000, WATER RES, V34, P1773, DOI 10.1016/S0043-1354(99)00325-5; Lee JH, 2002, SCI TOTAL ENVIRON, V293, P163, DOI 10.1016/S0048-9697(02)00006-2; Liu A, 2013, SCI TOTAL ENVIRON, V444, P255, DOI 10.1016/j.scitotenv.2012.11.053; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; Qin HP, 2010, SCI TOTAL ENVIRON, V408, P4613, DOI 10.1016/j.scitotenv.2010.07.021; Rijal G, 2009, WATER SCI TECHNOL, V60, P1847, DOI 10.2166/wst.2009.598; Sansalone JJ, 2004, J ENVIRON ENG, V130, P1301, DOI 10.1061/(ASCE)0733-9372(2004)130:11(1301); Taebi A, 2004, J ENVIRON ENG SCI, V3, P301, DOI 10.1139/s04-018; Yusop Z, 2005, WATER SCI TECHNOL, V52, P125, DOI 10.2166/wst.2005.0302; Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012; Zgheib S, 2011, WATER RES, V45, P913, DOI 10.1016/j.watres.2010.09.032; Zhang Z, 2008, SCI TOTAL ENVIRON, V390, P215, DOI 10.1016/j.scitotenv.2007.09.045	27	63	65	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118776	10.1371/journal.pone.0118776	http://dx.doi.org/10.1371/journal.pone.0118776			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774922	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500042
J	Park, SJ; Choi, NK; Seo, KH; Park, KH; Woo, SJ				Park, Sang Jun; Choi, Nam-Kyong; Seo, Kyung Ha; Park, Kyu Hyung; Woo, Se Joon			Retinal Vein Occlusion and Pregnancy, Pre-Eclampsia, and Eclampsia: The Results from a Nationwide, Population-Based Study Using the National Claim Database	PLOS ONE			English	Article							RISK-FACTORS; BRANCH; THROMBOPHILIA; THROMBOSIS; DISORDERS	Objective To investigate the incidence of retinal vein occlusion (RVO) in pregnant women and in the subpopulation of pregnant women with pre-eclampsia/eclampsia compared to that in the age-matched general female population to determine if there is increased risk of RVO in pregnancy. Design Nationwide population-based retrospective study using data entered into the Korean national health claims database from 2007 to 2011. Setting and Participants Of the incident RVO cases in the database, RVO cases that occurred during the pregnancy-associated period, which spanned a 52-week period from 40-weeks-before to 12-weeks-after childbirth, were identified. Of these cases, the presence of pre-eclampsia/eclampsia was determined. Main Outcome and Measure The standardized incidence ratios (SIRs) of RVO in the general pregnant population and in the pregnant population with pre-eclampsia/eclampsia were determined with respect to the age-matched general female population. Results Pregnancy-related RVO was identified in 33 cases from the 1.8 million women who experience childbirth during the study period, while the expected number of cases calculated by the direct standardization to the age-matched general population was 113. Of the 33 patients, 12 patients (36.4%) had pre-eclampsia or eclampsia. The SIR for the general pregnant population in reference to the age-matched general female population was 0.29 (95% CI, 0.20-0.41). In contrast, the SIR for the pregnant population with pre-eclampsia/eclampsia in reference to the age-matched general female population and the age-matched general pregnant population was 67.50 (95% CI, 34.88-117.92) and 246.50 (95% CI, 127.37-430.59), respectively. Conclusions and Relevance The results suggest that pre-eclampsia/eclampsia is a risk factor for RVO, while pregnancy itself may not be a risk factor for RVO.	[Park, Sang Jun; Park, Kyu Hyung; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea; [Choi, Nam-Kyong; Seo, Kyung Ha] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Choi, Nam-Kyong; Seo, Kyung Ha] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Choi, Nam-Kyong] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	sejoon1@snu.ac.kr	Park, Sang Jun/C-3234-2015	Park, Sang Jun/0000-0003-0542-2758; Hahn, Seokyung/0000-0002-4684-4917; Choi, Nam-Kyong/0000-0003-1153-9928	Seoul National University Bundang Hospital Research Fund [12-2013-019, 14-2014-022]	Seoul National University Bundang Hospital Research Fund	This study was supported by the grants (12-2013-019 and 14-2014-022) from the Seoul National University Bundang Hospital Research Fund. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DIRECT STANDARDIZATI; APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; CHEW EY, 1987, OPHTHALMOLOGY, V94, P1545; Eldor A, 2001, J THROMB THROMBOLYS, V12, P23, DOI 10.1023/A:1012730325902; Eldor A, 2001, THROMB HAEMOSTASIS, V86, P104; Errera MH, 2013, SURV OPHTHALMOL, V58, P127, DOI 10.1016/j.survophthal.2012.08.001; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; GABSI S, 1994, J FR OPHTALMOL, V17, P350; GOMBOS G M, 1975, Annals of Ophthalmology, V7, P215; Gonzalvo FJ, 2000, ACTA OPHTHALMOL SCAN, V78, P596, DOI 10.1034/j.1600-0420.2000.078005596.x; Gray G, 2012, BEST PRACT RES CL OB, V26, P53, DOI 10.1016/j.bpobgyn.2011.10.003; Green W R, 1981, Retina, V1, P27; Hayreh SS, 2005, PROG RETIN EYE RES, V24, P493, DOI 10.1016/j.preteyeres.2004.12.001; Herbold TM, 2005, OPHTHALMOLOGE, V102, P726, DOI 10.1007/s00347-004-1099-9; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Lake SR, 1999, BRIT J OPHTHALMOL, V83, P630; Larsen EC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-154; Lavik EB, 2013, DRUG DELIV, V1, P734; Matti AI, 2010, CAN J OPHTHALMOL, V45, P541, DOI 10.3129/i10-039; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; McLoone EM, 2004, EUR J OPHTHALMOL, V14, P65, DOI 10.1177/112067210401400112; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Park SJ, 2014, OPHTHALMOLOGY, V121, P1933, DOI 10.1016/j.ophtha.2014.04.029; Park SJ, 2014, OPHTHALMOLOGY, V121, P1274, DOI 10.1016/j.ophtha.2013.12.024; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Rahman I, 2006, EYE, V20, P955, DOI 10.1038/sj.eye.6702065; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; Roos NM, 2012, OBSTET GYNECOL SURV, V67, P242, DOI 10.1097/OGX.0b013e318250a457; Stem MS, 2013, OPHTHALMOLOGY, V120, P362, DOI 10.1016/j.ophtha.2012.07.080; Thornton C, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.042; Valachis A, 2010, OBSTET GYNECOL SURV, V65, P786, DOI 10.1097/OGX.0b013e31821285bf	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120067	10.1371/journal.pone.0120067	http://dx.doi.org/10.1371/journal.pone.0120067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774513	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500147
J	Ribeiro, AF; Pellini, ACG; Kitagawa, BY; Marques, D; Madalosso, G; Figueira, GDN; Fred, J; Albernaz, RKM; Marques, TRMPC; Zanetta, DMT				Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Nogueira Figueira, Gerrita de Cassia; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina; Trevisan Zanetta, Dirce Maria			Risk Factors for Death from Influenza A (H1N1)pdm09, State of Sao Paulo, Brazil, 2009	PLOS ONE			English	Article							PANDEMIC H1N1 2009; CRITICALLY-ILL PATIENTS; UNITED-STATES; HOSPITALIZED-PATIENTS; A(H1N1) INFECTION; EPIDEMIOLOGY; VIRUS; 1ST	This case-control study aimed to assess the risk factors for death from influenza A(H1N1) pdm09 in patients with laboratory confirmation, who had severe acute respiratory illness-SARI and were hospitalized between June 28th and August 29th 2009, in the metropolitan regions of Sao Paulo and Campinas, Brazil. Medical charts of all the 193 patients who died (cases) and the 386 randomly selected patients who recovered (controls) were investigated in 177 hospitals. Household interviews were conducted with those who had survived and the closest relative of those who had died. 73.6% of cases and 38.1% of controls were at risk of developing influenza-related complications. The 18-to-59-year age group (OR = 2.31, 95% CI: 1.31-4.10 (reference up to 18 years of age)), presence of risk conditions for severity of influenza (OR = 1.99, 95% CI: 1.11-3.57, if one or OR = 6.05, 95% CI: 2.76-13.28, if more than one), obesity (OR = 2.73, 95% CI: 1.28-5.83), immunosuppression (OR = 3.43, 95% CI: 1.28-9.19), and search for previous care associated with the hospitalization (OR = 3.35, 95% CI: 1.75-6.40) were risk factors for death. Antiviral treatment performed within 72 hours of the onset of symptoms (OR = 0.17, 95% CI: 0.08-0.37, if within 48hours, and OR = 0.30, 95% CI: 0.11-0.81, if between 48 and 72 hours) was protective against death. The identification of high-risk patients and early treatment are important factors for reducing morbi-mortality from influenza.	[Ribeiro, Ana Freitas; Guedes Pellini, Alessandra Cristina; Kitagawa, Beatriz Yuko; Marques, Daniel; Madalosso, Geraldine; Nogueira Figueira, Gerrita de Cassia; Fred, Joao; Mangabeira Albernaz, Ricardo Kerti; Marques Pinto Carvalhanas, Telma Regina] State Sao Paulo Dept Hlth, Dis Control Coordinat, Epidemiol Surveillance Ctr, Sao Paulo, Brazil; [Ribeiro, Ana Freitas; Trevisan Zanetta, Dirce Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Coordenadoria de Controle de Doencas da Secretaria de Estado; Universidade de Sao Paulo	Ribeiro, AF (corresponding author), State Sao Paulo Dept Hlth, Dis Control Coordinat, Epidemiol Surveillance Ctr, Sao Paulo, Brazil.	anafribeiro@uol.com.br	Zanetta, Dirce M T/G-4950-2013; Alessandra, Pellini C. G./K-5156-2013; Ribeiro, Ana Freitas/P-6862-2015	Alessandra, Pellini C. G./0000-0002-3799-9415; Zanetta, Dirce Maria/0000-0002-7273-5087; Madalosso, Geraldine/0000-0001-9501-6205; MARQUES, DANIEL/0000-0001-7281-3316	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health	Sao Paulo State Secretary of Health financed the data collection. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], SUBS PREV PROM SAL; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2010, B EL EP; Brasil. Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica Censo Demografico, 2010, NUPCIALIDADE FECUNDI; Centers for Disease Control and Prevention, PEOPLE AT HIGH RISK; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-97; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fowlkes AL, 2011, CLIN INFECT DIS, V52, pS60, DOI 10.1093/cid/ciq022; Fuhrman C, 2010, EUROSURVEILLANCE, V15, P17; Fukasawa L. O., 2010, Revista do Instituto Adolfo Lutz, V69, P131; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Godoy P, 2011, REV ESP SALUD PUBLIC, V85, P81, DOI [10.1590/S1135-57272011000100015, 10.1590/S1135-57272011000100010]; Gonzalez-Velez AE, 2011, MED INTENSIVA, V35, P463, DOI 10.1016/j.medin.2011.03.007; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mertz D, 2013, BMJ-BRIT MED J, V347, P1; Mytton OT, 2012, EPIDEMIOL INFECT, V140, P1533, DOI 10.1017/S0950268811001968; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; OLIVEIRA WK, 2009, EURO SURVEILL, V14; Paulo Sao, 2009, INF TECN AT INFL A H, V6, P19; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Peralta PS, 2010, REV ESP SALUD PUBLIC, V84, P547, DOI [10.1590/S1135-57272010000500008, 10.1590/s1135-57272010000500008]; Skarbinski J, 2011, CLIN INFECT DIS, V52, pS50, DOI 10.1093/cid/ciq021; SP-Leituras, 2013, BIBL VIV; Ward KA, 2011, EMERG INFECT DIS, V17, P1409, DOI 10.3201/eid1708.100842; WHO-World Health Organization, PAND H1N1 2009 SWIN; WHO-World Health Organization, PAND H1N1 2009 WORLD; World Health Organization, 2008, WKLY EPIDEMIOL RECOR, V83, P365; Yokota RTC, 2011, EMERG INFECT DIS, V17, P1467, DOI 10.3201/eid1708.101233	38	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118772	10.1371/journal.pone.0118772	http://dx.doi.org/10.1371/journal.pone.0118772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774804	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500041
J	Sharif, GM; Schmidt, MO; Yi, C; Hu, Z; Haddad, BR; Glasgow, E; Riegel, AT; Wellstein, A				Sharif, G. M.; Schmidt, M. O.; Yi, C.; Hu, Z.; Haddad, B. R.; Glasgow, E.; Riegel, A. T.; Wellstein, A.			Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling	ONCOGENE			English	Article							CONTACT INHIBITION; SIZE-CONTROL; TENASCIN-C; STEM-CELLS; METASTASIS; YAP; ANGIOGENESIS; ZEBRAFISH; BIOLOGY; PROGRESSION	Metastasis of cancer cells involves multiple steps, including their dissociation from the primary tumor and invasion through the endothelial cell barrier to enter the circulation and finding their way to distant organ sites where they extravasate and establish metastatic lesions. Deficient contact inhibition is a hallmark of invasive cancer cells, yet surprisingly the vascular invasiveness of commonly studied cancer cell lines is regulated by the density at which cells are propagated in culture. Cells grown at high density were less effective at invading an endothelial monolayer than cells grown at low density. This phenotypic difference was also observed in a zebrafish model of vascular invasion of cancer cells after injection into the yolk sac and extravasation of cancer cells into tissues from the vasculature. The vascular invasive phenotypes were reversible. A kinome-wide RNA interference screen was used to identify drivers of vascular invasion by panning small hairpin RNA (shRNA) library-transduced noninvasive cancer cell populations on endothelial monolayers. The selection of invasive subpopulations showed enrichment of shRNAs targeting the large tumor suppressor 1 (LATS1) kinase that inhibits the activity of the transcriptional coactivator yes-associated protein (YAP) in the Hippo pathway. Depletion of LATS1 from noninvasive cancer cells restored the invasive phenotype. Complementary to this, inhibition or depletion of YAP inhibited invasion in vitro and in vivo. The vascular invasive phenotype was associated with a YAP-dependent upregulation of the cytokines IL6, IL8 and C-X-C motif ligand 1, 2 and 3. Antibody blockade of cytokine receptors inhibited invasion and confirmed that they are rate-limiting drivers that promote cancer cell vascular invasiveness and could provide therapeutic targets.	[Sharif, G. M.; Schmidt, M. O.; Yi, C.; Hu, Z.; Haddad, B. R.; Glasgow, E.; Riegel, A. T.; Wellstein, A.] Georgetown Univ, Lombardi Canc Ctr, 3970 Reservoir Rd, Washington, DC 20057 USA	Georgetown University	Wellstein, A (corresponding author), Georgetown Univ, Lombardi Canc Ctr, 3970 Reservoir Rd, Washington, DC 20057 USA.	wellstea@georgetown.edu	Schmidt, Marcel/AAV-8054-2021	Schmidt, Marcel/0000-0002-3991-2766; Sharif, Ghada/0000-0001-5344-3575; Glasgow, Eric/0000-0001-7729-3954	NIH/NCI [CA71508, CA113477, CA51008]; NATIONAL CANCER INSTITUTE [P30CA051008, R01CA071508, T32CA009686, R01CA113477, P50CA058185, R01CA108440, R01CA101811, R33CA177466] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Joan Massague kindly provided the MDA-MB-231 derivative cell lines used here. We thank Caroline E Laverriere for excellent assistance with the zebrafish experiments. Work was supported by NIH/NCI grant CA71508 (AW) and CA113477 (ATR) and CA51008 for zebrafish and mouse studies.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Al-Otaiby M, 2012, AM J PATHOL, V180, P1474, DOI 10.1016/j.ajpath.2011.12.032; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chen DH, 2012, NAT MED, V18, P1511, DOI 10.1038/nm.2940; Chen Q, 2014, GENE DEV, V28, P432, DOI 10.1101/gad.233676.113; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Erez N, 2011, INT J CANCER, V128, P2536, DOI 10.1002/ijc.26032; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Greten FR, 2014, CELL, V158, P11, DOI 10.1016/j.cell.2014.06.021; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Iorns E, 2012, BREAST CANCER RES TR, V135, P79, DOI 10.1007/s10549-012-2068-7; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Melo SA, 2013, NAT CELL BIOL, V15, P139, DOI 10.1038/ncb2684; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Nallet-Staub F, 2014, J INVEST DERMATOL, V134, P123, DOI 10.1038/jid.2013.319; Nance J, 2014, J CELL BIOL, V206, P823, DOI 10.1083/jcb.201407064; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Connell JT, 2011, P NATL ACAD SCI USA, V108, P16002, DOI 10.1073/pnas.1109493108; Oehlers SHB, 2010, DEV COMP IMMUNOL, V34, P352, DOI 10.1016/j.dci.2009.11.007; Oh A, 2004, CANCER RES, V64, P8299, DOI 10.1158/0008-5472.CAN-04-0354; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rasanen K, 2012, CANCER DISCOV, V2, P775, DOI 10.1158/2159-8290.CD-12-0312; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stoletov K, 2008, ONCOGENE, V27, P4509, DOI 10.1038/onc.2008.95; Stoletov K, 2010, J CELL SCI, V123, P2332, DOI 10.1242/jcs.069443; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tassi E, 2011, AM J PATHOL, V179, P2220, DOI 10.1016/j.ajpath.2011.07.043; van der Aa LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012384; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	57	45	47	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 16	2015	34	48					5879	5889		10.1038/onc.2015.44	http://dx.doi.org/10.1038/onc.2015.44			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	VC0NX	25772246	Green Accepted			2022-12-26	WOS:000426437000001
J	Wagner, A				Wagner, Andreas			Causal Drift, Robust Signaling, and Complex Disease	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; IMPAIRED GLUCOSE-TOLERANCE; GENOME-WIDE ASSOCIATION; KINASE-C-ZETA; MISSING HERITABILITY; SKELETAL-MUSCLE; GLY972ARG POLYMORPHISM; GENETIC INTERACTIONS; REGULATORY NETWORKS; EVOLUTION	The phenotype of many regulatory circuits in which mutations can cause complex, polygenic diseases is to some extent robust to DNA mutations that affect circuit components. Here I demonstrate how such mutational robustness can prevent the discovery of genetic disease determinants. To make my case, I use a mathematical model of the insulin signaling pathway implicated in type 2 diabetes, whose signaling output is governed by 15 genetically determined parameters. Using multiple complementary measures of a parameter's importance for this phenotype, I show that any one disease determinant that is crucial in one genetic background will be virtually irrelevant in other backgrounds. In an evolving population that drifts through the parameter space of this or other robust circuits through DNA mutations, the genetic changes that can cause disease will vary randomly over time. I call this phenomenon causal drift. It means that mutations causing disease in one (human or non-human) population may have no effect in another population, and vice versa. Causal drift casts doubt on our ability to infer the molecular mechanisms of complex diseases from non-human model organisms.	[Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch			Swiss National Science Foundation, University Priority Research Program in Evolutionary Biology at the University of Zurich [31003A_146137]	Swiss National Science Foundation, University Priority Research Program in Evolutionary Biology at the University of Zurich	This work was supported by Swiss National Science Foundation grant 31003A_146137, University Priority Research Program in Evolutionary Biology at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Agresti A, 2013, CATEGORICAL DATA ANA; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; ALMIND K, 1993, LANCET, V342, P828, DOI 10.1016/0140-6736(93)92694-O; Baba T, 2007, LIFE SCI, V81, P850, DOI 10.1016/j.lfs.2007.07.023; BAR RS, 1976, J CLIN INVEST, V58, P1123, DOI 10.1172/JCI108565; Beeson M, 2003, DIABETES, V52, P1926, DOI 10.2337/diabetes.52.8.1926; Bezerra RMN, 2002, DIABETES CARE, V25, P550, DOI 10.2337/diacare.25.3.550; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Borisov N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.19; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Britton OJ, 2013, P NATL ACAD SCI USA, V110, pE2098, DOI 10.1073/pnas.1304382110; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Chan SH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-100; Chew YH, 2009, MOL CELL ENDOCRINOL, V303, P13, DOI 10.1016/j.mce.2009.01.018; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Delattre M, 2001, BIOESSAYS, V23, P807, DOI 10.1002/bies.1116; Delattre M, 2001, CURR BIOL, V11, P631, DOI 10.1016/S0960-9822(01)00202-0; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; Felix MA, 2000, DEV BIOL, V221, P68, DOI 10.1006/dbio.2000.9665; Slezak DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789; Frojdo S, 2009, BBA-MOL BASIS DIS, V1792, P83, DOI 10.1016/j.bbadis.2008.10.019; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hafner M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000534; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; HITMAN GA, 1995, DIABETOLOGIA, V38, P481, DOI 10.1007/s001250050309; IMAI Y, 1994, J CLIN ENDOCR METAB, V79, P1655, DOI 10.1210/jc.79.6.1655; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Kampourakis K, 2014, EMBO REP, V15, P472, DOI 10.1002/embr.201438641; Kitano H, 2004, DIABETES, V53, pS6, DOI 10.2337/diabetes.53.suppl_3.S6; Kong Ling-fang, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P387; Li C, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-39, 10.1186/1752-0509-4-92]; Li QX, 2013, CLIN CANCER RES, V19, P6252, DOI 10.1158/1078-0432.CCR-13-1093; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Machta BB, 2013, SCIENCE, V342, P604, DOI 10.1126/science.1238723; Makroglou A, 2006, APPL NUMER MATH, V56, P559, DOI 10.1016/j.apnum.2005.04.023; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; NOLAN JJ, 1994, J CLIN ENDOCR METAB, V78, P471, DOI 10.1210/jc.78.2.471; Nyman E, 2012, TRENDS ENDOCRIN MET, V23, P107, DOI 10.1016/j.tem.2011.12.007; Ocaranza MP, 2010, HYPERTENSION, V55, P23, DOI 10.1161/HYPERTENSIONAHA.109.141960; PATTI ME, 1995, J BIOL CHEM, V270, P24670, DOI 10.1074/jbc.270.42.24670; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Pedersen O, 1999, EXP CLIN ENDOCR DIAB, V107, P113, DOI 10.1055/s-0029-1212085; Pirola L, 2004, DIABETOLOGIA, V47, P170, DOI 10.1007/s00125-003-1313-3; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Saithong T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015589; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Shao HF, 2008, P NATL ACAD SCI USA, V105, P19910, DOI 10.1073/pnas.0810388105; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Sommer RJ, 2012, ADV EXP MED BIOL, V751, P79, DOI 10.1007/978-1-4614-3567-9_4; Sommer RJ, 1997, DEVELOPMENT, V124, P243; STAGSTED J, 1993, J PHARMACOL EXP THER, V267, P997; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Stumvoll M, 2001, DIABETES, V50, P882, DOI 10.2337/diabetes.50.4.882; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Tsong AE, 2006, NATURE, V443, P415, DOI 10.1038/nature05099; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Van Obberghen E, 2001, EUR J CLIN INVEST, V31, P966, DOI 10.1046/j.1365-2362.2001.00896.x; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Wang H, 2001, DIABETES, V50, P1949, DOI 10.2337/diabetes.50.8.1949; WANG YX, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PCBI.1002459; Waterfall JJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150601; Waters SB, 1996, TRENDS CELL BIOL, V6, P1, DOI 10.1016/0962-8924(96)81024-5; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; White MF, 1997, DIABETOLOGIA, V40, pS2, DOI 10.1007/s001250051387; Zamora-Sillero E, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-142; Zhang JJ, 2010, BIOPHYS J, V99, P1034, DOI 10.1016/j.bpj.2010.05.036; Zhao L, 2008, NMR BIOMED, V21, P159, DOI 10.1002/nbm.1173; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	96	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118413	10.1371/journal.pone.0118413	http://dx.doi.org/10.1371/journal.pone.0118413			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774510	Green Published, Green Accepted, gold			2022-12-26	WOS:000351183500030
J	Guo, ZL; Cui, GF				Guo, Ziliang; Cui, Guofa			Establishment of Nature Reserves in Administrative Regions of Mainland China	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; HOTSPOTS	Nature reserves are widely considered as one available strategy for protecting biodiversity, which is threatened by habitat fragmentation, and wildlife extinction. The Chinese government has established a goal of protecting 15% of its land area by 2015. We quantitated the characteristics and distribution of nature reserves in mainland China and evaluated the expansion process for national nature reserves. National nature reserves occupy 64.15% of the total area of nature reserves. Steppe and meadow ecosystem, ocean and seacoast ecosystem, and wild plant nature reserves represent lower percentages, particularly in national nature reserves, in which they comprised 0.76%, 0.54%, and 0.69%, respectively, of the area. Furthermore, medium and small nature reserves compose 92.32% of all nature reserves. The land area under any legal protection has reached 14.80%, although only 9.78% is strictly protected. However, if 9 super-large national nature reserves, located in Southwest and Northwest China were removed, the percentage of strictly protected area decreases to 2.66% of the land area of China. The areas contained in nature reserves in each province are not proportional to the areas of the provinces, particularly for national nature reserves, with higher protection rates in Southwest and Northwest China than in other regions. Of the 31 provinces, 22 provinces feature strict protection of less than 4% of their areas by national nature reserves; these provinces are mainly located in East, Central, South, and North China. Moreover, the unevenness indexes of the distribution of nature reserves and national nature reserves are 0.39 and 0.58, respectively. The construction of nature reserves has entered a steady development stage after a period of rapid expansion in mainland China. In recent years, the total area of national nature reserves has increased slowly, while the total area of nature reserves has not increased, although the number of nature reserves continues increase.	[Guo, Ziliang; Cui, Guofa] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Cui, GF (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	fa6716@163.com			Special Research Funds of Forestry Industry for Public Welfare of China [201104029]	Special Research Funds of Forestry Industry for Public Welfare of China	The authors are grateful for the support of the Special Research Funds of Forestry Industry for Public Welfare of China, Grant. No. 201104029. The funder's website is as follows: http://www.forestry.gov.cn.	Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cantu C, 2004, BIOL CONSERV, V115, P411, DOI 10.1016/S0006-3207(03)00158-7; CBD (Convention on Biological Diversity), 2014, 2010 BIOD TARG; Chen WL, 2012, B BIOL FR BELG, V47, P1; Chen Yahan, 2009, Shengwu Duoyangxing, V17, P664, DOI 10.3724/SP.J.1003.2009.08324; Cui GF, 2000, J BEIJING FORESTRY U, V22, P123; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Editorial Committee of China National Biodiversity Conservation Strategy and Action Plan, 2011, CHIN NAT BIOD CONS S; Evans D, 2012, NATURE CONSERVATION, V1, P11, DOI DOI 10.3897/NATURECONSERVATION.1.1808; Fan ZM, 2013, J GEOGR SCI, V23, P258, DOI 10.1007/s11442-013-1008-8; Ferretti Valentina, 2013, Environment Development and Sustainability, V15, P859, DOI 10.1007/s10668-012-9400-6; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; Han NY, 2000, J NATURAL RESOURCES, V15, P201, DOI DOI 10.3321/J.ISSN:1000-3037.2000.03.002; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Huang HW, 2011, BOT J LINN SOC, V166, P282, DOI 10.1111/j.1095-8339.2011.01157.x; IUCN, 2014, IUCN PROT AR CAT SYS; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jongman R.H., 2004, ECOLOGICAL NETWORKS; KAKWANI NC, 1977, ECONOMETRICA, V45, P719, DOI 10.2307/1911684; [马克平 Keping Ma], 2011, [生物多样性, Biodiversity Science], V19, P1; [李延梅 LI Yan-Mei], 2009, [生态学报, Acta Ecologica Sinica], V29, P2115; Liu ChengLin, 2008, Journal of Nanjing Forestry University (Natural Sciences Edition), V32, P138; Liu WJ, 2011, J BEIJING FORESTRY U, V33, P49; [卢爱刚 Lu Aigang], 2010, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V24, P7; Ma Jianzhang, 2012, Shengwu Duoyangxing, V20, P551, DOI 10.3724/SP.J.1003.2012.08118; Mendel LC, 2002, CONSERV BIOL, V16, P1520, DOI 10.1046/j.1523-1739.2002.01155.x; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Peng L, 2013, FORESTRY RESOURCES M, V5, P31; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Tang Xiaoping, 2005, Shengwu Duoyangxing, V13, P81; Tang ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019116; The People's Republic of China Ministry of Environmental Protection, 2014, WORK PRES NAT RES; United Nations, 2011, MILL DEV GOALS REP 2; Wang LL, 2012, J EMCC, V22, P19; Wang YS, 2003, ENV PROTECTION, V5, P19; [王智 Wang Zhi], 2004, [农村生态环境, Rural Eco-Environment], V20, P72; Xue D.Y., 1994, CHINA ENVIRON SCI, V4, P246; Yan X, 1989, J NE FORESTRY U, V17, P79; Yuan Hu, 2009, Biodiversity Science, V17, P280, DOI 10.3724/SP.J.1003.2009.08293; Zang RH., 2002, ECONOMICS; Zhang J., 2007, J SHANXI AGR U SOCIA, V6, P275, DOI [DOI 10.3969/J.ISSN.1671-816X.2007.03.015, 10.3969/j.issn.1671-816X.2007.03.015]	44	21	25	8	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119650	10.1371/journal.pone.0119650	http://dx.doi.org/10.1371/journal.pone.0119650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768791	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500089
J	Homann, G; Vieth, V; Weiss, D; Nikolaou, K; Heindel, W; Notohamiprodjo, M; Bockenfeld, Y				Homann, Georg; Vieth, Volker; Weiss, Daniel; Nikolaou, Konstantin; Heindel, Walter; Notohamiprodjo, Mike; Boeckenfeld, Yvonne			Semi-Quantitative vs. Volumetric Determination of Endolymphatic Space in Meniere's Disease Using Endolymphatic Hydrops 3T-HR-MRI after Intravenous Gadolinium Injection	PLOS ONE			English	Article							DIAGNOSIS; FLUID; MRI	Magnetic resonance imaging enhances the clinical diagnosis of Meniere's disease. This is accomplished by in vivo detection of endolymphatic hydrops, which are graded using different semi-quantitative grading systems. We evaluated an established, semi-quantitative endolymphatic hydrops score and with a quantitative method for volumetric assessment of the endolymphatic size. 11 patients with Meniere's disease and 2 healthy subjects underwent high resolution endolymphatic hydrops 3 Tesla MRI with highly T2 weighted FLAIR and T2DRIVE sequences. The degree of endolymphatic hydrops was rated semi-quantitatively and compared to the results of 3D-volumetry. Moreover, the grade of endolymphatic hydrops was correlated with pure tone audiometry. Semi-quantitative grading and volumetric evaluation of the endolymphatic hydrops are in accordance (r = 0.92) and the grade of endolymphatic hydrops correlates with pure tone audiometry. Patients with a sickness duration of >= 30 months showed a significant higher total labyrinth fluid volume (p = 0.03). Fast, semi-quantitative evaluation of endolymphatic hydrops is highly reliable compared to quantitative/volumetric assessment. Endolymphatic space is significantly higher in patients with longer sickness duration.	[Homann, Georg; Nikolaou, Konstantin; Notohamiprodjo, Mike] Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Vieth, Volker; Heindel, Walter] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Weiss, Daniel; Boeckenfeld, Yvonne] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munster; University of Munster	Homann, G (corresponding author), Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.	georg.homann@med.uni-tuebingen.de		Bier, Georg/0000-0002-1034-5681	Japan society for the promotion of science	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study has been supported by a travel grant of the Japan society for the promotion of science (https://www.jsps.go.jp) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroll M, 2012, OTOL NEUROTOL, V33, P816, DOI 10.1097/MAO.0b013e3182536ac6; Buckingham RA, 2001, ANN OTO RHINOL LARYN, V110, P113, DOI 10.1177/000348940111000204; Chung WH, 2004, OTOL NEUROTOL, V25, P144, DOI 10.1097/00129492-200403000-00011; Dinh TAD, 2009, PFLUG ARCH EUR J PHY, V458, P379, DOI 10.1007/s00424-008-0622-2; Fang ZM, 2012, J LARYNGOL OTOL, V126, P454, DOI 10.1017/S0022215112000060; Foster CA, 2013, MED HYPOTHESES, V81, P1108, DOI 10.1016/j.mehy.2013.10.015; Gurkov R, 2015, EUR RADIOL, V25, P585, DOI 10.1007/s00330-014-3414-4; Gurkov R, 2013, EUR ARCH OTO-RHINO-L, V270, P1231, DOI 10.1007/s00405-012-2087-3; Homann G, 2014, ROFO-FORTSCHR RONTG, V186, P225, DOI 10.1055/s-0033-1356221; Jerin C, 2014, OTOL NEUROTOL, V35, P880, DOI 10.1097/MAO.0000000000000393; Kirby SE, 2009, J PSYCHOSOM RES, V66, P111, DOI 10.1016/j.jpsychores.2008.05.027; Krombach GA, 2005, EUR RADIOL, V15, P1505, DOI 10.1007/s00330-005-2750-9; Liu F, 2012, ACTA OTO-LARYNGOL, V132, P234, DOI 10.3109/00016489.2011.637232; Melhem ER, 1998, AM J NEURORADIOL, V19, P1819; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Muzzi E, 2008, AM J OTOLARYNG, V29, P188, DOI 10.1016/j.amjoto.2007.04.011; Naganawa S, 2013, MAGN RESON MED SCI, V12, P261, DOI 10.2463/mrms.2013-0019; Naganawa S, 2012, MAGN RESON MED SCI, V11, P213, DOI 10.2463/mrms.11.213; Naganawa S, 2012, MAGN RESON MED SCI, V11, P145, DOI 10.2463/mrms.11.145; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Nakashima T, 2009, ACTA OTO-LARYNGOL, V129, P5, DOI 10.1080/00016480902729827; Salt AN, 2010, OTOLARYNG CLIN N AM, V43, P971, DOI 10.1016/j.otc.2010.05.007; Seo YJ, 2013, AURIS NASUS LARYNX, V40, P167, DOI 10.1016/j.anl.2012.07.009; Shi HB, 2014, OTOL NEUROTOL, V35, P315, DOI 10.1097/MAO.0000000000000196; Shimono M, 2013, OTOL NEUROTOL, V34, P1241, DOI 10.1097/MAO.0b013e3182990e81; STAHLE J, 1974, ACTA OTO-LARYNGOL, V78, P36, DOI 10.3109/00016487409126323; YAZAWA Y, 1994, ACTA OTO-LARYNGOL, P67	27	25	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120357	10.1371/journal.pone.0120357	http://dx.doi.org/10.1371/journal.pone.0120357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768940	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500122
J	Kazim, SF; Cardenas-Aguayo, MD; Arif, M; Blanchard, J; Fayyaz, F; Grundke-Iqbal, I; Iqbal, K				Kazim, Syed Faraz; Cardenas-Aguayo, Maria del Carmen; Arif, Mohammad; Blanchard, Julie; Fayyaz, Fatima; Grundke-Iqbal, Inge; Iqbal, Khalid			Sera from Children with Autism Induce Autistic Features Which Can Be Rescued with a CNTF Small Peptide Mimetic in Rats	PLOS ONE			English	Article							DENTATE GYRUS NEUROGENESIS; BEHAVIORAL TASKS RELEVANT; NEURONAL PROGENITOR CELLS; ANXIETY-RELATED BEHAVIOR; OXIDATIVE STRESS; NEUROTROPHIC FACTOR; ULTRASONIC VOCALIZATIONS; MOUSE MODEL; REFLEX-ONTOGENY; ALZHEIMERS-DISEASE	Autism is a neurodevelopmental disorder characterized clinically by impairments in social interaction and verbal and non-verbal communication skills as well as restricted interests and repetitive behavior. It has been hypothesized that altered brain environment including an imbalance in neurotrophic support during early development contributes to the pathophysiology of autism. Here we report that sera from children with autism which exhibited abnormal levels of various neurotrophic factors induced cell death and oxidative stress in mouse primary cultured cortical neurons. The effects of sera from autistic children were rescued by pre-treatment with a ciliary neurotrophic factor (CNTF) small peptide mimetic, Peptide 6 (P6), which was previously shown to exert its neuroprotective effect by modulating CNTF/JAK/STAT pathway and LIF signaling and by enhancing brain derived neurotrophic factor (BDNF) expression. Similar neurotoxic effects and neuroinflammation were observed in young Wistar rats injected intracerebroventricularly with autism sera within hours after birth. The autism sera injected rats demonstrated developmental delay and deficits in social communication, interaction, and novelty. Both the neurobiological changes and the behavioral autistic phenotype were ameliorated by P6 treatment. These findings implicate the involvement of neurotrophic imbalance during early brain development in the pathophysiology of autism and a proof of principle of P6 as a potential therapeutic strategy for autism.	[Kazim, Syed Faraz; Cardenas-Aguayo, Maria del Carmen; Arif, Mohammad; Blanchard, Julie; Fayyaz, Fatima; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil NYSIBR, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA; [Kazim, Syed Faraz] Suny Downstate Med Ctr, Neural & Behav Sci Grad Program, Brooklyn, NY 11203 USA; [Kazim, Syed Faraz; Iqbal, Khalid] SUNY Downstate NYSIBR Ctr Dev Neurosci CDN, Staten Isl, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil NYSIBR, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com	del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; Fayyaz, Fatima/0000-0002-1635-444X	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria; SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program	New York State Office of People with Developmental Disabilities; EVER NeuroPharma GmbH, Unterach, Austria; SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program	This work was supported in part by the New York State Office of People with Developmental Disabilities and EVER NeuroPharma GmbH, Unterach, Austria. S.F. Kazim is supported by SUNY Downstate/NYSIBR Center for Developmental Neuroscience (CDN) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MW, 2013, ACTA PSYCHIAT SCAND, V128, P61, DOI 10.1111/acps.12020; Acosta Maria T, 2003, Curr Neurol Neurosci Rep, V3, P149, DOI 10.1007/s11910-003-0067-0; Al-Ayadhi LY, 2012, NEUROCHEM RES, V37, P394, DOI 10.1007/s11064-011-0624-x; ALLIN J T, 1971, Developmental Psychobiology, V4, P149, DOI 10.1002/dev.420040206; ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Askvig JM, 2013, EXP NEUROL, V240, P75, DOI 10.1016/j.expneurol.2012.10.023; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Baio J., 2012, MORBIDITY MORTALITY, V61; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; BELL RW, 1974, DEV PSYCHOBIOL, V7, P235, DOI 10.1002/dev.420070307; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Blanchard J, 2011, J NEUROPATH EXP NEUR, V70, P1070, DOI 10.1097/NEN.0b013e318236e9ad; Blanchard J, 2010, ACTA NEUROPATHOL, V120, P605, DOI 10.1007/s00401-010-0734-6; Blanchard J, 2010, J ALZHEIMERS DIS, V21, P1185, DOI [10.3233/JAD-2010-100069, 10.3233/JAD-2010-1000069]; BLUMBERG MS, 1991, NEUROSCI BIOBEHAV R, V15, P383, DOI 10.1016/S0149-7634(05)80031-4; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Cardenas-Aguayo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053596; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Chapleau CA, 2009, J NEURODEV DISORD, V1, P185, DOI 10.1007/s11689-009-9027-6; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Chen ZY, 2001, CURR PROTEIN PEPT SC, V2, P261, DOI 10.2174/1389203013381125; Chohan MO, 2015, NEUROSURGERY, V76, P201, DOI 10.1227/NEU.0000000000000577; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Crawley JN, 2007, NEUROPEPTIDES, V41, P145, DOI 10.1016/j.npep.2007.02.002; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4; Dawson G, 2007, BIOL PSYCHIAT, V61, P458, DOI 10.1016/j.biopsych.2006.07.016; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; Doussard-Roosevelt JA, 2003, DEV PSYCHOPATHOL, V15, P277, DOI 10.1017/S0954579403000154; Ebadi M, 1996, PROG NEUROBIOL, V48, P1, DOI 10.1016/0301-0082(95)00029-1; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Garcia KLP, 2012, J NEUROPATH EXP NEUR, V71, P289, DOI 10.1097/NEN.0b013e31824b27e4; Guerin P, 1996, DEV MED CHILD NEUROL, V38, P203; Hashimoto K, 2006, PROG NEURO-PSYCHOPH, V30, P1529, DOI 10.1016/j.pnpbp.2006.06.018; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; HILL JM, 1993, BRAIN RES, V603, P222, DOI 10.1016/0006-8993(93)91241-J; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; HOFER MA, 1980, J COMP PHYSIOL PSYCH, V94, P271, DOI 10.1037/h0077665; HOLTZMAN DM, 1994, WESTERN J MED, V161, P246; Hutter-Paier B, 1998, J NEURAL TRANSM-SUPP, P363; Iqbal K, 2014, NEURAL REGEN RES, V9, P1518, DOI 10.4103/1673-5374.139477; Ishii J, 2007, NEUROSCI LETT, V423, P225, DOI 10.1016/j.neulet.2007.07.029; Katoh-Semba R, 2007, INT J DEV NEUROSCI, V25, P367, DOI 10.1016/j.ijdevneu.2007.07.002; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kazim SF, 2014, NEUROBIOL DIS, V71, P110, DOI 10.1016/j.nbd.2014.07.001; Kemper TL, 2002, MOL PSYCHIATR, V7, pS12, DOI 10.1038/sj.mp.4001165; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; Kern JK, 2006, J TOXICOL ENV HEAL B, V9, P485, DOI 10.1080/10937400600882079; Krasnoperova MG, 2003, ZH NEVROPATOL PSIKH, V103, P15; Kromkhun Pudcharaporn, 2013, Lab Anim Res, V29, P77, DOI 10.5625/lar.2013.29.2.77; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lotz B, 1996, NEUROLOGY, V46, P1244; Lu B, 2013, NAT REV NEUROSCI, V14, P401, DOI 10.1038/nrn3505; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; Mazur-Kolecka B, 2007, BRAIN RES, V1168, P11, DOI 10.1016/j.brainres.2007.06.084; Mazur-Kolecka B, 2014, BRAIN DEV-JPN, V36, P322, DOI 10.1016/j.braindev.2013.04.015; Mazur-Kolecka B, 2009, NEUROTOX RES, V16, P87, DOI 10.1007/s12640-009-9052-y; Metcalf D, 2003, STEM CELLS, V21, P5, DOI 10.1634/stemcells.21-1-5; Miller MT, 2005, INT J DEV NEUROSCI, V23, P201, DOI 10.1016/j.ijdevneu.2004.06.007; Miyazaki K, 2004, BRAIN DEV-JPN, V26, P292, DOI 10.1016/S0387-7604(03)00168-2; Moon C, 2002, P NATL ACAD SCI USA, V99, P9015, DOI 10.1073/pnas.132131699; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Murai KK, 2007, NEUROSCIENTIST, V13, P657, DOI 10.1177/1073858407304393; Muthaiyah B, 2011, NEUROCHEM RES, V36, P2096, DOI 10.1007/s11064-011-0533-z; Naito H, 2000, EXP ANIM TOKYO, V49, P289, DOI 10.1538/expanim.49.289; Nelson KB, 2001, ANN NEUROL, V49, P597, DOI 10.1002/ana.1024.abs; Nickl-Jockschat T, 2011, MOL PSYCHIATR, V16, P478, DOI 10.1038/mp.2010.103; Nickl-Jockschat T., 2014, COMPREHENSIVE GUIDE, P741; NOIROT E, 1968, ANIM BEHAV, V16, P129, DOI 10.1016/0003-3472(68)90123-1; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OSWALT GL, 1975, DEV PSYCHOBIOL, V8, P129, DOI 10.1002/dev.420080205; Pardo-Villamizar CA, 2010, Autism: Oxidative Stress, Inflammation, and Immune Abnormalities, P225; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Polsek D, 2011, TRANSL NEUROSCI, V2, P256, DOI 10.2478/s13380-011-0024-3; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; Ricci S, 2013, NEUROTOX RES, V24, P491, DOI 10.1007/s12640-013-9393-4; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Sajdel-Sulkowska EM, 2010, AUTISM: OXIDATIVE STRESS, INFLAMMATION, AND IMMUNE ABNORMALITIES, P47; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schwarting RKW, 2012, BRAZ J MED BIOL RES, V45, P337, DOI 10.1590/S0100-879X2012007500038; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SMART JL, 1971, BRAIN RES, V28, P85, DOI 10.1016/0006-8993(71)90526-9; SMART JL, 1971, BRAIN RES, V33, P303, DOI 10.1016/0006-8993(71)90105-3; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Taurines R, 2014, J NEURAL TRANSM, V121, P1117, DOI 10.1007/s00702-014-1162-x; Toso L, 2008, OBSTET GYNECOL, V112, P1242, DOI 10.1097/AOG.0b013e31818c91dc; Tsai SJ, 2005, MED HYPOTHESES, V65, P79, DOI 10.1016/j.mehy.2005.01.034; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Wang XC, 2014, ACTA NEUROPATHOL, V127, P243, DOI 10.1007/s00401-013-1175-9; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Wu CL, 2009, NEUROTOXICOLOGY, V30, P718, DOI 10.1016/j.neuro.2009.03.008; Wu CL, 2009, BIOCHEM BIOPH RES CO, V385, P112, DOI 10.1016/j.bbrc.2009.04.145; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107	124	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118627	10.1371/journal.pone.0118627	http://dx.doi.org/10.1371/journal.pone.0118627			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769033	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500035
J	Lee, YH; Liu, XY; Qiu, FM; O'Connor, TR; Yen, Y; Ann, DK				Lee, Young-Ho; Liu, Xiyong; Qiu, Fuming; O'Connor, Timothy R.; Yen, Yun; Ann, David K.			HP1 beta Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; POLY(ADP-RIBOSE) POLYMERASE; HETEROCHROMATIN PROTEIN-1; SYNTHETIC LETHALITY; MOLECULAR PORTRAITS; OVARIAN-CANCER; KI-67 PROTEIN; DNA-DAMAGE; TUMORS; MARKER	Members of the heterochromatin protein 1 family (HP1 alpha, beta and gamma) are mostly associated with heterochromatin and play important roles in gene regulation and DNA damage response. Altered expression of individual HP1 subtype has profound impacts on cell proliferation and tumorigenesis. We analyzed the expression profile of HP1 family by data mining using a published microarray data set coupled with retrospective immunohistochemistry analyses of archived breast cancer biospecimens. We found that the patient group overexpressing HP1 beta mRNA is associated with poorly differentiated breast tumors and with a significantly lower survival rate. Immunohistochemical staining against HP1 alpha, HP1 beta and HP1. shows that respective HP1 expression level is frequently altered in breast cancers. 57.4 - 60.1% of samples examined showed high HP1 beta expression and 39.9 - 42.6 % of examined tumors showed no or low expression of each HP1 subtype. Interestingly, comparative analysis on HP1 expression profile and breast cancer markers revealed a positive correlation between the respective expression level of all three HP1 subtypes and Ki-67, a cell proliferation and well-known breast cancer marker. To explore the effect of individual HP1 on PARP inhibitor therapy for breast cancer, MCF7 breast cancer cells and individually HP1-depleted MCF7 cells were treated with PARP inhibitor ABT-888 with or without carboplatin. Notably, HP1 beta-knockdown cells are hypersensitive to the PARP inhibitor ABT-888 alone and its combination with carboplatin. In summary, while increased HP1 beta expression is associated with the poor prognosis in breast cancer, compromised HP1 beta abundance may serve as a useful predictive marker for chemotherapy, including PARP inhibitors against breast cancer.	[Lee, Young-Ho; Liu, Xiyong; Yen, Yun; Ann, David K.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Qiu, Fuming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [O'Connor, Timothy R.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope	Lee, YH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA.	lyh205@gmail.com; dann@coh.org	Yen, Yun/H-9591-2016; Lee, Young-Ho/G-2361-2014; Liu, Xiyong/E-1646-2019	Lee, Young-Ho/0000-0001-6415-4912; Liu, Xiyong/0000-0002-0259-3669	National Institutes of Health Research [R01DE10742, R01DE14183]; NATIONAL CANCER INSTITUTE [R01CA176611, P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014183] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: This work was supported by National Institutes of Health Research Grants R01DE10742 and R01DE14183 to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2852; Ball AR, 2009, J CELL BIOL, V185, P573, DOI 10.1083/jcb.200904033; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chalasani P, 2013, ONCOLOGIST; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clark CC, 2012, MOL CANCER THER, V11, P1948, DOI 10.1158/1535-7163.MCT-11-0597; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; De Koning L, 2009, EMBO MOL MED, V1, P178, DOI 10.1002/emmm.200900022; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; Arranz EE, 2012, TRANSL ONCOL, V5, P398, DOI 10.1593/tlo.12244; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Kametaka A, 2002, GENES CELLS, V7, P1231, DOI 10.1046/j.1365-2443.2002.00596.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kirschmann DA, 2000, CANCER RES, V60, P3359; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee YH, 2013, NUCLEIC ACIDS RES, V41, P5784, DOI 10.1093/nar/gkt231; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Scholzen T, 2002, J PATHOL, V196, P135, DOI 10.1002/path.1016; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; Trihia H, 2003, CANCER, V97, P1321, DOI 10.1002/cncr.11188; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Wysham WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030042	45	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121207	10.1371/journal.pone.0121207	http://dx.doi.org/10.1371/journal.pone.0121207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769025	Green Published, gold			2022-12-26	WOS:000351277500139
J	Aydin, U; Vorwerk, J; Dumpelmann, M; Kupper, P; Kugel, H; Heers, M; Wellmer, J; Kellinghaus, C; Haueisen, J; Rampp, S; Stefan, H; Wolters, CH				Aydin, Uemit; Vorwerk, Johannes; Duempelmann, Matthias; Kuepper, Philipp; Kugel, Harald; Heers, Marcel; Wellmer, Joerg; Kellinghaus, Christoph; Haueisen, Jens; Rampp, Stefan; Stefan, Hermann; Wolters, Carsten H.			Combined EEG/MEG Can Outperform Single Modality EEG or MEG Source Reconstruction in Presurgical Epilepsy Diagnosis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SOURCE LOCALIZATION; HEAD MODEL; EPILEPTIFORM ACTIVITY; INTERICTAL SPIKES; HUMAN SKULL; ELECTRICAL-CONDUCTIVITY; EPILEPTOGENIC ZONE; VOLUME CONDUCTOR; INVERSE PROBLEM	We investigated two important means for improving source reconstruction in presurgical epilepsy diagnosis. The first investigation is about the optimal choice of the number of epileptic spikes in averaging to (1) sufficiently reduce the noise bias for an accurate determination of the center of gravity of the epileptic activity and (2) still get an estimation of the extent of the irritative zone. The second study focuses on the differences in single modality EEG (80-electrodes) or MEG (275-gradiometers) and especially on the benefits of combined EEG/MEG (EMEG) source analysis. Both investigations were validated with simultaneous stereo-EEG (sEEG) (167-contacts) and low-density EEG (ldEEG) (21-electrodes). To account for the different sensitivity profiles of EEG and MEG, we constructed a six-compartment finite element head model with anisotropic white matter conductivity, and calibrated the skull conductivity via somatosensory evoked responses. Our results show that, unlike single modality EEG or MEG, combined EMEG uses the complementary information of both modalities and thereby allows accurate source reconstructions also at early instants in time (epileptic spike onset), i.e., time points with low SNR, which are not yet subject to propagation and thus supposed to be closer to the origin of the epileptic activity. EMEG is furthermore able to reveal the propagation pathway at later time points in agreement with sEEG, while EEG or MEG alone reconstructed only parts of it. Subaveraging provides important and accurate information about both the center of gravity and the extent of the epileptogenic tissue that neither single nor grand-averaged spike localizations can supply.	[Aydin, Uemit; Vorwerk, Johannes; Kuepper, Philipp; Wolters, Carsten H.] Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany; [Aydin, Uemit; Haueisen, Jens] Tech Univ Ilmenau, Inst Biomed Engn & Informat, Ilmenau, Germany; [Duempelmann, Matthias; Kugel, Harald] Univ Freiburg Klinikum, Epilepsy Ctr, Freiburg, Germany; [Kuepper, Philipp; Kellinghaus, Christoph] Klin Osnabruck, Dept Neurol, Osnabruck, Germany; [Kugel, Harald] Univ Munster, Dept Clin Radiol, D-48149 Munster, Germany; [Heers, Marcel; Wellmer, Joerg; Rampp, Stefan] Univ Knappschaftskrankenhaus Bochum, Ruhr Epileptol Dept Neurol, Bochum, Germany; [Rampp, Stefan; Stefan, Hermann] Univ Erlangen Nurnberg, Dept Neurol, Epilepsy Ctr, Erlangen, Germany	University of Munster; Technische Universitat Ilmenau; University of Freiburg; University of Munster; Ruhr University Bochum; University of Erlangen Nuremberg	Aydin, U (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-48149 Munster, Germany.	umitaydin@ieee.org	Heers, Marcel/GRS-2648-2022; Wolters, Carsten H/R-4234-2016; Aydin, Ümit/HII-7669-2022; Duempelmann, Matthias/K-2583-2012; Heers, Marcel/AAF-9364-2019; Rampp, Stefan/J-9386-2019; Haueisen, Jens/B-7183-2011	Wolters, Carsten H/0000-0001-6233-424X; Duempelmann, Matthias/0000-0002-1476-7777; Heers, Marcel/0000-0001-5545-7014; Rampp, Stefan/0000-0002-4826-1520; Vorwerk, Johannes/0000-0003-3597-4203; Kugel, Harald/0000-0002-4349-1984; Haueisen, Jens/0000-0003-3871-2890; Aydin, Umit/0000-0002-6327-7811	DFG (Deutsche Forschungsgemeinschaft) [WO1425/2-1, 1665, WO1425/5-1, STE380/14-1]; Medical Faculty of Ruhr University Bochum; FoRUM research grant [K062-11]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Medical Faculty of Ruhr University Bochum; FoRUM research grant	This work was supported by DFG (Deutsche Forschungsgemeinschaft) project WO1425/2-1 and the Priority Program 1665 of the DFG (WO1425/5-1) for UA, JV and CHW; DFG project STE380/14-1 for SR and HS; and by the Medical Faculty of Ruhr University Bochum, by a FoRUM research grant (K062-11) for MH and JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre-Arrizubieta Z, 2014, BRAIN TOPOGR, V27, P197, DOI 10.1007/s10548-013-0330-x; Ahlfors S, 2014, 19 INT C BIOM AUG 24; Akhtari M, 2000, BRAIN TOPOGR, V13, P29, DOI 10.1023/A:1007882102297; Akhtari M, 2002, BRAIN TOPOGR, V14, P151, DOI 10.1023/A:1014590923185; Aydin U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093154; Badier JM, 1995, J PHYSIOLOGY-PARIS, V89, P255, DOI 10.1016/0928-4257(96)83642-4; Baillet S, 1999, IEEE T BIO-MED ENG, V46, P522, DOI 10.1109/10.759053; Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Bast T, 2006, J CLIN NEUROPHYSIOL, V23, P487, DOI 10.1097/01.wnp.0000232208.14060.c7; Baumann SB, 1997, IEEE T BIO-MED ENG, V44, P220, DOI 10.1109/10.554770; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boon P, 2002, J CLIN NEUROPHYSIOL, V19, P461, DOI 10.1097/00004691-200210000-00009; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Camacho DLA, 1997, J BIOMECH, V30, P1067, DOI 10.1016/S0021-9290(97)00073-0; COHEN D, 1987, PHYS MED BIOL, V32, P85, DOI 10.1088/0031-9155/32/1/013; Crouzeix A, 1999, CLIN NEUROPHYSIOL, V110, P2176, DOI 10.1016/S1388-2457(99)00174-1; Dannhauer M, 2013, BRAIN TOPOGR, V26, P229, DOI 10.1007/s10548-012-0263-9; Dannhauer M, 2011, HUM BRAIN MAPP, V32, P1383, DOI 10.1002/hbm.21114; Dassios G, 2007, INVERSE PROBL, V23, P2541, DOI 10.1088/0266-5611/23/6/016; de Munck JC, 2012, HANDBOOK OF NEURAL ACTIVITY MEASUREMENT, P192; Ebersole JS, 2010, J CLIN NEUROPHYSIOL, V27, P360, DOI 10.1097/WNP.0b013e318201ffc4; Ebersole JS, 1999, EEG CL N SU, V50, P167; Fischer MJM, 2005, BRAIN, V128, P153, DOI 10.1093/brain/awh333; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Fuchs M, 2004, CLIN NEUROPHYSIOL, V115, P1442, DOI 10.1016/j.clinph.2004.01.019; Fuchs M, 1998, ADV BIOMAGNETISM RES, V96, P213; Fuchs M, 2007, J CLIN NEUROPHYSIOL, V24, P101, DOI 10.1097/WNP.0b013e318038fb3e; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Goncalves S, 2003, IEEE T BIO-MED ENG, V50, P1124, DOI 10.1109/TBME.2003.816072; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Guggisberg AG, 2008, NEUROIMAGE, V39, P661, DOI 10.1016/j.neuroimage.2007.09.036; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hamid L, 2013, IEEE ENG MED BIO, P4819, DOI 10.1109/EMBC.2013.6610626; Haueisen J, 1997, IEEE T BIO-MED ENG, V44, P727, DOI 10.1109/10.605429; Haueisen J, 2012, J CLIN NEUROPHYSIOL, V29, P327, DOI 10.1097/WNP.0b013e3182624491; Heers M, 2014, HUM BRAIN MAPP, V35, P4396, DOI 10.1002/hbm.22482; Hoekema R, 2003, BRAIN TOPOGR, V16, P29, DOI 10.1023/A:1025606415858; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huiskamp G, 1999, IEEE T BIO-MED ENG, V46, P1281, DOI 10.1109/10.797987; Iwasaki M, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.0013-9580.2005.21104.x; Knake S, 2006, EPILEPSY RES, V69, P80, DOI 10.1016/j.eplepsyres.2006.01.001; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Kobayashi K, 2005, EPILEPSIA, V46, P397, DOI 10.1111/j.0013-9580.2005.31404.x; Kohling R, 2000, J NEUROPHYSIOL, V84, P2161, DOI 10.1152/jn.2000.84.4.2161; Lantz G, 2003, J CLIN NEUROPHYSIOL, V20, P311, DOI 10.1097/00004691-200309000-00003; Lew S, 2013, NEUROIMAGE, V76, P282, DOI 10.1016/j.neuroimage.2013.03.017; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Lucka F, 2013, 1 INT C BAS CLIN MUL; Lucka F, 2012, NEUROIMAGE, V61, P1364, DOI 10.1016/j.neuroimage.2012.04.017; Merlet I, 1998, ELECTROEN CLIN NEURO, V107, P206, DOI 10.1016/S0013-4694(98)00055-8; Montes-Restrepo V, 2014, BRAIN TOPOGR, V27, P95, DOI 10.1007/s10548-013-0313-y; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; MOSHER JC, 1993, ELECTROEN CLIN NEURO, V86, P303, DOI 10.1016/0013-4694(93)90043-U; Oishi M, 2006, EPILEPSIA, V47, P355, DOI 10.1111/j.1528-1167.2006.00428.x; Papanicolaou AC, 2005, J CLIN NEUROPHYSIOL, V22, P231, DOI 10.1097/01.WNP.0000172255.62072.E8; Pataraia E, 2004, NEUROLOGY, V62, P943, DOI 10.1212/01.WNL.0000115122.81621.FE; Pataraia E, 2005, NEUROIMAGE, V24, P607, DOI 10.1016/j.neuroimage.2004.09.031; Ramon C, 2004, BRAIN TOPOGR, V16, P245; Rampp S, 2007, EXPERT REV MED DEVIC, V4, P335, DOI 10.1586/17434440.4.3.335; Rice JK, 2013, NEUROIMAGE, V64, P476, DOI 10.1016/j.neuroimage.2012.09.041; Roth BJ, 1997, ELECTROEN CLIN NEURO, V102, P159, DOI 10.1016/S0013-4694(96)95111-5; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Ruthotto L, 2012, PHYS MED BIOL, V57, P5715, DOI 10.1088/0031-9155/57/18/5715; Salayev KA, 2006, CLIN NEUROPHYSIOL, V117, P1836, DOI 10.1016/j.clinph.2006.05.003; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Scheler G, 2007, HUM BRAIN MAPP, V28, P315, DOI 10.1002/hbm.20277; Speckmann EJ, 2012, NIEDERMEYERS ELECTRO; Stefan H, 2003, BRAIN, V126, P2396, DOI 10.1093/brain/awg239; Steinstrater O, 2010, HUM BRAIN MAPP, V31, P1907, DOI 10.1002/hbm.20986; Sutherling WW, 2008, NEUROLOGY, V71, P990, DOI 10.1212/01.wnl.0000326591.29858.1a; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Vorwerk J, 2012, BIOMED TECH BERLI S1, V57; Vorwerk J, 2014, NEUROIMAGE, V100, P590, DOI 10.1016/j.neuroimage.2014.06.040; Wennberg R, 2014, CLIN NEUROPHYSIOL, V125, P886, DOI 10.1016/j.clinph.2013.09.042; Wennberg R, 2013, CLIN NEUROPHYSIOL, V124, P941, DOI 10.1016/j.clinph.2012.10.022; Wolters CH, 2007, IEEE T BIO-MED ENG, V54, P1446, DOI 10.1109/TBME.2007.890736; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2615, DOI 10.1016/j.clinph.2006.07.319	82	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118753	10.1371/journal.pone.0118753	http://dx.doi.org/10.1371/journal.pone.0118753			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761059	Green Published, gold			2022-12-26	WOS:000351275000037
J	Cohen, AA; Milot, E; Li, Q; Bergeron, P; Poirier, R; Dusseault-Belanger, F; Fulop, T; Leroux, M; Legault, V; Metter, EJ; Fried, LP; Ferrucci, L				Cohen, Alan A.; Milot, Emmanuel; Li, Qing; Bergeron, Patrick; Poirier, Roxane; Dusseault-Belanger, Francis; Fueloep, Tamas; Leroux, Maxime; Legault, Veronique; Metter, E. Jeffrey; Fried, Linda P.; Ferrucci, Luigi			Detection of a Novel, Integrative Aging Process Suggests Complex Physiological Integration	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; BIOLOGICAL AGE; SYSTEMS BIOLOGY; HEPCIDIN; ANEMIA; DYSREGULATION; DECLINE; INFLAMMATION; BIOMARKERS; INCREASES	Many studies of aging examine biomarkers one at a time, but complex systems theory and network theory suggest that interpretations of individual markers may be context-dependent. Here, we attempted to detect underlying processes governing the levels of many biomarkers simultaneously by applying principal components analysis to 43 common clinical biomarkers measured longitudinally in 3694 humans from three longitudinal cohort studies on two continents (Women's Health and Aging I & II, InCHIANTI, and the Baltimore Longitudinal Study on Aging). The first axis was associated with anemia, inflammation, and low levels of calcium and albumin. The axis structure was precisely reproduced in all three populations and in all demographic sub-populations (by sex, race, etc.); we call the process represented by the axis "integrated albunemia." Integrated albunemia increases and accelerates with age in all populations, and predicts mortality and frailty - but not chronic disease - even after controlling for age. This suggests a role in the aging process, though causality is not yet clear. Integrated albunemia behaves more stably across populations than its component biomarkers, and thus appears to represent a higher-order physiological process emerging from the structure of underlying regulatory networks. If this is correct, detection of this process has substantial implications for physiological organization more generally.	[Cohen, Alan A.; Li, Qing; Bergeron, Patrick; Legault, Veronique] Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, Sherbrooke, PQ J1H 5N4, Canada; [Milot, Emmanuel] Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Trois Rivieres, PQ G9A 5H7, Canada; [Poirier, Roxane] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Dusseault-Belanger, Francis] Univ Sherbrooke, Dept Math, Sherbrooke, PQ J1K 2R1, Canada; [Fueloep, Tamas] Univ Sherbrooke, Dept Geriatr, Sherbrooke, PQ J1H 5N4, Canada; [Leroux, Maxime] Univ Quebec, ESG, Dept Econ, Montreal, PQ H2X 3X2, Canada; [Metter, E. Jeffrey; Ferrucci, Luigi] NIA, MedStar Harbor Hosp, Longitudinal Studies Sect, Translat Gerontol Branch,NIH, Baltimore, MD 21225 USA; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	University of Sherbrooke; University of Quebec; University of Quebec Trois Rivieres; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Quebec; University of Quebec Montreal; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Columbia University	Cohen, AA (corresponding author), Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, 3001 12e Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Alan.Cohen@USherbrooke.ca		Cohen, Alan/0000-0003-4113-3988; Li, Qing/0000-0002-4191-9596	FRQ-S; Canadian Institutes of Health Research grant [110789, 120305, 119485]; National Science and Engineering Research Council Discovery Grant [402079-2011]; Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000971, ZIAAG000995, ZIAAG001050] Funding Source: NIH RePORTER	FRQ-S; Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council Discovery Grant; Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AAC is a member of the Fonds de recherche du Quebec - Sante (FRQ-S)-supported Centre de recherche sur le vieillissement and Centre de recherche du CHUS, and is a funded Research Scholar of the FRQ-S. This research was supported by Canadian Institutes of Health Research grant #s 110789, 120305, 119485 and by National Science and Engineering Research Council Discovery Grant # 402079-2011 (all for AAC and TF), as well as by the Intramural Research Program of the National Institute on Aging (EJM and LF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cohen AA, 2014, EXP GERONTOL, V57, P203, DOI 10.1016/j.exger.2014.04.016; Cohen AA, 2013, MECH AGEING DEV, V134, P110, DOI 10.1016/j.mad.2013.01.004; Cohen AA, 2012, TRENDS ECOL EVOL, V27, P428, DOI 10.1016/j.tree.2012.04.008; Cohen AA, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-1; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Detivaud L, 2005, BLOOD, V106, P746, DOI 10.1182/blood-2004-12-4855; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dusseault-Belanger F, 2013, METAB SYNDR RELAT D, V11, P21, DOI 10.1089/met.2012.0094; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Ferrucci L., 2009, G GERONTOL, V57, P3; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; Finch CE, 2007, BIOL HUMAN LONGEVITY; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hoffman JM, 2014, AGING CELL; HOLLAND JH, 1992, DAEDALUS, V121, P17; Hood L, 2003, MECH AGEING DEV, V124, P9, DOI 10.1016/S0047-6374(02)00164-1; Johnson TE, 2006, EXP GERONTOL, V41, P1243, DOI 10.1016/j.exger.2006.09.006; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kauffman S.A., 1993, ORIGINS ORDER; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Klemera P, 2006, MECH AGEING DEV, V127, P240, DOI 10.1016/j.mad.2005.10.004; Kulminski AM, 2013, REJUV RES, V16, P304, DOI 10.1089/rej.2013.1441; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Lipsitz Lewis A, 2004, Sci Aging Knowledge Environ, V2004, ppe16; Matteini AM, 2010, J GERONTOL A-BIOL, V65, P1375, DOI 10.1093/gerona/glq154; Morrisette-Thomas V, 2014, MECH AGEING DEV, V139, P49, DOI 10.1016/j.mad.2014.06.005; NAKAMURA E, 1988, MECH AGEING DEV, V46, P1, DOI 10.1016/0047-6374(88)90109-1; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Park J, 2009, ARCH GERONTOL GERIAT, V49, P7, DOI 10.1016/j.archger.2008.04.003; Pearson CAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059046; R Core Team, 2018, R LANG ENV STAT COMP; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Seplaki CL, 2005, EXP GERONTOL, V40, P438, DOI 10.1016/j.exger.2005.03.002; Shock N.W., 1984, NORMAL HUMAN AGING B; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Wagner A, 1999, BIOL PHILOS, V14, P83, DOI 10.1023/A:1006580900476; Xu YJ, 2011, REGUL PEPTIDES, V172, P58, DOI 10.1016/j.regpep.2011.08.009; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189	50	45	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116489	10.1371/journal.pone.0116489	http://dx.doi.org/10.1371/journal.pone.0116489			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761112	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000005
J	Lee, IH; Song, SH; Cook, DI; Dinudom, A				Lee, Il-Ha; Song, Sung-Hee; Cook, David I.; Dinudom, Anuwat			H-Ras Mediates the Inhibitory Effect of Epidermal Growth Factor on the Epithelial Na+ Channel	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; SODIUM-CHANNEL; ENAC REGULATION; DOWN-REGULATION; ALPHA-SUBUNIT; LIPID RAFTS; PROTEIN; EGF; CELLS; CAVEOLIN-1	The present study investigates the role of small G-proteins of the Ras family in the epidermal growth factor (EGF)-activated cellular signalling pathway that downregulates activity of the epithelial Na+ channel (ENaC). We found that H-Ras is a key component of this EGF-activated cellular signalling mechanism in M1 mouse collecting duct cells. Expression of a constitutively active H-Ras mutant inhibited the amiloride-sensitive current. The H-Ras-mediated signalling pathway that inhibits activity of ENaC involves c-Raf, and that the inhibitory effect of H-Ras on ENaC is abolished by the MEK1/2 inhibitor, PD98059. The inhibitory effect of H-Ras is not mediated by Nedd4-2, a ubiquitin protein ligase that regulates the abundance of ENaC at the cell surface membrane, or by a negative effect of H-Ras on proteolytic activation of the channel. The inhibitory effects of EGF and H-Ras on ENaC, however, were not observed in cells in which expression of caveolin-1 (Cav-1) had been knocked down by siRNA. These findings suggest that the inhibitory effect of EGF on ENaC-dependent Na+ absorption is mediated via the H-Ras/c-Raf, MEK/ERK signalling pathway, and that Cav-1 is an essential component of this EGF-activated signalling mechanism. Taken together with reports that mice expressing a constitutive mutant of H-Ras develop renal cysts, our findings suggest that H-Ras may play a key role in the regulation of renal ion transport and renal development.	[Lee, Il-Ha; Song, Sung-Hee; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia	University of Sydney	Dinudom, A (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Physiol, Sydney, NSW 2006, Australia.	anuwat@physiol.usyd.edu.au			National Health and Medical Research Council of Australia [10027447]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by National Health and Medical Research Council of Australia, grant number 10027447, https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelaki S, 2009, CANCER BIOL THER, V8, P1470, DOI 10.4161/cbt.8.15.8939; Ambesi-Impiombato F S, 1979, Int Rev Cytol Suppl, P163; Baines DL, 2010, PFLUG ARCH EUR J PHY, V459, P451, DOI 10.1007/s00424-009-0717-4; Cao LS, 2005, BIOCHEM BIOPH RES CO, V331, P503, DOI 10.1016/j.bbrc.2005.03.201; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Falin R, 2005, AM J PHYSIOL-CELL PH, V288, pC1003, DOI 10.1152/ajpcell.00213.2004; Falin RA, 2007, J GEN PHYSIOL, V130, P313, DOI 10.1085/jgp.200709775; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gesualdo L, 1996, KIDNEY INT, V49, P656, DOI 10.1038/ki.1996.94; Gilbert E, 1997, INT J CANCER, V73, P749, DOI 10.1002/(SICI)1097-0215(19971127)73:5<749::AID-IJC23>3.0.CO;2-#; Giovannardi S, 2002, J BIOL CHEM, V277, P12158, DOI 10.1074/jbc.M110466200; Grossmann C, 2004, AM J PHYSIOL-RENAL, V286, pF1226, DOI 10.1152/ajprenal.00378.2003; HAHNEL C, 1992, EUR J NEUROSCI, V4, P361, DOI 10.1111/j.1460-9568.1992.tb00883.x; Hendron E, 2002, MOL BIOL CELL, V13, P3042, DOI 10.1091/mbc.E02-05-0260; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Ilatovskaya DV, 2013, AM J PHYSIOL-CELL PH, V304, pC102, DOI 10.1152/ajpcell.00231.2012; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Ko B, 2007, P NATL ACAD SCI USA, V104, P20120, DOI 10.1073/pnas.0709506104; Kocher HM, 2003, NEPHROL DIAL TRANSPL, V18, P2284, DOI 10.1093/ndt/gfg375; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lee IH, 2011, J BIOL CHEM, V286, P19259, DOI 10.1074/jbc.M111.239772; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Levchenko V, 2010, J CELL PHYSIOL, V223, P252, DOI 10.1002/jcp.22033; Liu L, 2009, AM J PHYSIOL-RENAL, V296, pF1417, DOI 10.1152/ajprenal.90337.2008; Markadieu N, 2005, AM J PHYSIOL-RENAL, V288, pF1201, DOI 10.1152/ajprenal.00383.2004; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MUTO S, 1991, AM J PHYSIOL, V260, pF163, DOI 10.1152/ajprenal.1991.260.2.F163; Nassar N, 2010, BIOCHEMISTRY-US, V49, P1970, DOI 10.1021/bi9020742; Nicod M, 2002, EMBO J, V21, P5109, DOI 10.1093/emboj/cdf509; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; PRadervand S, 1999, P NATL ACAD SCI USA, V96, P1732, DOI 10.1073/pnas.96.4.1732; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Shen J-P, 2003, AM J PHYSIOL-RENAL, V284, P57; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Spindler B, 1997, PFLUG ARCH EUR J PHY, V434, P323, DOI 10.1007/s004240050403; Spindler B, 1999, AM J PHYSIOL-CELL PH, V276, pC1154, DOI 10.1152/ajpcell.1999.276.5.C1154; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Stockand JD, 1999, J BIOL CHEM, V274, P35449, DOI 10.1074/jbc.274.50.35449; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Sweeney WE, 2000, KIDNEY INT, V57, P33, DOI 10.1046/j.1523-1755.2000.00829.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tong QS, 2005, AM J PHYSIOL-RENAL, V288, pF150, DOI 10.1152/ajprenal.00261.2004; TURNHEIM K, 1991, PHYSIOL REV, V71, P429, DOI 10.1152/physrev.1991.71.2.429; VEHASKARI VM, 1991, AM J PHYSIOL, V261, pF896, DOI 10.1152/ajprenal.1991.261.5.F896; Veizis IE, 2005, AM J PHYSIOL-RENAL, V288, pF474, DOI 10.1152/ajprenal.00227.2004; Wilson PD, 2004, KIDNEY INT, V65, P2441, DOI 10.1111/j.1523-1755.2004.00667.x; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; Zheleznova NN, 2011, BBA-MOL BASIS DIS, V1812, P1301, DOI 10.1016/j.bbadis.2010.10.004; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	75	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116938	10.1371/journal.pone.0116938	http://dx.doi.org/10.1371/journal.pone.0116938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774517	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500012
J	Lian, F; Cui, Y; Zhou, CL; Gao, KW; Wu, LW				Lian, Feng; Cui, Yong; Zhou, Chenliang; Gao, Kewei; Wu, Liwen			Identification of a Plasma Four-microRNA Panel as Potential Noninvasive Biomarker for Osteosarcoma	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; MICRORNAS; SERUM; CANCER	Background Circulating microRNAs (miRNAs) are emerging as promising biomarkers for human cancer. Osteosarcoma is the most common human primary malignant bone tumor in children and young adults. The objective of this study was to investigate whether circulating miRNAs in plasma could be a useful biomarker for detecting osteosarcoma and monitoring tumor removal dynamics. Methods Plasma samples were obtained from 90 patients before surgery, 50 patients after one month of surgery, and 90 healthy individuals. The study was divided into three steps: First, initial screening of the profiles of circulating miRNAs in pooled plasma samples from healthy controls and pre-operative osteosarcoma patients using a TaqMan low density array (TLDA). Second, evaluation of miRNA concentration in individual plasma samples from 90 pre-operative osteosarcoma patients and 90 healthy controls by a quantitative real time PCR (qRT-PCR) assay. Third, evaluation of miRNA concentration in paired plasma samples from 50 pre- and post-operative osteosarcoma patients by qRT-PCR assay. Results Four plasma miRNAs including miR-195-5p, miR-199a-3p, miR-320a, and miR-374a-5p were significantly increased in the osteosarcoma patients. Receiver operating characteristics curve analysis of the combined populations demonstrated that the four-miRNA signature could discriminate cases from controls with an area under the curve of 0.9608 (95% CI 0.9307-0.9912). These 4 miRNAs were markedly decreased in the plasma after operation. In addition, circulating miR-195-5p and miR-199a-3p were correlated with metastasis status, while miR-199a-3p and miR-320a were correlated with histological subtype. Conclusions Our data suggest that altered levels of circulating miRNAs might have great potential to serve as novel, non-invasive biomarkers for osteosarcoma.	[Lian, Feng; Cui, Yong; Zhou, Chenliang; Gao, Kewei; Wu, Liwen] Harbin Med Univ, Affiliated Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China	Harbin Medical University	Lian, F (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China.	lian_fenghum@163.com; wu_liwen@yeah.net	聂, 宏光/GYJ-8253-2022	聂, 宏光/0000-0002-9973-6354				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bielack SS, 2008, J CLIN ONCOL, V26, P3102, DOI 10.1200/JCO.2008.17.1108; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Tian Q, 2014, EJSO-EUR J SURG ONC, V40, P67, DOI 10.1016/j.ejso.2013.08.024; Tian Y, 2014, BIOSCI REP; Yang JL, 2013, CURR OPIN ONCOL, V25, P398, DOI 10.1097/CCO.0b013e3283622c1b; Yuan J, 2012, J INT MED RES, V40, P2090, DOI 10.1177/030006051204000606; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	22	66	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121499	10.1371/journal.pone.0121499	http://dx.doi.org/10.1371/journal.pone.0121499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775010	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500214
J	Ogawa, H; Fujikura, D; Ohnuma, M; Ohnishi, N; Hang'ombe, BM; Mimuro, H; Ezaki, T; Mweene, AS; Higashi, H				Ogawa, Hirohito; Fujikura, Daisuke; Ohnuma, Miyuki; Ohnishi, Naomi; Hang'ombe, Bernard M.; Mimuro, Hitomi; Ezaki, Takayuki; Mweene, Aaron S.; Higashi, Hideaki			A Novel Multiplex PCR Discriminates Bacillus anthracis and Its Genetically Related Strains from Other Bacillus cereus Group Species	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CHROMOSOMAL DNA; THURINGIENSIS; SEQUENCES; IDENTIFICATION; GENES; POPULATION; INFECTION; BACTERIA	Anthrax is an important zoonotic disease worldwide that is caused by Bacillus anthracis, a spore-forming pathogenic bacterium. A rapid and sensitive method to detect B. anthracis is important for anthrax risk management and control in animal cases to address public health issues. However, it has recently become difficult to identify B. anthracis by using previously reported molecular-based methods because of the emergence of B. cereus, which causes severe extra-intestinal infection, as well as the human pathogenic B. thuringiensis, both of which are genetically related to B. anthracis. The close genetic relation of chromosomal backgrounds has led to complexity of molecular-based diagnosis. In this study, we established a B. anthracis multiplex PCR that can screen for the presence of B. anthracis virulent plasmids and differentiate B. anthracis and its genetically related strains from other B. cereus group species. Six sets of primers targeting a chromosome of B. anthracis and B. anthracis-like strains, two virulent plasmids, pXO1 and pXO2, a bacterial gene, 16S rRNA gene, and a mammalian gene, actin-beta gene, were designed. The multiplex PCR detected approximately 3.0 CFU of B. anthracis DNA per PCR reaction and was sensitive to B. anthracis. The internal control primers also detected all bacterial and mammalian DNAs examined, indicating the practical applicability of this assay as it enables monitoring of appropriate amplification. The assay was also applied for detection of clinical strains genetically related to B. anthracis, which were B. cereus strains isolated from outbreaks of hospital infections in Japan, and field strains isolated in Zambia, and the assay differentiated B. anthracis and its genetically related strains from other B. cereus group strains. Taken together, the results indicate that the newly developed multiplex PCR is a sensitive and practical method for detecting B. anthracis.	[Ogawa, Hirohito; Higashi, Hideaki] Univ Zambia, Sch Vet Med, Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia; [Ogawa, Hirohito; Mweene, Aaron S.; Higashi, Hideaki] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia; [Fujikura, Daisuke; Ohnuma, Miyuki; Ohnishi, Naomi; Higashi, Hideaki] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido, Japan; [Hang'ombe, Bernard M.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka, Zambia; [Mimuro, Hitomi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Div Bacteriol,Dept Infect Dis Control, Tokyo, Japan; [Mimuro, Hitomi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Pathogen Microbes Repository Unit, Tokyo, Japan; [Ezaki, Takayuki] Gifu Univ, Grad Sch Med, Dept Microbiol Regenerat & Adv Med Sci, Gifu, Japan; [Higashi, Hideaki] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan	University of Zambia; University of Zambia; Hokkaido University; University of Zambia; University of Tokyo; University of Tokyo; Gifu University; Hokkaido University	Higashi, H (corresponding author), Univ Zambia, Sch Vet Med, Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia.	hidea-hi@czc.hokudai.ac.jp	Higashi, Hideaki/F-6872-2012; Ogawa, Hirohito/F-6918-2012; OHNISHI, Naomi/F-6914-2012	Ogawa, Hirohito/0000-0001-5738-4816; OHNISHI, Naomi/0000-0002-2382-3152	Government of the Republic of Zambia; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Government of the Republic of Zambia; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This work was supported by the Government of the Republic of Zambia and the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2013, VIRULENCE, V4, P671, DOI 10.4161/viru.26288; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; BEYER W, 1995, MICROBIOL RES, V150, P179, DOI 10.1016/S0944-5013(11)80054-6; Brightwell C, 1998, MOL CELL PROBE, V12, P367, DOI 10.1006/mcpr.1998.0195; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Granum PE, 1997, FEMS MICROBIOL LETT, V157, P223, DOI 10.1016/S0378-1097(97)00438-2; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Helgason E, 2000, J CLIN MICROBIOL, V38, P1615, DOI 10.1128/JCM.38.4.1615-1622.2000; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hicks CW, 2012, INTENS CARE MED, V38, P1092, DOI 10.1007/s00134-012-2541-0; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; HUTSON RA, 1993, J APPL BACTERIOL, V75, P463, DOI 10.1111/j.1365-2672.1993.tb02803.x; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Kurosaki Y, 2009, J APPL MICROBIOL, V107, P1947, DOI 10.1111/j.1365-2672.2009.04379.x; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Makino SI, 2001, LETT APPL MICROBIOL, V33, P237, DOI 10.1046/j.1472-765x.2001.00989.x; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ohnishi N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00116-14; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Ramisse V, 1996, FEMS MICROBIOL LETT, V145, P9, DOI 10.1016/0378-1097(96)00358-8; Ramisse V, 1999, J APPL MICROBIOL, V87, P224, DOI 10.1046/j.1365-2672.1999.00874.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sue D, 2006, J CLIN MICROBIOL, V44, P3426, DOI 10.1128/JCM.00873-06; TURNBULL PCB, 1979, J CLIN PATHOL, V32, P289, DOI 10.1136/jcp.32.3.289; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHO, 1998, GUID SURV CONTR ANTH; Winsley T, 2012, APPL ENVIRON MICROB, V78, P5938, DOI 10.1128/AEM.01299-12; Zhang JW, 2011, DIAGN MICR INFEC DIS, V70, P307, DOI 10.1016/j.diagmicrobio.2011.02.012	37	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122004	10.1371/journal.pone.0122004	http://dx.doi.org/10.1371/journal.pone.0122004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774512	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500219
J	Ouyang, X; Chen, KW; Yao, L; Wu, X; Zhang, JC; Li, K; Jin, Z; Guo, XJ				Ouyang, Xin; Chen, Kewei; Yao, Li; Wu, Xia; Zhang, Jiacai; Li, Ke; Jin, Zhen; Guo, Xiaojuan		Alzheimer's Dis Neuroimaging	Independent Component Analysis-Based Identification of Covariance Patterns of Microstructural White Matter Damage in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STRUCTURAL CONNECTIVITY; FRACTIONAL ANISOTROPY; VOXELWISE ANALYSIS; DTI; ARCHITECTURE; GREY; AD	The existing DTI studies have suggested that white matter damage constitutes an important part of the neurodegenerative changes in Alzheimer's disease (AD). The present study aimed to identify the regional covariance patterns of microstructural white matter changes associated with AD. In this study, we applied a multivariate analysis approach, independent component analysis (ICA), to identify covariance patterns of microstructural white matter damage based on fractional anisotropy (FA) skeletonised images from DTI data in 39 AD patients and 41 healthy controls (HCs) from the Alzheimer's Disease Neuroimaging Initiative database. The multivariate ICA decomposed the subject-dimension concatenated FA data into a mixing coefficient matrix and a source matrix. Twenty-eight independent components (ICs) were extracted, and a two sample t-test on each column of the corresponding mixing coefficient matrix revealed significant AD/HC differences in ICA weights for 7 ICs. The covariant FA changes primarily involved the bilateral corona radiata, the superior longitudinal fasciculus, the cingulum, the hippocampal commissure, and the corpus callosum in AD patients compared to HCs. Our findings identified covariant white matter damage associated with AD based on DTI in combination with multivariate ICA, potentially expanding our understanding of the neuropathological mechanisms of AD.	[Ouyang, Xin; Yao, Li; Wu, Xia; Zhang, Jiacai; Guo, Xiaojuan] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China; [Chen, Kewei] Banner Alzheimers Inst, Phoenix, AZ USA; [Chen, Kewei] Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Yao, Li; Wu, Xia; Guo, Xiaojuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Ke; Jin, Zhen] Beijing 306 Hosp, Lab Magnet Resonance Imaging, Beijing, Peoples R China	Beijing Normal University; Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Beijing Normal University	Guo, XJ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China.	gxj@bnu.edu.cn			National Key Basic Research Program (973 Program), China [2012CB720704]; National Natural Science Foundation (NNSF), China [81000603]; Funds for International Cooperation and Exchange of NNSF, China [61210001]; Key Program of NNSF, China [91320201]; National Institute of Mental Health, US [RO1 MH57899]; National Institute on Aging, US [9R01AG031581-10, P30 AG19610, k23 AG24062]; State of Arizona; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031581, P30AG019610, K23AG024062] Funding Source: NIH RePORTER	National Key Basic Research Program (973 Program), China; National Natural Science Foundation (NNSF), China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of NNSF, China; Key Program of NNSF, China; National Institute of Mental Health, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging, US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); State of Arizona; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Key Basic Research Program (973 Program), China (2012CB720704), the National Natural Science Foundation (NNSF), China (81000603), the Funds for International Cooperation and Exchange of NNSF, China (61210001), Key Program of NNSF, China (91320201), the National Institute of Mental Health, US (RO1 MH57899), the National Institute on Aging, US (9R01AG031581-10, P30 AG19610, k23 AG24062), and the State of Arizona. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Caprihan A, 2011, BRAIN CONNECT, V1, P133, DOI 10.1089/brain.2011.0015; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Fayed N, 2012, J ALZHEIMERS DIS, V31, pS5, DOI 10.3233/JAD-2011-111292; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guo XJ, 2012, NEUROSCI LETT, V531, P136, DOI 10.1016/j.neulet.2012.10.038; Guo XJ, 2010, NEUROSCI LETT, V468, P146, DOI 10.1016/j.neulet.2009.10.086; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Jack CR, 2011, NEUROBIOL AGING, V32, pS48, DOI 10.1016/j.neurobiolaging.2011.09.011; Kincses ZT, 2013, J ALZHEIMERS DIS, V36, P119, DOI 10.3233/JAD-122431; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Liu YW, 2011, NEUROBIOL AGING, V32, P1558, DOI 10.1016/j.neurobiolaging.2009.10.006; Luo L, 2012, BRAIN CONNECT, V2, P33, DOI 10.1089/brain.2011.0026; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Shu N, 2011, J ALZHEIMERS DIS, V26, P275, DOI 10.3233/JAD-2011-0024; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Teipel SJ, 2014, J ALZHEIMERS DIS, V41, P69, DOI 10.3233/JAD-131829; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Wu X, 2013, IEEE ACM T COMPUT BI, V10, P173, DOI 10.1109/TCBB.2012.141; Xie S, 2006, NEUROLOGY, V66, P1845, DOI 10.1212/01.wnl.0000219625.77625.aa; Xu L, 2009, NEUROIMAGE, V44, P777, DOI 10.1016/j.neuroimage.2008.09.051; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; Zhang Y, 2009, BRAIN, V132, P2579, DOI 10.1093/brain/awp071; Zhou YX, 2008, ALZHEIMERS DEMENT, V4, P265, DOI 10.1016/j.jalz.2008.04.006	35	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119714	10.1371/journal.pone.0119714	http://dx.doi.org/10.1371/journal.pone.0119714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775003	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500114
J	Fang, YF; Hsieh, MH; Chung, FT; Huang, YK; Chen, GY; Lin, SM; Lin, HC; Wang, CH; Kuo, HP				Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Huang, Yao-Kuang; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin			Flexible Bronchoscopy with Multiple Modalities for Foreign Body Removal in Adults	PLOS ONE			English	Article							ASPIRATION; EXPERIENCE; BODIES; AIRWAY; CRYOTHERAPY; CHILDREN; LUNG	Objectives Aspiration of the lower airways due to foreign body is rare in adults. This study aimed to determine the outcome of patients who received flexible bronchoscopy with different modalities for foreign body removal in the lower airways. Patients and Methods Between January 2003 and January 2014, 94 patients diagnosed with foreign body in the lower airways underwent flexible bronchoscopy with different modalities, which included forceps, loop, basket, knife, electromagnet, and cryotherapy. The clinical presentation, foreign body location and characteristics, and applications of flexible bronchoscopy were analyzed. Results Forty (43%) patients had acute aspiration, which developed within one week of foreign body entry and 54 (57%) had chronic aspiration. The most common foreign bodies were teeth or bone. More patients with chronic aspiration than those with acute aspiration were referred from the out-patient clinic (48% vs. 28%), but more patients with acute aspiration were referred from the emergency room (35% vs. 6%) and intensive care unit (18% vs. 2%). Flexible bronchoscopy with different modalities was used to remove the foreign bodies (85/94, 90%). Electromagnet or cryotherapy was used in nine patients to eliminate the surrounding granulation tissue before foreign body removal. In the nine patients with failed flexible bronchoscopy, eight underwent rigid bronchoscopy instead and one had right lower lung lobectomy for lung abscess. Conclusions Flexible bronchoscopy with multiple modalities is effective for diagnosing and removing foreign bodies in the lower respiratory airways in adults, with a high success rate (90%) and no difference between acute and chronic aspirations.	[Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin] Chang Gung Mem Hosp, Chang Gung Fdn, Dept Thorac Med, Taoyuan, Taiwan; [Fang, Yueh-Fu; Hsieh, Meng-Heng; Chung, Fu-Tsai; Huang, Yao-Kuang; Chen, Guan-Yuan; Lin, Shu-Min; Lin, Horng-Chyuan; Wang, Chin-Hwa; Kuo, Han-Pin] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Yao-Kuang] Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Kuo, HP (corresponding author), Chang Gung Mem Hosp, Chang Gung Fdn, Dept Thorac Med, Taoyuan, Taiwan.	q8828@ms11.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019; Huang, Yao-Kuang/AAK-5137-2021	Wang, Chun-Hua/0000-0002-3514-9353; Huang, Yao-Kuang/0000-0003-2699-2207				Boufersaoui A, 2013, INT J PEDIATR OTORHI, V77, P1683, DOI 10.1016/j.ijporl.2013.07.026; Casalini AG, 2013, J BRONCHOL INTERN PU, V20, P313, DOI 10.1097/LBR.0000000000000024; CASSON AG, 1987, CAN J SURG, V30, P193; Chen CH, 1997, CHEST, V112, P129, DOI 10.1378/chest.112.1.129; Chou CL, 2013, ANN THORAC SURG, V95, P982, DOI 10.1016/j.athoracsur.2012.11.044; Dikensoy O, 2002, POSTGRAD MED J, V78, P399, DOI 10.1136/pmj.78.921.399; ELHASSANI NB, 1988, J THORAC CARDIOV SUR, V96, P621; Hetzel J, 2012, EUR RESPIR J, V39, P685, DOI 10.1183/09031936.00033011; Hui H, 2008, J PEDIATR SURG, V43, P718, DOI 10.1016/j.jpedsurg.2007.10.010; Khan A, 2011, RESPIRATION, V81, P129, DOI 10.1159/000320262; LAN RS, 1989, AM REV RESPIR DIS, V140, P1734, DOI 10.1164/ajrccm/140.6.1734; Lee Seon-Heui, 2011, Korean Journal of Internal Medicine, V26, P137, DOI 10.3904/kjim.2011.26.2.137; LIMPER AH, 1990, ANN INTERN MED, V112, P604, DOI 10.7326/0003-4819-112-8-604; Tang LF, 2009, WORLD J PEDIATR, V5, P191, DOI 10.1007/s12519-009-0036-z; Vergnon JM, 2006, EUR RESPIR J, V28, P200, DOI 10.1183/09031936.06.00014006; Weber SM, 2005, LARYNGOSCOPE, V115, P687, DOI 10.1097/01.mlg.0000161353.45999.dd	16	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118993	10.1371/journal.pone.0118993	http://dx.doi.org/10.1371/journal.pone.0118993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768933	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500058
J	Maltarollo, VG; Togashi, M; Nascimento, AS; Honorio, KM				Maltarollo, Vinicius G.; Togashi, Marie; Nascimento, Alessandro S.; Honorio, Kathia M.			Structure-Based Virtual Screening and Discovery of New PPAR delta/gamma Dual Agonist and PPAR delta and gamma Agonists	PLOS ONE			English	Article							PROTEIN-LIGAND DOCKING; HORMONE RECEPTOR SUPERFAMILY; PEROXISOME-PROLIFERATOR; MOLECULAR DOCKING; METABOLIC SYNDROME; BINDING-AFFINITY; ACTIVATION; ALPHA; MODEL; ACID	Peroxisome proliferator-activated receptors (PPARs) are involved in the control of carbohydrate and lipid metabolism and are considered important targets to treat diabetes mellitus and metabolic syndrome. The available PPAR ligands have several side effects leading to health risks justifying the search for new bioactive ligands to activate the PPAR subtypes, in special PPAR delta, the less studied PPAR isoform. Here, we used a structure-based virtual screening protocol in order to find out new PPAR ligands. From a lead-like subset of purchasable compounds, we identified 5 compounds with potential PPAR affinity and, from preliminary in vitro assays, 4 of them showed promising biological activity. Therefore, from our in silico and in vitro protocols, new PPAR ligands are potential candidates to treat metabolic diseases.	[Maltarollo, Vinicius G.; Honorio, Kathia M.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil; [Maltarollo, Vinicius G.] Univ Sao Paulo, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Togashi, Marie] Univ Brasilia, Fac Ciencias Saude, Brasilia, DF, Brazil; [Nascimento, Alessandro S.] Univ Sao Paulo, Inst Fis Sao Carlos, Sao Paulo, Brazil; [Honorio, Kathia M.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade de Brasilia; Universidade de Sao Paulo; Universidade de Sao Paulo	Honorio, KM (corresponding author), Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil.	kmhonorio@usp.br	Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Nascimento, Alessandro/Y-3394-2019; Honorio, Kathia/AAG-9844-2020; Nascimento, Alessandro S/G-9547-2012; Honorio, Kathia M/D-4998-2012; Togashi, Marie/L-3092-2018	Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Nascimento, Alessandro/0000-0001-6656-5379; Honorio, Kathia/0000-0002-6938-0676; Nascimento, Alessandro S/0000-0001-6656-5379; Honorio, Kathia M/0000-0002-6938-0676; 	FAPESP [2011/18981-2, 2014/06565-2]; CNPq Brazilian agency; CAPES Brazilian agency	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq Brazilian agency(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Brazilian agency(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors would like to thank FAPESP (2011/18981-2, 2014/06565-2), CNPq and CAPES (Brazilian agencies) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SYBYL 8 1; Artis DR, 2009, P NATL ACAD SCI USA, V106, P262, DOI 10.1073/pnas.0811325106; Balakumar P, 2007, PHARMACOL RES, V56, P91, DOI 10.1016/j.phrs.2007.03.002; Batista FAH, 2012, PLOS ONE, V7, P1, DOI [10.1093/jscr/2012.7.1, DOI 10.1093/JSCR/2012.7.1]; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bolden A, 2012, PPAR RES, V2012, DOI 10.1155/2012/929052; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Buss ZD, 2012, INFLAMMATION, V35, P280, DOI 10.1007/s10753-011-9316-6; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Cole JC, 2005, PROTEINS, V60, P325, DOI 10.1002/prot.20497; Connors RV, 2009, BIOORG MED CHEM LETT, V19, P3550, DOI 10.1016/j.bmcl.2009.04.151; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Epple R, 2006, BIOORG MED CHEM LETT, V16, P5488, DOI 10.1016/j.bmcl.2006.08.052; Evans JL, 2005, CURR DIABETES REV, V1, P299, DOI 10.2174/157339905774574365; Evans KA, 2011, BIOORG MED CHEM LETT, V21, P2345, DOI 10.1016/j.bmcl.2011.02.077; Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Fyffe SA, 2006, MOL CELL, V21, P1, DOI 10.1016/j.molcel.2005.12.001; Garcia TS, 2011, J BRAZIL CHEM SOC, V22, P65, DOI 10.1590/S0103-50532011000100008; GEY GO, 1952, CANCER RES, V12, P264; Giaginis C, 2009, QSAR COMB SCI, V28, P802, DOI 10.1002/qsar.200860185; Gschwend DA, 1996, J COMPUT AID MOL DES, V10, P123, DOI 10.1007/BF00402820; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Iwashita A, 2007, J PHARMACOL EXP THER, V320, P1087, DOI 10.1124/jpet.106.115758; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jialal I, 2012, METAB SYNDR RELAT D, V10, P159, DOI 10.1089/met.2012.1500; Jin LH, 2011, J BIOL CHEM, V286, P31473, DOI 10.1074/jbc.M111.266023; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Keil S, 2011, CHEMMEDCHEM, V6, P633, DOI 10.1002/cmdc.201100047; Kilgore KS, 2008, CURR OPIN INVEST DR, V9, P463; Krishnamurthy Praveen T., 2013, CURR BIOACT COMPD, V9, P221, DOI [10.2174/157340720903140119153500, DOI 10.2174/157340720903140119153500]; Kroemer RT, 2004, J CHEM INF COMP SCI, V44, P871, DOI 10.1021/ci049970m; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Lather V, 2009, QSAR COMB SCI, V28, P447, DOI 10.1002/qsar.200810092; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Liu XY, 2011, PROTEIN PEPTIDE LETT, V18, P1021, DOI 10.2174/092986611796378701; Luckhurst CA, 2011, BIOORG MED CHEM LETT, V21, P492, DOI 10.1016/j.bmcl.2010.10.117; Makino S, 1997, J COMPUT CHEM, V18, P1812, DOI 10.1002/(SICI)1096-987X(19971115)18:14<1812::AID-JCC10>3.0.CO;2-H; Maltarollo VG, 2012, CHEM BIOL DRUG DES, V80, P533, DOI 10.1111/j.1747-0285.2012.01424.x; Maltarollo VG, 2012, J BRAZIL CHEM SOC, V23, P85, DOI 10.1590/S0103-50532012000100013; Maltarollo VG, 2011, J MOL MODEL, V17, P2549, DOI 10.1007/s00894-010-0935-x; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; McEwan Iain J., 2009, V505, P3, DOI 10.1007/978-1-60327-575-0_1; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Nascimento AS, 2010, BIOCHIMIE, V92, P499, DOI 10.1016/j.biochi.2010.01.018; Nevin DK, 2011, CURR MED CHEM, V18, P5598; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Oyama T, 2009, ACTA CRYSTALLOGR D, V65, P786, DOI 10.1107/S0907444909015935; Pereira R, 2006, BIOORG MED CHEM LETT, V16, P49, DOI 10.1016/j.bmcl.2005.09.060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersson I, 2007, BIOORG MED CHEM LETT, V17, P4625, DOI 10.1016/j.bmcl.2007.05.079; Pouwels Koen B, 2012, Int J Risk Saf Med, V24, P73, DOI 10.3233/JRS-2012-0559; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Robinson E, 2009, PHARMACOL THERAPEUT, V122, P246, DOI 10.1016/j.pharmthera.2009.03.003; Rogenhofer S, 2012, ANTICANCER RES, V32, P3479; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scientific D, 2006, PYMOL V0 99C; Shearer BG, 2008, BIOORG MED CHEM LETT, V18, P5018, DOI 10.1016/j.bmcl.2008.08.011; SHOICHET BK, 1991, J MOL BIOL, V221, P327, DOI 10.1016/0022-2836(91)80222-G; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082; Takada I, 2000, MOL ENDOCRINOL, V14, P733, DOI 10.1210/me.14.5.733; Teramoto R, 2007, J CHEM INF MODEL, V47, P526, DOI 10.1021/ci6004993; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang Y, 2012, MOL NUTR FOOD RES, V56, P1234, DOI 10.1002/mnfr.201100517; Wickens P, 2007, BIOORG MED CHEM LETT, V17, P4369, DOI 10.1016/j.bmcl.2007.03.057; Wilding JPH, 2012, DIABETES OBES METAB, V14, P973, DOI 10.1111/j.1463-1326.2012.01601.x; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Yu Y, 2012, HYPERTENSION, V59, P477, DOI 10.1161/HYPERTENSIONAHA.111.182345; Yue LD, 2005, BIOCHIMIE, V87, P539, DOI 10.1016/j.biochi.2005.02.002; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	86	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118790	10.1371/journal.pone.0118790	http://dx.doi.org/10.1371/journal.pone.0118790			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767888	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500044
J	Xu, F; Yao, PP; Xia, Y; Qian, L; Yang, ZN; Xie, RH; Sun, YS; Lu, HJ; Miao, ZP; Li, C; Li, X; Liang, WF; Huang, XX; Xia, SC; Chen, ZP; Jiang, JM; Zhang, YJ; Mei, LL; Liu, SL; Gu, H; Xu, ZY; Fu, XF; Zhu, ZY; Zhu, HP				Xu, Fang; Yao, Ping-Ping; Xia, Yong; Qian, Lei; Yang, Zhang-Nv; Xie, Rong-Hui; Sun, Yi-Sheng; Lu, Hang-Jing; Miao, Zi-Ping; Li, Chan; Li, Xiao; Liang, Wei-Feng; Huang, Xiao-Xiao; Xia, Shi-Chang; Chen, Zhi-Ping; Jiang, Jian-Min; Zhang, Yan-Jun; Mei, Ling-Ling; Liu, She-Lan; Gu, Hua; Xu, Zhi-Yao; Fu, Xiao-Fei; Zhu, Zhi-Yong; Zhu, Han-Ping			Enterovirus 71 Infection Causes Severe Pulmonary Lesions in Gerbils, Meriones unguiculatus, Which Can Be Prevented by Passive Immunization with Specific Antisera	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; CENTRAL-NERVOUS-SYSTEM; MOUTH-DISEASE; CLINICAL-FEATURES; RISK-FACTORS; MOUSE MODEL; HAND; FOOT; OUTBREAK; TAIWAN	Neurogenic pulmonary edema caused by severe brainstem encephalitis is the leading cause of death in young children infected by Enterovirus 71 (EV71). However, no pulmonary lesions have been found in EV71-infected transgenic or non-transgenic mouse models. Development of a suitable animal model is important for studying EV71 pathogenesis and assessing effect of therapeutic approaches. We had found neurological disorders in EV71-induced young gerbils previously. Here, we report severe pulmonary lesions characterized with pulmonary congestion and hemorrhage in a gerbil model for EV71 infection. In the EV71-infected gerbils, six 21-day-old or younger gerbils presented with a sudden onset of symptoms and rapid illness progression after inoculation with 1x10(5.5) TCID50 of EV71 via intraperitoneal (IP) or intramuscular (IM) route. Respiratory symptoms were observed along with interstitial pneumonia, pulmonary congestion and extensive lung hemorrhage could be detected in the lung tissues by histopathological examination. EV71 viral titer was found to be peak at late stages of infection. EV71-induced pulmonary lesions, together with severe neurological disorders were also observed in gerbils, accurately mimicking the disease process in EV71-infected patients. Passive transfer with immune sera from EV71 infected adult gerbils with a neutralizing antibody (GMT= 89) prevented severe pulmonary lesion formation after lethal EV71 challenge. These results establish this gerbil model as a useful platform for studying the pathogenesis of EV71-induced pulmonary lesions, immunotherapy and antiviral drugs.	[Xu, Fang; Yao, Ping-Ping; Xia, Yong; Qian, Lei; Yang, Zhang-Nv; Xie, Rong-Hui; Sun, Yi-Sheng; Lu, Hang-Jing; Miao, Zi-Ping; Li, Chan; Xia, Shi-Chang; Chen, Zhi-Ping; Jiang, Jian-Min; Zhang, Yan-Jun; Mei, Ling-Ling; Liu, She-Lan; Gu, Hua; Zhu, Zhi-Yong; Zhu, Han-Ping] Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China; [Li, Xiao] First Municipal Hosp Hangzhou, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Liang, Wei-Feng] Zhejiang Univ, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Xiao-Xiao] Hangzhou Sixth Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Xu, Zhi-Yao] Wenzhou Med Univ, Wenzhou, Peoples R China; [Fu, Xiao-Fei] Jiaxing Ctr Dis Control & Prevent, Jiaxing, Peoples R China	Zhejiang University; Wenzhou Medical University	Chen, ZP (corresponding author), Zhejiang Prov Ctr Dis Prevent & Control, Key Lab Vaccine Hemorrhag Fever Renal Syndrome, Hangzhou, Zhejiang, Peoples R China.	zhpchen@cdc.zj.cn; hanpingzhu@aliyun.com			Natural Science Foundation of Zhejiang Province [Y3100701]; Medical and Technological Project of Zhejiang Province [2010KYB027]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medical and Technological Project of Zhejiang Province	The work was granted by Natural Science Foundation of Zhejiang Province (Y3100701) and the Medical and Technological Project of Zhejiang Province (2010KYB027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Fujii K, 2013, P NATL ACAD SCI USA, V110, P14753, DOI 10.1073/pnas.1217563110; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; Kao SJ, 2004, CLIN INFECT DIS, V38, P1784, DOI 10.1086/421021; Khong WX, 2012, J VIROL, V86, P2121, DOI 10.1128/JVI.06103-11; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Liu JN, 2012, ARCH VIROL, V157, P539, DOI 10.1007/s00705-011-1198-2; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; Manki A, 1997, Nihon Rinsho, V55, P849; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Pallansch, 2007, FIELDS VIROLOGY, P839; REED L. J., 1938, AMER JOUR HYG, V27, P493; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang YF, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-31; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wu JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e26; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xiu JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-215; Xu W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-8; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051996; Yu CK, 2000, J BIOMED SCI, V7, P523, DOI 10.1007/BF02253368; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang DM, 2010, INT J INFECT DIS, V14, pE739, DOI 10.1016/j.ijid.2009.12.002; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	41	13	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119173	10.1371/journal.pone.0119173	http://dx.doi.org/10.1371/journal.pone.0119173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767882	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500068
J	Anderson, D; Cordell, HJ; Fakiola, M; Francis, RW; Syn, G; Scaman, ESH; Davis, E; Miles, SJ; McLeay, T; Jamieson, SE; Blackwell, JM				Anderson, Denise; Cordell, Heather J.; Fakiola, Michaela; Francis, Richard W.; Syn, Genevieve; Scaman, Elizabeth S. H.; Davis, Elizabeth; Miles, Simon J.; McLeay, Toby; Jamieson, Sarra E.; Blackwell, Jenefer M.			First Genome-Wide Association Study in an Australian Aboriginal Population Provides Insights into Genetic Risk Factors for Body Mass Index and Type 2 Diabetes	PLOS ONE			English	Article							HEALTH SIGNIFICANT PROGRESS; BETA-CELL FUNCTION; COMMON VARIANTS; GENOTYPE IMPUTATION; SUSCEPTIBILITY GENES; WAIST CIRCUMFERENCE; MULTIPLE ALIGNMENT; METABOLIC SYNDROME; LOCI; TRAITS	A body mass index (BMI) >22kg/m(2) is a risk factor for type 2 diabetes (T2D) in Aboriginal Australians. To identify loci associated with BMI and T2D we undertook a genome-wide association study using 1,075,436 quality-controlled single nucleotide polymorphisms (SNPs) genotyped (Illumina 2.5M Duo Beadchip) in 402 individuals in extended pedigrees from a Western Australian Aboriginal community. Imputation using the thousand genomes (1000G) reference panel extended the analysis to 6,724,284 post quality-control autosomal SNPs. No associations achieved genome-wide significance, commonly accepted as P<5x10(-8). Nevertheless, genes/pathways in common with other ethnicities were identified despite the arrival of Aboriginal people in Australia >45,000 years ago. The top hit (rs10868204 P-genotyped = 1.50x10(-6); rs11140653 P-imputed_1000G = 2.90x10(-7)) for BMI lies 5' of NTRK2, the type 2 neurotrophic tyrosine kinase receptor for brain-derived neurotrophic factor (BDNF) that regulates energy balance downstream of melanocortin-4 receptor (MC4R). PIK3C2G (rs12816270 P-genotyped = 8.06x10(-6); rs10841048 P-imputed_1000G = 6.28x10(-7)) was associated with BMI, but not with T2D as reported elsewhere. BMI also associated with CNTNAP2 (rs6960319 P-genotyped = 4.65x10(-5); rs13225016 P-imputed_1000G = 6.57x10(-5)), previously identified as the strongest gene-by-environment interaction for BMI in African-Americans. The top hit (rs11240074 P-genotyped = 5.59x10-6, P-imputed_1000G = 5.73x10(-6)) for T2D lies 5' of BCL9 that, along with TCF7L2, promotes beta-catenin's transcriptional activity in the WNT signaling pathway. Additional hits occurred in genes affecting pancreatic (KCNJ6, KCNA1) and/or GABA (GABRR1, KCNA1) functions. Notable associations observed for genes previously identified at genome-wide significance in other populations included MC4R (P-genotyped = 4.49x10(-4)) for BMI and IGF2BP2 P-imputed_1000G = 2.55x10(-6)) for T2D. Our results may provide novel functional leads in understanding disease pathogenesis in this Australian Aboriginal population.	[Anderson, Denise; Fakiola, Michaela; Francis, Richard W.; Syn, Genevieve; Scaman, Elizabeth S. H.; Davis, Elizabeth; Jamieson, Sarra E.; Blackwell, Jenefer M.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA 6008, Australia; [Cordell, Heather J.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge, England; [Fakiola, Michaela; Blackwell, Jenefer M.] Univ Cambridge, Dept Pathol, Cambridge, England; [Davis, Elizabeth] Princess Margaret Hosp Children, Dept Endocrinol & Diabet, Subiaco, WA 6008, Australia; [Miles, Simon J.; McLeay, Toby] Ngangganawili Aboriginal Hlth Serv, Wiluna, WA 6646, Australia	Telethon Kids Institute; University of Western Australia; Newcastle University - UK; University of Cambridge; University of Cambridge	Blackwell, JM (corresponding author), Univ Western Australia, Telethon Kids Inst, Subiaco, WA 6008, Australia.	jenefer.blackwell@telethonkids.org.au	Blackwell, Jenefer M/H-3015-2015; Francis, Richard/K-2812-2019	Francis, Richard/0000-0003-1580-7934; Davis, Elizabeth/0000-0003-4244-5473; Cordell, Heather/0000-0002-1879-5572; Fakiola, Michaela/0000-0001-9071-4709; Anderson, Denise/0000-0003-0643-4136	Australian National Health and Medical Research Council [APP634301]; Wellcome Trust [087436/Z/08/Z, 102858/Z/13/Z]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the Australian National Health and Medical Research Council (APP634301). HJC is supported by a Senior Research Fellowship in Basic Biomedical Science from the Wellcome Trust (Grant references 087436/Z/08/Z and 102858/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Al Safar HS, 2013, ANN HUM GENET, V77, P488, DOI 10.1111/ahg.12036; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alsmadi O, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-72; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Brudno M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-66; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Carlsson S, 2013, DIABETOLOGIA, V56, P1031, DOI 10.1007/s00125-013-2859-3; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Daimon M, 2008, BIOCHEM BIOPH RES CO, V365, P466, DOI 10.1016/j.bbrc.2007.10.180; Daniel M, 2002, DIABETES RES CLIN PR, V57, P23, DOI 10.1016/S0168-8227(02)00006-2; Davenport S, 2005, CLEARED OUT 1 CONTRA; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dodson M, 1999, J MED ETHICS, V25, P204, DOI 10.1136/jme.25.2.204; Donnelly P, 2011, SCIENCE, V331, P1024, DOI 10.1126/science.1204089; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Edwards DRV, 2013, HUM GENET, V132, P323, DOI 10.1007/s00439-012-1246-3; Ereqat S, 2010, ACTA DIABETOL, V47, pS195, DOI 10.1007/s00592-009-0161-0; Eu-ahsunthornwattana J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004445; Fesinmeyer MD, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-6; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gillett G, 2007, SOC SCI MED, V65, P2093, DOI 10.1016/j.socscimed.2007.06.024; Gottgens B, 2001, GENOME RES, V11, P87, DOI 10.1101/gr.153001; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Gunther T, 2011, OMICS, V15, P507, DOI 10.1089/omi.2010.0154; Guo TW, 2007, DIABETES, V56, P3082, DOI 10.2337/db07-0621; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Harb G, 2009, DIABETES, V58, P1852, DOI 10.2337/db08-0759; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hindorff LA, 2009, CATALOG PUBLISHED GE; Ho LKF, 1997, BIOCHEM BIOPH RES CO, V235, P130, DOI 10.1006/bbrc.1997.6747; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUGHES MJ, 1989, BIOCHEMISTRY-US, V28, P9137, DOI 10.1021/bi00449a027; Ikeno M, 2012, NUCLEIC ACIDS RES, V40, P10742, DOI 10.1093/nar/gks874; Johnson W, 2013, AM J HUM BIOL, V25, P378, DOI 10.1002/ajhb.22385; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kowal E., 2012, GENETIC RES ABORIGIN; Kowal E, 2012, BIOMAPPING INDIGENOU; Kowal E, 2012, J BIOETHIC INQ, V9, P419, DOI 10.1007/s11673-012-9391-x; Kowal EE, 2012, MED J AUSTRALIA, V197, P384, DOI 10.5694/mja.12.11113; Kowal EE, 2012, MED J AUSTRALIA, V197, P19, DOI 10.5694/mja12.10531; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Lin HJ, 2013, OPHTHALMIC GENET, V34, P35, DOI 10.3109/13816810.2012.736590; Lin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009697; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Ma ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018213; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McInnes RR, 2011, AM J HUM GENET, V88, P254, DOI 10.1016/j.ajhg.2011.02.014; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Murphy R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/920214; Naciff JM, 2005, TOXICOL SCI, V86, P396, DOI 10.1093/toxsci/kfi198; Nelson SC, 2013, G3-GENES GENOM GENET, V3, P1795, DOI 10.1534/g3.113.007161; Ning F, 2013, BEHAV GENET, V43, P340, DOI 10.1007/s10519-013-9597-7; Okamoto K, 2010, AM J HUM GENET, V86, P54, DOI 10.1016/j.ajhg.2009.12.009; Olney JJ, 2014, NEUROPEPTIDES, V48, P47, DOI 10.1016/j.npep.2013.11.001; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Qin LJ, 2013, GENET MOL RES, V12, P2990, DOI 10.4238/2013.August.20.1; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Robbins CA, 2012, EPILEPSIA, V53, P134, DOI 10.1111/j.1528-1167.2012.03484.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Saadi H, 2008, DIABETES RES CLIN PR, V80, P392, DOI 10.1016/j.diabres.2008.01.008; SAKURA H, 1995, FEBS LETT, V367, P193, DOI 10.1016/0014-5793(95)00498-X; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shia WC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S23; Skowronski AA, 2014, OBESITY, V22, P1287, DOI 10.1002/oby.20678; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Taneera J, 2012, DIABETOLOGIA, V55, P1985, DOI 10.1007/s00125-012-2548-7; Tonkinson R., 1991, MARDU ABORIGINES LIV; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; Vuillaume ML, 2014, AM J MED GENET A, V164, P1965, DOI 10.1002/ajmg.a.36587; Wagner R, 2014, MOL METAB, V3, P261, DOI 10.1016/j.molmet.2014.01.001; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xi B, 2014, CLIN ENDOCRINOL, V81, P702, DOI 10.1111/cen.12428; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	105	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119333	10.1371/journal.pone.0119333	http://dx.doi.org/10.1371/journal.pone.0119333			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760438	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000054
J	Besson, MT; Alegria, K; Garrido-Gerter, P; Barros, LF; Lievens, JC				Besson, Marie Therse; Alegria, Karin; Garrido-Gerter, Pamela; Barros, Luis Felipe; Lievens, Jean-Charles			Enhanced Neuronal Glucose Transporter Expression Reveals Metabolic Choice in a HD Drosophila Model	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; COMPLEX-II DEFECTS; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MITOCHONDRIAL DYSFUNCTION; CELL-DEATH; IN-VIVO; BRAIN; GENE	Huntington's disease is a neurodegenerative disorder caused by toxic insertions of polyglutamine residues in the Huntingtin protein and characterized by progressive deterioration of cognitive and motor functions. Altered brain glucose metabolism has long been suggested and a possible link has been proposed in HD. However, the precise function of glucose transporters was not yet determined. Here, we report the effects of the specifically-neuronal human glucose transporter expression in neurons of a Drosophila model carrying the exon 1 of the human huntingtin gene with 93 glutamine repeats (HQ93). We demonstrated that overexpression of the human glucose transporter in neurons ameliorated significantly the status of HD flies by increasing their lifespan, reducing their locomotor deficits and rescuing eye neurodegeneration. Then, we investigated whether increasing the major pathways of glucose catabolism, glycolysis and pentose-phosphate pathway (PPP) impacts HD. To mimic increased glycolytic flux, we overexpressed phosphofructokinase (PFK) which catalyzes an irreversible step in glycolysis. Overexpression of PFK did not affect HQ93 fly survival, but protected from photoreceptor loss. Overexpression of glucose-6-phosphate dehydrogenase (G6PD), the key enzyme of the PPP, extended significantly the lifespan of HD flies and rescued eye neurodegeneration. Since G6PD is able to synthesize NADPH involved in cell survival by maintenance of the redox state, we showed that tolerance to experimental oxidative stress was enhanced in flies co-expressing HQ93 and G6PD. Additionally overexpressions of hGluT3, G6PD or PFK were able to circumvent mitochondrial deficits induced by specific silencing of genes necessary for mitochondrial homeostasis. Our study confirms the involvement of bioenergetic deficits in HD course; they can be rescued by specific expression of a glucose transporter in neurons. Finally, the PPP and, to a lesser extent, the glycolysis seem to mediate the hGluT3 protective effects, whereas, in addition, the PPP provides increased protection to oxidative stress.	[Besson, Marie Therse; Lievens, Jean-Charles] Aix Marseille Univ, CNRS, CRN2M, UMR7286, F-13344 Marseille 15, France; [Alegria, Karin; Garrido-Gerter, Pamela; Barros, Luis Felipe] Ctr Estudios Cient, Valdivia, Chile; [Garrido-Gerter, Pamela] Univ Austral Chile, Valdivia, Chile	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universidad Austral de Chile	Besson, MT (corresponding author), Aix Marseille Univ, CNRS, CRN2M, UMR7286, F-13344 Marseille 15, France.	marie-therese.besson@univ-amu.fr		LIEVENS, Jean-Charles/0000-0002-0139-2291	CHDI Foundation, Inc.; Centre National de la Recherche Scientifique (CNRS); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	CHDI Foundation, Inc.; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT	This work was supported by a generous grant from the CHDI Foundation, Inc. and by the Centre National de la Recherche Scientifique (CNRS). The Centro de Estudios Cientificos (CECs) is funded by the Chilean Government through the Centers of Excellence Basal Financing Program of CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Besson MT, 2010, HUM MOL GENET, V19, P3372, DOI 10.1093/hmg/ddq249; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bittner C.X., 2010, FRONT NEUROENERGETIC, V2; Bittner CX, 2011, J NEUROSCI, V31, P4709, DOI 10.1523/JNEUROSCI.5311-10.2011; Bolanos JP, 2010, IUBMB LIFE, V62, P14, DOI 10.1002/iub.280; Brekke EMF, 2012, J CEREBR BLOOD F MET, V32, P1788, DOI 10.1038/jcbfm.2012.85; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Cocco T, 2009, NEUROBIOL AGING, V30, P622, DOI 10.1016/j.neurobiolaging.2007.08.002; COLVILLE CA, 1993, BIOCHEM J, V290, P701, DOI 10.1042/bj2900701; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; Costa V, 2012, EMBO J, V31, P1853, DOI 10.1038/emboj.2012.65; Damiano M, 2013, HUM MOL GENET, V22, P3869, DOI 10.1093/hmg/ddt242; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Dunn L, 2014, NEUROBIOL AGING, V35, P1111, DOI 10.1016/j.neurobiolaging.2013.11.001; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Escher SA, 1999, HEREDITAS, V130, P95, DOI 10.1111/j.1601-5223.1999.00095.x; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Freije WA, 2012, G3-GENES GENOM GENET, V2, P843, DOI 10.1534/g3.112.002584; GAMBERINO WC, 1994, J NEUROCHEM, V63, P1392; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Gouarne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081528; Haselton AT, 2010, AGING-US, V2, P523, DOI 10.18632/aging.100185; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jeong SJ, 2006, INT J DEV NEUROSCI, V24, P81, DOI 10.1016/j.ijdevneu.2005.10.001; Kim SY, 2005, NEUROCHEM RES, V30, P1245, DOI 10.1007/s11064-005-8796-x; Kita H, 2002, HUM MOL GENET, V11, P2279, DOI 10.1093/hmg/11.19.2279; Klepac N, 2007, J NEUROL, V254, P1676, DOI 10.1007/s00415-007-0611-y; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Krzyszton-Russjan J, 2013, J BIOENERG BIOMEMBR, V45, P71, DOI 10.1007/s10863-012-9479-3; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Legan SK, 2008, J BIOL CHEM, V283, P32492, DOI 10.1074/jbc.M805832200; Leino RL, 1997, J NEUROSCI RES, V49, P617; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MAHER F, 1992, BIOCHEM BIOPH RES CO, V182, P703, DOI 10.1016/0006-291X(92)91789-S; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; Mason RP, 2013, NAT GENET, V45, P1249, DOI 10.1038/ng.2732; Mazzola JL, 2002, MOL BRAIN RES, V100, P95, DOI 10.1016/S0169-328X(02)00160-2; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Mochel F, 2011, J CLIN INVEST, V121, P493, DOI 10.1172/JCI45691; Moumne L, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00127; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Oliveira JMA, 2010, J NEUROCHEM, V114, P1, DOI 10.1111/j.1471-4159.2010.06741.x; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Reddy PH, 2009, BRAIN RES REV, V61, P33, DOI 10.1016/j.brainresrev.2009.04.001; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Rzezniczak TZ, 2012, G3-GENES GENOM GENET, V2, P1613, DOI 10.1534/g3.112.003715; Senatorov VV, 2003, MOL CELL NEUROSCI, V22, P285, DOI 10.1016/S1044-7431(02)00013-1; Shin H, 2013, J CLIN NEUROL, V9, P21, DOI 10.3988/jcn.2013.9.1.21; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Smith R, 2009, HUM MOL GENET, V18, P3942, DOI 10.1093/hmg/ddp336; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Stack EC, 2008, ANN NY ACAD SCI, V1147, P79, DOI 10.1196/annals.1427.008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Turner C, 2010, J BIOENERG BIOMEMBR, V42, P193, DOI 10.1007/s10863-010-9290-y; Ugalde C, 2009, ADV EXP MED BIOL, V652, P85, DOI 10.1007/978-90-481-2813-6_7; Umeda-Kameyama Y, 2007, J BIOL CHEM, V282, P11180, DOI 10.1074/jbc.M700937200; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; VANNUCCI SJ, 1994, J NEUROCHEM, V62, P240; Varma H, 2007, P NATL ACAD SCI USA, V104, P14525, DOI 10.1073/pnas.0704482104; Vittori A, 2014, HUM MOL GENET, V23, P3129, DOI 10.1093/hmg/ddu022; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CT, 2012, AGING CELL, V11, P93, DOI 10.1111/j.1474-9726.2011.00762.x; Zabel C, 2009, MOL CELL PROTEOMICS, V8, P720, DOI 10.1074/mcp.M800277-MCP200	85	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118765	10.1371/journal.pone.0118765	http://dx.doi.org/10.1371/journal.pone.0118765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761110	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000038
J	Cuthbert, RJ; Giannoudis, PV; Wang, XN; Nicholson, L; Pawson, D; Lubenko, A; Tan, HB; Dickinson, A; McGonagle, D; Jones, E				Cuthbert, Richard J.; Giannoudis, Peter V.; Wang, Xiao N.; Nicholson, Lindsay; Pawson, David; Lubenko, Anatole; Tan, Hiang B.; Dickinson, Anne; McGonagle, Dennis; Jones, Elena			Examining the Feasibility of Clinical Grade CD271(+) Enrichment of Mesenchymal Stromal Cells for Bone Regeneration	PLOS ONE			English	Article							REAMER-IRRIGATOR-ASPIRATOR; VERSUS-HOST-DISEASE; STEM-CELLS; STEROID-RESISTANT; TRABECULAR BONE; FLOW-CYTOMETRY; MARROW; GROWTH; TRANSPLANTATION; OPTIMIZATION	Introduction Current clinical trials utilize mesenchymal stromal cells (MSCs) expanded in culture, however these interventions carry considerable costs and concerns pertaining to culture-induced losses of potency. This study assessed the feasibility of new clinical-grade technology to obtain uncultured MSC isolates from three human intra-osseous tissue sources based on immunomagnetic selection for CD271-positive cells. Materials and Methods MSCs were isolated from bone marrow (BM) aspirates or surgical waste materials; enzy-matically digested femoral heads (FHs) and reamer irrigator aspirator (RIA) waste fluids. Flow cytometry for the CD45(-/low) CD73(+) CD271(+) phenotype was used to evaluate uncultured MSCs before and after selection, and to measure MSC enrichment in parallel to colony forming-unit fibroblast assay. Trilineage differentiation assays and quantitative polymerase chain-reaction for key transcripts involved in bone regeneration was used to assess the functional utility of isolated cells for bone repair. Results Uncultured CD45(-/ low) CD271(+) MSCs uniformly expressed CD73, CD90 and CD105 but showed variable expression of MSCA-1 and SUSD2 (BM>RIA>FH). MSCs were enriched over 150-fold from BM aspirates and RIA fluids, whereas the highest MSC purities were obtained from FH digests. Enriched fractions expressed increased levels of BMP-2, COL1A2, VEGFC, SPARC and CXCL12 transcripts (BM>RIA>FH), with the highest up-regulation detected for CXCL12 in BM (>1300-fold). Following culture expansion, CD271-selected MSCS were tri-potential and phenotypically identical to plastic adherence-selected MSCs. Discussion A CD271-based GMP-compliant immunomagnetic selection resulted in a substantial increase in MSC purity and elevated expression of transcripts involved in bone formation, vascularisation and chemo-attraction. Although this technology, particularly from RIA fluids, can be immediately applied by orthopaedic surgeons as autologous therapy, further improvements in MSC purities and pre-clinical testing of product safety would be required to develop this process for allogeneic applications.	[Cuthbert, Richard J.; Giannoudis, Peter V.; Tan, Hiang B.; McGonagle, Dennis; Jones, Elena] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Wang, Xiao N.; Nicholson, Lindsay; Dickinson, Anne] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pawson, David; Lubenko, Anatole] Leeds Blood Ctr, Natl Hlth Serv Blood & Transplant, Leeds, W Yorkshire, England	University of Leeds; Newcastle University - UK; NHS Blood & Transplant (NHSBT)	Cuthbert, RJ (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.	medrjc@leeds.ac.uk	Giannoudis, Peter/AAA-3617-2020; Jones, Elena/AAL-2818-2021	Giannoudis, Peter/0000-0002-5205-7696; Jones, Elena/0000-0001-9365-2283; Dickinson, Anne/0000-0002-7356-7636	NIHR/LMBRU; WELMEC, a Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC [WT 088908/Z/09/Z]; Arthritis Research UK [19429]; CellEurope project, FP7-People-ITN [315963]	NIHR/LMBRU(National Institute for Health Research (NIHR)); WELMEC, a Centre of Excellence in Medical Engineering - Wellcome Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arthritis Research UK(Versus Arthritis); CellEurope project, FP7-People-ITN	This work was part-funded by the NIHR/LMBRU and WELMEC, a Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC, under grant number WT 088908/Z/09/Z. Additional funding came from Arthritis Research UK Award 19429 and CellEurope project, FP7-People-2012-ITN, No. 315963. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Aslan H, 2006, STEM CELLS, V24, P1728, DOI 10.1634/stemcells.2005-0546; Bianco P, 2013, EMBO J, V32, P1489, DOI 10.1038/emboj.2013.114; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Carcenac M, 2001, BRIT J CANCER, V85, P1787, DOI 10.1054/bjoc.2001.2170; Churchman SM, 2013, EUR CELLS MATER, V26, P252, DOI 10.22203/eCM.v026a18; Churchman SM, 2012, ARTHRITIS RHEUM-US, V64, P2632, DOI 10.1002/art.34434; Couto DS, 2012, TISSUE ENG PT A, V18, P2386, DOI [10.1089/ten.tea.2011.0639, 10.1089/ten.TEA.2011.0639]; Cox G, 2011, J BONE JOINT SURG BR, V93B, P517, DOI 10.1302/0301-620X.93B4.25506; Cox G, 2012, BONE, V50, P510, DOI 10.1016/j.bone.2011.07.016; Cuthbert R, 2012, CYTOTHERAPY, V14, P431, DOI 10.3109/14653249.2011.651533; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dozza B, 2011, J ORTHOP RES, V29, P961, DOI 10.1002/jor.21333; Dvorak CC, 2013, BONE MARROW TRANSPL, V48, P508, DOI 10.1038/bmt.2012.186; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2013, INT ORTHOP, V37, P2279, DOI 10.1007/s00264-013-2017-z; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Jarocha D, 2006, BLOOD, V108, p725A, DOI 10.1182/blood.V108.11.2566.2566; Jones E, 2010, ARTHRITIS RHEUM-US, V62, P1944, DOI 10.1002/art.27451; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li H, 2014, STEM CELL REP, V3, P1, DOI [10.1016/j.stemcr.2014.06.009, DOI 10.1016/J.STEMCR.2014.06.009]; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Mabuchi Y, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/507301; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Murphy JM, 2002, ARTHRITIS RHEUM-US, V46, P704, DOI 10.1002/art.10118; National Joint Registry for E Wales, 2011, ANN REPORT; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poloni A, 2009, CYTOTHERAPY, V11, P153, DOI 10.1080/14653240802582125; Porter RM, 2009, J ORTHOP RES, V27, P42, DOI 10.1002/jor.20715; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Qian H, 2012, J BIOL CHEM, V287, P25795, DOI 10.1074/jbc.M112.339622; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sato T, 2011, LAB INVEST, V91, P553, DOI 10.1038/labinvest.2010.202; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Sensebe L, 2012, CELL STEM CELL, V10, P9, DOI 10.1016/j.stem.2011.12.005; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Sobiesiak M, 2010, STEM CELLS DEV, V19, P669, DOI 10.1089/scd.2009.0290; TERSTAPPEN LWMM, 1988, CYTOMETRY, V9, P548, DOI 10.1002/cyto.990090607; Tormin A, 2011, BLOOD, V117, P5067, DOI 10.1182/blood-2010-08-304287; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Veyrat-Masson R, 2007, BRIT J HAEMATOL, V139, P312, DOI 10.1111/j.1365-2141.2007.06786.x; Vulcano E, 2013, EUR REV MED PHARMACO, V17, P2240; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Watson JT, 2013, CELLS TISSUES ORGANS, V197, P496, DOI 10.1159/000348794; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	60	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117855	10.1371/journal.pone.0117855	http://dx.doi.org/10.1371/journal.pone.0117855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760857	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000013
J	Li, Y; Balasubramanian, U; Cohen, D; Zhang, PW; Mosmiller, E; Sattler, R; Maragakis, NJ; Rothstein, JD				Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Mosmiller, Elizabeth; Sattler, Rita; Maragakis, Nicholas J.; Rothstein, Jeffrey D.			A Comprehensive Library of Familial Human Amyotrophic Lateral Sclerosis Induced Pluripotent Stem Cells	PLOS ONE			English	Article							MOTOR-NEURON DEGENERATION; HEXANUCLEOTIDE REPEAT; HUMAN FIBROBLASTS; IPS CELLS; ALS; DISEASE; GENE; ASTROCYTES; EFFICIENT; SOD1	Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower motor neurons, leading to paralysis of voluntary muscles. About 10% of all ALS cases are familial (fALS), among which 15-20% are linked to Cu/Zn superoxide dismutase (SOD1) mutations, usually inherited in an autosomal dominant manner. To date only one FDA approved drug is available which increases survival moderately. Our understanding of ALS disease mechanisms is largely derived from rodent model studies, however due to the differences between rodents and humans, it is necessary to have humanized models for studies of disease pathogenesis as well as drug development. Therefore, we generated a comprehensive library of a total 22 of fALS patient-specific induced pluripotent stem cell (iPSC) lines. These cells were thoroughly characterized before being deposited into the library. The library of cells includes a variety of C9orf72 mutations, sod1 mutations, FUS, ANG and FIG4 mutations. Certain mutations are represented with more than one line, which allows for studies of variable genetic backgrounds. In addition, these iPSCs can be successfully differentiated to astroglia, a cell type known to play a critical role in ALS disease progression. This library represents a comprehensive resource that can be used for ALS disease modeling and the development of novel therapeutics.	[Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Mosmiller, Elizabeth; Sattler, Rita; Maragakis, Nicholas J.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Li, Ying; Balasubramanian, Umamahesw; Cohen, Devon; Zhang, Ping-Wu; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Mosmiller, Elizabeth; Maragakis, Nicholas J.] Ansari ALS Ctr Stem Cell & Regenerat Res Johns Ho, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	jrothstein@jhmi.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020		National Institutes of Health (NIH/NINDS) [NS069395, 5U24NS078736]; P2ALS; Robert Packard Center for ALS Research; Emerald Foundation; Brain Science Institute and Muscular Dystrophy Association; ALS Association; NIH/NINDS [5U01NS062713]; Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS078736, R01NS085207, U01NS062713] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); P2ALS; Robert Packard Center for ALS Research; Emerald Foundation; Brain Science Institute and Muscular Dystrophy Association; ALS Association; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health (NIH/NINDS; NS069395; 5U24NS078736), P2ALS, Robert Packard Center for ALS Research, Emerald Foundation, Brain Science Institute and Muscular Dystrophy Association (to J. D. R.); the ALS Association (Milton Safenowitz Postdoctoral Fellowship to Y. L.); NIH/NINDS 5U01NS062713, Department of Defense ALSRP, Ansari Center for ALS Cell Therapy and Regeneration Research at Johns Hopkins (to N. J. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corti S, 2010, HUM MOL GENET, V19, P3782, DOI 10.1093/hmg/ddq293; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Hu BY, 2009, NAT PROTOC, V4, P1295, DOI 10.1038/nprot.2009.127; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mulder D W, 1982, Adv Neurol, V36, P15; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Su Z., 2014, NEURON; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043099; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	63	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118266	10.1371/journal.pone.0118266	http://dx.doi.org/10.1371/journal.pone.0118266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760436	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275000021
J	Scott, JJ; Breier, JA; Luther, GW; Emerson, D				Scott, Jarrod J.; Breier, John A.; Luther, George W., III; Emerson, David			Microbial Iron Mats at the Mid-Atlantic Ridge and Evidence that Zetaproteobacteria May Be Restricted to Iron-Oxidizing Marine Systems	PLOS ONE			English	Article							SHRIMP RIMICARIS-EXOCULATA; DEEP-SEA; HYDROTHERMAL VENTS; RARE BIOSPHERE; LOIHI SEAMOUNT; GILL CHAMBER; DIVERSITY; BACTERIA; COMMUNITIES; ECOLOGY	Chemolithoautotrophic iron-oxidizing bacteria play an essential role in the global iron cycle. Thus far, the majority of marine iron-oxidizing bacteria have been identified as Zetaproteobacteria, a novel class within the phylum Proteobacteria. Marine iron-oxidizing microbial communities have been found associated with volcanically active seamounts, crustal spreading centers, and coastal waters. However, little is known about the presence and diversity of iron-oxidizing communities at hydrothermal systems along the slow crustal spreading center of the Mid-Atlantic Ridge. From October to November 2012, samples were collected from rust-colored mats at three well-known hydrothermal vent systems on the Mid-Atlantic Ridge (Rainbow, Trans-Atlantic Geotraverse, and Snake Pit) using the ROV Jason II. The goal of these efforts was to determine if iron-oxidizing Zetaproteobacteria were present at sites proximal to black smoker vent fields. Small, diffuse flow venting areas with high iron(II) concentrations and rust-colored microbial mats were observed at all three sites proximal to black smoker chimneys. A novel, syringe-based precision sampler was used to collect discrete microbial iron mat samples at the three sites. The presence of Zetaproteobacteria was confirmed using a combination of 16S rRNA pyrosequencing and single-cell sorting, while light micros-copy revealed a variety of iron-oxyhydroxide structures, indicating that active iron-oxidizing communities exist along the Mid-Atlantic Ridge. Sequencing analysis suggests that these iron mats contain cosmopolitan representatives of Zetaproteobacteria, but also exhibit diversity that may be uncommon at other iron-rich marine sites studied to date. A meta-analysis of publically available data encompassing a variety of aquatic habitats indicates that Zetaproteobacteria are rare if an iron source is not readily available. This work adds to the growing understanding of Zetaproteobacteria ecology and suggests that this organism is likely locally restricted to iron-rich marine environments but may exhibit wide-scale geographic distribution, further underscoring the importance of Zetaproteobacteria in global iron cycling.	[Scott, Jarrod J.; Emerson, David] Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Breier, John A.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Luther, George W., III] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE USA	Bigelow Laboratory for Ocean Sciences; Woods Hole Oceanographic Institution; University of Delaware	Scott, JJ (corresponding author), Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA.	jscott@bigelow.org	Luther, George/A-6384-2008	Luther, George/0000-0002-0780-885X; Scott, Jarrod/0000-0001-9863-1318; Breier, John/0000-0002-3591-5548	National Science Foundation [OCE-0926805, OCE-1155754, OCE-1131109]; National Aeronautics and Space Administration [NNX12AG20G]; Division Of Ocean Sciences [1155754, 1131109] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation [grants OCE-0926805 (DE and JAB), OCE-1155754 (DE), and OCE-1131109 (GWL)] and the National Aeronautics and Space Administration [NNX12AG20G (GWL and DE)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agogue H, 2011, MOL ECOL, V20, P258, DOI 10.1111/j.1365-294X.2010.04932.x; ALT JC, 1988, MAR GEOL, V81, P227, DOI 10.1016/0025-3227(88)90029-1; Amaral-Zettler Linda, 2010, P223; Baker ET, 2004, GEOPHYS MONOGR SER, V148, P245, DOI 10.1029/148GM10; Bennett SA, 2011, GEOCHIM COSMOCHIM AC, V75, P5526, DOI 10.1016/j.gca.2011.06.039; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bourbonnais A, 2014, ANN MICROBIOL, V64, P1; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Breier JA, 2012, DEEP-SEA RES PT I, V70, P83, DOI 10.1016/j.dsr.2012.10.006; Chan CS, 2011, ISME J, V5, P717, DOI 10.1038/ismej.2010.173; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Dang HY, 2011, ENVIRON MICROBIOL, V13, P3059, DOI 10.1111/j.1462-2920.2011.02583.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dubilier N, 2001, NATURE, V411, P298, DOI 10.1038/35077067; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards KJ, 2011, ISME J, V5, P1748, DOI 10.1038/ismej.2011.48; Edwards KJ, 2005, TRENDS MICROBIOL, V13, P449, DOI 10.1016/j.tim.2005.07.005; Ellis D., 1919, IRON BACTERIA; Emerson D, 2004, GEOMICROBIOL J, V21, P405, DOI 10.1080/01490450490485881; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Emerson D, 2002, APPL ENVIRON MICROB, V68, P3085, DOI 10.1128/AEM.68.6.3085-3093.2002; Emerson D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000667; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Emerson D, 2010, OCEANOGRAPHY, V23, P148, DOI 10.5670/oceanog.2010.67; Field EK, 2014, ISME J, P1, DOI [10.1038/ismej.2014.99, DOI 10.1038/ISMEJ.2014.99]; Fleming EJ, 2014, ISME J, V8, P804, DOI 10.1038/ismej.2013.197; Fleming EJ, 2013, FEMS MICROBIOL ECOL, V85, P116, DOI 10.1111/1574-6941.12104; Flores GE, 2012, GEOBIOLOGY, V10, P333, DOI 10.1111/j.1472-4669.2012.00325.x; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Gartman A, 2014, CHEM GEOL, V366, P32, DOI 10.1016/j.chemgeo.2013.12.013; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Govenar B, 2012, OCEANOGRAPHY, V25, P246, DOI 10.5670/oceanog.2012.23; Harder E. C., 1919, IRON DEPOSITING BACT; HAYMON RM, 1983, NATURE, V301, P695, DOI 10.1038/301695a0; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; Jannasch HW, 1995, P ROY SOC LOND B BIO, V225, P277; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; KEMPTON RA, 1978, NATURE, V275, P252, DOI 10.1038/275252a0; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; MacDonald DJ, 2014, ENVIRON SCI-PROC IMP, V16, P2117, DOI 10.1039/c4em00073k; McBeth JM, 2011, APPL ENVIRON MICROB, V77, P1405, DOI 10.1128/AEM.02095-10; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Perner M, 2013, GEOBIOLOGY, V11, P340, DOI 10.1111/gbi.12039; Perner M, 2013, ENVIRON MICROBIOL, V15, P1551, DOI 10.1111/1462-2920.12038; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Reysenbach AL, 2006, NATURE, V442, P444, DOI 10.1038/nature04921; Roden EE, 2004, GEOMICROBIOL J, V21, P379, DOI 10.1080/01490450490485872; Roden EE, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00172; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Rubin-Blum M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091456; Saito MA, 2013, NAT GEOSCI, V6, P775, DOI [10.1038/ngeo1893, 10.1038/NGEO1893]; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sievert SM, 2012, OCEANOGRAPHY, V25, P218, DOI 10.5670/oceanog.2012.21; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025386; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Sylvan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00279-11; Toner BM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00118; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 1988, MAR BIOL, V98, P209, DOI 10.1007/BF00391196; Von Damm K.L., 1995, SEAFLOOR HYDROTHERMA, P222, DOI DOI 10.1029/GM091P0222; Wang JJ, 2009, ISME J, V3, P715, DOI 10.1038/ismej.2009.7; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; WIRSEN CO, 1993, J GEOPHYS RES-SOL EA, V98, P9693, DOI 10.1029/92JB01556; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026161; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237	99	45	46	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119284	10.1371/journal.pone.0119284	http://dx.doi.org/10.1371/journal.pone.0119284			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760332	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000052
J	Meyer, MR; Shah, S; Zhang, J; Rohrs, H; Rao, AG				Meyer, Matthew R.; Shah, Shweta; Zhang, J.; Rohrs, Henry; Rao, A. Gururaj			Evidence for Intermolecular Interactions between the Intracellular Domains of the Arabidopsis Receptor-Like Kinase ACR4, Its Homologs and the Wox5 Transcription Factor	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BRASSINOSTEROID SIGNAL-TRANSDUCTION; PROTEIN-PROTEIN INTERACTIONS; TGF-BETA RECEPTOR; TYROSINE KINASE; MASS-SPECTROMETRY; GENE FAMILY; ACTIVATION; EXCHANGE; HETERODIMERIZATION	Arabidopsis CRINKLY4 (ACR4) is a receptor-like kinase (RLK) involved in the global development of the plant. The Arabidopsis genome encodes four homologs of ACR4 that contain sequence similarity and analogous architectural elements to ACR4, termed Arabidopsis CRINKLY4 Related (AtCRRs) proteins. Additionally, a signaling module has been previously proposed including a postulated peptide ligand, CLE40, the ACR4 RLK, and the WOX5 transcription factor that engage in a possible feedback mechanism controlling stem cell differentiation. However, little biochemical evidence is available to ascertain the molecular aspects of receptor heterodimerization and the role of phosphorylation in these interactions. Therefore, we have undertaken an investigation of the in vitro interactions between the intracellular domains (ICD) of ACR4, the CRRs and WOX5. We demonstrate that interaction can occur between ACR4 and all four CRRs in the unphosphorylated state. However, phosphorylation dependency is observed for the interaction between ACR4 and CRR3. Furthermore, sequence analysis of the ACR4 gene family has revealed a conserved 'KDSAF' motif that may be involved in protein-protein interactions among the receptor family. We demonstrate that peptides harboring this conserved motif in CRR3 and CRK1are able to bind to the ACR4 kinase domain. Our investigations also indicate that the ACR4 ICD can interact with and phosphorylate the transcription factor WOX5.	[Shah, Shweta; Rao, A. Gururaj] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Meyer, Matthew R.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Zhang, J.; Rohrs, Henry] Washington Univ, Dept Chem, NIH NCRR Ctr Biomed & Bioorgan Mass Spectrometry, St Louis, MO 63130 USA	Iowa State University; Washington University (WUSTL); Washington University (WUSTL)	Rao, AG (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gururao@iastate.edu			Iowa State University	Iowa State University	The work was supported by internal funding from Iowa State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Albrecht C, 2008, PLANT PHYSIOL, V148, P611, DOI 10.1104/pp.108.123216; Bennett T, 2014, DEVELOPMENT, V141, P4055, DOI 10.1242/dev.110148; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busenlehner LS, 2005, ARCH BIOCHEM BIOPHYS, V433, P34, DOI 10.1016/j.abb.2004.09.002; Cao XY, 2005, PLANTA, V220, P645, DOI 10.1007/s00425-004-1378-3; Castells E, 2007, J EXP BOT, V58, P3503, DOI 10.1093/jxb/erm226; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; De Bodt S, 2012, NEW PHYTOL, V195, P707, DOI 10.1111/j.1469-8137.2012.04184.x; De Bodt S, 2010, PLANT PHYSIOL, V152, P1167, DOI 10.1104/pp.109.147215; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; Fiers M, 2007, CURR OPIN PLANT BIOL, V10, P39, DOI 10.1016/j.pbi.2006.11.003; Gifford ML, 2003, DEVELOPMENT, V130, P4249, DOI 10.1242/dev.00634; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Haffani YZ, 2004, CAN J BOT, V82, P1, DOI [10.1139/b03-126, 10.1139/B03-126]; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; He F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r181; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Llompart B, 2003, J BIOL CHEM, V278, P48105, DOI 10.1074/jbc.M307482200; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Meyer MR, 2013, ARCH BIOCHEM BIOPHYS, V535, P101, DOI 10.1016/j.abb.2013.03.014; Meyer MR, 2011, BIOCHEMISTRY-US, V50, P2170, DOI 10.1021/bi101935x; Miwa H, 2009, J PLANT RES, V122, P31, DOI 10.1007/s10265-008-0207-3; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Pascal BD, 2009, J AM SOC MASS SPECTR, V20, P601, DOI 10.1016/j.jasms.2008.11.019; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Soong TT, 2008, BIOINFORMATICS, V24, P2608, DOI 10.1093/bioinformatics/btn498; Stahl Y, 2013, CURR BIOL, V23, P362, DOI 10.1016/j.cub.2013.01.045; Stahl Y, 2009, CURR BIOL, V19, P909, DOI 10.1016/j.cub.2009.03.060; Stone JM, 1998, PLANT PHYSIOL, V117, P1217, DOI 10.1104/pp.117.4.1217; Tanaka H, 2002, PLANT CELL PHYSIOL, V43, P419, DOI 10.1093/pcp/pcf052; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wang GD, 2010, PROTOPLASMA, V240, P33, DOI 10.1007/s00709-009-0095-y; Wang XZ, 2008, INT J PATTERN RECOGN, V22, P1, DOI 10.1142/S0218001408006065; Watanabe M, 2004, PLANT J, V39, P298, DOI 10.1111/j.1365-313X.2004.02132.x; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yan Xuguang, 2009, V492, P255, DOI 10.1007/978-1-59745-493-3_15; Ye HX, 2011, J INTEGR PLANT BIOL, V53, P455, DOI 10.1111/j.1744-7909.2011.01046.x; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhou B, 2007, METHODS, V42, P227, DOI 10.1016/j.ymeth.2007.02.020; Zhou B, 2006, J BIOL CHEM, V281, P38834, DOI 10.1074/jbc.M608916200	73	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118861	10.1371/journal.pone.0118861	http://dx.doi.org/10.1371/journal.pone.0118861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756623	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700028
J	Crack, JC; Munnoch, J; Dodd, EL; Knowles, F; Al Bassam, MM; Kamali, S; Holland, AA; Cramer, SP; Hamilton, CJ; Johnson, MK; Thomson, AJ; Hutchings, MI; Le Brun, NE				Crack, Jason C.; Munnoch, John; Dodd, Erin L.; Knowles, Felicity; Al Bassam, Mahmoud M.; Kamali, Saeed; Holland, Ashley A.; Cramer, Stephen P.; Hamilton, Chris J.; Johnson, Michael K.; Thomson, Andrew J.; Hutchings, Matthew I.; Le Brun, Nick E.			NsrR from Streptomyces coelicolor Is a Nitric Oxide-sensing [4Fe-4S] Cluster Protein with a Specialized Regulatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; PYROCOCCUS-FURIOSUS FERREDOXIN; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; SPECTROSCOPIC CHARACTERIZATION; NEISSERIA-MENINGITIDIS; NITROSATIVE STRESS; S-NITROSYLATION; IDENTIFICATION; EXPRESSION	The Rrf2 family transcription factor NsrR controls expression of genes in a wide range of bacteria in response to nitric oxide (NO). The precise form of the NO-sensing module of NsrR is the subject of controversy because NsrR proteins containing either [2Fe-2S] or [4Fe-4S] clusters have been observed previously. Optical, Mossbauer, resonance Raman spectroscopies and native mass spectrometry demonstrate that Streptomyces coelicolor NsrR (ScNsrR), previously reported to contain a [2Fe-2S] cluster, can be isolated containing a [4Fe-4S] cluster. ChIP-seq experiments indicated that the ScNsrR regulon is small, consisting of only hmpA1, hmpA2, and nsrR itself. The hmpA genes encode NO-detoxifying flavohemoglobins, indicating that ScNsrR has a specialized regulatory function focused on NO detoxification and is not a global regulator like some NsrR orthologues. EMSAs and DNase I footprinting showed that the [4Fe-4S] form of ScNsrR binds specifically and tightly to an 11-bp inverted repeat sequence in the promoter regions of the identified target genes and that DNA binding is abolished following reaction with NO. Resonance Raman data were consistent with cluster coordination by three Cys residues and one oxygen-containing residue, and analysis of ScNsrR variants suggested that highly conserved Glu-85 may be the fourth ligand. Finally, we demonstrate that some low molecular weight thiols, but importantly not physiologically relevant thiols, such as cysteine and an analogue of mycothiol, bind weakly to the [4Fe-4S] cluster, and exposure of this bound form to O-2 results in cluster conversion to the [2Fe-2S] form, which does not bind to DNA. These data help to account for the observation of [2Fe-2S] forms of NsrR.	[Crack, Jason C.; Dodd, Erin L.; Thomson, Andrew J.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England; [Munnoch, John; Knowles, Felicity; Al Bassam, Mahmoud M.; Hutchings, Matthew I.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Hamilton, Chris J.] Univ E Anglia, Sch Pharm, Norwich NR4 7TJ, Norfolk, England; [Kamali, Saeed; Cramer, Stephen P.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Holland, Ashley A.; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Holland, Ashley A.; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA	University of East Anglia; University of East Anglia; University of East Anglia; University of California System; University of California Davis; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hutchings, MI (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	m.hutchings@uea.ac.uk; n.le-brun@uea.ac.uk	Regan, Clinton/E-6250-2012; hamilton, chris/C-5651-2009; Hutchings, Matthew/D-1923-2009	Le Brun, Nick/0000-0001-9780-4061; Hutchings, Matthew/0000-0001-6628-5940; Dodd, Erin/0000-0002-9870-2398; Crack, Jason C./0000-0002-4979-1910; Munnoch, John Tyson/0000-0002-9018-6026	National Institutes of Health [GM62524, GM65440]; Biotechnology and Biological Sciences Research Council [BB/J003247/1, BB/K02115X/1]; Natural Environment Research Council; BBSRC [BB/J003247/1, BB/L007673/1, BB/K02115X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L007673/1] Funding Source: researchfish; Natural Environment Research Council [1090758] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524, R01GM065440, R01GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62524 (to M. K. J.) and GM65440 (to S. P. C.). This work was also supported by Biotechnology and Biological Sciences Research Council Grants BB/J003247/1 (to N. L. B., M. I. H., and A. J. T.) and BB/K02115X/1 (to N. L. B.) and a Natural Environment Research Council Ph.D. studentship (to J. M.).	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Branchu P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003874; Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d; Bruckdorfer Richard, 2005, Molecular Aspects of Medicine, V26, P3, DOI 10.1016/j.mam.2004.09.002; CALZOLAI L, 1995, BIOCHEMISTRY-US, V34, P11373, DOI 10.1021/bi00036a010; Cervantes S, 2014, AUTOPHAGY, V10, P80, DOI 10.4161/auto.26743; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P11770, DOI 10.1021/bi0488505; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Crack JC, 2008, J AM CHEM SOC, V130, P1749, DOI 10.1021/ja077455+; Crack JC, 2014, METHODS MOL BIOL, V1122, P33, DOI 10.1007/978-1-62703-794-5_4; Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901; Crack JC, 2012, CURR OPIN CHEM BIOL, V16, P35, DOI 10.1016/j.cbpa.2012.02.009; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; CZERNUSZEWICZ RS, 1987, J AM CHEM SOC, V109, P7178, DOI 10.1021/ja00257a045; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; Demple B, 2002, MOL CELL BIOCHEM, V234, P11, DOI 10.1023/A:1015933216079; Dickson D. P. E., 1974, J PHYS-PARIS, DOI 10.1051/jphyscol:1974659; Fernandez-Martinez LT, 2011, ANTON LEEUW INT J G, V99, P515, DOI 10.1007/s10482-010-9518-1; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; GEORGE SJ, 1989, BIOCHEM J, V264, P275, DOI 10.1042/bj2640275; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Gruner I, 2011, J BIOL CHEM, V286, P2017, DOI 10.1074/jbc.M110.191940; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Heurlier K, 2008, J BACTERIOL, V190, P2488, DOI 10.1128/JB.01869-07; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Hutchings MI, 2002, J BACTERIOL, V184, P503, DOI 10.1128/JB.184.2.503-508.2002; Isabella VM, 2009, MOL MICROBIOL, V71, P227, DOI 10.1111/j.1365-2958.2008.06522.x; Jothivasan VK, 2008, NAT PROD REP, V25, P1091, DOI 10.1039/b616489g; Karlinsey JE, 2012, MOL MICROBIOL, V85, P1179, DOI 10.1111/j.1365-2958.2012.08167.x; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kieser T., 2000, PRACTICAL STREPTOMYC, P412; Kommineni S, 2010, MOL MICROBIOL, V78, P1280, DOI 10.1111/j.1365-2958.2010.07407.x; Kwon YM, 2009, J BACTERIOL, V191, P5369, DOI 10.1128/JB.00586-09; Moir JW, 2011, BIOCHEM SOC T, V39, P1890, DOI 10.1042/BST20110735; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; NEWTON GL, 1995, EUR J BIOCHEM, V230, P821; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568; Rancourt D.C., 1998, RECOIL MOSSBAUER SPE; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEPHENS PJ, 1978, BIOCHEMISTRY-US, V17, P4770, DOI 10.1021/bi00615a026; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stewart MJG, 2008, ORG BIOMOL CHEM, V6, P385, DOI 10.1039/b716380k; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623; Vine CE, 2011, FEMS MICROBIOL LETT, V325, P99, DOI 10.1111/j.1574-6968.2011.02425.x; Weiss B, 2006, J BACTERIOL, V188, P829, DOI 10.1128/JB.188.3.829-833.2006; Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x; Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109	61	62	62	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12689	12704		10.1074/jbc.M115.643072	http://dx.doi.org/10.1074/jbc.M115.643072			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25771538	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000354569000022
J	Mortenson, JB; Heppler, LN; Banks, CJ; Weerasekara, VK; Whited, MD; Piccolo, SR; Johnson, WE; Thompson, JW; Andersen, JL				Mortenson, Jeffrey B.; Heppler, Lisa N.; Banks, Courtney J.; Weerasekara, Vajira K.; Whited, Matthew D.; Piccolo, Stephen R.; Johnson, William E.; Thompson, J. Will; Andersen, Joshua L.			Histone Deacetylase 6 (HDAC6) Promotes the Pro-survival Activity of 14-3-3 zeta via Deacetylation of Lysines within the 14-3-3 zeta Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; MULTIPLE-MYELOMA; CELL-SURVIVAL; PROTEIN-TAU; PHOSPHORYLATION; BAD; INHIBITOR; APOPTOSIS; TARGETS; DEPHOSPHORYLATION	The phospho-binding protein 14-3-3 zeta acts as a signaling hub controlling a network of interacting partners and oncogenic pathways. We show here that lysines within the 14-3-3 zeta binding pocket and protein-protein interface can be modified by acetylation. The positive charge on two of these lysines, Lys(49) and Lys(120), is critical for coordinating 14-3-3 zeta -phosphoprotein interactions. Through screening, we identified HDAC6 as the Lys(49)/Lys(120) deacetylase. Inhibition of HDAC6 blocks 14-3-3 zeta interactions with two well described interacting partners, Bad and AS160, which triggers their dephosphorylation at Ser(112) and Thr(642), respectively. Expression of an acetylation-refractory K49R/K120R mutant of 14-3-3 zeta rescues both the HDAC6 inhibitor-induced loss of interaction and Ser(112)/Thr(642) phosphorylation. Furthermore, expression of the K49R/K120R mutant of 14-3-3 zeta inhibits the cytotoxicity of HDAC6 inhibition. These data demonstrate a novel role for HDAC6 in controlling 14-3-3 zeta binding activity.	[Mortenson, Jeffrey B.; Heppler, Lisa N.; Banks, Courtney J.; Weerasekara, Vajira K.; Whited, Matthew D.; Andersen, Joshua L.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Piccolo, Stephen R.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Johnson, William E.] Boston Univ, Sch Med, Div Computat Biomed, Boston, MA 02215 USA; [Thompson, J. Will] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA	Brigham Young University; Brigham Young University; Boston University; Duke University	Andersen, JL (corresponding author), Brigham Young Univ, E111 BNSN,685 E Univ Pkwy, Provo, UT 84602 USA.	jandersen@chem.byu.edu		Johnson, W. Evan/0000-0002-6247-6595	Elsa U. Pardee Foundation; Simmons Center for Cancer Research Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005692] Funding Source: NIH RePORTER	Elsa U. Pardee Foundation; Simmons Center for Cancer Research Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by funding from the Elsa U. Pardee Foundation (to J. L. A.) and a Simmons Center for Cancer Research Award (to L. N. H. and J. L. A.).	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Andersen JL, 2011, MOL CELL, V43, P834, DOI 10.1016/j.molcel.2011.07.028; Bergamaschi A, 2013, BREAST CANCER RES TR, V137, P689, DOI 10.1007/s10549-012-2390-0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chen S, 2011, TRENDS ENDOCRIN MET, V22, P429, DOI 10.1016/j.tem.2011.07.005; Cheng JC, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-14; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Du YH, 2013, ASSAY DRUG DEV TECHN, V11, P367, DOI 10.1089/adt.2013.507; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Garrido P, 2015, J CELL PHYSIOL, V230, P191, DOI 10.1002/jcp.24698; Ge F, 2010, J PROTEOME RES, V9, P5848, DOI 10.1021/pr100616g; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Lin MT, 2009, INT J CANCER, V125, P603, DOI 10.1002/ijc.24346; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Margolis SS, 2006, CELL, V127, P759, DOI 10.1016/j.cell.2006.10.035; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Maxwell SA, 2009, J BIOL CHEM, V284, P22379, DOI 10.1074/jbc.M109.022418; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Namdar M, 2010, P NATL ACAD SCI USA, V107, P20003, DOI 10.1073/pnas.1013754107; Neal CL, 2010, EXPERT OPIN THER TAR, V14, P1343, DOI 10.1517/14728222.2010.531011; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nutt LK, 2009, DEV CELL, V16, P856, DOI 10.1016/j.devcel.2009.04.005; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Pozuelo-Rubio M, 2010, FEBS J, V277, P3321, DOI 10.1111/j.1742-4658.2010.07730.x; Qureshi HY, 2013, BIOCHEMISTRY-US, V52, P6445, DOI 10.1021/bi400442d; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044265; Weerasekara VK, 2014, MOL CELL BIOL, V34, P4379, DOI 10.1128/MCB.00740-14; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yan J, 2014, DNA CELL BIOL, V33, P567, DOI 10.1089/dna.2013.2300; Yang PH, 2013, DRUG DISCOV THER, V7, P233, DOI 10.5582/ddt.2013.v7.6.233; Yang X, 2012, CANCER GENE THER, V19, P153, DOI 10.1038/cgt.2011.85; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012	53	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12487	12496		10.1074/jbc.M114.607580	http://dx.doi.org/10.1074/jbc.M114.607580			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25770209	Green Published, hybrid			2022-12-26	WOS:000354569000005
J	Manne, BK; Badolia, R; Dangelmaier, C; Eble, JA; Ellmeier, W; Kahn, M; Kunapuli, SP				Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Eble, Johannes A.; Ellmeier, Wilfried; Kahn, Mark; Kunapuli, Satya P.			Distinct Pathways Regulate Syk Protein Activation Downstream of Immune Tyrosine Activation Motif (ITAM) and hemITAM Receptors in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; X-LINKED AGAMMAGLOBULINEMIA; GLYCOPROTEIN-IB-IX; SRC-FAMILY KINASE; IN-VIVO ROLES; GAMMA-CHAIN; B-CELL; PHOSPHOINOSITIDE 3-KINASE; COLLAGEN RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE	Tyrosine kinase pathways are known to play an important role in the activation of platelets. In particular, the GPVI and CLEC-2 receptors are known to activate Syk upon tyrosine phosphorylation of an immune tyrosine activation motif (ITAM) and hemITAM, respectively. However, unlike GPVI, the CLEC-2 receptor contains only one tyrosine motif in the intracellular domain. The mechanisms by which this receptor activates Syk are not completely understood. In this study, we identified a novel signaling mechanism in CLEC-2-mediated Syk activation. CLEC-2-mediated, but not GPVI-mediated, platelet activation and Syk phosphorylation were abolished by inhibition of PI3K, which demonstrates that PI3K regulates Syk downstream of CLEC-2. Ibrutinib, a Tec family kinase inhibitor, also completely abolished CLEC-2-mediated aggregation and Syk phosphorylation in human and murine platelets. Furthermore, embryos lacking both Btk and Tec exhibited cutaneous edema associated with blood-filled vessels in a typical lymphatic pattern similar to CLEC-2 or Syk-deficient embryos. Thus, our data show, for the first time, that PI3K and Tec family kinases play a crucial role in the regulation of platelet activation and Syk phosphorylation downstream of the CLEC-2 receptor.	[Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sch Med, Philadelphia, PA 19140 USA; [Manne, Bhanu Kanth; Badolia, Rachit; Dangelmaier, Carol; Kunapuli, Satya P.] Temple Univ, Dept Physiol, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Eble, Johannes A.] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Ellmeier, Wilfried] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Div Immunobiol, Inst Immunol, A-1090 Vienna, Austria; [Kahn, Mark] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kahn, Mark] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Munster; Medical University of Vienna; University of Pennsylvania; University of Pennsylvania	Kunapuli, SP (corresponding author), Temple Univ, Dept Physiol, Rm 403 MRB,3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Regan, Clinton/E-6250-2012	Ellmeier, Wilfried/0000-0001-8192-8481	National Institutes of Health [HL93231, HL118593]; Deutsche Forschungsgemeinschaft [SFB1009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118593, R01HL093231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL93231 and HL118593 (to S. P. K.).; Supported by the Deutsche Forschungsgemeinschaft Grant SFB1009 Project A09.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-59; Asazuma N, 1997, BLOOD, V90, P4789, DOI 10.1182/blood.V90.12.4789.4789_4789_4798; Atkinson BT, 2003, BLOOD, V102, P3592, DOI 10.1182/blood-2003-04-1142; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Bhavaraju K, 2008, EUR J PHARMACOL, V580, P285, DOI 10.1016/j.ejphar.2007.11.009; Blair TA, 2014, ARTERIOSCL THROM VAS, V34, P1681, DOI 10.1161/ATVBAHA.114.303954; Bobe R, 2001, BLOOD, V97, P678, DOI 10.1182/blood.V97.3.678; Brass L, 2010, HEMATOL-AM SOC HEMAT, P387, DOI 10.1182/asheducation-2010.1.387; Cancro MP, 2001, INT IMMUNOL, V13, P1501, DOI 10.1093/intimm/13.12.1501; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; Clemetson KJ, 2011, HAMOSTASEOLOGIE, V31, P264, DOI 10.5482/ha-1152; Corken A, 2014, ARTERIOSCL THROM VAS, V34, P996, DOI 10.1161/ATVBAHA.113.303113; Dubovsky JA, 2013, BLOOD, V122, P2539, DOI 10.1182/blood-2013-06-507947; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; Falet H, 2000, BLOOD, V96, P3786, DOI 10.1182/blood.V96.12.3786.h8003786_3786_3792; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gardiner EE, 2013, J INFECT DIS, V208, P871, DOI 10.1093/infdis/jit305; Getz TM, 2011, J THROMB HAEMOST, V9, P608, DOI 10.1111/j.1538-7836.2011.04192.x; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5; Gitz E, 2014, BLOOD, V124, P2262, DOI 10.1182/blood-2014-05-572818; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Glassford J, 2003, ONCOGENE, V22, P2248, DOI 10.1038/sj.onc.1206425; Hamman BD, 2002, J BIOMOL SCREEN, V7, P45, DOI 10.1089/108705702753520332; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Humphries LA, 2004, J BIOL CHEM, V279, P37651, DOI 10.1074/jbc.M311985200; Jung SM, 2008, ADV EXP MED BIOL, V640, P53, DOI 10.1007/978-0-387-09789-3_5; KARNITZ LM, 1994, J EXP MED, V179, P1799, DOI 10.1084/jem.179.6.1799; Kim S, 2009, J BIOL CHEM, V284, P33763, DOI 10.1074/jbc.M109.048553; Krajewski S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038455; Laffargue M, 1999, FEBS LETT, V443, P66, DOI 10.1016/S0014-5793(98)01680-9; Levade M, 2014, BLOOD, V124, P3991, DOI 10.1182/blood-2014-06-583294; Manne BK, 2013, J BIOL CHEM, V288, P7717, DOI 10.1074/jbc.M112.424473; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Nonoyama S, 1998, J IMMUNOL, V161, P3925; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Oda A, 2000, BLOOD, V95, P1663; Okoh MP, 1999, BIOCHEM BIOPH RES CO, V265, P151, DOI 10.1006/bbrc.1999.1407; PACKHAM MA, 1994, CAN J PHYSIOL PHARM, V72, P278, DOI 10.1139/y94-043; Page C, 2014, CLIN EXP ALLERGY, V44, P901, DOI 10.1111/cea.12322; Pasquet JM, 2000, EMBO J, V19, P2793, DOI 10.1093/emboj/19.12.2793; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3; Quek LS, 2000, BLOOD, V96, P4246; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Riedl J, 2014, HAMOSTASEOLOGIE, V34, P54, DOI 10.5482/HAMO-13-10-0054; Schwarzbich MA, 2014, RECENT RESULTS CANC, V201, P259, DOI 10.1007/978-3-642-54490-3_17; Severin S, 2011, J BIOL CHEM, V286, P4107, DOI 10.1074/jbc.M110.167502; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Susa M, 1996, BIOCHEM BIOPH RES CO, V220, P729, DOI 10.1006/bbrc.1996.0472; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2004, BIOCHEM J, V378, P1023, DOI 10.1042/BJ20031430; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Vihinen M, 2000, FRONT BIOSCI-LANDMRK, V5, pD917, DOI 10.2741/vihinen; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Watson SP, 2010, J THROMB HAEMOST, V8, P1457, DOI 10.1111/j.1538-7836.2010.03875.x; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471	73	51	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11557	11568		10.1074/jbc.M114.629527	http://dx.doi.org/10.1074/jbc.M114.629527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767114	Green Published, hybrid			2022-12-26	WOS:000353719400031
J	George, A; Blankenship, KM				George, Annie; Blankenship, Kim M.			Peer Outreach Work as Economic Activity: Implications for HIV Prevention Interventions among Female Sex Workers	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; ANDHRA-PRADESH; PROGRAM; RISK; HIV/AIDS; INDIA; AIDS; VOLUNTEERISM; MOBILIZATION; KARNATAKA	Female sex workers (FSWs) who work as peer outreach workers in HIV prevention programs are drawn from poor socio-economic groups and consider outreach work, among other things, as an economic activity. Yet, while successful HIV prevention outcomes by such programs are attributed in part to the work of peers who have dense relations with FSW communities, there is scant discussion of the economic implications for FSWs of their work as peers. Using observational data obtained from an HIV prevention intervention for FSWs in south India, we examined the economic benefits and costs to peers of doing outreach work and their implications for sex workers' economic security. We found that peers considered their payment incommensurate with their workload, experienced long delays receiving compensation, and at times had to advance money from their pockets to do their assigned peer outreach work. For the intervention these conditions resulted in peer attrition and difficulties in recruitment of new peer workers. We discuss the implications of these findings for uptake of services, and the possibility of reaching desired HIV outcomes. Inadequate and irregular compensation to peers and inadequate budgetary outlays to perform their community-based outreach work could weaken peers' relationships with FSW community members, undermine the effectiveness of peer-mediated HIV prevention programs and invalidate arguments for the use of peers.	[Blankenship, Kim M.] Amer Univ, Dept Sociol, Washington, DC 20016 USA; [Blankenship, Kim M.] Amer Univ, Ctr Hlth Risk & Soc, Washington, DC 20016 USA	American University; American University	George, A (corresponding author), 206 Sun City B,NIBM Rd, Pune, Maharashtra, India.	anngeor@gmail.com			Bill & Melinda Gates Foundation [OPP30183_01]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant No OPP30183_01. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam K, 2012, SOC SCI MED, V75, P511, DOI 10.1016/j.socscimed.2012.03.039; Avahan, 2009, PEER LED OUTREACH SC; Banerjea N, 2011, CULT DYN, V23, P197, DOI 10.1177/0921374011430565; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Barker RD, 2002, SAMJ S AFR MED J, V92, P291; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Bhattacharya K, 2001, COMMUNITY HLTH WORKE; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Bowen KJ, 2011, ASIA-PAC J PUBLIC HE, V23, P843, DOI 10.1177/1010539509355190; Campbell C, 2011, GLOB PUBLIC HEALTH, V6, P125, DOI 10.1080/17441690903334232; Chakravarthy JBR, 2012, J EPIDEMIOL COMMUN H, V66, pII78, DOI 10.1136/jech-2011-200487; Chen Martha Alter, 2008, 4 WIEGO; Cornwall A, 2003, WORLD DEV, V31, P1325, DOI 10.1016/S0305-750X(03)00086-X; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Dil Y, 2012, J COMMUN HEALTH, V37, P1192, DOI 10.1007/s10900-012-9569-5; Evans C, 2008, SOC SCI MED, V66, P467, DOI 10.1016/j.socscimed.2007.08.030; Gaikwad SS, 2013, J EPIDEMIOLOGY COMMU, V66, pii69; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Government of India, 2011, WAG RAT RUR IND 2009; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Hanefeld J, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-8; Karnataka Health Promotion Trust (KHPT) and Population Council, 2008, PATTERNS OF MIGRATIO; Maes K, 2012, HUM ORGAN, V71, P54, DOI 10.17730/humo.71.1.axm39467485m22w4; Maes KC, 2010, SOC SCI MED, V71, P1375, DOI 10.1016/j.socscimed.2010.06.020; Maupin JN, 2011, HUM ORGAN, V70, P44, DOI 10.17730/humo.70.1.lw033538861270u6; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Muula AS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-208; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; NACO, 2007, TARG INT NACP 3 OP G, V1; Nkonki L, 2011, B WORLD HEALTH ORGAN, V89, P919, DOI 10.2471/BLT.11.087825; Nyamathi AM, 2011, HEALTH CARE WOMEN IN, V32, P300, DOI 10.1080/07399332.2010.536282; Population Council, 2008, PATT MOB HIV RISK FE; Rahman SM, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-12; Rao PJVR, 2010, SEX TRANSM INFECT, V86, pI7, DOI 10.1136/sti.2009.039297; Reed E, 2010, PUBLIC HEALTH REP, V125, P81, DOI 10.1177/00333549101250S412; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Sgaier SK, 2013, HEALTH AFFAIR, V32, P1265, DOI 10.1377/hlthaff.2012.0646; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Task shifting: rational redistribution of tasks among health workforce teams, 2008, GLOB REC GUID; Torri MC, 2013, INT Q COMMUNITY HEAL, V33, P3, DOI 10.2190/IQ.33.1.b; Tucker Saroj, 2012, Indian J Sex Transm Dis AIDS, V33, P9, DOI 10.4103/0253-7184.93787; Urada LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033282; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119729	10.1371/journal.pone.0119729	http://dx.doi.org/10.1371/journal.pone.0119729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775122	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500115
J	Salazar, KA; Joffe, NR; Dinguirard, N; Houde, P; Castillo, MG				Salazar, Karla A.; Joffe, Nina R.; Dinguirard, Nathalie; Houde, Peter; Castillo, Maria G.			Transcriptome Analysis of the White Body of the Squid Euprymna tasmanica with Emphasis on Immune and Hematopoietic Gene Discovery	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; THIOESTER-CONTAINING PROTEINS; HAWAIIAN BOBTAIL SQUID; KAPPA-B ACTIVATION; VIBRIO-FISCHERI; LIGHT-ORGAN; LINEAGE COMMITMENT; OCTOPUS-VULGARIS; BACTERIA-BINDING; INNATE IMMUNITY	In the mutualistic relationship between the squid Euprymna tasmanica and the bioluminescent bacterium Vibrio fischeri, several host factors, including immune-related proteins, are known to interact and respond specifically and exclusively to the presence of the symbiont. In squid and octopus, the white body is considered to be an immune organ mainly due to the fact that blood cells, or hemocytes, are known to be present in high numbers and in different developmental stages. Hence, the white body has been described as the site of hematopoiesis' in cephalopods. However, to our knowledge, there are no studies showing any molecular evidence of such functions. In this study, we performed a transcriptomic analysis of white body tissue of the Southern dumpling squid, Euprymna tasmanica. Our primary goal was to gain insights into the functions of this tissue and to test for the presence of gene transcripts associated with hematopoietic and immune processes. Several hematopoiesis genes including CPSF1, GATA 2, TFIID, and FGFR2 were found to be expressed in the white body. In addition, transcripts associated with immune-related signal transduction pathways, such as the toll-like receptor/NF-kappa beta, and MAPK pathways were also found, as well as other immune genes previously identified in Euprymna tasmanica's sister species, E. scolopes. This study is the first to analyze an immune organ within cephalopods, and to provide gene expression data supporting the white body as a hematopoietic tissue.	[Salazar, Karla A.; Joffe, Nina R.; Dinguirard, Nathalie; Houde, Peter; Castillo, Maria G.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	New Mexico State University	Castillo, MG (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	mcastill@nmsu.edu		Dinguirard, Nathalie/0000-0001-5843-2584	CONACyT PhD fellowship [216017/311449]; New Mexico State University Start-up fund	CONACyT PhD fellowship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); New Mexico State University Start-up fund	This work was supported by the CONACyT PhD fellowship 216017/311449 (http://www.conacyt.gob.mx/) to KAS and the New Mexico State University Start-up fund to MGC. The funders had no role in the study design, data collection and analysis, decision to publish or preparation in the manuscript.	Altura MA, 2013, ENVIRON MICROBIOL, V15, P2937, DOI 10.1111/1462-2920.12179; Altura MA, 2011, CELL MICROBIOL, V13, P527, DOI 10.1111/j.1462-5822.2010.01552.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200; Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200; Bolli N, 2011, BLOOD, V117, P3996, DOI 10.1182/blood-2010-08-304030; Carnaud C, 1999, J IMMUNOL, V163, P4647; Carter CG, 2009, COMP BIOCHEM PHYS A, V153, P185, DOI 10.1016/j.cbpa.2009.02.015; Castellanos-Martinez S, 2014, DEV COMP IMMUNOL, V44, P50, DOI 10.1016/j.dci.2013.11.013; Castellanos-Martinez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107873; Castillo MG, 2009, DEV COMP IMMUNOL, V33, P69, DOI 10.1016/j.dci.2008.07.013; CHOU CC, 1986, MOL CELL BIOL, V6, P566, DOI 10.1128/MCB.6.2.566; Chun CK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-154; Claes MF, 1996, ACTA ZOOL-STOCKHOLM, V77, P173, DOI 10.1111/j.1463-6395.1996.tb01262.x; Collins Andrew J, 2010, J Vis Exp, DOI 10.3791/1714; Collins AJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00091; COWDEN RR, 1972, J INVERTEBR PATHOL, V19, P113, DOI 10.1016/0022-2011(72)90196-6; Currie CR, 2007, NATURE, V98, P701; Davidson SK, 2004, CELL MICROBIOL, V6, P1139, DOI 10.1111/j.1462-5822.2004.00429.x; De Arras L, 2014, GENETICS, V197, P485, DOI 10.1534/genetics.113.160499; Detournay O, 2012, DEV COMP IMMUNOL, V38, P525, DOI 10.1016/j.dci.2012.08.008; DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001; Dishaw LJ, 2005, IMMUNOGENETICS, V57, P535, DOI 10.1007/s00251-005-0005-1; Dodds AW, 1998, IMMUNOL REV, V166, P15; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; Estevez-Calvar N, 2011, DEV COMP IMMUNOL, V35, P1015, DOI 10.1016/j.dci.2011.03.023; Franche C, 2007, PLANT SOIL, V321, P335; Franklin AM, 2012, BIOL LETTERS, V8, P754, DOI 10.1098/rsbl.2012.0556; Fujito NT, 2010, DEV COMP IMMUNOL, V34, P775, DOI 10.1016/j.dci.2010.02.011; Giesert C, 2003, ANN NY ACAD SCI, V996, P227, DOI 10.1111/j.1749-6632.2003.tb03250.x; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Goodson MS, 2005, APPL ENVIRON MICROB, V71, P6934, DOI 10.1128/AEM.71.11.6934-6946.2005; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Hart DO, 2009, DEV DYNAM, V238, P2540, DOI 10.1002/dvdy.22083; Heath-Heckman EAC, 2011, ZOOLOGY, V114, P191, DOI 10.1016/j.zool.2011.02.002; Hernandez-Campo PM, 2007, CYTOM PART B-CLIN CY, V72B, P34, DOI 10.1002/cyto.b.20143; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones BW, 2004, MAR BIOL, V144, P1151, DOI 10.1007/s00227-003-1285-3; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Koropatnick TA, 2007, BIOL BULL-US, V212, P29, DOI 10.2307/25066578; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Kremer N, 2013, CELL HOST MICROBE, V14, P183, DOI 10.1016/j.chom.2013.07.006; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Kvennefors ECE, 2010, DEV COMP IMMUNOL, V34, P1219, DOI 10.1016/j.dci.2010.06.016; Law SKA, 1997, PROTEIN SCI, V6, P263; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Mandel MJ, 2012, APPL ENVIRON MICROB, V78, P4620, DOI 10.1128/AEM.00377-12; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai M, 2010, SEMIN IMMUNOL, V22, P48, DOI 10.1016/j.smim.2009.11.003; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mills KHG, 2004, NAT REV IMMUNOL, V4, P841, DOI 10.1038/nri1485; Moltschaniwskyj NA, 2007, REV FISH BIOL FISHER, V17, P455, DOI 10.1007/s11160-007-9056-8; Nonaka M, 2004, MOL IMMUNOL, V40, P897, DOI 10.1016/j.molimm.2003.10.009; Nyholm SV, 2009, ENVIRON MICROBIOL, V11, P483, DOI 10.1111/j.1462-2920.2008.01788.x; Nyholm SV, 1998, BIOL BULL, V195, P89, DOI 10.2307/1542815; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Portela J, 2013, J INNATE IMMUN, V5, P261, DOI 10.1159/000345909; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Scaccabarozzi A, 2000, BRIT J HAEMATOL, V110, P978, DOI 10.1046/j.1365-2141.2000.02280.x; Schleicher TR, 2014, MOL CELL PROTEOMICS, V13, P2673, DOI 10.1074/mcp.M113.037259; Schleicher TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025649; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Septer AN, 2011, ENVIRON MICROBIOL, V13, P2855, DOI 10.1111/j.1462-2920.2011.02558.x; Sinn DL, 2005, J COMP PSYCHOL, V119, P99, DOI 10.1037/0735-7036.119.1.99; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; Squires ZE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037074; SUTHERLAND DR, 1991, BLOOD, V77, P84; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Wang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061213; Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200; WEI SL, 1989, MAR BIOL, V103, P541, DOI 10.1007/BF00399586; Wier AM, 2010, P NATL ACAD SCI USA, V107, P2259, DOI 10.1073/pnas.0909712107; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang T, 2014, DEV COMP IMMUNOL, V45, P141, DOI 10.1016/j.dci.2014.02.015; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318; Zouari I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-221	100	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119949	10.1371/journal.pone.0119949	http://dx.doi.org/10.1371/journal.pone.0119949			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775132	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500143
J	Zhu, LX; Shen, DX; Zhou, QM; Li, ZX; Fang, XD; Li, QZ				Zhu, Lingxiang; Shen, Dingxia; Zhou, Qiming; Li, Zexia; Fang, Xiangdong; Li, Quan-Zhen			A Locked Nucleic Acid (LNA)-Based Real-Time PCR Assay for the Rapid Detection of Multiple Bacterial Antibiotic Resistance Genes Directly from Positive Blood Culture	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; SPECTRUM BETA-LACTAMASES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; METHICILLIN-RESISTANT; CARBAPENEMASE GENES; DNA MICROARRAY; IDENTIFICATION; PREVALENCE	Bacterial strains resistant to various antibiotic drugs are frequently encountered in clinical infections, and the rapid identification of drug-resistant strains is highly essential for clinical treatment. We developed a locked nucleic acid (LNA)-based quantitative real-time PCR (LNA-qPCR) method for the rapid detection of 13 antibiotic resistance genes and successfully used it to distinguish drug-resistant bacterial strains from positive blood culture samples. A sequence-specific primer-probe set was designed, and the specificity of the assays was assessed using 27 ATCC bacterial strains and 77 negative blood culture samples. No cross-reaction was identified among bacterial strains and in negative samples, indicating 100% specificity. The sensitivity of the assays was determined by spiking each bacterial strain into negative blood samples, and the detection limit was 1-10 colony forming units (CFU) per reaction. The LNA-qPCR assays were first applied to 72 clinical bacterial isolates for the identification of known drug resistance genes, and the results were verified by the direct sequencing of PCR products. Finally, the LNA-qPCR assays were used for the detection in 47 positive blood culture samples, 19 of which (40.4%) were positive for antibiotic resistance genes, showing 91.5% consistency with phenotypic susceptibility results. In conclusion, LNA-qPCR is a reliable method for the rapid detection of bacterial antibiotic resistance genes and can be used as a supplement to phenotypic susceptibility testing for the early detection of antimicrobial resistance to allow the selection of appropriate antimicrobial treatment and to prevent the spread of resistant isolates.	[Zhu, Lingxiang; Fang, Xiangdong] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhu, Lingxiang; Li, Zexia; Li, Quan-Zhen] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Shen, Dingxia] Peoples Liberat Army, Gen Hosp, Dept Clin Microbiol, Beijing, Peoples R China; [Zhou, Qiming] Chinese Acad Sci, State Key Lab Mycol, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Microbiology, CAS	Li, QZ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	quan.li@utsouthwestern.edu			National Institutes of Health [R03 AR055778]; Nature Science Foundation of China [81270852]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the National Institutes of Health grant R03 AR055778 (http://grants.nih.gov/grants/funding/r03.htm) and the Nature Science Foundation of China (81270852) (http://www.nsfc.gov.cn/nsfc/cen/00/kxb/hxb/images/1000.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal SG, 2013, J CLIN MICROBIOL, V51, P3988, DOI 10.1128/JCM.01889-13; Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P4457, DOI 10.1128/AAC.00353-11; Brolund A, 2010, J MICROBIOL METH, V82, P229, DOI 10.1016/j.mimet.2010.06.006; Alvargonzalez JJC, 2014, J MED MICROBIOL, V63, P1093, DOI 10.1099/jmm.0.067280-0; Chaudhary M, 2014, IOSR J PHARM BIOL SC, V9, P155; Choi J, 2013, LAB CHIP, V13, P280, DOI 10.1039/c2lc41055a; Clinical and Laboratory Standards Institute (CLSI), 2012, CLSI DOCUMENT M07 A9; CLSI, 2012, M02A11 CLSI, V7th; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; DUTKAMALEN S, 1990, MOL GEN GENET, V224, P364, DOI 10.1007/BF00262430; Ellem J, 2011, J CLIN MICROBIOL, V49, P3074, DOI 10.1128/JCM.02647-10; Foster AGW, 2013, J CLIN MICROBIOL, V51, P3717, DOI 10.1128/JCM.01679-13; Fothergill A, 2013, J CLIN MICROBIOL, V51, P805, DOI 10.1128/JCM.02326-12; Grobner S, 2009, J CLIN MICROBIOL, V47, P1689, DOI 10.1128/JCM.02179-08; Gupta Gunjan, 2014, J Lab Physicians, V6, P1, DOI 10.4103/0974-2727.129082; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; He WQ, 2013, DIAGN MICR INFEC DIS, V77, P267, DOI 10.1016/j.diagmicrobio.2013.07.001; Hindiyeh M, 2011, J CLIN MICROBIOL, V49, P2480, DOI 10.1128/JCM.00149-11; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Ji S, 2014, EUR J CLIN MICROBIOL, V33, P989, DOI 10.1007/s10096-013-2037-z; Li B, 2014, CAN J MICROBIOL, V60, P691, DOI 10.1139/cjm-2014-0291; Li Y, 2014, J MICROBIOL IMMUNOL; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Ma L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-599; Machen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087870; McWilliams CS, 2014, J CLIN MICROBIOL, V52, P2653, DOI 10.1128/JCM.03613-13; Morrissey I, 2014, J MED MICROBIOL, V63, P556, DOI 10.1099/jmm.0.068981-0; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4038, DOI 10.1128/AAC.01734-10; Naas T, 2011, J CLIN MICROBIOL, V49, P1608, DOI 10.1128/JCM.02607-10; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Ong DCT, 2011, J ANTIMICROB CHEMOTH, V66, P1647, DOI 10.1093/jac/dkr184; Oxacelay C, 2009, J ANTIMICROB CHEMOTH, V64, P986, DOI 10.1093/jac/dkp336; Palladino S, 2003, J CLIN MICROBIOL, V41, P2483, DOI 10.1128/JCM.41.6.2483-2486.2003; Pasteran F, 2011, J CLIN MICROBIOL, V49, P697, DOI 10.1128/JCM.01178-10; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Saeed K, 2014, INFECTION, V42, P843, DOI 10.1007/s15010-014-0641-1; Steindor M, 2012, J CLIN MICROBIOL, V50, P157, DOI 10.1128/JCM.06086-11; Tojo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094064; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Wielders CLC, 2002, J CLIN MICROBIOL, V40, P3970, DOI 10.1128/JCM.40.11.3970-3975.2002; Yang J, 2013, CLIN MICROBIOL INFEC, V19, pE509, DOI 10.1111/1469-0691.12275; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang CM, 2014, INFECT GENET EVOL, V27, P271, DOI 10.1016/j.meegid.2014.07.031; Zhou G, 2014, EMERG INFECT DIS, V20, P340, DOI 10.3201/eid2002.121263; Zhu LX, 2007, J CLIN MICROBIOL, V45, P3514, DOI 10.1128/JCM.02340-06; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06; Zhu LX, 2014, WORLD J MICROB BIOT, V30, P967, DOI 10.1007/s11274-013-1515-x; Zhu LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066584	51	5	6	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120464	10.1371/journal.pone.0120464	http://dx.doi.org/10.1371/journal.pone.0120464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775001	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500178
J	Hirakawa, H; Zempo, H; Ogawa, M; Watanabe, R; Suzuki, J; Akazawa, H; Komuro, I; Isobe, M				Hirakawa, Hiroyuki; Zempo, Hirofumi; Ogawa, Masahito; Watanabe, Ryo; Suzuki, Jun-ichi; Akazawa, Hiroshi; Komuro, Issei; Isobe, Mitsuaki			A DPP-4 Inhibitor Suppresses Fibrosis and Inflammation on Experimental Autoimmune Myocarditis in Mice	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; ADENOSINE-DEAMINASE; POTENTIAL ROLE; T-CELLS; CD26; EXPRESSION; TRANSITION; ISCHEMIA; FAILURE; HEART	Myocarditis is a critical inflammatory disorder which causes life-threatening conditions. No specific or effective treatment has been established. DPP-4 inhibitors have salutary effects not only on type 2 diabetes but also on certain cardiovascular diseases. However, the role of a DPP-4 inhibitor on myocarditis has not been investigated. To clarify the effects of a DPP-4 inhibitor on myocarditis, we used an experimental autoimmune myocarditis (EAM) model in Balb/c mice. EAM mice were assigned to the following groups: EAM mice group treated with a DPP-4 inhibitor (linagliptin) (n = 19) and those untreated (n = 22). Pathological analysis revealed that the myocardial fibrosis area ratio in the treated group was significantly lower than in the untreated group. RT-PCR analysis demonstrated that the levels of mRNA expression of IL-2, TNF-alpha, IL-1 beta and IL-6 were significantly lower in the treated group than in the untreated group. Lymphocyte proliferation assay showed that treatment with the DPP-4 inhibitor had no effect on antigen-induced spleen cell proliferation. Administration of the DPP-4 inhibitor remarkably suppressed cardiac fibrosis and reduced inflammatory cytokine gene expression in EAM mice. Thus, the agents present in DPP-4 inhibitors may be useful to treat and/or prevent clinical myocarditis.	[Hirakawa, Hiroyuki; Zempo, Hirofumi; Ogawa, Masahito; Watanabe, Ryo; Isobe, Mitsuaki] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan; [Suzuki, Jun-ichi; Akazawa, Hiroshi] Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan; [Komuro, Issei] Univ Tokyo, Dept Cardiovasc Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo	Suzuki, J (corresponding author), Univ Tokyo, Dept Adv Clin Sci & Therapeut, Tokyo, Japan.	junichisuzuki-circ@umin.ac.jp	Zempo, Hirofumi/HHZ-7173-2022	Zempo, Hirofumi/0000-0003-2248-8580; Akazawa, Hiroshi/0000-0002-3574-9607				Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Darsalia V, 2013, DIABETES, V62, P1289, DOI 10.2337/db12-0988; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Futamatsu H, 2005, CIRC RES, V96, P823, DOI 10.1161/01.RES.0000163016.52653.2e; Futamatsua H, 2003, CARDIOVASC RES, V59, P95, DOI 10.1016/S0008-6363(03)00334-1; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kishimoto C, 2013, INT J CARDIOL, V167, P140, DOI 10.1016/j.ijcard.2011.12.058; Leuschner F, 2009, J AUTOIMMUN, V33, P282, DOI 10.1016/j.jaut.2009.07.009; Liu XM, 2012, CARDIOVASC DRUG THER, V26, P121, DOI 10.1007/s10557-012-6372-6; MARTIN M, 1995, J IMMUNOL, V155, P4630; Matteucci E, 2009, CURR MED CHEM, V16, P2943, DOI 10.2174/092986709788803114; Ohnuma K, 2009, BIOCHEM BIOPH RES CO, V386, P327, DOI 10.1016/j.bbrc.2009.06.027; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; Pummerer CL, 1996, J CLIN INVEST, V97, P2057, DOI 10.1172/JCI118642; REINHOLD D, 1994, IMMUNOBIOLOGY, V192, P121, DOI 10.1016/S0171-2985(11)80412-2; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Shauer A, 2013, ISR MED ASSOC J, V15, P180; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shin JW, 2008, EXP CELL RES, V314, P3048, DOI 10.1016/j.yexcr.2008.07.024; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Suzuki JI, 2007, J MOL CELL CARDIOL, V42, P432, DOI 10.1016/j.yjmcc.2006.10.006; Suzuki JI, 2006, J MOL CELL CARDIOL, V40, P688, DOI 10.1016/j.yjmcc.2006.01.006; Tang ZH, 2004, J MOL CELL CARDIOL, V36, P515, DOI 10.1016/j.yjmcc.2004.01.008; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Timmers L, 2009, J AM COLL CARDIOL, V53, P501, DOI 10.1016/j.jacc.2008.10.033; Watanabe R, 2013, AM J PHYSL HEART CIR; Zempo H, 2014, HEART VESSELS; Zhong JX, 2013, ATHEROSCLEROSIS, V226, P305, DOI 10.1016/j.atherosclerosis.2012.09.012; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	31	42	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119360	10.1371/journal.pone.0119360	http://dx.doi.org/10.1371/journal.pone.0119360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768281	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500079
J	Zhang, HH; Dai, LF; Chen, N; Zang, LL; Leng, XR; Du, L; Wang, JM; Jiang, YW; Zhang, F; Wu, XR; Wu, Y				Zhang, Haihua; Dai, Lifang; Chen, Na; Zang, Lili; Leng, Xuerong; Du, Li; Wang, Jingmin; Jiang, Yuwu; Zhang, Feng; Wu, Xiru; Wu, Ye			Fifteen Novel EIF2B1-5 Mutations Identified in Chinese Children with Leukoencephalopathy with VanishingWhiteMatter and a Long Term Follow-Up	PLOS ONE			English	Article							VANISHING WHITE-MATTER; GUANINE-NUCLEOTIDE EXCHANGE; EUKARYOTIC TRANSLATION INITIATION; EIF2B-RELATED DISORDERS; CHILDHOOD ATAXIA; NATURAL-HISTORY; DISEASE; SUBUNITS; PHOSPHORYLATION; SELECTION	Leukoencephalopathy with vanishing white matter (VWM) is one of the most prevalent inherited childhood white matter disorders, which caused by mutations in each of the five sub-units of eukaryotic translation initiation factor 2B (EIF2B1-5). In our study, 34 out of the 36 clinically diagnosed children (94%) were identified to have EIF2B1-5 mutations by sequencing. 15 novel mutations were identified. CNVs were not detected in patients with only one mutant allele and mutation-negative determined by gene sequencing. There is a significantly higher incidence of patients with EIF2B3 mutations compared with Caucasian patients (32% vs. 4%). c. 1037T>C (p. Ile346Thr) in EIF2B3 was confirmed to be a founder mutation in Chinese, which probably one of the causes of the genotypic differences between ethnicities. Our average 4.4 years-follow-up on infantile, early childhood and juvenile VWM children suggested a rapid deterioration in motor function. Episodic aggravation was presented in 90% of infantile cases and 71.4% of childhood cases. 10 patients died during the followup. The Kaplan-Meier curve showed that the median survival time is 8.83 +/- 1.51 years. This is the largest sample of children in a VWM follow-up study, which is helpful for a more depth understanding about the natural course.	[Zhang, Haihua; Dai, Lifang; Chen, Na; Zang, Lili; Leng, Xuerong; Du, Li; Wang, Jingmin; Jiang, Yuwu; Wu, Xiru; Wu, Ye] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [Zhang, Feng] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Peking University; Fudan University	Wu, Y (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	dryewu@263.net	Zhang, Feng/C-7735-2009; jiang, yu/HGU-0029-2022; leng, xuerong/HHM-7333-2022	Zhang, Feng/0000-0003-4556-8276; 	Natural Science Foundation of China [81171065, 30872793]; National Key Technology RD program [2012BAI09B00]; Key Laboratory Program of the Ministry of Education [2012-RG/ND-0001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD program(National Key Technology R&D Program); Key Laboratory Program of the Ministry of Education	This work was supported by the Natural Science Foundation of China (81171065, 30872793), the National Key Technology R&D program (2012BAI09B00), and the Key Laboratory Program of the Ministry of Education (2012-RG/ND-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugiani M, 2010, J NEUROPATH EXP NEUR, V69, P987, DOI 10.1097/NEN.0b013e3181f2eafa; Drayna D, 2005, SCI AM, V293, P78, DOI 10.1038/scientificamerican1005-78; Elsby R, 2011, J VIROL, V85, P9716, DOI 10.1128/JVI.05146-11; Fogli A, 2004, NEUROLOGY, V62, P1509, DOI 10.1212/01.WNL.0000123259.67815.DB; Fogli A, 2006, BIOCHEM SOC T, V34, P22, DOI 10.1042/BST0340022; Fogli A, 2004, EUR J HUM GENET, V12, P561, DOI 10.1038/sj.ejhg.5201189; Fogli A, 2003, AM J HUM GENET, V72, P1544, DOI 10.1086/375404; Fogli A, 2002, NEUROLOGY, V59, P1966, DOI 10.1212/01.WNL.0000041666.76863.47; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Horzinski L, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-94; Kantor L, 2005, HUM GENET, V118, P99, DOI 10.1007/s00439-005-0024-x; Kantor L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003783; Kimball SR, 1998, J BIOL CHEM, V273, P12841, DOI 10.1074/jbc.273.21.12841; Labauge P, 2009, BRAIN, V132, P2161, DOI 10.1093/brain/awp171; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Maletkovic J, 2008, J CHILD NEUROL, V23, P205, DOI 10.1177/0883073807308705; Ohlenbusch Andreas, 2005, Hum Mutat, V25, P411, DOI 10.1002/humu.9325; Pavitt GD, 2005, BIOCHEM SOC T, V33, P1487, DOI 10.1042/BST0331487; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pronk JC, 2006, MENT RETARD DEV D R, V12, P123, DOI 10.1002/mrdd.20104; Proud CG, 2012, FUTUR NEUROL, V7, P81, DOI 10.2217/FNL.11.63; Scali O, 2006, NEUROL SCI, V27, P271, DOI 10.1007/s10072-006-0683-y; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; Shi W, 2006, CHIN J EVID BASED PE, V2, P122; Shimada S, 2012, AM J MED GENET A, V158A, P1771, DOI 10.1002/ajmg.a.35431; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spilka R, 2014, CELL ONCOL, V37, P253, DOI 10.1007/s13402-014-0181-9; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knaap MS, 1998, NEUROLOGY, V51, P540, DOI 10.1212/WNL.51.2.540; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; van der Lei HDW, 2010, NEUROLOGY, V75, P1555, DOI 10.1212/WNL.0b013e3181f962ae; van Kollenburg B, 2006, NEUROBIOL DIS, V21, P496, DOI 10.1016/j.nbd.2005.08.009; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; Wu Y, 2009, J HUM GENET, V54, P74, DOI 10.1038/jhg.2008.10	39	12	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118001	10.1371/journal.pone.0118001	http://dx.doi.org/10.1371/journal.pone.0118001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761052	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275000015
J	Molinos, JG; Viana, M; Brennan, M; Donohue, I				Molinos, Jorge Garcia; Viana, Mafalda; Brennan, Michael; Donohue, Ian			Importance of Long-Term Cycles for Predicting Water Level Dynamics in Natural Lakes	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE-CHANGE; FRESH-WATER; SHALLOW LAKE; FLUCTUATIONS; VARIABILITY; BIODIVERSITY; MANAGEMENT; SEDIMENT; QUALITY	Lakes are disproportionately important ecosystems for humanity, containing 77% of the liquid surface freshwater on Earth and comprising key contributors to global biodiversity. With an ever-growing human demand for water and increasing climate uncertainty, there is pressing need for improved understanding of the underlying patterns of natural variability of water resources and consideration of their implications for water resource management and conservation. Here we use Bayesian harmonic regression models to characterise water level dynamics and study the influence of cyclic components in confounding estimation of long-term directional trends in water levels in natural Irish lakes. We found that the lakes were characterised by a common and well-defined annual seasonality and several inter-annual and inter-decadal cycles with strong transient behaviour over time. Importantly, failing to account for the longer-term cyclic components produced a significant overall underestimation of the trend effect. Our findings demonstrate the importance of contextualising lake water resource management to the specific physical setting of lakes.	[Molinos, Jorge Garcia; Viana, Mafalda; Brennan, Michael; Donohue, Ian] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Donohue, Ian] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Molinos, Jorge Garcia] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan	Trinity College Dublin; Trinity College Dublin; National Institute for Environmental Studies - Japan	Molinos, JG (corresponding author), SAMS, Dept Ecol, Oban, Argyll, Scotland.	Jorge.Garcia-Molinos@sams.ac.uk	Molinos, Jorge García/C-9252-2015; Donohue, Ian/A-7270-2010	Molinos, Jorge García/0000-0001-7516-1835; Donohue, Ian/0000-0002-4698-6448; Brennan, Michael/0000-0002-5646-028X	European Union [002862]	European Union(European Commission)	This work was funded by the European Union's INTERREG IVA Cross-border Programme managed by the Special EU Programmes Body under the project "Development of targeted ecological modelling tools for lake management; DOLMANT" (Ref. No: 002862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn DS, 2005, LIMNOL OCEANOGR, V50, P1752, DOI 10.4319/lo.2005.50.6.1752; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Biswas AK, 2004, WATER INT, V29, P248, DOI 10.1080/02508060408691775; Coops H, 2002, LAKE RESERV MANAGE, V18, P293, DOI 10.1080/07438140209353935; Crase L, 2008, AUSTRALAS J ENVIRON, V15, P21; Doll P, 2012, J GEODYN, V59-60, P143, DOI 10.1016/j.jog.2011.05.001; Donohue I, 2004, FRESHWATER BIOL, V49, P320, DOI 10.1111/j.1365-2427.2004.01187.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Erb KH, 2009, ECOL ECON, V69, P250, DOI 10.1016/j.ecolecon.2009.07.001; Evtimova VV, 2014, J APPL ECOL, V51, P1282, DOI 10.1111/1365-2664.12297; Foulds D., 1977, CAN WATER RESOUR J, V2, P43, DOI [10.4296/cwrj0201043, DOI 10.4296/CWRJ0201043]; Fox J, 2008, APPL REGRESSION ANAL; GASITH A, 1990, BROCK SPR S, P156; Ghanbari RN, 2008, ADV WATER RESOUR, V31, P1284, DOI 10.1016/j.advwatres.2008.05.002; Gibson JJ, 2006, HYDROL PROCESS, V20, P4155, DOI 10.1002/hyp.6424; GOTTGENS JF, 1994, ARCH HYDROBIOL, V130, P179; Grafton RQ, 2013, NAT CLIM CHANGE, V3, P315, DOI [10.1038/NCLIMATE1746, 10.1038/nclimate1746]; Hakanson L, 2000, ECOL MODEL, V128, P101, DOI 10.1016/S0304-3800(00)00200-3; Hambright KD, 2004, ENVIRON SCI TECHNOL, V38, P6460, DOI 10.1021/es0492992; Hampton SE, 2011, MAR FRESHWATER RES, V62, P350, DOI 10.1071/MF10229; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hofmann H, 2008, HYDROBIOLOGIA, V613, P85, DOI 10.1007/s10750-008-9474-1; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Ineson S, 2011, NAT GEOSCI, V4, P753, DOI [10.1038/ngeo1282, 10.1038/NGEO1282]; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Johnk KD, 2004, LIMNOLOGICA, V34, P15, DOI 10.1016/S0075-9511(04)80017-3; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; McElwain L., 2007, KEY METEOROLOGICAL I, P31; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Molinos JG, 2014, CLIMATIC CHANGE, V124, P333, DOI 10.1007/s10584-014-1077-4; Molinos JG, 2011, OECOLOGIA, V166, P795, DOI 10.1007/s00442-011-1923-2; Molinos JG, 2010, ECOL APPL, V20, P1794, DOI 10.1890/10-0018.1; Naselli-Flores L, 2003, HYDROBIOLOGIA, V506, P13, DOI 10.1023/B:HYDR.0000008550.34409.06; Nilsson C, 1997, SCIENCE, V276, P798, DOI 10.1126/science.276.5313.798; Noges T, 2003, HYDROBIOLOGIA, V506, P257, DOI 10.1023/B:HYDR.0000008540.06592.48; Pahl-Wostl C, 2007, WATER RESOUR MANAG, V21, P49, DOI 10.1007/s11269-006-9040-4; Palmer MA, 2010, NATURE, V467, P534, DOI 10.1038/467534a; Pasquini AI, 2008, GLOBAL PLANET CHANGE, V63, P290, DOI 10.1016/j.gloplacha.2008.07.001; Plummer M., 2003, P 3 INT WORKSH DISTR; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Shiklomanov Igor A., 1993, P13; Shilland P, 2009, REVISED RISK ASSESSM, P127, DOI [10.1007/s13280-014-0523-x, DOI 10.1007/S13280-014-0523-X]; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tomasino M, 2000, HYDROLOG SCI J, V45, P477, DOI 10.1080/02626660009492343; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Vadeboncoeur Y, 2011, BIOSCIENCE, V61, P526, DOI 10.1525/bio.2011.61.7.7; Van Geest GJ, 2005, J APPL ECOL, V42, P251, DOI 10.1111/j.1365-2664.2005.00995.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, BIOSCIENCE, V50, P753, DOI 10.1641/0006-3568(2000)050[0753:ADOTTW]2.0.CO;2; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Wildman RA, 2011, J ENVIRON QUAL, V40, P575, DOI 10.2134/jeq2010.0323; Zhang Q, 2006, J HYDROL, V324, P255, DOI 10.1016/j.jhydrol.2005.09.023; Zohary T, 2011, INLAND WATERS, V1, P47, DOI 10.5268/IW-1.1.406	58	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119253	10.1371/journal.pone.0119253	http://dx.doi.org/10.1371/journal.pone.0119253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757071	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351275700042
J	Png, CW; Weerasooriya, M; Guo, J; James, SJ; Poh, HM; Osato, M; Flavell, RA; Dong, C; Yang, H; Zhang, Y				Png, C. W.; Weerasooriya, M.; Guo, J.; James, S. J.; Poh, H. M.; Osato, M.; Flavell, R. A.; Dong, C.; Yang, H.; Zhang, Y.			DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis	ONCOGENE			English	Article							KRUPPEL-LIKE FACTOR-5; IMMUNE-RESPONSES; GENE-EXPRESSION; UP-REGULATION; CANCER; PHOSPHATASE; COLON; MUTATIONS; INNATE; KRAS	Dual specificity phosphatase 10 (DUSP10), also known as MAP kinase phosphatase 5 (MKP5), negatively regulates the activation of MAP kinases. Genetic polymorphisms and aberrant expression of this gene are associated with colorectal cancer (CRC) in humans. However, the role of DUSP10 in intestinal epithelial tumorigenesis is not clear. Here, we showed that DUSP10 knockout (KO) mice had increased intestinal epithelial cell (IEC) proliferation and migration and developed less severe colitis than wild-type (WT) mice in response to dextran sodium sulphate (DSS) treatment, which is associated with increased ERK1/2 activation and Kruppel-like factor 5 (KLF5) expression in IEC. In line with increased IEC proliferation, DUSP10 KO mice developed more colon tumours with increased severity compared with WT mice in response to administration of DSS and azoxymethane (AOM). Furthermore, survival analysis of CRC patients demonstrated that high DUSP10 expression in tumours was associated with significant improvement in survival probability. Overexpression of DUSP10 in Caco-2 and RCM-1 cells inhibited cell proliferation. Our study showed that DUSP10 negatively regulates IEC growth and acts as a suppressor for CRC. Therefore, it could be targeted for the development of therapies for colitis and CRC.	[Png, C. W.; Weerasooriya, M.; James, S. J.; Poh, H. M.; Zhang, Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Png, C. W.; Weerasooriya, M.; James, S. J.; Poh, H. M.; Zhang, Y.] Natl Univ Singapore, Inst Life Sci, Immunol Programme, Singapore 117597, Singapore; [Guo, J.; Osato, M.; Yang, H.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Flavell, R. A.] Yale Univ, Howard Hughes Med Inst, Dept Immunol, New Haven, CT 06511 USA; [Dong, C.] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China	National University of Singapore; National University of Singapore; National University of Singapore; Howard Hughes Medical Institute; Yale University; Tsinghua University	Zhang, Y (corresponding author), Natl Univ Singapore, Dept Microbiol, Ctr Life Sci Inst, Immunol Programme, 28 Med Dr, Singapore 117597, Singapore.	miczy@nus.edu.sg	Osato, Motomi/N-5056-2014; dong, chen/B-3181-2009	Osato, Motomi/0000-0003-3982-9054; dong, chen/0000-0002-0084-9130	Office of Deputy President, National University of Singapore; Ministry of Education [MOE2010-T2-1-079]; National Medical Research Council of Singapore [IRG10nov091, CBRG11nov101]	Office of Deputy President, National University of Singapore(National University of Singapore); Ministry of Education; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	We would like to thank Nicholas Gascoigne for advice and helpful discussion. This study was supported by grants from the Office of Deputy President, National University of Singapore, the Ministry of Education (MOE2010-T2-1-079) and the National Medical Research Council (IRG10nov091 and CBRG11nov101) of Singapore.	Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; Cornell TT, 2012, AM J PHYSIOL-LUNG C, V303, pL251, DOI 10.1152/ajplung.00063.2012; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Delaunoit T, 2006, CLIN GASTROENTEROL H, V4, P335, DOI 10.1016/j.cgh.2005.12.035; Egan LJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1028, DOI 10.1152/ajpcell.00167.2003; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Groschl B, 2013, INT J CANCER, V132, P1537, DOI 10.1002/ijc.27834; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Hrabe JE, 2014, J SURG ONCOL, V109, P117, DOI 10.1002/jso.23465; Kinnebrew MA, 2012, IMMUNOL REV, V245, P113, DOI 10.1111/j.1600-065X.2011.01081.x; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Matta R, 2012, AM J PHYSIOL-GASTR L, V302, pG1322, DOI 10.1152/ajpgi.00018.2012; McConnell BB, 2011, GASTROENTEROLOGY, V141, P1302, DOI 10.1053/j.gastro.2011.06.086; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; McConnell BB, 2009, CANCER RES, V69, P4125, DOI 10.1158/0008-5472.CAN-08-4402; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mori A, 2009, MOL CANCER RES, V7, P1390, DOI 10.1158/1541-7786.MCR-08-0525; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nandan MO, 2008, GASTROENTEROLOGY, V134, P120, DOI 10.1053/j.gastro.2007.10.023; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nomura M, 2012, ONCOL REP, V28, P931, DOI 10.3892/or.2012.1862; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Pai R, 1998, GASTROENTEROLOGY, V114, P706, DOI 10.1016/S0016-5085(98)70584-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Popovici V, 2012, J CLIN ONCOL, V30, P1288, DOI 10.1200/JCO.2011.39.5814; Qian F, 2012, AM J PHYSIOL-LUNG C, V302, pL866, DOI 10.1152/ajplung.00277.2011; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi H, 2013, J CLIN INVEST, V123, P2064, DOI 10.1172/JCI64375; Spain SL, 2012, HUM MOL GENET, V21, P934, DOI 10.1093/hmg/ddr523; Sturm A, 2008, WORLD J GASTROENTERO, V14, P348, DOI 10.3748/wjg.14.348; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Takahashi M, 2000, CARCINOGENESIS, V21, P1117, DOI 10.1093/carcin/21.6.1117; Takahashi M, 2004, CANCER SCI, V95, P475, DOI 10.1111/j.1349-7006.2004.tb03235.x; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Turusov VS, 1990, PATHOLOGY TUMOURS LA; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zhang JH, 2006, GASTROENTEROLOGY, V131, P1179, DOI 10.1053/j.gastro.2006.08.007; Zhang T, 2014, EUR J CANCER PREV, V23, P173, DOI 10.1097/CEJ.0b013e3283647408; Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	58	25	26	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					206	217		10.1038/onc.2015.74	http://dx.doi.org/10.1038/onc.2015.74			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25772234				2022-12-26	WOS:000368193900007
J	Zhang, YY; Huang, Y; He, QZ; Luo, J; Zhu, L; Lu, SS; Liu, JY; Huang, PF; Zeng, XZ; Liang, SP				Zhang, Yi-Ya; Huang, Yong; He, Quan-Ze; Luo, Ji; Zhu, Li; Lu, Shan-Shan; Liu, Jin-Yan; Huang, Peng-Fei; Zeng, Xiong-Zhi; Liang, Song-Ping			Structural and Functional Diversity of Peptide Toxins from Tarantula Haplopelma hainanum (Ornithoctonus hainana) Venom Revealed by Transcriptomic, Peptidomic, and Patch Clamp Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER SELENOCOSMIA-HUWENA; CHINESE BIRD SPIDER; FUNNEL-WEB SPIDER; MOLECULAR DIVERSIFICATION; GLAND TRANSCRIPTOME; HUWENTOXIN-V; NEUROTOXINS; PURIFICATION; FAMILY; DISCOVERY	Spider venom is a complex mixture of bioactive peptides to subdue their prey. Early estimates suggested that over 400 venom peptides are produced per species. In order to investigate the mechanisms responsible for this impressive diversity, transcriptomics based on second generation high throughput sequencing was combined with peptidomic assays to characterize the venom of the tarantula Haplopelma hainanum. The genes expressed in the venom glands were identified, and the bioactivity of their protein products was analyzed using the patch clamp technique. A total of 1,136 potential toxin precursors were identified that clustered into 90 toxin groups, of which 72 were novel. The toxin peptides clustered into 20 cysteine scaffolds that included between 4 and 12 cysteines, and 14 of these groups were newly identified in this spider. Highly abundant toxin peptide transcripts were present and resulted from hypermutation and/or fragment insertion/deletion. In combination with variable post-translational modifications, this genetic variability explained how a limited set of genes can generate hundreds of toxin peptides in venom glands. Furthermore, the intraspecies venom variability illustrated the dynamic nature of spider venom and revealed how complex components work together to generate diverse bioactivities that facilitate adaptation to changing environments, types of prey, and milking regimes in captivity.	[Zhang, Yi-Ya; He, Quan-Ze; Luo, Ji; Zhu, Li; Lu, Shan-Shan; Liu, Jin-Yan; Huang, Peng-Fei; Zeng, Xiong-Zhi; Liang, Song-Ping] Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China; [Huang, Yong] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China	Hunan Normal University; Beijing Institute of Microbiology & Epidemiology	Zeng, XZ (corresponding author), Hunan Normal Univ, Coll Life Sci, Key Lab Prot Chem & Dev Biol, Minist Educ, Changsha 410081, Hunan, Peoples R China.	xiongzhizeng@gmail.com; liangsp@hunnu.edu.cn		Zhang, Yiya/0000-0003-3644-3500	National Basic Research Program of China [2010CB529801]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China(National Basic Research Program of China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This work was supported by National Basic Research Program of China (973) Grant 2010CB529801 and by Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province Grant 20134486.	Adams ME, 2004, TOXICON, V43, P509, DOI 10.1016/j.toxicon.2004.02.004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BINDOKAS VP, 1991, J NEUROPHYSIOL, V66, P590, DOI 10.1152/jn.1991.66.2.590; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; CORDEIRO MD, 1993, TOXICON, V31, P35, DOI 10.1016/0041-0101(93)90354-L; Corzo G, 2003, CELL MOL LIFE SCI, V60, P2409, DOI 10.1007/s00018-003-3108-6; Deng MC, 2008, EUR J PHARMACOL, V582, P12, DOI 10.1016/j.ejphar.2007.12.014; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Duan D, 2011, ACTA NEUROCHIR, V153, P2085, DOI 10.1007/s00701-011-0955-z; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; Grishin E, 1999, EUR J BIOCHEM, V264, P276, DOI 10.1046/j.1432-1327.1999.00622.x; Huang RH, 2003, ACTA BIOCH BIOPH SIN, V35, P976; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Jiang LP, 2008, TOXICON, V51, P1479, DOI 10.1016/j.toxicon.2008.03.024; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; KAISER II, 1994, TOXICON, V32, P1083, DOI 10.1016/0041-0101(94)90392-1; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuzmenkov AI, 2013, BBA-BIOMEMBRANES, V1828, P724, DOI 10.1016/j.bbamem.2012.10.014; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Miranda DM, 2001, BRAIN RES BULL, V54, P533, DOI 10.1016/S0361-9230(01)00443-9; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Naamati G, 2009, NUCLEIC ACIDS RES, V37, pW363, DOI 10.1093/nar/gkp299; Oswald RE, 2002, J BIOL CHEM, V277, P34443, DOI 10.1074/jbc.M202715200; Park S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-50; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pimentel C, 2006, PROTEIN SCI, V15, P628, DOI 10.1110/ps.051860606; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; SAVELNIEMANN A, 1989, BIOL CHEM H-S, V370, P485, DOI 10.1515/bchm3.1989.370.1.485; SKINNER WS, 1989, J BIOL CHEM, V264, P2150; STAPLETON A, 1990, J BIOL CHEM, V265, P2054; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Urbarova I, 2012, MAR DRUGS, V10, P2265, DOI 10.3390/md10102265; Violette A, 2012, J PROTEOMICS, V75, P5215, DOI 10.1016/j.jprot.2012.06.001; Wen SP, 2005, PEPTIDES, V26, P2412, DOI 10.1016/j.peptides.2005.05.012; Wong ESW, 2012, GENE, V496, P1, DOI 10.1016/j.gene.2012.01.009; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zelanis A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001554; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang PF, 2003, TOXICON, V42, P15, DOI 10.1016/S0041-0101(03)00095-3; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100682; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	66	13	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					14192	14207		10.1074/jbc.M114.635458	http://dx.doi.org/10.1074/jbc.M114.635458			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25770214	Green Published, hybrid			2022-12-26	WOS:000355313000046
J	Staples, KJ; Nicholas, B; McKendry, RT; Spalluto, CM; Wallington, JC; Bragg, CW; Robinson, EC; Martin, K; Djukanovic, R; Wilkinson, TMA				Staples, Karl J.; Nicholas, Ben; McKendry, Richard T.; Spalluto, C. Mirella; Wallington, Joshua C.; Bragg, Craig W.; Robinson, Emily C.; Martin, Kirstin; Djukanovic, Ratko; Wilkinson, Tom M. A.			Viral Infection of Human Lung Macrophages Increases PDL1 Expression via IFN beta	PLOS ONE			English	Article							CD8(+) T-CELLS; UP-REGULATION; VIRUS-REPLICATION; INTERFERON-GAMMA; DENDRITIC CELLS; PD-1 EXPRESSION; DEFICIENT; DEFENSE; B7-H1; HIV	Lung macrophages are an important defence against respiratory viral infection and recent work has demonstrated that influenza-induced macrophage PDL1 expression in the murine lung leads to rapid modulation of CD8+ T cell responses via the PD1 receptor. This PD1/PDL1 pathway may downregulate acute inflammatory responses to prevent tissue damage. The aim of this study was to investigate the mechanisms of PDL1 regulation by human macrophages in response to viral infection. Ex-vivo viral infection models using influenza and RSV were established in human lung explants, isolated lung macrophages and monocyte-derived macrophages (MDM) and analysed by flow cytometry and RT-PCR. Incubation of lung explants, lung macrophages and MDM with X31 resulted in mean cellular infection rates of 18%, 18% and 29% respectively. Viral infection significantly increased cell surface expression of PDL1 on explant macrophages, lung macrophages and MDM but not explant epithelial cells. Infected MDM induced IFN beta release from autologous CD8+ T cells, an effect enhanced by PDL1 blockade. We observed increases in PDL1 mRNA and IFN beta mRNA and protein release by MDM in response to influenza infection. Knockdown of IFN beta by siRNA, resulted in a 37.5% reduction in IFN beta gene expression in response to infection, and a significant decrease in PDL1 mRNA. Furthermore, when MDM were incubated with IFN beta, this cytokine caused increased expression of PDL1 mRNA. These data indicate that human macrophage PDL1 expression modulates CD8+ cell IFN gamma. release in response to virus and that this expression is regulated by autologous IFN beta production.	[Staples, Karl J.; Nicholas, Ben; McKendry, Richard T.; Spalluto, C. Mirella; Wallington, Joshua C.; Bragg, Craig W.; Robinson, Emily C.; Martin, Kirstin; Djukanovic, Ratko; Wilkinson, Tom M. A.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Djukanovic, Ratko; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 4XY, Hants, England	University of Southampton; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Sir Henry Wellcome Labs,Southampton Gen Hosp, Southampton SO9 5NH, Hants, England.	k.staples@southampton.ac.uk		Nicholas, Benjamin/0000-0003-1467-9643; Staples, Karl/0000-0003-3844-6457; Wilkinson, Tom/0000-0003-1771-3851; Djukanovic, Ratko/0000-0001-6039-5612	Asthma UK [08/026]; British Medical Association HC Roscoe Award; Medical Research Council 4-year studentship	Asthma UK; British Medical Association HC Roscoe Award; Medical Research Council 4-year studentship	This work was part funded by a project grant from Asthma UK (08/026) and the British Medical Association HC Roscoe Award 2013 to KJS. RTM was funded by a Medical Research Council 4-year studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Boasso A, 2008, CLIN IMMUNOL, V129, P132, DOI 10.1016/j.clim.2008.05.009; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Do TTH, 2011, MICROBIOL IMMUNOL, V55, P751, DOI 10.1111/j.1348-0421.2011.00383.x; Erickson JJ, 2012, J CLIN INVEST, V122, P2967, DOI 10.1172/JCI62860; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Nicholas B, 2012, AM J RESP CRIT CARE, V185, pA5716; Nicod LP, 1999, RESPIRATION, V66, P2, DOI 10.1159/000029329; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; RODGERS BC, 1982, J MED VIROL, V9, P177, DOI 10.1002/jmv.1890090304; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; Trabattoni D, 2003, BLOOD, V101, P2514, DOI 10.1182/blood-2002-10-3065; Tudhope SJ, 2008, J PHARMACOL EXP THER, V324, P306, DOI 10.1124/jpet.107.127670; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; WARSHAUER D, 1977, AM REV RESPIR DIS, V115, P269; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Xie ZY, 2009, IMMUNOL INVEST, V38, P624, DOI 10.1080/08820130903062210	38	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121527	10.1371/journal.pone.0121527	http://dx.doi.org/10.1371/journal.pone.0121527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775126	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351183500215
J	Williams, M; Summers, BJ; Baxter, RHG				Williams, Marni; Summers, Brady J.; Baxter, Richard H. G.			Biophysical Analysis of Anopheles gambiae Leucine-Rich Repeat Proteins APL1A(1), APLB and APL1C and Their Interaction with LRIM1	PLOS ONE			English	Article							HUMAN MALARIA PARASITE; CRYSTAL-STRUCTURE; MOSQUITO; COMPLEMENT; RESISTANCE; VECTOR; MACROMOLECULES; SCATTERING; IMMUNITY; PROGRAM	Natural infection of Anopheles gambiae by malaria-causing Plasmodium parasites is significantly influenced by the APL1 genetic locus. The locus contains three closely related leucine-rich repeat (LRR) genes, APL1A, APL1B and APL1C. Multiple studies have reported the participation of APL1A-C in the immune response of A. gambiae to invasion by both rodent and human Plasmodium isolates. APL1C forms a heterodimer with the related LRR protein LRIM1 via a C-terminal coiled-coil domain that is also present in APL1A and APL1B. The LRIM1/APL1C heterodimer protects A. gambiae from infection by binding the complement-like protein TEP1 to form a stable and active immune complex. Here we report solution x-ray scatting data for the LRIM1/APL1C heterodimer, the oligomeric state of LRIM1/APL1 LRR domains in solution and the crystal structure of the APL1B LRR domain. The LRIM1/APL1C heterodimeric complex has a flexible and extended structure in solution. In contrast to the APL1A, APL1C and LRIM1 LRR domains, the APL1B LRR domain is a homodimer. The crystal structure of APL1B-LRR shows that the homodimer is formed by an N-terminal helix that complements for the absence of an N-terminal capping motif in APL1B, which is a unique distinction within the LRIM1/APL1 protein family. Full-length APL1A(1) and APL1B form a stable complex with LRIM1. These results support a model in which APL1A(1), APL1B and APL1C can all form an extended, flexible heterodimer with LRIM1, providing a repertoire of functional innate immune complexes to protect A. gambiae from a diverse array of pathogens.	[Williams, Marni; Summers, Brady J.; Baxter, Richard H. G.] Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Baxter, RHG (corresponding author), Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06520 USA.	richard.baxter@yale.edu	Baxter, Richard/F-3027-2013	Baxter, Richard/0000-0001-5140-1726	DOE Office of Biological and Environmental Research; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; National Institute of Health project MINOS [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institute of Health project MINOS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Prof. Kenneth Vernick for helpful discussions as well as originally supplying sequences for G3 alleles of APL1A<SUP>1</SUP>, APL1A<SUP>2</SUP> and APL1B. The authors would also like to thank Michael J. Robertson for helping with the initial studies on the APL1A<SUP>1</SUP> protein and Bill Eliason for the SEC-MALLS experiments. SAXS experiments were conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Diffraction data of APL1B-LRR were collected at National Synchrotron Light Source (NSLS) beam line X25C (Brookhaven National Laboratory). Use of the NSLS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. Additional support comes from the National Institute of Health project MINOS (R01GM105404).	Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020; [Anonymous], 2014, WHO WORLD MAL REP 20; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Blandin Stephanie A., 2008, V415, P365, DOI 10.1007/978-1-59745-570-1_21; Botos I, 2011, STRUCTURE, V19, P447, DOI 10.1016/j.str.2011.02.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guttman M, 2013, STRUCTURE, V21, P321, DOI 10.1016/j.str.2013.02.004; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Hohenester E, 2006, BIOCHEM SOC T, V34, P418, DOI 10.1042/BST0340418; Holm I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052684; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Kajander T, 2011, J MOL BIOL, V413, P1001, DOI 10.1016/j.jmb.2011.09.032; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Niemann HH, 2004, MICROBES INFECT, V6, P101, DOI 10.1016/j.micinf.2003.11.001; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rebsamen M, 2013, TRENDS IMMUNOL, V34, P610, DOI 10.1016/j.it.2013.05.002; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-87; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Seiradake E, 2009, EMBO REP, V10, P736, DOI 10.1038/embor.2009.95; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108	58	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118911	10.1371/journal.pone.0118911	http://dx.doi.org/10.1371/journal.pone.0118911			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775123	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500053
J	Atyame, CM; Cattel, J; Lebon, C; Flores, O; Dehecq, JS; Weill, M; Gouagna, LC; Tortosa, P				Atyame, Celestine M.; Cattel, Julien; Lebon, Cyrille; Flores, Olivier; Dehecq, Jean-Sebastien; Weill, Mylene; Gouagna, Louis Clement; Tortosa, Pablo			Wolbachia-Based Population Control Strategy Targeting Culex quinquefasciatus Mosquitoes Proves Efficient under Semi-Field Conditions	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; AEDES-ALBOPICTUS; PIPIENS-QUINQUEFASCIATUS; INSECTICIDE RESISTANCE; SPECIES COMPLEX; BLOCKS DENGUE; INFECTION; STRAIN; DENSITY; MALES	In mosquitoes, the maternally inherited bacterial Wolbachia induce a form of embryonic lethality called cytoplasmic incompatibility (CI). This property can be used to reduce the density of mosquito field populations through inundative releases of incompatible males in order to sterilize females (Incompatible Insect Technique, or IIT, strategy). We have previously constructed the LR[wPip(Is)] line representing a good candidate for controlling field populations of the Culex quinquefasciatus mosquito in the islands of the south-western Indian Ocean. The main purpose of the present study was to fill the gap between laboratory experiments and field implementation, i.e. assessing mating competitiveness of these incompatible males under semi-field conditions. In a first set of experiments, we analyzed crossing relationships between LR[wPip(Is)] males and La Reunion field females collected as larvae in 19 distinct localities throughout the island. This investigation revealed total embryonic mortality, confirming the strong sterilizing capacity of LR[wPip(Is)] males. Subsequently, mating competitiveness of LR[wPip(Is)] males was assessed under semi-field conditions in the presence of field males and females from La Reunion. Confrontations were carried out in April and December using different ratios of LR[wPip(Is)] to field males. The results indicated that the LR[wPip(Is)] males successfully compete with field males in mating with field females, displaying even higher competitiveness than field males in April. Our results support the implementation of small-scale field tests in order to assess the feasibility of IIT against Cx. quinquefasciatus in the islands of southwestern Indian Ocean where this mosquito species is a proven competent vector for human pathogens.	[Atyame, Celestine M.; Cattel, Julien; Lebon, Cyrille; Gouagna, Louis Clement; Tortosa, Pablo] CRVOI, Reunion Isl, France; [Atyame, Celestine M.; Cattel, Julien; Tortosa, Pablo] Univ Reunion, Reunion Isl, France; [Lebon, Cyrille] CNRS, IRD UM1 UM2, MIVEGEC, UMR 5290 224, Montpellier, France; [Flores, Olivier] UMR PVBMT, CIRAD, Reunion Isl, France; [Dehecq, Jean-Sebastien] ARS OI, St Denis, Reunion, France; [Weill, Mylene] CNRS, ISEM UMR 5554, UM2, Montpellier, France	University of La Reunion; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Atyame, CM (corresponding author), CRVOI, Ste Clotilde, Reunion Isl, France.	celestine.atyame-nten@univ-reunion.fr		Flores, Olivier/0000-0002-1416-0449; Weill, Mylene/0000-0002-4043-1601; Tortosa, Pablo/0000-0002-7928-7264; Gouagna, Louis Clement/0000-0003-0957-4484	European Union's Seventh Framework Programme ([FP7]) [263958]; French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	European Union's Seventh Framework Programme ([FP7]); French Ministry of Health; European Regional Development Fund (FEDER-Reunion)	Celestine M. Atyame Post-Doctoral position was funded by the European Union's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement no 263958 (RUN-Emerge project). This investigation had received the joint financial supports from the French Ministry of Health and the European Regional Development Fund (FEDER-Reunion) under the Convergence 2007-2013 Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x; Apostolaki A, 2011, J APPL ENTOMOL, V135, P546, DOI 10.1111/j.1439-0418.2011.01614.x; Atyame CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087336; Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440; Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083; Atyame CM, 2011, MOL ECOL, V20, P286, DOI 10.1111/j.1365-294X.2010.04937.x; Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78; BARR AR, 1980, NATURE, V283, P71, DOI 10.1038/283071a0; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271; Clark ME, 2003, MECH DEVELOP, V120, P185, DOI 10.1016/S0925-4773(02)00424-0; Crawley M.J., 2007, R BOOK; CURTIS CF, 1982, ENTOMOL EXP APPL, V31, P181, DOI 10.1111/j.1570-7458.1982.tb03133.x; Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965; Dumas E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-181; Duron O, 2006, P ROY SOC B-BIOL SCI, V273, P495, DOI 10.1098/rspb.2005.3336; Duron O, 2006, HEREDITY, V96, P493, DOI 10.1038/sj.hdy.6800831; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Duron O, 2011, HEREDITY, V106, P986, DOI 10.1038/hdy.2010.146; Duron O, 2007, J BACTERIOL, V189, P4442, DOI 10.1128/JB.00142-07; Duron O, 2012, P ROY SOC B-BIOL SCI, V279, P4473, DOI 10.1098/rspb.2012.1368; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Facchinelli L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002001; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2005, NATURE, V436, P189, DOI 10.1038/436189a; Jannat KNE, 2013, J VECTOR ECOL, V38, P120, DOI 10.1111/j.1948-7134.2013.12017.x; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010; Papathanos PA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S5; Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855; R Core Team, 2021, R LANGUAGE ENV STAT; Rasgon JL, 2003, GENETICS, V165, P2029; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Tantely ML, 2010, INSECT BIOCHEM MOLEC, V40, P317, DOI 10.1016/j.ibmb.2010.02.005; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2009, ENTOMOL EXP APPL, V132, P232, DOI 10.1111/j.1570-7458.2009.00886.x; Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837	57	33	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119288	10.1371/journal.pone.0119288	http://dx.doi.org/10.1371/journal.pone.0119288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768841	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500073
J	Inoue, M; Akama, T; Jiang, YB; Chun, TH				Inoue, Mayumi; Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa			The Exocyst Complex Regulates Free Fatty Acid Uptake by Adipocytes	PLOS ONE			English	Article							STIMULATED GLUT4 TRAFFICKING; DEPENDENT DIABETES-MELLITUS; INSULIN-RESISTANCE; PLASMA-MEMBRANE; LIPID DROPLETS; MICE LACKING; PROTEIN; PHOSPHORYLATION; TRANSPORT; OBESITY	The exocyst is an octameric molecular complex that drives vesicle trafficking in adipocytes, a rate-limiting step in insulin-dependent glucose uptake. This study assessed the role of the exocyst complex in regulating free fatty acid (FFA) uptake by adipocytes. Upon differentiating into adipocytes, 3T3-L1 cells acquire the ability to incorporate extracellular FFAs in an insulin-dependent manner. A kinetic assay using fluoresceinated FFA (C12 dodecanoic acid) uptake allows the real-time monitoring of FFA internalization by adipocytes. The insulin-dependent uptake of C12 dodecanoic acid by 3T3-L1 adipocytes is mediated by Akt and phosphatidylinositol 3 (PI3)-kinase. Gene silencing of the exocyst components Exo70 and Sec8 significantly reduced insulin-dependent FFA uptake by adipocytes. Consistent with the roles played by Exo70 and Sec8 in FFA uptake, mCherry-tagged Exo70 and HA-tagged Sec8 partially colocalize with lipid droplets within adipocytes, suggesting their active roles in the development of lipid droplets. Tubulin polymerization was also found to regulate FFA uptake in collaboration with the exocyst complex. This study demonstrates a novel role played by the exocyst complex in the regulation of FFA uptake by adipocytes.	[Inoue, Mayumi; Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet MEND, Ann Arbor, MI 48109 USA; [Akama, Takeshi; Jiang, Yibin; Chun, Tae-Hwa] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Inoue, M (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet MEND, Ann Arbor, MI 48109 USA.	mayu@umich.edu; taehwa@umich.edu	Chun, Tae-Hwa/H-5959-2019; Akama, Takeshi/C-9392-2011	Chun, Tae-Hwa/0000-0001-9333-2589; Akama, Takeshi/0000-0002-6470-7174	American Heart Association [0730028N]; National Institute of Health [R01DK095137]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK095137] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the American Heart Association Scientist Development Grant 0730028N (MI) and the National Institute of Health R01DK095137 (THC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Y, 2008, J BIOL CHEM, V283, P324, DOI 10.1074/jbc.M706873200; BARTER PJ, 1971, J CLIN INVEST, V50, P583, DOI 10.1172/JCI106528; Berk PD, 1999, MOL CELL BIOCHEM, V192, P17, DOI 10.1023/A:1006832001033; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; CHEN YDI, 1987, J CLIN ENDOCR METAB, V64, P17, DOI 10.1210/jcem-64-1-17; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chun TH, 2014, METHOD ENZYMOL, V538, P15, DOI 10.1016/B978-0-12-800280-3.00002-5; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Ewart MA, 2005, J BIOL CHEM, V280, P3812, DOI 10.1074/jbc.M409928200; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Georgiadi A, 2012, ADV NUTR, V3, P127, DOI 10.3945/an.111.001602; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kamp F, 2003, J BIOL CHEM, V278, P7988, DOI 10.1074/jbc.M206648200; Kampf JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1207, DOI 10.1152/ajpendo.00259.2007; Krahmer N, 2013, MOL CELL PROTEOMICS, V12, P1115, DOI 10.1074/mcp.M112.020230; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Liao JF, 2005, J LIPID RES, V46, P597, DOI 10.1194/jlr.D400023-JLR200; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Munoz MC, 2009, J ENDOCRINOL, V201, P185, DOI 10.1677/JOE-08-0276; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tsuboi T, 2005, J BIOL CHEM, V280, P25565, DOI 10.1074/jbc.M501674200; Weisburger JH, 1997, J AM DIET ASSOC, V97, pS16, DOI 10.1016/S0002-8223(97)00725-6; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067561; Xu S, 2013, BIOCHEMISTRY-US, V52, P7254, DOI 10.1021/bi400914c	49	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120289	10.1371/journal.pone.0120289	http://dx.doi.org/10.1371/journal.pone.0120289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768116	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500118
J	Jones, AC; Antillon, KS; Jenkins, SM; Janos, SN; Overton, HN; Shoshan, DS; Fischer, EG; Trujillo, KA; Bisoffi, M				Jones, Anna C.; Antillon, Kresta S.; Jenkins, Shannon M.; Janos, Sara N.; Overton, Heidi N.; Shoshan, Dor S.; Fischer, Edgar G.; Trujillo, Kristina A.; Bisoffi, Marco			Prostate Field Cancerization: Deregulated Expression of Macrophage Inhibitory Cytokine 1 (MIC-1) and Platelet Derived Growth Factor A (PDGF-A) in Tumor Adjacent Tissue	PLOS ONE			English	Article							GENE-EXPRESSION; INTRAEPITHELIAL NEOPLASIA; CLINICAL-IMPLICATIONS; CANCER; CARCINOGENESIS; INFLAMMATION; RECEPTOR	Prostate field cancerization denotes molecular alterations in histologically normal tissues adjacent to tumors. Such alterations include deregulated protein expression, as we have previously shown for the key transcription factor early growth response 1 (EGR-1) and the lipogenic enzyme fatty acid synthase (FAS). Here we add the two secreted factors macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) to the growing list of protein markers of prostate field cancerization. Expression of MIC-1 and PDGF-A was measured quantitatively by immunofluorescence and comprehensively analyzed using two methods of signal capture and several groupings of data generated in human cancerous (n = 25), histologically normal adjacent (n = 22), and disease-free (n = 6) prostate tissues. A total of 208 digitized images were analyzed. MIC-1 and PDGF-A expression in tumor tissues were elevated 7.1x to 23.4x and 1.7x to 3.7x compared to disease-free tissues, respectively (p< 0.0001 to p = 0.08 and p< 0.01 to p = 0.23, respectively). In support of field cancerization, MIC-1 and PDGF-A expression in adjacent tissues were elevated 7.4x to 38.4x and 1.4x to 2.7x, respectively (p< 0.0001 to p< 0.05 and p< 0.05 to p = 0.51, respectively). Also, MIC-1 and PDGF-A expression were similar in tumor and adjacent tissues (0.3x to 1.0x; p< 0.001 to p = 0.98 for MIC-1; 0.9x to 2.6x; p< 0.01 to p = 1.00 for PDGF-A). All analyses indicated a high level of inter-and intra-tissue heterogeneity across all types of tissues (mean coefficient of variation of 86.0%). Our data shows that MIC-1 and PDGF-A expression is elevated in both prostate tumors and structurally intact adjacent tissues when compared to disease-free specimens, defining field cancerization. These secreted factors could promote tumorigenesis in histologically normal tissues and lead to tumor multifocality. Among several clinical applications, they could also be exploited as indicators of disease in false negative biopsies, identify areas of repeat biopsy, and add molecular information to surgical margins.	[Jones, Anna C.; Antillon, Kresta S.; Jenkins, Shannon M.; Janos, Sara N.; Overton, Heidi N.; Trujillo, Kristina A.; Bisoffi, Marco] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Trujillo, Kristina A.; Bisoffi, Marco] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Fischer, Edgar G.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Shoshan, Dor S.; Bisoffi, Marco] Chapman Univ, Schmid Coll Sci & Technol, Biochem & Mol Biol, Biol Sci, Orange, CA USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico; University of New Mexico's Health Sciences Center; Chapman University System; Chapman University	Bisoffi, M (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA.	bisoffi@chapman.edu			National Institutes of Health (NIH) [RR0164880]; NATIONAL CANCER INSTITUTE [R03CA136030] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Grant RR0164880 and NIH Grant R03CA136030-02 (to M. Bisoffi), the University of New Mexico Cancer Center Support Grant NIH/ NCI P30CA118110, and a Summer Undergraduate Research Fellowship (SURF; to D. S. Shoshan) from the Chapman University Office of Undergraduate Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Braakhuis BJM, 2004, J PATHOL, V203, P620, DOI 10.1002/path.1549; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Dakubo GD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-2; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Epstein JI, 2010, INT J SURG PATHOL, V18, p142S, DOI 10.1177/1066896910370616; Haaland CM, 2009, INT J ONCOL, V35, P537, DOI 10.3892/ijo_00000365; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Heaphy CM, 2010, PROSTATE, V70, P1471, DOI 10.1002/pros.21182; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heldin CH, 2012, UPSALA J MED SCI, V117, P83, DOI 10.3109/03009734.2012.658119; Husaini Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043833; Jones AC, 2012, PROSTATE, V72, P1159, DOI 10.1002/pros.22465; Karan D, 2009, CANCER RES, V69, P2, DOI 10.1158/0008-5472.CAN-08-1230; Khaled YS, 2012, CANCER BIOMARK, V11, P183, DOI 10.3233/CBM-2012-00287; Kosari F, 2012, AM J PATHOL, V181, P34, DOI 10.1016/j.ajpath.2012.03.043; Mimeault M, 2010, J CELL PHYSIOL, V224, P626, DOI 10.1002/jcp.22196; Montironi R, 2000, J CLIN PATHOL, V53, P655, DOI 10.1136/jcp.53.9.655; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Peyromaure M, 2002, J UROLOGY, V167, P218, DOI 10.1016/S0022-5347(05)65416-X; Rosenberg A, 2013, EXPERT OPIN INV DRUG, V22, P787, DOI 10.1517/13543784.2013.787409; Selander KS, 2007, CANCER EPIDEM BIOMAR, V16, P532, DOI 10.1158/1055-9965.EPI-06-0841; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Squire JA, 2011, ADV CANCER RES, V112, P183, DOI 10.1016/B978-0-12-387688-1.00007-7; Svatek RS, 2008, CANCER-AM CANCER SOC, V112, P1058, DOI 10.1002/cncr.23276; Treat EG, 2010, UROLOGY, V75, P724, DOI 10.1016/j.urology.2009.04.032; Trujillo KA, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/302894; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	35	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119314	10.1371/journal.pone.0119314	http://dx.doi.org/10.1371/journal.pone.0119314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767870	Green Submitted, gold, Green Published			2022-12-26	WOS:000351277500076
J	Klaassen, EMM; Penders, J; Jobsis, Q; van de Kant, KDG; Thijs, C; Mommers, M; van Schayck, CP; van Eys, G; Koppelman, GH; Dompeling, E				Klaassen, Ester M. M.; Penders, John; Jobsis, Quirijn; van de Kant, Kim D. G.; Thijs, Carel; Mommers, Monique; van Schayck, Constant P.; van Eys, Guillaume; Koppelman, Gerard H.; Dompeling, Edward			An ADAM33 Polymorphism Associates with Progression of Preschool Wheeze into Childhood Asthma: A Prospective Case-Control Study with Replication in a Birth Cohort Study	PLOS ONE			English	Article							GENE POLYMORPHISMS; ORMDL3 EXPRESSION; CANDIDATE GENE; VARIANTS; SUSCEPTIBILITY; DISINTEGRIN; CHILDREN; ATOPY; IGE; EXPOSURE	Background The influence of asthma candidate genes on the development from wheeze to asthma in young children still needs to be defined. Objective To link genetic variants in asthma candidate genes to progression of wheeze to persistent wheeze into childhood asthma. Materials and Methods In a prospective study, children with recurrent wheeze from the ADEM (Asthma DEtection and Monitoring) study were followed until the age of six. At that age a classification (transient wheeze or asthma) was based on symptoms, lung function and medication use. In 198 children the relationship between this classification and 30 polymorphisms in 16 asthma candidate genes was assessed by logistic regression. In case of an association based on a p<0.10, replication analysis was performed in an independent birth cohort study (KOALA study, n = 248 included for the present analysis). Results In the ADEM study, the minor alleles of ADAM33 rs511898 and rs528557 and the ORMDL3/GSDMB rs7216389 polymorphisms were negatively associated, whereas the minor alleles of IL4 rs2243250 and rs2070874 polymorphisms were positively associated with childhood asthma. When replicated in the KOALA study, ADAM33 rs528557 showed a negative association of the CG/GG-genotype with progression of recurrent wheeze into childhood asthma (0.50 (0.26-0.97) p = 0.04) and no association with preschool wheeze. Conclusion Polymorphisms in ADAM33, ORMDL3/GSDMB and IL4 were associated with childhood asthma in a group of children with recurrent wheeze. The replication of the negative association of the CG/GG-genotype of rs528557 ADAM33 with childhood asthma in an independent birth cohort study confirms that a compromised ADAM33 gene may be implicated in the progression of wheeze into childhood asthma.	[Klaassen, Ester M. M.; Jobsis, Quirijn; van de Kant, Kim D. G.; Dompeling, Edward] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Resp Med, Maastricht, Netherlands; [Penders, John; Thijs, Carel; Mommers, Monique] MUMC, CAPHRI, Dept Epidemiol, Maastricht, Netherlands; [van Schayck, Constant P.] MUMC, CAPHRI, Dept Gen Practice, Maastricht, Netherlands; [van Eys, Guillaume] MUMC, CARIM, Cardiovasc Res Inst, Dept Genet & Cell Biol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp,Groningen Res Inst Asthma &, Dept Paediat Pulmonol & Paediat Allergol, Groningen, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen	Klaassen, EMM (corresponding author), MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Paediat Resp Med, Maastricht, Netherlands.	ester.klaassen@mumc.nl	Koppelman, Gerard/AAG-9187-2020; Penders, John/A-1280-2011; Thijs, Carel/H-8340-2019	Penders, John/0000-0001-9146-5919; Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252	Dutch Asthma Foundation [NAF3.4.05.033]; Stichting Astma Bestrijding [SAB 2006/018]; Maastricht University Medical Centre [PF 294]; Netherlands Organisation for Health Research and Development (ZonMW) [912-03-031]	Dutch Asthma Foundation; Stichting Astma Bestrijding; Maastricht University Medical Centre; Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	The ADEM study is funded by unrestricted grants from the Dutch Asthma Foundation (NAF3.4.05.033), Stichting Astma Bestrijding (SAB 2006/018), and Maastricht University Medical Centre (PF 294). The DNA collection of the KOALA study was financially supported by The Netherlands Organisation for Health Research and Development (ZonMW: grant number 912-03-031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basehore MJ, 2004, J ALLERGY CLIN IMMUN, V114, P80, DOI 10.1016/j.jaci.2004.05.035; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Bindels P J E, 2008, Ned Tijdschr Geneeskd, V152, P550; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Blekic M, 2013, ANN ALLERG ASTHMA IM, V110, P347, DOI 10.1016/j.anai.2013.01.021; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, J ALLERGY CLIN IMMUN, V126, P338, DOI 10.1016/j.jaci.2010.04.024; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Chang JC, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/270869; de Faria ICJ, 2008, J PEDIAT-BRAZIL, V84, P203, DOI [10.2223/JPED.1783, 10.1590/S0021-75572008000300004]; Foley SC, 2007, J ALLERGY CLIN IMMUN, V119, P863, DOI 10.1016/j.jaci.2006.12.665; FRANK EH, 2001, REGRESSION MODELING; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Haitchi HM, 2005, AM J RESP CRIT CARE, V171, P958, DOI 10.1164/rccm.200409-1251OC; Holloway John W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007963; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V125, pS81, DOI 10.1016/j.jaci.2009.10.071; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Ito I, 2007, J ALLERGY CLIN IMMUN, V119, P89, DOI 10.1016/j.jaci.2006.08.038; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Kavalar MS, 2012, INT J IMMUNOGENET, V39, P20, DOI 10.1111/j.1744-313X.2011.01051.x; Kedda MA, 2006, EUR J HUM GENET, V14, P1027, DOI 10.1038/sj.ejhg.5201662; Klaassen EMM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/162571; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lee JH, 2004, CLIN EXP ALLERGY, V34, P860, DOI 10.1111/j.1365-2222.2004.01977.x; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Noguchi E, 2006, CLIN EXP ALLERGY, V36, P602, DOI 10.1111/j.1365-2222.2006.02471.x; Pedersen SE, 2011, PEDIATR PULM, V46, P1, DOI 10.1002/ppul.21321; Pinto LA, 2008, J PEDIAT, V84, pS68, DOI [10.1590/S0021-75572008000500010, 10.2223/JPED.1781]; Postma DS, 2004, CLIN EXP ALLERGY, V34, P1, DOI 10.1111/j.1365-2222.2004.01845.x; Raby BA, 2004, J ALLERGY CLIN IMMUN, V113, P1071, DOI 10.1016/j.jaci.2004.03.035; Reijmerink NE, 2009, ALLERGY, V64, P898, DOI 10.1111/j.1398-9995.2009.01939.x; Rigoli L, 2011, INT J IMMUNOPATH PH, V24, P41, DOI 10.1177/03946320110240S409; Sambrook J., 2001, MOL CLONING LAB MANU; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Schubert K, 2006, DIS MARKERS, V22, P127, DOI 10.1155/2006/373620; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Steyerberg E., 2009, CLIN PREDICTION MODE; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Thomsen SF, 2011, RESP MED, V105, P1147, DOI 10.1016/j.rmed.2011.03.007; van de Kant KDG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-210; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	48	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119349	10.1371/journal.pone.0119349	http://dx.doi.org/10.1371/journal.pone.0119349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768087	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500078
J	Laura, M; Borghi, C; Bobbio, V; Allavena, A				Laura, Marina; Borghi, Cristina; Bobbio, Valentina; Allavena, Andrea			The Effect on the Transcriptome of Anemone coronaria following Infection with Rust (Tranzschelia discolor)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEINS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; DISEASE-RESISTANCE; RNA-SEQ; DIFFERENTIAL EXPRESSION; SEQUENCING TECHNOLOGIES; HYPERSENSITIVE RESPONSE; PATHOGEN INTERACTIONS; FLAVONOL SYNTHASE	In order to understand plant/pathogen interaction, the transcriptome of uninfected (1S) and infected (2I) plant was sequenced at 3'end by the GS FLX 454 platform. De novo assembly of high-quality reads generated 27,231 contigs leaving 37,191 singletons in the 1S and 38,393 in the 2I libraries. ESTcalc tool suggested that 71% of the transcriptome had been captured, with 99% of the genes present being represented by at least one read. Unigene annotation showed that 50.5% of the predicted translation products shared significant homology with protein sequences in GenBank. In all 253 differential transcript abundance (DTAs) were in higher abundance and 52 in lower abundance in the 2I library. 128 higher abundance DTA genes were of fungal origin and 49 were clearly plant sequences. A tBLASTn-based search of the sequences using as query the full length predicted polypeptide product of 50 R genes identified 16 R gene products. Only one R gene (PGIP) was upregulated. The response of the plant to fungal invasion included the up-regulation of several pathogenesis related protein (PR) genes involved in JA signaling and other genes associated with defense response and down regulation of cell wall associated genes, non-race-specific disease resistance1 (NDR1) and other genes like myb, presqualene diphosphate phosphatase (PSDPase), a UDP-glycosyltransferase 74E2-like (UGT). The DTA genes identified here should provide a basis for understanding the A. coronaria/T. discolor interaction and leads for biotechnology-based disease resistance breeding.	[Laura, Marina; Borghi, Cristina; Bobbio, Valentina; Allavena, Andrea] CRA Unita Ric Floricoltura & Specie Ornamentali, I-18038 San Remo, IM, Italy		Laura, M (corresponding author), CRA Unita Ric Floricoltura & Specie Ornamentali, Corso Inglesi 508, I-18038 San Remo, IM, Italy.	marina.laura@entecra.it			Italian Ministry of Agriculture and Forestry [DM 11960/7742010, DM 186/07]	Italian Ministry of Agriculture and Forestry	This work was funded by the Italian Ministry of Agriculture and Forestry (www.politicheagricole.it/) in the framework of the project "RESPAT" (grant number: DM 11960/7742010) and "ANEMOS" (grant number: DM 186/07). AA received the funding.	Ajeet S., 2009, INT J INTEGR BIOL, V7, P117; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andreeva L, 1999, INT J EXP PATHOL, V80, P305, DOI 10.1046/j.1365-2613.1999.00128.x; Arevalo-Rodriguez M, 2000, EMBO J, V19, P3739, DOI 10.1093/emboj/19.14.3739; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Bluthgen N, 2004, QBIO0407034 ARXIV; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Cacas JL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-144; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Coram TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X; De Lorenzo G, 2001, ANNU REV PHYTOPATHOL, V39, P313, DOI 10.1146/annurev.phyto.39.1.313; de Wit P J G M, 2007, Cell Mol Life Sci, V64, P2726; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dodds PN, 2009, NEW PHYTOL, V183, P993, DOI 10.1111/j.1469-8137.2009.02922.x; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Duplessis S, 2011, P NATL ACAD SCI USA, V108, P9166, DOI 10.1073/pnas.1019315108; Duplessis S, 2009, CRIT REV PLANT SCI, V28, P309, DOI 10.1080/07352680903241063; Edreva A., 2005, General and Applied Plant Physiology, V31, P105; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; El-kereamy A, 2013, CAN J PLANT SCI, V93, P599, DOI [10.4141/CJPS2013-009, 10.4141/cjps2013-009]; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Fritig B, 1998, CURR OPIN IMMUNOL, V10, P16, DOI 10.1016/S0952-7915(98)80025-3; Fukunaga K, 2006, J BIOL CHEM, V281, P9490, DOI 10.1074/jbc.M512970200; Galgoczy L, 2010, CURRENT RES TECHNOLO, P550; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gao XF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00137; Ghosh M, 2006, ANN BOT-LONDON, V98, P1145, DOI 10.1093/aob/mcl205; Glazebrook J, 1999, CURR OPIN PLANT BIOL, V2, P280, DOI 10.1016/S1369-5266(99)80050-8; Goritschnig S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002502; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Grennan AK, 2011, PLANT PHYSIOL, V155, P1750, DOI 10.1104/pp.111.900407; Gruner K, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00252; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P61, DOI 10.1016/0048-4059(82)90024-8; Hernandez-Blanco C, 2007, PLANT CELL, V19, P890, DOI 10.1105/tpc.106.048058; HERRERAESTRELLA L, 1983, NATURE, V303, P209, DOI 10.1038/303209a0; Hok S, 2010, MOL PLANT MICROBE IN, V23, P1253, DOI 10.1094/MPMI-04-10-0103; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; JOHNSTON DJ, 1993, J EXP BOT, V44, P971, DOI 10.1093/jxb/44.5.971; Joly DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-422; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Karim S, 2007, PLANTA, V225, P1431, DOI 10.1007/s00425-006-0451-5; Kariola T, 2006, PLANT PHYSIOL, V142, P1559, DOI 10.1104/pp.106.086223; Kimbrel JA, 2011, GENES-BASEL, V2, P689, DOI 10.3390/genes2040689; Knepper C, 2011, PLANT PHYSIOL, V156, P286, DOI 10.1104/pp.110.169656; Kohler A, 2002, PLANT PHYSIOL, V128, P1046, DOI 10.1104/pp.010744; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Laura M, 2013, TRANSGENIC RES, V22, P59, DOI 10.1007/s11248-012-9628-9; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Lipka V, 2007, ANNU REV CELL DEV BI, V23, P147, DOI 10.1146/annurev.cellbio.23.090506.123529; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Liu ZJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-42; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; LOPEZFRANCO RM, 1990, SYST BOT, V15, P560, DOI 10.2307/2419155; Lukacin R, 2003, PHYTOCHEMISTRY, V62, P287, DOI 10.1016/S0031-9422(02)00567-8; Luo B, 2007, PLANT CELL PHYSIOL, V48, P1790, DOI 10.1093/pcp/pcm152; Mahomed W, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-167; Maimbo M, 2007, PLANT PHYSIOL, V145, P1588, DOI 10.1104/pp.107.105353; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Marroni F, 2011, PLANT J, V67, P736, DOI 10.1111/j.1365-313X.2011.04627.x; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Moreno JE, 2013, PLANT PHYSIOL, V162, P1006, DOI 10.1104/pp.113.218164; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nezhad AS, 2013, J EXP BOT, V64, P4709, DOI 10.1093/jxb/ert254; Nishimura S, 2013, PLANT MOL BIOL, V81, P1, DOI 10.1007/s11103-012-9976-0; Nissim Y, 2004, EUPHYTICA, V136, P51, DOI 10.1023/B:EUPH.0000019520.19707.59; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park HJ, 2011, PLANT PATHOLOGY J, V27, P170, DOI 10.5423/PPJ.2011.27.2.170; Pauwels L, 2010, NATURE, V464, P788, DOI 10.1038/nature08854; PENG M, 1992, PHYTOPATHOLOGY, V82, P696, DOI 10.1094/Phyto-82-696; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Petriccione M, 2013, J PROTEOMICS, V78, P461, DOI 10.1016/j.jprot.2012.10.014; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Polesani M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-142; Powell ALT, 2000, MOL PLANT MICROBE IN, V13, P942, DOI 10.1094/MPMI.2000.13.9.942; Prescott AG, 2002, PHYTOCHEMISTRY, V60, P589, DOI 10.1016/S0031-9422(02)00155-3; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Rayapuram C, 2008, MOL PLANT MICROBE IN, V21, P988, DOI 10.1094/MPMI-21-7-0988; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; SALVI G, 1990, J PLANT PHYSIOL, V136, P513, DOI 10.1016/S0176-1617(11)80206-3; Saunders DGO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029847; Schilmiller AL, 2007, PLANT PHYSIOL, V143, P812, DOI 10.1104/pp.106.092916; Schneider DJ, 2010, ANNU REV PHYTOPATHOL, V48, P457, DOI 10.1146/annurev-phyto-073009-114411; Schulze-Lefert P, 2004, CURR BIOL, V14, pR22, DOI 10.1016/j.cub.2003.12.017; Sohani MM, 2009, PLANT BIOLOGY, V11, P105, DOI 10.1111/j.1438-8677.2008.00139.x; Sohn J, 2000, MOL PLANT MICROBE IN, V13, P629, DOI 10.1094/MPMI.2000.13.6.629; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Szabo LJ, 2001, P NATL ACAD SCI USA, V98, P7654, DOI 10.1073/pnas.151262398; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thara VK, 2003, MOL PLANT PATHOL, V4, P51, DOI 10.1046/j.1364-3703.2003.00142.x; Tremblay A, 2011, SEQUENCING, V2011, P1, DOI DOI 10.1155/2011/827250; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Van Loon LC, 1997, EUR J PLANT PATHOL, V103, P753, DOI 10.1023/A:1008638109140; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vivier E, 2005, NAT IMMUNOL, V6, P17, DOI 10.1038/ni1153; Wald FA, 2003, PLANT MOL BIOL, V52, P705, DOI 10.1023/A:1025061324856; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XQ, 1996, P NATL ACAD SCI USA, V93, P2598, DOI 10.1073/pnas.93.6.2598; Wang YX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034225, 10.1371/journal.pone.0039525, 10.1371/journal.pone.0037152]; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Way HM, 2000, MOL PLANT PATHOL, V1, P223, DOI 10.1046/j.1364-3703.2000.00027.x; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Worberg A, 2007, ORG DIVERS EVOL, V7, P55, DOI 10.1016/j.ode.2006.08.001; Wulff BBH, 2011, CURR OPIN PLANT BIOL, V14, P468, DOI 10.1016/j.pbi.2011.04.002; Yamamoto H, 2000, PHYTOCHEMISTRY, V53, P7, DOI 10.1016/S0031-9422(99)00471-9; Yu XM, 2010, FUNCT INTEGR GENOMIC, V10, P227, DOI 10.1007/s10142-010-0161-8; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2	137	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118565	10.1371/journal.pone.0118565	http://dx.doi.org/10.1371/journal.pone.0118565			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768012	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500029
J	Lim, HC; Chu, CC; Seufferheld, MJ; Cameron, SA				Lim, Haw Chuan; Chu, Chia-Ching; Seufferheld, Manfredo J.; Cameron, Sydney A.			Deep Sequencing and Ecological Characterization of Gut Microbial Communities of Diverse Bumble Bee Species	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; WESTERN HONEY-BEE; GEN. NOV.; BACTERIA; HYMENOPTERA; SYMBIONTS; PATTERNS; DECLINE; UNIFRAC; HINDGUT	Gut bacterial communities of bumble bees are correlated with defense against pathogens. Further understanding this host-microbe association is vitally important as bumble bees are currently experiencing global population declines, potentially due in part to emergent diseases. In this study, we used pyrosequencing and community fingerprinting (ARISA) to characterize the gut microbial communities of nine bumble species from across the Bombus phylogeny. Overall, we delimited 74 bacterial taxa (operational taxonomic units or OTUs) belonging to Betaproteobacteria, Gammaproteobacteria, Bacilli, Actinobacteria, Flavobacteria and Alphaproteobacteria. Each bacterial community was taxonomically simple, containing an average of 1.9 common (relative abundance per sample > 5%) bacterial OTUs. The most abundant and prevalent (occurring in 92% of the samples) bacterial OTU, based on 16S rRNA sequences, closely matched that of the previously described Betaproteobacteria species Snodgrassella alvi. Bacteria that were first described in bee-related external environments dominated a number of gut bacterial communities, suggesting that they are not strictly dependent on the internal gut environment. The ARISA data showed a correlation between bacterial community structures and the geographic locations where the bees were sampled, suggesting that at least a subset of the bacterial species may be transmitted environmentally. Using light and fluorescent microscopy, we demonstrated that the gut bacteria form a biofilm on the internal epithelial surface of the ileum, corroborating results obtained from Apis mellifera.	[Lim, Haw Chuan; Seufferheld, Manfredo J.; Cameron, Sydney A.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Chu, Chia-Ching] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Lim, HC (corresponding author), Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA.	limhc@si.edu; mseufferheld@gmail.com; scameron@life.illinois.edu	Lim, Haw Chuan/HGB-5079-2022	Chu, Chia-Ching/0000-0002-5032-0163	U.S. Department of Agriculture, National Institute of Food and Agriculture grant [2010-65104-05992]; U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant [2009-35505-06012]	U.S. Department of Agriculture, National Institute of Food and Agriculture grant; U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant	The work was supported by a U.S. Department of Agriculture, National Institute of Food and Agriculture grant (#2010-65104-05992) to SAC and by a U.S. Department of Agriculture, National Institute of Food and Agriculture grant grant (#2009-35505-06012) to MJS. Both grants supported the expenses for pyrosequencing, DNA fingerprinting, and materials/reagents used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Brown MJF, 2009, APIDOLOGIE, V40, P410, DOI 10.1051/apido/2009019; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; DILLON RJ, 1986, J INVERTEBR PATHOL, V47, P350, DOI 10.1016/0022-2011(86)90106-0; Edwards CG, 1998, J APPL MICROBIOL, V84, P698, DOI 10.1046/j.1365-2672.1998.00399.x; Endo A, 2011, INT J SYST EVOL MICR, V61, P898, DOI 10.1099/ijs.0.023838-0; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; GREENBERG B, 1970, Infection and Immunity, V2, P800; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; JAROSZ J, 1979, J INVERTEBR PATHOL, V34, P192, DOI 10.1016/0022-2011(79)90101-0; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jojima Y, 2004, INT J SYST EVOL MICR, V54, P2263, DOI 10.1099/ijs.0.02911-0; King JG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003058; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Koch H, 2012, J ANIM ECOL, V81, P1202, DOI 10.1111/j.1365-2656.2012.02004.x; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Maharramov J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081475; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; MICHENER C D, 1978, University of Kansas Science Bulletin, V51, P575; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Morales CL, 2013, FRONT ECOL ENVIRON, V11, P529, DOI 10.1890/120321; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ozer S, 2012, P 2012 IEEE INT C BI; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rolfe R., 1997, GASTROINTESTINAL MIC, P501; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2013, MBIO, V4, DOI 10.1128/mBio.00602-12; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Torretta JP, 2006, T AM ENTOMOL SOC, V132, P285; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; VEIVERS PC, 1982, J INSECT PHYSIOL, V28, P947, DOI 10.1016/0022-1910(82)90111-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	76	15	18	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118566	10.1371/journal.pone.0118566	http://dx.doi.org/10.1371/journal.pone.0118566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768110	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500030
J	Patil, VP; Karels, TJ; Hik, DS				Patil, Vijay P.; Karels, Timothy J.; Hik, David S.			Ecological, Evolutionary and Social Constraints on Reproductive Effort: Are Hoary Marmots Really Biennial Breeders?	PLOS ONE			English	Article							BODY CONDITION; CLIMATE-CHANGE; SURVIVAL; PATTERNS; COSTS; MASS; SUPPRESSION; POPULATION; HYPOTHESES; BEHAVIOR	Biennial breeding is a rare life-history trait observed in animal species living in harsh, unproductive environments. This reproductive pattern is thought to occur in 10 of 14 species in the genus Marmota, making marmots useful model organisms for studying its ecological and evolutionary implications. Biennial breeding in marmots has been described as an obligate pattern which evolved as a mechanism to mitigate the energetic costs of reproduction (Evolved Constraint hypothesis). However, recent anecdotal evidence suggests that it is a facultative pattern controlled by annual variation in climate and food availability (Environmental Constraint hypothesis). Finally, in social animals like marmots, biennial breeding could result from reproductive competition between females within social groups (Social Constraint hypothesis). We evaluated these three hypotheses using mark-recapture data from an 8-year study of hoary marmot (Marmota caligata) population dynamics in the Yukon. Annual variation in breeding probability was modeled using multi-state markrecapture models, while other reproductive life-history traits were modeled with generalized linear mixed models. Hoary marmots were neither obligate nor facultative biennial breeders, and breeding probability was insensitive to evolved, environmental, or social factors. However, newly mature females were significantly less likely to breed than older individuals. Annual breeding did not result in increased mortality. Female survival and, to a lesser extent, average fecundity were correlated with winter climate, as indexed by the Pacific Decadal Oscillation. Hoary marmots are less conservative breeders than previously believed, and the evidence for biennial breeding throughout Marmota, and in other arctic/alpine/antarctic animals, should be re-examined. Prediction of future population dynamics requires an accurate understanding of life history strategies, and of how life history traits allow animals to cope with changes in weather and other demographic influences.	[Patil, Vijay P.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Patil, Vijay P.; Karels, Timothy J.; Hik, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alaska System; University of Alaska Fairbanks; University of Alberta	Patil, VP (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.	vppatil@alaska.edu	Hik, David S/B-3462-2009	Hik, David S/0000-0002-8994-9305	Environment Canada; Natural Science and Engineering Research Council of Canada; Yellowstone to Yukon (Y2Y) Science Grants program; Canada Foundation for Innovation; Canada Research Chairs Program; Canadian Circumpolar Institute, University of Alberta	Environment Canada(CGIAR); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Yellowstone to Yukon (Y2Y) Science Grants program; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs); Canadian Circumpolar Institute, University of Alberta(University of Alberta)	Funding was provided by Environment Canada, the Natural Science and Engineering Research Council of Canada, the Yellowstone to Yukon (Y2Y) Science Grants program, the Canada Foundation for Innovation, the Canada Research Chairs Program, and the Canadian Circumpolar Institute, University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Anderson D. R., 2008, MODEL BASED INFERENC; Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; ARNOLD W, 1990, BEHAV ECOL SOCIOBIOL, V27, P239; Barash D.P., 1973, Animal Behav Monogr, V6, P171, DOI 10.1016/0003-3472(73)90002-X; BARASH DP, 1975, J MAMMAL, V56, P613, DOI 10.2307/1379473; BARASH DP, 1980, BEHAV ECOL SOCIOBIOL, V7, P201, DOI 10.1007/BF00299365; BARASH DP, 1974, ANIM BEHAV, V22, P256, DOI 10.1016/S0003-3472(74)80077-1; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENTON TG, 1995, EVOL ECOL, V9, P559, DOI 10.1007/BF01237655; Blumstein DT, 1998, BEHAV ECOL, V9, P8; Blumstein DT, 1999, OIKOS, V84, P369, DOI 10.2307/3546418; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyd IL, 1999, MARINE MAMMALS, V1, P218; Bryant AA, 2005, CAN J ZOOL, V83, P664, DOI 10.1139/Z05-056; Bryant AA, 1996, CAN J ZOOL, V74, P678, DOI 10.1139/z96-076; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CHASTEL O, 1995, IBIS, V137, P360, DOI 10.1111/j.1474-919X.1995.tb08033.x; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Dane B, 2002, BEHAVIOUR, V139, P1, DOI 10.1163/15685390252902247; DOBSON FS, 1992, AM NAT, V140, P109, DOI 10.1086/285405; Griffin SC, 2008, THESIS U MONTANA; Griffin SC, 2007, AM MIDL NAT, V158, P221, DOI 10.1674/0003-0031(2007)158[221:FOMMOR]2.0.CO;2; Hacklander K, 2003, ANIM BEHAV, V65, P1133, DOI 10.1006/anbe.2003.2159; HANSEN RM, 1975, AM MIDL NAT, V94, P348, DOI 10.2307/2424430; HARVEY PH, 1985, NATURE, V315, P319, DOI 10.1038/315319a0; HECTOR JAL, 1986, IBIS, V128, P9, DOI 10.1111/j.1474-919X.1986.tb02088.x; Holmes W.G., 1984, P250; HOLMES WG, 1979, THESIS U WASHINGTON; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; Karels TJ, 2004, OIKOS, V105, P575, DOI 10.1111/j.0030-1299.2004.12732.x; Kenward R., 1996, RANGES 5 ANAL SYSTEM; Kyle CJ, 2007, MOL ECOL, V16, P1245, DOI 10.1111/j.1365-294X.2006.03211.x; Laake J, 2005, PROGRAM MARK GENTLE; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Martin K, 2004, INTEGR COMP BIOL, V44, P177, DOI 10.1093/icb/44.2.177; Moore GWK, 2002, NATURE, V420, P401, DOI 10.1038/nature01229; Morrison SF, 2007, J ANIM ECOL, V76, P899, DOI 10.1111/j.1365-2656.2007.01276.x; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; Ozgul A, 2007, OECOLOGIA, V154, P95, DOI 10.1007/s00442-007-0817-9; Patil VP, 2013, OECOLOGIA, V173, P139, DOI 10.1007/s00442-013-2612-0; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Pilastro A, 2003, ECOLOGY, V84, P1784, DOI 10.1890/0012-9658(2003)084[1784:LLARSI]2.0.CO;2; R Developement Team RDC, 2009, R LANG ENV STAT COMP; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwartz OA, 2005, J ZOOL, V265, P73, DOI 10.1017/S0952836904006089; Scrucca L., 2004, R NEWS, V4, P11; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Stonehouse B., 1960, Q REV BIOL, V35, P17; Taulman JF, 1998, NW NAT, V70, P36; VANHEEZIK YM, 1994, IBIS, V136, P279; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; WEIMERSKIRCH H, 1987, J ANIM ECOL, V56, P1043, DOI 10.2307/4965; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	61	5	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119081	10.1371/journal.pone.0119081	http://dx.doi.org/10.1371/journal.pone.0119081			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768300	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500063
J	Singh, PK; Kumar, A				Singh, Pawan Kumar; Kumar, Ashok			Retinal Photoreceptor Expresses Toll-Like Receptors (TLRs) and Elicits Innate Responses Following TLR Ligand and Bacterial Challenge	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; STAPHYLOCOCCUS-AUREUS; MULLER GLIA; TRANSGENIC MICE; INFLAMMATION; IMMUNITY; ENDOPHTHALMITIS; DANGER; INJURY; TUMORS	Toll-like receptors (TLRs) play an important role in host defense against microbial pathogens. Our previous studies have shown that TLRs are expressed on various retinal cells (Microglia and Muller glia) and orchestrate retinal innate responses in bacterial endophthalmitis. In this study, we used a well-characterized mouse cone photoreceptor cell line (661W); and demonstrated that these cells express all known TLRs. Although the stimulation of 661W cells with TLR ligands (Pam3Cys, Polyl:C, LPS, Flagellin, Poly DT, and ODN) did not alter TLR expression, downstream TLR-signaling pathways (NF-kappa B, p38, and ERK) are activated. Moreover, TLR-activated 661W cells secreted significant amounts of inflammatory mediators (IL-6, IL-1 beta, MIP-2, and KC) in their culture supernatant, as assessed by ELISA. A similar trend was observed in 661W cells challenged with live bacteria (Staphylococcus aureus). Interestingly, the neutralization of TLR2, a major receptor for S. aureus recognition, did not significantly attenuate bacterial-induced inflammatory mediators, suggesting the existence of TLR2-independent mechanisms in photoreceptor cells. Together, these results indicate that photoreceptors constitutively express functional TLRs and possess the ability to initiate innate responses following pathogen challenge, implicating their role in retinal innate immunity.	[Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA; [Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Kumar, A (corresponding author), Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA.	akuma@med.wayne.edu		Singh, Pawan Kumar/0000-0001-5517-1120	NIH/NEI, Research to Prevent Blindness [R01-EY-19888]; NATIONAL EYE INSTITUTE [R01EY019888] Funding Source: NIH RePORTER	NIH/NEI, Research to Prevent Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by NIH/NEI R01-EY-19888, Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Jiang DH, 2006, CELL RES, V16, P693, DOI 10.1038/sj.cr.7310085; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kochan T, 2012, INFECT IMMUN, V80, P2076, DOI 10.1128/IAI.00149-12; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Kumar A, 2013, CRIT REV IMMUNOL, V33, P119, DOI 10.1615/CritRevImmunol.2013006618; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029830; Kumar A, 2010, J INFECT DIS, V201, P255, DOI 10.1086/649589; Lin Q, 2011, INT IMMUNOPHARMACOL; McClure R, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00386; Pandey RK, 2013, INDIAN J MED RES, V138, P609; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Sasai M, 2013, INT REV IMMUNOL, V32, P116, DOI 10.3109/08830185.2013.774391; Shamsuddin N, 2011, J IMMUNOL, V186, P7089, DOI 10.4049/jimmunol.1100565; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Suzuki T, 2011, INVEST OPHTH VIS SCI, V52, P3187, DOI 10.1167/iovs.10-6558; Talreja D, 2014, INVEST OPHTH VIS SCI, V55, P2392, DOI 10.1167/iovs.13-13401; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tu ZD, 2011, J NEUROIMMUNOL, V230, P183, DOI 10.1016/j.jneuroim.2010.07.022; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036560	30	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119541	10.1371/journal.pone.0119541	http://dx.doi.org/10.1371/journal.pone.0119541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767877	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500084
J	Su, LT; Liu, GX; Wang, H; Tian, Y; Zhou, ZH; Han, L; Yan, L				Su, Lingtao; Liu, Guixia; Wang, Han; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun			Research on Single Nucleotide Polymorphisms Interaction Detection from Network Perspective	PLOS ONE			English	Article							GENE-GENE; SNPS; ASSOCIATION; TOOL	Single Nucleotide Polymorphisms (SNPs) found in Genome-Wide Association Study (GWAS) mainly influence the susceptibility of complex diseases, but they still could not comprehensively explain the relationships between mutations and diseases. Interactions between SNPs are considered so important for deeply understanding of those relationships that several strategies have been proposed to explore such interactions. However, part of those methods perform poorly when marginal effects of disease loci are weak or absent, others may lack of considering high-order SNPs interactions, few methods have achieved the requirements in both performance and accuracy. Considering the above reasons, not only low-order, but also high-order SNP interactions as well as main-effect SNPs, should be taken into account in detection methods under an acceptable computational complexity. In this paper, a new pairwise (or low-order) interaction detection method IG (Interaction Gain) is introduced, in which disease models are not required and parallel computing is utilized. Furthermore, high-order SNP interactions were proposed to be detected by finding closely connected function modules of the network constructed from IG detection results. Tested by a wide range of simulated datasets and four WTCCC real datasets, the proposed methods accurately detected both low-order and high-order SNP interactions as well as disease-associated main-effect SNPS and it surpasses all competitors in performances. The research will advance complex diseases research by providing more reliable SNP interactions.	[Su, Lingtao; Liu, Guixia; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Su, Lingtao; Liu, Guixia; Tian, Yuan; Zhou, Zhihui; Han, Liang; Yan, Lun] Jilin Univ, Key Lab Symbol Computat & Knowledge Engn, Minist Educ, Changchun 130023, Peoples R China; [Wang, Han] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China	Jilin University; Jilin University; Northeast Normal University - China	Liu, GX (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	liugx@jlu.edu.cn	tian, yuan/V-2195-2018; siwei, benyi/AAA-5645-2021		National Natural Science Foundation of China [61373051, 61175023]; Science and Technology Development Program of Jilin Province [20140204004GX, 20140520072JH]; Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering); Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Fundamental Research Funds for the Central Universities, China [14QNJJ030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Jilin Province; Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering); Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by The National Natural Science Foundation of China (grants No. 61373051 and No. 61175023), the Science and Technology Development Program of Jilin Province (grant No. 20140204004GX, No. 20140520072JH), Project of Science and Technology Innovation Platform of Computing and Software Science (985 Engineering), and The Key Laboratory for Symbol Computation and Knowledge Engineering of the National Education Ministry of China, The Fundamental Research Funds for the Central Universities, China (grant No. 14QNJJ030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlborg O, 2000, GENETICS, V155, P2003; Chuang Li-Yeh, 2013, J Clin Bioinforma, V3, P4, DOI 10.1186/2043-9113-3-4; Chung YJ, 2007, BIOINFORMATICS, V23, P71, DOI 10.1093/bioinformatics/btl557; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Curk T, 2011, NUCLEIC ACIDS RES, V39, pW444, DOI 10.1093/nar/gkr321; Fan R, 2011, GENET EPIDEMIOL, V35, P706, DOI 10.1002/gepi.20621; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Liao YY, 2006, RADIOLOGY, V239, P300, DOI 10.1148/radiol.2391051114; Lin HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059688; Liu CN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S17; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Mc Mahon SS, 2014, SEMIN CELL DEV BIOL, V35, P98, DOI 10.1016/j.semcdb.2014.06.011; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Onay VU, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sapkota Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064896; Singh M, 2011, RHEUMATOL INT, V31, P421, DOI 10.1007/s00296-010-1449-7; Smith C, 2005, NATURE, V16, P435; Srihari S, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S021972001230002X; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Vogt M, 2007, J CHEM INF MODEL, V47, P337, DOI 10.1021/ci600418u; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Yang C, 2009, BIOINFORMATICS, V25, P504, DOI 10.1093/bioinformatics/btn652	35	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119146	10.1371/journal.pone.0119146	http://dx.doi.org/10.1371/journal.pone.0119146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763929	gold, Green Submitted, Green Published			2022-12-26	WOS:000351276300021
J	Bates, ORJ; Suki, B; Spector, PS; Bates, JHT				Bates, Oliver R. J.; Suki, Bela; Spector, Peter S.; Bates, Jason H. T.			Structural Defects Lead to Dynamic Entrapment in Cardiac Electrophysiology	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; NONLINEAR DYNAMICS; REENTRANT WAVES; SAFETY FACTOR; MODEL; RING; TISSUE; INHOMOGENEITIES; TERMINATION; EXCITATION	Biological networks are typically comprised of many parts whose interactions are governed by nonlinear dynamics. This potentially imbues them with the ability to support multiple attractors, and therefore to exhibit correspondingly distinct patterns of behavior. In particular, multiple attractors have been demonstrated for the electrical activity of the diseased heart in situations where cardioversion is able to convert a reentrant arrhythmia to a stable normal rhythm. Healthy hearts, however, are typically resilient to abnormal rhythms. This raises the question as to how a healthy cardiac cell network must be altered so that it can support multiple distinct behaviors. Here we demonstrate how anatomic defects can give rise to multistability in the heart as a function of the electrophysiological properties of the cardiac tissue and the timing of activation of ectopic foci. This leads to a form of hysteretic behavior, which we call dynamic entrapment, whereby the heart can become trapped in aberrant attractor as a result of a transient change in tissue properties. We show that this can lead to a highly inconsistent relationship between clinical symptoms and underlying pathophysiology, which raises the possibility that dynamic entrapment may underlie other forms of chronic idiopathic illness.	[Bates, Oliver R. J.; Suki, Bela] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Spector, Peter S.; Bates, Jason H. T.] Univ Vermont, Coll Med, Burlington, VT 05405 USA	Boston University; University of Vermont	Bates, JHT (corresponding author), Univ Vermont, Coll Med, 89 Beaumont Ave, Burlington, VT 05405 USA.	jason.h.bates@uvm.edu			Natural Sciences and Engineering Research Council of Canada; Evslin Family Foundation (PSS)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Evslin Family Foundation (PSS)	Funding provided by a Graduate Fellowship from the Natural Sciences and Engineering Research Council of Canada. URL-http://www.nserc-crsng.gc.ca/index_eng.asp (ORJB) and The Evslin Family Foundation (PSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Anafi RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014413; Bates JHT, 2006, INT C COMPL SYST BOS; Boyle PM, 2010, BIOPHYS J, V98, pL57, DOI 10.1016/j.bpj.2010.03.018; Cappato R, 1999, EUR HEART J, V20, P1766, DOI 10.1053/euhj.1999.1842; Colijn C, 2005, J THEOR BIOL, V237, P117, DOI 10.1016/j.jtbi.2005.03.033; Comtois P, 2007, CHAOS, V17, DOI 10.1063/1.2740673; Comtois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051927; COURTEMANCHE M, 1993, PHYS REV LETT, V70, P2182, DOI 10.1103/PhysRevLett.70.2182; Franz MR, 1997, J AM COLL CARDIOL, V30, P1785, DOI 10.1016/S0735-1097(97)00385-9; Fuster V, 2011, CIRCULATION, V124, pE333, DOI 10.1161/CIRCULATIONAHA.111.045211; Gaspo R, 1999, J PHARMACOL TOX MET, V42, P11, DOI 10.1016/S1056-8719(99)00042-8; Glass L, 2005, P NATL ACAD SCI USA, V102, P10409, DOI 10.1073/pnas.0504511102; Gong YF, 2007, CIRCULATION, V115, P2094, DOI 10.1161/CIRCULATIONAHA.106.656504; Gonzalez H, 2003, BIOSYSTEMS, V71, P71, DOI 10.1016/S0303-2647(03)00111-4; Gonzalez H, 2000, PROG THEOR PHYS SUPP, P83, DOI 10.1143/PTPS.139.83; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; ITO H, 1992, PHYSICA D, V56, P84, DOI 10.1016/0167-2789(92)90052-O; JOYNER RW, 1981, BIOPHYS J, V35, P113, DOI 10.1016/S0006-3495(81)84778-9; KAPLAN DT, 1988, MATH BIOSCI, V90, P19, DOI 10.1016/0025-5564(88)90056-9; Krogh-Madsen T, 2012, ANNU REV BIOMED ENG, V14, P179, DOI [10.1146/annurev-bioeng-071811-150106, 10.1146/annurev.bioeng-071811-150106]; Lenz TL, 2000, PHARMACOTHERAPY, V20, P776, DOI 10.1592/phco.20.9.776.35208; MACKEY MC, 1987, ANN NY ACAD SCI, V504, P16, DOI 10.1111/j.1749-6632.1987.tb48723.x; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; MILNE JR, 1984, EUR HEART J, V5, P99, DOI 10.1093/oxfordjournals.eurheartj.a061633; Mines GR, 1913, J PHYSIOL-LONDON, V46, P349; Pande A, 2000, PHYS REV E, V61, P6448, DOI 10.1103/PhysRevE.61.6448; Rohr S, 1997, SCIENCE, V275, P841, DOI 10.1126/science.275.5301.841; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Sinha S, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.061903; Sinha S, 2002, CHAOS, V12, P893, DOI 10.1063/1.1501176; Spector PS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P586, DOI 10.1161/CIRCEP.110.961524; Sridhar S, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/50003; Strogatz SH, 2001, NONLINEAR DYNAMICS C, P512; Waldo AL, 1996, J AM COLL CARDIOL, V28, P707, DOI 10.1016/0735-1097(96)00223-9; Wang Y, 2000, AM J PHYSIOL-HEART C, V278, pH1019, DOI 10.1152/ajpheart.2000.278.4.H1019; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119535	10.1371/journal.pone.0119535	http://dx.doi.org/10.1371/journal.pone.0119535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756656	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700048
J	Farzadi, L; Ghasemzadeh, A; Bahrami-Asl, Z; Shirdel, H				Farzadi, Laya; Ghasemzadeh, Aliyeh; Bahrami-asl, Zahra; Shirdel, Hossein			Predictors of Irrational Parenthood Cognitions in an Iranian Group of Infertile Women	PLOS ONE			English	Article							QUALITY-OF-LIFE; NATURAL-KILLER-CELL; DEPRESSION; ANXIETY; SUPPORT; STRESS	Objectives The aim of this study was to investigate possible predictors of irrational parenthood cognitions among infertile women seeking treatment. Methods In a cross-sectional study, 300 women who visited an Infertility Center in Iran during 2010 were studied. A pre-validated inventory was used to assess irrational parenthood cognitions. Potential predictors of the total irrational parenthood cognitions score were assessed. Results Mean irrational parenthood cognition score was 39.7( Range 0-56). Through bivariate analysis, the score on irrational parenthood cognition was inversely correlated with age and positively correlated with length of time seeking for infertility treatment and length of time expecting pregnancy. In a multivariate model, infertile women with higher education, especially academic education, or those with higher economic status were less likely to have irrational parenthood cognitions. However, higher motherhood motivation, no previous experience of pregnancy and being under social pressure, from others around, increased the likelihood of having irrational parenthood cognitions. Conclusions Some variables such as female spouse's educational level and being under social pressure can independently predict irrational parenthood cognitions among infertile women that may be of use in designing health promotion plans in order to target the vulnerable women.	[Farzadi, Laya; Ghasemzadeh, Aliyeh] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Bahrami-asl, Zahra] Tabriz Univ Med Sci, Alzahra Univ Hosp, Tabriz, Iran; [Shirdel, Hossein] Islamic Azad Univ, Dept Law, Tabriz Branch, Tabriz, Iran	Tabriz University of Medical Science; Alzahra University; Tabriz University of Medical Science; Islamic Azad University	Ghasemzadeh, A (corresponding author), Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran.	aliyeh.ghasemzadeh@yahoo.com	Ghasemzadeh, Aliyeh/M-5808-2017; Farzadi, Laya/M-2909-2017	Farzadi, Laya/0000-0001-9969-0352				Aliyeh G, 2007, MED SCI MONITOR, V13, pCR313; Amanati L., 2010, Iranian Journal of Obstetrics, Gynecology and Infertility, V12, P25; Amanati L, 2006, THESIS IRAN U MED SC; Borella P, 1999, PSYCHONEUROENDOCRINO, V24, P613, DOI 10.1016/S0306-4530(99)00016-5; Evers JLH, 2002, LANCET, V360, P151, DOI 10.1016/S0140-6736(02)09417-5; Faramarzi M, 2008, J AFFECT DISORDERS, V108, P159, DOI 10.1016/j.jad.2007.09.002; Farzadi L, 2014, J CLIN RES GOVT, V3, P147, DOI 10.13183/jcrg.v3i2.168; Farzadi L, 2013, J CLIN RES GOVERNANC, V2, P14; Farzadi L, 2008, TAIWAN J OBSTET GYNE, V47, P163, DOI 10.1016/S1028-4559(08)60074-1; Fekkes M, 2003, HUM REPROD, V18, P1536, DOI 10.1093/humrep/deg276; FREEMAN EW, 1985, FERTIL STERIL, V43, P48; Glover L, 1999, FERTIL STERIL, V72, P623, DOI 10.1016/S0015-0282(99)00304-0; Khayata GM, 2003, INT J GYNECOL OBSTET, V80, P183, DOI 10.1016/S0020-7292(02)00387-9; Matsubayashi H, 2004, GEN HOSP PSYCHIAT, V26, P398, DOI 10.1016/j.genhosppsych.2004.05.002; Oddens BJ, 1999, HUM REPROD, V14, P255, DOI 10.1093/humrep/14.1.255; Strauman TJ, 2004, BRAIN BEHAV IMMUN, V18, P544, DOI 10.1016/j.bbi.2004.01.003; STRAUMAN TJ, 1993, J PERS SOC PSYCHOL, V64, P1042, DOI 10.1037/0022-3514.64.6.1042; van BF, 1994, J PSYCHOSOM OBST GYN, V15, P157; Whiteford L M, 1995, Soc Sci Med, V40, P27, DOI 10.1016/0277-9536(94)00124-C	19	3	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0070239	10.1371/journal.pone.0070239	http://dx.doi.org/10.1371/journal.pone.0070239			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756990	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700001
J	Gasparetto, JC; Peccinini, RG; de Francisco, TMG; Cerqueira, LB; Campos, FR; Pontarolo, R				Gasparetto, Joao Cleverson; Peccinini, Rosangela Goncalves; Guimaraes de Francisco, Thais Martins; Cerqueira, Letcia Bonancio; Campos, Francinete Ramos; Pontarolo, Roberto			A Kinetic Study of the Main Guaco Metabolites Using Syrup Formulation and the Identification of an Alternative Route of Coumarin Metabolism in Humans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BIP. EX BAKER; KAURENOIC ACID; MIKANIA-GLOMERATA; BRONCHODILATOR ACTIVITY; HUMAN SERUM; LAEVIGATA; 7-HYDROXYCOUMARIN; PLASMA; PHARMACOKINETICS	For decades guaco species have been empirically used for the treatment of respiratory diseases. However, studies have shown that the toxic and therapeutic effects of the main guaco metabolites are dose-dependent, and none clinical study was done to evaluate the behavior of these substances in humans. In this work, a pilot study measuring the kinetic profile of the main guaco metabolites was performed leading to the knowledge of an alternative route of coumarin metabolism in humans. Initial screenings demonstrated that the administration of 60 mL of guaco syrup (single dose) did not provide sufficient levels of coumarin (COU), 7-hydroxycoumarin (7-HCOU), o-coumaric acid (OCA) and kaurenoic acid (KAU). The pharmacokinetic parameters were calculated by orally administering 60 mL of guaco syrup spiked with 1500 mg of COU. The kinetic study demonstrated that the plasmatic levels of 7-HCOU (considered the main metabolite of COU) were 10 times lower than the levels of COU, and the kinetic profile of 7-HCOU suggests sequential metabolism in the liver with low access of 7-HCOU to the systemic circulation. The study also demonstrated that OCA is one of the main bioavailable metabolites of COU. Therefore, the hydrolysis of the lactone ring forming a carboxylated compound is one of the possible routes of COU metabolism in humans. The half-lives of COU, 7-HCOU and OCA were approximately 4.0, 1.0 and 3.0 h, respectively and there was evidence that the recommended dosage of guaco syrup did not provide sufficient levels of COU, 7-HCOU or OCA to obtain a bronchodilation effect. Clinical studies are necessary to prove the efficacy and safety of products based on guaco.	[Gasparetto, Joao Cleverson; Guimaraes de Francisco, Thais Martins; Cerqueira, Letcia Bonancio; Campos, Francinete Ramos; Pontarolo, Roberto] Univ Fed Parana, Dept Pharm, Curitiba, PR, Brazil; [Peccinini, Rosangela Goncalves] Univ Estadual Paulista, Dept Nat Act Principles & Toxicol, Araraquara, SP, Brazil	Universidade Federal do Parana; Universidade Estadual Paulista	Pontarolo, R (corresponding author), Univ Fed Parana, Dept Pharm, Curitiba, PR, Brazil.	pontarolo@ufpr.br	CERQUEIRA, LETICIA/H-5121-2016; Campos, Francinete/AAU-1346-2020; Peccinini, Rosangela/G-6068-2015; Pontarolo, Roberto/G-6948-2014	Peccinini, Rosangela/0000-0002-2692-8101; Pontarolo, Roberto/0000-0002-7049-4363; CAMPOS, FRANCINETE/0000-0002-9688-2030	Fundacao Araucaria; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JCG received scholarship from Fundacao Araucaria and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Bogan DP, 1996, J CHROMATOGR B, V686, P267, DOI 10.1016/S0378-4347(96)00234-4; BOOTH AN, 1959, J BIOL CHEM, V234, P946; Born SL, 2000, DRUG METAB DISPOS, V28, P218; Cavalcanti BC, 2010, MUTAT RES-GEN TOX EN, V701, P153, DOI 10.1016/j.mrgentox.2010.06.010; Cavalcanti BC, 2006, FOOD CHEM TOXICOL, V44, P388, DOI 10.1016/j.fct.2005.08.011; Choi RJ, 2011, PHYTOMEDICINE, V18, P677, DOI 10.1016/j.phymed.2010.11.010; Costa-Lotufo LV, 2002, TOXICON, V40, P1231, DOI 10.1016/S0041-0101(02)00128-9; de Moura RS, 2002, J PHARM PHARMACOL, V54, P249, DOI 10.1211/0022357021778277; dos Santos SC, 2006, PLANTA MED, V72, P679, DOI 10.1055/s-2006-931577; EGAN DA, 1992, J CHROMATOGR-BIOMED, V582, P137, DOI 10.1016/0378-4347(92)80312-E; Fierro IM, 1999, J ETHNOPHARMACOL, V66, P19, DOI 10.1016/S0378-8741(98)00151-2; Food and D. Administration, 2001, BIOAN METH VAL GUID; Ford RA, 2001, FOOD CHEM TOXICOL, V39, P153, DOI 10.1016/S0278-6915(00)00123-X; Gasparetto JC, 2011, PHARM ANAL ACTA, V2, P1; Gasparetto JC, 2011, J SEP SCI, V34, P740, DOI 10.1002/jssc.201000792; Gasparetto JC, 2010, REV BRAS FARMACOGN, V20, P627, DOI 10.1590/S0102-695X2010000400025; Gasparetto JC, 2012, TOXICITY AND DRUG TESTING, P297; Graca C, 2007, J ETHNOPHARMACOL, V112, P430, DOI 10.1016/j.jep.2007.03.026; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Houston JB, 1982, PHARMACOL THERAPEUT, V15, P521; Labaune JP, 1993, FARMACOCINETICA, DOI [10.7399/FH.2013.37.6.742, DOI 10.7399/FH.2013.37.6.742]; Lacy A, 2004, CURR PHARM DESIGN, V10, P3797, DOI 10.2174/1381612043382693; Lake BG, 1999, FOOD CHEM TOXICOL, V37, P423, DOI 10.1016/S0278-6915(99)00010-1; LAKE BG, 1989, TOXICOL APPL PHARM, V97, P311, DOI 10.1016/0041-008X(89)90336-0; Napimoga MH, 2010, J PHARM PHARMACOL, V62, P809, DOI 10.1211/jpp.62.07.0001; NTP, 1993, NAT TOX PROGR TECH R, V422, P1; Ramanitrahasimbola D, 2005, J ETHNOPHARMACOL, V102, P400, DOI 10.1016/j.jep.2005.06.037; RITSCHEL WA, 1981, J CLIN PHARMACOL, V21, P294, DOI 10.1002/j.1552-4604.1981.tb01770.x; RITSCHEL WA, 1977, EUR J CLIN PHARMACOL, V12, P457, DOI 10.1007/BF00561066; RITSCHEL WA, 1984, METHOD FIND EXP CLIN, V6, P363; ROVEI V, 1982, BRIT J CLIN PHARMACO, V14, P769, DOI 10.1111/j.1365-2125.1982.tb02035.x; SHILLING WH, 1969, NATURE, V221, P664, DOI 10.1038/221664b0; Silva RZ, 2000, THESIS U FEDERAL SAN; Suyenaga ES, 2002, PHYTOTHER RES, V16, P519, DOI 10.1002/ptr.908; Teske M., 1997, HERBARIUM COMPENDIO; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; THORNES RD, 1982, LANCET, V2, P328; Tirapelli CR, 2004, EUR J PHARMACOL, V492, P233, DOI 10.1016/j.ejphar.2004.04.003; Tirapelli CR, 2002, FITOTERAPIA, V73, P56, DOI 10.1016/S0367-326X(01)00365-3; Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x; Vasconcelos JF, 2009, EUR J PHARMACOL, V609, P126, DOI 10.1016/j.ejphar.2009.03.027; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501	44	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118922	10.1371/journal.pone.0118922	http://dx.doi.org/10.1371/journal.pone.0118922			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757073	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700032
J	Kim, N; Kim, HM; Lee, ES; Lee, JO; Lee, HJ; Lee, SK; Moon, JW; Kim, JH; Kim, JK; Kim, SJ; Park, SH; Chung, CH; Kim, HS				Kim, Nami; Kim, Hong Min; Lee, Eun Soo; Lee, Jung Ok; Lee, Hye Jeong; Lee, Soo Kyung; Moon, Ji Wook; Kim, Ji Hae; Kim, Joong Kwan; Kim, Su Jin; Park, Sun Hwa; Chung, Choon Hee; Kim, Hyeon Soo			Dibenzoylmethane Exerts Metabolic Activity through Regulation of AMP-Activated Protein Kinase (AMPK)-Mediated Glucose Uptake and Adipogenesis Pathways	PLOS ONE			English	Article							CURCUMIN; MUSCLE; CELLS; RAT; STIMULATION; DERIVATIVES; INHIBITION; TRANSPORT; UPSTREAM; CASCADE	Dibenzoylmethane (DBM) has been shown to exert a variety of beneficial effects on human health. However, the mechanism of action is poorly understood. In this study, DBM increased phosphorylation of AMP-activated protein kinase (AMPK) and stimulated glucose uptake in a skeletal muscle cell line. Both knockdown of AMPK with siRNA and inhibition with AMPK inhibitor blocked DBM-induced glucose uptake. DBM increased the concentration of intracellular calcium and glucose uptake due to DBM was abolished by STO-609 (a calcium/calmodulin-dependent protein kinase inhibitor). DBM stimulated phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), which was blocked by pretreatment with compound C, an AMPK inhibitor. The expression of glucose transporter type 4 (GLUT4) was increased by DBM. The translocation of GLUT4 to the plasma membrane was also increased by DBM in AMPK dependently. In addition, DBM suppressed weight gain and prevented fat accumulation in the liver and abdomen in mice fed a high-fat diet. In preadipocyte cells, DBM decreased the activity of acetyl-CoA carboxylase (ACC), the rate-limiting enzyme of fatty acid synthesis. Expression of the adipogenic gene, fatty acid synthase (FAS), was suppressed by DBM in an AMPK-dependent manner. These results showed that the beneficial metabolic effects of DBM might be due to regulation of glucose uptake via AMPK in skeletal muscle and inhibition of adipogenesis in pre-adipocytes.	[Kim, Nami; Lee, Jung Ok; Lee, Hye Jeong; Lee, Soo Kyung; Moon, Ji Wook; Kim, Ji Hae; Kim, Joong Kwan; Kim, Su Jin; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Kim, Hong Min; Lee, Eun Soo; Chung, Choon Hee] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju 220701, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea.	anatomykim@korea.ac.kr		Chung, Choon/0000-0003-1144-7206	Korean government [NRF-2013R1A2A2A05004796]	Korean government(Korean Government)	The National Research Foundation of Korea funded by the Korean government supported this study (NRF-2013R1A2A2A05004796). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady PA, 1998, J AM COLL CARDIOL, V31, P950, DOI 10.1016/S0735-1097(98)00038-2; CHOSHI T, 1992, CHEM PHARM BULL, V40, P1047; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; FUKAI T, 1994, PHYTOCHEMISTRY, V35, P515, DOI 10.1016/S0031-9422(00)94793-9; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Huang MT, 1998, CARCINOGENESIS, V19, P1697, DOI 10.1093/carcin/19.9.1697; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jackson KM, 2002, CANCER LETT, V178, P161, DOI 10.1016/S0304-3835(01)00844-8; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JH, 2010, J CELL PHYSIOL, V223, P771, DOI 10.1002/jcp.22093; Lin CC, 2006, CARCINOGENESIS, V27, P131, DOI 10.1093/carcin/bgi199; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pan Y, 2013, J NUTR BIOCHEM, V24, P146, DOI 10.1016/j.jnutbio.2012.03.012; Pan YB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-323; Rozzo C, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-37; SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076; Somwar R, 2000, DIABETES, V49, P1794, DOI 10.2337/diabetes.49.11.1794; Srinivasan A, 2003, J PHARM PHARM SCI, V6, P327; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; WAHLSTROM B, 1978, ACTA PHARMACOL TOX, V43, P86; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xi X, 2001, J BIOL CHEM, V276, P41029, DOI 10.1074/jbc.M102824200; Yale JF, 2005, J AM SOC NEPHROL, V16, pS7, DOI 10.1681/ASN.2004110974; Zheng A, 2014, CURR CANCER DRUG TAR, V14, P156, DOI 10.2174/1568009613666131126115444	32	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120104	10.1371/journal.pone.0120104	http://dx.doi.org/10.1371/journal.pone.0120104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756788	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700059
J	Xiao, Y; Ma, F; Lv, YX; Cai, G; Teng, P; Xu, FG; Chen, SG				Xiao, Yi; Ma, Feng; Lv, Yixuan; Cai, Gui; Teng, Peng; Xu, FengGang; Chen, Shanguang			Sustained Attention is Associated with Error Processing Impairment: Evidence from Mental Fatigue Study in Four-Choice Reaction Time Task	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; CROSSMODAL DIVIDED ATTENTION; CHOICE REACTION TASKS; LATE ERP COMPONENTS; BRAIN ACTIVITY; FUNCTIONAL-SIGNIFICANCE; COGNITIVE CONTROL; ANTISACCADE TASK; PERFORMANCE; NEGATIVITY	Attention is important in error processing. Few studies have examined the link between sustained attention and error processing. In this study, we examined how error-related negativity (ERN) of a four-choice reaction time task was reduced in the mental fatigue condition and investigated the role of sustained attention in error processing. Forty-one recruited participants were divided into two groups. In the fatigue experiment group, 20 subjects performed a fatigue experiment and an additional continuous psychomotor vigilance test (PVT) for 1 h. In the normal experiment group, 21 subjects only performed the normal experimental procedures without the PVT test. Fatigue and sustained attention states were assessed with a questionnaire. Event-related potential results showed that ERN (p < 0.005) and peak (p < 0.05) mean amplitudes decreased in the fatigue experiment. ERN amplitudes were significantly associated with the attention and fatigue states in electrodes Fz, FC1, Cz, and FC2. These findings indicated that sustained attention was related to error processing and that decreased attention is likely the cause of error processing impairment.	[Xiao, Yi; Ma, Feng; Lv, Yixuan; Cai, Gui; Teng, Peng; Xu, FengGang; Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Ma, Feng] Tsinghua Univ, Sch Aerosp, Beijing 100084, Peoples R China; [Lv, Yixuan; Xu, FengGang] Beihang Univ BUAA, Sch Biol Sci & Med Engn, Dept Ergon, Beijing, Peoples R China	Chinese Academy of Sciences; Tsinghua University; Beihang University	Chen, SG (corresponding author), China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China.	Shanguang_chen@126.com			National Basic Research Program of China (973 Program) [2011CB711003]; National Natural Science Foundation of China [71201148]; Foundation of National Key Laboratory of Human Factors Engineering [HF2011-Z-Z-A-01, HF2011-Z-B-02, HF2011-Z-Z-B-02, HF2012-Z-B-02]; China Manned Space Medical Engineering Advanced Research Project [2012SY54B1701]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of National Key Laboratory of Human Factors Engineering; China Manned Space Medical Engineering Advanced Research Project	This study was supported by the National Basic Research Program of China (973 Program; No. 2011CB711003), the National Natural Science Foundation of China (71201148), the Foundation of National Key Laboratory of Human Factors Engineering (Grant Nos. HF2011-Z-Z-A-01, HF2011-Z-B-02, HF2011-Z-Z-B-02, and HF2012-Z-B-02), and the China Manned Space Medical Engineering Advanced Research Project (2012SY54B1701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholow BD, 2012, J ABNORM PSYCHOL, V121, P173, DOI 10.1037/a0023664; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Clayson PE, 2012, SOC COGN AFFECT NEUR, V7, P677, DOI 10.1093/scan/nsr040; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Endrass T, 2010, BIOL PSYCHOL, V84, P257, DOI 10.1016/j.biopsycho.2010.02.002; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grutzmann R, 2014, BIOL PSYCHOL, V96, P1, DOI 10.1016/j.biopsycho.2013.10.007; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Hajcak G, 2008, AM J PSYCHIAT, V165, P116, DOI 10.1176/appi.ajp.2007.07010143; HOHNSBEIN J, 1991, ELECTROEN CLIN NEURO, V78, P438, DOI 10.1016/0013-4694(91)90061-8; Hughes G, 2011, NEUROPSYCHOLOGIA, V49, P405, DOI 10.1016/j.neuropsychologia.2010.11.036; Johannes S, 2001, PSYCHIAT RES-NEUROIM, V108, P101, DOI 10.1016/S0925-4927(01)00117-2; Kato Y, 2009, INT J PSYCHOPHYSIOL, V72, P204, DOI 10.1016/j.ijpsycho.2008.12.008; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Luu P, 2000, J NEUROSCI, V20, P464, DOI 10.1523/JNEUROSCI.20-01-00464.2000; Maier ME, 2011, NEUROIMAGE, V56, P2339, DOI 10.1016/j.neuroimage.2011.03.083; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Overbeek TJM, 2005, J PSYCHOPHYSIOL, V19, P319, DOI 10.1027/0269-8803.19.4.319; Pailing PE, 2004, BRAIN COGNITION, V56, P215, DOI 10.1016/j.bandc.2004.06.005; Park JS, 2001, IND HEALTH, V39, P250, DOI 10.2486/indhealth.39.250; Pfabigan DM, 2013, NEUROPSYCHOLOGIA, V51, P613, DOI 10.1016/j.neuropsychologia.2012.12.008; Riba J, 2005, COGNITIVE BRAIN RES, V25, P554, DOI 10.1016/j.cogbrainres.2005.08.009; Ridderinkhof KR, 2002, SCIENCE, V298, P2209, DOI 10.1126/science.1076929; Riesel A, 2013, BIOL PSYCHOL, V93, P377, DOI 10.1016/j.biopsycho.2013.04.007; Riesel A, 2012, PSYCHOPHYSIOLOGY, V49, P239, DOI 10.1111/j.1469-8986.2011.01298.x; Scheffers MK, 1999, PSYCHOPHYSIOLOGY, V36, P149, DOI 10.1111/1469-8986.3620149; Shayler D J, 2000, SPRINGER PRAXIS BOOK, P45; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00240; Strozyk JV, 2012, BRAIN RES, V1460, P41, DOI 10.1016/j.brainres.2012.04.028; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635; Wessel JR, 2011, NEUROIMAGE, V54, P2105, DOI 10.1016/j.neuroimage.2010.10.033; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; Wiersema JR, 2005, J NEURAL TRANSM, V112, P1417, DOI 10.1007/s00702-005-0276-6; Wiswede D, 2009, SOCIAL COGNITIVE AFF; Wu JH, 2014, BIOL PSYCHOL, V99, P77, DOI 10.1016/j.biopsycho.2014.03.002; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; YOSHITAKE H, 1971, J SCI LABOUR, V47, P797	53	10	15	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117837	10.1371/journal.pone.0117837	http://dx.doi.org/10.1371/journal.pone.0117837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MX	25756780	gold, Green Published			2022-12-26	WOS:000351275700019
J	You, LY; Yan, KZ; Zou, JF; Zhao, H; Bertos, NR; Park, M; Wang, E; Yang, XJ				You, Linya; Yan, Kezhi; Zou, Jinfeng; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Wang, Edwin; Yang, Xiang-Jiao			The Chromatin Regulator Brpf1 Regulates Embryo Development and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; LEUKEMIA ZINC-FINGER; HISTONE ACETYLTRANSFERASE KAT6B; CAUSE GENITOPATELLAR SYNDROME; ACUTE MYELOID-LEUKEMIA; DE-NOVO MUTATIONS; MICE LACKING; PLACENTAL DEVELOPMENT; GENE-EXPRESSION; BREAST-CANCER	With hundreds of chromatin regulators identified in mammals, an emerging issue is how they modulate biological and pathological processes. BRPF1 (bromodomain-and PHD finger-containing protein 1) is a unique chromatin regulator possessing two PHD fingers, one bromodomain and a PWWP domain for recognizing multiple histone modifications. In addition, it binds to the acetyltransferases MOZ, MORF, and HBO1 (also known as KAT6A, KAT6B, and KAT7, respectively) to promote complex formation, restrict substrate specificity, and enhance enzymatic activity. Wehave recently showed that ablation of the mouse Brpf1 gene causes embryonic lethality at E9.5. Here we present systematic analyses of the mutant animals and demonstrate that the ablation leads to vascular defects in the placenta, yolk sac, and embryo proper, as well as abnormal neural tube closure. At the cellular level, Brpf1 loss inhibits proliferation of embryonic fibroblasts and hematopoietic progenitors. Molecularly, the loss reduces transcription of a ribosomal protein L10 (Rpl10)-like gene and the cell cycle inhibitor p27, and increases expression of the cell-cycle inhibitor p16 and a novel protein homologous to Scp3, a synaptonemal complex protein critical for chromosome association and embryo survival. These results uncover a crucial role of Brpf1 in controlling mouse embryo development and regulating cellular and gene expression programs.	[You, Linya; Yan, Kezhi; Zhao, Hong; Bertos, Nicholas R.; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [You, Linya; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; Park, Morag; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Zou, Jinfeng; Wang, Edwin] Natl Res Council Canada, Montreal, PQ H4P 2R2, Canada; [Park, Morag; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; National Research Council Canada; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca	Wang, Edwin/Y-1553-2019	You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by operating grants from Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC) (to X.-J. Y.).	Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Baron MH, 2013, BLOOD CELL MOL DIS, V51, P213, DOI 10.1016/j.bcmd.2013.07.006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Brooks SS, 2014, GENETICS, V198, P723, DOI 10.1534/genetics.114.168211; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Canault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013433; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chinen Y, 2014, GENE CHROMOSOME CANC, V53, P299, DOI 10.1002/gcc.22140; Chiocchetti A, 2011, AM J MED GENET A, V155A, P1472, DOI 10.1002/ajmg.a.33977; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Katsumoto T, 2006, GENE DEV, V20, P1321, DOI 10.1101/gad.1393106; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Kaufmann M. H., 1994, ATLAS MOUSE DEV; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Lynch H, 2013, BREAST J, V19, P520, DOI 10.1111/tbj.12145; MEMBERG SP, 1995, J NEUROBIOL, V27, P26, DOI 10.1002/neu.480270104; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Narla A, 2011, BLOOD, V118, P4300, DOI 10.1182/blood-2011-08-372250; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117010; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Perez-Campo FM, 2009, BLOOD, V113, P4866, DOI 10.1182/blood-2008-04-152017; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sengupta J, 2010, J CELL BIOL, V189, P1079, DOI 10.1083/jcb.201001124; Sheikh BN, 2015, BLOOD, V125, P1910, DOI 10.1182/blood-2014-08-594655; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; SIEGEL JN, 1987, J EXP MED, V166, P1702, DOI 10.1084/jem.166.6.1702; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Sulima SO, 2014, NUCLEIC ACIDS RES, V42, P2049, DOI 10.1093/nar/gkt1107; Szakszon K, 2013, AM J MED GENET A, V161A, P884, DOI 10.1002/ajmg.a.35848; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Thomas T, 2006, GENE DEV, V20, P1175, DOI 10.1101/gad.1382606; Thomas T, 2000, DEVELOPMENT, V127, P2537; Tsutsumi M, 2011, BIOL REPROD, V85, P165, DOI 10.1095/biolreprod.110.087270; Uechi T, 2002, NUCLEIC ACIDS RES, V30, P5369, DOI 10.1093/nar/gkf696; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Vandewalle J, 2009, AM J HUM GENET, V85, P809, DOI 10.1016/j.ajhg.2009.10.019; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265	89	26	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11349	11364		10.1074/jbc.M115.643189	http://dx.doi.org/10.1074/jbc.M115.643189			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25773539	Green Published, hybrid			2022-12-26	WOS:000353719400012
J	Bester, M; Forkert, ND; Stellmann, JP; Aly, L; Drabik, A; Young, KL; Heesen, C; Fiehler, J; Siemonsen, S				Bester, Maxim; Forkert, Nils Daniel; Stellmann, Jan Patrick; Aly, Lilian; Drabik, Anna; Young, Kim Lea; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			Increased Perfusion in Normal Appearing White Matter in High Inflammatory Multiple Sclerosis Patients	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; HEMODYNAMIC IMPAIRMENT; CEREBRAL PERFUSION; BRAIN; QUANTIFICATION; ABNORMALITIES; ANGIOGENESIS; PERMEABILITY; COMPONENT; ACCURATE	Purpose Although cerebral perfusion alterations have long been acknowledged in multiple sclerosis (MS), the relationship between measurable perfusion changes and the status of highly active MS has not been examined. We hypothesized that alteration of perfusion can be detected in normal appearing white matter and is increased in high inflammatory patients. Materials and Methods Thirty-three patients with relapsing-remitting MS underwent four monthly 3T MRI scans including dynamic susceptibility contrast perfusion-weighted MRI. Cerebral blood flow (CBF) and cerebral blood volume (CBV) were measured in normal appearing white matter. Patients were stratified in a high- and low-inflammatory group according to the number of new contrast enhancing lesions. Results Thirteen patients were classified as high-inflammatory. Compared to low-inflammatory patients, the high-inflammatory group demonstrated significantly higher CBV (p = 0.001) and CBF (p = 0.014) values. A mixed model analysis to assess independent variables associated with CBV and CBF revealed that white matter lesion load and atrophy measurements had no significant influence on CBF and CBV. Conclusion This work provides evidence that high inflammatory lesion load is associated with increased CBV and CBF, underlining the role of global modified microcirculation prior to leakage of the blood-brain barrier in the pathophysiology of MS. Perfusion changes might therefore be sensitive to active inflammation apart from lesion development without local blood-brain barrier breakdown, and could be utilized to further assess the metabolic aspect of current inflammation.	[Bester, Maxim; Forkert, Nils Daniel; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Forkert, Nils Daniel] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils Daniel] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Stellmann, Jan Patrick; Young, Kim Lea; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Dept Neurol, Hamburg, Germany; [Aly, Lilian] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany; [Drabik, Anna] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Calgary; University of Calgary; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bester, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	mbester@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020; Forkert, Nils Daniel/K-6273-2012	Stellmann, Jan-Patrick/0000-0003-2565-2833; Forkert, Nils Daniel/0000-0003-2556-3224; Sturner, Klarissa Hanja/0000-0003-2199-3315; Aly, Lilian/0000-0002-7051-124X; Gellissen, Susanne/0000-0002-7444-7265				ADAMS CWM, 1985, J NEUROL SCI, V69, P269, DOI 10.1016/0022-510X(85)90139-X; Adhya S, 2006, NEUROIMAGE, V33, P1029, DOI 10.1016/j.neuroimage.2006.08.008; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Cramer SP, 2014, NEUROIMAGE-CLIN, V4, P182, DOI 10.1016/j.nicl.2013.12.001; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Forkert ND, 2014, METHOD INFORM MED, V53, P469, DOI 10.3414/ME14-01-0007; Ge YL, 2005, AM J NEURORADIOL, V26, P1539; Giovannoni G, 2014, J NEUROL, V261, P316, DOI 10.1007/s00415-013-7196-4; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hartung T, 1996, DEV BIOL STAND, V86, P85; Haselhorst R, 2000, JMRI-J MAGN RESON IM, V11, P495, DOI 10.1002/(SICI)1522-2586(200005)11:5<495::AID-JMRI5>3.0.CO;2-S; Heales SJR, 1999, BBA-BIOENERGETICS, V1410, P215, DOI 10.1016/S0005-2728(98)00168-6; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Inglese M, 2008, J CEREBR BLOOD F MET, V28, P164, DOI 10.1038/sj.jcbfm.9600504; Inglese M, 2007, ARCH NEUROL-CHICAGO, V64, P196, DOI 10.1001/archneur.64.2.196; Ingrisch M, 2012, INVEST RADIOL, V47, P252, DOI 10.1097/RLI.0b013e31823bfc97; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Juurlink BHJ, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/598093; Kalman B, 2003, NEUROMOL MED, V3, P147, DOI 10.1385/NMM:3:3:147; Khan O, 2010, ANN NEUROL, V67, P286, DOI 10.1002/ana.22001; KOSTYK SK, 1989, BRAIN RES, V504, P284, DOI 10.1016/0006-8993(89)91369-3; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Law M, 2004, RADIOLOGY, V231, P645, DOI 10.1148/radiol.2313030996; Li XF, 2003, MAGN RESON IMAGING, V21, P1095, DOI 10.1016/S0730-725X(03)00205-4; Lucchinetti CF, 2005, NEUROL CLIN, V23, P77, DOI 10.1016/j.ncl.2004.09.002; Paling D, 2014, J CEREBR BLOOD F MET, V34, P34, DOI 10.1038/jcbfm.2013.161; Papadaki EZ, 2014, EUR J NEUROL, V21, P499, DOI 10.1111/ene.12338; Papadaki EZ, 2012, MAGN RESON MED, V68, P1932, DOI 10.1002/mrm.24194; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Putnam TJ, 1933, NEW ENGLAND J MED; Rashid W, 2004, J NEUROL NEUROSUR PS, V75, P1288, DOI 10.1136/jnnp.2003.026021; Raz E, 2010, RADIOLOGY, V254, P227, DOI 10.1148/radiol.2541090817; Roscoe WA, 2009, J NEUROIMMUNOL, V209, P6, DOI 10.1016/j.jneuroim.2009.01.009; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Soon D, 2007, MULT SCLER J, V13, P884, DOI 10.1177/1352458507076970; Varga AW, 2009, J NEUROL SCI, V282, P28, DOI 10.1016/j.jns.2008.12.036; WAKEFIELD AJ, 1994, J CLIN PATHOL, V47, P129, DOI 10.1136/jcp.47.2.129; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Zeis T, 2008, BRAIN, V131, P288, DOI 10.1093/brain/awm291	44	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119356	10.1371/journal.pone.0119356	http://dx.doi.org/10.1371/journal.pone.0119356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774497	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500084
J	Harteveld, AA; De Cocker, LJL; Dieleman, N; van der Kolk, AG; Zwanenburg, JJM; Robe, PA; Luijten, PR; Hendrikse, J				Harteveld, Anita A.; De Cocker, Laurens J. L.; Dieleman, Nikki; van der Kolk, Anja G.; Zwanenburg, Jaco J. M.; Robe, Pierre A.; Luijten, Peter R.; Hendrikse, Jeroen			High-Resolution Postcontrast Time-of-Flight MR Angiography of Intracranial Perforators at 7.0 Tesla	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; LENTICULOSTRIATE ARTERIES; 7 T; HEAD COIL; CONTRAST; STROKE; OPTIMIZATION; ACQUISITION; INFARCTION; OCCLUSION	Background and Purpose Different studies already demonstrated the benefits of 7T for precontrast TOF-MRA in the visualization of intracranial small vessels. The aim of this study was to assess the performance of high-resolution 7T TOF-MRA after the administration of a gadolinium-based contrast agent in visualizing intracranial perforating arteries. Materials and Methods Ten consecutive patients (7 male; mean age, 50.4 +/- 9.9 years) who received TOF-MRA at 7T after contrast administration were retrospectively included in this study. Intracranial perforating arteries, branching from the parent arteries of the circle of Willis, were identified on all TOF-MRA images. Provided a TOF-MRA before contrast administration was present, a direct comparison between pre- and postcontrast TOF-MRA was made. Results It was possible to visualize intracranial perforating arteries branching off from the entire circle of Willis, and their proximal branches. The posterior cerebral artery (P1 and proximal segment of P2) appeared to have the largest number of visible perforating branches (mean of 5.1 in each patient, with a range of 2-7). The basilar artery and middle cerebral artery (M1 and proximal segment M2) followed with a mean number of 5.0 and 3.5 visible perforating branches (range of 1-9 and 1-8, respectively). Venous contamination in the postcontrast scans sometimes made it difficult to discern the arterial or venous nature of a vessel. Conclusion High-resolution postcontrast TOF-MRA at 7T was able to visualize multiple intracranial perforators branching off from various parts of the circle of Willis and proximal intracranial arteries. Although confirmation in a larger study is needed, the administration of a contrast agent for high-resolution TOF-MRA at 7T seems to enable a better visualization of the distal segment of certain intracranial perforators.	[Harteveld, Anita A.; De Cocker, Laurens J. L.; Dieleman, Nikki; van der Kolk, Anja G.; Zwanenburg, Jaco J. M.; Luijten, Peter R.; Hendrikse, Jeroen] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Zwanenburg, Jaco J. M.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Robe, Pierre A.] Univ Med Ctr Utrecht, Dept Neurosurg, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Harteveld, AA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	a.a.harteveld-2@umcutrecht.nl	Zwanenburg, Jaco J.M./B-3857-2009	Zwanenburg, Jaco J.M./0000-0002-4282-5719; van der Kolk, Anja/0000-0002-8267-8848				Boeckh-Behrens T, 2012, EUR J RADIOL, V81, P1238, DOI 10.1016/j.ejrad.2011.02.057; Cho ZH, 2008, STROKE, V39, P1604, DOI 10.1161/STROKEAHA.107.508002; Conijn MMA, 2009, EUR RADIOL, V19, P2986, DOI 10.1007/s00330-009-1485-4; DAVIS WL, 1993, J COMPUT ASSIST TOMO, V17, P15, DOI 10.1097/00004728-199301000-00002; FISHER CM, 1971, NEUROLOGY, V21, P900, DOI 10.1212/WNL.21.9.900; FISHER CM, 1965, NEUROLOGY, V15, P774, DOI 10.1212/WNL.15.8.774; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Greenberg SM, 2006, NEW ENGL J MED, V354, P1451, DOI 10.1056/NEJMp068043; Hendrikse J, 2008, CEREBROVASC DIS, V26, P624, DOI 10.1159/000166838; Heverhagen JT, 2008, INVEST RADIOL, V43, P568, DOI 10.1097/RLI.0b013e31817e9b2c; Kang CK, 2010, INT J STROKE, V5, P374, DOI 10.1111/j.1747-4949.2010.00464.x; Kang CK, 2010, J MAGN RESON IMAGING, V32, P544, DOI 10.1002/jmri.22250; Kang CK, 2009, HYPERTENSION, V54, P1050, DOI 10.1161/HYPERTENSIONAHA.109.140350; Kang CK, 2009, MAGN RESON MED, V61, P136, DOI 10.1002/mrm.21786; Kang HS, 2005, AM J NEURORADIOL, V26, P306; Kumral E, 2004, NEUROLOGY, V63, P2429, DOI 10.1212/01.WNL.0000147261.22630.F8; Lang FF, 2001, J NEUROSURG, V95, P638, DOI 10.3171/jns.2001.95.4.0638; Liem MK, 2010, STROKE, V41, P2812, DOI 10.1161/STROKEAHA.110.586883; Marinkovic S, 1996, NEUROSURGERY, V39, P72, DOI 10.1097/00006123-199607000-00016; Moshel YA, 2008, J NEUROSURG, V109, P825, DOI 10.3171/JNS/2008/109/11/0825; Nowinski WL, 2013, J NEUROIMAGING, V23, P86, DOI 10.1111/j.1552-6569.2011.00597.x; Ozsarlak O, 2004, EUR RADIOL, V14, P2067, DOI 10.1007/s00330-004-2411-4; Schmitter S, 2012, MAGN RESON MED, V68, P188, DOI 10.1002/mrm.23226; Seo SW, 2012, J NEUROL SCI, V322, P200, DOI 10.1016/j.jns.2012.05.032; Stamm AC, 2013, MAGN RESON IMAGING, V31, P545, DOI 10.1016/j.mri.2012.10.023; Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012; van der Kolk AG, 2013, EUR J RADIOL, V82, P708, DOI 10.1016/j.ejrad.2011.07.007; von Morze C, 2007, J MAGN RESON IMAGING, V26, P900, DOI 10.1002/jmri.21097; Wardlaw JM, 2001, ANN NEUROL, V50, P208, DOI 10.1002/ana.1082; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028; Yang JJ, 2002, AM J NEURORADIOL, V23, P557; Yano T, 1997, ACTA RADIOL, V38, P47; Zhou Q, 2011, ACTA RADIOL, V52, P894, DOI 10.1258/ar.2011.110195	33	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121051	10.1371/journal.pone.0121051	http://dx.doi.org/10.1371/journal.pone.0121051			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774881	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500204
J	Shi, XW; Zhang, F; Lv, AL; Wen, Y; Guo, X				Shi, Xiaowei; Zhang, Feng; Lv, Aili; Wen, Yan; Guo, Xiong			COL9A1 Gene Polymorphism Is Associated with Kashin-Beck Disease in a Northwest Chinese Han Population	PLOS ONE			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; TANDEM REPEAT LOCI; ENDEMIC OSTEOARTHRITIS; LINKAGE ANALYSIS; CANDIDATE GENES; COLLAGEN-IX; RISK; HIP; MUTATIONS; ETIOLOGY	Objective We sought to determine whether genomic polymorphism in collagen IX genes (COL9A) was associated with Kashin-Beck disease (KBD). Methods Twenty seven single nucleotide polymorphisms (SNPs) in COL9A1, COL9A2 and COL9A3 were genotyped in 274 KBD cases and 248 healthy controls using the Sequenom MassARRAY system. Associations between the COL9A polymorphism and KBD risk were detected using an unconditional logistic regression model. Linkage disequilibrium (LD) and haplotypes analysis were performed with the Haploview software. Results After Bonferroni correction, the frequency distribution of genotypes in rs6910140 in COL9A1 was significantly different between the KBD and the control groups (X-2 = 16.74, df = 2, P = 0.0002). Regression analysis showed that the allele "C" in SNP rs6910140 had a significant protective effect on KBD [odds ratio (OR) = 0.49, 95% confidence interval (CI) = 0.34-0.70, P = 0.0001]. The frequencies of alleles and genotypes in rs6910140 were significantly different among subjects of different KBD stages (allele: X-2 = 7.82, df = 2, P = 0.02, genotype: X-2 = 14.81, df = 4, P = 0.005). However, haplotype analysis did not detect any significant association between KBD and COL9A1, COL9A2 and COL9A3. Conclusions We observed a significant association between rs6910140 of COL9A1 and KBD, suggesting a role of COL9A1 in the development of KBD.	[Shi, Xiaowei] Xi An Jiao Tong Univ, Ctr Maternal & Child Hlth Care, Affiliated Hosp 1, Med Collage, Xian 710049, Shannxi, Peoples R China; [Zhang, Feng; Lv, Aili; Wen, Yan; Guo, Xiong] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Key Lab Trace Elements & Endem Dis, Sch Publ Hlth,Hlth Sci Ctr,Minist Educ,Minist Hlt, Xian 710049, Shannxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Guo, X (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Key Lab Trace Elements & Endem Dis, Sch Publ Hlth,Hlth Sci Ctr,Minist Educ,Minist Hlt, Xian 710049, Shannxi, Peoples R China.	guox@mail.xjtu.edu.cn			National Natural Science Foundation of China [81273007]; Foundation of Shaanxi Province of China [2011K15-06-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shaanxi Province of China	This research was supported by grants from the National Natural Science Foundation of China (No. 81273007); The Foundation of Shaanxi Province of China (2011K15-06-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Cao J, 2008, OSTEOARTHR CARTILAGE, V16, P680, DOI 10.1016/j.joca.2007.09.002; Carlsen S, 2006, IEEE SPECTRUM, V43, P8; Chasseur C, 2001, INT ORTHOP, V25, P154, DOI 10.1007/s002640000218; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Guo X, 2014, OSTEOARTHR CARTILAGE, V22, P1774, DOI 10.1016/j.joca.2014.07.023; Ikeda T, 2002, J BONE MINER RES, V17, P1290, DOI 10.1359/jbmr.2002.17.7.1290; Jackson GC, 2010, AM J MED GENET A, V152A, P863, DOI 10.1002/ajmg.a.33240; Jakkula E, 2005, OSTEOARTHR CARTILAGE, V13, P497, DOI 10.1016/j.joca.2005.02.005; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Mathieu F, 1997, INT ORTHOP, V21, P151, DOI 10.1007/s002640050139; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; Mustafa Z, 2000, RHEUMATOLOGY, V39, P299, DOI 10.1093/rheumatology/39.3.299; Paassilta P, 2001, JAMA-J AM MED ASSOC, V285, P1843, DOI 10.1001/jama.285.14.1843; Rouault K, 2009, OSTEOARTHR CARTILAGE, V17, P1099, DOI 10.1016/j.joca.2008.12.012; Seki S, 2006, J HUM GENET, V51, P1063, DOI 10.1007/s10038-006-0062-9; SHAM PC, 1995, ANN HUM GENET, V59, P97, DOI 10.1111/j.1469-1809.1995.tb01608.x; Shi XW, 2010, SCAND J RHEUMATOL, V39, P259, DOI 10.3109/03009740903270599; Shi XW, 2010, J BONE JOINT SURG AM, V92A, P72, DOI 10.2106/JBJS.H.00502; Sudre P, 2001, INT ORTHOP, V25, P175, DOI 10.1007/s002640000179; Suetens C, 2001, INT ORTHOP, V25, P180, DOI 10.1007/s002640100247; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Videman T, 2009, ARTHRITIS RHEUM-US, V60, P470, DOI 10.1002/art.24268; Wang S, 2013, GENE, V512, P89, DOI 10.1016/j.gene.2012.10.006; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022983; Zhang GQ, 1989, CHIN J ENDEMIOL, V8, P27; Zhao QM, 2012, CLIN RHEUMATOL, V31, P1051, DOI 10.1007/s10067-012-1975-7; Zhou JQ, 2012, THROMB RES, V130, P602, DOI 10.1016/j.thromres.2012.05.023	31	13	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120365	10.1371/journal.pone.0120365	http://dx.doi.org/10.1371/journal.pone.0120365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774918	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500168
J	Zhang, JQ; Meng, SY; Wen, J; Rao, GY				Zhang, Jian-Qiang; Meng, Shi-Yong; Wen, Jun; Rao, Guang-Yuan			DNA Barcoding of Rhodiola (Crassulaceae): A Case Study on a Group of Recently Diversified Medicinal Plants from the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							SPECIES IDENTIFICATION; TRNL-F; CHLOROPLAST; PHYLOGENY; IDENTIFY; MATK; EVOLUTION; SELECTION; PRIMERS; REGIONS	DNA barcoding, the identification of species using one or a few short standardized DNA sequences, is an important complement to traditional taxonomy. However, there are particular challenges for barcoding plants, especially for species with complex evolutionary histories. We herein evaluated the utility of five candidate sequences-rbcL, matK, trnH-psbA, trnL-F and the internal transcribed spacer (ITS) - for barcoding Rhodiola species, a group of high-altitude plants frequently used as adaptogens, hemostatics and tonics in traditional Tibetan medicine. Rhodiola was suggested to have diversified rapidly recently. The genus is thus a good model for testing DNA barcoding strategies for recently diversified medicinal plants. This study analyzed 189 accessions, representing 47 of the 55 recognized Rhodiola species in the Flora of China treatment. Based on intraspecific and interspecific divergence and degree of monophyly statistics, ITS was the best single-locus barcode, resolving 66% of the Rhodiola species. The core combination rbcL+matK resolved only 40.4% of them. Unsurprisingly, the combined use of all five loci provided the highest discrimination power, resolving 80.9% of the species. However, this is weaker than the discrimination power generally reported in barcoding studies of other plant taxa. The observed complications may be due to the recent diversification, incomplete lineage sorting and reticulate evolution of the genus. These processes are common features of numerous plant groups in the high-altitude regions of the Qinghai-Tibetan Plateau.	[Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Wen, Jun] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	Peking University; Smithsonian Institution; Smithsonian National Museum of Natural History	Wen, J (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20560 USA.	wenj@si.edu; rao@pku.edu.cn		Meng, Shiyong/0000-0002-6855-2990	National Natural Science Foundation of China [31470313]; China Scholarship Council [201206010113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by National Natural Science Foundation of China (Grant no. 31470313). JQZ has been supported by a scholarship for exchanging Ph.D. candidates from the China Scholarship Council (No. 201206010113) for his studies at the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, PHARMACOPOEIA PEOPLE; Asmussen CB, 2001, AM J BOT, V88, P1103, DOI 10.2307/2657094; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen CW, 2013, ANN BOT-LONDON, V111, P663, DOI 10.1093/aob/mct004; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Dong LN, 2011, J SYST EVOL, V49, P189, DOI 10.1111/j.1759-6831.2011.00124.x; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Drummond A, 2011, GENEIOUS VERSION 7 1; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fu K. T., 2001, FLORA CHINA, V8, P202, DOI DOI 10.11646/PHYTOTAXA.292.2.5; Fu S.H., 1984, FLORA REIPUBLICAE PO, V34, P33; Fu YM, 2011, J SYST EVOL, V49, P237, DOI 10.1111/j.1759-6831.2011.00126.x; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Ipek M, 2014, TURK J BOT, V38, P203, DOI 10.3906/bot-1308-46; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Kelly G S, 2001, Altern Med Rev, V6, P293; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lei YD, 2006, GENET MOL BIOL, V29, P339, DOI 10.1590/S1415-47572006000200023; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mattioli L, 2012, PSYCHOPHARMACOLOGY, V221, P183, DOI 10.1007/s00213-012-2686-0; Mayuzumi S, 2004, SYST BOT, V29, P587, DOI 10.1600/0363644041744329; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; OHBA H, 1978, Journal of the Faculty of Science University of Tokyo Section III Botany, V12, P139; Ohba H, 1981, J FS U TOKYO, V3, P65; Ohba H, 1982, J FS U TOKYO, V3, P121; Ohba H, 1981, J FS U TOKYO, V3, P337; Ohba H, 1993, 15 INT BOT C; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Rohloff J, 2002, PHYTOCHEMISTRY, V59, P655, DOI 10.1016/S0031-9422(02)00004-3; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wen J, 2007, CAN J BOT, V85, P731, DOI 10.1139/B07-071; Xiang XG, 2011, J SYST EVOL, V49, P252, DOI 10.1111/j.1759-6831.2011.00116.x; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yan TF, 2003, CONSERV GENET, V4, P213, DOI 10.1023/A:1023342723814; Yang YC, 1991, TIBET MED; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zhang JQ, 2014, MOL PHYLOGENET EVOL, V77, P147, DOI 10.1016/j.ympev.2014.04.013; Zhang JQ, 2014, SYST BOT, V39, P441, DOI 10.1600/036364414X680753; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	70	24	28	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119921	10.1371/journal.pone.0119921	http://dx.doi.org/10.1371/journal.pone.0119921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774915	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500141
J	da Silva, R; Veneza, I; Sampaio, I; Araripe, J; Schneider, H; Gomes, G				da Silva, Raimundo; Veneza, Ivana; Sampaio, Iracilda; Araripe, Juliana; Schneider, Horacio; Gomes, Grazielle			High Levels of Genetic Connectivity among Populations of Yellowtail Snapper, Ocyurus chrysurus (Lutjanidae - Perciformes), in the Western South Atlantic Revealed through Multilocus Analysis	PLOS ONE			English	Article							RED SNAPPER; STATISTICAL-METHOD; DNA; MARINE; PHYLOGEOGRAPHY; SPECIATION; DIVERSITY; INFERENCE; PATTERNS; FISHES	In the present study, five loci (mitochondrial and nuclear) were sequenced to determine the genetic diversity, population structure, and demographic history of populations of the yellowtail snapper, Ocyurus chrysurus, found along the coast of the western South Atlantic. O. chrysurus is a lutjanid species that is commonly associated with coral reefs and exhibits an ample geographic distribution, and it can therefore be considered a good model for the investigation of phylogeographic patterns and genetic connectivity in marine environments. The results reflected a marked congruence between the mitochondrial and nuclear markers as well as intense gene flow among the analyzed populations, which represent a single genetic stock along the entire coast of Brazil between the states of Para and Espirito Santo. Our data also showed high levels of genetic diversity in the species (mainly mtDNA), as well a major historic population expansion, which most likely coincided with the sea level oscillations at the end of the Pleistocene. In addition, this species is intensively exploited by commercial fisheries, and data on the genetic structure of its populations will be essential for the development of effective conservation and management plans.	[da Silva, Raimundo; Veneza, Ivana; Gomes, Grazielle] Fed Univ Para, Inst Estudos Costeiros, Lab Genet Aplicada, Braganca, Para, Brazil; [Sampaio, Iracilda; Araripe, Juliana; Schneider, Horacio; Gomes, Grazielle] Fed Univ Para, Inst Estudos Costeiros, Lab Genet & Biol Mol, Braganca, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Gomes, G (corresponding author), Fed Univ Para, Inst Estudos Costeiros, Lab Genet Aplicada, Campus Braganca, Braganca, Para, Brazil.	grazielle@ufpa.br	Gomes, Grazielle/G-9326-2019; Araripe, Juliana/U-4665-2018; Schneider, Horacio/J-7131-2012; VENEZA, IVANA/AAX-2762-2021; VENEZA, IVANA B/P-3883-2018; Araripe, Juliana/N-9071-2019; SAMPAIO, IRACILDA/J-6514-2012	Gomes, Grazielle/0000-0001-8898-0311; Araripe, Juliana/0000-0002-8014-3081; Schneider, Horacio/0000-0002-5987-6395; VENEZA, IVANA/0000-0002-3528-1290; VENEZA, IVANA B/0000-0002-3528-1290; Araripe, Juliana/0000-0002-8014-3081; SAMPAIO, IRACILDA/0000-0002-2137-4656	CNPq [306233/2009-6]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this research was provided by CNPq (grants 306233/2009-6 to IS, 306233/2009-6 to HS and a young scientist scholarship to RS). The funders had no role in study design, data collection and analysis.	ALLEN G.R., 1985, FAO SPECIES CATALOGU, V6; [Anonymous], PECES MARINHOS VENEZ; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Barreto AMF, 2002, PALAEOGEOGR PALAEOCL, V179, P57, DOI 10.1016/S0031-0182(01)00408-4; Bellwood David R., 2002, P5, DOI 10.1016/B978-012615185-5/50003-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernardi G, 2013, MOL ECOL, V22, P5487, DOI 10.1111/mec.12494; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Craig MT, 2006, J BIOGEOGR, V33, P969, DOI 10.1111/j.1365-2699.2006.01467.x; de Oliveira JN, 2014, MOL PHYLOGENET EVOL, V77, P275, DOI 10.1016/j.ympev.2014.04.019; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Dmitriev DA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000113; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eytan RI, 2010, EVOLUTION, V64, P3380, DOI 10.1111/j.1558-5646.2010.01071.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Iriarte PJF, 2011, SCI MAR, V75, P701, DOI 10.3989/scimar.2011.75n4701; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Freitas MO, 2011, SCI MAR, V75, P135, DOI 10.3989/scimar.2011.75n1135; Fu YX, 1997, GENETICS, V147, P915; Gaither MR, 2012, P ROY SOC B-BIOL SCI, V279, P3948, DOI 10.1098/rspb.2012.1481; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; Garber AF, 2004, MAR BIOTECHNOL, V6, P175, DOI 10.1007/s10126-003-0023-7; Gold JR, 2011, N AM J FISH MANAGE, V31, P209, DOI 10.1080/02755947.2011.568864; Gomes G, 2008, GENET MOL BIOL, V31, P372, DOI 10.1590/S1415-47572008000200035; Gomes G, 2012, AN ACAD BRAS CIENC, V84, P979, DOI 10.1590/S0001-37652012000400013; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassan M, 2002, MOL ECOL NOTES, V2, P334, DOI 10.1046/j.1471-8286.2002.00236.x; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Hoareau TB, 2012, MOL PHYLOGENET EVOL, V62, P566, DOI 10.1016/j.ympev.2011.10.004; Hogan JD, 2007, B MAR SCI, V80, P219; HUDSON RR, 1985, GENETICS, V111, P147; Huelsenbeck JP, 2011, EVOL BIOINFORM, V7, P55, DOI 10.4137/EBO.S6761; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Karlsson S, 2009, MAR BIOL, V156, P1841, DOI 10.1007/s00227-009-1217-y; Khodri M, 2001, NATURE, V410, P570, DOI 10.1038/35069044; LEE WJ, 1995, J MOL EVOL, V41, P54; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindeman Kenneth C., 2001, Proceedings of the Gulf and Caribbean Fisheries Institute, V52, P732; Lindholm J., 2005, MOVEMENT YELLOWTAIL; Luiz OJ, 2012, P ROY SOC B-BIOL SCI, V279, P1033, DOI 10.1098/rspb.2011.1525; Menezes NA, 1980, MANUAL PEIXES MARINH, VIV; Nei M., 1987, MOL EVOLUTIONARY GEN; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; PAITHANKAR KR, 1991, NUCLEIC ACIDS RES, V19, P1346, DOI 10.1093/nar/19.6.1346; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8; Phillips NM, 2011, MAR BIOL, V158, P903, DOI 10.1007/s00227-010-1617-z; Pinsky ML, 2014, MOL ECOL, V23, P29, DOI 10.1111/mec.12509; Planes Serge, 2002, P201, DOI 10.1016/B978-012615185-5/50012-8; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2007, TRACER V1 4; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Rocha LA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-157; Rodrigues-Filho LFS, 2011, THESIS U FEDERAL; Rodriguez-Rey GT, 2014, MAR FRESHWATER RES, V65, P59, DOI 10.1071/MF12359; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Saillant EA, 2012, FISHERIES MANAG ECOL, V19, P301, DOI 10.1111/j.1365-2400.2011.00840.x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Sambrook J, 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selkoe KA, 2014, MOL ECOL, V23, P3064, DOI 10.1111/mec.12804; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Varela AI, 2012, MAR BIOL, V159, P1049, DOI 10.1007/s00227-012-1885-x; Vasconcellos AV, 2008, GENET MOL BIOL, V31, P308, DOI 10.1590/S1415-47572008000200026; WALLACE RK, 1977, B MAR SCI, V27, P292; Watson M, 2002, MAR ECOL PROG SER, V237, P247, DOI 10.3354/meps237247; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Zhang JB, 2006, ICES J MAR SCI, V63, P693, DOI 10.1016/j.icesjms.2006.01.004	87	13	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0122173	10.1371/journal.pone.0122173	http://dx.doi.org/10.1371/journal.pone.0122173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769032	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500147
J	Huang, TH; Yang, J; Liu, GP; Jin, W; Liu, Z; Zhao, SH; Yao, M				Huang, Tinghua; Yang, Jun; Liu, Guopin; Jin, Wei; Liu, Zhi; Zhao, Shuhong; Yao, Min			Quantification of Mature MicroRNAs Using Pincer Probes and Real-Time PCR Amplification	PLOS ONE			English	Article							EXPRESSION; RNAS; TISSUES; CELLS; ASSAY	The robust and reliable detection of small microRNAs (miRNAs) is important to understand the functional significance of miRNAs. Several methods can be used to quantify miRNAs. Selectively quantifying mature miRNAs among miRNA precursors, pri-miRNAs, and other miRNA-like sequences is challenging because of the short length of miRNAs. In this study, we developed a two-step miRNA quantification system based on pincer probe capture and real-time PCR amplification. The performance of the method was tested using synthetic mature miRNAs and clinical RNA samples. Results showed that the method demonstrated dynamic range of seven orders of magnitude and sensitivity of detection of hundreds of copies of miRNA molecules. The use of pincer probes allowed excellent discrimination of mature miRNAs from their precursors with five Cq (quantification cycle) values difference. The developed method also showed good discrimination of highly homologous family members with cross reaction less than 5%. The pincer probe-based approach is a potential alternative to currently used methods for mature miRNA quantification.	[Huang, Tinghua; Liu, Guopin; Jin, Wei] Yangtze Univ, Black Pig Res Inst, Jinzhou, Hubei, Peoples R China; [Huang, Tinghua; Yang, Jun; Liu, Guopin; Liu, Zhi; Yao, Min] Yangtze Univ, Coll Anim Sci, Jinzhou, Hubei, Peoples R China; [Zhao, Shuhong] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China	Yangtze University; Yangtze University; Huazhong Agricultural University	Zhao, SH (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Hubei, Peoples R China.	minyao01@126.com			National Natural Science Foundation of China [31402055, 30671138]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This project was supported by the National Natural Science Foundation of China (Grant No. 31402055 and 30671138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Duncan DD, 2006, ANAL BIOCHEM, V359, P268, DOI 10.1016/j.ab.2006.08.022; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jonstrup SP, 2006, RNA, V12, P1747, DOI 10.1261/rna.110706; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Lingam Swathi, 2014, Microrna, V3, P18; Lu David P, 2005, J RNAi Gene Silencing, V1, P44; Mocellin S, 2003, TRENDS MOL MED, V9, P189, DOI 10.1016/S1471-4914(03)00047-9; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Siva AC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-17; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Wang H, 2007, RNA, V13, P151, DOI 10.1261/rna.234507; Wang XS, 2010, INT J MOL SCI, V11, P3138, DOI 10.3390/ijms11093138; Yang HP, 2009, PLANT BIOTECHNOL J, V7, P621, DOI 10.1111/j.1467-7652.2009.00429.x; Yao B, 2009, RNA, V15, P1787, DOI 10.1261/rna.1555209; Zhang DC, 2013, MICROCHIM ACTA, V180, P397, DOI 10.1007/s00604-013-0945-3; Zhang Qi, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P87; Zhou YT, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq556	33	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120160	10.1371/journal.pone.0120160	http://dx.doi.org/10.1371/journal.pone.0120160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768430	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500112
J	Prohl, A; Lohr, M; Ostermann, C; Liebler-Tenorio, E; Berndt, A; Schroedl, W; Rothe, M; Schubert, E; Sachse, K; Reinhold, P				Prohl, Annette; Lohr, Markus; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Schroedl, Wieland; Rothe, Michael; Schubert, Evelyn; Sachse, Konrad; Reinhold, Petra			Enrofloxacin and Macrolides Alone or in Combination with Rifampicin as Antimicrobial Treatment in a Bovine Model of Acute Chlamydia psittaci Infection	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SUBCLINICAL PULMONARY ABSCESSES; CHLAMYDOPHILA-PSITTACI; NONGONOCOCCAL URETHRITIS; NATURAL COURSE; EFFICACY; PHARMACOKINETICS; DOXYCYCLINE; AZITHROMYCIN; SAFETY	Chlamydia psittaci is a zoonotic bacterium with a wide host range that can cause respiratory disease in humans and cattle. In the present study, effects of treatment with macrolides and quinolones applied alone or in combination with rifampicin were tested in a previously established bovine model of respiratory C. psittaci infection. Fifty animals were inoculated intrabronchially at the age of 6-8 weeks. Seven served as untreated controls, the others were assigned to seven treatment groups: (i) rifampicin, (ii) enrofloxacin, (iii) enrofloxacin + rifampicin, (iv) azithromycin, (v) azithromycin + rifampicin, (vi) erythromycin, and (vii) erythromycin + rifampicin. Treatment started 30 hours after inoculation and continued until 14 days after inoculation (dpi), when all animals were necropsied. The infection was successful in all animals and sufficient antibiotic levels were detected in blood plasma and tissue of the treated animals. Reisolation of the pathogen was achieved more often from untreated animals than from other groups. Nevertheless, pathogen detection by PCR was possible to the same extent in all animals and there were no significant differences between treated and untreated animals in terms of local (i.e. cell count and differentiation of BALF-cells) and systemic inflammation (i.e. white blood cells and concentration of acute phase protein LBP), clinical signs, and pathological findings at necropsy. Regardless of the reduced reisolation rate in treated animals, the treatment of experimentally induced respiratory C. psittaci infection with enrofloxacin, azithromycin or erythromycin alone or in combination with rifampicin was without obvious benefit for the host, since no significant differences in clinical and pathological findings or inflammatory parameters were detected and all animals recovered clinically within two weeks.	[Prohl, Annette; Lohr, Markus; Ostermann, Carola; Liebler-Tenorio, Elisabeth; Berndt, Angela; Schubert, Evelyn; Sachse, Konrad; Reinhold, Petra] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, D-07743 Jena, Germany; [Schroedl, Wieland] Univ Leipzig, Fac Vet, Inst Bacteriol & Mycol, D-04103 Leipzig, Germany; [Rothe, Michael] LIPIDOMIX GmbH, D-13125 Berlin, Germany; [Schubert, Evelyn; Sachse, Konrad] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, OIE Reference Lab Chlamydiosis, D-07743 Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Leipzig University; Friedrich Loeffler Institute	Reinhold, P (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Naumburger Str 96a, D-07743 Jena, Germany.	petra.reinhold@fli.bund.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	Federal Ministry of Education and Research (BMBF) of Germany [01 KI 0720]; LIPIDOMIX GmbH	Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF)); LIPIDOMIX GmbH	This study was financially supported by the Federal Ministry of Education and Research (BMBF) of Germany under Grant no. 01 KI 0720 "Zoonotic chlamydiae-Models of chronic and persistent infections in humans and animals". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LIPIDOMIX GmbH provided support in the form of salaries for author Michael Rothe, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	ACOCELLA G, 1983, REV INFECT DIS, V5, pS428; ACOCELLA G, 1978, CLIN PHARMACOKINET, V3, P108, DOI 10.2165/00003088-197803020-00002; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Biesenkamp-Uhe C, 2007, INFECT IMMUN, V75, P870, DOI 10.1128/IAI.00691-06; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P4455, DOI 10.1128/AAC.49.11.4455-4464.2005; Binet R, 2005, ANTIMICROB AGENTS CH, V49, P2865, DOI 10.1128/AAC.49.7.2865-2873.2005; BLOCK S, 1995, PEDIATR INFECT DIS J, V14, P471, DOI 10.1097/00006454-199506000-00002; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; BOVARNICK MR, 1950, J BACTERIOL, V59, P509, DOI 10.1128/JB.59.4.509-522.1950; Branley JM, 2008, EUR J CLIN MICROBIOL, V27, P269, DOI 10.1007/s10096-007-0431-0; BURROWS GE, 1980, J AM VET MED ASSOC, V176, P1072; Butaye P, 1997, ANTIMICROB AGENTS CH, V41, P2800, DOI 10.1128/AAC.41.12.2800; CAY B, 1989, VET MICROBIOL, V20, P123, DOI 10.1016/0378-1135(89)90035-7; Davis R, 1996, DRUGS, V51, P1019, DOI 10.2165/00003495-199651060-00010; Dessus-Babus S, 1998, ANTIMICROB AGENTS CH, V42, P2474, DOI 10.1128/AAC.42.10.2474; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Dukers-Muijrers NHTM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034108; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; EMEA, 2000, PROD TEAFTEOM UNIT V; *EMEA, 1998, 2 EMEA COMM VET MED; File TM, 1997, ANTIMICROB AGENTS CH, V41, P1965, DOI 10.1128/AAC.41.9.1965; Finch R, 2002, ANTIMICROB AGENTS CH, V46, P1746, DOI 10.1128/AAC.46.6.1746-1754.2002; Gao X, 2008, J STAT PLAN INFER, V138, P2574, DOI 10.1016/j.jspi.2007.10.015; Gerhardt N, 2006, VET REC, V159, P591, DOI 10.1136/vr.159.18.591; Griffith JE, 2010, J VET PHARMACOL THER, V33, P595, DOI 10.1111/j.1365-2885.2010.01169.x; Guzman DSM, 2010, J AVIAN MED SURG, V24, P35, DOI 10.1647/2009-009R.1; HAIGHT TH, 1952, P SOC EXP BIOL MED, V81, P188, DOI 10.3181/00379727-81-19817; Hammerschlag MR, 2000, INT J ANTIMICROB AG, V15, P149, DOI 10.1016/S0924-8579(00)00157-6; Harkinezhad T, 2007, J MED MICROBIOL, V56, P1097, DOI 10.1099/jmm.0.47157-0; Harris JAS, 1998, PEDIATR INFECT DIS J, V17, P865, DOI 10.1097/00006454-199810000-00004; Heddema ER, 2006, J MED MICROBIOL, V55, P1571, DOI 10.1099/jmm.0.46692-0; Hothorn T, 2008, J STAT SOFTW, V28, P1; Jaeger J, 2007, VET RES, V38, P711, DOI 10.1051/vetres:2007027; KAARTINEN L, 1995, J VET PHARMACOL THER, V18, P357, DOI 10.1111/j.1365-2885.1995.tb00604.x; Kauffold J, 2007, ANIM REPROD SCI, V102, P111, DOI 10.1016/j.anireprosci.2006.10.013; Kauffold J, 2006, THERIOGENOLOGY, V66, P1816, DOI 10.1016/j.theriogenology.2006.04.042; Knittler MR, 2014, INT J MED MICROBIOL, V304, P877, DOI 10.1016/j.ijmm.2014.06.010; Konietschke F, 2014, J STAT SOFTW, V61, P1; Krautwald-Junghanns ME, 2013, TIERAERZTL PRAX K H, V41, P392; Krebber R, 2009, ANAL CHIM ACTA, V637, P208, DOI 10.1016/j.aca.2008.11.006; Lakritz J, 1997, AM J VET RES, V58, P56; Lau CY, 2002, SEX TRANSM DIS, V29, P497, DOI 10.1097/00007435-200209000-00001; Lemon J., 2006, R R NEWS; Lenart J, 2001, ANTIMICROB AGENTS CH, V45, P2198, DOI 10.1128/AAC.45.8.2198-2203.2001; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; LIPSKY BA, 1990, AM J MED, V89, P722, DOI 10.1016/0002-9343(90)90212-V; LODE H, 1991, EUR J CLIN MICROBIOL, V10, P807, DOI 10.1007/BF01975832; MALINVERNI R, 1995, ANTIMICROB AGENTS CH, V39, P45, DOI 10.1128/AAC.39.1.45; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; McKellar Q, 1999, ANTIMICROB AGENTS CH, V43, P1988, DOI 10.1128/AAC.43.8.1988; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Moola S, 1999, CHEST, V116, P974, DOI 10.1378/chest.116.4.974; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Morrissey I, 2002, J ANTIMICROB CHEMOTH, V49, P757, DOI 10.1093/jac/dkf031; NELSON S, 1987, AM REV RESPIR DIS, V136, P1207, DOI 10.1164/ajrccm/136.5.1207; Osman KM, 2013, TRANSBOUND EMERG DIS, V60, P245, DOI 10.1111/j.1865-1682.2012.01337.x; Ostermann C, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-10; Ostermann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064066; Ostermann C, 2013, VET J, V196, P351, DOI 10.1016/j.tvjl.2012.10.035; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Patel T, 2000, RESP MED, V94, P97, DOI 10.1053/rmed.1999.0710; Pitt RA, 2013, INT J STD AIDS, V24, P469, DOI 10.1177/0956462412472815; Prohl A, 2014, PATHOG DIS, P1, DOI [10.1111/2049-632X.12211, DOI 10.1111/2049-632X.12211]; Prohl A, 2014, JOVE-J VIS EXP, DOI 10.3791/51557; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030125; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Reinhold P, 2011, VET J, V187, P405, DOI 10.1016/j.tvjl.2010.01.008; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Schwebke JR, 2011, CLIN INFECT DIS, V52, P163, DOI 10.1093/cid/ciq074; Senn L, 2005, EXPERT OPIN PHARMACO, V6, P2281, DOI 10.1517/14656566.6.13.2281; Smith KA, 2010, COMPENDIUM MEASURES; Solidoro P, 2013, Minerva Med, V104, P7; STJEAN G, 1991, VET CLIN N AM-FOOD A, V7, P793, DOI 10.1016/S0749-0720(15)31085-9; Theegarten D, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-14; THORNSBERRY C, 1983, REV INFECT DIS, V5, pS412; Thorpe EM, 1996, GENITOURIN MED, V72, P93; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Vanrompay D, 2007, EMERG INFECT DIS, V13, P1108, DOI 10.3201/eid1307.070074; Venner M, 2013, J VET INTERN MED, V27, P171, DOI 10.1111/jvim.12030; Venner M, 2012, VET J, V192, P293, DOI 10.1016/j.tvjl.2011.07.004; Verminnen K, 2008, J CLIN MICROBIOL, V46, P281, DOI 10.1128/JCM.01153-07; WEHRLI W, 1983, REV INFECT DIS, V5, pS407; Whatley J D, 1991, Int J STD AIDS, V2, P248; Wolf K, 1999, ANTIMICROB AGENTS CH, V43, P1491, DOI 10.1128/AAC.43.6.1491; Wolf K, 2010, APPROACHES ANTIMICRO, P36	86	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119736	10.1371/journal.pone.0119736	http://dx.doi.org/10.1371/journal.pone.0119736			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768665	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500096
J	Tropea, C; Stumpf, L; Greco, LSL				Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana			Effect of Temperature on Biochemical Composition, Growth and Reproduction of the Ornamental Red Cherry Shrimp Neocaridina heteropoda heteropoda (Decapoda, Caridea)	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; SEASONAL-VARIATIONS; LARVAL DEVELOPMENT; EMBRYONIC-DEVELOPMENT; CANCER-SETOSUS; CRUSTACEA; SURVIVAL; INCUBATION; SALINITY; CRAB	The effect of water temperature on biochemical composition, growth and reproduction of the ornamental shrimp, Neocaridina heteropoda heteropoda, was investigated to determine the optimum temperature for its culture. The effect of embryo incubation temperature on the subsequent performance of juveniles was also evaluated. Ovigerous females and recently hatched juveniles (JI) were maintained during egg incubation and for a 90-day period, respectively, at three temperatures (24, 28 and 32 degrees C). Incubation period increased with decreasing water temperature, but the number and size of JI were similar among treatments. At day 30 of the 90-day period, body weight and growth increment (GI) at 24 degrees C were lower than those at 28 and 32 degrees C. On subsequent days, GI at 24 degrees C exceeded that at 28 and 32 degrees C, leading to a similar body weight among treatments. These results suggest growth was delayed at 24 degrees C, but only for 30 days after hatching. The lipid concentration tended to be lowest, intermediate and highest at 28, 32 and 24 degrees C, respectively, possibly as a consequence of the metabolic processes involved in growth and ovarian maturation. Protein and glycogen concentrations were similar among treatments. Both the growth trajectory and biochemical composition of shrimps were affected by the temperature experienced during the 90-day growth period independently of the embryo incubation temperature. During the growth period, shrimps reached sexual maturity and mated, with the highest proportion of ovigerous females occurring at 28 degrees C. All the females that matured and mated at 32 degrees C lost their eggs, indicating a potentially stressful effect of high temperature on ovarian maturation. Based on high survival and good growth performance of shrimps at the three temperatures tested over the 90-day period it is concluded that N. heteropoda heteropoda is tolerant to a wide range of water temperatures, with 28 degrees C being the optimum temperature for its culture.	[Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana] Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Buenos Aires, DF, Argentina; [Tropea, Carolina; Stumpf, Liane; Lopez Greco, Laura Susana] CONICET UBA, IBBEA, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Greco, LSL (corresponding author), Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Cdad Univ C1428EHA, Buenos Aires, DF, Argentina.	laura@bg.fcen.uba.ar			(CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT) [01187, 1333]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP) [112-201101-00212]; Universidad de Buenos Aires Ciencia y Tecnica [20020100100003]; Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BR/11/21]	(CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica; Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Funding provided by (CT LS LLG) Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2007, project 01187 and PICT 2012, project 1333), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012-2014, number 112-201101-00212), Universidad de Buenos Aires Ciencia y Tecnica (project 20020100100003) and Ministerio de Ciencia, Tecnologia e Innovacion Producitiva-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)BR/11/21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER MO, 1984, J CRUSTACEAN BIOL, V4, P546, DOI 10.2307/1548068; Anger K, 2004, J EXP MAR BIOL ECOL, V306, P217, DOI 10.1016/j.jembe.2004.01.010; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brillon S, 2005, MAR BIOL, V147, P895, DOI 10.1007/s00227-005-1633-6; Buckup L, 2008, COMP BIOCHEM PHYS A, V149, P59, DOI 10.1016/j.cbpa.2007.10.008; Cai Yi-xiong, 1996, Acta Zootaxonomica Sinica, V21, P129; Calado R, 2005, AQUACULTURE, V245, P221, DOI 10.1016/j.aquaculture.2004.11.034; Calado R., 2009, MARINE ORNAMENTAL SH; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; da Silva-Castiglioni D, 2007, COMP BIOCHEM PHYS A, V148, P204, DOI 10.1016/j.cbpa.2007.04.005; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dutra BK, 2006, IHERINGIA SER ZOOL, V98, P355; Fischer S, 2009, J EXP MAR BIOL ECOL, V374, P160, DOI 10.1016/j.jembe.2009.04.019; Fischer S, 2009, MAR ECOL PROG SER, V377, P193, DOI 10.3354/meps07845; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garcia-Guerrero M, 2003, COMP BIOCHEM PHYS A, V135, P147, DOI 10.1016/S1095-6433(02)00354-9; Garcia-Guerrero MU, 2010, J WORLD AQUACULT SOC, V41, P84, DOI 10.1111/j.1749-7345.2009.00336.x; Hamasaki K, 2003, AQUACULTURE, V219, P561, DOI 10.1016/S0044-8486(02)00662-2; Hartnoll RG, 2001, HYDROBIOLOGIA, V449, P111, DOI 10.1023/A:1017597104367; Heerbrandt TC, 2006, J WORLD AQUACULT SOC, V37, P186, DOI 10.1111/j.1749-7345.2006.00025.x; Holland D.L., 1978, Biochemical and Biophysical Perspectives in Marine Biology, V4, P85; Kumlu M, 2000, AQUACULTURE, V188, P167, DOI 10.1016/S0044-8486(00)00330-6; Lemos D, 2001, AQUACULTURE, V199, P131, DOI 10.1016/S0044-8486(01)00523-3; Morris S, 1998, S AFR J ZOOL, V33, P87; MOURENTE G, 1991, MAR BIOL, V110, P21, DOI 10.1007/BF01313088; Nelson K., 1991, Crustacean Issues, V7, P77; Nur F.A.H., 2013, Asian Journal of Animal and Veterinary Advances, V8, P108; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Palacios E, 2000, AQUACULTURE, V185, P353, DOI 10.1016/S0044-8486(99)00362-2; Parado-Estepa FD, 1998, ISR J AQUACULT-BAMID, V50, P174; Paula J, 2001, HYDROBIOLOGIA, V449, P141, DOI 10.1023/A:1017505506184; Perez-Velazquez M, 2003, AQUAC RES, V34, P1205, DOI 10.1046/j.1365-2109.2003.00931.x; Portner HO, 2005, SCI MAR, V69, P271; Ritar AJ, 2003, COMP BIOCHEM PHYS A, V136, P353, DOI 10.1016/S1095-6433(03)00167-3; SHIRLEY SM, 1987, MAR BIOL, V95, P371, DOI 10.1007/BF00409567; Smith GG, 2002, AQUACULTURE, V209, P157, DOI 10.1016/S0044-8486(01)00758-X; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Tong LJ, 2000, MAR FRESHWATER RES, V51, P243, DOI 10.1071/MF99049; Tropea C, 2012, J CRUSTACEAN BIOL, V32, P883, DOI 10.1163/1937240X-00002103; Urzua A, 2013, HELGOLAND MAR RES, V67, P267, DOI 10.1007/s10152-012-0321-4; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Wang WN, 2006, AQUACULTURE, V256, P624, DOI 10.1016/j.aquaculture.2006.02.009; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918; Wehrtmann IS, 2003, J NAT HIST, V37, P2165, DOI 10.1080/00222930210133291; Weiss M, 2009, J EXP MAR BIOL ECOL, V376, P48, DOI 10.1016/j.jembe.2009.06.002	47	50	50	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119468	10.1371/journal.pone.0119468	http://dx.doi.org/10.1371/journal.pone.0119468			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768918	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500082
J	Yang, XL; Liu, CX; Zhang, JX; Han, HY; Wang, XY; Liu, ZL; Xu, YM				Yang, Xinglong; Liu, Chuanxin; Zhang, Jinxiang; Han, Hongying; Wang, Xiuyan; Liu, Zhoulin; Xu, Yanming			Association of Histamine N-Methyltransferase Thr105Ile Polymorphism with Parkinson's Disease and Schizophrenia in Han Chinese: A Case-Control Study	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; METABOLIZING ENZYMES; NEURONAL DEATH; MODEL; DOPAMINE; RISK; GENE; PREVALENCE; ANTAGONISM; MUTATIONS	Parkinson's disease (PD) and schizophrenia (SCZ) are frequent central nervous disorders that have unclear etiologies but that show similarities in their pathogenesis. Since elevated histamine levels in the brain have been associated with PD and SCZ, we wanted to explore whether the Thr105Ile substitution in the histamine N-methyltransferase gene (HNMT-Thr105Ile), which impairs histamine degradation, is associated with either disease. We used the ligase detection reaction to genotype a case-control cohort of Han Chinese patients with PD or SCZ and healthy controls at the HNMT-Thr105Ile locus. The Ile allele was associated with reduced risk of PD (OR 0.516, 95% CI 0.318 to 0.838, p = 0.007) and of SCZ (OR 0.499, 95% CI 0.288 to 0.865, p = 0.011). Genotype frequencies and minor allele frequencies were similar between patients and controls when we compared males with females or early-onset patients with late-onset ones. Genotype and allele frequencies were not significantly different between PD patients with dyskinesia and PD patients without dyskinesia. Our results suggest that the heterozygous Thr/Ile genotype at the HNMT-Thr105Ile locus and the minor Ile105 allele protect against PD and SCZ in Han Chinese.	[Yang, Xinglong; Xu, Yanming] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610041, Sichuan Provinc, Peoples R China; [Liu, Chuanxin] Sichuan Univ, Coll Basic & Forens Med, Chengdu 610041, Sichuan Provinc, Peoples R China; [Liu, Chuanxin] Jining Med Coll, Dept Psychiat, Jining 272051, Shandong, Peoples R China; [Zhang, Jinxiang] Jining Mental Hosp, Dept Psychiat, Jining 272051, Shandong, Peoples R China; [Han, Hongying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Psychiat, Guangzhou 510630, Guangdong, Peoples R China; [Wang, Xiuyan] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth, Changsha 410011, Hunan, Peoples R China; [Liu, Zhoulin] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510080, Guangdong, Peoples R China	Sichuan University; Sichuan University; Jining Medical University; Sun Yat Sen University; Central South University; Sun Yat Sen University	Xu, YM (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan Provinc, Peoples R China.	neuroxym999@163.com	Xu, yanming/Q-4931-2019		National Natural Science Foundation of China [81471300]; Sichuan Province Applied Basic Research Program [2014JY0247]; Sichuan Key Project of Science and Technology [2010SZ0086]; Ministry of Science and Technology of China [2012AA02A514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Province Applied Basic Research Program; Sichuan Key Project of Science and Technology; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This research was supported by the National Natural Science Foundation of China (no. 81471300), the Sichuan Province Applied Basic Research Program (no. 2014JY0247), the Sichuan Key Project of Science and Technology (no. 2010SZ0086) and the Ministry of Science and Technology of China (2012AA02A514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2014, J CLIN PSYCHIAT, V75, P274, DOI [10.4088/JCP.13078co7c, 10.4088/JCP.13078tx2c]; Agundez JAG, 2008, NEUROMOL MED, V10, P10, DOI 10.1007/s12017-007-8017-7; Alonso-Navarro H, 2014, CURR DRUG METAB, V15, P129, DOI 10.2174/138920021502140327175404; Anichtchik OV, 2000, EXP NEUROL, V163, P20, DOI 10.1006/exnr.2000.7362; Brisch R, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00047; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Chen GL, 2002, CLIN CHIM ACTA, V326, P163, DOI 10.1016/S0009-8981(02)00299-1; Chen ML, 2014, PARKINSONISM RELAT D, V20, P280, DOI 10.1016/j.parkreldis.2013.11.009; COELHO MH, 1991, MOL CHEM NEUROPATHOL, V14, P77, DOI 10.1007/BF03159928; DUCH DS, 1978, BIOCHEM PHARMACOL, V27, P1507, DOI 10.1016/0006-2952(78)90109-0; First MB, 1996, PSYCHIAT CLIN N AM, V19, P29, DOI 10.1016/S0193-953X(05)70271-9; Garcia-Martin E, 2007, CLIN EXP ALLERGY, V37, P1175, DOI 10.1111/j.1365-2222.2007.02769.x; Garcia-Martin E, 2009, PHARMACOGENOMICS, V10, P867, DOI 10.2217/PGS.09.26; Han HY, 2011, PSYCHIAT RES, V190, P163, DOI 10.1016/j.psychres.2011.04.026; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073777; Iwabuchi K, 2005, EUR NEUROPSYCHOPHARM, V15, P185, DOI 10.1016/j.euroneuro.2004.10.001; Johnston TH, 2010, MOVEMENT DISORD, V25, P1379, DOI 10.1002/mds.23069; Kalia LV, 2013, MOVEMENT DISORD, V28, P131, DOI 10.1002/mds.25273; Keeling BH, 2010, PARKINSONISM RELAT D, V16, P112, DOI 10.1016/j.parkreldis.2009.08.011; Kellermayer B, 2013, HUM IMMUNOL, V74, P1701, DOI 10.1016/j.humimm.2013.07.016; Kiyohara C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-89; LANGLAIS PJ, 1994, J NEUROSCI RES, V38, P565, DOI 10.1002/jnr.490380509; Ledesma MC, 2008, NEUROMOL MED, V10, P356, DOI 10.1007/s12017-008-8040-3; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Meskanen K, 2013, J CLIN PSYCHOPHARM, V33, P472, DOI 10.1097/JCP.0b013e3182970490; Miyasaki JM, 2010, J NEUROL, V257, pS309, DOI 10.1007/s00415-010-5718-x; Nowak P, 2008, NEUROTOX RES, V13, P231, DOI 10.1007/BF03033506; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Palada V, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.015; Pang YP, 2001, BIOCHEM BIOPH RES CO, V287, P204, DOI 10.1006/bbrc.2001.5570; PRELL GD, 1991, AGENT ACTION SUPPL, V33, P343; PRELL GD, 1995, SCHIZOPHR RES, V14, P93, DOI 10.1016/0920-9964(94)00034-6; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Shan L, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.016; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Vizuete ML, 2000, J NEUROCHEM, V75, P540, DOI 10.1046/j.1471-4159.2000.0750540.x; Voisey J, 2012, EUR PSYCHIAT, V27, P372, DOI 10.1016/j.eurpsy.2010.08.004; Wei YL, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-42; Yan L, 2000, PHARMACOGENETICS, V10, P261, DOI 10.1097/00008571-200004000-00007; Yan L, 2000, AM J MED GENET, V96, P404, DOI 10.1002/1096-8628(20000612)96:3<404::AID-AJMG31>3.0.CO;2-D	42	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119692	10.1371/journal.pone.0119692	http://dx.doi.org/10.1371/journal.pone.0119692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768024	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500093
J	Bulatovic, I; Ibarra, C; Osterholm, C; Wang, H; Beltran-Rodriguez, A; Varas-Godoy, M; Mansson-Broberg, A; Uhlen, P; Simon, A; Grinnemo, KH				Bulatovic, Ivana; Ibarra, Cristian; Osterholm, Cecilia; Wang, Heng; Beltran-Rodriguez, Antonio; Varas-Godoy, Manuel; Mansson-Broberg, Agneta; Uhlen, Per; Simon, Andras; Grinnemo, Karl-Henrik			Sublethal Caspase Activation Promotes Generation of Cardiomyocytes from Embryonic Stem Cells	PLOS ONE			English	Article							MUSCLE DIFFERENTIATION; BETA-CATENIN; APOPTOSIS; HEART; REGENERATION; PROGENITORS; RENEWAL; MULTIPOTENT; DROSOPHILA; SIGNALS	Generation of new cardiomyocytes is critical for cardiac repair following myocardial injury, but which kind of stimuli is most important for cardiomyocyte regeneration is still unclear. Here we explore if apoptotic stimuli, manifested through caspase activation, influences cardiac progenitor up-regulation and cardiomyocyte differentiation. Using mouse embryonic stem cells as a cellular model, we show that sublethal activation of caspases increases the yield of cardiomyocytes while concurrently promoting the proliferation and differentiation of c-Kit(+)/alpha-actinin(low)cardiac progenitor cells. A broad-spectrum caspase inhibitor blocked these effects. In addition, the caspase inhibitor reversed the mRNA expression of genes expressed in cardiomyocytes and their precursors. Our study demonstrates that sublethal caspase-activation has an important role in cardiomyocyte differentiation and may have significant implications for promoting cardiac regeneration after myocardial injury involving exogenous or endogenous cell sources.	[Bulatovic, Ivana; Osterholm, Cecilia; Grinnemo, Karl-Henrik] Karolinska Inst, Div Cardiothorac Surg & Anesthesiol, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden; [Ibarra, Cristian; Varas-Godoy, Manuel; Uhlen, Per] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Wang, Heng; Simon, Andras] Karolinska Inst, Dept Cellular & Mol Biol, Stockholm, Sweden; [Beltran-Rodriguez, Antonio] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Mansson-Broberg, Agneta] Karolinska Inst, Div Cardiol, Dept Med Huddinge, Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Grinnemo, KH (corresponding author), Karolinska Inst, Div Cardiothorac Surg & Anesthesiol, Dept Mol Med & Surg, Karolinska Univ Hosp, Stockholm, Sweden.	karl-henrik.grinnemo@karolinska.se	Corbascio, Cecilia Österholm/ABF-2213-2020; Broberg, Agneta Månsson/O-3849-2017	Corbascio, Cecilia Österholm/0000-0001-7506-084X; Grinnemo, Karl-Henrik/0000-0001-6717-3393; Varas-Godoy, Manuel/0000-0001-5857-4793; Uhlen, Per/0000-0003-1446-1062; Simon, Andras/0000-0002-1018-1891; Mansson Broberg, Agneta/0000-0002-1478-0947; Grinnemo, Karl-Henrik/0000-0002-6100-6209	Swedish Research Council; Stockholm County Council; Heart and Lung Foundation; Karolinska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Research Foundation	This study was supported by grants from the Swedish Research Council, The Stockholm County Council, the Heart and Lung Foundation and the Karolinska Research Foundation. The funders had no esign, data collection and analysis, decision to publish, or preparation of trole in study dhe manuscript.	Abdul-Ghani M, 2008, CELL STEM CELL, V2, P515, DOI 10.1016/j.stem.2008.05.013; Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akbari-Birgani S, 2014, J BIOL CHEM, V289, P16905, DOI 10.1074/jbc.M113.536730; Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Chan SSK, 2009, BIOCHEM BIOPH RES CO, V387, P723, DOI 10.1016/j.bbrc.2009.07.122; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Genead R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036804; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Hunter AL, 2007, FEBS LETT, V581, P879, DOI 10.1016/j.febslet.2007.01.050; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Larsen BD, 2010, P NATL ACAD SCI USA, V107, P4230, DOI 10.1073/pnas.0913089107; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Steinhauser ML, 2011, EMBO MOL MED, V3, P701, DOI 10.1002/emmm.201100175; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; von Roretz C, 2010, J BIOL CHEM, V285, P16806, DOI 10.1074/jbc.M109.087320; Welt FGP, 2013, CIRC-HEART FAIL, V6, P99, DOI 10.1161/CIRCHEARTFAILURE.112.972273	35	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120176	10.1371/journal.pone.0120176	http://dx.doi.org/10.1371/journal.pone.0120176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763592	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300036
J	Ibrahim, S; Salilew-Wondim, D; Rings, F; Hoelker, M; Neuhoff, C; Tholen, E; Looft, C; Schellander, K; Tesfaye, D				Ibrahim, Sally; Salilew-Wondim, Dessie; Rings, Franca; Hoelker, Michael; Neuhoff, Christiane; Tholen, Ernst; Looft, Christian; Schellander, Karl; Tesfaye, Dawit			Expression Pattern of Inflammatory Response Genes and Their Regulatory MicroRNAs in Bovine Oviductal Cells in Response to Lipopolysaccharide: Implication for Early Embryonic Development	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; FEMALE REPRODUCTIVE-TRACT; TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; IN-VITRO; INDUCED APOPTOSIS; INNATE IMMUNITY; CULTURE; PREGNANCY; DISEASE	In the present study, we used an in vitro model to investigate the response of the oviduct with respect to inflammatory mediators and their regulatory microRNAs in case of bacterial infection and subsequent association with embryo survival. For this, we conducted two experiments. In the first experiment, cultured primary bovine oviductal cells (BOEC) were challenged with lipopolysaccharide (LPS) for 24h and the temporal expression pattern of inflammatory mediators and their regulatory microRNAs were measured at 0, 3, 6, 12, 24 and 48h after LPS treatment. Intriguingly, the temporal patterns of all miRNAs except miR-21 were significantly up-regulated at 6h after LPS treatment. Whereas, we observed significant overexpression of pro-inflammatory mediators as tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL1 beta) after LPS challenge for 24h. On the other hand, the expression level of essential elements like oviductal glycoprotein 1 (OVGP1) and insulin-like growth factor 2 (IGF2) was significantly decreased in challenged groups compared with control. Moreover, miR-155, miR-146a, miR-223, miR-21, miR-16 and miR-215 have shown a clear suppression in challenged group after LPS treatment. In the 2nd experiment there were four groups of blastocysts produced, namely embryo+LPS free media, embryo+LPS, BOEC+embryo and BOEC+embryo+LPS. The suboptimal oviduct environment due to LPS challenge is found to have a significant influence on the expression of inflammatory response genes (TNF alpha and CSF1), stress response genes (SOD and CAT), mitochondrial activity, reactive oxygen species (ROS) accumulation and apoptotic level either in cultured or co-cultured blastocysts. Collectively, LPS challenge led to aberrant changes in oviductal transcriptome profile, which could lead to a suboptimal environment for embryo development.	[Ibrahim, Sally; Salilew-Wondim, Dessie; Rings, Franca; Hoelker, Michael; Neuhoff, Christiane; Tholen, Ernst; Looft, Christian; Schellander, Karl; Tesfaye, Dawit] Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany	University of Bonn	Tesfaye, D (corresponding author), Univ Bonn, Inst Anim Sci, Anim Breeding & Husb Grp, Bonn, Germany.	tesfaye@itw.uni-bonn.de		Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Chen, Lu/0000-0002-9580-8576; Ibrahim, Sally/0000-0003-2098-6463				Altmae S, 2012, MOL ENDOCRINOL, V26, P203, DOI 10.1210/me.2011-1196; An L, 2012, ARCH TOXICOL, V86, P1337, DOI 10.1007/s00204-012-0814-6; Balboula AZ, 2010, MOL REPROD DEV, V77, P1031, DOI 10.1002/mrd.21250; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chapwanya A, 2009, THERIOGENOLOGY, V71, P1396, DOI 10.1016/j.theriogenology.2009.01.006; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Cronin JG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092718; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eulalio A, 2012, RNA BIOL, V9, P742, DOI 10.4161/rna.20018; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; Hailemariam D, 2013, REPROD FERT DEVELOP, P898; Hardy K, 1999, REV REPROD, V4, P125; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Herath S, 2007, REPRODUCTION, V134, P683, DOI 10.1530/REP-07-0229; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Herath S, 2009, ENDOCRINOLOGY, V150, P1912, DOI 10.1210/en.2008-1379; Holm P, 1999, THERIOGENOLOGY, V52, P683, DOI 10.1016/S0093-691X(99)00162-4; Horne AW, 2008, REPRODUCTION, V135, P739, DOI 10.1530/REP-07-0564; Humblot P, 2001, THERIOGENOLOGY, V56, P1417, DOI 10.1016/S0093-691X(01)00644-6; Hunter RHF, 2012, BIOL REV, V87, P244, DOI 10.1111/j.1469-185X.2011.00196.x; Hunter RHF, 2003, REPROD DOMEST ANIM, V38, P147, DOI 10.1046/j.1439-0531.2003.00402.x; Hvid M, 2007, CELL MICROBIOL, V9, P2795, DOI 10.1111/j.1462-5822.2007.00996.x; Jaiswal YK, 2006, INFECT DIS OBSTET GY, V2006, P32050, DOI [DOI 10.1155/IDOG/2006/32050, 10.1155/IDOG/2006/32050]; Kasahara E, 2011, FEBS LETT, V585, P2263, DOI 10.1016/j.febslet.2011.05.049; Kastl L, 2014, FEBS LETT, V588, P175, DOI 10.1016/j.febslet.2013.11.033; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; Kowsar R, 2013, J REPROD DEVELOP, V59, P470, DOI 10.1262/jrd.2013-036; Makarevich AV, 2002, BIOL REPROD, V66, P386, DOI 10.1095/biolreprod66.2.386; Makarevich AV MP, 2008, SLOVAK J ANIM SCI, V41, P153; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; McGregor JA, 2000, OBSTET GYNECOL SURV, V55, pS1; Murphy AJ, 2010, J IMMUNOL, V184, P5029, DOI 10.4049/jimmunol.0903463; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; Oron E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045002; Pan Q, 2008, SEMIN REPROD MED, V26, P479, DOI 10.1055/s-0028-1096128; Park J, 2013, J NEUROCHEM, V127, P221, DOI 10.1111/jnc.12361; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; Paula-Lopes FF, 2002, BIOL REPROD, V66, P1169, DOI 10.1093/biolreprod/66.4.1169; Raghupathy R, 2008, FRONT BIOSCI-LANDMRK, V13, P985, DOI 10.2741/2737; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Rottmayer R, 2006, REPRODUCTION, V132, P637, DOI 10.1530/rep.1.01136; Rozen S, 2000, Methods Mol Biol, V132, P365; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Sugino N, 1998, BIOL REPROD, V59, P208, DOI 10.1095/biolreprod59.1.208; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Teng GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056709; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Walsh SW, 2011, ANIM REPROD SCI, V123, P127, DOI 10.1016/j.anireprosci.2010.12.001; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Williams EJ, 2007, THERIOGENOLOGY, V68, P549, DOI 10.1016/j.theriogenology.2007.04.056; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Yilmaz O, 2012, THERIOGENOLOGY, V77, P1312, DOI 10.1016/j.theriogenology.2011.10.036	63	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119388	10.1371/journal.pone.0119388	http://dx.doi.org/10.1371/journal.pone.0119388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764515	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300026
J	Lai, IC; Shih, PH; Yao, CJ; Yeh, CT; Wang-Peng, J; Lui, TN; Chuang, SE; Hu, TS; Lai, TY; Lai, GM				Lai, I-Chun; Shih, Ping-Hsiao; Yao, Chih-Jung; Yeh, Chi-Tai; Wang-Peng, Jacqueline; Lui, Tai-Ngar; Chuang, Suang-En; Hu, Tsai-Shu; Lai, Tung-Yuan; Lai, Gi-Ming			Elimination of Cancer Stem-Like Cells and Potentiation of Temozolomide Sensitivity by Honokiol in Glioblastoma Multiforme Cells	PLOS ONE			English	Article							SIDE POPULATION; PATHWAY; BREAST; GLIOMA; TUMORS; INHIBITION; TARGETS	Glioblastoma multiforme (GBM) is the most common adult malignant glioma with poor prognosis due to the resistance to radiotherapy and chemotherapy, which might be critically involved in the repopulation of cancer stem cells (CSCs) after treatment. We had investigated the characteristics of cancer stem-like side population (SP) cells sorted from GBM cells, and studied the effect of Honokiol targeting on CSCs. GBM8401 SP cells possessed the stem cell markers, such as nestin, CD133 and Oct4, and the expressions of self-renewal related stemness genes, such as SMO, Notch3 and IHH (Indian Hedgehog). Honokiol inhibited the proliferation of both GBM8401 parental cells and SP cells in a dose-dependent manner, the IC50 were 5.3 +/- 0.72 and 11 +/- 1.1 mu M, respectively. The proportions of SP in GBM8401 cells were diminished by Honokiol from 1.5 +/- 0.22% down to 0.3 +/- 0.02% and 0.2 +/- 0.01% at doses of 2.5 mu M and 5 mu M, respectively. The SP cells appeared to have higher expression of O-6-methylguanine-DNA methyltransferase (MGMT) and be more resistant to Temozolomide (TMZ). The resistance to TMZ could be only slightly reversed by MGMT inhibitor O-6-benzylguanine (O-6-BG), but markedly further enhanced by Honokiol addition. Such significant enhancement was accompanied with the higher induction of apoptosis, greater down-regulation of Notch3 as well as its downstream Hes1 expressions in SP cells. Our data indicate that Honokiol might have clinical benefits for the GBM patients who are refractory to TMZ treatment.	[Lai, I-Chun] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan; [Shih, Ping-Hsiao; Yao, Chih-Jung; Yeh, Chi-Tai; Wang-Peng, Jacqueline; Lai, Gi-Ming] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Shih, Ping-Hsiao] Taipei Med Univ, Shuang Ho Hosp, Dept Pediat, New Taipei City, Taiwan; [Yao, Chih-Jung; Wang-Peng, Jacqueline; Hu, Tsai-Shu; Lai, Gi-Ming] Taipei Med Univ, Wan Fang Hosp, Ctr Canc, Taipei, Taiwan; [Yao, Chih-Jung; Lai, Gi-Ming] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yeh, Chi-Tai] Taipei Med Univ, Shuang Ho Hosp, Ctr Canc, Taipei, Taiwan; [Lui, Tai-Ngar] Taipei Med Univ, Wan Fang Hosp, Div Neurosurg, Taipei, Taiwan; [Chuang, Suang-En; Lai, Gi-Ming] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Lai, Tung-Yuan] Taipei Med Univ, Coll Pharm, Grad Inst Pharmacognosy, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; National Health Research Institutes - Taiwan; Taipei Medical University	Lai, GM (corresponding author), Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan.	gminlai@nhri.org.tw	Chuang, Shuang-En/D-2080-2010; Shih, Ping-Hsiao/GPG-2472-2022	Shih, Ping-Hsiao/0000-0002-8387-105X	Ministry of Health and Welfare, Taiwan [MOHW103-TD-B-111-01]; National Health Research Institutes, Taiwan [03A1 CAPP33-014]; Ministry of Science and Technology, Taiwan [NSC 100-2632-B-038-001-MY3]	Ministry of Health and Welfare, Taiwan; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grants from Ministry of Health and Welfare, Taiwan (MOHW103-TD-B-111-01), National Health Research Institutes, Taiwan (03A1 CAPP33-014) and Ministry of Science and Technology, Taiwan (NSC 100-2632-B-038-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Crane C, 2009, J IMMUNOTHER, V32, P585, DOI 10.1097/CJI.0b013e3181a8efe6; Darkes MJM, 2002, AM J CANC, V1, P55, DOI DOI 10.2165/00024669-200201010-00006; Dikalov S, 2008, BIOCHEM PHARMACOL, V76, P589, DOI 10.1016/j.bcp.2008.06.012; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Kanamori M, 2007, J NEUROSURG, V106, P417, DOI 10.3171/jns.2007.106.3.417; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Kim M, 2002, CLIN CANCER RES, V8, P22; Lin JW, 2012, NEURO-ONCOLOGY, V14, P302, DOI 10.1093/neuonc/nor217; Lin YR, 2005, NEUROPHARMACOLOGY, V49, P542, DOI 10.1016/j.neuropharm.2005.04.009; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mannal PW, 2011, J SURG ONCOL, V104, P260, DOI 10.1002/jso.21936; McDonald SAC, 2009, VIRCHOWS ARCH, V455, P1, DOI 10.1007/s00428-009-0783-1; Mimeault M, 2010, CANCER LETT, V295, P69, DOI 10.1016/j.canlet.2010.02.015; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Pistollato F, 2010, STEM CELLS, V28, P851, DOI 10.1002/stem.415; Ponnurangam S, 2012, MOL CANCER THER, V11, P963, DOI 10.1158/1535-7163.MCT-11-0999; Quinn JA, 2009, J CLIN ONCOL, V27, P1262, DOI 10.1200/JCO.2008.18.8417; Shin TY, 2001, ARCH PHARM RES, V24, P249, DOI 10.1007/BF02978266; Singh SK, 2003, CANCER RES, V63, P5821; Singh T, 2011, INT J ONCOL, V38, P769, DOI 10.3892/ijo.2011.899; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Ulasov IV, 2011, MOL MED, V17, P103, DOI 10.2119/molmed.2010.00062; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018490; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	30	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0114830	10.1371/journal.pone.0114830	http://dx.doi.org/10.1371/journal.pone.0114830			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763821	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300001
J	Ornelles, DA; Gooding, LR; Garnett-Benson, C				Ornelles, David A.; Gooding, Linda R.; Garnett-Benson, C.			Neonatal Infection with Species C Adenoviruses Confirmed in Viable Cord Blood Lymphocytes	PLOS ONE			English	Article							INTRAUTERINE VIRAL-INFECTION; ACUTE LYMPHOBLASTIC-LEUKEMIA; POLYMERASE-CHAIN-REACTION; GUTHRIE CARDS; CHILDHOOD LEUKEMIA; AMNIOTIC-FLUID; DEOXYRIBONUCLEIC-ACID; PRENATAL ORIGIN; HUMAN TONSIL; DNA	Credible but conflicting reports address the frequency of prenatal infection by species C adenovirus. This question is important because these viruses persist in lymphoid cells and suppress double-stranded DNA-break repair. Consequently, prenatal adenovirus infections may generate the aberrant clones of lymphocytes that precede development of childhood acute lymphoblastic leukemia (ALL). The present study was designed to overcome technical limitations of prior work by processing cord blood lymphocytes within a day of collection, and by analyzing sufficient numbers of lymphocytes to detect adenovirus-containing cells at the lower limits determined by our previous studies of tonsil lymphocytes. By this approach, adenoviral DNA was identified in 19 of 517 (3.7%) samples, providing definitive evidence for the occurrence of prenatal infection with species C adenoviruses in a significant fraction of neonates predominantly of African American and Hispanic ancestry. Cord blood samples were also tested for the presence of the ETV6-RUNX1 translocation, the most common genetic abnormality in childhood ALL. Using a nested PCR assay, the ETV6-RUNX1 transcript was detected in four of 196 adenovirus-negative samples and one of 14 adenovirus-positive cord blood samples. These findings indicate that this method will be suitable for determining concordance between adenovirus infection and the leukemia-associated translocations in newborns.	[Garnett-Benson, C.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Ornelles, David A.] Wake Forest Sch Med, Dept Microbiol & Immunol, Winston Salem, NC USA; [Gooding, Linda R.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	University System of Georgia; Georgia State University; Wake Forest University; Emory University	Garnett-Benson, C (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	cgarnettbenson@gsu.edu			National Cancer Institute [R01 CA127621]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA127621] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, grant number R01 CA127621 to LRG, DAO, CGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alkhalaf MA, 2013, J MED VIROL, V85, P1947, DOI 10.1002/jmv.23678; [Anonymous], 2014, R LANG ENV STAT COMP; Baschat A A, 2003, J Matern Fetal Neonatal Med, V13, P381, DOI 10.1080/jmf.13.6.381.384; BECK R, 1994, IMMUNOL CELL BIOL, V72, P440, DOI 10.1038/icb.1994.65; Bianchi DW, 2001, CLIN CHEM, V47, P1867; Buscone S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098222; Chirumbolo S, 2011, CYTOM PART B-CLIN CY, V80B, P248, DOI 10.1002/cyto.b.20588; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chow EJ, 2010, CANCER-AM CANCER SOC, V116, P3045, DOI 10.1002/cncr.25099; Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5; Durepaire N, 1997, J ACQ IMMUN DEF SYND, V14, P189; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Fernandez-Soria V, 2002, ONCOL REP, V9, P897; Flomenberg P, 1997, J MED VIROL, V51, P182, DOI 10.1002/(SICI)1096-9071(199703)51:3<182::AID-JMV7>3.0.CO;2-2; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Gervasi MT, 2012, J MATERN-FETAL NEO M, V25, P2002, DOI 10.3109/14767058.2012.683899; Greaves M, 2005, EARLY HUM DEV, V81, P123, DOI 10.1016/j.earlhumdev.2004.10.004; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Greaves Mel, 2006, Discov Med, V6, P24; Gruhn B, 2008, LEUKEMIA, V22, P1692, DOI 10.1038/leu.2008.152; Gustafsson B, 2007, BRIT J CANCER, V97, P992, DOI 10.1038/sj.bjc.6603983; Gustafsson B, 2007, PEDIATR HEMAT ONCOL, V24, P607, DOI 10.1080/08880010701640341; Harrell Jr FE, 2012, HMISC HARRELL MISCEL; HARRIS DT, 1992, P NATL ACAD SCI USA, V89, P10006, DOI 10.1073/pnas.89.21.10006; Hart LS, 2005, J BIOL CHEM, V280, P1474, DOI 10.1074/jbc.M409934200; Honkaniemi E, 2010, BRIT J CANCER, V102, P796, DOI 10.1038/sj.bjc.6605581; Lausten-Thomsen U, 2011, BLOOD, V117, P186, DOI 10.1182/blood-2010-05-282764; MCLEAN LK, 1995, AM J OBSTET GYNECOL, V173, P1282, DOI 10.1016/0002-9378(95)91371-8; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Meru N, 2002, BLOOD, V99, P531, DOI 10.1182/blood.V99.2.531; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; NEUMANN R, 1987, VIRUS RES, V7, P93, DOI 10.1016/0168-1702(87)90060-8; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; O'Connor SM, 2007, ENVIRON HEALTH PERSP, V115, P146, DOI 10.1289/ehp.9024; Olsen M, 2006, J PEDIAT HEMATOL ONC, V28, P734, DOI 10.1097/01.mph.0000243652.33561.0f; Olsen M, 2012, J PEDIAT HEMATOL ONC, V34, P301, DOI 10.1097/MPH.0b013e3182332268; Reddy UM, 2005, FETAL DIAGN THER, V20, P203, DOI 10.1159/000083906; Roman E, 2009, BLOOD CELL MOL DIS, V42, P126, DOI 10.1016/j.bcmd.2008.10.007; ROMANA SP, 1995, BLOOD, V86, P4263, DOI 10.1182/blood.V86.11.4263.bloodjournal86114263; Skorvaga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091116; Smith M, 1997, J IMMUNOTHER, V20, P89, DOI 10.1097/00002371-199703000-00001; Strauchen JA, 2001, AM J CLIN PATHOL, V116, P12; Taub JW, 2004, LEUKEMIA LYMPHOMA, V45, P19, DOI 10.1080/1042819031000149403; Tollefson A.E., 2007, METHODS MOL MED, V130, P223; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; Van den Veyver IB, 1998, MOL GENET METAB, V63, P85, DOI 10.1006/mgme.1997.2651; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vasconcelos GM, 2008, BRIT J CANCER, V99, P1668, DOI 10.1038/sj.bjc.6604714; von Goessel H, 2009, LEUKEMIA RES, V33, P1082, DOI 10.1016/j.leukres.2008.11.001; Wenstrom KD, 1998, OBSTET GYNECOL, V92, P420, DOI 10.1016/S0029-7844(98)00210-5; Wiemels J, 2012, CHEM-BIOL INTERACT, V196, P59, DOI 10.1016/j.cbi.2012.01.007; ZHANG LQ, 1993, LEUKEMIA, V7, P1865; Zhang YG, 2010, J VIROL, V84, P8799, DOI 10.1128/JVI.00562-10; Zuna J, 2011, BLOOD, V117, P368, DOI 10.1182/blood-2010-09-309070; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119256	10.1371/journal.pone.0119256	http://dx.doi.org/10.1371/journal.pone.0119256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764068	gold, Green Published, Green Submitted			2022-12-26	WOS:000351276300022
J	Ano, Y; Ozawa, M; Kutsukake, T; Sugiyama, S; Uchida, K; Yoshida, A; Nakayama, H				Ano, Yasuhisa; Ozawa, Makiko; Kutsukake, Toshiko; Sugiyama, Shinya; Uchida, Kazuyuki; Yoshida, Aruto; Nakayama, Hiroyuki			Preventive Effects of a Fermented Dairy Product against Alzheimer's Disease and Identification of a Novel Oleamide with Enhanced Microglial Phagocytosis and Anti-Inflammatory Activity	PLOS ONE			English	Article							FATTY-ACID AMIDES; AMYLOID-BETA; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; MOUSE MODEL; PPAR-GAMMA; INFLAMMATION; IMPAIRMENT; BRAIN	Despite the ever-increasing number of patients with dementia worldwide, fundamental therapeutic approaches to this condition have not been established. Epidemiological studies suggest that intake of fermented dairy products prevents cognitive decline in the elderly. However, the active compounds responsible for the effect remain to be elucidated. The present study aims to elucidate the preventive effects of dairy products on Alzheimer's disease and to identify the responsible component. Here, in a mouse model of Alzheimer's disease (5xFAD), intake of a dairy product fermented with Penicillium candidum had preventive effects on the disease by reducing the accumulation of amyloid beta (A beta) and hippocampal inflammation (TNF-alpha and MIP-1 alpha production), and enhancing hippocampal neurotrophic factors (BDNF and GDNF). A search for preventive substances in the fermented dairy product identified oleamide as a novel dual-active component that enhanced microglial A beta phagocytosis and anti-inflammatory activity towards LPS stimulation in vitro and in vivo. During the fermentation, oleamide was synthesized from oleic acid, which is an abundant component of general dairy products owing to lipase enzymatic amidation. The present study has demonstrated the preventive effect of dairy products on Alzheimer's disease, which was previously reported only epidemiologically. Moreover, oleamide has been identified as an active component of dairy products that is considered to reduce A beta accumulation via enhanced microglial phagocytosis, and to suppress microglial inflammation after A beta deposition. Because fermented dairy products such as camembert cheese are easy to ingest safely as a daily meal, their consumption might represent a preventive strategy for dementia.	[Ano, Yasuhisa; Kutsukake, Toshiko; Yoshida, Aruto] Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Ozawa, Makiko; Uchida, Kazuyuki; Nakayama, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Sugiyama, Shinya] Koiwai Dairy Prod Co Ltd, Shizukuishi, Iwate 0200507, Japan	University of Tokyo	Ano, Y (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Kanazawa Ku, 1-13-5 Fukuura, Yokohama, Kanagawa 2360004, Japan.	Yasuhisa_Ano@kirin.co.jp		Ozawa, Makiko/0000-0002-9871-1526	Kirin Company Ltd.; Koiwai Dairy Products Co., Ltd.; Kirin; Koiwai	Kirin Company Ltd.; Koiwai Dairy Products Co., Ltd.; Kirin; Koiwai	The authors received no specific funding for this work. Kirin Company Ltd. and Koiwai Dairy Products Co., Ltd. provided support in the form of salaries for authors Y.A., T.K., A.Y. and S.S., but did not have any role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.]. Pls also update COI: [We declare the following interests. Yasuhisa Ano, Toshiko Kutsukake and Aruto Yoshida are employed by Kirin Company Ltd., and Shinya Sugiyama is employed by Koiwai Dairy Products Co., Ltd. Koiwai Dairy Foods Co., Ltd. is a subsidiary company of Kirin Company, Ltd., and all research was executed at Kirin Company, Ltd. using Kirin's sources under a joint research agreement between Kirin and Koiwai. This does not alter our adherence to all of the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Alkam T, 2007, BEHAV BRAIN RES, V180, P139, DOI 10.1016/j.bbr.2007.03.001; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Awasthi Neeraj Praphulla, 2007, J Oleo Sci, V56, P507; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boger DL, 1998, CURR PHARM DESIGN, V4, P303; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Cotman CW, 2005, NEUROCHEM RES, V30, P877, DOI 10.1007/s11064-005-6960-y; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Crichton GE, 2010, ASIA PAC J CLIN NUTR, V19, P161; Dionisi M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-51; Fernandez PL, 2013, J ALZHEIMERS DIS, V33, P297, DOI 10.3233/JAD-2012-121222; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lourenco MV, 2013, J NEUROSCI, V33, P5083, DOI 10.1523/JNEUROSCI.0172-13.2013; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Lu P, 2009, BRIT J PHARMACOL, V157, P1270, DOI 10.1111/j.1476-5381.2009.00295.x; Malm T, 2010, GLIA, V58, P889, DOI 10.1002/glia.20973; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Miklossy J, 2008, J ALZHEIMERS DIS, V13, P381; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Mrak RE, 2005, J ALZHEIMERS DIS, V8, P369; Naert G, 2011, CURR ALZHEIMER RES, V8, P151, DOI 10.2174/156720511795256035; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oh YT, 2010, NEUROSCI LETT, V474, P148, DOI 10.1016/j.neulet.2010.03.026; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Rezai-Zadeh K, 2011, CURR ALZHEIMER RES, V8, P156, DOI 10.2174/156720511795256017; Sastre M, 2011, CURR ALZHEIMER RES, V8, P132, DOI 10.2174/156720511795256062; Slotema WF, 2003, BIOTECHNOL BIOENG, V82, P664, DOI 10.1002/bit.10613; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sugama Shuei, 2009, Inflammation & Allergy Drug Targets, V8, P277; Sultana T, 2006, J CHROMATOGR A, V1101, P278, DOI 10.1016/j.chroma.2005.10.027; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Vassallo Neville, 2013, Curr Aging Sci, V6, P150; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Yamada K, 2010, BRAIN RES, V1352, P176, DOI 10.1016/j.brainres.2010.07.006; Yamanaka M, 2012, J NEUROSCI, V32, P17321, DOI 10.1523/JNEUROSCI.1569-12.2012	49	59	60	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118512	10.1371/journal.pone.0118512	http://dx.doi.org/10.1371/journal.pone.0118512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760987	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000026
J	Fancourt, BA; Hawkins, CE; Cameron, EZ; Jones, ME; Nicol, SC				Fancourt, Bronwyn A.; Hawkins, Clare E.; Cameron, Elissa Z.; Jones, Menna E.; Nicol, Stewart C.			Devil Declines and Catastrophic Cascades: Is Mesopredator Release of Feral Cats Inhibiting Recovery of the Eastern Quoll?	PLOS ONE			English	Article							FACIAL TUMOR DISEASE; TROPHIC CASCADES; FELIS-CATUS; SOUTHEASTERN AUSTRALIA; DASYURUS-VIVERRINUS; POPULATION DECLINE; PREDATOR; ECOLOGY; IMPACT; CONSERVATION	The eastern quoll (Dasyurus viverrinus) is a medium-sized Australian marsupial carnivore that has recently undergone a rapid and severe population decline over the 10 years to 2009, with no sign of recovery. This decline has been linked to a period of unfavourable weather, but subsequent improved weather conditions have not been matched by quoll recovery. A recent study suggested another mechanism: that declines in Tasmanian devil (Sarcophilus harrisii) populations, due to the spread of the fatal Devil Facial Tumour Disease, have released feral cats (Felis catus) from competitive suppression, with eastern quoll declines linked to a subsequent increase in cat sightings. Yet current evidence of intraguild suppression among devils, cats and quolls is scant and equivocal. We therefore assessed the influences of top-down effects on abundance and activity patterns among devils, feral cats and eastern quolls. Between 2011 and 2013, we monitored four carnivore populations using longitudinal trapping and camera surveys, and performed camera surveys at 12 additional sites throughout the eastern quoll's range. We did not find evidence of a negative relationship between devil and cat abundance, nor of higher cat abundance in areas where devil populations had declined the longest. Cats did not appear to avoid devils spatially; however, there was evidence of temporal separation of cat and devil activity, with reduced separation and increasing nocturnal activity observed in areas where devils had declined the longest. Cats and quolls used the same areas, and there was no evidence that cat and quoll abundances were negatively related. Temporal overlap in observed cat and quoll activity was higher in summer than in winter, but this seasonal difference was unrelated to devil declines. We suggest that cats did not cause the recent quoll decline, but that predation of juvenile quolls by cats could be inhibiting low density quoll populations from recovering their former abundance through a 'predator pit' effect following weather-induced decline. Predation intensity could increase further should cats become increasingly nocturnal in response to devil declines.	[Fancourt, Bronwyn A.; Hawkins, Clare E.; Cameron, Elissa Z.; Jones, Menna E.; Nicol, Stewart C.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia	University of Tasmania	Fancourt, BA (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia.	Bronwyn.Fancourt@utas.edu.au	Fancourt, Bronwyn/R-4278-2019; Cameron, Elissa/B-8053-2014	Fancourt, Bronwyn/0000-0003-2969-1530; Cameron, Elissa/0000-0002-9243-0547	Holsworth Wildlife Research Endowment; Royal Zoological Society of NSW; Australian Wildlife Society; MA Ingram Trust; Leisure Solutions (through the Foundation for National Parks Wildlife); National Environmental Research Program	Holsworth Wildlife Research Endowment; Royal Zoological Society of NSW; Australian Wildlife Society; MA Ingram Trust; Leisure Solutions (through the Foundation for National Parks Wildlife); National Environmental Research Program	This project was funded by grants from the Holsworth Wildlife Research Endowment, Royal Zoological Society of NSW (Ethel Mary Read grant), Australian Wildlife Society, the MA Ingram Trust, Leisure Solutions (through the Foundation for National Parks & Wildlife) with in-kind support from the Australian Research Foundation and the National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Ian, 2008, Conservation Science Western Australia, V7, P1; Agostinelli C., 2013, R PACKAGE CIRCULAR C; Allen BL, 2015, BIOL INVASIONS, V17, P761, DOI 10.1007/s10530-014-0767-1; Allen BL, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-39; [Anonymous], OVERLAP ESTIMATES CO; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Australian Bureau of Meteorology, 2009, TASM RAINF DEF 1 JAN; Batschelet E, 1981, CIRCULAR STAT BIOL; Beschta RL, 2015, ECOHYDROLOGY, V8, P58, DOI 10.1002/eco.1487; Bischof R, 2014, J ZOOL, V293, P40, DOI 10.1111/jzo.12100; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; CARO TM, 1980, BEHAV NEURAL BIOL, V29, P1, DOI 10.1016/S0163-1047(80)92442-5; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chamaille-Jammes S, 2014, OECOLOGIA, V174, P1151, DOI 10.1007/s00442-013-2843-0; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; Denny E., 2010, REV CAT ECOLOGY MANA; Department of Primary Industries Parks Water and Environment, 2011, NAT VAL ATL; Dickman CR, APPL ANIM B IN PRESS; Elmhagen B, 2007, ECOL LETT, V10, P197, DOI 10.1111/j.1461-0248.2006.01010.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fancourt B. A., 2010, THESIS; Fancourt BA, 2014, AUST MAMMAL, V36, P247, DOI 10.1071/AM14004; Fancourt Bronwyn A., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P102, DOI 10.1016/j.ijppaw.2014.05.001; Fancourt BA, 2013, AUST MAMMAL, V35, P195, DOI 10.1071/AM13004; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gehrt SD, 2007, BEHAV ECOL, V18, P204, DOI 10.1093/beheco/arl075; Gibson David F., 1994, Australian Mammalogy, V17, P103; Glen AS, 2010, CONSERV GENET, V11, P1099, DOI 10.1007/s10592-009-9888-y; Godsell J., 1982, P199; Godsell J., 1983, THESIS; Guiler ER, 1985, THYLACINE TRAGEDY TA; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Harrington LA, 2009, ECOLOGY, V90, P1207, DOI 10.1890/08-0302.1; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Hayward MW, 2014, J APPL ECOL, V51, P835, DOI 10.1111/1365-2664.12250; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hollings T, 2014, CONSERV BIOL, V28, P63, DOI 10.1111/cobi.12152; JONES E, 1981, AUST WILDLIFE RES, V8, P537; JONES E, 1982, AUST WILDLIFE RES, V9, P111; Jones ME, 2000, WILDLIFE RES, V27, P289, DOI 10.1071/WR98069; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones ME, 2004, ANIM CONSERV, V7, P155, DOI 10.1017/S136794300400126X; Jones ME, 1996, PRELIMINARY ASSESSME; Jones ME, 2007, ECOHEALTH, V4, P326, DOI 10.1007/s10393-007-0120-6; KOENKER R., 2013, QUANTREG QUANTILE RE; Krebs CJ, 1996, J MAMMAL, V77, P8, DOI 10.2307/1382705; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lazenby B., 2012, THESIS; Lazenby BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059846; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; McKnight M, 2008, IUCN RED LIST THREAT; Meredith M, 2014, OVERVIEW OVERLAP PAC; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; Morris DW, 2009, ANN NY ACAD SCI, V1162, P334, DOI 10.1111/j.1749-6632.2009.04494.x; Moseby Katherine E., 2012, International Journal of Ecology, P1; Nicholson KL, 2014, OECOLOGIA, V176, P69, DOI 10.1007/s00442-014-3004-9; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1980, J ANIM ECOL, V49, P667; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Raupach M., 2001, PROJECT DESCRIPTION; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROUNSEVELL DE, 1991, WILDLIFE RES, V18, P699, DOI 10.1071/WR9910699; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Saunders A., 2012, THESIS; Sergio F, 2008, IBIS, V150, P132, DOI 10.1111/j.1474-919X.2008.00786.x; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Taylor Robert J., 1993, Papers and Proceedings of the Royal Society of Tasmania, V127, P33; Terborgh J., 1999, WILD EARTH, P42; Troy S. N., 2014, THESIS; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; van Dijk AIJM, 2013, WATER RESOUR RES, V49, P1040, DOI 10.1002/wrcr.20123; Wang YW, 2012, WILDLIFE RES, V39, P611, DOI 10.1071/WR11210; Weitzman Murray S, 1970, MEASURES OVERLAP INC; Woinarski JCZ, 2014, ACTION PLAN AUSTR MA	92	36	36	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119303	10.1371/journal.pone.0119303	http://dx.doi.org/10.1371/journal.pone.0119303			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760348	gold, Green Published			2022-12-26	WOS:000351275000053
J	Kinoshita, T; Imamura, R; Kushiyama, H; Suda, T				Kinoshita, Takeshi; Imamura, Ryu; Kushiyama, Hiroko; Suda, Takashi			NLRP3 Mediates NF-kappa B Activation and Cytokine Induction in Microbially Induced and Sterile Inflammation	PLOS ONE			English	Article							INNATE IMMUNE ACTIVATION; NALP3 INFLAMMASOME; TOLL-LIKE; INTERLEUKIN-8 PRODUCTION; ASC; PROTEIN; CRYSTALS; INJURY; HYALURONAN; RECEPTORS	Nucleotide-binding domain and leucine-rich repeat-containing family, pyrin domain containing 3 (NLRP3) has recently emerged as a central regulator of innate immunity and inflammation in response to both sterile inflammatory and microbial invasion signals. Although its ability to drive proteolytic procaspase-1 processing has drawn more attention, NLPR3 can also activate NF-kappa B. To clarify the physiological relevance of this latter function, we examined the effect of NLRP3 on NF-kappa B activation and cytokine induction in RNA-interference-based NLRP3-knock down cell lines generated from the human monocytic cell line THP-1. Knocking down NLRP3 reduced NF-kappa B activation and cytokine induction in the early stages of Staphylococcus aureus infection. Expression of cytokine genes induced by Staphylococcus aureus was not inhibited by a caspase-1 inhibitor, and did not occur through an autocrine mechanism in response to newly synthesized cytokines. We also demonstrated that NLRP3 could activate NF-kappa B and induce cytokines in response to sterile signals, monosodium urate crystals and aluminum adjuvant. Thus, NLRP3 mediates NF-kappa B activation in both sterile and microbially induced inflammation. Our findings show that not only does NLRP3 activate caspase-1 post-translationally, but it also induces multiple cytokine genes in the innate immune system.	[Kinoshita, Takeshi; Imamura, Ryu; Kushiyama, Hiroko; Suda, Takashi] Kanazawa Univ, Canc Res Inst, Div Immunol & Mol Biol, Kanazawa, Ishikawa, Japan	Kanazawa University	Suda, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Immunol & Mol Biol, Kanazawa, Ishikawa, Japan.	sudat@staff.kanazawa-u.ac.jp	KINOSHITA, Takeshi/D-8436-2015		Japan Society for the Promotion of Science [23390092, 23590327]; Japanese government	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese government	This work was supported by Grants-in-Aid for Scientific Research (B) (No. 23390092 to TS) and Grants-in-Aid for Scientific Research (C) (No. 23590327 to TK) from the Japan Society for the Promotion of Science, and the basal research budget for the department of immunology and molecular biology, cancer research institute, Kanazawa University from the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hoffman HM, 2011, J BIOL CHEM, V286, P10889, DOI 10.1074/jbc.R110.135491; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shigeoka AA, 2010, J IMMUNOL, V185, P6277, DOI 10.4049/jimmunol.1002330; Subramanian N, 2013, CELL, V153, P348, DOI 10.1016/j.cell.2013.02.054; Taxman DJ, 2012, J DENT RES, V91, P877, DOI 10.1177/0022034512454541; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Wang W, 2013, J IMMUNOL, V190, P1239, DOI 10.4049/jimmunol.1201959; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yamasaki K, 2009, J BIOL CHEM, V284, P12762, DOI 10.1074/jbc.M806084200; Zuurbier CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040643	43	36	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119179	10.1371/journal.pone.0119179	http://dx.doi.org/10.1371/journal.pone.0119179			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761061	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000050
J	Mansur, S; Ishak, A; Pop, I				Mansur, Syahira; Ishak, Anuar; Pop, Ioan			The Magnetohydrodynamic Stagnation Point Flow of a Nanofluid over a Stretching/Shrinking Sheet with Suction	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; NON-NEWTONIAN NANOFLUID; HEAT-TRANSFER ANALYSIS; THERMAL-RADIATION; PERISTALTIC FLOW; POROUS-MEDIUM; VERTICAL PLATE; VISCOUS-FLOW; FLUID-FLOW; MHD	The magnetohydrodynamic (MHD) stagnation point flow of a nanofluid over a permeable stretching/ shrinking sheet is studied. Numerical results are obtained using boundary value problem solver bvp4c in MATLAB for several values of parameters. The numerical results show that dual solutions exist for the shrinking case, while for the stretching case, the solution is unique. A stability analysis is performed to determine the stability of the dual solutions. For the stable solution, the skin friction is higher in the presence of magnetic field and increases when the suction effect is increased. It is also found that increasing the Brownian motion parameter and the thermophoresis parameter reduces the heat transfer rate at the surface.	[Mansur, Syahira] Univ Tun Hussein Onn Malaysia, Fac Sci Technol & Human Dev, Dept Math & Stat, Batu Pahat, Johor, Malaysia; [Ishak, Anuar] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Math Sci, Ukm Bangi, Selangor, Malaysia; [Pop, Ioan] Univ Babes Bolyai, Dept Math, R-3400 Cluj Napoca, Romania	University of Tun Hussein Onn Malaysia; Universiti Kebangsaan Malaysia; Babes Bolyai University from Cluj	Ishak, A (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Sci Technol & Human Dev, Dept Math & Stat, Batu Pahat, Johor, Malaysia.	anuar_mi@ukm.edu.my	Ishak, Anuar/AAN-1341-2021; Mansur, Syahira/AAH-4368-2021; Ishak, Anuar/F-1093-2010; Pop, Ioan/ABE-6678-2020	Ishak, Anuar/0000-0002-2353-5919; Mansur, Syahira/0000-0003-0057-9035; Ishak, Anuar/0000-0002-2353-5919; Pop, Ioan/0000-0002-0660-6543	Universiti Kebangsaan Malaysia [DIP-2012-31]	Universiti Kebangsaan Malaysia	Funding was provided by Universiti Kebangsaan Malaysia (www.ukm.my); Grant number: DIP-2012-31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14185-0; Akbar NS, 2014, INT J THERM SCI, V85, P54, DOI 10.1016/j.ijthermalsci.2014.06.009; Akbar NS, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14155-6; Andersson HI, 2002, ACTA MECH, V158, P121, DOI 10.1007/BF01463174; [Anonymous], 1995, ENHANCING THERMAL CO; Bachok N, 2012, INT J HEAT MASS TRAN, V55, P2102, DOI 10.1016/j.ijheatmasstransfer.2011.12.013; Bachok N, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-623; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; Bejan A., 2013, CONVECTION HEAT TRAN, V4th, P30; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P302, DOI 10.1016/j.ijheatmasstransfer.2010.09.043; Bhattacharyya K, 2011, INT J HEAT MASS TRAN, V54, P308, DOI 10.1016/j.ijheatmasstransfer.2010.09.041; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Ellahi R, 2013, J POROUS MEDIA, V16, P205, DOI 10.1615/JPorMedia.v16.i3.30; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2012, MATH COMPUT MODEL, V55, P1876, DOI 10.1016/j.mcm.2011.11.043; Fang TG, 2010, COMMUN NONLINEAR SCI, V15, P1831, DOI 10.1016/j.cnsns.2009.07.017; Fischer E.G., 1976, EXTRUSION PLASTICS; GUPTA PS, 1977, CAN J CHEM ENG, V55, P744, DOI 10.1002/cjce.5450550619; Harris SD, 2009, TRANSPORT POROUS MED, V77, P267, DOI 10.1007/s11242-008-9309-6; Ibrahim W, 2013, INT J HEAT MASS TRAN, V56, P1, DOI 10.1016/j.ijheatmasstransfer.2012.08.034; Ishak A, 2014, INT J MECH AEROSPACE, V8, P872; Ishak A, 2009, NONLINEAR ANAL-REAL, V10, P2909, DOI 10.1016/j.nonrwa.2008.09.010; Khan WA, 2011, INT J THERM SCI, V50, P1207, DOI 10.1016/j.ijthermalsci.2011.02.015; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Lok YY, 2011, INT J NUMER METHOD H, V21, P61, DOI 10.1108/09615531111095076; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mandal IC, 2013, AIN SHAMS ENG J, V4, P103, DOI 10.1016/j.asej.2012.06.004; Masuda H., 1993, NETSU BUSSEI, V4, P227, DOI [10.2963/jjtp.7.227, DOI 10.2963/JJTP.7.227]; MERKIN JH, 1986, J ENG MATH, V20, P171, DOI 10.1007/BF00042775; Miklavcic M, 2006, Q APPL MATH, V64, P283, DOI 10.1090/S0033-569X-06-01002-5; Nadeem S, 2014, APPL NANOSCI, V4, P613, DOI 10.1007/s13204-013-0238-5; Nadeem S, 2015, J AEROSPACE ENG, V28, DOI 10.1061/(ASCE)AS.1943-5525.0000299; Nadeem S, 2014, J TAIWAN INST CHEM E, V45, P121, DOI 10.1016/j.jtice.2013.04.006; Nadeem S, 2014, J COMPUT THEOR NANOS, V11, P32, DOI 10.1166/jctn.2014.3313; Nadeem S, 2014, ALEX ENG J, V53, P219, DOI 10.1016/j.aej.2013.11.003; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Saidur R, 2011, RENEW SUST ENERG REV, V15, P1646, DOI 10.1016/j.rser.2010.11.035; Shampine L., 2003, SOLVING ODES MATLAB; Shampine L.F., 2000, TUTORIAL NOTES; Sheikholeslami M, 2014, J COMPUT THEOR NANOS, V11, P486, DOI 10.1166/jctn.2014.3384; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sheikholeslami M, 2014, J MAGN MAGN MATER, V369, P69, DOI 10.1016/j.jmmm.2014.06.017; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Ul Haq R, 2015, PHYSICA E, V65, P17, DOI 10.1016/j.physe.2014.07.013; Ul Haq R, 2014, CENT EUR J PHYS, V12, P862, DOI 10.2478/s11534-014-0522-3; Ul Haq R, 2014, PHYSICA E, V63, P215, DOI 10.1016/j.physe.2014.06.004; Wang CY, 2009, NONLINEAR ANAL-REAL, V10, P375, DOI 10.1016/j.nonrwa.2007.09.013; Wang CY, 2008, INT J NONLIN MECH, V43, P377, DOI 10.1016/j.ijnonlinmec.2007.12.021; Wang CY, 2002, CHEM ENG SCI, V57, P3745, DOI 10.1016/S0009-2509(02)00267-1; Weidman PD, 2006, INT J ENG SCI, V44, P730, DOI 10.1016/j.ijengsci.2006.04.005; Wong KV, 2010, ADV MECH ENG, DOI 10.1155/2010/519659; Yian LY, 2011, SAINS MALAYS, V40, P1179; Zaimi K, 2012, ADV MECH ENG, DOI 10.1155/2012/340354; Zeeshan A, 2014, J COMPUT THEOR NANOS, V11, P646, DOI 10.1166/jctn.2014.3408	58	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0117733	10.1371/journal.pone.0117733	http://dx.doi.org/10.1371/journal.pone.0117733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760733	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000012
J	Radovcic, D; Srsen, AO; Radovcic, J; Frayer, DW				Radovcic, Davorka; Srsen, Ankica Oros; Radovcic, Jakov; Frayer, David W.			Evidence for Neandertal Jewelry: Modified White-Tailed Eagle Claws at Krapina	PLOS ONE			English	Article							MIDDLE STONE-AGE; SHELL BEADS; CAVE; ART	We describe eight, mostly complete white-tailed eagle (Haliaetus [Haliaeetus] albicilla) talons from the Krapina Neandertal site in present-day Croatia, dating to approximately 130 kyrs ago. Four talons bear multiple, edge-smoothed cut marks; eight show polishing facets and/or abrasion. Three of the largest talons have small notches at roughly the same place along the plantar surface, interrupting the proximal margin of the talon blade. These features suggest they were part of a jewelry assemblage,- the manipulations a consequence of mounting the talons in a necklace or bracelet. An associated phalanx articulates with one of the talons and has numerous cut marks, some of which are smoothed. These white-tailed eagle bones, discovered more than 100 years ago, all derive from a single level at Krapina and represent more talons than found in the entire European Mousterian period. Presence of eight talons indicates that the Krapina Neandertals acquired and curated eagle talons for some kind of symbolic purpose. Some have argued that Neandertals lacked symbolic ability or copied this behavior from modern humans. These remains clearly show that the Krapina Neandertals made jewelry well before the appearance of modern humans in Europe, extending ornament production and symbolic activity early into the European Mousterian.	[Radovcic, Davorka; Radovcic, Jakov] Croatian Nat Hist Museum, Dept Geol & Paleontol, Zagreb 10000, Croatia; [Srsen, Ankica Oros] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, Zagreb 10000, Croatia; [Frayer, David W.] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA	Croatian Academy of Sciences & Arts; University of Kansas	Frayer, DW (corresponding author), Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA.	frayer@ku.edu	Oros Sršen, Ankica/GLT-5976-2022					BEDNARIK RG, 1995, CURR ANTHROPOL, V36, P605, DOI 10.1086/204406; BEDNARIK RG, 1994, ANTHROPOS, V89, P169; Blasco R, 2014, SCI REP-UK, V4, DOI 10.1038/srep05971; Blasco R, 2009, J ARCHAEOL SCI, V36, P2213, DOI 10.1016/j.jas.2009.06.006; Carciumaru M, 2002, ANTIQUITY, V76, P681, DOI 10.1017/S0003598X00091122; Carciumaru M., 2009, ANN U VALAHIA TARGOV, VXI, P7; CHASE PG, 1987, J ANTHROPOL ARCHAEOL, V6, P263, DOI 10.1016/0278-4165(87)90003-1; Dominguez-Rodrigo M, 2009, J ARCHAEOL SCI, V36, P2643, DOI 10.1016/j.jas.2009.07.017; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fiore I, 2004, INT J OSTEOARCHAEOL, V14, P273, DOI 10.1002/oa.761; Gavris G.G., 2012, BIRDS PREY DYNAMIC E, P7; GAVRIS GG, 2004, MIDDLE PALEOLITHIC E, V104, P79; Gorjanovi-Kramberger D, 1901, MITT ANTHRO GESELL W, V31, P164; Gorjanovic-Kramberger D., 1906, STUDIEN ENTWICKLUNGS, VII, P9; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Klein R., 2009, HUMAN CAREER; Lambrecht, 1933, HDB PALAEORNITHOLOGI; Lambrecht K, 1915, BARLANGKUTATAS, V3, P116; Malez M., 1989, Geoloski Vjesnik (Zagreb), V42, P49; Malez M, 1988, RAD JUG AKAD ZNAN UM, V441, P115; Miracle P.T, 2007, KRAPINA PALEOLITHIC; Miracle P.T, 2011, FRAGMENTS ICE ENV, V21, P85; Moncel MH, 2012, ARCHAEOL ETHNOL ANTH, V40, P24, DOI 10.1016/j.aeae.2012.05.004; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Peresani M., PNAS, V108, P3888; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Radov~ci J., 1988, KRAPINA HOMINIDS ILL; Radovcic J, 1988, DRAGUTIN GORJANOVIC; Radovic A, 2009, BIOLOGIA, V64, P156, DOI 10.2478/s11756-009-0011-0; RINK WJ, 1995, NATURE, V378, P24, DOI 10.1038/378024a0; Rodriguez-Vidal J, 2014, P NATL ACAD SCI USA, V111, P13301, DOI 10.1073/pnas.1411529111; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Romandini M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101278; Serjeantson D, 2009, CAMB MAN ARCHAEOL, P1; Simek JF, 1997, J HUM EVOL, V32, P561, DOI 10.1006/jhev.1996.0129; Soressi M., 2007, NEANDERTALIENS BIOL, V23, P297, DOI DOI 10.1183/09031936.00022909; Tattersall I., 2013, MASTERS PLANET; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Wilson GL, 1928, ANTH PAPERS AM MUS N, V30, P98; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	44	110	112	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119802	10.1371/journal.pone.0119802	http://dx.doi.org/10.1371/journal.pone.0119802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CD7MQ	25760648	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000066
J	Serratos, IN; Castellanos, P; Pastor, N; Millan-Pacheco, C; Rembao, D; Perez-Montfort, R; Cabrera, N; Reyes-Espinosa, F; Diaz-Garrido, P; Lopez-Macay, A; Martinez-Flores, K; Lopez-Reyes, A; Sanchez-Garcia, A; Cuevas, E; Santamaria, A				Serratos, Iris N.; Castellanos, Pilar; Pastor, Nina; Millan-Pacheco, Cesar; Rembao, Daniel; Perez-Montfort, Ruy; Cabrera, Nallely; Reyes-Espinosa, Francisco; Diaz-Garrido, Paulina; Lopez-Macay, Ambar; Martinez-Flores, Karina; Lopez-Reyes, Alberto; Sanchez-Garcia, Aurora; Cuevas, Elvis; Santamaria, Abel			Modeling the Interaction between Quinolinate and the Receptor for Advanced Glycation End Products (RAGE): Relevance for Early Neuropathological Processes	PLOS ONE			English	Article							ACID-INDUCED NEUROTOXICITY; ENDPRODUCTS RAGE; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; RAT-BRAIN; ACTIVATION; EXCITOTOXICITY; RECOGNITION; ANTIOXIDANT; NEURODEGENERATION	The receptor for advanced glycation end products (RAGE) is a pattern-recognition receptor involved in neurodegenerative and inflammatory disorders. RAGE induces cellular signaling upon binding to a variety of ligands. Evidence suggests that RAGE up-regulation is involved in quinolinate (QUIN)-induced toxicity. We investigated the QUIN-induced toxic events associated with early noxious responses, which might be linked to signaling cascades leading to cell death. The extent of early cellular damage caused by this receptor in the rat striatum was characterized by image processing methods. To document the direct interaction between QUIN and RAGE, we determined the binding constant (K-b) of RAGE (VC1 domain) with QUIN through a fluorescence assay. We modeled possible binding sites of QUIN to the VC1 domain for both rat and human RAGE. QUIN was found to bind at multiple sites to the VC1 dimer, each leading to particular mechanistic scenarios for the signaling evoked by QUIN binding, some of which directly alter RAGE oligomerization. This work contributes to the understanding of the phenomenon of RAGE-QUIN recognition, leading to the modulation of RAGE function.	[Serratos, Iris N.; Reyes-Espinosa, Francisco] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico; [Serratos, Iris N.; Diaz-Garrido, Paulina; Santamaria, Abel] SSA, Manuel Velasco Suarez, Inst Nacl Neurol & Neurocirugia, Lab Aminocidos Excitadores, Mexico City, DF, Mexico; [Castellanos, Pilar] Univ Autonoma Metropolitana Iztapalapa, Dept Ingn Elect, Mexico City 09340, DF, Mexico; [Pastor, Nina] Univ Autonoma Estado Morelos, Fac Ciencias, Cuernavaca, Morelos, Mexico; [Millan-Pacheco, Cesar] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Cuernavaca 62191, Morelos, Mexico; [Rembao, Daniel; Sanchez-Garcia, Aurora] Inst Nacl Neurol & Neurocirug, Neuropatol, Manuel Velasco Suarez, Mexico City 09340, DF, Mexico; [Perez-Montfort, Ruy; Cabrera, Nallely] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim & Biol Estruct, Mexico City 04510, DF, Mexico; [Lopez-Macay, Ambar; Martinez-Flores, Karina; Lopez-Reyes, Alberto] SSA, Inst Nacl Rehabil, Lab Liquido Sinovial, Mexico City, DF, Mexico; [Cuevas, Elvis] Natl Ctr Toxicol Research, FDA, Div Neurotoxicol, Neurochem Lab, Jefferson, AR USA	Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma Metropolitana - Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; US Food & Drug Administration (FDA)	Serratos, IN (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Mexico City 09340, DF, Mexico.	natzielly@gmail.com; absada@yahoo.com	Espinosa, Francisco Reyes/D-8113-2019; Serratos, Iris N./E-4530-2018; Millan-Pacheco, Cesar/I-4030-2016; Macay, ambar Lopez/ABH-9850-2020; Pastor, Nina/W-4452-2019	Espinosa, Francisco Reyes/0000-0003-0727-8251; Serratos, Iris N./0000-0002-8352-2423; Millan-Pacheco, Cesar/0000-0001-5180-6504; Pastor, Nina/0000-0001-7755-2936; Diaz-Garrido, Paulina/0000-0002-3885-0487; Lopez-Reyes, Alberto/0000-0002-2575-2589; Perez-Montfort, Ruy/0000-0003-0810-1159; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996; Martinez-Flores, Karina/0000-0003-0675-0227; Santamaria, Abel/0000-0002-9874-7182; Lopez Macay, Ambar/0000-0002-2916-7424	Consejo Nacional de Ciencia y Tecnologia [168692]; Secretaria de Educacion Publica [12412137]; No code Committe for Aid and Education in Neurochemistry	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica; No code Committe for Aid and Education in Neurochemistry	The work was supported by the following: 168692 Consejo Nacional de Ciencia y Tecnologia http://www.conacyt.gob.mx/pci/index.php/component/users/?task = user.login INS; 12412137 Secretaria de Educacion Publica http://promep.sep.gob.mx/solicitudesv3 INS; and No code Committe for Aid and Education in Neurochemistry http://neurochemistry.org/funding/committee-for-aid-and-education-in-neurochemistry-caen.html INS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello Z, 2010, BIOCHEMISTRY-US, V49, P1388, DOI 10.1021/bi9018225; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Borgonovo J, 2009, J NEURAL TRANSM, V116, P1201, DOI 10.1007/s00702-009-0262-5; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chaney MO, 2005, BBA-MOL BASIS DIS, V1741, P199, DOI 10.1016/j.bbadis.2005.03.014; Chen RC, 2014, MOL CELL BIOCHEM, V390, P271, DOI 10.1007/s11010-014-1978-6; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cuevas E, 2010, NEUROSCI LETT, V474, P74, DOI 10.1016/j.neulet.2010.03.007; Pasquali MAD, 2013, CELL SIGNAL, V25, P939, DOI 10.1016/j.cellsig.2013.01.013; Essa MM, 2013, NEUROTOX RES, V23, P393, DOI 10.1007/s12640-012-9354-3; Feng QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091512; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Gonzalez R. C., 2018, DIGITAL IMAGE PROCES, V4th, P119; Gonzalez-Mondragon E, 2004, BIOCHEMISTRY-US, V43, P3255, DOI 10.1021/bi036077s; Gospodarska E, 2011, BBA-PROTEINS PROTEOM, V1814, P592, DOI 10.1016/j.bbapap.2011.02.011; Grimsley G.R., 2004, CURR PROTOC PROTEIN; Haas SJP, 2004, J ANAT, V204, P271, DOI 10.1111/j.0021-8782.2004.00279.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kang R, 2014, ONCOGENE, V33, P567, DOI 10.1038/onc.2012.631; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leclerc Estelle, 2010, Cardiovasc Psychiatry Neurol, V2010, P539581, DOI 10.1155/2010/539581; Lee D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069669; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Malik SS, 2014, PROTEINS, V82, P405, DOI 10.1002/prot.24406; MATLAB, 2019, MATLAB VERS 9 10 0 1; Mueller GA, 2013, ALLERGY, V68, P1546, DOI 10.1111/all.12261; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Olney JW, 1990, CAN DIS WKLY REP, V16, P57; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Paxinos G., 2007, THE RAT BRAIN IN STE; Perez-De La Cruz V, 2012, INT J TRYPTOPHAN RES, V5, P1, DOI 10.4137/IJTR.S8158; Perez-Severiano F, 2004, NEUROCHEM INT, V45, P1175, DOI 10.1016/j.neuint.2004.06.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rai V, 2012, J BIOL CHEM, V287, P5133, DOI 10.1074/jbc.M111.277731; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reverdatto S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065180; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SANCHEZPOZO A, 1982, ANAL BIOCHEM, V127, P159, DOI 10.1016/0003-2697(82)90159-2; Santamaria A, 2003, J NEUROCHEM, V86, P479, DOI 10.1046/j.1471-4159.2003.01857.x; SCHWARCZ R, 1984, LIFE SCI, V35, P19, DOI 10.1016/0024-3205(84)90148-6; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Serratos IN, 2011, J MOL BIOL, V405, P158, DOI 10.1016/j.jmb.2010.10.018; Silva-Adaya D, 2008, J NEUROCHEM, V105, P677, DOI 10.1111/j.1471-4159.2007.05174.x; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Sitkiewicz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076353; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stone TW, 2003, CLIN CHEM LAB MED, V41, P852, DOI 10.1515/CCLM.2003.129; Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005; Tenorio-Lopez FA, 2007, CHROMATOGRAPHIA, V65, P725, DOI 10.1365/s10337-007-0241-7; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Todorova J, 2012, ONCOL LETT, V3, P214, DOI 10.3892/ol.2011.459; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Velazquez-Campoy A, 2004, CURR PROTOC CELL BIO; Vicente Miranda H, 2010, J PATHOL, V221, P13, DOI 10.1002/path.2682; Wilton R, 2006, PROTEIN EXPRES PURIF, V47, P25, DOI 10.1016/j.pep.2006.01.008; Xu D, 2013, ACS CHEM BIOL, V8, P1611, DOI 10.1021/cb4001553; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yan SF, 2009, ANN MED, V41, P408, DOI 10.1080/07853890902806576; Yang WI, 2014, CIRC J, V78, P1197, DOI 10.1253/circj.CJ-13-1235; Yatime L, 2014, J EXP MED, V211, P749, DOI 10.1084/jem.20132526; Yatime L, 2013, FEBS J, V280, P6556, DOI 10.1111/febs.12556; Zadori D, 2012, J NEUROL SCI, V322, P187, DOI 10.1016/j.jns.2012.06.004; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	75	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120221	10.1371/journal.pone.0120221	http://dx.doi.org/10.1371/journal.pone.0120221			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757085	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700062
J	Shen, CJ; Xu, HB; Alvarez, X; Lackner, AA; Veazey, RS; Wang, XL				Shen, Chanjuan; Xu, Huanbin; Alvarez, Xavier; Lackner, Andrew A.; Veazey, Ronald S.; Wang, Xiaolei			Reduced Expression of CD27 by Collagenase Treatment: Implications for Interpreting B Cell Data in Tissues	PLOS ONE			English	Article							CD4(+) T-CELLS; GASTROINTESTINAL-TRACT; PERIPHERAL-BLOOD; RHESUS MACAQUE; SIV INFECTION; IN-VIVO; MEMORY; DEPLETION; RESPONSES; IGA	Surface markers have been used to identify distinct cell subpopulations and to delineate various stages of maturation or activation of lymphocytes. In particular CD27 is used for delineation of naive and memory B cell populations, and is readily detected by flow cytometry. We here used flow cytometry to examine the expression of CD27 on lymphocytes isolated from various tissues of rhesus macaques, and found its expression was consistently low to absent on intestinal cell suspensions. However, immunohistochemistry revealed abundant CD27+ cells in intestinal tissue sections. Further investigation showed the marked loss of CD27 expression on processed intestinal cells was due to collagenase digestion of intestinal tissues, yet CD27 expression was recoverable within hours of cell isolation. By combining confocal microscopy, we confirmed that only a fraction of B cells express CD27, in contrast to expression on all T cells from tissues examined including the gut. Taken together, our results suggest that CD27 may be a memory marker for B cells, but not for T cells, since essentially all CD3 T cells expressed CD27. In summary, it is important to consider the influence of isolation procedures on cell surface expression of phenotypic markers, especially when examining tissue-resident lymphocytes by flow cytometry.	[Shen, Chanjuan; Xu, Huanbin; Alvarez, Xavier; Lackner, Andrew A.; Veazey, Ronald S.; Wang, Xiaolei] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA	Tulane University	Wang, XL (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA.	xwang@tulane.edu	Xu, Huanbin/S-4870-2019		NIH [AI099795, AI084793]; National Center for Research Resources; Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health [OD011104-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099795, R01AI084793] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104, S10OD019964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by NIH grants AI099795 (XW), AI084793 (RSV), and the National Center for Research Resources and the Office of Research Infrastructure Programs (ORIP) of the National Institutes of Health through grant no. OD011104-51. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Agematsu K, 2000, HISTOL HISTOPATHOL, V15, P573, DOI 10.14670/HH-15.573; Arens R, 2001, IMMUNITY, V15, P801, DOI 10.1016/S1074-7613(01)00236-9; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Chen Z, 2014, J IMMUNOL METHODS; Das A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016524; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; HINTZEN RQ, 1995, J IMMUNOL, V154, P2612; Kaul R, 1999, AIDS, V13, P23, DOI 10.1097/00002030-199901140-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mazzoli S, 1999, J INFECT DIS, V180, P871, DOI 10.1086/314934; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Nagumo H, 1998, J IMMUNOL, V161, P6496; Raman VS, 2003, J IMMUNOL, V171, P5876, DOI 10.4049/jimmunol.171.11.5876; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087; Thomas MA, 2014, VACCINE, V32, P872, DOI 10.1016/j.vaccine.2013.12.014; Titanji K, 2010, J CLIN INVEST, V120, P3878, DOI 10.1172/JCI43271; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Veazey RS, 2000, J VIROL, V74, P11001, DOI 10.1128/JVI.74.23.11001-11007.2000; Wang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027207; Xiao YL, 2004, J IMMUNOL, V172, P7432, DOI 10.4049/jimmunol.172.12.7432; Xu HB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00085	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0116667	10.1371/journal.pone.0116667	http://dx.doi.org/10.1371/journal.pone.0116667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756877	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700010
J	Francy, CA; Alvarez, FJD; Zhou, L; Ramachandran, R; Mears, JA				Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Ramachandran, Rajesh; Mears, Jason A.			The Mechanoenzymatic Core of Dynamin-related Protein 1 Comprises the Minimal Machinery Required for Membrane Constriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; GTPASE DRP1; DIVISION; DOMAIN; PHOSPHORYLATION; MORPHOLOGY; APOPTOSIS; FUSION; DNM1; INHIBITION	Mitochondria are dynamic organelles that continually undergo cycles of fission and fusion. Dynamin-related protein 1 (Drp1), a large GTPase of the dynamin superfamily, is the main mediator of mitochondrial fission. Like prototypical dynamin, Drp1 is composed of a mechanochemical core consisting of the GTPase, middle, and GTPase effector domain regions. In place of the pleckstrin homology domain in dynamin, however, Drp1 contains an unstructured variable domain, whose function is not yet fully resolved. Here, using time-resolved EM and rigorous statistical analyses, we establish the ability of full-length Drp1 to constrict lipid bilayers through a GTP hydrolysis-dependent mechanism. We also show the variable domain limits premature Drp1 assembly in solution and promotes membrane curvature. Furthermore, the mechanochemical core of Drp1, absent of the variable domain, is sufficient to mediate GTP hydrolysis-dependent membrane constriction.	[Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Francy, Christopher A.; Alvarez, Frances J. D.; Zhou, Louie; Ramachandran, Rajesh; Mears, Jason A.] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Ramachandran, Rajesh] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Mears, JA (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	jason.mears@case.edu	Regan, Clinton/E-6250-2012; Ramachandran, Rajesh/A-1337-2011	Ramachandran, Rajesh/0000-0002-4645-2841; Mears, Jason/0000-0002-5199-4872; Alvarez, Frances/0000-0001-9742-6064	National Institutes of Health [2T32GM008803-11A1]; American Heart Association [SDG12SDG9130039, 13BGIA14810010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 2T32GM008803-11A1 (to C. A. F.). This work was also supported by American Heart Association Grants SDG12SDG9130039 (to J. A. M.) and 13BGIA14810010 (to R. R.).	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bustillo-Zabalbeitia I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102738; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Herzig S, 2008, CURR MOL MED, V8, P131, DOI 10.2174/156652408783769625; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lackner LL, 2010, CHEM BIOL, V17, P578, DOI 10.1016/j.chembiol.2010.05.016; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Mears JA, 2008, METHOD CELL BIOL, V88, P237, DOI 10.1016/S0091-679X(08)00413-5; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Strack S, 2012, J BIOL CHEM, V287, P10990, DOI 10.1074/jbc.M112.342105; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang YF, 2011, J BIOCHEM, V150, P627, DOI 10.1093/jb/mvr102; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	53	65	65	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11692	11703		10.1074/jbc.M114.610881	http://dx.doi.org/10.1074/jbc.M114.610881			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25770210	hybrid, Green Published			2022-12-26	WOS:000353719400042
J	Lewinski, MK; Jafari, M; Zhang, H; Opella, SJ; Guatelli, J				Lewinski, Mary K.; Jafari, Moein; Zhang, Hua; Opella, Stanley J.; Guatelli, John			Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR; CELL-SURFACE; TRANSMEMBRANE DOMAIN; PARTICLE RELEASE; VIRION RELEASE; PROTEIN VPU; TETHERIN; BST-2/TETHERIN; MICRODOMAINS; DEGRADATION	The restriction factor BST2 (tetherin) prevents the release of enveloped viruses from the host cell and is counteracted by HIV-1 Vpu. Vpu and BST2 interact directly via their transmembrane domains. This interaction enables Vpu to induce the surface down-regulation and the degradation of BST2, but neither of these activities fully accounts for the ability of Vpu to enhance virion release. During a study of naturally occurring Vpu proteins, we found that a tryptophan residue near the Vpu C terminus is particularly important for enhancing virion release. Vpu proteins with a W76G polymorphism degraded and down-regulated BST2 from the cell surface, yet they inefficiently stimulated virion release. Here we explore the mechanism of this anomaly. We find that Trp-76 is critical for the ability of Vpu to displace BST2 from sites of viral assembly in the plane of the plasma membrane. This effect does not appear to involve a general reorganization of the membrane microdomains associated with virion assembly, but rather is a specific effect of Vpu on BST2. Using NMR spectroscopy, we find that the cytoplasmic domain of Vpu and Trp-76 specifically interact with lipids. Moreover, paramagnetic relaxation enhancement studies show that Trp-76 inserts into the lipid. These data are consistent with a model whereby Trp-76 anchors the C terminus of the cytoplasmic tail of Vpu to the plasma membrane, enabling the movement of Vpu-bound BST2 away from viral assembly sites.	[Lewinski, Mary K.; Jafari, Moein; Guatelli, John] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Zhang, Hua; Opella, Stanley J.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Lewinski, Mary K.; Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Opella, SJ (corresponding author), Nat Sci Bldg,Rm 3121,9500 Gilman Dr,MC 307, La Jolla, CA 92093 USA.	sopella@ucsd.edu; jguatelli@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R21AI114397, R37AI081668, P41EB002031, RO1EB005161, RO1GM099986, RO1GM066978, T32 AI007384]; James B. Pendleton Charitable Trust; University of California, San Diego, Center for AIDS Research (CFAR); NIH [P30 AI036214]; NIAID; NCI; NIMH; NIDA; NICHD; NHLBI; NIA; NIGMS; NIDDK; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007384, R37AI081668, P30AI036214, R21AI114397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005161, P41EB002031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099986, R01GM066978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; University of California, San Diego, Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI114397 (to J. G. and M. K. L.), R37AI081668 (to J. G.), and P41EB002031, RO1EB005161, RO1GM099986, and RO1GM066978 (to S. J. O.), The James B. Pendleton Charitable Trust and the University of California, San Diego, Center for AIDS Research (CFAR), NIH funded program Grant P30 AI036214, which is supported by the NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, and NIDDK.; Supported in part by National Institutes of Health Training Grant T32 AI007384.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Bour S, 1999, J BIOL CHEM, V274, P33800, DOI 10.1074/jbc.274.47.33800; Campos B, 1998, BIOCHEMISTRY-US, V37, P8004, DOI 10.1021/bi973142n; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jafari M, 2014, J VIROL, V88, P5062, DOI 10.1128/JVI.03472-13; Janvier K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001265; Jia XF, 2014, ELIFE, V3, DOI 10.7554/eLife.02362; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kobayashi T, 2011, J VIROL, V85, P932, DOI 10.1128/JVI.01668-10; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Kuhl A, 2011, J INFECT DIS, V204, pS850, DOI 10.1093/infdis/jir378; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lau D, 2011, J VIROL, V85, P9834, DOI 10.1128/JVI.02633-10; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; McNatt MW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003299; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petit SJ, 2011, J GEN VIROL, V92, P2937, DOI 10.1099/vir.0.035931-0; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Skasko M, 2012, J BIOL CHEM, V287, P58, DOI 10.1074/jbc.M111.296772; Thali M, 2011, BIOCHEM SOC T, V39, P529, DOI 10.1042/BST0390529; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Wittlich M, 2009, FEBS J, V276, P6560, DOI 10.1111/j.1742-4658.2009.07363.x	45	29	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10919	10933		10.1074/jbc.M114.630095	http://dx.doi.org/10.1074/jbc.M114.630095			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759385	Green Published, hybrid			2022-12-26	WOS:000353404500030
J	Lugenbiel, P; Wenz, F; Govorov, K; Schweizer, PA; Katus, HA; Thomas, D				Lugenbiel, Patrick; Wenz, Fabian; Govorov, Katharina; Schweizer, Patrick A.; Katus, Hugo A.; Thomas, Dierk			Atrial Fibrillation Complicated by Heart Failure Induces Distinct Remodeling of Calcium Cycling Proteins	PLOS ONE			English	Article							TACHYCARDIA; CONTRACTILE; DYSFUNCTION; MECHANISMS; MODEL; ARRHYTHMOGENESIS; SUPPRESSION; CHANNELS; DOGS	Atrial fibrillation (AF) and heart failure (HF) are two of the most common cardiovascular diseases. They often coexist and account for significant morbidity and mortality. Alterations in cellular Ca2+ homeostasis play a critical role in AF initiation and maintenance. This study was designed to specifically elucidate AF-associated remodeling of atrial Ca2+ cycling in the presence of mild HF. AF was induced in domestic pigs by atrial burst pacing. The animals underwent electrophysiologic and echocardiographic examinations. Ca2+ handling proteins were analyzed in right atrial tissue obtained from pigs with AF (day 7; n = 5) and compared to sinus rhythm (SR) controls (n = 5). During AF, animals exhibited reduction of left ventricular ejection fraction (from 73% to 58%) and prolonged atrial refractory periods. AF and HF were associated with suppression of protein kinase A (PKA)R-II (-62%) and Ca2+-calmodulin-dependent kinase II (CaMKII) delta by 37%, without changes in CaMKII delta autophosphorylation. We further detected downregulation of L-type calcium channel (LTCC) subunit alpha(2) (-75%), sarcoplasmic reticulum Ca2+-ATPase (Serca) 2a (-29%), phosphorylated phospholamban (Ser16, -92%; Thr17, -70%), and phospho-ryanodine receptor 2 (RyR2) (Ser2808, -62%). Na+-Ca2+ exchanger (NCX) levels were upregulated (+ 473%), whereas expression of Ser2814-phosphorylated RyR2 and LTCCa1c subunits was not significantly altered. In conclusion, AF produced distinct arrhythmogenic remodeling of Ca2+ handling in the presence of tachycardia-induced mild HF that is different from AF without structural alterations. The changes may provide a starting point for personalized approaches to AF treatment.	[Lugenbiel, Patrick; Wenz, Fabian; Govorov, Katharina; Schweizer, Patrick A.; Katus, Hugo A.; Thomas, Dierk] Med Univ Hosp, Dept Cardiol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thomas, D (corresponding author), Med Univ Hosp, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.	dierk.thomas@med.uni-heidelberg.de	Thomas, Dierk/ABA-4706-2021; Thomas, Dierk/V-3940-2017	Thomas, Dierk/0000-0002-5687-7843; 	University of Heidelberg, Faculty of Medicine; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation; Cardiology Career Program of the Department of Cardiology, University of Heidelberg	University of Heidelberg, Faculty of Medicine; DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); German Cardiac Society; Hengstberger Foundation; Joachim Siebeneicher Foundation; Cardiology Career Program of the Department of Cardiology, University of Heidelberg	This study was supported in part by research grants from the University of Heidelberg, Faculty of Medicine (Postdoc Fellowship to P.L.), from the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung-German Centre for Cardiovascular Research) and from the BMBF (German Ministry of Education and Research) (to H.A.K. and D.T.), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D.T.), and from the Joachim Siebeneicher Foundation (to D.T.). F.W. was supported by the Cardiology Career Program of the Department of Cardiology, University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Bauer A, 2004, CARDIOVASC RES, V61, P764, DOI 10.1016/j.cardiores.2003.12.013; Bikou O, 2011, CARDIOVASC RES, V92, P218, DOI 10.1093/cvr/cvr209; Cha TJ, 2004, CIRCULATION, V110, P1520, DOI 10.1161/01.CIR.0000142052.03565.87; Dobrev D, 2010, N-S ARCH PHARMACOL, V381, P195, DOI 10.1007/s00210-009-0457-1; Duhme N, 2013, EUR HEART J, V34, P2768, DOI 10.1093/eurheartj/ehs391; Elvan A, 1996, CIRCULATION, V94, P2953, DOI 10.1161/01.CIR.94.11.2953; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Greiser M, 2009, J MOL CELL CARDIOL, V46, P385, DOI 10.1016/j.yjmcc.2008.11.012; Heijman J, 2014, CIRC RES, V114, P1483, DOI 10.1161/CIRCRESAHA.114.302226; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Joung B, 2010, HEART RHYTHM, V7, P88, DOI 10.1016/j.hrthm.2009.09.018; Kato T, 2004, CIRC J, V68, P568, DOI 10.1253/circj.68.568; Kerr CR, 2005, AM HEART J, V149, P489, DOI 10.1016/j.ahj.2004.09.053; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Lugenbiel P, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000372; Lugenbiel P, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0265-5; Nattel S, 2005, PROG CARDIOVASC DIS, V48, P9, DOI 10.1016/j.pcad.2005.06.002; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Schmidt C, 2014, HEART RHYTHM, V11, P1798, DOI 10.1016/j.hrthm.2014.06.020; Schmidt C, 2014, LIFE SCI, V97, P107, DOI 10.1016/j.lfs.2013.12.006; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Schweizer PA, 2014, J AM COLL CARDIOL, V64, P757, DOI 10.1016/j.jacc.2014.06.1155; Soucek R, 2012, HEART RHYTHM, V9, P265, DOI 10.1016/j.hrthm.2011.09.008; Stambler BS, 2008, CIRC-ARRHYTHMIA ELEC, V1, P77, DOI 10.1161/CIRCEP.108.785071; Stambler BS, 2004, J CARDIOVASC ELECTR, V15, P933, DOI 10.1046/j.1540-8167.2004.04336.x; Trappe K, 2013, EUR HEART J, V34, P147, DOI 10.1093/eurheartj/ehr269; Voigt N, 2014, CIRCULATION, V129, P145, DOI 10.1161/CIRCULATIONAHA.113.006641; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P530, DOI 10.1161/CIRCEP.109.933036; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Yue LX, 1997, CIRC RES, V81, P512, DOI 10.1161/01.RES.81.4.512	34	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116395	10.1371/journal.pone.0116395	http://dx.doi.org/10.1371/journal.pone.0116395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775120	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500008
J	Panneerselvam, J; Jin, JK; Shanker, M; Lauderdale, J; Bates, J; Wang, Q; Zhao, YD; Archibald, SJ; Hubin, TJ; Ramesh, R				Panneerselvam, Janani; Jin, Jiankang; Shanker, Manish; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Zhao, Yan D.; Archibald, Stephen J.; Hubin, Timothy J.; Ramesh, Rajagopal			IL-24 Inhibits Lung Cancer Cell Migration and Invasion by Disrupting The SDF-1/CXCR4 Signaling Axis	PLOS ONE			English	Article							DIFFERENTIATION-ASSOCIATED GENE-7; CHEMOKINE RECEPTOR; TUMOR-GROWTH; CXCR4 ANTAGONIST; EXPRESSION; METASTASIS; MDA-7/IL-24; MDA-7; KINASES; PATHWAY	Background The stromal cell derived factor (SDF)-1/chemokine receptor (CXCR)-4 signaling pathway plays a key role in lung cancer metastasis and is molecular target for therapy. In the present study we investigated whether interleukin (IL)-24 can inhibit the SDF-1/CXCR4 axis and suppress lung cancer cell migration and invasion in vitro. Further, the efficacy of IL-24 in combination with CXCR4 antagonists was investigated. Methods Human H1299, A549, H460 and HCC827 lung cancer cell lines were used in the present study. The H1299 lung cancer cell line was stably transfected with doxycycline-inducible plasmid expression vector carrying the human IL-24 cDNA and used in the present study to determine the inhibitory effects of IL-24 on SDF-1/CXCR4 axis. H1299 and A549 cell lines were used in transient transfection studies. The inhibitory effects of IL-24 on SDF1/CXCR4 and its downstream targets were analyzed by quantitative RT-PCR, western blot, luciferase reporter assay, flow cytometry and immunocytochemistry. Functional studies included cell migration and invasion assays. Principal Findings Endogenous CXCR4 protein expression levels varied among the four human lung cancer cell lines. Doxycycline-induced IL-24 expression in the H1299-IL24 cell line resulted in reduced CXCR4 mRNA and protein expression. IL-24 post-transcriptionally regulated CXCR4 mRNA expression by decreasing the half-life of CXCR4 mRNA (>40%). Functional studies showed IL-24 inhibited tumor cell migration and invasion concomitant with reduction in CXCR4 and its downstream targets (pAKT(S473), pmTOR(S2448), pPRAS40(T246) and HIF-1 alpha). Additionally, IL-24 inhibited tumor cell migration both in the presence and absence of the CXCR4 agonist, SDF-1. Finally, IL-24 when combined with CXCR4 inhibitors (AMD3100, SJA5) or with CXCR4 siRNA demonstrated enhanced inhibitory activity on tumor cell migration. Conclusions IL-24 disrupts the SDF-1/CXCR4 signaling pathway and inhibits lung tumor cell migration and invasion. Additionally, IL-24, when combined with CXCR4 inhibitors exhibited enhanced anti-metastatic activity and is an attractive therapeutic strategy for lung metastasis.	[Panneerselvam, Janani; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Zhao, Yan D.; Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA; [Panneerselvam, Janani; Lauderdale, Jason; Bates, Jonathan; Wang, Qi; Hubin, Timothy J.; Ramesh, Rajagopal] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA; [Shanker, Manish] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Zhao, Yan D.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Archibald, Stephen J.] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Hubin, Timothy J.] Southwestern Oklahoma State Univ, Dept Chem, Weatherford, OK USA; [Ramesh, Rajagopal] Grad Program Biomed Sci, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Hull	Ramesh, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73106 USA.	rajagopal-ramesh@ouhsc.edu	Archibald, Steve/I-8723-2012; Hubin, Timothy J/A-9399-2009	Archibald, Steve/0000-0001-7581-8817; Hubin, Timothy J/0000-0003-2277-1191	Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics; Experimental Therapeutics Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20 GM103639]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103639] Funding Source: NIH RePORTER	Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics; Experimental Therapeutics Program; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by funds received from the Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics (RR); seed grant from the Experimental Therapeutics Program (TJH, RR). The authors thank the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, OK and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20 GM103639 for the use of Cancer Functional Genomic Core, which provided real-time PCR service. Assistance received from the molecular imaging core facility for conducting flow cytometric studies is appreciated. RR is an Oklahoma TSET Research Scholar and holds the Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2013, TRANSL ONCOL, V6, P660, DOI 10.1593/tlo.13559; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Chu HY, 2007, INT J BIOCHEM CELL B, V39, P197, DOI 10.1016/j.biocel.2006.07.008; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; D'Alterio C, 2012, CANCER IMMUNOL IMMUN, V61, P1713, DOI 10.1007/s00262-012-1223-7; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; FIFE RS, 1995, J LAB CLIN MED, V125, P407; Florio T, 2006, MOL PHARMACOL, V69, P539, DOI 10.1124/mol.105.015255; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Furusato B, 2010, PATHOL INT, V60, P497, DOI 10.1111/j.1440-1827.2010.02548.x; Ierano C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.269; Inoue S, 2006, CURR GENE THER, V6, P73, DOI 10.2174/156652306775515574; Ishikawa S, 2005, CLIN CANCER RES, V11, P1198; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khan A, 2009, J AM CHEM SOC, V131, P3416, DOI 10.1021/ja807921k; Koizumi K, 2007, CANCER SCI, V98, P1652, DOI 10.1111/j.1349-7006.2007.00606.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lam WK, 2007, RESPIROLOGY, V12, P471, DOI 10.1111/j.1440-1843.2007.01105.x; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu L, 2013, CANCER EPIDEMIOL, V37, P71, DOI 10.1016/j.canep.2012.08.005; Mhashilkar AM, 2001, MOL MED, V7, P271, DOI 10.1007/BF03401847; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Minamiya Y, 2010, LUNG CANCER, V68, P466, DOI 10.1016/j.lungcan.2009.07.015; Monterrubio M, 2009, BIOCHEM BIOPH RES CO, V388, P199, DOI 10.1016/j.bbrc.2009.07.153; Na IK, 2008, HUM PATHOL, V39, P1751, DOI 10.1016/j.humpath.2008.04.017; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Oonakahara K, 2004, AM J RESP CELL MOL, V30, P671, DOI 10.1165/rcmb.2003-0340OC; Otsuka S, 2011, J THORAC ONCOL, V6, P1169, DOI 10.1097/JTO.0b013e3182199a99; Panneerselvam J, 2013, P 104 ANN M AM ASS C, P542; Panneerselvam Janani, 2013, J Mol Signal, V8, P15, DOI 10.1186/1750-2187-8-15; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Peled A, 2012, EXPERT OPIN INV DRUG, V21, P341, DOI 10.1517/13543784.2012.656197; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Ramesh R, 2004, DNA CELL BIOL, V23, P850, DOI 10.1089/dna.2004.23.850; Ramesh R, 2004, MOL THER, V9, P510, DOI 10.1016/j.ymthe.2004.01.019; Ramesh R, 2003, CANCER RES, V63, P5105; Ramsey DM, 2013, BIOORG MED CHEM LETT, V23, P20, DOI 10.1016/j.bmcl.2012.10.138; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Saeki T, 2000, GENE THER, V7, P2051, DOI 10.1038/sj.gt.3301330; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Stewart AL, 2002, MOL MED, V8, P451, DOI 10.1007/BF03402025; Su LP, 2005, CLIN CANCER RES, V11, P8273, DOI 10.1158/1078-0432.CCR-05-0537; Sun XJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-17; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Uchida D, 2011, EUR J CANCER, V47, P452, DOI 10.1016/j.ejca.2010.09.028; Uy GL, 2012, BLOOD, V119, P3917, DOI 10.1182/blood-2011-10-383406; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wagner PL, 2009, J THORAC CARDIOV SUR, V137, P615, DOI 10.1016/j.jtcvs.2008.07.039; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350	69	51	56	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0122439	10.1371/journal.pone.0122439	http://dx.doi.org/10.1371/journal.pone.0122439			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775124	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500224
J	Pezzolla, D; Lopez-Beas, J; Lachaud, CC; Dominguez-Rodriguez, A; Smani, T; Hmadcha, A; Soria, B				Pezzolla, Daniela; Lopez-Beas, Javier; Lachaud, Christian C.; Dominguez-Rodriguez, Alejandro; Smani, Tarik; Hmadcha, Abdelkrim; Soria, Bernat			Resveratrol Ameliorates the Maturation Process of beta- Cell-Like Cells Obtained from an Optimized Differentiation Protocol of Human Embryonic Stem Cells	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; HIGHLY EFFICIENT DIFFERENTIATION; PANCREATIC DUODENAL HOMEOBOX-1; CONCENTRATION-DEPENDENT MANNER; IN-VITRO; UNCOUPLING PROTEIN-2; SECRETING CELLS; DIRECTED DIFFERENTIATION; DEFINITIVE ENDODERM; GENERATION	Human embryonic stem cells (hESCs) retain the extraordinary capacity to differentiate into different cell types of an adult organism, including pancreatic beta-cells. For this particular lineage, although a lot of effort has been made in the last ten years to achieve an efficient and reproducible differentiation protocol, it was not until recently that this aim was roughly accomplished. Besides, several studies evidenced the impact of resveratrol (RSV) on insulin secretion, even though the mechanism by which this polyphenol potentiates glucose-stimulated insulin secretion (GSIS) is still not clear. The aim of this study was to optimize an efficient differentiation protocol that mimics in vivo pancreatic organogenesis and to investigate whether RSV may improve the final maturation step to obtain functional insulin-secreting cells. Our results indicate that treatment of hESCs (HS-181) with activin-A induced definitive endoderm differentiation as detected by the expression of SOX17 and FOXA2. Addition of retinoic acid (RA), Noggin and Cyclopamine promoted pancreatic differentiation as indicated by the expression of the early pancreatic progenitor markers ISL1, NGN3 and PDX1. Moreover, during maturation in suspension culture, differentiating cells assembled in islet-like clusters, which expressed specific endocrine markers such as PDX1, SST, GCG and INS. Similar results were confirmed with the human induced Pluripotent Stem Cell (hiPSC) line MSUH-001. Finally, differentiation protocols incorporating RSV treatment yielded numerous insulin-positive cells, induced significantly higher PDX1 expression and were able to transiently normalize glycaemia when transplanted in streptozotocin (STZ) induced diabetic mice thus promoting its survival. In conclusion, our strategy allows the efficient differentiation of hESCs into pancreatic endoderm capable of generating beta-cell-like cells and demonstrates that RSV improves the maturation process.	[Pezzolla, Daniela; Lopez-Beas, Javier; Lachaud, Christian C.; Hmadcha, Abdelkrim; Soria, Bernat] FPS, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain; [Dominguez-Rodriguez, Alejandro; Smani, Tarik] Inst Biomed Seville IBIS, Cardiovasc Pathophysiol, Seville, Spain; [Pezzolla, Daniela; Lopez-Beas, Javier; Hmadcha, Abdelkrim; Soria, Bernat] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Hmadcha, A (corresponding author), FPS, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Stem Cells, Seville, Spain.	karim.hmadcha@cabimer.es	Hmadcha, Abdelkrim/T-1173-2019; Hajami, Tarik Smani/D-5372-2016; , Bernat/AAL-6470-2021; López-Beas, Javier/Q-3935-2018; Lachaud, Christian Claude/C-2036-2017; IBIS, CARDIOVASCULAR/P-3910-2015	Hmadcha, Abdelkrim/0000-0002-4105-3702; Hajami, Tarik Smani/0000-0002-1877-7438; López-Beas, Javier/0000-0002-2463-947X; Lachaud, Christian Claude/0000-0001-8698-4589; Soria, Bernat/0000-0002-2356-0380; Dominguez Rodriguez, Alejandro/0000-0002-3508-8538	(Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia [PI-0022/2008]; Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia [CTS-6505, INP-2011-1615-900000, P10-CVI-6095]; Instituto de Salud Carlos III (Red TerCel-Grant) [RD06/0010/0025, RD12/0019/0028, RD12/0042/0041, PI10/00964, PI14/01015, PI10/00871]; Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant) [TRA-120]; FEDER	(Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III (Red TerCel-Grant)(Instituto de Salud Carlos III); Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant); FEDER(European Commission)	Authors are supported by the nonprofit Foundation (Fundacion Progreso y Salud) Consejeria de Salud, Junta de Andalucia (Grant PI-0022/2008); FEDER co-funded grants from Consejeria de Innovacion Ciencia y Empresa, Junta de Andalucia (Grant CTS-6505; INP-2011-1615-900000 and P10-CVI-6095); FEDER co-funded grants from Instituto de Salud Carlos III (Red TerCel-Grant RD06/0010/0025, RD12/0019/0028 and RD12/0042/0041; PI10/00964, PI14/01015 and PI10/00871) and the Ministry of Health and Consumer Affairs (Advanced Therapies Program Grant TRA-120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim H, 2009, J CELL MOL MED, V13, P1464, DOI 10.1111/j.1582-4934.2009.00837.x; Affourtit C, 2008, BBA-BIOENERGETICS, V1777, P973, DOI 10.1016/j.bbabio.2008.03.022; Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Azzu V, 2008, BBA-BIOENERGETICS, V1777, P1378, DOI 10.1016/j.bbabio.2008.07.001; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bashmakov Yuriy K, 2014, ISRN Endocrinol, V2014, P816307, DOI 10.1155/2014/816307; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bonal C, 2008, INT J DEV BIOL, V52, P823, DOI 10.1387/ijdb.072444cb; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; Brand MD, 2010, DIABETES OBES METAB, V12, P134, DOI 10.1111/j.1463-1326.2010.01264.x; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Bruin JE, 2014, STEM CELL RES, V12, P194, DOI 10.1016/j.scr.2013.10.003; Calvanese V, 2010, P NATL ACAD SCI USA, V107, P13736, DOI 10.1073/pnas.1001399107; Cano DA, 2014, CELL MOL LIFE SCI, V71, P2383, DOI 10.1007/s00018-013-1510-2; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Lachaud CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055181; Crandall JP, 2013, DIABETES, V62, P1022, DOI 10.2337/db12-1788; Crandall JP, 2012, J GERONTOL A-BIOL, V67, P1307, DOI 10.1093/gerona/glr235; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Fiori JL, 2013, DIABETES, V62, P3500, DOI 10.2337/db13-0266; Guo SR, 2014, CELL BIOL INT, V38, P849, DOI 10.1002/cbin.10274; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hrvatin S, 2014, P NATL ACAD SCI USA, V111, P3038, DOI 10.1073/pnas.1400709111; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Johannesson M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004794; Kim SK, 1998, P NATL ACAD SCI USA, V95, P13036, DOI 10.1073/pnas.95.22.13036; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Leon-Quinto T, 2004, DIABETOLOGIA, V47, P1442, DOI 10.1007/s00125-004-1458-8; Loh KM, 2014, CELL STEM CELL, V14, P237, DOI 10.1016/j.stem.2013.12.007; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rajagopal J, 2003, SCIENCE, V299, P363; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2013, STEM CELLS, V31, P2432, DOI 10.1002/stem.1489; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Soria B, 2001, DIFFERENTIATION, V68, P205, DOI 10.1046/j.1432-0436.2001.680408.x; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Soria B, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P837, DOI 10.1016/B978-0-12-398358-9.00041-0; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Tsaniras SC, 2011, VITAM HORM, V87, P79, DOI 10.1016/B978-0-12-386015-6.00025-1; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Vaca P, 2006, STEM CELLS, V24, P258, DOI 10.1634/stemcells.2005-0058; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Watanabe H, 2008, PANCREAS, V36, P153, DOI 10.1097/MPA.0b013e318157753e; Xie S, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-47; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhang YJ, 2004, J AGR FOOD CHEM, V52, P228, DOI 10.1021/jf034616u	67	27	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119904	10.1371/journal.pone.0119904	http://dx.doi.org/10.1371/journal.pone.0119904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774684	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500139
J	Takahashi, M; Miyazaki, S; Myojo, M; Sawaki, D; Iwata, H; Kiyosue, A; Higashikuni, Y; Tanaka, T; Fujita, D; Ando, J; Fujita, H; Hirata, Y; Komuro, I				Takahashi, Masao; Miyazaki, Susumu; Myojo, Masahiro; Sawaki, Daigo; Iwata, Hiroshi; Kiyosue, Arihiro; Higashikuni, Yasutomi; Tanaka, Tomofumi; Fujita, Daishi; Ando, Jiro; Fujita, Hideo; Hirata, Yasunobu; Komuro, Issei			Impact of the Distance from the Stent Edge to the Residual Plaque on Edge Restenosis following Everolimus-Eluting Stent Implantation	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND ASSESSMENT; OPTICAL COHERENCE TOMOGRAPHY; CORONARY; PREDICTORS; LESIONS; INTERVENTION; DEPLOYMENT; INJURY	Objectives This study aimed to assess the relation between stent edge restenosis (SER) and the distance from the stent edge to the residual plaque using quantitative intravascular ultrasound. Background Although percutaneous coronary intervention with drug-eluting stents has improved SER rates, determining an appropriate stent edge landing zone can be challenging in cases of diffuse plaque lesions. It is known that edge vascular response can occur within 2 mm from the edge of a bare metal stent, but the distance to the adjacent plaque has not been evaluated for drug-eluting stents. Methods A total of 97 proximal residual plaque lesions (plaque burden [PB] > 40%) treated with ever-olimus- eluting stents were retrospectively evaluated to determine the distance from the stent edge to the residual plaque. Results The SER group had significantly higher PB (59.1 +/- 6.1% vs. 51.9 +/- 9.1% for non-SER; P = 0.04). Higher PB was associated with SER, with the cutoff value of 54.74% determined using receiver operating characteristic (ROC) curve analysis. At this cutoff value of PB, the distance from the stent edge to the lesion was significantly associated with SER (odds ratio = 2.05, P = 0.035). The corresponding area under the ROC curve was 0.725, and the cutoff distance value for predicting SER was 1.0 mm. Conclusion An interval less than 1 mm from the proximal stent edge to the nearest point with the determined PB cutoff value of 54.74% was significantly associated with SER in patients with residual plaque lesions.	[Takahashi, Masao; Myojo, Masahiro; Sawaki, Daigo; Iwata, Hiroshi; Kiyosue, Arihiro; Higashikuni, Yasutomi; Tanaka, Tomofumi; Fujita, Daishi; Ando, Jiro; Fujita, Hideo; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Miyazaki, Susumu] Univ Tokyo, Dept Med Engn, Tokyo, Japan; [Hirata, Yasunobu] Tokyo Teishin Hosp, Tokyo, Japan	University of Tokyo; University of Tokyo	Takahashi, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	masaotakahashi-gi@umin.org	SAWAKI, Daigo/T-6871-2018; FUJITA, HIDEO/AHC-6839-2022	SAWAKI, Daigo/0000-0003-1417-2033; HIGASHIKUNI, YASUTOMI/0000-0002-2232-567X; Fujita, Hideo/0000-0002-4901-3502; Takahashi, Masao/0000-0002-3799-2256	Ministry of Education, Culture, Sports, Science, and Technology of Japan [17659229]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid #17659229 (to YH), Core Research for Evolutional Science and Technology from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claessen BE, 2009, CIRC-CARDIOVASC INTE, V2, P339, DOI 10.1161/CIRCINTERVENTIONS.108.831800.108.831800; Colombo A, 2007, CIRCULATION, V116, P1424, DOI 10.1161/CIRCULATIONAHA.106.621359; Costa MA, 2008, AM J CARDIOL, V101, P1704, DOI 10.1016/j.amjcard.2008.02.053; Gada H, 2013, JACC-CARDIOVASC INTE, V6, P1263, DOI 10.1016/j.jcin.2013.07.009; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; Gillett MJ, 2009, CLIN BIOCH REV AUSTR, V32, P1327; Gogas BD, 2013, JACC-CARDIOVASC INTE, V6, P211, DOI 10.1016/j.jcin.2013.01.132; Kang SJ, 2013, AM J CARDIOL, V111, P1401, DOI 10.1016/j.amjcard.2013.01.291; Kang SJ, 2013, AM J CARDIOL, V111, P1408, DOI 10.1016/j.amjcard.2013.01.288; Kaple RK, 2009, ULTRASOUND MED BIOL, V35, P550, DOI 10.1016/j.ultrasmedbio.2008.09.024; Kawamori H, 2013, EUR HEART J-CARD IMG, V14, P865, DOI 10.1093/ehjci/jes299; Liu XB, 2009, JACC-CARDIOVASC INTE, V2, P997, DOI 10.1016/j.jcin.2009.07.012; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Mudra H, 2001, CIRCULATION, V104, P1343, DOI 10.1161/hc3701.096064; Sakurai R, 2005, AM J CARDIOL, V96, P1251, DOI 10.1016/j.amjcard.2005.06.066; Schofer J, 2003, LANCET, V362, P1093, DOI 10.1016/S0140-6736(03)14462-5; Serruys PW, 2002, J AM COLL CARDIOL, V39, P393, DOI 10.1016/S0735-1097(01)01760-0; Shimohama T, 2010, AM J CARDIOL, V106, P13, DOI 10.1016/j.amjcard.2010.02.008; van der Giessen WJ, 2001, CIRCULATION, V104, P2236, DOI 10.1161/hc4301.097873; Waksman R, 1997, CIRCULATION, V96, P1944, DOI 10.1161/01.CIR.96.6.1944; Weissman NJ, 2007, EUR HEART J, V28, P1574, DOI 10.1093/eurheartj/ehm174; Weissman NJ, 2001, AM J CARDIOL, V88, P248, DOI 10.1016/S0002-9149(01)01635-6; Zhang QY, 2012, CHINESE MED J-PEKING, V125, P1547, DOI 10.3760/cma.j.issn.0366-6999.2012.09.005	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121079	10.1371/journal.pone.0121079	http://dx.doi.org/10.1371/journal.pone.0121079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775115	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500206
J	Taubert, J; Hou, B; Risselada, HJ; Mehner, D; Lunsdorf, H; Grubmuller, H; Bruser, T				Taubert, Johannes; Hou, Bo; Risselada, H. Jelger; Mehner, Denise; Luensdorf, Heinrich; Grubmueller, Helmut; Brueser, Thomas			TatBC-Independent TatA/Tat Substrate Interactions Contribute to Transport Efficiency	PLOS ONE			English	Article							TWIN-ARGININE TRANSLOCATION; DEPENDENT PROTEIN-TRANSPORT; COLI PLASMA-MEMBRANE; ESCHERICHIA-COLI; SIGNAL PEPTIDE; STREPTOMYCES-LIVIDANS; PATHWAY SPECIFICITY; PRECURSOR PROTEINS; BACILLUS-SUBTILIS; BINDING-SITE	The Tat system can transport folded, signal peptide-containing proteins (Tat substrates) across energized membranes of prokaryotes and plant plastids. A twin-arginine motif in the signal peptide of Tat substrates is recognized by TatC-containing complexes, and TatA permits the membrane passage. Often, as in the model Tat systems of Escherichia coli and plant plastids, a third component-TatB-is involved that resembles TatA but has a higher affinity to TatC. It is not known why most TatA dissociates from TatBC complexes in vivo and distributes more evenly in the membrane. Here we show a TatBC-independent substrate-binding to TatA from Escherichia coli, and we provide evidence that this binding enhances Tat transport. First hints came from in vivo cross-linking data, which could be confirmed by affinity co-purification of TatA with the natural Tat substrates HiPIP and NrfC. Two positions on the surface of HiPIP could be identified that are important for the TatA interaction and transport efficiency, indicating physiological relevance of the interaction. Distributed TatA thus may serve to accompany membrane-interacting Tat substrates to the few TatBC spots in the cells.	[Taubert, Johannes; Hou, Bo; Mehner, Denise; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, D-30167 Hannover, Germany; [Risselada, H. Jelger; Grubmueller, Helmut] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Luensdorf, Heinrich] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	Leibniz University Hannover; Max Planck Society; Helmholtz Association; Helmholtz-Center for Infection Research	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Schneiderberg 50, D-30167 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Mehner-Breitfeld, Denise/0000-0002-6785-898X; Bruser, Thomas/0000-0002-5889-8306	Deutsche Forschungsgemeinschaft [GRK 1026]; Open Access Publishing Fund of the Leibniz Universitat Hannover; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the Leibniz Universitat Hannover; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (GRK 1026). The authors acknowledge support by the Open Access Publishing Fund of the Leibniz Universitat Hannover and the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berthelmann F, 2004, FEBS LETT, V569, P82, DOI 10.1016/j.febslet.2004.05.054; Berthelmann F, 2008, J BIOL CHEM, V283, P25281, DOI 10.1074/jbc.M707757200; Blaudeck N, 2003, J BACTERIOL, V185, P2811, DOI 10.1128/JB.185.9.2811-2819.2003; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bolhuis A, 2000, FEBS LETT, V472, P88, DOI 10.1016/S0014-5793(00)01428-9; Brehmer T, 2012, LANGMUIR, V28, P3534, DOI 10.1021/la204473t; Bruser T, 1998, FEMS MICROBIOL LETT, V164, P329; Bruser T, 2003, EUR J BIOCHEM, V270, P1211, DOI 10.1046/j.1432-1033.2003.03481.x; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; Dabney-Smith C, 2009, MOL BIOL CELL; Dahlberg M, 2010, J CHEM THEORY COMPUT, V6, P1638, DOI 10.1021/ct900654e; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Keersmaeker S, 2005, BIOCHEM BIOPH RES CO, V335, P973, DOI 10.1016/j.bbrc.2005.07.165; De Keersmaeker S, 2005, FEBS LETT, V579, P797, DOI 10.1016/j.febslet.2004.12.059; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; Dilks M, 2005, J BACTERIOL, V187, P8104, DOI 10.1128/JB.187.23.8104-8113.2005; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gerard F, 2007, J BIOL CHEM, V282, P5263, DOI 10.1074/jbc.M610337200; Halbig D, 1999, EUR J BIOCHEM, V263, P543, DOI 10.1046/j.1432-1327.1999.00536.x; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinsley AP, 2001, FEBS LETT, V497, P45, DOI 10.1016/S0014-5793(01)02428-0; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hou B, 2006, J MOL BIOL, V355, P957, DOI 10.1016/j.jmb.2005.11.029; Hou Bo, 2011, Biomol Concepts, V2, P507, DOI 10.1515/BMC.2011.040; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Ize B, 2002, J MOL BIOL, V317, P327, DOI 10.1006/jmbi.2002.5431; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kerth A, 2012, CHEMBIOCHEM, V13, P231, DOI 10.1002/cbic.201100458; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Leake MC, 2008, P NATL ACAD SCI USA, V105, P15376, DOI 10.1073/pnas.0806338105; Lindenstrauss U, 2009, FEMS MICROBIOL LETT, V295, P135, DOI 10.1111/j.1574-6968.2009.01600.x; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Mehner D, 2012, J BIOL CHEM; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Pal D, 2012, PLANT PHYSL; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Pop OI, 2003, J BIOL CHEM, V278, P38428, DOI 10.1074/jbc.M306516200; Ray N, 2005, J BIOL CHEM, V280, P17961, DOI 10.1074/jbc.M413521200; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sargent F, 2001, EUR J BIOCHEM, V268, P3361, DOI 10.1046/j.1432-1327.2001.02263.x; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; SCOTTI PD, 1985, J VIROL METHODS, V12, P149, DOI 10.1016/0166-0934(85)90015-1; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Taubert J, 2014, BIOL CHEM, V395, P827, DOI 10.1515/hsz-2014-0170; Tullman-Ercek D, 2007, J BIOL CHEM; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wilms B, 2001, BIOTECHNOL BIOENG, V73, P95, DOI 10.1002/bit.1041; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	77	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119761	10.1371/journal.pone.0119761	http://dx.doi.org/10.1371/journal.pone.0119761			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774531	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500120
J	Cui, JL; Guo, TT; Ren, ZX; Zhang, NS; Wang, ML				Cui, Jin-Long; Guo, Ting-Ting; Ren, Zhen-Xing; Zhang, Na-Sha; Wang, Meng-Liang			Diversity and Antioxidant Activity of Culturable Endophytic Fungi from Alpine Plants of Rhodiola crenulata, R-angusta, and R-sachalinensis	PLOS ONE			English	Article							PESTALOTIOPSIS-MICROSPORA; SALIDROSIDE; L.; CELLS; ROSEA; IMBRICATA; EXTRACTS; RESOURCE; TYROSOL; TAXOL	Rhodiola spp. are rare and endangered alpine plants widely used as medicines and food additives by many civilizations since ancient times. Their main effective ingredients (such as salidroside and p-tyrosol) are praised to exhibit pharmacologic effects on high-altitude sickness and possess anti-aging and other adaptogenic capacities based on their antioxidant properties. In this study, 347 endophytic fungi were isolated from R. crenulata, R. angusta, and R. sachalinensis, and the molecular diversity and antioxidant activities of these fungi were investigated for the first time. These fungi were categorized into 180 morphotypes based on cultural characteristics, and their rRNA gene ITS sequences were analyzed by BLAST search in the GenBank database. Except for 12 unidentified fungi (6.67%), all others were affiliated to at least 57 genera in 20 orders of four phyla, namely, Ascomycota (88.89%), Basidiomycota (2.78%), Zygomycota (1.11%), and Glomeromycota (0.56%), which exhibited high abundance and diversity. Antioxidant assay showed that the DPPH radical-scavenging rates of 114 isolates (63.33%) were >50%, and those of five isolates (Rct45, Rct63, Rct64, Rac76, and Rsc57) were >90%. The EC50 values of five antioxidant assays suggested significant potential of these fungi on scavenging DPPH center dot, O-2-center dot, and OH center dot radicals, as well as scavenging nitrite and chelating Fe2+, which showed preference and selection between endophytic fungi and their hosts. Further research also provided the first evidence that Rac12 could produce salidrosides and p-tyrosol. Results suggested that versatile endophytic fungi associated with Rhodiola known as antioxidants could be exploited as potential sources of novel antioxidant products.	[Cui, Jin-Long; Guo, Ting-Ting; Ren, Zhen-Xing; Zhang, Na-Sha; Wang, Meng-Liang] Shanxi Univ, Inst Appl Chem, Taiyuan 030006, Shanxi Province, Peoples R China; [Guo, Ting-Ting; Zhang, Na-Sha] Shanxi Univ, Inst Biotechnol, Taiyuan 030006, Shanxi Province, Peoples R China	Shanxi University; Shanxi University	Wang, ML (corresponding author), Shanxi Univ, Inst Appl Chem, Taiyuan 030006, Shanxi Province, Peoples R China.	cjl717@sxu.edu.cn						Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Bayman P, 2006, WORLD J MICROB BIOT, V27, P1009; Bosshard PP, 2003, J CLIN MICROBIOL, V41, P4134, DOI 10.1128/JCM.41.9.4134-4140.2003; Chawla R, 2010, J PHARM BIOALLIED SC, V2, P213, DOI 10.4103/0975-7406.68503; Chen SL, 2008, CHROMATOGRAPHIA, V68, P299, DOI 10.1365/s10337-008-0705-4; Chiang HM, 2014, FOOD CHEM TOXICOL, V65, P129, DOI 10.1016/j.fct.2013.12.032; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Choi SY, 2006, J AGR FOOD CHEM, V54, P6075, DOI 10.1021/jf060845f; Chu YH, 2014, J AGR FOOD CHEM, V62, P3742, DOI 10.1021/jf5004094; Cui JL, 2011, PHYTOTHER RES, V25, P1189, DOI 10.1002/ptr.3361; DINIS TCP, 1994, ARCH BIOCHEM BIOPHYS, V315, P161, DOI 10.1006/abbi.1994.1485; Ganley RJ, 2004, P NATL ACAD SCI USA, V101, P10107, DOI 10.1073/pnas.0401513101; Guo T, 2011, FOOD CHEM, V127, P1634, DOI 10.1016/j.foodchem.2011.02.030; Gupta V, 2010, FOOD CHEM TOXICOL, V48, P1019, DOI 10.1016/j.fct.2010.01.012; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Huang WY, 2007, ECON BOT, V61, P14, DOI 10.1663/0013-0001(2007)61[14:APAREF]2.0.CO;2; Hung SK, 2011, PHYTOMEDICINE, V18, P235, DOI 10.1016/j.phymed.2010.08.014; Ishaque S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-70; Khanum F, 2005, COMPR REV FOOD SCI F, V4, P55, DOI 10.1111/j.1541-4337.2005.tb00073.x; Ma CY, 2008, CHROMATOGRAPHIA, V67, P383, DOI 10.1365/s10337-008-0539-0; Ma LQ, 2007, PLANT CELL REP, V26, P989, DOI 10.1007/s00299-007-0317-8; Nicoletti R, 2008, WORLD J MICROB BIOT, V24, P189, DOI 10.1007/s11274-007-9455-y; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Panossian A, 2010, PHYTOMEDICINE, V17, P481, DOI 10.1016/j.phymed.2010.02.002; Panossian A, 2014, PHYTOMEDICINE, V21, P1325, DOI 10.1016/j.phymed.2014.07.008; Petrini Orlando, 1992, Natural Toxins, V1, P185, DOI 10.1002/nt.2620010306; Raj K., 2010, Pharmacognosy Journal, V2, P431; Ravindran C, 2012, BOT MAR, V55, P269, DOI 10.1515/bot-2011-0095; Redkin SC, 1996, ENDOPHYTIC FUNGI GRA; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez R, 2005, P NATL ACAD SCI USA, V102, P3175, DOI 10.1073/pnas.0500367102; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Saucedo-Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098454; Shrestha UB, 2013, BIOL CONSERV, V159, P514, DOI 10.1016/j.biocon.2012.10.032; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Skerget M, 2005, FOOD CHEM, V89, P191, DOI 10.1016/j.foodchem.2004.02.025; Song YC, 2005, BIOL PHARM BULL, V28, P506, DOI 10.1248/bpb.28.506; STIERLE A, 1993, SCIENCE, V260, P214, DOI 10.1126/science.8097061; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Strobel G, 2002, PHYTOCHEMISTRY, V60, P179, DOI 10.1016/S0031-9422(02)00062-6; Sun LW, 2012, LIFE SCI, V91, P151, DOI 10.1016/j.lfs.2012.06.026; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Surveswaran S, 2007, FOOD CHEM, V102, P938, DOI 10.1016/j.foodchem.2006.06.033; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Wearn JA, 2012, J ECOL, V100, P1085, DOI 10.1111/j.1365-2745.2012.01997.x; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; WynnWilliams DD, 1996, BIODIVERS CONSERV, V5, P1271, DOI 10.1007/BF00051979; Xu L, 2008, LETT APPL MICROBIOL, V46, P68, DOI 10.1111/j.1472-765X.2007.02264.x; Yin H, 2011, PHYTOMEDICINE, V18, P802, DOI 10.1016/j.phymed.2011.01.005; Yu NH, 2014, POLAR BIOL, V37, P27, DOI 10.1007/s00300-013-1406-5; Zhao JT, 2012, J AGR FOOD CHEM, V60, P4314, DOI 10.1021/jf205097y; Zheng P, 2013, APPL MICROBIOL BIOT, V97, P2797, DOI 10.1007/s00253-013-4771-7	56	71	82	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118204	10.1371/journal.pone.0118204	http://dx.doi.org/10.1371/journal.pone.0118204			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768014	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500021
J	Moro, C; Cornette, R; Vieaud, A; Bruneau, N; Gourichon, D; Bed'hom, B; Tixier-Boichard, M				Moro, Celine; Cornette, Raphael; Vieaud, Agathe; Bruneau, Nicolas; Gourichon, David; Bed'hom, Bertrand; Tixier-Boichard, Michele			Quantitative Effect of a CNV on a Morphological Trait in Chickens	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENOME	Copy Number Variation has been associated with morphological traits, developmental defects or disease susceptibility. The autosomal dominant Pea-comb mutation in chickens is due to the massive amplification of a CNV in intron 1 of SOX5 and provides a unique opportunity to assess the effect of variation in the number of repeats on quantitative traits such as comb size and comb mass in Pea-comb chickens. The quantitative variation of comb size was estimated by 2D morphometry and the number of repeats (RQ) was estimated by qPCR, in a total of 178 chickens from 3 experimental lines, two of them showing segregation for the Pea-comb mutation. This study included only Pea-comb chickens. Analysis of variance showed highly significant effects of line and sex on comb measurements. Adult body weight (BW) and RQ were handled as covariates. BW significantly influenced comb mass but not comb size. RQ values significantly influenced comb size, and the linear regression coefficient was highest for heterozygous carriers: the higher the number of repeats, the smaller the comb size. A similar trend was observed for comb mass. The CNV contributed to 3.4% of the phenotypic variance of comb size in heterozygous carriers of the CNV, an order of magnitude frequently encountered for QTLs. Surprisingly, there was no such relationship between RQ values and comb size in the homozygous line. It may be concluded that heterozygosity for a CNV in a non-coding region may contribute to phenotypic plasticity.	[Moro, Celine; Vieaud, Agathe; Bruneau, Nicolas; Bed'hom, Bertrand; Tixier-Boichard, Michele] AgroParisTech, Inst Natl Rech Agron, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Cornette, Raphael] Museum Natl Hist Nat, UMR 7205, Inst Systemat, Evolut,Biodivers, F-75231 Paris, France; [Gourichon, David] INRA, Pole Experimentat Avicole Tours UE1295, Nouzilly, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; INRAE	Tixier-Boichard, M (corresponding author), AgroParisTech, Inst Natl Rech Agron, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France.	michele.boichard@jouy.inra.fr	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Cornette, Raphael/0000-0003-4182-4201	Animal Genetics division of Institut National de la Recherche Agronomique (INRA)	Animal Genetics division of Institut National de la Recherche Agronomique (INRA)	This study was supported by a grant from the Animal Genetics division of Institut National de la Recherche Agronomique (INRA), in the frame of project funding for the teams of the division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson J., 1933, P 5 WORLDS POULTR C, V2, P273, DOI [10.1513/pats.200908-092RM, DOI 10.1513/PATS.200908-092RM.EMERGING]; Boije H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050890; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Clop A, 2012, ANIM GENET, V43, P503, DOI 10.1111/j.1365-2052.2012.02317.x; Hai R, 2012, J HUM GENET, V57, P33, DOI 10.1038/jhg.2011.125; Hayes B, 2001, GENET SEL EVOL, V33, P209, DOI 10.1051/gse:2001117; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moro C, 2013, 10 FRENCH POULTR RES; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roussot O, 2003, GENET SEL EVOL, V35, P559, DOI [10.1186/1297-9686-35-6-559, 10.1051/gse:2003039]; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Tian M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-262; Tufvesson M, 1999, J ANIM BREED GENET, V116, P127, DOI 10.1046/j.1439-0388.1999.00179.x; Wright D, 2008, EVOLUTION, V62, P86, DOI 10.1111/j.1558-5646.2007.00281.x; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512	16	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118706	10.1371/journal.pone.0118706	http://dx.doi.org/10.1371/journal.pone.0118706			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768125	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500038
J	Tigner, J; Bayne, EM; Boutin, S				Tigner, Jesse; Bayne, Erin M.; Boutin, Stan			American Marten Respond to Seismic Lines in Northern Canada at Two Spatial Scales	PLOS ONE			English	Article							WINTER HABITAT SELECTION; RESIDUAL FOREST STANDS; LOGGED BOREAL FORESTS; HOME-RANGE SIZE; ENERGY DEVELOPMENT; DETECTION PROBABILITIES; LANDSCAPE PATTERN; WOODLAND CARIBOU; OCCUPANCY RATES; SOUTHERN FRINGE	Development of hydrocarbon resources across northwest Canada has spurred economic prosperity and generated concerns over impacts to biodiversity. To balance these interests, numerous jurisdictions have adopted management thresholds that allow for limited energy development but minimize undesirable impacts to wildlife. Used for exploration, seismic lines are the most abundant linear feature in the boreal forest and exist at a variety of widths and recovery states. We used American marten (Martes americana) as a model species to measure how line attributes influence species' response to seismic lines, and asked whether responses to individual lines trigger population impacts. Marten response to seismic lines was strongly influenced by line width and recovery state. Compared to forest interiors, marten used open seismic lines >= 3 m wide less often, but used open lines <= 2 m wide and partially recovered lines >= 6 m wide similarly. Marten response to individual line types appeared to trigger population impacts. The probability of occurrence at the home range scale declined with increasing seismic line density, and the inclusion of behavioral response to line density calculations improved model fit. In our top performing model, we excluded seismic lines <= 2 m from our calculation of line density, and the probability of occurrence declined > 80% between home ranges with the lowest and highest line densities. Models that excluded seismic lines did not strongly explain occurrence. We show how wildlife-derived metrics can inform regulatory guidelines to increase the likelihood those guidelines meet intended management objectives. With respect to marten, not all seismic lines constitute disturbances, but avoidance of certain line types scales to population impacts. This approach provides the ecological context required to understand cause and effect relationships among socio-economic and ecological conservation goals.	[Tigner, Jesse; Bayne, Erin M.; Boutin, Stan] Univ Alberta, Dept Biol Sci, Integrated Landscape Management Grp, Edmonton, AB T6G 2E9, Canada	University of Alberta	Tigner, J (corresponding author), Explor, Suite 1500,630 6th Ave SW, Calgary, AB T2P 0S8, Canada.	tigner@explor.net	; Boutin, Stan/A-2619-2014	Bayne, Erin/0000-0002-0679-4521; Boutin, Stan/0000-0001-6317-038X	Environmental Studies Research Fund; National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks; Wildlife Foundation DIP Program; Canadian Circumpolar Institute C/Bar Program; Canadian Association of Geophysical Contractors; British Columbia Ministry of Environment; Government of the Northwest Territories; IHS Energy; Ducks Unlimited Canada; Canadian Wildlife Service; Aboriginal Affairs and Northern Development Canada; Acho Dene Koe; Dehcho First Nations; Apache Canada; Canadian Natural; EOG Canada; Nexen; Nabors International; University of Alberta	Environmental Studies Research Fund; National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks; Wildlife Foundation DIP Program; Canadian Circumpolar Institute C/Bar Program; Canadian Association of Geophysical Contractors; British Columbia Ministry of Environment; Government of the Northwest Territories; IHS Energy; Ducks Unlimited Canada; Canadian Wildlife Service; Aboriginal Affairs and Northern Development Canada; Acho Dene Koe; Dehcho First Nations; Apache Canada; Canadian Natural; EOG Canada; Nexen; Nabors International; University of Alberta(University of Alberta)	Funding from Environmental Studies Research Fund, National Science and Engineering Research Council (NSERC) Integrated Landscape Management Chair, Alberta Sports, Recreation, Parks, and Wildlife Foundation DIP Program, Canadian Circumpolar Institute C/Bar Program, Canadian Association of Geophysical Contractors, British Columbia Ministry of Environment, Government of the Northwest Territories, IHS Energy, Ducks Unlimited Canada, Canadian Wildlife Service, Aboriginal Affairs and Northern Development Canada, Acho Dene Koe and the Dehcho First Nations, Apache Canada, Canadian Natural, EOG Canada, Nexen, Nabors International, and the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Andruskiw M, 2008, ECOLOGY, V89, P2273, DOI 10.1890/07-1428.1; Ashenhurst AR, 2008, ARCTIC, V61, P190; Baldwin RA, 2008, J MAMMAL, V89, P419, DOI 10.1644/07-MAMM-A-053R1.1; Bayne E., 2011, ECOLOGICALLY BASED C; Bayne EM, 2005, LANDSCAPE ECOL, V20, P203, DOI 10.1007/s10980-004-2265-9; Bayne EM, 2005, ECOSCIENCE, V12, P216, DOI 10.2980/i1195-6860-12-2-216.1; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; BenDavid M, 1997, OECOLOGIA, V111, P280, DOI 10.1007/s004420050236; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BUSKIRK SW, 1989, J WILDLIFE MANAGE, V53, P997, DOI 10.2307/3809601; Caro T, 1999, TRENDS ECOL EVOL, V14, P366, DOI 10.1016/S0169-5347(99)01663-8; Chapin TG, 1997, J WILDLIFE MANAGE, V61, P707, DOI 10.2307/3802178; Chapin TG, 1998, CONSERV BIOL, V12, P1327, DOI 10.1046/j.1523-1739.1998.96227.x; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Cheveau M, 2013, J WILDLIFE MANAGE, V77, P749, DOI 10.1002/jwmg.511; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Darling AF, 2009, THESIS U ALBERTA; Dehcho Land Use Planning Committee, 2006, RESP LAND DEHCH LAND; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; DOUGLASS RJ, 1983, CAN FIELD NAT, V97, P71; Dyer SJ, 2002, CAN J ZOOL, V80, P839, DOI [10.1139/z02-060, 10.1139/Z02-060]; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Ecosystem Classification Group, 2007, EC REG NW TERR TAIG; Environment and Climate Change Canada, 2021, REC STR BARN OWL TYT; Flynn RW, 2009, J WILDLIFE MANAGE, V73, P1269, DOI 10.2193/2008-169; Fortin Clement, 1994, P179; Francis CD, 2011, LANDSCAPE ECOL, V26, P1269, DOI 10.1007/s10980-011-9609-z; Fuller AK, 2005, J WILDLIFE MANAGE, V69, P710, DOI 10.2193/0022-541X(2005)069[0710:IOPTHO]2.0.CO;2; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; GILL JA, 2000, BEHAV CONSERVATION, P51; Godbout G, 2008, ECOSCIENCE, V15, P332, DOI 10.2980/15-3-3091; Godbout G, 2010, ECOSCIENCE, V17, P175, DOI 10.2980/17-2-3288; Griffin SC, 2007, CONSERV BIOL, V21, P1070, DOI 10.1111/j.1523-1739.2007.00688.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hargis CD, 1999, J APPL ECOL, V36, P157, DOI 10.1046/j.1365-2664.1999.00377.x; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Hearn BJ, 2010, J WILDLIFE MANAGE, V74, P719, DOI 10.2193/2009-138; HODGMAN TP, 1994, J WILDLIFE MANAGE, V58, P593, DOI 10.2307/3809671; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Indian and Northern Affairs Canada, 2007, PREL STAT KNOWL REP; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Johnson CA, 2009, P R SOC B, V276, P3361, DOI 10.1098/rspb.2008.1958; Jorgenson JC, 2010, ECOL APPL, V20, P205, DOI 10.1890/08-1856.1; Kemper JT, 2009, J VEG SCI, V20, P557, DOI 10.1111/j.1654-1103.2009.01069.x; Kennett S., 2006, SCI BASED THRESHOLDS; Kirk TA, 2009, LANDSCAPE ECOL, V24, P759, DOI 10.1007/s10980-009-9349-5; Komers PE, 2013, GLOBAL CHANGE BIOL, V19, P2916, DOI 10.1111/gcb.12266; Lankau HE, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00596-080105; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; MacFarlane A, 2003, THESIS U ALBERTA; Machtans CS, 2006, CAN J ZOOL, V84, P1421, DOI 10.1139/Z06-134; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCann NP, 2010, J WILDLIFE MANAGE, V74, P1502, DOI 10.2193/2009-297; Moriarty KM, 2011, J WILDLIFE MANAGE, V75, P1774, DOI 10.1002/jwmg.228; Neufeld L, 2006, THESIS U ALBERTA; Nielsen SE, 2007, BIOL CONSERV, V137, P403, DOI 10.1016/j.biocon.2007.02.024; Northrup JM, 2013, ECOL LETT, V16, P112, DOI 10.1111/ele.12009; Oberg PR, 2001, THESIS U ALBERTA; Otis DL, 1987, WILDLIFE MONOGR, P62; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Payer DC, 2000, CAN J FOREST RES, V30, P1965, DOI 10.1139/cjfr-30-12-1965; Payer DC, 2003, FOREST ECOL MANAG, V179, P145, DOI 10.1016/S0378-1127(02)00517-0; PAYER DC, 1999, THESIS U MAINE; Poole KG, 2004, CAN J ZOOL, V82, P423, DOI [10.1139/z04-006, 10.1139/Z04-006]; Porter AD, 2005, CAN J FOREST RES, V35, P901, DOI 10.1139/X05-014; Potvin F, 2000, CONSERV BIOL, V14, P844, DOI 10.1046/j.1523-1739.2000.99036.x; Potvin Francois, 1997, P452; Powell Roger A., 1994, P101; REVEL RD, 1984, FOREST GROWTH REGENE; Robitaille JF, 2000, ACTA THERIOL, V45, P137, DOI 10.4098/AT.arch.00-15; ROUGHTON RD, 1982, J WILDLIFE MANAGE, V46, P217, DOI 10.2307/3808424; Ruggiero LF, 1994, SCI BASIS CONSERVING; [Salmo Consulting Axys Environmental Consulting Forem Technologies Wildlife & Company], 2004, DEH CHO CUM EFF STUD; Salmo Consulting Diversified Environmental Services Gaia Consultants Forem Technologies Axys Environmental Consulting, 2003, CUM EFF IND THRESH C; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schmiegelow FKA, 2002, ECOL APPL, V12, P375; Schneider RR, 2003, CONSERV ECOL, V7; Schneider RR, 2002, ALTERNATIVE FUTURES, DOI [10.2527/jas.2014-7375, DOI 10.2527/JAS.2014-7375]; Slauson KM, 2007, J WILDLIFE MANAGE, V71, P458, DOI 10.2193/2004-332; Smith AC, 2002, CAN J ZOOL, V80, P1602, DOI 10.1139/Z02-166; Smith JB, 2007, J WILDLIFE MANAGE, V71, P2412, DOI 10.2193/2007-091; SNYDER JE, 1987, CAN J ZOOL, V65, P169, DOI 10.1139/z87-024; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; SOUTIERE EC, 1979, J WILDLIFE MANAGE, V43, P850, DOI 10.2307/3808268; St-Laurent MH, 2008, FOREST ECOL MANAG, V254, P261, DOI 10.1016/j.foreco.2007.08.006; Strimbu B, 2011, J ENVIRON MANAGE, V92, P1740, DOI 10.1016/j.jenvman.2011.02.007; Thompson ID, 2008, FOREST CHRON, V84, P741, DOI 10.5558/tfc84741-5; THOMPSON ID, 1994, J WILDLIFE MANAGE, V58, P280, DOI 10.2307/3809392; THOMPSON ID, 1994, J WILDLIFE MANAGE, V58, P272, DOI 10.2307/3809391; Tigner J, 2014, J WILDLIFE MANAGE, V78, P282, DOI 10.1002/jwmg.664; Vanderwel MC, 2010, J WILDLIFE MANAGE, V74, P1492, DOI 10.2193/2009-426; Vigeant-Langlois C, 2011, CAN J FOREST RES, V41, P2202, DOI [10.1139/X11-133, 10.1139/x11-133]; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Weclaw P, 2004, ECOL MODEL, V177, P75, DOI 10.1016/j.ecolmodel.2003.12.052; Wiebe PA, 2013, J WILDLIFE MANAGE, V77, P379, DOI 10.1002/jwmg.471; Wulder MA, 2003, FOREST CHRON, V79, P1075, DOI 10.5558/tfc791075-6; Zielinski WJ, 2008, J WILDLIFE MANAGE, V72, P1558, DOI 10.2193/2007-397; Zielinski WJ, 1996, ECOL APPL, V6, P1254, DOI 10.2307/2269605; Zwolak R, 2009, FOREST ECOL MANAG, V258, P539, DOI 10.1016/j.foreco.2009.05.033	108	26	27	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118720	10.1371/journal.pone.0118720	http://dx.doi.org/10.1371/journal.pone.0118720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768848	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500041
J	Aslankoohi, E; Rezaei, MN; Vervoort, Y; Courtin, CM; Verstrepen, KJ				Aslankoohi, Elham; Rezaei, Mohammad Naser; Vervoort, Yannick; Courtin, Christophe M.; Verstrepen, Kevin J.			Glycerol Production by Fermenting Yeast Cells Is Essential for Optimal Bread Dough Fermentation	PLOS ONE			English	Article							CRYOTOLERANT SACCHAROMYCES STRAINS; 3-PHOSPHATE DEHYDROGENASE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; OSMOTIC-STRESS; BAKERS-YEAST; WATER-STRESS; CEREVISIAE; GPD1; OSMOREGULATION; MUTANT	Glycerol is the main compatible solute in yeast Saccharomyces cerevisiae. When faced with osmotic stress, for example during semi-solid state bread dough fermentation, yeast cells produce and accumulate glycerol in order to prevent dehydration by balancing the intracellular osmolarity with that of the environment. However, increased glycerol production also results in decreased CO2 production, which may reduce dough leavening. We investigated the effect of yeast glycerol production level on bread dough fermentation capacity of a commercial bakery strain and a laboratory strain. We find that Delta gpd1 mutants that show decreased glycerol production show impaired dough fermentation. In contrast, overexpression of GPD1 in the laboratory strain results in increased fermentation rates in high-sugar dough and improved gas retention in the fermenting bread dough. Together, our results reveal the crucial role of glycerol production level by fermenting yeast cells in dough fermentation efficiency as well as gas retention in dough, thereby opening up new routes for the selection of improved commercial bakery yeasts.	[Aslankoohi, Elham; Vervoort, Yannick; Verstrepen, Kevin J.] VIB, Lab Syst Biol, Leuven, Belgium; [Aslankoohi, Elham; Vervoort, Yannick; Verstrepen, Kevin J.] Katholieke Univ Leuven, CMPG Lab Genet & Genom, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium; [Rezaei, Mohammad Naser; Courtin, Christophe M.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven	Courtin, CM (corresponding author), Katholieke Univ Leuven, Lab Food Chem & Biochem, Leuven, Belgium.	Christophe.Courtin@biw.kuleuven.be; Kevin.Verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021; Courtin, Christophe M/Q-1916-2016	Courtin, Christophe M/0000-0002-1203-9063; Verstrepen, Kevin/0000-0002-3077-6219; Rezaei, Mohammad Naser/0000-0002-6626-6739	ERC Starting Grant [241426]; VIB; HFSP research grant [RGP0050/2013]; FWO; IWT; KU Leuven IDO project [IDO/12/011]; FWO project [G.0544.10N]; EMBO YIP program	ERC Starting Grant; VIB; HFSP research grant; FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven IDO project; FWO project(FWO); EMBO YIP program	Research in the lab of KJV is supported by ERC Starting Grant 241426, VIB, EMBO YIP program, HFSP research grant RGP0050/2013, FWO, and IWT. The authors specifically acknowledge financial support from KU Leuven IDO project IDO/12/011 and FWO project funding (G.0544.10N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC International, 2000, APPR METH AN; Abelson J., 2004, GUIDE YEAST GENETICS; ALBERTYN J, 1994, CURR GENET, V25, P12, DOI 10.1007/BF00712960; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; [Anonymous], 2000, AUST J GRAPE WINE R, DOI DOI 10.1111/J.1755-0238.2000.TB00181.X; Ansell R, 1997, EMBO J, V16, P2179, DOI 10.1093/emboj/16.9.2179; Aslankoohi E, 2013, APPL ENVIRON MICROB, V79, P7325, DOI 10.1128/AEM.02649-13; Attfield PV, 2000, LETT APPL MICROBIOL, V31, P323, DOI [10.1046/j.1472-765x.2000.00825.x, 10.1046/j.1472-765X.2000.00825.x]; Baik MY, 2002, CEREAL CHEM, V79, P376, DOI 10.1094/CCHEM.2002.79.3.376; Barrett AH, 2000, CEREAL CHEM, V77, P169, DOI 10.1094/CCHEM.2000.77.2.169; Bell PJL, 2001, LETT APPL MICROBIOL, V32, P224, DOI 10.1046/j.1472-765X.2001.00894.x; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Bertolini L, 1996, AM J ENOL VITICULT, V47, P343; BLOMBERG A, 1989, J BACTERIOL, V171, P1087, DOI 10.1128/jb.171.2.1087-1092.1989; Burke D, 2000, METHODS YEAST GENETI, P205; Cambon B, 2006, APPL ENVIRON MICROB, V72, P4688, DOI 10.1128/AEM.02975-05; CASTELLARI L, 1994, VITIS, V33, P49; CZUCHAJOWSKA Z, 1993, CEREAL FOOD WORLD, V38, P499; ERIKSSON P, 1995, MOL MICROBIOL, V17, P95, DOI 10.1111/j.1365-2958.1995.mmi_17010095.x; Hirasawa R, 2001, FEMS MICROBIOL LETT, V194, P159, DOI 10.1016/S0378-1097(00)00521-8; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P303, DOI 10.1007/s00253-004-1688-1; Izawa S, 2004, APPL MICROBIOL BIOT, V66, P108, DOI 10.1007/s00253-004-1624-4; Jayaram VB, 2014, FOOD CHEM, V151, P421, DOI 10.1016/j.foodchem.2013.11.025; Kieffer R, 1998, J CEREAL SCI, V27, P53, DOI 10.1006/jcrs.1997.0136; LARSSON K, 1993, MOL MICROBIOL, V10, P1101, DOI 10.1111/j.1365-2958.1993.tb00980.x; Michnick S, 1997, YEAST, V13, P783, DOI 10.1002/(SICI)1097-0061(199707)13:9<783::AID-YEA128>3.0.CO;2-W; Myers DK, 1998, FOOD MICROBIOL, V15, P51, DOI 10.1006/fmic.1997.0131; Nash D, 2006, CEREAL CHEM, V83, P255, DOI 10.1094/CC-83-0255; Nevoigt E, 1997, FEMS MICROBIOL REV, V21, P231, DOI 10.1111/j.1574-6976.1997.tb00352.x; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Oliveira BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087290; Oliveira R, 2003, BBA-BIOMEMBRANES, V1613, P57, DOI 10.1016/S0005-2736(03)00138-X; Remize F, 1999, APPL ENVIRON MICROB, V65, P143; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rezaei MN, 2014, FOOD MICROBIOL, V39, P108, DOI 10.1016/j.fm.2013.11.013; Sambrook J., 2001, MOL CLONING LAB MANU, V1, P2344; Somero G, 2011, COMPR PHYSL; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Toh TH, 2000, S AFRICAN J ENOLOGY, P92; VANECK JH, 1989, J GEN MICROBIOL, V135, P3505; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yeh LT, 2009, J FOOD SCI, V74, pS399, DOI 10.1111/j.1750-3841.2009.01337.x	44	39	41	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119364	10.1371/journal.pone.0119364	http://dx.doi.org/10.1371/journal.pone.0119364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764309	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300024
J	Albersen, M; Bosma, M; Jans, JJM; Hofstede, FC; Van Hasselt, PM; de Sain-van der Velden, MGM; Visser, G; Verhoeven-Duif, NM				Albersen, Monique; Bosma, Marjolein; Jans, Judith J. M.; Hofstede, Floris C.; Van Hasselt, Peter M.; de Sain-van der Velden, Monique G. M.; Visser, Gepke; Verhoeven-Duif, Nanda M.			Vitamin B6 in Plasma and Cerebrospinal Fluid of Children	PLOS ONE			English	Article							PYRIDOXINE DEPENDENT EPILEPSY; PNPO DEFICIENCY; 5'-PHOSPHATE; MUTATIONS; ANTIQUITIN; DIAGNOSIS; SEIZURES; PYRIDOXAL-5'-PHOSPHATE; HYPERHOMOCYSTEINEMIA; HOMOCYSTEINE	Background Over the past years, the essential role of vitamin B6 in brain development and functioning has been recognized and genetic metabolic disorders resulting in functional vitamin B6 deficiency have been identified. However, data on B6 vitamers in children are scarce. Materials and Methods B6 vitamer concentrations in simultaneously sampled plasma and cerebrospinal fluid (CSF) of 70 children with intellectual disability were determined by ultra performance liquid chromatography-tandem mass spectrometry. For ethical reasons, CSF samples could not be obtained from healthy children. The influence of sex, age, epilepsy and treatment with antiepileptic drugs, were investigated. Results The B6 vitamer composition of plasma (pyridoxal phosphate (PLP) > pyridoxic acid > pyridoxal (PL)) differed from that of CSF (PL > PLP > pyridoxic acid > pyridoxamine). Strong correlations were found for B6 vitamers in and between plasma and CSF. Treatment with anti-epileptic drugs resulted in decreased concentrations of PL and PLP in CSF. Conclusion We provide concentrations of all B6 vitamers in plasma and CSF of children with intellectual disability (+/- epilepsy), which can be used in the investigation of known and novel disorders associated with vitamin B6 metabolism as well as in monitoring of the biochemical effects of treatment with vitamin B6.	[Albersen, Monique; Bosma, Marjolein; Jans, Judith J. M.; de Sain-van der Velden, Monique G. M.; Verhoeven-Duif, Nanda M.] UMC Utrecht, Dept Med Genet, Utrecht, Netherlands; [Hofstede, Floris C.; Van Hasselt, Peter M.; Visser, Gepke] Wilhelmina Childrens Hosp, UMC Utrecht, Dept Paediat Metab Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Verhoeven-Duif, NM (corresponding author), UMC Utrecht, Dept Med Genet, Utrecht, Netherlands.	N.Verhoeven@umcutrecht.nl		Jans, Judith/0000-0003-0960-6263				Albersen M, 2014, AM J CLIN NUTR, V100, P587, DOI 10.3945/ajcn.113.082008; Albersen M, 2012, PEDIATRICS, V130, pE191, DOI 10.1542/peds.2011-3751; Apeland T, 2006, CLIN BIOCHEM, V39, P282, DOI 10.1016/j.clinbiochem.2006.01.007; Apeland T, 2003, CLIN CHEM, V49, P1005, DOI 10.1373/49.6.1005; Apeland T, 2002, EPILEPSY RES, V51, P237, DOI 10.1016/S0920-1211(02)00153-5; Bates CJ, 1999, PUBLIC HEALTH NUTR, V2, P529, DOI 10.1017/S1368980099000713; Bates CJ, 1999, CLIN CHIM ACTA, V280, P101, DOI 10.1016/S0009-8981(98)00173-9; Bok LA, 2012, DEV MED CHILD NEUROL, V54, P849, DOI 10.1111/j.1469-8749.2012.04347.x; FLEISHER GA, 1977, CLIN CHEM, V23, P469; Footitt EJ, 2012, J INHERIT METAB DIS, V35, pS18, DOI 10.1007/s10545-012-9493-y; Footitt EJ, 2011, J INHERIT METAB DIS, V34, P529, DOI 10.1007/s10545-011-9279-7; Goyal M, 2013, PEDIATR NEUROL, V48, P227, DOI 10.1016/j.pediatrneurol.2012.11.006; Hartmann H, 2011, DEV MED CHILD NEUROL, V53, P1150, DOI 10.1111/j.1469-8749.2011.04033.x; Hazra A, 2009, HUM MOL GENET, V18, P4677, DOI 10.1093/hmg/ddp428; Hoffmann GF, 2007, J INHERIT METAB DIS, V30, P96, DOI 10.1007/s10545-006-0508-4; Jortner BS, 2000, TOXICOL PATHOL, V28, P54, DOI 10.1177/019262330002800108; Khayat M, 2008, MOL GENET METAB, V94, P431, DOI 10.1016/j.ymgme.2008.04.008; Marszall ML, 2009, J CHROMATOGR B, V877, P3151, DOI 10.1016/j.jchromb.2009.08.014; Mercimek-Mahmutoglu S, 2013, MOL GENET METAB, V110, P197, DOI 10.1016/j.ymgme.2013.04.018; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Mills PB, 2014, BRAIN, V137, P1350, DOI 10.1093/brain/awu051; Morris MS, 2008, AM J CLIN NUTR, V87, P1446, DOI 10.1093/ajcn/87.5.1446; Ormazabal A, 2008, MOL GENET METAB, V94, P173, DOI 10.1016/j.ymgme.2008.01.004; Plecko B, 2014, NEUROLOGY, V82, P1425, DOI 10.1212/WNL.0000000000000344; Porri S, 2014, NEUROPEDIATRICS, V45, P64, DOI 10.1055/s-0033-1353489; Ruiz A, 2008, MOL GENET METAB, V93, P216, DOI 10.1016/j.ymgme.2007.10.003; SCHIELE F, 1983, CLIN CHEM, V29, P634; Schwaninger M, 1999, EPILEPSIA, V40, P345, DOI 10.1111/j.1528-1157.1999.tb00716.x; SHIN YS, 1984, LANCET, V2, P870; Stockler S, 2011, MOL GENET METAB, V104, P48, DOI 10.1016/j.ymgme.2011.05.014; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018; Verrotti A, 2000, EPILEPSY RES, V41, P253, DOI 10.1016/S0920-1211(00)00150-9; Vilaseca M A, 2000, Eur J Paediatr Neurol, V4, P269, DOI 10.1053/ejpn.2000.0379; Walker V, 2000, ARCH DIS CHILD, V82, P236, DOI 10.1136/adc.82.3.236; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440	37	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120972	10.1371/journal.pone.0120972	http://dx.doi.org/10.1371/journal.pone.0120972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760040	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275000073
J	Gilgien, M; Crivelli, P; Sporri, J; Kroll, J; Muller, E				Gilgien, Matthias; Crivelli, Philip; Spoerri, Joerg; Kroll, Joesef; Mueller, Erich			Characterization of Course and Terrain and Their Effect on Skier Speed in World Cup Alpine Ski Racing	PLOS ONE			English	Article							SYSTEMATIC VIDEO ANALYSIS; CRUCIATE LIGAMENT INJURY; RISK; MECHANISMS; KINEMATICS	World Cup (WC) alpine ski racing consists of four main competition disciplines (slalom, giant slalom, super-G and downhill), each with specific course and terrain characteristics. The International Ski Federation (FIS) has regulated course length, altitude drop from start to finish and course setting in order to specify the characteristics of the respective competition disciplines and to control performance and injury-related aspects. However to date, no detailed data on course setting and its adaptation to terrain is available. It is also unknown how course and terrain characteristics influence skier speed. Therefore, the aim of the study was to characterize course setting, terrain geomorphology and their relationship to speed in male WC giant slalom, super-G and downhill. The study revealed that terrain was flatter in downhill compared to the other disciplines. In all disciplines, variability in horizontal gate distance (gate offset) was larger than in gate distance (linear distance from gate to gate). In giant slalom the horizontal gate distance increased with terrain inclination, while super-G and downhill did not show such a connection. In giant slalom and super-G, there was a slight trend towards shorter gate distances as the steepness of the terrain increased. Gates were usually set close to terrain transitions in all three disciplines. Downhill had a larger proportion of extreme terrain inclination changes along the skier trajectory per unit time skiing than the other disciplines. Skier speed decreased with increasing steepness of terrain in all disciplines except for downhill. In steep terrain, speed was found to be controllable by increased horizontal gate distances in giant slalom and by shorter gate distances in giant slalom and super-G. Across the disciplines skier speed was largely explained by course setting and terrain inclination in a multiple linear model.	[Gilgien, Matthias] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Spoerri, Joerg; Kroll, Joesef; Mueller, Erich] Salzburg Univ, Dept Sport Sci & Kinesiol, Hallein Rif, Austria; [Crivelli, Philip] WSL, Inst Snow & Avalanche Res SLF, Grp Snowsports, Davos, Switzerland	Norwegian School of Sport Sciences; Salzburg University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Gilgien, M (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway.	matthias.gilgien@nih.no		Sporri, Jorg/0000-0002-0353-1021	International Skiing Federation (FIS) through the FIS Injury Surveillance System	International Skiing Federation (FIS) through the FIS Injury Surveillance System	This study was financially supported by the International Skiing Federation (FIS) through the FIS Injury Surveillance System. URL: http://www.fis-ski.com/inside-fis/medical-antidoping/injury-surveillance-system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelle C, 2004, J APPL BIOMECH, V20, P167, DOI 10.1123/jab.20.2.167; Bere T, 2013, SCAND J MED SCI SPOR; Bere T, 2014, BRIT J SPORT MED, V48, P738, DOI 10.1136/bjsports-2014-093528; Bere T, 2013, AM J SPORT MED, V41, P1067, DOI 10.1177/0363546513479341; Bere T, 2011, BRIT J SPORT MED, V45, P1294, DOI 10.1136/bjsports-2011-090517; Bere T, 2011, AM J SPORT MED, V39, P1421, DOI 10.1177/0363546511405147; Fauve M., 2002, PREPARATION MAINTENA; Federolf P, 2006, ENG SPORT 6, P285; Florenes TW, 2012, SCAND J MED SCI SPOR, V22, P58, DOI 10.1111/j.1600-0838.2010.01147.x; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; Gilgien M., 2008, 13 ANN C EUR COLL SP, P569; Gilgien M, 2008, ANN C EUR COLL SPORT; Gilgien M, 2013, J SPORT SCI IN PRESS; Gilgien M., 2014, THESIS NORWEGIAN SCH; Gilgien M, 2014, SENSORS-BASEL, V14, P18433, DOI 10.3390/s141018433; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Heinrich D, 2014, SCAND J MED SCI SPOR, V24, pE180, DOI 10.1111/sms.12120; Hugentobler M., 2004, TERRAIN MODELLING TR; Kroll J, 2013, SPORT ORTHOPADIE SPO, V29, P288; Luthi A., 2006, ENG SPORT 6, V1, P299; Meyer F, 2012, MED SCI SPORT EXER, V44, P1109, DOI 10.1249/MSS.0b013e3182443315; Nachbauer W, 1996, AM SOC TEST MATER, V1266, P178, DOI 10.1520/STP37927S; Nachbauer W., 2004, P ENG SPORT 5 WINF I, P472; Raschner C, 2012, BRIT J SPORT MED, V46, P1065, DOI 10.1136/bjsports-2012-091050; Reid R.C, 2010, THESIS NORWEGIAN SCH; Ruedl G, 2011, INT J SPORTS MED, V32, P801, DOI 10.1055/s-0031-1279719; Schiestl M., 2006, ENG SPORT, P269; Schindelwig K, 2014, SCAND J MED SCI SPOR; Sporri J, 2012, INT J SPORTS SCI COA, V7, P647, DOI 10.1260/1747-9541.7.4.647; Sporri J, 2012, BRIT J SPORT MED, V46, P1072, DOI 10.1136/bjsports-2012-091425; Sporri J, 2012, BRIT J SPORT MED, V46, P1059, DOI 10.1136/bjsports-2012-091048; Supej M, 2013, SCAND J MED SCI SPOR, V23, pe38, DOI 10.1111/sms.12007; Supej M, 2014, INT J SPORTS PHYSL P; Supej M., 2005, KINESIOLOGY, V37, P151; Wolfsperger F, 2013, INT C SCI SKIING; Yamazaki J, 2014, ANAL SEVERE HE UNPUB	37	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118119	10.1371/journal.pone.0118119	http://dx.doi.org/10.1371/journal.pone.0118119			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760039	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000018
J	Yu, GJ; Yin, YL; Yu, WH; Liu, W; Jin, YX; Shrestha, A; Yang, Q; Ye, XD; Sun, H				Yu, Guo-Jun; Yin, Ya-Lin; Yu, Wen-Hui; Liu, Wei; Jin, Yan-Xia; Shrestha, Alok; Yang, Qing; Ye, Xiang-Dong; Sun, Hui			Proteome Exploration to Provide a Resource for the Investigation of Ganoderma lucidum	PLOS ONE			English	Article							FUNGAL IMMUNOMODULATORY PROTEIN; CARBOHYDRATE-ACTIVE ENZYMES; TRICARBOXYLIC-ACID CYCLE; LING ZHI-8 LZ-8; NF-KAPPA-B; PHARMACOLOGICAL FUNCTIONS; SACCHAROMYCES-CEREVISIAE; RECOMBINANT EXPRESSION; STAPHYLOCOCCUS-AUREUS; AGROCYBE-AEGERITA	Ganoderma lucidum is a basidiomycete white rot fungus that has been used for medicinal purposes worldwide. Although information concerning its genome and transcriptome has recently been reported, relatively little information is available for G. lucidum at the proteomic level. In this study, protein fractions from G. lucidum at three developmental stages (16-day mycelia, and fruiting bodies at 60 and 90 days) were prepared and subjected to LC-MS/MS analysis. A search against the G. lucidum genome database identified 803 proteins. Among these proteins, 61 lignocellulose degrading proteins were detected, most of which (49 proteins) were found in the 90-day fruiting bodies. Fourteen TCA-cycle related proteins, 17 peptidases, two argonaute-like proteins, and two immunomodulatory proteins were also detected. A majority (470) of the 803 proteins had GO annotations and were classified into 36 GO terms, with "binding", "catalytic activity", and "hydrolase activity"having high percentages. Additionally, 357 out of the 803 proteins were assigned to at least one COG functional category and grouped into 22 COG classifications. Based on the results from the proteomic and sequence alignment analyses, a potentially new immunomodulatory protein (GL18769) was expressed and shown to have high immunomodulatory activity. In this study, proteomic and biochemical analyses of G. lucidum were performed for the first time, revealing that proteins from this fungus can play significant bioactive roles and providing a new foundation for the further functional investigations that this fungus merits.	[Yu, Guo-Jun; Yin, Ya-Lin; Yu, Wen-Hui; Liu, Wei; Jin, Yan-Xia; Shrestha, Alok; Yang, Qing; Ye, Xiang-Dong; Sun, Hui] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Sun, Hui] Wuhan Univ, Key Lab Combinatorial Biosynthesis & Drug Discove, Minist Educ, Wuhan 430072, Peoples R China; [Sun, Hui] Hubei Univ Technol, Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Key Lab Fermentat Engn, Minist Educ, Wuhan, Peoples R China	Wuhan University; Wuhan University; Hubei University of Technology	Sun, H (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	sunhui@whu.edu.cn	Jin, Yanxia/W-8478-2019		National Science Foundation of China (NSFC) [31301426, 31370849]; Research Fund for the Doctoral Program of Higher Education of China program [20130146120019]; National Key Technologies RD Program [2009ZX09103-676, 2012ZX10001-006]; Chinese 111 project [B06018]; Wuhan University project [2042014kf0226]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China program; National Key Technologies RD Program(National Key Technology R&D Program); Chinese 111 project(Ministry of Education, China - 111 Project); Wuhan University project	The present research project was funded by the National Science Foundation of China (NSFC) program [31301426, 31370849] (http://www.nsfc.gov.cn/), the Research Fund for the Doctoral Program of Higher Education of China program [20130146120019], the National Key Technologies R&D Program [2009ZX09103-676, 2012ZX10001-006] (http://www.nmp.gov.cn/), the Chinese 111 project [B06018], and Wuhan University project [No. 2042014kf0226]. The funders had no role in study	Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Aoshima M, 2007, APPL MICROBIOL BIOT, V75, P249, DOI 10.1007/s00253-007-0893-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao XF, 2001, CARBOHYD RES, V332, P67, DOI 10.1016/S0008-6215(01)00075-1; Barros BHR, 2010, FUNGAL BIOL-UK, V114, P572, DOI 10.1016/j.funbio.2010.04.007; Bharti RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091300; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; D'Ambrosio C, 2013, J PROTEOMICS, V78, P39, DOI 10.1016/j.jprot.2012.11.008; D'Souza TM, 1999, APPL ENVIRON MICROB, V65, P5307; de Oliveira JMPF, 2011, APPL MICROBIOL BIOT, V89, P225, DOI 10.1007/s00253-010-2900-0; Douglas CM, 2001, MED MYCOL, V39, P55, DOI 10.1080/mmy.39.1.55.66; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Guranowski A, 2004, FEBS LETT, V561, P83, DOI 10.1016/s0014-5793(04)00126-7; Horie K, 2008, J PROTEOME RES, V7, P1819, DOI 10.1021/pr070369o; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hsu HC, 1997, BIOCHEM J, V323, P557, DOI 10.1042/bj3230557; Huang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061127; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Jakucs Elizabeth, 1994, Acta Microbiologica et Immunologica Hungarica, V41, P23; Jiang S, 2012, BIOCHEM J, V443, P369, DOI 10.1042/BJ20112061; Johnson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104155; Johswich A, 2014, J BIOL CHEM, V289, P15927, DOI 10.1074/jbc.M114.563734; Kimura Y, 2002, ANTICANCER RES, V22, P3309; KINO K, 1989, J BIOL CHEM, V264, P472; Ko EM, 2001, APPL MICROBIOL BIOT, V57, P98, DOI 10.1007/s002530100727; KO JL, 1995, EUR J BIOCHEM, V228, P244, DOI 10.1111/j.1432-1033.1995.tb20256.x; Kuan YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021004; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li F, 2012, PROTEIN EXPRES PURIF, V82, P339, DOI 10.1016/j.pep.2012.01.015; Li P, 2013, NAT PROD RES, V27, P17, DOI 10.1080/14786419.2011.652961; Li SY, 2014, INT J MOL SCI, V15, P17751, DOI 10.3390/ijms151017751; Liebminger E, 2011, J BIOL CHEM, V286, P10793, DOI 10.1074/jbc.M110.178020; Lin CH, 2010, J AGR FOOD CHEM, V58, P12014, DOI 10.1021/jf103068w; Liu DL, 2001, FOOD CHEM TOXICOL, V39, P461, DOI 10.1016/S0278-6915(00)00161-7; Liu DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036146; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo Hongmei, 2010, Chin Med, V5, P9, DOI 10.1186/1749-8546-5-9; Matallana-Surget S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099076; McNeil MB, 2014, FEBS LETT, V588, P414, DOI 10.1016/j.febslet.2013.12.019; Monteiro R, 2012, J PROTEOMICS, V75, P2892, DOI 10.1016/j.jprot.2011.12.036; Nunes-Nesi A, 2013, CURR OPIN PLANT BIOL, V16, P335, DOI 10.1016/j.pbi.2013.01.004; Ohnuma K, 2011, ADV CLIN CHEM, V53, P51, DOI 10.1016/S0065-2423(11)53003-3; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Rahmad N, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-30; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Ren A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065027; Restelli L, 2014, J PROTEOMICS, V108, P295, DOI 10.1016/j.jprot.2014.05.027; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sanfelix-Haywood N, 2011, J APPL MICROBIOL, V111, P433, DOI 10.1111/j.1365-2672.2011.05045.x; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Scherl A, 2005, J MICROBIOL METH, V60, P247, DOI 10.1016/j.mimet.2004.09.017; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sickmann A, 2003, ADV BIOCHEM ENG BIOT, V83, P141; Sripuan T, 2003, BIOSCI BIOTECH BIOCH, V67, P1485, DOI 10.1271/bbb.67.1485; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; TANAKA S, 1989, J BIOL CHEM, V264, P16372; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terol J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-222; Tomm JM, 2013, J INVEST ALLERG CLIN, V23, P443; Wang JG, 2013, CARBOHYD POLYM, V91, P33, DOI 10.1016/j.carbpol.2012.08.017; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056686; Wu GS, 2013, EXPERT OPIN INV DRUG, V22, P981, DOI 10.1517/13543784.2013.805202; Wu X, 2013, INT J MED MUSHROOMS, V15, P383, DOI 10.1615/IntJMedMushr.v15.i4.60; Wu YL, 2009, J PROTEOME RES, V8, P436, DOI 10.1021/pr800554w; Yang JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002179; Yao ZY, 2012, APPL MICROBIOL BIOT, V93, P1999, DOI 10.1007/s00253-011-3541-7; Yin YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051853; Yoon HM, 2013, EXP THER MED, V5, P957, DOI 10.3892/etm.2013.895; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang CR, 2008, NAT PROD RES, V22, P1137, DOI 10.1080/14786410601129721; Zhao CG, 2003, BIOCHEM J, V374, P321, DOI 10.1042/BJ20030300; Zheng HY, 2013, PROTEINS, V81, P1031, DOI 10.1002/prot.24227; Zhou XW, 2007, AM J CHINESE MED, V35, P559, DOI 10.1142/S0192415X07005065	83	17	20	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119439	10.1371/journal.pone.0119439	http://dx.doi.org/10.1371/journal.pone.0119439			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756518	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275700047
J	Suh, J; Moncaster, JA; Wang, LR; Hafeez, I; Herz, J; Tanzi, RE; Goldstein, LE; Guenette, SY				Suh, Jaehong; Moncaster, Juliet A.; Wang, Lirong; Hafeez, Imran; Herz, Joachim; Tanzi, Rudolph E.; Goldstein, Lee E.; Guenette, Suzanne Y.			FE65 and FE65L1 amyloid precursor protein-binding protein compound null mice display adult-onset cataract and muscle weakness	FASEB JOURNAL			English	Article						APP; congenital muscular dystrophy; extracellular matrix; laminin; lens	APP FAMILY-MEMBERS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; MYOTONIC-DYSTROPHY; BRAIN-DEVELOPMENT; SKELETAL-MUSCLE; MAMMALIAN FE65; DEFICIENT MICE; BETA	FE65 and FE65L1 are cytoplasmic adaptor proteins that bind a variety of proteins, including the amyloid precursor protein, and that mediate the assembly of multimolecular complexes. We previously reported that FE65/FE65L1 double knockout (DKO) mice display disorganized laminin in meningeal fibroblasts and a cobblestone lissencephaly-like phenotype in the developing cortex. Here, we examined whether loss of FE65 and FE65L1 causes ocular and muscular deficits, 2 phenotypes that frequently accompany cobblestone lissencephaly. Eyes of FE65/FE65L1 DKO mice develop normally, but lens degeneration becomes apparent in young adult-mice. Abnormal lens epithelial cell migration, widespread small vacuole formation, and increased laminin expression underneath lens capsules suggest impaired interaction between epithelial cells and capsular extracellular matrix in DKO lenses. Cortical cataracts develop in FE65L1 knockout (KO) mice aged 16 months or more but are absent in wild-type or FE65 KO mice. FE65 family KO mice show attenuated grip strength, and the nuclei of DKO muscle cells frequently locate in the middle of muscle fibers. These findings reveal that FE65 and FE65L1 are essential for the maintenance of lens transparency, and their loss produce phenotypes in brain, eye, and muscle that are comparable to the clinical features of congenital muscular dystrophies in humans.	[Suh, Jaehong; Wang, Lirong; Hafeez, Imran; Tanzi, Rudolph E.; Guenette, Suzanne Y.] Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Genet & Aging Res Unit,Dept Neurol,Med Sch, Boston, MA 02129 USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Med, Mol Aging & Dev Lab, Boston, MA 02118 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Suh, J (corresponding author), Harvard Univ, MassGen Inst Neurodegenerat Dis, Massachusetts Gen Hosp, Genet & Aging Res Unit,Dept Neurol,Med Sch, 114 16th St, Boston, MA 02129 USA.	suh.jaehong@mgh.harvard.edu; suzanne.guenette@gmail.com	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Moncaster, Juliet/0000-0002-7849-4325	U.S. National Institutes of Health; Korea Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Foundation(National Research Foundation of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank D. Romano for her technical assistance in muscle pathology experiments. The authors also thank M. Lawlor (Boston Children Hospital) for his advice on muscle tissue preparation and C. Vanderburg (Massachusetts General Hospital) for his scientific expertise and advice on the muscle study. This work was supported by grants from the U.S. National Institutes of Health (to S.Y.G. and R.E.T.) and by a fellowship from the Korea Research Foundation (to J.S.).	Bassez G, 2008, J NEUROPATH EXP NEUR, V67, P319, DOI 10.1097/NEN.0b013e31816b4acc; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Beyreuther K, 1996, ANN NY ACAD SCI, V777, P74, DOI 10.1111/j.1749-6632.1996.tb34403.x; Bimonte M, 2004, EUR J NEUROSCI, V20, P1483, DOI 10.1111/j.1460-9568.2004.03611.x; Caceres J, 1997, J CELL BIOCHEM, V65, P145, DOI 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; Cheung HNM, 2014, FASEB J, V28, P337, DOI 10.1096/fj.13-232694; daCunha RP, 1996, AM J OPHTHALMOL, V122, P236, DOI 10.1016/S0002-9394(14)72015-X; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; Dumanis SB, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-9; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Forni PE, 2011, J NEUROSCI, V31, P480, DOI 10.1523/JNEUROSCI.4698-10.2011; Francis PJ, 1999, TRENDS GENET, V15, P191, DOI 10.1016/S0168-9525(99)01738-2; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Jun G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043728; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Kerbage C., AM J ALZHEI IN PRESS; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Mendell JR, 2006, PEDIATR DEVEL PATHOL, V9, P427, DOI 10.2350/06-07-0127.1; Meng Hui, 2014, J Vis Exp, DOI 10.3791/51586; Michael R, 2013, EXP EYE RES, V106, P5, DOI 10.1016/j.exer.2012.10.012; Minopoli G, 2012, IUBMB LIFE, V64, P936, DOI 10.1002/iub.1094; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; Nensa FM, 2014, MOL CELL PROTEOMICS, V13, P475, DOI 10.1074/mcp.M113.029280; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Ralston E, 2006, J CELL PHYSIOL, V209, P874, DOI 10.1002/jcp.20780; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rodrigues ADC, 2007, MICROSURG, V27, P664, DOI 10.1002/micr.20428; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; Schoser BGH, 2004, MUSCLE NERVE, V29, P275, DOI 10.1002/mus.10545; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Suh J, 2011, J NEUROCHEM, V119, P377, DOI 10.1111/j.1471-4159.2011.07419.x; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Truscott RJW, 2003, INT J BIOCHEM CELL B, V35, P1500, DOI 10.1016/S1357-2725(03)00145-6; Waite A, 2012, TRENDS NEUROSCI, V35, P487, DOI 10.1016/j.tins.2012.04.004; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang Y, 2009, LEARN MEMORY, V16, P537, DOI 10.1101/lm.1499309; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zambrano N, 2002, J CELL SCI, V115, P1411; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	63	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2628	2639		10.1096/fj.14-261453	http://dx.doi.org/10.1096/fj.14-261453			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757569	Green Published			2022-12-26	WOS:000355209500038
J	Gonzalez-Foruria, I; Santulli, P; Chouzenoux, S; Carmona, F; Batteux, F; Chapron, C				Gonzalez-Foruria, Inaki; Santulli, Pietro; Chouzenoux, Sandrine; Carmona, Francisco; Batteux, Frederic; Chapron, Charles			Soluble Ligands for the NKG2D Receptor Are Released during Endometriosis and Correlate with Disease Severity	PLOS ONE			English	Article							NATURAL-KILLER-CELL; DEEPLY INFILTRATING ENDOMETRIOSIS; PERITONEAL-FLUID; BLADDER ENDOMETRIOSIS; WOMEN; EXPRESSION; CYTOTOXICITY; MANAGEMENT; SERUM; PATHOGENESIS	Background Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the immune control of endometriosis. Methods and Findings This is a prospective laboratory study conducted in a tertiary-care university hospital between January 2011 and April 2013. We investigated non-pregnant, younger than 42-year-old patients (n = 202) during surgery for benign gynaecological conditions. After complete surgical exploration of the abdominopelvic cavity, 121 women with histologically proven endometriosis and 81 endometriosis-free controls women were enrolled. Patients with endometriosis were classified according to a surgical classification in three different types of endometriosis: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE). Peritoneal fluid samples were obtained from all study participants during the surgery in order to detect soluble NKG2D ligands (MICA, MICB and ULBP-2). When samples with undetectable peritoneal fluid levels of MICA, MICB and ULBP-2 were excluded, MICA ratio levels were significantly higher in endometriosis patients than in controls (median, 1.1 pg/mg; range, 0.1-143.5 versus median, 0.6 pg/mg; range, 0.1-3.5; p=0.003). In a similar manner peritoneal fluid MICB levels were also increased in endometriosis-affected patients compared with disease-free women (median, 4.6 pg/mg; range, 1.2-4702 versus median, 3.4 pg/mg; range, 0.7-20.1; p=0.001). According to the surgical classification, peritoneal fluid soluble MICA, MICB and ULBP-2 ratio levels were significantly increased in DIE as compared to controls (p=0.015, p=0.003 and p=0.045 respectively). MICA ratio levels also correlated with dysmenorrhea (r=0.232; p=0.029), total rAFS score (r=0.221; p=0.031) and adhesions rAFS score (r=0.221; p=0.031). Conclusions We demonstrate a significant increase of peritoneal fluid NKG2D ligands in women with endometriosis especially in those cases presenting DIE. This study suggests that NKG2D ligands shedding is a novel pathway in endometriosis complex pathogenesis that impairs NK cell function.	[Gonzalez-Foruria, Inaki; Santulli, Pietro; Chouzenoux, Sandrine; Batteux, Frederic; Chapron, Charles] INSERM, Inst Cochin, Dept Dev Reprod & Canc, Paris, France; [Gonzalez-Foruria, Inaki; Santulli, Pietro; Chapron, Charles] Univ Paris 05, Dept Gynecol Obstet & Reprod Med 2, Grp Hosp Univ GHU Ouest,Ctr Hosp Univ CHU Cochin, AP HP,Sorbone Paris Cite,Fac Med, Paris, France; [Gonzalez-Foruria, Inaki; Carmona, Francisco] Univ Barcelona, Hosp Clin, IDIBAPS, Inst Clin Gynecol Obstet & Neonatol,Fac Med, Barcelona, Spain; [Batteux, Frederic] Hop Cochin, Serv Immunol Biol, F-75674 Paris 14, France; [Batteux, Frederic; Chapron, Charles] Hop Cochin, DHU Risque & Grossesse, F-75674 Paris 14, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP	Batteux, F (corresponding author), INSERM, Inst Cochin, Dept Dev Reprod & Canc, Paris, France.	frederic.batteux@cch.aphp.fr	Batteux, Frederic/O-7889-2017; Santulli, Pietro/T-5201-2019; Santulli, Pi/O-8756-2017; Chapron, Charles/O-8567-2017; Carmona, Francisco/AAT-1363-2020	Batteux, Frederic/0000-0002-1265-7996; Gonzalez-Foruria, Inaki/0000-0003-4846-0578	University Paris Descartes; INSERM; Fundacion Alfonso Martin Escudero	University Paris Descartes; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fundacion Alfonso Martin Escudero	This work was supported by grants from University Paris Descartes, INSERM, and Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews WC, 1985, FERTIL STERIL, V44, P7, DOI DOI 10.1016/S0015-0282(16)48797-2; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berkkanoglu M, 2003, AM J REPROD IMMUNOL, V50, P48, DOI 10.1034/j.1600-0897.2003.00042.x; Borghese B, 2008, MOL ENDOCRINOL, V22, P2557, DOI 10.1210/me.2008-0322; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chapron C, 2004, ANN NY ACAD SCI, V1034, P326, DOI 10.1196/annals.1335.035; Chapron C, 2006, HUM REPROD, V21, P1839, DOI 10.1093/humrep/del079; Chapron C, 2011, HUM REPROD, V26, P2028, DOI 10.1093/humrep/der156; Chapron C, 2011, FERTIL STERIL, V95, P877, DOI 10.1016/j.fertnstert.2010.10.027; Chapron C, 2010, FERTIL STERIL, V94, P2353, DOI 10.1016/j.fertnstert.2010.04.020; Chapron C, 2010, HUM REPROD, V25, P884, DOI 10.1093/humrep/deq017; Chapron C, 2009, FERTIL STERIL, V92, P453, DOI 10.1016/j.fertnstert.2008.06.003; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; de Ziegler D, 2010, LANCET, V376, P730, DOI 10.1016/S0140-6736(10)60490-4; Donnez J, 1996, FERTIL STERIL, V66, P362, DOI 10.1016/S0015-0282(16)58501-X; Dousset B, 2010, ANN SURG, V251, P887, DOI 10.1097/SLA.0b013e3181d9722d; Fauconnier A, 2005, HUM REPROD UPDATE, V11, P595, DOI 10.1093/humupd/dmi029; Fauconnier A, 2002, FERTIL STERIL, V78, P719, DOI 10.1016/S0015-0282(02)03331-9; Funamizu A, 2014, AM J REPROD IMMUNOL, V71, P359, DOI 10.1111/aji.12206; Garzetti GG, 1996, OBSTET GYNECOL, V88, P234; GARZETTI GG, 1993, OBSTET GYNECOL, V81, P665; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; HALME J, 1983, AM J OBSTET GYNECOL, V145, P333, DOI 10.1016/0002-9378(83)90720-2; Huergo-Zapico L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00106; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; KANZAKI H, 1992, AM J OBSTET GYNECOL, V167, P257, DOI 10.1016/S0002-9378(11)91670-6; Katsuki Y, 1998, EUR J ENDOCRINOL, V138, P216, DOI 10.1530/eje.0.1380216; KhoshdelRad N, 2014, ARCH GYNECOL OBSTET, V289, P1107, DOI 10.1007/s00404-013-3082-7; Knapp VJ, 1999, FERTIL STERIL, V72, P10; Laschke MW, 2011, HUM REPROD UPDATE, V17, P628, DOI 10.1093/humupd/dmr023; Leconte M, 2014, J REPROD IMMUNOL, V103, P45, DOI 10.1016/j.jri.2013.12.121; Lopez-Soto A, 2014, INT J CANC; Maeda N, 2002, FERTIL STERIL, V77, P297, DOI 10.1016/S0015-0282(01)02964-8; Matarese G, 2003, TRENDS MOL MED, V9, P223, DOI 10.1016/S1471-4914(03)00051-0; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Ngo C, 2009, AM J PATHOL, V175, P225, DOI 10.2353/ajpath.2009.080804; OOSTERLYNCK DJ, 1991, FERTIL STERIL, V56, P45; OOSTERLYNCK DJ, 1992, FERTIL STERIL, V58, P290; OOSTERLYNCK DJ, 1994, ACTA OBSTET GYN SCAN, V73, P333, DOI 10.3109/00016349409015774; OOSTERLYNCK DJ, 1993, OBSTET GYNECOL, V82, P206; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Salih HR, 2008, FRONT BIOSCI, V13, P3448; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sampson JA, 1927, AM J PATHOL, V3, P93; Santulli P, 2014, J CLIN ENDOCR METAB, V99, P881, DOI 10.1210/jc.2013-2950; Santulli P, 2013, HUM REPROD, V28, P2126, DOI 10.1093/humrep/det238; Santulli P, 2013, FERTIL STERIL, V99, P219, DOI 10.1016/j.fertnstert.2012.08.055; Senturk LM, 1999, J REPROD IMMUNOL, V43, P67, DOI 10.1016/S0165-0378(98)00079-5; Somigliana E, 2007, FERTIL STERIL, V87, P1287, DOI 10.1016/j.fertnstert.2006.11.090; Streuli I, 2013, EXPERT OPIN PHARMACO, V14, P291, DOI 10.1517/14656566.2013.767334; Umesaki N, 1999, GYNECOL OBSTET INVES, V48, P66, DOI 10.1159/000010137; Vinatier D, 1996, HUM REPROD UPDATE, V2, P371, DOI 10.1093/humupd/2.5.371; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; WILSON TJ, 1994, FERTIL STERIL, V62, P1086; Wu MH, 2005, J CLIN ENDOCR METAB, V90, P286, DOI 10.1210/jc.2004-1612; Wu MY, 2000, FERTIL STERIL, V74, P1187, DOI 10.1016/S0015-0282(00)01592-2; Yuge A, 2007, HUM REPROD, V22, P938, DOI 10.1093/humrep/del485	59	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119961	10.1371/journal.pone.0119961	http://dx.doi.org/10.1371/journal.pone.0119961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775242	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500144
J	Shankar, V; Hori, H; Kihira, K; Lei, Q; Toyoda, H; Iwamoto, S; Komada, Y				Shankar, Vipin; Hori, Hiroki; Kihira, Kentaro; Lei, Qi; Toyoda, Hidemi; Iwamoto, Shotaro; Komada, Yoshihiro			Mesenchymal Stromal Cell Secretome Up-Regulates 47 kDa CXCR4 Expression, and Induce Invasiveness in Neuroblastoma Cell Lines	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; CHEMOKINE RECEPTOR CXCR4; BONE-MARROW; CANCER-CELLS; TUMOR-CELLS; MICROENVIRONMENT; METASTASIS; GROWTH; HETEROGENEITY; SENSITIVITY	Neuroblastoma accounts for 15% of childhood cancer deaths and presents with metastatic disease of the bone and the bone marrow at diagnosis in 70% of the cases. Previous studies have shown that the Mesenchymal Stromal Cell (MSC) secretome, triggers metastases in several cancer types such as breast and prostate cancer, but the specific role of the MSC factors in neuroblastoma metastasis is unclear. To better understand the effect of MSC secretome on chemokine receptors in neuroblastoma, and its role in metastasis, we studied a panel of 20 neuroblastoma cell lines, and compared their invasive potential towards MSC-conditioned-RPMI (mRPMI) and their cytokine receptor expression profiles. Western blot analysis revealed the expression of multiple CXCR4 isoforms in neuroblastoma cells. Among the five major isoforms, the expression of the 47 kDa isoform showed significant correlation with high invasiveness. Pretreatment with mRPMI up-regulated the expression of the 47 kDa CXCR4 isoform and also increased MMP-9 secretion, expression of integrin alpha 3 and integrin beta 1, and the invasive potential of the cell; while blocking CXCR4 either with AMD 3100, a CXCR4 antagonist, or with an anti-47 kDa CXCR4 neutralizing antibody decreased the secretion of MMP-9, the expression of integrin alpha 3 and integrin beta 1, and the invasive potential of the cell. Pretreatment with mRPMI also protected the 47 kDa CXCR4 isoform from ubiquitination and subsequent degradation. Our data suggest a modulatory role of the MSC secretome on the expression of the 47 kDa CXCR4 isoform and invasion potential of the neuroblastoma cells to the bone marrow.	[Shankar, Vipin; Hori, Hiroki; Kihira, Kentaro; Lei, Qi; Toyoda, Hidemi; Iwamoto, Shotaro; Komada, Yoshihiro] Mie Univ, Grad Sch Med, Dept Pediat, Tsu, Mie 514, Japan	Mie University	Hori, H (corresponding author), Mie Univ, Grad Sch Med, Dept Pediat, 2-174 Edobashi, Tsu, Mie 514, Japan.	hhori@clin.medic.mie-u.ac.jp	Chelakkot, Vipin Shankar/GPX-2558-2022	Chelakkot, Vipin Shankar/0000-0002-2385-9489				Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chantrain CF, 2008, CANCER MICROENVIRON, V1, P23, DOI 10.1007/s12307-008-0010-7; Chinni SR, 2006, PROSTATE, V66, P32, DOI 10.1002/pros.20318; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Fukuda M, 2001, J PEDIAT HEMATOL ONC, V23, P10, DOI 10.1097/00043426-200101000-00004; Furusato B, 2009, CANCER DRUG DISCOV D, P31, DOI 10.1007/978-1-60327-267-4_2; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Granchi D, 2011, BONE, V48, P152, DOI 10.1016/j.bone.2010.06.028; Hiraiwa H, 1997, CANCER, V79, P2036, DOI 10.1002/(SICI)1097-0142(19970515)79:10<2036::AID-CNCR27>3.3.CO;2-M; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Iwamoto S, 2007, J CLIN INVEST, V117, P1049, DOI 10.1172/JCI30235; Jacobson O, 2009, BIOORGAN MED CHEM, V17, P1486, DOI 10.1016/j.bmc.2009.01.014; Kisenge RR, 2003, CANCER SCI, V94, P598, DOI 10.1111/j.1349-7006.2003.tb01489.x; Kollar Katarina, 2009, Int J Cell Biol, V2009, P904682, DOI 10.1155/2009/904682; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Komada Y, 1998, CANCER, V82, P591, DOI 10.1002/(SICI)1097-0142(19980201)82:3<591::AID-CNCR23>3.3.CO;2-E; Kukreja P, 2005, CANCER RES, V65, P9891, DOI 10.1158/0008-5472.CAN-05-1293; Lapham CK, 2002, J LEUKOCYTE BIOL, V72, P1206; Lee S, 2012, ONCOTARGET, V3, P1576; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 2008, LANCET ONCOL, V9, P195, DOI 10.1016/S1470-2045(08)70046-9; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Mishra A, 2011, CANCER MICROENVIRON, V4, P221, DOI 10.1007/s12307-011-0083-6; Ogawa M, 2005, CLIN CANCER RES, V11, P3485, DOI 10.1158/1078-0432.CCR-04-1781; Ootsuka S, 2008, BIOL PHARM BULL, V31, P1071, DOI 10.1248/bpb.31.1071; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Qi L, 2013, CANCER SCI, V104, P1162, DOI 10.1111/cas.12204; Raffaghello L, 2009, SEMIN CANCER BIOL, V19, P97, DOI 10.1016/j.semcancer.2008.10.003; Reynolds CP, 2004, PEDIATR TRANSPLANT, V8, P56, DOI 10.1111/j.1398-2265.2004.00216.x; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Sloane AJ, 2005, IMMUNOL CELL BIOL, V83, P129, DOI 10.1111/j.1440-1711.2004.01304.x; Sohara Y, 2005, CANCER LETT, V228, P203, DOI 10.1016/j.canlet.2005.01.059; Somasundaram R, 2009, SEMIN CANCER BIOL, V19, P92, DOI 10.1016/j.semcancer.2008.11.002; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Ura H, 1998, SURG TODAY, V28, P1001, DOI 10.1007/BF02483952; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhao HY, 2013, CHILD NERV SYST, V29, P1097, DOI 10.1007/s00381-013-2086-8	49	16	16	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120069	10.1371/journal.pone.0120069	http://dx.doi.org/10.1371/journal.pone.0120069			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774696	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500148
J	Fillmore, N; Huqi, A; Jaswal, JS; Mori, J; Paulin, R; Haromy, A; Onay-Besikci, A; Ionescu, L; Thebaud, B; Michelakis, E; Lopaschuk, GD				Fillmore, Natasha; Huqi, Alda; Jaswal, Jagdip S.; Mori, Jun; Paulin, Roxane; Haromy, Alois; Onay-Besikci, Arzu; Ionescu, Lavinia; Thebaud, Bernard; Michelakis, Evangelos; Lopaschuk, Gary D.			Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival	PLOS ONE			English	Article							PROLIFERATION; APOPTOSIS; DIFFERENTIATION; GROWTH; AKT; DEHYDROGENASE; ACTIVATION; OXIDATION; PATHWAY; STRESS	Successful stem cell therapy requires the optimal proliferation, engraftment, and differentiation of stem cells into the desired cell lineage of tissues. However, stem cell therapy clinical trials to date have had limited success, suggesting that a better understanding of stem cell biology is needed. This includes a better understanding of stem cell energy metabolism because of the importance of energy metabolism in stem cell proliferation and differentiation. We report here the first direct evidence that human bone marrow mesenchymal stem cell (BMMSC) energy metabolism is highly glycolytic with low rates of mitochondrial oxidative metabolism. The contribution of glycolysis to ATP production is greater than 97% in undifferentiated BMMSCs, while glucose and fatty acid oxidation combined only contribute 3% of ATP production. We also assessed the effect of physiological levels of fatty acids on human BMMSC survival and energy metabolism. We found that the saturated fatty acid palmitate induces BMMSC apoptosis and decreases proliferation, an effect prevented by the unsaturated fatty acid oleate. Interestingly, chronic exposure of human BMMSCs to physiological levels of palmitate (for 24 hr) reduces palmitate oxidation rates. This decrease in palmitate oxidation is prevented by chronic exposure of the BMMSCs to oleate. These results suggest that reducing saturated fatty acid oxidation can decrease human BMMSC proliferation and cause cell death. These results also suggest that saturated fatty acids may be involved in the long-term impairment of BMMSC survival in vivo.	[Fillmore, Natasha; Huqi, Alda; Jaswal, Jagdip S.; Mori, Jun; Paulin, Roxane; Haromy, Alois; Onay-Besikci, Arzu; Ionescu, Lavinia; Thebaud, Bernard; Michelakis, Evangelos; Lopaschuk, Gary D.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta	Lopaschuk, GD (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada.	gary.lopaschuk@ualberta.ca	Huqi, Alda/AAC-2422-2019; Onay-Besikci, Arzu/AAH-1413-2020	Huqi, Alda/0000-0003-2818-7113; Onay-Besikci, Arzu/0000-0001-6883-1757; Fillmore, Natasha/0000-0002-6723-0869	Canadian Institutes of Health Research [123472]; Alberta Innovates Health Solutions studentship; Alberta Innovates [201200975] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions studentship; Alberta Innovates; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: Supported by a grant from the Canadian Institutes of Health Research 123472. http://www.cihrirsc.gc.ca/e/193.html. GDL is an Alberta Heritage Foundation for Medical Research Scientist. NF holds an Alberta Innovates Health Solutions studentship. http://www.aihealthsolutions.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dawud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039896; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BOONE CW, 1971, IN VITRO CELL DEV B, V7, P174, DOI 10.1007/BF02617963; Burgess RJ, 2014, J INTERN MED, V276, P12, DOI 10.1111/joim.12247; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Chung S, 2010, J MOL CELL CARDIOL, V48, P725, DOI 10.1016/j.yjmcc.2009.12.014; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Copland IB, 2011, SEMIN IMMUNOPATHOL, V33, P535, DOI 10.1007/s00281-011-0274-8; de Meester C, 2014, CARDIOVASC RES, V101, P20, DOI 10.1093/cvr/cvt227; Guarnerio J, 2014, STEM CELL REP, V2, P794, DOI 10.1016/j.stemcr.2014.04.002; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Kang JX, 2014, STEM CELLS, V32, P1092, DOI 10.1002/stem.1620; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kong JY, 2003, ARCH BIOCHEM BIOPHYS, V412, P196, DOI 10.1016/S0003-9861(03)00008-0; Krieg RC, 2004, J BIOCHEM BIOPH METH, V58, P119, DOI 10.1016/j.jbbm.2003.10.002; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Lim SY, 2006, CARDIOVASC RES, V70, P530, DOI 10.1016/j.cardiores.2006.02.016; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Lu J, 2012, ENDOCRINOLOGY, V153, P5275, DOI 10.1210/en.2012-1418; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Mylotte LA, 2008, STEM CELLS, V26, P1325, DOI 10.1634/stemcells.2007-1072; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; Pattappa G, 2011, J CELL PHYSIOL, V226, P2562, DOI 10.1002/jcp.22605; Paulin R, 2014, EUR RESPIR J, V43, P531, DOI 10.1183/09031936.00181312; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; Smith AN, 2012, J CELL PHYSIOL, V227, P3225, DOI 10.1002/jcp.24013; SORRENTINO D, 1989, J CLIN INVEST, V84, P1325, DOI 10.1172/JCI114301; Sutendra G, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001327; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Tzouvelekis A, 2013, CURR DRUG TARGETS, V14, P246, DOI 10.2174/1389450111314020009; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wanet A, 2014, INT J BIOCHEM CELL B, V54, P174, DOI 10.1016/j.biocel.2014.07.015; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1924, BIOCHEM Z, V152, P309; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	46	48	53	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120257	10.1371/journal.pone.0120257	http://dx.doi.org/10.1371/journal.pone.0120257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768019	gold, Green Submitted, Green Published			2022-12-26	WOS:000351277500117
J	Kremers, KS; Hollister, RD; Oberbauer, SF				Kremers, Kelseyann S.; Hollister, Robert D.; Oberbauer, Steven F.			Diminished Response of Arctic Plants to Warming over Time	PLOS ONE			English	Article							OPEN-TOP CHAMBERS; CLIMATE-CHANGE; GLOBAL CHANGE; TERRESTRIAL ECOSYSTEMS; NORTHERN ALASKA; CONCEPTUAL-FRAMEWORK; VEGETATION CHANGE; SHRUB ABUNDANCE; SHORT-TERM; TUNDRA	The goal of this study is to determine if the response of arctic plants to warming is consistent across species, locations and time. This study examined the impact of experimental warming and natural temperature variation on plants at Barrow and Atqasuk, Alaska beginning in 1994. We considered observations of plant performance collected from 1994-2000 "shortterm" and those from 2007-2012 "long-term". The plant traits reported are the number of inflorescences, inflorescence height, leaf length, and day of flower emergence. These traits can inform us about larger scale processes such as plant reproductive effort, plant growth, and plant phenology, and therefore provide valuable insight into community dynamics, carbon uptake, and trophic interactions. We categorized traits of all species monitored at each site into temperature response types. We then compared response types across traits, plant growth forms, sites, and over time to analyze the consistency of plant response to warming. Graminoids were the most responsive to warming and showed a positive response to temperature, while shrubs were generally the least responsive. Almost half (49%) of response types (across all traits, species, and sites combined) changed from short-term to long-term. The percent of plants responsive to warming decreased from 57% (short-term) to 46% (long-term). These results indicate that the response of plants to warming varies over time and has diminished overall in recent years.	[Kremers, Kelseyann S.; Hollister, Robert D.] Grand Valley State Univ, Biol, Allendale, MI 49401 USA; [Oberbauer, Steven F.] Florida Int Univ, Biol Sci, Miami, FL 33199 USA	Grand Valley State University; State University System of Florida; Florida International University	Kremers, KS (corresponding author), Univ Notre Dame, Biol Sci, Notre Dame, IN 46556 USA.	kkremers@nd.edu		Hollister, Robert/0000-0002-4764-7691	National Science Foundation [9714103, 0632263, 0856516]; Directorate For Geosciences [0856710] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by National Science Foundation, www.nsf.gov, OPP #9714103, #0632263, #0856516 (SO, RH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V64, P91; Bokhorst S, 2013, GLOBAL CHANGE BIOL, V19, P64, DOI 10.1111/gcb.12028; Bolmgren K, 2013, INT J BIOMETEOROL, V57, P367, DOI 10.1007/s00484-012-0560-8; Brooker R, 2003, J VEG SCI, V14, P535, DOI 10.1111/j.1654-1103.2003.tb02180.x; CALLAGHAN TV, 1995, PHILOS T R SOC A, V352, P259, DOI 10.1098/rsta.1995.0069; Chapin FS, 2005, SCIENCE, V310, P657, DOI 10.1126/science.1117368; CHAPIN FS, 1985, ECOLOGY, V66, P564, DOI 10.2307/1940405; CHAPIN FS, 1983, POLAR BIOL, V2, P47, DOI 10.1007/BF00258285; CHAPIN FS, 1995, NATURE, V377, P199, DOI 10.1038/377199a0; Cleland EE, 2012, ECOLOGY, V93, P1765, DOI 10.1890/11-1912.1; Diggle PK, 1997, AM J BOT, V84, P154, DOI 10.2307/2446077; Dormann CF, 2002, FUNCT ECOL, V16, P4, DOI 10.1046/j.0269-8463.2001.00596.x; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hollister RD, 2000, GLOBAL CHANGE BIOL, V6, P835, DOI 10.1046/j.1365-2486.2000.00363.x; Hollister RD, 2005, GLOBAL CHANGE BIOL, V11, P525, DOI 10.1111/j.1365-2486.2005.00926.x; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hollister RD, 2006, ARCT ANTARCT ALP RES, V38, P206, DOI 10.1657/1523-0430(2006)38[206:STATRT]2.0.CO;2; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Hudson JMG, 2010, J ECOL, V98, P1035, DOI 10.1111/j.1365-2745.2010.01690.x; Iler AM, 2013, AM J BOT, V100, P1398, DOI 10.3732/ajb.1200490; IPCC core writing team: IPCC, 2013, CLIM CHANG 2013 SYNT; JONASSON S, 1992, OIKOS, V63, P420, DOI 10.2307/3544968; Kaarlejarvi E, 2012, ECOSYSTEMS, V15, P1219, DOI 10.1007/s10021-012-9580-9; Korner C, 1999, ALPINE PLANT LIFE FU; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Liancourt P, 2013, ECOLOGY, V94, P444, DOI 10.1890/12-0780.1; Lin DL, 2010, NEW PHYTOL, V188, P187, DOI 10.1111/j.1469-8137.2010.03347.x; Liu YZ, 2011, ECOLOGY, V92, P1201, DOI 10.1890/10-2060.1; Loranty M. M., 2011, ENVIRON RES LETT, V6, P1; Luo YQ, 2011, GLOBAL CHANGE BIOL, V17, P843, DOI 10.1111/j.1365-2486.2010.02265.x; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Meloche CG, 2001, AM J BOT, V88, P980, DOI 10.2307/2657079; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; REYNOLDS JF, 1992, ARCTIC ECOSYSTEMS CH, P413; Shaver G. R., 1992, ARCTIC ECOSYSTEMS CH, P193; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Shaver GR, 2007, PLANT FUNCTIONAL TYP, P153; Starr G, 2000, GLOBAL CHANGE BIOL, V6, P357, DOI 10.1046/j.1365-2486.2000.00316.x; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Ulrich A., 1978, Vegetation and production ecology of an Alaskan arctic tundra., P457; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Wahren CHA, 2005, GLOBAL CHANGE BIOL, V11, P537, DOI 10.1111/j.1365-2486.2005.00927.x; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021	53	15	15	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116586	10.1371/journal.pone.0116586	http://dx.doi.org/10.1371/journal.pone.0116586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767881	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500012
J	Yeka, A; Nankabirwa, J; Mpimbaza, A; Kigozi, R; Arinaitwe, E; Drakeley, C; Greenhouse, B; Kamya, MR; Dorsey, G; Staedke, SG				Yeka, Adoke; Nankabirwa, Joaniter; Mpimbaza, Arthur; Kigozi, Ruth; Arinaitwe, Emmanuel; Drakeley, Chris; Greenhouse, Bryan; Kamya, Moses R.; Dorsey, Grant; Staedke, Sarah G.			Factors Associated with Malaria Parasitemia, Anemia and Serological Responses in a Spectrum of Epidemiological Settings in Uganda	PLOS ONE			English	Article							TRANSMISSION INTENSITY; YOUNG-CHILDREN; ATLAS PROJECT; MORBIDITY; TANZANIA; KENYA; INDICATOR; AFRICA; IMPACT; RISK	Background Understanding the current epidemiology of malaria and the relationship between intervention coverage, transmission intensity, and burden of disease is important to guide control activities. We aimed to determine the prevalence of anemia, parasitemia, and serological responses to P. falciparum antigens, and factors associated with these indicators, in three different epidemiological settings in Uganda. Methods and Findings In 2012, cross-sectional surveys were conducted in 200 randomly selected households from each of three sites: Walukuba, Jinja district (peri-urban); Kihihi, Kanungu district (rural); and Nagongera, Tororo district (rural) with corresponding estimates of annual entomologic inoculation rates (aEIR) of 3.8, 26.6, and 125.0, respectively. Of 2737 participants, laboratory testing was done in 2227 (81.4%), including measurement of hemoglobin, parasitemia using microscopy, and serological responses to P. falciparum apical membrane antigen 1 (AMA-1) and merozoite surface protein 1, 19 kilodalton fragment (MSP-119). Analysis of laboratory results was restricted to 1949 (87.5%) participants aged <= 40 years. Prevalence of anemia (hemoglobin < 11.0 g/dL) was significantly higher in Walukuba (18.9%) and Nagongera (17.4%) than in Kihihi (13.1%), and was strongly associated with decreasing age for those <= 5 years at all sites. Parasite prevalence was significantly higher in Nagongera (48.3%) than in Walukuba (12.2%) and Kihihi (12.8%), and significantly increased with age to 11 years, and then significantly decreased at all sites. Seropositivity to AMA-1 was 53.3% in Walukuba, 63.0% in Kihihi, and 83.7% in Nagongera and was associated with increasing age at all sites. AMA-1 seroconversion rates strongly correlated with transmission intensity, while serological responses to MSP-1(19) did not. Conclusion Anemia was predominant in young children and parasitemia peaked by 11 years across 3 sites with varied transmission intensity. Serological responses to AMA-1 appeared to best reflect transmission intensity, and may be a more accurate indicator for malaria surveillance than anemia or parasitemia.	[Yeka, Adoke] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Nankabirwa, Joaniter; Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mpimbaza, Arthur] Makerere Univ, Coll Hlth Sci, Child Hlth & Dev Ctr, Kampala, Uganda; [Yeka, Adoke; Nankabirwa, Joaniter; Mpimbaza, Arthur; Kigozi, Ruth; Arinaitwe, Emmanuel; Kamya, Moses R.; Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda; [Drakeley, Chris; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England; [Greenhouse, Bryan; Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco	Yeka, A (corresponding author), Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda.	yadoke@yahoo.com		Greenhouse, Bryan/0000-0003-0287-9111	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program [U19AI089674]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089674] Funding Source: NIH RePORTER	National Institutes of Health, International Centers of Excellence in Malaria Research (ICMER) program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health as part of the International Centers of Excellence in Malaria Research (ICMER) program (U19AI089674). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhwale WS, 2004, ACTA TROP, V91, P167, DOI 10.1016/j.actatropica.2004.02.010; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Bukirwa H, 2009, AM J TROP MED HYG, V81, P611, DOI 10.4269/ajtmh.2009.09-0126; BURKOT TR, 1995, ANN TROP MED PARASIT, V89, P125, DOI 10.1080/00034983.1995.11812943; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Estevez PT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-104; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Green HK, 2011, PARASITOLOGY, V138, P1534, DOI 10.1017/S0031182011001016; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Karema C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-236; Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Mathanga DP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-107; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-37; Osterbauer B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-432; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, AM J TROP MED HYG, V67, P371, DOI 10.4269/ajtmh.2002.67.371; PREMJI Z, 1995, ACTA TROP, V59, P55, DOI 10.1016/0001-706X(94)00079-G; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; Reithinger R, 2013, T ROY SOC TROP MED H, V107, P769, DOI 10.1093/trstmh/trt096; Riley E, 1996, PARASITOL TODAY, V12, P410, DOI 10.1016/0169-4758(96)80633-8; Roll Back Malaria, 2010, SAV LIV MAL CONTR CO; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Supargiyono S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-444; Talisuna A, 2012, ACTA TROP, V121, P196, DOI 10.1016/j.actatropica.2011.06.013; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	42	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118901	10.1371/journal.pone.0118901	http://dx.doi.org/10.1371/journal.pone.0118901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768015	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500053
J	Porro, LB; Rayfield, EJ; Clack, JA				Porro, Laura B.; Rayfield, Emily J.; Clack, Jennifer A.			Descriptive Anatomy and Three-Dimensional Reconstruction of the Skull of the Early Tetrapod Acanthostega gunnari Jarvik, 1952	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; VIVO BONE STRAIN; FUNCTIONAL INTERPRETATION; SUTURE MORPHOLOGY; EVOLUTION; BIOMECHANICS; PATTERNS; ORIGIN; ROOF; JAWS	The early tetrapod Acanthostega gunnari is an iconic fossil taxon exhibiting skeletal morphology reflecting the transition of vertebrates from water onto land. Computed tomography data of two Acanthostega skulls was segmented using visualization software to digitally separate bone from matrix and individual bones of the skull from each other. A revised description of cranial and lower jaw anatomy in this taxon based on CT data includes new details of sutural morphology, the previously undescribed quadrate and articular bones, and the mandibular symphysis. Sutural morphology is used to infer loading regime in the skull during feeding, and suggests Acanthostega used its anterior jaws to initially seize prey while smaller posterior teeth were used to restrain struggling prey during ingestion. Novel methods were used to repair and retrodeform the skull, resulting in a three-dimensional digital reconstruction that features a longer postorbital region and more strongly hooked anterior lower jaw than previous attempts while supporting the presence of a midline gap between the nasals and median rostrals.	[Porro, Laura B.; Rayfield, Emily J.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Porro, Laura B.; Clack, Jennifer A.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Porro, Laura B.] Univ Cambridge, Dept Zool, Cambridge, England	University of London; University of London Royal Veterinary College; University of Bristol; University of Cambridge	Porro, LB (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England.	lporro@rvc.ac.uk	Rayfield, Emily/F-5038-2010	Rayfield, Emily/0000-0002-2618-750X; Porro, Laura/0000-0002-0546-2381	Marie Curie International Incoming Research Fellowship ("Tetrapods Rising") [303161]; Natural Environment Research Council [NE/G00711X/1] Funding Source: researchfish; NERC [NE/G00711X/1] Funding Source: UKRI	Marie Curie International Incoming Research Fellowship ("Tetrapods Rising"); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by a Marie Curie International Incoming Research Fellowship ("Tetrapods Rising", 303161, (http://cordis.europa.eu/projects/rcn/103929_en.html) to LBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Anderson PSL, 2013, INTEGR COMP BIOL, V53, P197, DOI 10.1093/icb/ict006; Anderson PSL, 2011, NATURE, V476, P206, DOI 10.1038/nature10207; BEAUMONT EH, 1977, PHILOS T ROY SOC B, V280, P29, DOI 10.1098/rstb.1977.0099; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; BOLT JR, 1974, J PALEONTOL, V48, P434; Bright JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031769; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; CARROLL RL, 1969, BIOL REV, V44, P393, DOI 10.1111/j.1469-185X.1969.tb01218.x; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack J. A., 2012, GAINING GROUND ORIGI; CLACK JA, 1988, PALAEONTOLOGY, V31, P699; Clack JA, 1998, ZOOL J LINN SOC-LOND, V122, P61, DOI 10.1006/zjls.1997.0114; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2003, T ROY SOC EDIN-EARTH, V93, P163; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; Clack JA, 2012, PALAEONTOLOGY, V55, P73, DOI 10.1111/j.1475-4983.2011.01117.x; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Holliday CM, 2010, ANAT REC, V293, P1350, DOI 10.1002/ar.21180; Holliday CM, 2008, J VERTEBR PALEONTOL, V28, P1073, DOI 10.1671/0272-4634-28.4.1073; Jarvik E., 1952, Meddelelser om Gronland, V114, P1; Jasinoski SC, 2010, J MORPHOL, V271, P705, DOI 10.1002/jmor.10828; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; Kathe W, 1999, ZOOL J LINN SOC-LOND, V126, P1; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Markey MJ, 2006, J EXP BIOL, V209, P2085, DOI 10.1242/jeb.02266; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Metzger KA, 2005, ANAT REC PART A, V283A, P331, DOI 10.1002/ar.a.20167; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Neenan JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2689; OLSON EC, 1961, AM ZOOL, V1, P205; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; Porro LB, 2010, EARTH ENV SCI T R SO, V101, P351, DOI 10.1017/S175569101102010X; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Reed DA, 2011, J ANAT, V218, P59, DOI 10.1111/j.1469-7580.2010.01319.x; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Rucklin M, 2012, NATURE, V491, P748, DOI 10.1038/nature11555; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Save-Soderbergh G., 1932, Medd Grenland, V94 T, P1; Schwenk Kurt, 2000, P175, DOI 10.1016/B978-012632590-4/50009-5; Thomason JJ, 2001, ANAT REC, V264, P325, DOI 10.1002/ar.10025; Tilley EH, 1971, THESIS U NEWCASTLE U; Wang Q, 2008, ANAT REC, V293, P1477; Zollikofer CPE, 1998, EVOL ANTHROPOL, V6, P41, DOI 10.1002/(SICI)1520-6505(1998)6:2<41::AID-EVAN2>3.0.CO;2-Z	62	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118882	10.1371/journal.pone.0118882	http://dx.doi.org/10.1371/journal.pone.0118882			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760343	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000351275000042
J	Sibbe, M; Kuner, E; Althof, D; Frotscher, M				Sibbe, Mirjam; Kuner, Emanuel; Althof, Daniel; Frotscher, Michael			Stem- and Progenitor Cell Proliferation in the Dentate Gyrus of the Reeler Mouse	PLOS ONE			English	Article							RADIAL GLIAL-CELLS; ADULT HIPPOCAMPUS; BIPOLAR DISORDER; MUTANT MICE; NEUROGENESIS; NEURONS; SCHIZOPHRENIA; APOER2; MEMORY; MAINTENANCE	Adult hippocampal neurogenesis has been implicated in hippocampus-dependent learning and memory. Furthermore, the decline of neurogenesis accompanying aging could be involved in age-related cognitive deficits. It is believed that the neural stem cell niche comprises a specialized microenvironment regulating stem cell activation and maintenance. However, little is known about the significance of the extracellular matrix in controlling adult stem cells. Reelin is a large glycoprotein of the extracelluar matrix known to be of crucial importance for neuronal migration. Here, we examined the local interrelation between Reelin expressing interneurons and putative hippocampal stem cells and investigated the effects of Reelin deficiency on stem cell and progenitor cell proliferation. Reelin-positive cells are found in close vicinity to putative stem cell processes, which would allow for stem cell regulation by Reelin. We investigated the proliferation of stem cells in the Reelin-deficient reeler hippocampus by Ki67 labeling and found a strong reduction of mitotic cells. A detailed analysis of dividing Type 1, type 2 and type 3 cells indicated that once a stem cell is recruited for proliferation, the progression to the next progenitor stage as well as the number of mitotic cycles is not altered in reeler. Our data point to a role for Reelin in either regulating stem cell quiescence or maintenance.	[Sibbe, Mirjam; Kuner, Emanuel] Univ Freiburg, Inst Anat & Cell Biol, Ctr Neurosci, D-79104 Freiburg, Germany; [Althof, Daniel] Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; [Frotscher, Michael] Ctr Mol Neurobiol, Inst Struct Neurobiol, D-20251 Hamburg, Germany	University of Freiburg; University of Freiburg	Sibbe, M (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Ctr Neurosci, Albertstr 23, D-79104 Freiburg, Germany.	Mirjam.Sibbe@anat.uni-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB/TR3, FR 620/12-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors' work was supported by Deutsche Forschungsgemeinschaft (DFG) SFB/TR3 and FR 620/12-1. MF is a Senior Research Professor of the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; CAVINESS VS, 1976, J COMP NEUROL, V170, P435, DOI 10.1002/cne.901700404; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Deller T, 1999, EXP NEUROL, V156, P239, DOI 10.1006/exnr.1999.7020; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Drakew A, 2002, EXP NEUROL, V176, P12, DOI 10.1006/exnr.2002.7918; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim HM, 2002, P NATL ACAD SCI USA, V99, P4020, DOI 10.1073/pnas.062698299; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Massalini S, 2009, MOL CELL NEUROSCI, V42, P341, DOI 10.1016/j.mcn.2009.08.006; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Miranda CJ, 2012, AGING CELL; Nguyen L, 2003, J NEUROSCI, V23, P3278; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161; Pesold C, 1998, P NATL ACAD SCI USA, V95, P3221, DOI 10.1073/pnas.95.6.3221; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; Teixeira CM, 2012, J NEUROSCI, V32, P12051, DOI 10.1523/JNEUROSCI.1857-12.2012; Teixeira CM, 2011, NEUROPSYCHOPHARMACOL, V36, P2395, DOI 10.1038/npp.2011.153; Weiss KH, 2003, J COMP NEUROL, V460, P56, DOI 10.1002/cne.10644; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Zhao S, 2007, DEV NEUROSCI-BASEL, V29, P84, DOI 10.1159/000096213	40	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119643	10.1371/journal.pone.0119643	http://dx.doi.org/10.1371/journal.pone.0119643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760459	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275000065
J	Fieber, C; Janos, M; Koestler, T; Gratz, N; Li, XD; Castiglia, V; Aberle, M; Sauert, M; Wegner, M; Alexopoulou, L; Kirschning, CJ; Chen, ZJJ; von Haeseler, A; Kovarik, P				Fieber, Christina; Janos, Marton; Koestler, Tina; Gratz, Nina; Li, Xiao-Dong; Castiglia, Virginia; Aberle, Marion; Sauert, Martina; Wegner, Mareike; Alexopoulou, Lena; Kirschning, Carsten J.; Chen, Zhijian J.; von Haeseler, Arndt; Kovarik, Pavel			Innate Immune Response to Streptococcus pyogenes Depends on the Combined Activation of TLR13 and TLR2	PLOS ONE			English	Article							GROUP-A-STREPTOCOCCUS; CELLS; RECOGNITION; MACROPHAGES; RECEPTOR; DIFFERENTIATION; PATHOGENESIS; RESISTANCE	Innate immune recognition of the major human-specific Gram-positive pathogen Streptococcus pyogenes is not understood. Here we show that mice employ Toll-like receptor (TLR) 2- and TLR13-mediated recognition of S. pyogenes. These TLR pathways are non-redundant in the in vivo context of animal infection, but are largely redundant in vitro, as only inactivation of both of them abolishes inflammatory cytokine production by macrophages and dendritic cells infected with S. pyogenes. Mechanistically, S. pyogenes is initially recognized in a phagocytosis-independent manner by TLR2 and subsequently by TLR13 upon internalization. We show that the TLR13 response is specifically triggered by S. pyogenes rRNA and that Tlr13(-/-) cells respond to S. pyogenes infection solely by engagement of TLR2. TLR13 is absent from humans and, remarkably, we find no equivalent route for S. pyogenes RNA recognition in human macrophages. Phylogenetic analysis reveals that TLR13 occurs in all kingdoms but only in few mammals, including mice and rats, which are naturally resistant against S. pyogenes. Our study establishes that the dissimilar expression of TLR13 in mice and humans has functional consequences for recognition of S. pyogenes in these organisms.	[Fieber, Christina; Janos, Marton; Gratz, Nina; Castiglia, Virginia; Aberle, Marion; Sauert, Martina; Kovarik, Pavel] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Koestler, Tina; von Haeseler, Arndt] Univ Vienna, Med Univ Vienna, Ctr Integrat Bioinformat Vienna, Max F Perutz Labs, Vienna, Austria; [Wegner, Mareike] Univ Freiburg Klinikum, Univ Hautklin, Freiburg, Germany; [Alexopoulou, Lena] Aix Marseille Univ 2, CIML, Marseille, France; [Kirschning, Carsten J.] Univ Duisburg Essen, Inst Med Microbiol, Essen, Germany; [Li, Xiao-Dong; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX 75390 USA; [von Haeseler, Arndt] Univ Vienna, Fac Comp Sci, Bioinformat & Computat Biol, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Duisburg Essen; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Vienna	Kovarik, P (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	pavel.kovarik@univie.ac.at	Alexopoulou, Lena/A-5041-2017; Chen, Zhijian/C-6039-2012; Kovarik, Pavel/D-1184-2014; von Haeseler, Arndt/HCI-9958-2022	Alexopoulou, Lena/0000-0003-4619-697X; Chen, Zhijian/0000-0002-8475-8251; Kovarik, Pavel/0000-0003-2956-0944; von Haeseler, Arndt/0000-0002-3366-4458; Janos, Marton/0000-0003-1266-1466; Sauert, Martina/0000-0002-2179-9515; Li, Xiao-Dong/0000-0002-4349-6996	Austrian Science Fund (FWF) [P24540-B21, W1220-B09]; European Union [FP7-PEOPLE-2012-ITN, PITN-GA-2012-316682]; University of Vienna; Medical University of Vienna; Austrian Science Fund (FWF) [P 24540] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Union(European Commission); University of Vienna; Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) grants P24540-B21 and W1220-B09 DP 'Molecular Mechanisms of Cell Signaling' to PK, by funding from the European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) for the project INBIONET under grant agreement PITN-GA-2012-316682, and by a joint research cluster initiative of the University of Vienna and the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Fieber C, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00140; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Fox GF, 2002, LAB ANIMAL MED; Goldmann O, 2004, INFECT IMMUN, V72, P2956, DOI 10.1128/IAI.72.5.2956-2963.2004; Gratz N, 2008, J BIOL CHEM, V283, P19879, DOI 10.1074/jbc.M802848200; Gratz N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001345; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Harder J, 2009, J IMMUNOL; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Johansson L, 2010, CLIN INFECT DIS, V51, P58, DOI 10.1086/653116; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Koestler T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-417; Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Li XD, 2012, ELIFE, V1, DOI 10.7554/eLife.00102; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Loof TG, 2010, AM J PATHOL, V176, P754, DOI 10.2353/ajpath.2010.090422; Medina Eva, 2005, Briefings in Functional Genomics & Proteomics, V4, P248, DOI 10.1093/bfgp/4.3.248; Mishalian I, 2011, J IMMUNOL, V187, P6022, DOI 10.4049/jimmunol.1101385; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Navarini AA, 2009, P NATL ACAD SCI USA, V106, P7107, DOI 10.1073/pnas.0901162106; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sha WW, 2014, P NATL ACAD SCI USA, V111, P16059, DOI 10.1073/pnas.1412487111; Shi ZC, 2011, J BIOL CHEM, V286, P4517, DOI 10.1074/jbc.M110.159590; Signorino G, 2014, INFECT IMMUN, V82, P5013, DOI 10.1128/IAI.02282-14; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; Wessels MR, 2011, NEW ENGL J MED, V364, P648, DOI 10.1056/NEJMcp1009126; Yasuda K, 2005, J IMMUNOL, V174, P6129, DOI 10.4049/jimmunol.174.10.6129; Zinkernagel AS, 2012, J INNATE IMMUN, V4, P213, DOI 10.1159/000329550	51	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119727	10.1371/journal.pone.0119727	http://dx.doi.org/10.1371/journal.pone.0119727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756897	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275700050
J	Lindgren, H; Lindgren, L; Golovliov, I; Sjostedt, A				Lindgren, Helena; Lindgren, Lena; Golovliov, Igor; Sjostedt, Anders			Mechanisms of Heme Utilization by Francisella tularensis	PLOS ONE			English	Article							LIVE VACCINE STRAIN; VIBRIO-CHOLERAE; IRON-METABOLISM; OUTER-MEMBRANE; SIDEROPHORE; VIRULENCE; IDENTIFICATION; TRANSPORT; GENES; TULAREMIA	Francisella tularensis is a highly virulent facultative intracellular pathogen causing the severe disease tularemia in mammals. As for other bacteria, iron is essential for its growth but very few mechanisms for iron acquisition have been identified. Here, we analyzed if and how F. tularensis can utilize heme, a major source of iron in vivo. This is by no means obvious since the bacterium lacks components of traditional heme-uptake systems. We show that SCHU S4, the prototypic strain of subspecies tularensis, grew in vitro with heme as the sole iron source. By screening a SCHU S4 transposon insertion library, 16 genes were identified as important to efficiently utilize heme, two of which were required to avoid heme toxicity. None of the identified genes appeared to encode components of a potential heme-uptake apparatus. Analysis of SCHU S4 deletion mutants revealed that each of the components FeoB, the siderophore system, and FupA, contributed to the heme-dependent growth. In the case of the former two systems, iron acquisition was impaired, whereas the absence of FupA did not affect iron uptake but led to abnormally high binding of iron to macromolecules. Overall, the present study demonstrates that heme supports growth of F. tularensis and that the requirements for the utilization are highly complex and to some extent novel.	[Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Clin Bacteriol, Umea, Sweden; Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	Umea University; Umea University	Sjostedt, A (corresponding author), Umea Univ, Dept Clin Microbiol, Clin Bacteriol, Umea, Sweden.	Anders.Sjostedt@umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	Swedish Medical Research Council [K2013-56X-22356-01-3]; Kempe foundation; Medical Faculty, Umea University, Umea, Sweden	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Kempe foundation; Medical Faculty, Umea University, Umea, Sweden	The work was funded by the Swedish Medical Research Council (www.vr.se K2013-56X-22356-01-3), the Kempe foundation and the Medical Faculty, Umea University, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; BERG JM, 1992, INFECT IMMUN, V60, P690, DOI 10.1128/IAI.60.2.690-693.1992; Bolzan AD, 2001, MUTAT RES-REV MUTAT, V488, P25, DOI 10.1016/S1383-5742(00)00062-4; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Douet V, 2009, J BACTERIOL, V191, P795, DOI 10.1128/JB.00845-08; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; HENDERSON DP, 1994, INFECT IMMUN, V62, P5120, DOI 10.1128/IAI.62.11.5120-5125.1994; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Knutson M, 2003, CRIT REV BIOCHEM MOL, V38, P61, DOI 10.1080/713609210; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; OConnell WA, 1996, INFECT IMMUN, V64, P842, DOI 10.1128/IAI.64.3.842-848.1996; Olakanmi O, 2010, ANTIMICROB AGENTS CH, V54, P244, DOI 10.1128/AAC.00655-09; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Ramakrishnan G, 2014, MICROBIOL-SGM, V160, P446, DOI 10.1099/mic.0.072835-0; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Thomas-Charles CA, 2013, INFECT IMMUN, V81, P2828, DOI 10.1128/IAI.00170-13; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Wyckoff EE, 2007, BIOMETALS, V20, P405, DOI 10.1007/s10534-006-9073-4	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119143	10.1371/journal.pone.0119143	http://dx.doi.org/10.1371/journal.pone.0119143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756756	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700039
J	Harrington, CR; Storey, JMD; Clunas, S; Harrington, KA; Horsley, D; Ishaq, A; Kemp, SJ; Larch, CP; Marshall, C; Nicoll, SL; Rickard, JE; Simpson, M; Sinclair, JP; Storey, LJ; Wischik, CM				Harrington, Charles R.; Storey, John M. D.; Clunas, Scott; Harrington, Kathleen A.; Horsley, David; Ishaq, Ahtsham; Kemp, Steven J.; Larch, Christopher P.; Marshall, Colin; Nicoll, Sarah L.; Rickard, Janet E.; Simpson, Michael; Sinclair, James P.; Storey, Lynda J.; Wischik, Claude M.			Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; TRUNCATED TAU; NEUROFIBRILLARY DEGENERATION; ENDOPLASMIC-RETICULUM; MICROTUBULE BINDING; METHYLENE-BLUE; IN-VITRO; PROTEIN; EXPRESSION; CELLS	Alzheimer disease (AD) is a degenerative tauopathy characterized by aggregation of Tau protein through the repeat domain to form intraneuronal paired helical filaments (PHFs). We report two cell models in which we control the inherent toxicity of the core Tau fragment. These models demonstrate the properties of prion-like recruitment of full-length Tau into an aggregation pathway in which template-directed, endogenous truncation propagates aggregation through the core Tau binding domain. We use these in combination with dissolution of native PHFs to quantify the activity of Tau aggregation inhibitors (TAIs). We report the synthesis of novel stable crystalline leucomethylthioninium salts (LMTX (R)), which overcome the pharmacokinetic limitations of methylthioninium chloride. LMTX (R), as either a dihydromesylate or a dihydrobromide salt, retains TAI activity in vitro and disrupts PHFs isolated from AD brain tissues at 0.16 mu M. The K-i value for intracellular TAI activity, which we have been able to determine for the first time, is 0.12 mu M. These values are close to the steady state trough brain concentration of methylthioninium ion (0.18 mu M) that is required to arrest progression of AD on clinical and imaging end points and the minimum brain concentration (0.13 mu M) required to reverse behavioral deficits and pathology in Tau transgenic mice.	[Harrington, Charles R.; Harrington, Kathleen A.; Horsley, David; Rickard, Janet E.; Wischik, Claude M.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZP, Scotland; [Harrington, Charles R.; Storey, John M. D.; Wischik, Claude M.] TauRx Therapeut Ltd, Singapore 068805, Singapore; [Harrington, Charles R.; Storey, John M. D.; Clunas, Scott; Ishaq, Ahtsham; Kemp, Steven J.; Larch, Christopher P.; Marshall, Colin; Nicoll, Sarah L.; Simpson, Michael; Sinclair, James P.; Storey, Lynda J.] Univ Aberdeen, Dept Chem, Aberdeen AB24 3UE, Scotland	University of Aberdeen; University of Aberdeen	Harrington, CR (corresponding author), Univ Aberdeen, Sch Med & Dent, Foresterhill, Aberdeen AB25 2ZP, Scotland.	c.harrington@abdn.ac.uk; cmw@taurx.com		Harrington, Charles/0000-0003-2250-3920; Storey, John/0000-0002-5261-5467; Larch, Christopher/0000-0003-2463-3120	TauRx Therapeutics Ltd.	TauRx Therapeutics Ltd.	This work was supported by grants from TauRx Therapeutics Ltd. C. R. H. (Chief Scientific Officer), J. M. D. S. (Head of Technical), and C. M. W. (Executive Chairman) are officers in TauRx Therapeutics Ltd., and C. R. H., J. M. D. S., S. C., D. H., A. I., S. J. K., C. P. L., C. M., S. L. N., J. E. R., M. S., J. P. S., L. J. S., and C. M. W. are co-inventors on various patents related to this investigation.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Bacallao R., 2006, HDB BIOL CONFOCAL MI, P368, DOI [10.1007/978-0-387-45524-2_18, DOI 10.1007/978-0-387-45524-2_18]; Baddeley TC, 2015, J PHARMACOL EXP THER, V352, P110, DOI 10.1124/jpet.114.219352; BANCHER C, 1993, NEUROSCI LETT, V162, P179, DOI 10.1016/0304-3940(93)90590-H; Bancher C, 1996, EUR ARCH PSY CLIN N, V246, P137, DOI 10.1007/BF02189115; BAUM L, 1995, MOL BRAIN RES, V34, P1, DOI 10.1016/0169-328X(95)00111-5; Bulic B, 2007, ANGEW CHEM INT EDIT, V46, P9215, DOI 10.1002/anie.200704051; Bulic B, 2009, ANGEW CHEM INT EDIT, V48, P1741, DOI 10.1002/anie.200802621; Chidley J. S., 1969, United States Patent, Patent No. 3463532; Chirita C, 2004, BIOCHEMISTRY-US, V43, P2879, DOI 10.1021/bi036094h; Clavaguera F, 2013, BRAIN PATHOL, V23, P342, DOI 10.1111/bpa.12044; Crowe A, 2007, BIOCHEM BIOPH RES CO, V358, P1, DOI 10.1016/j.bbrc.2007.03.056; CROWTHER RA, 1992, FEBS LETT, V309, P199, DOI 10.1016/0014-5793(92)81094-3; Duyckaerts C, 1997, NEUROBIOL AGING, V18, P267, DOI 10.1016/S0197-4580(97)80306-5; Fasulo L., 1996, ALZHEIMERS RES, V2, P195; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Giannakopoulos P, 1997, BRAIN RES REV, V25, P217, DOI 10.1016/S0165-0173(97)00023-4; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GORMAN CM, 1983, NUCLEIC ACIDS RES, V11, P7631, DOI 10.1093/nar/11.21.7631; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; Hall GF, 2002, J MOL NEUROSCI, V19, P253; HARRINGTON CR, 1991, P NATL ACAD SCI USA, V88, P5842, DOI 10.1073/pnas.88.13.5842; Honson NS, 2007, BIOCHEM BIOPH RES CO, V363, P229, DOI 10.1016/j.bbrc.2007.08.166; Hrnkova M, 2007, BRAIN RES, V1130, P206, DOI 10.1016/j.brainres.2006.10.085; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LAI RYK, 1995, NEUROBIOL AGING, V16, P433, DOI 10.1016/0197-4580(95)00041-C; LEE G, 1992, J CELL SCI, V102, P227; Li WK, 2009, J NEUROCHEM, V110, P1339, DOI 10.1111/j.1471-4159.2009.06224.x; MARR HE, 1973, ACTA CRYSTALLOGR B, VB 29, P847, DOI 10.1107/S0567740873003432; Melis V., 2015, CELL MOL LIFE SCI, DOI [10.1007/s00018-00014-01804-z, DOI 10.1007/S00018-00014-01804-Z]; Melisa V, 2015, BEHAV PHARMACOL, V26, P353, DOI 10.1097/FBP.0000000000000133; MENA R, 1995, ACTA NEUROPATHOL, V89, P50, DOI 10.1007/BF00294259; Mena R, 1996, ACTA NEUROPATHOL, V91, P633, DOI 10.1007/s004010050477; NOVAK M, 1991, P NATL ACAD SCI USA, V88, P5837, DOI 10.1073/pnas.88.13.5837; Partridge KA, 1999, CYTOTECHNOLOGY, V30, P37, DOI 10.1023/A:1008079901508; Perreault S, 2009, J NEUROPATH EXP NEUR, V68, P503, DOI 10.1097/NEN.0b013e3181a1fc49; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; Rager T, 2012, PHYS CHEM CHEM PHYS, V14, P8074, DOI 10.1039/c2cp40128b; Rankin CA, 2008, J ALZHEIMERS DIS, V14, P411; RESCH JF, 1991, BIOORG MED CHEM LETT, V1, P519, DOI 10.1016/S0960-894X(01)80457-1; ROGALSKI AA, 1984, J CELL BIOL, V99, P1092, DOI 10.1083/jcb.99.3.1092; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; Wischik C., 1997, BRAIN MICROTUBULE AS, P185; Wischik CM, 2015, J ALZHEIMERS DIS, V44, P705, DOI 10.3233/JAD-142874; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Wischik CM, 2008, US Patent, Patent No. 7335505; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029	57	63	76	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10862	10875		10.1074/jbc.M114.616029	http://dx.doi.org/10.1074/jbc.M114.616029			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759392	Green Published, hybrid			2022-12-26	WOS:000353404500026
J	MacDonald, MJ; Ade, L; Ntambi, JM; Ansari, IU; Stoker, SW				MacDonald, Michael J.; Ade, Lacmbouh; Ntambi, James M.; Ansari, Israr-Ul H.; Stoker, Scott W.			Characterization of Phospholipids in Insulin Secretory Granules and Mitochondria in Pancreatic Beta Cells and Their Changes with Glucose Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-CITRATE-LYASE; FATTY-ACID SYNTHASE; PYRUVATE-CARBOXYLASE; INS-1 CELLS; LIPID-COMPOSITION; SUBCELLULAR MEMBRANES; CHROMAFFIN GRANULES; UNRESPONSIVE POOLS; TARGET MEMBRANE; ISLETS	The lipid composition of insulin secretory granules (ISG) has never previously been thoroughly characterized. We characterized the phospholipid composition of ISG and mitochondria in pancreatic beta cells without and with glucose stimulation. The phospholipid/protein ratios of most phospholipids containing unsaturated fatty acids were higher in ISG than in whole cells and in mitochondria. The concentrations of negatively charged phospholipids, phosphatidylserine, and phosphatidylinositol in ISG were 5-fold higher than in the whole cell. In ISG phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, and sphingomyelin, fatty acids 12:0 and 14:0 were high, as were phosphatidylserine and phosphatidylinositol containing 18-carbon unsaturated FA. With glucose stimulation, the concentration of many ISG phosphatidylserines and phosphatidylinositols increased; unsaturated fatty acids in phosphatidylserine increased; and most phosphatidylethanolamines, phosphatidylcholines, sphingomyelins, and lysophosphatidylcholines were unchanged. Unsaturation and shorter fatty acid length in phospholipids facilitate curvature and fluidity of membranes, which favors fusion of membranes. Recent evidence suggests that negatively charged phospholipids, such as phosphatidylserine, act as coupling factors enhancing the interaction of positively charged regions in SNARE proteins in synaptic or secretory vesicle membrane lipid bilayers with positively charged regions in SNARE proteins in the plasma membrane lipid bilayer to facilitate docking of vesicles to the plasma membrane during exocytosis. The results indicate that ISG phospholipids are in a dynamic state and are consistent with the idea that changes in ISG phospholipids facilitate fusion of ISG with the plasma membrane-enhancing glucose-stimulated insulin exocytosis.	[MacDonald, Michael J.; Ansari, Israr-Ul H.; Stoker, Scott W.] Univ Wisconsin, Childrens Diabet Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ade, Lacmbouh; Ntambi, James M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Ntambi, James M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	MacDonald, MJ (corresponding author), Univ Wisconsin, Childrens Diabet Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mjmacdon@wisc.edu		ANSARI, Israrul/0000-0003-0326-0329; MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Nowlin Family Trust of the In Faith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nowlin Family Trust of the In Faith Community Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Nowlin Family Trust of the In Faith Community Foundation.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRECKENRIDGE WC, 1973, BIOCHIM BIOPHYS ACTA, V320, P681, DOI 10.1016/0304-4165(73)90148-7; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1996, DIABETES, V45, P190, DOI 10.2337/diabetes.45.2.190; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; CASTLE JD, 1987, ANN NY ACAD SCI, V493, P448, DOI 10.1111/j.1749-6632.1987.tb27230.x; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Clark MR, 2011, NAT IMMUNOL, V12, P373, DOI 10.1038/ni.2024; Cline GW, 2011, DIABETES METAB J, V35, P458, DOI 10.4093/dmj.2011.35.5.458; Cline GW, 2011, BIOCHEM BIOPH RES CO, V415, P30, DOI 10.1016/j.bbrc.2011.09.153; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; de Haro L, 2004, P NATL ACAD SCI USA, V101, P1578, DOI 10.1073/pnas.0303274101; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Dobrzyn A, 2005, J BIOL CHEM, V280, P23356, DOI 10.1074/jbc.M502436200; Domanska MK, 2010, BIOPHYS J, V99, P2936, DOI 10.1016/j.bpj.2010.09.011; DREYFUS H, 1977, BIOCHIM BIOPHYS ACTA, V489, P89, DOI 10.1016/0005-2760(77)90235-1; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Flamez D, 2002, DIABETES, V51, P2018, DOI 10.2337/diabetes.51.7.2018; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; KELLEY GG, 1995, AM J PHYSIOL-ENDOC M, V269, pE575, DOI 10.1152/ajpendo.1995.269.3.E575; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; KOWLURU A, 1985, ARCH BIOCHEM BIOPHYS, V242, P72, DOI 10.1016/0003-9861(85)90481-3; KOWLURU A, 1994, BBA-MOL CELL RES, V1222, P348, DOI 10.1016/0167-4889(94)90040-X; Kruit JK, 2011, DIABETES, V60, P3186, DOI 10.2337/db11-0081; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; MacDonald MJ, 2013, HORM METAB RES, V45, P391, DOI 10.1055/s-0032-1329987; MacDonald MJ, 2008, MOL CELL BIOCHEM, V313, P195, DOI 10.1007/s11010-008-9757-x; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2008, ARCH BIOCHEM BIOPHYS, V470, P153, DOI 10.1016/j.abb.2007.11.017; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2013, ARCH BIOCHEM BIOPHYS, V532, P23, DOI 10.1016/j.abb.2013.01.002; MacDonald MJ, 2011, J BIOL CHEM, V286, P18383, DOI 10.1074/jbc.M111.241182; MACDONALD MJ, 1981, BIOCHIM BIOPHYS ACTA, V663, P302, DOI 10.1016/0005-2760(81)90216-2; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Morton LA, 2013, ACS CHEM BIOL, V8, P218, DOI 10.1021/cb300429e; Mourad NI, 2010, AM J PHYSIOL-CELL PH, V299, pC389, DOI 10.1152/ajpcell.00138.2010; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Oh E, 2012, J BIOL CHEM, V287, P25821, DOI 10.1074/jbc.M112.361501; Panten U, 2013, METABOLISM, V62, P1375, DOI 10.1016/j.metabol.2013.05.006; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Quetglas S, 2002, EMBO J, V21, P3970, DOI 10.1093/emboj/cdf404; RAMANADHAM S, 1993, BIOCHEMISTRY-US, V32, P13499, DOI 10.1021/bi00212a015; Ramanadham S, 1998, BIOCHEMISTRY-US, V37, P4553, DOI 10.1021/bi9722507; RANA RS, 1985, J BIOL CHEM, V260, P7861; RANA RS, 1986, J CELL BIOCHEM, V32, P143, DOI 10.1002/jcb.240320206; RANA RS, 1986, ARCH BIOCHEM BIOPHYS, V245, P411, DOI 10.1016/0003-9861(86)90232-8; RANA RS, 1987, J BIOL CHEM, V262, P13567; RHODES CJ, 1989, J BIOL CHEM, V264, P14240; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Spurlin BA, 2006, MOL ENDOCRINOL, V20, P183, DOI 10.1210/me.2005-0157; Straub SG, 2004, AM J PHYSIOL-CELL PH, V287, pC565, DOI 10.1152/ajpcell.00079.2004; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Thiele C, 1998, SEMIN CELL DEV BIOL, V9, P511, DOI 10.1006/scdb.1998.0259; Thurmond D. C., 2000, MADAME CURIE BIOSCIE; Thurmond DC, 2003, MOL ENDOCRINOL, V17, P732, DOI 10.1210/me.2002-0333; TURK J, 1986, BIOCHEM J, V237, P259, DOI 10.1042/bj2370259; TURK J, 1986, BIOCHIM BIOPHYS ACTA, V879, P399, DOI 10.1016/0005-2760(86)90232-8; van der Mark VA, 2013, INT J MOL SCI, V14, P7897, DOI 10.3390/ijms14047897; Vance DE, 2008, N COMP BIOC, P213, DOI 10.1016/B978-044453219-0.50010-6; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Wang TT, 2009, BIOPHYS J, V96, P4122, DOI 10.1016/j.bpj.2009.02.050; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; WESTHEAD EW, 1987, ANN NY ACAD SCI, V493, P92, DOI 10.1111/j.1749-6632.1987.tb27186.x; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; WINKLER H, 1976, NEUROSCIENCE, V1, P65, DOI 10.1016/0306-4522(76)90001-4; Xu J, 2008, DIABETOLOGIA, V51, P2022, DOI 10.1007/s00125-008-1130-9; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	87	35	35	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11075	11092		10.1074/jbc.M114.628420	http://dx.doi.org/10.1074/jbc.M114.628420			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25762724	hybrid, Green Published			2022-12-26	WOS:000353404500043
J	Overland, AC; Insel, PA				Overland, Aaron C.; Insel, Paul A.			Heterotrimeric G Proteins Directly Regulate MMP14/Membrane Type-1 Matrix Metalloprotease A NOVEL MECHANISM FOR GPCR-EGFR TRANSACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); G Protein-coupled Receptor (GPCR); Matrix Metalloproteinase (MMP); Membrane Protein; Signal Transduction	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR TRANSACTIVATION; COUPLED RECEPTORS; ANGIOTENSIN-II; ECTODOMAIN CLEAVAGE; CANCER-THERAPY; MT1-MMP; CELLS; ACTIVATION; KINASE	Agonist stimulation of G protein-coupled receptors (GPCRs) can transactivate epidermal growth factor receptors (EGFRs), but the precise mechanisms for this transactivation have not been defined. Key to this process is the protease-mediated shedding of membrane-tethered ligands, which then activate EGFRs. The specific proteases and the events involved in GPCR-EGFR transactivation are not fully understood. We have tested the hypothesis that transactivation can occur by a membrane-delimited process: direct increase in the activity of membrane type-1 matrix metalloprotease (MMP14, MT1-MMP) by heterotrimeric G proteins, and in turn, the generation of heparin-binding epidermal growth factor (HB-EGF) and activation of EGFR. Using membranes prepared from adult rat cardiac myocytes and fibroblasts, we found that MMP14 activity is increased by angiotensin II, phenylephrine, GTP, and guanosine 5-O-[-thio]triphosphate (GTPS). MMP14 activation by GTPS occurs in a concentration- and time-dependent manner, does not occur in response to GMP or adenosine 5-[-thio]triphosphate (ATPS), and is not blunted by inhibitors of Src, PKC, phospholipase C (PLC), PI3K, or soluble MMPs. This activation is specific to MMP14 as it is inhibited by a specific MMP14 peptide inhibitor and siRNA knockdown. MMP14 activation by GTPS is pertussis toxin-sensitive. A role for heterotrimeric G protein subunits was shown by using the G inhibitor gallein and the direct activation of recombinant MMP14 by purified subunits. GTPS-stimulated activation of MMP14 also results in membrane release of HB-EGF and the activation of EGFR. These results define a previously unrecognized, membrane-delimited mechanism for EGFR transactivation via direct G protein activation of MMP14 and identify MMP14 as a heterotrimeric G protein-regulated effector.	[Overland, Aaron C.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			American Heart Association [13POST14810015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007444] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an American Heart Association postdoctoral fellowship (13POST14810015) (to A. C. O.).	Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Arroyo AG, 2007, CURR PHARM DESIGN, V13, P1787, DOI 10.2174/138161207780831284; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Brown CL, 1998, J BIOL CHEM, V273, P17258, DOI 10.1074/jbc.273.27.17258; Castagliuolo I, 2000, J BIOL CHEM, V275, P26545, DOI 10.1074/jbc.M003990200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Dempsey PJ, 1997, J CELL BIOL, V138, P747, DOI 10.1083/jcb.138.4.747; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Huang SM, 1999, INVEST NEW DRUG, V17, P259, DOI 10.1023/A:1006384521198; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kim J, 2009, J BIOL CHEM, V284, P11953, DOI 10.1074/jbc.M808176200; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Luttrell LM, 1996, J BIOL CHEM, V271, P19443, DOI 10.1074/jbc.271.32.19443; Mahajan R, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004075; Miyamoto S, 2004, CANCER RES, V64, P5720, DOI 10.1158/0008-5472.CAN-04-0811; Nishihara T, 2015, J BIOL CHEM, V290, P3693, DOI 10.1074/jbc.M114.603431; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rosse C, 2014, P NATL ACAD SCI USA, V111, pE1872, DOI 10.1073/pnas.1400749111; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rusinova R, 2007, J BIOL CHEM, V282, P34019, DOI 10.1074/jbc.M704928200; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Shah BH, 2006, J NEUROCHEM, V96, P520, DOI 10.1111/j.1471-4159.2005.03585.x; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Smith NJ, 2004, CELL MOL LIFE SCI, V61, P2695, DOI 10.1007/s00018-004-4244-3; Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Suojanen J, 2009, CANCER BIOL THER, V8, P2362, DOI 10.4161/cbt.8.24.10139; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Uchiyama-Tanaka Y, 2002, KIDNEY INT, V62, P799, DOI 10.1046/j.1523-1755.2002.00537.x; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	45	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					9941	9947		10.1074/jbc.C115.647073	http://dx.doi.org/10.1074/jbc.C115.647073			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759388	Green Published, hybrid			2022-12-26	WOS:000353241100001
J	Guo, J; Yao, HW; Lin, X; Xu, HD; Dean, D; Zhu, Z; Liu, G; Sime, P				Guo, Jia; Yao, Hongwei; Lin, Xin; Xu, Haodong; Dean, David; Zhu, Zhou; Liu, Gang; Sime, Patricia			IL-13 Induces YY1 through the AKT Pathway in Lung Fibroblasts	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR; MYOFIBROBLAST DIFFERENTIATION; 3-KINASE/AKT PATHWAY; FIBROGENIC FACTORS; TISSUE FIBROSIS; GENE-EXPRESSION; INTERLEUKIN-13; CELLS; ACTIVATION	A key feature of lung fibrosis is the accumulation of myofibroblasts. Interleukin 13 (IL-13) is a pro-fibrotic mediator that directly and indirectly influences the activation of myofibroblasts. Transforming growth factor beta (TGF-beta) promotes the differentiation of fibroblasts into myofibroblasts, and can be regulated by IL-13. However, IL-13's downstream signaling pathways are not completely understood. We previously reported that the transcription factor Yin Yang 1 (YY1) is upregulated in fibroblasts treated with TGF-beta and in the lungs of mice and patients with pulmonary fibrosis. Moreover, YY1 directly regulates collagen and alpha smooth muscle actin (alpha-SMA) expression in fibroblasts. However, it is not known if IL-13 regulates fibroblast activation through YY1 expression. We hypothesize that IL-13 upregulates YY1 expression through regulation of AKT activation, leading to fibroblast activation. In this study we found that YY1 was upregulated by IL-13 in lung fibroblasts in a dose- and time-dependent manner, resulting in increased alpha-SMA. Conversely, knockdown of YY1 blocked IL-13-induced alpha-SMA expression in fibroblasts. Furthermore, AKT phosphorylation was increased in fibroblasts treated with IL-13, and AKT overexpression upregulated YY1, whereas blockade of AKT phosphorylation suppressed the induction of YY1 by IL-13 in vitro. In vivo YY1 was upregulated in fibrotic lungs from CC10-IL-13 transgenic mice compared to that from wild-type littermates, which was associated with increased AKT phosphorylation. Taken together, these findings demonstrate that IL-13 is a potent stimulator and activator of fibroblasts, at least in part, through AKT-mediated YY1 activation.	[Guo, Jia; Sime, Patricia] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14620 USA; [Yao, Hongwei] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Lin, Xin; Dean, David; Sime, Patricia] Univ Rochester, Dept Pediat, Rochester, NY USA; [Xu, Haodong] Univ Calif Los Angeles, David Geffen Sch Med, Pathol & Lab Med, Los Angeles, CA 90095 USA; [Zhu, Zhou] Yale Univ, Dept Allergy & Clin Immunol, New Haven, CT USA; [Liu, Gang] Univ Alabama Birmingham, Dept Med Pulm & Crit Care, Birmingham, AL USA	University of Rochester; University of Rochester; University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; University of Alabama System; University of Alabama Birmingham	Guo, J (corresponding author), Univ Rochester, Sch Med, Dept Med, Rochester, NY 14620 USA.	jia_guo@urmc.rochester.edu	Yao, Hongwei/G-6444-2010; xu, hao/GWQ-7394-2022	, Gang/0000-0002-6999-7633; Liu, Gang/0000-0003-2615-131X	American Lung Associate and American Thoracic Society [RG-10327-N, 214017]; American Heart Associate [11SDG560007]; US National Institutes of Health [HL75432]; URMC Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075432] Funding Source: NIH RePORTER	American Lung Associate and American Thoracic Society; American Heart Associate; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); URMC Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by the grants from the American Lung Associate and American Thoracic Society (RG-10327-N and Award #214017 to J.G.), (http://www.pulmonaryfibrosis.org/), the American Heart Associate (11SDG560007), (http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@rsch/documents/downloadable/ucm_432230.pdf); US National Institutes of Health (HL75432 to P.S), and support from the URMC Department of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Borowski A, 2008, CLIN EXP ALLERGY, V38, P619, DOI 10.1111/j.1365-2222.2008.02944.x; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Elias JA, 2003, CHEST, V123, p339S, DOI 10.1378/chest.123.3_suppl.339S-a; Fallon PG, 2000, J IMMUNOL, V164, P2585, DOI 10.4049/jimmunol.164.5.2585; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Garneau-Tsodikova S, 2008, CURR MED CHEM, V15, P2632, DOI 10.2174/092986708785908969; Gharaee-Kermani M, 2007, EXPERT OPIN EMERG DR, V12, P627, DOI 10.1517/14728214.12.4.627; Grehan JF, 2005, J IMMUNOL, V175, P1903, DOI 10.4049/jimmunol.175.3.1903; Guo JA, 1997, GENOMICS, V42, P141, DOI 10.1006/geno.1997.4628; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hasegawa M, 1997, J RHEUMATOL, V24, P328; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kaviratne M, 2004, J IMMUNOL, V173, P4020, DOI 10.4049/jimmunol.173.6.4020; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Kulkarni AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015909; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lin X, 2011, AM J RESP CRIT CARE, V183, P1689, DOI 10.1164/rccm.201002-0232OC; Moriya C, 2011, J INVEST DERMATOL, V131, P655, DOI 10.1038/jid.2010.361; Rosada RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008721; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Vittal R, 2005, AM J PATHOL, V166, P367, DOI 10.1016/S0002-9440(10)62260-2; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	39	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119039	10.1371/journal.pone.0119039	http://dx.doi.org/10.1371/journal.pone.0119039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775215	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500063
J	Pereira, RC; Juppner, H; Gales, B; Salusky, IB; Wesseling-Perry, K				Pereira, Renata C.; Jueppner, Harald; Gales, Barbara; Salusky, Isidro B.; Wesseling-Perry, Katherine			Osteocytic Protein Expression Response to Doxercalciferol Therapy in Pediatric Dialysis Patients	PLOS ONE			English	Article							GROWTH-FACTOR 23; DENTIN MATRIX PROTEIN-1; CHRONIC KIDNEY-DISEASE; C-TERMINAL FRAGMENT; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; PHOSPHATE HOMEOSTASIS; RENAL OSTEODYSTROPHY; BREAST-CARCINOMA; GENE-EXPRESSION	Background Osteocytic protein expression is dysregulated in CKD and is affected by changes in mineral metabolism; however the effects of active vitamin D sterol therapy on osteocyte protein expression in advanced CKD is unknown. Methods Eleven pediatric patients with end stage kidney disease underwent bone biopsy, were treated for 8 months with doxercalciferol, and then underwent a second bone biopsy. Bone expression of fibroblast growth factor 23 (FGF23), dentin matrix protein 1 (DMP1), and sclerostin were determined by immunohistochemistry and quantified by Ariol Scanning. Western blot analysis and qRT-PCR was performed on bone abstracts of a subset of study subjects to determine the nature (i.e. size) of FGF23 and DMP1 in bone before and after therapy. Results As assessed by immunohistochemistry, bone FGF23, DMP1 and sclerostin protein all increased with therapy. In the case of FGF23, this increase was due to an increase in the full-length molecule without the appearance of FGF23 fragments. DMP1 was present primarily in its full-length formin healthy controls while 57kDa and 37kDa fragments of DMP1 were apparent in bone of dialysis patients at baseline and the 57 kDa appeared to decrease with therapy. Conclusion Marked changes in osteocytic protein expression accompany doxercalciferol therapy, potentially impacting bone mineralization and the skeletal response to PTH. The effects of these bone changes on long-term outcomes remain to be determined.	[Pereira, Renata C.; Gales, Barbara; Salusky, Isidro B.; Wesseling-Perry, Katherine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Jueppner, Harald] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; [Jueppner, Harald] Harvard Univ, Sch Med, Boston, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wesseling-Perry, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	kwesseling@mednet.ucla.edu			USPHS [DK-67563, DK-35423, DK-080984, PO-1DK11794]; CTSI [UL1 TR-000124]; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, R01DK035423, K23DK080984, R01DK067563] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); CTSI; Casey Lee Ball Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by USPHS grants DK-67563, DK-35423, DK-080984, PO-1DK11794, and CTSI grant UL1 TR-000124 and funds from the Casey Lee Ball Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacchetta J, 2013, CLIN J AM SOC NEPHRO, V8, P824, DOI 10.2215/CJN.00330112; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bhattacharyya N, 2012, TRENDS ENDOCRIN MET, V23, P610, DOI 10.1016/j.tem.2012.07.002; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P877, DOI 10.2215/CJN.06550810; Chaussain C, 2009, EUR CELLS MATER, V18, P84, DOI 10.22203/eCM.v018a08; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Gokhale S, 2007, APPL IMMUNOHISTO M M, V15, P451, DOI 10.1097/PAI.0b013e31802ee998; Gomes SA, 2008, J BONE MINER METAB, V26, P110, DOI 10.1007/s00774-007-0788-2; GOODMAN WG, 1994, KIDNEY INT, V46, P1160, DOI 10.1038/ki.1994.380; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hollis BW, 1996, CLIN CHEM, V42, P586; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Jiang Z, 2004, HISTOPATHOLOGY, V45, P218, DOI 10.1111/j.1365-2559.2004.01930.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Leys CM, 2007, SURGERY, V141, P41, DOI 10.1016/j.surg.2006.05.009; Liu SG, 2008, AM J PHYSIOL-ENDOC M, V295, pE254, DOI 10.1152/ajpendo.90201.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu YB, 2011, J BONE MINER RES, V26, P331, DOI 10.1002/jbmr.226; Martin A, 2012, MOL ENDOCRINOL, V26, P1883, DOI 10.1210/me.2012-1062; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Nociti FH, 2014, J DENT RES, V93, P148, DOI 10.1177/0022034513516344; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Sabbagh Y, 2012, J BONE MINER RES, V27, P1757, DOI 10.1002/jbmr.1630; Sanchez CP, 1998, KIDNEY INT, V53, P1358, DOI 10.1046/j.1523-1755.1998.00866.x; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Smith ER, 2012, J CLIN ENDOCR METAB, V97, P3357, DOI 10.1210/jc.2012-1811; Turbin DA, 2008, BREAST CANCER RES TR, V110, P417, DOI 10.1007/s10549-007-9736-z; von Marschall Z, 2008, J BIOL CHEM, V283, P32730, DOI 10.1074/jbc.M804283200; Wesseling-Perry K, 2012, CLIN J AM SOC NEPHRO, V7, P146, DOI 10.2215/CJN.05940611; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352	37	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120856	10.1371/journal.pone.0120856	http://dx.doi.org/10.1371/journal.pone.0120856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774916	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500195
J	Steiner, J; Wu, WC; Jankowich, M; Maron, BA; Sharma, S; Choudhary, G				Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Maron, Bradley A.; Sharma, Satish; Choudhary, Gaurav			Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities	PLOS ONE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; HEART-FAILURE; ARTERY PRESSURE; PROGNOSTIC IMPORTANCE; OXYGEN-THERAPY; DIAGNOSIS; ACCURACY; DISEASE; TERM; DYSFUNCTION	Objective We aimed to identify the echocardiographic measures associated with survival in a patient population with a high prevalence of co-morbid cardiovascular and pulmonary disease that have significantly elevated estimated pulmonary artery systolic pressures (ePASP). Background Pulmonary hypertension (PH) is a clinical feature of several cardiopulmonary diseases that are prevalent among elderly. While certain echocardiographic parameters have been shown to be important in the prognosis in specific PH groups, the prognostic relevance of echocardiographic characteristics in a cohort with multiple cardiopulmonary comorbidities is unclear. Methods We retrospectively identified 152 patients with ePASP > 60 mmHg by echocardiography over a five year period (6/2006-11/2011) and followed until 4/2013. Candidate clinical and echocardiographic characteristics suggestive of PH severity were compared between deceased and surviving subpopulations. Cox proportional hazard modeling was used to identify echocardiographic predictors of death adjusted for age and clinical characteristics. Results This was a predominantly elderly (age 78.8 +/- 10.2 years), male (98.7%) cohort with several cardiopulmonary comorbidities. Overall mortality was high (69.7%, median survival 129 days). After adjusting for age and clinical characteristics, decreased right ventricular (RV) systolic function assessed by tricuspid annular plane systolic excursion (HR 0.56, 95% CI 0.33-0.96, p = 0.034) and increased RV thickness (HR: 4.34, 95% CI: 1.49-12.59, p = 0.007) were independently associated with mortality. In contrast, left ventricular systolic function, left ventricular diastolic parameters, ePASP, or echo-derived pulmonary vascular resistance (PVR) were not associated with increased mortality. Conclusion In a cohort of patients with PH and high prevalence of cardio-pulmonary comorbidities, RV systolic function and hypertrophy are associated with mortality and may be the most relevant echocardiographic markers for prognosis.	[Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Sharma, Satish; Choudhary, Gaurav] Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA; [Steiner, Johannes; Wu, Wen-Chih; Jankowich, Matthew; Sharma, Satish; Choudhary, Gaurav] Brown Univ, Dept Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Maron, Bradley A.] Vet Affairs Boston Healthcare Syst, Dept Cardiol, Boston, MA USA; [Maron, Bradley A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Maron, Bradley A.] Harvard Univ, Sch Med, Dept Internal Med, Div Cardiovasc Med, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhary, G (corresponding author), Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA.	Gaurav_Choudhary@brown.edu	Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	Department of Veterans Affairs; MERIT Review Award [IBX000711A]; Research Enhancement Award Program grant [REA 08-263]; American Heart Association [11POST6720000]; United States National Institutes of Health [1K08HL111207-01A1]; Lerner and Klarman Foundation at Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139613, K08HL111207] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); MERIT Review Award(US Department of Veterans Affairs); Research Enhancement Award Program grant; American Heart Association(American Heart Association); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner and Klarman Foundation at Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Department of Veterans Affairs; MERIT Review Award to GC (IBX000711A) Research Enhancement Award Program grant (REA 08-263) to W-CW, and awards from American Heart Association (11POST6720000), United States National Institutes of Health (1K08HL111207-01A1) and the Lerner and Klarman Foundation at Brigham and Women's Hospital to BAM. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2003, J AM COLL CARDIOL, V41, P1021, DOI 10.1016/S0735-1097(02)02973-X; Agarwal R, 2012, NEPHROL DIAL TRANSPL, V27, P310, DOI 10.1093/ndt/gfr320; Almagro P, 2006, RESPIRATION, V73, P311, DOI 10.1159/000088092; Burke MA, 2014, CIRC-HEART FAIL, V7, P288, DOI 10.1161/CIRCHEARTFAILURE.113.000854; Cogswell R, 2013, J HEART LUNG TRANSPL, V32, P293, DOI 10.1016/j.healun.2012.11.012; Dadfarmay Sina, 2010, Congest Heart Fail, V16, P287, DOI 10.1111/j.1751-7133.2010.00192.x; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Ghio S, 2013, EUR J HEART FAIL, V15, P408, DOI 10.1093/eurjhf/hfs208; Guazzi M, 2012, EUR RESPIR REV, V21, P338, DOI 10.1183/09059180.00004612; Guglin M, 2010, J CARD FAIL, V16, P461, DOI 10.1016/j.cardfail.2010.01.003; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Hoeper MM, 2009, J AM COLL CARDIOL, V54, pS85, DOI 10.1016/j.jacc.2009.04.008; Kjaergaard J, 2007, EUR J HEART FAIL, V9, P610, DOI 10.1016/j.ejheart.2007.03.001; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Maron BA, 2013, CIRC-HEART FAIL, V6, P906, DOI 10.1161/CIRCHEARTFAILURE.112.000091; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; McClanahan A, 2011, J CARD FAIL, V17, P1023, DOI 10.1016/j.cardfail.2011.08.011; Meluzin J, 2005, J AM SOC ECHOCARDIOG, V18, P435, DOI 10.1016/j.echo.2005.02.004; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Opotowsky AR, 2012, CIRC-CARDIOVASC IMAG, V5, P765, DOI 10.1161/CIRCIMAGING.112.976654; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; SAITO H, 1992, AM REV RESPIR DIS, V146, P1576, DOI 10.1164/ajrccm/146.6.1576; Sato T, 2012, J AM SOC ECHOCARDIOG, V25, P280, DOI 10.1016/j.echo.2011.12.012; Shah SJ, 2012, JAMA-J AM MED ASSOC, V308, P1366, DOI 10.1001/jama.2012.12347; Steckelberg RC, 2013, J AM SOC ECHOCARDIOG, V26, P464, DOI 10.1016/j.echo.2013.01.006; Strange G, 2012, HEART, V98, P1805, DOI 10.1136/heartjnl-2012-301992; van de Veerdonk MC, 2011, J AM COLL CARDIOL, V58, P2511, DOI 10.1016/j.jacc.2011.06.068; WilhelmBurger MJB, 2008, DIGITAL IMAGE PROCES; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000	33	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119277	10.1371/journal.pone.0119277	http://dx.doi.org/10.1371/journal.pone.0119277			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774911	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500078
J	van der Torren, CR; van Hensbergen, Y; Luther, S; Aghai, Z; Rychnavska, ZS; Slot, M; Scherjon, S; Kroger, N; Ganser, A; Weissinger, EM; Goulmy, E; Hambach, L				van der Torren, Cornelis R.; van Hensbergen, Yvette; Luther, Susanne; Aghai, Zohara; Rychnavska, Zuzana Stachova; Slot, Manon; Scherjon, Sicco; Kroeger, Nicolaus; Ganser, Arnold; Weissinger, Eva M.; Goulmy, Els; Hambach, Lothar			Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; VERSUS-HOST-DISEASE; 1ST INTERNATIONAL WORKSHOP; ACUTE MYELOID-LEUKEMIA; HISTOCOMPATIBILITY ANTIGENS; PROGNOSTIC-FACTORS; GRAFT; MARROW; IMMUNOTHERAPY; RELAPSE	Persistent complete donor chimerism is an important clinical indicator for remissions of hematological malignancies after HLA-matched allogeneic stem cell transplantation (SCT). However, the mechanisms mediating the persistence of complete donor chimerism are poorly understood. The frequent coincidence of complete donor chimerism with graft-versus- leukemia effects and graft-versus-host disease suggests that immune responses against minor histocompatibility antigens (mHags) are playing an important role in suppressing the host hematopoiesis after allogeneic SCT. Here, we investigated a possible relationship between donor immune responses against the hematopoiesis-restricted mHag HA-1 and the long-term kinetics of host hematopoietic chimerism in a cohort of 10 patients after allogeneic HLA-matched, HA-1 mismatched SCT. Functional HA-1 specific CTLs (HA1 CTLs) were detectable in 6/10 patients lysing host-type hematopoietic cells in vitro. Presence of HA-1 CTLs in the peripheral blood coincided with low host hematopoiesis levels quantified by highly sensitive mHag specific PCR. Additionally, co-incubation of host type CD34(+) cells with HA-1 CTLs isolated after allogeneic SCT prevented progenitor and cobblestone area forming cell growth in vitro and human hematopoietic engraftment in immunodeficient mice. Conversely, absence or loss of HA-1 CTLs mostly coincided with high host hematopoiesis levels and/or relapse. In summary, in this first study, presence of HA-1 CTLs paralleled low host hematopoiesis levels. This coincidence might be supported by the capacity of HA-1 CTLs isolated after allogeneic SCT to specifically eliminate host type hematopoietic stem/progenitor cells. Additional studies involving multiple mismatched mHags in more patients are required to confirm this novel characteristic of mHag CTLs as factor for the persistence of complete donor chimerism and leukemia remission after allogeneic SCT.	[van der Torren, Cornelis R.; Aghai, Zohara; Rychnavska, Zuzana Stachova; Goulmy, Els; Hambach, Lothar] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [van Hensbergen, Yvette; Slot, Manon] Sanquin Blood Supply Fdn, Div Res, Dept Transfus Med, Leiden, Netherlands; [Luther, Susanne; Ganser, Arnold; Weissinger, Eva M.; Hambach, Lothar] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Scherjon, Sicco] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Kroeger, Nicolaus] Univ Med Ctr Hamburg Eppendorf, Dept Bone Marrow Transplantat, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Hannover Medical School; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hambach, L (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	hambach.lothar@mh-hannover.de			Sander foundation (Munich, Germany) [2005.111.1]; Integrated Research and Treatment Center Transplantation (IFB-Tx) - German Federal Ministry of Education and Research [01EO0802, 01EO1302]; Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands) [UL2006-3482]; Netherlands Organization for Scientific Research (NWO) Den Haag, The Netherlands	Sander foundation (Munich, Germany); Integrated Research and Treatment Center Transplantation (IFB-Tx) - German Federal Ministry of Education and Research; Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands)(KWF KankerbestrijdingNetherlands Government); Netherlands Organization for Scientific Research (NWO) Den Haag, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government)	This work is supported in part by funding from: Sander foundation (Munich, Germany, project code 2005.111.1); [http://www.wilhelm-sanderstiftung. de/]; the Integrated Research and Treatment Center Transplantation (IFB-Tx) funded by the German Federal Ministry of Education and Research (reference number: 01EO0802 and 01EO1302); [http://www.ifb-tx.de/]; the Dutch Cancer Society (Koningin Wilhelmina Fonds, Amsterdam, The Netherlands, project code UL2006-3482); [http://www. kwf.nl/]; the Netherlands Organization for Scientific Research (NWO; Den Haag, The Netherlands); [http://www.nwo.nl/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MH, 2014, LEUKEMIA, V28, P1784, DOI 10.1038/leu.2014.108; Bethge WA, 2004, BLOOD, V103, P790, DOI 10.1182/blood-2003-07-2344; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Boeck S, 2006, BONE MARROW TRANSPL, V37, P57, DOI 10.1038/sj.bmt.1705217; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bonnet D, 2001, P NATL ACAD SCI USA, V96, P8639; Borchers S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050248; BRETAGNE S, 1987, BLOOD, V70, P1692; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; Dey BR, 2003, BIOL BLOOD MARROW TR, V9, P320, DOI 10.1016/S1083-8791(03)00077-6; Diaconescu R, 2004, BLOOD, V104, P1550, DOI 10.1182/blood-2004-03-0804; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; Dierselhuis MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091274; Dupriez B, 1996, BLOOD, V88, P1013; FALKENBURG JHF, 1991, J EXP MED, V174, P27, DOI 10.1084/jem.174.1.27; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOULMY E, 1983, NATURE, V302, P159, DOI 10.1038/302159a0; Hambach L, 2005, CURR OPIN IMMUNOL, V17, P202, DOI 10.1016/j.coi.2005.01.010; Hambach L, 2006, LEUKEMIA, V20, P371, DOI 10.1038/sj.leu.2404056; Hobo W, 2013, BIOL BLOOD MARROW TR, V19, P274, DOI 10.1016/j.bbmt.2012.09.008; Holloway PA, 2004, LEUKEMIA, V18, P1543, DOI 10.1038/sj.leu.2403445; HOROWITZ MM, 1990, BLOOD, V75, P555; Kroger N, 2010, BIOL BLOOD MARROW TR, V16, P1325, DOI 10.1016/j.bbmt.2010.07.001; Kroger N, 2010, BIOL BLOOD MARROW TR, V16, P1187, DOI 10.1016/j.bbmt.2010.06.008; Marijt WAE, 2003, P NATL ACAD SCI USA, V100, P2742, DOI 10.1073/pnas.0530192100; MARIJT WAF, 1993, BLOOD, V82, P3778; Martinez-Climent JA, 2010, HAEMATOL-HEMATOL J, V95, P293, DOI 10.3324/haematol.2009.013318; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Mutis T, 2010, LEUKEMIA, V24, P1388, DOI 10.1038/leu.2010.115; Mutis T, 1999, BLOOD, V93, P2336, DOI 10.1182/blood.V93.7.2336.407k26_2336_2341; Mutis T, 1999, NAT MED, V5, P839, DOI 10.1038/10563; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Rosinski KV, 2008, BLOOD, V111, P4817, DOI 10.1182/blood-2007-06-096313; Rufer N, 1998, BONE MARROW TRANSPL, V22, P895, DOI 10.1038/sj.bmt.1701466; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Spierings E, 2003, LANCET, V362, P610, DOI 10.1016/S0140-6736(03)14191-8; Spierings E, 2007, PLOS GENET, V3, P1108, DOI 10.1371/journal.pgen.0030103; Spierings E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000042; Spierings E, 2013, BIOL BLOOD MARROW TR, V19, P1244, DOI 10.1016/j.bbmt.2013.06.001; Spierings E, 2009, J IMMUNOL, V182, P4809, DOI 10.4049/jimmunol.0803911; Stern M, 2008, BLOOD, V112, P2990, DOI 10.1182/blood-2008-01-135285; Toes REM, 1998, J IMMUNOL, V160, P4449; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; VANDERHARST D, 1994, BLOOD, V83, P1060; Verdijk RM, 2004, BLOOD, V103, P1961, DOI 10.1182/blood-2003-05-1625; Vogt MHJ, 2002, BLOOD, V99, P3027, DOI 10.1182/blood.V99.8.3027; Wagner K, 2011, HAEMATOL-HEMATOL J, V96, P681, DOI 10.3324/haematol.2010.034074; Wiedemann B, 2010, EXP HEMATOL, V38, P1261, DOI 10.1016/j.exphem.2010.08.006; Wilke Martina, 2003, Hematol J, V4, P315, DOI 10.1038/sj.thj.6200318	49	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119595	10.1371/journal.pone.0119595	http://dx.doi.org/10.1371/journal.pone.0119595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774796	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500104
J	Bersten, DC; Sullivan, AE; Li, D; Bhakti, V; Bent, SJ; Whitelaw, ML				Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Bent, Stephen J.; Whitelaw, Murray L.			Inducible and Reversible Lentiviral and Recombination Mediated Cassette Exchange (RMCE) Systems for Controlling Gene Expression	PLOS ONE			English	Article							RNA INTERFERENCE; IN-VITRO; MICE; RESOURCE; MOUSE; PURIFICATION; INTEGRATION; GENERATION; PROTEINS; DESIGN	Manipulation of gene expression to invoke loss of function (LoF) or gain of function (GoF) phenotypes is important for interrogating complex biological questions both in vitro and in vivo. Doxycycline (Dox)-inducible gene expression systems are commonly used although success is often limited by high background and insufficient sensitivity to Dox. Here we develop broadly applicable platforms for reliable, tightly controlled and reversible Dox-inducible systems for lentiviral mediated generation of cell lines or FLP Recombination-Mediated Cassette Exchange (RMCE) into the Collagen 1a1 (Col1a1) locus (FLP-In Col1a1) in mouse embryonic stem cells. We significantly improve the flexibility, usefulness and robustness of the Dox-inducible system by using Tetracycline (Tet) activator (Tet-On) variants which are more sensitive to Dox, have no background activity and are expressed from single Gateway-compatible constructs. We demonstrate the usefulness of these platforms in ectopic gene expression or gene knockdown in multiple cell lines, primary neurons and in FLP-In Col1a1 mouse embryonic stem cells. We also improve the flexibility of RMCE Dox-inducible systems by generating constructs that allow for tissue or cell type-specific Dox-inducible expression and generate a shRNA selection algorithm that can effectively predict potent shRNA sequences able to knockdown gene expression from single integrant constructs. These platforms provide flexible, reliable and broadly applicable inducible expression systems for studying gene function.	[Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Whitelaw, Murray L.] Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia; [Bersten, David C.; Sullivan, Adrienne E.; Li, Dian; Bhakti, Veronica; Whitelaw, Murray L.] Univ Adelaide, Inst Mol Pathol, Adelaide, SA, Australia; [Bent, Stephen J.] Univ Adelaide, Sch Mol & Biomed Sci Genet, Adelaide, SA, Australia; [Bent, Stephen J.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Robinson Research Institute; University of Adelaide	Bersten, DC (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci Biochem, Adelaide, SA, Australia.	david.bersten@adelaide.edu.au; murray.whitelaw@adelaide.edu.au	Bent, Stephen/A-7094-2011	Bent, Stephen/0000-0003-1563-2855; Sullivan, Adrienne/0000-0003-3967-892X	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Australian Research Council and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bersten DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085768; Bersten DC, 2013, NAT REV CANCER, V13, P827, DOI 10.1038/nrc3621; Brown CY, 2010, HUM GENE THER, V21, P1005, DOI 10.1089/hum.2009.107; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Haenebalcke L, 2013, CELL REP, V3, P335, DOI 10.1016/j.celrep.2013.01.016; Hao N, 2013, NUCLEIC ACIDS RES, V41, P5626, DOI 10.1093/nar/gkt206; Heinz N, 2011, HUM GENE THER, V22, P166, DOI 10.1089/hum.2010.099; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Kakinuma H, 2003, CANCER RES, V63, P7840; Kleibeuker W, 2009, HUM GENE THER, V20, P524, DOI 10.1089/hum.2008.182; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Loew R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-81; Matveeva Olga V., 2012, Frontiers in Genetics, V3, P163, DOI 10.3389/fgene.2012.00163; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Ramachandrappa S, 2013, J CLIN INVEST, V123, P3042, DOI 10.1172/JCI68016; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Sciabola S, 2013, NUCLEIC ACIDS RES, V41, P1383, DOI 10.1093/nar/gks1191; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tan X, 2012, P NATL ACAD SCI USA, V109, P869, DOI 10.1073/pnas.1119873109; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wu S, 2008, NAT PROTOC, V3, P1056, DOI 10.1038/nprot.2008.70; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhou X, 2006, GENE THER, V13, P1382, DOI 10.1038/sj.gt.3302780; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	46	3	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116373	10.1371/journal.pone.0116373	http://dx.doi.org/10.1371/journal.pone.0116373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768837	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500009
J	Wilkens, CA; Gerdtzen, ZP				Wilkens, Camila A.; Gerdtzen, Ziomara P.			Comparative Metabolic Analysis of CHO Cell Clones Obtained through Cell Engineering, for IgG Productivity, Growth and Cell Longevity	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE DINUCLEOTIDE; YEAST PYRUVATE-CARBOXYLASE; FLUX ANALYSIS; EXPRESSION; GLUCOSE; IMPROVEMENT; CULTURE; ERYTHROPOIETIN; MITOCHONDRIA; REDUCTION	Cell engineering has been used to improve animal cells' central carbon metabolism. Due to the central carbon metabolism's inefficiency and limiting input of carbons into the TCA cycle, key reactions belonging to these pathways have been targeted to improve cultures' performance. Previous works have shown the positive effects of overexpressing PYC2, MDH II and fructose transporter. Since each of these modifications was performed in different cell lines and culture conditions, no comparisons between these modifications can be made. In this work we aim at contrasting the effect of each of the modifications by comparing pools of transfected IgG producing CHO cells cultivated in batch cultures. Results of the culture performance of engineered clones indicate that even though all studied clones had a more efficient metabolism, not all of them showed the expected improvement on cell proliferation and/or specific productivity. CHO cells overexpressing PYC2 were able to improve their exponential growth rate but IgG synthesis was decreased, MDH II overexpression lead to a reduction in cell growth and protein production, and cells transfected with the fructose transporter gene were able to increase cell density and reach the same volumetric protein production as parental CHO cells in glucose. We propose that a redox unbalance caused by the new metabolic flux distribution could affect IgG assembly and protein secretion. In addition to reaction dynamics, thermodynamic aspects of metabolism are also discussed to further understand the effect of these modifications over central carbon metabolism.	[Wilkens, Camila A.; Gerdtzen, Ziomara P.] Univ Chile, CeBiB, Dept Chem Engn, Santiago 8370448, Chile	Universidad de Chile	Gerdtzen, ZP (corresponding author), Univ Chile, CeBiB, Dept Chem Engn, Beauchef 850, Santiago 8370448, Chile.	zgerdtze@ing.uchile.cl	Gerdtzen, Ziomara/H-2711-2013	Gerdtzen, Ziomara/0000-0002-7486-8537	V.I. D. UChile Enlace [Fondecyt-2013-14116]; Conicyt Doctorate Fellowship [21100286-2010]; PIA Conicyt [FB0001]; Fondecyt [1130317]; Fondecyt Initiation [11090268]	V.I. D. UChile Enlace; Conicyt Doctorate Fellowship; PIA Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondecyt Initiation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors acknowledge funding from V.I. D. UChile Enlace Fondecyt-2013-14116, Conicyt Doctorate Fellowship 21100286-2010, PIA Conicyt FB0001, Fondecyt Grant 1130317 and Fondecyt Initiation Grant 11090268. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano C, 2000, BIOTECHNOL PROGR, V16, P69, DOI 10.1021/bp990124j; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; BOISSEL JP, 1993, J BIOL CHEM, V268, P15983; Borth N, 2005, BIOTECHNOL PROGR, V21, P106, DOI 10.1021/bp0498241; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; EAGLE H, 1958, J BIOL CHEM, V233, P551; Elias CB, 2003, BIOTECHNOL PROGR, V19, P90, DOI 10.1021/bp025572x; Europa AF, 2000, BIOTECHNOL BIOENG, V67, P25, DOI 10.1002/(SICI)1097-0290(20000105)67:1<25::AID-BIT4>3.0.CO;2-K; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fussenegger M, 1997, BIOTECHNOL BIOENG, V55, P927, DOI 10.1002/(SICI)1097-0290(19970920)55:6<927::AID-BIT10>3.0.CO;2-4; Gambhir A, 2003, J BIOSCI BIOENG, V95, P317, DOI 10.1263/jbb.95.317; GLACKEN MW, 1988, BIO-TECHNOL, V6, P1041, DOI 10.1038/nbt0988-1041; GLACKEN MW, 1986, BIOTECHNOL BIOENG, V28, P1376, DOI 10.1002/bit.260280912; Inoue Y, 2010, CYTOTECHNOLOGY, V62, P301, DOI 10.1007/s10616-010-9289-6; Irani N, 2002, J BIOTECHNOL, V93, P269, DOI 10.1016/S0168-1656(01)00409-6; Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO;2-6; Jones ML, 2010, J IMMUNOL METHODS, V354, P85, DOI 10.1016/j.jim.2010.02.001; KERBEY AL, 1977, BIOCHEM J, V164, P509, DOI 10.1042/bj1640509; Korke R, 2004, J BIOTECHNOL, V107, P1, DOI 10.1016/j.jbiotec.2003.09.007; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; KURANO N, 1990, J BIOTECHNOL, V15, P113, DOI 10.1016/0168-1656(90)90055-G; LONGMORE WJ, 1969, J BIOL CHEM, V244, P6451; MOONEY RA, 1982, EUR J BIOCHEM, V121, P281, DOI 10.1111/j.1432-1033.1982.tb05783.x; Nelson D. L., 2008, LEHNINGER PRINCIPLES, V5th, P926; ROBINSON BH, 1971, J BIOL CHEM, V246, P5280; Rozwarski DA, 1996, PROTEINS, V26, P304, DOI 10.1002/(SICI)1097-0134(199611)26:3<304::AID-PROT6>3.0.CO;2-D; SCHUSTER R, 1988, BIOSYSTEMS, V22, P19, DOI 10.1016/0303-2647(88)90047-0; Siddiquee KA, 2004, APPL MICROBIOL BIOT, V63, P407, DOI 10.1007/s00253-003-1357-9; SIES H, 1973, EUR J BIOCHEM, V38, P247, DOI 10.1111/j.1432-1033.1973.tb03056.x; Terada S, 1996, CYTOKINE, V8, P889, DOI 10.1006/cyto.1996.0119; Wilkens CA, 2011, BIOTECHNOL BIOPROC E, P16; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; Wlaschin KF, 2007, J BIOTECHNOL, V131, P168, DOI 10.1016/j.jbiotec.2007.06.006; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Zupke C, 1995, APPL MICROBIOL BIOT, V44, P27	37	22	24	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119053	10.1371/journal.pone.0119053	http://dx.doi.org/10.1371/journal.pone.0119053			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768021	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500061
J	Berggren, M; Bergstrom, AK; Karlsson, J				Berggren, Martin; Bergstrom, Ann-Kristin; Karlsson, Jan			Intraspecific Autochthonous and Allochthonous Resource Use by Zooplankton in a Humic Lake during the Transitions between Winter, Summer and Fall	PLOS ONE			English	Article							AQUATIC FOOD WEBS; ORGANIC-CARBON; STABLE-ISOTOPES; CRUSTACEAN ZOOPLANKTON; BACTERIAL PRODUCTION; TERRESTRIAL SUPPORT; PHYTOPLANKTON; BOREAL; SUBSIDIES; MATTER	Seasonal patterns in assimilation of externally produced, allochthonous, organic matter into aquatic food webs are poorly understood, especially in brown-water lakes. We studied the allochthony (share biomass of terrestrial origin) in cladoceran, calanoid and cyclopoid micro-crustacean zooplankton from late winter to fall during two years in a small humic lake (Sweden). The use of allochthonous resources was important for sustaining a small population of calanoids in the water column during late winter. However, in summer the calanoids shifted to 100% herbivory, increasing their biomass several-fold by making efficient use of the pelagic primary production. In contrast, the cyclopoids and cladocerans remained at high levels of allochthony throughout the seasons, both groups showing the mean allochthony of 0.56 (range in mean 0.17-0.79 and 0.34-0.75, for the respective group, depending on model parameters). Our study shows that terrestrial organic matter can be an important resource for cyclopoids and cladocerans on an annual basis, forming a significant link between terrestrial organic matter and the higher trophic levels of the food web, but it can also be important for sustaining otherwise herbivorous calanoids during periods of low primary production in late winter.	[Berggren, Martin] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Bergstrom, Ann-Kristin; Karlsson, Jan] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Lund University; Umea University	Berggren, M (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.	martin.berggren@nateko.lu.se	Berggren, Martin/G-1401-2012	Berggren, Martin/0000-0003-0657-0971	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2010-126]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas)	MB was supported by a strong research environment funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas grant #2010-126 to D.J. Conley et al.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLGREN G, 1983, ARCH HYDROBIOL, V98, P489; Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; Ask J, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003951; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Batt RD, 2012, LIMNOL OCEANOGR, V57, P1443, DOI 10.4319/lo.2012.57.5.1443; Berggren M, 2010, ECOL LETT, V13, P870, DOI 10.1111/j.1461-0248.2010.01483.x; Berggren M, 2014, ECOLOGY, V95, P1947, DOI 10.1890/13-0615.1; Berggren M, 2009, LIMNOL OCEANOGR, V54, P1333, DOI 10.4319/lo.2009.54.4.1333; Blackburn N, 1998, APPL ENVIRON MICROB, V64, P3246; BOTTRELL HH, 1976, NORW J ZOOL, V24, P419; Brett MT, 2009, P NATL ACAD SCI USA, V106, P21197, DOI 10.1073/pnas.0904129106; Broglio E, 2003, AQUAT MICROB ECOL, V31, P267, DOI 10.3354/ame031267; Caraco N, 2010, ECOLOGY, V91, P2385, DOI 10.1890/09-0330.1; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Dobberfuhl DR, 1997, AQUAT MICROB ECOL, V12, P29, DOI 10.3354/ame012029; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Drakare S, 2002, FRESHWATER BIOL, V47, P41, DOI 10.1046/j.1365-2427.2002.00779.x; Fry JC, 1988, METHODS AQUATIC BACT, P27; Gentsch E, 2009, J PLANKTON RES, V31, P45, DOI 10.1093/plankt/fbn097; Grey J, 2001, LIMNOL OCEANOGR, V46, P505, DOI 10.4319/lo.2001.46.3.0505; HESSEN DO, 1990, HYDROBIOLOGIA, V206, P217, DOI 10.1007/BF00014087; Iwabuchi T, 2010, ECOL RES, V25, P619, DOI 10.1007/s11284-010-0692-4; Jansson M, 2000, ECOLOGY, V81, P3250, DOI 10.1890/0012-9658(2000)081[3250:AOCAPB]2.0.CO;2; Jansson M, 1999, ARCH HYDROBIOL, V144, P409; Jones RI, 2000, FRESHWATER BIOL, V45, P219, DOI 10.1046/j.1365-2427.2000.00672.x; Karlsson J, 2004, FRESHWATER BIOL, V49, P526, DOI 10.1111/j.1365-2427.2004.01208.x; Karlsson J, 2002, ECOLOGY, V83, P2902, DOI 10.1890/0012-9658(2002)083[2902:SRBPPA]2.0.CO;2; Karlsson J, 2012, LIMNOL OCEANOGR, V57, P1042, DOI 10.4319/lo.2012.57.4.1042; Laudon H, 2013, WATER RESOUR RES, V49, P7154, DOI 10.1002/wrcr.20520; Martin-Creuzburg D, 2011, FEMS MICROBIOL ECOL, V76, P592, DOI 10.1111/j.1574-6941.2011.01076.x; Matthews B, 2006, ECOLOGY, V87, P2800, DOI 10.1890/0012-9658(2006)87[2800:HSATEO]2.0.CO;2; Meili M, 2000, VERH INT VER LIMNOL, V27, P1940; Muller-Navarra DC, 2008, INT REV HYDROBIOL, V93, P489, DOI 10.1002/iroh.200711046; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rautio M, 2011, LIMNOL OCEANOGR, V56, P1513, DOI 10.4319/lo.2011.56.4.1513; SCHINDLER DW, 1972, J FISH RES BOARD CAN, V29, P1627, DOI 10.1139/f72-250; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Solomon CT, 2011, ECOLOGY, V92, P1115, DOI 10.1890/i0012-9658-92-5-1115; Solomon CT, 2009, OECOLOGIA, V161, P313, DOI 10.1007/s00442-009-1370-5; Taipale SJ, 2014, ECOLOGY, V95, P563, DOI 10.1890/13-0650.1; Tittel J, 2009, AQUAT SCI, V71, P46, DOI 10.1007/s00027-008-8121-2; TRANVIK LJ, 1988, MICROBIAL ECOL, V16, P311, DOI 10.1007/BF02011702; Wenzel A, 2012, CAN J FISH AQUAT SCI, V69, P1870, DOI 10.1139/f2012-110; Wenzel A, 2012, FRESHWATER BIOL, V57, P835, DOI 10.1111/j.1365-2427.2012.02751.x; Wesche A, 2007, MAR BIOL, V151, P1309, DOI 10.1007/s00227-006-0560-5; Wilkinson GM, 2013, GLOBAL BIOGEOCHEM CY, V27, P43, DOI 10.1029/2012GB004453; Zigah PK, 2012, BIOGEOSCIENCES, V9, P3663, DOI 10.5194/bg-9-3663-2012	49	35	35	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120575	10.1371/journal.pone.0120575	http://dx.doi.org/10.1371/journal.pone.0120575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764501	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300044
J	Huang, HY; Lin, JH; Lee, WC				Huang, Hsiao-Yuan; Lin, Jui-Hsiang; Lee, Wen-Chung			A Permutation Test for Oligoset DNA Pooling Studies	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; HERITABILITY; DISEASE; IMPACTS; SNPS; BIAS	Case-control association studies often suffer from population stratification bias. A previous triple combination strategy of stratum matching, genomic controlling, and multiple DNA pooling can correct the bias and save genotyping cost. However the method requires researchers to prepare a multitude of DNA pools-more than 30 case-control pooling sets in total (polyset). In this paper, the authors propose a permutation test for oligoset DNA pooling studies. Monte-Carlo simulations show that the proposed test has a type I error rate under control and a power comparable to that of individual genotyping. For a researcher on a tight budget, oligoset DNA pooling is a viable option.	[Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan; Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		LIN, JUI-HSIANG/0000-0002-1303-2736; Lee, Wen-Chung/0000-0003-3171-7672	Ministry of Science and Technology, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This work is partly supported by grants from the Ministry of Science and Technology, Taiwan (NSC 102-2628-B-002-036-MY3) and the National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Chiang CWK, 2011, HUM GENET, V130, P607, DOI 10.1007/s00439-011-0974-0; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Golan D, 2012, BIOINFORMATICS, V28, pI197, DOI 10.1093/bioinformatics/bts208; Gui HS, 2014, ANN HUM GENET, V78, P381, DOI 10.1111/ahg.12076; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang HY, 2011, J CLIN EPIDEMIOL, V64, P517, DOI 10.1016/j.jclinepi.2010.07.004; Ioannidis JPA, 2006, AM J EPIDEMIOL, V164, P609, DOI 10.1093/aje/kwj259; Konig IR, 2004, GENET EPIDEMIOL, V26, P31, DOI 10.1002/gepi.10290; Lee JS, 2011, GENET EPIDEMIOL, V35, P139, DOI 10.1002/gepi.20561; Lee WC, 2005, CANCER EPIDEM BIOMAR, V14, P958, DOI 10.1158/1055-9965.EPI-04-0503; Lee WC, 2004, GENET EPIDEMIOL, V27, P1, DOI 10.1002/gepi.20011; Lee WC, 2008, AM J EPIDEMIOL, V167, P86, DOI 10.1093/aje/kwm257; Lee WC, 2009, J CLIN EPIDEMIOL, V62, P62, DOI 10.1016/j.jclinepi.2008.02.016; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; Vinkhuyzen AAE, 2013, ANNU REV GENET, V47, P75, DOI 10.1146/annurev-genet-111212-133258; Witte JS, 1999, AM J EPIDEMIOL, V149, P693; Yamada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020468; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zou GH, 2004, GENET EPIDEMIOL, V26, P1, DOI 10.1002/gepi.10277; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	23	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119096	10.1371/journal.pone.0119096	http://dx.doi.org/10.1371/journal.pone.0119096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763822	Green Submitted, gold, Green Published			2022-12-26	WOS:000351276300019
J	Canessa, S; Heard, GW; Robertson, P; Sluiter, IRK				Canessa, Stefano; Heard, Geoffrey W.; Robertson, Peter; Sluiter, Ian R. K.			Dealing with Trade-Offs in Destructive Sampling Designs for Occupancy Surveys	PLOS ONE			English	Article							DETECTION PROBABILITIES; IMPERFECT DETECTION; SPECIES OCCURRENCE; SITE OCCUPANCY; CONSERVATION; NONDETECTION; PRECISION; ABSENCE; MODELS; RATES	Occupancy surveys should be designed to minimise false absences. This is commonly achieved by increasing replication or increasing the efficiency of surveys. In the case of destructive sampling designs, in which searches of individual microhabitats represent the repeat surveys, minimising false absences leads to an inherent trade-off. Surveyors can sample more low quality microhabitats, bearing the resultant financial costs and producing wider-spread impacts, or they can target high quality microhabitats were the focal species is more likely to be found and risk more severe impacts on local habitat quality. We show how this trade-off can be solved with a decision-theoretic approach, using the Millewa Skink Hemiergis millewae from southern Australia as a case study. Hemiergis millewae is an endangered reptile that is best detected using destructive sampling of grass hummocks. Within sites that were known to be occupied by H. millewae, logistic regression modelling revealed that lizards were more frequently detected in large hummocks. If this model is an accurate representation of the detection process, searching large hummocks is more efficient and requires less replication, but this strategy also entails destruction of the best microhabitats for the species. We developed an optimisation tool to calculate the minimum combination of the number and size of hummocks to search to achieve a given cumulative probability of detecting the species at a site, incorporating weights to reflect the sensitivity of the results to a surveyor's priorities. The optimisation showed that placing high weight on minimising volume necessitates impractical replication, whereas placing high weight on minimising replication requires searching very large hummocks which are less common and may be vital for H. millewae. While destructive sampling methods are sometimes necessary, surveyors must be conscious of the ecological impacts of these methods. This study provides a simple tool for identifying sampling strategies that minimise those impacts.	[Canessa, Stefano; Heard, Geoffrey W.] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Robertson, Peter; Sluiter, Ian R. K.] Federat Univ, Sch Sci Informat Technol & Engn, Ballarat, Vic, Australia	University of Melbourne; Federation University Australia	Canessa, S (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia.	science@canessas.com	Canessa, Stefano/J-2069-2014	Canessa, Stefano/0000-0002-0932-826X	Mallee Catchment Management Authority; Federation University, Australia; Australian Research Council Centre of Excellence for Environmental Decisions	Mallee Catchment Management Authority; Federation University, Australia; Australian Research Council Centre of Excellence for Environmental Decisions(Australian Research Council)	This study was supported by Mallee Catchment Management Authority (PR, IRKS) (http://www.malleecma.vic.gov.au); Federation University, Australia (SC, GH, PR, IRKS) (http://federation.edu.au/); Australian Research Council Centre of Excellence for Environmental Decisions (SC, GH) (http://ceed.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey LL, 2007, ECOL APPL, V17, P281, DOI 10.1890/1051-0761(2007)017[0281:SDTIOS]2.0.CO;2; Basset Y., 1996, CANOPY ARTHROPODS, P27; Brown S, 2009, BIOL CONSERV, V142, P432, DOI 10.1016/j.biocon.2008.11.005; Cogger H, 2000, REPTILES AMPHIBIANS; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Goode MJ, 2005, BIOL CONSERV, V125, P47, DOI 10.1016/j.biocon.2005.03.010; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Heyer W.R., 1994, MEASURING MONITORING; Kelly LT, 2011, DIVERS DISTRIB, V17, P462, DOI 10.1111/j.1472-4642.2011.00754.x; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kubecka J, 2012, FISH RES, V123, P1, DOI 10.1016/j.fishres.2011.11.013; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; McDonald PJ, 2012, AUST J ZOOL, V60, P166, DOI 10.1071/ZO12068; Nimmo DG, 2012, GLOBAL ECOL BIOGEOGR, V21, P1062, DOI 10.1111/j.1466-8238.2011.00747.x; Nimmo DG, 2008, VICTORIAN NAT, V125, P110; Otto CRV, 2013, ECOGRAPHY, V36, P1299, DOI 10.1111/j.1600-0587.2013.00137.x; Parris KM, 1999, HERPETOLOGICA, V55, P271; Plummer, 2005, P 3 INT WORKSH DISTR; Robertson P, 2011, SURVEY THREATE UNPUB; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wintle BA, 2004, ECOL APPL, V14, P703, DOI 10.1890/02-5166; Wintle BA, 2012, DIVERS DISTRIB, V18, P417, DOI 10.1111/j.1472-4642.2011.00874.x	33	0	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120340	10.1371/journal.pone.0120340	http://dx.doi.org/10.1371/journal.pone.0120340			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760868	gold, Green Published, Green Submitted			2022-12-26	WOS:000351275000068
J	Turtle, L; McGill, F; Bettridge, J; Matata, C; Christley, R; Solomon, T				Turtle, Lance; McGill, Fiona; Bettridge, Judy; Matata, Claire; Christley, Rob; Solomon, Tom			A Survey of UK Healthcare Workers' Attitudes on Volunteering to Help with the Ebola Outbreak in West Africa	PLOS ONE			English	Article								Objective To understand the barriers and enablers for UK healthcare workers who are considering going to work in the current Ebola outbreak in West Africa, but have not yet volunteered. Design After focus group discussions, and a pilot questionnaire, an anonymous survey was conducted using SurveyMonkey to determine whether people had considered going to West Africa, what factors might make them more or less likely to volunteer, and whether any of these were modifiable factors. Participants The survey was publicised among doctors, nurses, laboratory staff and allied health professionals. 3109 people answered the survey, of whom 472 (15%) were considering going to work in the epidemic but had not yet volunteered. 1791 (57.6%) had not considered going, 704 (22.6%) had considered going but decided not to, 53 (1.7%) had volunteered to go and 14 (0.45%) had already been and worked in the epidemic. Results For those considering going to West Africa, the most important factor preventing them from volunteering was a lack of information to help them decide; fear of getting Ebola and partners' concerns came next. Uncertainty about their potential role, current work commitments and inability to get agreement from their employer were also important barriers, whereas clarity over training would be an important enabler. In contrast, for those who were not considering going, or who had decided against going, family considerations and partner concerns were the most important factors. Conclusions More UK healthcare workers would volunteer to help tackle Ebola in West Africa if there was better information available, including clarity about roles, cover arrangements, and training. This could be achieved with a well-publicised high quality portal of reliable information.	[Turtle, Lance; McGill, Fiona; Bettridge, Judy; Matata, Claire; Christley, Rob; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England; [Turtle, Lance; Christley, Rob; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit, Liverpool L69 7BE, Merseyside, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool L9 7LJ, Merseyside, England	University of Liverpool; University of Liverpool; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Ronald Ross Bldg, Liverpool L69 7BE, Merseyside, England.	tsolomon@liv.ac.uk		Turtle, Lance/0000-0002-0778-1693; Christley, Robert/0000-0001-9250-3032; Bettridge, Judy/0000-0002-3917-4660; Solomon, Tom/0000-0001-7266-6547	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health; Public Health England (PHE); NIHR; University of Liverpool; Wellcome Trust [087757/Z/08/Z]; National Institute for Health Research [IS-HPU-1112-10117, NF-SI-0514-10177, CL-2013-07-005] Funding Source: researchfish	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health; Public Health England (PHE); NIHR(National Institute for Health Research (NIHR)); University of Liverpool; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the University of Liverpool Institute of Infection and Global health in partnership with Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. LT, FM and CM are funded by the NIHR as a clinical lecturer, doctoral research fellow and research nurse, respectively. This work was conducted independently of influence from the NIHR. This study was sponsored by the University of Liverpool. Dr Lance Turtle was funded by Wellcome Trust postdoctoral clinical fellowship 087757/Z/08/Z. The sponsor took no part in the design, conduct, analysis or writing of this research.	[Anonymous], 2003, Wkly Epidemiol Rec, V78, P223; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P370; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P345; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; British Red Cross, MED STAFF NEED EB RE; Centres for Disease Control and Prevention, SEC CAS EB DIAGN US; Chevalier MS, 2014, MMWR-MORBID MORTAL W, V63, P1087; European Centres for Disease Control and Prevention, NEWS EP UPD 1 EB CAS; GMC General medical council, LIST REG MED PRACT S; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6305; Khan AS, 1999, J INFECT DIS, V179, pS76, DOI 10.1086/514306; Lewis D, FEAR INDIFFERENCE LE; MacNeil A, 2011, J INFECT DIS, V204, pS761, DOI 10.1093/infdis/jir294; Medecins Sans Frontieres, WORK OV; Medecins Sans Frontieres, W AFR BIOD RESP URG; O'Carroll L., WORLD NEWS; Oksanen J., 2016, R PACKAG; Okware SI, 2002, TROP MED INT HEALTH, V7, P1068, DOI 10.1046/j.1365-3156.2002.00944.x; Read JM, 2015, LANCET, V385, P23, DOI 10.1016/S0140-6736(14)61894-8; Solomon T, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6443	21	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120013	10.1371/journal.pone.0120013	http://dx.doi.org/10.1371/journal.pone.0120013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760763	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000351275000067
J	Seferovic, MD; Goodspeed, DM; Chu, DM; Krannich, LA; Gonzalez-Rodriguez, PJ; Cox, JE; Aagaard, KM				Seferovic, Maxim D.; Goodspeed, Danielle M.; Chu, Derrick M.; Krannich, Laura A.; Gonzalez-Rodriguez, Pablo J.; Cox, James E.; Aagaard, Kjersti M.			Heritable IUGR and adult metabolic syndrome are reversible and associated with alterations in the metabolome following dietary supplementation of 1-carbon intermediates	FASEB JOURNAL			English	Article						DOHaD; metabolism; placental insufficiency; epigenomics	INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; TRANSGENERATIONAL EPIGENETIC INHERITANCE; IMPROVES INSULIN SENSITIVITY; ONE-CARBON METABOLISM; RAT SKELETAL-MUSCLE; DNA METHYLATION; DIABETES-MELLITUS; GENE-EXPRESSION; FETAL-GROWTH	Metabolic syndrome (MetS), following intrauterine growth restriction (IUGR), is epigenetically heritable. Recently, we abrogated the F2 adult phenotype with essential nutrient supplementation (ENS) of intermediates along the 1-carbon pathway. With the use of the same grandparental uterine artery ligation model, we profiled the F2 serum metabolome at weaning [postnatal day (d)21; n = 76] and adulthood (d160; n = 12) to test if MetS is preceded by alterations in the metabolome. Indicative of developmentally programmed MetS, adult F2, formerly IUGR rats, were obese (621 vs. 461g; P < 0.0001), dyslipidemic (133 vs. 67 mg/dl; P < 0.001), and glucose intolerant (26 vs. 15 mg/kg/min; P < 0.01). Unbiased gas chromatography-mass spectrometry (GC-MS) profiling revealed 34 peaks corresponding to 12 nonredundant metabolites and 9 unknowns to be changing at weaning [false discovery rate (FDR) < 0.05]. Markers of later-inlife MetS included citric acid, glucosamine, myoinositol, and proline (P < 0.03). Hierarchical clustering revealed grouping by IUGR lineage and supplementation at d21 and d160. Weanlings grouped distinctly for ENS and IUGR by partial least-squares discriminate analysis (PLS-DA; P < 0.01), whereas paternal and maternal IUGR(IUGR(pat)/IUGR(mat), respectively) control-fed rats, destined for MetS, had a distinct metabolome at weaning (randomForest analysis; class error < 0.1) and adulthood (PLS-DA; P < 0.05). In sum, we have found that alterations in the metabolome accompany heritable IUGR, precede adult-onset MetS, and are partially amenable to dietary intervention.	[Seferovic, Maxim D.; Goodspeed, Danielle M.; Krannich, Laura A.; Gonzalez-Rodriguez, Pablo J.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chu, Derrick M.; Aagaard, Kjersti M.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Cox, James E.] Univ Utah, Dept Biochem, Salt Lake City, UT USA; [Cox, James E.] Univ Utah, Metabol Core, Salt Lake City, UT USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, One Baylor Plaza,Jones 314, Houston, TX 77030 USA.	aagaardt@bcm.edu			U.S. National Institutes of Health (NIH) [DP21DP2OD001500-01]; NIH National Center for Infectious Diseases Reproductive Scientist Development Program [5K12HD00849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK089201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Infectious Diseases Reproductive Scientist Development Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the U.S. National Institutes of Health (NIH) Grant DP21DP2OD001500-01, "Mapping the Fetal Primate Epigenome and Metabolome," and the NIH National Center for Infectious Diseases Reproductive Scientist Development Program Grant 5K12HD00849, "Transgenerational Growth Restriction through Altered Placental Epigenetics" (both to K.M.A.). The authors thank Dr. Jun Ma for his statistical consultation, Drs. Melissa Suter and Amanda Prince, and Mr. Derek O'Neil for insightful review of the manuscript.	Alexandre-Gouabau MC, 2013, J PROTEOME RES, V12, P2764, DOI 10.1021/pr400122v; Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Almholt K, 2003, ONCOGENE, V22, P4389, DOI 10.1038/sj.onc.1206601; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Atherton HJ, 2006, PHYSIOL GENOMICS, V27, P178, DOI 10.1152/physiolgenomics.00060.2006; Banister CE, 2011, EPIGENETICS-US, V6, P920, DOI 10.4161/epi.6.7.16079; Barberini L, 2014, J MATERN-FETAL NEO M, V27, P20, DOI 10.3109/14767058.2014.954786; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baserga M, 2005, AM J PHYSIOL-REG I, V289, pR1348, DOI 10.1152/ajpregu.00211.2005; Baserga M, 2007, AM J PHYSIOL-REG I, V292, pR1943, DOI 10.1152/ajpregu.00558.2006; Baserga M, 2006, AM J PHYSIOL-REG I, V291, pR412, DOI 10.1152/ajpregu.00880.2005; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; CLEMENTS RS, 1977, DIABETES, V26, P215, DOI 10.2337/diabetes.26.3.215; Cooney CA, 2002, J NUTR, V132, p2393S; Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011; Croze ML, 2013, J NUTR BIOCHEM, V24, P457, DOI 10.1016/j.jnutbio.2012.01.008; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; D'Anna R, 2013, DIABETES CARE, V36, P854, DOI 10.2337/dc12-1371; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dayeh T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004160; Dessi A, 2011, J MATERN-FETAL NEO M, V24, P36, DOI 10.3109/14767058.2011.605868; Dodson RB, 2014, AM J PHYSIOL-HEART C, V306, pH429, DOI 10.1152/ajpheart.00472.2013; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Einstein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008887; Ertel NH, 2003, DIABETES CARE, V26, P549, DOI 10.2337/diacare.26.2.549; Favretto D, 2012, ANAL BIOANAL CHEM, V402, P1109, DOI 10.1007/s00216-011-5540-z; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Ganu RS, 2012, ILAR J, V53, P306, DOI 10.1093/ilar.53.3-4.306; Gao KG, 2012, AMINO ACIDS, V42, P2207, DOI 10.1007/s00726-011-0960-9; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Goodspeed D, 2015, FASEB J, V29, P807, DOI 10.1096/fj.14-259614; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Ivorra C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-142; Koklu E, 2007, ACTA PAEDIATR, V96, P1858, DOI 10.1111/j.1651-2227.2007.00531.x; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Lane RH, 1998, PEDIATR RES, V43, P563, DOI 10.1203/00006450-199805000-00001; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; Lane RH, 1999, AM J PHYSIOL-ENDOC M, V276, pE135, DOI 10.1152/ajpendo.1999.276.1.E135; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lin G, 2012, J NUTR, V142, P990, DOI 10.3945/jn.111.153411; Lumey LH, 1997, AM J PUBLIC HEALTH, V87, P1962, DOI 10.2105/AJPH.87.12.1962; Luo ZC, 2012, J CLIN ENDOCR METAB, V97, P1720, DOI 10.1210/jc.2011-3296; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Mateo RD, 2007, J NUTR, V137, P652, DOI 10.1093/jn/137.3.652; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Nissen PM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/378268; OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8; OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010; Ortmeyer HK, 1996, OBES RES, V4, P569, DOI 10.1002/j.1550-8528.1996.tb00271.x; Osborne-Majnik A, 2013, CLIN OBSTET GYNECOL, V56, P622, DOI 10.1097/GRF.0b013e31829cb99a; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Qatanani M, 2013, DIABETES, V62, P855, DOI 10.2337/db12-0399; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Regnault TRH, 2010, EXP BIOL MED, V235, P999, DOI 10.1258/ebm.2010.009360; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Santamaria A, 2012, CLIMACTERIC, V15, P490, DOI 10.3109/13697137.2011.631063; Sanz-Cortes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080121; Short KR, 2004, NEW ENGL J MED, V350, P2419; Simonen PP, 2002, DIABETES CARE, V25, P1511, DOI 10.2337/diacare.25.9.1511; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; St-Pierre J, 2012, EPIGENETICS-US, V7, P1125, DOI 10.4161/epi.21855; Story L, 2013, EUR J OBSTET GYN R B, V170, P77, DOI 10.1016/j.ejogrb.2013.05.006; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; Suter M, 2010, METABOLISM, V59, P1481, DOI 10.1016/j.metabol.2010.01.013; Suter MA, 2013, MOL HUM REPROD, V19, P1, DOI 10.1093/molehr/gas050; Teeninga N, 2008, NEPHROL DIAL TRANSPL, V23, P1615, DOI 10.1093/ndt/gfm829; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; Thompson JA, 2011, J PHYSIOL-LONDON, V589, P3319, DOI 10.1113/jphysiol.2011.210625; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Trygg J., 2005, ANAL CHEM, V77, P8086; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; van Vliet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064545; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Watson JA, 2010, EPIGENETICS-US, V5, P293, DOI 10.4161/epi.5.4.11684; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zhao Y, 2014, EUR J HUM GENET, V22, P734, DOI 10.1038/ejhg.2013.226	100	16	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2640	2652		10.1096/fj.14-266387	http://dx.doi.org/10.1096/fj.14-266387			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757570	Green Published			2022-12-26	WOS:000355209500039
J	Ji, L; Xu, JJ; Liu, J; Amjad, A; Zhang, K; Liu, QW; Zhou, L; Xiao, JR; Li, XT				Ji, Lei; Xu, Jinjin; Liu, Jian; Amjad, Ali; Zhang, Kun; Liu, Qingwu; Zhou, Lei; Xiao, Jianru; Li, Xiaotao			Mutant p53 Promotes Tumor Cell Malignancy by Both Positive and Negative Regulation of the Transforming Growth Factor beta (TGF-beta) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELLS; WILD-TYPE; DIFFERENTIAL REGULATION; MOUSE MODELS; SMAD2; GAIN; EXPRESSION; MUTATIONS; GENE; SUPPRESSOR	Specific p53 mutations abrogate tumor-suppressive functions by gaining new abilities to promote tumorigenesis. Inactivation of p53 is known to distort TGF-beta signaling, which paradoxically displays both tumor-suppressive and pro-oncogenic functions. The molecular mechanisms of how mutant p53 simultaneously antagonizes the tumor-suppressive and synergizes the tumor-promoting function of the TGF-beta pathway remain elusive. Here we demonstrate that mutant p53 differentially regulates subsets of TGF-beta target genes by enhanced binding to the MH2 domain in Smad3 upon the integration of ERK signaling, therefore disrupting Smad3/Smad4 complex formation. Silencing Smad2, inhibition of ERK, or introducing a phosphorylation-defective mutation at Ser-392 in p53 abrogates the R175H mutant p53-dependent regulation of these TGF-beta target genes. Our study shows a mechanism to reconcile the seemingly contradictory observations that mutant p53 can both attenuate and cooperate with the TGF-beta pathway to promote cancer cell malignancy in the same cell type.	[Ji, Lei; Xu, Jinjin; Amjad, Ali; Zhang, Kun; Liu, Qingwu; Zhou, Lei; Li, Xiaotao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai Key Lab Brain Funct Genom,Minist Educ, Shanghai 200241, Peoples R China; [Liu, Jian; Li, Xiaotao] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, Shanghai 200003, Peoples R China	East China Normal University; Baylor College of Medicine; Naval Medical University	Xiao, JR (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	jianruxiao@163.com; xiaotaol@bcm.edu	Xiao, Jian/GYU-4351-2022	Liu, Jian/0000-0002-1447-0973; Ji, Lei/0000-0002-6608-6009	National Basic Research Program of China [2011CB504200, 2015CB910403]; National Natural Science Foundation of China [814710066, 81261120555, 31071875, 31200878]; Science and Technology Commission of Shanghai Municipality [14430712100]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Basic Research Program of China Grants 2011CB504200 and 2015CB910403; National Natural Science Foundation of China Grants 814710066, 81261120555, 31071875, and 31200878; and Science and Technology Commission of Shanghai Municipality Grant 14430712100.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ali A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3667; Attisano L, 2001, MOL CELL ENDOCRINOL, V180, P3, DOI 10.1016/S0303-7207(01)00524-X; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Chen YB, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-328; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Deb D, 2002, ONCOGENE, V21, P176, DOI 10.1038/sj/onc/1205035; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Di Minin G, 2014, MOL CELL, V56, P617, DOI 10.1016/j.molcel.2014.10.013; Duda DG, 2003, ONCOGENE, V22, P6857, DOI 10.1038/sj.onc.1206751; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Kalo E, 2007, MOL CELL BIOL, V27, P8228, DOI 10.1128/MCB.00374-07; Kim E, 2004, J CELL BIOCHEM, V93, P878, DOI 10.1002/jcb.20271; Kretschmer A, 2003, ONCOGENE, V22, P6748, DOI 10.1038/sj.onc.1206791; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lanyi A, 1998, ONCOGENE, V16, P3169, DOI 10.1038/sj.onc.1201857; Lee HJ, 2004, J BIOL CHEM, V279, P2666, DOI 10.1074/jbc.M310591200; Lin Xia, 2005, J RNAi Gene Silencing, V1, P38; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng XM, 2010, J AM SOC NEPHROL, V21, P1477, DOI 10.1681/ASN.2009121244; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Peng BL, 2002, CLIN CANCER RES, V8, P3628; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Powell DW, 2002, J BIOL CHEM, V277, P21639, DOI 10.1074/jbc.M203167200; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Shinto O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-652; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Takenoshita S, 1998, GENOMICS, V48, P1, DOI 10.1006/geno.1997.5149; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang H, 2005, J BIOL CHEM, V280, P5154, DOI 10.1074/jbc.M411575200; Wang H, 2008, ONCOGENE, V27, P6791, DOI 10.1038/onc.2008.291; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Zhang L, 2015, MOL CELL BIOCHEM, V400, P17, DOI 10.1007/s11010-014-2258-1	51	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11729	11740		10.1074/jbc.M115.639351	http://dx.doi.org/10.1074/jbc.M115.639351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25767119	Green Published, hybrid			2022-12-26	WOS:000353719400045
J	Kamal, M; Gbahou, F; Guillaume, JL; Daulat, AM; Benleulmi-Chaachoua, A; Luka, M; Chen, P; Anaraki, DK; Baroncini, M; la Cour, CM; Millan, MJ; Prevot, V; Delagrange, P; Jockers, R				Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Baroncini, Marc; la Cour, Clotilde Mannoury; Millan, Mark J.; Prevot, Vincent; Delagrange, Philippe; Jockers, Ralf			Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEIN; ALZHEIMERS-DISEASE; BETA-ARRESTIN; LIVING CELLS; MT2; HETERODIMERIZATION; DIMERS; DESENSITIZATION; TRANSDUCTION; DIMERIZATION	Inasmuch as the neurohormone melatonin is synthetically derived from serotonin (5-HT), a close interrelationship between both has long been suspected. The present study reveals a hitherto unrecognized cross-talk mediated via physical association of melatonin MT2 and 5-HT2C receptors into functional heteromers. This is of particular interest in light of the "synergistic" melatonin agonist/5-HT2C antagonist profile of the novel antidepressant agomelatine. A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacological techniques was exploited to demonstrate formation of functional MT2 and 5-HT2C receptor heteromers both in transfected cells and in human cortex and hippocampus. MT2/5-HT2C heteromers amplified the 5-HT-mediated Gq/phospholipase C response and triggered melatonin-induced unidirectional transactivation of the 5-HT2C protomer of MT2/5-HT2C heteromers. Pharmacological studies revealed distinct functional properties for agomelatine, which shows "biased signaling." These observations demonstrate the existence of functionally unique MT2/5-HT2C heteromers and suggest that the antidepressant agomelatine has a distinctive profile at these sites potentially involved in its therapeutic effects on major depression and generalized anxiety disorder. Finally, MT2/5-HT2C heteromers provide a new strategy for the discovery of novel agents for the treatment of psychiatric disorders.	[Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] CNRS, UMR 8104, F-75014 Paris, France; [Kamal, Maud; Gbahou, Florence; Guillaume, Jean-Luc; Daulat, Avais M.; Benleulmi-Chaachoua, Abla; Luka, Marine; Chen, Patty; Anaraki, Dina Kalbasi; Jockers, Ralf] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Baroncini, Marc; Prevot, Vincent] Jean Pierre Aubert Res Ctr, U837, INSERM, F-59045 Lille, France; [la Cour, Clotilde Mannoury; Millan, Mark J.; Delagrange, Philippe] Inst Rech Servier, F-78290 Croissy Sur Seine, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Servier; Institut de Recherches Internationales Servier	Jockers, R (corresponding author), Inst Cochin, 22 Rue Mechain, F-75014 Paris, France.	ralf.jockers@inserm.fr	Prevot, Vincent/E-5720-2016; Gbahou, Florence/L-4664-2017; Jockers, Ralf/Q-2100-2019; Jockers, Ralf/P-2272-2017	Prevot, Vincent/0000-0001-7185-3615; Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Daulat, Avais/0000-0002-3076-2132	Fondation Recherche Medicale (Equipe FRM); French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale [MED-HET-REC-2]; INSERM; CNRS; Who am I? laboratory of excellence - French Government [ANR-11-LABX-0071]; ANR [ANR-11-IDEX-0005-01]	Fondation Recherche Medicale (Equipe FRM); French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Who am I? laboratory of excellence - French Government; ANR(French National Research Agency (ANR))	This work was supported by grants from the Fondation Recherche Medicale (Equipe FRM to R. J.), The French National Research Agency (ANR) Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2," INSERM, CNRS, and the Who am I? laboratory of excellence ANR-11-LABX-0071 funded by the French Government through its "Investments for the Future" program operated by the ANR under Grant ANR-11-IDEX-0005-01.	Audinot V, 2003, N-S ARCH PHARMACOL, V367, P553, DOI 10.1007/s00210-003-0751-2; Berthouze M, 2005, FEBS LETT, V579, P2973, DOI 10.1016/j.febslet.2005.04.040; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Brunner P, 2006, EUR J HISTOCHEM, V50, P311; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Chaste P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011495; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Guillaume JL, 2008, J BIOL CHEM, V283, P16762, DOI 10.1074/jbc.M802069200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Jockers R, 1998, ENDOCRINOLOGY, V139, P2676, DOI 10.1210/en.139.6.2676; Kamal Maud, 2009, Biotechnology Journal, V4, P1337, DOI 10.1002/biot.200900016; MacKenzie RS, 2002, BIOCHEM PHARMACOL, V63, P587, DOI 10.1016/S0006-2952(01)00881-4; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Millan MJ, 2003, J PHARMACOL EXP THER, V306, P954, DOI 10.1124/jpet.103.051797; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Pasqualetti M, 1999, NEUROSCIENCE, V92, P601, DOI 10.1016/S0306-4522(99)00011-1; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Prosser RA, 1999, BRAIN RES, V818, P408, DOI 10.1016/S0006-8993(98)01295-5; Racagni G, 2011, WORLD J BIOL PSYCHIA, V12, P574, DOI 10.3109/15622975.2011.595823; Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x; Wong EHF, 2010, PHARMACOL THERAPEUT, V126, P173, DOI 10.1016/j.pharmthera.2010.02.001; Ying SW, 1996, EUR J PHARMACOL, V296, P33, DOI 10.1016/0014-2999(95)00684-2	31	70	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11537	11546		10.1074/jbc.M114.559542	http://dx.doi.org/10.1074/jbc.M114.559542			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25770211	Green Published, hybrid			2022-12-26	WOS:000353719400029
J	Assent, D; Bourgot, I; Hennuy, B; Geurts, P; Noel, A; Foidart, JM; Maquoi, E				Assent, Delphine; Bourgot, Isabelle; Hennuy, Benoit; Geurts, Pierre; Noel, Agnes; Foidart, Jean-Michel; Maquoi, Erik			A Membrane-Type-1 Matrix Metalloproteinase (MT1-MMP) - Discoidin Domain Receptor 1 Axis Regulates Collagen-Induced Apoptosis in Breast Cancer Cells	PLOS ONE			English	Article							TYROSINE KINASES; GENE-EXPRESSION; ACTIVATION; INVASION; PROTEIN; METASTASIS; INHIBITION; DIVERSITY; SURVIVAL; ROLES	During tumour dissemination, invading breast carcinoma cells become confronted with a reactive stroma, a type I collagen-rich environment endowed with anti-proliferative and proapoptotic properties. To develop metastatic capabilities, tumour cells must acquire the capacity to cope with this novel microenvironment. How cells interact with and respond to their microenvironment during cancer dissemination remains poorly understood. To address the impact of type I collagen on the fate of tumour cells, human breast carcinoma MCF-7 cells were cultured within three-dimensional type I collagen gels (3D COL1). Using this experimental model, we have previously demonstrated that membrane type-1 matrix metalloproteinase (MT1-MMP), a proteinase overexpressed in many aggressive tumours, promotes tumour progression by circumventing the collagen-induced up-regulation of BIK, a pro-apoptotic tumour suppressor, and hence apoptosis. Here we performed a transcriptomic analysis to decipher the molecular mechanisms regulating 3D COL1-induced apoptosis in human breast cancer cells. Control and MT1-MMP expressing MCF-7 cells were cultured on two-dimensional plastic plates or within 3D COL1 and a global transcriptional time-course analysis was performed. Shifting the cells from plastic plates to 3D COL1 activated a complex reprogramming of genes implicated in various biological processes. Bioinformatic analysis revealed a 3D COL1-mediated alteration of key cellular functions including apoptosis, cell proliferation, RNA processing and cytoskeleton remodelling. By using a panel of pharmacological inhibitors, we identified discoidin domain receptor 1 (DDR1), a receptor tyrosine kinase specifically activated by collagen, as the initiator of 3D COL1-induced apoptosis. Our data support the concept that MT1-MMP contributes to the inactivation of the DDR1-BIK signalling axis through the cleavage of collagen fibres and/or the alteration of DDR1 receptor signalling unit, without triggering a drastic remodelling of the transcriptome of MCF-7 cells.	[Assent, Delphine; Bourgot, Isabelle; Noel, Agnes; Foidart, Jean-Michel; Maquoi, Erik] Univ Liege, Unit Canc, Grp Interdisciplinaire Genoproteom Appl, Lab Tumour & Dev Biol, Liege, Belgium; [Hennuy, Benoit] Univ Liege, GIGA Genom Platform, Liege, Belgium; [Geurts, Pierre] Univ Liege, Dept Elect Engn & Comp Sci, Syst & Modelling, Liege, Belgium; [Geurts, Pierre] Univ Liege, GIGA R, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Maquoi, E (corresponding author), Univ Liege, Unit Canc, Grp Interdisciplinaire Genoproteom Appl, Lab Tumour & Dev Biol, Liege, Belgium.	erik.maquoi@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium); Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium); Plan National Cancer (Service Public Federal)	Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation contre le Cancer (foundation of public interest, Belgium); Fonds speciaux de la Recherche (University of Liege)(University of Liege); Centre Anticancereux pres l'Universite de Liege; Fonds Leon Fredericq (University of Liege)(University of Liege); Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium); Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); Plan National Cancer (Service Public Federal)	This work was supported by grants from the Fonds de la Recherche Scientifique - FNRS (F.R.S.- FNRS, Belgium), the Fondation contre le Cancer (foundation of public interest, Belgium), the Fonds speciaux de la Recherche (University of Liege), the Centre Anticancereux pres l'Universite de Liege, the Fonds Leon Fredericq (University of Liege), the Direction Generale Operationnelle de l'Economie, de l'Emploi et de la Recherche from the Service Public de Wallonie (SPW, Belgium), the Interuniversity Attraction Poles Programme - Belgian Science Policy (Brussels, Belgium), the Plan National Cancer (Service Public Federal). The Actions de Recherche Concertees (University of Liege, Belgium). DA is a recipient of a Televie fellowship from the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium). EM is a Research Associate from the Fonds de la Recherche Scientifique - FNRS (F.R.S.-FNRS, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WJ, 2004, J CELL BIOL, V167, P745, DOI 10.1083/jcb.200404018; Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barone FC, 2001, J PHARMACOL EXP THER, V296, P312; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; BIRKEDALHANSEN H, 1987, METHOD ENZYMOL, V144, P140; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Blencowe BJ, 2002, CURR BIOL, V12, pR147, DOI 10.1016/S0960-9822(02)00711-X; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Brandvold KR, 2012, ACS CHEM BIOL, V7, P1393, DOI 10.1021/cb300172e; Cader FZ, 2013, BLOOD, V122, P4237, DOI 10.1182/blood-2013-04-499004; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Chen LC, 2010, CELL DEATH DIFFER, V17, P1463, DOI 10.1038/cdd.2010.24; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen ZY, 2011, CARCINOGENESIS, V32, P1419, DOI 10.1093/carcin/bgr088; Cheng J, 2011, CANCER LETT, V310, P35, DOI 10.1016/j.canlet.2011.06.001; Cui H, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00134; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599; Fujisaki H, 2002, EXP CELL RES, V280, P255, DOI 10.1006/excr.2002.5639; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gilles C, 1997, LAB INVEST, V76, P651; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001; Henriet P, 2000, P NATL ACAD SCI USA, V97, P10026, DOI 10.1073/pnas.170290997; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Huang XF, 2012, ONCOL REP, V27, P1541, DOI 10.3892/or.2012.1672; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Kubow Kristopher E, 2011, Nat Cell Biol, V13, P3, DOI 10.1038/ncb0111-3; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; McDonald PC, 2012, ONCOTARGET, V3, P84, DOI 10.18632/oncotarget.422; McGowan PM, 2008, ANN ONCOL, V19, P1566, DOI 10.1093/annonc/mdn180; Millerot-Serrurot E, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-26; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Noel A, 1999, CURR TOPICS PATHOL, V93, P183; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Noel A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00140; O'Reilly D, 2013, GENOME RES, V23, P281, DOI 10.1101/gr.142968.112; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Rauch J, 2010, CANCER RES, V70, P1679, DOI 10.1158/0008-5472.CAN-09-2740; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rowe RG, 2008, TRENDS CELL BIOL, V18, P560, DOI 10.1016/j.tcb.2008.08.007; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Sakamoto T, 2011, J BIOL CHEM, V286, P14691, DOI 10.1074/jbc.M110.188714; Schofield AV, 2013, CRIT REV BIOCHEM MOL, V48, P301, DOI 10.3109/10409238.2013.786671; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Sodek KL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-223; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; UEHARA Y, 1988, VIROLOGY, V164, P294, DOI 10.1016/0042-6822(88)90649-6; Ureshino H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041312; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vijayalingam S, 2010, Genes Cancer, V1, P964, DOI 10.1177/1947601910386110; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang Q, 2013, MOL BIOL REP, V40, P3723, DOI 10.1007/s11033-012-2448-4; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	100	30	32	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116006	10.1371/journal.pone.0116006	http://dx.doi.org/10.1371/journal.pone.0116006			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774665	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500004
J	Pescador, DS; de Bello, F; Valladares, F; Escudero, A				Pescador, David S.; de Bello, Francesco; Valladares, Fernando; Escudero, Adrian			Plant Trait Variation along an Altitudinal Gradient in Mediterranean High Mountain Grasslands: Controlling the Species Turnover Effect	PLOS ONE			English	Article							INTRASPECIFIC VARIABILITY; FUNCTIONAL DIVERSITY; LEAF-AREA; ENVIRONMENTAL FILTERS; POSITIVE INTERACTIONS; ALPINE PLANTS; COMMUNITY; GROWTH; INCREASE; PATTERNS	Assessing changes in plant functional traits along gradients is useful for understanding the assembly of communities and their response to global and local environmental drivers. However, these changes may reflect the effects of species composition (i.e. composition turnover), species abundance (i.e. species interaction), and intra-specific trait variability (i.e. species plasticity). In order to determine the relevance of the latter, trait variation can be assessed under minimal effects of composition turnover. Nine sampling sites were established along an altitudinal gradient in a Mediterranean high mountain grassland community with low composition turnover (Madrid, Spain; 1940 m-2419 m). Nine functional traits were also measured for ten individuals of around ten plant species at each site, for a total of eleven species across all sites. The relative importance of different sources of variability (within/between site and intra-/inter-specific functional diversity) and trait variation at species and community level along the considered gradients were explored. We found a weak individual species response to altitude and other environmental variables although in some cases, individuals were smaller and leaves were thicker at higher elevations. This lack of species response was most likely due to greater within-than between-site species variation. At the community level, inter-specific functional diversity was generally greater than the intra-specific component except for traits linked to leaf element content (leaf carbon content, leaf nitrogen content, delta C-13 and delta N-15). Inter-specific functional diversity decreased with lower altitude for four leaf traits (specific leaf area, leaf dry matter content, delta C-13 and delta N-15), suggesting trait convergence between species at lower elevations, where water shortage may have a stronger environmental filtering effect than colder temperatures at higher altitudes. Our results suggest that, within a vegetation type encompassing various environmental gradients, both, changes in species abundance and intra-specific trait variability adjust for the community functional response to environmental changes.	[Pescador, David S.; Valladares, Fernando; Escudero, Adrian] Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain; [de Bello, Francesco] Acad Sci Czech Republ, Inst Bot, Trebon, Czech Republic; [de Bello, Francesco] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic; [Valladares, Fernando] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Universidad Rey Juan Carlos; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Pescador, DS (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Madrid, Spain.	david.sanchez@urjc.es	de Bello, Francesco/AFQ-8650-2022; Escudero, Adrián/H-5046-2015; de Bello, Francesco/HCI-1196-2022; Pescador, David Sánchez/F-2672-2015; de Bello, Francesco/H-1582-2014	Escudero, Adrián/0000-0002-1427-5465; de Bello, Francesco/0000-0001-9202-8198; Pescador, David Sánchez/0000-0003-0395-9543; de Bello, Francesco/0000-0001-9202-8198	Comunidad de Madrid [CM-S2009/AMB-1783]; Spanish Ministry of Science and Innovation [CGL2012-38427]	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was supported by the Comunidad de Madrid under the project REMEDINAL 2 [CM-S2009/AMB-1783] and by Spanish Ministry of Science and Innovation, under the project MOUNTAINS [CGL2012-38427]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Angert AL, 2006, OECOLOGIA, V148, P183, DOI 10.1007/s00442-006-0361-z; [Anonymous], 2010, R LANG ENV STAT COMP; Auger S, 2013, J VEG SCI, V24, P419, DOI 10.1111/j.1654-1103.2012.01473.x; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Chambers J., 1992, STAT MODELS S WADSWO, DOI 10.1201/9780203738535-4; CODIGNOLA A, 1987, NORD J BOT, V7, P673, DOI 10.1111/j.1756-1051.1987.tb02036.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; de Bello F, 2013, ECOGRAPHY, V36, P393, DOI 10.1111/j.1600-0587.2012.07438.x; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Fajardo A, 2011, NEW PHYTOL, V189, P259, DOI 10.1111/j.1469-8137.2010.03468.x; Gandullo J, 1974, I NAC INVESTIG AGRAR, V1, P95; Garcia-Fernandez A, 2013, AM J BOT, V100, P1641, DOI 10.3732/ajb.1200653; Garcia-Fernandez A, 2012, ANN BOT-LONDON, V110, P1221, DOI 10.1093/aob/mcs195; Gottfried M, 1998, ARCTIC ALPINE RES, V30, P207, DOI 10.2307/1551968; Grassein F, 2010, ANN BOT-LONDON, V106, P637, DOI 10.1093/aob/mcq154; Gross N, 2013, J ECOL, V101, P637, DOI 10.1111/1365-2745.12063; Gutierrez-Giron A, 2015, GEODERMA, V237, P1, DOI 10.1016/j.geoderma.2014.08.005; Gutierrez-Giron A, 2013, PLANT ECOL DIVERS, V6, P435, DOI 10.1080/17550874.2013.783641; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hsiao TC, 1985, SOC EXP BIOL SEMINAR, P239; Huber E, 2007, PLANT SOIL, V301, P65, DOI 10.1007/s11104-007-9422-2; Jung V, 2014, J ECOL, V102, P45, DOI 10.1111/1365-2745.12177; Jung V, 2010, J ECOL, V98, P1134, DOI 10.1111/j.1365-2745.2010.01687.x; Kahmen A, 2008, OECOLOGIA, V156, P861, DOI 10.1007/s00442-008-1028-8; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Korner C, 1987, FUNCT ECOL, V1, P179, DOI 10.2307/2389420; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Leps J, 2011, ECOGRAPHY, V34, P856, DOI 10.1111/j.1600-0587.2010.06904.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Milla R, 2009, FUNCT ECOL, V23, P111, DOI 10.1111/j.1365-2435.2008.01484.x; Perez RSA, 1997, ERIA, V43, P227; Perez-Ramos IM, 2012, J ECOL, V100, P1315, DOI 10.1111/1365-2745.12000; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Prentice IC, 2011, NEW PHYTOL, V190, P169, DOI 10.1111/j.1469-8137.2010.03579.x; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Roche P, 2004, PLANT ECOL, V174, P37, DOI 10.1023/B:VEGE.0000046056.94523.57; Rodrigo A, 1997, ECOL MODEL, V102, P325, DOI 10.1016/S0304-3800(97)00067-7; Scheepens JF, 2010, OECOLOGIA, V164, P141, DOI 10.1007/s00442-010-1650-0; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Turunen M, 2005, ENVIRON POLLUT, V137, P390, DOI 10.1016/j.envpol.2005.01.030; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; WOODWARD FI, 1983, NEW PHYTOL, V95, P313, DOI 10.1111/j.1469-8137.1983.tb03498.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x	65	63	69	6	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118876	10.1371/journal.pone.0118876	http://dx.doi.org/10.1371/journal.pone.0118876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774532	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500048
J	Vu, LT; Keschrumrus, V; Zhang, X; Zhong, JF; Su, QN; Kabeer, MH; Loudon, WG; Li, SC				Vu, Long T.; Keschrumrus, Vic; Zhang, Xi; Zhong, Jiang F.; Su, Qingning; Kabeer, Mustafa H.; Loudon, William G.; Li, Shengwen Calvin			Tissue Elasticity Regulated Tumor Gene Expression: Implication for Diagnostic Biomarkers of Primitive Neuroectodermal Tumor	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; MMP9 EXPRESSION; BREAST-CANCER; WEB SERVER; CELLS; CAVEOLIN; ACTIVATION; INDUCTION; INVASION	Background The tumor microenvironment consists of both physical and chemical factors. Tissue elasticity is one physical factor contributing to the microenvironment of tumor cells. To test the importance of tissue elasticity in cell culture, primitive neuroectodermal tumor (PNET) stem cells were cultured on soft polyacrylamide (PAA) hydrogel plates that mimics the elasticity of brain tissue compared with PNET on standard polystyrene (PS) plates. We report the molecular profiles of PNET grown on either PAA or PS. Methodology/Principal Findings A whole-genome microarray profile of transcriptional expression between the two culture conditions was performed as a way to probe effects of substrate on cell behavior in culture. The results showed more genes downregulated on PAA compared to PS. This led us to propose microRNA (miRNA) silencing as a potential mechanism for downregulation. Bioinformatic analysis predicted a greater number of miRNA binding sites from the 3' UTR of downregulated genes and identified as specific miRNA binding sites that were enriched when cells were grown on PAA-this supports the hypothesis that tissue elasticity plays a role in influencing miRNA expression. Thus, Dicer was examined to determine if miRNA processing was affected by tissue elasticity. Dicer genes were downregulated on PAA and had multiple predicted miRNA binding sites in its 3' UTR that matched the miRNA binding sites found enriched on PAA. Many differentially regulated genes were found to be present on PS but downregulated on PAA were mapped onto intron sequences. This suggests expression of alternative polyadenylation sites within intron regions that provide alternative 3' UTRs and alternative miRNA binding sites. This results in tissue specific transcriptional downregulation of mRNA in humans by miRNA. We propose a mechanism, driven by the physical characteristics of the microenvironment by which downregulation of genes occur. We found that tissue elasticity-mediated cytokines (TGF beta 2 and TNF alpha) signaling affect expression of ECM proteins. Conclusions Our results suggest that tissue elasticity plays important roles in miRNA expression, which, in turn, regulate tumor growth or tumorigenicity.	[Vu, Long T.; Keschrumrus, Vic; Kabeer, Mustafa H.; Loudon, William G.; Li, Shengwen Calvin] Univ Calif Irvine, Neurooncol & Stem Cell Res Lab, Ctr Neurosci Res, CHOC Childrens Hosp Res Inst, Orange, CA 92868 USA; [Loudon, William G.] St Joseph Hosp, Dept Neurol Surg, Orange, CA 92868 USA; [Loudon, William G.] Univ Calif Irvine, Sch Med, Dept Neurol Surg, Orange, CA 92862 USA; [Li, Shengwen Calvin] Univ Calif Irvine, Dept Neurol, Sch Med, Orange, CA 92697 USA; [Vu, Long T.; Li, Shengwen Calvin] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92834 USA; [Zhang, Xi; Zhong, Jiang F.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Kabeer, Mustafa H.] CHOC Childrens Hosp, Dept Pediat Surg, Orange, CA 92868 USA; [Su, Qingning] Shenzhen Univ, Bioengn Res Ctr, Sch Med, Shenzhen 518057, Guangdong, Peoples R China; [Kabeer, Mustafa H.] Univ Calif Irvine, Sch Med, Dept Surg, Orange, CA 92868 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; California State University System; California State University Fullerton; University of Southern California; Shenzhen University; University of California System; University of California Irvine	Zhong, JF (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	jzhong@usc.edu; shengwel@uci.edu	li, wj/HGD-7322-2022; Li, Shengwen Calvin/H-1725-2012	Li, Shengwen Calvin/0000-0002-9699-9204	Children's Hospital of Orange County (CHOC) Children's Foundation; CHOC Neuroscience Institute; Austin Ford Tribute Fund; W. M. Keck Foundation; National Institutes of Health [R21CA134391]; National Science Foundation [AW 0852720]; NATIONAL CANCER INSTITUTE [R21CA134391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Children's Hospital of Orange County (CHOC) Children's Foundation; CHOC Neuroscience Institute; Austin Ford Tribute Fund; W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Children's Hospital of Orange County (CHOC) Children's Foundation, CHOC Neuroscience Institute, Austin Ford Tribute Fund, W. M. Keck Foundation, Grant R21CA134391 from the National Institutes of Health, and Grant AW 0852720 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Alexiou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009171; Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chellaiah MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/302392; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chou YC, 2010, CHEM-BIOL INTERACT, V184, P403, DOI 10.1016/j.cbi.2010.01.010; Cobaleda C, 2008, STEM CELL REV, V4, P67, DOI 10.1007/s12015-008-9012-6; Deb S, 1999, J NEUROSCI RES, V55, P44, DOI 10.1002/(SICI)1097-4547(19990101)55:1<44::AID-JNR6>3.0.CO;2-G; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Favre G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043435; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gonzalez-Sarmiento R, 2008, CURR STEM CELL RES T, V3, P55; Han YP, 2001, J BIOL CHEM, V276, P22341, DOI 10.1074/jbc.M010839200; Han YP, 2007, J BIOL CHEM, V282, P12928, DOI 10.1074/jbc.M700554200; Hsieh WP, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-222; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Keklikoglou I, 2012, ONCOGENE, V31, P4150, DOI 10.1038/onc.2011.571; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li SW, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P127, DOI 10.1016/B978-012370465-8/50015-6; Li SC, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-41; Li SC, 2012, STEM CELLS DEV, V21, P503, DOI 10.1089/scd.2011.0267; Li SC, 2011, P NATL ACAD SCI USA, V108, P12793, DOI 10.1073/pnas.1100509108; Li SC, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-9; Li SW, 1996, J BIOL CHEM, V271, P568, DOI 10.1074/jbc.271.1.568; Li SW, 1998, FEBS LETT, V434, P127, DOI 10.1016/S0014-5793(98)00945-4; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Li SW, 1996, J BIOL CHEM, V271, P3863; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Liu ZG, 2014, NEURO-ONCOLOGY, V16, P787, DOI 10.1093/neuonc/not244; Lockwood CJ, 2008, BIOL REPROD, V78, P1064, DOI 10.1095/biolreprod.107.063743; Lovett DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034177; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Munchar MJJ, 2003, PATHOLOGY, V35, P125, DOI 10.1080/0031302031000082214; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; Port M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-52; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rippe V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009485; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Tu SM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-40; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yang K, 2009, INT J CLIN EXP PATHO, V2, P361	60	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120336	10.1371/journal.pone.0120336	http://dx.doi.org/10.1371/journal.pone.0120336			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774514	Green Published, gold			2022-12-26	WOS:000351183500165
J	Appelqvist, C; Al-Hamdani, ZK; Jonsson, PR; Havenhand, JN				Appelqvist, Christin; Al-Hamdani, Zyad K.; Jonsson, Per R.; Havenhand, Jon N.			Climate Envelope Modeling and Dispersal Simulations Show Little Risk of Range Extension of the Shipworm, Teredo navalis (L.), in the Baltic Sea	PLOS ONE			English	Article							SWEDISH WEST COAST; DISSOLVED-OXYGEN; GEOGRAPHICAL-DISTRIBUTION; LARVAL DEVELOPMENT; CYCLOPE-NERITEA; BANKIA-GOULDI; MARINE; BIVALVIA; SHIFTS; TEREDINIDAE	The shipworm, Teredo navalis, is absent from most of the Baltic Sea. In the last 20 years, increased frequency of T. navalis has been reported along the southern Baltic Sea coasts of Denmark, Germany, and Sweden, indicating possible range-extensions into previously unoccupied areas. We evaluated the effects of historical and projected near-future changes in salinity, temperature, and oxygen on the risk of spread of T. navalis in the Baltic. Specifically, we developed a simple, GIS-based, mechanistic climate envelope model to predict the spatial distribution of favourable conditions for adult reproduction and larval metamorphosis of T. navalis, based on published environmental tolerances to these factors. In addition, we used a high-resolution three-dimensional hydrographic model to simulate the probability of spread of T. navalis larvae within the study area. Climate envelope modeling showed that projected near-future climate change is not likely to change the overall distribution of T. navalis in the region, but will prolong the breeding season and increase the risk of shipworm establishment at the margins of the current range. Dispersal simulations indicated that the majority of larvae were philopatric, but those that spread over a wider area typically spread to areas unfavourable for their survival. Overall, therefore, we found no substantive evidence for climate-change related shifts in the distribution of T. navalis in the Baltic Sea, and no evidence for increased risk of spread in the near-future.	[Appelqvist, Christin; Jonsson, Per R.; Havenhand, Jon N.] Univ Gothenburg, Dept Biol Environm Sci, S-45296 Tjarno, Stromstad, Sweden; [Al-Hamdani, Zyad K.] Geol Survey Denmark & Greenland, DK-1350 Copenhagen K, Denmark	University of Gothenburg; Geological Survey Of Denmark & Greenland	Havenhand, JN (corresponding author), Univ Gothenburg, Dept Biol Environm Sci, S-45296 Tjarno, Stromstad, Sweden.	jon.havenhand@bioenv.gu.se	Alhamdani, Z-K-/AAW-9316-2020	Havenhand, Jonathan/0000-0001-6721-7763; Jonsson, Per/0000-0002-1793-5473	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS") [2004-631]; EU ("WreckProtect", FP7) [226225]; Swedish Research Council VR; Swedish Research Council FORMAS	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS")(Swedish Research Council Formas); EU ("WreckProtect", FP7); Swedish Research Council VR(Swedish Research Council); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This work was conducted with financial support from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning ("FORMAS" grant no. 2004-631: CA JH), the EU ("WreckProtect", FP7 grant no. 226225: CA ZAL JH), and a Linnaeus grant from the Swedish Research Councils VR and FORMAS (http://cemeb.science.gu.se/: PJ JH). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; BAKER SM, 1992, BIOL BULL, V182, P265, DOI 10.2307/1542120; Beaugrand G, 2013, NAT CLIM CHANGE, V3, P263, DOI 10.1038/NCLIMATE1753; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Bjordal CG, 2008, J ARCHAEOL SCI, V35, P862, DOI 10.1016/j.jas.2007.06.005; Bjordal CG, 2012, CONSERV MANAGE ARCHA, V14, P201, DOI 10.1179/1350503312Z.00000000017; Blum HF, 1922, U CALIFORNIA PUBLICA, V224, P349; Bonsdorff E, 2006, J EXP MAR BIOL ECOL, V330, P383, DOI 10.1016/j.jembe.2005.12.041; Borges LMS, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-13; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Carlton JT, 1999, MALACOLOGIA, V41, P439; Cederlund CO, 2004, MONITORING SAFEGUARD; Chen JH, 2007, FISH SHELLFISH IMMUN, V22, P272, DOI 10.1016/j.fsi.2006.06.003; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Clapp W. F., 1963, MARINE BORERS ANNOTA; Couceiro L, 2012, INTEGR ZOOL, V7, P286, DOI 10.1111/j.1749-4877.2012.00305.x; CULLINEY JL, 1975, MAR BIOL, V29, P245, DOI 10.1007/BF00391850; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; DOOS K, 1995, J GEOPHYS RES-OCEANS, V100, P13499, DOI 10.1029/95JC00337; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, ANN REV ECOLOGY EVOL, V402009, P677; GALLAGER SM, 1981, J EXP MAR BIOL ECOL, V52, P63, DOI 10.1016/0022-0981(81)90171-4; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Goddard JHR, 2002, VELIGER, V45, P331; Grave BH, 1928, BIOL BULL-US, V55, P260, DOI 10.2307/1537080; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P89; Hordoir R, 2013, CONT SHELF RES, V64, P1, DOI 10.1016/j.csr.2013.05.006; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IMAI TAKEO, 1950, TOHOKU JOUR AGRIC RES, V1, P199; Karlson K, OCEANOGRAPHY MARINE, V40, P427; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kristensen E., 1969, Videnskabelige Meddelelser Dansk naturh Foren, V132, P199; KRISTENSEN ES, 1979, OPHELIA, V18, P235; Kuhl H., 1972, OCEAN MAR BIOL ANN R, V10, P225; LANE CE, 1952, AM J PHYSIOL, V171, P741; Langer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054443; Leonel RMV, 2002, J MAR BIOL ASSOC UK, V82, P1039, DOI 10.1017/S002531540200663X; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2592, DOI 10.1111/j.1365-2486.2007.01451.x; Lima FP, 2007, GLOBAL CHANGE BIOL, V13, P2065, DOI 10.1111/j.1365-2486.2007.01424.x; Ling SD, 2009, GLOBAL CHANGE BIOL, V15, P719, DOI 10.1111/j.1365-2486.2008.01734.x; Lodola A, 2013, ITAL J ZOOL, V80, P303, DOI 10.1080/11250003.2013.775363; Long WC, 2008, J EXP MAR BIOL ECOL, V359, P34, DOI 10.1016/j.jembe.2008.02.013; Loosanoff V. L., 1963, Advances in Marine Biology, V1, P1, DOI 10.1016/S0065-2881(08)60257-6; MacLeod Colin D., 2009, Endangered Species Research, V7, P125, DOI 10.3354/esr00197; Madec G, 2008, NEMO OCEAN ENGINE; MANN R, 1985, J EXP MAR BIOL ECOL, V85, P211, DOI 10.1016/0022-0981(85)90159-5; Meier HEM, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034005; MORRISON G, 1971, J FISH RES BOARD CAN, V28, P379, DOI 10.1139/f71-050; NAIR NB, 1971, ADV MAR BIOL, V9, P335, DOI 10.1016/S0065-2881(08)60345-4; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Noppe KN, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P116; NORMAN E, 1977, OPHELIA, V16, P233, DOI 10.1080/00785326.1977.10425473; NORMAN E, 1976, Material und Organismen (Berlin), V11, P303; Norman E., 1976, Material und Organismen Beihefte, V3, P531; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Przeslawski R, 2012, ESTUAR COAST SHELF S, V113, P205, DOI 10.1016/j.ecss.2012.08.005; Rilov G, 2009, BIOL INVASIONS MARIN, V204; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Roginskaya IS, 1997, VELIGER, V40, P160; SCHELTEMA RS, 1971, MAR BIOL, V11, P5, DOI 10.1007/BF00348015; Serrano E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052739; Shanks AL, 2009, BIOL BULL-US, V216, P373; Simon-Bouhet B, 2006, MOL ECOL, V15, P1699, DOI 10.1111/j.1365-294X.2006.02881.x; Soldatova IN., 1961, T I OCEANOL, V59, P167; Soldatova IN, 1961, T I OCEANOL, V59, P161; Sordyl VH, 1998, DTSCH GEWAESSERKUNDL, V42, P142; Spicer JI, 2003, SARSIA, V88, P302, DOI 10.1080/00364820310002263; Tuente U, 2002, HELGOLAND MAR RES, V56, P87, DOI 10.1007/s10152-002-0101-7; Turner R.D., 1966, PROVIDES GORGEOUSLY; Uhrenholdt T, 11805776 DHI; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Wichmann G, 2005, RISK FACTOR WATER SP; Winsor P, 2001, CLIM RES, V18, P5, DOI 10.3354/cr018005	82	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119217	10.1371/journal.pone.0119217	http://dx.doi.org/10.1371/journal.pone.0119217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768305	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500071
J	Bezzina, C; Verret, L; Juan, C; Remaud, J; Halley, H; Rampon, C; Dahan, L				Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel			Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; TRANSGENIC MICE; NEUROPEPTIDE-Y; NEURONAL-ACTIVITY; SPATIAL MEMORY; COGNITIVE IMPAIRMENTS; EPILEPTIFORM ACTIVITY; FUNCTIONAL-CHANGES; LIMBIC SEIZURES; RAT HIPPOCAMPUS	Cortical and hippocampal hypersynchrony of neuronal networks seems to be an early event in Alzheimer's disease pathogenesis. Many mouse models of the disease also present neuronal network hypersynchrony, as evidenced by higher susceptibility to pharmacologically-induced seizures, electroencephalographic seizures accompanied by spontaneous interictal spikes and expression of markers of chronic seizures such as neuropeptide Y ectopic expression in mossy fibers. This network hypersynchrony is thought to contribute to memory deficits, but whether it precedes the onset of memory deficits or not in mouse models remains unknown. The earliest memory impairments in the Tg2576 mouse model of Alzheimer's disease have been observed at 3 months of age. We thus assessed network hypersynchrony in Tg2576 and non-transgenic male mice at 1.5, 3 and 6 months of age. As soon as 1.5 months of age, Tg2576 mice presented higher seizure susceptibility to systemic injection of a GABA(A) receptor antagonist. They also displayed spontaneous interictal spikes on EEG recordings. Some Tg2576 mice presented hippocampal ectopic expression of neuropeptide Y which incidence seems to increase with age among the Tg2576 population. Our data reveal that network hypersynchrony appears very early in Tg2576 mice, before any demonstrated memory impairments.	[Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel] Univ Toulouse, UPS, Ctr Rech Cognit Anim, F-31062 Toulouse 09, France; [Bezzina, Charlotte; Verret, Laure; Juan, Cecile; Remaud, Jessica; Halley, Helene; Rampon, Claire; Dahan, Lionel] CNRS, Ctr Rech Cognit Anim, F-31062 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Dahan, L (corresponding author), Univ Toulouse, UPS, Ctr Rech Cognit Anim, 118 Route Narbonne, F-31062 Toulouse 09, France.	lionel.dahan@univ-tlse3.fr	Dahan, Lionel/C-2760-2009; Verret, Laure/D-9224-2017	Verret, Laure/0000-0001-5272-6063; Dahan, Lionel/0000-0001-7810-6233; rampon, claire/0000-0001-8551-8682	Agence Nationale pour la Recherche [ANR-10-05-MALZ]; Centre National de la Recherche Scientifique; University of Toulouse; Agence Regionale de Sante; French Ministry of Research	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Toulouse; Agence Regionale de Sante; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	The authors acknowledge the support of the Agence Nationale pour la Recherche (ANR-10-05-MALZ to CR); the Centre National de la Recherche Scientifique (CNRS, PEPS to LD), the University of Toulouse. C. Bezzina was supported by the Agence Regionale de Sante and J. Remaud was supported by the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Born HA, 2014, J NEUROSCI, V34, P3826, DOI 10.1523/JNEUROSCI.5171-13.2014; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; Corbett BF, 2013, J NEUROSCI, V33, P7020, DOI 10.1523/JNEUROSCI.2325-12.2013; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387; Duffy AM, 2015, NEUROBIOL AGING, V36, P134, DOI 10.1016/j.neurobiolaging.2014.07.001; FORSTL H, 1992, ARCH NEUROL-CHICAGO, V49, P1038, DOI 10.1001/archneur.1992.00530340054018; Francis BM, 2012, NEUROBIOL AGING, V33, P555, DOI 10.1016/j.neurobiolaging.2010.04.003; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Goodman T, 2010, NEUROSCIENCE, V171, P769, DOI 10.1016/j.neuroscience.2010.09.047; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; Higgins GA, 2003, BEHAV PHARMACOL, V14, P419, DOI 10.1097/01.fbp.0000088420.18414.ff; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; KLAPSTEIN GJ, 1993, HIPPOCAMPUS, V3, P103, DOI 10.1002/hipo.450030111; Kleen JK, 2013, NEUROLOGY, V81, P18, DOI 10.1212/WNL.0b013e318297ee50; Kleen JK, 2010, ANN NEUROL, V67, P250, DOI 10.1002/ana.21896; Krezymon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076497; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Lassalle JM, 2008, BEHAV BRAIN RES, V191, P104, DOI 10.1016/j.bbr.2008.03.017; Lee SH, 2012, J NEUROSCI, V32, P5953, DOI 10.1523/JNEUROSCI.0465-12.2012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Mann DMA, 2001, AM J PATHOL, V158, P2165, DOI 10.1016/S0002-9440(10)64688-3; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mouri A, 2007, FASEB J, V21, P2135, DOI 10.1096/fj.06-7685com; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Orban G, 2010, BRAIN RES, V1354, P227, DOI 10.1016/j.brainres.2010.07.061; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sjogren T, 1952, ACTA PSYCH NEUROL SC, V82, P9; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Vegh MJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0076-z; Verret L, 2013, NEUROBIOL AGING, V34, P211, DOI 10.1016/j.neurobiolaging.2012.05.013; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vezzani A, 1996, EPILEPSY RES, V26, P267, DOI 10.1016/S0920-1211(96)00059-9; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Zilberter M, 2013, J NEUROCHEM, V125, P157, DOI 10.1111/jnc.12127	61	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119910	10.1371/journal.pone.0119910	http://dx.doi.org/10.1371/journal.pone.0119910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768013	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500101
J	Cai, SR; Chen, JH; Chen, CQ; Wu, KM; Zhang, XH; Song, W; He, YL				Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong			Survival of Proper Hepatic Artery Lymph Node Metastasis in Patients with Gastric Cancer: Implications for D2 Lymphadenectomy	PLOS ONE			English	Article							ADENOCARCINOMA	Background and Aims There is a discrepancy between the American Joint Committee on Cancer (AJCC) guidelines (7th edition) and the Japanese treatment guidelines (3rd edition) with regard to the extent of D2 lymphadenectomy for gastric cancer. In the AJCC, hepatic artery station (No. 12a) lymph node (LN) metastasis is classified as distant metastasis, whereas in the Japanese guidelines, this classified is regional metastasis. This study aimed to evaluate whether it is appropriate to reclassify No. 12a LN metastasis as distant metastasis in consideration of survival outcome. Methods In this retrospective analysis, data from patients with gastric cancer who underwent regular D2 or greater lymphadenectomy between 1996 and 2006 were evaluated to determine any association between the clinicopathological features of hepatic artery LNs and survival prognosis. Results Among the 247 patients with gastric cancer who underwent No. 12 LN harvest, 45 (18.2%) were positive for No. 12a LN metastasis. No. 12a LN metastasis was significantly associated with poor clinicopathological features, advanced tumor stage, and poor overall survival. The 5-year survival rate of patients with No. 12a LN metastasis was significantly better than that of patients with distant metastasis (P < 0.05), but was similar to that of patients with LN involvement in the D2 lymphadenectomy region (P > 0.05). No. 12a LN metastasis was shown to significantly influence survival outcome in univariate analysis, but was not identified as a significant independent predictor in multivariate analysis. In logistic multivariate regression analysis, T stage, N stage, and station No. 3, 5, and 6 LN metastasis were independent predictors of No. 12a LN involvement. Conclusions It is inappropriate to reclassify No. 12a LN metastasis as distant metastasis. We propose that this be considered as regional metastasis and be included in the extent of D2 lymphadenectomy to improve survival outcomes in patients with gastric cancer.	[Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong] Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China; [Cai Shirong; Chen Jianhui; Chen Chuangqi; Wu Kaiming; Zhang Xinhua; Song Wu; He Yulong] Sun Yat Sen Univ, Gastr Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	He, YL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Div Gastrointestinal Surg, Guangzhou 510275, Guangdong, Peoples R China.	YLH@medmail.com.cn			National Nature Science Foundation of China [30972883, 81272637]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from the National Nature Science Foundation of China (No. 30972883, No. 81272637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Degiuli M, 2014, BRIT J SURG, V101, P23, DOI 10.1002/bjs.9345; Dikken JL, 2012, ANN SURG ONCOL, V19, P2443, DOI 10.1245/s10434-012-2403-6; Edge SB, 2010, AJCC CANC STAGING MA; Greene FLPA, 2002, AJCC CANC STAGING MA, P99; Japanese Gastric Cancer Association, 2011, GASTRIC CANC; Jiang L, 2013, J SURG ONCOL, V107, P807, DOI 10.1002/jso.23325; Kim HI, 2013, ANN SURG ONCOL, V20, P2713, DOI 10.1245/s10434-013-2898-5; Kim R, 2013, CRIT REV ONCOL HEMAT, V88, P416, DOI 10.1016/j.critrevonc.2013.05.007; Lee SL, 2014, BRIT J SURG, V101, P518, DOI 10.1002/bjs.9438; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; Menges M, 2011, WORLD J GASTRO ONCOL, V3, P10, DOI 10.4251/wjgo.v3.i1.10; Sobin L, 2010, UICC TNM CLASSIFICAT; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2	14	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118953	10.1371/journal.pone.0118953	http://dx.doi.org/10.1371/journal.pone.0118953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768441	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500056
J	Liccioli, S; Bialowas, C; Ruckstuhl, KE; Massolo, A				Liccioli, Stefano; Bialowas, Carly; Ruckstuhl, Kathreen E.; Massolo, Alessandro			Feeding Ecology Informs Parasite Epidemiology: Prey Selection Modulates Encounter Rate with Echinococcus multilocularis in Urban Coyotes	PLOS ONE			English	Article							WHITE-TAILED DEER; RED-BACKED VOLE; CANIS-LATRANS; ALVEOLAR ECHINOCOCCOSIS; MYODES-GAPPERI; PREDATION; FOXES; MORTALITY; LEUCKART; WINTER	We investigated the role of urban coyote feeding ecology in the transmission of Echinococcus multilocularis, the causative agent of Alveolar Echinococcosis in humans. As coyotes can play a main role in the maintenance of this zoonotic parasite within North American urban settings, such study can ultimately aid disease risk management. Between June 2012 and June 2013, we collected 251 coyote feces and conducted trapping of small mammals (n = 971) in five parks in the city of Calgary, Alberta, Canada. We investigated E. multilocularis epidemiology by assessing seasonal variations of coyote diet and the selective consumption of different rodent intermediate host species. Furthermore, accounting for small mammal digestibility and coyote defecation rates we estimated the number of small mammal preys ingested by coyote and consequently, coyote encounter rates with the parasite. Dominant food items included small mammals, fruit and vegetation, although hare and deer were seasonally relevant. The lowest frequency of occurrence per scat of small mammals was recorded in winter (39.4 %), when consumption of deer was highest (36.4 %). However, highest encounter rates (number of infected hosts predated/season) with E. multilocularis (95% CI: 1.0 - 22.4), combined with the lack of predation on non-competent small mammal species, suggest that winter is the critical season for transmission and control of this parasite. Within the small mammal assemblage, voles (Microtus pennsylvanicus and Myodes gapperi) were the selected preys of urban coyotes and likely played a key role for the maintenance of the urban sylvatic life-cycle of E. multilocularis in Calgary.	[Liccioli, Stefano; Bialowas, Carly; Massolo, Alessandro] Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, Calgary, AB T2N 4Z6, Canada; [Liccioli, Stefano; Bialowas, Carly; Ruckstuhl, Kathreen E.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary	Massolo, A (corresponding author), Univ Calgary, Fac Vet Med, Dept Ecosyst & Publ Hlth, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	amassolo@ucalgary.ca	Massolo, Alessandro/AAO-5344-2021; Massolo, Alessandro/I-3437-2012; Ruckstuhl, Kathreen Eva/B-4469-2013	Massolo, Alessandro/0000-0002-6333-4281; Ruckstuhl, Kathreen/0000-0002-2949-242X; Liccioli, Stefano/0000-0003-1548-731X	Canadian Institutes of Health Research [736488]; Institute for Public Health [10002391]; Calgary Parks [RT: 10001048]; University of Calgary, Department of Ecosystem & Public Health (University of Calgary); Alberta Innovates Health Solutions [10006087]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Public Health; Calgary Parks; University of Calgary, Department of Ecosystem & Public Health (University of Calgary); Alberta Innovates Health Solutions	Funding: This work has been supported by the following funders: Canadian Institutes of Health Research (RT#: 736488; http://www.cihr-irsc.gc.ca/e/193.html), Institute for Public Health (RT#: 10002391; http://obrieniph.ucalgary.ca/), and Calgary Parks (RT: 10001048; http://www.calgary.ca/CSPS/Parks/Pages/home.aspx). SL was supported by studentships from the University of Calgary, Department of Ecosystem & Public Health (University of Calgary) and Alberta Innovates Health Solutions (RT#: 10006087; http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorjan A. S., 1969, MANUAL IDENTIFICATIO; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; Bagchi S, 2004, ANIM CONSERV, V7, P121, DOI 10.1017/S1367943003001148; BONDRUPNIELSEN S, 1987, CAN J ZOOL, V65, P277, DOI 10.1139/z87-043; BOWEN WD, 1981, CAN J ZOOL, V59, P639, DOI 10.1139/z81-094; Burlet P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-6; BYERS CR, 1984, J WILDLIFE MANAGE, V48, P1050, DOI 10.2307/3801467; Catalano S, 2012, EMERG INFECT DIS, V18, P1625, DOI [10.3201/eid1810.120119, 10.3201/eid.1810.120119]; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; Craig PS, 1996, ADV PARASIT, V38, P169, DOI 10.1016/S0065-308X(08)60035-4; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Deplazes P, 2004, TRENDS PARASITOL, V20, P77, DOI 10.1016/j.pt.2003.11.011; Eckert J., 2001, WHO/OIE manual on echinococcosis in humans and animals: a public health problem of global concern, pi; ENGEMAN RM, 1993, WILDLIFE SOC B, V21, P70; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foley J., 2006, CALGARYS NATURAL PAR; GESE EM, 1995, AM MIDL NAT, V133, P36, DOI 10.2307/2426345; Gese EM, 1996, CAN J ZOOL, V74, P784, DOI 10.1139/z96-090; Gesy K, 2013, PARASITOLOGY, V140, P1133, DOI 10.1017/S0031182013000607; Giraudoux P, 2003, PARASITOLOGY, V127, pS121, DOI 10.1017/S0031182003003512; Giraudoux P, 2013, PARASITOLOGY, V140, P1655, DOI 10.1017/S0031182013000644; Grigione MM, 2011, URBAN ECOSYST, V14, P655, DOI 10.1007/s11252-011-0159-6; Guerra D, 2014, PARASITOLOGY, P1; HAMLIN KL, 1984, J WILDLIFE MANAGE, V48, P489, DOI 10.2307/3801181; HARRISON DJ, 1989, J WILDLIFE MANAGE, V53, P181, DOI 10.2307/3801327; Hayward MW, 2006, J MAMMAL, V87, P1122, DOI 10.1644/05-MAMM-A-304R2.1; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; HNATIUK JM, 1966, CAN J ZOOLOG, V44, P493, DOI 10.1139/z66-048; HOLMES JC, 1971, CAN J ZOOLOG, V49, P575, DOI 10.1139/z71-090; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jones JK, 1992, ILLUSTRATED KEY SKUL; Jung TS, 2006, CAN FIELD NAT, V120, P331, DOI 10.22621/cfn.v120i3.324; Kapel CMO, 2006, INT J PARASITOL, V36, P79, DOI 10.1016/j.ijpara.2005.08.012; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly BT, 1997, CAN J ZOOL, V75, P1811, DOI 10.1139/z97-810; Kelly BT., 1991, CARNIVORE SCAT ANAL; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Lafferty KD, 1999, PARASITOL TODAY, V15, P111, DOI 10.1016/S0169-4758(99)01397-6; LEE CF, 1969, CAN J ZOOLOG, V47, P733, DOI 10.1139/z69-124; LEIBY PD, 1970, J PARASITOL, V56, P1141, DOI 10.2307/3277560; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; Liccioli S, 2012, CAN J ZOOL, V90, P1023, DOI [10.1139/Z2012-070, 10.1139/z2012-070]; Liccioli S, 2014, INT J PARASITOL, V44, P457, DOI 10.1016/j.ijpara.2014.03.007; Liccioli S, 2013, PARASITOL INT, V62, P355, DOI 10.1016/j.parint.2013.03.007; Lidicker WZ, 2000, OIKOS, V91, P435; Lingle S, 2002, ECOLOGY, V83, P2037; LITVAITIS JA, 1980, J WILDLIFE MANAGE, V44, P62, DOI 10.2307/3808351; Loucks CJ, 2003, CONSERV BIOL, V17, P558, DOI 10.1046/j.1523-1739.2003.01494.x; Loveridge AJ, 2003, J ZOOL, V259, P143, DOI 10.1017/S0952836902003114; Lukasik VM., 2012, CITIES ENV, V4, P8, DOI DOI 10.15365/CATE.4182011; Monroy-Vilchis O, 2006, SOUTHWEST NAT, V51, P272, DOI 10.1894/0038-4909(2006)51[272:DAEROC]2.0.CO;2; Moore T.D., 1997, IDENTIFICATION DORSA; Morey PS, 2007, AM MIDL NAT, V158, P147, DOI 10.1674/0003-0031(2007)158[147:SATVIT]2.0.CO;2; NELLIS CH, 1976, J WILDLIFE MANAGE, V40, P389, DOI 10.2307/3799940; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; Prugh LR, 2005, OIKOS, V110, P253, DOI 10.1111/j.0030-1299.2005.13478.x; PRUITT W O JR, 1984, Carnegie Museum of Natural History Special Publication, P1; Quinn T, 1997, NORTHWEST SCI, V71, P1; Ramakrishnan U, 1999, BIOL CONSERV, V89, P113, DOI 10.1016/S0006-3207(98)00159-1; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Schwingel H, 2010, NORTHEAST NAT, V17, P531, DOI 10.1656/045.017.0402; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; THURBER JM, 1992, CAN J ZOOL, V70, P2494, DOI 10.1139/z92-335; Tsukada H, 2000, PARASITOLOGY, V120, P423, DOI 10.1017/S0031182099005582; VanDeelen TR, 1997, J WILDLIFE MANAGE, V61, P903, DOI 10.2307/3802199; VEIT P, 1995, PARASITOLOGY, V110, P79, DOI 10.1017/S0031182000081075; Viel JF, 1999, AM J TROP MED HYG, V61, P559, DOI 10.4269/ajtmh.1999.61.559; VILLAGE A, 1990, J ZOOL, V222, P681, DOI 10.1111/j.1469-7998.1990.tb06023.x; Vuitton DA, 2003, PARASITOLOGY, V127, pS87, DOI 10.1017/S0031182003004153	71	17	17	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121646	10.1371/journal.pone.0121646	http://dx.doi.org/10.1371/journal.pone.0121646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768437	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500144
J	Liu, Y; Xi, DG; Li, ZL				Liu, Yu; Xi, Du-Gang; Li, Zhao-Liang			Determination of the Optimal Training Principle and Input Variables in Artificial Neural Network Model for the Biweekly Chlorophyll-a Prediction: A Case Study of the Yuqiao Reservoir, China	PLOS ONE			English	Article							REGRESSION-MODELS	Predicting the levels of chlorophyll-a (Chl-a) is a vital component of water quality management, which ensures that urban drinking water is safe from harmful algal blooms. This study developed a model to predict Chl-a levels in the Yuqiao Reservoir (Tianjin, China) biweekly using water quality and meteorological data from 1999-2012. First, six artificial neural networks (ANNs) and two non-ANN methods (principal component analysis and the support vector regression model) were compared to determine the appropriate training principle. Subsequently, three predictors with different input variables were developed to examine the feasibility of incorporating meteorological factors into Chl-a prediction, which usually only uses water quality data. Finally, a sensitivity analysis was performed to examine how the Chl-a predictor reacts to changes in input variables. The results were as follows: first, ANN is a powerful predictive alternative to the traditional modeling techniques used for Chl-a prediction. The back program (BP) model yields slightly better results than all other ANNs, with the normalized mean square error (NMSE), the correlation coefficient (Corr), and the NashSutcliffe coefficient of efficiency (NSE) at 0.003 mg/l, 0.880 and 0.754, respectively, in the testing period. Second, the incorporation of meteorological data greatly improved Chl-a prediction compared to models solely using water quality factors or meteorological data; the correlation coefficient increased from 0.574-0.686 to 0.880 when meteorological data were included. Finally, the Chl-a predictor is more sensitive to air pressure and pH compared to other water quality and meteorological variables.	[Liu, Yu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Liu, Yu] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Xi, Du-Gang] PLA Informat Engn Univ, Zhengzhou, Peoples R China; [Xi, Du-Gang] Naval Inst Hydrog Surveying & Charting, Tianjin, Peoples R China; [Li, Zhao-Liang] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Agriinformat, Minist Agr, Beijing 100193, Peoples R China; [Li, Zhao-Liang] CNRS, UdS, ICube, F-67412 Illkirch Graffenstaden, France	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; PLA Information Engineering University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Li, ZL (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	lizhaoliang@caas.cn			National Natural Science Foundation of China [41301379, 41231170]; China Postdoctoral Science Foundation [2013M541029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China under grants 41301379 and 41231170 and the China Postdoctoral Science Foundation under grant 2013M541029. The funders covered the money needed in the study design, data collection and publishing of the manuscript.	Camdevyren H, 2005, ECOL MODEL, V181, P581, DOI 10.1016/j.ecolmodel.2004.06.043; CHAPRA S.C, 1997, SURFACE WATER QUALIT, P844; Chen CW, 1970, J SANITARY ENG DIVIS, V96, P1085; Cho KH, 2009, SCI TOTAL ENVIRON, V407, P2536, DOI 10.1016/j.scitotenv.2009.01.017; DITORO DM, 1971, ADV CHEM SER, P131; French M, 1994, COMPUTER TECHNIQUES, VII, P87; Jeong KS, 2006, ECOL INFORM, V1, P235, DOI 10.1016/j.ecoinf.2006.04.001; Karul C, 2006, ECOLOGICAL INFORM, P309; Lee JHW, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P187, DOI 10.1007/1-4020-3655-8_13; Lek S, 1996, ECOL MODEL, V90, P39, DOI 10.1016/0304-3800(95)00142-5; Liu Y, 2010, ECOL MODEL, V221, P681, DOI 10.1016/j.ecolmodel.2009.03.010; Liu Y, 2009, SENSORS-BASEL, V9, P5558, DOI 10.3390/s90705558; Luo HuaJun, 2012, Journal of Environmental Protection, V3, P420, DOI 10.4236/jep.2012.35052; Maier HR, 2001, ECOL MODEL, V146, P85, DOI 10.1016/S0304-3800(01)00298-8; Malek S, 2012, BMC BIOINFORMATICS, V12, pS12; Martin J.L., 1998, HYDRODYNAMICS TRANSP, P816; Onderka M, 2007, ECOL MODEL, V209, P412, DOI 10.1016/j.ecolmodel.2007.07.028; Orlob G.T., 1983, MATH MODELING WATER, P518; Primpas I, 2010, ECOL INDIC, V10, P178, DOI 10.1016/j.ecolind.2009.04.007; Xu M, 2005, J ENVIRON SCI, V17, P946; Yabunaka K, 1997, WATER SCI TECHNOL, V36, P89, DOI 10.1016/S0273-1223(97)00464-2	21	4	5	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119082	10.1371/journal.pone.0119082	http://dx.doi.org/10.1371/journal.pone.0119082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768650	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500064
J	Schwartz, AJ; Sarver, DC; Sugg, KB; Dzierzawski, JT; Gumucio, JP; Mendias, CL				Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Dzierzawski, Justin T.; Gumucio, Jonathan P.; Mendias, Christopher L.			p38 MAPK Signaling in Postnatal Tendon Growth and Remodeling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; COLLAGEN-SYNTHESIS; TISSUE; DIFFERENTIATION; HYALURONAN; INHIBITION; EXPRESSION; CELLS; HYPERTROPHY	Tendon is a dynamic tissue whose structure and function is influenced by mechanical loading, but little is known about the fundamental mechanisms that regulate tendon growth and remodeling in vivo. Data from cultured tendon fibroblasts indicated that the p38 MAPK pathway plays an important role in tendon fibroblast proliferation and collagen synthesis in vitro. To gain greater insight into the mechanisms of tendon growth, and explore the role of p38 MAPK signaling in this process, we tested the hypotheses that inducing plantaris tendon growth through the ablation of the synergist Achilles tendon would result in rapid expansion of a neotendon matrix surrounding the original tendon, and that treatment with the p38 MAPK inhibitor SB203580 would prevent this growth. Rats were treated with vehicle or SB203580, and subjected to synergist ablation by bilateral tenectomy of the Achilles tendon. Changes in histological and biochemical properties of plantaris tendons were analyzed 3, 7, or 28 days after overload, and comparisons were made to non-overloaded animals. By 28 days after overload, tendon mass had increased by 30% compared to non-overloaded samples, and cross-sectional area (CSA) increased by around 50%, with most of the change occurring in the neotendon. The expansion in CSA initially occurred through the synthesis of a hyaluronic acid rich matrix that was progressively replaced with mature collagen. Pericytes were present in areas of active tendon growth, but never in the original tendon ECM. Inhibition of p38 MAPK resulted in a profound decrease in IL6 expression, and had a modest effect on the expression of other ECM and cell proliferation genes, but had a negligible impact on overall tendon growth. The combined results from this study provided novel insights into tendon mechanobiology, and suggest that p38 MAPK signaling does not appear to be necessary for tendon growth in vivo.	[Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Dzierzawski, Justin T.; Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Schwartz, Andrew J.; Sarver, Dylan C.; Sugg, Kristoffer B.; Gumucio, Jonathan P.; Mendias, Christopher L.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Sugg, Kristoffer B.] Univ Michigan, Sch Med, Dept Surg, Sect Plast Surg, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mendias, CL (corresponding author), Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA.	cmendias@umich.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171	NIH/NIAMS [R01-AR063649, F31-AR065931, F32-AR067086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR067086, R01AR063649, F31AR065931] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Support for this study was provided by NIH/NIAMS grants R01-AR063649, F31-AR065931, and F32-AR067086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/783632; Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Andersen MB, 2011, J APPL PHYSIOL, V110, P1549, DOI 10.1152/japplphysiol.00037.2010; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Baud A, 2013, NAT GENET, V45, P767, DOI 10.1038/ng.2644; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Birbrair A, 2013, AM J PHYSIOL-CELL PH, V305, pC1098, DOI 10.1152/ajpcell.00171.2013; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013; Eliasson P, 2013, J APPL PHYSIOL, V114, P1519, DOI 10.1152/japplphysiol.01500.2012; ESSER KA, 1995, J APPL PHYSIOL, V78, P30, DOI 10.1152/jappl.1995.78.1.30; Ettema GJC, 1996, J EXP BIOL, V199, P1277; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Gumucio JP, 2014, J APPL PHYSIOL, V117, P1287, DOI 10.1152/japplphysiol.00720.2014; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Heinemeier KM, 2013, FASEB J, V27, P2074, DOI 10.1096/fj.12-225599; Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kjaer M, 2009, SCAND J MED SCI SPOR, V19, P500, DOI 10.1111/j.1600-0838.2009.00986.x; Langberg H, 2002, J PHYSIOL-LONDON, V542, P985, DOI 10.1113/jphysiol.2002.019141; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Li JH, 2006, AM J PATHOL, V169, P1527, DOI 10.2353/ajpath.2006.060169; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Mendias CL, 2012, J ORTHOP RES, V30, P606, DOI 10.1002/jor.21550; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; MICHNA H, 1989, INT ORTHOP, V13, P161, DOI 10.1007/BF00268040; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Munoz-Canoves P, 2013, FEBS J, V280, P4131, DOI 10.1111/febs.12338; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Perez-Schindler J, 2013, P NATL ACAD SCI USA, V110, P20314, DOI 10.1073/pnas.1312039110; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Rowe RG, 2011, AM J PHYSIOL-LUNG C, V301, pL683, DOI 10.1152/ajplung.00187.2011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugg KB, 2014, J ORTHOP RES, V32, P944, DOI 10.1002/jor.22624; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	56	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120044	10.1371/journal.pone.0120044	http://dx.doi.org/10.1371/journal.pone.0120044			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768932	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500106
J	Tong, Q; Cai, Q; de Mooij, T; Xu, X; Dai, SM; Qu, WC; Zhao, DB				Tong, Qiang; Cai, Qing; de Mooij, Tristan; Xu, Xia; Dai, Shengming; Qu, Wenchun; Zhao, Dongbao			Adverse Events of Anti-Tumor Necrosis Factor alpha Therapy in Ankylosing Spondylitis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TNF-ALPHA; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; INFLIXIMAB; BLOCKERS; DISEASE; SAFETY; POLYMORPHISM; ETANERCEPT	Objective This study aims to investigate the prevalence of short-term and long-term adverse events associated with tumor necrosis factor-alpha (TNF-alpha) blocker treatment in Chinese Han patients suffering from ankylosing spondylitis (AS). Methods The study included 402 Chinese Han AS patients treated with TNF-alpha blockers. Baseline data was collected. All patients were monitored for adverse events 2 hours following administration. Long-term treatment was evaluated at 8, 12, 52 and 104 weeks follow-up for 172 patients treated with TNF-alpha blockers. Results Short-term adverse events occurred in 20.15% (81/402), including rash (3.5%; 14/402), pruritus (1.2%; 5/402), nausea (2.2%; 9/402), headache (0.7%; 3/402), skin allergies (4.0%; 16/402), fever (0.5%; 2/402), palpitations (3.0%; 12/402), dyspnea (0.5%; 2/402), chest pain (0.2%; 2/402), abdominal pain (1.0%; 4/402), hypertension (2.2%; 9/402), papilledema (0.5%; 2/402), laryngeal edema (0.2%; 1/402) and premature ventricular contraction (0.2%; 1/402). Long-term adverse events occurred in 59 (34.3%; 59/172) patients, including pneumonia (7.6%; 13/172), urinary tract infections (9.9%; 17/172), otitis media (4.7%; 8/172), tuberculosis (3.5%; 17/172), abscess (1.2%; 2/172), oral candidiasis (0.6%; 1/172), elevation of transaminase (1.7%; 3/172), anemia (1.2%; 2/172), hematuresis (0.6%; 1/172), constipation (2.3%; 4/172), weight loss (0.6%; 1/172), exfoliative dermatitis (0.6%; 1/172). CRP, ESR and disease duration were found to be associated with an increased risk of immediate and long-term adverse events (P<0.05). Long-term treatment with Infliximab was associated with more adverse events than rhTNFR-Fc (P<0.01). Conclusion This study reports on the prevalence of adverse events in short-term and long-term treatment with TNF-alpha blocker monotherapy in Chinese Han AS patients. Duration of disease, erythrocyte sedimentation rate, and c-reactive protein serum levels were found to be associated with increased adverse events with anti-TNF-alpha therapy. Long-term treatment with Infliximab was associated with more adverse events than rhTNFR-Fc.	[Tong, Qiang; Cai, Qing; Xu, Xia; Dai, Shengming; Zhao, Dongbao] Second Mil Med Univ, Dept Rheumatol & Immunol, Shanghai 200433, Peoples R China; [de Mooij, Tristan] Mayo Clin, Dept Neurosurg, Rochester, MN 55902 USA; [Qu, Wenchun] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55902 USA; [Qu, Wenchun] Mayo Clin, Dept Anesthesiol Pain Div, Rochester, MN 55902 USA	Naval Medical University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Zhao, DB (corresponding author), Second Mil Med Univ, Dept Rheumatol & Immunol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	dongbaozhao@163.com	Tong, Qiang/AAA-2670-2021	Dai, Sheng-Ming/0000-0001-8876-4205	National Natural Science Foundation of China (NSFC) [H1008, 81302580]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding has generously been supplied by National Natural Science Foundation of China (NSFC) under grant number H1008, 81302580 to Qiang Tong (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten D, 2003, ANN RHEUM DIS, V62, P829, DOI 10.1136/ard.62.9.829; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Bakland G, 2011, J RHEUMATOL, V38, P479, DOI 10.3899/jrheum.100686; de Moraes JCB, 2010, REV BRAS REUMATOL, V50, P165, DOI 10.1590/S0482-50042010000200006; Bonafede M, 2012, ADV THER, V29, P664, DOI 10.1007/s12325-012-0037-5; Braun J, 2011, ARTHRITIS RHEUM-US, V63, P1543, DOI 10.1002/art.30223; Callhoff J, 2014, ANN RHEUM DIS; Dillon CF, 2011, AM J MED SCI, V341, P281, DOI 10.1097/MAJ.0b013e31820f8c83; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Eudy A, 2014, LUPUS; Fouache D, 2009, RHEUMATOLOGY, V48, P761, DOI 10.1093/rheumatology/kep083; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gerloni V, 2008, ANN RHEUM DIS, V67, P1145, DOI 10.1136/ard.2007.069484; Guellec D, 2014, JOINT BONE SPINE, V81, P308, DOI 10.1016/j.jbspin.2014.01.003; Huang Feng, 2006, Zhonghua Nei Ke Za Zhi, V45, P122; Kapetanovic MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2020; Lee HH, 2007, BRIT J DERMATOL, V156, P486, DOI 10.1111/j.1365-2133.2007.07682.x; Martin-Mola E, 2010, CLIN EXP RHEUMATOL, V28, P238; Nagy Gabriella, 2011, Orvosi Hetilap, V152, P212, DOI 10.1556/OH.2011.28987; National Cancer Institute, 2009, COMM TERM CRIT ADV E; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Schett G, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S4, 10.1186/ar3095]; Suwannalai P, 2009, INT J RHEUM DIS, V12, P118, DOI 10.1111/j.1756-185X.2009.01393.x; Tong Q, 2013, PHARMACOGENOMICS, V14, P1691, DOI 10.2217/pgs.13.146; Tong Q, 2012, PHARMACOGENOMICS, V13, P1459, DOI [10.2217/PGS.12.133, 10.2217/pgs.12.133]; Tristano AG, 2010, J NEUROL, V257, P1421, DOI 10.1007/s00415-010-5591-7; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vultaggio A, 2010, ALLERGY, V65, P657, DOI 10.1111/j.1398-9995.2009.02280.x	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119897	10.1371/journal.pone.0119897	http://dx.doi.org/10.1371/journal.pone.0119897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764452	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300034
J	Versluis, M; de Lange, MJ; van Pelt, SI; Ruivenkamp, CAL; Kroes, WGM; Cao, JF; Jager, MJ; Luyten, GPM; van der Velden, PA				Versluis, Mieke; de lange, Mark J.; van Pelt, Sake I.; Ruivenkamp, Claudia A. L.; Kroes, Wilma G. M.; Cao, Jinfeng; Jager, Martine J.; Luyten, Gre P. M.; van der Velden, Pieter A.			Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma	PLOS ONE			English	Article							DEPENDENT PROBE AMPLIFICATION; ABNORMALITIES; GENOME	Background Uveal melanoma (UM) development and progression is correlated with specific molecular changes. Recurrent mutations in GNAQ and GNA11 initiate UM development while tumour progression is correlated with monosomy of chromosome 3 and gain of chromosome 8q. Hence, molecular analysis of UM is useful for diagnosis and prognosis. The aim of this study is to evaluate the use of digital PCR (dPCR) for molecular analysis of UM. Methods A series of 66 UM was analysed with dPCR for three hotspot mutations in GNAQ/GNA11 with mutation specific probes. The status of chromosomes 3 and 8 were analysed with genomic probes. The results of dPCR analysis were cross-validated with Sanger sequencing, SNP array analysis, and karyotyping. Results Using dPCR, we were able to reconstitute the molecular profile of 66 enucleated UM. With digital PCR, GNAQ/GNA11 mutations were detected in 60 of the 66 UM. Sanger sequencing revealed three rare variants, and, combined, these assays revealed GNAQ/GNA11 mutations in 95% of UM. Monosomy 3 was present in 43 and chromosome 8 aberrations in 52 of the 66 UM. Survival analysis showed that increasing 8q copy numbers were positively correlated with metastasis risk. Conclusion Molecular analysis with dPCR is fast and sensitive. Just like the recurrent genomic aberrations of chromosome 3 and 8, hotspot mutations in GNAQ and GNA11 are effectively detected in heterogeneous samples. Increased sensitivity contributes to the number of mutations and chromosomal aberrations detected. Moreover, quantification of copy number with dPCR validated 8q dosage as a sensitive prognostic tool in UM, of which implementation in disease prediction models will further improve prognostication.	[Versluis, Mieke; de lange, Mark J.; van Pelt, Sake I.; Cao, Jinfeng; Jager, Martine J.; Luyten, Gre P. M.; van der Velden, Pieter A.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Ruivenkamp, Claudia A. L.; Kroes, Wilma G. M.] Leiden Univ, Med Ctr, Dept Clin Genet, Lab Diagnost Genome Anal LDGA, Leiden, Netherlands; [Cao, Jinfeng] Jilin Univ, Hosp 2, Dept Ophthalmol, Changchun 130023, Peoples R China	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Jilin University	de Lange, MJ (corresponding author), Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands.	delange@lumc.nl	Jager, Martine/AAR-3525-2020; Kroes, Wilma/AAC-4436-2022	Jager, Martine/0000-0003-2261-3820; Kroes, Wilma/0000-0002-9469-2807; van der Velden, Pieter/0000-0002-5710-9256	Dutch cancer society [UL2011-4991]	Dutch cancer society(KWF Kankerbestrijding)	The work was supported by Dutch cancer society, grant no. UL2011-4991, received by PAvdV.	Cassoux N, 2014, BRIT J OPHTHALMOL, V98, P769, DOI 10.1136/bjophthalmol-2013-303867; Damato B, 2010, CLIN CANCER RES, V16, P6083, DOI 10.1158/1078-0432.CCR-10-2076; Damato B, 2009, INVEST OPHTH VIS SCI, V50, P3048, DOI 10.1167/iovs.08-3165; DELACHAPELLE A, 1982, CANCER GENET CYTOGEN, V5, P173, DOI 10.1016/0165-4608(82)90007-3; EGAN KM, 1988, SURV OPHTHALMOL, V32, P239, DOI 10.1016/0039-6257(88)90173-7; Ewens KG, 2013, INVEST OPHTH VIS SCI, V54, P5721, DOI 10.1167/iovs.13-12195; Hoglund M, 2004, INT J CANCER, V108, P57, DOI 10.1002/ijc.11558; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; MCLEAN IW, 1983, AM J OPHTHALMOL, V96, P502, DOI 10.1016/S0002-9394(14)77914-0; Parrella P, 2001, INVEST OPHTH VIS SCI, V42, P1679; Parrella P, 1999, CANCER RES, V59, P3032; Prescher G, 1996, LANCET, V347, P1222; PRESCHER G, 1990, J NATL CANCER I, V82, P1765, DOI 10.1093/jnci/82.22.1765; PRESCHER G, 1994, CANCER GENET CYTOGEN, V77, P144, DOI 10.1016/0165-4608(94)90230-5; SINGH AD, 1994, CANCER GENET CYTOGEN, V72, P109, DOI 10.1016/0165-4608(94)90125-2; Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2; Trolet J, 2009, INVEST OPHTH VIS SCI, V50, P2572, DOI 10.1167/iovs.08-2296; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2008, NATURE; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wang J, 2010, CLIN CHEM, V56, P623, DOI 10.1373/clinchem.2009.134973	21	67	67	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0116371	10.1371/journal.pone.0116371	http://dx.doi.org/10.1371/journal.pone.0116371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25764247	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300006
J	Dawes, P; Emsley, R; Cruickshanks, KJ; Moore, DR; Fortnum, H; Edmondson-Jones, M; McCormack, A; Munro, KJ				Dawes, Piers; Emsley, Richard; Cruickshanks, Karen J.; Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby; Munro, Kevin J.			Hearing Loss and Cognition: The Role of Hearing Aids, Social Isolation and Depression	PLOS ONE			English	Article							OLDER-ADULTS; SELF-EFFICACY; IMPAIRMENT; DECLINE; AGE; LIFE; ASSOCIATION; POPULATION; CONNECTION; PREVALENCE	Hearing loss is associated with poor cognitive performance and incident dementia and may contribute to cognitive decline. Treating hearing loss with hearing aids may ameliorate cognitive decline. The purpose of this study was to test whether use of hearing aids was associated with better cognitive performance, and if this relationship was mediated via social isolation and/or depression. Structural equation modelling of associations between hearing loss, cognitive performance, social isolation, depression and hearing aid use was carried out with a subsample of the UK Biobank data set (n = 164,770) of UK adults aged 40 to 69 years who completed a hearing test. Age, sex, general health and socioeconomic status were controlled for as potential confounders. Hearing aid use was associated with better cognition, independently of social isolation and depression. This finding was consistent with the hypothesis that hearing aids may improve cognitive performance, although if hearing aids do have a positive effect on cognition it is not likely to be via reduction of the adverse effects of hearing loss on social isolation or depression. We suggest that any positive effects of hearing aid use on cognition may be via improvement in audibility or associated increases in self-efficacy. Alternatively, positive associations between hearing aid use and cognition may be accounted for by more cognitively able people seeking and using hearing aids. Further research is required to determine the direction of association, if there is any direct causal relationship between hearing aid use and better cognition, and whether hearing aid use results in reduction in rates of cognitive decline measured longitudinally.	[Dawes, Piers; Munro, Kevin J.] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Emsley, Richard] Univ Manchester, Ctr Biostat, Inst Populat Hlth, Manchester, Lancs, England; [Cruickshanks, Karen J.] Univ Wisconsin, Populat Hlth Sci & Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Moore, David R.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Moore, David R.] Univ Cincinnati, Coll Med, Dept Otolaryngol, Cincinnati, OH USA; [Moore, David R.; Fortnum, Heather; Edmondson-Jones, Mark; McCormack, Abby] NIHR Nottingham Hearing Biomed Res Unit, Nottingham, England; [Moore, David R.; McCormack, Abby] MRC, Inst Hearing Res, Nottingham, England; [Fortnum, Heather; Edmondson-Jones, Mark] Univ Nottingham, Sch Med, Div Clin Neurosci, Otol & Hearing Grp, Nottingham NG7 2RD, England; [Munro, Kevin J.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Wisconsin System; University of Wisconsin Madison; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Nottingham; University of Manchester	Dawes, P (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	piers.dawes@manchester.ac.uk	Emsley, Richard/N-1342-2016; munro, kevin/A-2899-2015	Emsley, Richard/0000-0002-1218-675X; munro, kevin/0000-0001-6543-9098; Hunter, Abby/0000-0002-6533-6918; Dawes, Piers/0000-0003-3180-9884	National Institute for Health Research (NIHR); Intramural Programme of the Medical Research Council [U135097130]; Cincinnati Children's Hospital; Research to Prevent Blindness;  [R37AG11099];  [R01AG021917]; Medical Research Council [MC_qA137853, MC_U135097130] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R37AG011099, R01AG021917] Funding Source: NIH RePORTER; MRC [MC_U135097130] Funding Source: UKRI	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Intramural Programme of the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cincinnati Children's Hospital; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper presents independent research funded in part by the National Institute for Health Research (NIHR). The Nottingham Hearing Biomedical Research Unit is funded by the National Institute for Health Research. DRM was supported by the Intramural Programme of the Medical Research Council [grant U135097130] and by Cincinnati Children's Hospital. KJC was supported by R37AG11099, R01AG021917 and an Unrestricted Grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Barnes LL, 2004, NEUROLOGY, V63, P2322, DOI 10.1212/01.WNL.0000147473.04043.B3; Berg AO, 2002, ANN INTERN MED, V136, P760, DOI 10.7326/0003-4819-136-10-200205210-00012; Birren JE, 1964, PSYCHOL AGING; BOUFFARDBOUCHARD T, 1990, J SOC PSYCHOL, V130, P353, DOI 10.1080/00224545.1990.9924591; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Hall J.S., 2006, DEV NEW ENGLISH SENT; Kalluri S, 2012, AM J AUDIOL, V21, P338, DOI 10.1044/1059-0889(2012/12-0026); Kline R.B., 2011, PRINCIPLES PRACTICE; Kochkin S., 2000, HEAR REV, V7, P6; Kramer SE, 2002, J AGING HEALTH, V14, P122, DOI 10.1177/089826430201400107; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin MY, 2004, J AM GERIATR SOC, V52, P1996, DOI 10.1111/j.1532-5415.2004.52554.x; LINDENBERGER U, 1994, PSYCHOL AGING, V9, P339, DOI 10.1037/0882-7974.9.3.339; Moyer VA, 2012, ANN INTERN MED, V157, P655, DOI 10.7326/0003-4819-157-9-201211060-00526; MULROW CD, 1990, ANN INTERN MED, V113, P188, DOI 10.7326/0003-4819-113-3-188; Norman P., 2010, APPL SPAT ANAL POLIC, V3, P107, DOI [10.1007/s12061-009-9036-6, DOI 10.1007/S12061-009-9036-6]; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; RABBITT P, 1991, ACTA OTO-LARYNGOL, P167; Smits C, 2004, INT J AUDIOL, V43, P15, DOI 10.1080/14992020400050004; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Tay T, 2006, GERONTOLOGY, V52, P386, DOI 10.1159/000095129; TeschRomer C, 1997, J GERONTOL B-PSYCHOL, V52, pP127, DOI 10.1093/geronb/52B.3.P127; Ulhmann R.F., 1989, JAMA-J AM MED ASSOC, V261, P1916; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; Vlaming MSMG, 2011, ACTA ACUST UNITED AC, V97, P175, DOI 10.3813/AAA.918397; Wahl HW, 2003, GENERATIONS, V27, P39; Wimo A, 2010, WORLD ALZHEIMER REPO	34	238	243	6	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119616	10.1371/journal.pone.0119616	http://dx.doi.org/10.1371/journal.pone.0119616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760329	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000063
J	Makino, S; Zhulyn, O; Mo, R; Puviindran, V; Zhang, XY; Murata, T; Fukumura, R; Ishitsuka, Y; Kotaki, H; Matsumaru, D; Ishii, S; Hui, CC; Gondo, Y				Makino, Shigeru; Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Murata, Takuya; Fukumura, Ryutaro; Ishitsuka, Yuichi; Kotaki, Hayato; Matsumaru, Daisuke; Ishii, Shunsuke; Hui, Chi-Chung; Gondo, Yoichi			T396I Mutation of Mouse Sufu Reduces the Stability and Activity of Gli3 Repressor	PLOS ONE			English	Article							SONIC HEDGEHOG; INDEPENDENT REGULATION; NEGATIVE REGULATOR; SUPPRESSOR; SHH; ACTIVATION; DETERMINANT; INVOLVEMENT; MUTANTS; DEFECTS	Hedgehog signaling is primarily transduced by two transcription factors: Gli2, which mainly acts as a full-length activator, and Gli3, which tends to be proteolytically processed from a full-length form (Gli3(FL)) to an N-terminal repressor (Gli3(REP)). Recent studies using a Sufu knockout mouse have indicated that Sufu is involved in regulating Gli2 and Gli3 activator and repressor activity at multiple steps of the signaling cascade; however, the mechanism of specific Gli2 and Gli3 regulation remains to be elucidated. In this study, we established an allelic series of ENU-induced mouse strains. Analysis of one of the missense alleles, Sufu(T396I), showed that Thr(396)residue of Sufu played a key role in regulation of Gli3 activity. Sufu(T396I)/(T396I) embryos exhibited severe polydactyly, which is indicative of compromised Gli3 activity. Concomitantly, significant quantitative reductions of unprocessed Gli3 (Gli3(FL)) and processed Gli3 (Gli3(REP)) were observed in vivo as well as in vitro. Genetic experiments showed that patterning defects in the limb buds of Sufu(T396I)/(T396I) were rescued by a constitutive Gli3(REP) allele (Gli3.699), strongly suggesting that Sufu(T396I) reduced the truncated Gli3 repressor. In contrast, Sufu(T396I) qualitatively exhibited no mutational effects on Gli2 regulation. Taken together, the results of this study show that the Thr396residue of Sufu is specifically required for regulation of Gli3 but not Gli2. This implies a novel Sufu-mediated mechanism in which Gli2 activator and Gli3 repressor are differentially regulated.	[Makino, Shigeru; Murata, Takuya; Fukumura, Ryutaro; Ishitsuka, Yuichi; Kotaki, Hayato; Gondo, Yoichi] RIKEN, BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki, Japan; [Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Hui, Chi-Chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Zhulyn, Olena; Mo, Rong; Puviindran, Vijitha; Zhang, Xiaoyun; Hui, Chi-Chung] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Matsumaru, Daisuke] Wakayama Med Univ, Inst Adv Med, Dept Dev Genet, Wakayama, Japan; [Ishii, Shunsuke] RIKEN, Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki, Japan	RIKEN; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wakayama Medical University; RIKEN	Makino, S (corresponding author), RIKEN, BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki, Japan.	shmakino@brc.riken.jp	Murata, Takuya/L-3298-2016; Gondo, Yoichi/A-5375-2016; Ishii, Shunsuke/A-5271-2016; Murata, Takuya/AAE-8001-2020	Murata, Takuya/0000-0003-4185-1883; Gondo, Yoichi/0000-0003-2184-6489; Ishii, Shunsuke/0000-0002-6530-2478; Murata, Takuya/0000-0003-4185-1883; Matsumaru, Daisuke/0000-0002-1832-624X	JSPS (Japan Society for the Promotion of Science) [21700454, 25440096, 21240043, 25241016, 15200032]; Incentive Research Grant of RIKEN; Grants-in-Aid for Scientific Research [25440096] Funding Source: KAKEN	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Incentive Research Grant of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 21700454, (SM), 25440096 (SM), 21240043 (YG, SM, TM, and RF), 25241016 (YG), 15200032 (YG) and Incentive Research Grant of RIKEN (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CB, 2002, DEVELOPMENT, V129, P4753; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Ding Q, 1998, DEVELOPMENT, V125, P2533; Galli A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000901; Gondo Y, 2008, NAT REV GENET, V9, P803, DOI 10.1038/nrg2431; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W; Hill P, 2009, DEV BIOL, V328, P506, DOI 10.1016/j.ydbio.2009.02.017; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Law KKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050193; Liu JL, 2012, DEV BIOL, V362, P141, DOI 10.1016/j.ydbio.2011.11.022; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Meng XW, 2001, J BIOL CHEM, V276, P40113, DOI 10.1074/jbc.M105317200; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Mo R, 1997, DEVELOPMENT, V124, P113; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Park HL, 2000, DEVELOPMENT, V127, P1593; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Ribes V, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002014; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Stone DM, 1999, J CELL SCI, V112, P4437; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Welscher PT, 2002, GENE DEV, V16, P421, DOI 10.1101/gad.219202; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zeller R, 2010, CURR OPIN GENET DEV, V20, P384, DOI 10.1016/j.gde.2010.04.014; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	53	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119455	10.1371/journal.pone.0119455	http://dx.doi.org/10.1371/journal.pone.0119455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760946	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000058
J	Andersson, J; Hjalten, J; Dynesius, M				Andersson, Jon; Hjalten, Joakim; Dynesius, Mats			Wood-Inhabiting Beetles in Low Stumps, High Stumps and Logs on Boreal Clear-Cuts: Implications for Dead Wood Management	PLOS ONE			English	Article							SAPROXYLIC BEETLES; SPECIES RICHNESS; FOMES-FOMENTARIUS; FUNCTIONAL-GROUPS; FOREST LANDSCAPE; SPRUCE FORESTS; NORWAY SPRUCE; PICEA-ABIES; SWEDEN; BIODIVERSITY	The increasing demand for biofuels from logging residues require serious attention on the importance of dead wood substrates on clear-cuts for the many forestry-intolerant saproxylic (wood-inhabiting) species. In particular, the emerging harvest of low stumps motivates further study of these substrates. On ten clear-cuts we compared the species richness, abundance and species composition of saproxylic beetles hatching from four to nine year old low stumps, high stumps and logs of Norway spruce. By using emergence traps we collected a total of 2,670 saproxylic beetles among 195 species during the summers of 2006, 2007 and 2009. We found that the species assemblages differed significantly between high stumps and logs all three years. The species assemblages of low stumps, on the other hand, were intermediate to those found in logs and high stumps. There were also significant difference in species richness between the three examined years, and we found significant effect of substrate type on richness of predators and fungivores. As shown in previous studies of low stumps on clear-cuts they can sustain large numbers of different saproxylic beetles, including red-listed species. Our study does, in addition to this fact, highlight a possible problem in creating just one type of substrate as a tool for conservation in forestry. Species assemblages in high stumps did not differ significantly from those found in low stumps. Instead logs, which constitute a scarcer substrate type on clear-cuts, provided habitat for a more distinct assemblage of saproxylic species than high stumps. It can therefore be questioned whether high stumps are an optimal tool for nature conservation in clear-cutting forestry. Our results also indicate that low stumps constitute an equally important substrate as high stumps and logs, and we therefore suggest that stump harvesting is done after carefully evaluating measures to provide habitat for saproxylic organisms.	[Andersson, Jon; Hjalten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Dynesius, Mats] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Swedish University of Agricultural Sciences; Umea University	Andersson, J (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Jon.Andersson@slu.se	Dynesius, Mats/A-6219-2009	Dynesius, Mats/0000-0003-0628-4203; Hjalten, Joakim/0000-0002-8279-6633	Swedish Energy Agency	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	The study was financed by The Swedish Energy Agency (http://www.energimyndigheten.se, Grant to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson M, 2006, FOREST ECOL MANAG, V226, P230, DOI 10.1016/j.foreco.2006.01.046; Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; [Anonymous], 2007, SAPROXYLIC DATABASE; Bates D, LME4 LINEAR MIXED EF; BERG A, 1994, CONSERV BIOL, V8, P718, DOI 10.1046/j.1523-1739.1994.08030718.x; Berglund H, 2011, ECOGRAPHY, V34, P864, DOI 10.1111/j.1600-0587.2010.06141.x; Berglund H, 2011, FOREST ECOL MANAG, V261, P1293, DOI 10.1016/j.foreco.2011.01.008; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Bouget C, 2012, CAN J FOREST RES, V42, P1421, DOI [10.1139/X2012-078, 10.1139/x2012-078]; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; Dahlberg A, 2004, VEDLEVANDE ARTERS KR; Dahlberg A, 2011, CAN J FOREST RES, V41, P1220, DOI [10.1139/X11-034, 10.1139/x11-034]; Djupstrom LB, 2012, BIOL CONSERV, V155, P44, DOI 10.1016/j.biocon.2012.06.009; Egnell G, 2007, ENERGIMYNDIGHETEN, P40; Ekbom B, 2006, FOREST ECOL MANAG, V221, P2, DOI 10.1016/j.foreco.2005.10.038; Erajaa S, 2010, SILVA FENN, V44, P203, DOI 10.14214/sf.150; Esseen P-A, 1992, ECOLOGICAL PRINCIPLE, P252; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Faldt J, 1999, J CHEM ECOL, V25, P567, DOI 10.1023/A:1020958005023; Fossestol KO, 2009, SCAND J FOREST RES, V24, P403, DOI 10.1080/02827580903143871; Franc N, 2007, CAN J FOREST RES, V37, P2494, DOI 10.1139/X07-096; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Gardenfors U., 2010, RED LIST SWEDISH SPE; Geijer E, 2014, J FOREST ECON, V20, P111, DOI 10.1016/j.jfe.2014.01.001; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hjalten J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041100; Hjalten J, 2010, FOREST ECOL MANAG, V260, P1149, DOI 10.1016/j.foreco.2010.07.003; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsell M, 2007, BIOL CONSERV, V138, P89, DOI 10.1016/j.biocon.2007.04.003; Jonsell M, 2011, SILVA FENN, V45, P1053, DOI 10.14214/sf.86; Jonsell Mats, 2001, Ecological Bulletins, V49, P173; Jonsson BG, 2005, SILVA FENN, V39, P289, DOI 10.14214/sf.390; Kaila L, 1997, BIODIVERS CONSERV, V6, P1, DOI 10.1023/A:1018399401248; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P115, DOI 10.1007/BF02289694; Kruys N, 1999, CAN J FOREST RES, V29, P1295, DOI 10.1139/cjfr-29-8-1295; Linder P, 1997, FOREST ECOL MANAG, V98, P17, DOI 10.1016/S0378-1127(97)00076-5; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; Lindhe A, 2004, FOREST ECOL MANAG, V203, P1, DOI 10.1016/j.foreco.2004.07.047; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oksanen J., **DATA OBJECT**; Ols C, 2013, FOREST ECOL MANAG, V290, P15, DOI 10.1016/j.foreco.2012.08.040; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; R Development Core Team, R LANG ENV STAT COMP; Russo D, 2011, J INSECT CONSERV, V15, P685, DOI 10.1007/s10841-010-9366-3; Schroeder LM, 2006, CAN J FOREST RES, V36, P2168, DOI 10.1139/X06-119; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; Silfverberg H., 2004, ENUMERATIO NOVA COEL; Speight M.C., 1989, SAPROXYLIC INVERTEBR; Stenbacka F, 2010, ECOL APPL, V20, P2310, DOI 10.1890/09-0815.1; Stokland JN, 2012, ECOL BIODIVERS CONS, P110; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; Thunes KH, 1997, J NAT HIST, V31, P471, DOI 10.1080/00222939700770241; Walmsley JD, 2010, FORESTRY, V83, P17, DOI 10.1093/forestry/cpp028; Wang Y, MVABUND STAT METHODS; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weslien J, 2011, J ANIM ECOL, V80, P1155, DOI 10.1111/j.1365-2656.2011.01860.x; Wikars LO, 2005, CAN ENTOMOL, V137, P304, DOI 10.4039/N04-104	62	30	31	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118896	10.1371/journal.pone.0118896	http://dx.doi.org/10.1371/journal.pone.0118896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756871	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700030
J	Chen, Q; Xu, HS; Xu, AJ; Ross, T; Bowler, E; Hu, Y; Lesnefsky, EJ				Chen, Qun; Xu, Haishan; Xu, Aijun; Ross, Thomas; Bowler, Elizabeth; Hu, Ying; Lesnefsky, Edward J.			Inhibition of Bcl-2 Sensitizes Mitochondrial Permeability Transition Pore (MPTP) Opening in Ischemia-Damaged Mitochondria	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; ELECTRON-TRANSPORT; MEMBRANE PERMEABILIZATION; CYTOCHROME-OXIDASE; MYOCARDIAL INJURY; CARDIAC ISCHEMIA; REPERFUSION; APOPTOSIS; PROTECTS; CARDIOPROTECTION	Background Mitochondria are critical to cardiac injury during reperfusion as a result of damage sustained during ischemia, including the loss of bcl-2. We asked if bcl-2 depletion not only leads to selective permeation of the outer mitochondrial membrane (MOMP) favoring cytochrome c release and programmed cell death, but also favors opening of the mitochondrial permeability transition pore (MPTP). An increase in MPTP susceptibility would support a role for bcl-2 depletion mediated cell death in the calcium overload setting of early reperfusion via MPTP as well as later in reperfusion via MOMP as myocardial calcium content normalizes. Methods Calcium retention capacity (CRC) was used to reflect the sensitivity of the MPTP opening in isolated cardiac mitochondria. To study the relationship between bcl-2 inhibition and MPTP opening, mitochondria were incubated with a bcl-2 inhibitor (HA14-1) and CRC measured. The contribution of preserved bcl-2 content to MPTP opening following ischemia-reperfusion was explored using transgenic bcl-2 overexpressed mice. Results CRC was decreased in mitochondria following reperfusion compared to ischemia alone, indicating that reperfusion further sensitizes to MPTP opening. Incubation of ischemia-damaged mitochondria with increasing HA14-1concentrations increased calcium-stimulated MPTP opening, supporting that functional inhibition of bcl-2 during simulated reperfusion favors MPTP opening. Moreover, HA14-1 sensitivity was increased by ischemia compared to non-ischemic controls. Overexpression of bcl-2 attenuated MPTP opening in following ischemia-reperfusion. HA14-1 inhibition also increased the permeability of the outer membrane in the absence of exogenous calcium, indicating that bcl-2 inhibition favors MOMP when calcium is low. Conclusions The depletion and functional inhibition of bcl-2 contributes to cardiac injury by increasing susceptibility to MPTP opening in high calcium environments and MOMP in the absence of calcium overload. Thus, ischemia-damaged mitochondria with decreased bcl-2 content are susceptible to MPTP opening in early reperfusion and MOMP later in reperfusion when cytosolic calcium has normalized.	[Chen, Qun; Xu, Haishan; Xu, Aijun; Ross, Thomas; Bowler, Elizabeth; Hu, Ying; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Biochem, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Richmond, VA USA; [Xu, Aijun] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Bowler, Elizabeth] Univ W England, Bristol BS16 1QY, Avon, England	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Huazhong University of Science & Technology; University of West England	Lesnefsky, EJ (corresponding author), Virginia Commonwealth Univ, Dept Med, Pauley Heart Ctr, Div Cardiol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	edward.lesnefsky@va.gov	Chen, Qun/HGD-0868-2022		Office of Research and Development, Medical Research Service, Department of Veterans Affairs; Scientist Development Grant from the American Heart Association; Pauley Heart Center of Virginia Commonwealth University	Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Scientist Development Grant from the American Heart Association(American Heart Association); Pauley Heart Center of Virginia Commonwealth University	This work was supported by the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (EJL), a Scientist Development Grant from the American Heart Association (QC) and the Pauley Heart Center of Virginia Commonwealth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JZ, 2001, AM J PHYSIOL-HEART C, V281, pH1508, DOI 10.1152/ajpheart.2001.281.4.H1508; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen Q, 2006, J PHARMACOL EXP THER, V316, P200, DOI 10.1124/jpet.105.091702; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2012, J CARDIOVASC PHARM, V59, P101, DOI 10.1097/FJC.0b013e31823827cc; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Lesnefsky EJ, 1977, AM J PHYSIOL-HEART C, V273, pH1544; Murphy E, 2005, TRENDS CARDIOVAS MED, V15, P283, DOI 10.1016/j.tcm.2005.09.002; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Obame FN, 2007, J PHARMACOL EXP THER, V323, P336, DOI 10.1124/jpet.107.124255; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Paillard M, 2009, J MOL CELL CARDIOL, V46, P902, DOI 10.1016/j.yjmcc.2009.02.017; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Parks RJ, 2018, METHODS MOL BIOL, V1782, P187, DOI [10.1007/978-1-61779-382-0_15, 10.1007/978-1-4939-7831-1_11]; Picard M, 2008, AM J PHYSIOL-REG I, V295, pR659, DOI 10.1152/ajpregu.90357.2008; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Xu AJ, 2013, BIOCHEM BIOPH RES CO, V435, P627, DOI 10.1016/j.bbrc.2013.05.033; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	32	40	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118834	10.1371/journal.pone.0118834	http://dx.doi.org/10.1371/journal.pone.0118834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756500	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700027
J	Manavalan, LP; Prince, SJ; Musket, TA; Chaky, J; Deshmukh, R; Vuong, TD; Song, L; Cregan, PB; Nelson, JC; Shannon, JG; Specht, JE; Nguyen, HT				Manavalan, Lakshmi P.; Prince, Silvas J.; Musket, Theresa A.; Chaky, Julian; Deshmukh, Rupesh; Vuong, Tri D.; Song, Li; Cregan, Perry B.; Nelson, James C.; Shannon, J. Grover; Specht, James E.; Nguyen, Henry T.			Identification of Novel QTL Governing Root Architectural Traits in an Interspecific Soybean Population	PLOS ONE			English	Article							CYST-NEMATODE RESISTANCE; RECOMBINANT INBRED LINES; GLYCINE-SOJA SIEB.; DROUGHT TOLERANCE; TRANSCRIPTION FACTOR; NITROGEN-FIXATION; WATER RELATIONS; YIELD; SEED; WILD	Cultivated soybean (Glycine max L.) cv. Dunbar (PI 552538) and wild G. soja (PI 326582A) exhibited significant differences in root architecture and root-related traits. In this study, phenotypic variability for root traits among 251 BC2F5 backcross inbred lines (BILs) developed from the cross Dunbar/PI 326582A were identified. The root systems of the parents and BILs were evaluated in controlled environmental conditions using a cone system at seedling stage. The G. max parent Dunbar contributed phenotypically favorable alleles at a major quantitative trait locus on chromosome 8 (Satt315-I locus) that governed root traits (tap root length and lateral root number) and shoot length. This QTL accounted for >10% of the phenotypic variation of both tap root and shoot length. This QTL region was found to control various shoot-and root-related traits across soybean genetic backgrounds. Within the confidence interval of this region, eleven transcription factors (TFs) were identified. Based on RNA sequencing and Affymetrix expression data, key TFs including MYB, AP2-EREBP and bZIP TFs were identified in this QTL interval with high expression in roots and nodules. The backcross inbred lines with different parental allelic combination showed different expression pattern for six transcription factors selected based on their expression pattern in root tissues. It appears that the marker interval Satt315-I locus on chromosome 8 contain an essential QTL contributing to early root and shoot growth in soybean.	[Manavalan, Lakshmi P.; Prince, Silvas J.; Musket, Theresa A.; Deshmukh, Rupesh; Vuong, Tri D.; Song, Li; Shannon, J. Grover; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; [Chaky, Julian; Specht, James E.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Cregan, Perry B.] USDA ARS, Soybean Genom & Improvement Lab, Beltsville, MD USA; [Nelson, James C.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln; United States Department of Agriculture (USDA); Kansas State University	Nguyen, HT (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	nguyenhenry@missouri.edu	Deshmukh, Rupesh Kailasrao/C-6479-2012; prince, silvas/I-1100-2019; PRINCE, SILVAS/I-6550-2019; Nelson, James/K-4263-2019	Deshmukh, Rupesh Kailasrao/0000-0003-4167-6552; PRINCE, SILVAS/0000-0002-7609-3210; 	United Soybean Board; Missouri Soybean Merchandising Council	United Soybean Board; Missouri Soybean Merchandising Council	This research was supported by the United Soybean Board, http://unitedsoybean.org/, and Missouri Soybean Merchandising Council, http://mosoy.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Haleem H, 2011, THEOR APPL GENET, V122, P935, DOI 10.1007/s00122-010-1500-9; Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Alcivar A, 2007, J AGR FOOD ENV SCI, V1, P1; Arahana VS, 2001, CROP SCI, V41, P180, DOI 10.2135/cropsci2001.411180x; Bauer S., 2007, Nematropica, V37, P277; Brensha W., 2012, J PLANT GENOME SCI, V1, P1, DOI DOI 10.5147/JPGS.2012.0051; Myers DB, 2007, CROP SCI, V47, P1498, DOI 10.2135/cropsci2006.07.0460; Brucker E, 2005, THEOR APPL GENET, V111, P44, DOI 10.1007/s00122-005-1970-3; Carter TE, 2004, SOYBEANS IMPROVEMENT, P301; Chen P, 2007, J PLANT REGIST, V1, P166, DOI 10.3198/jpr2007.01.0046crg; Chen YY, 2006, CROP SCI, V46, P2041, DOI 10.2135/cropsci2005.12.0466; Ha CV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/759657; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Concibido VC, 2003, THEOR APPL GENET, V106, P575, DOI 10.1007/s00122-002-1071-5; CORTES PM, 1986, CROP SCI, V26, P993, DOI 10.2135/cropsci1986.0011183X002600050031x; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Devi MJ, 2013, CROP SCI, V53, P2072, DOI 10.2135/cropsci2013.02.0095; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Fenta B.A., 2011, SOYBEAN GENETICS NOV, P181; GIZLICE Z, 1994, CROP SCI, V34, P1143, DOI 10.2135/cropsci1994.0011183X003400050001x; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Guo B, 2005, THEOR APPL GENET, V111, P965, DOI 10.1007/s00122-005-0031-2; Han YP, 2012, THEOR APPL GENET, V125, P671, DOI 10.1007/s00122-012-1859-x; HARTMAN GL, 1992, PLANT DIS, V76, P396, DOI 10.1094/PD-76-0396; Hoeck JA, 2003, CROP SCI, V43, P68, DOI 10.2135/cropsci2003.0068; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hufstetler EV, 2007, CROP SCI, V47, P25, DOI 10.2135/cropsci2006.04.0243; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Joshi T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S15; Kabelka EA, 2004, CROP SCI, V44, P784, DOI 10.2135/cropsci2004.0784; Kanamaru K, 2008, BREEDING SCI, V58, P393, DOI 10.1270/jsbbs.58.393; Kim HK, 2005, PLANT BREEDING, V124, P582, DOI 10.1111/j.1439-0523.2005.01152.x; Kim KS, 2010, THEOR APPL GENET, V120, P1063, DOI 10.1007/s00122-009-1234-8; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lauter ANM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-702; Lenis JM, 2011, J AGRON CROP SCI, V197, P302, DOI 10.1111/j.1439-037X.2011.00466.x; Li DD, 2008, CROP SCI, V48, P571, DOI 10.2135/cropsci2007.06.0361; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liang HZ, 2014, THEOR APPL GENET, V127, P2127, DOI 10.1007/s00122-014-2366-z; Liu B, 2007, ANN BOT-LONDON, V100, P1027, DOI 10.1093/aob/mcm149; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Liu Ying, 2005, Acta Agronomica Sinica, V31, P1132; [刘莹 LIU Ying], 2007, [大豆科学, Soybean Science], V26, P127; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C., 2010, ACTA AGRON SIN, V36, P1476; Manavalan LP, 2010, PLANT SOIL, V330, P503, DOI 10.1007/s11104-009-0222-8; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Matsuo N, 2013, PLANT PROD SCI, V16, P374, DOI 10.1626/pps.16.374; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Nguyen HT, 1997, CROP SCI, V37, P1426, DOI 10.2135/cropsci1997.0011183X003700050002x; Nishimura R, 2002, PLANT CELL PHYSIOL, V43, P853, DOI 10.1093/pcp/pcf098; Pantalone VR, 1996, CROP SCI, V36, P456, DOI 10.2135/cropsci1996.0011183X003600020039x; PETRIE CL, 1992, AUST J PLANT PHYSIOL, V19, P591, DOI 10.1071/PP9920591; Pooprompan P., 2006, Kasetsart Journal, Natural Sciences, V40, P573; Price AH, 2002, PLANT MOL BIOL, V48, P683, DOI 10.1023/A:1014805625790; Prince S. J., 2013, GENOMICS BREEDING CL, P67, DOI 10.1007/978-3-642-37048-9; Prince SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1334-6; Reinprecht Y, 2006, GENOME, V49, P1510, DOI 10.1139/G06-112; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; Rong Z., 2011, ACTA AGRON SIN, V37, P1151, DOI DOI 10.1016/S1875-2780(11)60032-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Salas P, 2006, THEOR APPL GENET, V113, P1459, DOI 10.1007/s00122-006-0392-1; Sayama T, 2009, PLANT SCI, V176, P514, DOI 10.1016/j.plantsci.2009.01.007; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Sinclair TR, 2007, FIELD CROP RES, V101, P68, DOI 10.1016/j.fcr.2006.09.010; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Suji KK, 2012, FIELD CROP RES, V137, P89, DOI 10.1016/j.fcr.2012.08.006; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; TAYLOR HM, 1978, Z ACKER PFLANZENBAU, V146, P33; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tuberosa R, 2011, ROOT GENOMICS, P179; Turner NC, 2001, ADV AGRON, V71, P193, DOI 10.1016/S0065-2113(01)71015-2; Varshney RK, 2011, ROOT GENOMICS, P233; Wang D, 2004, THEOR APPL GENET, V108, P458, DOI 10.1007/s00122-003-1449-z; Wasson AP, 2012, J EXP BOT, V63, P3485, DOI 10.1093/jxb/ers111; WEISEMANN JM, 1992, THEOR APPL GENET, V85, P136, DOI 10.1007/BF00222850; Xiao JH, 1998, GENETICS, V150, P899	81	47	51	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120490	10.1371/journal.pone.0120490	http://dx.doi.org/10.1371/journal.pone.0120490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756528	Green Published, gold			2022-12-26	WOS:000351275700067
J	Thandavan, TMK; Gani, SMA; Wong, CS; Nor, RM				Thandavan, Tamil Many K.; Gani, Siti Meriam Abdul; Wong, Chiow San; Nor, Roslan Md.			Enhanced Photoluminescence and Raman Properties of Al-Doped ZnO Nanostructures Prepared Using Thermal Chemical Vapor Deposition of Methanol Assisted with Heated Brass	PLOS ONE			English	Article							ZINC-OXIDE FILMS; THIN-FILMS; METHYL FORMATE; DEHYDROGENATION; NANOPARTICLES; FABRICATION; NANOWIRES; DECOMPOSITION; OXIDATION; NETWORKS	Vapor phase transport (VPT) assisted by mixture of methanol and acetone via thermal evaporation of brass (CuZn) was used to prepare un-doped and Al-doped zinc oxide (ZnO) nanostructures (NSs). The structure and morphology were characterized by field emission scanning electron microscopy (FESEM) and x-ray diffraction (XRD). Photoluminescence (PL) properties of un-doped and Al-doped ZnO showed significant changes in the optical properties providing evidence for several types of defects such as zinc interstitials (Zn-i), oxygen interstitials (O-i), zinc vacancy (V-zn), singly charged zinc vacancy (V-Zn(-)), oxygen vacancy (V-o), singly charged oxygen vacancy (V-o(+)) and oxygen anti-site defects (O-Zn) in the grown NSs. The Al-doped ZnO NSs have exhibited shifted PL peaks at near band edge (NBE) and red luminescence compared to the un-doped ZnO. The Raman scattering results provided evidence of Al doping into the ZnO NSs due to peak shift from 145 cm(-1) to an anomalous peak at 138 cm(-1). Presence of enhanced Raman signal at around 274 and 743 cm(-1) further confirmed Al in ZnO NSs. The enhanced D and G band in all Al-doped ZnO NSs shows possible functionalization and doping process in ZnO NSs.	[Thandavan, Tamil Many K.; Wong, Chiow San; Nor, Roslan Md.] Univ Malaya, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 59100, Malaysia; [Gani, Siti Meriam Abdul] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya	Thandavan, TMK (corresponding author), Univ Malaya, Dept Phys, Plasma Technol Res Ctr, Kuala Lumpur 59100, Malaysia.	tamilmanykthandavan@gmail.com; rmdnor@um.edu.my	NOR, ROSLAN MD/B-5221-2010; K Thandavan, Tamil Many/AEQ-6139-2022; Thandavan, Tamil Many K/J-2458-2014; Wong, C.S./C-1047-2010	NOR, ROSLAN MD/0000-0003-0649-2272; Thandavan, Tamil Many K/0000-0003-4965-7540; Wong, C.S./0000-0002-7186-2578	Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya [PS212/2009A]; UMRG [RG247-12AFR]	Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya; UMRG	This work is supported by Peruntukan Penyelidikan Pascasiswazah (PPP) of University Malaya Grant No.: PS212/2009A and UMRG Grant No.: RG247-12AFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054175; AI M, 1984, APPL CATAL, V11, P259, DOI 10.1016/S0166-9834(00)81884-9; Bahedi K., 2009, 2009 3rd ICTON Mediterranean Winter Conference (ICTON-MW 2009); Baskoutas S, 2007, THIN SOLID FILMS, V515, P8461, DOI 10.1016/j.tsf.2007.03.150; Ben Ayadi Z, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/44/445702; Bruice P. Y., 2006, ORGANIC CHEM; Bundesmann C, 2003, APPL PHYS LETT, V83, P1974, DOI 10.1063/1.1609251; CHEN AK, 1995, SURF SCI, V343, P17, DOI 10.1016/0039-6028(95)00649-4; Chrissanthopoulos A, 2011, PHOTONIC NANOSTRUCT, V9, P132, DOI 10.1016/j.photonics.2010.11.002; Cusco R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165202; Das J, 2010, PHYSICA B, V405, P2492, DOI 10.1016/j.physb.2010.03.020; El Manouni A, 2006, SUPERLATTICE MICROST, V39, P185, DOI 10.1016/j.spmi.2005.08.041; Fang XS, 2009, CRIT REV SOLID STATE, V34, P190, DOI 10.1080/10408430903245393; Feng QJ, 2010, APPL SURF SCI, V257, P1084, DOI 10.1016/j.apsusc.2010.08.018; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; GUERRERORUIZ A, 1991, APPL CATAL, V72, P119, DOI 10.1016/0166-9834(91)85033-R; Guo M, 2004, CHINESE CHEM LETT, V15, P1113; Harikumar KR, 1999, J PHYS CHEM B, V103, P2445, DOI 10.1021/jp983730q; Harikumar KR, 1999, CHEM COMMUN, P341, DOI 10.1039/a808076c; Henley SJ, 2004, SURF COAT TECH, V177, P271, DOI 10.1016/j.surfcoat.2003.09.005; Hrkac V, 2013, J APPL CRYSTALLOGR, V46, P396, DOI 10.1107/S0021889812051333; Hsieh CT, 2003, APPL PHYS LETT, V83, P3383, DOI 10.1063/1.1619229; Jagadish C, 2006, ZINC OXIDE BULK, THIN FILMS AND NANOSTRUCTURES: PROCESSING, PROPERTIES AND APPLICATIONS, P1; Jeong C, 2008, JPN J APPL PHYS, V47, P5656, DOI 10.1143/JJAP.47.5656; Jun MC, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-639; Khan Wasi, 2013, International Journal of Modern Physics: Conference Series, V22, P630, DOI 10.1142/S2010194513010775; Khanderi J, 2009, J MATER CHEM, V19, P5039, DOI 10.1039/b904822g; Kim HW, 2010, CURR APPL PHYS, V10, P60, DOI 10.1016/j.cap.2009.04.012; Kim J-H, 2012, APPL PHYS EXPRESS, V5; Kim S, 2006, J CRYST GROWTH, V290, P485, DOI 10.1016/j.jcrysgro.2006.01.043; Lao CS, 2006, NANO LETT, V6, P263, DOI 10.1021/nl052239p; LEVIS RJ, 1989, J AM CHEM SOC, V111, P4605, DOI 10.1021/ja00195a013; Lim YS, 2006, MAT SCI ENG B-SOLID, V129, P100, DOI 10.1016/j.mseb.2005.12.021; Liu KW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3291106; Liu W, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2169908; Liu YD, 2009, J ALLOY COMPD, V485, P529, DOI 10.1016/j.jallcom.2009.06.019; Lockman Z, 2010, J ALLOY COMPD, V493, P699, DOI 10.1016/j.jallcom.2009.12.196; Lu CG, 2011, IEEE PHOTONIC TECH L, V23, P561, DOI 10.1109/LPT.2011.2116154; Lupan O, 2009, SOL ENERG MAT SOL C, V93, P1417, DOI 10.1016/j.solmat.2009.03.012; MILOSLAVSKII VK, 1972, PHYS STATUS SOLIDI B, V51, pK99, DOI 10.1002/pssb.2220510252; Mishra YK, 2014, KONA POWDER PART J, P92; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Panchakarla LS, 2007, J CLUST SCI, V18, P660, DOI 10.1007/S10876-007-0129-6; Patterson CH, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144432; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Reimer T, 2014, ACS APPL MATER INTER, V6, P7806, DOI 10.1021/am5010877; Rufael TS, 1997, SURF SCI, V384, P156, DOI 10.1016/S0039-6028(97)00197-0; Shan FK, 2003, J KOREAN PHYS SOC, V42, pS1374; Thandavan TMK, 2014, MATER EXPRESS, V4, P475, DOI 10.1166/mex.2014.1193; Thandavan TMK, 2014, J NANOMATER, V2014, DOI 10.1155/2014/105875; TONNER SP, 1984, IND ENG CHEM PROD RD, V23, P384, DOI 10.1021/i300015a012; Tonto P, 2008, CERAM INT, V34, P57, DOI 10.1016/j.ceramint.2006.08.003; Van LH, 2008, J ALLOY COMPD, V449, P207, DOI 10.1016/j.jallcom.2006.02.114; Vanheusden K, 1996, J APPL PHYS, V79, P7983, DOI 10.1063/1.362349; WAGNER P, 1974, J PHYS CHEM SOLIDS, V35, P327, DOI 10.1016/S0022-3697(74)80026-0; Wang L, 2010, J PHYS CHEM C, V114, P17358, DOI 10.1021/jp104706q; Wang M, 2007, MATER LETT, V61, P1118, DOI 10.1016/j.matlet.2006.06.065; Wang SL, 2010, J ALLOY COMPD, V502, P118, DOI 10.1016/j.jallcom.2010.04.042; Wei OY, 2008, MATER LETT, V62, P2557, DOI 10.1016/j.matlet.2007.12.051; Willander M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/33/332001; Ye JD, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3067997; Yi GY, 2005, SEMICONDUCTOR SCI TE, V20; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205; Zhang WY, 2010, OPTOELECTRON ADV MAT, V4, P1651; Zhou HM, 2007, THIN SOLID FILMS, V515, P6909, DOI 10.1016/j.tsf.2007.01.041	66	38	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0121756	10.1371/journal.pone.0121756	http://dx.doi.org/10.1371/journal.pone.0121756			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756598	Green Published, gold			2022-12-26	WOS:000351275700078
J	Maeng, YS; Aguilar, B; Choi, SI; Kim, EK				Maeng, Y-S; Aguilar, B.; Choi, S-I; Kim, E. K.			Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis	ONCOGENE			English	Article							CELL-ADHESION; VEGF-C; VASCULAR-PERMEABILITY; MOLECULAR-MECHANISMS; ENDOTHELIAL-CELLS; BREAST-CANCER; BETA-IG-H3; BETA; PROTEIN; GROWTH	Transforming growth factor-beta-induced protein (TGFBIp) is an extracellular matrix protein that has a role in a wide range of pathological conditions. However, the role of TGFBIp signaling in lymphangiogenesis is poorly understood. The purpose of this study was therefore to analyze the effects of TGFBIp on lymphangiogenesis and determine whether TGFBIp-related lymphangiogenesis is important for the metastasis of tumor cells. TGFBIp increased adhesion, migration, and morphologic differentiation of human lymphatic endothelial cells (LECs), consistent with an increase in lymphatic vessel sprouting in a three-dimensional lymphatic ring assay. TGFBIp also induced phosphorylation of intracellular signaling molecules SRC, FAK, AKT, JNK and ERK. TGFBIp-induced lymphatic vessel sprouting was inhibited by addition of anti-integrin beta 3 antibody and pharmacologic inhibitors of FAK, AKT, JNK or ERK. TGFBIp increased both CCL21 expression in LECs, a chemokine that actively recruits tumor cells expressing the cognate chemokine receptors to lymphatic vessels and LEC permeability by inducing the dissociation of VE-cadherin junctions between LECs via the activation of SRC signaling. In vivo, inhibition of TGFBIp expression in SW620 cancer cells dramatically reduced tumor lymphangiogenesis and metastasis. Collectively, our findings demonstrate that TGFBIp is a lymphangiogenic factor contributing to tumor dissemination and represents a potential target to inhibit metastasis.	[Maeng, Y-S; Choi, S-I; Kim, E. K.] Yonsei Univ, Coll Med, Dept Ophthalmol, Corneal Dystrophy Res Inst, Seoul 120752, South Korea; [Aguilar, B.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Kim, E. K.] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of California System; University of California San Diego; Yonsei University; Yonsei University Health System	Kim, EK (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, 250 Seongsanno, Seoul 120752, South Korea.	eungkkim@yuhs.ac		Kim, Eung Kweon/0000-0002-1453-8042; Maeng, Yong-Sun/0000-0003-1694-8405; choi, seung-il/0000-0001-7168-8795	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2011-0028699]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0028699).	Aguilar B, 2012, CANCER RES, V72, P5833, DOI 10.1158/0008-5472.CAN-12-1229; Albrecht I, 2011, INT J DEV BIOL, V55, P483, DOI 10.1387/ijdb.103226ia; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Becker J, 2006, CANCER RES, V66, P5314, DOI 10.1158/0008-5472.CAN-05-3049; Boensch C, 1999, J BIOL CHEM, V274, P10582, DOI 10.1074/jbc.274.15.10582; Bruyere F, 2008, NAT METHODS, V5, P431, DOI [10.1038/nmeth.1205, 10.1038/NMETH.1205]; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Christiansen Ailsa, 2011, Genes Cancer, V2, P1146, DOI 10.1177/1947601911423028; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; FIDLER IJ, 1987, CURR PROB SURG, V24, P137, DOI 10.1016/0011-3840(87)90002-5; Hewitt RE, 2000, J PATHOL, V192, P446; Kim JE, 2000, J CELL BIOCHEM, V77, P169, DOI 10.1002/(SICI)1097-4644(20000501)77:2<169::AID-JCB1>3.0.CO;2-L; Kim JE, 2003, ONCOGENE, V22, P2045, DOI 10.1038/sj.onc.1206269; Kim YH, 2012, J BIOL CHEM, V287, P38957, DOI 10.1074/jbc.M112.357863; Lee AS, 2011, CANCER RES, V71, P4506, DOI 10.1158/0008-5472.CAN-10-3787; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; Min JK, 2007, BLOOD, V109, P1495, DOI 10.1182/blood-2006-06-029298; Miyagaki T, 2011, J INVEST DERMATOL, V131, P1927, DOI 10.1038/jid.2011.135; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Nam JO, 2003, J BIOL CHEM, V278, P25902, DOI 10.1074/jbc.M300358200; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Schoppmann SF, 2006, SURGERY, V139, P839, DOI 10.1016/j.surg.2005.12.008; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171, DOI 10.1055/s-0037-1615158; Ween MP, 2012, INT J MOL SCI, V13, P10461, DOI 10.3390/ijms130810461; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648	35	18	18	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					196	205		10.1038/onc.2015.73	http://dx.doi.org/10.1038/onc.2015.73			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25772247				2022-12-26	WOS:000368193900006
J	Renner-Schneck, M; Hinderberger, I; Gisin, J; Exner, T; Mayer, C; Stehle, T				Renner-Schneck, Michaela; Hinderberger, Isabel; Gisin, Jonathan; Exner, Thomas; Mayer, Christoph; Stehle, Thilo			Crystal Structure of the N-Acetylmuramic Acid alpha-1-Phosphate (MurNAc-alpha 1-P) Uridylyltransferase MurU, a Minimal Sugar Nucleotidyltransferase and Potential Drug Target Enzyme in Gram-negative Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; PYROPHOSPHORYLASE; NUCLEOTIDYLYLTRANSFERASE; RESISTANCE	The N-acetylmuramic acid alpha-1-phosphate (MurNAc-alpha 1-P) uridylyltransferase MurU catalyzes the synthesis of uridine diphosphate (UDP)-MurNAc, a crucial precursor of the bacterial peptidoglycan cell wall. MurU is part of a recently identified cell wall recycling pathway in Gram-negative bacteria that bypasses the general de novo biosynthesis of UDP-MurNAc and contributes to high intrinsic resistance to the antibiotic fosfomycin, which targets UDP-MurNAc de novo biosynthesis. To provide insights into substrate binding and specificity, we solved crystal structures of MurU of Pseudomonas putida in native and ligand-bound states at high resolution. With the help of these structures, critical enzyme-substrate interactions were identified that enable tight binding of MurNAc-alpha 1-P to the active site of MurU. The MurU structures define a "minimal domain" required for general nucleotidyltransferase activity. They furthermore provide a structural basis for the chemical design of inhibitors of MurU that could serve as novel drugs in combination therapy against multidrug-resistant Gram-negative pathogens.	[Renner-Schneck, Michaela; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem IFIB, D-72076 Tubingen, Germany; [Hinderberger, Isabel; Gisin, Jonathan; Mayer, Christoph] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen IMI, Dept Biol, D-72076 Tubingen, Germany; [Exner, Thomas] Univ Tubingen, Inst Pharm, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Mayer, C (corresponding author), Interfac Inst Microbiol & Infect Med Tubingen IMI, Morgenstelle 28, D-72076 Tubingen, Germany.	christoph.mayer@uni-tuebingen.de; thilo.stehle@uni-tuebingen.de	Mayer, Christoph/S-8666-2017	Mayer, Christoph/0000-0003-4731-4851				Abendroth Jan, 2011, Journal of Structural and Functional Genomics, V12, P83, DOI 10.1007/s10969-011-9101-7; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barton WA, 2002, P NATL ACAD SCI USA, V99, P13397, DOI 10.1073/pnas.192468299; Barton WA, 2001, NAT STRUCT BIOL, V8, P545, DOI 10.1038/88618; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Blankenfeldt W, 2000, EMBO J, V19, P6652, DOI 10.1093/emboj/19.24.6652; Borisova M, 2014, MICROB DRUG RESIST, V20, P231, DOI 10.1089/mdr.2014.0036; Brown K, 1999, EMBO J, V18, P4096, DOI 10.1093/emboj/18.15.4096; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Dahl U, 2004, J BACTERIOL, V186, P2385, DOI 10.1128/JB.186.8.2385-2392.2004; Dauter Miroslawa, 2007, Methods Mol Biol, V364, P149; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gisin J, 2013, NAT CHEM BIOL, V9, P491, DOI 10.1038/nchembio.1289; Hadi T, 2008, BIOCHEMISTRY-US, V47, P11547, DOI 10.1021/bi8014532; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jaeger T, 2008, CELL MOL LIFE SCI, V65, P928, DOI 10.1007/s00018-007-7399-x; Jaeger T, 2005, J BIOL CHEM, V280, P30100, DOI 10.1074/jbc.M502208200; Jagtap PKA, 2013, J MOL BIOL, V425, P1745, DOI 10.1016/j.jmb.2013.02.019; Johnson JW, 2013, ANN NY ACAD SCI, V1277, P54, DOI 10.1111/j.1749-6632.2012.06813.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Litzinger S, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P3, DOI 10.1007/978-3-642-05062-6_1; Maruyama D, 2007, J BIOL CHEM, V282, P17221, DOI 10.1074/jbc.M611873200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer C., 2012, ENCY LIFE SCI; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michalopoulos AS, 2011, INT J INFECT DIS, V15, pE732, DOI 10.1016/j.ijid.2011.07.007; Moretti R, 2007, J BIOL CHEM, V282, P16942, DOI 10.1074/jbc.M701951200; Moretti R, 2011, J BIOL CHEM, V286, P13235, DOI 10.1074/jbc.M110.206433; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Pelissier MC, 2010, J BIOL CHEM, V285, P27468, DOI 10.1074/jbc.M109.095182; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Singh S, 2012, NAT PROD REP, V29, P1201, DOI 10.1039/c2np20039b; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	13	14	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10804	10813		10.1074/jbc.M114.620989	http://dx.doi.org/10.1074/jbc.M114.620989			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767118	Green Published, hybrid			2022-12-26	WOS:000353404500021
J	Zhang, TZ; Sell, P; Braun, U; Leitges, M				Zhang, Thianzhou; Sell, Philip; Braun, Ursula; Leitges, Michael			PKD1 Protein Is Involved in Reactive Oxygen Species-mediated Mitochondrial Depolarization in Cooperation with Protein Kinase C delta (PKC delta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Gene Knockout; Mitochondrial Apoptosis; Protein Kinase C (PKC); Protein Kinase D (PKD); Reactive Oxygen Species (ROS)	NF-KAPPA-B; BAX; APOPTOSIS; ACTIVATION; BCL-2; PHOSPHORYLATION; IDENTIFICATION; SURVIVAL; SITE; D1	Background: The in vivo functions of PKD1 are potentially associated with cancer development and aging. Results: Our results indicate that PKD1 is a key regulator involved in determining the threshold at which mitochondrial membranes depolarize after reactive oxygen-induced stress. Conclusion: This study defines a new function for PKD1 during reactive oxygen signaling. Significance: The involvement of PKD1 in mitochondrial depolarization suggests that PKD1 may be a therapeutic target. In this study, we used gene targeting in mice to identify the in vivo functions of PKD1. In addition to phenotypically characterizing the resulting knock-out animals, we also used mouse embryonic fibroblasts to investigate the associated signaling pathways in detail. This study is the first to use genetic deletion to reveal that PKD1 is a key regulator involved in determining the threshold of mitochondrial depolarization that leads to the production of reactive oxygen species. In addition, we also provide clear evidence that PKC is upstream of PKD1 in this process and acts as the activating kinase of PKD1. Therefore, our in vivo data indicate that PKD1 functions not only in the context of aging but also during nutrient deprivation, which occurs during specific phases of tumor growth.	[Zhang, Thianzhou; Sell, Philip; Braun, Ursula; Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0349 Oslo, Norway	University of Oslo	Leitges, M (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, Gaustadalleen 21, N-0349 Oslo, Norway.	michael.leitges@biotek.uio.no	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Norwegian Research Council [197261]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (Grant 197261).	BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; Joyner A., 1999, GENE TARGETING PRACT, P36; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Michels Judith, 2013, Int J Cell Biol, V2013, P705294, DOI 10.1155/2013/705294; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Steinberg SF, 2012, MOL PHARMACOL, V81, P284, DOI 10.1124/mol.111.075986; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; Storz P, 2005, MOL CELL BIOL, V25, P8520, DOI 10.1128/MCB.25.19.8520-8530.2005; Wang QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013393; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	26	16	19	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 17	2015	290	16					10472	10485		10.1074/jbc.M114.619148	http://dx.doi.org/10.1074/jbc.M114.619148			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG4FU	25759386	Green Published, hybrid			2022-12-26	WOS:000353241100046
J	Gong, SW; Guo, R; Zhang, T; Guo, JX				Gong, Shiwei; Guo, Rui; Zhang, Tao; Guo, Jixun			Warming and Nitrogen Addition Increase Litter Decomposition in a Temperate Meadow Ecosystem	PLOS ONE			English	Article							LEAF-LITTER; NUTRIENT DYNAMICS; INNER-MONGOLIA; CLIMATE-CHANGE; FOREST LITTER; CARBON; GRASSLAND; QUALITY; AVAILABILITY; BIODIVERSITY	Background Litter decomposition greatly influences soil structure, nutrient content and carbon sequestration, but how litter decomposition is affected by climate change is still not well understood. Methodology/Principal Findings A field experiment with increased temperature and nitrogen (N) addition was established in April 2007 to examine the effects of experimental warming, N addition and their interaction on litter decomposition in a temperate meadow steppe in northeastern China. Warming, N addition and warming plus N addition reduced the residual mass of L. chinensis litter by 3.78%, 7.51% and 4.53%, respectively, in 2008 and 2009, and by 4.73%, 24.08% and 16.1%, respectively, in 2010. Warming, N addition and warming plus N addition had no effect on the decomposition of P. communis litter in 2008 or 2009, but reduced the residual litter mass by 5.58%, 15.53% and 5.17%, respectively, in 2010. Warming and N addition reduced the cellulose percentage of L. chinensis and P. communis, specifically in 2010. The lignin percentage of L. chinensis and P. communis was reduced by warming but increased by N addition. The C, N and P contents of L. chinensis and P. communis litter increased with time. Warming and N addition reduced the C content and C: N ratios of L. chinensisand P. communis litter, but increased the N and P contents. Significant interactive effects of warming and N addition on litter decomposition were observed (P<0.01). Conclusion/Significance The litter decomposition rate was highly correlated with soil temperature, soil water content and litter quality. Warming and N addition significantly impacted the litter decomposition rate in the Songnen meadow ecosystem, and the effects of warming and N addition on litter decomposition were also influenced by the quality of litter. These results highlight how climate change could alter grassland ecosystem carbon, nitrogen and phosphorus contents in soil by influencing litter decomposition.	[Gong, Shiwei; Zhang, Tao; Guo, Jixun] NE Normal Univ, Minist Educ, Inst Grassland Sci, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China; [Guo, Rui] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Key Lab Dryland Agr, Minist Agr, Beijing 100081, Peoples R China	Northeast Normal University - China; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, T (corresponding author), NE Normal Univ, Minist Educ, Inst Grassland Sci, Key Lab Vegetat Ecol, Changchun 130024, Peoples R China.	zhangt946@nenu.edu.cn; gjixun@nenu.edu.cn			National Natural Science Foundation of China [31170303, 31300097, 31100332]; Fundamental Research Funds for the Central Universities [12QNJJ017]; State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences	This research was supported by the National Natural Science Foundation of China (No. 31170303, 31300097 and 31100332), the Fundamental Research Funds for the Central Universities (No. 12QNJJ017), and State Key Laboratory of Desert and Oasis Ecology, Xinjiang Institute of Ecology and Geography, ChineseAcademy of Sciences.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bontti EE, 2009, GLOBAL CHANGE BIOL, V15, P1356, DOI 10.1111/j.1365-2486.2008.01815.x; Bragazza L, 2012, GLOBAL CHANGE BIOL, V18, P1163, DOI 10.1111/j.1365-2486.2011.02585.x; Butenschoen O, 2011, SOIL BIOL BIOCHEM, V43, P1902, DOI 10.1016/j.soilbio.2011.05.011; Cantarel AAM, 2013, J VEG SCI, V24, P113, DOI 10.1111/j.1654-1103.2012.01452.x; Cheng XL, 2010, AGR ECOSYST ENVIRON, V138, P206, DOI 10.1016/j.agee.2010.04.019; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Deng Xiao-wen, 2009, Journal of Forestry Research (Harbin), V20, P111, DOI 10.1007/s11676-009-0020-4; Dias T, 2013, SOIL BIOL BIOCHEM, V58, P163, DOI 10.1016/j.soilbio.2012.10.027; Fang H, 2007, PLANT SOIL, V297, P233, DOI 10.1007/s11104-007-9339-9; Flury S, 2014, BASIC APPL ECOL, V15, P219, DOI 10.1016/j.baae.2014.04.002; FOG K, 1988, BIOL REV, V63, P433, DOI 10.1111/j.1469-185X.1988.tb00725.x; GALLARDO A, 1992, BIOGEOCHEMISTRY, V15, P213; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Henry HAL, 2005, OECOLOGIA, V142, P465, DOI 10.1007/s00442-004-1713-1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Johansson O, 2012, GLOBAL CHANGE BIOL, V18, P2626, DOI 10.1111/j.1365-2486.2012.02723.x; Keeler BL, 2009, ECOSYSTEMS, V12, P1, DOI 10.1007/s10021-008-9199-z; Knops JMH, 2007, GLOBAL CHANGE BIOL, V13, P1960, DOI 10.1111/j.1365-2486.2007.01405.x; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Kuperman RG, 1999, SOIL BIOL BIOCHEM, V31, P237, DOI 10.1016/S0038-0717(98)00105-9; Li LJ, 2011, J ARID ENVIRON, V75, P787, DOI 10.1016/j.jaridenv.2011.04.009; Liu P, 2006, APPL SOIL ECOL, V34, P266, DOI 10.1016/j.apsoil.2005.12.009; Magill AH, 2000, SOIL BIOL BIOCHEM, V32, P603, DOI 10.1016/S0038-0717(99)00187-X; Milchunas DG, 2001, ECOSYSTEMS, V4, P139, DOI 10.1007/s100210000064; Nadelhoffer K.J., 1992, ARCTIC ECOSYSTEMS CH, P281, DOI DOI 10.1016/B978-0-12-168250-7.50019-5; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Pregitzer KS, 2004, BIOGEOCHEMISTRY, V68, P179, DOI 10.1023/B:BIOG.0000025737.29546.fd; Qu GuoHui, 2003, Acta Prataculturae Sinica, V12, P18; ROWLAND AP, 1994, COMMUN SOIL SCI PLAN, V25, P269, DOI 10.1080/00103629409369035; Salah YMS, 2011, PROCEDIA ENVIRON SCI, V6, P180, DOI 10.1016/j.proenv.2011.05.019; Sanchez FG, 2001, FOREST ECOL MANAG, V152, P85, DOI 10.1016/S0378-1127(00)00592-2; Sardans J, 2008, APPL SOIL ECOL, V39, P223, DOI 10.1016/j.apsoil.2007.12.011; Saura-Mas S, 2012, ENVIRON EXP BOT, V77, P274, DOI 10.1016/j.envexpbot.2011.11.014; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Sjoberg G, 2004, SOIL BIOL BIOCHEM, V36, P1761, DOI 10.1016/j.soilbio.2004.03.010; Sjoberg G, 2003, SOIL BIOL BIOCHEM, V35, P1305, DOI 10.1016/S0038-0717(03)00201-3; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song CC, 2011, ECOL ENG, V37, P1578, DOI 10.1016/j.ecoleng.2011.03.036; van Meeteren MM, 2008, APPL SOIL ECOL, V38, P119, DOI 10.1016/j.apsoil.2007.09.006; Waldrop MP, 2004, ECOL APPL, V14, P1172, DOI 10.1890/03-5120; Wang Z, 2006, CHINESE AGR SCI B, V22, P241; Xu GP, 2010, PLANT ECOL, V209, P257, DOI 10.1007/s11258-009-9714-0; Xu GP, 2010, NUTR CYCL AGROECOSYS, V87, P49, DOI 10.1007/s10705-009-9311-6; Zhang CaiHong, 2013, Journal of Resources and Ecology, V4, P20	50	14	16	18	153	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0116013	10.1371/journal.pone.0116013	http://dx.doi.org/10.1371/journal.pone.0116013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774776	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500005
J	Olsvik, PA; Berntssen, MHG; Softeland, L				Olsvik, Pal A.; Berntssen, Marc H. G.; Softeland, Liv			Modifying Effects of Vitamin E on Chlorpyrifos Toxicity in Atlantic Salmon	PLOS ONE			English	Article							ACETYLCHOLINESTERASE INHIBITION; LIPID-PEROXIDATION; PLANT INGREDIENTS; OXIDATIVE STRESS; FISH; ORGANOPHOSPHATE; INSECTICIDE; PARATHION; CYTOCHROME-P450; GLUTATHIONE	The aim of this study was to elucidate how vitamin E (alpha tocopherol) may ameliorate the toxicity of the pesticide chlorpyrifos in Atlantic salmon. Freshly isolated hepatocytes were exposed to vitamin E, chlorpyrifos or a combination of vitamin E and chlorpyrifos (all 100 mu M). Transcriptomics (RNA-seq) and metabolomics were used to screen for effects of vitamin E and chlorpyrifos. By introducing vitamin E, the number of upregulated transcripts induced by chlorpyrifos exposure was reduced from 941 to 626, while the number of downregulated transcripts was reduced from 901 to 742 compared to the control. Adding only vitamin E had no effect on the transcriptome. Jak-STAT signaling was the most significantly affected pathway by chlorpyrifos treatment according to the transcriptomics data. The metabolomics data showed that accumulation of multiple long chain fatty acids and dipeptides and amino acids in chlorpyrifos treated cells was partially alleviated by vitamin E treatment. Significant interaction effects between chlorpyrifos and vitamin E were seen for 15 metabolites, including 12 dipeptides. The antioxidant had relatively modest effects on chlorpyrifosinduced oxidative stress. By combining the two data sets, the study suggests that vitamin E supplementation prevents uptake and accumulation of fatty acids, and counteracts inhibited carbohydrate metabolism. Overall, this study shows that vitamin E only to a moderate degree modifies chlorpyrifos toxicity in Atlantic salmon liver cells.	[Olsvik, Pal A.; Berntssen, Marc H. G.; Softeland, Liv] Natl Inst Nutr & Seafood Res, Bergen, Norway		Olsvik, PA (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	pal.olsvik@nifes.no	Olsvik, Pål A/B-8232-2012; Berntssen, Marc/O-9406-2018	Olsvik, Pål A/0000-0002-5641-9420; 	Norwegian Research Council [200506/I30]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Norwegian Research Council Grant 200506/I30 http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2009, CHEM BIOL, V16, P712, DOI 10.1016/j.chembiol.2009.05.011; Alavanja MCR, 2013, CA-CANCER J CLIN, V63, P120, DOI 10.3322/caac.21170; Almeida JR, 2010, ECOTOXICOLOGY, V19, P1369, DOI 10.1007/s10646-010-0523-y; Ambali SF, 2010, FOOD CHEM TOXICOL, V48, P3477, DOI 10.1016/j.fct.2010.09.026; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2008, STAT WORLD FISH AQ 2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Elskus AA, 2005, BIOCH MOLEC, V6, P119; EPA, 2006, INT RER EL DEC CHLOR; Fulton MH, 2014, FISH PHYSIOL, V33, P309, DOI 10.1016/B978-0-12-398254-4.00006-6; Fulton MH, 2001, ENVIRON TOXICOL CHEM, V20, P37, DOI [10.1897/1551-5028(2001)020&lt;0037:AIIEFA&gt;2.0.CO;2, 10.1002/etc.5620200104]; GALGANI F, 1992, MAR ECOL PROG SER, V91, P77, DOI 10.3354/meps091077; Giesy John P., 1999, Reviews of Environmental Contamination and Toxicology, V160, P1; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; GRINBERGFUNES RA, 1994, CARCINOGENESIS, V15, P2449, DOI 10.1093/carcin/15.11.2449; Gunduz F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-143; Hodgson E, 2008, PEST MANAG SCI, V64, P617, DOI 10.1002/ps.1563; ISO, 1099352009 ISO; Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015; Gomez-Lechon MJ, 2009, CURR DRUG METAB, V10, P692, DOI 10.2174/138920009789895543; Jouvet P, 2000, MOL BIOL CELL, V11, P1919, DOI 10.1091/mbc.11.5.1919; Kaiser JP, 2012, INT J TOXICOL, V31, P551, DOI 10.1177/1091581812466418; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; Kaur R, 2008, ENVIRON TOXICOL PHAR, V26, P45, DOI 10.1016/j.etap.2008.01.004; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Krovel AV, 2010, COMP BIOCHEM PHYS C, V151, P175, DOI 10.1016/j.cbpc.2009.10.003; Lavado R, 2011, AQUAT TOXICOL, V101, P57, DOI 10.1016/j.aquatox.2010.09.002; Lukaszewicz-Hussain A, 2004, POL J ENVIRON STUD, V13, P397; Magnarelli G, 2013, ADV BIOL CHEM, V03, P460, DOI [10.4236/abc.2013.35050, DOI 10.4236/ABC.2013.35050]; Mansour SA, 2009, PESTIC BIOCHEM PHYS, V93, P34, DOI 10.1016/j.pestbp.2008.09.004; Moon YJ, 2006, TOXICOL IN VITRO, V20, P187, DOI 10.1016/j.tiv.2005.06.048; Moreira EG, 2010, TOXICOL APPL PHARM, V245, P310, DOI 10.1016/j.taap.2010.03.015; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MOUSHUMI L, 1994, PHYTOTHER RES, V8, P237, DOI 10.1002/ptr.2650080410; Nacher-Mestre J, 2014, J AGR FOOD CHEM, V62, P2165, DOI 10.1021/jf405366n; Olsvik PA, 2011, FOOD CHEM TOXICOL, V49, P3258, DOI 10.1016/j.fct.2011.09.025; Oruc E, 2012, B ENVIRON CONTAM TOX, V88, P678, DOI 10.1007/s00128-012-0548-4; Richard AJ, 2014, BBA-MOL BASIS DIS, V1842, P431, DOI 10.1016/j.bbadis.2013.05.030; Salyha YT, 2013, NEUROPHYSIOLOGY+, V45, P193, DOI 10.1007/s11062-013-9356-7; Saxena Ronika, 2011, Toxicol Int, V18, P73, DOI 10.4103/0971-6580.75871; SCHIMMEL SC, 1983, J AGR FOOD CHEM, V31, P104, DOI 10.1021/jf00115a027; Softeland L, 2014, FOOD CHEM TOXICOL, V73, P157, DOI 10.1016/j.fct.2014.08.008; Softeland L, 2009, TOXICOL IN VITRO, V23, P1455, DOI 10.1016/j.tiv.2009.07.014; Sun LB, 2013, AQUAT TOXICOL, V126, P148, DOI 10.1016/j.aquatox.2012.11.002; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; Verma RS, 2009, PESTIC BIOCHEM PHYS, V95, P152, DOI 10.1016/j.pestbp.2009.08.004; Waagbo R, 2013, AQUACULT NUTR, V19, P598, DOI 10.1111/anu.12010; Xing HJ, 2014, CHEMOSPHERE, V104, P244, DOI 10.1016/j.chemosphere.2014.01.002; Xing HJ, 2013, ENVIRON TOXICOL PHAR, V35, P47, DOI 10.1016/j.etap.2012.11.004; Xu WN, 2012, J AQUAT ANIM HEALTH, V24, P185, DOI 10.1080/08997659.2012.675937; Yeh ST, 2006, FISH SHELLFISH IMMUN, V20, P332, DOI 10.1016/j.fsi.2005.05.008; Yen J, 2011, NEUROTOXICOL TERATOL, V33, P735, DOI 10.1016/j.ntt.2011.10.004	53	37	40	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119250	10.1371/journal.pone.0119250	http://dx.doi.org/10.1371/journal.pone.0119250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774794	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500077
J	Zhang, YC; Zhai, WJ; Zhao, MF; Li, DG; Chai, X; Cao, XL; Meng, JX; Chen, J; Xiao, X; Li, Q; Mu, J; Shen, JC; Meng, AM				Zhang, Yuchen; Zhai, Wenjing; Zhao, Mingfeng; Li, Deguan; Chai, Xiao; Cao, Xiaoli; Meng, Juanxia; Chen, Jie; Xiao, Xia; Li, Qing; Mu, Juan; Shen, Jichun; Meng, Aimin			Effects of Iron Overload on the Bone Marrow Microenvironment in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; OXIDATIVE STRESS; HEMATOPOIETIC MICROENVIRONMENT; OSTEOGENIC DIFFERENTIATION; CHELATION-THERAPY; STROMAL CELLS; LOW-LEVEL; MAINTENANCE; CULTURE; COMBINATION	Objective Using a mouse model, Iron Overload (IO) induced bone marrow microenvironment injury was investigated, focusing on the involvement of reactive oxygen species (ROS). Methods Mice were intraperitoneally injected with iron dextran (12.5, 25, or 50mg) every three days for two, four, and six week durations. Deferasirox(DFX) 125mg/ml and N-acetyl-L-cysteine (NAC) 40mM were co-administered. Then, bone marrow derived mesenchymal stem cells (BM-MSCs) were isolated and assessed for proliferation and differentiation ability, as well as related gene changes. Immunohistochemical analysis assessed the expression of haematopoietic chemokines. Supporting functions of BM-MSCs were studied by co-culture system. Results In IO condition (25mg/ml for 4 weeks), BM-MSCs exhibited proliferation deficiencies and un-balanced osteogenic/adipogenic differentiation. The IO BM-MSCs showed a longer double time (2.07 +/- 0.14 days) than control (1.03 +/- 0.07 days) (P<0.05). The immunohistochemical analysis demonstrated that chemokine stromal cell-derived factor-1, stem cell factor-1, and vascular endothelial growth factor-1 expression were decreased. The co-cultured system demonstrated that bone marrow mononuclear cells (BM-MNCs) co-cultured with IO BM-MSCs had decreased colony forming unit (CFU) count (p<0.01), which indicates IO could lead to decreased hematopoietic supporting functions of BM-MSCs. This effect was associated with elevated phosphatidylinositol 3 kinase (PI3K) and reduced of Forkhead box protein O3 (FOXO3) mRNA expression, which could induce the generation of ROS. Results also demonstrated that NAC or DFX treatment could partially attenuate cell injury and inhibit signaling pathway striggered by IO. Conclusion These results demonstrated that IO can impair the bone marrow microenvironment, including the quantity and quality of BM-MSCs.	[Zhang, Yuchen; Zhao, Mingfeng; Chai, Xiao; Cao, Xiaoli; Meng, Juanxia; Chen, Jie; Xiao, Xia; Li, Qing; Mu, Juan] Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China; [Zhai, Wenjing] Chinese Acad Med Sci, Blood Dis Hosp, Dept Stem Cells Transplantat, Tianjin, Peoples R China; [Li, Deguan; Meng, Aimin] Chinese Acad Med Sci, Inst Radiat Med, Key Lab Radiat Med & Mol Nucl Med, Tianjin, Peoples R China; [Li, Deguan; Meng, Aimin] Peking Union Med Coll, Tianjin, Peoples R China; [Shen, Jichun] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Dept Hematol, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, MF (corresponding author), Tianjin First Cent Hosp, Dept Hematol, Tianjin, Peoples R China.	zmfzmf@hotmail.com	Zhang, Yuchen/GYI-8858-2022	Zhao, Mingfeng/0000-0002-5995-7558	National Natural Science Foundation of China [81041043]; National Natural Science Foundation of Tianjin [13JCYBJC23400]; Science and Technique Foundation of Tianjin [13KG106, 2013KR07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Tianjin; Science and Technique Foundation of Tianjin	This study was supported by the National Natural Science Foundation of China (81041043), the National Natural Science Foundation of Tianjin (13JCYBJC23400), and Science and Technique Foundation of Tianjin (13KG106,2013KR07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghaban Eslaminejad Mohamadreza, 2014, World J Stem Cells, V6, P344, DOI 10.4252/wjsc.v6.i3.344; Bakhshi T, 2008, TRANSFUSION, V48, P2638, DOI 10.1111/j.1537-2995.2008.01926.x; Bird RJ, 2012, INTERN MED J, V42, P450, DOI 10.1111/j.1445-5994.2012.02734.x; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; CLOPTON DA, 1995, BIOCHEM BIOPH RES CO, V210, P189, DOI 10.1006/bbrc.1995.1645; Cornejo P, 2005, NITRIC OXIDE-BIOL CH, V13, P54, DOI 10.1016/j.niox.2005.04.009; Danjou F, 2013, BLOOD CELL MOL DIS, V51, P142, DOI 10.1016/j.bcmd.2013.06.001; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Dolado I, 2008, CANCER CELL, V14, P427, DOI 10.1016/j.ccr.2008.11.006; Fei CM, 2014, TUMOR BIOL, V35, P4307, DOI 10.1007/s13277-013-1565-6; Gattermann N, 2012, HAEMATOL-HEMATOL J, V97, P1364, DOI 10.3324/haematol.2011.048546; Guariglia R, 2011, LEUKEMIA RES, V35, P566, DOI 10.1016/j.leukres.2010.11.027; Habermann TM, 2008, BLOOD, V112, P2694, DOI 10.1182/blood-2007-09-111658; Haidar R, 2012, SPINE, V37, P334, DOI 10.1097/BRS.0b013e31821bd095; Hamada Y, 2009, BONE, V44, P936, DOI 10.1016/j.bone.2008.12.011; Hammoud M, 2012, J CELL PHYSIOL, V227, P2750, DOI 10.1002/jcp.23019; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin HT, 2012, INT ORTHOP, V36, P2589, DOI 10.1007/s00264-012-1674-7; Lee SE, 2013, ACTA HAEMATOL-BASEL, V129, P72, DOI 10.1159/000342772; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WY, 2013, EUR J HAEMATOL, V91, P249, DOI 10.1111/ejh.12159; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; Okabe H, 2014, EUR J HAEMATOL, V93, P118, DOI 10.1111/ejh.12309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prus E, 2008, CYTOM PART A, V73A, P22, DOI 10.1002/cyto.a.20491; Rahal A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/761264; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Saigo K, 2011, J INT MED RES, V39, P1941, DOI 10.1177/147323001103900539; Shao LJ, 2011, INT J HEMATOL, V94, P24, DOI 10.1007/s12185-011-0872-1; Suzuki T, 2008, INT J HEMATOL, V88, P30, DOI 10.1007/s12185-008-0119-y; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xie Fang, 2011, Zhonghua Yi Xue Za Zhi, V91, P3284; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhang Y, 2013, J CELL BIOCHEM, V114, P2595, DOI 10.1002/jcb.24607; Zhao MF, 2010, BLOOD, V116, P1724, DOI 10.1182/blood.V116.21.4247.4247; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	46	50	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120219	10.1371/journal.pone.0120219	http://dx.doi.org/10.1371/journal.pone.0120219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774923	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500159
J	Bian, C; Zhao, ZQ; Zhang, YQ; Lu, N				Bian, Chao; Zhao, Zhi-Qi; Zhang, Yu-Qiu; Lu, Ning			Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation	PLOS ONE			English	Article							EVOKED FIELD POTENTIALS; NF-KAPPA-B; IL-23 P19 EXPRESSION; DORSAL-HORN; NERVE INJURY; TNF-ALPHA; P38 MAPK; PAIN; FRACTALKINE; INDUCTION	The long-term potentiation (LTP) of spinal C-fiber-evoked field potentials is considered as a fundamental mechanism of central sensitization in the spinal cord. Accumulating evidence has showed the contribution of spinal microglia to spinal LTP and pathological pain. As a key signaling of neurons-microglia interactions, the involvement of CX3CL1/CX3CR1 signaling in pathological pain has also been investigated extensively. The present study examined whether CX3CL1/CX3CR1 signaling plays a role in spinal LTP. The results showed that 10-trains tetanic stimulation (100 Hz, 2s) of the sciatic nerve (TSS) produced a significant LTP of C-fiber-evoked field potentials lasting for over 3 h in the rat spinal dorsal horn. Blockade of CX3CL1/CX3CR1 signaling with an anti-CX3CR1 neutralizing antibody (CX3CR1 AB) markedly suppressed TSS-induced LTP. Exogenous CX3CL1 significantly potentiated 3-trains TSS-induced LTP in rats. Consistently, spinal LTP of C-fiber-evoked field potentials was also induced by TSS (100 Hz, 1s, 4 trains) in all C57BL/6 wild type (WT) mice. However, in CX3CR1(-/-) mice, TSS failed to induce LTP and behavioral hypersensitivity, confirming an essential role of CX3CR1 in spinal LTP induction. Furthermore, blockade of IL-18 or IL-23, the potential downstream factors of CX3CL1/CX3CR1 signaling, with IL-18 BP or anti-IL-23 neutralizing antibody (IL-23 AB), obviously suppressed spinal LTP in rats. These results suggest that CX3CL1/CX3CR1 signaling is involved in LTP of C-fiber-evoked field potentials in the rodent spinal dorsal horn.	[Zhang, Yu-Qiu] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China; Fudan Univ, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Zhang, YQ (corresponding author), Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200032, Peoples R China.	yuqiuzhang@fudan.edu.cn; ninglu@fudan.edu.cn	Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020		National Basic Research Program of China [2013CB531900]; National Natural Science Foundation of China [31420103903, 31421091, 81471130, 31271183]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531900, www.973.gov.cn/English/Index.aspx) and the National Natural Science Foundation of China (31420103903, 31421091, 81471130, and 31271183: www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azkue JJ, 2003, PAIN, V106, P373, DOI 10.1016/j.pain.2003.08.007; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bertollini C, 2006, NEUROPHARMACOLOGY, V51, P816, DOI 10.1016/j.neuropharm.2006.05.027; Bian C, 2013, BRAIN BEHAV IMMUN; Bian C, 2014, BRAIN BEHAV IMMUN, V37, P220, DOI 10.1016/j.bbi.2013.12.011; Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen SZ, 2002, J NEUROIMMUNOL, V133, P46, DOI 10.1016/S0165-5728(02)00354-5; Chu YX, 2012, NEUROSCI BULL, V28, P49, DOI 10.1007/s12264-012-1058-4; Chu YX, 2010, BRAIN BEHAV IMMUN, V24, P1176, DOI 10.1016/j.bbi.2010.06.001; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Clark AK, 2012, EXP NEUROL, V234, P283, DOI 10.1016/j.expneurol.2011.09.012; Clark AK, 2011, CURR PHARM BIOTECHNO, V12, P1707; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cook A, 2010, J BIOL CHEM, V285, P10563, DOI 10.1074/jbc.M109.035477; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gong QJ, 2009, GLIA, V57, P583, DOI 10.1002/glia.20786; Gruber-Schoffnegger D, 2013, J NEUROSCI, V33, P6540, DOI 10.1523/JNEUROSCI.5087-12.2013; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2013, PAIN; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Lee KM, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.10.017; Li YH, 2008, EXP MOL PATHOL, V84, P1, DOI 10.1016/j.yexmp.2007.09.004; Li YH, 2007, BRAIN, V130, P490, DOI 10.1093/brain/awl273; Liang LL, 2010, J NEUROSCI RES, V88, P2899, DOI 10.1002/jnr.22439; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Lindia JA, 2005, J PAIN, V6, P434, DOI 10.1016/j.jpain.2005.02.001; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Liu Xian-Guo, 2008, Shengli Xuebao, V60, P653; Liu YL, 2007, NEUROPHARMACOLOGY, V52, P708, DOI 10.1016/j.neuropharm.2006.09.011; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; Ma JY, 2002, NEUROREPORT, V13, P1781, DOI 10.1097/00001756-200210070-00017; Ma JY, 2001, BRAIN RES BULL, V56, P575, DOI 10.1016/S0361-9230(01)00728-6; Maggi L, 2009, J NEUROIMMUNOL, V215, P36, DOI 10.1016/j.jneuroim.2009.07.016; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mizutani N, 2007, J IMMUNOL, V179, P7478, DOI 10.4049/jimmunol.179.11.7478; Niimi N, 2013, J NEUROIMMUNOL, V254, P39, DOI 10.1016/j.jneuroim.2012.08.015; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; Park CK, 2011, J NEUROSCI, V31, P15072, DOI 10.1523/JNEUROSCI.2443-11.2011; Piccinin S, 2010, J NEUROIMMUNOL, V224, P85, DOI 10.1016/j.jneuroim.2010.05.012; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Rygh LJ, 2005, PSYCHONEUROENDOCRINO, V30, P959, DOI 10.1016/j.psyneuen.2005.04.007; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sasaki A, 2013, NEUROREPORT, V24, P137, DOI 10.1097/WNR.0b013e32835df4d9; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Shan S, 2011, NEUROBIOL AGING, V32, P443, DOI 10.1016/j.neurobiolaging.2009.03.004; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Sun JL, 2013, J NEUROSCI RES, V91, P545, DOI 10.1002/jnr.23168; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Verri WA, 2007, BRAIN BEHAV IMMUN, V21, P535, DOI 10.1016/j.bbi.2006.11.005; Yang HW, 2004, J NEUROPHYSIOL, V91, P1122, DOI 10.1152/jn.00735.2003; Ying B, 2006, BIOCHEM BIOPH RES CO, V340, P1264, DOI 10.1016/j.bbrc.2005.12.139; Zhang Hong-Mei, 2004, Shengli Xuebao, V56, P591; Zhang XC, 2006, NEUROPHARMACOLOGY, V50, P748, DOI 10.1016/j.neuropharm.2005.11.021; Zhao J, 2010, LIFE SCI, V87, P120, DOI 10.1016/j.lfs.2010.05.015; Zhu LX, 2012, CYTOKINE, V60, P171, DOI 10.1016/j.cyto.2012.05.016; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	69	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118842	10.1371/journal.pone.0118842	http://dx.doi.org/10.1371/journal.pone.0118842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768734	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500049
J	Cai, Y; Hirata, A; Nakayama, S; VanderLaan, PA; Levantini, E; Yamamoto, M; Hirai, H; Wong, KK; Costa, DB; Watanabe, H; Kobayashi, SS				Cai, Yi; Hirata, Ayako; Nakayama, Sohei; VanderLaan, Paul A.; Levantini, Elena; Yamamoto, Mihoko; Hirai, Hideyo; Wong, Kwok-Kin; Costa, Daniel B.; Watanabe, Hideo; Kobayashi, Susumu S.			CCAAT/Enhancer Binding Protein beta Is Dispensable for Development of Lung Adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-CELL PROLIFERATION; C/EBP-BETA; TRANSCRIPTION FACTORS; DIFFERENTIAL EXPRESSION; DOWN-REGULATION; ALPHA; CANCER; FAMILY; GENE; EXPANSION	Lung cancer is the leading cause of cancer death worldwide. Although disruption of normal proliferation and differentiation is a vital component of tumorigenesis, the mechanisms of this process in lung cancer are still unclear. A transcription factor, C/EBP beta is a critical regulator of proliferation and/or differentiation in multiple tissues. In lung, C/EBP beta is expressed in alveolar pneumocytes and bronchial epithelial cells; however, its roles on normal lung homeostasis and lung cancer development have not been well described. Here we investigated whether C/EBP beta is required for normal lung development and whether its aberrant expression and/or activity contribute to lung tumorigenesis. We showed that C/EBP beta was expressed in both human normal pneumocytes and lung adenocarcinoma cell lines. We found that overall lung architecture was maintained in Cebpb knockout mice. Neither overexpression of nuclear C/EBP beta nor suppression of CEBPB expression had significant effects on cell proliferation. C/EBP beta expression and activity remained unchanged upon EGF stimulation. Furthermore, deletion of Cebpb had no impact on lung tumor burden in a lung specific, conditional mutant EGFR lung cancer mouse model. Analyses of data from The Cancer Genome Atlas (TCGA) revealed that expression, promoter methylation, or copy number of CEBPB was not significantly altered in human lung adenocarcinoma. Taken together, our data suggest that C/EBP beta is dispensable for development of lung adenocarcinoma.	[Cai, Yi; Hirata, Ayako; Nakayama, Sohei; Levantini, Elena; Yamamoto, Mihoko; Costa, Daniel B.; Kobayashi, Susumu S.] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [VanderLaan, Paul A.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Levantini, Elena] CNR, Natl Res Council, Inst Biomed Technol, I-56100 Pisa, Italy; [Hirata, Ayako; Hirai, Hideyo] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kyoto 606, Japan; [Wong, Kwok-Kin; Watanabe, Hideo] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Watanabe, Hideo] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA USA; [Kobayashi, Susumu S.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); Kyoto University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Watanabe, H (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	hideo_watanabe@dfci.harvard.edu; skobayas@bidmc.harvard.edu	levantini, elena/AAK-7201-2021; VanderLaan, Paul Andrew/AAX-8124-2020; Levantini, Elena/AGY-0242-2022	levantini, elena/0000-0003-4612-3105; VanderLaan, Paul Andrew/0000-0002-7234-5652; wong, kwok kin/0000-0001-6323-235X; Nakayama, Sohei/0000-0002-6487-0422; Costa, Daniel/0000-0002-0689-395X	National Institution of Health [R00CA126026, R01CA169259]; Harvard Stem Cell Institute [DP-0110-12-00]; Lung Cancer Foundation of America-International Association; American Cancer Society [RSG-13-047, RSG-11-186]; Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA169259, R00CA126026] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Lung Cancer Foundation of America-International Association; American Cancer Society(American Cancer Society); Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by National Institution of Health grants (R00CA126026 and R01CA169259 to S. S. K.); Harvard Stem Cell Institute (DP-0110-12-00); an Lung Cancer Foundation of America-International Association to Study Lung Cancer grant (D. B. C.); an American Cancer Society grant (RSG-13-047 to S. S. K. and RSG-11-186 to D. B. C.); and Bonnie J. Addario Lung Cancer Foundation grant (S. N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAM T, 1992, J BIOL CHEM, V267, P5021; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Burgess-Beusse BL, 1999, HEPATOLOGY, V29, P597, DOI 10.1002/hep.510290245; Cassel TN, 2003, AM J PHYSIOL-LUNG C, V285, pL773, DOI 10.1152/ajplung.00023.2003; Cersosimo RJ, 2002, AM J HEALTH-SYST PH, V59, P611, DOI 10.1093/ajhp/59.7.611; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Costa DB, 2007, LUNG CANCER, V56, P97, DOI 10.1016/j.lungcan.2006.11.023; Costa DB, 2006, LUNG CANCER, V53, P253, DOI 10.1016/j.lungcan.2006.04.011; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Dubois-Pot-Schneider H, 2014, HEPATOLOGY, V60, P2077, DOI 10.1002/hep.27353; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Halmos B, 2002, CANCER RES, V62, P528; Herceg Z, 2011, EPIGENETICS-US, V6, P804, DOI 10.4161/epi.6.7.16262; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Jones LC, 2002, BLOOD, V99, P2032, DOI 10.1182/blood.V99.6.2032; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liloglou Triantafillos, 2014, Cancer Lett, V342, P200, DOI 10.1016/j.canlet.2012.04.018; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Nakayama S, 2014, CANCER RES, V74, P5891, DOI 10.1158/0008-5472.CAN-14-0184; NATSUKA S, 1992, BLOOD, V79, P460; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Roos AB, 2012, DEV DYNAM, V241, P911, DOI 10.1002/dvdy.23773; SCOTT LM, 1992, BLOOD, V80, P1725; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sugahara K, 1999, CELL TISSUE RES, V297, P261, DOI 10.1007/s004410051354; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Tada T, 2006, JNCI-J NATL CANCER I, V98, P396, DOI 10.1093/jnci/djj093; Tadokoro T, 2014, P NATL ACAD SCI USA, V111, pE3641, DOI 10.1073/pnas.1409781111; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; WEDEL A, 1995, IMMUNOBIOLOGY, V193, P171, DOI 10.1016/S0171-2985(11)80541-3; XING Z, 1994, J IMMUNOL, V153, P4059; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yeh JE, 2013, CURR OPIN ONCOL, V25, P652, DOI 10.1097/01.cco.0000432528.88101.1a	45	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120647	10.1371/journal.pone.0120647	http://dx.doi.org/10.1371/journal.pone.0120647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767874	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500132
J	Gao, MM; Ma, YJ; Liu, DX				Gao, Mingming; Ma, Yongjie; Liu, Dexi			High-Fat Diet-Induced Adiposity, Adipose Inflammation, Hepatic Steatosis and Hyperinsulinemia in Outbred CD-1 Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; GLUCOSE-INTOLERANCE; HYDRODYNAMIC DELIVERY; C57BL/6J MICE; PROTECTS MICE; WEIGHT-GAIN; TISSUE; LIVER; MOUSE	High-fat diet (HFD) has been applied to a variety of inbred mouse strains to induce obesity and obesity related metabolic complications. In this study, we determined HFD induced development of metabolic disorders on outbred female CD-1 mice in a time dependent manner. Compared to mice on regular chow, HFD-fed CD-1 mice gradually gained more fat mass and consequently exhibited accelerated body weight gain, which was associated with adipocyte hypertrophy and up-regulated expression of adipose inflammatory chemokines and cytokines such as Mcp-1 and Tnf-alpha. Increased fat accumulation in white adipose tissue subsequently led to ectopic fat deposition in brown adipose tissue, giving rise to whitening of brown adipose tissue without altering plasma level of triglyceride. Ectopic fat deposition was also observed in the liver, which was associated with elevated expression of key genes involved in hepatic lipid sequestration, including Ppar-gamma 2, Cd36 and Mgat1. Notably, adipose chronic inflammation and ectopic lipid deposition in the liver and brown fat were accompanied by glucose intolerance and insulin resistance, which was correlated with hyperinsulinemia and pancreatic islet hypertrophy. Collectively, these results demonstrate sequentially the events that HFD induces physiological changes leading to metabolic disorders in an outbred mouse model more closely resembling heterogeneity of the human population.	[Gao, Mingming; Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	MA, YONGJIE/O-3861-2015; Gao, Mingming/F-4317-2016		NIH [RO1EB007357, RO1HL098295]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The study was supported in part by grants from NIH (RO1EB007357 and RO1HL098295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Barron AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078554; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Breslin WL, 2010, LAB ANIM-UK, V44, P231, DOI 10.1258/la.2010.009114; Bu L, 2013, AAPS J, V15, P1001, DOI 10.1208/s12248-013-9501-7; Chen HC, 2002, J LIPID RES, V43, P986; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gao MM, 2014, DISCOV MED, V17, P319; Gao MM, 2014, J CONTROL RELEASE, V185, P1, DOI 10.1016/j.jconrel.2014.03.047; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Gao MM, 2013, MOL THER, V21, P1852, DOI 10.1038/mt.2013.125; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Gao MM, 2013, AAPS J, V15, P744, DOI 10.1208/s12248-013-9473-7; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Garg N, 2011, BIOCHEM BIOPH RES CO, V413, P476, DOI 10.1016/j.bbrc.2011.08.123; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Gunawardana SC, 2012, DIABETES, V61, P674, DOI 10.2337/db11-0510; Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525; Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Nov O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053626; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Podrini C, 2013, MAMM GENOME, V24, P240, DOI 10.1007/s00335-013-9456-0; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Wu Y, 2013, J ENDOCRINOL, V219, P195, DOI 10.1530/JOE-13-0160; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	52	94	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119784	10.1371/journal.pone.0119784	http://dx.doi.org/10.1371/journal.pone.0119784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768847	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500097
J	Kim, YU; Lim, H; Jung, HE; Wetsel, RA; Chung, Y				Kim, Young Uk; Lim, Hoyong; Jung, Ha Eun; Wetsel, Rick A.; Chung, Yeonseok			Regulation of Autoimmune Germinal Center Reactions in Lupus-Prone BXD2 Mice by Follicular Helper T Cells	PLOS ONE			English	Article							B-CELLS; T(H)17 CELLS; IL-21; DIFFERENTIATION; EXPRESSION; INTERLEUKIN-17; ACTIVATION; GENERATION; PHENOTYPE; EXPANSION	BXD2 mice spontaneously develop autoantibodies and subsequent glomerulonephritis, offering a useful animal model to study autoimmune lupus. Although initial studies showed a critical contribution of IL-17 and Th17 cells in mediating autoimmune B cell responses in BXD2 mice, the role of follicular helper T (Tfh) cells remains incompletely understood. We found that both the frequency of Th17 cells and the levels of IL-17 in circulation in BXD2 mice were comparable to those of wild-type. By contrast, the frequency of PD-1(+)CXCR5(+) Tfh cells was significantly increased in BXD2 mice compared with wild-type mice, while the frequency of PD-1(+)CXCR5(+)Foxp3(+) follicular regulatory T (Tfr) cells was reduced in the former group. The frequency of Tfh cells rather than that of Th17 cells was positively correlated with the frequency of germinal center B cells as well as the levels of autoantibodies to dsDNA. More importantly, CXCR5(+) CD4(+) T cells isolated from BXD2 mice induced the production of IgG from naive B cells in an IL-21-dependent manner, while CCR6(+) CD4(+) T cells failed to do so. These results together demonstrate that Tfh cells rather than Th17 cells contribute to the autoimmune germinal center reactions in BXD2 mice.	[Kim, Young Uk; Jung, Ha Eun; Wetsel, Rick A.] Univ Texas Med Sch Houston, Inst Mol Med, Ctr Immunol & Autoimmune Dis, Houston, TX USA; [Kim, Young Uk; Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lim, Hoyong; Chung, Yeonseok] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Immunobiol Lab, Seoul, South Korea; [Lim, Hoyong] Korea Natl Inst Hlth, Div Aids, Cheongwon, Chungbuk, South Korea	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Seoul National University (SNU); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Chung, Y (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Immunobiol Lab, Seoul, South Korea.	yeonseok@snu.ac.kr		Chung, Yeonseok/0000-0001-5780-4841; Kim, Young Uk/0000-0002-2518-0189	SNU; National Research Foundation of Korea (NRF) - Korea government (MEST) [2014R1A2A1A11054364]; National Institutes of Health [1R01HL118361]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118361] Funding Source: NIH RePORTER	SNU; National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work is supported by research grants SNU invitation for distinguished scholar (to YC), 2014R1A2A1A11054364 (to YC) from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST), 1R01HL118361 (to YC and RAW) from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cheng F, 2009, ANN RHEUM DIS, V68, P604, DOI 10.1136/ard.2008.097089; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Ding YN, 2013, J IMMUNOL, V191, P1614, DOI 10.4049/jimmunol.1300479; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Feng XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051982; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hsu HC, 2006, ARTHRITIS RHEUM-US, V54, P343, DOI 10.1002/art.21550; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hsu HC, 2007, J IMMUNOL, V178, P5357, DOI 10.4049/jimmunol.178.8.5357; Hsu HC, 2011, ARTHRITIS RHEUM-US, V63, P2038, DOI 10.1002/art.30257; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kuchen S, 2007, J IMMUNOL, V179, P5886, DOI 10.4049/jimmunol.179.9.5886; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; Ma J., 2012, CLIN DEV IMMUNOL, V2012, P827; Martin JC, 2014, CLIN IMMUNOL, V154, P1, DOI 10.1016/j.clim.2014.05.004; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; MORSE HC, 1979, J EXP MED, V149, P1183, DOI 10.1084/jem.149.5.1183; Mountz JD, 2005, SCAND J IMMUNOL, V61, P128, DOI 10.1111/j.0300-9475.2005.01548.x; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Vincent FB, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4277; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu YL, 2005, ARTHRITIS RHEUM-US, V52, P3257, DOI 10.1002/art.21354; Xie ST, 2010, J IMMUNOL, V184, P2289, DOI 10.4049/jimmunol.0903133; Zhang X, 2013, OCHSNER J, V13, P131; Zhao XF, 2010, MOL BIOL REP, V37, P81, DOI 10.1007/s11033-009-9533-3; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	50	29	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120294	10.1371/journal.pone.0120294	http://dx.doi.org/10.1371/journal.pone.0120294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768299	Green Submitted, Green Published, gold			2022-12-26	WOS:000351277500119
J	Ma, SQ; Johnson, D; Ashby, C; Xiong, DH; Cramer, CL; Moore, JH; Zhang, SZ; Huang, XZ				Ma, Shiqian; Johnson, Daniel; Ashby, Cody; Xiong, Donghai; Cramer, Carole L.; Moore, Jason H.; Zhang, Shuzhong; Huang, Xiuzhen			SPARCoC: A New Framework for Molecular Pattern Discovery and Cancer Gene Identification	PLOS ONE			English	Article							LUNG-CANCER; TUMOR HETEROGENEITY; EXPRESSION; CLASSIFICATION; ADENOCARCINOMA; PREDICTION; SURVIVAL	It is challenging to cluster cancer patients of a certain histopathological type into molecular subtypes of clinical importance and identify gene signatures directly relevant to the subtypes. Current clustering approaches have inherent limitations, which prevent them from gauging the subtle heterogeneity of the molecular subtypes. In this paper we present a new framework: SPARCoC (Sparse-CoClust), which is based on a novel Common-background and Sparse-foreground Decomposition (CSD) model and the Maximum Block Improvement (MBI) co-clustering technique. SPARCoC has clear advantages compared with widely-used alternative approaches: hierarchical clustering (Hclust) and nonnegative matrix factorization (NMF). We apply SPARCoC to the study of lung adenocarcinoma (ADCA), an extremely heterogeneous histological type, and a significant challenge for molecular subtyping. For testing and verification, we use high quality gene expression profiling data of lung ADCA patients, and identify prognostic gene signatures which could cluster patients into subgroups that are significantly different in their overall survival (with p-values < 0.05). Our results are only based on gene expression profiling data analysis, without incorporating any other feature selection or clinical information; we are able to replicate our findings with completely independent datasets. SPARCoC is broadly applicable to large-scale genomic data to empower pattern discovery and cancer gene identification.	[Ma, Shiqian] Chinese Univ Hong Kong, Dept Syst Engn & Engn Management, Shatin, Hong Kong, Peoples R China; [Johnson, Daniel; Ashby, Cody] Arkansas State Univ, Mol Biosci Program, Jonesboro, AR 72467 USA; [Xiong, Donghai] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Xiong, Donghai] Med Coll Wisconsin, Ctr Canc, Milwaukee, WI 53226 USA; [Cramer, Carole L.] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72467 USA; [Cramer, Carole L.] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72467 USA; [Moore, Jason H.] Dartmouth Coll, Geisel Sch Med, Lebanon, NH 03756 USA; [Zhang, Shuzhong] Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN 55455 USA; [Huang, Xiuzhen] Arkansas State Univ, Dept Comp Sci, Jonesboro, AR 72467 USA	Chinese University of Hong Kong; Arkansas State University; Medical College of Wisconsin; Medical College of Wisconsin; Arkansas State University; Arkansas State University; Dartmouth College; University of Minnesota System; University of Minnesota Twin Cities; Arkansas State University	Zhang, SZ (corresponding author), Univ Minnesota, Dept Ind & Syst Engn, Minneapolis, MN 55455 USA.	zhangs@umn.edu; xhuang@astate.edu	Moore, Jason H./AAV-9645-2021	Moore, Jason H./0000-0002-5015-1099; Ashby, Cody/0000-0002-9361-0283	Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) [CUHK 439513]; NSF [CMMI-1161242]; NIH [LM010098, LM009012]; National Institute of Health grants from the National Center for Research Resources [P20RR016460]; National Institute of General Medical Sciences [P20GM103429]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098, R01LM009012] Funding Source: NIH RePORTER; EPSCoR [1003970] Funding Source: National Science Foundation	Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health grants from the National Center for Research Resources; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	S.M. is supported by Hong Kong Research Grants Council (RGC) Early Career Scheme (ECS) (Project ID: CUHK 439513). S.Z. is supported by NSF grant (CMMI-1161242). J.M. is supported by NIH grants LM010098 and LM009012. This work is also partially supported by the National Institute of Health grants from the National Center for Research Resources (P20RR016460) and the National Institute of General Medical Sciences (P20GM103429). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard PL, 2013, NATURE, V501, P355, DOI 10.1038/nature12627; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chandrasekaran V, 2011, SIAM J OPTIMIZ, V21, P572, DOI 10.1137/090761793; Cho H., 2004, P 4 SIAM INT C DAT M; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dettling M, 2004, BIOINFORMATICS, V20, P3583, DOI 10.1093/bioinformatics/bth447; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordon GJ, 2002, CANCER RES, V62, P4963; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Lee M, 2010, BIOMETRICS, V66, P1087, DOI 10.1111/j.1541-0420.2010.01392.x; Li GJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp491; Li X, 2013, IEEE T IMAGE P UNPUB; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Park YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044225; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Shabalin AA, 2009, ANN APPL STAT, V3, P985, DOI 10.1214/09-AOAS239; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Urbach D, 2012, TRENDS GENET, V28, P538, DOI 10.1016/j.tig.2012.07.001; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Zhang SZ, 2012, LECT NOTES COMPUT SC, V7632, P59, DOI 10.1007/978-3-642-34123-6_6; Zhang SZ, 2011, LECT N BIOINFORMAT, V7036, P1, DOI 10.1007/978-3-642-24855-9_1	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0117135	10.1371/journal.pone.0117135	http://dx.doi.org/10.1371/journal.pone.0117135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768286	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500015
J	Modin, O; Alam, SS; Persson, F; Wilen, BM				Modin, Oskar; Alam, Soroush Saheb; Persson, Frank; Wilen, Britt-Marie			Sorption and Release of Organics by Primary, Anaerobic, and Aerobic Activated Sludge Mixed with Raw Municipal Wastewater	PLOS ONE			English	Article							SIZE DISTRIBUTION; MATTER; BIOSORPTION; REMOVAL; CARBON; PERFORMANCE; ABSORBENCY	New activated sludge processes that utilize sorption as a major mechanism for organics removal are being developed to maximize energy recovery from wastewater organics, or as enhanced primary treatment technologies. To model and optimize sorption-based activated sludge processes, further knowledge about sorption of organics onto sludge is needed. This study compared primary-, anaerobic-, and aerobic activated sludge as sorbents, determined sorption capacity and kinetics, and investigated some characteristics of the organics being sorbed. Batch sorption assays were carried out without aeration at a mixing velocity of 200 rpm. Only aerobic activated sludge showed net sorption of organics. Sorption of dissolved organics occurred by a near-instantaneous sorption event followed by a slower process that obeyed 1st order kinetics. Sorption of particulates also followed 1st order kinetics but there was no instantaneous sorption event; instead there was a release of particles upon mixing. The 5-min sorption capacity of activated sludge was 6.5 +/- 10.8 mg total organic carbon (TOC) per g volatile suspend solids (VSS) for particulate organics and 5.0 +/- 4.7 mgTOC/gVSS for dissolved organics. The observed instantaneous sorption appeared to be mainly due to organics larger than 20 kDa in size being sorbed, although molecules with a size of about 200 Da with strong UV absorbance at 215-230 nm were also rapidly removed.	[Modin, Oskar; Alam, Soroush Saheb; Persson, Frank; Wilen, Britt-Marie] Chalmers Univ Technol, Dept Civil & Environm Engn, Div Water Environm Technol, S-41296 Gothenburg, Sweden	Chalmers University of Technology	Modin, O (corresponding author), Chalmers Univ Technol, Dept Civil & Environm Engn, Div Water Environm Technol, S-41296 Gothenburg, Sweden.	oskar.modin@chalmers.se	Modin, Oskar/D-8440-2014; Modin, Oskar/AAN-4715-2020; Persson, Frank/F-7209-2016; Saheb Alam, Soroush/P-8176-2015; Wilen, Britt-Marie/B-5042-2016	Modin, Oskar/0000-0002-9232-6096; Modin, Oskar/0000-0002-9232-6096; Persson, Frank/0000-0002-0269-9375; Saheb Alam, Soroush/0000-0002-0028-458X; Wilen, Britt-Marie/0000-0001-6155-7759	Swedish Research Council Formas [2012-1433]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The project was funded by the Swedish Research Council Formas (http://formas.se/), grant number 2012-1433. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardern E., 1914, J SOC CHEM IND LOND, V33, P523, DOI [DOI 10.1002/JCTB.5000331005, DOI 10.1002/JCTB.50003]; Barbot E, 2010, CHEM ENG J, V163, P230, DOI 10.1016/j.cej.2010.07.050; Boehnke B, 1997, WATER ENG MANAG, V144, P30; Boehnke B, 1998, WATER ENG MANAG, V145, P31; Boehnke B, 1997, WATER ENG MANAG, V144, P18; Brandstetter A, 1996, Z PFLANZ BODENKUNDE, V159, P605, DOI 10.1002/jpln.1996.3581590612; Clescerl L.S., 1999, STANDARD METHODS EXA, V20th ed.; Constantine T., 2012, P WATER ENV FED, P5771; Diamantis V, 2014, BIORESOURCE TECHNOL, V156, P314, DOI 10.1016/j.biortech.2014.01.061; Dulekgurgen E, 2006, WATER RES, V40, P273, DOI 10.1016/j.watres.2005.10.032; Faust L, 2014, WATER RES, V56, P258, DOI 10.1016/j.watres.2014.03.006; Guellil A, 2001, WATER RES, V35, P143, DOI 10.1016/S0043-1354(00)00240-2; Gustavsson DJI, 2013, WATER SCI TECHNOL, V68, P887, DOI 10.2166/wst.2013.318; Henze M, 2000, ACTIVATED SLUDGE MOD, DOI [10.1007/s00449-010-0446-2, DOI 10.1007/S00449-010-0446-2]; Huang JC, 2000, J ENVIRON SCI HEAL A, V35, P123, DOI 10.1080/10934520009376958; IMHOFF K, 1955, SEWAGE IND WASTES, V27, P431; Jimenez JA, 2005, WATER ENVIRON RES, V77, P437, DOI 10.2175/106143005X67340; Jorand F, 1995, RECENT PROGR GENIE P, V44, P61; Korshin GV, 1997, WATER RES, V31, P1787, DOI 10.1016/S0043-1354(97)00006-7; Lim CP, 2015, BIOCHEM ENG J, V93, P128, DOI 10.1016/j.bej.2014.10.003; McConnell J.S., 1993, J ARKANSAS ACAD SCI, V47, P73; RENSINK JH, 1991, WATER SCI TECHNOL, V23, P857, DOI 10.2166/wst.1991.0537; RIFFAT R, 1995, WATER ENVIRON RES, V67, P1104, DOI 10.2175/106143095X133365; ROSS RD, 1985, J WATER POLLUT CON F, V57, P1022; Schmid FX, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0003142, DOI 10.1038/NPG.ELS.0003142]; Shon HK, 2006, KOREAN J CHEM ENG, V23, P581, DOI 10.1007/BF02706798; Tan KN, 1997, ENVIRON MONIT ASSESS, V44, P211, DOI 10.1023/A:1005732506663; Tchobanoglous G., 2004, WASTEWATER ENG TREAT; ULLRICH AH, 1951, SEWAGE IND WASTES, V23, P1248; VERSPRILLE AI, 1985, WATER SCI TECHNOL, V17, P235, DOI 10.2166/wst.1985.0133; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; YAMAMOTO K, 1989, WATER SCI TECHNOL, V21, P43, DOI 10.2166/wst.1989.0209; Yetis U, 2002, ENVIRON TECHNOL, V23, P363, DOI 10.1080/09593332508618395; Zhao W, 2000, ACTA BIOTECHNOL, V20, P53, DOI 10.1002/abio.370200109	34	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119371	10.1371/journal.pone.0119371	http://dx.doi.org/10.1371/journal.pone.0119371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768429	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500080
J	Watkins, DA; Mvundura, M; Nordet, P; Mayosi, BM				Watkins, David A.; Mvundura, Mercy; Nordet, Porfirio; Mayosi, Bongani M.			A Cost-Effectiveness Analysis of a Program to Control Rheumatic Fever and Rheumatic Heart Disease in Pinar del Rio, Cuba	PLOS ONE			English	Article							PRIMARY PREVENTION; GLOBAL BURDEN; PHARYNGITIS; MANAGEMENT; HEALTH	Background Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) persist in many low-and middle-income countries. To date, the cost-effectiveness of population-based, combined primary and secondary prevention strategies has not been assessed. In the Pinar del Rio province of Cuba, a comprehensive ARF/RHD control program was undertaken over 1986 - 1996. The present study analyzes the cost-effectiveness of this Cuban program. Methods and Findings We developed a decision tree model based on the natural history of ARF/RHD, comparing the costs and effectiveness of the 10-year Cuban program to a "do nothing" approach. Our population of interest was the cohort of children aged 5 - 24 years resident in Pinar del Rio in 1986. We assessed costs and health outcomes over a lifetime horizon, and we took the healthcare system perspective on costs but did not apply a discount rate. We used epidemiologic, clinical, and direct medical cost inputs that were previously collected for publications on the Cuban program. We estimated health gains as disability-adjusted life years (DALYs) averted using standard approaches developed for the Global Burden of Disease studies. Cost-effectiveness acceptability thresholds were defined by one and three times per capita gross domestic product per DALY averted. We also conducted an uncertainty analysis using Monte Carlo simulations and several scenario analyses exploring the impact of alternative assumptions about the program's effects and costs. We found that, compared to doing nothing, the Cuban program averted 5051 DALYs (1844 per 100,000 school-aged children) and saved $7,848,590 (2010 USD) despite a total program cost of $202,890 over 10 years. In the scenario analyses, the program remained cost saving when a lower level of effectiveness and a reduction in averted years of life lost were assumed. In a worst-case scenario including 20-fold higher costs, the program still had a 100% of being cost-effective and an 85% chance of being cost saving. Conclusions A 10-year program to control ARF/RHD in Pinar del Rio, Cuba dramatically reduced morbidity and premature mortality in children and young adults and was cost saving. The results of our analysis were robust to higher program costs and more conservative assumptions about the program's effectiveness. It is possible that the program's effectiveness resulted from synergies between primary and secondary prevention strategies. The findings of this study have implications for non-communicable disease policymaking in other resource-limited settings.	[Watkins, David A.] Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA; [Watkins, David A.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Watkins, David A.; Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Mvundura, Mercy] PATH, Seattle, WA USA; [Nordet, Porfirio] WHO, Retired Cardiovasc Dis Programme, CH-1211 Geneva, Switzerland	University of Washington; University of Washington Seattle; University of Cape Town; University of Cape Town; World Health Organization	Watkins, DA (corresponding author), Univ Washington, Div Gen Internal Med, Dept Med, Seattle, WA 98195 USA.	davidaw@uw.edu	Watkins, David/ABC-3783-2020	Watkins, David/0000-0001-6341-9595; Mvundura, Mercy/0000-0002-7711-9558	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		ARGUEDAS A, 1992, J PEDIATR-US, V121, P569, DOI 10.1016/S0022-3476(05)81146-1; Bach JF, 1996, LANCET, V347, P644, DOI 10.1016/S0140-6736(96)91202-7; Carapetis JR, 2007, NEW ENGL J MED, V357, P439, DOI 10.1056/NEJMp078039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; GORDIS L, 1985, CIRCULATION, V72, P1155, DOI 10.1161/01.CIR.72.6.1155; Irlam J, 2013, CIRC-CARDIOVASC QUAL, V6, P343, DOI 10.1161/CIRCOUTCOMES.111.000032; Karthikeyan G, 2009, CIRCULATION, V120, P709, DOI 10.1161/CIRCULATIONAHA.108.836510; Lopez RR, 1986, FIEBRE REUMATICA EST; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manji RA, 2013, EXPERT REV PHARM OUT, V13, P715, DOI 10.1586/14737167.2013.852470; Michaud CRR, 1999, RHEUMATIC FEVER, P485; Nordet P, 2008, CARDIOVASC J AFR, V19, P135; Organization WH, 2016, GLOBAL STATUS REPORT; R Core Team, R LANG ENV STAT COMP; Remenyi B, 2013, NAT REV CARDIOL, V10, P284, DOI 10.1038/nrcardio.2013.34; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; Robertson KA, 2008, SAMJ S AFR MED J, V98, P780; Soudarssanane MB, 2007, INDIAN J PEDIATR, V74, P567, DOI 10.1007/s12098-007-0094-y; TOMPKINS RK, 1977, ANN INTERN MED, V86, P481, DOI 10.7326/0003-4819-86-4-481; Van Howe RS, 2006, PEDIATRICS, V117, P609, DOI 10.1542/peds.2005-0879; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2001, NAT BURD DIS MAN; WHO Expert Consultation Report, 2001, RHEUM FEV RHEUM HEAR; World Bank, 2014, CUB COUNTR PROF; World Bank, 2014, INFL CONS PRIC ANN; World Health Organization (WHO), 2013, LIF EXP LIF TABL COU; Wyber R, 2014, B WORLD HEALTH ORGAN, V92, P768, DOI 10.2471/BLT.13.134486	29	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121363	10.1371/journal.pone.0121363	http://dx.doi.org/10.1371/journal.pone.0121363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768008	Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500141
J	Zhu, L; Wu, GY; Zhou, X; Li, JL; Wen, Z; Lin, FC				Zhu, Ling; Wu, Guangyao; Zhou, Xin; Li, Jielan; Wen, Zhi; Lin, Fuchun			Altered Spontaneous Brain Activity in Patients with Acute Spinal Cord Injury Revealed by Resting-State Functional MRI	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN MOTOR CORTEX; REGIONAL HOMOGENEITY; COGNITIVE CONTROL; PARAPLEGIC PATIENTS; AREAS; REORGANIZATION; FMRI; ORGANIZATION; METAANALYSIS	Background Previous neuroimaging studies have provided evidence of structural and functional reorganization of brain in patients with chronic spinal cord injury (SCI). However, it remains unknown whether the spontaneous brain activity changes in acute SCI. In this study, we investigated intrinsic brain activity in acute SCI patients using a regional homogeneity (ReHo) analysis based on resting-state functional magnetic resonance imaging. Methods A total of 15 patients with acute SCI and 16 healthy controls participated in the study. The ReHo value was used to evaluate spontaneous brain activity, and voxel-wise comparisons of ReHo were performed to identify brain regions with altered spontaneous brain activity between groups. We also assessed the associations between ReHo and the clinical scores in brain regions showing changed spontaneous brain activity. Results Compared with the controls, the acute SCI patients showed decreased ReHo in the bilateral primary motor cortex/primary somatosensory cortex, bilateral supplementary motor area/dorsal lateral prefrontal cortex, right inferior frontal gyrus, bilateral dorsal anterior cingulate cortex and bilateral caudate; and increased ReHo in bilateral precuneus, the left inferior parietal lobe, the left brainstem/hippocampus, the left cingulate motor area, bilateral insula, bilateral thalamus and bilateral cerebellum. The average ReHo values of the left thalamus and right insula were negatively correlated with the international standards for the neurological classification of spinal cord injury motor scores. Conclusion Our findings indicate that acute distant neuronal damage has an immediate impact on spontaneous brain activity. In acute SCI patients, the ReHo was prominently altered in brain regions involved in motor execution and cognitive control, default mode network, and which are associated with sensorimotor compensatory reorganization. Abnormal ReHo values in the left thalamus and right insula could serve as potential biomarkers for assessment of neuronal damage and the prediction of clinical outcomes in acute SCI.	[Zhu, Ling; Wu, Guangyao; Li, Jielan; Wen, Zhi] Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China; [Zhou, Xin; Lin, Fuchun] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Wu, GY (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Magnet Resonance Imaging, Wuhan 430072, Hubei, Peoples R China.	wuguangy2002@163.com; fclin@wipm.ac.cn	Lin, Fuchun/D-2371-2012; Lin, Fuchun/M-2789-2019; Zhou, Xin/D-9987-2016	Lin, Fuchun/0000-0002-2282-6474; Lin, Fuchun/0000-0002-2282-6474; Zhou, Xin/0000-0002-5580-7907; Wu, Guangyao/0000-0002-0456-3682; Wen, Zhi/0000-0003-2946-3650	Natural Science Foundation of China [81171315, 81227902]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Nos. 81171315 and 81227902 to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cermik TF, 2006, BRAIN RES, V1109, P54, DOI 10.1016/j.brainres.2006.06.044; Curt A, 2002, J NEUROTRAUM, V19, P43, DOI 10.1089/089771502753460222; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; Dietz V, 2006, LANCET NEUROL, V5, P688, DOI 10.1016/S1474-4422(06)70522-1; DONOGHUE JP, 1990, EXP BRAIN RES, V79, P492; Fang WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069199; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Guleria S, 2008, J NEUROSCI RES, V86, P2271, DOI 10.1002/jnr.21664; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Herrero MT, 2002, CHILD NERV SYST, V18, P386, DOI 10.1007/s00381-002-0604-1; Hiroshima S, 2014, NEUROL MED-CHIR, V54, P511, DOI 10.2176/nmc.oa2012-0321; Hotz-Boendermaker S, 2011, NEUROREHAB NEURAL RE, V25, P469, DOI 10.1177/1545968310389184; Jain N, 1997, NATURE, V386, P495, DOI 10.1038/386495a0; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Jurkiewicz MT, 2006, NEUROLOGY, V66, P762, DOI 10.1212/01.wnl.0000201276.28141.40; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Liakakis G, 2011, BEHAV BRAIN RES, V225, P341, DOI 10.1016/j.bbr.2011.06.022; Liu HH, 2006, NEUROREPORT, V17, P19, DOI 10.1097/01.wnr.0000195666.22714.35; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mestres-Misse A, 2012, NEUROIMAGE, V62, P41, DOI 10.1016/j.neuroimage.2012.05.021; Mutha PK, 2014, CORTEX, V57, P299, DOI 10.1016/j.cortex.2014.03.001; Nardone R, 2013, BRAIN RES, V1504, P58, DOI 10.1016/j.brainres.2012.12.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelled G, 2004, MAGN RESON MED, V52, P913, DOI 10.1002/mrm.20229; Philip NS, 2013, PSYCHIAT RES-NEUROIM, V214, P247, DOI 10.1016/j.pscychresns.2013.07.013; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Procyk E, 2006, J NEUROSCI, V26, P11313, DOI 10.1523/JNEUROSCI.2157-06.2006; Qiu CJ, 2011, PSYCHIAT RES-NEUROIM, V194, P47, DOI 10.1016/j.pscychresns.2011.01.010; Song YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089493; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Wu T, 2007, NEUROSCI LETT, V423, P189, DOI 10.1016/j.neulet.2007.06.057; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030	47	21	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118816	10.1371/journal.pone.0118816	http://dx.doi.org/10.1371/journal.pone.0118816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768010	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500045
J	Kuosmanen, SM; Hartikainen, J; Hippelainen, M; Kokki, H; Levonen, AL; Tavi, P				Kuosmanen, Suvi M.; Hartikainen, Juha; Hippelainen, Mikko; Kokki, Hannu; Levonen, Anna-Liisa; Tavi, Pasi			MicroRNA Profiling of Pericardial Fluid Samples from Patients with Heart Failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE-CELLS; CIRCULATING MICRORNAS; ENDOTHELIAL-CELLS; CARDIOVASCULAR-DISEASES; NONCODING RNAS; STEM-CELLS; EXPRESSION; EXOSOMES; GROWTH	Aims Multicellular organisms maintain vital functions through intercellular communication. Release of extracellular vesicles that carry signals to even distant target organs is one way of accomplishing this communication. MicroRNAs can also be secreted from the cells in exo-somes and act as paracrine signalling molecules. In addition, microRNAs have been implicated in the pathogenesis of a large number of diseases, including cardiovascular diseases, and are considered as promising candidate biomarkers due to their relative stability and easy quantification from clinical samples. Pericardial fluid contains hormones secreted by the heart and is known to reflect the cardiac function. In this study, we sought to investigate whether pericardial fluid contains microRNAs and if so, whether they could be used to distinguish between different cardiovascular pathologies and disease stages. Methods and Results Pericardial fluid was collected from heart failure patients during open-heart surgery. MicroRNA profiles of altogether 51 patients were measured by quantitative real-time PCR (qPCR) using Exiqon human panels I and II. On the average, 256 microRNAs were detected per sample, and 70 microRNAs out of 742 profiled microRNAs were detected in every sample. The five most abundant microRNAs in pericardial fluid were miR-21-5b, miR-451a, miR-125b-5p, let-7b-5p and miR-16-5p. No specific signatures for cardiovascular pathologies or clinically assessed heart failure stages could be detected from the profiles and, overall, microRNA profiles of the samples were found to be very similar despite the heterogeneity in the study population. Conclusion Measured microRNA profiles did not separate the samples according to the clinical features of the patients. However, several previously identified heart failure marker microRNAs were detected. The pericardial fluid microRNA profile appeared to be a result of an active and selective secretory process indicating that microRNAs may act as paracrine signalling factors by mediating the local crosstalk between cardiac cells.	[Kuosmanen, Suvi M.; Levonen, Anna-Liisa; Tavi, Pasi] Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Hartikainen, Juha; Kokki, Hannu] Univ Eastern Finland, Sch Med, Kuopio, Finland; [Hartikainen, Juha; Hippelainen, Mikko] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Kokki, Hannu] Kuopio Univ Hosp, Anesthesia Serv, SF-70210 Kuopio, Finland; [Kokki, Hannu] Kuopio Univ Hosp, Operat Serv, SF-70210 Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Levonen, AL (corresponding author), Univ Eastern Finland, Dept Biotechnol & Mol Med, AI Virtanen Inst Mol Sci, Kuopio, Finland.	Anna-Liisa.Levonen@uef.fi; Pasi.Tavi@uef.fi	Linna-Kuosmanen, Suvi/P-4574-2018	Linna-Kuosmanen, Suvi/0000-0002-3278-2727; Levonen, Anna-Liisa/0000-0002-6575-2137	European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation; Academy of Finland; Sigrid Juselius Foundation; Instrufoundation	European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Instrufoundation	This work was supported by the European Regional Development Fund of the Finnish Funding Agency for Technology and Innovation (PT), the Academy of Finland (ALL, PT), the Sigrid Juselius Foundation (ALL, PT), and the Instrufoundation (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellatif M, 2012, CIRC RES, V110, P638, DOI 10.1161/CIRCRESAHA.111.247437; Abe N, 2006, J AM COLL CARDIOL, V48, P1387, DOI 10.1016/j.jacc.2006.06.048; Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Ardite E, 2012, J CELL BIOL, V196, P163, DOI 10.1083/jcb.201105013; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Barile L, 2014, CARDIOVASC RES; Ben-Horin S, 2005, AM J MED, V118, P636, DOI 10.1016/j.amjmed.2005.01.066; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Chau BN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003205; Chen LJ, 2013, BIOCHEM BIOPH RES CO, V431, P566, DOI 10.1016/j.bbrc.2013.01.015; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Condorelli G, 2014, J AM COLL CARDIOL, V63, P2177, DOI 10.1016/j.jacc.2014.01.050; Corda S, 1997, CIRC RES, V81, P679; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Elzenaar I, 2013, CLIN PHARMACOL THER, V94, P480, DOI 10.1038/clpt.2013.138; Emanueli C, 2013, CELL RES, V23, P866, DOI 10.1038/cr.2013.57; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; Fujita M, 2001, INT J CARDIOL, V77, P113, DOI 10.1016/S0167-5273(00)00462-9; GIBSON AT, 1978, J PHYSIOL-LONDON, V277, P367, DOI 10.1113/jphysiol.1978.sp012277; Gidlof O, 2013, BLOOD, V121, P3908, DOI 10.1182/blood-2012-10-461798; Goldraich LA, 2014, BIOMARKERS, V19, P135, DOI 10.3109/1354750X.2013.870605; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Harada M, 2014, CIRC RES, V114, P689, DOI 10.1161/CIRCRESAHA.114.301798; Hausser J, 2014, NAT REV GENET, V15, P599, DOI 10.1038/nrg3765; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Horkay F, 1997, LIFE SCI, V62, P267, DOI 10.1016/S0024-3205(97)01105-3; Huang SL, 2014, CIRC-CARDIOVASC GENE, V7, P189, DOI 10.1161/CIRCGENETICS.113.000294; Iwakura A, 2000, J AM COLL CARDIOL, V35, P1785, DOI 10.1016/S0735-1097(00)00651-3; Kamanu TKK, 2013, SCI REP-UK, V3, DOI 10.1038/srep02940; Kane NM, 2012, STEM CELLS, V30, P643, DOI 10.1002/stem.1026; Kirby TJ, 2013, FREE RADICAL BIO MED, V64, P95, DOI 10.1016/j.freeradbiomed.2013.07.004; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Lai CTM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-73; Li ZC, 2014, SCI WORLD J, DOI 10.1155/2014/931845; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Long GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050926; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Melman YF, 2014, CIRC-HEART FAIL, V7, P203, DOI 10.1161/CIRCHEARTFAILURE.113.000266; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Ren JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080738; Sahoo S, 2014, CIRC RES, V114, P333, DOI 10.1161/CIRCRESAHA.114.300639; Sala V, 2014, CELL MOL LIFE SCI, V71, P1439, DOI 10.1007/s00018-013-1504-0; Selmeci L, 2000, CORONARY ARTERY DIS, V11, P53, DOI 10.1097/00019501-200002000-00010; Shan Z, 2013, CHINESE MED J-PEKING, V126, P515, DOI 10.3760/cma.j.issn.0366-6999.20122289; Sluijter JPG, 2014, CARDIOVASC RES, V102, P302, DOI 10.1093/cvr/cvu022; Tambara K, 2002, HEART, V87, P242, DOI 10.1136/heart.87.3.242; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; Vacchi-Suzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052442; Viereck J, 2014, CARDIOVASC RES, V102, P290, DOI 10.1093/cvr/cvu039; Voellenkle C, 2010, PHYSIOL GENOMICS, V42, P420, DOI 10.1152/physiolgenomics.00211.2009; Waldenstrom A, 2014, CIRC RES, V114, P315, DOI 10.1161/CIRCRESAHA.114.300584; Wang XH, 2012, CARDIOVASC RES, V94, P379, DOI 10.1093/cvr/cvs096; Wang XH, 2014, CARDIOVASC RES, V102, P385, DOI 10.1093/cvr/cvu044; Watanabe M, 2009, CLIN CARDIOL, V32, P159, DOI 10.1002/clc.20306; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Yellon DM, 2014, CIRC RES, V114, P325, DOI 10.1161/CIRCRESAHA.113.300636; Yoneda T, 2000, JPN CIRC J, V64, P495, DOI 10.1253/jcj.64.495; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883	78	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119646	10.1371/journal.pone.0119646	http://dx.doi.org/10.1371/journal.pone.0119646			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763857	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300029
J	Martinez, MC; Kok, CC; Baleriola, C; Robertson, P; Rawlinson, WD				Martinez, Maria Carmela; Kok, Chee Choy; Baleriola, Cristina; Robertson, Peter; Rawlinson, William D.			Investigation of Occult Hepatitis B Virus Infection in Anti-HBc Positive Patients from a Liver Clinic	PLOS ONE			English	Article							BLOOD-DONORS; SURFACE-ANTIGEN; MOLECULAR CHARACTERIZATION; GENOTYPE-C; GENE VARIANTS; CARRIERS; MUTANTS; SERUM; PREVALENCE; CHINA	Occult hepatitis B infection (OBI) is manifested by presence of very low levels (< 200IU/mL) of Hepatitis B viral DNA (HBV DNA) in the blood and the liver while exhibiting undetectable HBV surface antigen (HBsAg). The molecular mechanisms underlying this occurrence are still not completely understood. This study investigated the prevalence of OBI in a high-risk Australian population and compared the HBV S gene sequences of our cohort with reference sequences. Serum from HBV DNA positive, HBsAg negative, and hepatitis B core antibody (anti-HBc) positive patients (study cohort) were obtained from samples tested at SEALS Serology Laboratory using the Abbott Architect, as part of screening and diagnostic testing. From a total of 228,108 samples reviewed, 1,451 patients were tested for all three OBI markers. Only 10 patients (0.69%) out of the 1,451 patients were found to fit the selection criteria for OBI. Sequence analysis of the HBV S gene from 5 suspected OBI infected patients showed increased sequence variability in the ` a' epitope of the major hydrophilic region compared to reference sequences. In addition, a total of eight consistent nucleotide substitutions resulting in seven amino acid changes were observed, and three patients had truncated S gene sequence. These mutations appeared to be stable and may result in alterations in HBsAg conformation. These may negatively impact the affinity of hepatitis B surface antibody (anti-HBs) and may explain the false negative results in serological HBV diagnosis. These changes may also enable the virus to persist in the liver by evading immune surveillance. Further studies on a bigger cohort are required to determine whether these amino acid variations have been acquired in the process of immune escape and serve as markers of OBI.	[Martinez, Maria Carmela; Rawlinson, William D.] Prince Wales Hosp, Div Virol, Sydney, NSW, Australia; [Kok, Chee Choy; Baleriola, Cristina; Robertson, Peter; Rawlinson, William D.] Prince Wales Hosp, SEALS Microbiol, Sydney, NSW, Australia; [Martinez, Maria Carmela; Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Baleriola, C (corresponding author), Prince Wales Hosp, SEALS Microbiol, Sydney, NSW, Australia.	Cristina.Baleriola@sesiahs.health.nsw.gov.au		Rawlinson, William/0000-0003-0988-7827				Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Candotti D, 2009, J HEPATOL, V51, P798, DOI 10.1016/j.jhep.2009.05.020; Chan HLY, 2004, GUT, V53, P1494, DOI 10.1136/gut.2003.033324; Chemin I, 2005, J CLIN VIROL, V34, pS15, DOI 10.1016/S1386-6532(05)80005-8; Coleman PF, 1999, J MED VIROL, V59, P19, DOI 10.1002/(SICI)1096-9071(199909)59:1<19::AID-JMV4>3.0.CO;2-B; Fang Y, 2009, J MED VIROL, V81, P826, DOI 10.1002/jmv.21463; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Health Protection Agency, 2007, REC PROT HBV GEN ANT; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hou JL, 2001, HEPATOLOGY, V34, P1027, DOI 10.1053/jhep.2001.28708; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Huang XY, 2013, J MED VIROL, V85, P979, DOI 10.1002/jmv.23556; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Katsoulidou A, 2009, J MED VIROL, V81, P815, DOI 10.1002/jmv.21499; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim SM, 2007, J INFECTION, V54, P185, DOI 10.1016/j.jinf.2006.02.002; Liu CJ, 2006, J CLIN VIROL, V36, pS33, DOI 10.1016/S1386-6532(06)80007-7; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Moerman B, 2004, Clin Lab, V50, P159; Morsica G, 2009, INFECTION, V37, P445, DOI 10.1007/s15010-008-8194-9; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Pujol FH, 2009, CANCER LETT, V286, P80, DOI 10.1016/j.canlet.2009.07.013; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Scheiblauer H, 2006, J MED VIROL, V78, pS66, DOI 10.1002/jmv.20611; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Schories M, 2000, J HEPATOL, V33, P799, DOI 10.1016/S0168-8278(00)80313-X; Squadrito G, 2014, ANN GASTROENTEROL, V27, P15; Tian YJ, 2007, J CLIN MICROBIOL, V45, P2971, DOI 10.1128/JCM.00508-07; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Wang JT, 2002, TRANSFUSION, V42, P1592, DOI 10.1046/j.1537-2995.2002.00274.x; Weinberger KM, 2000, J GEN VIROL, V81, P1165, DOI 10.1099/0022-1317-81-5-1165; Yuan Q, 2010, J CLIN MICROBIOL, V48, P357, DOI 10.1128/JCM.01781-09	33	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0117275	10.1371/journal.pone.0117275	http://dx.doi.org/10.1371/journal.pone.0117275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763579	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300009
J	Wan, YQ; Liu, YH; Wang, XB; Wu, JL; Liu, KZ; Zhou, J; Liu, L; Zhang, CX				Wan, Yunqiang; Liu, Yuanhui; Wang, Xiaobin; Wu, Jiali; Liu, Kezhi; Zhou, Jun; Liu, Li; Zhang, Chunxiang			Identification of Differential MicroRNAs in Cerebrospinal Fluid and Serum of Patients with Major Depressive Disorder	PLOS ONE			English	Article							DISEASE; EXPRESSION; BDNF; ASSOCIATION; INVOLVEMENT; BIOMARKER; BEHAVIOR; STRESS; GENES; MODEL	Major depression is a debilitating disease. To date, the development of biomarkers of major depressive disorder (MDD) remains a challenge. Recently, alterations in the expression of microRNAs (miRNAs) from post-mortem brain tissue and peripheral blood have been linked to MDD. The goals of this study were to detect the differential miRNAs in cerebrospinal fluid (CSF) and serum of MDD patients. First, the relative expression levels of 179 miRNAs (relative high levels in serum) were analyzed by miRNA PCR Panel in the CSF of MDD patients. Then, the differentially altered miRNAs from CSF were further assessed by qRT-PCR in the serum of the same patients. Finally, the serum differentially altered miRNAs were further validated by qRT-PCR in the serum of another MDD patients. The CSF-results indicated that 11 miRNAs in MDD patients were significantly higher than these in control subjects, and 5 miRNAs were significantly lower than these in control subjects. The serum-results from the same patients showed that 3 miRNAs (miR-221-3p, miR-34a-5p, and let-7d-3p) of the 11 miRNAs were significantly higher than these in control subjects, and 1 miRNA (miR-451a) of 5 miRNAs was significantly lower than these in control subjects. The up-regulation of miR-221-3p, miR-34a-5p, let-7d-3p and down-regulation of miR-451a was further validated in another 32 MDD patients. ROC analysis showed that the area under curve of let-7d-3p, miR-34a-5p, miR-221-3p and miR-451a was 0.94, 0.98, 0.97 and 0.94, with specificity of 90.48%, 95.24%, 90.48% and 90.48%, and sensitivity of 93.75%, 96.88%, 90.63% and 84.85%, respectively. In addition, target gene prediction found that the altered miRNAs are involved in affecting some important genes and pathway related to MDD. Our results suggested that differentially altered miRNAs in CSF might be involved in MDD, and serum miR-221-3p, miR-34a-5p, let-7d-3p, and miR-451a might be able to serve as biomarkers for MDD.	[Wan, Yunqiang; Liu, Yuanhui; Wang, Xiaobin; Wu, Jiali; Zhou, Jun; Liu, Li] Luzhou Med Coll, Dept Anesthesiol & Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China; [Liu, Kezhi] Luzhou Med Coll, Dept Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Chicago, IL 60612 USA	Southwest Medical University; Southwest Medical University; Rush University	Wang, XB (corresponding author), Luzhou Med Coll, Dept Anesthesiol & Psychiat, Affiliated Hosp, Luzhou, Sichuan Provinc, Peoples R China.	wangxiaobin67@163.com	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495; Zhou, Jun/0000-0002-7571-9314	Projects of the National Natural Science Foundation of China [81271478]; International Cooperation, Department of Science & Technology of Sichuan Province [2011HH0031]; Department of Education of Sichuan Province [14106]; Innovative Team, Department of Education of Sichuan Province [14TD0018]	Projects of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation, Department of Science & Technology of Sichuan Province; Department of Education of Sichuan Province; Innovative Team, Department of Education of Sichuan Province	This project was supported by the Projects of the National Natural Science Foundation of China (Grant No. 81271478); International Cooperation, Department of Science & Technology of Sichuan Province (Grant No. 2011HH0031); Department of Education of Sichuan Province (Grant No. 14106); and Innovative Team, Department of Education of Sichuan Province (Grant No. 14TD0018) to X. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Angelucci F, 2011, PHARMACOLOGY, V87, P5, DOI 10.1159/000322528; Baraniskin A, 2012, NEURO-ONCOLOGY, V14, P29, DOI 10.1093/neuonc/nor169; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bocchio-Chiavetto L, 2013, EUR NEUROPSYCHOPHARM, V23, P602, DOI 10.1016/j.euroneuro.2012.06.013; Cappuzzo F, 2014, CLIN COLORECTAL CANC, V13, P37, DOI 10.1016/j.clcc.2013.11.006; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Choi Eunhyun, 2014, Cells, V3, P899, DOI 10.3390/cells3030899; Croce N, 2013, MOL CELL BIOCHEM, V376, P189, DOI 10.1007/s11010-013-1567-0; Dwivedi Y, 2011, J CHEM NEUROANAT, V42, P142, DOI 10.1016/j.jchemneu.2011.04.002; Fan HM, 2014, J PSYCHIATR RES, V59, P45, DOI 10.1016/j.jpsychires.2014.08.007; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Gallego JA, 2012, J MOL NEUROSCI, V47, P243, DOI 10.1007/s12031-012-9731-7; Ghourchian Shadi, 2014, Med J Islam Repub Iran, V28, P9; Golimbet VE, 2014, B EXP BIOL MED+, V156, P680, DOI 10.1007/s10517-014-2424-1; Kishi T, 2010, J AFFECT DISORDERS, V126, P167, DOI 10.1016/j.jad.2010.04.003; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leibrock C, 2013, CELL PHYSIOL BIOCHEM, V32, P766, DOI 10.1159/000354478; Li LS, 2013, CLIN EXP MED, V13, P109, DOI 10.1007/s10238-012-0186-5; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Liu XL, 2014, J AFFECT DISORDERS, V163, P133, DOI 10.1016/j.jad.2013.12.035; Muller M, 2014, NEUROBIOL AGING, V35, P152, DOI 10.1016/j.neurobiolaging.2013.07.005; Oh DH, 2014, J NEURAL TRANSM, V121, P783, DOI 10.1007/s00702-014-1189-z; Oved K, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.86; Prins SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083166; Ray MT, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.26; Serafini G, 2014, CELL MOL NEUROBIOL, V34, P17, DOI 10.1007/s10571-013-9997-5; Smalheiser NR, 2014, PLOS ONE, V7; Varendi K, 2014, CELL MOL LIFE SCI, V71, P4443, DOI 10.1007/s00018-014-1628-x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wan QR, 2014, BEHAV BRAIN RES, V271, P1, DOI 10.1016/j.bbr.2014.05.031; Wang ZW, 2014, J AFFECT DISORDERS, V162, P116, DOI 10.1016/j.jad.2014.03.047; Wibrand K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041688; Zhou R, 2009, NEUROPSYCHOPHARMACOL, V34, P1395, DOI 10.1038/npp.2008.131; Zhou XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065040, 10.1371/journal.pone.0062245]	35	117	122	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0121975	10.1371/journal.pone.0121975	http://dx.doi.org/10.1371/journal.pone.0121975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763923	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300048
J	Ledochowski, L; Ruedl, G; Taylor, AH; Kopp, M				Ledochowski, Larissa; Ruedl, Gerhard; Taylor, Adrian H.; Kopp, Martin			Acute Effects of Brisk Walking on Sugary Snack Cravings in Overweight People, Affect and Responses to a Manipulated Stress Situation and to a Sugary Snack Cue: A Crossover Study	PLOS ONE			English	Article							BLOOD-PRESSURE RESPONSES; REGULAR CHOCOLATE EATERS; FOOD-CRAVINGS; EATING BEHAVIOR; EXERCISE; VALIDATION; SMOKING; TRAIT; MOOD; INTERFERENCE	Research has shown that acute exercise reduces urges for chocolate in normal weight people. This study aimed to examine the effects of an acute exercise bout on urges to consume sugary snacks, affect as well as 'psychological and physiological responses' to stress and a 'sugary snack cue', in overweight individuals. Following 3 days of chocolate-abstinence, 47 overweight, sugary snack consumers were assessed, in 2 randomly ordered conditions, in a within-subject design: 15-min brisk walk or passive control. Following each, participants completed 2 tasks: Stroop color-word interference task, and handling sugary snacks. Urges for sugary snacks, affective activation and valence were assessed. ANOVAs revealed significant condition x time interaction effects for: urges to consume sugary snacks, affective valence and activation. Obtained data show that exercise reduces urges for sugary snacks and attenuates urges in response to the stress situation and the cue in overweight people.	[Ledochowski, Larissa; Ruedl, Gerhard; Kopp, Martin] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Taylor, Adrian H.] Univ Plymouth, Peninsula Sch Med, Plymouth PL6 8BX, Devon, England; [Taylor, Adrian H.] Univ Plymouth, Peninsula Sch Dent, Plymouth PL6 8BX, Devon, England	University of Innsbruck; University of Plymouth; University of Plymouth	Ledochowski, L (corresponding author), Univ Innsbruck, Dept Sport Sci, Furstenweg 185, A-6020 Innsbruck, Austria.	larissa.ledochowski@uibk.ac.at	Kopp, Martin/K-1369-2017; Taylor, Adrian/GME-5077-2022	Kopp, Martin/0000-0002-3011-387X; Taylor, Adrian/0000-0003-2701-9468				Adam TC, 2007, PHYSIOL BEHAV, V91, P449, DOI 10.1016/j.physbeh.2007.04.011; Borg G., 1998, BORGS PERCEIVED EXER; Borg G., 2004, DEUT ARZTEBLATT, V101, P1016; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Cepeda-Benito A, 2000, BEHAV THER, V31, P151, DOI 10.1016/S0005-7894(00)80009-X; Cepeda-Benito A, 2000, BEHAV RES THER, V38, P1125, DOI 10.1016/S0005-7967(99)00141-2; COOLS J, 1992, J ABNORM PSYCHOL, V101, P348, DOI 10.1037/0021-843X.101.2.348; Ekkekakis P, 2000, J BEHAV MED, V23, P245, DOI 10.1023/A:1005558025163; Ekkekakis P, 2002, PSYCHOL SPORT EXERC, V2, P205; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Hamer M, 2006, BIOL PSYCHOL, V71, P183, DOI 10.1016/j.biopsycho.2005.04.004; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; King NA, 2012, BRIT J SPORT MED, V46, P315, DOI 10.1136/bjsm.2010.082495; Kopp M, 2012, DIABETES RES CLIN PR, V95, P25, DOI 10.1016/j.diabres.2011.09.017; Macht M, 2007, APPETITE, V49, P667, DOI 10.1016/j.appet.2007.05.004; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; Oh H, 2014, HEALTH PSYCHOL, V33, P349, DOI 10.1037/a0032423; Oh H, 2013, APPETITE, V71, P144, DOI 10.1016/j.appet.2013.07.015; Oh H, 2012, APPETITE, V58, P387, DOI 10.1016/j.appet.2011.11.006; Ouwehand C, 2008, OBESITY, V16, P1788, DOI 10.1038/oby.2008.316; Polivy J, 2005, INT J EAT DISORDER, V38, P301, DOI 10.1002/eat.20195; Renaud P, 1997, INT J PSYCHOPHYSIOL, V27, P87, DOI 10.1016/S0167-8760(97)00049-4; Rodriguez S, 2005, BIOL PSYCHOL, V70, P9, DOI 10.1016/j.biopsycho.2004.10.001; Rodriguez S, 2007, APPETITE, V49, P245, DOI 10.1016/j.appet.2007.01.001; Rogers PJ, 2000, PHARMACOL BIOCHEM BE, V66, P3, DOI 10.1016/S0091-3057(00)00197-0; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shaban R, 2008, AUSTRALAS EMERG NURS, V11, P1, DOI 10.1016/j.aenj.2007.12.003; STONE AA, 1994, PSYCHOL HEALTH, V9, P425, DOI 10.1080/08870449408407469; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; SVEBAK S, 1985, J PERS SOC PSYCHOL, V48, P107, DOI 10.1037/0022-3514.48.1.107; Tanofsky-Kraff M, 2000, INT J EAT DISORDER, V27, P411, DOI 10.1002/(SICI)1098-108X(200005)27:4<411::AID-EAT5>3.0.CO;2-P; Taylor A, 2006, PSYCHOPHARMACOLOGY, V184, P247, DOI 10.1007/s00213-005-0275-1; Taylor AH, 2007, ADDICTION, V102, P534, DOI 10.1111/j.1360-0443.2006.01739.x; Taylor AH, 2009, APPETITE, V52, P155, DOI 10.1016/j.appet.2008.09.004; Tetley AC, 2010, EAT BEHAV, V11, P138, DOI 10.1016/j.eatbeh.2009.12.004; Thayer R.E., 2003, CALM ENERGY PEOPLE R; THAYER RE, 1987, J PERS SOC PSYCHOL, V52, P119, DOI 10.1037/0022-3514.52.1.119; THAYER RE, 1978, PSYCHOL REP, V42, P747, DOI 10.2466/pr0.1978.42.3.747; THAYER RE, 1993, PERS INDIV DIFFER, V14, P97, DOI 10.1016/0191-8869(93)90178-6; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Wardle J, 2000, J PSYCHOSOM RES, V48, P195, DOI 10.1016/S0022-3999(00)00076-3; WEINGARTEN HP, 1991, APPETITE, V17, P167, DOI 10.1016/0195-6663(91)90019-O; Zellner DA, 1999, APPETITE, V33, P61, DOI 10.1006/appe.1999.0234	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119278	10.1371/journal.pone.0119278	http://dx.doi.org/10.1371/journal.pone.0119278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD7MQ	25760042	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000051
J	Czarniak, P; Bint, L; Favie, L; Parsons, R; Hughes, J; Sunderland, B				Czarniak, Petra; Bint, Lewis; Favie, Laurent; Parsons, Richard; Hughes, Jeff; Sunderland, Bruce			Clinical Setting Influences Off-Label and Unlicensed Prescribing in a Paediatric Teaching Hospital	PLOS ONE			English	Article							INTENSIVE-CARE UNIT; DRUG-USE; MEDICATION USE; CHILDREN; MEDICINES; WARDS; FINLAND	Purpose To estimate the prevalence of off-label and unlicensed prescribing during 2008 at a major paediatric teaching hospital in Western Australia. Methods A 12-month retrospective study was conducted at Princess Margaret Hospital using medication chart records randomly selected from 145,550 patient encounters from the Emergency Department, Inpatient Wards and Outpatient Clinics. Patient and prescribing data were collected. Drugs were classified as off-label or unlicensed based on Australian registration data. A hierarchical system of age, indication, route of administration and dosage was used. Drugs were classified according to the Anatomical Therapeutic Chemical Code. Results A total of 1,037 paediatric patients were selected where 2,654 prescriptions for 330 different drugs were prescribed to 699 patients (67.4%). Most off-label drugs (n = 295; 43.3%) were from the nervous system; a majority of unlicensed drugs were systemic hormonal preparations excluding sex hormones (n = 22, 32.4%). Inpatients were prescribed more off-label drugs than outpatients or Emergency Department patients (p < 0.0001). Most off-label prescribing occurred in infants and children (31.7% and 35.9% respectively) and the highest percentage of unlicensed prescribing (7.2%) occurred in infants (p < 0.0001). There were 25.7% of off-label and 2.6% of unlicensed medications prescribed across all three settings. Common reasons for off-label prescribing were dosage (47.4%) and age (43.2%). Conclusion This study confirmed off-label and unlicensed use of drugs remains common. Further, that prevalence of both is influenced by the clinical setting, which has implications in regards to medication misadventure, and the need to have systems in place to minimise medication errors. Further, there remains a need for changes in the regulatory system in Australia to ensure that manufacturers incorporate, as it becomes available, evidence regarding efficacy and safety of their drugs in children in the official product information.	[Czarniak, Petra; Parsons, Richard; Hughes, Jeff; Sunderland, Bruce] Curtin Univ, Bentley, WA, Australia; [Bint, Lewis] Princess Margaret Hosp, Subiaco, WA, Australia; [Favie, Laurent] Univ Utrecht, Dept Pharmaceut Sci, NL-3508 TC Utrecht, Netherlands	Curtin University; Utrecht University	Czarniak, P (corresponding author), Curtin Univ, Bentley, WA, Australia.	P.Czarniak@curtin.edu.au						AMH Children's Dosing Companion, 2013, AMH CHILDR DOS COMP; [Anonymous], 2008, THER GOODS ADM PROD; Avenel S, 2000, ARCH PEDIATRIE, V7, P143, DOI 10.1016/S0929-693X(00)88083-5; Bajcetic M, 2005, EUR J CLIN PHARMACOL, V61, P775, DOI 10.1007/s00228-005-0981-y; Ballard CDJ, 2013, J PAEDIATR CHILD H, V49, P38, DOI 10.1111/jpc.12065; Barr J, 2002, AM J PERINAT, V19, P67, DOI 10.1055/s-2002-23557; Conroy S, 2003, ANN ONCOL, V14, P42, DOI 10.1093/annonc/mdg031; Conroy S, 1999, ARCH DIS CHILD-FETAL, V80, pF142, DOI 10.1136/fn.80.2.F142; Conroy S, 2001, PAEDIATR ANAESTH, V11, P431, DOI 10.1046/j.1460-9592.2001.00697.x; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; Craig J S, 2001, Ir Med J, V94, P237; Di Paolo Ermindo R, 2006, Swiss Med Wkly, V136, P218; European Medicines Agency, 2001, ICH TOP E11 CLIN INV; Gavrilov V, 2000, ISRAEL MED ASSOC J, V2, P595; Hsien L, 2008, PHARM WORLD SCI, V30, P497, DOI 10.1007/s11096-008-9193-8; LEE JHW, 2013, J HYDRO ENVIRON RES, V0007; Lindell-Osuagwu L, 2014, J CLIN PHARM THER, V39, P144, DOI 10.1111/jcpt.12119; Lindell-Osuagwu L, 2009, J CLIN PHARM THER, V34, P277, DOI 10.1111/j.1365-2710.2008.01005.x; McKinzie JP, 1997, AM J EMERG MED, V15, P118, DOI 10.1016/S0735-6757(97)90079-6; MIMS Australia, 2008, MONTHL IND MED SPEC; Neubert A, 2004, DRUG SAFETY, V27, P1059, DOI 10.2165/00002018-200427130-00006; O'Donnell CPF, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e52; Palcevski G, 2012, EUR J CLIN PHARMACOL, V68, P1073, DOI 10.1007/s00228-012-1221-x; Ribeiro M, 2012, I CONF SENS TECHNOL, P1, DOI 10.1109/ICSensT.2012.6461670; Santos DB, 2008, EUR J CLIN PHARMACOL, V64, P1111, DOI 10.1007/s00228-008-0543-1; Sinha Y, 2007, J PAEDIATR CHILD H, V43, P107, DOI 10.1111/j.1440-1754.2007.00970.x; 't Jong GW, 2002, EUR J CLIN PHARMACOL, V58, P293, DOI 10.1007/s00228-002-0479-9; 't Jong GW, 2001, PEDIATRICS, V108, P1089, DOI 10.1542/peds.108.5.1089; Turner S, 1996, LANCET, V347, P549, DOI 10.1016/S0140-6736(96)91182-4; Turner Sean, 1999, Australian Journal of Hospital Pharmacy, V29, P265; Zanon D, 2012, EUROPEAN J PEDIAT, P1	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120630	10.1371/journal.pone.0120630	http://dx.doi.org/10.1371/journal.pone.0120630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756896	Green Published, gold			2022-12-26	WOS:000351275700070
J	Nakanishi, A; Kishikawa, J; Tamakoshi, M; Yokoyama, K				Nakanishi, Atsuko; Kishikawa, Jun-ichi; Tamakoshi, Masatada; Yokoyama, Ken			The Ingenious Structure of Central Rotor Apparatus in VoV1; Key for Both Complex Disassembly and Energy Coupling between V-1 and V-o	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; ROTARY MOTOR; ATPASE; SUBUNIT; V-1-ATPASE; STALK; INHIBITION; MECHANISM	Vacuolar type rotary H+-ATPases (VoV1) couple ATP synthesis/hydrolysis by V-1 with proton translocation by V-o via rotation of a central rotor apparatus composed of the V-1-DF rotor shaft, a socket-like V-o-C (eukaryotic V-o-d) and the hydrophobic rotor ring. Reconstitution experiments using subcomplexes revealed a weak binding affinity of V-1-DF to V-o-C despite the fact that torque needs to be transmitted between V-1-DF and V-o-C for the tight energy coupling between V-1 and V-o. Mutation of a short helix at the tip of V-1-DF caused intramolecular uncoupling of VoV1, suggesting that proper fitting of the short helix of V-1-D into the socket of V-o-C is required for tight energy coupling between V-1 and V-o. To account for the apparently contradictory properties of the interaction between V-1-DF and V-o-C (weak binding affinity but strict requirement for torque transmission), we propose a model in which the relationship between V-1-DF and V-o-C corresponds to that between a slotted screwdriver and a head of slotted screw. This model is consistent with our previous result in which the central rotor apparatus is not the major factor for the association of V-1 with V-o (Kishikawa and Yokoyama, J Biol Chem. 2012 24597-24603).	[Nakanishi, Atsuko; Kishikawa, Jun-ichi; Yokoyama, Ken] Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 603, Japan; [Tamakoshi, Masatada] Tokyo Univ Pharm & Life Sci, Dept Mol Biol, Hachioji, Tokyo 19203, Japan	Kyoto Sangyo University; Tokyo University of Pharmacy & Life Sciences	Yokoyama, K (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Kita Ku, Kyoto 603, Japan.	yokoken@cc.kyoto-su.ac.jp		Nakanishi, Atsuko/0000-0001-8262-0796; Kishikawa, Jun-ichi/0000-0003-3913-7330	Ministry of Education, Science, Sports and Culture of Japan [24370059, 26650039]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan No. 24370059 and 26650039 to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Imamura H, 2004, J BIOL CHEM, V279, P18085, DOI 10.1074/jbc.M314204200; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kakinuma Y, 1999, J BIOENERG BIOMEMBR, V31, P7, DOI 10.1023/A:1005499126939; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kishikawa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064695; Kishikawa J, 2012, J BIOL CHEM, V287, P24597, DOI 10.1074/jbc.M112.367813; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Saijo S, 2011, P NATL ACAD SCI USA, V108, P19955, DOI 10.1073/pnas.1108810108; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Stewart AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1693; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Takeda M, 2009, BIOPHYS J, V96, P1210, DOI 10.1016/j.bpj.2008.10.031; Tamakoshi M, 1997, J BACTERIOL, V179, P4811, DOI 10.1128/jb.179.15.4811-4814.1997; Tani K, 2013, MICROSCOPY-JPN, V62, P467, DOI 10.1093/jmicro/dft020; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119602	10.1371/journal.pone.0119602	http://dx.doi.org/10.1371/journal.pone.0119602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756791	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275700049
J	Schneider, N; Goncalves, FDC; Pinto, FO; Lopez, PLD; Araujo, AB; Pfaffenseller, B; Passos, EP; Cirne-Lima, EO; Meurer, L; Lamers, ML; Paz, AH				Schneider, Natalia; Goncalves, Fabiany da Costa; Pinto, Fernanda Otesbelgue; da Costa Lopez, Patrcia Luciana; Araujo, Anelise Bergmann; Pfaffenseller, Bianca; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino; Meurer, Luise; Lamers, Marcelo Lazzaron; Paz, Ana Helena			Dexamethasone and Azathioprine Promote Cytoskeletal Changes and Affect Mesenchymal Stem Cell Migratory Behavior	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; UMBILICAL-CORD; INTERNATIONAL-SOCIETY; EXPERIMENTAL COLITIS; THERAPY; ADHESION; TRANSPLANTATION; PROLIFERATION; EXPRESSION	Glucocorticoids and immunosuppressive drugs are commonly used to treat inflammatory disorders, such as inflammatory bowel disease (IBD), and despite a few improvements, the remission of IBD is still difficult to maintain. Due to their immunomodulatory properties, mesenchymal stem cells (MSCs) have emerged as regulators of the immune response, and their viability and activation of their migratory properties are essential for successful cell therapy. However, little is known about the effects of immunosuppressant drugs used in IBD treatment on MSC behavior. The aim of this study was to evaluate MSC viability, nuclear morphometry, cell polarity, F-actin and focal adhesion kinase (FAK) distribution, and cell migratory properties in the presence of the immunosuppressive drugs azathioprine (AZA) and dexamethasone (DEX). After an initial characterization, MSCs were treated with DEX (10 mu M) or AZA (1 mu M) for 24 hrs or 7 days. Neither drug had an effect on cell viability or nuclear morphometry. However, AZA treatment induced a more elongated cell shape, while DEX was associated with a more rounded cell shape (P < 0.05) with a higher presence of ventral actin stress fibers (P < 0.05) and a decrease in protrusion stability. After 7 days of treatment, AZA improved the cell spatial trajectory (ST) and increased the migration speed (24.35%, P < 0.05, n = 4), while DEX impaired ST and migration speed after 24 hrs and 7 days of treatment (-28.69% and -25.37%, respectively; P < 0.05, n = 4). In conclusion, our data suggest that these immunosuppressive drugs each affect MSC morphology and migratory capacity differently, possibly impacting the success of cell therapy.	[Schneider, Natalia; Goncalves, Fabiany da Costa; Pinto, Fernanda Otesbelgue; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino; Paz, Ana Helena] Hosp Clin Porto Alegre, Expt Res Ctr, Embryol & Cell Differentiat Lab, BR-90035 Porto Alegre, RS, Brazil; [Schneider, Natalia; Goncalves, Fabiany da Costa; Meurer, Luise; Paz, Ana Helena] Univ Fed Rio Grande do Sul, Grad Program Gastroenterol & Hepatol Sci, BR-90035 Porto Alegre, RS, Brazil; [da Costa Lopez, Patrcia Luciana; Araujo, Anelise Bergmann; Pfaffenseller, Bianca] Hosp Clin Porto Alegre, Expt Res Ctr, BR-90035 Porto Alegre, RS, Brazil; [Lamers, Marcelo Lazzaron; Paz, Ana Helena] Univ Fed Rio Grande do Sul, Hlth Basic Sci Inst, Dept Morphol Sci, BR-90050 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Paz, AH (corresponding author), Hosp Clin Porto Alegre, Expt Res Ctr, Embryol & Cell Differentiat Lab, Ramiro Barcelos 2350, BR-90035 Porto Alegre, RS, Brazil.	anahpaz@gmail.com	Araújo, Anelise/W-4990-2019; Pfaffenseller, Bianca/AAA-3635-2021; Passos, Eduardo P/A-2842-2012; Paz, Ana Helena/V-6082-2019; LAMERS, MARCELO/A-5291-2013; Cirne-Lima, Elizabeth Obino/N-9796-2018	Araújo, Anelise/0000-0001-5277-1964; LAMERS, MARCELO/0000-0001-5296-5662; Otesbelgue Pinto, Fernanda/0000-0003-0549-2457; Paz, Ana Helena/0000-0003-3668-7054; Schneider Nunes, Natalia/0000-0003-1950-4391	FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [479527/2012-1]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Authors would like to thank FIPE (Fundo de Incentivo a Pesquisa e Eventos) from Hospital de Clinicas de Porto Alegre, CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (#479527/2012-1) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for research funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2013, GUT, V62, P1131, DOI 10.1136/gutjnl-2012-302152; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Boscher C, 2012, ADV EXP MED BIOL, V729, P29, DOI 10.1007/978-1-4614-1222-9_3; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Buron F, 2009, TRANSPL P, V41, P3347, DOI 10.1016/j.transproceed.2009.08.030; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Charwat S, 2008, EXP HEMATOL, V36, P672, DOI 10.1016/j.exphem.2008.01.005; Chen JC, 2013, J CELL MOL MED, V17, P863, DOI 10.1111/jcmm.12069; Chen X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.537; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; ClinicalTrials, OS THER PHAS 3 MULT; ClinicalTrials.gov, RAND DOUBL BLIND PLA; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Martinez-Montiel MD, 2014, WORLD J GASTROENTERO, V20, P1211, DOI 10.3748/wjg.v20.i5.1211; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2011, CYTOTHERAPY, V13, P1066, DOI 10.3109/14653249.2011.597379; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Filippi-Chiela EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042522; Forbes GM, 2014, CLIN GASTROENTEROL H, V12, P64, DOI 10.1016/j.cgh.2013.06.021; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Gazouli M, 2014, INFLAMM BOWEL DIS, V20, P952, DOI 10.1097/01.MIB.0000442922.85569.21; Geissler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052700; Giamarellos-Bourboulis EJ, 2010, CYTOKINE, V49, P89, DOI 10.1016/j.cyto.2009.08.016; Goncalves FD, 2014, WORLD J GASTROENTERO, V20, P18228, DOI 10.3748/wjg.v20.i48.18228; Gonzalez-Rey E, 2009, GUT, V58, P929, DOI 10.1136/gut.2008.168534; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hoogduijn MJ, 2008, TRANSPLANTATION, V86, P1283, DOI 10.1097/TP.0b013e31818aa536; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Igarashi J, 2013, AM J PHYSIOL-CELL PH, V304, pC790, DOI 10.1152/ajpcell.00268.2012; Indumathi S, 2013, TISSUE CELL, V45, P434, DOI 10.1016/j.tice.2013.07.007; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kholodenko IV, 2012, B EXP BIOL MED+, V154, P118, DOI 10.1007/s10517-012-1890-6; Kim JW, 2013, SPINE, V38, pE1065, DOI 10.1097/BRS.0b013e31829839fa; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Lamers ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022865; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li G, 2009, PROTEOMICS, V9, P20, DOI 10.1002/pmic.200701195; Li Li, 2011, Front Med, V5, P33, DOI 10.1007/s11684-011-0114-1; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Li XY, 2014, INT J MOL MED, V34, P695, DOI 10.3892/ijmm.2014.1821; Liang J, 2012, GUT, V61, P468, DOI 10.1136/gutjnl-2011-300083; Liang L, 2011, CELL TRANSPLANT, V20, P1395, DOI 10.3727/096368910X557245; Liu L, 2009, INT IMMUNOPHARMACOL, V9, P1568, DOI 10.1016/j.intimp.2009.09.013; Lopez PLC, 2012, ONCOLOGY-BASEL, V83, P75, DOI 10.1159/000337978; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Mancheno-Corvo P, 2013, BIORESEARCH OPEN ACC, V2, P431, DOI 10.1089/biores.2013.0040; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moggio A, 2012, FERTIL STERIL, V98, P1521, DOI 10.1016/j.fertnstert.2012.08.003; Mokbel AN, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-259; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller N, 2013, J IMMUNOL, V190, P4360, DOI 10.4049/jimmunol.1201520; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Nuzzi R, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/946090; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pham PTT, 2012, NEPHROL DIAL TRANSPL, V27, P2965, DOI 10.1093/ndt/gfr731; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Poppe D, 2006, J IMMUNOL, V176, P640, DOI 10.4049/jimmunol.176.1.640; Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schroll S, 2005, REGUL PEPTIDES, V131, P1, DOI 10.1016/j.regpep.2005.03.001; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Song IH, 2009, J ORTHOP RES, V27, P216, DOI 10.1002/jor.20726; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Xinaris C, 2013, CELL TRANSPLANT, V22, P423, DOI 10.3727/096368912X653246; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhu YZ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt436; Zhuo W, 2013, TRANSPL P, V45, P503, DOI 10.1016/j.transproceed.2012.07.162	79	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0120538	10.1371/journal.pone.0120538	http://dx.doi.org/10.1371/journal.pone.0120538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756665	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700068
J	Burin, D; Livelli, A; Garbarini, F; Fossataro, C; Folegatti, A; Gindri, P; Pia, L				Burin, Dalila; Livelli, Alessandro; Garbarini, Francesca; Fossataro, Carlotta; Folegatti, Alessia; Gindri, Patrizia; Pia, Lorenzo			Are Movements Necessary for the Sense of Body Ownership? Evidence from the Rubber Hand Illusion in Pure Hemiplegic Patients	PLOS ONE			English	Article							AROUSAL RESPONSES; UNAFFECTED LIMBS; STROKE PATIENTS; BODILY SELF; ANOSOGNOSIA; INTEGRATION; EMBODIMENT; STIMULATION; SENSITIVITY; POSITION	A question still debated within cognitive neuroscience is whether signals present during actions significantly contribute to the emergence of human's body ownership. In the present study, we aimed at answer this question by means of a neuropsychological approach. We administered the classical rubber hand illusion paradigm to a group of healthy participants and to a group of neurological patients affected by a complete left upper limb hemiplegia, but without any propriceptive/tactile deficits. The illusion strength was measured both subjectively (i.e., by a self-report questionnaire) and behaviorally (i.e., the location of one's own hand is shifted towards the rubber hand). We aimed at examining whether, and to which extent, an enduring absence of movements related signals affects body ownership. Our results showed that patients displayed, respect to healthy participants, stronger illusory effects when the left (affected) hand was stimulated and no effects when the right (unaffected) hand was stimulated. In other words, hemiplegics had a weaker/more flexible sense of body ownership for the affected hand, but an enhanced/more rigid one for the healthy hand. Possible interpretations of such asymmetrical distribution of body ownership, as well as limits of our results, are discussed. Broadly speaking, our findings suggest that the alteration of the normal flow of signals present during movements impacts on human's body ownership. This in turn, means that movements have a role per se in developing and maintaining a coherent body ownership.	[Burin, Dalila; Livelli, Alessandro; Garbarini, Francesca; Fossataro, Carlotta; Folegatti, Alessia; Gindri, Patrizia; Pia, Lorenzo] Univ Turin, Dept Psychol, SAMBA SpAtial Motor & Bodily Awareness Res Grp, Turin, Italy; [Pia, Lorenzo] NIT Neurosci Inst Turin, Turin, Italy; [Gindri, Patrizia] San Camillo Hosp, Turin, Italy	University of Turin	Pia, L (corresponding author), Univ Turin, Dept Psychol, SAMBA SpAtial Motor & Bodily Awareness Res Grp, Turin, Italy.	lorenzo.pia@unito.it	Pia, Lorenzo/R-5263-2016; Garbarini, Francesca/L-9350-2019; Burin, Dalila/U-8108-2019	Pia, Lorenzo/0000-0002-0360-3152; Garbarini, Francesca/0000-0003-1210-0175; Burin, Dalila/0000-0002-9884-7650; Fossataro, Carlotta/0000-0001-8145-006X	MASTER DEI TALENTI Scholarship	MASTER DEI TALENTI Scholarship	This work was supported by MASTER DEI TALENTI 2013 Scholarship to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Cocchini G, 2001, NEUROPSYCHOL REHABIL, V11, P17, DOI 10.1080/09602010042000132; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Desaphy JF, 2001, BRAIN, V124, P1100, DOI 10.1093/brain/124.6.1100; Diller L, 1977, Adv Neurol, V18, P63; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Farne A, 2000, BRAIN, V123, P2350, DOI 10.1093/brain/123.11.2350; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gallese V, 2010, NEUROPSYCHOLOGIA, V48, P746, DOI 10.1016/j.neuropsychologia.2009.09.038; Garbarini F, 2014, CURR BIOL, V24, pR738, DOI 10.1016/j.cub.2014.07.023; Garbarini F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00737; Garbarini F, 2013, J NEUROL NEUROSUR PS, V84, P416, DOI 10.1136/jnnp-2012-302838; Garbarini F, 2013, CURR BIOL, V23, pR57, DOI 10.1016/j.cub.2012.12.003; GUIARD Y, 1987, J MOTOR BEHAV, V19, P486; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Merleau-Ponty M., 1962, PHENOMENOLOGY OF PER; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pia L, 2014, TRANSLATIONAL NEUROS, V5, P1, DOI DOI 10.2478/S13380-014-0227-5; Pia L, 2014, CORTEX, V61, P158, DOI 10.1016/j.cortex.2014.08.006; Pia L, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00298; Pia L, 2013, CORTEX, V49, P1694, DOI 10.1016/j.cortex.2012.08.017; Pia L, 2013, J NEUROPSYCHOL, V7, P45, DOI 10.1111/j.1748-6653.2012.02034.x; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Riemer M, 2013, EXP BRAIN RES, V229, P383, DOI 10.1007/s00221-012-3374-3; Rognini G, 2013, EUR J NEUROSCI, V37, P1120, DOI 10.1111/ejn.12128; Romano D, 2014, BEHAV BRAIN RES, V261, P275, DOI 10.1016/j.bbr.2013.12.049; Romano D, 2013, RESTOR NEUROL NEUROS, V31, P373, DOI 10.3233/RNN-120273; Sato Y, 2005, J NEUROL SCI, V231, P13, DOI 10.1016/j.jns.2004.12.005; Sato Y, 1999, STROKE, V30, P414, DOI 10.1161/01.STR.30.2.414; Scandola M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00404; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Spinazzola L., 2014, APPL PSYCHOLOG B, V62, P37; Tidoni E, 2014, RESTORATIVE NEUROLOG; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Walsh LD, 2011, J PHYSIOL-LONDON, V589, P3009, DOI 10.1113/jphysiol.2011.204941; Wilson B., 1987, THE BEHAVIOURAL INAT; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zanette G, 2004, CLIN NEUROPHYSIOL, V115, P1264, DOI 10.1016/j.clinph.2003.12.033	54	75	76	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117155	10.1371/journal.pone.0117155	http://dx.doi.org/10.1371/journal.pone.0117155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775041	Green Published, gold			2022-12-26	WOS:000351183500016
J	Chou, CL; Pang, CY; Lee, TJF; Fang, TC				Chou, Chu-Lin; Pang, Cheng-Yoong; Lee, Tony J. F.; Fang, Te-Chao			Beneficial Effects of Calcitriol on Hypertension, Glucose Intolerance, Impairment of Endothelium-Dependent Vascular Relaxation, and Visceral Adiposity in Fructose-Fed Hypertensive Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HYPERINSULINEMIA-INDUCED HYPERTENSION; VITAMIN-D DEFICIENCY; BLOOD-PRESSURE; 1,25-DIHYDROXYVITAMIN D-3; INSULIN-RESISTANCE; METABOLIC SYNDROME; RECEPTOR; INCREASES; CALCIUM	Besides regulating calcium homeostasis, the effects of vitamin D on vascular tone and metabolic disturbances remain scarce in the literature despite an increase intake with high-fructose corn syrup worldwide. We investigated the effects of calcitriol, an active form of vitamin D, on vascular relaxation, glucose tolerance, and visceral fat pads in fructose-fed rats. Male Wistar-Kyoto rats were divided into 4 groups (n = 6 per group). Group Con: standard chow diet for 8 weeks; Group Fru: high-fructose diet (60% fructose) for 8 weeks; Group Fru-HVD: high-fructose diet as Group Fru, high-dose calcitriol treatment (20 ng/100 g body weight per day) 4 weeks after the beginning of fructose feeding; and Group Fru-LVD: high-fructose diet as Group Fru, low-dose calcitriol treatment (10 ng/100 g body weight per day) 4 weeks after the beginning of fructose feeding. Systolic blood pressure was measured twice a week by the tail-cuff method. Blood was examined for serum ionized calcium, phosphate, creatinine, glucose, triglycerides, and total cholesterol. Intra-peritoneal glucose intolerance test, aortic vascular reactivity, the weight of visceral fat pads, adipose size, and adipose angiotensin II levels were analyzed at the end of the study. The results showed that the fructose-fed rats significantly developed hypertension, impaired glucose tolerance, heavier weight and larger adipose size of visceral fat pads, and raised adipose angiotensin II expressions compared with the control rats. High-and low-dose calcitriol reduced modestly systolic blood pressure, increased endothelium-dependent aortic relaxation, ameliorated glucose intolerance, reduced the weight and adipose size of visceral fat pads, and lowered adipose angiotensin II expressions in the fructose-fed rats. However, high-dose calcitriol treatment mildly increased serum ionized calcium levels (1.44 +/- 0.05 mmol/L). These results suggest a protective role of calcitriol treatment on endothelial function, glucose tolerance, and visceral adiposity in fructose-fed rats.	[Chou, Chu-Lin; Pang, Cheng-Yoong] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lee, Tony J. F.] Tzu Chi Univ, Inst Life Sci Pharmacol & Toxicol & Med Sci, Hualien, Taiwan; [Lee, Tony J. F.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA; [Fang, Te-Chao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Fang, Te-Chao] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; Southern Illinois University System; Southern Illinois University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Fang, TC (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	fangtechao@yahoo.com.tw	Pang, Cheng-Yoong/AFO-1562-2022; Pang, Cheng-Yoong/R-4990-2019	Pang, Cheng-Yoong/0000-0002-9063-2858; Chou, Chu-Lin/0000-0002-9695-1067	Tzu Chi General Hospital, Hualien, Taiwan [TCRD 102-50]	Tzu Chi General Hospital, Hualien, Taiwan	This study was supported by a grant from Tzu Chi General Hospital (TCRD 102-50), Hualien, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Atchison DK, 2013, AM J PHYSIOL-RENAL, V305, pF1109, DOI 10.1152/ajprenal.00010.2013; Bas A, 2006, J BONE MINER RES, V21, P484, DOI 10.1359/JBMR.051211; Baz-Hecht M, 2010, CURR OPIN ENDOCRINOL, V17, P113, DOI 10.1097/MED.0b013e3283372859; Boucher BJ, 2011, CURR DRUG TARGETS, V12, P61; Cheng Q, 2011, DIABETOLOGIA, V54, P2077, DOI 10.1007/s00125-011-2100-1; Chou CL, 2013, HYPERTENS RES, V36, P123, DOI 10.1038/hr.2012.124; Chou CL, 2011, ARCH MED SCI, V7, P882, DOI 10.5114/aoms.2011.25566; de Boer IH, 2008, CURR OPIN NEPHROL HY, V17, P566, DOI 10.1097/MNH.0b013e32830fe377; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Douard V, 2013, AM J PHYSIOL-ENDOC M, V304, pE1303, DOI 10.1152/ajpendo.00582.2012; Fang TC, 1998, HYPERTENSION, V32, P235, DOI 10.1161/01.HYP.32.2.235; Fang TC, 1998, J HYPERTENS, V16, P1767, DOI 10.1097/00004872-199816120-00009; Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408; Frigolet ME, 2013, J NUTR BIOCHEM, V24, P2003, DOI 10.1016/j.jnutbio.2013.07.002; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Ghiadoni L, 2012, CURR VASC PHARMACOL, V10, P42, DOI 10.2174/157016112798829823; Giacchetti G, 2000, J HYPERTENS, V18, P695, DOI 10.1097/00004872-200018060-00006; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Goltzman D, 2010, ANN NY ACAD SCI, V1192, P145, DOI 10.1111/j.1749-6632.2009.05226.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; HWANG IS, 1989, AM J HYPERTENS, V2, P424, DOI 10.1093/ajh/2.6.424; HWANG IS, 1987, HYPERTENSION, V10, P512, DOI 10.1161/01.HYP.10.5.512; Ikeda A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/863410; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Kinzig KP, 2010, ENDOCRINOLOGY, V151, P3105, DOI 10.1210/en.2010-0175; KOBAYASHI R, 1993, HYPERTENSION, V21, P1051, DOI 10.1161/01.HYP.21.6.1051; Lastra G, 2008, AM J PHYSIOL-ENDOC M, V295, pE110, DOI 10.1152/ajpendo.00258.2007; Lin HW, 2008, P NATL ACAD SCI USA, V105, P19526, DOI 10.1073/pnas.0810262105; Maestro B, 2000, ENDOCR J, V47, P383, DOI 10.1507/endocrj.47.383; Mancuso P, 2008, J CARDIOVASC PHARM, V51, P559, DOI 10.1097/FJC.0b013e3181761906; Maurer AD, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-77; Mellanby E, 1919, LANCET, V1, P407; Min LJ, 2014, AM J HYPERTENS, V27, P1036, DOI 10.1093/ajh/hpu015; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; MORTENSEN JT, 1993, PHARMACOL TOXICOL, V72, P124, DOI 10.1111/j.1600-0773.1993.tb00302.x; Nagai Y, 2009, EXP PHYSIOL, V94, P1016, DOI 10.1113/expphysiol.2009.048108; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Osaki A, 2014, HYPERTENS RES, V37, P185, DOI 10.1038/hr.2013.122; Parikh SJ, 2004, J CLIN ENDOCR METAB, V89, P1196, DOI 10.1210/jc.2003-031398; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Pittas AG, 2010, ANN INTERN MED, V152, P307, DOI 10.7326/0003-4819-152-5-201003020-00009; Reungjui S, 2007, J AM SOC NEPHROL, V18, P2724, DOI 10.1681/ASN.2007040416; Saito H, 2014, J STEROID BIOCHEM, V144, P189, DOI 10.1016/j.jsbmb.2013.11.013; Saito H, 2013, J STEROID BIOCHEM, V136, P178, DOI 10.1016/j.jsbmb.2012.10.004; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; Sergeev IN, 2014, MOL NUTR FOOD RES, V58, P1342, DOI 10.1002/mnfr.201300503; Soares MJ, 2011, EUR J CLIN NUTR, V65, P994, DOI 10.1038/ejcn.2011.106; Strahorn P, 2005, J HYPERTENS, V23, P2179, DOI 10.1097/01.hjh.0000191904.26853.b8; Stucchi P, 2009, BRIT J PHARMACOL, V158, P771, DOI 10.1111/j.1476-5381.2009.00355.x; Takiishi T, 2010, ENDOCRIN METAB CLIN, V39, P419, DOI 10.1016/j.ecl.2010.02.013; Tamez H, 2012, CURR OPIN NEPHROL HY, V21, P492, DOI 10.1097/MNH.0b013e3283557bf0; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Vieth R, 2007, J BONE MINER RES, V22, pV64, DOI 10.1359/JBMR.07S221; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Witham MD, 2009, J HYPERTENS, V27, P1948, DOI 10.1097/HJH.0b013e32832f075b; Wong MSK, 2008, AM J PHYSIOL-HEART C, V295, pH289, DOI 10.1152/ajpheart.00116.2008; Wong MSK, 2010, AM J PHYSIOL-HEART C, V299, pH1226, DOI 10.1152/ajpheart.00288.2010; Wu K, 2010, ENDOCRINOLOGY, V151, P3566, DOI 10.1210/en.2010-0204; Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x; Yen TH, 2013, LUPUS, V22, P180, DOI 10.1177/0961203312471871; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zebger-Gong H, 2011, J HYPERTENS, V29, P339, DOI 10.1097/HJH.0b013e328340aa30; Zhou CL, 2008, KIDNEY INT, V74, P170, DOI 10.1038/ki.2008.101; Zittermann A, 2007, CURR OPIN LIPIDOL, V18, P41, DOI 10.1097/MOL.0b013e328011c6fc	67	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119843	10.1371/journal.pone.0119843	http://dx.doi.org/10.1371/journal.pone.0119843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774877	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500132
J	Schreiner, B; Ingold-Heppner, B; Pehl, D; Locatelli, G; Berrit-SchNthaler, H; Becher, B				Schreiner, Bettina; Ingold-Heppner, Barbara; Pehl, Debora; Locatelli, Giuseppe; BerritSch Nthaler, Helia; Becher, Burkhard			Deletion of Jun Proteins in Adult Oligodendrocytes Does Not Perturb Cell Survival, or Myelin Maintenance In Vivo	PLOS ONE			English	Article							C-JUN; AXONAL REGENERATION; TRANSCRIPTION FACTORS; MULTIPLE-SCLEROSIS; MOUSE DEVELOPMENT; SCHWANN-CELLS; INDUCED DEATH; KAPPA-B; AP-1; ACTIVATION	Oligodendrocytes, the myelin-forming glial cells of the central nervous system (CNS), are fundamental players in rapid impulse conduction and normal axonal functions. JunB and c-Jun are DNA-binding components of the AP-1 transcription factor, which is known to regulate different processes such as proliferation, differentiation, stress responses and death in several cell types, including cultured oligodendrocyte/lineage cells. By selectively inactivating Jun B and c-Jun in myelinating oligodendrocytes in vivo, we generated mutant mice that developed normally, and within more than 12 months showed normal ageing and survival rates. In the adult CNS, absence of JunB and c-Jun from mature oligodendrocytes caused low-grade glial activation without overt signs of demyelination or secondary leukocyte infiltration into the brain. Even after exposure to toxic or autoimmune oligodendrocyte insults, signs of altered oligodendrocyte viability were mild and detectable only upon cuprizone treatment. We conclude that JunB and c-Jun expression in post-mitotic oligodendrocytes is mostly dispensable for the maintainance of white matter tracts throughout adult life, even under demyelinating conditions.	[Schreiner, Bettina; Locatelli, Giuseppe; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; [Schreiner, Bettina] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Ingold-Heppner, Barbara] Charite, Inst Pathol, D-13353 Berlin, Germany; [Pehl, Debora] Charite, Inst Neuropathol, D-13353 Berlin, Germany; [Locatelli, Giuseppe] LMU Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany; [BerritSch Nthaler, Helia] Spanish Natl Canc Res Ctr, Madrid, Spain	University of Zurich; University of Zurich; University Zurich Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Centro Nacional de Investigaciones Oncologicas (CNIO)	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Sternwartstr 2, CH-8091 Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Locatelli, Giuseppe/0000-0002-2179-4407	Swiss National Science Foundation [316030_150768, 310030_146130, CRSII3_136203, SPUM 33CM30-124111/1]; European Union; university research priority project translational cancer research; Stiftung fur Forschung an der Medizinischen Fakultat	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); university research priority project translational cancer research; Stiftung fur Forschung an der Medizinischen Fakultat	This study was supported by grants from the Swiss National Science Foundation (316030_150768 (BB), 310030_146130 (BB), CRSII3_136203 (BB) and SPUM 33CM30-124111/1 (BB, BS)), European Union FP7 project TargetBraIn, NeuroKine and ATECT (BB), the university research priority project translational cancer research (BB) and "Stiftung fur Forschung an der Medizinischen Fakultat" (BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RC, 2006, J NEUROPATH EXP NEUR, V65, P245, DOI 10.1097/01.jnen.0000205142.08716.7e; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barnett SC, 1995, DEVELOPMENT, V121, P3969; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; FitzGerald UF, 2000, MOL CELL NEUROSCI, V16, P453, DOI 10.1006/mcne.2000.0886; FitzGerald UF, 2003, MOL CELL NEUROSCI, V22, P516, DOI 10.1016/S1044-7431(02)00040-4; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Jurewicz A, 2006, GLIA, V53, P158, DOI 10.1002/glia.20249; Jurewicz A, 2003, BRAIN, V126, P1358, DOI 10.1093/brain/awg146; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kipp M, 2009, ACTA NEUROPATHOL, V118, P723, DOI 10.1007/s00401-009-0591-3; Ladiwala U, 1998, J NEUROSCI, V18, P1297; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MATTHIEU JM, 1990, DEV NEUROSCI-BASEL, V12, P293, DOI 10.1159/000111858; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; PHAMDINH D, 1993, P NATL ACAD SCI USA, V90, P7990, DOI 10.1073/pnas.90.17.7990; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Ruff CA, 2012, J NEUROCHEM, V121, P607, DOI 10.1111/j.1471-4159.2012.07706.x; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Solly SK, 1996, GLIA, V18, P39, DOI 10.1002/(SICI)1098-1136(199609)18:1<39::AID-GLIA4>3.3.CO;2-T; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; WAGNER T, 1977, EXP CELL RES, V107, P1, DOI 10.1016/0014-4827(77)90379-2; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang PS, 1996, J NEUROSCI RES, V46, P114, DOI 10.1002/(SICI)1097-4547(19961001)46:1<114::AID-JNR14>3.0.CO;2-5	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120454	10.1371/journal.pone.0120454	http://dx.doi.org/10.1371/journal.pone.0120454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774663	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000351183500175
J	Singh, N; Mishra, RK				Singh, Niharika; Mishra, Ramesh Kumar			Unintentional Activation of Translation Equivalents in Bilinguals Leads to Attention Capture in a Cross-Modal Visual Task	PLOS ONE			English	Article							EYE-MOVEMENTS; IRRELEVANT SPEECH; DIFFERENT SCRIPTS; WORD RECOGNITION; TIME-COURSE; LANGUAGE; 2ND-LANGUAGE; REPRESENTATION; MECHANISMS; FIXATION	Using a variant of the visual world eye tracking paradigm, we examined if language non-selective activation of translation equivalents leads to attention capture and distraction in a visual task in bilinguals. High and low proficient Hindi-English speaking bilinguals were instructed to programme a saccade towards a line drawing which changed colour among other distractor objects. A spoken word, irrelevant to the main task, was presented before the colour change. On critical trials, one of the line drawings was a phonologically related word of the translation equivalent of the spoken word. Results showed that saccade latency was significantly higher towards the target in the presence of this cross-linguistic translation competitor compared to when the display contained completely unrelated objects. Participants were also slower when the display contained the referent of the spoken word among the distractors. However, the bilingual groups did not differ with regard to the interference effect observed. These findings suggest that spoken words activates translation equivalent which bias attention leading to interference in goal directed action in the visual domain.	[Singh, Niharika; Mishra, Ramesh Kumar] Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India; [Mishra, Ramesh Kumar] Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad 500134, Andhra Pradesh, India	University of Allahabad; University of Hyderabad	Mishra, RK (corresponding author), Univ Allahabad, Ctr Behav & Cognit Sci, Allahabad 211002, Uttar Pradesh, India.	rkmishra@uohyd.ac.in	SINGH, NIHARIKA/GQH-0296-2022		Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was funded by Department of Science and Technology, Government of India to RKM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann G. T. M., 2011, OXFORD HDB EYE MOVEM, P979; Bertels J, 2011, J COGN PSYCHOL, V23, P435, DOI 10.1080/20445911.2011.535513; Blumenfeld H. K., 2007, LANG COGNITIVE PROC, V22, P633, DOI 10.1080/01690960601000746; Blumenfeld HK, 2014, BILING-LANG COGN, V17, P610, DOI 10.1017/S1366728913000564; Cleland AA, 2012, LANG COGNITIVE PROC, V27, P572, DOI 10.1080/01690965.2011.564942; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; de Groot AMB, 2000, Q J EXP PSYCHOL-A, V53, P397, DOI 10.1080/713755891; DEGROOT AMB, 1991, J MEM LANG, V30, P90, DOI 10.1016/0749-596X(91)90012-9; Dijkstra T, 2000, J MEM LANG, V42, P445, DOI 10.1006/jmla.1999.2697; Dimitropoulou M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00188; Duyck W, 2005, J EXP PSYCHOL LEARN, V31, P1340, DOI 10.1037/0278-7393.31.6.1340; Elliott EM, 2012, ACTA PSYCHOL, V140, P64, DOI 10.1016/j.actpsy.2012.02.009; Gollan TH, 1997, J EXP PSYCHOL LEARN, V23, P1122, DOI 10.1037/0278-7393.23.5.1122; Grainger J, 1998, LANG COGNITIVE PROC, V13, P601, DOI 10.1080/016909698386393; Guo TM, 2012, J EXP PSYCHOL LEARN, V38, P1165, DOI 10.1037/a0028076; Hermans D., 1998, BILING-LANG COGN, V1, P213, DOI [10.1017/S1366728998000364, DOI 10.1017/S1366728998000364]; Huettig F, 2005, COGNITION, V96, pB23, DOI 10.1016/j.cognition.2004.10.003; Huettig F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00394; Ju M, 2004, PSYCHOL SCI, V15, P314, DOI 10.1111/j.0956-7976.2004.00675.x; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kroll JF, 2010, BILING-LANG COGN, V13, P373, DOI 10.1017/S136672891000009X; Lagrou E, 2011, J EXP PSYCHOL LEARN, V37, P952, DOI 10.1037/a0023217; LeCompte DC, 1997, J EXP PSYCHOL LEARN, V23, P472, DOI 10.1037/0278-7393.23.2.472; Lemhofer K, 2012, BEHAV RES METHODS, V44, P325, DOI 10.3758/s13428-011-0146-0; Lupyan G, 2011, QUARTERLY JOURNAL OF, P1; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Marian V, 2003, APPL PSYCHOLINGUIST, V24, P173, DOI 10.1017/S0142716403000092; Marian V, DIFFERENTIAL RECRUIT; Marian V., 2003, BILING-LANG COGN, V6, P97, DOI DOI 10.1017/S1366728903001068; Marian V, 2008, J PSYCHOLINGUIST RES, V37, P141, DOI 10.1007/s10936-007-9064-9; Mishra RK, 2009, PROG BRAIN RES, V176, P277, DOI 10.1016/S0079-6123(09)17616-1; Mishra RK, 2012, PROGRESS IN BRAIN RE, V212; Mishra RK, 2013, READ WRIT, V27, P129; Salverda AP, 2011, J EXP PSYCHOL HUMAN, V37, P1122, DOI 10.1037/a0023101; Salverda AP, 2011, ACTA PSYCHOL, V137, P172, DOI 10.1016/j.actpsy.2010.09.010; Schoonbaert S, 2007, J MEM LANG, V56, P153, DOI 10.1016/j.jml.2006.10.002; Shook A, 2013, BILING-LANG COGN, V16, P304, DOI 10.1017/S1366728912000466; Sunderman G, 2006, STUD SECOND LANG ACQ, V28, P387, DOI 10.1017/S0272263106060177; Sunderman GL, 2012, LANG COGNITIVE PROC, V27, P1265, DOI 10.1080/01690965.2011.596420; Weber A, 2004, J MEM LANG, V50, P1, DOI 10.1016/S0749-596X(03)00105-0; Wu YJ, 2013, COGNITION, V129, P418, DOI 10.1016/j.cognition.2013.08.005; Wu YJ, 2012, J NEUROSCI, V32, P6485, DOI 10.1523/JNEUROSCI.6119-11.2012; Wu YJ, 2010, J NEUROSCI, V30, P7646, DOI 10.1523/JNEUROSCI.1602-10.2010; Yee E, 2006, J EXP PSYCHOL LEARN, V32, P1, DOI 10.1037/0278-7393.32.1.1; Zeelenberg R, 2010, COGNITION, V115, P202, DOI 10.1016/j.cognition.2009.12.004; Zhang TL, 2011, PSYCHOL SCI, V22, P1237, DOI 10.1177/0956797611421492	49	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120131	10.1371/journal.pone.0120131	http://dx.doi.org/10.1371/journal.pone.0120131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CD6EY	25775184	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500152
J	Hale, M; Itani, F; Buchta, CM; Wald, G; Bing, M; Norian, LA				Hale, Malika; Itani, Farah; Buchta, Claire M.; Wald, Gal; Bing, Megan; Norian, Lyse A.			Obesity Triggers Enhanced MDSC Accumulation in Murine Renal Tumors via Elevated Local Production of CCL2	PLOS ONE			English	Article							MYELOID SUPPRESSOR-CELLS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; VISCERAL OBESITY; IMMUNE-RESPONSE; INFLAMMATION; CANCER; CARCINOMA; RISK; ARGINASE	Obesity is one of the leading risk factors for developing renal cell carcinoma, an immunogenic tumor that is treated clinically with immunostimulatory therapies. Currently, however, the mechanisms linking obesity with renal cancer incidence are unclear. Using a model of diet-induced obesity, we found that obese BALB/c mice with orthotopic renal tumors had increased total frequencies of myeloid-derived suppressor cells (MDSC) in renal tumors and spleens by d14 post-tumor challenge, relative to lean counterparts. Renal tumors from obese mice had elevated concentrations of the known myeloid cell chemoattractant CCL2, which was produced locally by increased percentages of dendritic cells, macrophages, B cells, and CD45(-) cells in tumors. MDSC expression of the CCL2 receptor, CCR2, was unaltered by obesity but greater percentages of CCR2(+) MDSCs were present in renal tumors from obese mice. Of note, the intracellular arginase levels and per-cell suppressive capacities of tumor-infiltrating and splenic MDSCs were unchanged in obese mice relative to lean controls. Thus, our findings suggest that obesity promotes renal tumor progression via development of a robust immunosuppressive environment that is characterized by heightened local and systemic MDSC prevalence. Targeted intervention of the CCL2/CCR2 pathway may facilitate immune-mediated renal tumor clearance in the obese.	[Hale, Malika; Buchta, Claire M.; Wald, Gal; Bing, Megan; Norian, Lyse A.] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Itani, Farah; Norian, Lyse A.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Norian, Lyse A.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Norian, Lyse A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Norian, LA (corresponding author), Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.	lyse-norian@uiowa.edu		Norian, Lyse/0000-0003-1016-313X; Hale, Malika/0000-0002-0822-7141	National Cancer Institute [1 R01 CA181088-01]; University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award [P30CA086862]; American Cancer Society; NATIONAL CANCER INSTITUTE [R01CA181088, P30CA086862] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LAN: American Cancer Society Seed Grant administered through the Holden Comprehensive Cancer Center at the University of Iowa (http://www.cancer.org/); National Cancer Institute #1 R01 CA181088-01 (www.cancer.gov/) and University of Iowa Flow Cytometry Core Facility: National Cancer Institute Award #P30CA086862 (www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Arendt LM, 2013, CANCER RES, V73, P6080, DOI 10.1158/0008-5472.CAN-13-0926; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Catalan V, 2007, OBES SURG, V17, P1464, DOI 10.1007/s11695-008-9424-z; Chehval V, 2014, IMMUNOL RES, V59, P211, DOI 10.1007/s12026-014-8533-0; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Colli JL, 2009, UROLOGY, V73, P431, DOI 10.1016/j.urology.2008.06.044; Daurkin I, 2011, CANCER RES, V71, P6400, DOI 10.1158/0008-5472.CAN-11-1261; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gilbert CA, 2013, ANNU REV MED, V64, P45, DOI 10.1146/annurev-med-121211-091527; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanson HL, 2000, IMMUNITY, V13, P265, DOI 10.1016/S1074-7613(00)00026-1; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; James BR, 2014, CANCER IMMUNOL IMMUN, V63, P1213, DOI 10.1007/s00262-014-1598-8; James BR, 2012, J IMMUNOL, V189, P1311, DOI 10.4049/jimmunol.1100587; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Jung JI, 2015, INT J CANCER, V136, P258, DOI 10.1002/ijc.28983; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Ladoire S, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2010-0227; Lukesova S, 2008, FOLIA BIOL-PRAGUE, V54, P134; Naya Y, 2010, UROL INT, V85, P30, DOI 10.1159/000318988; Norian LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031085; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Okwan-Duodu D, 2013, AM J CANCER RES, V3, P21; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; SAYERS TJ, 1990, CANCER RES, V50, P5414; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Sejima T, 2013, UROL ONCOL-SEMIN ORI, V31, P1343, DOI 10.1016/j.urolonc.2011.09.008; Steffens S, 2011, ONCOLOGIST, V16, P1565, DOI 10.1634/theoncologist.2011-0213; Tateya S, 2010, ENDOCRINOLOGY, V151, P971, DOI 10.1210/en.2009-0926; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Wald G, 2014, UROL ONCOL-SEMIN ORI, V32, P589, DOI 10.1016/j.urolonc.2014.01.023; Walter S, 2012, NAT MED, V18, P1254, DOI 10.1038/nm.2883; Wang FR, 2014, INT J CANCER, V135, P1673, DOI 10.1002/ijc.28813; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhu Y, 2013, J UROLOGY, V189, P447, DOI 10.1016/j.juro.2012.09.030	45	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118784	10.1371/journal.pone.0118784	http://dx.doi.org/10.1371/journal.pone.0118784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25769110	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500043
J	Araneda, R; De Volder, AG; Deggouj, N; Renier, L				Araneda, Rodrigo; De Volder, Anne G.; Deggouj, Naima; Renier, Laurent			Altered Inhibitory Control and Increased Sensitivity to Cross-Modal Interference in Tinnitus during Auditory and Visual Tasks	PLOS ONE			English	Article							SELECTIVE ATTENTION; PREFRONTAL CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; GENERATION; NEUROSCIENCE; STIMULATION; SUPPRESSION; PERCEPTION; MODULATION	Tinnitus is the perception of sound in the absence of external stimulus. Currently, the pathophysiology of tinnitus is not fully understood, but recent studies indicate that alterations in the brain involve non-auditory areas, including the prefrontal cortex. In experiment 1, we used a go/no-go paradigm to evaluate the target detection speed and the inhibitory control in tinnitus participants (TP) and control subjects (CS), both in unimodal and bimodal conditions in the auditory and visual modalities. We also tested whether the sound frequency used for target and distractors affected the performance. We observed that TP were slower and made more false alarms than CS in all unimodal auditory conditions. TP were also slower than CS in the bimodal conditions. In addition, when comparing the response times in bimodal and auditory unimodal conditions, the expected gain in bimodal conditions was present in CS, but not in TP when tinnitus-matched frequency sounds were used as targets. In experiment 2, we tested the sensitivity to cross-modal interference in TP during auditory and visual go/no-go tasks where each stimulus was preceded by an irrelevant pre-stimulus in the untested modality (e.g. high frequency auditory pre-stimulus in visual no/no-go condition). We observed that TP had longer response times than CS and made more false alarms in all conditions. In addition, the highest false alarm rate occurred in TP when tinnitusmatched/ high frequency sounds were used as pre-stimulus. We conclude that the inhibitory control is altered in TP and that TP are abnormally sensitive to cross-modal interference, reflecting difficulties to ignore irrelevant stimuli. The fact that the strongest interference effect was caused by tinnitus-like auditory stimulation is consistent with the hypothesis according to which such stimulations generate emotional responses that affect cognitive processing in TP. We postulate that executive functions deficits play a key-role in the perception and maintenance of tinnitus.	[Araneda, Rodrigo; De Volder, Anne G.; Deggouj, Naima; Renier, Laurent] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [Deggouj, Naima] Catholic Univ Louvain, Dept Otorhinolaryngol & Head & Neck Surg, B-1200 Brussels, Belgium; [Deggouj, Naima] Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Renier, L (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	laurent.renier@uclouvain.be	Araneda, Rodrigo/AHB-4339-2022	Araneda, Rodrigo/0000-0002-0890-5504	Becas Chile Program (Chile); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium); FRSM (Belgium) [3.4502.08]	Becas Chile Program (Chile); Brussels Institute for Research and Innovation (INNOVIRIS, Belgium)(Innoviris); FRSM (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The Becas Chile Program (Chile), Brussels Institute for Research and Innovation (INNOVIRIS, Belgium), the FRSM grant #3.4502.08 (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2005, CYBERPSYCHOL BEHAV, V8, P32, DOI 10.1089/cpb.2005.8.32; Andersson G, 2002, CLIN OTOLARYNGOL, V27, P270, DOI 10.1046/j.1365-2273.2002.00581.x; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Dalton P, 2009, Q J EXP PSYCHOL, V62, P2126, DOI 10.1080/17470210903023646; Das SK, 2012, LARYNGOSCOPE, V122, P2533, DOI 10.1002/lary.23555; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; Hesser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064540; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Langguth B, 2011, CURR MED RES OPIN, V27, P1635, DOI 10.1185/03007995.2011.595781; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Laurens KR, 2005, HUM BRAIN MAPP, V24, P35, DOI 10.1002/hbm.20062; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Liesefeld AM, 2014, PSYCHOL SCI, V25, P325, DOI 10.1177/0956797613501170; Machado L, 2013, Q J EXP PSYCHOL, V66, P138, DOI 10.1080/17470218.2012.701651; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Newman C W, 1998, J Am Acad Audiol, V9, P153; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Puel JL, 2002, ADV OTO-RHINO-LARYNG, V59, P124; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Ries M, 2005, NEUROPSYCHOLOGY, V19, P476, DOI 10.1037/0894-4105.19.4.476; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Scharf B, 1997, HEARING RES, V103, P101, DOI 10.1016/S0378-5955(96)00168-2; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Schrobsdorff H, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00491; Seydell-Greenwald A, 2012, BRAIN RES, V1485, P22, DOI 10.1016/j.brainres.2012.08.052; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Vanneste S, 2013, EXP BRAIN RES, V226, P25, DOI 10.1007/s00221-013-3406-7; Vanneste S, 2012, EXP BRAIN RES, V221, P345, DOI 10.1007/s00221-012-3177-6; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanneste S, 2010, EXP BRAIN RES, V202, P779, DOI 10.1007/s00221-010-2183-9; Walther S, 2010, NEUROREPORT, V21, P191, DOI 10.1097/WNR.0b013e328335640f; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wittekindt A, 2014, J NEUROSCI, V34, P9995, DOI 10.1523/JNEUROSCI.4861-13.2014; Zhang JS, 2013, HEARING RES, V295, P38, DOI 10.1016/j.heares.2012.05.007	63	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120387	10.1371/journal.pone.0120387	http://dx.doi.org/10.1371/journal.pone.0120387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763867	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300039
J	Bezie, S; Picarda, E; Tesson, L; Renaudin, K; Durand, J; Menoret, S; Merieau, E; Chiffoleau, E; Guillonneau, C; Caron, L; Anegon, I				Bezie, Severine; Picarda, Elodie; Tesson, Laurent; Renaudin, Karine; Durand, Justine; Menoret, Severine; Merieau, Emmanuel; Chiffoleau, Elise; Guillonneau, Carole; Caron, Lise; Anegon, Ignacio			Fibrinogen-Like Protein 2/Fibroleukin Induces Long-Term Allograft Survival in a Rat Model through Regulatory B Cells	PLOS ONE			English	Article							RENAL-TRANSPLANT TOLERANCE; T-CELLS; PROTHROMBINASE ACTIVITY; TARGETED DELETION; IMMUNE-RESPONSES; VIRAL-HEPATITIS; DENDRITIC CELLS; CD8(+) TREGS; IFN-GAMMA; REJECTION	We previously described that in a rat model of heart transplantation tolerance was dependent on CD8+CD45RC(low) Tregs that over-expressed fibrinogen-like protein 2 (FGL2)/fibroleukin. Little is known on the immunoregulatory properties of FGL2. Here we analyzed the transplantation tolerance mechanisms that are present in Lewis 1A rats treated with FGL2. Over-expression of FGL2 in vivo through adenovirus associated virus-mediated gene transfer without any further treatment resulted in inhibition of cardiac allograft rejection. Adoptive cell transfer of splenocytes from FGL2-treated rats with long-term graft survival (> 80 days) in animals that were transplanted with cardiac allografts inhibited acute and chronic organ rejection in a donor-specific and transferable tolerance manner, since iterative adoptive transfer up to a sixth consecutive recipient resulted in transplantation tolerance. Adoptive cell transfer also efficiently inhibited anti-donor antibody production. Analysis of all possible cell populations among splenocytes revealed that B lymphocytes were sufficient for this adoptive cell tolerance. These B cells were also capable of inhibiting the proliferation of CD4(+) T cells in response to allogeneic stimuli. Moreover, gene transfer of FGL2 in B cell deficient rats did not prolong graft survival. Thus, this is the first description of FGL2 resulting in long-term allograft survival. Furthermore, allograft tolerance was transferable and B cells were the main cells responsible for this effect.	[Bezie, Severine; Picarda, Elodie; Tesson, Laurent; Durand, Justine; Menoret, Severine; Merieau, Emmanuel; Chiffoleau, Elise; Guillonneau, Carole; Caron, Lise; Anegon, Ignacio] CHU Nantes, INSERM UMR ITUN 1064, Fac Med, F-44035 Nantes 01, France; [Renaudin, Karine] CHU Nantes, Fac Med, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Anegon, I (corresponding author), CHU Nantes, INSERM UMR ITUN 1064, Fac Med, F-44035 Nantes 01, France.	Ignacio.Anegon@inserm.fr	Chiffoleau, Elise/N-2982-2018; Anegon, Ignacio/I-7760-2018; Anegon, Ignacio/I-7498-2018	Chiffoleau, Elise/0000-0001-6167-682X; 	French Transplantation Society; Fondation Progreffe; Roche Organ Transplantation Research Foundation; Labex IGO project - Investissements d'Avenir French Government program [ANR-11-LABX-0016-01]	French Transplantation Society; Fondation Progreffe; Roche Organ Transplantation Research Foundation; Labex IGO project - Investissements d'Avenir French Government program(French National Research Agency (ANR))	Support was provided by the French Transplantation Society and the Fondation Progreffe to SB and the Roche Organ Transplantation Research Foundation to IA. This work has been carried out thanks to the support of the Labex IGO project (no. ANR-11-LABX-0016-01) funded by the Investissements d'Avenir French Government program, managed by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Anjubault T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033713; Blair PA, 2009, J IMMUNOL, V182, P3492, DOI 10.4049/jimmunol.0803052; BRUGGEMANN M, 1989, J IMMUNOL, V142, P3145; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Chan CWY, 2002, J IMMUNOL, V168, P5170, DOI 10.4049/jimmunol.168.10.5170; CUTURI MC, 1994, EUR J IMMUNOL, V24, P1627, DOI 10.1002/eji.1830240726; Deng SP, 2007, J IMMUNOL, V178, P6028, DOI 10.4049/jimmunol.178.10.6028; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Foerster K, 2010, J HEPATOL, V53, P608, DOI 10.1016/j.jhep.2010.04.020; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Ghanekar A, 2004, J IMMUNOL, V172, P5693, DOI 10.4049/jimmunol.172.9.5693; Guillonneau C, 2007, J CLIN INVEST, V117, P1096, DOI 10.1172/JCI28801; Guillonneau C, 2010, CURR OPIN ORGAN TRAN, V15, P751, DOI 10.1097/MOT.0b013e32834016d1; Guillot C, 2002, J IMMUNOL, V168, P1600, DOI 10.4049/jimmunol.168.4.1600; Hancock WW, 2004, P NATL ACAD SCI USA, V101, P3005, DOI 10.1073/pnas.0308369101; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Kendal AR, 2010, CURR OPIN IMMUNOL, V22, P560, DOI 10.1016/j.coi.2010.08.002; Le Guiner C, 2007, CURR GENE THER, V7, P334; Le Texier L, 2011, AM J TRANSPLANT, V11, P429, DOI 10.1111/j.1600-6143.2010.03336.x; Lee KM, 2012, AM J TRANSPLANT, V12, P2072, DOI 10.1111/j.1600-6143.2012.04055.x; Li XL, 2010, J IMMUNOL, V185, P823, DOI 10.4049/jimmunol.1000120; Liu H, 2008, EUR J IMMUNOL, V38, P3114, DOI 10.1002/eji.200838338; Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x; Mann MK, 2007, J IMMUNOL, V178, P3447, DOI 10.4049/jimmunol.178.6.3447; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Melnyk MC, 2011, SCAND J RHEUMATOL, V40, P269, DOI 10.3109/03009742.2010.536163; Mendicino M, 2005, CIRCULATION, V112, P248, DOI 10.1161/CIRCULATIONAHA.105.534271; Menoret S, 2010, EUR J IMMUNOL, V40, P2932, DOI 10.1002/eji.201040939; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Ning Q, 2005, J IMMUNOL, V174, P7403, DOI 10.4049/jimmunol.174.11.7403; Pallier A, 2010, KIDNEY INT, V78, P503, DOI 10.1038/ki.2010.162; Picarda E, 2014, J CLIN INVEST, V124, P2497, DOI 10.1172/JCI71533; Picarda E, 2011, IMMUNOTHERAPY-UK, V3, P35, DOI [10.2217/IMT.11.37, 10.2217/imt.11.37]; Qian L, 2012, BLOOD, V120, P581, DOI 10.1182/blood-2011-08-377242; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; SCHWARTZ BS, 1982, J EXP MED, V155, P1464, DOI 10.1084/jem.155.5.1464; Shalev I, 2008, J IMMUNOL, V180, P249, DOI 10.4049/jimmunol.180.1.249; Shalev I, 2009, HEPATOLOGY, V49, P387, DOI 10.1002/hep.22684; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Wei B, 2005, P NATL ACAD SCI USA, V102, P2010, DOI 10.1073/pnas.0409449102; Xie L, 2012, LIVER TRANSPLANT, V18, P444, DOI 10.1002/lt.22480; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119686	10.1371/journal.pone.0119686	http://dx.doi.org/10.1371/journal.pone.0119686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763980	Green Published, Green Submitted, gold			2022-12-26	WOS:000351276300030
J	Oberckal, J; Kovacic, L; Sribar, J; Leonardi, A; Dolinar, K; Janez, AP; Krizaj, I				Oberckal, Jernej; Kovacic, Lidija; Sribar, Jernej; Leonardi, Adrijana; Dolinar, Klemen; Janez, Anja Pucer; Krizaj, Igor			On the Role of Protein Disulfide Isomerase in the Retrograde Cell Transport of Secreted Phospholipases A(2)	PLOS ONE			English	Article							CHOLERA-TOXIN; GROUP-V; ENDOPLASMIC-RETICULUM; EMERGING ROLES; PDI FAMILY; GROUP-II; AMMODYTOXIN; MECHANISMS; MEMBRANE; ENZYMES	Following the finding that ammodytoxin (Atx), a neurotoxic secreted phospholipase A(2) (sPLA(2)) in snake venom, binds specifically to protein disulfide isomerase (PDI) in vitro we show that these proteins also interact in living rat PC12 cells that are able to internalize this group IIA (GIIA) sPLA(2). Atx and PDI co-localize in both differentiated and non-differentiated PC12 cells, as shown by fluorescence microscopy. Based on a model of the complex between Atx and yeast PDI (yPDI), a three-dimensional model of the complex between Atx and human PDI (hPDI) was constructed. The Atx binding site on hPDI is situated between domains b and b '. Atx interacts hPDI with an extensive area on its interfacial binding surface. The mammalian GIB, GIIA, GV and GX sPLA(2)s have the same fold as Atx. The first three sPLA(2)s have been detected intracellularly but not the last one. The models of their complexes with hPDI were constructed by replacement of Atx with the respective mammalian sPLA(2) in the Atx-hPDI complex and molecular docking of the structures. According to the generated models, mammalian GIB, GIIA and GV sPLA(2)s form complexes with hPDI very similar to that with Atx. The contact area between GX sPLA(2) and hPDI is however different from that of the other sPLA(2)s. Heterologous competition of Atx binding to hPDI with GV and GX sPLA(2)s confirmed the model-based expectation that GV sPLA(2) was a more effective inhibitor than GX sPLA(2), thus validating our model. The results suggest a role of hPDI in the (patho) physiology of some snake venom and mammalian sPLA(2)s by assisting the retrograde transport of these molecules from the cell surface. The sPLA(2)-hPDI model constitutes a valuable tool to facilitate further insights into this process and into the (patho) physiology of sPLA(2)s in relation to their action intracellularly.	[Oberckal, Jernej; Kovacic, Lidija; Sribar, Jernej; Leonardi, Adrijana; Dolinar, Klemen; Janez, Anja Pucer; Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia; [Krizaj, Igor] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Krizaj, I (corresponding author), Jozef Stefan Inst, Dept Mol & Biomed Sci, Ljubljana, Slovenia.	igor.krizaj@ijs.si		Sribar, Jernej/0000-0003-0646-5602	Slovenian Research Agency [P1-0207, Z1-4071]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by grants P1-0207 (to IK) and Z1-4071 (to LK) from the Slovenian Research Agency (http://www.arrs.gov.si/sl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Birts CN, 2008, J BIOL CHEM, V283, P5034, DOI 10.1074/jbc.M708844200; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brglez V, 2014, BIOCHIMIE, V107, P114, DOI 10.1016/j.biochi.2014.09.023; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DODDS D, 1995, J NEUROCHEM, V64, P2339; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Fayard JM, 1998, J CELL SCI, V111, P985; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Forster ML, 2009, J BIOL CHEM, V284, P13045, DOI 10.1074/jbc.M808352200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUBENSEK F, 1980, PERIOD BIOL, V82, P443; Herkert M, 2001, EUR J NEUROSCI, V14, P821, DOI 10.1046/j.0953-816x.2001.01699.x; Hseu MJ, 1997, BIOCHEM BIOPH RES CO, V239, P18, DOI 10.1006/bbrc.1997.7416; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kovacic L, 2007, BIOORG CHEM, V35, P295, DOI 10.1016/j.bioorg.2006.12.002; Kovacic L, 2010, PROTEIN ENG DES SEL, V23, P479, DOI 10.1093/protein/gzq019; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Krizaj I, 2014, PROTEIN PEPTIDE LETT, V21, P1201; Krizaj I, 2011, TOXICON, V58, P219, DOI 10.1016/j.toxicon.2011.06.009; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Leslie Christina C, 2004, Methods Mol Biol, V284, P229; Logonder U, 2009, EXP NEUROL, V219, P591, DOI 10.1016/j.expneurol.2009.07.017; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Macchioni L, 2004, J BIOL CHEM, V279, P37860, DOI 10.1074/jbc.M303855200; Murakami M, 2013, BIOCHIMIE, V95, P43, DOI 10.1016/j.biochi.2012.09.007; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Nardicchi V, 2007, BBA-MOL CELL BIOL L, V1771, P1345, DOI 10.1016/j.bbalip.2007.08.007; Petan T, 2005, BIOCHEMISTRY-US, V44, P12535, DOI 10.1021/bi051024r; Petrovic U, 2005, BIOCHEM J, V391, P383, DOI 10.1042/BJ20050417; Petrovic U, 2004, BIOCHEM BIOPH RES CO, V324, P981, DOI 10.1016/j.bbrc.2004.09.144; Praznikar ZJ, 2008, BBA-MOL CELL RES, V1783, P1129, DOI 10.1016/j.bbamcr.2008.01.011; RADVANYI F, 1989, ANAL BIOCHEM, V177, P103, DOI 10.1016/0003-2697(89)90022-5; Ren PY, 2003, J PHYS CHEM B, V107, P5933, DOI 10.1021/jp027815+; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Sribar J, 2005, BIOCHEM BIOPH RES CO, V329, P733, DOI 10.1016/j.bbrc.2005.02.036; Sribar J, 2001, J BIOL CHEM, V276, P12493, DOI 10.1074/jbc.C100048200; Sribar J, 2011, ACTA CHIM SLOV, V58, P678; Taylor M, 2011, J BIOL CHEM, V286, P22090, DOI 10.1074/jbc.M111.237966; Taylor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018825; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	55	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0120692	10.1371/journal.pone.0120692	http://dx.doi.org/10.1371/journal.pone.0120692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763817	Green Published, gold, Green Submitted			2022-12-26	WOS:000351276300046
J	Ghosh, CC; Mukherjee, A; David, S; Milam, KE; Hunter, JT; Parikh, SM				Ghosh, Chandra C.; Mukherjee, Aditi; David, Sascha; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.			Angiopoietin-1 Requires Oxidant Signaling through p47phox to Promote Endothelial Barrier Defense	PLOS ONE			English	Article							MULTIPLE-ORGAN DYSFUNCTION; VASCULAR LEAKAGE; AGONIST PEPTIDE; NADPH OXIDASE; LUNG INJURY; RECEPTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; CONTRIBUTE	Background Reactive oxygen species (ROS) are largely considered to be pathogenic to normal endothelial function in disease states such as sepsis. We hypothesized that Angiopoietin-1 (Angpt-1), an endogenous agonist of the endothelial-specific receptor, Tie-2, promotes barrier defense by activating NADPH oxidase (NOX) signaling. Methods and Findings Using primary human microvascular endothelial cells (HMVECs), we found that Angpt-1 stimulation induces phosphorylation of p47phox and a brief oxidative burst that is lost when chemical inhibitors of NOX activity or siRNA against the NOX component p47phox were applied. As a result, there was attenuated ROS activity, disrupted junctional contacts, enhanced actin stress fiber accumulation, and induced gap formation between confluent HMVECs. All of these changes were associated with weakened barrier function. The ability of Angpt-1 to prevent identical changes induced by inflammatory permeability mediators, thrombin and lipopolysaccharides (LPS), was abrogated by p47phox knockdown. P47phox was required for Angpt-1 to activate Rac1 and inhibit mediator-induced activation of the small GTPase RhoA. Finally, Angpt-1 gene transfer prevented vascular leakage in wildtype mice exposed to systemically administered LPS, but not in p47phox knock out (p47(-/-)) littermates. Conclusions These results suggest an essential role for NOX signaling in Angpt-1-mediated endothelial barrier defense against mediators of systemic inflammation. More broadly, oxidants generated for signal transduction may have a barrier-promoting role in vascular endothelium.	[Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Beth Israel Deaconess Med Ctr, Div Nephrol, Boston, MA 02215 USA; [Ghosh, Chandra C.; Mukherjee, Aditi; Milam, Katelyn E.; Hunter, Jon T.; Parikh, Samir M.] Harvard Univ, Sch Med, Boston, MA USA; [David, Sascha] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Hannover Medical School	Ghosh, CC (corresponding author), Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA.	cghosh@bidmc.harvard.edu; sparikh1@bidmc.harvard.edu	David, Sascha/AAL-6909-2021		National Institutes of Health [R01-HL093234, DK095072]; American Diabetes Association; German Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125275, R01HL093234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); German Research Foundation(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	SMP is supported by the National Institutes of Health (R01-HL093234 and DK095072) and the American Diabetes Association. SD is supported by funding from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Ahmad S, 2010, HYPERTENSION, V56, P477, DOI 10.1161/HYPERTENSIONAHA.110.155556; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Cascone I, 2003, BLOOD, V102, P2482, DOI 10.1182/blood-2003-03-0670; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; David S, 2012, CRIT CARE M IN PRESS; David S, 2011, ARTERIOSCLER THROMB; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; David S, 2011, AM J PHYSIOL-LUNG C, V300, pL851, DOI 10.1152/ajplung.00459.2010; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Ghosh CC, 2012, P NATL ACAD SCI USA, V109, P10024, DOI 10.1073/pnas.1120755109; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Hwang JA, 2009, BIOCHEM BIOPH RES CO, V381, P592, DOI 10.1016/j.bbrc.2009.02.096; Kim DH, 2009, KIDNEY INT, V76, P1180, DOI 10.1038/ki.2009.387; Kim YM, 2006, CANCER RES, V66, P6167, DOI 10.1158/0008-5472.CAN-05-3640; Kumpers P, 2011, CRIT CARE, V15, DOI 10.1186/cc10523; Kunsch C, 1999, CIRC RES, V85, P753, DOI 10.1161/01.RES.85.8.753; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mishina NM, 2013, METHOD ENZYMOL, V526, P45, DOI 10.1016/B978-0-12-405883-5.00003-X; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Xie ZH, 2014, AM J RESP CRIT CARE, V189, P1145, DOI 10.1164/rccm.201310-1746LE	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0119577	10.1371/journal.pone.0119577	http://dx.doi.org/10.1371/journal.pone.0119577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761062	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000060
J	Chang, MY; Chang, CH; Chen, CH; Cheng, B; Lin, YD; Luo, CY; Wu, HL; Yang, YJ; Chen, JH; Hsieh, PCH				Chang, Ming-Yao; Chang, Chih-Han; Chen, Chien-Hsi; Cheng, Bill; Lin, Yi-Dong; Luo, Chwan-Yau; Wu, Hua-Lin; Yang, Yu-Jen; Chen, Jyh-Hong; Hsieh, Patrick C. H.			The Time Window for Therapy with Peptide Nanofibers Combined with Autologous Bone Marrow Cells in Pigs after Acute Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; MESENCHYMAL STEM-CELLS; MONONUCLEAR-CELLS; DOUBLE-BLIND; DELIVERY; DISEASE; REPAIR; METAANALYSIS; INJECTION; APOPTOSIS	Background We previously showed that injection of peptide nanofibers (NF) combined with autologous bone marrow mononuclear cells (MNC) immediately after coronary artery ligation improves cardiac performance in pigs. To evaluate the clinical feasibility, this study was performed to determine the therapeutic time window for NF/MNC therapy in acute myocardial infarction (MI). Methods and Results A total of 45 adult minipigs were randomly grouped into 7 groups: sham or MI plus treatment with NS (normal saline), or NF or MNC alone at 1 day (1D)post-MI, or NF/MNC at 1, 4, or 7 days post-MI (N>6). Cardiac function was assessed by echocardiography and ventricular catheterization. Compared with the NS control, pigs treated with NF/MNC at 1 day post-MI (NF/MC-1D) had the greatest improvement in left ventricle ejection fraction (LVEF; 55.1 +/- 1.6%; P<0.01 vs. NS) 2 months after MI. In contrast, pigs treated with either NF/MNC-4D or NF/MNC-7D showed 48.9 +/- 0.8%( P<0.05 vs. NS) and 43.5 +/- 2.3%(n.s.vs. NS) improvements, respectively. The +dP/dt and -dP/dt, infarct size and interstitial collagen content were also improved in the NF/MNC-1D and -4D groups but not in the -7D group. Mechanistically, MNC quality and the states of systemic inflammation and damaged heart tissue influence the therapeutic efficiency of NF/MNC therapy, as revealed by another independent study using 16 pigs. Conclusions Injection of NF/MNC at 1 or 4 days, but not at 7 days post-MI, improves cardiac performance and prevents ventricular remodeling, confirming the importance of early intervention when using this therapy for acute MI.	[Chang, Ming-Yao; Chang, Chih-Han; Hsieh, Patrick C. H.] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Chen, Chien-Hsi; Cheng, Bill; Lin, Yi-Dong; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Luo, Chwan-Yau; Yang, Yu-Jen; Hsieh, Patrick C. H.] Natl Cheng Kung Univ Hosp, Dept Surg, Tainan 70428, Taiwan; [Wu, Hua-Lin] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Chen, Jyh-Hong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan	National Cheng Kung University; Academia Sinica - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Hsieh, PCH (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	phsieh@ibms.sinica.edu.tw		Cheng, Bill/0000-0002-0692-4349	National Research Program for Biopharmaceuticals [DOH101-TD-PB-111-TM027, DOH101-TD-PB-111-TM028]; National Science Council [NSC101-2325-B-006-013]; National Health Research Institutes [NHRI-EX101-10026SI]; Academia Sinica Translational Medicine Program; Celgene Cellular Therapeutics; Meridigen Biotech Co.	National Research Program for Biopharmaceuticals; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes(National Health Research Institutes, Japan); Academia Sinica Translational Medicine Program; Celgene Cellular Therapeutics(Bristol-Myers SquibbCelgene Corporation); Meridigen Biotech Co.	This work was supported by the National Research Program for Biopharmaceuticals (DOH101-TD-PB-111-TM027 and DOH101-TD-PB-111-TM028), the National Science Council (NSC101-2325-B-006-013), the National Health Research Institutes (NHRI-EX101-10026SI), the Academia Sinica Translational Medicine Program and Celgene Cellular Therapeutics and Meridigen Biotech Co. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Chen CH, 2013, MOL THER, V21, P670, DOI 10.1038/mt.2012.268; Dhanantwari P, 2008, BIOCHEM BIOPH RES CO, V371, P298, DOI 10.1016/j.bbrc.2008.04.070; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841; Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Robbers LF, 2014, RADIOLOGY; Rosenberg M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-115; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Swijnenburg RJ, 2010, CIRC-CARDIOVASC IMAG, V3, P77, DOI 10.1161/CIRCIMAGING.109.872085; Traverse JH, 2011, JAMA-J AM MED ASSOC, V306, P2110, DOI 10.1001/jama.2011.1670; van der Laan AM, 2013, EUR HEART J; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wang X., 2011, SCI TRANSL MED, V3; Yuan CJ, 2013, INT J CARDIOL, V168, P2767, DOI 10.1016/j.ijcard.2013.03.131; Zhang Y, 2011, CARDIOVASC PATHOL, V20, P204, DOI [10.1016/j.carpath.2010.06.007, 10.1088/1674-1056/20/11/110204]	31	11	11	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0115430	10.1371/journal.pone.0115430	http://dx.doi.org/10.1371/journal.pone.0115430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757076	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700002
J	Gutierrez, AP; Yanez, JM; Fukui, S; Swift, B; Davidson, WS				Gutierrez, Alejandro P.; Yanez, Jose M.; Fukui, Steve; Swift, Bruce; Davidson, William S.			Genome-Wide Association Study (GWAS) for Growth Rate and Age at Sexual Maturation in Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; BODY-WEIGHT; GENETIC-IMPROVEMENT; COHO SALMON; MATURITY; QTL; PARAMETERS; SELECTION	Early sexual maturation is considered a serious drawback for Atlantic salmon aquaculture as it retards growth, increases production times and affects flesh quality. Although both growth and sexual maturation are thought to be complex processes controlled by several genetic and environmental factors, selection for these traits has been continuously accomplished since the beginning of Atlantic salmon selective breeding programs. In this genome-wide association study (GWAS) we used a 6.5K single-nucleotide polymorphism (SNP) array to genotype similar to 480 individuals from the Cermaq Canada broodstock program and search for SNPs associated with growth and age at sexual maturation. Using a mixed model approach we identified markers showing a significant association with growth, grilsing (early sexual maturation) and late sexual maturation. The most significant associations were found for grilsing, with markers located in Ssa10, Ssa02, Ssa13, Ssa25 and Ssa12, and for late maturation with markers located in Ssa28, Ssa01 and Ssa21. A lower level of association was detected with growth on Ssa13. Candidate genes, which were linked to these genetic markers, were identified and some of them show a direct relationship with developmental processes, especially for those in association with sexual maturation. However, the relatively low power to detect genetic markers associated with growth (days to 5 kg) in this GWAS indicates the need to use a higher density SNP array in order to overcome the low levels of linkage disequilibrium observed in Atlantic salmon before the information can be incorporated into a selective breeding program.	[Gutierrez, Alejandro P.; Davidson, William S.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Yanez, Jose M.] Univ Chile, Fac Vet & Anim Sci, Santiago, Chile; [Fukui, Steve] Cermaq Canada, Campbell River, BC, Canada; [Swift, Bruce] TRI GEN Fish Improvement Ltd, Agassiz, BC, Canada	Simon Fraser University; Universidad de Chile	Davidson, WS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	wdavidso@sfu.ca	Davidson, Willie/M-1992-2019; Yáñez, José M/H-5279-2013	Yáñez, José M/0000-0002-6612-4087	Natural Sciences and Engineering Research Council of Canada [STPGP/381479-2009]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), Strategic grant: STPGP/381479-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAILEY GS, 1970, J BIOL CHEM, V245, P5927; Baranski M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-17; Boulding EG, 2008, HEREDITY, V101, P381, DOI 10.1038/hdy.2008.67; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Debacker K, 2007, HUM MOL GENET, V16, pR150, DOI 10.1093/hmg/ddm136; Easton AA, 2011, J FISH BIOL, V78, P602, DOI 10.1111/j.1095-8649.2010.02881.x; Eisbrenner WS, 2014, HEREDITY, V113, P86, DOI 10.1038/hdy.2013.55; FERGUSON MM, 1985, CAN J GENET CYTOL, V27, P289, DOI 10.1139/g85-043; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Gidskehaug L, 2011, BIOINFORMATICS, V27, P303, DOI 10.1093/bioinformatics/btq673; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; GJERDE B, 1984, AQUACULTURE, V38, P229, DOI 10.1016/0044-8486(84)90147-9; GJERDE B, 1994, LIVEST PROD SCI, V38, P133, DOI 10.1016/0301-6226(94)90057-4; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Gjoen HM, 1997, ICES J MAR SCI, V54, P1009, DOI 10.1016/S1054-3139(97)80005-7; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gutierrez AP, 2012, AQUACULTURE, V358, P61, DOI 10.1016/j.aquaculture.2012.06.017; Gutierrez AP, 2013, MAR BIOTECHNOL, P1; Haidle L, 2008, MAR BIOTECHNOL, V10, P579, DOI 10.1007/s10126-008-9098-5; Hata Y, 1998, NEUROSCI RES, V32, P1, DOI 10.1016/S0168-0102(98)00069-8; Heifetz EM, 2005, GENETICS, V171, P1173, DOI 10.1534/genetics.105.040782; Horstgen-Schwark G, 1998, AQUACULTURE, V167, P123, DOI 10.1016/S0044-8486(98)00308-1; Houston RD, 2009, ANIM GENET, V40, P753, DOI 10.1111/j.1365-2052.2009.01883.x; Houston RD, 2008, GENETICS, V178, P1109, DOI 10.1534/genetics.107.082974; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Huang YZ, 2010, J APPL GENET, V51, P199, DOI 10.1007/BF03195728; Johnston SE, 2014, MOL ECOL, V23, P3452, DOI 10.1111/mec.12832; Jonasson J, 1997, AQUACULTURE, V157, P205, DOI 10.1016/S0044-8486(97)00060-4; Kause A, 2003, AQUACULTURE, V228, P53, DOI 10.1016/S0044-8486(03)00244-8; Kent M. P., 2009, PLANT AN GEN 17 C SA; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Kuttner E, 2011, MOL GENET GENOMICS, V286, P67, DOI 10.1007/s00438-011-0628-x; Leder EH, 2006, J HERED, V97, P74, DOI 10.1093/jhered/esj004; LIEN S, 2011, BMC GENOMICS, V12, DOI DOI 10.1186/1471-2164-12-; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Martyniuk CJ, 2003, J FISH BIOL, V63, P746, DOI 10.1046/j.1095-8649.2003.00188.x; McClelland EK, 2010, HEREDITY, V105, P562, DOI 10.1038/hdy.2010.22; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Moghadam HK, 2007, MOL GENET GENOMICS, V277, P647, DOI 10.1007/s00438-007-0215-3; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; NAEVDAL G, 1983, AQUACULTURE, V33, P97, DOI 10.1016/0044-8486(83)90390-3; O'Malley KG, 2010, J HERED, V101, P628, DOI 10.1093/jhered/esq063; O'Malley KG, 2003, J HERED, V94, P273, DOI 10.1093/jhered/esg067; Paibomesai Marion I, 2010, BMC Res Notes, V3, P215, DOI 10.1186/1756-0500-3-215; Pedersen S, 2013, AQUACULTURE, V410, P164, DOI 10.1016/j.aquaculture.2013.06.039; Phillips RB, 2006, GENETICS, V174, P1661, DOI 10.1534/genetics.105.055269; Phillips RB, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-46; Quinton CD, 2005, AQUACULTURE, V247, P211, DOI 10.1016/j.aquaculture.2005.02.030; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sarafidou T, 2004, GENOMICS, V84, P69, DOI 10.1016/j.ygeno.2003.12.017; Sodeland M, 2013, AQUACULTURE, V408, P169, DOI 10.1016/j.aquaculture.2013.05.029; Sonesson A. K., 2007, Marker-assisted selection: current status and future perspectives in crops, livestock, forestry and fish, P309; Sonesson AK, 2007, GENET SEL EVOL, V39, P301, DOI 10.1051/gse:2007005; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; SUMPTER JP, 1992, AQUACULTURE, V100, P299, DOI 10.1016/0044-8486(92)90386-Y; Suzuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033558; SVED J A, 1971, Theoretical Population Biology, V2, P125; THOMPSON EA, 1990, BIOMETRICS, V46, P399, DOI 10.2307/2531445; Thorpe J.E., 1994, Aquaculture and Fisheries Management, V25, P77; Thorpe JE, 1998, AQUACULTURE, V168, P95, DOI 10.1016/S0044-8486(98)00342-1; WILD V, 1994, AQUACULTURE, V128, P51, DOI 10.1016/0044-8486(94)90101-5; Withler RE, 2007, AQUACULTURE, V272, pS318, DOI 10.1016/j.aquaculture.2007.07.201; Wringe BF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-63	71	101	108	4	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119730	10.1371/journal.pone.0119730	http://dx.doi.org/10.1371/journal.pone.0119730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25757012	Green Published, Green Submitted, gold			2022-12-26	WOS:000351275700051
J	Barakat, DJ; Zhang, J; Barberi, T; Denmeade, SR; Friedman, AD; Paz-Priel, I				Barakat, D. J.; Zhang, J.; Barberi, T.; Denmeade, S. R.; Friedman, A. D.; Paz-Priel, I.			CCAAT/Enhancer binding protein beta controls androgen-deprivation-induced senescence in prostate cancer cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SP1; C/EBP-BETA; GENE-EXPRESSION; SECRETORY PHENOTYPE; RECEPTOR; PROLIFERATION; DIFFERENTIATION; THERAPY; ALPHA; OVEREXPRESSION	The processes associated with transition to castration-resistant prostate cancer (PC) growth are not well understood. Cellular senescence is a stable cell cycle arrest that occurs in response to sublethal stress. It is often overcome in malignant transformation to confer a survival advantage. CCAAT/Enhancer Binding Protein (C/EBP) beta function is frequently deregulated in human malignancies and interestingly, androgen-sensitive PC cells express primarily the liver-enriched inhibitory protein isoform. We found that C/EBP beta expression is negatively regulated by androgen receptor (AR) activity and that treatment of androgen-sensitive cell lines with anti-androgens increases C/EBP beta mRNA and protein levels. Accordingly, we also find that C/EBP beta levels are significantly elevated in primary PC samples from castration-resistant compared with therapy-naive patients. Chromatin immunoprecipitation demonstrated enhanced binding of the AR to the proximal promoter of the CEBPB gene in the presence of dihydroxytestosterone. Upon androgen deprivation, induction of C/EBP beta is facilitated by active transcription as evident by increased histone 3 acetylation at the C/EBP beta promoter. Also, the androgen agonist R1881 suppresses the activity of a CEBPB promoter reporter. Loss of C/EBP beta expression prevents growth arrest following androgen deprivation or anti-androgen challenge. Accordingly, suppression of C/EBP beta under low androgen conditions results in reduced expression of senescence-associated secretory genes, significantly decreased number of cells displaying heterochromatin foci and increased numbers of Ki67-positive cells. Ectopic expression of C/EBP beta caused pronounced morphological changes, reduced PC cell growth and increased the number of senescent LNCaP cells. Lastly, we found that senescence contributes to PC cell survival under androgen deprivation, and C/EBP beta-deficient cells were significantly more susceptible to killing by cytotoxic chemotherapy following androgen deprivation. Our data demonstrate that upregulation of C/EBP beta is critical for complete maintenance of androgen deprivation-induced senescence and that targeting C/EBP beta expression may synergize with anti-androgen or chemotherapy in eradicating PC.	[Barakat, D. J.; Zhang, J.; Barberi, T.; Friedman, A. D.; Paz-Priel, I.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Pediat Oncol, Baltimore, MD 21231 USA; [Denmeade, S. R.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Med Oncol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Paz-Priel, I (corresponding author), Johns Hopkins Univ, Bunting Blaustein Canc Res Bldg 1,Room 208,1650 O, Baltimore, MD 21231 USA.	ipazpri1@jhmi.edu		Barakat, David/0000-0001-7057-178X	St Baldrick's Foundation; Mitchell Foundation; Walsh Prostate Cancer Research Fund; Samuel Waxman Cancer Research Foundation; Department of Defense [PC131609]; National Institutes of Health [T32 CA60441]; Giant Food Children's Cancer Research Fund;  [P30 CA006973]; NATIONAL CANCER INSTITUTE [P30CA006973, T32CA060441] Funding Source: NIH RePORTER	St Baldrick's Foundation; Mitchell Foundation; Walsh Prostate Cancer Research Fund; Samuel Waxman Cancer Research Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giant Food Children's Cancer Research Fund; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the St Baldrick's Foundation (to IP-P), the Mitchell Foundation (to IP-P), the Walsh Prostate Cancer Research Fund (to IP-P and ADF), the Samuel Waxman Cancer Research Foundation (to ADF), Department of Defense grant PC131609 (to DJB), National Institutes of Health T32 CA60441 (to TB), the Giant Food Children's Cancer Research Fund and P30 CA006973.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; American Cancer Society, 2013, CANC FACTS FIG 2013; Bagchi MK, 2006, CELL CYCLE, V5, P922, DOI 10.4161/cc.5.9.2712; Baretton GB, 1999, BRIT J CANCER, V80, P546, DOI 10.1038/sj.bjc.6690390; Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Burton DGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068003; Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Calkhoven CF, 2000, GENE DEV, V14, P1920; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christenson LK, 1999, J BIOL CHEM, V274, P26591, DOI 10.1074/jbc.274.37.26591; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Dean JP, 2008, BRIT J CANCER, V98, P245, DOI 10.1038/sj.bjc.6604087; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Denmeade S R, 1996, Adv Pharmacol, V35, P281, DOI 10.1016/S1054-3589(08)60278-1; Denmeade SR, 1996, PROSTATE, V28, P251; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Henshall SM, 2001, CLIN CANCER RES, V7, P544; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Kawabata R, 2011, INT J ONCOL, V38, P1489, DOI 10.3892/ijo.2011.991; Kim MH, 2008, PROSTATE, V68, P1362, DOI 10.1002/pros.20801; Kim MH, 2009, PROSTATE, V69, P1435, DOI 10.1002/pros.20993; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kurz DJ, 2000, J CELL SCI, V113, P3613; Lee CT, 1999, CLIN CANCER RES, V5, P977; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Manna S, 2013, J IMMUNOL, V191, P2837, DOI 10.4049/jimmunol.1300895; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Martinez LA, 2002, CARCINOGENESIS, V23, P1289, DOI 10.1093/carcin/23.8.1289; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paz-Priel I, 2011, BLOOD, V117, P4085, DOI 10.1182/blood-2010-07-294470; Pernicova Z, 2011, NEOPLASIA, V13, P526, DOI 10.1593/neo.11182; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Steinman RA, 2000, MOL MED, V6, P736, DOI 10.1007/BF03402190; Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921; Tanabe A, 2000, BIOL PHARM BULL, V23, P1424, DOI 10.1248/bpb.23.1424; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Wang WZ, 2007, PROSTATE, V67, P1238, DOI 10.1002/pros.20595; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Yuan HQ, 2005, CARCINOGENESIS, V26, P793, DOI 10.1093/carcin/bgi021; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang ZH, 2006, MODERN PATHOL, V19, P1339, DOI 10.1038/modpathol.3800655; Zhou JF, 2001, CANCER RES, V61, P2328	57	23	23	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	2015	34	48					5912	5922		10.1038/onc.2015.41	http://dx.doi.org/10.1038/onc.2015.41			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CX1CO	25772238	Green Accepted			2022-12-26	WOS:000365434000006
J	Sasso, O; Migliore, M; Habrant, D; Armirotti, A; Albani, C; Summa, M; Moreno-Sanz, G; Scarpelli, R; Piomelli, D				Sasso, Oscar; Migliore, Marco; Habrant, Damien; Armirotti, Andrea; Albani, Clara; Summa, Maria; Moreno-Sanz, Guillermo; Scarpelli, Rita; Piomelli, Daniele			Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage	FASEB JOURNAL			English	Article						anandamide; cannabinoid receptor; inflammatory bowel disease; multitarget inhibitors	ENDOGENOUS CANNABINOID SYSTEM; BOWEL-DISEASE; EXPERIMENTAL COLITIS; ENDOCANNABINOID OXYGENATION; ULCERATIVE-COLITIS; RECEPTOR AGONIST; LIPID MEDIATORS; PAIN INITIATION; CROHNS-DISEASE; CB2 RECEPTORS	The ability of nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit cyclooxygenase (Cox)-1 and Cox-2 underlies the therapeutic efficacy of these drugs, as well as their propensity to damage the gastrointestinal (GI) epithelium. This toxic action greatly limits the use of NSAIDs in inflammatory bowel disease (IBD) and other chronic pathologies. Fatty acid amide hydrolase (FAAH) degrades the endocannabinoid anandamide, which attenuates inflammation and promotes GI healing. Here, we describe the first class of systemically active agents that simultaneously inhibit FAAH, Cox-1, and Cox-2 with high potency and selectivity. The class prototype 4 (ARN2508) is potent at inhibiting FAAH, Cox-1, and Cox-2 (median inhibitory concentration: FAAH, 0.031 +/- 0.002 mu M; Cox-1, 0.012 +/- 0.002 mu M; and Cox-2, 0.43 +/- 0.025 mu M) but does not significantly interact with a panel of >100 off targets. After oral administration in mice, ARN2508 engages its intended targets and exerts profound therapeutic effects in models of intestinal inflammation. Unlike NSAIDs, ARN2508 causes no gastric damage and indeed protects the GI from NSAID-induced damage through a mechanism that requires FAAH inhibition. Multitarget FAAH/Cox blockade may provide a transformative approach to IBD and other pathologies in which FAAH and Cox are overactive.	[Sasso, Oscar; Migliore, Marco; Habrant, Damien; Armirotti, Andrea; Albani, Clara; Summa, Maria; Scarpelli, Rita; Piomelli, Daniele] Ist Italiano Tecnol, Dept Drug Discovery & Dev, Genoa, Italy; [Moreno-Sanz, Guillermo; Piomelli, Daniele] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol & Biol Chem, Irvine, CA 92697 USA	Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of California System; University of California Irvine	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	piomelli@uci.edu	Armirotti, Andrea/AAB-3284-2019; Scarpelli, Rita/O-9422-2015	Armirotti, Andrea/0000-0002-3766-8755; Summa, Maria/0000-0002-8410-2607	U.S. National Institutes of Health National Institute on Drug Abuse [DA012413]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012413] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Drs. Angelo Reggiani and Tiziano Bandiera for helpful discussions; Ms. Sine Mandrup-Bertozzi, Ms. Silvia Venzano, and Mr. Luca Goldoni for technical help; and the U.S. National Institutes of Health National Institute on Drug Abuse (Grant DA012413 to D.P.) for financial support. D.P., R.S., M.M., and D.H. are inventors on patent application WO2014023643, filed by the University of California-Irvine (Irvine, CA, USA) and the Istituto Italiano di Tecnologia, which protects novel compounds disclosed in this paper.	Araldi D, 2013, P NATL ACAD SCI USA, V110, P3603, DOI 10.1073/pnas.1220668110; Bayly CI, 1999, BIOORG MED CHEM LETT, V9, P307, DOI 10.1016/S0960-894X(98)00717-3; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Blackler RW, 2014, CURR OPIN PHARMACOL, V19, P11, DOI 10.1016/j.coph.2014.05.008; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Bradshaw HB, 2009, VITAM HORM, V81, P191, DOI 10.1016/S0083-6729(09)81008-X; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cencioni MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008688; CHAN CC, 1995, J PHARMACOL EXP THER, V274, P1531; Chiurchiu V, 2013, ANN NEUROL, V73, P626, DOI 10.1002/ana.23875; Clapper JR, 2010, NAT NEUROSCI, V13, P1265, DOI 10.1038/nn.2632; Cluny NL, 2010, J PHARMACOL EXP THER, V334, P973, DOI 10.1124/jpet.110.169946; Costa-Romero M, 2008, INFLAMM BOWEL DIS, V14, P1462, DOI 10.1002/ibd.20450; Di Paola R, 2010, J LEUKOCYTE BIOL, V88, P291, DOI 10.1189/jlb.0110053; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Fowler CJ, 2009, BRIT J PHARMACOL, V156, P412, DOI 10.1111/j.1476-5381.2008.00029.x; Hoffmann JC, 2002, PATHOBIOLOGY, V70, P121, DOI 10.1159/000068143; Holt S, 2007, EUR J PHARMACOL, V565, P26, DOI 10.1016/j.ejphar.2007.02.051; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LAURITSEN K, 1988, GUT, V29, P1316, DOI 10.1136/gut.29.10.1316; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Maccarrone M, 2001, FUNCT NEUROL, V16, P53; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Mileni M, 2010, J MOL BIOL, V400, P743, DOI 10.1016/j.jmb.2010.05.034; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morphy R, 2006, J MED CHEM, V49, P4961, DOI 10.1021/jm0603015; Naidu PS, 2009, J PHARMACOL EXP THER, V329, P48, DOI 10.1124/jpet.108.143487; Patrono C, 2009, MOL INTERV, V9, P31, DOI 10.1124/mi.9.1.8; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Riccardi L, 2009, SHOCK, V31, P308, DOI 10.1097/SHK.0b013e31818339e7; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Richardson D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2401; RISDALL PC, 1978, XENOBIOTICA, V8, P691, DOI 10.3109/00498257809069581; Roberts MS, 2002, CLIN PHARMACOKINET, V41, P751, DOI 10.2165/00003088-200241100-00005; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Russo R, 2007, EUR J PHARMACOL, V566, P117, DOI 10.1016/j.ejphar.2007.03.007; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Sasso O, 2012, PHARMACOL RES, V65, P553, DOI 10.1016/j.phrs.2012.02.012; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shi Y, 2011, WORLD J GASTROENTERO, V17, P3733, DOI 10.3748/wjg.v17.i32.3733; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Suarez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037729; Tarzia G, 2003, J MED CHEM, V46, P2352, DOI 10.1021/jm021119g; Wallace JL, 2004, J PHARMACOL EXP THER, V309, P626, DOI 10.1124/jpet.103.063453; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; WILSON DE, 1991, J CLIN GASTROENTEROL, V13, pS65, DOI 10.1097/00004836-199112001-00011; Wright K, 2005, GASTROENTEROLOGY, V129, P437, DOI 10.1053/j.gastro.2005.05.026	56	53	54	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2616	2627		10.1096/fj.15-270637	http://dx.doi.org/10.1096/fj.15-270637			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757568	Green Submitted, Green Published			2022-12-26	WOS:000355209500037
J	Balasubramaniam, SL; Gopalakrishnapillai, A; Gangadharan, V; Duncan, RL; Barwe, SP				Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Gangadharan, Vimal; Duncan, Randall L.; Barwe, Sonali P.			Sodium-Calcium Exchanger 1 Regulates Epithelial Cell Migration via Calcium-dependent Extracellular Signal-regulated Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA,K-ATPASE BETA-SUBUNIT; NA+/K+-ATPASE BETA-1-SUBUNIT; NA+/CA2+ EXCHANGERS; NA+-CA2+ EXCHANGER; REVERSE-MODE; MAP KINASES; CA2+ INFLUX; PHOSPHORYLATION; ACTIVATION; EXPRESSION	Na+/Ca(2+)exchanger-1 (NCX1) is a major calcium extrusion mechanism in renal epithelial cells enabling the efflux of one Ca2+ ion and the influx of three Na+ ions. The gradient for this exchange activity is provided by Na, K-ATPase, a hetero-oligomer consisting of a catalytic alpha-subunit and a regulatory beta-subunit (Na, K-beta) that also functions as a motility and tumor suppressor. We showed earlier that mice with heart-specific ablation (KO) of Na, K-beta had a specific reduction in NCX1 protein and were ouabain-insensitive. Here, we demonstrate that Na, K-beta associates with NCX1 and regulates its localization to the cell surface. Madin-Darby canine kidney cells with Na, K-beta knockdown have reduced NCX1 protein and function accompanied by 2.1-fold increase in free intracellular calcium and a corresponding increase in the rate of cell migration. Increased intracellular calcium up-regulated ERK1/2 via calmodulin-dependent activation of PI3K. Both myosin light chain kinase and Rho-associated kinase acted as mediators of ERK1/2-dependent migration. Restoring NCX1 expression in beta-KD cells reduced migration rate and ERK1/2 activation, suggesting that NCX1 functions downstream of Na, K-beta in regulating cell migration. In parallel, inhibition of NCX1 by KB-R7943 in Madin-Darby canine kidney cells, LLC-PK1, and human primary renal epithelial cells (HREpiC) increased ERK1/2 activation and cell migration. This increased migration was associated with high myosin light chain phosphorylation by PI3K/ERK-dependent mechanism in HREpiC cells. These data confirm the role of NCX1 activity in regulating renal epithelial cell migration.	[Balasubramaniam, Sona Lakshme; Gopalakrishnapillai, Anilkumar; Barwe, Sonali P.] Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE 19803 USA; [Balasubramaniam, Sona Lakshme; Gangadharan, Vimal; Duncan, Randall L.; Barwe, Sonali P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	Nemours Alfred I. duPont Hospital for Children; University of Delaware	Barwe, SP (corresponding author), Alfred I duPont Hosp Children, Nemours Ctr Childhood Canc Res, 1701 Rockland Rd, Wilmington, DE 19803 USA.	barwe@medsci.udel.edu	Duncan, Randall/AAK-3888-2020; Regan, Clinton/E-6250-2012; gopala, Anilkumar/AAG-2713-2021	Barwe, Sonali/0000-0003-4162-3004; Duncan, Randall/0000-0001-5733-6603; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	National Institutes of Health [8 P20GM103446-13, P20GM103464, U54GM104941]; American Heart Association [10SDG260011]; Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464, U54GM104941, P20GM103446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Nemours Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 8 P20GM103446-13 (to the Delaware Bioimaging Center (IDeA Networks of Biomedical Research Excellence (INBRE)-NIGMS), P20GM103464 (to the Cell Science Core of the Center for Pediatric Research), and U54GM104941 (to DE-CTR ACCEL). This work was also supported by American Heart Association Grant 10SDG260011 and by the Nemours Foundation.	Amran MS, 2003, CARDIOVASC DRUG REV, V21, P255; Andrikopoulos P, 2011, J BIOL CHEM, V286, P37919, DOI 10.1074/jbc.M111.251777; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Barwe SP, 2009, J MOL CELL CARDIOL, V47, P552, DOI 10.1016/j.yjmcc.2009.07.018; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Billman G E, 2001, Curr Opin Investig Drugs, V2, P1740; BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367, DOI 10.1152/ajpcell.1993.264.6.C1367; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brouland JP, 2005, AM J PATHOL, V167, P233, DOI 10.1016/S0002-9440(10)62968-9; Buchanan CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071337; Carmosino M, 2014, J HYPERTENS, V32, P1842, DOI 10.1097/HJH.0000000000000258; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Chifflet S, 2012, WOUND REPAIR REGEN, V20, P28, DOI 10.1111/j.1524-475X.2011.00749.x; DHAND R, 1994, EMBO J, V13, P522, DOI 10.1002/j.1460-2075.1994.tb06290.x; Dong H, 2010, AM J PHYSIOL-CELL PH, V299, pC1493, DOI 10.1152/ajpcell.00242.2010; Dunn J, 2002, J BIOL CHEM, V277, P33957, DOI 10.1074/jbc.M206677200; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Goldhaber JI, 2013, ADV EXP MED BIOL, V961, P355, DOI 10.1007/978-1-4614-4756-6_30; Hamming KSC, 2010, DIABETES, V59, P1686, DOI 10.2337/db09-0630; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; IKEBE M, 1985, J BIOL CHEM, V260, P27; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jha S, 2009, FEBS LETT, V583, P3109, DOI 10.1016/j.febslet.2009.08.039; Joyal JL, 1997, J BIOL CHEM, V272, P28183, DOI 10.1074/jbc.272.45.28183; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kemeny LV, 2013, AM J PHYSIOL-GASTR L, V305, pG552, DOI 10.1152/ajpgi.00394.2012; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Kip SN, 2003, AM J PHYSIOL-RENAL, V284, pF122, DOI 10.1152/ajprenal.00161.2002; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Li J, 2010, BIOCHEM BIOPH RES CO, V392, P516, DOI 10.1016/j.bbrc.2009.12.183; Li W, 1997, AM J PHYSIOL-ENDOC M, V273, pE599, DOI 10.1152/ajpendo.1997.273.3.E599; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Matsuda T, 1997, JPN J PHARMACOL, V74, P1, DOI 10.1254/jjp.74.1; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Monteith GR, 2012, J BIOL CHEM, V287, P31666, DOI 10.1074/jbc.R112.343061; Ottolia M, 2007, J BIOL CHEM, V282, P3695, DOI 10.1074/jbc.M610425200; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Prevarskaya N, 2013, EXPERT OPIN THER TAR, V17, P225, DOI 10.1517/14728222.2013.741594; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Raizman JE, 2007, J CELL PHYSIOL, V213, P540, DOI 10.1002/jcp.21134; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2005, SEMIN NEPHROL, V25, P328, DOI 10.1016/j.semnephrol.2005.03.008; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2004, MOL BIOL CELL, V15, P3224, DOI 10.1091/mbc.e04-03-0222; Reeves JP, 1998, J BIOENERG BIOMEMBR, V30, P151, DOI 10.1023/A:1020569224915; Reuter H, 2002, CIRC RES, V90, P305, DOI 10.1161/hh0302.104562; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Rotfeld H, 2014, REPRODUCTION, V147, P347, DOI 10.1530/REP-13-0560; Sakamoto K, 2009, J PHYSIOL-LONDON, V587, P5345, DOI 10.1113/jphysiol.2009.172080; Schwab A, 1997, PFLUG ARCH EUR J PHY, V434, P70, DOI 10.1007/s004240050364; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Tong XP, 2009, J CELL BIOL, V186, P113, DOI 10.1083/jcb.200811071; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Treloar KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067389; Tsavaler L, 2001, CANCER RES, V61, P3760; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wiegert JS, 2011, CELL CALCIUM, V49, P296, DOI 10.1016/j.ceca.2010.11.009; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003	68	13	14	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12463	12473		10.1074/jbc.M114.629519	http://dx.doi.org/10.1074/jbc.M114.629519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25770213	hybrid, Green Published			2022-12-26	WOS:000354569000003
J	Cavanaugh, AR; Schwartz, GJ; Blouet, C				Cavanaugh, Althea R.; Schwartz, Gary J.; Blouet, Clemence			High-Fat Feeding Impairs Nutrient Sensing and Gut Brain Integration in the Caudomedial Nucleus of the Solitary Tract in Mice	PLOS ONE			English	Article							DIET-INDUCED OBESITY; EXTRACELLULAR AMINO-ACIDS; REGULATES FOOD-INTAKE; MEAL SIZE; MAMMALIAN TARGET; PARAVENTRICULAR NUCLEUS; HINDBRAIN NEURONS; SKELETAL-MUSCLE; ENERGY-BALANCE; RATS	Hyperphagic obesity is characterized in part by a specific increase in meal size that contributes to increased daily energy intake, but the mechanisms underlying impaired activity of meal size regulatory circuits, particularly those converging at the caudomedial nucleus of the solitary tract in the hindbrain (cmNTS), remain poorly understood. In this paper, we assessed the consequences ofhigh-fat (HF) feeding and diet-induced obesity (DIO) on cmNTS nutrient sensing and metabolic integration in the control of meal size. Mice maintained on a standard chow diet, low-fat (LF) diet or HF diet for 2 weeks or 6 months were implanted with a bilateral brain cannula targeting the cmNTS. Feeding behavior was assessed using behavioral chambers and meal-pattern analysis following cmNTS L-leucine injections alone or together with ip CCK. Molecular mechanisms implicated in the feeding responses were assessed using western blot, immunofluorescence and pharmacological inhibition of the amino acid sensing mTORC1 pathway (mammalian target of rapamycin complex 1). We found that HF feeding blunts the anorectic consequences of cmNTS L-leucine administration. Increased baseline activity of the L-leucine sensor P70 S6 kinase 1 and impaired L-leucine-induced activation of this pathway in the cmNTS of HF-fed mice indicate that HF feeding is associated with an impairment in cmNTS mTOR nutritional and hormonal sensing. Interestingly, the acute orexigenic effect of the mTORC1 inhibitor rapamycin was preserved in HF-fed mice, supporting the assertion that HF-induced increase in baseline cmNTS mTORC1 activity underlies the defect in L-leucine sensing. Last, the synergistic feeding-suppressive effect of CCK and cmNTS L-leucine was abrogated in DIO mice. These results indicate that HF feeding leads to an impairment in cmNTS nutrient sensing and metabolic integration in the regulation of meal size.	[Cavanaugh, Althea R.; Schwartz, Gary J.; Blouet, Clemence] Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Blouet, Clemence] Univ Cambridge, MRC, Inst Metab Sci, Metab Dis Unit, Cambridge, England	Yeshiva University; Albert Einstein College of Medicine; University of Cambridge	Schwartz, GJ (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.	gary.schwartz@einstein.yu.edu; csb69@medschl.cam.ac.uk		Blouet, Clemence/0000-0002-1752-1270	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [K99 DK 093724, R00 DK 020541]; Ajinomoto Amino Acid Research Program (3ARP); Medical Research Council [MC_UU_12012/5/B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK093724, P30DK020541, R01DK105441, P30DK026687, P60DK020541] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ajinomoto Amino Acid Research Program (3ARP); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (K99 DK 093724 and R00 DK 020541) and the Ajinomoto Amino Acid Research Program (3ARP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 2006, PHYSIOL BEHAV, V89, P517, DOI 10.1016/j.physbeh.2006.08.018; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Choi YH, 2000, LIFE SCI, V66, P1105, DOI 10.1016/S0024-3205(00)00414-8; Choi YH, 2001, BRAIN RES, V892, P320, DOI 10.1016/S0006-8993(00)03267-4; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008; Covasa M, 1998, PEPTIDES, V19, P1407, DOI 10.1016/S0196-9781(98)00096-5; Covasa M, 1999, AM J PHYSIOL-REG I, V277, pR279, DOI 10.1152/ajpregu.1999.277.1.R279; CURRIE PJ, 1995, LIFE SCI, V57, P1911, DOI 10.1016/0024-3205(95)02178-L; Cyr NE, 2014, ENDOCRINOLOGY, V155, P2423, DOI 10.1210/en.2013-1998; Donovan MJ, 2009, BRAIN RES, V1248, P136, DOI 10.1016/j.brainres.2008.10.042; Duca FA, 2013, INT J OBESITY, V37, P375, DOI 10.1038/ijo.2012.45; Farley C, 2003, OBES RES, V11, P845, DOI 10.1038/oby.2003.116; Fei W, 2012, PEPTIDES, P23, DOI [10.1016/j.peptides.2012.04.009, DOI 10.1016/J.PEPTIDES.2012.04.009]; Grill HJ, 2006, OBESITY, V14, P216, DOI 10.1038/oby.2006.312; Grill HJ, 2012, CELL METAB, V16, P296, DOI 10.1016/j.cmet.2012.06.015; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Kageyama T, 2000, NEUROREPORT, V11, P3663, DOI 10.1097/00001756-200011270-00015; Kanoski SE, 2012, AM J PHYSIOL-ENDOC M, V303, pE496, DOI 10.1152/ajpendo.00205.2012; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lutz TA, 2013, DIABETES OBES METAB, V15, P99, DOI 10.1111/j.1463-1326.2012.01670.x; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Orr ME, 2014, NEUROBIOL AGING, V35, P1233, DOI 10.1016/j.neurobiolaging.2013.12.006; Smith GP, 1996, NEUROSCI BIOBEHAV R, V20, P41, DOI 10.1016/0149-7634(95)00038-G; Treesukosol Y, 2014, APPETITE, V75, P21, DOI 10.1016/j.appet.2013.12.004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Williams DL, 2011, PHYSIOL BEHAV, V103, P557, DOI 10.1016/j.physbeh.2011.04.005; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Zhao S, 2012, INT J OBESITY, V36, P1522, DOI 10.1038/ijo.2011.265	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118888	10.1371/journal.pone.0118888	http://dx.doi.org/10.1371/journal.pone.0118888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774780	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500050
J	Ding, T; Hong, MH; Richards, AM; Wong, TI; Zhou, XD; Drum, CL				Ding, Tao; Hong, Minghui; Richards, A. Mark; Wong, Ten It; Zhou, Xiaodong; Drum, Chester Lee			Quantification of a Cardiac Biomarker in Human Serum Using Extraordinary Optical Transmission (EOT)	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; SUBWAVELENGTH HOLE ARRAYS; CHEST-PAIN SYMPTOMS; TO-BALLOON TIME; MYOCARDIAL-INFARCTION; DIAGNOSTIC PROTOCOL; NANOHOLE ARRAYS; HIGH-THROUGHPUT; METAL-FILMS; REAL-TIME	Nanoimprinting lithography (NIL) is a manufacturing process that can produce macroscale surface areas with nanoscale features. In this paper, this technique is used to solve three fundamental issues for the application of localized surface plasmonic resonance (LSPR) in practical clinical measurements: assay sensitivity, chip-to-chip variance, and the ability to perform assays in human serum. Using NIL, arrays of 140 nm square features were fabricated on a sensing area of 1.5 mm x 1.5 mm with low cost. The high reproducibility of NIL allowed for the use of a one-chip, one-measurement approach with 12 individually manufactured surfaces with minimal chip-to-chip variations. To better approximate a real world setting, all chips were modified with a biocompatible, multi-component monolayer and interchip variability was assessed by measuring a bioanalyte standard (2.5-75 ng/ml) in the presence of a complex biofluid, human serum. In this setting, nanoimprinted LSPR chips were able to provide sufficient characteristics for a 'low-tech' approach to laboratory-based bioanalyte measurement, including: 1) sufficient size to interface with a common laboratory light source and detector without the need for a microscope, 2) high sensitivity in serum with a cardiac troponin limit of detection of 0.55 ng/ml, and 3) very low variability in chip manufacturing to produce a figure of merit (FOM) of 10.5. These findings drive LSPR closer to technical comparability with ELISA-based assays while preserving the unique particularities of a LSPR based sensor, suitability for multiplexing and miniaturization, and point-of-care detections.	[Ding, Tao; Richards, A. Mark; Drum, Chester Lee] Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Res Inst, Singapore 117595, Singapore; [Hong, Minghui] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Wong, Ten It; Zhou, Xiaodong] ASTAR, Inst Mat Res Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Drum, CL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Cardiovasc Res Inst, Singapore 117595, Singapore.	mdccld@nus.edu.sg	Zhou, Xiao Dong/AAZ-3659-2020; Wong, Ten It/Q-1987-2016; Drum, Chester/A-6089-2015	Zhou, Xiao Dong/0000-0002-0195-4186; Wong, Ten It/0000-0002-5616-3365; Drum, Chester/0000-0001-6327-4584	Singapore Ministry of Health's National Medical Research Council [NMRC/CSA/035/2012]; National University of Singapore	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); National University of Singapore(National University of Singapore)	This research is supported by the Singapore Ministry of Health's National Medical Research Council under its clinician scientist funding scheme, NMRC/CSA/035/2012 and the National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhagawati M, 2013, ANAL CHEM, V85, P9564, DOI 10.1021/ac401673e; Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Chang TY, 2011, LAB CHIP, V11, P3596, DOI 10.1039/c1lc20475k; Coe JV, 2008, ANNU REV PHYS CHEM, V59, P179, DOI 10.1146/annurev.physchem.59.032607.093703; Dahlin AB, 2006, ANAL CHEM, V78, P4416, DOI 10.1021/ac0601967; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Garcia-Vidal FJ, 2010, REV MOD PHYS, V82, P729, DOI 10.1103/RevModPhys.82.729; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Guo LH, 2012, BIOSENS BIOELECTRON, V31, P567, DOI 10.1016/j.bios.2011.10.047; Im H, 2012, ANAL CHEM, V84, P1941, DOI 10.1021/ac300070t; Ji J, 2008, ANAL CHEM, V80, P2491, DOI 10.1021/ac7023206; Kim JH, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2355468; Krishnan A, 2001, OPT COMMUN, V200, P1, DOI 10.1016/S0030-4018(01)01558-9; Lesuffleur A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2747668; Lin EH, 2014, OPT EXPRESS, V22, P19621, DOI 10.1364/OE.22.019621; Liu HT, 2008, NATURE, V452, P728, DOI 10.1038/nature06762; Live LS, 2010, ANAL CHEM, V82, P3780, DOI 10.1021/ac100177j; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Nahshol O, 2008, ANAL BIOCHEM, V383, P52, DOI 10.1016/j.ab.2008.08.017; Nakamoto K, 2012, ANAL CHEM, V84, P3187, DOI 10.1021/ac203160r; Schwind M, 2013, NANO LETT, V13, P1743, DOI 10.1021/nl400328x; Sharpe JC, 2008, ANAL CHEM, V80, P2244, DOI 10.1021/ac702555r; Shon YS, 2009, PLASMONICS, V4, P95, DOI 10.1007/s11468-009-9079-1; Stark PRH, 2005, METHODS, V37, P37, DOI 10.1016/j.ymeth.2005.05.006; Stewart ME, 2006, P NATL ACAD SCI USA, V103, P17143, DOI 10.1073/pnas.0606216103; Than M, 2012, J AM COLL CARDIOL, V59, P2091, DOI 10.1016/j.jacc.2012.02.035; Than M, 2011, LANCET, V377, P1077, DOI 10.1016/S0140-6736(11)60310-3; Valsecchi C, 2013, LANGMUIR, V29, P5638, DOI 10.1021/la400085r; Wong TI, 2013, LAB CHIP, V13, P2405, DOI 10.1039/c3lc41396a; Wu L, 2012, IEEE PHOTONICS J, V4, P26, DOI 10.1109/JPHOT.2011.2177652; Wu L, 2012, J OPT SOC AM B, V29, P521, DOI 10.1364/JOSAB.29.000521; Xiang GS, 2010, NANOSCALE RES LETT, V5, P818, DOI 10.1007/s11671-010-9566-5; Yang J, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.66; Yang JC, 2010, NANO LETT, V10, P3173, DOI 10.1021/nl102078j	36	12	12	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120974	10.1371/journal.pone.0120974	http://dx.doi.org/10.1371/journal.pone.0120974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774658	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500202
J	Huang, Q; Wen, S; Wang, B; Wang, QD; Guo, CG; Wu, XY; Zhang, R; Yang, R; Chen, F; Xiao, WB				Huang, Qiang; Wen, Song; Wang, Bo; Wang, Qidong; Guo, Chuangen; Wu, Xinying; Zhang, Rui; Yang, Rong; Chen, Feng; Xiao, Wenbo			C5b-9-Targeted Molecular MR Imaging in Rats with Heymann Nephritis: A New Approach in the Evaluation of Nephrotic Syndrome	PLOS ONE			English	Article							GLOMERULAR MESANGIAL CELLS; IRON-OXIDE NANOPARTICLES; SUBLYTIC C5B-9 COMPLEXES; IN-VIVO; AFFIBODY MOLECULES; THY-1 NEPHRITIS; APOPTOSIS; INJURY; MODEL	Membranous nephropathy (MN) is the major cause of adult nephrotic syndrome, which severely affects patients' quality of life. Currently, percutaneous renal biopsy is required to definitively diagnose MN. However, this technique is invasive and may cause severe complications. Therefore, an urgent clinical need exists for dynamic noninvasive monitoring of the renal state. In-depth molecular imaging studies could assist in finding a solution. Membrane attack complex C5b-9 is the key factor in the development of MN, and this protein primarily deposits in the glomerulus. The present study bound polyclonal antibodies to C5b-9 with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles to obtain C5b-9-targeted magnetic resonance molecular imaging probes. The probes were injected intravenously into rats with Heymann nephritis, a classic disease model of MN. The signal intensity in the T2*-weighted imaging of kidneys in vivo using 7.0 Tesla magnetic resonance imaging decreased significantly 24 hours after injection compared to the untargeted and control groups. This signal change was consistent with the finding of nanoparticle deposits in pathological glomeruli. This study demonstrated a novel molecular imaging technique for the assessment of MN.	[Huang, Qiang; Wang, Qidong; Guo, Chuangen; Zhang, Rui; Yang, Rong; Chen, Feng; Xiao, Wenbo] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China; [Wen, Song] Southeast Univ, Sch Med, Jiangsu Key Lab Mol & Funct Imaging, Nanjing, Jiangsu, Peoples R China; [Wang, Bo] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Xinying] Nanjing Med Univ, Nanjing Hosp 1, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Southeast University - China; Zhejiang University; Nanjing Medical University	Xiao, WB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Radiol, Hangzhou 310003, Zhejiang, Peoples R China.	chenfengbe@aliyun.com; xiaowb.111@163.com			National Natural Science Foundation of P.R. China [81171388, 81201128]; Ministry of Health Research Foundation of P.R. China [WKJ2011-2-004]; Medical Science and technology development Foundation, Nanjing Department of Health [YKK13102]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Ministry of Health Research Foundation of P.R. China; Medical Science and technology development Foundation, Nanjing Department of Health	This study was supported by grants from the National Natural Science Foundation of P.R. China (81171388), and partly from the Ministry of Health Research Foundation of P.R. China (WKJ2011-2-004), the National Natural Science Foundation of P.R. China (81201128), Key Project supported by Medical Science and technology development Foundation, Nanjing Department of Health (YKK13102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altai M, 2014, EUR J MED CHEM, V87, P519, DOI 10.1016/j.ejmech.2014.09.082; Altai M, 2013, CANCER BIOTHER RADIO, V28, P187, DOI 10.1089/cbr.2012.1304; Cai QY, 2012, NANOMED-NANOTECHNOL, V8, P365, DOI 10.1016/j.nano.2011.06.019; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Fei XN, 2010, MOLECULES, V15, P6983, DOI 10.3390/molecules15106983; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; Hauger O, 1999, MAGNET RESON MED, V41, P156, DOI 10.1002/(SICI)1522-2594(199901)41:1<156::AID-MRM22>3.0.CO;2-C; He C, 2005, J IMMUNOL, V174, P5750, DOI 10.4049/jimmunol.174.9.5750; HEYMANN W, 1959, P SOC EXP BIOL MED, V100, P660; Honarvar H, 2013, NUCL MED BIOL, V40, P378, DOI 10.1016/j.nucmedbio.2012.12.009; Korbet SM, 2002, SEMIN NEPHROL, V22, P254, DOI 10.1053/snep.2002.31713; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Liu SJ, 2009, MOL PHARMACEUT, V6, P1074, DOI 10.1021/mp900143a; LOTAN D, 1984, KIDNEY INT, V25, P778, DOI 10.1038/ki.1984.90; Madhav D, 2011, SAUDI J KIDNEY DIS T, V22, P544; MALATHI P, 1979, BIOCHIM BIOPHYS ACTA, V554, P259, DOI 10.1016/0005-2736(79)90023-3; NOMURA A, 1995, J CLIN INVEST, V96, P2348, DOI 10.1172/JCI118291; Qiao JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018103; Qiao RR, 2012, ACS NANO, V6, P3304, DOI 10.1021/nn300240p; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Salzer R, 2007, ANAL BIOANAL CHEM, V389, P1101, DOI 10.1007/s00216-007-1529-z; Sargsyan SA, 2012, KIDNEY INT, V81, P152, DOI 10.1038/ki.2011.332; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7; Munoz AT, 2011, ARCH MED SCI, V7, P823, DOI 10.5114/aoms.2011.25557; Trivedi RA, 2004, STROKE, V35, P1631, DOI 10.1161/01.STR.0000131268.50418.b7; Wallberg H, 2011, PROTEIN EXPRES PURIF, V76, P127, DOI 10.1016/j.pep.2010.10.008; Wen S, 2012, J LIPID RES, V53, P829, DOI 10.1194/jlr.M018895; Zhang YQ, 2000, KIDNEY INT, V58, P1300, DOI 10.1046/j.1523-1755.2000.00286.x	30	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0121244	10.1371/journal.pone.0121244	http://dx.doi.org/10.1371/journal.pone.0121244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774523	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500210
J	Pandey, R; Botros, MA; Nacev, BA; Albig, AR				Pandey, Raghav; Botros, Mark A.; Nacev, Benjamin A.; Albig, Allan R.			Cyclosporin A Disrupts Notch Signaling and Vascular Lumen Maintenance	PLOS ONE			English	Article							VESSEL FORMATION; ANKYRIN DOMAIN; GROWTH-FACTOR; ZEBRAFISH; ANGIOGENESIS; CALCINEURIN; ACTIVATION; TARGET; MORPHOGENESIS; INHIBITION	Cyclosporin A (CSA) suppresses immune function by blocking the cyclophilin A and calcineurin/NFAT signaling pathways. In addition to immunosuppression, CSA has also been shown to have a wide range of effects in the cardiovascular system including disruption of heart valve development, smooth muscle cell proliferation, and angiogenesis inhibition. Circumstantial evidence has suggested that CSA might control Notch signaling which is also a potent regulator of cardiovascular function. Therefore, the goal of this project was to determine if CSA controls Notch and to dissect the molecular mechanism(s) by which CSA impacts cardiovascular homeostasis. We found that CSA blocked JAG1, but not DII4 mediated Notch1 NICD cleavage in transfected 293T cells and decreased Notch signaling in zebrafish embryos. CSA suppression of Notch was linked to cyclophilin A but not calcineurin/NFAT inhibition since N-MeVal-4-CsA but not FK506 decreased Notch1 NICD cleavage. To examine the effect of CSA on vascular development and function, double transgenic Fli1-GFP/Gata1-RFP zebrafish embryos were treated with CSA and monitored for vasculogenesis, angiogenesis, and overall cardiovascular function. Vascular patterning was not obviously impacted by CSA treatment and contrary to the anti-angiogenic activity ascribed to CSA, angiogenic sprouting of ISV vessels was normal in CSA treated embryos. Most strikingly, CSA treated embryos exhibited a progressive decline in blood flow that was associated with eventual collapse of vascular luminal structures. Vascular collapse in zebrafish embryos was partially rescued by global Notch inhibition with DAPT suggesting that disruption of normal Notch signaling by CSA may be linked to vascular collapse. However, multiple signaling pathways likely cause the vascular collapse phenotype since both cyclophilin A and calcineurin/NFAT were required for normal vascular function. Collectively, these results show that CSA is a novel inhibitor of Notch signaling and vascular function in zebrafish embryos.	[Pandey, Raghav] Univ Cincinnati, Dept Canc & Cell Biol, Cincinnati, OH USA; [Botros, Mark A.] Duke Univ, Dept Biol, Durham, NC USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Nacev, Benjamin A.] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, Baltimore, MD USA; [Albig, Allan R.] Boise State Univ, Dept Biol, Boise, ID 83725 USA	University System of Ohio; University of Cincinnati; Duke University; Johns Hopkins University; Johns Hopkins University; Idaho; Boise State University	Albig, AR (corresponding author), Boise State Univ, Dept Biol, Boise, ID 83725 USA.	allanalbig@boisestate.edu			National Institutes of Health (NIH) [3R15CA133829-01A1S1]; ISU College of Graduate and Professional Studies (CGPS, Student Research Fund); INBRE program (NIH) [P20 RR016454, GM103408]; NIH medical Scientist Training Program [T32GM07309]; NATIONAL CANCER INSTITUTE [R15CA133829] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, T32GM007309, P20GM109095] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISU College of Graduate and Professional Studies (CGPS, Student Research Fund); INBRE program (NIH); NIH medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (NIH) (Grant # 3R15CA133829-01A1S1 to ARA), ISU College of Graduate and Professional Studies (CGPS, Student Research Fund to RP), the INBRE program (NIH Grant # P20 RR016454 (National Center for Research Resources) and # P20 GM103408 (National Institute of General Medical Sciences), and the NIH medical Scientist Training Program Grant T32GM07309 (BAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Alvarez-Arroyo MV, 2002, CIRC RES, V91, P202, DOI 10.1161/01.RES.0000027562.91075.56; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bradley CM, 2005, J MOL BIOL, V352, P253, DOI 10.1016/j.jmb.2005.06.041; Cannon JE, 2010, BRIT J PHARMACOL, V161, P140, DOI 10.1111/j.1476-5381.2010.00871.x; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; CLIPSTONE NA, 1993, ANN NY ACAD SCI, V696, P20; Courtwright A, 2009, CANCER RES, V69, P4621, DOI 10.1158/0008-5472.CAN-08-3402; Iurlaro M, 1998, EXP HEMATOL, V26, P1215; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kim SH, 2004, AM J PATHOL, V164, P1567, DOI 10.1016/S0002-9440(10)63715-7; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Bradley CM, 2006, STRUCTURE, V14, P1303, DOI 10.1016/j.str.2006.06.013; Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793; Nacev BA, 2011, J PHARMACOL EXP THER, V338, P466, DOI 10.1124/jpet.111.180851; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; NORRBY K, 1992, EXPERIENTIA, V48, P1135, DOI 10.1007/BF01948007; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Rafiee Parvaneh, 2004, Cell Commun Signal, V2, P3, DOI 10.1186/1478-811X-2-3; Ribatti D, 2000, INFLAMM RES, V49, P418, DOI 10.1007/s000110050610; Ruchoux MM, 2003, AM J PATHOL, V162, P329, DOI 10.1016/S0002-9440(10)63824-2; RUSCETTI FW, 1981, BLOOD, V57, P379; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Shah G, 2008, J SURG RES, V149, P171, DOI 10.1016/j.jss.2008.03.016; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Siamakpour-Reihani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020412; Vajkoczy P, 1999, J MOL MED, V77, P111, DOI 10.1007/s001090050314; Wang YY, 2014, DEVELOPMENT, V141, P307, DOI 10.1242/dev.096107; WELTE K, 1982, J EXP MED, V156, P454, DOI 10.1084/jem.156.2.454; Zanotti S, 2011, J BIOL CHEM, V286, P4576, DOI 10.1074/jbc.M110.161893; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zeini M, 2009, DEVELOPMENT, V136, P3335, DOI 10.1242/dev.037903	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119279	10.1371/journal.pone.0119279	http://dx.doi.org/10.1371/journal.pone.0119279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775018	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500079
J	Peng, Q; Li, SP; Ma, KZ; Li, WR; Ma, Q; He, XG; He, YJ; He, T; Lu, XM				Peng, Qi; Li, Siping; Ma, Keze; Li, Wenrui; Ma, Qiang; He, Xiaoguang; He, Yuejing; He, Ting; Lu, Xiaomei			Large Cohort Screening of G6PD Deficiency and the Mutational Spectrum in the Dongguan District in Southern China	PLOS ONE			English	Article							DOT-BLOT ASSAY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; HAPLOTYPES	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzymatic disorder of the erythrocytes that affects 400 million people worldwide. We developed a PCR-reverse dot blot (RDB) assay to screen twenty genotypes of seventeen Chinese G6PD mutations and investigate the spectrum of G6PD deficiency mutations in Dongguan District, Guangdong Province, in southern China. Method The PCR-RDB assay consists of multiplex PCR amplification of seven fragments in the G6PD target sequence of wild-type and mutant genomic DNA samples followed by hybridization to a test strip containing allele-specific oligonucleotide probes. A total of 16,464 individuals were analyzed by a combination of phenotypic screening and genotypic detection using the PCR-RDB assay and DNA sequence analysis. Results The PCR-RDB assay had a detection rate of 98.1%, which was validated by direct sequencing in a blind study with 100% concordance. The G6PD deficiency incidence rate in Dongguan District is 4.08%. Thirty-two genotypes from 469 individuals were found. The two most common variants were c.1376G>T and c.1388G>A, followed by c.95A>G, c.871G>A, c.392G>T, and c.1024C>T. In addition, two rare mutations (c.703C>A and c.406C>T) were detected by DNA sequencing analysis. In our study, 65 cases harbored the C1311T/IVS polymorphism and 67 cases were homozygote. Conclusion The PCR-RDB assay we established is a reliable and effective method for screening G6PD mutations in the Chinese population. Data on the spectrum of mutations in the Dongguan District is beneficial to the clinical diagnosis and prevention of G6PD deficiency.	[Peng, Qi; Li, Siping; Ma, Keze; Li, Wenrui; Ma, Qiang; He, Xiaoguang; He, Yuejing; He, Ting; Lu, Xiaomei] Eighth Peoples Hosp Dongguan, Dongguan Inst Pediat, Dongguan, Guangdong, Peoples R China		Lu, XM (corresponding author), Eighth Peoples Hosp Dongguan, Dongguan Inst Pediat, Dongguan, Guangdong, Peoples R China.	lxm020@126.com			Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology [2011105102017]	Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology	This work was supported by the Dongguan Bureau of Science and Technology for the City Key Program of Science and Technology (Project Number:2011105102017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1961, NATURE, V189, P686, DOI 10.1038/189686a0; BEUTLER E, 1991, ACTA HAEMATOL-BASEL, V86, P179; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CHAN TK, 1964, BRIT MED J, V2, P102, DOI 10.1136/bmj.2.5401.102; Chen Y, 2006, INT J LAB MED, V27, P385; Chiang Szu-Hui, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P72; CHIU DTY, 1993, BLOOD, V81, P2150, DOI 10.1182/blood.V81.8.2150.2150; DU CS, 1988, HUM GENET, V80, P385, DOI 10.1007/BF00273657; Hao Ying, 2011, Zhonghua Xue Ye Xue Za Zhi, V32, P245; HERZ F, 1970, BLOOD-J HEMATOL, V35, P90, DOI 10.1182/blood.V35.1.90.90; Jiang WY, 2006, HUM GENET, V119, P463, DOI 10.1007/s00439-005-0126-5; Li Jun, 2014, Zhonghua Yu Fang Yi Xue Za Zhi, V48, P192; Li L, 2008, BLOOD CELL MOL DIS, V41, P17, DOI 10.1016/j.bcmd.2008.01.007; Li Youqiong, 2014, Zhonghua Xue Ye Xue Za Zhi, V35, P724, DOI 10.3760/cma.j.issn.0253-2727.2014.08.012; Lu XM, 2013, CLIN CHIM ACTA, V418, P45, DOI 10.1016/j.cca.2012.12.023; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Pan SL, 2007, CHIN J HLTH BIRTH CH, V13, P42; TANG TK, 1995, BLOOD, V85, P3767, DOI 10.1182/blood.V85.12.3767.bloodjournal85123767; TANG TK, 1995, HUM GENET, V95, P630; XU WM, 1995, BLOOD, V85, P257, DOI 10.1182/blood.V85.1.257.bloodjournal851257; XU YK, 1985, HEREDITY DIS, V2, P67; Yan JB, 2010, J MOL DIAGN, V12, P305, DOI 10.2353/jmoldx.2010.090104; Yan TZ, 2006, HAEMATOLOGICA, V91, P1321; Yang Guang, 2004, Zhonghua Gan Zang Bing Za Zhi, V12, P677; Zaffanello M, 2004, EUR J EPIDEMIOL, V19, P255, DOI 10.1023/B:EJEP.0000020445.48298.3f	30	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120683	10.1371/journal.pone.0120683	http://dx.doi.org/10.1371/journal.pone.0120683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775246	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500189
J	van Oort, PAJ; de Vries, ME; Yoshida, H; Saito, K				van Oort, Pepijn A. J.; de Vries, Michiel E.; Yoshida, Hiroe; Saito, Kazuki			Improved Climate Risk Simulations for Rice in Arid Environments	PLOS ONE			English	Article							TEMPERATURE-INDUCED STERILITY; INDUCED SPIKELET STERILITY; IRRIGATED RICE; EXPLORING OPTIONS; MODELING APPROACH; SOLAR-RADIATION; AIR-TEMPERATURE; LOWLAND RICE; HEAT-STRESS; LESS WATER	We integrated recent research on cardinal temperatures for phenology and early leaf growth, spikelet formation, early morning flowering, transpirational cooling, and heat- and cold-induced sterility into an existing to crop growth model ORYZA2000. We compared for an arid environment observed potential yields with yields simulated with default ORYZA2000, with modified subversions of ORYZA2000 and with ORYZA_S, a model developed for the region of interest in the 1990s. Rice variety 'IR64' was sown monthly 15-times in a row in two locations in Senegal. The Senegal River Valley is located in the Sahel, near the Sahara desert with extreme temperatures during day and night. The existing subroutines underestimated cold stress and overestimated heat stress. Forcing the model to use observed spikelet number and phenology and replacing the existing heat and cold subroutines improved accuracy of yield simulation from EF = -0.32 to EF = 0.70 (EF is modelling efficiency). The main causes of improved accuracy were that the new model subversions take into account transpirational cooling (which is high in arid environments) and early morning flowering for heat sterility, and minimum rather than average temperature for cold sterility. Simulations were less accurate when also spikelet number and phenology were simulated. Model efficiency was 0.14 with new heat and cold routines and improved to 0.48 when using new cardinal temperatures for phenology and early leaf growth. The new adapted subversion of ORYZA2000 offers a powerful analytic tool for climate change impact assessment and cropping calendar optimisation in arid regions.	[van Oort, Pepijn A. J.; Saito, Kazuki] Africa Rice Ctr AfricaRice, Cotonou, Benin; [van Oort, Pepijn A. J.] Wageningen Univ, Ctr Crop Syst Anal, Crop & Weed Ecol Grp, NL-6700 AK Wageningen, Netherlands; [de Vries, Michiel E.] J Joordens Zaadhandel BV, NL-5995 ZG Kessel, Netherlands; [Yoshida, Hiroe] Natl Agr & Food Res Org, Tsukuba, Ibaraki 3058666, Japan	CGIAR; Africa Rice Center; Wageningen University & Research; National Agriculture & Food Research Organization - Japan	de Vries, ME (corresponding author), J Joordens Zaadhandel BV, NL-5995 ZG Kessel, Netherlands.	michielerikdevries@gmail.com; hiroey@affrc.go.jp; K.Saito@cgiar.org	Saito, Kazuki/ABE-5432-2021; van Oort, Pepijn/E-9903-2016	Saito, Kazuki/0000-0002-8609-2713; van Oort, Pepijn/0000-0001-7617-5382; De Vries, Michiel/0000-0002-1453-7672	CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS); J. Joordens' Zaadhandel B.V.	CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS); J. Joordens' Zaadhandel B.V.	This research was funded by the CGIAR Consortium Research Program on Climate Change, Agriculture and Food Security (CCAFS). J. Joordens' Zaadhandel B.V. provided support in the form of a salary for author M.E. de Vries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Belder P, 2007, AGR SYST, V92, P91, DOI 10.1016/j.agsy.2006.03.001; Boling AA, 2007, AGR SYST, V92, P115, DOI 10.1016/j.agsy.2006.05.003; Boling AA, 2011, NJAS-WAGEN J LIFE SC, V58, P11, DOI 10.1016/j.njas.2010.05.001; Bouman B., 2001, ORYZA2000 MODELING L; Bouman BAM, 2007, AGR WATER MANAGE, V88, P23, DOI 10.1016/j.agwat.2006.10.005; Bouman BAM, 2006, AGR SYST, V87, P249, DOI 10.1016/j.agsy.2004.09.011; Confalonieri R, 2005, ECOL MODEL, V183, P269, DOI 10.1016/j.ecolmodel.2004.07.031; de Mey Y, 2012, J AGR ECON, V63, P175, DOI 10.1111/j.1477-9552.2011.00323.x; de Vries ME, 2010, FIELD CROP RES, V116, P154, DOI 10.1016/j.fcr.2009.12.006; Devries ME, 2011, EXP AGR, V47, P69, DOI 10.1017/S0014479710001328; Dingkuhn M, 1997, SYST APPR S, V6, P79; DINGKUHN M, 1995, AGR SYST, V48, P385, DOI 10.1016/0308-521X(94)00027-I; Dingkuhn M, 2012, CIRADIRRI07042012; DINGKUHN M, 1997, IRRIGATED RICE SAHEL, P361; Ephrath JE, 1996, AGR SYST, V51, P377, DOI 10.1016/0308-521X(95)00068-G; Farrell TC, 2006, FIELD CROP RES, V98, P178, DOI 10.1016/j.fcr.2006.01.003; Feng LP, 2007, AGR WATER MANAGE, V88, P1, DOI 10.1016/j.agwat.2006.10.006; Gaydon DS, 2012, AGR WATER MANAGE, V115, P1, DOI 10.1016/j.agwat.2012.08.007; Gourdji SM, ENV RES LETT, V8, P24; Haefele SM, 2002, FIELD CROP RES, V78, P119, DOI 10.1016/S0378-4290(02)00117-X; Heinemann AB, 2008, EUPHYTICA, V162, P395, DOI 10.1007/s10681-007-9579-z; Horie T., 1993, J AGR METEOROL, V48, P567, DOI DOI 10.2480/AGRMET.48.567; Horie T, 2001, RICE RES FOOD SECURI; Ishimaru T, 2010, ANN BOT-LONDON, V106, P515, DOI 10.1093/aob/mcq124; Jagadish KSV, 2011, FUNCT PLANT BIOL, V38, P261, DOI 10.1071/FP10224; Jagadish SVK, 2008, CROP SCI, V48, P1140, DOI 10.2135/cropsci2007.10.0559; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jing Q, 2007, EUR J AGRON, V26, P166, DOI 10.1016/j.eja.2006.09.005; Jing Q, 2008, AGR SYST, V98, P177, DOI 10.1016/j.agsy.2008.06.005; Julia C, 2012, THESIS U MONTPELLIER; Julia C, 2013, EUR J AGRON, V49, P50, DOI 10.1016/j.eja.2013.03.006; Julia C, 2012, EUR J AGRON, V43, P166, DOI 10.1016/j.eja.2012.06.007; Kato Y, 2010, FIELD CROP RES, V117, P237, DOI 10.1016/j.fcr.2010.03.006; Kobata T, 2010, PLANT PROD SCI, V13, P289, DOI 10.1626/pps.13.289; Kobayasi K, 2010, PLANT PROD SCI, V13, P21, DOI 10.1626/pps.13.21; Kropff MJ, 1993, ORYZA1 BASIC MODEL I; Kuwagata T, 2008, AGR FOREST METEOROL, V148, P1754, DOI 10.1016/j.agrformet.2008.06.011; Li T, 2013, FIELD CROP RES, V149, P312, DOI 10.1016/j.fcr.2013.05.006; Matsui T, 1999, ANN BOT-LONDON, V84, P501, DOI 10.1006/anbo.1999.0943; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; Matsui Tsutomu, 2000, Plant Production Science, V3, P430, DOI 10.1626/pps.3.430; Matthews RB, 1997, AGR SYST, V54, P399, DOI 10.1016/S0308-521X(95)00060-I; Matthews Robin B., 1995, MODELING IMPACT CLIM; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; NISHIYAMA I, 1976, P159; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Rebolledo MC, 2012, J AGRON CROP SCI, V198, P374, DOI 10.1111/j.1439-037X.2012.00528.x; Sanchez B, 2014, GLOBAL CHANGE BIOL, V20, P408, DOI 10.1111/gcb.12389; Sheehy JE, 2001, FIELD CROP RES, V71, P77, DOI 10.1016/S0378-4290(01)00145-9; Shimono H, 2007, FIELD CROP RES, V101, P221, DOI 10.1016/j.fcr.2006.11.010; Soundharajan B, 2009, PADDY WATER ENVIRON, V7, P135, DOI 10.1007/s10333-009-0156-z; Spitters CJT, 1995, SIMULATION MONOGRAPH; Teixeira EI, 2013, AGR FOREST METEOROL, V170, P206, DOI 10.1016/j.agrformet.2011.09.002; tenBerge HFM, 1997, FIELD CROP RES, V51, P29, DOI 10.1016/S0378-4290(96)01042-8; Uchijima, 1976, J AGROMETEOROL, V31, P199, DOI [10.2480/agrmet.31.199, DOI 10.2480/AGRMET.31.199]; van Laar H.H., 1997, QUANTITATIVE APPROAC, V14; van Oort PAJ, 2014, FIELD CROP RES, V156, P303, DOI 10.1016/j.fcr.2013.11.007; van Oort PAJ, 2011, AGR FOREST METEOROL, V151, P1545, DOI 10.1016/j.agrformet.2011.06.012; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; White JW, 2011, AGRON J, V103, P1242, DOI 10.2134/agronj2011.0038; Yin XY, 1997, FIELD CROP RES, V51, P189, DOI 10.1016/S0378-4290(96)03456-9; YIN XY, 1995, AGR FOREST METEOROL, V77, P1, DOI 10.1016/0168-1923(95)02236-Q; Yoshida H, 2006, FIELD CROP RES, V97, P337, DOI 10.1016/j.fcr.2005.11.004; Yoshida S, 1981, FUNDAMENTALS RICE CR; Yoshimoto M., 2005, J AGRIC METEOROL, V60, P597, DOI [10.2480/agrmet.597, DOI 10.2480/AGRMET.597]; Yoshimoto Mayumi, 2011, Journal of Agricultural Meteorology, V67, P233, DOI 10.2480/agrmet.67.4.8; Zhang S, 2013, EUR J AGRON, V45, P165, DOI 10.1016/j.eja.2012.10.005	71	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0118114	10.1371/journal.pone.0118114	http://dx.doi.org/10.1371/journal.pone.0118114			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774909	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500024
J	Bashar, K; Zafar, A; Elsheikh, S; Healy, DA; Clarke-Moloney, M; Casserly, L; Burke, PE; Kavanagh, EG; Walsh, SR				Bashar, Khalid; Zafar, Adeel; Elsheikh, Sawsan; Healy, Donagh A.; Clarke-Moloney, Mary; Casserly, Liam; Burke, Paul E.; Kavanagh, Eamon G.; Walsh, Stewart R.			Predictive Parameters of Arteriovenous Fistula Functional Maturation in a Population of Patients with End-Stage Renal Disease	PLOS ONE			English	Article							VASCULAR ACCESS; SURVIVAL; OUTCOMES; STENOSIS	Introduction With increasing numbers of patients diagnosed with ESRD, arteriovenous fistula (AVF) maturation has become a major factor in improving both dialysis related outcomes and quality of life of those patients. Compared to other types of access it has been established that a functional AVF access is the least likely to be associated with thrombosis, infection, hospital admissions, secondary interventions to maintain patency and death. Aim Study of demographic factors implicated in the functional maturation of arteriovenous fistulas. Also, to explore any possible association between preoperative haematological investigations and functional maturation. Methods We performed a retrospective chart review of all patients with ESRD who were referred to the vascular service in the University Hospital of Limerick for creation of vascular access for HD. We included patients with primary AVFs; and excluded those who underwent secondary procedures. Results Overall AVF functional maturation rate in our study was 53.7%(52/97). Female gender showed significant association with nonmaturation (P = 0.004) and was the only predictor for non-maturation in a logistic regression model (P = 0.011). Patients who had history of renal transplant (P = 0.036), had relatively lower haemoglobin levels (P = 0.01) and were on calcium channel blockers (P = 0.001) showed better functional maturation rates. Conclusion Female gender was found to be associated with functional non-maturation, while a history kidney transplant, calcium channel-blocker agents and low haemoglobin levels were all associated with successful functional maturation. In view of the conflicting evidence in the literature, large prospective multi-centre registry-based studies with well-defined outcomes are needed.	[Bashar, Khalid; Zafar, Adeel; Healy, Donagh A.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.] Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland; [Elsheikh, Sawsan] James Connolly Mem Hosp, Dept Acute Med, Dublin, Ireland; [Casserly, Liam] Univ Hosp Limerick, Dept Nephrol, Limerick, Ireland; [Walsh, Stewart R.] Natl Univ Ireland, Dept Surg, Galway, Ireland	University of Limerick; University of Limerick; Ollscoil na Gaillimhe-University of Galway	Bashar, K (corresponding author), Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland.	khalid@live.ie	Walsh, Stewart R/AAC-1229-2021	Walsh, Stewart/0000-0002-1006-9541				Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Allon M, 2001, KIDNEY INT, V60, P2013, DOI 10.1046/j.1523-1755.2001.00031.x; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Allon M, 2011, AM J KIDNEY DIS, V58, P437, DOI 10.1053/j.ajkd.2011.04.018; Amorim Pedro, 2013, Rev Port Cir Cardiotorac Vasc, V20, P211; Bashar K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104931; Bhalodia R, 2011, SEMIN DIALYSIS, V24, P355, DOI 10.1111/j.1525-139X.2010.00760.x; Centre Ecotox Centre Suisse d'ecotoxicologie appliquee (Eawag/EPFL), 2012, SURV QUAL SED SUISS, P34; Chand DH, 2009, PEDIATR NEPHROL, V24, P1121, DOI 10.1007/s00467-008-0812-3; Conte MS, 2011, J VASC SURG, V54, P1383, DOI 10.1016/j.jvs.2011.05.005; Corp I, 2013, IBM SPSS STAT WIND V; COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Dixon BS, 2002, AM J KIDNEY DIS, V39, P92, DOI 10.1053/ajkd.2002.29886; Feldman HI, 2003, AM J KIDNEY DIS, V42, P1000, DOI 10.1016/j.ajkd.2003.07.003; Frankel A, 2006, EUR J VASC ENDOVASC, V31, P417, DOI 10.1016/j.ejvs.2005.10.003; Jemcov TK, 2013, J VASC ACCESS, V14, P356, DOI 10.5301/jva.5000163; KDOQI NKF-, 2006, UPD CLIN PRACT GUID; Lee T, 2011, CLIN J AM SOC NEPHRO, V6, P575, DOI 10.2215/CJN.06630810; LEVENE H, 1949, ANN MATH STAT, V20, P91, DOI 10.1214/aoms/1177730093; Lok CE, 2005, KIDNEY INT, V67, P2462, DOI 10.1111/j.1523-1755.2005.00355.x; MILLER VM, 1992, AM J PHYSIOL, V263, pH103, DOI 10.1152/ajpheart.1992.263.1.H103; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Ocak G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-79; Oliver MJ, 2001, KIDNEY INT, V60, P1532, DOI 10.1046/j.1523-1755.2001.00956.x; Peterson WJ, 2008, CLIN J AM SOC NEPHRO, V3, P437, DOI 10.2215/CJN.03480807; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Rayner HC, 2004, AM J KIDNEY DIS, V44, pS22, DOI 10.1053/j.ajkd.2004.08.007; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Renaud CJ, 2012, J VASC SURG, V56, P433, DOI 10.1016/j.jvs.2012.01.063; Rodriguez JA, 2000, NEPHROL DIAL TRANSPL, V15, P402, DOI 10.1093/ndt/15.3.402; Salmela B, 2013, CLIN J AM SOC NEPHRO, V8, P962, DOI 10.2215/CJN.03860412; Santoro A, 2006, J NEPHROL, V19, P259; Sedlacek M, 2001, AM J KIDNEY DIS, V38, P560, DOI 10.1053/ajkd.2001.26873; Stoumpos S, 2014, AM J NEPHROL, V39, P491, DOI 10.1159/000362744; Yilmaz H, 2014, RENAL FAILURE, V36, P1390, DOI 10.3109/0886022X.2014.945183; Zadeh MK, 2008, J VASC ACCESS, V9, P133, DOI 10.1177/112972980800900210; Zadeh MK, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/942950	39	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119958	10.1371/journal.pone.0119958	http://dx.doi.org/10.1371/journal.pone.0119958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768440	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500104
J	Wang, SH; Bao, YL; Meng, QM; Xia, YJ; Zhao, YC; Wang, Y; Tang, F; ZhuGe, XK; Yu, SQ; Han, XG; Dai, JJ; Lu, CP				Wang, Shaohui; Bao, Yinli; Meng, Qingmei; Xia, Yongjie; Zhao, Yichao; Wang, Yang; Tang, Fang; ZhuGe, Xiangkai; Yu, Shengqing; Han, Xiangan; Dai, Jianjun; Lu, Chengping			IbeR Facilitates Stress-Resistance, Invasion and Pathogenicity of Avian Pathogenic Escherichia coli	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; BLOOD-BRAIN-BARRIER; BACTERIOPHAGE-T7 RNA-POLYMERASE; NEONATAL MENINGITIS; VIRULENCE FACTOR; AUTOTRANSPORTER ADHESIN; TYPE-1 FIMBRIAE; URINARY-TRACT; IN-VIVO; EXPRESSION	Systemic infections by avian pathogenic Escherichia coli (APEC) are economically devastating to poultry industries worldwide. IbeR, located on genomic island GimA, was shown to serve as an RpoS-like regulator in rpoS gene mutation neonatal meningitis E. coli(NMEC) RS218. However, the role of IbeR in pathogenicity of APEC carrying active RpoS has not yet been investigated. We showed that the APEC IbeR could elicit antibodies in infected ducks, suggesting that IbeR might be involved in APEC pathogenicity. To investigate the function of IbeR in APEC pathogenesis, mutant and complementation strains were constructed and characterized. Inactivation of ibeR led to attenuated virulence and reduced invasion capacity towards DF-1 cells, brains and cerebrospinal fluid (CSF) in vitro and in vivo. Bactericidal assays demonstrated that the mutant strain had impaired resistance to environmental stress and specific pathogen-free (SPF) chicken serum. These virulence-related phenotypes were restored by genetic complementation. Quantitative real-time reverse transcription PCR revealed that IbeR controlled expression of stress-resistance genes and virulence genes, which might led to the associated virulence phenotype.	[Wang, Shaohui; Zhao, Yichao; Wang, Yang; Yu, Shengqing; Han, Xiangan] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Wang, Shaohui; Bao, Yinli; Meng, Qingmei; Xia, Yongjie; Wang, Yang; Tang, Fang; ZhuGe, Xiangkai; Dai, Jianjun; Lu, Chengping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Jiangsu, Peoples R China; [Xia, Yongjie] Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Fudan University	Dai, JJ (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing 210095, Jiangsu, Peoples R China.	daijianjun@njau.edu.cn; lucp@njau.edu.cn	Dai, Jianjun/ABB-7353-2021	Han, Xiangan/0000-0001-5625-637X	National Natural Science Foundation of China [81201266, 31370045]; Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Basic Fund for Institutes - Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences [2013JB05]; Fundamental Research Funds for Central Universities - Nanjing Agricultural University [KYZ201326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Basic Fund for Institutes - Shanghai Veterinary Research Institute; Chinese Academy of Agricultural Sciences; Fundamental Research Funds for Central Universities - Nanjing Agricultural University	This work was supported by supported by the funds of the National Natural Science Foundation of China (81201266, 31370045), The Fund of Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), The National Basic Fund for Institutes, which is supported by Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences (2013JB05) and The Fundamental Research Funds for Central Universities which is supported by Nanjing Agricultural University (KYZ201326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x; Chi F, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/520283; Cortes MAM, 2008, INFECT IMMUN, V76, P4129, DOI 10.1128/IAI.00334-08; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; Dho-Moulin M, 1999, VET RES, V30, P299; Ewers C, 2003, BERL MUNCH TIERARZTL, V116, P381; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12; Gao QQ, 2013, J BACTERIOL, V195, P2474, DOI 10.1128/JB.02074-12; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Gunther NW, 2002, INFECT IMMUN, V70, P3344, DOI 10.1128/IAI.70.7.3344-3354.2002; Han XA, 2013, MICROB PATHOGENESIS, V55, P21, DOI 10.1016/j.micpath.2012.09.008; Hoffman JA, 1999, INFECT IMMUN, V67, P3566, DOI 10.1128/IAI.67.7.3566-3570.1999; Houdouin V, 2002, INFECT IMMUN, V70, P5865, DOI 10.1128/IAI.70.10.5865-5869.2002; HUANG SH, 1995, INFECT IMMUN, V63, P4470, DOI 10.1128/IAI.63.11.4470-4475.1995; Huang SH, 2001, J INFECT DIS, V183, P1071, DOI 10.1086/319290; Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; Kim K S, 2000, Subcell Biochem, V33, P47; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; La Ragione RM, 2002, RES VET SCI, V73, P27, DOI 10.1016/S0034-5288(02)00075-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; MOBLEY HLT, 1993, MOL MICROBIOL, V10, P143, DOI 10.1111/j.1365-2958.1993.tb00911.x; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Pourbakhsh SA, 1997, MICROB PATHOGENESIS, V22, P331, DOI 10.1006/mpat.1996.0116; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; REED L. J., 1938, AMER JOUR HYG, V27, P493; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Wang SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00588; Wang SH, 2012, VET MICROBIOL, V159, P411, DOI 10.1016/j.vetmic.2012.04.015; Wang SH, 2011, FEMS IMMUNOL MED MIC, V63, P328, DOI 10.1111/j.1574-695X.2011.00862.x; Wang SH, 2011, INFECT IMMUN, V79, P279, DOI 10.1128/IAI.00821-10; Zhang K, 2009, MED MICROBIOL IMMUN, V198, P195, DOI 10.1007/s00430-009-0119-4; ZhuGe XK, 2013, INFECT IMMUN, V81, P2437, DOI 10.1128/IAI.00102-13	39	12	16	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119698	10.1371/journal.pone.0119698	http://dx.doi.org/10.1371/journal.pone.0119698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768126	gold, Green Published, Green Submitted			2022-12-26	WOS:000351277500094
J	Zhu, SL; Shala, A; Bezginov, A; Sljoka, A; Audette, G; Wilson, DJ				Zhu, Shaolong; Shala, Agnesa; Bezginov, Alexandr; Sljoka, Adnan; Audette, Gerald; Wilson, Derek J.			Hyperphosphorylation of Intrinsically Disordered Tau Protein Induces an Amyloidogenic Shift in Its Conformational Ensemble	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; PHOSPHORYLATION SITES; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; DYNAMICS; KINASE; DOMAIN; AGGREGATION; REGIONS	Tau is an intrinsically disordered protein (IDP) whose primary physiological role is to stabilize microtubules in neuronal axons at all stages of development. In Alzheimer's and other tauopathies, tau forms intracellular insoluble amyloid aggregates known as neurofibrillary tangles, a process that appears in many cases to be preceded by hyperphosphorylation of tau monomers. Understanding the shift in conformational bias induced by hyperphosphorylation is key to elucidating the structural factors that drive tau pathology, however, as an IDP, tau is not amenable to conventional structural characterization. In this work, we employ a straightforward technique based on Time-Resolved ElectroSpray Ionization Mass Spectrometry (TRESI-MS) and Hydrogen/Deuterium Exchange (HDX) to provide a detailed picture of residual structure in tau, and the shifts in conformational bias induced by hyperphosphorylation. By comparing the native and hyperphosphorylated ensembles, we are able to define specific conformational biases that can easily be rationalized as enhancing amyloidogenic propensity. Representative structures for the native and hyperphosphorylated tau ensembles were generated by refinement of a broad sample of conformations generated by low-computational complexity modeling, based on agreement with the TRESI-HDX profiles.	[Zhu, Shaolong; Shala, Agnesa; Audette, Gerald; Wilson, Derek J.] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Bezginov, Alexandr] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sljoka, Adnan] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Wilson, Derek J.] York Univ, Fac Sci, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada	York University - Canada; University of Toronto; Toronto Metropolitan University; York University - Canada	Wilson, DJ (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	dkwilson@yorku.ca	Audette, Gerald F./E-2609-2012	Audette, Gerald F./0000-0002-5695-9830; Sljoka, Adnan/0000-0002-2398-9523	Natural Sciences and Research Council of Canada [22522]; Alzheimer's Society of Canada [56798]	Natural Sciences and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alzheimer's Society of Canada	Funding: This work was supported by the Natural Sciences and Research Council of Canada Disocvery Grant (22522) and Alzheimer's Society of Canada Biomedical Grant (56798). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Barghorn Stefan, 2004, V299, P35; BRION JP, 1986, LANCET, V2, P1098, DOI 10.1016/S0140-6736(86)90495-2; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Elbaum-Garfinkle S, 2012, J AM CHEM SOC, V134, P16607, DOI 10.1021/ja305206m; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Ferguson PL, 2007, ANAL CHEM, V79, P153, DOI 10.1021/ac061261f; HAGESTEDT T, 1989, J CELL BIOL, V109, P1643, DOI 10.1083/jcb.109.4.1643; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Konermann L, 2003, MASS SPECTROM REV, V22, P1, DOI 10.1002/mas.10044; Konermann L, 2014, ANAL CHEM, V86, P213, DOI 10.1021/ac4039306; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kragelj J, 2013, CHEMPHYSCHEM, V14, P3034, DOI 10.1002/cphc.201300387; Kunze G, 2012, BBA-BIOMEMBRANES, V1818, P2302, DOI 10.1016/j.bbamem.2012.03.019; Lee HG, 2005, TRENDS MOL MED, V11, P164, DOI 10.1016/j.molmed.2005.02.008; Liuni P, 2012, ANGEW CHEM INT EDIT, V51, P9666, DOI 10.1002/anie.201204903; Liuni P, 2010, RAPID COMMUN MASS SP, V24, P315, DOI 10.1002/rcm.4391; Mandelkow EM, 2012, COLD SPRING HARB PER, V2, P25; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Nath A, 2012, BIOPHYS J, V103, P1940, DOI 10.1016/j.bpj.2012.09.032; Nubling G, 2012, EXP NEUROL, V237, P470, DOI 10.1016/j.expneurol.2012.07.018; Ozenne V, 2012, J AM CHEM SOC, V134, P15138, DOI 10.1021/ja306905s; Rankin CA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-12; Resetca D, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.595454; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rob T, 2012, ANAL CHEM, V84, P3771, DOI 10.1021/ac300365u; Rob T, 2009, J AM SOC MASS SPECTR, V20, P124, DOI 10.1016/j.jasms.2008.09.005; Sjogren M, 2001, J NEUROL NEUROSUR PS, V70, P624, DOI 10.1136/jnnp.70.5.624; Sljoka A, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056013; SPERBER BR, 1995, NEUROSCI LETT, V197, P149, DOI 10.1016/0304-3940(95)11902-9; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Steinhilb ML, 2007, MOL BIOL CELL, V18, P5060, DOI 10.1091/mbc.E07-04-0327; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; WANG QM, 1994, J BIOL CHEM, V269, P14566; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhang Y-Z, 2003, THESIS U PENNSYLVANI	50	59	59	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120416	10.1371/journal.pone.0120416	http://dx.doi.org/10.1371/journal.pone.0120416			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25767879	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500124
J	Li, JJ; Xia, YJ; Liu, T; Wang, JS; Dai, WQ; Wang, F; Zheng, YY; Chen, K; Li, SN; Abudumijiti, H; Zhou, Z; Wang, JR; Lu, WX; Zhu, R; Yang, J; Zhang, HW; Yin, Q; Wang, CF; Zhou, YQ; Lu, J; Zhou, YQ; Guo, CY				Li, Jingjing; Xia, Yujing; Liu, Tong; Wang, Junshan; Dai, Weiqi; Wang, Fan; Zheng, Yuanyuan; Chen, Kan; Li, Sainan; Abudumijiti, Huerxidan; Zhou, Zheng; Wang, Jianrong; Lu, Wenxia; Zhu, Rong; Yang, Jing; Zhang, Huawei; Yin, Qin; Wang, Chengfen; Zhou, Yuqing; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong			Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; EXPERIMENTAL LIVER-INJURY; TNF-ALPHA; ENDOPLASMIC-RETICULUM; INTERFERON-GAMMA; IN-VITRO; INFLAMMATION; KINASE; MECHANISMS	Objective Astaxanthin, a potent antioxidant, exhibits a wide range of biological activities, including antioxidant, atherosclerosis and antitumor activities. However, its effect on concanavalin A (ConA)-induced autoimmune hepatitis remains unclear. The aim of this study was to investigate the protective effects of astaxanthin on ConA-induced hepatitis in mice, and to elucidate the mechanisms of regulation. Materials and Methods Autoimmune hepatitis was induced in in Balb/C mice using ConA (25 mg/kg), and astaxanthin was orally administered daily at two doses (20 mg/kg and 40 mg/kg) for 14 days before ConA injection. Levels of serum liver enzymes and the histopathology of inflammatory cytokines and other maker proteins were determined at three time points (2, 8 and 24 h). Primary hepatocytes were pretreated with astaxanthin (80 mu M) in vitro 24 h before stimulation with TNF-alpha (10 ng/ml). The apoptosis rate and related protein expression were determined 24 h after the administration of TNF-a. Results Astaxanthin attenuated serum liver enzymes and pathological damage by reducing the release of inflammatory factors. It performed anti-apoptotic effects via the descending phosphorylation of Bcl-2 through the down-regulation of the JNK/p-JNK pathway. Conclusion This research firstly expounded that astaxanthin reduced immune liver injury in ConA-induced autoimmune hepatitis. The mode of action appears to be downregulation of JNK/p-JNK-mediated apoptosis and autophagy.	[Li, Jingjing; Xia, Yujing; Liu, Tong; Wang, Junshan; Dai, Weiqi; Wang, Fan; Zheng, Yuanyuan; Chen, Kan; Li, Sainan; Abudumijiti, Huerxidan; Yang, Jing; Wang, Chengfen; Lu, Jie; Zhou, Yingqun; Guo, Chuanyong] Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Zhou, Zheng; Wang, Jianrong; Lu, Wenxia; Zhu, Rong] Nanjing Med Univ, Clin Med Coll 1, Dept Gastroenterol, Shanghai Peoples Hosp 10, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Huawei; Yin, Qin; Zhou, Yuqing] Soochow Univ, Shanghai Peoples Hosp 10, Dept Gastroenterol, Suzhou 215006, Peoples R China	Tongji University; Nanjing Medical University; Soochow University - China	Zhou, YQ (corresponding author), Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China.	yqzh02@163.com; yqzh02@163.com; guochuanyong@hotmail.com	Zhou, Yu/HHN-3071-2022; Lu, Wenxia/GPK-3897-2022	Lu, Wenxia/0000-0003-2848-7570; Guo, Chuanyong/0000-0002-6527-4673; Li, Sainan/0000-0002-1880-6294	National Natural Science Foundation of China [81270515]; China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund [20100021, 20120005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund	This study was supported by the National Natural Science Foundation of China (grant No. 81270515), China Foundation for Hepatitis Prevention and Control WBN liver Disease Research Fund (grant No. 20100021 and 20120005). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Bhuvaneswari S, 2014, CELL STRESS CHAPERON, V19, P183, DOI 10.1007/s12192-013-0443-x; Bozza M, 1999, HEPATOLOGY, V30, P1441, DOI 10.1002/hep.510300616; Chen NY, 2001, CANCER RES, V61, P3908; Cheng P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/935251; Chew BP, 1999, ANTICANCER RES, V19, P1849; Cho H, 2014, J NAT PRODUCTS; Choi YS, 2014, GUT; Cui JZ, 2012, BIOCHEM BIOPH RES CO, V422, P268, DOI 10.1016/j.bbrc.2012.04.145; Czaja AJ, 2012, DIGEST DIS SCI, V57, P2248, DOI 10.1007/s10620-012-2179-3; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dyson JK, 2014, J HEPATOL; Fassett RG, 2009, FUTUR CARDIOL, V5, P333, DOI 10.2217/FCA.09.19; Fassett RG, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-17; Goda S, 2014, INT ENDOD J; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Gutowska I, 2013, TOXICOL IND HLTH; Hama S, 2012, J PHARM SCI-US, V101, P2909, DOI 10.1002/jps.23216; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kou W, 2014, SAUDI MED J, V35, P945; Ksontini R, 1998, J IMMUNOL, V160, P4082; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Lee SJ, 2003, MOL CELLS, V16, P97; Liberal R, 2011, BEST PRACT RES CL GA, V25, P653, DOI 10.1016/j.bpg.2011.09.009; Liu XB, 2007, BIOCHEM BIOPH RES CO, V357, P187, DOI 10.1016/j.bbrc.2007.03.120; Lu Y, 2014, PAIN; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nakao R, 2010, ANTICANCER RES, V30, P2721; Nakao R, 2010, ANTICANCER RES, V30, P2171; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Ohgami K, 2003, INVEST OPHTH VIS SCI, V44, P2694, DOI 10.1167/iovs.02-0822; Park A, 1996, J BIOL CHEM, V271, P9858, DOI 10.1074/jbc.271.16.9858; Rao AR, 2013, J AGR FOOD CHEM, V61, P3842, DOI 10.1021/jf304609j; Renton JP, 2010, J NEUROSCI RES, V88, P2239, DOI 10.1002/jnr.22381; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Schwabe RF, 2004, FASEB J, V18, P720, DOI 10.1096/fj.03-0771fje; Shen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087977; Shen M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/954502; Shen M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/461536; Speranza L, 2012, MAR DRUGS, V10, P890, DOI 10.3390/md10040890; Strassburg CP, 2011, BEST PRACT RES CL GA, V25, P673, DOI 10.1016/j.bpg.2011.08.003; Streetz K, 2001, J IMMUNOL, V167, P514, DOI 10.4049/jimmunol.167.1.514; Suzuki Y, 2006, EXP EYE RES, V82, P275, DOI 10.1016/j.exer.2005.06.023; Tao YY, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-449; Tiegs G, 2007, Z GASTROENTEROL, V45, P63, DOI 10.1055/s-2006-927397; TIEGS G, 1989, BIOCHEM PHARMACOL, V38, P627, DOI 10.1016/0006-2952(89)90208-6; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Tu CT, 2011, MOL CELL BIOCHEM, V358, P53, DOI [10.1007/s11010-011-0920-4, 10.1007/s11010-011-0978-z]; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Volk A, 2014, J EXP MED, V211, P1093, DOI 10.1084/jem.20130990; Wang CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108855; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wolf D, 2001, J IMMUNOL, V166, P1300, DOI 10.4049/jimmunol.166.2.1300; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zhang NN, 2012, INFLAMM RES, V61, P17, DOI 10.1007/s00011-011-0383-9	58	61	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0120440	10.1371/journal.pone.0120440	http://dx.doi.org/10.1371/journal.pone.0120440			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25761053	Green Submitted, Green Published, gold			2022-12-26	WOS:000351275000070
J	Maani, R; Yang, YH; Kalra, S				Maani, Rouzbeh; Yang, Yee Hong; Kalra, Sanjay			Voxel-Based Texture Analysis of the Brain	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORPUS-CALLOSUM; MRI; PATTERN; ATROPHY; FEATURES; MAPS	This paper presents a novel voxel-based method for texture analysis of brain images. Texture analysis is a powerful quantitative approach for analyzing voxel intensities and their interrelationships, but has been thus far limited to analyzing regions of interest. The proposed method provides a 3D statistical map comparing texture features on a voxel-by-voxel basis. The validity of the method was examined on artificially generated effects as well as on real MRI data in Alzheimer's Disease (AD). The artificially generated effects included hyperintense and hypointense signals added to T1-weighted brain MRIs from 30 healthy subjects. The AD dataset included 30 patients with AD and 30 age/sex matched healthy control subjects. The proposed method detected artificial effects with high accuracy and revealed statistically significant differences between the AD and control groups. This paper extends the usage of texture analysis beyond the current region of interest analysis to voxel-by-voxel 3D statistical mapping and provides a hypothesis-free analysis tool to study cerebral pathology in neurological diseases.	[Maani, Rouzbeh; Yang, Yee Hong; Kalra, Sanjay] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Kalra, Sanjay] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Kalra, Sanjay] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Kalra, S (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	sanjay.kalra@ualberta.ca		Kalra, Sanjay/0000-0003-4762-8746	Natural Sciences and Engineering Research Council of Canada; Killam Memorial Scholarship; Alberta Innovates Graduate Student Scholarship; ALS Society of Canada; ALS Association	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Killam Memorial Scholarship; Alberta Innovates Graduate Student Scholarship; ALS Society of Canada; ALS Association	This work was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) to YHY; Killam Memorial Scholarship (http://killamlaureates.ca/) to RM; Alberta Innovates Graduate Student Scholarship (www.albertatechfutures.ca) to RM; ALS Society of Canada (https://www.als.ca/) to SK; and ALS Association (www.alsa.org/) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bernasconi A, 2001, ANN NEUROL, V49, P770, DOI 10.1002/ana.1013; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Chaim TM, 2007, PSYCHIAT RES-NEUROIM, V154, P59, DOI 10.1016/j.pscychresns.2006.04.003; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; de Oliveira MS, 2011, AM J NEURORADIOL, V32, P60, DOI 10.3174/ajnr.A2232; Freeborough PA, 1998, IEEE T MED IMAGING, V17, P475, DOI 10.1109/42.712137; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Glodzik L, 2012, NEUROBIOL AGING, V33, P1215, DOI 10.1016/j.neurobiolaging.2011.02.012; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Herlidou-Meme S, 2003, MAGN RESON IMAGING, V21, P989, DOI 10.1016/S0730-725X(03)00212-1; Irish M, 2014, HUM BRAIN MAPP, V35, P1422, DOI 10.1002/hbm.22263; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kurani AS, 2004, Proceedings of the Seventh IASTED International Conference on Computer Graphics and Imaging, P447; Maani R, 2014, IEEE T IMAGE PROCESS, V23, P4625, DOI 10.1109/TIP.2014.2351620; Maani R, 2013, PATTERN RECOGN, V46, P2103, DOI 10.1016/j.patcog.2013.01.014; Maani R, 2013, IEEE T IMAGE PROCESS, V22, P2409, DOI 10.1109/TIP.2013.2249081; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mayerhoefer ME, 2009, MED PHYS, V36, P1236, DOI 10.1118/1.3081408; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Rabinovici G D, 2007, Am J Alzheimers Dis Other Demen, V22, P474, DOI 10.1177/1533317507308779; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Sankar T, 2008, HUM BRAIN MAPP, V29, P931, DOI 10.1002/hbm.20437; Shiino A, 2006, NEUROIMAGE, V33, P17, DOI 10.1016/j.neuroimage.2006.06.010; Shin J, 2010, NEUROIMAGE, V52, P488, DOI 10.1016/j.neuroimage.2010.04.013; Thomann PA, 2006, DEMENT GERIATR COGN, V21, P215, DOI 10.1159/000090971; Tozer DJ, 2009, J MAGN RESON IMAGING, V30, P506, DOI 10.1002/jmri.21885; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Whitwell JL, 2007, BRAIN, V130, P708, DOI 10.1093/brain/awl388; Yu O, 2001, MAGN RESON IMAGING, V19, P1305, DOI 10.1016/S0730-725X(01)00464-7; Zhang J, 2008, MAGN RESON IMAGING, V26, P1160, DOI 10.1016/j.mri.2008.01.016; Zhang YY, 2009, NEUROIMAGE, V47, P107, DOI 10.1016/j.neuroimage.2009.03.075; Zook JM, 2005, MAGN RESON IMAGING, V23, P671, DOI 10.1016/j.mri.2005.04.002	36	35	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117759	10.1371/journal.pone.0117759	http://dx.doi.org/10.1371/journal.pone.0117759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756621	Green Submitted, gold, Green Published			2022-12-26	WOS:000351275700018
J	Searle, LJ; Meric, G; Porcelli, I; Sheppard, SK; Lucchini, S				Searle, Laura J.; Meric, Guillaume; Porcelli, Ida; Sheppard, Samuel K.; Lucchini, Sacha			Variation in Siderophore Biosynthetic Gene Distribution and Production across Environmental and Faecal Populations of Escherichia coli	PLOS ONE			English	Article							PHYLOGENETIC DISTRIBUTION; PLANT COLONIZATION; VIRULENCE GENES; IRON UPTAKE; STRAINS; RHIZOSPHERE; AEROBACTIN; TRAITS; PREVALENCE; GROWTH	Iron is essential for Escherichia coli growth and survival in the host and the external environment, but its availability is generally low due to the poor solubility of its ferric form in aqueous environments and the presence of iron-withholding proteins in the host. Most E. coli can increase access to iron by excreting siderophores such as enterobactin, which have a very strong affinity for Fe3+. A smaller proportion of isolates can generate up to 3 additional siderophores linked with pathogenesis; aerobactin, salmochelin, and yersiniabactin. However, non-pathogenic E. coli are also able to synthesise these virulence-associated siderophores. This raises questions about their role in the ecology of E. coli, beyond virulence, and whether specific siderophores might be linked with persistence in the external environment. Under the assumption that selection favours phenotypes that confer a fitness advantage, we compared siderophore production and gene distribution in E. coli isolated either from agricultural plants or the faeces of healthy mammals. This population-level comparison has revealed that under iron limiting growth conditions plant-associated isolates produced lower amounts of siderophores than faecal isolates. Additionally, multiplex PCR showed that environmental isolates were less likely to contain loci associated with aerobactin and yersiniabactin synthesis. Although aerobactin was linked with strong siderophore excretion, a significant difference in production was still observed between plant and faecal isolates when the analysis was restricted to strains only able to synthesise enterobactin. This finding suggests that the regulatory response to iron limitation may be an important trait associated with adaptation to the non-host environment. Our findings are consistent with the hypothesis that the ability to produce multiple siderophores facilitates E. coli gut colonisation and plays an important role in E. coli commensalism.	[Searle, Laura J.; Meric, Guillaume; Porcelli, Ida; Lucchini, Sacha] Inst Food Res, Gut Hlth & Food Safety, Norwich NR4 7UA, Norfolk, England; [Meric, Guillaume; Sheppard, Samuel K.] Swansea Univ, Coll Med, Inst Life Sci, Swansea, W Glam, Wales; [Sheppard, Samuel K.] Univ Oxford, Dept Zool, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Swansea University; University of Oxford	Lucchini, S (corresponding author), Inst Food Res, Gut Hlth & Food Safety, Norwich NR4 7UA, Norfolk, England.	sacha.lucchini@ifr.ac.uk	Méric, Guillaume/R-3947-2017; Méric, Guillaume/AAD-2364-2019	Méric, Guillaume/0000-0001-6288-9958; Méric, Guillaume/0000-0001-6288-9958; Sheppard, Samuel/0000-0001-6901-3203	Biotechnology and Biological Sciences Research Council, DTG Studentship [BB/J004529/1, BB/I02464X/1]; Wellcome Trust [088786/C/09/Z]; Biotechnology and Biological Sciences Research Council [1105690, BB/I02464X/1] Funding Source: researchfish; Health and Care Research Wales [HF-14-13] Funding Source: researchfish; BBSRC [BB/I02464X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, DTG Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Health and Care Research Wales; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SL, IP, GM received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grant number: BB/J004529/1. LJS received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), DTG Studentship. SKS received funding from Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk), grant number: BB/I02464X/1; Wellcome Trust (http://www.wellcome.ac.uk), grant number 088786/C/09/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Beuchat LR, 2002, MICROBES INFECT, V4, P413, DOI 10.1016/S1286-4579(02)01555-1; Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chen SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005497; Cornelis P, 2010, APPL MICROBIOL BIOT, V86, P1637, DOI 10.1007/s00253-010-2550-2; Crowley DE, 2007, MICROBIAL SIDEROPHOR; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; DEVOS CR, 1986, PLANT PHYSIOL, V81, P842, DOI 10.1104/pp.81.3.842; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Garenaux A, 2011, VET MICROBIOL, V153, P89, DOI 10.1016/j.vetmic.2011.05.023; Hao LY, 2012, APPL ENVIRON MICROB, V78, P4561, DOI 10.1128/AEM.07867-11; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hilali F, 2000, INFECT IMMUN, V68, P3983, DOI 10.1128/IAI.68.7.3983-3989.2000; Jackson SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-349; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2008, J CLIN MICROBIOL, V46, P3906, DOI 10.1128/JCM.00949-08; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Johnson JR, 2001, ASM NEWS, V67, P288; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; JURKEVITCH E, 1992, APPL ENVIRON MICROB, V58, P119, DOI 10.1128/AEM.58.1.119-124.1992; Kudinha T, 2012, APPL ENVIRON MICROB, V78, P1198, DOI 10.1128/AEM.06921-11; Kummerli R, 2009, P ROY SOC B-BIOL SCI, V276, P3531, DOI 10.1098/rspb.2009.0861; Lee S, 2010, ANN CLIN LAB SCI, V40, P361; Lv HT, 2014, J PROTEOME RES, V13, P1397, DOI 10.1021/pr4009749; Mao BH, 2012, J CLIN MICROBIOL, V50, P449, DOI 10.1128/JCM.00640-11; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; MILLER RD, 1986, EVOLUTION, V40, P1, DOI 10.1111/j.1558-5646.1986.tb05712.x; Nowrouzian F, 2003, PEDIATR RES, V54, P8, DOI 10.1203/01.PDR.0000069843.20655.EE; Nowrouzian F, 2001, EPIDEMIOL INFECT, V126, P11, DOI 10.1017/S0950268801005118; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Payne SM, 1984, METHOD ENZYMOL, V235, P329; Pi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050020; REID RK, 1984, PEDOBIOLOGIA, V26, P263; RUSSO TA, 1995, J INFECT DIS, V172, P440, DOI 10.1093/infdis/172.2.440; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Tedin K, 1996, J BIOL CHEM, V271, P17675, DOI 10.1074/jbc.271.30.17675; Unno T, 2011, MICROBES ENVIRON, V26, P198, DOI 10.1264/jsme2.ME10194; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Vokes SA, 1999, MOL MICROBIOL, V33, P63, DOI 10.1046/j.1365-2958.1999.01448.x; Vollmerhausen TL, 2011, J MED MICROBIOL, V60, P574, DOI 10.1099/jmm.0.027037-0; Watts RE, 2012, INFECT IMMUN, V80, P333, DOI 10.1128/IAI.05594-11; White AP, 2011, APPL ENVIRON MICROB, V77, P7620, DOI 10.1128/AEM.05909-11	47	38	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0117906	10.1371/journal.pone.0117906	http://dx.doi.org/10.1371/journal.pone.0117906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756870	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700020
J	Cecon, E; Chen, M; Marcola, M; Fernandes, PAC; Jockers, R; Markus, RP				Cecon, Erika; Chen, Min; Marcola, Marina; Fernandes, Pedro A. C.; Jockers, Ralf; Markus, Regina P.			Amyloid beta peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway	FASEB JOURNAL			English	Article						Alzheimer disease; nuclear factor kappa B	NF-KAPPA-B; PROTEIN-COUPLED RECEPTORS; ALZHEIMERS-DISEASE; NICOTINIC RECEPTORS; MOUSE MODEL; TNF-ALPHA; DYSFUNCTION; OLIGOMERS; IMMUNE; INFLAMMATION	Melatonin is the hormone produced by the pineal gland known to regulate physiologic rhythms and to display immunomodulatory and neuroprotective properties. It has been reported that Alzheimer disease patients show impaired melatonin production and altered expression of the 2 G protein-coupled melatonin receptors (MTRs), MT1 and MT2, but the underlying mechanisms are not known. Here we evaluated whether this dysfunction of the melatonergic system is directly caused by amyloid beta peptides (A beta(1-40) and A beta(1-42)). A beta treatment of rat pineal glands elicited an inflammatory response within the gland, evidenced by the up-regulation of 52 inflammatory genes, and decreased the production of melatonin up to 75% compared to vehicle-treated glands. Blocking NF-kappa B activity prevented this effect. Exposure of HEK293 cells stably expressing recombinant MT1 or MT2 receptors to A beta lead to a 40% reduction in [I-125] iodomelatonin binding to MT1. ERK1/2 activation triggered by MTRs, but not by the beta(2)-adrenergic receptor, was markedly impaired by A beta in HEK293 transfected cells, as well as in primary rat endothelial cells expressing endogenous MTRs. Our data reveal the melatonergic system as a new target of A beta, opening new perspectives to Alzheimer disease diagnosis and therapeutic intervention.	[Cecon, Erika; Marcola, Marina; Fernandes, Pedro A. C.; Markus, Regina P.] Univ Sao Paulo, Inst Biosci, Chronopharmacol Lab, Sao Paulo, Brazil; [Cecon, Erika; Chen, Min; Jockers, Ralf] INSERM, Inst Cochin, U1016, Paris, France; [Cecon, Erika; Chen, Min; Jockers, Ralf] CNRS, Unite Mixte Rech 8104, Paris, France; [Cecon, Erika; Chen, Min; Jockers, Ralf] Univ Paris 05, Sorbonne Paris Cite, Paris, France	Universidade de Sao Paulo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Markus, RP (corresponding author), Rua Matao 101,Travessa 14, BR-05508090 Sao Paulo, Brazil.	rpmarkus@usp.br	Marçola, Marina/D-4097-2015; Cecon, Erika/F-9842-2014; Jockers, Ralf/P-2272-2017; Cecon, Erika/AAG-9413-2020; Markus, Regina P/K-2954-2012; Cecon, Erika/B-3444-2016; Fernandes, Pedro/L-1869-2013; Markus, Regina P./AAC-1505-2021; Jockers, Ralf/Q-2100-2019	Cecon, Erika/0000-0003-2387-9313; Jockers, Ralf/0000-0002-4354-1750; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P/0000-0003-4606-6120; Cecon, Erika/0000-0003-2387-9313; Markus, Regina P./0000-0003-4606-6120; Jockers, Ralf/0000-0002-4354-1750	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/13691-1, 2007/07871-6]; Brazilian Ministry of Education (CNPq) [480097/2013-5]; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20130326503]; Association pour la Recherch sur le Cancer [SFI20121205906]; Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale [MED-HET-REC-2]; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Who Am I? Laboratory of Excellence [ANR-11-LABX-0071]; French government through its Investments for the Future program [ANR-11-IDEX-0005-01]; Sao Paulo Research Foundation (FAPESP) [2009/17923-9, 2011/01304-8]; overseas study program of the Guangzhou Elite Project; Guangzhou Pharmaceutical Company Limited	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Ministry of Education (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); Association pour la Recherch sur le Cancer; Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Who Am I? Laboratory of Excellence; French government through its Investments for the Future program(French National Research Agency (ANR)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); overseas study program of the Guangzhou Elite Project; Guangzhou Pharmaceutical Company Limited	The authors gratefully thank D. Aparecida Moura (technical fellow, Brazilian National Council for Research in Science and Technology; CNPq 3778555/2013-8) and E. Braga Fernandes for technical support. This work was supported by grants to R.P.M. from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 2013/13691-1; 2007/07871-6) and from the Brazilian Ministry of Education (CNPq 480097/2013-5). This work was also performed within the Departement Hopital-Universitaire Autoimmune and Hormonal Diseases and supported by grants to R.J. from the Fondation pour la Recherche Medicale (Equipe FRM DEQ20130326503), Association pour la Recherch sur le Cancer No SFI20121205906, Agence Nationale pour la Recherche (ANR) Recherches Partenariales et Innovation Biomedicale 2012 "MED-HET-REC-2," Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, and the Who Am I? Laboratory of Excellence, No. ANR-11-LABX-0071, funded by the French government through its Investments for the Future program, operated by the ANR under Grant ANR-11-IDEX-0005-01. E.C. and M.M. were supported by a doctoral fellowship from the Sao Paulo Research Foundation (FAPESP; 2009/17923-9; 2011/01304-8); M.C. was supported by a doctoral fellowship from the overseas study program of the Guangzhou Elite Project and the Guangzhou Pharmaceutical Company Limited. R.P.M. is a senior fellow of CNPq (304637/2013-0).	AbdAlla S, 2009, J BIOL CHEM, V284, P6566, DOI 10.1074/jbc.M808277200; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Cardinali DP, 2010, CURR NEUROPHARMACOL, V8, P218, DOI 10.2174/157015910792246209; CARNEIRO RCG, 1991, J PHARMACOL EXP THER, V259, P614; Carvalho-Sousa Claudia Emanuele, 2011, Front Endocrinol (Lausanne), V2, P10, DOI 10.3389/fendo.2011.00010; Cecon E, 2011, RECENT PATENTS ENDOC, V5, P91, DOI 10.2174/187221411799015381; CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044; Chromy BA, 2003, BIOCHEMISTRY-US, V42, P12749, DOI 10.1021/bi030029q; Corrales A, 2014, J PINEAL RES, V56, P51, DOI 10.1111/jpi.12097; Couturier C, 2003, J BIOL CHEM, V278, P26604, DOI 10.1074/jbc.M302002200; Cruz-Machado SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040142; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Espino J, 2013, J PINEAL RES, V54, P442, DOI 10.1111/jpi.12042; Feng Z, 2004, J PINEAL RES, V37, P257, DOI 10.1111/j.1600-079X.2004.00164.x; Feng Z, 2004, J PINEAL RES, V37, P129, DOI 10.1111/j.1600-079X.2004.00144.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Ferreira ZS, 2003, PHARMACOLOGY, V69, P33, DOI 10.1159/000071264; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hoshino T, 2011, J NEUROSCI, V31, P5225, DOI 10.1523/JNEUROSCI.5478-10.2011; Janickova H, 2013, NEUROPHARMACOLOGY, V67, P272, DOI 10.1016/j.neuropharm.2012.11.014; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larson J, 2006, NEUROSCI LETT, V393, P23, DOI 10.1016/j.neulet.2005.09.040; Lin L, 2013, INT J MOL SCI, V14, P14575, DOI 10.3390/ijms140714575; Ling ZQ, 2009, J ALZHEIMERS DIS, V16, P287, DOI 10.3233/JAD-2009-0949; Liu RY, 1999, J CLIN ENDOCR METAB, V84, P323, DOI 10.1210/jc.84.1.323; Liu S, 2011, MOL ENDOCRINOL, V25, P1301, DOI 10.1210/me.2010-0455; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Lyros E, 2014, CURR ALZHEIMER RES, V11, P18, DOI 10.2174/1567205010666131119235254; Magri F, 1997, CHRONOBIOL INT, V14, P385, DOI 10.3109/07420529709001459; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; Markus RP, 2013, INT J MOL SCI, V14, P10979, DOI 10.3390/ijms140610979; Markus RP, 2010, PHARMACOL THERAPEUT, V126, P251, DOI 10.1016/j.pharmthera.2010.02.009; Markus RP, 2003, J PHARMACOL EXP THER, V305, P525, DOI 10.1124/jpet.102.045625; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Muxel SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052010; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; O'Neal-Moffitt G, 2014, NEUROSCIENCE, V277, P506, DOI 10.1016/j.neuroscience.2014.07.018; Pinato L, BRAIN STRUCT FUNCT; Polimeni G, 2014, FRONT BIOSCI-LANDMRK, V19, P429, DOI 10.2741/4217; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Savaskan E, 2005, J PINEAL RES, V38, P10, DOI 10.1111/j.1600-079X.2004.00169.x; Seeman P, 2011, SYNAPSE, V65, P1289, DOI 10.1002/syn.20957; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Takano M, 2013, NEUROSCI LETT, V534, P85, DOI 10.1016/j.neulet.2012.11.010; Tamura EK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013958; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tosini G, 2014, BIOESSAYS, V36, P778, DOI 10.1002/bies.201400017; Walls KC, 2012, J BIOL CHEM, V287, P30317, DOI 10.1074/jbc.M112.365890; Wu YH, 2003, J CLIN ENDOCR METAB, V88, P5898, DOI 10.1210/jc.2003-030833; Wu YH, 2007, NEUROBIOL AGING, V28, P1239, DOI 10.1016/j.neurobiolaging.2006.06.002; Zhu LQ, 2004, J PINEAL RES, V37, P71, DOI 10.1111/j.1600-079X.2004.00136.x; Zlotos DP, 2014, J MED CHEM, V57, P3161, DOI 10.1021/jm401343c	69	40	41	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2566	2582		10.1096/fj.14-265678	http://dx.doi.org/10.1096/fj.14-265678			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25757565				2022-12-26	WOS:000355209500033
J	Duda, T; Wen, XH; Isayama, T; Sharma, RK; Makino, CL				Duda, Teresa; Wen, Xiao-Hong; Isayama, Tomoki; Sharma, Rameshwar K.; Makino, Clint L.			Bicarbonate Modulates Photoreceptor Guanylate Cyclase (ROS-GC) Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE ACTIVITY; HYDROGEN-ION BUFFERS; VERTEBRATE PHOTORECEPTOR; FUNCTIONAL CONSEQUENCES; TISSUE METABOLISM; FLASH RESPONSES; SALAMANDER RODS; CA2+ SENSOR; ROS-GC1; CALCIUM	By generating the second messenger cGMP in retinal rods and cones, ROS-GC plays a central role in visual transduction. Guanylate cyclase-activating proteins (GCAPs) link cGMP synthesis to the light-induced fall in [Ca2+](i) to help set absolute sensitivity and assure prompt recovery of the response to light. The present report discloses a surprising feature of this system: ROS-GC is a sensor of bicarbonate. Recombinant ROS-GCs synthesized cGMP from GTP at faster rates in the presence of bicarbonate with an ED50 of 27 mM for ROS-GC1 and 39 mM for ROS-GC2. The effect required neither Ca2+ nor use of the GCAPs domains; however, stimulation of ROS-GC1 was more powerful in the presence of GCAP1 or GCAP2 at low [Ca2+]. When applied to retinal photoreceptors, bicarbonate enhanced the circulating current, decreased sensitivity to flashes, and accelerated flash response kinetics. Bicarbonate was effective when applied either to the outer or inner segment of red-sensitive cones. In contrast, bicarbonate exerted an effect when applied to the inner segment of rods but had little efficacy when applied to the outer segment. The findings define a new regulatory mechanism of the ROS-GC system that affects visual transduction and is likely to affect the course of retinal diseases caused by cGMP toxicity.	[Duda, Teresa; Sharma, Rameshwar K.] Salus Univ, Div Biochem Res, Unit Regulatory & Mol Biol, Elkins Pk, PA 19027 USA; [Duda, Teresa; Sharma, Rameshwar K.] Salus Univ, Res Div Mol Biol, Unit Regulatory & Mol Biol, Elkins Pk, PA 19027 USA; [Wen, Xiao-Hong; Isayama, Tomoki; Makino, Clint L.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Wen, Xiao-Hong; Isayama, Tomoki; Makino, Clint L.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Makino, CL (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.	cmakino@meei.harvard.edu	Makino, Clint Lawrence/H-8428-2019; Cote, Rick H/G-3363-2013	Makino, Clint Lawrence/0000-0002-6005-9069; Cote, Rick H/0000-0002-1573-6526	National Institutes of Health [EY011358, EY014104, EY023980]; Research to Prevent Blindness; Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE [R29EY011358, R01EY023980, R01EY011358, P30EY014104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011358, EY014104, and EY023980. This work was also supported by Research to Prevent Blindness and the Howe Laboratory Endowment of the Massachusetts Eye and Ear Infirmary.	Astakhova LA, 2012, J GEN PHYSIOL, V140, P421, DOI 10.1085/jgp.201210811; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; Bok D, 2003, NAT GENET, V34, P313, DOI 10.1038/ng1176; Bright SR, 2005, MOL VIS, V11, P1141; BROEDERS GCJM, 1988, OPHTHALMOLOGICA, V196, P103, DOI 10.1159/000309884; Brooks MJ, 2011, MOL VIS, V17, P3034; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Craig FN, 1943, J GEN PHYSIOL, V26, P473, DOI 10.1085/jgp.26.5.473; DONNER K, 1990, J PHYSIOL-LONDON, V426, P297, DOI 10.1113/jphysiol.1990.sp018139; Duda T, 2005, BIOCHEMISTRY-US, V44, P7336, DOI 10.1021/bi050068x; Duda T, 1999, BIOCHEMISTRY-US, V38, P509, DOI 10.1021/bi9824137; Duda T, 2002, EMBO J, V21, P2547, DOI 10.1093/emboj/21.11.2547; Duda T, 2008, BIOCHEM BIOPH RES CO, V367, P440, DOI 10.1016/j.bbrc.2007.12.153; Duda T, 2011, BIOCHEM BIOPH RES CO, V408, P236, DOI 10.1016/j.bbrc.2011.03.134; Duda T, 2010, BIOCHEM BIOPH RES CO, V391, P1379, DOI 10.1016/j.bbrc.2009.12.068; FERGUSON WJ, 1980, ANAL BIOCHEM, V104, P300, DOI 10.1016/0003-2697(80)90079-2; FINDL O, 1995, INVEST OPHTH VIS SCI, V36, P1019; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; Fletcher EL, 2011, PROG MOL BIOL TRANSL, V100, P211, DOI 10.1016/B978-0-12-384878-9.00006-6; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Han JJ, 2013, MOL VIS, V19, P2579; Heikkinen H, 2012, INVEST OPHTH VIS SCI, V53, P5653, DOI 10.1167/iovs.12-9678; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; JIN J, 1994, VISUAL NEUROSCI, V11, P389, DOI 10.1017/S0952523800001735; Kalamkarov G, 1996, VISION RES, V36, P3029, DOI 10.1016/0042-6989(96)00052-1; Kao LY, 2011, J BIOL CHEM, V286, P32563, DOI 10.1074/jbc.M111.249961; Koenekoop RK, 2002, ARCH OPHTHALMOL-CHIC, V120, P1325, DOI 10.1001/archopht.120.10.1325; Kolandaivelu S, 2014, ADV EXP MED BIOL, V801, P43, DOI 10.1007/978-1-4614-3209-8_6; KOSKELAINEN A, 1994, VISION RES, V34, P983, DOI 10.1016/0042-6989(94)90002-7; KOSKELAINEN A, 1993, VISION RES, V33, P2181, DOI 10.1016/0042-6989(93)90098-H; Kwok MCM, 2008, MOL CELL PROTEOMICS, V7, P1053, DOI 10.1074/mcp.M700571-MCP200; LAMB TD, 1981, J PHYSIOL-LONDON, V319, P463, DOI 10.1113/jphysiol.1981.sp013921; LAMB TD, 1984, J PHYSIOL-LONDON, V346, P557, DOI 10.1113/jphysiol.1984.sp015041; Lange C, 1999, FEBS LETT, V460, P27, DOI 10.1016/S0014-5793(99)01312-5; Laser H, 1937, BIOCHEM J, V31, P1671, DOI 10.1042/bj0311671; LIEBMAN PA, 1984, J PHYSIOL-LONDON, V347, P85, DOI 10.1113/jphysiol.1984.sp015055; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; MacLeish PR, 2007, J NEUROPHYSIOL, V98, P86, DOI 10.1152/jn.00775.2006; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; MEYERTHOLEN EP, 1980, BIOCHEM BIOPH RES CO, V96, P785, DOI 10.1016/0006-291X(80)91423-0; MEYERTHOLEN EP, 1986, VISION RES, V26, P521, DOI 10.1016/0042-6989(86)90001-5; MUSSER GL, 1973, EXP EYE RES, V15, P467, DOI 10.1016/0014-4835(73)90138-3; MUSSER GL, 1973, EXP EYE RES, V15, P105, DOI 10.1016/0014-4835(73)90195-4; NAMBI P, 1982, ARCH BIOCHEM BIOPHYS, V217, P638, DOI 10.1016/0003-9861(82)90545-8; NORK TM, 1990, INVEST OPHTH VIS SCI, V31, P1451; ODOM JV, 1994, VISION RES, V34, P829, DOI 10.1016/0042-6989(94)90220-8; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; PARTHE V, 1981, J NEUROSCI RES, V6, P119, DOI 10.1002/jnr.490060112; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Sharma RK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00056; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; van Hateren J H, 2006, BMC Neurosci, V7, P34; Venkataraman V, 2008, BIOCHEMISTRY-US, V47, P6590, DOI 10.1021/bi800394s; Wen XH, 2014, INVEST OPHTH VIS SCI, V55; Wen XH, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00045; Wen XH, 2012, CELL PHYSIOL BIOCHEM, V29, P417, DOI 10.1159/000338496; WINKLER BS, 1977, INVEST OPHTH VIS SCI, V16, P1151; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013	70	11	11	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					11052	11060		10.1074/jbc.M115.650408	http://dx.doi.org/10.1074/jbc.M115.650408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25767116	Green Published, hybrid			2022-12-26	WOS:000353404500041
J	Lacerda-Queiroz, N; Brant, F; Rodrigues, DH; Vago, JP; Rachid, MA; Sousa, LP; Teixeira, MM; Teixeira, AL				Lacerda-Queiroz, Norinne; Brant, Fatima; Rodrigues, David Henrique; Vago, Juliana Priscila; Rachid, Milene Alvarenga; Sousa, Lirlandia Pires; Teixeira, Mauro Martins; Teixeira, Antonio Lucio			Phosphatidylinositol 3-Kinase gamma Is Required for the Development of Experimental Cerebral Malaria	PLOS ONE			English	Article							ACTIVATING-FACTOR RECEPTOR; CD8(+) T-CELLS; PATHOGENESIS; MODELS; INFLAMMATION; DYSFUNCTION; PARASITE; PLAYS	Experimental cerebral malaria (ECM) is characterized by a strong immune response, with leukocyte recruitment, blood-brain barrier breakdown and hemorrhage in the central nervous system. Phosphatidylinositol 3-kinase gamma (PI3K gamma) is central in signaling diverse cellular functions. Using PI3K gamma-deficient mice (PI3K gamma(-/-)) and a specific PI3K gamma inhibitor, we investigated the relevance of PI3K gamma for the outcome and the neuroinflammatory process triggered by Plasmodium berghei ANKA (PbA) infection. Infected PI3K gamma(-/-) mice had greater survival despite similar parasitemia levels in comparison with infected wild type mice. Histopathological analysis demonstrated reduced hemorrhage, leukocyte accumulation and vascular obstruction in the brain of infected PI3K gamma(-/-) mice. PI3K gamma deficiency also presented lower microglial activation (Iba-1+reactive microglia) and T cell cytotoxicity (Granzyme B expression) in the brain. Additionally, on day 6 post-infection, CD3(+)CD8(+) T cells were significantly reduced in the brain of infected PI3K gamma(-/-) mice when compared to infected wild type mice. Furthermore, expression of CD44 in CD8+ T cell population in the brain tissue and levels of phospho-IkB-alpha in the whole brain were also markedly lower in infected PI3K gamma(-/-) mice when compared with infected wild type mice. Finally, AS605240, a specific PI3K gamma inhibitor, significantly delayed lethality in infected wild type mice. In brief, our results indicate a pivotal role for PI3K gamma in the pathogenesis of ECM.	[Lacerda-Queiroz, Norinne; Brant, Fatima; Rodrigues, David Henrique; Rachid, Milene Alvarenga; Sousa, Lirlandia Pires; Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Lab Immunopharmacol, Belo Horizonte, MG, Brazil; [Vago, Juliana Priscila; Sousa, Lirlandia Pires] Univ Fed Minas Gerais, Fac Pharm, Dept Clin & Toxicol Anal, Belo Horizonte, MG, Brazil; [Teixeira, Mauro Martins; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Interdisciplinary Lab Med Invest, Sch Med, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Lacerda-Queiroz, N (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Lab Immunopharmacol, Belo Horizonte, MG, Brazil.	norinneq@yahoo.com.br; altexr@gmail.com	Rachid, Milene Alvarenga/C-3530-2017; DA SILVA, JULIANA PRISCILA VAGO/F-7386-2019; Teixeira, Antonio L/N-3315-2014	Rachid, Milene Alvarenga/0000-0002-3142-6552; DA SILVA, JULIANA PRISCILA VAGO/0000-0001-8188-3738; Teixeira, Antonio L/0000-0002-9621-5422	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Instituto Nacional de Ciencia e Tecnologia em Dengue (INCT/Dengue), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi J, 2012, DIABETES, V61, P1509, DOI 10.2337/db11-0134; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464; Chang WL, 2001, INFECT IMMUN, V69, P7341, DOI 10.1128/IAI.69.12.7341-7348.2001; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; de Souza JB, 2002, MICROBES INFECT, V4, P291, DOI 10.1016/S1286-4579(02)01541-1; Deb C, 2008, J NEUROVIROL, V14, P261, DOI 10.1080/13550280802105002; Desruisseaux MS, 2008, J INFECT DIS, V197, P1621, DOI 10.1086/587908; Fauconnier M, 2011, AM J PATHOL, V178, P212, DOI 10.1016/j.ajpath.2010.11.008; GRAU GE, 1986, J IMMUNOL, V137, P2348; Grau GER, 2012, FUTURE MICROBIOL, V7, P291, DOI [10.2217/FMB.11.155, 10.2217/fmb.11.155]; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Jin R, 2011, STROKE, V42, P2033, DOI 10.1161/STROKEAHA.110.601369; Lacerda-Queiroz N, 2013, INT J PARASITOL, V43, P11, DOI 10.1016/j.ijpara.2012.11.008; Lacerda-Queiroz N, 2012, AM J PATHOL, V180, P246, DOI 10.1016/j.ajpath.2011.09.038; LaFrance-Corey RG, 2011, JOVE-J VIS EXP, DOI 10.3791/2747; Li H, 2013, NEUROSCIENCE, V253, P89, DOI 10.1016/j.neuroscience.2013.08.051; Machado FS, 2006, EXP BIOL MED, V231, P1176; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rodrigues DH, 2010, J NEUROIMMUNOL, V222, P90, DOI 10.1016/j.jneuroim.2010.02.016; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; SENALDI G, 1994, INFECT IMMUN, V62, P1144, DOI 10.1128/IAI.62.4.1144-1149.1994; Van den Steen PE, 2013, TRENDS PARASITOL, V29, P346, DOI 10.1016/j.pt.2013.04.006	32	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119633	10.1371/journal.pone.0119633	http://dx.doi.org/10.1371/journal.pone.0119633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25775137	Green Submitted, Green Published, gold			2022-12-26	WOS:000351183500107
J	Liu, H; Ding, JX; Wang, JC; Wang, YA; Yang, MD; Zhang, YB; Chang, F; Chen, XS				Liu, He; Ding, Jianxun; Wang, Jincheng; Wang, Yinan; Yang, Modi; Zhang, Yanbo; Chang, Fei; Chen, Xuesi			Remission of Collagen-Induced Arthritis through Combination Therapy of Microfracture and Transplantation of Thermogel-Encapsulated Bone Marrow Mesenchymal Stem Cells	PLOS ONE			English	Article							CHRONIC INFLAMMATORY JOINT; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; IN-VITRO; HYDROGELS; OSTEOARTHRITIS; FIBROBLASTS; REVERSAL; REPAIR; ALPHA	The persistent inflammation of rheumatoid arthritis (RA) always leads to partial synovial hyperplasia and the destruction of articular cartilage. Bone marrow mesenchymal stem cells (BMMSCs) have been proven to possess immunosuppressive effects, and widely explored in the treatment of autoimmune diseases. However, poor inhibitory effect on local inflammatory state and limited capacity of preventing destruction of articular cartilage by systemic BMMSCs transplantation were observed. Herein, toward the classical type II collagen-induced arthritis in rats, the combination treatment of microfracture and in situ transplantation of thermogel-encapsulated BMMSCs was verified to obviously down-regulate the ratio of CD4(+) to CD8(+) T lymphocytes in peripheral blood. In addition, it resulted in the decreased levels of inflammatory cytokines, such as interleukin-1 beta, tumor necrosis factor-a and anti-collagen type II antibody, in the serum. Simultaneously, the combination therapy also could inhibit the proliferation of antigen specific lymphocytes and local joint inflammatory condition, and prevent the articular cartilage damage. The results indicated that the treatment programs could effectively stimulate the endogenous and exogenous BMMSCs to exhibit the immunosuppression and cartilage protection capability. This study provided a new therapeutic strategy for autoimmune inflammatory diseases, such as RA.	[Liu, He; Wang, Jincheng; Yang, Modi; Zhang, Yanbo; Chang, Fei] Jilin Univ, Dept Orthoped, Hosp 2, Changchun 130023, Peoples R China; [Ding, Jianxun; Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China; [Wang, Yinan] Jilin Univ, Acad Translat Med, Bethune Hosp 1, Changchun 130023, Peoples R China	Jilin University; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Jilin University	Wang, YA (corresponding author), Jilin Univ, Acad Translat Med, Bethune Hosp 1, Changchun 130023, Peoples R China.	wyn7859@aliyun.com; ccfei_cn@hotmail.com	Ding, Jianxun/A-6155-2013; Chen, Xuesi/ABB-5039-2020	Ding, Jianxun/0000-0002-5232-8863; Wang, Jincheng/0000-0002-1217-5962	National Natural Science Foundation of China [81171681, 51303174]; National Science Foundation for Post-doctoral Scientists of China [2013M530990]; Jilin Provincial Research Foundation for Basic Research, China [201215055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Post-doctoral Scientists of China(China Postdoctoral Science FoundationNational Natural Science Foundation of China (NSFC)); Jilin Provincial Research Foundation for Basic Research, China	This work was financially supported by the National Natural Science Foundation of China (No. 81171681 and 51303174), the National Science Foundation for Post-doctoral Scientists of China (No. 2013M530990), and the Jilin Provincial Research Foundation for Basic Research, China (No. 201215055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Barkholt L, 2013, CYTOTHERAPY, V15, P753, DOI 10.1016/j.jcyt.2013.03.005; Beane OS, 2012, ANN BIOMED ENG, V40, P2079, DOI 10.1007/s10439-012-0639-8; Buckley CD, 2004, ANN RHEUM DIS, V63, P92, DOI 10.1136/ard.2004.028332; Cake MA, 2000, OSTEOARTHR CARTILAGE, V8, P404, DOI 10.1053/joca.1999.0315; Chang F, 2008, J ORTHOP RES, V26, P18, DOI 10.1002/jor.20470; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Cui HT, 2014, BIOMACROMOLECULES, V15, P1115, DOI 10.1021/bm4018963; Danoff JR, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/185340; de Isla NG, 2008, BIORHEOLOGY, V45, P433, DOI 10.3233/BIR-2008-0503; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Endres M, 2007, J ORTHOP RES, V25, P1299, DOI 10.1002/jor.20394; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Keerthi N, 2013, CURR STEM CELL RES T, V8, P444, DOI 10.2174/1574888X1130800062; Kehoe O, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-157; Kotake S, 2014, BBA-GEN SUBJECTS, V1840, P1209, DOI 10.1016/j.bbagen.2013.12.013; Krenn V, 2002, PATHOL RES PRACT, V198, P317, DOI 10.1078/0344-0338-5710261; Kyburz D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13865; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lequerre T, 2013, REV MED INTERNE, V34, P754, DOI 10.1016/j.revmed.2013.09.010; Liu YY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3187; Liu Y, 2014, CLIN EXP MED, V14, P13, DOI 10.1007/s10238-012-0218-1; Liu ZZ, 2014, IN VITRO CELL DEV-AN, V50, P464, DOI 10.1007/s11626-013-9725-y; Ma HC, 2014, BIOMATERIALS, V35, P8723, DOI 10.1016/j.biomaterials.2014.06.045; Mao F, 2010, INFLAMM RES, V59, P219, DOI 10.1007/s00011-009-0090-y; Matheu V, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-25; Mohanty ST, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3098; Niranjan R, 2013, INT J BIOL MACROMOL, V54, P24, DOI 10.1016/j.ijbiomac.2012.11.026; OTTE P, 1991, Z RHEUMATOL, V50, P304; Poulet B, 2013, OSTEOARTHR CARTILAGE, V21, pS68, DOI 10.1016/j.joca.2013.02.148; Sanchez-Berna I, 2015, MED CLIN-BARCELONA, V144, P88, DOI 10.1016/j.medcli.2014.01.014; SEKI N, 1988, J IMMUNOL, V140, P1477; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Tan HP, 2010, MATERIALS, V3, P1746, DOI 10.3390/ma3031746; Teuschl AH, 2013, EUR SURG, V45, P142, DOI 10.1007/s10353-013-0217-9; Tyndall A, 2009, BONE MARROW TRANSPL, V43, P821, DOI 10.1038/bmt.2009.63; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Zhang YB, 2014, CHINESE J POLYM SCI, V32, P1590, DOI 10.1007/s10118-014-1551-5; Zheng ZH, 2008, RHEUMATOLOGY, V47, P22, DOI 10.1093/rheumatology/kem284	50	17	19	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120596	10.1371/journal.pone.0120596	http://dx.doi.org/10.1371/journal.pone.0120596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774788	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500185
J	Sein, H; Varv, S; Kristjuhan, A				Sein, Henel; Varv, Signe; Kristjuhan, Arnold			Distribution and Maintenance of Histone H3 Lysine 36 Trimethylation in Transcribed Locus	PLOS ONE			English	Article							RNA-POLYMERASE-II; DOMAIN-CONTAINING PROTEINS; SACCHAROMYCES-CEREVISIAE; JMJC-DOMAIN; METHYLATION; SET2; DEMETHYLATION; ELONGATION; CHROMATIN; REGIONS	Post-translational modifications of core histones play an important role in the epigenetic regulation of chromatin dynamics and gene expression. In Saccharomyces cerevisiae methylation marks at K4, K36, and K79 of histone H3 are associated with gene transcription. Although Set2-mediated H3K36 methylation is enriched throughout the coding region of active genes and prevents aberrant transcriptional initiation within coding sequences, it is not known if transcription of one locus impacts the methylation pattern of neighbouring areas and for how long H3K36 methylation is maintained after transcription termination. Our results demonstrate that H3K36 methylation is restricted to the transcribed sequence only and the modification does not spread to adjacent loci downstream from transcription termination site. We also show that H3K36 trimethylation mark persists in the locus for at least 60 minutes after transcription inhibition, suggesting a short epigenetic memory for recently occurred transcriptional activity. Our results indicate that both replication-dependent exchange of nucleosomes and the activity of histone demethylases Rph1, Jhd1 and Gis1 contribute to the turnover of H3K36 methylation upon shut-down of transcription.	[Sein, Henel; Varv, Signe; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, EE-51010 Tartu, Estonia	University of Tartu	Kristjuhan, A (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Cell Biol, Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee		Kristjuhan, Arnold/0000-0002-5842-4952	Estonian Research Council [ETF9188, IUT20-23]	Estonian Research Council	This work was supported by the Estonian Research Council (grants ETF9188 and IUT20-23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Du HN, 2010, J BIOL CHEM, V285, P11704, DOI 10.1074/jbc.M109.085043; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fuchs SM, 2009, BBA-GENE REGUL MECH, V1789, P26, DOI 10.1016/j.bbagrm.2008.07.008; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Mellor J, 2006, TRENDS GENET, V22, P320, DOI 10.1016/j.tig.2006.03.008; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Varv S, 2007, BIOCHEM BIOPH RES CO, V358, P666, DOI 10.1016/j.bbrc.2007.05.003; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120200	10.1371/journal.pone.0120200	http://dx.doi.org/10.1371/journal.pone.0120200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774516	Green Published, gold, Green Submitted			2022-12-26	WOS:000351183500156
J	Hroncova, Z; Havlik, J; Killer, J; Doskocil, I; Tyl, J; Kamler, M; Titera, D; Hakl, J; Mrazek, J; Bunesova, V; Rada, V				Hroncova, Zuzana; Havlik, Jaroslav; Killer, Jiri; Doskocil, Ivo; Tyl, Jan; Kamler, Martin; Titera, Dalibor; Hakl, Josef; Mrazek, Jakub; Bunesova, Vera; Rada, Vojtech			Variation in Honey Bee Gut Microbial Diversity Affected by Ontogenetic Stage, Age and Geographic Location	PLOS ONE			English	Article							BOMBI SP NOV.; GEN. NOV.; DIGESTIVE-TRACT; DEVELOPMENTAL-STAGES; BACTERIAL DIVERSITY; HYMENOPTERA; MEMBER; STOMACH; LARVAE	Social honey bees, Apis mellifera, host a set of distinct microbiota, which is similar across the continents and various honey bee species. Some of these bacteria, such as lactobacilli, have been linked to immunity and defence against pathogens. Pathogen defence is crucial, particularly in larval stages, as many pathogens affect the brood. However, information on larval microbiota is conflicting. Seven developmental stages and drones were sampled from 3 colonies at each of the 4 geographic locations of Apis mellifera carnica, and the samples were maintained separately for analysis. We analysed the variation and abundance of important bacterial groups and taxa in the collected bees. Major bacterial groups were evaluated over the entire life of honey bee individuals, where digestive tracts of same aged bees were sampled in the course of time. The results showed that the microbial tract of 6-day-old 5th instar larvae were nearly equally rich in total microbial counts per total digestive tract weight as foraging bees, showing a high percentage of various lactobacilli (Firmicutes) and Gilliamella apicola (Gammaproteobacteria 1). However, during pupation, microbial counts were significantly reduced but recovered quickly by 6 days post-emergence. Between emergence and day 6, imago reached the highest counts of Firmicutes and Gammaproteobacteria, which then gradually declined with bee age. Redundancy analysis conducted using denaturing gradient gel electrophoresis identified bacterial species that were characteristic of each developmental stage. The results suggest that 3-day 4th instar larvae contain low microbial counts that increase 2-fold by day 6 and then decrease during pupation. Microbial succession of the imago begins soon after emergence. We found that bacterial counts do not show only yearly cycles within a colony, but vary on the individual level. Sampling and pooling adult bees or 6th day larvae may lead to high errors and variability, as both of these stages may be undergoing dynamic succession.	[Hroncova, Zuzana; Havlik, Jaroslav; Killer, Jiri; Doskocil, Ivo; Bunesova, Vera; Rada, Vojtech] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic; [Killer, Jiri; Mrazek, Jakub] Acad Sci Czech Republ, Inst Anim Physiol & Genet Vvi, Prague, Czech Republic; [Tyl, Jan; Kamler, Martin; Titera, Dalibor] Bee Res Inst Dol, Libcice Nad Vltavou, Czech Republic; [Titera, Dalibor] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic; [Hakl, Josef] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Forage Crops & Grassland Management, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; Bee Research Institute at Dol; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Havlik, J (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic.	havlik@af.czu.cz	Mrazek, Jakub/AAS-9861-2020; Hroncova, Zuzana/Y-3038-2018; Hakl, Josef/F-3689-2018; Killer, Jiri/G-7197-2014; Killer, Jiri/R-4276-2018; Havlík, Jaroslav/F-3371-2011; Doskocil, Ivo/I-7814-2016; Mrazek, Jakub/B-7764-2017; Bunesova, Vera/R-4013-2018	Mrazek, Jakub/0000-0003-1907-3333; Hroncova, Zuzana/0000-0003-0065-3418; Hakl, Josef/0000-0003-4822-3441; Killer, Jiri/0000-0002-8878-7826; Havlík, Jaroslav/0000-0003-1900-0951; Doskocil, Ivo/0000-0002-7373-1360; Mrazek, Jakub/0000-0003-1907-3333; Bunesova, Vera/0000-0002-7596-4360; Kamler, Martin/0000-0001-7542-7867	National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic [QJ 1210047]; Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague [20132013]	National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic; Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague	This research was supported by the National Agency for Agricultural Research-NAZV of the Ministry of Agriculture of Czech Republic, project No. QJ 1210047 and the Internal Grant Agency (CIGA) of the Czech University of Life Sciences Prague, project No. 20132013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2013, GUT MICROBES, V4, P60, DOI 10.4161/gmic.22517; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Killer J, 2014, INT J SYST EVOL MICR, V64, P2611, DOI 10.1099/ijs.0.063602-0; Killer J, 2014, INT J SYST EVOL MICR, V64, P152, DOI 10.1099/ijs.0.053033-0; Killer J, 2013, SYST APPL MICROBIOL, V36, P11, DOI 10.1016/j.syapm.2012.09.001; Killer J, 2011, INT J SYST EVOL MICR, V61, P1315, DOI 10.1099/ijs.0.022525-0; Killer J, 2010, SYST APPL MICROBIOL, V33, P359, DOI 10.1016/j.syapm.2010.08.002; Killer J, 2009, INT J SYST EVOL MICR, V59, P2020, DOI 10.1099/ijs.0.002915-0; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Kwong WK, 2013, INT J SYST EVOL MICR, V63, P2008, DOI 10.1099/ijs.0.044875-0; Ludvigsen J, 2013, THESIS NORWEGIAN U L; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; MICHELETTE ERD, 1993, APIDOLOGIE, V24, P431, DOI 10.1051/apido:19930410; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mrazek J, 2008, FOLIA MICROBIOL, V53, P229, DOI 10.1007/s12223-008-0032-z; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2014, INT J SYST EVOL MICR, V64, P3109, DOI 10.1099/ijs.0.059600-0; Patruica S, 2012, B ENTOMOL RES, V102, P619, DOI 10.1017/S0007485312000144; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; REMBOLD H, 1980, APIDOLOGIE, V11, P29, DOI 10.1051/apido:19800104; Rettedal EA, 2010, FEMS MICROBIOL LETT, V312, P55, DOI 10.1111/j.1574-6968.2010.02097.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Yoshiyama M, 2009, J INVERTEBR PATHOL, V102, P91, DOI 10.1016/j.jip.2009.07.005; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	45	55	60	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0118707	10.1371/journal.pone.0118707	http://dx.doi.org/10.1371/journal.pone.0118707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768309	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000351277500039
J	Lawson, MA; Paton-Hough, JM; Evans, HR; Walker, RE; Harris, W; Ratnabalan, D; Snowden, JA; Chantry, AD				Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Snowden, John A.; Chantry, Andrew D.			NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MOUSE MODEL; TUMOR BURDEN; MURINE MODEL; CELLS; DIFFERENTIATION; INHIBITION; ACTIVATION; INDUCTION; LESIONS	Animal models of multiple myeloma vary in terms of consistency of onset, degree of tumour burden and degree of myeloma bone disease. Here we describe five pre-clinical models of myeloma in NOD/SCID-GAMMA mice to specifically study the effects of therapeutic agents on myeloma bone disease. Groups of 7-8 week old female irradiated NOD/SCID-GAMMA mice were injected intravenously via the tail vein with either 1x10(6) JJN3, U266, XG-1 or OPM-2 human myeloma cell lines or patient-derivedmyeloma cells. At the first signs of morbidity in each tumour group all animals were sacrificed. Tumour load was measured by histological analysis, and bone disease was assessed by micro-CT and standard histomorphometric methods. Mice injected with JJN3, U266 or OPM-2 cells showed high tumour bone marrow infiltration of the long bones with low variability, resulting in osteolytic lesions. In contrast, mice injected with XG-1 or patient-derivedmyeloma cells showed lower tumour bone marrow infiltration and less bone disease with high variability. Injection of JJN3 cells into NOD/SCID-GAMMA mice resulted in an aggressive, short-term model of myeloma with mice exhibiting signs of morbidity 3 weeks later. Treating these mice with zoledronic acid at the time of tumour cell injection or once tumour was established prevented JJN3-induced bone disease but did not reduce tumour burden, whereas, carfilzomib treatment given once tumour was established significantly reduced tumour burden. Injection of U266, XG-1, OPM-2 and patient-derivedmyeloma cells resulted in less aggressive longer-term models of myeloma with mice exhibiting signs of morbidity 8 weeks later. Treating U266-induced disease with zoledronic acid prevented the formation of osteolytic lesions and trabecular bone loss as well as reducing tumour burden whereas, carfilzomib treatment only reduced tumour burden. In summary, JJN3, U266 or OPM-2 cells injected into NOD/SCID-GAMMA mice provide robust models to study anti-myeloma therapies, particularly those targetingmyeloma bone disease.	[Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Snowden, John A.; Chantry, Andrew D.] Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England; [Lawson, Michelle A.; Paton-Hough, Julia M.; Evans, Holly R.; Walker, Rebecca E.; Harris, William; Ratnabalan, Dharshi; Chantry, Andrew D.] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Snowden, John A.; Chantry, Andrew D.] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Dept Haematol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Lawson, MA (corresponding author), Univ Sheffield, Dept Oncol, Sheffield, S Yorkshire, England.	m.a.lawson@sheffield.ac.uk	Lawson, Michelle/M-6095-2019; Harris, William Stephen/T-1674-2019	Lawson, Michelle/0000-0002-5446-923X; Harris, William Stephen/0000-0003-3042-9353; Chantry, Andrew/0000-0002-2797-7626; SNOWDEN, JOHN/0000-0001-6819-3476	Yorkshire Cancer Research & Cancer Research UK (Pump Priming & Development Fund); Leukaemia and Lymphoma Research (Specialist Programme) [12053]	Yorkshire Cancer Research & Cancer Research UK (Pump Priming & Development Fund); Leukaemia and Lymphoma Research (Specialist Programme)	Yorkshire Cancer Research (http://yorkshirecancerresearch.org.uk) & Cancer Research UK (http://www.cancerresearchuk.org) (Pump Priming & Development Fund) and Leukaemia and Lymphoma Research (Specialist Programme Grant No. 12053, http://leukaemialymphomaresearch.org.uk) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee E, 2012, BIOL BLOOD MARROW TR, V18, P1540, DOI 10.1016/j.bbmt.2012.04.004; Carpenter RO, 2013, CLIN CANCER RES, V19, P2048, DOI 10.1158/1078-0432.CCR-12-2422; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Croucher PI, 2003, J BONE MINER RES, V18, P482, DOI 10.1359/jbmr.2003.18.3.482; Cruz JC, 2001, EXP HEMATOL, V29, P441, DOI 10.1016/S0301-472X(01)00618-X; Dallas SL, 1999, BLOOD, V93, P1697, DOI 10.1182/blood.V93.5.1697.405a17_1697_1706; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Epstein Joshua, 2005, V113, P183, DOI 10.1385/1-59259-916-8:183; EVANS CE, 1989, J BONE JOINT SURG BR, V71, P288, DOI 10.1302/0301-620X.71B2.2925748; EVANS CE, 1992, CLIN EXP METASTAS, V10, P33, DOI 10.1007/BF00163574; Fryer RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057641; Fuhler GM, 2012, MOL MED, V18, P65, DOI 10.2119/molmed.2011.00178; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Giuliani N, 2005, BLOOD, V106, P2472, DOI 10.1182/blood-2004-12-4986; Hjorth-Hansen H, 1999, J BONE MINER RES, V14, P256, DOI 10.1359/jbmr.1999.14.2.256; Hofgaard PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051892; Hu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074191; HUANG YW, 1993, CANCER RES, V53, P1392; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Koduru S, 2012, BLOOD, V119, P2302, DOI 10.1182/blood-2011-08-376236; Miyakawa Y, 2004, BIOCHEM BIOPH RES CO, V313, P258, DOI 10.1016/j.bbrc.2003.11.120; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Schueler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079939; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Swift BE, 2012, HAEMATOL-HEMATOL J, V97, P1020, DOI 10.3324/haematol.2011.054254; Udi J, 2013, BRIT J HAEMATOL, V161, P104, DOI 10.1111/bjh.12226; Vanderkerken K, 1996, BRIT J CANCER, V73, P1463, DOI 10.1038/bjc.1996.277	29	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0119546	10.1371/journal.pone.0119546	http://dx.doi.org/10.1371/journal.pone.0119546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768011	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000351277500085
J	Li, YW; Feng, SM; Wu, WP; Li, FX				Li, Yingwei; Feng, Shangming; Wu, Wenping; Li, Faxin			Temperature Dependent Mechanical Property of PZT Film: An Investigation by Nanoindentation	PLOS ONE			English	Article							PIEZORESPONSE FORCE MICROSCOPY; THIN-FILMS; BARIUM-TITANATE; RESIDUAL-STRESS; YOUNGS MODULUS; HARDNESS; DEFORMATION; BEHAVIOR	Load-depth curves of an unpoled Lead Zirconate Titanate (PZT) film composite as a function of temperature were measured by nanoindentation technique. Its reduce modulus and hardness were calculated by the typical Oliver-Pharr method. Then the true modulus and hardness of the PZT film were assessed by decoupling the influence of substrate using methods proposed by Zhou et al. and Korsunsky et al., respectively. Results show that the indentation depth and modulus increase, but the hardness decreases at elevated temperature. The increasing of indentation depth and the decreasing of hardness are thought to be caused by the decreasing of the critical stress needed to excite dislocation initiation at high temperature. The increasing of true modulus is attributed to the reducing of recoverable indentation depth induced by back-switched domains. The influence of residual stress on the indentation behavior of PZT film composite was also investigated by measuring its load-depth curves with pre-load strains.	[Li, Yingwei; Feng, Shangming; Wu, Wenping] Wuhan Univ, Dept Engn Mech, Sch Civil Engn, Wuhan 430072, Peoples R China; [Li, Yingwei] Wuhan Univ, State Key Lab Water Resources & Hydropower Engn S, Wuhan 430072, Peoples R China; [Li, Faxin] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China	Wuhan University; Wuhan University; Peking University	Li, YW (corresponding author), Wuhan Univ, Dept Engn Mech, Sch Civil Engn, Wuhan 430072, Peoples R China.	yingweili@whu.edu.cn; lifaxin@pku.edu.cn	Li, Faxin/B-2286-2008	Li, Faxin/0000-0002-1662-8674	research start-up foundation of Wuhan University	research start-up foundation of Wuhan University	Financial support from the research start-up foundation of Wuhan University is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DF, 1999, MAT SCI ENG A-STRUCT, V259, P126, DOI 10.1016/S0921-5093(98)00868-5; Clyne TW, 1993, INTRO METAL MATRIX C, DOI [10.1017/CBO9780511623080, DOI 10.1017/CBO9780511623080]; Delobelle P, 2007, J EUR CERAM SOC, V27, P223, DOI 10.1016/j.jeurceramsoc.2006.05.095; Delobelle P, 2004, APPL PHYS LETT, V85, P5185, DOI 10.1063/1.1827331; Devos A, 2001, PHYS REV LETT, V86, P2669, DOI 10.1103/PhysRevLett.86.2669; Djemia P, 2001, J APPL PHYS, V90, P3771, DOI 10.1063/1.1402667; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Duan ZC, 2009, JOM-US, V61, P32, DOI 10.1007/s11837-009-0177-5; Fett T, 2002, FERROELECTRICS, V274, P67, DOI 10.1080/00150190213958; GAO HJ, 1992, INT J SOLIDS STRUCT, V29, P2471, DOI 10.1016/0020-7683(92)90004-D; Ji DW, 2013, ACTA MATER, V61, P1, DOI 10.1016/j.actamat.2012.08.050; Kalinin SV, 2006, IEEE T ULTRASON FERR, V53, P2226, DOI 10.1109/TUFFC.2006.169; Kim SH, 2002, THIN SOLID FILMS, V416, P264, DOI 10.1016/S0040-6090(02)00726-5; Korsunsky AM, 1998, SURF COAT TECH, V99, P171, DOI 10.1016/S0257-8972(97)00522-7; LEFKI K, 1994, J APPL PHYS, V76, P1764, DOI 10.1063/1.357693; Li YW, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4795330; Li YW, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/17/175501; Lim JE, 2002, APPL PHYS LETT, V81, P3224, DOI 10.1063/1.1516830; Liu D, 2006, ACTA MATER, V54, P4525, DOI 10.1016/j.actamat.2006.05.039; Liu D, 2011, J AM CERAM SOC, V94, P3698, DOI 10.1111/j.1551-2916.2011.04867.x; Luginbuhl P, 1996, SENSOR ACTUAT A-PHYS, V54, P530, DOI 10.1016/S0924-4247(95)01196-X; Marsilius M, 2010, J AM CERAM SOC, V93, P2850, DOI 10.1111/j.1551-2916.2010.03801.x; Muralt P, 2000, J MICROMECH MICROENG, V10, P136, DOI 10.1088/0960-1317/10/2/307; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Saha R, 2002, ACTA MATER, V50, P23, DOI 10.1016/S1359-6454(01)00328-7; Schneider GA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830331; Schneider GA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920410; Scholz T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2177364; Scholz T, 2004, APPL PHYS LETT, V84, P3055, DOI 10.1063/1.1711164; Scholz T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766846; Schuh CA, 2005, NAT MATER, V4, P617, DOI 10.1038/nmat1429; Schuh CA, 2006, J MATER RES, V21; Scott J.F., 2000, FERROELECTRIC MEMORI; Shepard JF, 1998, SENSOR ACTUAT A-PHYS, V71, P133, DOI 10.1016/S0924-4247(98)00161-7; Suna ZH, 2008, J APPL PHYS, V104; Szuecs F, 1999, J APPL PHYS, V86, P6010, DOI 10.1063/1.371648; Tsui TY, 1996, J MATER RES, V11, P752, DOI 10.1557/JMR.1996.0091; Uchino K., 2000, FERROELECTRIC DEVICE; Webber KG, 2009, ACTA MATER, V57, P4614, DOI 10.1016/j.actamat.2009.06.037; Wheeler JM, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4824710; Wong MF, 2008, PHILOS MAG, V88, P3105, DOI 10.1080/14786430802524330; Yan F, 2002, THIN SOLID FILMS, V406, P282, DOI 10.1016/S0040-6090(01)01745-X; Yao K, 2003, APPL PHYS LETT, V82, P4540, DOI 10.1063/1.1587272; Zheng JH, 1996, J AM CERAM SOC, V79, P3193, DOI 10.1111/j.1151-2916.1996.tb08095.x; Zheng XJ, 2004, ACTA MATER, V52, P3313, DOI 10.1016/j.actamat.2004.02.047; Zheng XJ, 2003, ACTA MATER, V51, P3985, DOI 10.1016/S1359-6454(03)00208-8; Zhou B, 2010, EXP MECH, V50, P793, DOI 10.1007/s11340-009-9309-7; Zhou B, 2010, J MATER RES, V25, P1671, DOI 10.1557/JMR.2010.0228; Zhou H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4865773	49	4	4	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0116478	10.1371/journal.pone.0116478	http://dx.doi.org/10.1371/journal.pone.0116478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768957	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500010
J	Stein, V; Kubala, MH; Steen, J; Grimmond, SM; Alexandrov, K				Stein, Viktor; Kubala, Marta H.; Steen, Jason; Grimmond, Sean M.; Alexandrov, Kirill			Towards the Systematic Mapping and Engineering of the Protein Prenylation Machinery in Saccharomyces cerevisiae	PLOS ONE			English	Article							GERANYLGERANYLTRANSFERASE TYPE-I; PLASMA-MEMBRANE LOCALIZATION; A-FACTOR; SUBSTRATE RECOGNITION; PEPTIDE LIBRARIES; RAS PROTEINS; FARNESYLTRANSFERASE; YEAST; GENE; SPECIFICITY	Protein prenylation is a widespread and highly conserved eukaryotic post-translational modification that endows proteins with the ability to reversibly attach to intracellular membranes. The dynamic interaction of prenylated proteins with intracellular membranes is essential for their signalling functions and is frequently deregulated in disease processes such as cancer. As a result, protein prenylation has been pharmacologically targeted by numerous drug discovery programs, albeit with limited success. To a large extent, this can be attributed to an insufficient understanding of the interplay of different protein prenyltransferases and the combinatorial diversity of the prenylatable sequence space. Here, we report a high-throughput, growth-based genetic selection assay in Saccharomyces cerevisiae based on the Ras Recruitment System which, for the first time, has allowed us to create a comprehensive map of prenylatable protein sequences in S. cerevisiae. We demonstrate that potential prenylatable space is sparsely (6.2%) occupied leaving room for creation of synthetic orthogonal prenylatable sequences. To experimentally demonstrate that, we used the developed platform to engineer mutant farnesyltransferases that efficiently prenylate substrate motives that are not recognised by endogenous protein prenyltransferases. These uncoupled mutants can now be used as starting points for the systematic engineering of the eukaryotic protein prenylation machinery.	[Stein, Viktor; Kubala, Marta H.; Steen, Jason; Grimmond, Sean M.; Alexandrov, Kirill] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Stein, V (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	k.alexandrov@uq.edu.au; v.stein@uq.edu.au	Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019; Stein, Viktor/AAL-6191-2021; Alexandrov, Kirill/A-5830-2013	Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Steen, Jason/0000-0003-1351-5815; Alexandrov, Kirill/0000-0002-0957-6511; Stein, Viktor/0000-0001-6965-3657	Australian Research Council [DP1094080, FT0991611]; National Health and Medical Research Council [569652, APP1037320]; Australian Research Council; National Health and Medical Research Council	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This work was supported by the Australian Research Council [DP1094080, FT0991611] and National Health and Medical Research Council [Project Grant 569652, Program Grant APP1037320] to KA. Funding for open access charge: Australian Research Council and National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Broder YC, 1998, CURR BIOL, V8, P1121, DOI 10.1016/S0960-9822(98)70467-1; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; Charron G, 2013, P NATL ACAD SCI USA, V110, P11085, DOI 10.1073/pnas.1302564110; Dong XW, 2003, MOL CELL BIOL, V23, P6574, DOI 10.1128/MCB.23.18.6574-6584.2003; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dursina B, 2006, J AM CHEM SOC, V128, P2822, DOI 10.1021/ja052196e; Gangopadhyay SA, 2014, BIOCHEMISTRY-US, V53, P434, DOI 10.1021/bi4011732; GOMEZ R, 1993, BIOCHEM J, V289, P25, DOI 10.1042/bj2890025; HE B, 1991, P NATL ACAD SCI USA, V88, P11373, DOI 10.1073/pnas.88.24.11373; Hougland JL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404954; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Hougland JL, 2009, BIOCHEMISTRY-US, V48, P1691, DOI 10.1021/bi801710g; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kohler F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng016; Kovtun O, 2011, METHODS, V55, P58, DOI 10.1016/j.ymeth.2011.06.006; Krzysiak AJ, 2010, BIOORG MED CHEM LETT, V20, P767, DOI 10.1016/j.bmcl.2009.11.011; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Maroun M, 1999, Nucleic Acids Res, V27, pe4, DOI 10.1093/nar/27.13.e4; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Nguyen Uyen T T, 2010, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1403s62; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; OHYA Y, 1993, MOL BIOL CELL, V4, P1017, DOI 10.1091/mbc.4.10.1017; OHYA Y, 1991, J BIOL CHEM, V266, P12356; PETITJEAN A, 1990, GENETICS, V124, P797; Porcu G, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-197; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; Prior IA, 2012, SEMIN CELL DEV BIOL, V23, P145, DOI 10.1016/j.semcdb.2011.09.002; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sanchez-Mir L, 2014, MOL CELL BIOL, V34, P2745, DOI 10.1128/MCB.01515-13; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Stein V, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp589; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; Terry KL, 2006, BIOCHEMISTRY-US, V45, P9746, DOI 10.1021/bi060295e; Trueblood CE, 1997, P NATL ACAD SCI USA, V94, P10774, DOI 10.1073/pnas.94.20.10774; Trueblood CE, 2000, MOL CELL BIOL, V20, P4381, DOI 10.1128/MCB.20.12.4381-4392.2000; Villiers BRM, 2010, PROTEIN ENG DES SEL, V23, P1, DOI 10.1093/protein/gzp063; Wang YC, 2014, ACS CHEM BIOL, V9, P1726, DOI 10.1021/cb5002312; Wang YC, 2012, CHEM COMMUN, V48, P8228, DOI 10.1039/c2cc31713c; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Yalovsky S, 1997, MOL CELL BIOL, V17, P1986, DOI 10.1128/MCB.17.4.1986; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0120716	10.1371/journal.pone.0120716	http://dx.doi.org/10.1371/journal.pone.0120716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768003	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500133
J	Casas-Monroy, O; Linley, RD; Adams, JK; Chan, FT; Drake, DAR; Bailey, SA				Casas-Monroy, Oscar; Linley, Robert D.; Adams, Jennifer K.; Chan, Farrah T.; Drake, D. Andrew R.; Bailey, Sarah A.			Relative Invasion Risk for Plankton across Marine and Freshwater Systems: Examining Efficacy of Proposed International Ballast Water Discharge Standards	PLOS ONE			English	Article							PROPAGULE PRESSURE; SHIPS; ESTABLISHMENT; TEMPERATURE; SALINITY; EXCHANGE; COASTAL; COMMUNITIES; TRANSPORT; SURVIVAL	Understanding the implications of different management strategies is necessary to identify best conservation trajectories for ecosystems exposed to anthropogenic stressors. For example, science-based risk assessments at large scales are needed to understand efficacy of different vector management approaches aimed at preventing biological invasions associated with commercial shipping. We conducted a landscape-scale analysis to examine the relative invasion risk of ballast water discharges among different shipping pathways (e.g., Transoceanic, Coastal or Domestic), ecosystems (e.g., freshwater, brackish and marine), and timescales (annual and per discharge event) under current and future management regimes. The arrival and survival potential of nonindigenous species (NIS) was estimated based on directional shipping networks and their associated propagule pressure, environmental similarity between donor-recipient ecosystems (based on salinity and temperature), and effects of current and future management strategies (i.e., ballast water exchange and treatment to meet proposed international biological discharge standards). Our findings show that current requirements for ballast water exchange effectively reduce invasion risk to freshwater ecosystems but are less protective of marine ecosystems because of greater environmental mismatch between source (oceanic) and recipient (freshwater) ecoregions. Future requirements for ballast water treatment are expected to reduce risk of zooplankton NIS introductions across ecosystem types but are expected to be less effective in reducing risk of phytoplankton NIS. This large-scale risk assessment across heterogeneous ecosystems represents a major step towards understanding the likelihood of invasion in relation to shipping networks, the relative efficacy of different invasion management regimes and seizing opportunities to reduce the ecological and economic implications of biological invasions.	[Casas-Monroy, Oscar; Linley, Robert D.; Adams, Jennifer K.; Bailey, Sarah A.] Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, Burlington, ON L7S 1A1, Canada; [Chan, Farrah T.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Drake, D. Andrew R.] Univ Toronto Scarborough, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada	Fisheries & Oceans Canada; University of Windsor; University of Toronto; University Toronto Scarborough	Casas-Monroy, O (corresponding author), Fisheries & Oceans Canada, Great Lakes Lab Fisheries & Aquat Sci, 867 Lakeshore Rd, Burlington, ON L7S 1A1, Canada.	Oscar.Casas-Monroy@dfo-mpo.gc.ca	Bailey, Sarah/E-8356-2010	Bailey, Sarah/0000-0003-3635-919X; Chan, Farrah/0000-0002-1062-6707; Adams, Jennifer/0000-0002-0380-3832	Natural Sciences and Engineering Research Council of Canada [371454-2010 RGPIN]; Transport Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program; Fisheries and Oceans Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Transport Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program; Fisheries and Oceans Canada through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program	Funding for this study was provided by Transport Canada and Fisheries and Oceans Canada, both directly and through the Natural Sciences and Engineering Research Council of Canada Visiting Fellowships in Canadian Government Laboratories program, and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (SAB), #371454-2010 RGPIN. (https://www.tc.gc.ca, http://www.dfo-mpo.gc.ca, http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo AA, 2014, BIOL INVASIONS, V16, P793, DOI 10.1007/s10530-013-0537-5; Albert RJ, 2013, ECOL APPL, V23, P289, DOI 10.1890/12-0669.1; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; [Anonymous], 2012, TRANSP CAN DIS PAP C; Antonov J.I., 2006, WORLD OCEAN ATLAS 20, V2, P182; Bailey SA, 2011, ENVIRON SCI TECHNOL, V45, P2554, DOI 10.1021/es102655j; Bailey SA, 2009, CAN J FISH AQUAT SCI, V66, P261, DOI 10.1139/F08-200; Barry SC, 2008, ICES J MAR SCI, V65, P121, DOI 10.1093/icesjms/fsn004; Bradie J, 2015, J APPL ECOL, V52, P100, DOI 10.1111/1365-2664.12376; Briski E, 2013, ENVIRON SCI TECHNOL, V47, P1216, DOI 10.1021/es3029445; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; Brockerhoff EG, 2014, ECOLOGY, V95, P594, DOI 10.1890/13-0465.1; Browne RA, 2000, J EXP MAR BIOL ECOL, V244, P29, DOI 10.1016/S0022-0981(99)00125-2; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; CARVER CE, 2002, ASSESSMENT RISK BALL; Casas-Monroy O, 2012, THESIS U QUEBEC RIMO; Casas-Monroy O, 2014, DFO CAN SCI ADVIS SE, P128; Chan FT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1517; Chan FT, 2013, BIOL INVASIONS, V15, P295, DOI 10.1007/s10530-012-0284-z; Cordell JR, 2009, AQUAT CONSERV, V19, P322, DOI 10.1002/aqc.986; Dextrase AJ, 2006, BIOL INVASIONS, V8, P13, DOI 10.1007/s10530-005-0232-2; DiBacco C, 2012, ICES J MAR SCI, V69, P483, DOI 10.1093/icesjms/fsr133; Dickman M, 1999, MAR ECOL PROG SER, V176, P253, DOI 10.3354/meps176253; Drake JM, 2006, BIOL INVASIONS, V8, P365, DOI 10.1007/s10530-004-8122-6; Duncan RP, 2014, METHODS ECOL EVOL, V5, P1255, DOI 10.1111/2041-210X.12288; Gertzen EL, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00170.1; Gollasch Stephan, 2007, Aquatic Invasions, V2, P313, DOI 10.3391/ai.2007.2.4.3; Gregg Matthew, 2009, Aquatic Invasions, V4, P521, DOI 10.3391/ai.2009.4.3.14; Hulme PE, 2006, J APPL ECOL, V46, P10; Humphrey DB, 2008, THESIS U BRIT COLUMB; IMO, 2004, INT CONV CONTR MAN S; Jerde CL, 2007, AM NAT, V170, P1, DOI 10.1086/518179; Johnson TB, 2005, J GREAT LAKES RES, V31, P238, DOI 10.1016/S0380-1330(05)70317-8; Katsanevakis S, 2013, OCEAN COAST MANAGE, V76, P64, DOI 10.1016/j.ocecoaman.2013.02.024; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Klein G, 2009, ACTA BOT CROAT, V68, P325; Lavoie DM, 1999, ESTUAR COAST SHELF S, V48, P551, DOI 10.1006/ecss.1999.0467; Lawrence DJ, 2010, BIOL CONSERV, V143, P700, DOI 10.1016/j.biocon.2009.12.008; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Levings CD, 2004, DFO CAN SCI ADVIS SE, P118; LEWIS MA, 1997, SPATIAL ECOLOGY ROLE; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McCollin T, 2008, MAR POLLUT BULL, V56, P834, DOI 10.1016/j.marpolbul.2008.02.004; Mead A, 2011, BIOL INVASIONS, V13, P1991, DOI 10.1007/s10530-011-0016-9; NRC [National Research Council], 2011, ASS REL PROP PRESS I; Roy S, 2012, CAN J FISH AQUAT SCI, V69, P627, DOI [10.1139/F2012-008, 10.1139/f2012-008]; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 2013, ECOL APPL, V23, P311, DOI 10.1890/11-1660.1; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simard N, 2011, J PLANKTON RES, V33, P1378, DOI 10.1093/plankt/fbr038; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simkanin C, 2009, MAR POLLUT BULL, V58, P366, DOI 10.1016/j.marpolbul.2008.10.013; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Steichen JL, 2012, MAR POLLUT BULL, V64, P779, DOI 10.1016/j.marpolbul.2012.01.028; Taylor MD, 2007, MAR ECOL PROG SER, V350, P41, DOI 10.3354/meps07016; Tsolaki E, 2010, J CHEM TECHNOL BIOT, V85, P19, DOI 10.1002/jctb.2276; US EPA, 2013, VESS GEN PERM DISCH; Verween A, 2007, J EXP MAR BIOL ECOL, V348, P111, DOI 10.1016/j.jembe.2007.04.011; Ware C, 2014, DIVERS DISTRIB, V20, P10, DOI 10.1111/ddi.12117; Wonham MJ, 2013, ECOL APPL, V23, P1691, DOI 10.1890/12-1985.1	60	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0118267	10.1371/journal.pone.0118267	http://dx.doi.org/10.1371/journal.pone.0118267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763859	gold, Green Published, Green Submitted			2022-12-26	WOS:000351276300012
J	Ren, YS; Han, XL; Ho, SP; Harris, SE; Cao, ZG; Economides, AN; Qin, CL; Ke, HZ; Liu, M; Feng, JQ				Ren, Yinshi; Han, Xianglong; Ho, Sunita P.; Harris, Stephen E.; Cao, Zhengguo; Economides, Aris N.; Qin, Chunlin; Ke, Huazhu; Liu, Min; Feng, Jian Q.			Removal of SOST or blocking its product sclerostin rescues defects in the periodontitis mouse model	FASEB JOURNAL			English	Article						PDL; periostin; alveolar bone	INCREASES BONE-FORMATION; POSTMENOPAUSAL WOMEN; MONOCLONAL-ANTIBODY; TARGETED DELETION; DIABETES-MELLITUS; MINERAL DENSITY; IN-VIVO; MICE; DISEASE; DENTIN	Understanding periodontal ligament (PDL) biology and developing an effective treatment for bone and PDL damage due to periodontitis have been long-standing aims in dental medicine. Here, we first demonstrated by cell lineage tracing and mineral double-labeling approaches that murine PDL progenitor cells display a 2- and 3-fold higher mineral deposition rate than the periosteum and endosteum at the age of 4 weeks, respectively. We next proved that the pathologic changes in osteocytes (Ocys; changes from a spindle shape to round shape with a >50% reduction in the dendrite number/length, and an increase in SOST) are the key pathologic factors responsible for bone and PDL damage in periostin-null mice (a periodontitis animal model) using a newly developed 3-dimensional FITC-Imaris technique. Importantly, we proved that deleting the Sost gene (a potent inhibitor of WNT signaling) or blocking sclerostin function by using the mAb in this periodontitis model significantly restores bone and PDL defects (n = 4-5; P < 0.05). Together, identification of the key contribution of the PDL in normal alveolar bone formation, the pathologic changes of the Ocys in periodontitis bone loss, and the novel link between sclerostin and Wnt signaling in the PDL will aid future drug development in the treatment of patients with periodontitis.	[Ren, Yinshi; Han, Xianglong; Qin, Chunlin; Feng, Jian Q.] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Han, Xianglong] Sichuan Univ, State Key Lab Oral Dis, West China Hosp Stomatol, Chengdu, Sichuan, Peoples R China; [Ho, Sunita P.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Cao, Zhengguo] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430072, Peoples R China; [Cao, Zhengguo] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Wuhan 430072, Peoples R China; [Economides, Aris N.] Regeneron Pharmaceut, Tarrytown, NY USA; [Ke, Huazhu; Liu, Min] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Sichuan University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; Wuhan University; Wuhan University; Regeneron; Amgen	Ho, SP (corresponding author), Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, 707 Parnassus Ave, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu; jfeng@bcd.tamhsc.edu	Ho, Sunita P/B-1084-2008	Cao, Zhengguo/0000-0002-4261-9034; Ren, Yinshi/0000-0003-3361-6015; Economides, Aris/0000-0002-6508-8942	NIH [DE018486, DE022789, R01DE022032-01A1]; National Natural Science Foundation of China Grant [81371172]; Amgen and Union chimique belge Pharma Research funds; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025014, R01DE018486, R56DE022789, R01DE022032, R01DE024797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China Grant(National Natural Science Foundation of China (NSFC)); Amgen and Union chimique belge Pharma Research funds; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. Simon J. Conway (Indiana University, Indianapolis, IN, USA) for providing the periostin knockout mice and Dr. Gabriela G. Loots (Lawrence Livermore National Laboratory, Livermore, CA, USA) for providing the Sost-knockout mice. The authors also thank Dr. Larry Fisher [U.S. National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research, Bethesda, MD, USA] for providing the anti-decorin and biglycan antibodies. The authors gratefully acknowledge Ying Liu's excellent scanning electron microscopy work and Mrs. Jeanne Santa Cruz for her English grammar editing. This study was supported in part by NIH Grants DE018486 and DE022789 (to J.Q.F.) and R01DE022032-01A1 (to S.P.H.), National Natural Science Foundation of China Grant 81371172 (to X.H.), and Amgen and Union chimique belge Pharma Research funds (to J.Q.F.). M.L. and H.K. are Amgen employees and stockholders.	Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; Costa AG, 2014, EXPERT OPIN BIOL TH, V14, P697, DOI 10.1517/14712598.2014.895808; de Souza DM, 2010, J APPL ORAL SCI, V18, P493, DOI 10.1590/S1678-77572010000500011; Douglass C W, 1993, Adv Dent Res, V7, P25; Eddleston A, 2009, J BONE MINER RES, V24, P1662, DOI [10.1359/JBMR.090403, 10.1359/jbmr.090403]; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fox C H, 1992, Curr Opin Dent, V2, P5; FOX CH, 1994, J PERIODONTOL, V65, P676, DOI 10.1902/jop.1994.65.7.676; Hallmon W W, 1992, Diabetes Educ, V18, P310, DOI 10.1177/014572179201800409; Hurng JM, 2011, BIOMATERIALS, V32, P7106, DOI 10.1016/j.biomaterials.2011.06.021; Jawad MU, 2013, J ORTHOP RES, V31, P155, DOI 10.1002/jor.22186; Khader YS, 2006, J DIABETES COMPLICAT, V20, P59, DOI 10.1016/j.jdiacomp.2005.05.006; Kucher U, 2014, INT J ORAL SCI, V6, P70, DOI 10.1038/ijos.2014.12; Kuhr A, 2004, J PERIODONTAL RES, V39, P101, DOI 10.1111/j.1600-0765.2004.00710.x; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lim WH, 2014, J PERIODONTAL RES, V49, P751, DOI 10.1111/jre.12158; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; MARTIN DM, 1978, J MICROSC-OXFORD, V112, P345, DOI 10.1111/j.1365-2818.1978.tb00085.x; Chavarry NGM, 2009, ORAL HLTH PREV DENT, V7, P107; McClung MR, 2014, NEW ENGL J MED, V370, P412, DOI 10.1056/NEJMoa1305224; McColm J, 2014, J BONE MINER RES, V29, P935, DOI 10.1002/jbmr.2092; Mealey BL, 2000, PERIODONTOL, V44, P127, DOI DOI 10.1111/J.1600-0757.2006.00193.X; MILLER SC, 1985, J DENT RES, V64, P1062, DOI 10.1177/00220345850640080701; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2011, J BONE MINER RES, V26, P19, DOI 10.1002/jbmr.173; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ren Y, 2014, CONNECT TISSUE RES, V55, P129, DOI 10.3109/03008207.2014.923879; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Roguljic H, 2013, J DENT RES, V92, P709, DOI 10.1177/0022034513493434; Salvi GE, 2008, J CLIN PERIODONTOL, V35, P398, DOI 10.1111/j.1600-051X.2008.01282.x; Taut AD, 2013, J BONE MINER RES, V28, P2347, DOI 10.1002/jbmr.1984; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8	42	48	51	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2702	2711		10.1096/fj.14-265496	http://dx.doi.org/10.1096/fj.14-265496			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25757567	Green Published			2022-12-26	WOS:000356859100003
J	Chan, GKL; Witkowski, A; Gantz, DL; Zhang, TQO; Zanni, MT; Jayaraman, S; Cavigiolio, G				Chan, Gary K. L.; Witkowski, Andrzej; Gantz, Donald L.; Zhang, Tianqi O.; Zanni, Martin T.; Jayaraman, Shobini; Cavigiolio, Giorgio			Myeloperoxidase-mediated Methionine Oxidation Promotes an Amyloidogenic Outcome for Apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL EFFLUX; HUMAN ATHEROSCLEROTIC LESIONS; MASS-SPECTROMETRY; FIBRIL FORMATION; HUMAN ATHEROMA; BETA-SHEET; REVEALS; CHLORINATION; NITRATION	High plasma levels of apolipoprotein A-I (apoA-I) correlate with cardiovascular health, whereas dysfunctional apoA-I is a cause of atherosclerosis. In the atherosclerotic plaques, amyloid deposition increases with aging. Notably, apoA-I is the main component of these amyloids. Recent studies identified high levels of oxidized lipid-free apoA-I in atherosclerotic plaques. Likely, myeloperoxidase (MPO) secreted by activated macrophages in atherosclerotic lesions is the promoter of such apoA-I oxidation. We hypothesized that apoA-I oxidation by MPO levels similar to those present in the artery walls in atherosclerosis can promote apoA-I structural changes and amyloid fibril formation. ApoA-I was exposed to exhaustive chemical (H2O2) oxidation or physiological levels of enzymatic (MPO) oxidation and incubated at 37 degrees C and pH 6.0 to induce fibril formation. Both chemically and enzymatically oxidized apoA-I produced fibrillar amyloids after a few hours of incubation. The amyloid fibrils were composed of full-length apoA-I with differential oxidation of the three methionines. Met to Leu apoA-I variants were used to establish the predominant role of oxidation of Met-86 and Met-148 in the fibril formation process. Importantly, a small amount of preformed apoA-I fibrils was able to seed amyloid formation in oxidized apoA-I at pH7.0. In contrast to hereditary amyloidosis, wherein specific mutations of apoA-I cause protein destabilization and amyloid deposition, oxidative conditions similar to those promoted by local inflammation in atherosclerosis are sufficient to transform full-length wild-type apoA-I into an amyloidogenic protein. Thus, MPO-mediated oxidation may be implicated in the mechanism that leads to amyloid deposition in the atherosclerotic plaques in vivo.	[Chan, Gary K. L.; Witkowski, Andrzej; Cavigiolio, Giorgio] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Gantz, Donald L.; Jayaraman, Shobini] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Zhang, Tianqi O.; Zanni, Martin T.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Boston University; University of Wisconsin System; University of Wisconsin Madison	Cavigiolio, G (corresponding author), Childrens Hosp Oakland, Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org	Regan, Clinton/E-6250-2012	Cavigiolio, Giorgio/0000-0002-1622-0628; Witkowski, Andrzej/0000-0002-0442-4586; /0000-0003-1616-5347	National Institutes of Health [HL113059, DK79895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079895] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL113059 (to G. C.) and DK79895 (to M. T. Z.).	Amarzguioui M, 1998, BIOCHEM BIOPH RES CO, V242, P534, DOI 10.1006/bbrc.1997.8005; Andreola A, 2003, J BIOL CHEM, V278, P2444, DOI 10.1074/jbc.M204801200; Audet A, 2012, HISTOPATHOLOGY, V61, P610, DOI 10.1111/j.1365-2559.2012.04265.x; Benson MD, 2005, AMYLOID, V12, P75, DOI 10.1080/13506120500106925; BRAHMS S, 1977, P NATL ACAD SCI USA, V74, P3208, DOI 10.1073/pnas.74.8.3208; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Eriksson M, 2009, J MOL DIAGN, V11, P257, DOI 10.2353/jmoldx.2009.080161; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; Jonas A., 1982, BIOL CHEM, V257, P10961; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kim YS, 2009, P NATL ACAD SCI USA, V106, P17751, DOI 10.1073/pnas.0909888106; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Loavenbruck AJ, 2012, MUSCLE NERVE, V46, P817, DOI 10.1002/mus.23415; Mangione P, 2001, PROTEIN SCI, V10, P187, DOI 10.1110/ps.29201; MATSUNAGA T, 1991, P NATL ACAD SCI USA, V88, P2793, DOI 10.1073/pnas.88.7.2793; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/nchem.1293, 10.1038/NCHEM.1293]; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Moran SD, 2012, P NATL ACAD SCI USA, V109, P3329, DOI 10.1073/pnas.1117704109; MUCCHIANO G, 1992, AM J PATHOL, V140, P871; Mucchiano GI, 2001, J PATHOL, V193, P270, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH753>3.0.CO;2-S; Mucchiano GI, 2001, AM J CLIN PATHOL, V115, P298; Murphy C, 2011, AMYLOID, V18, P219, DOI 10.3109/13506129.2011.574354082; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Obici L, 1999, AM J PATHOL, V155, P695, DOI 10.1016/S0002-9440(10)65167-X; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Petrlova J, 2012, J LIPID RES, V53, P390, DOI 10.1194/jlr.M020883; Raimondi S, 2011, J MOL BIOL, V407, P465, DOI 10.1016/j.jmb.2011.01.044; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2008, METHOD ENZYMOL, V440, P33, DOI 10.1016/S0076-6879(07)00803-8; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Smith JD, 2010, J CLIN LIPIDOL, V4, P382, DOI 10.1016/j.jacl.2010.08.007; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Srinivasan S, 2013, J BIOL CHEM, V288, P2744, DOI 10.1074/jbc.M112.394155; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; WESTERMARK P, 1995, AM J PATHOL, V147, P1186; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	51	30	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2015	290	17					10958	10971		10.1074/jbc.M114.630442	http://dx.doi.org/10.1074/jbc.M114.630442			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CG6IX	25759391	Green Published, hybrid			2022-12-26	WOS:000353404500033
J	Bassino, E; Fornero, S; Gallo, MP; Gallina, C; Femmino, S; Levi, R; Tota, B; Alloatti, G				Bassino, Eleonora; Fornero, Sara; Gallo, Maria Pia; Gallina, Clara; Femmino, Saveria; Levi, Renzo; Tota, Bruno; Alloatti, Giuseppe			Catestatin Exerts Direct Protective Effects on Rat Cardiomyocytes Undergoing Ischemia/Reperfusion by Stimulating PI3K-Akt-GSK3 beta Pathway and Preserving Mitochondrial Membrane Potential	PLOS ONE			English	Article							CHROMOGRANIN-A; PEPTIDE CATESTATIN; PERMEABILITY TRANSITION; MYOCARDIAL PRODUCTION; EARLY DECLINE; GENETIC RISK; NITRIC-OXIDE; HEART; HUMANS; CARDIOPROTECTION	Catestatin (Cst) is a 21-amino acid peptide deriving from Chromogranin A. Cst exerts an overall protective effect against an excessive sympathetic stimulation of cardiovascular system, being able to antagonize catecholamine secretion and to reduce their positive inotropic effect, by stimulating the release of nitric oxide (NO) from endothelial cells. Moreover, Cst reduces ischemia/reperfusion (I/R) injury, improving post-ischemic cardiac function and cardiomyocyte survival. To define the cardioprotective signaling pathways activated by Cst (5 nM) we used isolated adult rat cardiomyocytes undergoing simulated I/R. We evaluated cell viability rate with propidium iodide labeling and mitochondrial membrane potential (MMP) with the fluorescent probe JC-1. The involvement of Akt, GSK3 beta, eNOS and phospholamban (PLN) cascade was studied by immunofluorescence. The role of PI3K-Akt/NO/ cGMP pathway was also investigated by using the pharmacological blockers wortmannin (Wm), L-NMMA and ODQ. Our experiments revealed that Cst increased cell viability rate by 65% and reduced cell contracture in I/R cardiomyocytes. Wm, L-NMMA and ODQ limited the protective effect of Cst. The protective outcome of Cst was related to its ability to maintain MMP and to increase Akt(Ser473), GSK3 beta(Ser9), PLNThr17 and eNOS(Ser1179) phosphorylation, while treatment with Wm abolished these effects. Thus, the present results show that Cst is able to exert a direct action on cardiomyocytes and give new insights into the molecular mechanisms involved in its protective effect, highlighting the PI3K/NO/cGMP pathway as the trigger and the MMP preservation as the end point of its action.	[Bassino, Eleonora; Fornero, Sara; Gallo, Maria Pia; Gallina, Clara; Levi, Renzo; Alloatti, Giuseppe] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Femmino, Saveria] Univ Turin, Dept Clin & Biol Sci, I-10043 Orbassano, TO, Italy; [Tota, Bruno] Univ Calabria, Dept Cell Biol, I-87030 Cosenza, Italy; [Tota, Bruno; Alloatti, Giuseppe] Natl Inst Cardiovasc Res, I-40126 Bologna, Italy	University of Turin; University of Turin; University of Calabria	Alloatti, G (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Via Accademia Albertina 13, I-10123 Turin, Italy.	giuseppe.alloatti@unito.it	Bassino, Eleonora/X-1370-2019; Gallo, Mariana C/J-2832-2014; Femmino, Saveria/J-6848-2018	Femmino, Saveria/0000-0003-4644-0784; Gallo, Maria Pia/0000-0002-0382-7607	National Institute of Cardiovascular Research (INRC); PRIN	National Institute of Cardiovascular Research (INRC); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by National Institute of Cardiovascular Research (INRC); ex-60% (GA, MPG and RL) and PRIN-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Angelone T, 2012, AM J PHYSIOL-HEART C, V302, pH431, DOI 10.1152/ajpheart.00491.2011; Bassino E, 2011, CARDIOVASC RES, V91, P617, DOI 10.1093/cvr/cvr129; Biswas N, 2010, CELL TISSUE RES, V342, P353, DOI 10.1007/s00441-010-1059-4; Brar BK, 2010, REGUL PEPTIDES, V165, P63, DOI 10.1016/j.regpep.2010.07.153; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; Cerra MC, 2008, FASEB J, V22, P3992, DOI 10.1096/fj.08-110239; Cohen MV, 2011, J CARDIOVASC PHARM T, V16, P273, DOI 10.1177/1074248411407071; DeSantiago J, 2004, J MOL CELL CARDIOL, V36, P67, DOI 10.1016/j.yjmcc.2003.10.012; Dev NB, 2010, ENDOCRINOLOGY, V151, P2760, DOI 10.1210/en.2009-1110; Fornero S, 2012, CURR MED CHEM, V19, P4059, DOI 10.2174/092986712802429984; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Murphy E, 2008, CIRC RES, V103, P226, DOI 10.1161/CIRCRESAHA.108.181602; O'Connor DT, 2008, CIRCULATION, V118, P247, DOI 10.1161/CIRCULATIONAHA.107.709105; O'Connor DT, 2002, ANN NY ACAD SCI, V971, P533, DOI 10.1111/j.1749-6632.2002.tb04520.x; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Ramella R, 2010, J CELL BIOCHEM, V110, P70, DOI 10.1002/jcb.22510; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ruiz-Meana M, 2009, AM J PHYSIOL-HEART C, V297, pH1281, DOI 10.1152/ajpheart.00435.2009; Theurl M, 2010, CIRC RES, V107, P1326, DOI 10.1161/CIRCRESAHA.110.219493; Tota B, 2008, CURR MED CHEM, V15, P1444, DOI 10.2174/092986708784567662; Wang PH, 1996, J BIOL CHEM, V271, P29223, DOI 10.1074/jbc.271.46.29223; Willis M, 2011, J NEURAL TRANSM, V118, P727, DOI 10.1007/s00702-011-0648-z; Xie Y, 2005, AM J PHYSIOL-HEART C, V288, pH2594, DOI 10.1152/ajpheart.00926.2004	35	28	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119790	10.1371/journal.pone.0119790	http://dx.doi.org/10.1371/journal.pone.0119790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774921	gold, Green Published, Green Submitted			2022-12-26	WOS:000351183500123
J	Pidala, J; Bloom, GC; Eschrich, S; Sarwal, M; Enkemann, S; Betts, BC; Beato, F; Yoder, S; Anasetti, C				Pidala, Joseph; Bloom, Gregory C.; Eschrich, Steven; Sarwal, Minnie; Enkemann, Steve; Betts, Brian C.; Beato, Francisca; Yoder, Sean; Anasetti, Claudio			Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; REGULATORY T-CELLS; PROBE LEVEL DATA; ADAPTER PROTEIN; B-CELLS; IDENTIFICATION; MECHANISMS; RECIPIENTS; PROFILES; GAMMA	Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n = 15, median 38.5 months post-HCT) and non-tolerant (n = 17, median 39.5 post-HCT) HCT recipients and healthy control subjects (n = 10) for analysis of immune cell subsets and differential gene expression. There were no significant differences in immune subsets across groups. We identified 281 probe sets unique to the tolerant (TOL) group and 122 for non-tolerant (non-TOL). These were enriched for process networks including NK cell cytotoxicity, antigen presentation, lymphocyte proliferation, and cell cycle and apoptosis. Differential gene expression was enriched for CD56, CD66, and CD14 human lineage-specific gene expression. Differential expression of 20 probe sets between groups was sufficient to develop a classifier with > 90% accuracy, correctly classifying 14/15 TOL cases and 15/17 non-TOL cases. These data suggest that differential gene expression can be utilized to accurately classify tolerant patients following HCT. Prospective investigation of immune tolerance biologic markers is warranted.	[Pidala, Joseph; Betts, Brian C.; Beato, Francisca; Anasetti, Claudio] Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA; [Bloom, Gregory C.; Eschrich, Steven] Univ S Florida, H Lee Moffitt Canc Ctr, Bioinformat, Tampa, FL 33682 USA; [Sarwal, Minnie] UCSF Sch Med, Dept Surg, San Francisco, CA USA; [Enkemann, Steve; Yoder, Sean] Univ S Florida, H Lee Moffitt Canc Ctr, Mol Genom, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Pidala, J (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Blood & Marrow Transplantat, Tampa, FL 33682 USA.	joseph.pidala@moffitt.org	Eschrich, Steven/K-6848-2013	Eschrich, Steven/0000-0002-9833-2788; Betts, Brian/0000-0001-7643-2422	American Society for Blood and Marrow Transplantation; American Cancer Society [MRSG-11-149-01-LIB]; NCI [CA132197]; Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	American Society for Blood and Marrow Transplantation; American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Cancer Center Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Society for Blood and Marrow Transplantation (New Investigator Award, PI: Pidala, J), the American Cancer Society (MRSG-11-149-01-LIB, PI: Pidala, J), NCI (CA132197, PI: Anasetti, C), and the Moffitt Cancer Center Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen IW, 2005, HAEMATOLOGICA, V90, P86; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Bluestone JA, 2011, IMMUNOL REV, V241, P5, DOI 10.1111/j.1600-065X.2011.01019.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Braud C, 2008, J CELL BIOCHEM, V103, P1681, DOI 10.1002/jcb.21574; Brouard S, 2007, P NATL ACAD SCI USA, V104, P15448, DOI 10.1073/pnas.0705834104; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Choi J, 2012, BLOOD, V120, P4093, DOI 10.1182/blood-2012-01-403196; Choubey D, 2012, IMMUNOL LETT, V147, P10, DOI 10.1016/j.imlet.2012.07.003; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Goldstein DR, 2003, J CLIN INVEST, V111, P1571, DOI 10.1172/JCI200317573; Hu ZD, 2011, J CLIN IMMUNOL, V31, P346, DOI 10.1007/s10875-010-9492-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307; Kawasaki M, 2007, INT SURG, V92, P276; Kochi Y, 2009, J IMMUNOL, V183, P5502, DOI 10.4049/jimmunol.0901982; Koenecke C, 2012, J IMMUNOL, V189, P2890, DOI 10.4049/jimmunol.1200413; Kohrt HE, 2013, CLIN IMMUNOL, V148, P124, DOI 10.1016/j.clim.2013.04.013; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Liu Y, 2008, J LEUKOCYTE BIOL, V84, P842, DOI 10.1189/jlb.0208087; Lu Y, 2009, BIOL BLOOD MARROW TR, V15, P1347, DOI 10.1016/j.bbmt.2009.07.015; Martinez-Llordella M, 2008, J CLIN INVEST, V118, P2845, DOI 10.1172/JCI35342; McLean S, 2010, BIOCHEM J, V429, P137, DOI 10.1042/BJ20091598; Nagata S, 2009, J IMMUNOL, V182, P7518, DOI 10.4049/jimmunol.0802230; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Pidala J, 2011, BIOL BLOOD MARROW TR, V17, P1528, DOI 10.1016/j.bbmt.2011.03.006; Porrett PM, 2008, J IMMUNOL, V181, P1692, DOI 10.4049/jimmunol.181.3.1692; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sarantopoulos S, 2007, CLIN CANCER RES, V13, P6107, DOI 10.1158/1078-0432.CCR-07-1290; Sarantopoulos S, 2009, BLOOD, V113, P3865, DOI 10.1182/blood-2008-09-177840; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Skert C, 2009, BONE MARROW TRANSPL, V44, P729, DOI 10.1038/bmt.2009.80; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Zhao Y, 2013, CELL MOL IMMUNOL, V10, P165, DOI 10.1038/cmi.2012.58	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0117001	10.1371/journal.pone.0117001	http://dx.doi.org/10.1371/journal.pone.0117001			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774806	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500014
J	Shyu, VBH; Hsu, CE; Chen, CH; Chen, CT				Shyu, Victor Bong-Hang; Hsu, Chung-En; Chen, Chih-hao; Chen, Chien-Tzung			3D-Assisted Quantitative Assessment of Orbital Volume Using an Open-Source Software Platform in a Taiwanese Population	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RECONSTRUCTION; ENOPHTHALMOS; LIVER	Orbital volume evaluation is an important part of pre-operative assessments in orbital trauma and congenital deformity patients. The availability of the affordable, open-source software, OsiriX, as a tool for preoperative planning increased the popularity of radiological assessments by the surgeon. A volume calculation method based on 3D volume rendering-assisted region-of-interest computation was used to determine the normal orbital volume in Taiwanese patients after reorientation to the Frankfurt plane. Method one utilized 3D points for intuitive orbital rim outlining. The mean normal orbital volume for left and right orbits was 24.3 +/- 1.51 ml and 24.7 +/- 1.17 ml in male and 21.0 +/- 1.21 ml and 21.1 +/- 1.30 ml in female subjects. Another method (method two) based on the bilateral orbital lateral rim was also used to calculate orbital volume and compared with method one. The mean normal orbital volume for left and right orbits was 19.0 +/- 1.68 ml and 19.1 +/- 1.45 ml in male and 16.0 +/- 1.01 ml and 16.1 +/- 0.92 ml in female subjects. The inter-rater reliability and intra-rater measurement accuracy between users for both methods was found to be acceptable for orbital volume calculations. 3D-assisted quantification of orbital volume is a feasible technique for orbital volume assessment. The normal orbital volume can be used as controls in cases of unilateral orbital reconstruction with a mean size discrepancy of less than 3.1 +/- 2.03% in females and 2.7 +/- 1.32% in males. The OsiriX software can be used reliably by the individual surgeon as a comprehensive preoperative planning and imaging tool for orbital volume measurement and computed tomography reorientation.	[Shyu, Victor Bong-Hang; Hsu, Chung-En; Chen, Chih-hao] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Plast & Reconstruct Surg, Craniofacial Res Ctr,Coll Med, Taoyuan, Taiwan; [Chen, Chien-Tzung] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Chen, Chien-Tzung] Chang Gung Mem Hosp Keelung, Dept Plast & Reconstruct Surg, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chen, CT (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.	ctchenap@cgmh.org.tw						Acer N, 2009, J CRANIOFAC SURG, V20, P921, DOI 10.1097/SCS.0b013e3181a1686d; BLAND JM, 1995, INT J EPIDEMIOL, V24, pS7, DOI 10.1093/ije/24.Supplement_1.S7; Chau A, 2004, OPHTHAL PHYSL OPT, V24, P436, DOI 10.1111/j.1475-1313.2004.00217.x; Chen Chien-Tzung, 2006, Chang Gung Med J, V29, P251; Chen Zhe, 2006, Zhonghua Yan Ke Za Zhi, V42, P222; Cooper W C, 1985, Trans Am Ophthalmol Soc, V83, P546; Dello SAWG, 2011, WORLD J SURG, V35, P386, DOI 10.1007/s00268-010-0877-6; Deveci M, 2000, J ORAL MAXIL SURG, V58, P645, DOI 10.1016/S0278-2391(00)90157-5; FORBES G, 1985, AM J NEURORADIOL, V6, P419; Fruhwald J, 2008, J CRANIOFAC SURG, V19, P22, DOI 10.1097/scs.0b013e318052ff1a; Furuta M, 2001, JPN J OPHTHALMOL, V45, P600, DOI 10.1016/S0021-5155(01)00419-1; Gellrich NC, 2002, PLAST RECONSTR SURG, V110, P1417, DOI 10.1097/01.PRS.0000029807.35391.E5; GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009; Ji YR, 2010, J ANAT, V217, P501, DOI 10.1111/j.1469-7580.2010.01286.x; Kim SP, 2012, OPHTHALMIC RES, V47, P98, DOI 10.1159/000329572; Koppel DA, 2003, J CRANIO MAXILL SURG, V31, P88, DOI 10.1016/S1010-5182(02)00170-1; Lagravere MO, 2011, ORAL SURG ORAL MED O, V111, P771, DOI 10.1016/j.tripleo.2011.02.017; Lo LJ, 2007, J PLAST RECONSTR AES, V60, P125, DOI 10.1016/j.bjps.2006.05.021; Lukats O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050333; McGurk M, 1992, Dentomaxillofac Radiol, V21, P70; P'An TH, 1933, J ANAT, V67, P596; PARSONS GS, 1988, ARCH OTOLARYNGOL, V114, P743; Ramieri G, 2000, DENTOMAXILLOFAC RAD, V29, P302, DOI 10.1038/sj.dmfr.4600551; Regensburg NI, 2008, INVEST OPHTH VIS SCI, V49, P1758, DOI 10.1167/iovs.07-1030; Sicurezza E, 2011, ORAL SURG ORAL MED O, V111, P503, DOI 10.1016/j.tripleo.2010.11.022; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; WHITEHOUSE RW, 1994, BRIT J OPHTHALMOL, V78, P618, DOI 10.1136/bjo.78.8.618	27	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119589	10.1371/journal.pone.0119589	http://dx.doi.org/10.1371/journal.pone.0119589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774683	gold, Green Submitted, Green Published			2022-12-26	WOS:000351183500103
J	Wakasa, Y; Takagi, H; Watanabe, N; Kitamura, N; Fujiwara, Y; Ogo, Y; Hayashi, S; Yang, LJ; Ohta, M; Tin, WWT; Sekikawa, K; Takano, M; Ozawa, K; Hiroi, T; Takaiwa, F				Wakasa, Yuhya; Takagi, Hidenori; Watanabe, Nobumasa; Kitamura, Noriko; Fujiwara, Yoshihiro; Ogo, Yuko; Hayashi, Shimpei; Yang, Lijun; Ohta, Masaru; Tin, Wai Wai Thet; Sekikawa, Kenji; Takano, Makoto; Ozawa, Kenjirou; Hiroi, Takachika; Takaiwa, Fumio			Concentrated Protein Body Product Derived from Rice Endosperm as an Oral Tolerogen for Allergen-Specific Immunotherapy-A New Mucosal Vaccine Formulation against Japanese Cedar Pollen Allergy	PLOS ONE			English	Article							SEED; TOLERANCE; EXPRESSION	The endoplasmic reticulum-derived type-I protein body (PB-I) from rice endosperm cells is an ideal candidate formulation for the oral delivery of bioencapsulated peptides as tolerogens for allergen-specific immunotherapy. In the present study, PBs containing the deconstructed Japanese cedar pollen allergens Cryptomeria japonica 1 (Cry j 1) and Cry j 2 were concentrated by treatment with thermostable a-amylase at 90 degrees C to remove the starch from milled rice powder, which resulted in a 12.5-fold reduction of dry weight compared to the starting material. The modified Cry j 1 and Cry j 2 antigens in this concentrated PB product were more resistant to enzymatic digestion than those in the milled seed powder despite the absence of intact cell wall and starch, and remained stable for at least 10 months at room temperature without detectable loss or degradation. The high resistance of these allergens could be attributed to changes in protein physicochemical properties induced by the high temperature concentration process, as suggested by the decreased solubility of the antigens and seed proteins in PBs in step-wise-extraction experiments. Confocal microscopy showed that the morphology of antigen-containing PB-Is was preserved in the concentrated PB product. The concentrated PB product induced specific immune tolerance against Cry j 1 and Cry j 2 in mice when orally administered, supporting its potential use as a novel oral tolerogen formulation.	[Wakasa, Yuhya; Takagi, Hidenori; Ogo, Yuko; Hayashi, Shimpei; Yang, Lijun; Ohta, Masaru; Tin, Wai Wai Thet; Takano, Makoto; Ozawa, Kenjirou; Takaiwa, Fumio] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan; [Watanabe, Nobumasa; Kitamura, Noriko; Hiroi, Takachika] Tokyo Metropolitan Inst Med Sci, Dept Allergy & Immunol, Setagaya Ku, Tokyo 113, Japan; [Fujiwara, Yoshihiro; Sekikawa, Kenji] PrevenTec Inc, Tsukuba, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute of Medical Science	Takaiwa, F (corresponding author), Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan.	takaiwa@nias.affrc.go.jp		Wakasa, Yuhya/0000-0002-5764-9359	Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan	Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported by the Agri-Health Translational Research Project from the Ministry of Agriculture, Forestry and Fisheries of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier R, 1998, AM J PHYSIOL-GASTR L, V275, pG130, DOI 10.1152/ajpgi.1998.275.1.G130; Crowther J R, 1995, Methods Mol Biol, V42, P1; Derycke V, 2005, CEREAL CHEM, V82, P468, DOI 10.1094/CC-82-0468; KRISHNAN HB, 1986, PLANTA, V169, P471, DOI 10.1007/BF00392095; Kunisawa J, 2012, ADV DRUG DELIVER REV, V64, P523, DOI 10.1016/j.addr.2011.07.003; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Mayer L, 2004, NAT REV IMMUNOL, V4, P407, DOI 10.1038/nri1370; Nochi T, 2007, P NATL ACAD SCI USA, V104, P10986, DOI 10.1073/pnas.0703766104; OGAWA M, 1987, PLANT CELL PHYSIOL, V28, P1517; Ou JQ, 2014, PLANT CELL REP, V33, P585, DOI 10.1007/s00299-013-1559-2; Pabst O, 2012, MUCOSAL IMMUNOL, V5, P232, DOI 10.1038/mi.2012.4; Qu LQ, 2004, PLANT BIOTECHNOL J, V2, P113, DOI 10.1111/j.1467-7652.2004.00055.x; Sabalza M, 2013, CURR PHARM DESIGN, V19, P5543, DOI 10.2174/1381612811319310009; Stoger E, 2005, CURR OPIN BIOTECH, V16, P167, DOI 10.1016/j.copbio.2005.01.005; Streatfield SJ, 2006, METHODS, V38, P150, DOI 10.1016/j.ymeth.2005.09.013; Suzuki K, 2011, PLANT BIOTECHNOL J, V9, P982, DOI 10.1111/j.1467-7652.2011.00613.x; Takagi H, 2005, PLANT BIOTECHNOL J, V3, P521, DOI 10.1111/j.1467-7652.2005.00143.x; Takagi H, 2006, J AGR FOOD CHEM, V54, P9901, DOI 10.1021/jf061848v; Takagi H, 2010, PEPTIDES, V31, P1421, DOI 10.1016/j.peptides.2010.04.032; Takaiwa F, 2013, IMMUNOTHERAPY, V5, P1, DOI [10.2217/imt.12.148, DOI 10.2217/IMT.12.148]; Takaiwa F, 2011, HUM VACCINES, V7, P357, DOI 10.4161/hv.7.3.14302; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; Wakasa Y, 2006, PLANT BIOTECHNOL J, V4, P499, DOI 10.1111/j.1467-7652.2006.00199.x; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Wakasa Y, 2013, PLANT BIOTECHNOL J, V11, P66, DOI 10.1111/pbi.12007; Wang SY, 2013, PLANT CELL PHYSIOL, V54, P917, DOI 10.1093/pcp/pct043; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yang LJ, 2007, PLANT BIOTECHNOL J, V5, P815, DOI 10.1111/j.1467-7652.2007.00287.x; Yang LJ, 2012, J EXP BOT, V63, P2947, DOI 10.1093/jxb/ers006; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098	31	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0120209	10.1371/journal.pone.0120209	http://dx.doi.org/10.1371/journal.pone.0120209			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774686	Green Submitted, gold, Green Published			2022-12-26	WOS:000351183500157
J	Yamanishi, K; Doe, N; Sumida, M; Watanabe, Y; Yoshida, M; Yamamoto, H; Xu, YF; Li, W; Yamanishi, H; Okamura, H; Matsunaga, H				Yamanishi, Kyosuke; Doe, Nobutaka; Sumida, Miho; Watanabe, Yuko; Yoshida, Momoko; Yamamoto, Hideyuki; Xu, Yunfeng; Li, Wen; Yamanishi, Hiromichi; Okamura, Haruki; Matsunaga, Hisato			Hepatocyte Nuclear Factor 4 Alpha Is a Key Factor Related to Depression and Physiological Homeostasis in the Mouse Brain	PLOS ONE			English	Article							PREFRONTAL CORTEX; STRESS; METAANALYSIS; DISORDER; COAGULATION; EXPRESSION; CYTOKINES; RISK; FIBRINOLYSIS; METABOLISM	Major depressive disorder (MDD) is a common psychiatric disorder that involves marked disabilities in global functioning, anorexia, and severe medical comorbidities. MDD is associated with not only psychological and sociocultural problems, but also pervasive physical dysfunctions such as metabolic, neurobiological and immunological abnormalities. Nevertheless, the mechanisms underlying the interactions between these factors have yet to be determined in detail. The aim of the present study was to identify the molecular mechanisms responsible for the interactions between MDD and dysregulation of physiological homeostasis, including immunological function as well as lipid metabolism, coagulation, and hormonal activity in the brain. We generated depression-like behavior in mice using chronic mild stress (CMS) as a model of depression. We compared the gene expression profiles in the prefrontal cortex (PFC) of CMS and control mice using microarrays. We subsequently categorized genes using two web-based bioinformatics applications: Ingenuity Pathway Analysis and The Database for Annotation, Visualization, and Integrated Discovery. We then confirmed significant group-differences by analyzing mRNA and protein expression levels not only in the PFC, but also in the thalamus and hippocampus. These web tools revealed that hepatocyte nuclear factor 4 alpha (Hnf4a) may exert direct effects on various genes specifically associated with amine synthesis, such as genes involved in serotonin metabolism and related immunological functions. Moreover, these genes may influence lipid metabolism, coagulation, and hormonal activity. We also confirmed the significant effects of Hnf4a on both mRNA and protein expression levels in the brain. These results suggest that Hnf4a may have a critical influence on physiological homeostasis under depressive states, and may be associated with the mechanisms responsible for the interactions between MDD and the dysregulation of physiological homeostasis in humans.	[Yamanishi, Kyosuke; Matsunaga, Hisato] Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan; [Yamamoto, Hideyuki; Xu, Yunfeng; Li, Wen; Okamura, Haruki] Hyogo Coll Med, Lab Tumor Immunol & Cell Therapy, Nishinomiya, Hyogo 6638501, Japan; [Doe, Nobutaka] Hyogo Coll Med, Lab Neurogenesis & CNS Repair, Nishinomiya, Hyogo 6638501, Japan; [Doe, Nobutaka; Sumida, Miho] Kouiken Co Ltd, Sect Behav Sci, Akashi, Hyogo, Japan; [Yamanishi, Kyosuke; Watanabe, Yuko; Yoshida, Momoko; Yamanishi, Hiromichi] Hirakata Gen Hosp Dev Disorders, Hirakata, Osaka, Japan	Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine	Matsunaga, H (corresponding author), Hyogo Coll Med, Dept Neuropsychiat, Nishinomiya, Hyogo 6638501, Japan.	hisa1311@hyo-med.ac.jp	Yamanishi, Kyosuke/GQH-4743-2022		Department of Neuropsychiatry in Hyogo College of Medicine	Department of Neuropsychiatry in Hyogo College of Medicine	This work was internally supported by the fund of Department of Neuropsychiatry in Hyogo College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery RA, 2000, NEUROPSYCHOPHARMACOL, V23, P240, DOI 10.1016/S0893-133X(00)00111-1; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bonzo JA, 2012, J BIOL CHEM, V287, P7345, DOI 10.1074/jbc.M111.334599; Brown ES, 2010, ALLERGY ASTHMA PROC, V31, P331, DOI 10.2500/aap.2010.31.3338; Bulla GA, 2001, J CELL SCI, V114, P1205; Chien IC, 2013, J PSYCHOSOM RES, V75, P270, DOI 10.1016/j.jpsychores.2013.06.003; Diener C, 2012, NEUROIMAGE, V61, P677, DOI 10.1016/j.neuroimage.2012.04.005; Dong JY, 2012, STROKE, V43, P32, DOI 10.1161/STROKEAHA.111.630871; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Geiser F, 2008, PSYCHOTHER PSYCHOSOM, V77, P377, DOI 10.1159/000151518; Geiser F, 2011, PSYCHIAT CLIN NEUROS, V65, P518, DOI 10.1111/j.1440-1819.2011.02241.x; Gilabert-Juan J, 2013, BRAIN STRUCT FUNCT, V218, P1591, DOI 10.1007/s00429-012-0479-1; Hage MP, 2012, J THROID RES, V2012, DOI 10.1155/2012/590648; Health Statistics Office Vital Health and Social Statistics Division, 2011, PAT SURV; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jagannathan K, 2010, BIOL PSYCHIAT, V68, P657, DOI 10.1016/j.biopsych.2010.06.002; Kahl KG, 2012, EUR ARCH PSY CLIN N, V262, P313, DOI 10.1007/s00406-011-0277-4; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kurose Y, 1999, BRAIN RES, V828, P115, DOI 10.1016/S0006-8993(99)01339-6; Laine B, 2000, FEBS LETT, V479, P41, DOI 10.1016/S0014-5793(00)01864-0; Lee Margherita M, 2013, Curr Top Behav Neurosci, V14, P153, DOI 10.1007/7854_2012_226; Light SN, 2011, BIOL PSYCHIAT, V70, P962, DOI 10.1016/j.biopsych.2011.06.031; Ma XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020955; Mao ZM, 1999, BIOL PSYCHIAT, V46, P1259, DOI 10.1016/S0006-3223(99)00139-0; Marazziti D, 2013, CNS SPECTRUMS, V18, P6, DOI 10.1017/S1092852912000740; McIntyre RS, 2007, CURR OPIN PSYCHIATR, V20, P406, DOI 10.1097/YCO.0b013e3281938102; Mehta D, 2013, BRAIN BEHAV IMMUN, V31, P205, DOI 10.1016/j.bbi.2013.04.004; Ministry of Health Labour and Welfare, 2010, HLTH LAB WELF REP; Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56; Paizanis Eleni, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/73754; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Ross DA, 2012, J NEURO-ONCOL, V109, P439, DOI 10.1007/s11060-012-0919-z; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Sawyer K, 2012, AGING MENT HEALTH, V16, P753, DOI 10.1080/13607863.2012.678478; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; Schroeder V, 2007, EUR J CARDIOV PREV R, V14, P782, DOI 10.1097/HJR.0b013e32828622e8; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Shelton RC, 2010, PROG NEUROBIOL, V91, P275, DOI 10.1016/j.pneurobio.2010.04.004; Slattery DA, 2004, FUND CLIN PHARMACOL, V18, P1, DOI 10.1111/j.1472-8206.2004.00195.x; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Vazquez-Borsetti P, 2011, INT J NEUROPSYCHOPH, V14, P289, DOI 10.1017/S1461145710000349; Wahlqvist ML, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-150; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; You ZL, 2011, BEHAV BRAIN RES, V225, P135, DOI 10.1016/j.bbr.2011.07.006; Young EA, 2002, ENDOCRIN METAB CLIN, V31, P63, DOI 10.1016/S0889-8529(01)00002-0	52	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 16	2015	10	3							e0119021	10.1371/journal.pone.0119021	http://dx.doi.org/10.1371/journal.pone.0119021			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD6EY	25774879	Green Published, Green Submitted, gold			2022-12-26	WOS:000351183500060
J	Naumenko, AN; Timoshevskiy, VA; Kinney, NA; Kokhanenko, AA; Debruyn, BS; Lovin, DD; Stegniy, VN; Severson, DW; Sharakhov, IV; Sharakhova, MV				Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Kinney, Nicholas A.; Kokhanenko, Alina A.; deBruyn, Becky S.; Lovin, Diane D.; Stegniy, Vladimir N.; Severson, David W.; Sharakhov, Igor V.; Sharakhova, Maria V.			Mitotic-Chromosome-Based Physical Mapping of the Culex quinquefasciatus Genome	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MALARIA PARASITE SUSCEPTIBILITY; TUBULE POLYTENE CHROMOSOMES; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; LINKAGE MAP; MOSQUITO; PIPIENS; DIPTERA; SEQUENCE	The genome assembly of southern house mosquito Cx. quinquefasciatus is represented by a high number of supercontigs with no order or orientation on the chromosomes. Although cytogenetic maps for the polytene chromosomes of this mosquito have been developed, their utilization for the genome mapping remains difficult because of the low number of high-quality spreads in chromosome preparations. Therefore, a simple and robust mitotic-chromosome-based approach for the genome mapping of Cx. quinquefasciatus still needs to be developed. In this study, we performed physical mapping of 37 genomic supercontigs using fluorescent in situ hybridization on mitotic chromosomes from imaginal discs of 4th instar larvae. The genetic linkage map nomenclature was adopted for the chromosome numbering based on the direct positioning of 58 markers that were previously genetically mapped. The smallest, largest, and intermediate chromosomes were numbered as 1, 2, and 3, respectively. For idiogram development, we analyzed and described in detail the morphology and proportions of the mitotic chromosomes. Chromosomes were subdivided into 19 divisions and 72 bands of four different intensities. These idiograms were used for mapping the genomic supercontigs/genetic markers. We also determined the presence of length polymorphism in the q arm of sex-determining chromosome 1 in Cx. quinquefasciatus related to the size of ribosomal locus. Our physical mapping and previous genetic linkage mapping resulted in the chromosomal assignment of 13% of the total genome assembly to the chromosome bands. We provided the first detailed description, nomenclature, and idiograms for the mitotic chromosomes of Cx. quinquefasciatus. Further application of the approach developed in this study will help to improve the quality of the southern house mosquito genome.	[Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA; [Naumenko, Anastasia N.; Timoshevskiy, Vladimir A.; Sharakhov, Igor V.; Sharakhova, Maria V.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA; [Kinney, Nicholas A.] Virginia Tech, Dept Genom Bioinformat & Computat Biol, Blacksburg, VA USA; [Kokhanenko, Alina A.; Stegniy, Vladimir N.; Sharakhova, Maria V.] Tomsk State Univ, Inst Biol & Biophys, Tomsk 634050, Russia; [deBruyn, Becky S.; Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [deBruyn, Becky S.; Lovin, Diane D.; Severson, David W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Tomsk State University; University of Notre Dame; University of Notre Dame	Sharakhova, MV (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.	msharakh@vt.edu	Kinney, Nicholas/I-7168-2016; Kokhanenko, Alina A/F-9438-2017; Sharakhov, Igor/B-1972-2008; Stegniy, Vladimir/N-7656-2014; Stegniy, Vladimir/ABC-6763-2020	Kinney, Nicholas/0000-0002-4563-1813; Sharakhov, Igor/0000-0003-0752-3747; Stegniy, Vladimir/0000-0001-8947-041X	National Institute of Allergy and Infectious Diseases, National Institute of Health [R21-AI101345]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101345] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by grant R21-AI101345 to MVS from the National Institute of Allergy and Infectious Diseases, National Institute of Health www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bachtrog D, 2013, NAT REV GENET, V14, P113, DOI 10.1038/nrg3366; Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162; Bosio CF, 2000, GENETICS, V156, P687; Brown SE, 1997, INSECT MOL BIOL, V6, P197, DOI 10.1111/j.1365-2583.1997.tb00088.x; Campos J, 2003, MEM I OSWALDO CRUZ, V98, P387, DOI 10.1590/S0074-02762003000300017; Campos J, 2003, MEM I OSWALDO CRUZ, V98, P383, DOI 10.1590/S0074-02762003000300016; Coluzzi M., 1967, Parassitologia, V9, P73; Demin S, 2011, CYTOGENET GENOME RES, V132, P151, DOI 10.1159/000321676; DENNHOFER L, 1968, CHROMOSOMA, V25, P365, DOI 10.1007/BF01183127; DENNHOFER L, 1975, THEOR APPL GENET, V45, P250, DOI 10.1007/BF00831896; George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x; Gomez-Machorro C, 2004, INSECT MOL BIOL, V13, P637, DOI 10.1111/j.0962-1075.2004.00522.x; Heyse D, 1996, J AM MOSQUITO CONTR, V12, P199; Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040; Hickner Paul V., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-358; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jimenez LV, 2004, INSECT MOL BIOL, V13, P37, DOI 10.1046/j.0962-1075.2004.00456.x; KUMAR A, 1990, HEREDITAS, V113, P277, DOI 10.1111/j.1601-5223.1990.tb00094.x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; McAbee RD, 2007, J MED ENTOMOL, V44, P229, DOI 10.1603/0022-2585(2007)44[229:ADLSGP]2.0.CO;2; MCDONALD PT, 1970, GENETICS, V66, P475; Mori A, 2007, INSECT MOL BIOL, V16, P515, DOI 10.1111/j.1365-2583.2007.00746.x; Mori A, 1999, J HERED, V90, P160, DOI 10.1093/jhered/90.1.160; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; RAI K. S., 1963, ANN ENTOMOL SOC AMER, V56, P160, DOI 10.1093/aesa/56.2.160; Reddy BPN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-63; Severson David W., 1994, Insect Molecular Biology, V3, P67, DOI 10.1111/j.1365-2583.1994.tb00153.x; SEVERSON DW, 1995, GENETICS, V139, P1711; Severson DW, 2002, INSECT MOL BIOL, V11, P371, DOI 10.1046/j.1365-2583.2002.00347.x; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Sharakhov IV, 2002, SCIENCE, V298, P182, DOI 10.1126/science.1076803; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001335; Sharakhova MV, 2010, AM J TROP MED HYG, V83, P1023, DOI 10.4269/ajtmh.2010.10-0366; Timoshevskiy VA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-27; Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052; Timoshevskiy VA, 2012, JOVE-J VIS EXP, DOI 10.3791/4215; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; Zambetaki A, 1998, GENOME, V41, P751, DOI 10.1139/gen-41-6-751; Zhong DB, 2006, GENETICS, V173, P1337, DOI 10.1534/genetics.105.055178	43	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0115737	10.1371/journal.pone.0115737	http://dx.doi.org/10.1371/journal.pone.0115737			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25768920	Green Published, gold, Green Submitted			2022-12-26	WOS:000351277500002
J	Qin, F; Wang, YF; Ferguson, DK; Chen, WL; Li, YM; Cai, Z; Wang, Q; Ma, HZ; Li, CS				Qin, Feng; Wang, Yu-Fei; Ferguson, David K.; Chen, Wen-Li; Li, Ya-Meng; Cai, Zhe; Wang, Qing; Ma, Hong-Zhen; Li, Cheng-Sen			Utility of Surface Pollen Assemblages to Delimit Eastern Eurasian Steppe Types	PLOS ONE			English	Article							VEGETATION; PRECIPITATION; GRASSLANDS; TRANSECT; SEQUENCE; SPECTRA; RECORDS; LAKE; TOOL	Modern pollen records have been used to successfully distinguish between specific prairie types in North America. Whether the pollen records can be used to detect the occurrence of Eurasian steppe, or even to further delimit various steppe types was until now unclear. Here we characterized modern pollen assemblages of meadow steppe, typical steppe and desert steppe from eastern Eurasia along an ecological humidity gradient. The multivariate ordination of the pollen data indicated that Eurasian steppe types could be clearly differentiated. The different steppe types could be distinguished primarily by xerophilous elements in the pollen assemblages. Redundancy analysis indicated that the relative abundances of Ephedra, Tamarix, Nitraria and Zygophyllaceae were positively correlated with aridity. The relative abundances of Ephedra increased from meadow steppe to typical steppe and desert steppe. Tamarix and Zygophyllaceae were found in both typical steppe and desert steppe, but not in meadow steppe. Nitraria was only found in desert steppe. The relative abundances of xerophilous elements were greater in desert steppe than in typical steppe. These findings indicate that Eurasian steppe types can be differentiated based on recent pollen rain.	[Qin, Feng; Wang, Yu-Fei; Ferguson, David K.; Chen, Wen-Li; Cai, Zhe; Li, Cheng-Sen] Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Beijing 100093, Peoples R China; [Ferguson, David K.] Univ Vienna, Inst Palaeontol, A-1090 Vienna, Austria; [Li, Ya-Meng] Linyi Univ, Inst Geol & Paleontol, Linyi 276005, Peoples R China; [Wang, Qing] Beijing Acad Sci & Technol, Beijing Radiat Ctr, Beijing 100875, Peoples R China; [Ma, Hong-Zhen] Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China; [Qin, Feng] Chinese Acad Sci, Key Lab Land Surface Pattern & Simulat, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; University of Vienna; Linyi University; Beijing Academy of Science & Technology; Beijing Forestry University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, YF (corresponding author), Chinese Acad Sci, State Key Lab Systemat & Evolutionary Bot, Inst Bot, Nanxincun 20, Beijing 100093, Peoples R China.	wangyf@ibcas.ac.cn; lics@ibcas.ac.cn			China National Key Basic Research Program [2014CB954201]; National Natural Science Foundation of China [30990241]; State Key Laboratory of Systematic and Evolutionary Botany [LSEB2012-09]	China National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Systematic and Evolutionary Botany	This research was supported by the China National Key Basic Research Program (2014CB954201), the National Natural Science Foundation of China (No. 30990241), and the State Key Laboratory of Systematic and Evolutionary Botany (No. LSEB2012-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen S.H., 2005, METEOR SCI TECHNOL, V33, P340; Court-Picon M, 2005, REV PALAEOBOT PALYNO, V135, P13, DOI 10.1016/j.revpalbo.2005.02.003; Davies CP, 2001, J BIOGEOGR, V28, P1195, DOI 10.1046/j.1365-2699.2001.00630.x; De Martonne E., 1926, METEOROLOGIE, P449; Edwards EJ, 2010, SCIENCE, V328, P587, DOI 10.1126/science.1177216; ELMOSLIMANY AP, 1990, REV PALAEOBOT PALYNO, V64, P343, DOI 10.1016/0034-6667(90)90150-H; Fall PL, 2012, REV PALAEOBOT PALYNO, V185, P79, DOI 10.1016/j.revpalbo.2012.08.002; Gaillard M.-J., 1992, VEGETAT HIST ARCHAEO, V1, P3, DOI DOI 10.1007/BF00190697; Gosling WD, 2009, REV PALAEOBOT PALYNO, V153, P70, DOI 10.1016/j.revpalbo.2008.06.007; Grimm E.C., 2011, TILIA 1 7 16; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hicks S, 1996, VEG HIST ARCHAEOBOT, V5, P257; Hou JiHua, 2004, Acta Phytoecologica Sinica, V28, P609; Hoyt CA, 2000, J BIOGEOGR, V27, P687, DOI 10.1046/j.1365-2699.2000.00437.x; Institute of Botany and South China Institute of Botany, 1982, ANG POLL FLOR TROP S; Institute of Botany Chinese Academy of Sciences, 1976, SPOR PTER SIN; Integrated Survey Team of Inner Mongolia and Ningxia Chinese Academy of Sciences (ISTIMN), 1985, VEG INN MONG; Leps J, 2003, MULTIVARIATE ANAL EC; Li XQ, 1999, ACTA BOT SIN, V41, P782; [李月丛 Li Yuecong], 2005, [生态学报, Acta Ecologica Sinica], V25, P555; Lin R, 1991, FLORA CHINA, V76; Liu HY, 1999, REV PALAEOBOT PALYNO, V105, P237, DOI 10.1016/S0034-6667(98)00074-8; Ma YZ, 2008, J BIOGEOGR, V35, P1512, DOI 10.1111/j.1365-2699.2007.01871.x; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Mazier F, 2006, HOLOCENE, V16, P91, DOI 10.1191/0959683606hl908rp; Mensing SA, 2004, QUATERNARY RES, V62, P29, DOI 10.1016/j.yqres.2004.04.002; Moore P.D., 1991, BLACKWELL SCI PUBLI; Prentice IC, 1996, CLIM DYNAM, V12, P185, DOI 10.1007/BF00211617; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; [舒军武 SHU Jun-wu], 2009, [微体古生物学报, Acta Micropalaeontologica Sinica], V26, P405; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Wan T, 1999, POLLEN MORPHOLOGY MO; Wang F.Y., 1996, ACTA BOT SIN, V38, P902; Wang FX, 1995, POLLEN FLORA CHINA; Wang L, 2006, PALAEOGEOGR PALAEOCL, V241, P118, DOI 10.1016/j.palaeo.2006.06.012; Wang W, 2011, QUATERN INT, V229, P74, DOI 10.1016/j.quaint.2010.06.005; Weng Cheng-Yu, 1993, Acta Botanica Sinica, V35, P69; Wu ZY, 1980, VEGETATION CHINA, P505; Xi Y.Z., 1994, YUSHANIA, V11, P119; Xu QH, 2009, REV PALAEOBOT PALYNO, V153, P86, DOI 10.1016/j.revpalbo.2008.07.003; [许清海 Xu Qinghai], 2005, [地理研究, Geographical Research], V24, P394; Xu QH, 2007, SCI CHINA SER D, V50, P582, DOI 10.1007/s11430-007-2044-y; Zhang Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P621, DOI 10.1111/j.1466-8238.2010.00534.x; Zhao Y, 2012, HOLOCENE, V22, P1385, DOI 10.1177/0959683612449762	49	7	8	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2015	10	3							e0119412	10.1371/journal.pone.0119412	http://dx.doi.org/10.1371/journal.pone.0119412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7ND	25763576	Green Submitted, Green Published, gold			2022-12-26	WOS:000351276300027
J	Jing, L; Wang, WL; Zhang, SS; Xie, MJ; Tian, DS; Luo, X; Wang, DW; Ning, Q; Lu, JG; Wang, W				Jing, Liang; Wang, Wenlong; Zhang, Shuangshuang; Xie, Minjie; Tian, Daishi; Luo, Xiang; Wang, Daowen; Ning, Qin; Lu, Jiagao; Wang, Wei			Targeted Inhibitory Effect of Lenti-SM22alpha-p27-EGFP Recombinant Lentiviral Vectors on Proliferation of Vascular Smooth Muscle Cells without Compromising Re-Endothelialization in a Rat Carotid Artery Balloon Injury Model	PLOS ONE			English	Article							IN-STENT RESTENOSIS; INTRATHECAL INJECTION; ELUTING STENTS; PACLITAXEL; EXPRESSION; GENE; APOPTOSIS; RAPAMYCIN; REENDOTHELIALIZATION; IMPLANTATION	Aims In-stent restenosis remains a serious problem after the implantation of drug-eluting stents, which is attributable to neointima formation and re-endothelialization. Here, we tried to find a new method which aims at selectively inhibiting proliferation of vascular smooth muscle cells (VSMC) proliferation without inhibition of re-endothelialization. Methods and Results We used the smooth muscle-specific SM22alpha promoter in a recombinant lentiviral vector to drive overexpression of cell-cycle inhibitor, p27, in VSMCs. p27 effectively inhibited VSMC proliferation mediated by cell cycle arrest at the G0/G1 checkpoint. The SM22alpha-p27 lentiviral vector inhibited VSMC proliferation more effectively than paclitaxel. Rats infected with Lenti-SM22alpha-p27 had a significantly lower intima/media (I/M) ratio and also showed inhibition of restenosis on day 28 after balloon injury. Moreover, the repair of injured endothelium, and re-endothelialization of the carotid artery wall, was not affected by the smooth muscle cell-specific expression of p27. Conclusion A recombinant lentiviral vector carrying the SM22alpha promoter was used to effectively infect and selectively overexpress p27 protein in VSMCs, leading to inhibition of intimal hyperplasia without compromising endothelial repair.	[Jing, Liang; Xie, Minjie; Tian, Daishi; Luo, Xiang; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Peoples R China; [Wang, Wenlong; Zhang, Shuangshuang; Wang, Daowen; Ning, Qin; Lu, Jiagao] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiovasc Med, Wuhan 430030, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept & Inst Infect Dis, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, JG (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Cardiovasc Med, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	lujiagao@tjh.tjmu.edu.cn; wwang@vip.126.com	Zhang, Shuangshuang/GVS-0109-2022	Tian, Dai-shi/0000-0002-7627-0811	Natural Science Foundation of China [81030021, 30870641]; National Basic Research Program [2011CB504403]; Program for Changjiang Scholars and Innovative Research Team in University	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from Natural Science Foundation of China (81030021 to WW, 30870641 to LJ) and National Basic Research Program (2011CB504403 to WW) and Program for Changjiang Scholars and Innovative Research Team in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauriedel G, 2008, J VASC RES, V45, P173, DOI 10.1159/000110417; Blumenschein GR, 2008, J CLIN ONCOL, V26, P1879, DOI 10.1200/JCO.2007.12.2689; Breen DM, 2009, ARTERIOSCL THROM VAS, V29, P1060, DOI 10.1161/ATVBAHA.109.185447; Cheng W, 2009, EUR J PHARMACOL, V614, P44, DOI 10.1016/j.ejphar.2009.04.052; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; El-Kareh AW, 2008, AAPS J, V10, P15, DOI 10.1208/s12248-007-9003-6; Fasciano S, 2005, J BIOL CHEM, V280, P15682, DOI 10.1074/jbc.M411458200; Fuchs AT, 2008, ENDOTHELIUM-J ENDOTH, V15, P85, DOI 10.1080/10623320802092484; Gabrielson M, 2013, ONCOL REP, V29, P1268, DOI 10.3892/or.2013.2247; Henley D, 2007, CANCER CHEMOTH PHARM, V59, P235, DOI 10.1007/s00280-006-0262-1; Hoppmann P, 2009, JACC-CARDIOVASC INTE, V2, P1149, DOI 10.1016/j.jcin.2009.08.021; Huang YY, 2009, J INTERV CARDIOL, V22, P466, DOI 10.1111/j.1540-8183.2009.00489.x; Hughes TS, 2009, MOL THER, V17, P88, DOI 10.1038/mt.2008.230; Jean-Baptiste E, 2012, EUR J VASC ENDOVASC, V43, P188, DOI 10.1016/j.ejvs.2011.10.017; Jimenez RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007373; Jimenez-Valero Santiago, 2008, Ther Adv Cardiovasc Dis, V2, P137, DOI 10.1177/1753944708090573; Katsaros KM, 2008, J THROMB HAEMOST, V6, P508, DOI 10.1111/j.1538-7836.2007.02884.x; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; LANDAU C, 1994, NEW ENGL J MED, V330, P981, DOI 10.1056/NEJM199404073301407; Li Y, 2009, CLIN CANCER RES, V15, P6724, DOI 10.1158/1078-0432.CCR-09-1296; Liao PC, 2005, LIFE SCI, V76, P1623, DOI 10.1016/j.lfs.2004.09.021; Lin Ping, 2009, Shengli Xuebao, V61, P331; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Oliver LN, 2008, INT J CARDIOL, V126, P216, DOI 10.1016/j.ijcard.2007.03.132; OSBOURN JK, 1995, GENE, V154, P249, DOI 10.1016/0378-1119(94)00847-L; Pan JJ, 2009, J CLIN ONCOL, V27, P799, DOI 10.1200/JCO.2008.18.9670; Paul A, 2012, BIOMATERIALS, V33, P7655, DOI 10.1016/j.biomaterials.2012.06.096; Pelisek J, 2006, J GENE MED, V8, P835, DOI 10.1002/jgm.905; POPMA JJ, 1991, CIRCULATION, V84, P1426, DOI 10.1161/01.CIR.84.3.1426; Shammas NW, 2009, CARDIOVASC REVASCULA, V10, P151, DOI 10.1016/j.carrev.2009.01.007; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shu CH, 1997, APOPTOSIS, V2, P463, DOI 10.1023/A:1026422111457; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Sroka IM, 2010, MOL PHARMACOL, V77, P255, DOI 10.1124/mol.109.060327; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tanner FC, 1998, CIRC RES, V82, P396, DOI 10.1161/01.RES.82.3.396; Tepe G, 2006, STROKE, V37, P492, DOI 10.1161/01.STR.0000199080.94177.ba; Thipparaboina R, 2013, INT J PHARMACEUT, V454, P4, DOI 10.1016/j.ijpharm.2013.07.005; Tiroch K, 2009, CARDIOLOGY, V112, P263, DOI 10.1159/000151695; Tu KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068574; Wang Jin, 2005, Yaoxue Xuebao, V40, P1099; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang W, 2009, PROG NEUROBIOL, V89, P1, DOI 10.1016/j.pneurobio.2009.01.007; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang J, 2013, BIOMATERIALS, V34, P1635, DOI 10.1016/j.biomaterials.2012.11.006; Zhao YM, 2008, ACTA PHARMACOL SIN, V29, P481, DOI 10.1111/j.1745-7254.2008.00767.x; Zisis Charalambos, 2004, Interact Cardiovasc Thorac Surg, V3, P245, DOI 10.1016/j.icvts.2003.10.001	48	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0118826	10.1371/journal.pone.0118826	http://dx.doi.org/10.1371/journal.pone.0118826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760326	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275000041
J	Zheng, YL; Zhang, LP; Zhang, XL; Wang, K; Zheng, YJ				Zheng, Yan-Ling; Zhang, Li-Ping; Zhang, Xue-Liang; Wang, Kai; Zheng, Yu-Jian			Forecast Model Analysis for the Morbidity of Tuberculosis in Xinjiang, China	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; HEMORRHAGIC-FEVER; RENAL SYNDROME; DENGUE INCIDENCE; ARIMA MODEL; PREDICTION	Tuberculosis is a major global public health problem, which also affects economic and social development. China has the second largest burden of tuberculosis in the world. The tuberculosis morbidity in Xinjiang is much higher than the national situation; therefore, there is an urgent need for monitoring and predicting tuberculosis morbidity so as to make the control of tuberculosis more effective. Recently, the Box-Jenkins approach, specifically the autoregressive integrated moving average (ARIMA) model, is typically applied to predict the morbidity of infectious diseases; it can take into account changing trends, periodic changes, and random disturbances in time series. Autoregressive conditional heteroscedasticity (ARCH) models are the prevalent tools used to deal with time series heteroscedasticity. In this study, based on the data of the tuberculosis morbidity from January 2004 to June 2014 in Xinjiang, we establish the single ARIMA (1, 1, 2) (1, 1, 1)(12) model and the combined ARIMA (1, 1, 2) (1, 1, 1)(12)-ARCH (1) model, which can be used to predict the tuberculosis morbidity successfully in Xinjiang. Comparative analyses show that the combined model is more effective. To the best of our knowledge, this is the first study to establish the ARIMA model and ARIMA-ARCH model for prediction and monitoring the monthly morbidity of tuberculosis in Xinjiang. Based on the results of this study, the ARIMA (1, 1, 2) (1, 1, 1)(12)-ARCH (1) model is suggested to give tuberculosis surveillance by providing estimates on tuberculosis morbidity trends in Xinjiang, China.	[Zheng, Yan-Ling; Zhang, Li-Ping; Zheng, Yu-Jian] Xinjiang Med Univ, Coll Publ Hlth, Urumqi 830011, Peoples R China; [Zheng, Yan-Ling; Zhang, Li-Ping; Zhang, Xue-Liang; Wang, Kai] Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi 830011, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Zheng, YJ (corresponding author), Xinjiang Med Univ, Coll Publ Hlth, Urumqi 830011, Peoples R China.	zhyujian6@hotmail.com	Zhang, Li/GWM-7501-2022		National Natural Science Foundation of P.R. China [11461073, 81260410]; Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics [XYDXK50780308]; Research and Innovation Project of Xinjiang Graduate [XJGRI2014101]	National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics; Research and Innovation Project of Xinjiang Graduate	The entire study and the paper were financially supported by the National Natural Science Foundation of P.R. China (grant no. 11461073 and 81260410) and Academic Discipline Project of Xinjiang Medical University Health Measurements and Health Economics (grant no. XYDXK50780308) and Research and Innovation Project of Xinjiang Graduate (grant no. XJGRI2014101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, MODEL SELECTION MODE; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Catalano R, 2001, J CLIN EPIDEMIOL, V54, P830, DOI 10.1016/S0895-4356(01)00348-1; Chinese Center for Disease Control and Prevention, 2010, CURR SIT TUB; Cunha GB, 2010, REV SOC BRASILEIRA M, V43, P67; Earnest A, 2005, BMC HEALTH SERV RES, V5, P316; Engle R, 2001, J ECON PERSPECT, V15, P157, DOI 10.1257/jep.15.4.157; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; Guo Li-chun, 2008, Journal of China Medical University, V37, P839; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; KUHN L, 1994, AM J EPIDEMIOL, V140, P943, DOI 10.1093/oxfordjournals.aje.a117183; Lee YS, 2011, KNOWL-BASED SYST, V24, P66, DOI 10.1016/j.knosys.2010.07.006; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Liu HP, 2011, APPL ENERG, V88, P724, DOI 10.1016/j.apenergy.2010.09.028; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Nsoesie EO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002779; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Purwanto, 2012, APPL INTELL, V37, P511, DOI 10.1007/s10489-012-0344-1; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Rojas I, 2008, NEUROCOMPUTING, V71, P519, DOI 10.1016/j.neucom.2007.07.018; Tol RSJ, 1997, THEOR APPL CLIMATOL, V56, P113, DOI 10.1007/BF00863788; Wang YJ, 2006, CHINESE J VECTOR BIO, V17, P333; Wongkoon S, 2012, ASIAN PAC J TROP MED, V5, P249, DOI 10.1016/S1995-7645(12)60034-0; Wu Wei, 2008, Journal of China Medical University, V37, P52; Wu ZeMing, 2006, Zhongguo Meijieshengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V17, P223; Yi Jing, 2007, Zhonghua Yufang Yixue Zazhi, V41, P118; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang LP, 2014, COMPUT BIOL MED, V49, P67, DOI 10.1016/j.compbiomed.2014.02.008	37	29	45	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2015	10	3							e0116832	10.1371/journal.pone.0116832	http://dx.doi.org/10.1371/journal.pone.0116832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MQ	25760345	gold, Green Submitted, Green Published			2022-12-26	WOS:000351275000009
J	Bao, K; Bostanci, N; Selevsek, N; Thurnheer, T; Belibasakis, GN				Bao, Kai; Bostanci, Nagihan; Selevsek, Nathalie; Thurnheer, Thomas; Belibasakis, Georgios N.			Quantitative Proteomics Reveal Distinct Protein Regulations Caused by Aggregatibacter actinomycetemcomitans within Subgingival Biofilms	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; FUSOBACTERIUM-NUCLEATUM; TANNERELLA-FORSYTHIA; PERIODONTITIS; MODEL; COMMUNITIES; VALIDATION; DISRUPTION; EXPRESSION	Periodontitis is an infectious disease that causes the inflammatory destruction of the tooth-supporting (periodontal) tissues, caused by polymicrobial biofilm communities growing on the tooth surface. Aggressive periodontitis is strongly associated with the presence of Aggregatibacter actinomycetemcomitans in the subgingival biofilms. Nevertheless, whether and how A. actinomycetemcomitans orchestrates molecular changes within the biofilm is unclear. The aim of this work was to decipher the interactions between A. actinomycetemcomitans and other bacterial species in a multi-species biofilm using proteomic analysis. An in vitro 10-species "subgingival" biofilm model, or its derivative that included additionally A. actinomycetemcomitans, were anaerobically cultivated on hydroxyapatite discs for 64 h. When present, A. actinomycetemcomitans formed dense intra-species clumps within the biofilm mass, and did not affect the numbers of the other species in the biofilm. Liquid chromatography- tandem mass spectrometry was used to identify the proteomic content of the biofilm lysate. A total of 3225 and 3352 proteins were identified in the biofilm, in presence or absence of A. actinomycetemcomitans, respectively. Label-free quantitative proteomics revealed that 483 out of the 728 quantified bacterial proteins (excluding those of A. actinomycetemcomitans) were accordingly regulated. Interestingly, all quantified proteins from Prevotella intermedia were up-regulated, and most quantified proteins from Campylobacter rectus, Streptococcus anginosus, and Porphyromonas gingivalis were down-regulated in presence of A. actinomycetemcomitans. Enrichment of Gene Ontology pathway analysis showed that the regulated groups of proteins were responsible primarily for changes in the metabolic rate, the ferric iron-binding, and the 5S RNA binding capacities, on the universal biofilm level. While the presence of A. actinomycetemcomitans did not affect the numeric composition or absolute protein numbers of the other biofilm species, it caused qualitative changes in their overall protein expression profile. These molecular shifts within the biofilm warrant further investigation on their potential impact on its virulence properties, and association with periodontal pathogenesis.	[Bao, Kai; Bostanci, Nagihan] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Translat Res, Zurich, Switzerland; [Selevsek, Nathalie] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Thurnheer, Thomas; Belibasakis, Georgios N.] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Microbiol & Immunol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich	Belibasakis, GN (corresponding author), Univ Zurich, Ctr Dent Med, Inst Oral Biol, Oral Microbiol & Immunol, Zurich, Switzerland.	George.Belibasakis@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020; Bostanci, Nagihan/ABD-5524-2020; Bao, Kai/S-4223-2017	Belibasakis, Georgios/0000-0002-8164-0653; Bostanci, Nagihan/0000-0002-6742-3556; Bao, Kai/0000-0002-1183-5607; Thurnheer, Thomas/0000-0002-8615-8209				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Ammann TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083090; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Bachtiar EW, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00094; Bao K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0258-7; Belibasakis GN, 2014, MOL ORAL MICROBIOL, V29, P174, DOI 10.1111/omi.12053; Belibasakis GN, 2014, J PERIODONTOL, V85, P204, DOI 10.1902/jop.2013.130144; Belibasakis GN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081581; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; Comas I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-147; Daep CA, 2011, INFECT IMMUN, V79, P67, DOI 10.1128/IAI.00361-10; Dahlen G, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23977; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; GMUR R, 1983, INFECT IMMUN, V42, P459; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2015, VIRULENCE; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Haraguchi A, 2014, MOL ORAL MICROBIOL, V29, P131, DOI 10.1111/omi.12051; Haubek D, 2008, LANCET, V371, P237, DOI 10.1016/S0140-6736(08)60135-X; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Hendrickson EL, 2014, MICROBIOLOGYOPEN, V3, P729, DOI 10.1002/mbo3.204; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Hendrickson EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-185; Kachlany SC, 2010, J DENT RES, V89, P561, DOI 10.1177/0022034510363682; Kesavalu L, 2007, INFECT IMMUN, V75, P1704, DOI 10.1128/IAI.00733-06; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lamont RJ, 2014, TRENDS MOL MED; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Lundberg KC, 2015, MOL CELL PROTEOMICS, V14, P109, DOI 10.1074/mcp.M114.042242; Mahajan A, 2013, SCI WORLD J, DOI 10.1155/2013/765434; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Orth RKH, 2011, MOL ORAL MICROBIOL, V26, P229, DOI 10.1111/j.2041-1014.2011.00612.x; Pereira CS, 2012, MOL MICROBIOL, V84, P93, DOI 10.1111/j.1365-2958.2012.08010.x; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Raja M, 2014, J CLIN DIAGN RES, V8, pZE13, DOI 10.7860/JCDR/2014/9845.4766; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Reddi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043899; Rhodes ER, 2007, BIOMETALS, V20, P365, DOI 10.1007/s10534-006-9058-3; Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x; Roberts AP, 2006, PERIODONTOL 2000, V42, P36, DOI 10.1111/j.1600-0757.2006.00149.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Settem RP, 2012, INFECT IMMUN, V80, P2436, DOI 10.1128/IAI.06276-11; Shao HJ, 2007, J BACTERIOL, V189, P5559, DOI 10.1128/JB.00387-07; Sharma A, 2005, ORAL MICROBIOL IMMUN, V20, P39, DOI 10.1111/j.1399-302X.2004.00175.x; Shen YY, 2015, J PROTEOMICS, V112, P274, DOI 10.1016/j.jprot.2014.10.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takasaki K, 2013, J PERIODONTAL RES, V48, P286, DOI 10.1111/jre.12006; Thurnheer T, 2014, INTEGRATION NONORAL; Tsaousoglou P, 2014, J MED MICROBIOL, V63, P284, DOI 10.1099/jmm.0.065441-0; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu XP, 2001, INFECT IMMUN, V69, P4465, DOI 10.1128/IAI.69.7.4465-4472.2001; Zainal-Abidin Z, 2012, J PROTEOME RES, V11, P4449, DOI 10.1021/pr300201c; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071727; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	71	31	33	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0119222	10.1371/journal.pone.0119222	http://dx.doi.org/10.1371/journal.pone.0119222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756960	gold, Green Published, Green Accepted			2022-12-26	WOS:000351275700041
J	Mischiati, C; Ura, B; Roncoroni, L; Elli, L; Cervellati, C; Squerzanti, M; Conte, D; Doneda, L; de Laureto, PP; de Franceschi, G; Calza, R; Barrero, CA; Merali, S; Ferrari, C; Bergamini, CM; Agostinelli, E				Mischiati, Carlo; Ura, Blendi; Roncoroni, Leda; Elli, Luca; Cervellati, Carlo; Squerzanti, Monica; Conte, Dario; Doneda, Luisa; de laureto, Patrizia Polverino; de Franceschi, Giorgia; Calza, Roberta; Barrero, Carlos A.; Merali, Salim; Ferrari, Carlo; Bergamini, Carlo M.; Agostinelli, Enzo			Changes in Protein Expression in Two Cholangiocarcinoma Cell Lines Undergoing Formation of Multicellular Tumor Spheroids In Vitro	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TISSUE TRANSGLUTAMINASE; MECHANICAL STRAIN; INITIATING CELLS; CANCER CELLS; STEM-CELLS; IDENTIFICATION; HEAD; METASTASIS	Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates with worsening disease progression due to its implications in metastases and resistance to therapeutic interventions. Although EMT is known to occur in several types of solid tumors, the information concerning tumors arising from the epithelia of the bile tract is still limited. In order to approach the problem of EMT in cholangiocarcinoma, we decided to investigate the changes in protein expression occurring in two cell lines under conditions leading to growth as adherent monolayers or to formation of multicellular tumor spheroids (MCTS), which are considered culture models that better mimic the growth characteristics of in-vivo solid tumors. In our system, changes in phenotypes occur with only a decrease in transmembrane E-cadherin and vimentin expression, minor changes in the transglutaminase protein/activity but with significant differences in the proteome profiles, with declining and increasing expression in 6 and in 16 proteins identified by mass spectrometry. The arising protein patterns were analyzed based on canonical pathways and network analysis. These results suggest that significant metabolic rearrangements occur during the conversion of cholangiocarcinomas cells to the MCTS phenotype, which most likely affect the carbohydrate metabolism, protein folding, cytoskeletal activity, and tissue sensitivity to oxygen.	[Mischiati, Carlo; Cervellati, Carlo; Squerzanti, Monica; Calza, Roberta; Bergamini, Carlo M.] Univ Ferrara, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy; [Ura, Blendi] Univ Trieste, IRCCS Burlo Garofalo, Inst Maternal & Child Hlth, Trieste, Italy; [Roncoroni, Leda; Elli, Luca; Conte, Dario] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Prevent & Diag Coeliac Disease Gastroenterol, Milan, Italy; [Roncoroni, Leda; Doneda, Luisa] Univ Milan, Dept Biomed Surg & Odontoiatr Sci, Milan, Italy; [de laureto, Patrizia Polverino; de Franceschi, Giorgia] Univ Padua, CRIBI Ctr Innovat Biotechnol, Padua, Italy; [Barrero, Carlos A.; Merali, Salim] Temple Univ, Sch Pharm, Moulder Ctr Drug Discovery Res, Philadelphia, PA 19122 USA; [Ferrari, Carlo] Le Marche Polytech Univ, Fac Med, Dept Clin & Mol Sci, Ancona, Italy; [Agostinelli, Enzo] Univ Roma La Sapienza, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Agostinelli, Enzo] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, I-00185 Rome, Italy; [Agostinelli, Enzo] CNR, Inst Biol, Rome, Italy; [Agostinelli, Enzo] Inst Mol Pathol, Rome, Italy	University of Ferrara; IRCCS Burlo Garofolo; University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Marche Polytechnic University; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR)	Bergamini, CM (corresponding author), Univ Ferrara, Dept Biomed & Surg Sci, I-44100 Ferrara, Italy.	bgc@unife.it	Cervellati, Carlo/K-6453-2015; Elli, Luca/K-6084-2016; Ferrari, Carlo/D-5663-2017; Mischiati, Carlo/AAF-2016-2020; Carlo, Bergamini/K-5664-2016	Cervellati, Carlo/0000-0003-4777-6300; Elli, Luca/0000-0002-0873-0759; Ferrari, Carlo/0000-0002-5461-6842; Carlo, Bergamini/0000-0002-9430-8625; Mischiati, Carlo/0000-0002-0029-2205; Barrero, Carlos/0000-0001-5779-6642; URA, BLENDI/0000-0003-2669-439X	University of Ferrara; San Marco Bioenergie, Bando d'Argenta, FE; Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); Istituto Superiore di Sanita "Project Italy-USA"; Istituto Pasteur Fondazione Cenci Bolognetti	University of Ferrara; San Marco Bioenergie, Bando d'Argenta, FE; Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); Istituto Superiore di Sanita "Project Italy-USA"; Istituto Pasteur Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This research was financially supported by grants from University of Ferrara (to CMB) and from San Marco Bioenergie, Bando d'Argenta, FE (to CM). Further, it was funded by the Italian MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca), by Istituto Superiore di Sanita "Project Italy-USA" and by Istituto Pasteur Fondazione Cenci Bolognetti (to EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Bastid J, 2012, CANCER METAST REV, V31, P277, DOI 10.1007/s10555-011-9344-6; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bergamini Carlo M, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P1; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budillon A, 2013, AMINO ACIDS, V44, P63, DOI 10.1007/s00726-011-1167-9; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CARBONEL.J, 1973, EUR J BIOCHEM, V37, P148, DOI 10.1111/j.1432-1033.1973.tb02969.x; Carcoforo P, 2013, MOL MED REP, V7, P1700, DOI 10.3892/mmr.2013.1375; Gallardo-Perez JC, 2014, BBA-MOL CELL RES, V1843, P1043, DOI 10.1016/j.bbamcr.2014.01.013; Cervellati C, 2012, AMINO ACIDS, V42, P2233, DOI 10.1007/s00726-011-0963-6; Chu K, 2013, ONCOTARGET, V4, P446, DOI 10.18632/oncotarget.872; Cleland W. W., 1969, METHOD ENZYMOL, V13, P30, DOI 10.1016/0076-6879(69)13011-6; Dupourque D, 1969, CYTOPLASMIC MITOCHON, V13, P116; Gao DC, 2012, CANCER RES, V72, P4883, DOI 10.1158/0008-5472.CAN-12-1223; Girard YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075345; Grassian AR, 2014, CURR OPIN GASTROEN, V30, P295, DOI 10.1097/MOG.0000000000000050; Gu MJ, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201806; Huang SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077497; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jung HJ, 2012, BLOOD, V119, P2568, DOI 10.1182/blood-2011-09-377598; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai TS, 2007, FASEB J, V21, P4131, DOI 10.1096/fj.06-7598com; Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3; Mathias RA, 2009, BBA-PROTEINS PROTEOM, V1794, P1325, DOI 10.1016/j.bbapap.2009.05.001; McMahon KM, 2012, J PROTEOME RES, V11, P2863, DOI 10.1021/pr2012472; Nijkamp MM, 2011, RADIOTHER ONCOL, V99, P344, DOI 10.1016/j.radonc.2011.05.066; Okamoto K, 2012, INT J ONCOL, V41, P573, DOI 10.3892/ijo.2012.1499; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Prensner JR, 2011, NAT MED, V17, P291, DOI 10.1038/nm0311-291; Razumilava N, 2014, LANCET, V383, P2168, DOI 10.1016/S0140-6736(13)61903-0; RICHARDS OC, 1961, J BIOL CHEM, V236, P3185; Rodriguez FJ, 2012, BBA-REV CANCER, V1826, P23, DOI 10.1016/j.bbcan.2012.03.002; Roncoroni L, 2008, LIVER INT, V28, P1426, DOI 10.1111/j.1478-3231.2008.01749.x; Sanchez-Tillo E, 2012, CELL MOL LIFE SCI, V69, P3429, DOI 10.1007/s00018-012-1122-2; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Smith A, 2013, ORAL ONCOL, V49, P287, DOI 10.1016/j.oraloncology.2012.10.009; Techasen A, 2012, ASIAN PAC J CANCER P, V13, P115, DOI 10.7314/APJCP.2012.13.KKSuppl.115; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Yao XL, 2014, EUR REV MED PHARMACO, V18, P3149; Yao X, 2014, BIOCHEM BIOPH RES CO, V455, P277, DOI 10.1016/j.bbrc.2014.11.007; Yonglitthipagon P, 2012, CLIN BIOCHEM, V45, P827, DOI 10.1016/j.clinbiochem.2012.04.004; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	54	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2015	10	3							e0118906	10.1371/journal.pone.0118906	http://dx.doi.org/10.1371/journal.pone.0118906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7MX	25756965	Green Published, gold, Green Submitted			2022-12-26	WOS:000351275700031
J	Abebe, AS; Mikko, S; Johansson, AM				Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.			Genetic Diversity of Five Local Swedish Chicken Breeds Detected by Microsatellite Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; MANAGEMENT; SOFTWARE; CLUSTERS; DISTANCE; NUMBER	This study aimed at investigating the genetic diversity, relationship and population structure of 110 local Swedish chickens derived from five breeds (Gotlandshona, Hedemorahona, Olandsk dvarghona, Skansk blommehona, and Bohuslan-Dals svarthona, in the rest of the paper the shorter name Svarthona is used) using 24 microsatellite markers. In total, one hundred thirteen alleles were detected in all populations, with a mean of 4.7 alleles per locus. For the five chicken breeds, the observed and expected heterozygosity ranged from 0.225 to 0.408 and from 0.231 to 0.515, with the lowest scores for the Svarthona and the highest scores for the Skansk blommehona breeds, respectively. Similarly, the average within breed molecular kinship varied from 0.496 to 0.745, showing high coancestry, with Skansk blommehona having the lowest and Svarthona the highest coancestry. Furthermore, all breeds showed significant deviations from Hardy-Weinberg expectations. Across the five breeds, the global heterozygosity deficit (FIT) was 0.545, population differentiation index (F-ST) was 0.440, and the global inbreeding of individuals within breed (F-IS) was 0.187. The phylogenetic relationships of chickens were examined using neighbor-joining trees constructed at the level of breeds and individual samples. The neighbor-joining tree constructed at breed level revealed two main clusters, with Hedemorahona and Olandsk dvarghona breeds in one cluster, and Gotlandshona and Svarthona breeds in the second cluster leaving the Skansk blommehona in the middle. Based on the results of the STRUCTURE analysis, the most likely number of clustering of the five breeds was at K = 4, with Hedemorahona, Gotlandshona and Svarthona breeds forming their own distinct clusters, while Olandsk dvarghona and Skansk blommehona breeds clustered together. Losses in the overall genetic diversity of local Swedish chickens due to breeds extinction varied from -1.46% to -6.723%. The results of the current study can be used as baseline genetic information for genetic conservation program, for instance, to control inbreeding and to implement further genetic studies in local Swedish chickens.	[Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences	Johansson, AM (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Anna.Johansson@slu.se	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AMJ received funding for the collection of blood samples and genotyping from the Erik PhilipSorensen foundation (www.epss.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cuc NTK, 2010, ANIM GENET, V41, P545, DOI 10.1111/j.1365-2052.2010.02039.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Englund T, 2014, HEREDITAS, V151, P229, DOI 10.1111/hrd2.00064; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Muchadeyi FC, 2007, ANIM GENET, V38, P332, DOI 10.1111/j.1365-2052.2007.01606.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U., 2007, Indian Journal of Animal Sciences, V77, P1194; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tadano R, 2008, ANIM GENET, V39, P71, DOI 10.1111/j.1365-2052.2007.01690.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	40	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120580	10.1371/journal.pone.0120580	http://dx.doi.org/10.1371/journal.pone.0120580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855978	gold, Green Published, Green Submitted			2022-12-26	WOS:000352588500013
J	Rana, Y; Haberer, J; Huang, HJ; Kambugu, A; Mukasa, B; Thirumurthy, H; Wabukala, P; Wagner, GJ; Linnemayr, S				Rana, Yashodhara; Haberer, Jessica; Huang, Haijing; Kambugu, Andrew; Mukasa, Barbara; Thirumurthy, Harsha; Wabukala, Peter; Wagner, Glenn J.; Linnemayr, Sebastian			Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; ADOLESCENTS; INFORMATION; MOTIVATION	This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work. We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda. We find that youth commonly use SMS as over 90% of this study's youths knew how to read, write and send messages and almost three-fourths of them had phones. Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status. Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth. Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support. Youths' suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.	[Rana, Yashodhara; Huang, Haijing; Wagner, Glenn J.; Linnemayr, Sebastian] RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA; [Haberer, Jessica] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Mukasa, Barbara; Wabukala, Peter] Mildmay Uganda, Kampala, Uganda; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	RAND Corporation; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill	Rana, Y (corresponding author), RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA.	yrana@rand.org	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	National Institute of Child Health and Human Development [R01HD074925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by Grant R01HD074925 from The National Institute of Child Health and Human Development (PI Sebastian Linnemayr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; [Anonymous], PUTT YOUNG PEOPL CTR; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gray WN, 2011, J HEALTH PSYCHOL, V16, P828, DOI 10.1177/1359105310394230; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kitara D L, 2012, Afr J Infect Dis, V6, P12; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thaler R.H., 2021, NUDGE FINAL EDITION	25	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125187	10.1371/journal.pone.0125187	http://dx.doi.org/10.1371/journal.pone.0125187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25855978	Green Submitted, Green Published, gold			2022-12-26	WOS:000353016500115
J	Lodwick, RK; Nakagawa, F; van Sighem, A; Sabin, CA; Phillips, AN				Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N.			Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; PREVALENCE; INFECTION; DISEASE; SIZE	Background It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead to presentation for care, and hence diagnosis of HIV, arises in undiagnosed people with a given CD4 count. The method requires surveillance data on numbers of new HIV diagnoses with HIV-related symptoms, and the CD4 count at diagnosis. The CD4 count-specific rate at which HIV-related symptoms develop are estimated from cohort data. 95% confidence intervals can be constructed using a simple simulation method. Results For example, if there were 13 HIV diagnoses with HIV-related symptoms made in one year with CD4 count at diagnosis between 150-199 cells/mm(3), then since the CD4 count-specific rate of HIV-related symptoms is estimated as 0.216 per person-year, the estimated number of person years lived in people with undiagnosed HIV with CD4 count 150-199 cells/mm3 is 13/0.216 = 60 (95% confidence interval: 29-100), which is considered an estimate of the number of people living with undiagnosed HIV in this CD4 count stratum. Conclusions The method is straightforward to implement within a short period once a surveillance system of all new HIV diagnoses, collecting data on HIV-related symptoms at diagnosis, is in place and is most suitable for estimating the number of undiagnosed people with CD4 count <200 cells/mm3 due to the low rate of developing HIV-related symptoms at higher CD4 counts. A potential source of bias is under-diagnosis and under-reporting of diagnoses with HIV-related symptoms. Although this method has limitations as with all approaches, it is important for prompting increased efforts to identify undiagnosed people, particularly those with low CD4 count, and for informing levels of unmet need for ART.	[Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Nakagawa, Fumiyo; Sabin, Caroline A.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands	University of London; University College London; University of London; University College London	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	HIV in Europe; European Centre for Disease Prevention and Control (ECDC) [FWC/ECDC/012/050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	HIV in Europe; European Centre for Disease Prevention and Control (ECDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: The authors acknowledge funding from HIV in Europe and European Centre for Disease Prevention and Control (ECDC) framework contract FWC/ECDC/012/050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR-MORBID MORTAL W, V41; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; British HIV Association Audit & Standards Sub-Committee, 2010 11 SURV HIV TES; BROOKMEYER R, 1986, LANCET, V2, P1320; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; European AIDS Clinical Society, 2011, EACS GUID VERS 6 1; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Porter K., 2011, COMMUNICATION; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; Sweeting MJ, 2005, STAT MED, V24, P3991, DOI 10.1002/sim.2432; Van Sighem A, 2014, C RETR OPP INF CROI; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Working Group on Estimation of HIV Prevalence in Europe, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087	22	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121992	10.1371/journal.pone.0121992	http://dx.doi.org/10.1371/journal.pone.0121992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25855978	Green Published, gold			2022-12-26	WOS:000351277500146
